data_2m6r_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m6r _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 113.521 0.934 . . . . 1.0 113.521 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -123.46 123.74 41.33 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.991 1.316 . . . . 1.0 110.48 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 mp -117.11 115.6 49.38 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.065 0 C-N-CA 126.168 1.787 . . . . 1.0 112.845 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.48 119.48 5.61 Favored Glycine 0 C--O 1.224 -0.519 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 169.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.6 mt -103.25 120.97 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 118.04 0.92 . . . . 1.0 109.171 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -118.39 115.99 25.81 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.153 -1.054 . . . . 1.0 108.153 -171.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.473 0.685 0 C-N-CA 122.833 0.453 . . . . 1.0 112.109 -170.602 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.5 tp . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 115.123 1.527 . . . . 1.0 115.123 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.5 t -54.77 -32.5 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.667 0.787 . . . . 1.0 112.529 -169.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.92 -48.81 78.81 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.852 -1.155 . . . . 1.0 113.461 172.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -69.15 -30.38 68.6 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.545 0.738 . . . . 1.0 110.969 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.73 -47.91 70.83 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.537 0.735 . . . . 1.0 109.237 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.432 ' HA ' HG12 ' A' ' 141' ' ' VAL . . . -64.96 -43.35 92.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 112.559 0.577 . . . . 1.0 112.559 -175.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -53.54 -48.69 68.86 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.051 0.94 . . . . 1.0 110.455 170.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.17 -37.84 69.24 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.495 0.718 . . . . 1.0 112.697 -174.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.7 mt -65.55 -46.65 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 CA-C-N 119.288 0.949 . . . . 1.0 109.141 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -35.48 80.22 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 119.442 -0.903 . . . . 1.0 110.276 -176.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.6 m -62.34 -41.19 98.38 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.21 1.404 . . . . 1.0 113.57 170.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.94 -33.81 75.4 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.397 1.079 . . . . 1.0 111.9 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -71.59 -29.01 64.21 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.749 1.22 . . . . 1.0 112.806 172.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.44 25.92 2.54 Favored Glycine 0 N--CA 1.468 0.812 0 C-N-CA 124.378 0.989 . . . . 1.0 114.323 169.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -114.11 146.19 40.61 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.536 1.134 . . . . 1.0 109.574 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -84.1 83.27 8.02 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.859 1.263 . . . . 1.0 108.729 -173.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.91 146.65 26.41 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.301 0.641 . . . . 1.0 111.13 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.8 m -146.98 137.95 23.89 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.696 0.799 . . . . 1.0 112.772 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.3 t -84.35 136.76 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 115.109 1.522 . . . . 1.0 115.109 171.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -115.75 117.6 30.69 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.871 2.069 . . . . 1.0 110.595 169.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -93.12 147.93 22.44 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.287 1.835 . . . . 1.0 110.717 173.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 41.84 61.07 8.57 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 125.125 1.37 . . . . 1.0 112.022 -169.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -48.79 123.87 10.3 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.406 3.404 . . . . 1.0 119.883 -168.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -94.28 146.62 23.9 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.907 1.283 . . . . 1.0 111.285 168.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -71.09 -25.01 62.42 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 121.447 -0.783 . . . . 1.0 110.141 169.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.7 m -67.15 -19.02 65.53 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.493 -0.754 . . . . 1.0 112.609 170.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -91.7 -21.9 20.5 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.587 1.155 . . . . 1.0 113.443 169.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -79.54 -35.02 40.56 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 120.028 1.286 . . . . 1.0 113.36 172.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.1 mt -50.86 -39.54 55.29 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 117.622 -1.18 . . . . 1.0 113.884 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -52.55 -16.62 5.62 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 124.432 3.421 . . . . 1.0 117.495 171.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -107.85 8.61 28.74 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.982 1.845 . . . . 1.0 115.982 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -52.7 -31.12 35.83 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.224 1.81 . . . . 1.0 113.749 173.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -112.66 13.35 19.9 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.102 1.361 . . . . 1.0 112.389 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -126.97 -158.3 0.86 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.613 2.365 . . . . 1.0 111.214 -174.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -114.14 162.81 16.04 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 122.947 1.356 . . . . 1.0 111.833 172.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.71 156.99 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.329 1.452 . . . . 1.0 109.007 -171.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.0 tp -137.38 129.3 28.96 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.813 1.245 . . . . 1.0 109.117 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.6 t -106.03 122.17 59.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.216 -0.661 . . . . 1.0 109.216 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.1 t -120.11 111.31 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 106.871 -1.529 . . . . 1.0 106.871 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 114.217 1.191 . . . . 1.0 114.217 -168.341 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.1 tt . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 114.236 1.198 . . . . 1.0 114.236 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -43.33 -53.07 11.89 Favored Pre-proline 0 N--CA 1.478 0.948 0 C-N-CA 124.643 1.177 . . . . 1.0 112.604 168.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.83 -31.71 19.67 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 121.576 1.517 . . . . 1.0 111.774 -172.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.4 tp -63.47 -51.26 66.39 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.333 1.053 . . . . 1.0 111.419 169.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -56.31 -52.46 64.45 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.121 0.968 . . . . 1.0 112.364 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -63.2 -39.41 94.56 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.787 0.835 . . . . 1.0 111.443 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.72 -36.84 92.83 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.064 0.84 . . . . 1.0 112.728 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 86.4 mt -65.37 -51.18 67.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 119.949 1.875 . . . . 1.0 107.976 172.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.4 ptmm? -69.25 -31.14 69.49 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 120.39 -1.444 . . . . 1.0 113.564 -169.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -103.43 -38.0 7.37 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.777 1.631 . . . . 1.0 115.279 -176.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.6 m -95.57 -20.88 18.63 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.468 1.107 . . . . 1.0 113.229 -175.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.67 -71.94 0.61 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 106.872 -1.529 . . . . 1.0 106.872 169.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.98 -18.92 1.06 Allowed Glycine 0 CA--C 1.539 1.58 0 C-N-CA 127.644 2.545 . . . . 1.0 115.265 169.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -151.87 138.99 19.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 128.386 2.674 . . . . 1.0 107.896 169.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -137.75 121.78 11.85 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 118.664 -0.684 . . . . 1.0 109.637 -171.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.72 -35.77 0.28 Allowed 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.422 2.081 . . . . 1.0 115.39 -169.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -141.68 15.51 2.15 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.292 1.219 . . . . 1.0 114.292 -169.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 64.9 tp -80.79 139.93 35.77 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 120.563 -1.336 . . . . 1.0 113.027 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -137.12 154.74 50.21 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.66 2.384 . . . . 1.0 109.032 169.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -161.02 163.85 31.35 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.244 0.929 . . . . 1.0 112.217 -176.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.65 172.22 16.27 Favored Glycine 0 N--CA 1.467 0.703 0 C-N-CA 125.707 1.622 . . . . 1.0 112.109 169.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -160.52 145.56 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 O-C-N 121.161 -1.199 . . . . 1.0 114.086 -169.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.6 mt -134.76 100.26 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 127.794 2.438 . . . . 1.0 106.942 -175.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.27 146.17 24.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.267 1.427 . . . . 1.0 111.581 173.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.6 mp -140.09 156.45 46.57 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.453 0.701 . . . . 1.0 112.269 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.496 0 CA-C-N 116.208 -0.451 . . . . 1.0 112.499 169.438 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.545 0.772 0 N-CA-C 113.191 0.812 . . . . 1.0 113.191 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -53.01 -25.51 12.47 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.082 1.353 . . . . 1.0 114.37 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.87 -43.47 60.88 Favored Glycine 0 CA--C 1.538 1.519 0 CA-C-N 121.522 1.965 . . . . 1.0 114.878 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -80.12 -33.5 32.51 Favored Glycine 0 N--CA 1.481 1.691 0 O-C-N 120.711 -1.464 . . . . 1.0 113.768 173.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -62.41 -33.41 74.72 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 121.366 -1.079 . . . . 1.0 112.672 174.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 40.7 mm-40 -60.63 -42.57 97.16 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.891 0.876 . . . . 1.0 111.163 169.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -64.05 -36.82 85.25 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.566 -0.709 . . . . 1.0 111.998 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -62.42 -49.62 74.74 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.405 -0.81 . . . . 1.0 112.498 173.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.34 -35.73 67.97 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.503 0.556 . . . . 1.0 112.503 174.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.04 -51.3 70.25 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 123.113 1.435 . . . . 1.0 110.926 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 mt -65.74 -38.84 90.21 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 121.033 -1.042 . . . . 1.0 111.64 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -70.51 -18.92 62.95 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.344 0.868 . . . . 1.0 113.344 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.83 -19.01 58.03 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.298 0.954 . . . . 1.0 110.869 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -99.86 -76.8 0.54 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.886 1.274 . . . . 1.0 110.953 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.9 m -178.17 -2.88 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.587 1.955 . . . . 1.0 112.818 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.95 162.47 26.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 122.31 1.052 . . . . 1.0 113.304 -169.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -102.53 174.58 5.84 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.817 1.647 . . . . 1.0 113.221 -168.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.6 153.3 42.4 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.159 2.184 . . . . 1.0 112.433 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.5 t -126.78 127.66 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 126.206 1.802 . . . . 1.0 108.46 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 49.21 -156.52 1.53 Allowed Glycine 0 N--CA 1.48 1.615 0 C-N-CA 125.032 1.301 . . . . 1.0 114.615 -169.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -118.22 144.82 45.46 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.856 1.662 . . . . 1.0 109.803 169.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -71.91 155.39 40.43 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.224 1.012 . . . . 1.0 113.063 -169.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.45 ' HB2' ' CD1' ' A' ' 140' ' ' TRP . 1.1 tm? -84.18 139.62 32.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.048 -0.978 . . . . 1.0 109.815 170.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.5 mt -127.38 110.15 12.5 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.363 1.465 . . . . 1.0 110.098 173.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 24.4 mt -98.56 129.86 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.092 0.957 . . . . 1.0 112.749 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -103.75 110.92 23.2 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 122.278 1.037 . . . . 1.0 112.55 171.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.21 -22.44 64.8 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.623 1.169 . . . . 1.0 113.379 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.0 t -65.13 -21.99 66.87 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.897 0.879 . . . . 1.0 112.795 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -119.25 -30.5 4.92 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.162 1.785 . . . . 1.0 111.98 -174.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -142.34 85.95 10.32 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.073 1.349 . . . . 1.0 111.975 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.79 7.84 2.22 Favored 'Trans proline' 0 CA--C 1.551 1.333 0 C-N-CA 123.625 2.883 . . . . 1.0 114.419 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -113.79 69.56 1.63 Allowed Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 127.432 2.293 . . . . 1.0 109.909 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -56.6 -24.45 54.06 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.667 2.245 . . . . 1.0 116.304 -169.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.8 pm0 -66.08 -24.43 66.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 119.385 0.993 . . . . 1.0 111.725 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 15.1 p -73.78 -15.53 61.19 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.661 -1.274 . . . . 1.0 112.27 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -105.02 -55.44 2.33 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.296 1.838 . . . . 1.0 111.482 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 65.7 p -69.29 -33.88 73.87 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 113.938 1.088 . . . . 1.0 113.938 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -60.57 -57.45 26.44 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 120.801 1.637 . . . . 1.0 112.485 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -62.96 -23.35 74.13 Favored 'Trans proline' 0 C--N 1.354 0.832 0 CA-C-N 121.386 1.531 . . . . 1.0 112.449 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.45 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 86.8 t90 -67.12 -46.82 72.98 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 119.258 0.936 . . . . 1.0 110.749 173.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.432 HG12 ' HA ' ' A' ' 22' ' ' ALA . 96.1 t -63.4 -33.83 63.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 108.922 -0.77 . . . . 1.0 108.922 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.76 -28.35 65.7 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.823 1.249 . . . . 1.0 113.132 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -81.83 -56.96 3.65 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.169 1.388 . . . . 1.0 112.073 169.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 85.1 t90 -57.14 -36.93 71.3 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 125.498 1.519 . . . . 1.0 112.727 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.83 -33.01 34.65 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.766 1.174 . . . . 1.0 113.765 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.8 p -65.79 -13.99 60.5 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.576 1.325 . . . . 1.0 114.576 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.27 -16.78 53.93 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.008 1.723 . . . . 1.0 112.005 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.17 -176.98 5.89 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.174 1.39 . . . . 1.0 110.754 -176.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 31.9 m . . . . . 0 C--O 1.253 1.277 0 C-N-CA 125.624 1.57 . . . . 1.0 115.01 -172.045 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.403 0 N-CA-C 112.678 0.622 . . . . 1.0 112.678 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -120.67 124.42 45.18 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.664 1.586 . . . . 1.0 110.466 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 mp -123.14 113.47 37.95 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.071 0 C-N-CA 125.963 1.705 . . . . 1.0 112.664 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.8 123.64 7.18 Favored Glycine 0 C--O 1.224 -0.523 0 N-CA-C 110.551 -1.019 . . . . 1.0 110.551 169.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.4 mt -105.15 122.23 58.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 118.184 0.992 . . . . 1.0 109.459 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -114.16 108.75 17.39 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 124.869 1.268 . . . . 1.0 108.277 -169.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.533 0.307 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.037 -173.284 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.4 tp . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 115.265 1.58 . . . . 1.0 115.265 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.2 t -53.65 -35.29 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.913 1.685 . . . . 1.0 112.47 -175.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.21 -45.79 87.02 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.858 -1.151 . . . . 1.0 112.487 174.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.83 -31.08 68.77 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.586 1.154 . . . . 1.0 110.759 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -66.56 -48.23 70.3 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.239 0.616 . . . . 1.0 109.341 170.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.425 ' HA ' HG13 ' A' ' 141' ' ' VAL . . . -65.41 -42.9 92.05 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 112.823 0.675 . . . . 1.0 112.823 -173.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -54.01 -49.24 69.31 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 123.717 0.807 . . . . 1.0 110.409 169.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.99 -37.0 69.92 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.285 0.634 . . . . 1.0 112.491 -174.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.4 mt -66.41 -46.96 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 119.015 0.825 . . . . 1.0 109.191 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.52 -34.65 77.54 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 119.57 -0.852 . . . . 1.0 110.613 -176.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.6 m -62.58 -40.07 95.71 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.226 1.41 . . . . 1.0 113.484 170.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.87 -32.72 72.58 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.177 0.991 . . . . 1.0 112.066 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -70.6 -29.77 66.26 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.597 1.159 . . . . 1.0 113.059 170.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.91 23.05 3.12 Favored Glycine 0 N--CA 1.47 0.95 0 C-N-CA 124.516 1.055 . . . . 1.0 114.585 169.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -109.61 151.99 26.11 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.363 1.065 . . . . 1.0 109.652 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.3 tptt -85.39 85.55 7.43 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.756 1.223 . . . . 1.0 108.665 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.3 145.44 28.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.68 -0.691 . . . . 1.0 111.11 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.2 m -147.3 139.02 24.13 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.843 0.857 . . . . 1.0 112.341 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.1 t -86.78 136.08 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 115.022 1.49 . . . . 1.0 115.022 171.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -113.43 113.5 25.27 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.331 1.852 . . . . 1.0 110.017 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -93.56 138.24 32.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.131 1.772 . . . . 1.0 110.848 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 42.39 55.06 9.8 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 124.498 1.119 . . . . 1.0 111.309 -169.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -67.84 140.09 49.66 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.699 2.933 . . . . 1.0 117.089 -168.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.448 ' HB3' ' H ' ' A' ' 42' ' ' SER . 48.6 mm-40 -93.64 163.46 13.54 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 122.466 1.127 . . . . 1.0 111.986 168.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.76 -22.61 66.04 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 121.074 -1.016 . . . . 1.0 110.738 167.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.448 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 68.2 p -68.57 -18.44 64.34 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.959 1.254 . . . . 1.0 112.386 171.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -82.67 -25.22 33.24 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.174 0.99 . . . . 1.0 112.276 169.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.1 t-105 -89.38 -33.81 16.73 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.175 1.176 . . . . 1.0 114.175 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.6 mt -48.2 -38.67 22.38 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 117.549 -1.215 . . . . 1.0 114.046 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.2 -6.92 7.24 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 124.053 3.169 . . . . 1.0 116.863 175.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -114.76 6.17 15.48 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 116.126 1.899 . . . . 1.0 116.126 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -50.25 -29.44 9.56 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.562 1.945 . . . . 1.0 113.824 171.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -105.53 7.92 33.14 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 128.144 2.578 . . . . 1.0 113.156 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -132.78 -161.36 1.13 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.933 2.093 . . . . 1.0 112.728 -168.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -110.59 157.48 19.62 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 123.191 1.472 . . . . 1.0 111.042 171.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.81 155.63 14.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 124.941 1.297 . . . . 1.0 108.285 -172.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.6 tp -134.98 127.74 31.09 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 124.568 1.147 . . . . 1.0 108.642 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.8 t -102.8 124.21 56.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.338 -0.616 . . . . 1.0 109.338 175.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.7 t -124.64 108.72 20.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 106.493 -1.669 . . . . 1.0 106.493 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 113.923 1.083 . . . . 1.0 113.923 -167.99 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.7 tt . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 113.818 1.044 . . . . 1.0 113.818 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.1 t -45.77 -53.5 20.06 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.432 1.093 . . . . 1.0 112.52 168.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -67.98 -33.66 25.41 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.531 1.487 . . . . 1.0 111.537 -173.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.4 tp -61.2 -53.03 62.1 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 124.586 1.154 . . . . 1.0 111.287 170.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -54.3 -53.49 53.1 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.128 0.971 . . . . 1.0 112.25 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -64.02 -40.5 96.47 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.792 0.837 . . . . 1.0 111.531 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.11 -35.93 89.6 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.563 0.601 . . . . 1.0 112.642 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.8 mt -64.82 -47.79 87.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 120.173 1.986 . . . . 1.0 108.259 172.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -71.5 -32.58 68.39 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.566 -1.333 . . . . 1.0 113.201 -171.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -105.17 -36.97 7.07 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.161 1.541 . . . . 1.0 115.161 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.9 m -94.05 -24.98 17.39 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.23 1.012 . . . . 1.0 112.84 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.49 -71.59 0.61 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.415 -1.328 . . . . 1.0 107.415 169.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.98 -8.46 2.5 Favored Glycine 0 CA--C 1.543 1.786 0 C-N-CA 126.419 1.962 . . . . 1.0 115.13 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -153.88 146.45 24.12 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 129.851 3.26 . . . . 1.0 106.906 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -136.62 125.37 15.25 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 123.192 0.597 . . . . 1.0 111.099 -176.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.97 -41.85 0.14 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 121.983 1.789 . . . . 1.0 114.314 -171.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -147.84 22.54 1.12 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.829 1.252 . . . . 1.0 113.129 -171.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.0 tp -83.2 137.6 33.96 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.624 -1.298 . . . . 1.0 113.909 -169.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -135.23 153.94 51.75 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 127.821 2.448 . . . . 1.0 108.957 169.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.449 ' CD1' HD11 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -158.07 164.77 36.37 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.316 -0.865 . . . . 1.0 112.302 -177.352 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -124.88 172.26 17.02 Favored Glycine 0 N--CA 1.467 0.766 0 C-N-CA 125.703 1.62 . . . . 1.0 111.978 169.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -159.03 146.45 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 O-C-N 120.875 -1.367 . . . . 1.0 114.44 -169.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.7 mt -133.45 105.64 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 127.308 2.243 . . . . 1.0 107.738 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.91 144.32 26.03 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.416 1.486 . . . . 1.0 110.863 175.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.5 mp -137.93 155.35 49.0 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.652 0.612 . . . . 1.0 112.652 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.598 0 CA-C-N 116.15 -0.477 . . . . 1.0 113.639 169.361 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.406 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 17.4 p . . . . . 0 CA--C 1.541 0.61 0 N-CA-C 113.019 0.748 . . . . 1.0 113.019 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -62.06 -19.04 62.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.257 1.423 . . . . 1.0 114.257 -169.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.34 -52.62 52.12 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-N 120.432 1.469 . . . . 1.0 113.732 174.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.41 -34.98 68.59 Favored Glycine 0 N--CA 1.479 1.51 0 O-C-N 120.807 -1.408 . . . . 1.0 112.995 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.406 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 87.0 mttt -63.41 -35.33 80.05 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.536 1.134 . . . . 1.0 113.137 173.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -64.34 -39.72 94.45 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 119.062 -0.495 . . . . 1.0 111.735 169.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -61.34 -33.49 73.71 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 118.961 0.801 . . . . 1.0 111.843 174.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -66.32 -51.81 53.53 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.571 0.748 . . . . 1.0 111.359 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.76 -35.24 63.56 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.657 0.783 . . . . 1.0 112.863 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.05 -49.91 75.27 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-O 123.3 1.524 . . . . 1.0 110.867 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.449 HD11 ' CD1' ' A' ' 87' ' ' TYR . 12.4 mt -67.27 -37.53 83.6 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 120.907 -1.12 . . . . 1.0 112.117 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -69.12 -20.87 64.05 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.54 -16.43 58.67 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.249 0.931 . . . . 1.0 110.991 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -100.29 -78.51 0.51 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.165 1.386 . . . . 1.0 110.175 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -175.72 -13.58 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.751 -1.568 . . . . 1.0 113.347 -169.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -80.44 163.06 24.1 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.966 1.469 . . . . 1.0 114.966 -168.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -103.76 175.5 5.46 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.046 1.738 . . . . 1.0 112.183 -169.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.02 141.89 48.52 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.232 1.813 . . . . 1.0 110.349 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.447 HG13 ' H ' ' A' ' 120' ' ' GLY 0.257 12.9 t -93.54 -161.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 125.55 1.54 . . . . 1.0 106.85 174.004 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.447 ' H ' HG13 ' A' ' 119' ' ' VAL . . . -49.53 149.49 5.12 Favored Glycine 0 CA--C 1.547 2.066 0 O-C-N 119.775 -1.828 . . . . 1.0 114.589 177.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.11 149.65 40.69 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.973 1.309 . . . . 1.0 112.48 -172.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -70.57 157.05 38.6 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 122.546 1.165 . . . . 1.0 113.759 -169.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.427 ' CD1' HG13 ' A' ' 125' ' ' ILE . 0.9 OUTLIER -87.5 141.43 28.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.309 -1.314 . . . . 1.0 109.795 170.137 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.9 mt -124.33 103.5 8.25 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 125.508 1.523 . . . . 1.0 110.948 175.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.427 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.5 mt -89.61 128.07 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.41 1.484 . . . . 1.0 112.344 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -106.35 108.43 19.94 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.066 0.936 . . . . 1.0 112.139 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.02 -22.57 64.97 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.008 0.923 . . . . 1.0 113.29 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.9 t -65.18 -21.78 66.81 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.379 1.072 . . . . 1.0 112.935 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -119.36 -29.72 5.08 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.061 1.744 . . . . 1.0 112.096 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -143.33 84.89 9.9 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 125.448 1.499 . . . . 1.0 112.048 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.44 7.29 2.29 Favored 'Trans proline' 0 CA--C 1.551 1.333 0 C-N-CA 123.742 2.961 . . . . 1.0 114.45 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -111.74 71.31 0.95 Allowed Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 127.592 2.357 . . . . 1.0 109.966 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -58.69 -20.15 49.38 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.89 2.393 . . . . 1.0 116.747 -169.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -66.16 -27.0 67.68 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 119.596 1.089 . . . . 1.0 111.639 172.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 22.1 p -74.56 -21.67 59.39 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.544 1.065 . . . . 1.0 111.943 -172.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -93.19 -51.29 5.09 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.335 1.454 . . . . 1.0 111.996 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 77.3 p -73.26 -33.64 65.38 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 115.711 1.745 . . . . 1.0 115.711 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -56.22 -58.07 18.78 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 121.003 1.728 . . . . 1.0 111.836 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -62.21 -24.35 76.12 Favored 'Trans proline' 0 C--N 1.352 0.761 0 CA-C-N 121.514 1.577 . . . . 1.0 113.155 175.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.416 ' CD1' HD21 ' A' ' 123' ' ' LEU . 91.2 t90 -68.12 -47.73 67.34 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 118.972 0.805 . . . . 1.0 110.982 174.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 22' ' ' ALA . 86.6 t -64.66 -33.57 64.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 176.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -69.34 -28.97 66.69 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.761 1.225 . . . . 1.0 112.085 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -81.5 -60.44 2.26 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.137 1.775 . . . . 1.0 112.021 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 82.1 t90 -56.0 -36.0 67.42 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 126.2 1.8 . . . . 1.0 112.654 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.59 -32.31 23.89 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.771 1.177 . . . . 1.0 113.764 173.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.2 p -69.45 -12.77 61.93 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.333 1.234 . . . . 1.0 114.333 177.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.57 -16.89 50.22 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.209 1.804 . . . . 1.0 111.862 175.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.25 174.79 11.19 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.378 1.071 . . . . 1.0 111.168 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.251 1.156 0 N-CA-C 115.242 1.571 . . . . 1.0 115.242 -175.068 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.569 0 N-CA-C 112.714 0.635 . . . . 1.0 112.714 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -125.77 122.81 37.29 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.903 1.281 . . . . 1.0 110.254 175.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mp -120.99 116.89 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 126.2 1.8 . . . . 1.0 113.044 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.8 124.34 7.8 Favored Glycine 0 N--CA 1.467 0.758 0 CA-C-O 119.382 -0.677 . . . . 1.0 111.507 169.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 mt -107.37 121.39 60.19 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-N 118.8 1.3 . . . . 1.0 109.743 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -116.71 109.58 17.34 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 124.661 1.185 . . . . 1.0 108.615 -169.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.466 0.33 0 CA-C-N 116.0 -0.545 . . . . 1.0 111.502 -178.062 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 37.0 tp . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 114.765 1.395 . . . . 1.0 114.765 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.4 t -53.97 -37.7 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.807 0.843 . . . . 1.0 112.183 -172.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.27 -38.47 86.87 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.956 -1.09 . . . . 1.0 112.407 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -75.9 -32.41 59.64 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.138 0.575 . . . . 1.0 111.439 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -60.52 -45.49 93.62 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.219 -1.03 . . . . 1.0 108.219 170.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.421 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.46 -40.66 93.46 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 112.624 0.601 . . . . 1.0 112.624 -174.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -57.34 -48.3 79.36 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.193 0.451 . . . . 1.0 109.8 169.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.38 -35.12 75.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 112.89 0.7 . . . . 1.0 112.89 -173.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.9 mt -72.66 -46.44 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 O-C-N 121.321 -0.862 . . . . 1.0 109.346 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.81 -33.36 75.81 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 119.162 -1.015 . . . . 1.0 109.976 -178.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.1 m -62.14 -45.99 90.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.984 1.314 . . . . 1.0 113.133 169.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.69 -33.03 74.99 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.193 0.997 . . . . 1.0 112.69 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -69.91 -29.8 67.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.941 1.297 . . . . 1.0 112.378 172.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.24 21.51 2.28 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.729 1.157 . . . . 1.0 115.175 169.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -117.02 153.37 32.8 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.432 1.093 . . . . 1.0 110.655 -175.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -87.12 72.16 10.03 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 123.118 1.437 . . . . 1.0 110.278 -173.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.11 144.9 27.28 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 112.954 -1.93 . . . . 1.0 111.941 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.6 m -142.63 136.23 28.91 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 125.746 1.618 . . . . 1.0 108.739 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.71 143.9 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.697 1.199 . . . . 1.0 113.437 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.65 133.82 53.1 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.329 1.851 . . . . 1.0 111.316 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -107.14 141.17 38.84 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.673 1.989 . . . . 1.0 111.13 178.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 t0 41.3 55.47 8.36 Favored Pre-proline 0 CA--C 1.559 1.309 0 C-N-CA 124.519 1.128 . . . . 1.0 112.478 -172.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.78 148.16 45.92 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.531 2.821 . . . . 1.0 117.072 -168.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.418 ' HB3' ' H ' ' A' ' 42' ' ' SER . 56.3 mm-40 -99.25 164.75 12.0 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.951 1.3 . . . . 1.0 112.461 168.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -68.15 -22.35 64.86 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 121.03 -1.044 . . . . 1.0 110.727 167.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.418 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 67.4 p -68.19 -20.21 64.83 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.656 1.117 . . . . 1.0 112.219 171.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -81.68 -24.9 35.96 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.253 1.021 . . . . 1.0 112.359 169.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -88.85 -34.78 16.89 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.346 1.239 . . . . 1.0 114.346 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.4 mt -47.5 -38.46 16.24 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-O 117.358 -1.306 . . . . 1.0 114.314 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -57.1 -18.77 30.4 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.43 2.753 . . . . 1.0 116.416 175.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -105.79 7.49 32.41 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 116.13 1.9 . . . . 1.0 116.13 -172.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -51.43 -34.71 36.25 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.619 1.967 . . . . 1.0 113.525 174.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -110.35 8.53 23.38 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.791 1.636 . . . . 1.0 112.373 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -115.78 -163.93 0.92 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.639 2.376 . . . . 1.0 110.299 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -108.48 164.26 12.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 122.613 1.197 . . . . 1.0 112.147 170.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -148.35 162.12 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.121 1.369 . . . . 1.0 109.906 -170.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.3 tp -144.9 128.65 17.25 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.931 1.292 . . . . 1.0 108.852 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.69 128.3 58.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 C-N-CA 124.141 0.976 . . . . 1.0 109.728 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.2 t -127.04 108.87 19.43 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 108.033 -1.099 . . . . 1.0 108.033 -170.761 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.5 tt . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 113.618 0.97 . . . . 1.0 113.618 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.7 t -40.71 -52.78 6.24 Favored Pre-proline 0 N--CA 1.478 0.951 0 CA-C-O 117.477 -1.249 . . . . 1.0 112.665 168.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -67.15 -32.31 34.26 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 121.725 1.616 . . . . 1.0 112.181 -173.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.1 tp -65.73 -52.96 47.01 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 124.051 0.94 . . . . 1.0 111.302 169.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -56.24 -52.41 64.57 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.727 0.811 . . . . 1.0 112.666 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -64.04 -40.33 96.06 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.669 1.188 . . . . 1.0 111.445 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.68 -35.85 90.42 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 123.604 0.621 . . . . 1.0 112.808 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 90.5 mt -66.42 -46.54 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 120.199 2.0 . . . . 1.0 108.578 172.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.4 ptmm? -72.25 -30.63 65.04 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.039 -1.663 . . . . 1.0 113.267 -171.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -109.77 -37.48 5.64 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.402 1.63 . . . . 1.0 115.402 -173.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.7 m -90.55 -26.8 19.53 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.302 1.041 . . . . 1.0 112.695 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.12 -71.44 0.62 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.214 -1.402 . . . . 1.0 107.214 169.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.7 -6.21 2.85 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 126.317 1.913 . . . . 1.0 115.496 172.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -156.22 146.78 21.74 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.035 2.934 . . . . 1.0 107.315 173.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -137.94 126.06 14.17 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 123.73 0.812 . . . . 1.0 110.207 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -84.63 -37.99 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 121.924 1.75 . . . . 1.0 114.414 -172.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -147.64 18.66 1.16 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.757 1.223 . . . . 1.0 114.14 -169.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 38.2 tp -77.31 139.98 39.9 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.5 -1.375 . . . . 1.0 113.629 -169.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -132.85 146.76 52.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 128.815 2.846 . . . . 1.0 107.252 169.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.434 ' CD1' HD11 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -159.33 167.63 28.38 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 118.981 0.81 . . . . 1.0 113.069 -177.494 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.452 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -125.32 173.49 17.4 Favored Glycine 0 N--CA 1.474 1.208 0 C-N-CA 125.025 1.298 . . . . 1.0 114.228 173.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.6 t -144.61 131.43 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.185 0.994 . . . . 1.0 113.641 -169.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.4 mt -131.54 102.24 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.846 1.658 . . . . 1.0 107.203 169.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -91.94 145.32 24.63 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.859 0.838 . . . . 1.0 111.27 170.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.5 mp -139.86 152.96 46.88 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.07 1.348 . . . . 1.0 110.622 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.31 0 C-N-CA 120.851 -0.69 . . . . 1.0 113.676 169.378 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 113.417 0.895 . . . . 1.0 113.417 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -60.18 -17.96 44.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.886 1.674 . . . . 1.0 115.005 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.2 -41.01 98.04 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-N 120.833 1.652 . . . . 1.0 114.37 175.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -75.91 -34.58 47.45 Favored Glycine 0 N--CA 1.477 1.429 0 O-C-N 120.626 -1.514 . . . . 1.0 112.935 172.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -62.97 -33.88 76.33 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 121.23 -1.159 . . . . 1.0 112.418 173.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -59.97 -41.72 92.58 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.601 1.16 . . . . 1.0 111.539 170.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -64.9 -37.74 88.64 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.729 0.695 . . . . 1.0 111.546 174.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -62.56 -49.43 75.29 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.181 -0.949 . . . . 1.0 110.994 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.19 -33.81 63.35 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.953 0.901 . . . . 1.0 113.111 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.2 -49.75 75.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 122.933 1.349 . . . . 1.0 110.613 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.434 HD11 ' CD1' ' A' ' 87' ' ' TYR . 10.3 mt -65.86 -37.49 86.3 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 120.945 -1.097 . . . . 1.0 112.083 178.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -68.95 -21.16 64.21 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.922 1.082 . . . . 1.0 113.922 174.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.89 -17.82 58.7 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.532 1.06 . . . . 1.0 111.188 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -97.66 -74.21 0.58 Allowed 'General case' 0 C--N 1.343 0.299 0 C-N-CA 125.129 1.372 . . . . 1.0 110.999 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.9 m 176.6 -2.69 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 127.384 2.274 . . . . 1.0 112.141 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.84 161.06 27.03 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 122.264 1.03 . . . . 1.0 113.507 -169.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -104.25 170.42 7.92 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.19 -1.368 . . . . 1.0 112.224 -169.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.75 145.35 50.94 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.924 1.29 . . . . 1.0 111.894 176.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 50.9 t -101.73 132.04 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 127.591 2.356 . . . . 1.0 108.639 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 46.97 -142.3 5.97 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.401 1.0 . . . . 1.0 113.889 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -100.65 -162.31 0.93 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.405 1.482 . . . . 1.0 110.29 169.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.72 157.12 22.62 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.215 1.806 . . . . 1.0 111.042 168.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.52 142.11 27.81 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 125.409 1.484 . . . . 1.0 109.484 169.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.5 mt -125.82 113.97 17.96 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.858 1.663 . . . . 1.0 110.379 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 40.5 mt -106.44 132.45 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 124.696 1.198 . . . . 1.0 113.101 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -107.57 96.9 6.72 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 128.145 2.578 . . . . 1.0 112.991 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.77 -22.8 66.85 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.913 1.079 . . . . 1.0 113.913 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.3 t -60.07 -25.25 65.23 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.434 1.094 . . . . 1.0 112.71 172.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -122.53 -29.06 4.14 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.373 1.869 . . . . 1.0 112.276 -170.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -138.5 89.36 13.77 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.794 1.238 . . . . 1.0 111.687 175.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -76.78 11.02 2.07 Favored 'Trans proline' 0 CA--C 1.549 1.246 0 C-N-CA 123.943 3.096 . . . . 1.0 114.255 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -114.54 66.68 1.72 Allowed Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 127.326 2.25 . . . . 1.0 110.112 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -57.73 -18.62 34.48 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.927 2.418 . . . . 1.0 117.738 -169.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -68.2 -25.6 65.3 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.446 1.476 . . . . 1.0 111.386 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 28.6 p -70.41 -23.46 62.75 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.756 1.162 . . . . 1.0 112.24 -173.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -93.66 -56.56 2.86 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.802 1.641 . . . . 1.0 112.081 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 79.0 p -68.58 -30.28 69.0 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 114.325 1.231 . . . . 1.0 114.325 -174.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -60.98 -59.28 14.34 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 120.773 1.624 . . . . 1.0 112.395 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -62.91 -24.43 74.19 Favored 'Trans proline' 0 C--N 1.352 0.743 0 CA-C-N 121.124 1.437 . . . . 1.0 113.002 173.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 73.8 t90 -70.39 -45.12 66.61 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 119.005 0.821 . . . . 1.0 111.704 175.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.421 HG11 ' HA ' ' A' ' 22' ' ' ALA . 69.1 t -66.5 -32.95 60.36 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 C-N-CA 123.167 0.587 . . . . 1.0 110.094 175.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -63.5 -48.11 78.93 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.162 -0.961 . . . . 1.0 109.822 173.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -64.16 -55.99 17.91 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.871 1.268 . . . . 1.0 111.651 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.452 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 89.0 t90 -57.17 -35.79 69.98 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 125.222 1.409 . . . . 1.0 111.785 172.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -49.75 -34.65 22.02 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.864 1.697 . . . . 1.0 113.938 171.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.6 p -67.86 -13.62 62.29 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.85 1.426 . . . . 1.0 114.85 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.18 -18.24 50.18 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.395 1.478 . . . . 1.0 111.886 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -86.32 167.87 14.39 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.193 0.997 . . . . 1.0 111.952 -175.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 11.2 m . . . . . 0 C--O 1.251 1.178 0 N-CA-C 115.725 1.75 . . . . 1.0 115.725 -169.861 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.408 0 N-CA-C 115.321 1.6 . . . . 1.0 115.321 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -125.49 122.35 36.36 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.645 1.578 . . . . 1.0 110.706 172.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 mp -121.89 113.41 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 C-N-CA 126.26 1.824 . . . . 1.0 112.416 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.12 123.75 7.27 Favored Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.169 -1.173 . . . . 1.0 110.169 169.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.9 mt -104.54 123.51 58.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 123.946 0.898 . . . . 1.0 109.355 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -115.6 111.03 20.06 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 124.766 1.227 . . . . 1.0 107.921 -170.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 112.412 0.523 . . . . 1.0 112.412 -175.427 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.3 tp . . . . . 0 CA--C 1.53 0.185 0 N-CA-C 112.494 0.553 . . . . 1.0 112.494 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.1 t -58.35 -37.26 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 119.127 -0.464 . . . . 1.0 111.132 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.56 -45.87 88.52 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.768 1.167 . . . . 1.0 112.859 173.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -63.49 -33.4 75.49 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.454 0.645 . . . . 1.0 110.966 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -69.93 -46.93 64.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.762 0.825 . . . . 1.0 109.818 176.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.412 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -55.42 -45.43 76.73 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.959 1.304 . . . . 1.0 113.017 176.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.33 -49.26 78.52 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.855 0.462 . . . . 1.0 110.181 173.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.6 -37.47 73.88 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.449 -0.782 . . . . 1.0 112.867 -173.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.5 mt -69.42 -48.17 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 124.501 1.12 . . . . 1.0 109.447 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.17 -34.86 77.21 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 122.485 1.136 . . . . 1.0 109.185 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.3 m -62.28 -44.9 95.47 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.602 1.161 . . . . 1.0 112.704 172.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.78 -29.82 69.12 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.676 1.19 . . . . 1.0 113.439 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -65.23 -33.94 77.17 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.516 1.526 . . . . 1.0 110.981 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.52 13.3 1.13 Allowed Glycine 0 CA--C 1.535 1.293 0 N-CA-C 115.864 1.105 . . . . 1.0 115.864 169.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 -108.02 177.02 4.93 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.985 1.314 . . . . 1.0 111.725 -169.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -101.5 99.71 10.06 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.053 1.341 . . . . 1.0 108.564 169.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.26 148.85 36.78 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.58 0.752 . . . . 1.0 111.217 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.4 m -149.0 146.12 27.64 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.146 0.978 . . . . 1.0 111.459 -174.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.9 t -95.93 137.08 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 114.168 1.173 . . . . 1.0 114.168 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -115.34 122.4 45.76 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.135 1.774 . . . . 1.0 110.995 169.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -103.21 137.0 41.95 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.597 1.959 . . . . 1.0 111.272 -177.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.6 t0 41.48 53.15 6.95 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 124.339 1.056 . . . . 1.0 111.237 -169.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -68.28 142.43 55.13 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.861 3.041 . . . . 1.0 116.85 -168.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.461 ' HB3' ' H ' ' A' ' 42' ' ' SER . 49.9 mm-40 -92.41 163.43 13.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 122.666 1.222 . . . . 1.0 111.309 168.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.0 -20.84 66.32 Favored 'General case' 0 N--CA 1.442 -0.856 0 O-C-N 120.688 -1.257 . . . . 1.0 110.388 167.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.461 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 16.1 m -68.49 -20.54 64.6 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 120.793 -1.192 . . . . 1.0 112.126 172.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -82.58 -24.47 33.94 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.292 1.037 . . . . 1.0 112.446 170.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 12.3 t-105 -88.68 -35.05 16.99 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.453 1.279 . . . . 1.0 114.453 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.7 mt -47.73 -37.37 12.71 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-O 117.466 -1.254 . . . . 1.0 114.129 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -58.79 -11.02 10.77 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.697 2.932 . . . . 1.0 117.27 175.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -114.81 9.31 16.25 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 116.303 1.964 . . . . 1.0 116.303 -174.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -51.24 -27.15 8.37 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 127.259 2.224 . . . . 1.0 114.048 175.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -117.28 13.02 14.51 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.299 1.84 . . . . 1.0 113.323 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -126.85 -155.41 0.69 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.889 2.476 . . . . 1.0 110.978 -175.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -115.96 162.64 17.07 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 122.906 1.336 . . . . 1.0 112.073 175.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -152.24 157.36 5.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 124.798 1.239 . . . . 1.0 109.053 -171.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.4 tp -139.98 127.82 21.98 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.559 1.143 . . . . 1.0 109.388 176.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.1 t -103.41 120.43 53.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 124.271 1.028 . . . . 1.0 109.001 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.0 t -118.4 112.21 37.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 105.602 -1.999 . . . . 1.0 105.602 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 115.237 1.569 . . . . 1.0 115.237 -168.161 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 114.692 1.368 . . . . 1.0 114.692 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -42.76 -52.62 10.84 Favored Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 124.532 1.133 . . . . 1.0 112.588 168.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -67.8 -32.04 30.55 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.87 1.713 . . . . 1.0 111.985 -173.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.7 tp -63.64 -53.19 55.38 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 124.283 1.033 . . . . 1.0 111.225 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -55.05 -52.99 61.46 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.726 0.81 . . . . 1.0 112.572 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -64.32 -40.52 96.08 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.813 0.845 . . . . 1.0 111.433 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.61 -35.29 89.69 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 119.662 -0.521 . . . . 1.0 112.557 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.1 mt -65.69 -47.46 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 120.145 1.972 . . . . 1.0 108.382 172.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -71.43 -32.22 68.11 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 120.309 -1.494 . . . . 1.0 113.508 -171.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -105.92 -36.82 6.87 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 115.028 1.492 . . . . 1.0 115.028 -173.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 m -94.73 -24.85 16.94 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.261 1.025 . . . . 1.0 112.663 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.23 -72.53 0.56 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.15 -1.426 . . . . 1.0 107.15 169.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.0 -9.35 2.06 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 126.316 1.912 . . . . 1.0 115.265 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -152.35 145.87 24.91 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.929 2.892 . . . . 1.0 107.499 171.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -136.82 128.5 16.84 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-O 118.438 -0.792 . . . . 1.0 110.435 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -83.68 -42.86 0.08 OUTLIER 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.148 1.899 . . . . 1.0 114.445 -171.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -147.32 20.7 1.21 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.045 1.338 . . . . 1.0 113.74 -170.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.0 tp -78.46 141.34 38.34 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.451 -1.405 . . . . 1.0 113.459 -169.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.87 149.73 49.12 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 128.766 2.826 . . . . 1.0 108.196 169.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.42 ' CD1' HD13 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -159.9 168.16 26.4 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.382 0.882 . . . . 1.0 113.382 -178.151 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.435 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -124.39 168.95 16.43 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 125.361 1.457 . . . . 1.0 114.026 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.0 t -143.75 133.39 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.536 1.134 . . . . 1.0 113.338 -169.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.7 mt -129.43 100.15 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 126.036 1.735 . . . . 1.0 107.346 169.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.48 145.62 25.18 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.686 1.194 . . . . 1.0 112.045 174.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.6 mp -138.04 150.83 47.29 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.804 0.841 . . . . 1.0 112.774 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.571 0 C-N-CA 121.081 -0.58 . . . . 1.0 113.744 169.248 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 21.7 m . . . . . 0 CA--C 1.547 0.831 0 N-CA-C 115.54 1.682 . . . . 1.0 115.54 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -63.97 -18.24 64.08 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.17 1.174 . . . . 1.0 114.17 -175.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.34 -49.28 69.62 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-N 119.872 1.214 . . . . 1.0 113.368 171.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -75.47 -34.25 50.66 Favored Glycine 0 N--CA 1.478 1.443 0 O-C-N 120.705 -1.468 . . . . 1.0 113.23 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -61.35 -34.47 75.34 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.263 -1.139 . . . . 1.0 112.731 173.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -63.3 -39.77 95.51 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.865 0.866 . . . . 1.0 112.316 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.1 -40.0 96.35 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.036 0.835 . . . . 1.0 110.697 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -41.07 98.03 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.427 -0.796 . . . . 1.0 112.583 176.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.63 -46.19 89.74 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 118.744 -0.646 . . . . 1.0 111.997 170.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.56 -49.31 46.86 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.259 2.224 . . . . 1.0 111.932 -172.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.42 HD13 ' CD1' ' A' ' 87' ' ' TYR . 8.1 mt -66.0 -43.03 88.93 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.214 -0.903 . . . . 1.0 111.439 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -66.96 -22.03 65.95 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -66.08 -35.87 81.67 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.422 1.089 . . . . 1.0 111.46 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -82.65 -75.87 0.29 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 113.785 -1.552 . . . . 1.0 110.432 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.7 t 179.0 -3.22 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.11 2.164 . . . . 1.0 111.574 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.24 150.44 38.59 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 122.775 1.274 . . . . 1.0 112.83 -169.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -90.61 172.48 8.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.271 -1.786 . . . . 1.0 113.036 -168.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.36 139.03 46.58 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.322 1.849 . . . . 1.0 109.914 -175.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.433 HG13 ' H ' ' A' ' 120' ' ' GLY 0.258 20.2 t -90.86 -163.3 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 107.786 -1.19 . . . . 1.0 107.786 178.035 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.433 ' H ' HG13 ' A' ' 119' ' ' VAL . . . -48.6 149.73 3.89 Favored Glycine 0 CA--C 1.544 1.867 0 O-C-N 120.067 -1.646 . . . . 1.0 113.936 177.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -59.73 146.49 41.27 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.21 1.404 . . . . 1.0 112.701 -171.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -67.62 158.78 31.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.767 1.627 . . . . 1.0 114.759 -168.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.443 ' HB2' ' CD1' ' A' ' 140' ' ' TRP . 1.0 OUTLIER -90.44 138.91 31.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.272 -1.331 . . . . 1.0 109.133 169.083 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.1 mt -126.61 110.05 12.78 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.359 1.464 . . . . 1.0 109.828 173.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 27.3 mt -97.59 129.07 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 124.06 0.944 . . . . 1.0 112.394 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -103.76 110.35 22.41 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.113 0.959 . . . . 1.0 111.709 173.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.39 -22.08 64.66 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.298 1.039 . . . . 1.0 113.241 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.6 t -64.55 -22.41 66.96 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.679 0.792 . . . . 1.0 112.895 173.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -119.93 -30.17 4.78 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.267 1.827 . . . . 1.0 112.0 -173.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.26 82.78 12.81 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.904 1.282 . . . . 1.0 112.515 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -75.42 6.56 3.5 Favored 'Trans proline' 0 CA--C 1.549 1.235 0 C-N-CA 123.791 2.994 . . . . 1.0 114.737 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -109.7 72.23 0.58 Allowed Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 127.2 2.2 . . . . 1.0 110.074 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -59.09 -26.92 83.51 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.481 2.12 . . . . 1.0 117.073 -169.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -65.91 -24.67 66.88 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.924 1.238 . . . . 1.0 110.983 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 31.9 p -71.42 -18.1 62.35 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.937 -1.102 . . . . 1.0 112.311 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -102.22 -55.17 2.53 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.296 1.838 . . . . 1.0 111.442 177.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.4 p -68.64 -35.04 76.75 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 114.18 1.178 . . . . 1.0 114.18 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -60.36 -55.4 45.59 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 120.992 1.724 . . . . 1.0 112.392 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -63.41 -26.88 70.8 Favored 'Trans proline' 0 C--N 1.351 0.68 0 CA-C-N 121.881 1.708 . . . . 1.0 112.665 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.443 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 88.8 t90 -63.57 -45.64 89.53 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 118.807 0.731 . . . . 1.0 111.192 172.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.412 HG11 ' HA ' ' A' ' 22' ' ' ALA . 53.1 t -66.75 -34.09 67.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.437 1.095 . . . . 1.0 109.537 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -70.63 -21.22 62.65 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.469 1.508 . . . . 1.0 113.189 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -87.64 -58.07 2.71 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.435 1.894 . . . . 1.0 109.878 168.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.435 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 89.8 t90 -58.58 -39.62 80.85 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.001 1.72 . . . . 1.0 113.861 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -53.5 -27.15 33.02 Favored Glycine 0 CA--C 1.537 1.439 0 O-C-N 121.11 -0.994 . . . . 1.0 113.936 173.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.4 p -68.94 -15.0 63.37 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.729 1.764 . . . . 1.0 114.045 175.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.77 -15.98 56.44 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.431 1.492 . . . . 1.0 111.669 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -76.59 169.34 18.45 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.97 0.908 . . . . 1.0 111.214 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.255 1.343 0 N-CA-C 114.866 1.432 . . . . 1.0 114.866 -173.368 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 113.084 0.772 . . . . 1.0 113.084 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -121.73 121.81 38.12 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.56 1.144 . . . . 1.0 110.709 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 mp -117.31 114.34 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 C-N-CA 126.138 1.775 . . . . 1.0 112.597 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.54 121.86 6.4 Favored Glycine 0 C--O 1.224 -0.522 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 169.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 mt -105.51 125.25 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 118.666 1.233 . . . . 1.0 109.411 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -118.31 111.78 19.2 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.763 -0.829 . . . . 1.0 108.763 -169.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 N--CA 1.467 0.414 0 N-CA-C 112.165 0.431 . . . . 1.0 112.165 -173.761 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.5 tp . . . . . 0 N--CA 1.465 0.315 0 N-CA-C 118.336 2.717 . . . . 1.0 118.336 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 81.2 t -56.46 -36.36 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 118.697 0.68 . . . . 1.0 112.071 -169.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.76 -38.61 86.95 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.682 -1.261 . . . . 1.0 112.732 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -66.65 -35.72 80.85 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.015 0.436 . . . . 1.0 110.869 174.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -66.29 -44.81 82.46 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 123.806 0.843 . . . . 1.0 109.1 176.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.44 ' HA ' HG13 ' A' ' 141' ' ' VAL . . . -63.88 -41.49 97.72 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 123.343 0.657 . . . . 1.0 112.671 -176.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -56.06 -48.85 75.26 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 170.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.19 -38.23 75.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.684 0.794 . . . . 1.0 112.828 -173.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.7 mt -66.61 -47.6 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-N 119.177 0.899 . . . . 1.0 108.945 175.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.17 -33.9 76.81 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 119.459 -0.897 . . . . 1.0 111.021 -176.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.9 m -63.2 -41.9 99.23 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.325 1.45 . . . . 1.0 113.207 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.52 -32.1 71.81 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.105 0.962 . . . . 1.0 112.433 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -69.56 -29.16 66.67 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.432 1.093 . . . . 1.0 113.051 170.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.17 29.33 2.58 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.526 1.06 . . . . 1.0 113.668 170.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -112.32 155.59 23.84 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.441 1.096 . . . . 1.0 109.267 175.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -86.95 78.46 9.0 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.688 1.195 . . . . 1.0 108.369 -177.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.5 142.84 26.97 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.374 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 96.4 m -143.32 127.48 17.56 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 124.484 1.113 . . . . 1.0 109.333 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 p -92.28 140.67 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 114.378 1.251 . . . . 1.0 114.378 170.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -114.44 127.64 55.93 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.808 2.043 . . . . 1.0 111.144 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -100.86 132.54 46.21 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.637 1.975 . . . . 1.0 110.481 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.6 t0 43.76 55.59 12.2 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 124.1 0.96 . . . . 1.0 111.653 -169.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -68.81 144.24 58.49 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.067 3.178 . . . . 1.0 117.061 -168.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.451 ' HB3' ' H ' ' A' ' 42' ' ' SER . 54.9 mm-40 -95.22 163.89 13.08 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 122.465 1.126 . . . . 1.0 111.979 168.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -66.55 -21.23 66.15 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 120.959 -1.088 . . . . 1.0 110.16 167.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.451 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 18.8 m -68.1 -21.51 64.95 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.864 -1.148 . . . . 1.0 112.242 172.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -82.02 -24.37 35.41 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.355 1.062 . . . . 1.0 112.449 170.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -88.55 -34.23 17.44 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.115 1.154 . . . . 1.0 114.115 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.1 mt -48.41 -38.41 22.3 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-O 117.538 -1.22 . . . . 1.0 114.209 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -57.81 -18.64 35.22 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.669 2.912 . . . . 1.0 116.435 174.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -105.03 7.4 33.98 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.774 1.768 . . . . 1.0 115.774 -171.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -53.37 -31.12 43.19 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.507 1.923 . . . . 1.0 113.857 176.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -112.42 8.48 19.48 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.081 1.352 . . . . 1.0 112.664 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -113.72 -162.86 0.83 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.815 2.446 . . . . 1.0 110.727 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -109.1 161.63 15.01 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.849 1.309 . . . . 1.0 111.443 169.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.89 157.35 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.537 1.135 . . . . 1.0 109.268 -171.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.1 tp -138.99 128.99 25.13 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.891 1.276 . . . . 1.0 108.553 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.4 t -103.36 128.59 56.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.933 -0.765 . . . . 1.0 108.933 175.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.45 112.15 30.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 105.925 -1.88 . . . . 1.0 105.925 176.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 115.181 1.548 . . . . 1.0 115.181 -167.833 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 114.141 1.163 . . . . 1.0 114.141 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -43.27 -53.25 11.43 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 124.383 1.073 . . . . 1.0 112.034 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -67.81 -31.1 32.6 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 121.677 1.585 . . . . 1.0 111.873 -173.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.8 tp -65.35 -53.18 47.32 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 124.475 1.11 . . . . 1.0 111.417 170.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -55.51 -53.23 58.9 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.778 0.831 . . . . 1.0 112.385 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -69.08 -35.17 76.2 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.63 -0.714 . . . . 1.0 111.813 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.68 -35.79 91.51 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 121.819 -0.551 . . . . 1.0 112.502 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 87.4 mt -65.12 -49.77 77.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.899 1.849 . . . . 1.0 108.296 171.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -69.72 -31.43 69.43 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.505 -1.372 . . . . 1.0 112.947 -169.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -105.28 -39.91 6.02 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 115.334 1.605 . . . . 1.0 115.334 -175.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.8 m -93.88 -23.04 18.26 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.239 1.016 . . . . 1.0 112.962 -174.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.1 -70.33 0.69 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 106.81 -1.552 . . . . 1.0 106.81 169.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.03 -11.44 1.35 Allowed Glycine 0 CA--C 1.538 1.481 0 C-N-CA 127.438 2.446 . . . . 1.0 116.514 169.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -155.77 141.08 17.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.825 2.45 . . . . 1.0 108.513 172.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -137.43 125.84 14.62 Favored Pre-proline 0 CA--C 1.546 0.815 0 O-C-N 121.281 -0.887 . . . . 1.0 111.097 -173.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.81 -40.52 0.09 OUTLIER 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.849 2.366 . . . . 1.0 114.87 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -140.31 13.85 2.39 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.866 1.432 . . . . 1.0 114.866 -169.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 40.9 tp -74.86 141.26 44.24 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.582 -1.323 . . . . 1.0 113.491 -169.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -132.83 147.39 52.3 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.195 2.598 . . . . 1.0 107.719 169.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.95 165.53 35.92 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.219 0.918 . . . . 1.0 113.349 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -127.0 173.33 18.41 Favored Glycine 0 N--CA 1.471 0.978 0 C-N-CA 125.35 1.452 . . . . 1.0 112.338 170.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -158.81 146.22 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 114.536 1.31 . . . . 1.0 114.536 -169.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.0 mt -133.5 109.41 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 127.478 2.311 . . . . 1.0 107.736 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -94.68 142.0 27.96 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.023 1.729 . . . . 1.0 111.466 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.6 mp -137.26 154.39 50.14 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.375 0.88 . . . . 1.0 113.375 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.73 0 N-CA-C 114.274 0.47 . . . . 1.0 114.274 168.775 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.449 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 20.8 p . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 114.329 1.233 . . . . 1.0 114.329 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -61.01 -21.22 63.38 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.831 1.252 . . . . 1.0 114.299 -170.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.93 -37.85 95.6 Favored Glycine 0 CA--C 1.535 1.326 0 CA-C-N 119.881 1.219 . . . . 1.0 113.109 171.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.79 -38.22 24.23 Favored Glycine 0 N--CA 1.476 1.318 0 O-C-N 121.407 -1.055 . . . . 1.0 113.046 172.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.449 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 89.2 mttt -62.12 -29.31 70.24 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 120.978 -1.307 . . . . 1.0 113.388 173.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -64.03 -28.98 70.17 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.059 0.763 . . . . 1.0 113.059 171.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -66.36 -35.57 80.67 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.643 1.11 . . . . 1.0 111.304 171.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -63.53 -48.96 75.39 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.239 -0.913 . . . . 1.0 110.968 172.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.25 -34.61 66.55 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.804 0.668 . . . . 1.0 112.804 175.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.93 -49.94 75.7 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 123.321 1.534 . . . . 1.0 110.83 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.9 mt -66.08 -37.83 86.78 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 120.908 -1.12 . . . . 1.0 111.717 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -69.02 -21.16 64.14 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.992 1.108 . . . . 1.0 113.992 174.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.91 -18.13 58.49 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.277 0.944 . . . . 1.0 111.238 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -96.83 -76.7 0.51 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.287 1.435 . . . . 1.0 110.574 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.3 m 178.32 -2.57 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 127.318 2.247 . . . . 1.0 112.154 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.13 159.55 29.68 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.043 0.925 . . . . 1.0 112.877 -169.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -100.97 174.19 6.13 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.246 -1.343 . . . . 1.0 111.559 -169.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.4 ttm105 -127.36 156.38 42.09 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.865 1.266 . . . . 1.0 112.731 171.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.41 HG11 ' H ' ' A' ' 120' ' ' GLY . 17.3 t -95.43 -168.81 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 C-N-CA 127.333 2.253 . . . . 1.0 105.93 169.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.41 ' H ' HG11 ' A' ' 119' ' ' VAL . . . -49.05 154.96 1.87 Allowed Glycine 0 CA--C 1.542 1.762 0 O-C-N 120.402 -1.436 . . . . 1.0 115.586 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -59.17 149.59 27.81 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.085 1.354 . . . . 1.0 113.15 -171.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -73.78 157.8 35.75 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 122.462 1.125 . . . . 1.0 112.38 -169.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.432 ' CD1' HG13 ' A' ' 125' ' ' ILE . 1.2 tm? -86.7 140.51 29.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.824 -1.08 . . . . 1.0 109.39 171.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.6 mt -123.65 104.39 8.99 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.818 1.247 . . . . 1.0 110.886 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.432 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.9 mt -90.26 128.21 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 125.109 1.363 . . . . 1.0 111.652 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -108.16 109.52 20.94 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 124.3 1.0 . . . . 1.0 112.174 171.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.76 -20.74 65.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.788 0.835 . . . . 1.0 112.948 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.2 t -63.6 -21.4 66.34 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.724 1.21 . . . . 1.0 112.675 173.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -124.67 -29.62 3.41 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.149 1.78 . . . . 1.0 112.584 -173.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -140.59 87.11 11.77 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.479 1.512 . . . . 1.0 112.068 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.2 6.85 2.8 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 123.675 2.917 . . . . 1.0 114.631 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -112.81 71.86 1.33 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 127.449 2.299 . . . . 1.0 109.699 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -57.87 -23.32 58.59 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.434 2.089 . . . . 1.0 116.827 -168.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -65.62 -25.69 67.49 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 119.128 0.876 . . . . 1.0 111.733 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 p -73.5 -16.99 61.27 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 120.902 -1.124 . . . . 1.0 111.706 -175.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -102.27 -53.87 2.81 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.163 1.785 . . . . 1.0 111.212 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 59.3 p -72.14 -33.9 68.13 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 114.706 1.372 . . . . 1.0 114.706 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -60.18 -55.55 44.2 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 120.923 1.692 . . . . 1.0 112.64 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -62.33 -22.64 74.39 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 121.329 1.51 . . . . 1.0 112.628 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.417 ' CD1' HD22 ' A' ' 123' ' ' LEU . 90.1 t90 -70.26 -45.55 66.19 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 121.67 -0.644 . . . . 1.0 111.264 174.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.44 HG13 ' HA ' ' A' ' 22' ' ' ALA . 91.5 t -64.69 -34.22 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.835 -0.802 . . . . 1.0 108.835 176.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.75 -29.77 68.24 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.132 1.373 . . . . 1.0 112.195 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -79.9 -61.38 2.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.104 1.762 . . . . 1.0 112.239 171.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 85.3 t90 -56.76 -36.43 69.78 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 126.724 2.01 . . . . 1.0 112.49 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.46 -32.28 22.86 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.684 1.135 . . . . 1.0 113.438 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 p -70.22 -13.12 62.04 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.332 1.234 . . . . 1.0 114.332 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.0 -14.72 55.57 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.151 1.78 . . . . 1.0 111.773 175.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.57 -178.27 5.77 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.223 1.009 . . . . 1.0 110.45 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 9.7 m . . . . . 0 C--O 1.254 1.324 0 C-N-CA 126.607 1.963 . . . . 1.0 114.251 -179.444 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.406 0 CA-C-O 121.731 0.777 . . . . 1.0 113.058 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -113.73 124.73 52.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.369 -1.287 . . . . 1.0 111.877 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 mp -120.92 112.82 37.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 126.424 1.889 . . . . 1.0 113.044 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.64 122.59 6.84 Favored Glycine 0 N--CA 1.467 0.742 0 N-CA-C 110.918 -0.873 . . . . 1.0 110.918 169.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.5 mt -104.17 119.63 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 118.464 1.132 . . . . 1.0 109.804 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -112.17 108.91 18.33 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.635 -1.246 . . . . 1.0 107.635 -171.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.47 0.536 0 CA-C-O 121.288 0.566 . . . . 1.0 112.434 -169.925 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.8 tp . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 116.121 1.896 . . . . 1.0 116.121 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.4 t -47.87 -32.36 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.114 1.366 . . . . 1.0 112.727 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.15 -49.19 76.72 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.632 -1.293 . . . . 1.0 113.113 172.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -67.71 -30.33 69.8 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.674 1.19 . . . . 1.0 110.648 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.29 -46.62 69.82 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 123.397 0.679 . . . . 1.0 109.297 173.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.452 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.36 -42.12 93.13 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 123.225 0.61 . . . . 1.0 112.329 -176.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -54.27 -49.13 70.28 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.121 0.968 . . . . 1.0 110.312 169.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.57 -38.7 70.9 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.633 0.773 . . . . 1.0 112.453 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.4 mt -68.04 -45.81 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 O-C-N 121.117 -0.989 . . . . 1.0 109.357 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -31.5 72.52 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.56 1.073 . . . . 1.0 110.708 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.6 m -63.14 -45.05 93.78 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.241 1.016 . . . . 1.0 112.919 169.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.65 -30.89 69.69 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.777 1.231 . . . . 1.0 113.163 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -67.33 -27.64 67.31 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.485 1.914 . . . . 1.0 111.809 172.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.32 26.21 2.73 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.535 1.064 . . . . 1.0 114.737 171.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -117.54 173.19 6.86 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.999 1.319 . . . . 1.0 110.304 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -102.04 94.14 5.62 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 125.459 1.503 . . . . 1.0 108.429 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.34 147.44 31.51 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.283 0.633 . . . . 1.0 111.459 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.3 m -146.81 140.38 25.75 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.153 0.981 . . . . 1.0 112.428 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.1 t -87.2 137.71 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 115.071 1.508 . . . . 1.0 115.071 172.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -116.86 109.86 17.62 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.132 2.173 . . . . 1.0 109.993 169.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -88.04 145.93 25.73 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.081 1.752 . . . . 1.0 110.84 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.1 t0 43.33 57.77 12.21 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 124.517 1.127 . . . . 1.0 110.264 -169.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -55.23 128.06 28.89 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.775 3.65 . . . . 1.0 118.486 -167.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -91.75 150.34 21.15 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.368 1.467 . . . . 1.0 113.131 169.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -70.6 -25.9 63.26 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.342 -0.849 . . . . 1.0 110.175 168.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.1 m -66.53 -20.97 66.16 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.494 -0.753 . . . . 1.0 112.272 171.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -87.14 -24.07 24.63 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.252 1.021 . . . . 1.0 113.249 169.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.2 t-105 -79.4 -36.08 39.67 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.608 1.095 . . . . 1.0 113.529 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.9 mt -48.82 -40.53 43.41 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 117.845 -1.074 . . . . 1.0 113.879 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -53.8 -15.72 7.37 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.613 3.542 . . . . 1.0 117.826 172.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -110.46 8.0 22.94 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 116.139 1.903 . . . . 1.0 116.139 -172.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -53.11 -29.28 29.89 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.612 1.965 . . . . 1.0 114.115 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -114.28 11.68 17.46 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.151 1.781 . . . . 1.0 113.267 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -125.57 -159.54 0.91 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.611 2.365 . . . . 1.0 110.818 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -113.24 158.9 19.91 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 123.211 1.481 . . . . 1.0 113.073 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.37 156.61 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 125.302 1.441 . . . . 1.0 109.796 -170.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.4 tp -139.36 127.59 22.62 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.733 1.213 . . . . 1.0 109.044 176.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.9 t -102.42 123.03 55.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 123.762 0.825 . . . . 1.0 109.151 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.4 t -122.46 111.96 32.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 105.057 -2.201 . . . . 1.0 105.057 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 113.852 1.056 . . . . 1.0 113.852 -167.765 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.8 tt . . . . . 0 N--CA 1.47 0.541 0 N-CA-C 114.394 1.257 . . . . 1.0 114.394 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.9 t -45.13 -51.95 22.2 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 124.267 1.027 . . . . 1.0 111.717 168.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.42 -29.5 20.61 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.329 1.353 . . . . 1.0 111.664 -173.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.4 tp -64.75 -50.61 66.17 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.255 1.022 . . . . 1.0 110.909 169.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -55.2 -53.72 52.38 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.0 0.92 . . . . 1.0 112.473 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -69.06 -34.47 75.23 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.704 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.27 -34.69 88.79 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 123.876 0.75 . . . . 1.0 112.747 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 90.8 mt -65.23 -51.88 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 120.119 -1.812 . . . . 1.0 108.438 170.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -67.78 -32.32 72.82 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.524 -1.36 . . . . 1.0 113.178 -170.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -104.07 -36.59 7.67 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.27 1.582 . . . . 1.0 115.27 -173.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.7 m -97.22 -19.63 18.46 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.196 0.999 . . . . 1.0 112.938 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.62 -70.92 0.69 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 107.534 -1.284 . . . . 1.0 107.534 169.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.63 -13.32 1.69 Allowed Glycine 0 CA--C 1.536 1.404 0 C-N-CA 127.257 2.36 . . . . 1.0 116.454 169.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -155.76 141.49 17.97 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 127.668 2.387 . . . . 1.0 108.603 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -135.33 124.35 16.09 Favored Pre-proline 0 CA--C 1.546 0.808 0 O-C-N 121.449 -0.782 . . . . 1.0 111.237 -171.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.4 -39.07 0.2 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.35 2.034 . . . . 1.0 114.415 -171.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -146.7 18.1 1.29 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.255 1.206 . . . . 1.0 114.255 -170.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.0 tp -77.83 141.78 38.95 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 120.424 -1.422 . . . . 1.0 113.373 -169.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -136.73 146.65 46.07 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 129.519 3.127 . . . . 1.0 108.36 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.425 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -159.4 168.53 26.08 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.053 0.842 . . . . 1.0 113.126 -177.144 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.434 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -127.64 170.52 19.19 Favored Glycine 0 N--CA 1.472 1.082 0 C-N-CA 124.678 1.133 . . . . 1.0 114.281 172.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 86.6 t -142.28 133.5 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.668 1.187 . . . . 1.0 113.34 -169.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.5 mt -128.12 98.57 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.151 1.78 . . . . 1.0 106.781 169.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.27 145.37 25.43 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.151 1.38 . . . . 1.0 111.09 173.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.8 mp -138.88 149.79 45.25 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.601 -0.687 . . . . 1.0 111.974 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.347 0 C-N-CA 119.38 -1.39 . . . . 1.0 115.793 169.295 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.9 m . . . . . 0 CA--C 1.544 0.722 0 N-CA-C 113.03 0.752 . . . . 1.0 113.03 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -53.65 -23.98 12.89 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.57 1.948 . . . . 1.0 114.28 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -54.89 -50.12 59.64 Favored Glycine 0 CA--C 1.536 1.36 0 CA-C-N 120.039 1.29 . . . . 1.0 113.237 173.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -77.89 -34.21 39.13 Favored Glycine 0 N--CA 1.479 1.54 0 O-C-N 120.798 -1.413 . . . . 1.0 113.639 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -59.6 -34.74 73.14 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.431 -1.04 . . . . 1.0 112.904 173.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -62.98 -39.3 94.32 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.869 0.868 . . . . 1.0 112.232 172.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -62.87 -39.76 95.43 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.435 1.016 . . . . 1.0 110.689 173.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.29 -40.1 96.42 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.802 0.441 . . . . 1.0 111.664 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.08 83.06 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 118.496 -0.764 . . . . 1.0 111.786 169.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.21 -49.05 34.39 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.391 2.277 . . . . 1.0 111.864 -172.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.425 HD12 ' CD1' ' A' ' 87' ' ' TYR . 7.3 mt -65.91 -43.86 86.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.939 -1.028 . . . . 1.0 111.35 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -65.92 -24.74 66.89 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.883 1.068 . . . . 1.0 113.883 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -66.1 -32.82 74.5 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.522 1.129 . . . . 1.0 111.466 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -83.08 -73.3 0.41 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.369 -1.287 . . . . 1.0 109.1 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.5 p 176.02 -15.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 127.32 2.248 . . . . 1.0 113.8 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.08 148.88 50.35 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 122.888 1.328 . . . . 1.0 113.927 -169.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -90.16 171.76 9.29 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 113.131 -1.85 . . . . 1.0 112.899 -168.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.94 138.14 49.61 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.239 1.816 . . . . 1.0 110.195 -175.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.2 t -88.57 -168.26 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 124.818 1.247 . . . . 1.0 107.832 174.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -51.38 153.4 4.89 Favored Glycine 0 CA--C 1.544 1.86 0 O-C-N 119.779 -1.826 . . . . 1.0 115.604 -176.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.58 137.5 15.31 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.123 1.769 . . . . 1.0 114.596 -172.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -68.22 159.35 31.37 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.505 1.522 . . . . 1.0 113.088 -169.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.443 ' HB2' ' CD1' ' A' ' 140' ' ' TRP . 1.3 tm? -91.2 139.1 31.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.539 -1.21 . . . . 1.0 109.86 169.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.6 mt -127.87 111.49 13.66 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.624 1.569 . . . . 1.0 109.52 174.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 25.7 mt -100.58 133.44 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.612 1.165 . . . . 1.0 113.499 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.05 97.0 10.42 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.478 1.511 . . . . 1.0 111.346 174.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.08 -25.2 65.22 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.145 -1.597 . . . . 1.0 112.72 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.4 m -63.66 -17.74 63.24 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.722 2.009 . . . . 1.0 113.75 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -125.14 -29.32 3.31 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.233 1.813 . . . . 1.0 112.129 -173.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -143.12 89.5 7.76 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.475 1.51 . . . . 1.0 110.754 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -77.41 12.41 1.86 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.03 3.154 . . . . 1.0 114.026 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -111.34 65.53 0.57 Allowed Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 127.428 2.291 . . . . 1.0 109.915 174.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -57.36 -22.67 50.97 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.366 2.044 . . . . 1.0 115.956 -169.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.8 pm0 -63.94 -24.31 67.68 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.332 0.969 . . . . 1.0 111.603 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.4 p -72.4 -17.55 61.8 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 120.765 -1.209 . . . . 1.0 112.111 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -104.64 -54.7 2.47 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.06 1.744 . . . . 1.0 111.895 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.0 p -69.7 -33.91 73.19 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.704 1.002 . . . . 1.0 113.704 -177.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -59.51 -57.09 29.55 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 120.765 1.62 . . . . 1.0 112.435 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -62.09 -23.94 76.07 Favored 'Trans proline' 0 C--N 1.352 0.735 0 CA-C-N 121.304 1.502 . . . . 1.0 112.776 174.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.443 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 87.5 t90 -67.35 -46.69 72.66 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 119.094 0.861 . . . . 1.0 110.725 174.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.452 HG11 ' HA ' ' A' ' 22' ' ' ALA . 92.5 t -64.42 -32.29 57.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 122.337 1.065 . . . . 1.0 109.253 175.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -71.16 -22.73 62.01 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 120.066 -1.646 . . . . 1.0 113.359 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -88.53 -59.38 2.25 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.379 1.871 . . . . 1.0 111.247 168.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.434 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 89.5 t90 -56.93 -36.49 70.28 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.697 1.599 . . . . 1.0 113.388 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.62 -30.72 35.56 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 121.315 -0.865 . . . . 1.0 114.196 173.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.6 p -68.22 -12.55 61.17 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.213 1.19 . . . . 1.0 114.213 176.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.74 -16.19 51.9 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.98 1.712 . . . . 1.0 111.881 176.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.78 177.08 9.09 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.198 0.999 . . . . 1.0 110.829 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 8.9 m . . . . . 0 C--O 1.251 1.149 0 N-CA-C 115.882 1.808 . . . . 1.0 115.882 -172.014 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.475 0 N-CA-C 113.687 0.995 . . . . 1.0 113.687 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -124.2 125.37 44.31 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.479 1.511 . . . . 1.0 110.267 173.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 mp -121.51 114.99 45.18 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 C-N-CA 126.026 1.73 . . . . 1.0 112.832 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.4 123.37 7.13 Favored Glycine 0 C--O 1.225 -0.446 0 N-CA-C 110.313 -1.115 . . . . 1.0 110.313 169.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.8 mt -103.67 116.22 47.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 118.167 0.983 . . . . 1.0 109.312 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -112.3 112.05 23.36 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.198 -1.408 . . . . 1.0 107.198 -172.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.469 0.498 0 CA-C-N 116.66 -0.246 . . . . 1.0 111.582 -172.58 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.6 tp . . . . . 0 N--CA 1.468 0.44 0 N-CA-C 117.326 2.343 . . . . 1.0 117.326 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.6 t -58.18 -35.15 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 118.685 0.675 . . . . 1.0 111.861 -169.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.24 -48.1 83.0 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 120.845 -1.159 . . . . 1.0 112.679 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -67.09 -30.95 71.12 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.879 0.371 . . . . 1.0 111.312 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -66.31 -48.31 70.76 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 173.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.401 ' HA ' HG12 ' A' ' 141' ' ' VAL . . . -63.04 -44.0 97.1 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 112.673 0.62 . . . . 1.0 112.673 -176.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -53.56 -49.43 67.71 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.376 1.07 . . . . 1.0 110.701 170.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.06 -37.51 75.51 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.632 0.773 . . . . 1.0 112.656 -175.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.5 mt -69.49 -45.56 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 119.119 0.872 . . . . 1.0 109.568 175.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -33.84 76.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 119.651 -0.819 . . . . 1.0 110.269 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.4 m -61.71 -45.03 95.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.392 1.477 . . . . 1.0 112.669 169.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.69 -32.98 74.64 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.346 1.058 . . . . 1.0 113.011 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -68.44 -30.62 69.55 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.752 1.221 . . . . 1.0 112.102 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.87 20.93 2.01 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.847 1.213 . . . . 1.0 115.214 169.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -118.85 153.53 34.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.785 1.234 . . . . 1.0 111.167 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -88.31 75.38 8.53 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.244 1.417 . . . . 1.0 110.637 -172.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.01 144.85 25.55 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.387 -1.733 . . . . 1.0 112.449 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.1 m -147.52 141.48 25.9 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.986 1.315 . . . . 1.0 112.055 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -88.96 139.23 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 115.56 1.689 . . . . 1.0 115.56 172.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -116.95 109.85 17.55 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.181 2.192 . . . . 1.0 110.327 169.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -88.23 144.02 26.69 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.384 1.874 . . . . 1.0 110.462 171.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 43.06 59.48 11.26 Favored Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 124.488 1.115 . . . . 1.0 111.193 -169.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -60.85 130.94 34.93 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 124.483 3.455 . . . . 1.0 118.356 -168.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -93.15 150.26 20.64 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.683 1.593 . . . . 1.0 112.896 169.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -69.56 -25.81 64.18 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.2 -0.937 . . . . 1.0 110.031 168.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.9 m -66.68 -20.6 66.01 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.446 -0.784 . . . . 1.0 112.615 171.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -88.73 -22.29 23.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.669 1.188 . . . . 1.0 113.207 169.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -80.53 -35.58 34.34 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.799 1.181 . . . . 1.0 113.863 174.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.1 mt -49.43 -40.24 47.29 Favored Pre-proline 0 CA--C 1.551 1.006 0 CA-C-O 117.785 -1.103 . . . . 1.0 113.828 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -55.97 -14.06 10.39 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 124.509 3.473 . . . . 1.0 117.153 172.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -109.48 7.49 24.84 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.967 1.84 . . . . 1.0 115.967 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -53.13 -31.54 42.86 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.607 1.963 . . . . 1.0 113.819 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -112.12 11.62 20.41 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.966 1.307 . . . . 1.0 112.689 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -120.17 -157.59 0.71 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.977 2.511 . . . . 1.0 110.895 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -115.45 165.53 12.89 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.629 1.204 . . . . 1.0 111.445 171.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.14 159.54 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.616 1.166 . . . . 1.0 109.214 -170.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.5 tp -140.29 129.01 23.07 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 124.425 1.09 . . . . 1.0 108.954 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.6 t -107.11 123.95 62.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 124.299 1.039 . . . . 1.0 109.626 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.0 t -123.04 111.71 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 107.546 -1.279 . . . . 1.0 107.546 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.488 1.435 0 C-N-CA 124.288 1.035 . . . . 1.0 108.958 -169.694 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.4 tt . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 113.477 0.918 . . . . 1.0 113.477 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -42.37 -52.23 10.32 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 124.638 1.175 . . . . 1.0 112.533 168.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -71.27 -29.84 16.59 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.383 1.389 . . . . 1.0 111.662 -173.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.9 tp -64.91 -49.66 69.57 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 124.227 1.011 . . . . 1.0 110.767 169.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -56.4 -52.57 64.13 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.312 1.045 . . . . 1.0 112.483 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -64.02 -40.75 97.02 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.864 0.866 . . . . 1.0 111.4 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.95 -33.66 84.62 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.943 0.783 . . . . 1.0 112.801 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 91.8 mt -66.54 -50.76 64.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 120.116 1.958 . . . . 1.0 108.47 170.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -69.6 -30.23 67.94 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.371 -1.456 . . . . 1.0 112.998 -170.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -106.94 -37.74 6.25 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.779 1.77 . . . . 1.0 115.779 -175.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.1 m -93.99 -22.41 18.57 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.958 0.903 . . . . 1.0 113.028 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.74 -71.1 0.67 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.204 -1.406 . . . . 1.0 107.204 169.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.02 -11.44 1.34 Allowed Glycine 0 CA--C 1.538 1.5 0 C-N-CA 127.213 2.339 . . . . 1.0 116.41 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -155.3 140.12 17.17 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.508 2.323 . . . . 1.0 108.38 172.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -135.81 123.58 15.03 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 121.267 -0.895 . . . . 1.0 111.365 -173.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -82.73 -39.3 0.14 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.845 2.363 . . . . 1.0 114.654 -173.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -141.28 13.57 2.2 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 115.14 1.533 . . . . 1.0 115.14 -169.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.8 tp -79.4 140.72 37.34 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.585 -1.322 . . . . 1.0 113.138 -169.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.83 151.3 48.98 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 127.959 2.504 . . . . 1.0 109.188 169.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.446 ' CD1' HD11 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -160.62 166.13 29.46 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.329 0.968 . . . . 1.0 113.603 -175.008 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.407 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -121.15 169.95 14.48 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 125.662 1.601 . . . . 1.0 113.876 175.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 66.0 t -145.78 132.38 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 114.364 1.246 . . . . 1.0 114.364 -169.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.5 mt -134.21 110.92 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.591 1.556 . . . . 1.0 108.774 169.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -105.07 146.94 28.44 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.6 -0.687 . . . . 1.0 111.546 171.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.24 153.39 44.8 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.441 1.497 . . . . 1.0 109.915 177.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.604 0 CA-C-O 122.116 0.842 . . . . 1.0 114.137 169.294 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 7.2 m . . . . . 0 CA--C 1.542 0.654 0 CA-C-O 121.364 0.602 . . . . 1.0 112.491 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -61.28 -21.83 64.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.154 1.538 . . . . 1.0 115.154 -169.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.93 -51.2 57.3 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 121.679 2.036 . . . . 1.0 114.099 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.55 -35.55 92.07 Favored Glycine 0 N--CA 1.474 1.228 0 O-C-N 120.547 -1.561 . . . . 1.0 112.845 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -63.5 -38.55 91.55 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.255 1.022 . . . . 1.0 113.119 173.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -58.32 -46.5 86.04 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.748 0.819 . . . . 1.0 111.021 170.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -63.17 -37.93 89.15 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.738 -0.601 . . . . 1.0 111.792 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.78 -45.61 93.12 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.464 -0.773 . . . . 1.0 112.081 177.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.63 -36.65 74.41 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.066 0.765 . . . . 1.0 113.066 171.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.65 -49.03 79.35 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 123.351 1.548 . . . . 1.0 111.199 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.446 HD11 ' CD1' ' A' ' 87' ' ' TYR . 8.9 mt -66.1 -39.95 90.37 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 120.789 -1.194 . . . . 1.0 111.47 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -71.27 -19.1 62.39 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.136 0.791 . . . . 1.0 113.136 177.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.23 -21.93 58.27 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.407 1.003 . . . . 1.0 111.098 176.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -92.05 -78.4 0.41 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 125.356 1.462 . . . . 1.0 110.019 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.4 t -178.89 -3.75 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.085 2.154 . . . . 1.0 112.027 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.54 148.58 38.79 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 122.632 1.206 . . . . 1.0 112.639 -169.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -90.8 170.29 10.23 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.17 1.788 . . . . 1.0 114.048 -168.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.73 143.35 50.82 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.885 2.074 . . . . 1.0 111.018 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.9 t -118.22 130.15 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.25 1.42 . . . . 1.0 108.664 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 48.51 -154.44 1.77 Allowed Glycine 0 N--CA 1.48 1.575 0 C-N-CA 124.834 1.207 . . . . 1.0 114.317 -170.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -119.16 147.52 44.1 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.986 1.714 . . . . 1.0 109.961 169.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.26 157.66 37.28 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.239 -0.913 . . . . 1.0 113.301 -169.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.448 ' CD1' HG13 ' A' ' 125' ' ' ILE . 0.8 OUTLIER -93.99 134.79 36.03 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.221 1.009 . . . . 1.0 110.573 171.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.3 mt -120.69 107.61 13.0 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.468 1.507 . . . . 1.0 111.451 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.448 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.9 mt -93.56 130.78 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 126.344 1.858 . . . . 1.0 113.054 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -106.13 89.51 3.08 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.663 2.385 . . . . 1.0 113.245 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.32 -24.68 67.74 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.893 -1.13 . . . . 1.0 113.26 -175.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.7 m -60.68 -18.13 52.12 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.424 2.29 . . . . 1.0 113.865 172.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -127.9 -31.94 2.36 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.148 2.179 . . . . 1.0 112.501 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -138.06 91.91 12.81 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 126.046 1.739 . . . . 1.0 111.483 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -75.83 9.05 2.46 Favored 'Trans proline' 0 CA--C 1.549 1.235 0 C-N-CA 123.589 2.859 . . . . 1.0 114.517 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -112.05 70.45 0.98 Allowed Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 127.482 2.313 . . . . 1.0 110.057 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -57.81 -20.51 43.97 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.627 2.218 . . . . 1.0 116.417 -169.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -65.0 -26.67 68.39 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 118.91 0.777 . . . . 1.0 111.713 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.0 p -72.6 -16.7 61.73 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 120.866 -1.146 . . . . 1.0 111.743 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -101.1 -56.16 2.38 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.179 1.792 . . . . 1.0 111.711 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 60.3 p -69.59 -32.22 70.83 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.777 1.399 . . . . 1.0 114.777 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -62.1 -55.41 40.99 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 120.939 1.7 . . . . 1.0 113.176 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -62.84 -23.59 74.34 Favored 'Trans proline' 0 C--N 1.355 0.882 0 CA-C-N 121.28 1.493 . . . . 1.0 112.255 175.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.445 ' CD1' HD21 ' A' ' 123' ' ' LEU . 92.6 t90 -69.29 -47.5 64.37 Favored 'General case' 0 C--O 1.218 -0.594 0 C-N-CA 123.258 0.623 . . . . 1.0 111.053 174.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.401 HG12 ' HA ' ' A' ' 22' ' ' ALA . 95.7 t -66.45 -32.79 59.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 N-CA-C 109.554 -0.535 . . . . 1.0 109.554 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -64.51 -50.35 67.74 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.228 -0.92 . . . . 1.0 109.477 173.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -63.47 -54.73 31.88 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.703 1.201 . . . . 1.0 111.743 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.407 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 86.3 t90 -56.58 -37.7 70.95 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 125.843 1.657 . . . . 1.0 111.262 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.2 -33.68 23.46 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.434 1.492 . . . . 1.0 113.619 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.3 p -68.8 -14.03 62.77 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 114.802 1.408 . . . . 1.0 114.802 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.53 -19.63 45.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.35 1.46 . . . . 1.0 111.692 176.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -83.68 173.7 11.13 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.48 1.112 . . . . 1.0 110.583 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--O 1.252 1.213 0 C-N-CA 124.662 1.185 . . . . 1.0 113.923 -176.23 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.48 0 N-CA-C 112.597 0.592 . . . . 1.0 112.597 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -122.48 125.08 45.06 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.035 1.334 . . . . 1.0 110.04 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 mp -121.58 114.07 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 126.778 2.031 . . . . 1.0 112.346 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.31 125.55 8.06 Favored Glycine 0 C--O 1.223 -0.539 0 N-CA-C 110.315 -1.114 . . . . 1.0 110.315 169.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 mt -106.16 121.37 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-N 118.547 1.174 . . . . 1.0 109.803 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -113.35 108.58 17.42 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.514 -1.291 . . . . 1.0 107.514 -169.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.467 0.419 0 O-C-N 123.375 0.422 . . . . 1.0 111.869 -174.185 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.3 tp . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 112.954 0.724 . . . . 1.0 112.954 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.1 t -56.35 -32.85 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.017 0.527 . . . . 1.0 111.5 -173.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.47 -47.62 85.34 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.793 -1.192 . . . . 1.0 113.105 172.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -66.98 -30.35 70.44 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.682 0.793 . . . . 1.0 111.117 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -68.86 -48.36 63.64 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 123.795 0.838 . . . . 1.0 109.394 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.432 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -63.8 -42.84 97.64 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 112.769 0.655 . . . . 1.0 112.769 -176.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -53.96 -49.44 68.73 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.093 0.957 . . . . 1.0 110.129 170.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.09 -37.84 72.4 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.484 0.713 . . . . 1.0 112.737 -174.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.5 mt -66.18 -46.83 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 119.355 0.98 . . . . 1.0 109.117 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.98 -35.14 79.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 119.543 -0.863 . . . . 1.0 110.468 -176.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 51.8 m -61.9 -41.92 98.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.24 1.416 . . . . 1.0 113.711 170.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.2 -33.06 74.58 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.049 0.94 . . . . 1.0 112.272 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -70.64 -30.04 66.56 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.629 1.172 . . . . 1.0 113.203 171.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.91 23.11 2.81 Favored Glycine 0 N--CA 1.468 0.799 0 C-N-CA 124.543 1.068 . . . . 1.0 114.433 169.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -111.52 148.96 32.08 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.543 1.137 . . . . 1.0 109.55 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.91 90.57 6.46 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.05 1.34 . . . . 1.0 108.008 -176.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.07 145.71 31.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.576 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 56.5 m -148.49 139.89 23.43 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.545 0.738 . . . . 1.0 112.076 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.45 138.72 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 115.48 1.659 . . . . 1.0 115.48 173.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -119.94 112.76 19.58 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.195 2.198 . . . . 1.0 110.292 169.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -95.01 138.23 33.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.725 2.01 . . . . 1.0 110.461 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.9 t70 42.95 54.39 10.02 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 123.753 0.821 . . . . 1.0 111.379 -169.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -71.18 147.74 54.48 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.777 2.985 . . . . 1.0 117.064 -168.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.427 ' HB3' ' H ' ' A' ' 42' ' ' SER . 55.4 mm-40 -98.02 164.81 12.19 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 124.934 1.294 . . . . 1.0 113.034 168.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -68.01 -22.5 64.98 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 121.169 -0.957 . . . . 1.0 110.523 167.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.427 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 67.0 p -68.33 -20.22 64.72 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.759 1.163 . . . . 1.0 112.481 171.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -81.13 -25.38 36.96 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.232 1.013 . . . . 1.0 112.248 169.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.7 t-105 -88.28 -35.39 17.29 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.504 1.298 . . . . 1.0 114.504 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.6 mt -47.72 -38.39 17.47 Favored Pre-proline 0 CA--C 1.554 1.116 0 CA-C-O 117.681 -1.152 . . . . 1.0 114.058 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -58.99 -14.47 23.13 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 123.674 2.916 . . . . 1.0 116.526 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -110.54 9.53 23.13 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.63 1.715 . . . . 1.0 115.63 -174.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -51.44 -30.4 19.46 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.86 2.064 . . . . 1.0 113.729 174.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -108.82 7.2 26.1 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.316 1.847 . . . . 1.0 113.489 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -122.39 -163.18 1.06 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.888 2.475 . . . . 1.0 110.706 -174.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -110.62 165.33 11.9 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 123.081 1.419 . . . . 1.0 111.963 171.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.86 159.97 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.485 1.514 . . . . 1.0 109.567 -172.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.2 tp -139.25 130.09 26.2 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.006 1.322 . . . . 1.0 108.308 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.3 t -106.63 123.05 61.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 C-N-CA 123.944 0.897 . . . . 1.0 108.959 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.9 t -122.1 111.89 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 106.222 -1.77 . . . . 1.0 106.222 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 113.731 1.012 . . . . 1.0 113.731 -167.875 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.4 tt . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 114.138 1.162 . . . . 1.0 114.138 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -44.54 -53.53 14.59 Favored Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 124.912 1.285 . . . . 1.0 112.073 168.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -68.39 -30.55 29.68 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.833 1.689 . . . . 1.0 111.746 -173.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.7 tp -65.31 -52.87 51.16 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 123.908 0.883 . . . . 1.0 111.126 169.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -55.86 -53.2 59.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.78 0.832 . . . . 1.0 112.498 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -69.52 -34.81 74.81 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.837 -0.619 . . . . 1.0 111.696 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.95 -35.41 90.69 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.77 -0.581 . . . . 1.0 112.473 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.4 mt -65.47 -50.08 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.87 1.835 . . . . 1.0 108.707 171.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -69.37 -31.83 70.49 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 120.324 -1.485 . . . . 1.0 113.303 -170.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -105.69 -39.33 6.11 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.309 1.596 . . . . 1.0 115.309 -173.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.9 m -93.29 -22.94 18.69 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.054 0.941 . . . . 1.0 112.901 -176.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.75 -71.33 0.65 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.164 -1.421 . . . . 1.0 107.164 169.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.63 -13.6 1.62 Allowed Glycine 0 CA--C 1.539 1.536 0 C-N-CA 127.413 2.435 . . . . 1.0 116.587 169.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -154.18 141.05 19.18 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 127.342 2.257 . . . . 1.0 108.72 171.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -136.97 125.0 14.63 Favored Pre-proline 0 CA--C 1.544 0.729 0 O-C-N 121.287 -0.883 . . . . 1.0 111.668 -172.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -86.54 -36.63 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.037 2.492 . . . . 1.0 114.967 -174.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -142.53 15.89 2.0 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.534 1.309 . . . . 1.0 114.534 -169.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.3 tp -84.78 138.46 32.59 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.514 -1.366 . . . . 1.0 112.773 -169.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.9 mtm-85 -135.74 156.43 48.83 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 127.944 2.498 . . . . 1.0 109.558 169.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.402 ' CD1' HD13 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -162.44 169.0 21.15 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.186 -0.946 . . . . 1.0 111.587 -177.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -129.58 173.11 19.75 Favored Glycine 0 N--CA 1.475 1.291 0 C-N-CA 124.734 1.159 . . . . 1.0 114.189 170.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.01 141.39 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 114.3 1.222 . . . . 1.0 114.3 -169.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.5 mt -131.94 99.3 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 125.915 1.686 . . . . 1.0 107.11 169.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.3 143.34 26.9 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.575 1.55 . . . . 1.0 111.998 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.2 mp -137.88 161.46 36.56 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.813 0.845 . . . . 1.0 112.966 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.62 0 CA-C-N 116.231 -0.441 . . . . 1.0 114.055 168.748 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.469 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 20.7 p . . . . . 0 CA--C 1.542 0.655 0 N-CA-C 114.376 1.25 . . . . 1.0 114.376 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -60.61 -16.99 44.03 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 115.112 1.523 . . . . 1.0 115.112 -169.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.17 -40.68 98.9 Favored Glycine 0 N--CA 1.474 1.231 0 CA-C-N 120.69 1.586 . . . . 1.0 113.314 173.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.61 -37.34 35.27 Favored Glycine 0 N--CA 1.477 1.392 0 O-C-N 120.974 -1.309 . . . . 1.0 112.806 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.469 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 84.2 mttt -61.29 -33.53 73.72 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 121.155 -1.203 . . . . 1.0 112.857 174.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -63.28 -36.04 82.34 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.523 0.729 . . . . 1.0 112.503 170.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -63.0 -37.19 86.18 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.285 0.948 . . . . 1.0 111.196 172.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -46.96 83.8 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.81 -0.556 . . . . 1.0 111.72 174.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.91 -44.51 78.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.702 -0.666 . . . . 1.0 111.82 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -49.45 57.76 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.862 2.065 . . . . 1.0 112.018 -175.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.402 HD13 ' CD1' ' A' ' 87' ' ' TYR . 7.9 mt -66.37 -41.78 88.96 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.313 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -68.85 -20.03 64.27 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.747 1.017 . . . . 1.0 113.747 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -66.98 -36.14 81.52 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.749 1.22 . . . . 1.0 111.112 172.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -84.26 -75.15 0.35 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 113.777 -1.556 . . . . 1.0 110.336 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.6 m 177.91 -0.55 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.605 2.362 . . . . 1.0 112.024 172.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.83 149.3 34.39 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 122.638 1.208 . . . . 1.0 113.373 -169.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -85.77 171.35 11.64 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.255 1.822 . . . . 1.0 111.884 -169.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 2.2 ttm105 -133.87 152.77 51.97 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.353 1.061 . . . . 1.0 112.135 175.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.0 t -119.1 124.17 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.521 1.528 . . . . 1.0 109.14 -172.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 51.85 -168.03 0.69 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.941 1.257 . . . . 1.0 115.352 -172.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -102.35 145.1 29.98 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.984 1.314 . . . . 1.0 108.563 169.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -78.14 159.81 28.39 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.118 1.155 . . . . 1.0 114.118 -169.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 140' ' ' TRP . 1.4 tm? -85.17 138.48 32.35 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.854 1.261 . . . . 1.0 110.079 170.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.6 mt -127.53 108.76 11.07 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.714 1.605 . . . . 1.0 109.676 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 25.5 mt -97.82 130.76 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 124.045 0.938 . . . . 1.0 112.304 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -105.35 110.24 22.53 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.963 0.905 . . . . 1.0 112.422 170.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.92 -24.57 66.11 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.146 1.378 . . . . 1.0 113.7 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.45 -17.62 64.77 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.896 1.073 . . . . 1.0 113.896 173.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -118.99 -28.72 5.46 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.88 1.672 . . . . 1.0 111.958 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -143.81 86.08 8.83 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 125.41 1.484 . . . . 1.0 111.947 -178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.92 6.06 3.12 Favored 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 123.537 2.825 . . . . 1.0 114.443 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -112.63 70.83 1.16 Allowed Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 127.221 2.208 . . . . 1.0 110.163 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -57.59 -22.16 50.32 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.455 2.104 . . . . 1.0 116.756 -169.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -64.6 -26.19 68.29 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.325 0.966 . . . . 1.0 111.864 174.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 p -73.62 -14.23 61.14 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.864 -1.148 . . . . 1.0 112.1 -175.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -106.99 -55.86 2.27 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 126.811 2.044 . . . . 1.0 111.464 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.9 p -69.49 -33.86 73.48 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.929 1.085 . . . . 1.0 113.929 -177.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -61.15 -57.65 24.49 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 120.623 1.556 . . . . 1.0 112.266 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -62.32 -23.84 75.48 Favored 'Trans proline' 0 C--N 1.353 0.772 0 CA-C-N 121.359 1.521 . . . . 1.0 112.502 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 88.4 t90 -68.15 -46.87 69.6 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 119.104 0.865 . . . . 1.0 111.226 174.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.432 HG11 ' HA ' ' A' ' 22' ' ' ALA . 98.3 t -62.31 -33.57 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 175.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -68.62 -29.85 68.44 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.99 1.316 . . . . 1.0 112.588 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -81.49 -57.96 3.24 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.369 1.467 . . . . 1.0 112.397 170.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 84.4 t90 -56.84 -36.87 70.49 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 125.352 1.461 . . . . 1.0 112.633 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.27 -32.55 21.89 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.531 1.062 . . . . 1.0 113.871 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.8 p -68.14 -14.05 62.69 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.373 1.249 . . . . 1.0 114.373 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.44 -17.68 53.75 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.997 1.719 . . . . 1.0 111.843 175.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.38 172.3 10.5 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.842 1.257 . . . . 1.0 111.269 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 13.5 m . . . . . 0 C--O 1.25 1.086 0 N-CA-C 116.085 1.883 . . . . 1.0 116.085 -169.586 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.349 0 N-CA-C 114.943 1.461 . . . . 1.0 114.943 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -118.86 124.33 46.88 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.221 1.808 . . . . 1.0 110.241 175.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mp -121.75 116.07 48.31 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 C-N-CA 126.937 2.095 . . . . 1.0 112.416 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.91 125.49 8.27 Favored Glycine 0 C--O 1.225 -0.45 0 N-CA-C 110.158 -1.177 . . . . 1.0 110.158 169.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 mt -104.84 117.63 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-N 118.133 0.966 . . . . 1.0 109.21 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -109.29 109.68 20.65 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.732 -1.581 . . . . 1.0 106.732 -171.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.467 0.383 0 N-CA-C 112.543 0.572 . . . . 1.0 112.543 -169.432 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.7 tp . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 115.979 1.844 . . . . 1.0 115.979 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.7 t -44.8 -35.48 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.506 1.522 . . . . 1.0 112.916 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.7 -48.81 79.84 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 120.384 1.447 . . . . 1.0 113.198 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -66.69 -32.72 74.2 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.093 0.957 . . . . 1.0 110.775 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -65.63 -47.47 75.52 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 123.675 0.79 . . . . 1.0 109.287 173.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.35 -42.62 96.14 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 123.385 0.674 . . . . 1.0 112.724 -175.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.68 -48.59 72.21 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.906 0.482 . . . . 1.0 109.777 169.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.53 -37.07 76.96 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.994 0.738 . . . . 1.0 112.994 -175.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.0 mt -70.02 -46.22 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-N 119.194 0.907 . . . . 1.0 109.258 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.78 -34.98 79.62 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 119.606 -0.838 . . . . 1.0 110.088 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.3 m -60.67 -46.14 91.47 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.122 1.369 . . . . 1.0 112.91 169.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.95 -32.64 74.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.341 1.056 . . . . 1.0 112.891 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -70.31 -29.12 65.77 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.932 1.293 . . . . 1.0 112.333 172.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.62 23.02 2.16 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.673 1.13 . . . . 1.0 115.119 169.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -121.34 148.51 44.25 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.563 1.145 . . . . 1.0 110.301 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -79.98 93.56 5.74 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 125.267 1.427 . . . . 1.0 108.69 -175.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.32 147.34 35.32 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.068 0.547 . . . . 1.0 111.373 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 93.0 m -150.08 146.73 27.1 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.518 1.127 . . . . 1.0 111.096 -173.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.5 t -97.98 138.84 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 114.049 1.129 . . . . 1.0 114.049 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -118.12 106.69 13.13 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.726 2.011 . . . . 1.0 110.692 169.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -85.26 146.51 27.02 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.917 1.687 . . . . 1.0 110.909 175.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t0 41.75 57.81 9.7 Favored Pre-proline 0 CA--C 1.557 1.236 0 C-N-CA 124.644 1.177 . . . . 1.0 111.174 -169.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -57.93 130.0 36.13 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 125.122 3.881 . . . . 1.0 118.706 -167.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -91.24 150.53 21.3 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.751 1.62 . . . . 1.0 112.288 168.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -70.15 -25.34 63.41 Favored 'General case' 0 N--CA 1.444 -0.757 0 O-C-N 121.13 -0.981 . . . . 1.0 110.282 168.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.2 m -66.26 -21.67 66.29 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.65 -0.656 . . . . 1.0 112.31 171.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -86.93 -23.79 25.02 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.159 0.983 . . . . 1.0 112.994 169.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 12.3 t-105 -80.16 -34.63 37.44 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.806 1.185 . . . . 1.0 113.778 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.8 mt -50.11 -39.62 48.31 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-O 117.744 -1.122 . . . . 1.0 113.589 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -52.65 -13.36 2.38 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 124.843 3.696 . . . . 1.0 117.892 170.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -112.87 8.02 18.54 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 116.332 1.975 . . . . 1.0 116.332 -176.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -50.86 -30.74 15.31 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.2 1.8 . . . . 1.0 113.642 174.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -107.11 8.13 30.01 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.821 2.049 . . . . 1.0 113.407 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -127.97 -159.66 0.96 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.274 2.229 . . . . 1.0 112.267 -169.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -112.41 159.33 18.83 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 122.805 1.288 . . . . 1.0 110.907 171.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -148.47 154.86 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 124.909 1.284 . . . . 1.0 108.735 -171.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.1 tp -133.99 128.05 33.61 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.06 0.944 . . . . 1.0 108.865 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.5 t -103.75 124.18 57.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 C-N-CA 124.326 1.05 . . . . 1.0 109.184 176.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.9 t -125.39 112.06 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 107.183 -1.414 . . . . 1.0 107.183 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 113.628 0.973 . . . . 1.0 113.628 -168.244 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.2 tt . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 113.407 0.892 . . . . 1.0 113.407 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.8 t -44.15 -52.6 15.69 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 125.302 1.441 . . . . 1.0 112.289 168.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.89 -29.43 18.5 Favored 'Trans proline' 0 C--N 1.35 0.641 0 CA-C-N 120.774 1.312 . . . . 1.0 111.272 -173.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.4 tp -65.08 -50.46 66.06 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 124.046 0.939 . . . . 1.0 110.793 169.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -55.53 -52.13 64.73 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.219 1.008 . . . . 1.0 112.213 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -64.35 -40.34 95.66 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.094 0.958 . . . . 1.0 111.733 176.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.73 -35.81 90.3 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.073 0.844 . . . . 1.0 112.628 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 91.5 mt -64.73 -51.3 69.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 120.071 1.935 . . . . 1.0 107.988 171.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.4 ptmm? -68.59 -31.72 71.1 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.394 -1.441 . . . . 1.0 113.289 -169.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -103.64 -37.25 7.6 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.513 1.671 . . . . 1.0 115.513 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.1 m -96.43 -19.52 19.11 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.416 1.087 . . . . 1.0 113.266 -174.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.15 -73.08 0.57 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.158 -1.423 . . . . 1.0 107.158 169.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.35 -21.43 1.45 Allowed Glycine 0 CA--C 1.536 1.347 0 C-N-CA 127.756 2.598 . . . . 1.0 114.727 169.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -151.19 141.32 22.19 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 128.392 2.677 . . . . 1.0 108.041 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -138.15 121.79 11.45 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.74 0.816 . . . . 1.0 110.165 -169.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -78.55 -38.02 0.59 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.121 1.881 . . . . 1.0 115.822 -169.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -143.98 21.17 1.78 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.129 1.159 . . . . 1.0 114.129 -169.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.8 tp -84.51 140.26 31.58 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.559 -1.338 . . . . 1.0 114.6 -169.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -137.12 155.31 49.76 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 128.64 2.776 . . . . 1.0 108.065 169.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.36 171.81 19.11 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.355 -0.841 . . . . 1.0 111.589 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -131.73 172.25 20.99 Favored Glycine 0 N--CA 1.471 0.974 0 C-N-CA 124.902 1.239 . . . . 1.0 113.415 170.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.57 143.38 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 114.009 1.114 . . . . 1.0 114.009 -169.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.1 mt -133.16 98.17 2.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 106.532 -1.655 . . . . 1.0 106.532 169.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.44 144.12 26.56 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.442 1.497 . . . . 1.0 111.349 171.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.1 mp -140.79 154.98 46.49 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.447 0.906 . . . . 1.0 113.447 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.659 0 N-CA-C 114.227 0.451 . . . . 1.0 114.227 168.957 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 6.9 m . . . . . 0 CA--C 1.548 0.866 0 N-CA-C 113.685 0.994 . . . . 1.0 113.685 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -54.13 -23.14 13.04 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.72 1.608 . . . . 1.0 114.611 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.31 -46.93 85.63 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 120.661 1.573 . . . . 1.0 113.588 175.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.75 -35.6 39.78 Favored Glycine 0 N--CA 1.478 1.435 0 O-C-N 120.766 -1.432 . . . . 1.0 113.141 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -60.59 -32.4 71.52 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 121.264 -1.139 . . . . 1.0 112.86 172.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -66.82 -34.99 79.02 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.033 0.933 . . . . 1.0 112.361 169.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -62.75 -35.45 79.83 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.603 1.092 . . . . 1.0 111.136 170.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -65.99 -49.04 69.23 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.804 -0.56 . . . . 1.0 111.062 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.5 -33.58 66.14 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.876 0.871 . . . . 1.0 113.272 174.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.91 -50.59 72.81 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 123.117 1.437 . . . . 1.0 110.867 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.6 mt -65.68 -40.03 91.93 Favored 'General case' 0 C--N 1.321 -0.67 0 O-C-N 121.074 -1.016 . . . . 1.0 111.478 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -67.17 -20.52 65.75 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.534 0.938 . . . . 1.0 113.534 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.03 -17.06 57.51 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.589 1.086 . . . . 1.0 111.112 177.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -100.42 -73.57 0.63 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.8 1.24 . . . . 1.0 109.75 -178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 77.4 p -179.37 -19.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.165 1.786 . . . . 1.0 114.147 -174.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.69 161.1 31.4 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 123.14 1.448 . . . . 1.0 114.139 -169.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -98.47 179.53 4.68 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.306 1.842 . . . . 1.0 110.934 -170.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.0 ttm105 -131.37 158.35 40.97 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.519 1.127 . . . . 1.0 112.828 169.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.9 t -96.96 -173.44 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 C-N-CA 126.493 1.917 . . . . 1.0 106.394 169.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.49 164.69 3.06 Favored Glycine 0 CA--C 1.545 1.919 0 N-CA-C 116.924 1.529 . . . . 1.0 116.924 -170.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -43.75 131.42 5.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.859 2.064 . . . . 1.0 113.953 -175.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -74.16 157.62 35.63 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.333 1.053 . . . . 1.0 111.869 -172.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.427 ' HB2' ' CD1' ' A' ' 140' ' ' TRP . 1.4 tm? -91.48 137.27 32.49 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.215 -0.902 . . . . 1.0 110.353 174.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.6 mt -127.26 110.69 13.11 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.844 1.657 . . . . 1.0 109.445 174.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 24.0 mt -99.15 131.5 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 124.085 0.954 . . . . 1.0 112.582 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -104.31 108.97 20.62 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.118 0.967 . . . . 1.0 112.606 170.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.43 -24.99 66.54 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.88 1.272 . . . . 1.0 113.775 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.64 -17.46 64.61 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.776 1.028 . . . . 1.0 113.776 173.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -116.46 -29.28 6.21 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.677 1.591 . . . . 1.0 111.633 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -145.16 87.73 7.04 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 125.323 1.449 . . . . 1.0 111.901 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.98 5.01 3.24 Favored 'Trans proline' 0 CA--C 1.549 1.247 0 C-N-CA 123.689 2.926 . . . . 1.0 114.731 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -113.72 71.02 1.75 Allowed Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 127.179 2.192 . . . . 1.0 109.634 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -54.93 -28.3 58.39 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.391 2.061 . . . . 1.0 115.845 -169.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -62.99 -24.38 67.89 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.611 0.642 . . . . 1.0 112.006 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.1 p -75.08 -16.57 60.56 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 120.612 -1.305 . . . . 1.0 111.82 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -101.56 -55.68 2.47 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.371 1.868 . . . . 1.0 111.438 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 90.7 p -65.23 -34.13 77.62 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 113.779 1.029 . . . . 1.0 113.779 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 -64.03 -55.2 34.13 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 120.501 1.501 . . . . 1.0 112.92 -175.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -62.1 -24.42 76.47 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 CA-C-N 121.328 1.51 . . . . 1.0 112.849 172.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.427 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 87.5 t90 -68.28 -45.44 73.07 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 118.592 0.633 . . . . 1.0 111.314 173.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 83.3 t -66.41 -33.64 64.82 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -63.69 -48.77 75.79 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.225 -0.922 . . . . 1.0 109.528 173.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -63.99 -54.98 25.85 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.489 1.116 . . . . 1.0 111.827 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -58.49 -35.61 72.49 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 125.611 1.564 . . . . 1.0 111.76 174.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.19 -34.53 25.06 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.583 1.563 . . . . 1.0 113.458 171.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.9 p -67.82 -12.99 61.76 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.826 1.417 . . . . 1.0 114.826 176.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.35 -16.29 49.74 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.869 1.667 . . . . 1.0 112.072 176.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.57 -179.56 7.47 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.289 1.036 . . . . 1.0 110.924 -177.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 C--O 1.25 1.129 0 C-N-CA 126.202 1.801 . . . . 1.0 114.52 -175.549 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.405 0 N-CA-C 112.905 0.706 . . . . 1.0 112.905 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -120.84 123.83 43.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.08 1.352 . . . . 1.0 110.502 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 mp -120.43 112.79 37.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 C-N-CA 126.632 1.973 . . . . 1.0 112.497 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.61 124.27 7.3 Favored Glycine 0 C--O 1.223 -0.561 0 N-CA-C 110.328 -1.109 . . . . 1.0 110.328 169.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.5 mt -105.27 119.23 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-N 118.614 1.207 . . . . 1.0 109.691 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -110.01 107.45 17.33 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.181 -1.414 . . . . 1.0 107.181 -170.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.4 p . . . . . 0 N--CA 1.466 0.354 0 CA-C-O 121.484 0.659 . . . . 1.0 111.105 -172.742 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.1 tp . . . . . 0 C--O 1.225 -0.231 0 N-CA-C 109.935 -0.394 . . . . 1.0 109.935 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.7 t -56.01 -34.43 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.176 0.59 . . . . 1.0 111.243 -173.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.44 -45.57 88.27 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.783 -1.198 . . . . 1.0 113.414 173.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -68.81 -30.36 68.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.303 0.573 . . . . 1.0 111.048 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -68.18 -47.11 68.85 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 123.761 0.824 . . . . 1.0 109.109 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.443 ' HA ' HG12 ' A' ' 141' ' ' VAL . . . -64.32 -43.32 95.04 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 123.56 0.744 . . . . 1.0 112.804 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -53.57 -48.67 68.97 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.092 0.957 . . . . 1.0 110.456 170.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.31 -37.97 71.76 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.593 0.757 . . . . 1.0 112.285 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.0 mt -68.79 -45.83 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 O-C-N 121.63 -0.669 . . . . 1.0 109.338 175.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.99 -31.45 72.36 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.495 1.043 . . . . 1.0 110.649 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.4 m -63.12 -45.04 93.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.586 1.154 . . . . 1.0 112.711 169.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.08 -31.36 70.93 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.799 1.239 . . . . 1.0 113.032 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -67.68 -29.03 68.2 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.211 1.804 . . . . 1.0 111.695 172.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.43 28.27 2.39 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.715 1.15 . . . . 1.0 114.905 171.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -120.52 164.39 16.51 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.016 1.326 . . . . 1.0 110.169 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -93.44 89.81 6.47 Favored 'General case' 0 CA--C 1.52 -0.183 0 O-C-N 120.659 -1.275 . . . . 1.0 108.559 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.16 145.87 29.57 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 122.766 0.426 . . . . 1.0 111.22 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.7 m -147.77 139.08 23.61 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.864 0.866 . . . . 1.0 112.041 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.4 t -86.93 137.72 20.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 114.916 1.45 . . . . 1.0 114.916 172.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -117.89 113.74 22.19 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.85 2.06 . . . . 1.0 110.32 171.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -94.7 137.75 33.4 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.686 1.994 . . . . 1.0 111.158 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.5 t70 41.79 55.37 9.07 Favored Pre-proline 0 CA--C 1.559 1.293 0 C-N-CA 124.61 1.164 . . . . 1.0 111.08 -169.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -68.59 145.63 64.71 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.016 3.144 . . . . 1.0 117.638 -167.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -88.79 154.5 20.22 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.892 1.677 . . . . 1.0 112.442 168.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -69.41 -21.72 63.74 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 120.899 -1.125 . . . . 1.0 109.762 168.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.1 m -66.13 -22.89 66.4 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.284 -0.885 . . . . 1.0 112.332 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -82.52 -24.94 33.87 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.136 0.974 . . . . 1.0 113.098 169.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.8 t-105 -83.9 -35.54 24.01 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.799 1.182 . . . . 1.0 113.994 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.3 mt -48.16 -39.17 25.32 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-O 117.58 -1.2 . . . . 1.0 113.897 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -55.31 -14.98 10.27 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.306 3.337 . . . . 1.0 117.224 172.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -109.03 8.24 26.12 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 116.027 1.862 . . . . 1.0 116.027 -174.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -52.98 -23.47 7.38 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.977 2.111 . . . . 1.0 114.218 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -124.91 17.74 8.57 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.546 1.538 . . . . 1.0 113.484 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -126.47 -158.24 0.85 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.936 2.494 . . . . 1.0 110.345 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -116.79 161.85 18.63 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 122.984 1.373 . . . . 1.0 112.313 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.08 160.59 4.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 125.14 1.376 . . . . 1.0 108.966 -172.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.4 tp -138.17 130.05 28.35 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.007 1.323 . . . . 1.0 108.369 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.8 t -105.23 124.21 59.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 124.088 0.955 . . . . 1.0 109.03 174.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.1 t -122.26 111.86 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 105.476 -2.046 . . . . 1.0 105.476 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 114.227 1.195 . . . . 1.0 114.227 -167.536 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.0 tt . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 114.477 1.288 . . . . 1.0 114.477 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.9 t -44.06 -52.73 15.0 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 124.424 1.09 . . . . 1.0 112.912 168.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.36 -31.48 17.77 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.686 1.591 . . . . 1.0 111.757 -172.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.2 tp -62.67 -52.16 64.4 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 124.602 1.161 . . . . 1.0 111.336 169.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -55.83 -51.44 67.49 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.718 0.807 . . . . 1.0 112.65 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -63.15 -39.32 94.31 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.424 0.69 . . . . 1.0 111.682 176.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.18 -34.65 81.37 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 123.801 0.715 . . . . 1.0 113.009 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 91.6 mt -65.66 -44.14 93.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 120.354 2.077 . . . . 1.0 108.866 171.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? -74.39 -32.01 62.55 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.304 -1.498 . . . . 1.0 113.415 -173.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -106.55 -38.57 6.12 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 115.138 1.532 . . . . 1.0 115.138 -174.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.7 m -91.06 -25.05 19.84 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.252 1.021 . . . . 1.0 112.712 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.04 -71.06 0.65 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 107.497 -1.297 . . . . 1.0 107.497 169.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.0 -8.22 2.66 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 126.369 1.938 . . . . 1.0 115.481 171.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -156.0 147.97 23.24 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 129.322 3.049 . . . . 1.0 107.023 171.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -134.84 127.92 18.57 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.113 0.565 . . . . 1.0 111.037 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -81.3 -44.65 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 121.847 1.698 . . . . 1.0 113.485 -172.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -148.49 28.11 0.89 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.674 1.189 . . . . 1.0 112.88 -172.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.4 tp -85.51 137.95 32.54 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.691 -1.256 . . . . 1.0 112.682 -169.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.2 mtm-85 -134.46 157.71 45.77 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.461 2.305 . . . . 1.0 109.153 169.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.429 ' CD1' HD13 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -163.24 169.41 19.24 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.136 0.88 . . . . 1.0 111.441 -177.591 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -129.92 173.47 19.8 Favored Glycine 0 N--CA 1.469 0.848 0 C-N-CA 124.096 0.855 . . . . 1.0 113.558 169.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.55 140.81 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 114.133 1.16 . . . . 1.0 114.133 -169.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.6 mt -131.57 97.23 2.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 106.841 -1.54 . . . . 1.0 106.841 168.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.12 148.97 28.24 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.806 1.242 . . . . 1.0 111.47 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.7 mp -141.61 151.61 43.28 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.853 0.686 . . . . 1.0 112.853 176.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.531 0 C-N-CA 121.691 -0.29 . . . . 1.0 112.691 169.287 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 9.5 m . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 113.469 0.914 . . . . 1.0 113.469 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -63.0 -12.37 25.37 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.861 1.265 . . . . 1.0 114.289 -174.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.36 -39.37 97.15 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-N 120.308 1.413 . . . . 1.0 113.599 171.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -77.25 -36.04 36.08 Favored Glycine 0 N--CA 1.477 1.432 0 O-C-N 120.616 -1.52 . . . . 1.0 112.737 172.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -62.85 -31.62 72.67 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.256 -1.144 . . . . 1.0 112.469 173.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -62.52 -41.21 98.71 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.211 1.004 . . . . 1.0 111.071 169.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -62.8 -38.67 91.61 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 118.804 0.729 . . . . 1.0 111.41 174.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -61.86 -48.63 79.65 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.387 -0.821 . . . . 1.0 112.316 173.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.95 -35.28 70.91 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.278 0.631 . . . . 1.0 112.699 174.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.68 -49.22 78.37 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 125.456 1.502 . . . . 1.0 111.079 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.429 HD13 ' CD1' ' A' ' 87' ' ' TYR . 11.0 mt -67.31 -40.21 85.99 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 120.9 -1.125 . . . . 1.0 111.762 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -70.15 -18.69 63.22 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.244 0.831 . . . . 1.0 113.244 176.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.75 -18.45 59.55 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.674 1.124 . . . . 1.0 111.198 175.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -97.23 -72.83 0.63 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.089 1.355 . . . . 1.0 109.608 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.6 p 176.54 -18.04 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.476 2.31 . . . . 1.0 113.348 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.44 151.54 46.68 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 123.149 1.452 . . . . 1.0 114.457 -169.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -90.93 168.07 11.96 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.73 2.012 . . . . 1.0 114.006 -168.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.97 154.43 27.61 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.172 2.189 . . . . 1.0 111.454 176.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.1 t -124.92 129.46 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.301 1.441 . . . . 1.0 108.764 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 49.79 -154.49 2.7 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 125.328 1.442 . . . . 1.0 115.279 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -111.52 143.35 42.51 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.31 1.844 . . . . 1.0 109.914 169.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -77.07 156.46 31.74 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.731 0.777 . . . . 1.0 112.257 -173.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.442 HD21 ' CD1' ' A' ' 140' ' ' TRP . 0.8 OUTLIER -92.26 137.15 32.61 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 123.87 0.868 . . . . 1.0 110.291 174.118 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.2 mt -123.16 102.54 8.01 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.825 1.25 . . . . 1.0 110.532 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.7 mt -79.41 133.21 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 C-N-CA 124.461 1.104 . . . . 1.0 111.22 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -109.48 106.98 16.94 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 122.374 1.083 . . . . 1.0 113.448 172.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.21 -23.47 64.82 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.093 0.957 . . . . 1.0 113.26 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.2 t -62.91 -22.97 67.13 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.371 1.068 . . . . 1.0 112.665 174.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -120.0 -29.6 4.89 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.361 1.864 . . . . 1.0 111.925 -174.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -144.8 84.68 8.79 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.756 1.622 . . . . 1.0 112.058 -172.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -73.65 8.25 2.0 Allowed 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 123.635 2.89 . . . . 1.0 114.495 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -111.54 71.17 0.88 Allowed Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 127.953 2.501 . . . . 1.0 109.551 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -57.67 -22.21 51.21 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.696 2.264 . . . . 1.0 116.554 -169.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -64.48 -26.16 68.31 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 118.963 0.802 . . . . 1.0 111.758 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.7 p -77.12 -19.05 57.45 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 120.434 -1.416 . . . . 1.0 112.046 -174.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -94.82 -51.99 4.45 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.028 1.331 . . . . 1.0 111.883 172.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.8 p -72.17 -35.58 69.06 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 115.078 1.51 . . . . 1.0 115.078 -176.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -59.85 -55.04 49.65 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 120.612 1.551 . . . . 1.0 112.54 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -63.35 -23.12 71.94 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 121.482 1.565 . . . . 1.0 112.515 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.442 ' CD1' HD21 ' A' ' 123' ' ' LEU . 89.6 t90 -69.19 -46.75 66.7 Favored 'General case' 0 C--O 1.218 -0.572 0 O-C-N 121.828 -0.545 . . . . 1.0 110.846 174.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 22' ' ' ALA . 91.7 t -64.77 -32.25 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.877 0.846 . . . . 1.0 108.85 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -71.82 -23.51 61.56 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.154 -1.591 . . . . 1.0 113.292 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -86.91 -61.21 1.78 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.867 2.067 . . . . 1.0 111.698 169.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 89.4 t90 -54.72 -37.68 66.18 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 126.715 2.006 . . . . 1.0 112.658 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.85 -29.57 34.44 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 121.519 -0.738 . . . . 1.0 114.383 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.2 p -69.05 -13.47 62.46 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.273 1.212 . . . . 1.0 114.273 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.43 -18.33 52.43 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.651 1.58 . . . . 1.0 111.833 176.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.41 171.79 12.31 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.672 1.189 . . . . 1.0 110.964 -176.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 C--O 1.253 1.253 0 N-CA-C 116.17 1.915 . . . . 1.0 116.17 -169.67 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.331 0 N-CA-C 113.116 0.784 . . . . 1.0 113.116 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -120.17 122.34 40.77 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.454 1.502 . . . . 1.0 110.231 174.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 mp -122.4 113.36 38.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 126.622 1.969 . . . . 1.0 111.972 -176.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.9 124.52 7.58 Favored Glycine 0 C--O 1.224 -0.52 0 N-CA-C 110.263 -1.135 . . . . 1.0 110.263 169.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 mt -105.44 123.96 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-N 118.069 0.934 . . . . 1.0 109.225 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -115.47 109.35 17.71 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 124.195 0.998 . . . . 1.0 108.368 -169.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.535 0.384 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.105 -177.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.1 tp . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 116.683 2.105 . . . . 1.0 116.683 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.4 t -53.34 -33.67 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.968 0.907 . . . . 1.0 112.914 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.46 -46.84 87.62 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 120.285 1.402 . . . . 1.0 112.48 173.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -68.64 -32.09 71.7 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.077 0.951 . . . . 1.0 111.046 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -65.21 -49.12 70.91 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.982 -0.748 . . . . 1.0 108.982 171.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.4 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.19 -42.41 93.6 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 112.983 0.734 . . . . 1.0 112.983 -172.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -53.95 -49.99 67.48 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.701 0.8 . . . . 1.0 110.09 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.83 -35.64 74.94 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 112.625 0.602 . . . . 1.0 112.625 -175.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.1 mt -70.47 -46.01 72.29 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 119.063 0.847 . . . . 1.0 109.658 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.72 -33.6 76.25 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 119.863 -0.735 . . . . 1.0 110.189 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 54.0 m -61.96 -44.6 96.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.058 1.343 . . . . 1.0 113.085 169.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.78 -32.03 73.05 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.196 0.998 . . . . 1.0 112.92 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -70.03 -29.43 66.47 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.846 1.259 . . . . 1.0 112.279 171.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.13 21.8 2.49 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.723 1.154 . . . . 1.0 115.056 169.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -114.24 158.39 21.44 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.816 1.246 . . . . 1.0 110.792 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -86.03 89.47 7.81 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 125.461 1.504 . . . . 1.0 108.587 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.23 145.35 31.68 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 122.446 0.298 . . . . 1.0 111.123 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 78.6 m -148.08 138.71 23.0 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.642 0.777 . . . . 1.0 112.018 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.7 t -85.57 134.58 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.726 1.21 . . . . 1.0 114.151 171.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -110.3 109.9 20.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.799 1.64 . . . . 1.0 110.385 169.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -87.47 137.52 32.27 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.113 1.765 . . . . 1.0 111.115 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.2 t0 40.89 56.85 8.34 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 124.868 1.267 . . . . 1.0 111.354 -169.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -68.9 140.95 47.37 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.898 3.065 . . . . 1.0 116.973 -168.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.465 ' HB3' ' H ' ' A' ' 42' ' ' SER . 52.6 mm-40 -93.83 163.47 13.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 122.357 1.075 . . . . 1.0 111.847 168.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -65.86 -22.04 66.51 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 120.886 -1.134 . . . . 1.0 109.796 167.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.465 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 17.9 m -68.3 -19.7 64.71 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.878 -1.139 . . . . 1.0 112.613 172.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -83.1 -24.69 32.53 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.385 1.074 . . . . 1.0 112.444 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 -88.68 -34.56 17.17 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.075 1.139 . . . . 1.0 114.075 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.9 mt -48.09 -38.57 20.96 Favored Pre-proline 0 CA--C 1.554 1.109 0 CA-C-O 117.608 -1.186 . . . . 1.0 114.103 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.71 -11.68 21.7 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.132 3.221 . . . . 1.0 116.352 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -109.36 6.9 24.8 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 116.095 1.887 . . . . 1.0 116.095 -174.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -52.88 -31.02 37.3 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.88 2.072 . . . . 1.0 113.723 172.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -109.81 11.5 24.33 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.176 1.391 . . . . 1.0 112.499 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -124.83 -159.03 0.86 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.904 2.482 . . . . 1.0 111.034 -174.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -116.13 162.85 16.82 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 122.874 1.321 . . . . 1.0 111.834 170.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.93 160.52 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.432 1.093 . . . . 1.0 109.182 -172.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.8 tp -139.29 128.0 23.29 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.68 1.192 . . . . 1.0 108.924 175.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.1 t -100.52 128.3 52.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 174.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.4 t -126.04 110.92 25.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 106.254 -1.758 . . . . 1.0 106.254 175.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 113.228 0.825 . . . . 1.0 113.228 -168.15 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.2 tt . . . . . 0 N--CA 1.471 0.575 0 N-CA-C 113.712 1.004 . . . . 1.0 113.712 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.1 t -44.96 -53.27 16.48 Favored Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 124.444 1.098 . . . . 1.0 112.238 168.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -68.09 -32.38 27.89 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.747 1.631 . . . . 1.0 111.819 -173.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.2 tp -63.15 -53.24 56.51 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 124.429 1.092 . . . . 1.0 111.259 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -55.2 -53.75 52.09 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.747 0.819 . . . . 1.0 112.393 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -68.38 -35.1 77.21 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.769 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.36 -35.3 90.02 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 121.709 -0.62 . . . . 1.0 112.585 175.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 88.7 mt -65.98 -50.14 71.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 119.926 1.863 . . . . 1.0 108.414 171.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.6 ptmm? -69.35 -32.28 71.27 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.222 -1.549 . . . . 1.0 113.145 -170.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -104.61 -40.47 6.01 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.054 1.501 . . . . 1.0 115.054 -174.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.3 m -92.01 -24.13 19.31 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.006 0.922 . . . . 1.0 113.011 -175.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.1 -71.04 0.65 Allowed 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 106.804 -1.554 . . . . 1.0 106.804 169.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.43 -13.53 1.11 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 127.61 2.529 . . . . 1.0 117.011 168.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -155.24 140.39 17.5 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.557 2.343 . . . . 1.0 108.398 172.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -136.33 128.41 17.28 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 121.328 -0.858 . . . . 1.0 112.028 -172.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -89.3 -34.98 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.948 2.432 . . . . 1.0 115.123 -175.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -142.52 12.97 1.94 Allowed 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 115.138 1.533 . . . . 1.0 115.138 -169.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.9 tp -84.39 132.7 34.56 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.51 -1.369 . . . . 1.0 113.362 -169.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.7 mtm-85 -130.32 153.64 48.46 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.395 1.878 . . . . 1.0 109.716 169.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.414 ' CD1' HD11 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -160.82 165.27 30.53 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.548 1.067 . . . . 1.0 112.277 -176.46 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -124.0 173.37 16.68 Favored Glycine 0 N--CA 1.467 0.726 0 C-N-CA 125.401 1.476 . . . . 1.0 112.109 169.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -159.54 142.54 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 O-C-N 120.854 -1.38 . . . . 1.0 114.416 -169.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.9 mt -132.01 109.72 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 126.806 2.043 . . . . 1.0 108.24 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.11 145.47 24.49 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.192 1.397 . . . . 1.0 110.846 172.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.9 mp -137.09 152.41 49.99 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.466 0.706 . . . . 1.0 112.222 177.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.629 0 CA-C-N 116.354 -0.384 . . . . 1.0 112.421 169.342 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.551 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 19.8 p . . . . . 0 CA--C 1.537 0.476 0 N-CA-C 114.017 1.118 . . . . 1.0 114.017 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -57.44 -21.41 36.75 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.477 1.288 . . . . 1.0 114.477 -173.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -54.21 -44.24 74.74 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 120.592 1.542 . . . . 1.0 113.467 174.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -79.54 -36.61 25.93 Favored Glycine 0 N--CA 1.479 1.547 0 O-C-N 120.993 -1.298 . . . . 1.0 113.476 174.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.551 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 78.7 mttt -60.04 -34.41 73.35 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.207 1.004 . . . . 1.0 112.789 174.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -64.79 -38.28 90.46 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.159 0.984 . . . . 1.0 111.914 172.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -64.25 -37.71 88.44 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.421 1.009 . . . . 1.0 111.036 173.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.53 -43.57 93.6 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.132 0.573 . . . . 1.0 112.229 176.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.41 82.77 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.857 -0.592 . . . . 1.0 111.754 170.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.46 -49.46 45.28 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.868 2.067 . . . . 1.0 111.939 -173.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.414 HD11 ' CD1' ' A' ' 87' ' ' TYR . 8.5 mt -65.59 -43.96 88.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.463 -0.79 . . . . 1.0 111.005 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -67.1 -21.68 65.85 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.941 1.089 . . . . 1.0 113.941 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -66.13 -36.47 83.24 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.415 1.086 . . . . 1.0 110.938 173.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -81.02 -77.61 0.2 Allowed 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 113.996 -1.456 . . . . 1.0 109.888 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.7 t -179.72 -2.34 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.195 2.198 . . . . 1.0 111.498 170.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.19 146.8 43.11 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 114.819 1.415 . . . . 1.0 114.819 -168.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.13 167.31 18.88 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.657 2.383 . . . . 1.0 114.896 -168.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.43 149.5 42.92 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.907 2.083 . . . . 1.0 111.693 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.8 t -123.93 128.66 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.775 1.63 . . . . 1.0 108.497 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 50.25 -155.03 2.82 Favored Glycine 0 CA--C 1.542 1.77 0 C-N-CA 124.908 1.242 . . . . 1.0 114.988 -171.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -114.59 144.38 43.49 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.317 1.847 . . . . 1.0 109.962 169.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.18 155.71 39.34 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 122.134 0.969 . . . . 1.0 111.424 -174.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.446 HD21 ' CD1' ' A' ' 140' ' ' TRP . 0.9 OUTLIER -93.73 140.04 30.11 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.309 1.043 . . . . 1.0 110.197 176.16 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.7 mt -124.83 102.13 7.41 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.082 1.353 . . . . 1.0 110.891 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.403 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.2 mt -86.11 128.75 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.576 1.55 . . . . 1.0 111.909 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -108.03 110.5 22.21 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 124.328 1.018 . . . . 1.0 112.261 174.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -70.13 -23.3 63.0 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.132 0.973 . . . . 1.0 112.79 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.5 t -62.77 -23.17 67.08 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.291 1.036 . . . . 1.0 112.73 173.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -119.27 -29.94 5.06 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.293 1.837 . . . . 1.0 112.2 -173.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -143.79 91.11 6.76 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 125.196 1.398 . . . . 1.0 112.603 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.76 7.17 3.28 Favored 'Trans proline' 0 CA--C 1.552 1.39 0 C-N-CA 123.414 2.743 . . . . 1.0 114.483 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -110.07 71.52 0.61 Allowed Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 127.307 2.243 . . . . 1.0 110.116 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -58.34 -18.8 39.92 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.803 2.335 . . . . 1.0 117.629 -168.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -69.47 -25.45 64.09 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.122 1.328 . . . . 1.0 111.644 172.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 28.0 p -72.78 -22.85 60.77 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.942 1.246 . . . . 1.0 111.969 -173.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -91.01 -54.2 4.06 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.654 1.582 . . . . 1.0 111.767 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.7 p -70.88 -32.78 69.87 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 115.022 1.489 . . . . 1.0 115.022 -176.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -58.42 -55.62 43.79 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 120.94 1.7 . . . . 1.0 112.705 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -64.32 -24.45 64.82 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 CA-C-N 121.277 1.492 . . . . 1.0 113.134 174.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.446 ' CD1' HD21 ' A' ' 123' ' ' LEU . 92.2 t90 -68.0 -48.2 66.4 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 118.795 0.725 . . . . 1.0 110.728 174.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' A' ' 22' ' ' ALA . 96.2 t -67.04 -33.09 61.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 C-N-CA 122.842 0.457 . . . . 1.0 110.044 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.59 -48.9 73.22 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.02 -1.05 . . . . 1.0 109.785 173.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -64.35 -54.77 27.68 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.539 1.136 . . . . 1.0 112.102 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 87.3 t90 -56.24 -37.17 69.37 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 125.886 1.674 . . . . 1.0 111.401 173.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -49.99 -34.1 22.67 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.505 1.526 . . . . 1.0 113.482 173.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.6 p -68.78 -13.37 62.35 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 115.097 1.518 . . . . 1.0 115.097 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.61 -20.03 44.13 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.619 1.568 . . . . 1.0 111.778 176.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -84.18 172.5 11.85 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.65 1.18 . . . . 1.0 110.879 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--O 1.252 1.222 0 C-N-CA 124.655 1.182 . . . . 1.0 113.941 -176.052 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 112.822 0.675 . . . . 1.0 112.822 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -122.89 121.56 36.48 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.562 1.545 . . . . 1.0 110.845 177.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mp -121.77 117.79 53.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 127.418 2.287 . . . . 1.0 112.65 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.32 125.7 8.47 Favored Glycine 0 N--CA 1.465 0.615 0 N-CA-C 110.785 -0.926 . . . . 1.0 110.785 169.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.6 mt -104.61 120.77 55.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-N 118.565 1.183 . . . . 1.0 109.81 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -113.13 111.18 21.67 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 125.109 1.363 . . . . 1.0 107.638 -171.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.468 0.456 0 N-CA-C 112.515 0.561 . . . . 1.0 112.515 -170.328 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.8 tp . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 115.936 1.828 . . . . 1.0 115.936 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.7 t -52.0 -33.52 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 118.782 0.719 . . . . 1.0 112.602 -176.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.89 -49.91 76.0 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.001 -1.062 . . . . 1.0 113.048 173.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.73 -28.15 62.48 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.256 0.622 . . . . 1.0 110.771 -178.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -62.13 -49.42 75.94 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.122 -1.066 . . . . 1.0 108.122 169.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.406 ' HA ' HG13 ' A' ' 141' ' ' VAL . . . -65.02 -42.41 94.44 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 112.725 0.639 . . . . 1.0 112.725 -173.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.87 -49.67 70.58 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.196 0.598 . . . . 1.0 110.145 169.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.66 -35.76 77.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.381 0.512 . . . . 1.0 112.381 -175.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.7 mt -71.82 -45.42 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 O-C-N 121.023 -1.048 . . . . 1.0 109.71 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.62 -33.46 75.96 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 119.572 -0.851 . . . . 1.0 110.049 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.2 m -61.86 -45.09 95.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.206 1.402 . . . . 1.0 113.084 169.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.07 -32.26 73.63 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.343 1.057 . . . . 1.0 112.888 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -70.97 -28.37 64.41 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.901 1.281 . . . . 1.0 112.578 172.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.14 27.11 2.11 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.721 1.153 . . . . 1.0 114.622 170.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -121.95 148.9 44.2 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.67 1.188 . . . . 1.0 110.415 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -77.43 101.33 6.35 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 125.4 1.48 . . . . 1.0 108.092 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.48 148.06 42.98 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 122.745 0.418 . . . . 1.0 110.937 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.5 m -149.54 146.61 27.45 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.305 1.042 . . . . 1.0 111.749 -172.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.1 t -97.9 137.18 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 114.485 1.291 . . . . 1.0 114.485 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -119.93 109.24 15.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.659 1.984 . . . . 1.0 110.878 169.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -89.82 139.94 30.09 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.462 1.905 . . . . 1.0 111.235 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t0 40.93 55.73 7.92 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 124.869 1.267 . . . . 1.0 111.613 -169.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -71.03 144.01 46.22 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.949 3.099 . . . . 1.0 117.606 -168.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -86.51 155.87 20.33 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.637 1.575 . . . . 1.0 112.616 168.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -68.5 -23.46 64.55 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 120.595 -1.316 . . . . 1.0 109.887 168.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.6 m -66.25 -21.35 66.28 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.5 -0.75 . . . . 1.0 112.488 170.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -85.31 -24.52 27.64 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.488 1.115 . . . . 1.0 112.928 169.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.9 t-105 -82.13 -35.51 28.43 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.86 1.209 . . . . 1.0 113.743 175.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.5 mt -50.57 -39.8 54.88 Favored Pre-proline 0 CA--C 1.552 1.039 0 CA-C-O 117.678 -1.153 . . . . 1.0 113.781 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -55.07 -14.47 8.55 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 124.059 3.173 . . . . 1.0 117.023 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -110.46 9.98 23.28 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 115.391 1.626 . . . . 1.0 115.391 -175.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -53.26 -34.91 59.16 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.281 1.832 . . . . 1.0 113.463 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.33 -0.6 38.07 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.462 1.505 . . . . 1.0 113.379 177.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -111.03 -164.7 0.93 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.695 2.398 . . . . 1.0 111.108 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -109.4 165.66 11.47 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 122.871 1.32 . . . . 1.0 111.359 169.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.62 160.85 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.91 1.284 . . . . 1.0 109.677 -171.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.1 tp -142.37 124.76 15.63 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.949 0.9 . . . . 1.0 108.975 177.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.9 t -99.26 123.43 51.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 123.86 0.864 . . . . 1.0 109.244 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.2 t -121.64 115.81 47.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.984 -1.858 . . . . 1.0 105.984 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 113.283 0.845 . . . . 1.0 113.283 -168.632 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.2 tt . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 114.057 1.132 . . . . 1.0 114.057 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.8 t -48.16 -51.7 47.23 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 125.047 1.339 . . . . 1.0 111.918 168.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.47 -31.59 21.5 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.32 1.347 . . . . 1.0 111.259 -173.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.2 tp -63.11 -51.52 66.23 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.747 1.219 . . . . 1.0 111.205 169.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -52.86 -55.12 25.51 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.706 1.203 . . . . 1.0 112.544 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -67.65 -35.55 79.08 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.753 -0.658 . . . . 1.0 111.8 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.62 -36.72 92.78 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.586 0.613 . . . . 1.0 112.566 176.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 92.3 mt -64.37 -50.94 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 120.114 1.957 . . . . 1.0 108.111 171.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.7 ptmm? -67.91 -31.76 71.75 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.561 -1.337 . . . . 1.0 113.281 -170.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -103.74 -37.37 7.5 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.63 1.572 . . . . 1.0 115.157 -175.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.8 m -97.06 -19.17 18.9 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.566 1.146 . . . . 1.0 113.235 -174.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.07 -72.27 0.62 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 107.086 -1.45 . . . . 1.0 107.086 169.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.65 -20.8 1.3 Allowed Glycine 0 CA--C 1.539 1.567 0 C-N-CA 127.715 2.579 . . . . 1.0 114.873 170.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -152.73 141.84 21.35 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 128.528 2.731 . . . . 1.0 107.985 169.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -137.6 119.57 10.98 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.016 0.926 . . . . 1.0 109.485 -170.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.03 -36.49 1.95 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.223 1.949 . . . . 1.0 115.737 -169.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -144.4 18.46 1.71 Allowed 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.993 1.109 . . . . 1.0 113.993 -169.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.6 tp -82.22 139.93 33.98 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 120.681 -1.262 . . . . 1.0 113.441 -169.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.7 mtm-85 -136.6 152.82 50.87 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.976 2.51 . . . . 1.0 109.56 169.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.407 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -161.22 168.14 24.71 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.467 1.03 . . . . 1.0 112.854 -175.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -124.8 171.36 16.86 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.176 1.37 . . . . 1.0 113.908 173.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 88.3 t -143.57 133.5 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.639 1.175 . . . . 1.0 113.585 -169.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.2 mt -130.63 103.53 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.144 1.778 . . . . 1.0 108.293 170.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.83 142.28 27.5 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.224 1.409 . . . . 1.0 111.656 173.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.9 mp -138.71 150.17 45.88 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.414 -0.804 . . . . 1.0 113.079 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.686 0 CA-C-N 116.676 -0.238 . . . . 1.0 113.042 169.317 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.44 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 22.3 p . . . . . 0 CA--C 1.537 0.48 0 N-CA-C 114.889 1.44 . . . . 1.0 114.889 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -54.46 -22.87 13.92 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 124.801 1.24 . . . . 1.0 114.271 -173.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.19 -49.05 70.21 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 121.121 1.782 . . . . 1.0 113.829 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -72.14 -35.1 60.98 Favored Glycine 0 N--CA 1.477 1.38 0 O-C-N 120.72 -1.459 . . . . 1.0 112.842 175.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.44 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 82.2 mttt -64.66 -35.87 82.42 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.693 1.197 . . . . 1.0 112.805 176.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -61.48 -43.44 98.87 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.628 1.171 . . . . 1.0 111.23 170.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -62.09 -39.08 91.25 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.41 0.55 . . . . 1.0 111.087 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -44.85 94.98 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.264 0.626 . . . . 1.0 111.781 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.03 74.16 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.037 0.754 . . . . 1.0 113.037 171.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.91 -49.53 77.45 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 123.44 1.591 . . . . 1.0 110.859 -175.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.407 HD12 ' CD1' ' A' ' 87' ' ' TYR . 4.0 mt -67.07 -40.57 87.05 Favored 'General case' 0 C--N 1.32 -0.692 0 O-C-N 120.885 -1.134 . . . . 1.0 110.936 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -69.29 -18.76 63.87 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.313 0.857 . . . . 1.0 113.313 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.81 -18.0 58.67 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.69 1.132 . . . . 1.0 110.765 175.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -100.03 -73.45 0.63 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.086 1.354 . . . . 1.0 109.606 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 62.2 p 179.76 -18.92 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.414 1.886 . . . . 1.0 114.075 -174.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.71 150.9 44.07 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 114.794 1.405 . . . . 1.0 114.794 -169.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -88.96 166.51 13.88 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 113.017 -1.901 . . . . 1.0 113.342 -168.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.21 136.72 52.43 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.269 1.828 . . . . 1.0 110.645 -175.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.3 t -113.59 128.9 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.889 1.276 . . . . 1.0 109.345 -173.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 50.98 -158.12 2.23 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 124.884 1.23 . . . . 1.0 114.324 -171.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -115.39 144.69 43.41 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.751 1.62 . . . . 1.0 109.445 169.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -71.19 158.16 36.9 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.918 1.081 . . . . 1.0 113.918 -169.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.443 ' HB2' ' CD1' ' A' ' 140' ' ' TRP . 1.4 tm? -89.49 138.39 31.49 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.049 1.34 . . . . 1.0 110.139 169.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 mt -127.78 107.81 10.2 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.708 1.603 . . . . 1.0 109.32 173.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 25.3 mt -96.51 128.15 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 121.086 -1.009 . . . . 1.0 111.541 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -104.98 109.2 21.1 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 124.628 1.205 . . . . 1.0 111.705 174.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.25 -22.06 64.79 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.269 1.028 . . . . 1.0 113.24 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.7 t -65.13 -20.23 66.36 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.867 1.267 . . . . 1.0 112.602 173.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -120.09 -29.9 4.79 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.071 1.748 . . . . 1.0 112.298 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -143.43 88.14 8.12 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.975 1.31 . . . . 1.0 112.266 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.25 4.98 4.39 Favored 'Trans proline' 0 CA--C 1.546 1.125 0 C-N-CA 123.521 2.814 . . . . 1.0 114.761 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -111.55 73.82 1.13 Allowed Pre-proline 0 N--CA 1.469 0.503 0 C-N-CA 126.794 2.038 . . . . 1.0 110.233 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -60.42 -25.88 81.46 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.999 2.466 . . . . 1.0 116.135 -169.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -65.63 -24.42 67.04 Favored 'General case' 0 C--O 1.222 -0.384 0 O-C-N 120.983 -1.073 . . . . 1.0 111.521 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 30.1 p -72.75 -18.38 61.51 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.183 -0.948 . . . . 1.0 112.498 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -100.84 -55.05 2.67 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.256 1.822 . . . . 1.0 111.297 177.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 63.4 p -67.38 -31.64 72.01 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 117.771 -1.109 . . . . 1.0 113.906 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -59.11 -59.89 12.34 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-N 121.192 1.814 . . . . 1.0 112.854 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -61.92 -26.4 78.92 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 CA-C-N 121.203 1.465 . . . . 1.0 112.813 174.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.443 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 91.1 t90 -65.6 -48.88 70.78 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.353 0.979 . . . . 1.0 110.66 174.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.406 HG13 ' HA ' ' A' ' 22' ' ' ALA . 80.0 t -66.05 -32.92 60.27 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 C-N-CA 123.08 0.552 . . . . 1.0 110.143 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.72 -51.18 68.16 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 121.076 -1.015 . . . . 1.0 109.958 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 60.0 m170 -65.19 -51.63 59.86 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.178 0.991 . . . . 1.0 111.431 -177.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 86.9 t90 -57.42 -37.3 72.53 Favored 'General case' 0 C--O 1.219 -0.514 0 C-N-CA 125.293 1.437 . . . . 1.0 111.542 171.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -49.42 -34.69 19.71 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.751 1.644 . . . . 1.0 113.507 172.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 p -68.62 -13.69 62.52 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 114.896 1.443 . . . . 1.0 114.896 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.48 -19.54 45.71 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.609 1.563 . . . . 1.0 111.87 175.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -84.04 169.23 15.15 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.219 1.007 . . . . 1.0 111.193 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 C--O 1.252 1.19 0 N-CA-C 115.652 1.723 . . . . 1.0 115.652 -169.645 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 113.71 1.004 . . . . 1.0 113.71 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -126.1 125.05 41.92 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.661 1.584 . . . . 1.0 110.305 174.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 mp -121.68 113.94 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 126.152 1.781 . . . . 1.0 113.262 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.32 122.21 6.64 Favored Glycine 0 C--O 1.223 -0.544 0 O-C-N 121.33 -0.856 . . . . 1.0 111.245 169.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.3 mt -104.4 122.18 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-N 118.407 1.103 . . . . 1.0 109.872 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -114.72 112.7 23.24 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.089 1.355 . . . . 1.0 107.455 -171.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.469 0.482 0 C-N-CA 122.586 0.355 . . . . 1.0 111.473 -172.201 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.9 tp . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 114.626 1.343 . . . . 1.0 114.626 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.9 t -56.8 -31.14 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.22 -0.925 . . . . 1.0 112.269 -171.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.58 -48.2 80.03 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.193 -0.942 . . . . 1.0 113.203 171.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.67 -28.41 62.7 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.031 0.532 . . . . 1.0 110.72 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -63.15 -49.7 73.3 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.924 -0.769 . . . . 1.0 108.924 169.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.421 ' HA ' HG12 ' A' ' 141' ' ' VAL . . . -65.16 -43.36 92.02 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 112.521 0.563 . . . . 1.0 112.521 -173.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -53.34 -49.99 65.95 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.07 0.948 . . . . 1.0 110.291 169.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.71 -37.09 73.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.2 0.6 . . . . 1.0 112.345 -174.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.9 mt -67.43 -46.74 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 118.994 0.816 . . . . 1.0 109.084 176.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.51 -34.13 76.49 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 119.667 -0.813 . . . . 1.0 110.457 -176.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.5 m -62.83 -40.26 96.87 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.731 1.612 . . . . 1.0 113.325 170.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.56 -33.26 73.77 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.978 0.911 . . . . 1.0 112.029 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -69.3 -31.48 69.99 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.529 1.132 . . . . 1.0 112.45 170.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 126.68 18.61 2.16 Favored Glycine 0 N--CA 1.472 1.058 0 C-N-CA 124.409 1.004 . . . . 1.0 115.066 169.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -111.22 152.32 27.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.637 1.175 . . . . 1.0 111.007 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.9 73.65 9.9 Favored 'General case' 0 CA--C 1.51 -0.561 0 C-N-CA 124.629 1.172 . . . . 1.0 110.391 -172.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.99 142.39 27.83 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.29 -1.777 . . . . 1.0 112.061 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.6 m -147.94 138.97 23.33 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.549 1.14 . . . . 1.0 112.36 -177.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.5 t -84.64 135.29 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 114.781 1.401 . . . . 1.0 114.781 171.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -116.34 114.54 24.46 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.732 2.013 . . . . 1.0 110.536 169.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -95.32 139.01 32.24 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.465 1.906 . . . . 1.0 111.138 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.2 t0 41.18 54.92 7.93 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 124.865 1.266 . . . . 1.0 111.982 -169.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -71.92 143.06 40.13 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.902 3.068 . . . . 1.0 116.553 -168.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.446 ' HB3' ' H ' ' A' ' 42' ' ' SER . 50.7 mm-40 -94.27 164.93 12.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 122.431 1.11 . . . . 1.0 111.85 168.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -65.8 -22.16 66.54 Favored 'General case' 0 N--CA 1.44 -0.93 0 O-C-N 120.859 -1.151 . . . . 1.0 110.064 167.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.446 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 16.3 m -68.18 -20.08 64.84 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.07 -1.019 . . . . 1.0 112.376 172.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -83.73 -23.99 31.38 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.605 1.162 . . . . 1.0 112.47 169.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.9 t-105 -88.41 -33.96 17.7 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.064 1.135 . . . . 1.0 114.064 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.3 mt -49.89 -38.54 35.8 Favored Pre-proline 0 CA--C 1.555 1.163 0 CA-C-O 117.558 -1.21 . . . . 1.0 113.944 178.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -58.76 -8.81 6.3 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 124.031 3.154 . . . . 1.0 116.797 173.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -114.89 8.04 15.84 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 116.091 1.885 . . . . 1.0 116.091 -177.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -51.05 -32.35 21.59 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.935 1.694 . . . . 1.0 113.436 171.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -102.11 6.23 40.79 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.721 2.408 . . . . 1.0 113.588 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -128.79 -159.47 0.96 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 127.056 2.142 . . . . 1.0 112.222 -169.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -112.57 160.8 17.48 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 122.862 1.315 . . . . 1.0 111.404 170.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.92 159.4 9.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 125.076 1.35 . . . . 1.0 108.908 -171.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.7 tp -141.76 125.86 17.35 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 124.197 0.999 . . . . 1.0 109.211 177.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.5 t -102.37 120.41 52.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 C-N-CA 123.767 0.827 . . . . 1.0 109.182 176.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.4 t -119.77 113.53 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 105.944 -1.873 . . . . 1.0 105.944 177.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 113.561 0.949 . . . . 1.0 113.561 -168.331 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.0 tt . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 113.682 0.993 . . . . 1.0 113.682 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -44.61 -52.74 16.89 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 124.768 1.227 . . . . 1.0 112.622 168.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.73 -32.7 29.55 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 121.851 1.701 . . . . 1.0 111.954 -173.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 tp -62.92 -52.85 61.48 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.523 1.129 . . . . 1.0 111.375 169.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -55.13 -53.08 60.42 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.629 0.771 . . . . 1.0 112.651 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 -64.61 -40.58 95.75 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.717 0.807 . . . . 1.0 111.465 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.94 -35.78 91.2 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.41 -0.661 . . . . 1.0 112.333 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.4 mt -64.81 -50.09 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 120.229 2.015 . . . . 1.0 108.246 172.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -69.46 -31.83 70.38 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.326 -1.484 . . . . 1.0 113.188 -170.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -101.76 -37.61 8.23 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 115.133 1.531 . . . . 1.0 115.133 -175.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 m -97.79 -19.51 18.13 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.333 1.053 . . . . 1.0 113.446 -174.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.86 -72.53 0.6 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 107.391 -1.337 . . . . 1.0 107.391 169.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.81 -20.67 1.38 Allowed Glycine 0 CA--C 1.539 1.564 0 C-N-CA 127.541 2.496 . . . . 1.0 114.902 170.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -153.21 142.08 21.14 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 128.408 2.683 . . . . 1.0 108.07 169.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -137.35 119.96 11.38 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.929 0.891 . . . . 1.0 109.701 -169.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -77.55 -35.3 1.61 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.451 2.101 . . . . 1.0 115.965 -169.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -143.64 19.28 1.84 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.056 1.132 . . . . 1.0 114.056 -169.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.1 tp -85.84 140.06 30.75 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.686 -1.259 . . . . 1.0 114.176 -169.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.4 mtm-85 -137.33 153.57 50.22 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.989 2.516 . . . . 1.0 109.619 169.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.411 ' CD1' HD11 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -161.56 168.17 24.04 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.073 0.851 . . . . 1.0 112.543 -176.485 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -125.19 170.54 17.13 Favored Glycine 0 N--CA 1.472 1.093 0 C-N-CA 125.201 1.382 . . . . 1.0 114.134 174.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.3 t -142.44 132.7 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.658 1.183 . . . . 1.0 113.695 -169.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.1 mt -129.54 102.84 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.802 1.641 . . . . 1.0 108.035 170.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -91.86 142.3 27.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.526 1.531 . . . . 1.0 111.726 173.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.5 mp -138.13 152.7 48.97 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.235 -0.915 . . . . 1.0 112.793 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.697 0 C-N-CA 121.528 -0.368 . . . . 1.0 112.583 169.207 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.439 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 26.7 p . . . . . 0 CA--C 1.537 0.46 0 N-CA-C 114.519 1.303 . . . . 1.0 114.519 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -58.18 -21.63 48.17 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 117.573 -1.203 . . . . 1.0 114.08 -173.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.95 -43.0 87.77 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-N 121.371 1.896 . . . . 1.0 114.007 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -77.59 -36.88 32.25 Favored Glycine 0 N--CA 1.478 1.471 0 O-C-N 120.909 -1.348 . . . . 1.0 113.036 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.439 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 85.2 mttt -63.58 -33.49 75.71 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.34 1.056 . . . . 1.0 112.978 176.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -59.93 -44.15 94.5 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.263 1.425 . . . . 1.0 111.012 169.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -63.65 -39.12 93.55 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.662 -0.649 . . . . 1.0 110.948 175.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -42.99 99.63 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.774 -0.579 . . . . 1.0 111.709 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.83 -35.64 77.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 112.978 0.733 . . . . 1.0 112.978 171.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.91 -49.66 76.97 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 123.463 1.601 . . . . 1.0 110.902 -175.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.411 HD11 ' CD1' ' A' ' 87' ' ' TYR . 4.0 mt -67.52 -40.3 85.1 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 120.92 -1.112 . . . . 1.0 110.996 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -70.09 -17.87 63.24 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.364 0.876 . . . . 1.0 113.364 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.77 -17.08 59.26 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.488 1.04 . . . . 1.0 110.957 174.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -101.63 -73.28 0.66 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.147 1.379 . . . . 1.0 109.904 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 65.8 p 179.52 -19.32 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.106 1.763 . . . . 1.0 113.984 -174.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.1 151.59 42.95 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 123.06 1.41 . . . . 1.0 114.464 -169.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -87.75 165.37 15.4 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 113.071 -1.877 . . . . 1.0 113.298 -169.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.69 133.32 47.0 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.222 1.809 . . . . 1.0 110.21 -174.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 32.6 t -112.46 130.99 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.61 1.164 . . . . 1.0 109.857 -171.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 52.46 -157.72 3.77 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 125.314 1.435 . . . . 1.0 114.765 -173.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -111.9 139.82 47.07 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.839 1.656 . . . . 1.0 110.097 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -70.61 155.29 40.92 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 122.332 1.063 . . . . 1.0 112.222 -171.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.437 ' HB2' ' CD1' ' A' ' 140' ' ' TRP . 1.2 tm? -87.96 139.07 30.89 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.722 -1.127 . . . . 1.0 109.957 171.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 mt -127.65 106.57 9.24 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.404 1.482 . . . . 1.0 109.69 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 23.8 mt -95.84 127.79 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 O-C-N 121.169 -0.957 . . . . 1.0 112.042 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -104.68 109.59 21.57 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 122.4 1.095 . . . . 1.0 111.982 173.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.74 -22.71 66.04 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.558 1.143 . . . . 1.0 113.433 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.1 t -64.38 -22.48 66.97 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.035 0.934 . . . . 1.0 112.718 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -118.1 -29.91 5.46 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.0 1.72 . . . . 1.0 111.961 -175.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -142.54 87.72 9.11 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 125.086 1.354 . . . . 1.0 112.06 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.62 8.11 2.42 Favored 'Trans proline' 0 CA--C 1.552 1.404 0 C-N-CA 123.655 2.904 . . . . 1.0 114.271 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -114.73 69.97 2.24 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 127.2 2.2 . . . . 1.0 109.859 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -56.9 -23.13 49.45 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.723 2.282 . . . . 1.0 116.197 -169.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 pm0 -67.03 -24.13 65.97 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 121.028 -1.045 . . . . 1.0 112.251 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.9 p -74.77 -17.92 60.56 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.329 0.968 . . . . 1.0 112.301 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -100.33 -54.05 2.96 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.456 1.903 . . . . 1.0 111.509 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.5 p -68.19 -33.82 75.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 117.764 -1.112 . . . . 1.0 113.912 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -57.47 -61.69 6.73 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 120.877 1.671 . . . . 1.0 112.009 176.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -60.54 -23.58 75.81 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 CA-C-N 121.882 1.708 . . . . 1.0 113.744 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.437 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 87.9 t90 -68.87 -47.13 66.66 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 119.217 0.917 . . . . 1.0 110.984 173.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.421 HG12 ' HA ' ' A' ' 22' ' ' ALA . 93.2 t -65.27 -33.83 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 176.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.01 -31.0 70.38 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.0 1.32 . . . . 1.0 112.038 177.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -77.56 -62.34 1.69 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.994 1.718 . . . . 1.0 111.877 169.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -55.06 -36.89 66.05 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 126.191 1.796 . . . . 1.0 112.709 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.93 -31.93 25.72 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.98 1.276 . . . . 1.0 113.803 174.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.0 p -70.2 -13.77 62.33 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 114.352 1.241 . . . . 1.0 114.352 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.41 -17.02 53.04 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.85 1.66 . . . . 1.0 111.705 175.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -81.75 172.38 13.44 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.06 0.944 . . . . 1.0 111.6 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 C--O 1.255 1.371 0 C-N-CA 125.637 1.575 . . . . 1.0 112.619 -172.31 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.553 0 N-CA-C 113.348 0.87 . . . . 1.0 113.348 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -122.23 121.28 36.44 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.342 1.457 . . . . 1.0 110.346 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 mp -120.15 114.03 42.55 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 C-N-CA 126.057 1.743 . . . . 1.0 112.857 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.48 122.53 6.79 Favored Glycine 0 C--O 1.222 -0.624 0 N-CA-C 110.573 -1.011 . . . . 1.0 110.573 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.4 mt -103.18 120.93 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-N 118.113 0.956 . . . . 1.0 109.271 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -114.2 113.21 24.35 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.245 -1.391 . . . . 1.0 107.245 -171.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.467 0.398 0 N-CA-C 112.66 0.615 . . . . 1.0 112.66 -171.011 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.4 tp . . . . . 0 N--CA 1.468 0.453 0 N-CA-C 113.641 0.978 . . . . 1.0 113.641 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.6 t -55.04 -33.93 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.639 0.776 . . . . 1.0 111.567 -173.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.27 -45.89 92.6 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.706 -1.246 . . . . 1.0 113.04 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -66.61 -29.98 70.15 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.774 0.83 . . . . 1.0 110.844 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -70.2 -47.14 62.8 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.79 0.836 . . . . 1.0 109.139 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.458 ' HA ' HG12 ' A' ' 141' ' ' VAL . . . -64.0 -41.35 97.52 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 113.297 0.851 . . . . 1.0 113.297 -176.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -56.26 -48.46 76.52 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.307 1.043 . . . . 1.0 110.572 170.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.27 -37.8 71.88 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.754 0.822 . . . . 1.0 112.055 -174.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.1 mt -69.29 -45.55 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 O-C-N 121.322 -0.862 . . . . 1.0 109.602 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.67 -31.52 72.57 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.878 1.217 . . . . 1.0 110.816 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.5 m -62.56 -45.82 91.17 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.843 1.257 . . . . 1.0 112.687 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.22 -31.02 70.23 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.675 1.19 . . . . 1.0 113.254 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -67.65 -29.46 68.77 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.121 1.768 . . . . 1.0 111.606 171.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.02 27.6 2.22 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.802 1.192 . . . . 1.0 114.882 171.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -123.42 159.2 29.5 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.083 1.353 . . . . 1.0 110.389 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -90.61 87.54 6.76 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 120.645 -1.284 . . . . 1.0 108.649 -177.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.83 146.62 27.99 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.113 0.565 . . . . 1.0 111.379 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.9 m -147.31 140.86 25.52 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.472 1.109 . . . . 1.0 112.188 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.0 t -89.76 139.22 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 115.613 1.709 . . . . 1.0 115.613 173.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -121.04 111.88 18.03 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.303 2.241 . . . . 1.0 110.136 169.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -95.13 139.15 31.88 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.011 1.724 . . . . 1.0 111.634 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.4 t70 42.63 52.94 8.18 Favored Pre-proline 0 CA--C 1.56 1.365 0 C-N-CA 124.943 1.297 . . . . 1.0 111.581 -169.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -70.96 147.63 55.6 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.075 3.183 . . . . 1.0 117.013 -168.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.451 ' HB3' ' H ' ' A' ' 42' ' ' SER . 52.4 mm-40 -93.81 163.81 13.37 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.452 1.101 . . . . 1.0 112.035 168.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -65.52 -22.26 66.7 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 120.729 -1.232 . . . . 1.0 110.269 167.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.451 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 16.8 m -68.29 -20.41 64.77 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.921 -1.112 . . . . 1.0 112.116 172.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -82.96 -25.51 32.25 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.499 1.12 . . . . 1.0 112.31 169.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.9 t-105 -86.42 -35.43 19.73 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.909 1.077 . . . . 1.0 113.909 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.1 mt -48.21 -38.43 21.04 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 114.464 1.283 . . . . 1.0 114.464 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -60.59 -11.75 18.4 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 123.691 2.928 . . . . 1.0 116.573 175.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -111.14 8.31 21.66 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 116.243 1.942 . . . . 1.0 116.243 -172.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -54.3 -35.04 62.19 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.073 1.749 . . . . 1.0 113.628 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -99.03 -2.39 37.35 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.025 1.73 . . . . 1.0 113.274 177.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -109.64 -164.98 0.97 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.819 2.447 . . . . 1.0 110.938 -176.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -109.77 163.22 13.71 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.937 1.351 . . . . 1.0 111.773 169.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.25 157.7 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.822 1.249 . . . . 1.0 109.519 -170.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.2 tp -139.33 124.37 18.83 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 124.235 1.014 . . . . 1.0 108.735 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.7 t -99.36 121.53 50.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.383 -0.826 . . . . 1.0 109.238 174.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.7 t -120.06 113.98 42.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 105.319 -2.104 . . . . 1.0 105.319 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 115.161 1.541 . . . . 1.0 115.161 -168.298 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.7 tt . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 113.894 1.072 . . . . 1.0 113.894 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.8 t -43.46 -52.38 13.52 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.835 1.254 . . . . 1.0 112.878 168.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.86 -33.11 34.62 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.714 1.609 . . . . 1.0 111.915 -173.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 tp -63.41 -53.83 46.21 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 124.235 1.014 . . . . 1.0 111.223 169.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -54.69 -52.81 61.22 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.796 0.839 . . . . 1.0 112.477 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -64.85 -40.77 95.69 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.424 1.09 . . . . 1.0 111.384 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.44 -34.91 86.1 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.371 0.51 . . . . 1.0 112.656 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.79 -49.31 80.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.866 1.833 . . . . 1.0 108.558 171.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.4 ptmm? -70.91 -32.12 68.96 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.2 -1.562 . . . . 1.0 112.85 -169.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -104.62 -38.49 6.72 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.082 1.512 . . . . 1.0 115.082 -174.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.2 m -95.0 -23.37 17.41 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.26 1.024 . . . . 1.0 113.171 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.32 -70.98 0.66 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 169.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.24 -11.95 1.95 Allowed Glycine 0 CA--C 1.538 1.507 0 C-N-CA 126.776 2.131 . . . . 1.0 116.255 169.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -157.6 141.84 16.16 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 127.81 2.444 . . . . 1.0 108.366 174.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -136.0 123.15 14.53 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.962 0.905 . . . . 1.0 111.148 -172.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.41 -37.82 0.36 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.205 1.937 . . . . 1.0 114.724 -171.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -146.94 19.07 1.27 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.069 1.137 . . . . 1.0 114.069 -169.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.8 tp -79.46 140.56 37.3 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.404 -1.435 . . . . 1.0 113.861 -169.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -133.49 150.2 51.71 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 128.636 2.774 . . . . 1.0 107.571 169.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.416 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -160.88 166.85 27.78 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.319 -0.863 . . . . 1.0 112.932 -178.166 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.436 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -124.65 171.85 16.83 Favored Glycine 0 N--CA 1.475 1.295 0 C-N-CA 125.003 1.287 . . . . 1.0 114.531 173.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.5 t -143.52 133.08 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 114.852 1.427 . . . . 1.0 114.852 -169.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.0 mt -130.79 104.85 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.683 1.593 . . . . 1.0 107.968 169.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -91.74 143.19 26.8 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.891 1.677 . . . . 1.0 111.797 175.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.9 mp -137.44 148.41 46.1 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.448 0.907 . . . . 1.0 113.448 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.63 0 N-CA-C 114.805 0.682 . . . . 1.0 114.805 169.014 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 20.1 p . . . . . 0 CA--C 1.542 0.66 0 N-CA-C 114.193 1.183 . . . . 1.0 114.193 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -55.95 -23.49 32.45 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.481 1.912 . . . . 1.0 114.607 -172.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.32 -48.44 83.66 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-N 120.357 1.435 . . . . 1.0 113.412 174.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.25 -36.51 50.41 Favored Glycine 0 N--CA 1.478 1.474 0 O-C-N 120.782 -1.422 . . . . 1.0 113.248 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -60.31 -35.8 76.45 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.928 0.891 . . . . 1.0 113.168 172.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -65.24 -33.94 77.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 118.603 -0.713 . . . . 1.0 112.826 172.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -63.95 -37.4 87.28 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.689 1.131 . . . . 1.0 111.032 172.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -63.14 -49.88 72.64 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.027 0.831 . . . . 1.0 110.473 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.64 -33.0 59.96 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.251 0.834 . . . . 1.0 113.251 173.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.27 -50.28 73.66 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 123.238 1.494 . . . . 1.0 110.727 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.416 HD12 ' CD1' ' A' ' 87' ' ' TYR . 8.0 mt -65.1 -39.27 92.9 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 120.966 -1.084 . . . . 1.0 111.19 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -67.31 -22.39 65.63 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.557 0.947 . . . . 1.0 113.557 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.54 -17.53 59.19 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.393 0.997 . . . . 1.0 111.464 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -96.51 -73.61 0.59 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.994 1.318 . . . . 1.0 109.206 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 56.2 p 177.18 -18.32 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.755 2.022 . . . . 1.0 113.534 -175.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.59 157.26 34.86 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.793 1.282 . . . . 1.0 113.933 -169.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -99.4 173.39 6.78 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 113.239 -1.8 . . . . 1.0 112.155 -169.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -128.63 160.49 32.26 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.758 1.223 . . . . 1.0 113.509 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.1 t -119.25 126.71 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 127.232 2.213 . . . . 1.0 108.811 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 52.35 -165.0 1.42 Allowed Glycine 0 CA--C 1.542 1.762 0 C-N-CA 124.748 1.166 . . . . 1.0 115.628 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -107.56 149.41 28.06 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.726 1.611 . . . . 1.0 110.118 169.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.78 159.15 32.35 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.717 1.207 . . . . 1.0 113.188 -169.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.438 ' CD1' HG13 ' A' ' 125' ' ' ILE . 1.2 tm? -91.32 139.57 30.61 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.098 0.959 . . . . 1.0 110.165 169.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.4 mt -122.83 105.76 10.3 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.205 1.402 . . . . 1.0 111.103 174.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.438 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.9 mt -91.95 131.19 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 125.331 1.452 . . . . 1.0 112.341 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -108.25 92.27 3.99 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.86 2.464 . . . . 1.0 112.617 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.4 -23.6 67.0 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.995 1.318 . . . . 1.0 112.794 -173.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.7 p -53.47 -30.39 40.64 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 129.329 3.052 . . . . 1.0 114.334 169.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -124.79 -26.53 3.77 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.849 2.06 . . . . 1.0 111.585 -171.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -143.22 88.59 8.07 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.44 1.496 . . . . 1.0 112.184 -177.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -76.53 11.19 1.95 Allowed 'Trans proline' 0 CA--C 1.549 1.251 0 C-N-CA 123.77 2.98 . . . . 1.0 114.211 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -111.62 68.77 0.77 Allowed Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 127.672 2.389 . . . . 1.0 110.042 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -57.38 -21.39 44.6 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.777 2.318 . . . . 1.0 116.809 -169.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -64.25 -27.25 68.92 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 118.934 0.788 . . . . 1.0 111.902 174.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.6 p -72.27 -18.78 61.78 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 120.939 -1.1 . . . . 1.0 111.813 -174.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -99.22 -53.66 3.18 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.807 1.643 . . . . 1.0 111.933 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 48.1 p -71.28 -33.77 70.06 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 114.599 1.333 . . . . 1.0 114.599 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -59.32 -56.63 34.06 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 120.723 1.601 . . . . 1.0 112.453 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -62.66 -22.64 74.15 Favored 'Trans proline' 0 C--N 1.355 0.871 0 CA-C-N 121.459 1.557 . . . . 1.0 112.735 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.426 ' CD1' HD22 ' A' ' 123' ' ' LEU . 91.4 t90 -69.19 -47.37 65.05 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 123.279 0.632 . . . . 1.0 111.093 174.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 22' ' ' ALA . 97.5 t -65.23 -32.0 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 122.03 0.919 . . . . 1.0 108.899 176.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.93 -22.33 61.48 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 120.045 -1.659 . . . . 1.0 113.401 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -87.07 -62.52 1.48 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.858 2.063 . . . . 1.0 111.265 169.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.436 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 87.6 t90 -54.88 -38.26 67.32 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 126.892 2.077 . . . . 1.0 112.99 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.96 -29.26 27.11 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 121.42 -0.8 . . . . 1.0 114.488 173.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.1 p -69.32 -13.29 62.3 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.809 1.304 . . . . 1.0 114.367 175.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.5 -18.59 51.64 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.34 1.456 . . . . 1.0 111.774 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -84.41 170.1 13.91 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.517 1.127 . . . . 1.0 111.521 -175.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.251 1.182 0 N-CA-C 116.697 2.11 . . . . 1.0 116.697 -169.465 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 116.469 2.026 . . . . 1.0 116.469 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -121.46 124.49 44.6 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 126.643 1.977 . . . . 1.0 110.057 170.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 mp -126.62 113.06 31.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 126.8 2.04 . . . . 1.0 111.898 -174.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.19 124.51 7.81 Favored Glycine 0 C--O 1.224 -0.518 0 N-CA-C 110.01 -1.236 . . . . 1.0 110.01 169.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.8 mt -104.59 123.34 58.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 118.151 0.976 . . . . 1.0 109.545 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -115.95 110.63 19.23 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.598 1.159 . . . . 1.0 108.266 -169.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.469 0.478 0 CA-C-N 116.619 -0.264 . . . . 1.0 111.441 -175.363 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.7 tp . . . . . 0 C--O 1.223 -0.322 0 CA-C-O 120.892 0.377 . . . . 1.0 110.663 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -56.66 -39.23 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 O-C-N 121.79 -0.569 . . . . 1.0 110.891 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.7 -49.65 74.25 Favored 'General case' 0 C--O 1.23 0.062 0 CA-C-N 119.606 1.093 . . . . 1.0 112.615 176.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -67.79 -26.93 66.33 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.105 0.479 . . . . 1.0 112.055 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -70.74 -48.72 53.01 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 123.952 0.901 . . . . 1.0 109.938 169.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.98 -44.38 97.46 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 112.651 0.611 . . . . 1.0 112.651 -176.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -51.52 -51.24 56.9 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.521 1.128 . . . . 1.0 110.221 169.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.86 -35.62 74.87 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.633 0.773 . . . . 1.0 112.764 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.7 mt -70.43 -45.41 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 O-C-N 121.175 -0.953 . . . . 1.0 109.342 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.86 -34.44 78.16 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 120.028 -0.669 . . . . 1.0 110.213 -178.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.4 m -61.75 -44.42 96.93 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.973 1.309 . . . . 1.0 113.155 169.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.17 -32.61 73.83 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.62 1.168 . . . . 1.0 112.944 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -66.49 -32.78 74.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.534 1.134 . . . . 1.0 111.75 170.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.27 12.98 1.56 Allowed Glycine 0 CA--C 1.532 1.135 0 N-CA-C 116.091 1.196 . . . . 1.0 116.091 169.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -105.85 168.32 9.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.865 1.266 . . . . 1.0 112.116 -170.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? -90.64 97.26 11.08 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.914 1.286 . . . . 1.0 107.847 170.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.91 144.87 42.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.64 0.257 . . . . 1.0 110.693 174.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.6 m -147.59 138.74 23.61 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.72 0.808 . . . . 1.0 111.91 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.1 t -86.92 136.64 22.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 114.502 1.297 . . . . 1.0 114.502 171.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -111.59 114.63 27.81 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.135 1.774 . . . . 1.0 110.464 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -94.04 139.23 31.21 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.332 1.853 . . . . 1.0 110.61 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.6 t0 43.12 54.82 10.7 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 124.274 1.029 . . . . 1.0 110.664 -169.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -64.15 140.22 70.44 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.855 3.036 . . . . 1.0 117.259 -167.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -89.36 154.25 20.22 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.742 1.617 . . . . 1.0 112.043 168.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -69.47 -21.62 63.69 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 120.674 -1.266 . . . . 1.0 109.648 168.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 26.0 m -66.79 -21.86 66.04 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.286 -0.884 . . . . 1.0 112.448 169.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -82.47 -28.58 31.14 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.789 0.836 . . . . 1.0 112.599 169.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.0 t-105 -80.17 -38.75 30.7 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.571 1.078 . . . . 1.0 113.515 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.3 mt -44.1 -47.31 23.12 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 114.411 1.263 . . . . 1.0 114.411 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.1 4.98 1.61 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.79 2.327 . . . . 1.0 115.811 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -113.06 5.63 17.24 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 116.053 1.871 . . . . 1.0 116.053 174.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -49.51 -30.74 8.83 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 126.836 2.054 . . . . 1.0 113.275 170.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -104.65 7.83 35.04 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.228 2.611 . . . . 1.0 113.288 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -133.5 -155.4 0.67 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.518 2.327 . . . . 1.0 112.096 -169.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -114.3 160.34 19.18 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-O 123.504 1.621 . . . . 1.0 111.801 169.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.48 150.75 14.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 125.289 1.436 . . . . 1.0 107.454 -174.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.0 tp -129.63 127.31 40.33 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 124.753 1.221 . . . . 1.0 108.666 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.7 t -99.82 127.65 52.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 t -127.01 104.12 12.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.518 -1.66 . . . . 1.0 106.518 175.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 113.502 0.927 . . . . 1.0 113.502 -167.773 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.9 tt . . . . . 0 N--CA 1.469 0.522 0 N-CA-C 114.015 1.117 . . . . 1.0 114.015 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.8 t -42.66 -51.26 12.12 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 124.788 1.235 . . . . 1.0 112.612 168.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.0 -31.7 18.96 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.385 1.39 . . . . 1.0 111.776 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.7 tp -64.15 -51.03 65.8 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 124.219 1.008 . . . . 1.0 110.961 169.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -54.91 -53.63 53.06 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.502 1.121 . . . . 1.0 112.478 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -67.21 -34.6 77.83 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.964 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.55 -37.1 93.97 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.701 0.667 . . . . 1.0 112.523 174.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 78.6 mt -65.44 -49.43 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.96 1.88 . . . . 1.0 108.264 171.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -69.35 -31.16 69.4 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.241 -1.537 . . . . 1.0 113.358 -171.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -105.66 -38.02 6.55 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.406 1.632 . . . . 1.0 115.406 -174.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.6 m -93.85 -23.02 18.29 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.153 0.981 . . . . 1.0 112.873 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.11 -71.13 0.66 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 106.277 -1.749 . . . . 1.0 106.277 169.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.5 -10.21 1.51 Allowed Glycine 0 CA--C 1.539 1.571 0 C-N-CA 127.386 2.422 . . . . 1.0 115.554 169.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -153.19 146.62 24.91 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 129.269 3.028 . . . . 1.0 107.214 170.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 39.7 mm-40 -136.01 125.57 16.07 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.339 0.656 . . . . 1.0 110.548 -174.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -82.8 -39.94 0.13 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.352 2.035 . . . . 1.0 114.241 -173.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -146.87 18.01 1.26 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.596 1.158 . . . . 1.0 113.785 -169.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 42.1 tp -76.88 140.48 40.6 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.598 -1.314 . . . . 1.0 113.412 -169.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -133.45 147.85 51.71 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 129.421 3.088 . . . . 1.0 107.714 170.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.409 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -157.27 166.04 34.24 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.835 1.198 . . . . 1.0 112.384 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -130.05 173.63 19.81 Favored Glycine 0 N--CA 1.467 0.74 0 C-N-CA 125.43 1.491 . . . . 1.0 112.142 170.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -160.07 143.14 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 114.829 1.418 . . . . 1.0 114.829 -169.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.39 113.74 37.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 126.721 2.008 . . . . 1.0 108.397 169.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.59 150.13 20.92 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 125.342 1.457 . . . . 1.0 110.462 169.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.97 152.05 44.65 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 121.801 -0.562 . . . . 1.0 111.419 173.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.754 0 N-CA-C 115.515 0.966 . . . . 1.0 115.515 169.588 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 115.718 1.747 . . . . 1.0 115.718 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -59.0 -23.74 62.17 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.921 1.288 . . . . 1.0 114.196 -175.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.21 -46.2 94.17 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-N 120.335 1.425 . . . . 1.0 113.004 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.95 -36.29 47.39 Favored Glycine 0 N--CA 1.478 1.469 0 O-C-N 121.014 -1.286 . . . . 1.0 113.121 176.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -59.54 -34.97 73.32 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 117.922 0.861 . . . . 1.0 112.806 172.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 -67.04 -33.09 74.77 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.997 0.74 . . . . 1.0 112.997 173.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -62.16 -35.96 80.39 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.796 1.18 . . . . 1.0 111.314 171.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.22 -44.62 83.32 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.233 0.469 . . . . 1.0 111.342 175.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.72 -44.12 81.3 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 118.807 -0.616 . . . . 1.0 112.086 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.18 -48.97 61.79 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.746 2.018 . . . . 1.0 111.49 -177.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.409 HD12 ' CD1' ' A' ' 87' ' ' TYR . 8.0 mt -66.03 -40.07 90.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.331 -0.849 . . . . 1.0 111.928 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -67.4 -24.91 65.71 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.95 1.092 . . . . 1.0 113.95 175.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -64.62 -35.13 80.02 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.409 1.084 . . . . 1.0 111.491 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -83.96 -73.28 0.43 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 113.709 -1.587 . . . . 1.0 110.461 -175.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.5 m 174.14 -0.89 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.118 2.567 . . . . 1.0 111.821 173.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.19 159.58 32.34 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 122.414 1.102 . . . . 1.0 113.541 -169.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -100.69 171.46 7.68 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 113.898 -1.501 . . . . 1.0 111.362 -169.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 2.2 ttm105 -126.43 154.02 44.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.547 1.139 . . . . 1.0 112.779 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.4 t -92.86 -173.1 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 C-N-CA 127.009 2.124 . . . . 1.0 106.009 169.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -51.17 154.76 3.79 Favored Glycine 0 CA--C 1.543 1.838 0 O-C-N 120.345 -1.472 . . . . 1.0 115.929 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -48.9 143.33 5.54 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.327 1.851 . . . . 1.0 114.771 -172.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -75.62 156.57 34.77 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.669 1.187 . . . . 1.0 111.879 -169.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.413 HD23 ' CD1' ' A' ' 140' ' ' TRP . 0.9 OUTLIER -90.98 137.81 32.08 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.537 -0.756 . . . . 1.0 109.719 174.325 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.5 mt -122.41 109.13 14.0 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.641 1.176 . . . . 1.0 110.459 174.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.404 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.2 mt -91.45 130.44 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.062 1.345 . . . . 1.0 112.611 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.74 98.52 10.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.206 1.002 . . . . 1.0 110.039 175.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -70.4 -23.93 62.84 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.108 -1.62 . . . . 1.0 112.232 -175.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.65 -30.65 44.13 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 130.191 3.396 . . . . 1.0 114.12 169.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -124.67 -26.86 3.75 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.539 1.935 . . . . 1.0 111.957 -169.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -141.92 83.23 12.9 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 125.565 1.546 . . . . 1.0 111.276 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.76 12.45 1.41 Allowed 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 124.009 3.14 . . . . 1.0 113.904 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -109.64 65.5 0.36 Allowed Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 127.899 2.479 . . . . 1.0 109.553 174.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -58.65 -19.08 43.68 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.496 2.131 . . . . 1.0 116.952 -168.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -65.12 -28.44 69.44 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 121.343 -0.848 . . . . 1.0 111.919 173.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.6 p -70.75 -21.75 62.49 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.226 0.921 . . . . 1.0 112.181 -175.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -96.24 -54.69 3.2 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.899 1.679 . . . . 1.0 111.399 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 85.6 p -68.4 -33.07 73.58 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.656 1.354 . . . . 1.0 114.656 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.27 -50.03 51.5 Favored Pre-proline 0 CA--C 1.542 0.645 0 O-C-N 120.315 -1.49 . . . . 1.0 113.014 -173.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.69 -23.44 69.68 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 CA-C-N 121.289 1.496 . . . . 1.0 112.552 170.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.413 ' CD1' HD23 ' A' ' 123' ' ' LEU . 90.6 t90 -70.28 -46.32 64.57 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 123.342 0.657 . . . . 1.0 110.832 175.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 88.9 t -66.08 -34.63 71.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -63.55 -48.46 77.37 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.216 -0.928 . . . . 1.0 110.043 174.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -63.7 -55.68 21.52 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.73 1.212 . . . . 1.0 111.67 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.2 t90 -58.09 -35.05 70.86 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 125.693 1.597 . . . . 1.0 111.953 175.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.47 -32.87 31.69 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.462 1.505 . . . . 1.0 113.811 172.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.0 p -70.12 -12.65 61.75 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.832 1.419 . . . . 1.0 114.832 175.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.94 -17.33 43.99 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.67 1.588 . . . . 1.0 111.882 176.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -77.79 171.46 14.93 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 118.945 0.793 . . . . 1.0 110.871 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 56.4 m . . . . . 0 C--O 1.252 1.187 0 C-N-CA 125.44 1.496 . . . . 1.0 114.777 -173.416 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.306 0 N-CA-C 114.694 1.368 . . . . 1.0 114.694 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -121.0 123.75 43.18 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.669 1.587 . . . . 1.0 109.775 173.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 mp -124.27 112.92 34.35 Favored 'Isoleucine or valine' 0 C--O 1.23 0.05 0 C-N-CA 125.856 1.662 . . . . 1.0 112.439 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.22 125.49 7.92 Favored Glycine 0 C--O 1.224 -0.492 0 N-CA-C 110.24 -1.144 . . . . 1.0 110.24 169.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.5 mt -105.79 124.14 60.71 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 118.523 1.162 . . . . 1.0 109.591 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -115.57 110.22 18.91 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 125.109 1.364 . . . . 1.0 107.813 -170.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 N--CA 1.466 0.354 0 O-C-N 123.266 0.354 . . . . 1.0 111.468 -175.006 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.7 tp . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 116.829 2.159 . . . . 1.0 116.829 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.8 t -57.44 -32.76 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 119.344 -0.36 . . . . 1.0 111.717 -170.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.47 -45.29 94.28 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.76 1.164 . . . . 1.0 112.521 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -68.42 -31.06 70.13 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.81 0.844 . . . . 1.0 111.017 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -67.7 -47.15 70.22 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 173.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.451 ' HA ' HG12 ' A' ' 141' ' ' VAL . . . -64.74 -42.45 95.17 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 113.122 0.786 . . . . 1.0 113.122 -176.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -54.72 -48.43 72.51 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.344 1.058 . . . . 1.0 110.404 170.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.89 -38.21 70.02 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.517 0.727 . . . . 1.0 112.067 -174.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.3 mt -68.26 -45.48 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 O-C-N 121.33 -0.856 . . . . 1.0 109.35 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.16 -31.02 71.61 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.653 1.115 . . . . 1.0 110.884 -178.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 34.6 m -63.07 -45.55 91.66 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.796 1.238 . . . . 1.0 112.539 169.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.39 -31.97 71.7 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.57 1.148 . . . . 1.0 113.236 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -65.74 -30.47 71.14 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.123 1.769 . . . . 1.0 111.648 171.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.0 31.61 1.7 Allowed Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.702 1.144 . . . . 1.0 114.833 172.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -124.7 161.66 25.86 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.302 1.441 . . . . 1.0 110.739 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -91.8 86.24 5.86 Favored 'General case' 0 N--CA 1.46 0.071 0 C-N-CA 125.034 1.334 . . . . 1.0 108.939 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.5 146.2 28.46 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.05 0.54 . . . . 1.0 111.404 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.2 m -147.5 140.66 25.16 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.344 1.058 . . . . 1.0 112.198 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -87.04 137.31 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 115.108 1.521 . . . . 1.0 115.108 171.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -111.86 120.86 43.39 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.262 1.825 . . . . 1.0 111.126 169.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -99.92 138.23 37.28 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.587 1.955 . . . . 1.0 110.942 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.7 t0 42.18 54.85 9.34 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 124.39 1.076 . . . . 1.0 111.378 -169.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -63.56 137.32 58.9 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.836 3.024 . . . . 1.0 116.707 -168.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -88.56 157.35 18.63 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.547 1.539 . . . . 1.0 111.706 168.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -68.52 -21.27 64.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 120.261 -1.525 . . . . 1.0 109.567 167.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.2 m -68.86 -19.83 64.25 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.455 -0.778 . . . . 1.0 112.319 169.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -81.98 -28.57 32.57 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.546 1.138 . . . . 1.0 112.129 169.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 12.6 t-105 -82.7 -36.9 25.47 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.671 0.989 . . . . 1.0 113.671 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.8 mt -48.6 -39.83 34.87 Favored Pre-proline 0 CA--C 1.552 1.054 0 CA-C-O 117.482 -1.246 . . . . 1.0 114.123 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -57.59 -12.36 11.1 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 124.428 3.418 . . . . 1.0 117.144 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -110.53 8.13 22.84 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 116.121 1.897 . . . . 1.0 116.121 -174.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -52.72 -30.94 35.11 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.941 2.096 . . . . 1.0 113.782 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -113.48 13.1 18.81 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.882 1.273 . . . . 1.0 112.602 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -122.65 -159.51 0.84 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.273 2.629 . . . . 1.0 110.854 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -115.12 165.09 13.29 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 123.018 1.389 . . . . 1.0 111.763 170.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.49 163.19 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.331 1.452 . . . . 1.0 108.945 -172.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.4 tp -141.45 127.08 19.0 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.509 1.123 . . . . 1.0 108.951 175.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.46 124.0 52.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 124.055 0.942 . . . . 1.0 109.533 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.0 t -122.58 112.37 34.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 174.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 115.136 1.532 . . . . 1.0 115.136 -167.98 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.6 tt . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 113.471 0.915 . . . . 1.0 113.471 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.5 t -40.77 -50.61 7.29 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 124.638 1.175 . . . . 1.0 112.816 168.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.38 -30.03 20.04 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.506 1.471 . . . . 1.0 111.913 -172.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.5 tp -66.45 -50.58 62.85 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 123.804 0.842 . . . . 1.0 110.534 169.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -54.69 -54.31 43.44 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.018 0.927 . . . . 1.0 112.306 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -68.05 -35.4 78.17 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.132 -0.486 . . . . 1.0 111.915 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.18 -36.72 93.58 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 123.941 0.781 . . . . 1.0 112.367 176.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 79.7 mt -62.43 -51.87 66.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.521 1.661 . . . . 1.0 108.136 170.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -68.43 -32.59 72.73 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 120.435 -1.415 . . . . 1.0 113.141 -169.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -99.58 -37.26 9.23 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.771 1.629 . . . . 1.0 114.808 -174.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 m -99.8 -19.17 16.83 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.613 1.165 . . . . 1.0 113.17 -174.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.3 -71.54 0.66 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 106.409 -1.7 . . . . 1.0 106.409 169.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.89 -13.88 1.65 Allowed Glycine 0 CA--C 1.537 1.426 0 C-N-CA 127.642 2.544 . . . . 1.0 116.719 168.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -154.67 137.89 15.7 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.872 2.069 . . . . 1.0 108.633 172.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -134.92 124.0 16.31 Favored Pre-proline 0 CA--C 1.546 0.816 0 O-C-N 121.354 -0.841 . . . . 1.0 111.499 -171.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.83 -39.62 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.015 2.477 . . . . 1.0 114.72 -174.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -140.63 14.84 2.34 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.5 1.296 . . . . 1.0 114.5 -169.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 70.0 tp -80.84 138.06 36.21 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.579 -1.326 . . . . 1.0 112.862 -169.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.1 mtm-85 -135.97 156.76 48.26 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.963 2.505 . . . . 1.0 109.085 169.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.78 166.82 21.63 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.306 -0.871 . . . . 1.0 112.181 -176.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.448 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -120.05 171.92 14.69 Favored Glycine 0 N--CA 1.472 1.058 0 C-N-CA 125.487 1.518 . . . . 1.0 114.438 173.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.0 t -146.35 133.07 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 115.63 1.715 . . . . 1.0 115.63 -169.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.5 mt -131.6 108.38 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 125.719 1.608 . . . . 1.0 107.481 168.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.84 148.3 23.26 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.236 1.414 . . . . 1.0 112.017 170.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.8 mp -139.78 149.04 43.07 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.869 0.692 . . . . 1.0 112.869 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.566 0 CA-C-N 116.115 -0.493 . . . . 1.0 113.443 169.254 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 CA--C 1.545 0.774 0 N-CA-C 113.609 0.966 . . . . 1.0 113.609 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -61.48 -16.03 43.37 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.494 1.517 . . . . 1.0 114.545 -173.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.32 -42.02 97.17 Favored Glycine 0 CA--C 1.537 1.408 0 CA-C-N 120.271 1.396 . . . . 1.0 113.22 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.97 -36.53 46.51 Favored Glycine 0 N--CA 1.48 1.626 0 O-C-N 120.258 -1.731 . . . . 1.0 112.724 174.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -63.02 -33.36 75.26 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.871 0.868 . . . . 1.0 112.785 174.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -58.4 -42.73 87.77 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.807 0.843 . . . . 1.0 111.856 170.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -62.06 -37.89 86.69 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.763 0.71 . . . . 1.0 111.14 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.55 -46.16 84.03 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.657 0.662 . . . . 1.0 111.366 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.61 -43.48 68.7 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.442 -0.789 . . . . 1.0 112.0 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.24 -49.44 64.0 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.787 2.035 . . . . 1.0 111.733 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.3 mt -65.31 -40.35 93.63 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.471 -0.786 . . . . 1.0 111.232 178.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -67.65 -22.81 65.29 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.247 1.203 . . . . 1.0 114.247 175.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -64.42 -35.7 81.76 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.666 1.186 . . . . 1.0 110.7 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -86.01 -78.46 0.27 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 113.361 -1.745 . . . . 1.0 110.041 -175.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.2 t 179.26 0.01 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.474 1.91 . . . . 1.0 112.171 172.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.45 155.48 33.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 122.264 1.031 . . . . 1.0 113.443 -169.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -92.8 170.84 9.39 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.997 1.719 . . . . 1.0 112.018 -169.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -129.36 159.91 34.7 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.779 1.231 . . . . 1.0 112.342 172.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.0 t -122.62 126.09 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 125.981 1.712 . . . . 1.0 108.209 -176.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 52.4 -168.71 0.74 Allowed Glycine 0 CA--C 1.542 1.739 0 C-N-CA 125.642 1.591 . . . . 1.0 116.199 -176.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -92.37 146.76 23.44 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.163 1.385 . . . . 1.0 110.038 169.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.88 156.34 36.52 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.764 0.826 . . . . 1.0 111.456 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.417 HD22 ' CD1' ' A' ' 140' ' ' TRP . 1.0 OUTLIER -92.52 138.54 31.42 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.937 0.895 . . . . 1.0 110.258 170.509 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.3 mt -121.71 104.46 9.61 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.764 1.226 . . . . 1.0 111.265 173.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.68 131.49 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 C-N-CA 125.034 1.334 . . . . 1.0 112.049 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -107.54 106.29 16.59 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.175 0.988 . . . . 1.0 112.925 172.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -69.24 -22.86 63.83 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.565 0.95 . . . . 1.0 113.565 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.9 t -63.8 -22.52 66.95 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.389 1.076 . . . . 1.0 112.512 173.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -116.13 -30.2 6.06 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.279 1.831 . . . . 1.0 111.884 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -145.6 91.52 5.7 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 124.909 1.283 . . . . 1.0 112.601 -173.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.4 2.54 7.19 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 123.363 2.709 . . . . 1.0 114.383 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -109.82 72.35 0.61 Allowed Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 129.152 2.981 . . . . 1.0 110.444 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -60.5 -12.53 21.15 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.622 2.881 . . . . 1.0 116.723 -169.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -67.0 -28.19 68.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.803 0.729 . . . . 1.0 111.541 172.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 44.3 p -68.91 -26.21 64.98 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.117 -0.99 . . . . 1.0 111.935 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -93.78 -53.1 4.15 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.849 1.26 . . . . 1.0 111.818 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.7 t -72.42 -32.26 66.19 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.503 1.297 . . . . 1.0 114.503 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -61.17 -55.4 44.36 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 121.243 1.838 . . . . 1.0 112.731 -177.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -62.99 -22.65 73.92 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 121.567 1.595 . . . . 1.0 112.676 175.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.417 ' CD1' HD22 ' A' ' 123' ' ' LEU . 92.0 t90 -68.53 -48.62 63.87 Favored 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.345 0.658 . . . . 1.0 110.602 174.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.451 HG12 ' HA ' ' A' ' 22' ' ' ALA . 83.9 t -65.43 -32.06 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 122.002 0.906 . . . . 1.0 109.042 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.96 -23.22 61.4 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 119.991 -1.693 . . . . 1.0 113.336 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -86.79 -61.98 1.61 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.978 2.111 . . . . 1.0 111.403 169.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.448 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 83.9 t90 -54.98 -38.2 67.49 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 126.844 2.058 . . . . 1.0 112.823 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.2 -28.71 27.37 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 118.913 0.778 . . . . 1.0 114.513 173.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.5 p -69.93 -12.78 61.87 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.808 1.304 . . . . 1.0 114.043 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.03 -18.98 48.75 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.91 1.684 . . . . 1.0 111.615 176.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.88 171.99 11.08 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.991 1.316 . . . . 1.0 111.194 -177.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 C--O 1.255 1.35 0 C-N-CA 125.252 1.421 . . . . 1.0 114.743 -171.92 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 117.717 2.488 . . . . 1.0 117.717 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -122.23 126.95 49.31 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.582 1.953 . . . . 1.0 109.726 173.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mp -123.91 114.25 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 C-N-CA 127.078 2.151 . . . . 1.0 112.213 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.71 124.44 7.63 Favored Glycine 0 C--O 1.224 -0.512 0 N-CA-C 110.315 -1.114 . . . . 1.0 110.315 169.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.0 mt -104.43 118.97 52.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 118.283 1.042 . . . . 1.0 109.618 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -111.51 108.79 18.43 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.941 -1.503 . . . . 1.0 106.941 -170.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 N--CA 1.465 0.276 0 O-C-N 123.235 0.334 . . . . 1.0 111.375 -176.221 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.5 tp . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 112.644 0.609 . . . . 1.0 112.644 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.5 t -52.63 -33.14 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.17 0.988 . . . . 1.0 112.184 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.19 -48.69 80.37 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 120.0 1.273 . . . . 1.0 113.208 173.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -65.79 -33.11 75.09 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.577 0.751 . . . . 1.0 110.682 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -66.46 -47.79 72.0 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 123.934 0.893 . . . . 1.0 109.406 173.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.448 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -63.78 -43.07 97.45 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 112.584 0.587 . . . . 1.0 112.584 -176.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.11 -49.01 72.82 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.951 0.5 . . . . 1.0 110.029 170.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.42 -38.07 74.53 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.776 0.658 . . . . 1.0 112.776 -173.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.9 mt -65.88 -47.5 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 174.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.14 -34.32 77.33 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 119.651 -0.82 . . . . 1.0 110.573 -175.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.0 m -62.76 -41.63 99.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.691 1.597 . . . . 1.0 113.52 170.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.5 -32.81 73.88 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.825 0.85 . . . . 1.0 112.308 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -71.49 -29.32 64.68 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.638 1.175 . . . . 1.0 113.447 171.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.53 26.83 2.3 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.393 0.996 . . . . 1.0 114.086 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -116.35 146.56 42.36 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.381 1.072 . . . . 1.0 109.769 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -79.99 89.41 5.34 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 125.088 1.355 . . . . 1.0 108.448 -175.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.52 146.61 30.4 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 122.552 0.341 . . . . 1.0 110.737 -178.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.7 m -149.29 146.76 27.71 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.011 0.924 . . . . 1.0 111.399 -172.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.3 t -97.51 139.27 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 114.794 1.405 . . . . 1.0 114.794 176.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -122.61 113.66 19.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.974 2.11 . . . . 1.0 109.966 169.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -98.88 138.11 36.48 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.746 1.618 . . . . 1.0 111.188 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 43.24 55.45 11.31 Favored Pre-proline 0 CA--C 1.564 1.496 0 C-N-CA 124.518 1.127 . . . . 1.0 111.475 -169.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.52 152.09 59.61 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 125.167 3.911 . . . . 1.0 119.198 -167.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -93.84 155.47 17.17 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.216 2.206 . . . . 1.0 113.008 168.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -69.46 -23.22 63.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 120.827 -1.171 . . . . 1.0 109.983 168.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.6 m -65.93 -23.13 66.56 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.27 -0.894 . . . . 1.0 112.228 171.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -83.07 -24.68 32.61 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.242 1.017 . . . . 1.0 113.122 169.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.6 t-105 -82.27 -35.82 27.69 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.74 1.154 . . . . 1.0 113.786 177.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.4 mt -50.08 -38.62 38.33 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-O 117.567 -1.206 . . . . 1.0 114.098 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -52.92 -16.92 6.72 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 124.202 3.268 . . . . 1.0 117.319 171.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -109.24 9.88 25.84 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 115.486 1.662 . . . . 1.0 115.486 -175.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -52.6 -33.09 44.72 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 126.08 1.752 . . . . 1.0 113.708 177.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -105.01 1.69 28.88 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.555 1.542 . . . . 1.0 113.576 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -112.56 -164.05 0.89 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.62 2.368 . . . . 1.0 110.932 -175.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -109.04 164.98 11.94 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 122.982 1.373 . . . . 1.0 111.541 169.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.64 159.92 5.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 125.245 1.418 . . . . 1.0 109.164 -172.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.4 tp -138.73 129.95 27.01 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 124.792 1.237 . . . . 1.0 108.698 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.8 t -105.16 125.55 60.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 124.247 1.019 . . . . 1.0 108.964 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.59 114.45 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 107.484 -1.302 . . . . 1.0 107.484 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 113.797 1.036 . . . . 1.0 113.797 -169.199 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.8 tt . . . . . 0 N--CA 1.471 0.618 0 N-CA-C 112.78 0.659 . . . . 1.0 112.78 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.4 t -46.24 -50.56 37.86 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 125.18 1.392 . . . . 1.0 112.298 167.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.6 -28.19 31.75 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.688 1.592 . . . . 1.0 111.609 -173.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 tp -70.46 -51.66 27.63 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 123.673 0.789 . . . . 1.0 110.722 169.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -55.4 -55.38 32.28 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.234 1.014 . . . . 1.0 112.493 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -68.05 -35.36 78.1 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.44 0.696 . . . . 1.0 111.832 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.13 -35.91 92.58 Favored Glycine 0 CA--C 1.529 0.91 0 O-C-N 121.662 -0.649 . . . . 1.0 112.359 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 88.8 mt -65.88 -51.57 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 119.871 1.835 . . . . 1.0 107.901 170.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? -68.28 -30.52 69.55 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 120.165 -1.585 . . . . 1.0 113.715 -169.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -107.61 -37.45 6.17 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.995 1.718 . . . . 1.0 115.217 -176.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.5 m -94.1 -21.0 19.39 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.985 0.914 . . . . 1.0 113.197 -176.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.38 -71.49 0.64 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 106.523 -1.658 . . . . 1.0 106.523 169.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.94 -19.33 1.0 Allowed Glycine 0 CA--C 1.535 1.314 0 C-N-CA 127.945 2.688 . . . . 1.0 115.38 169.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -152.19 139.31 19.23 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 128.185 2.594 . . . . 1.0 107.885 169.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -137.86 121.8 11.75 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 118.829 -0.605 . . . . 1.0 109.838 -170.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -81.61 -35.99 0.37 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.713 2.275 . . . . 1.0 115.496 -169.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -142.91 15.84 1.93 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.18 1.178 . . . . 1.0 114.18 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 67.2 tp -81.74 140.1 34.48 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.716 -1.24 . . . . 1.0 112.881 -169.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.5 mtm-85 -136.51 154.68 50.66 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.694 2.397 . . . . 1.0 109.311 169.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.419 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -160.18 170.29 21.48 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.286 0.948 . . . . 1.0 111.87 -177.714 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -129.25 171.45 20.01 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 124.744 1.164 . . . . 1.0 113.393 170.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.88 138.41 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.134 0.973 . . . . 1.0 113.521 -169.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.1 mt -130.81 96.52 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.631 1.572 . . . . 1.0 107.096 169.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.92 145.61 25.42 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.494 1.518 . . . . 1.0 111.066 172.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.4 mp -140.71 157.32 45.61 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 121.611 -0.681 . . . . 1.0 112.17 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.68 0 CA-C-O 121.976 0.764 . . . . 1.0 114.715 169.342 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 15.5 m . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 113.2 0.815 . . . . 1.0 113.2 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -54.12 -30.34 48.4 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.013 1.725 . . . . 1.0 114.722 -174.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.88 -41.55 94.23 Favored Glycine 0 N--CA 1.473 1.132 0 CA-C-N 121.477 1.944 . . . . 1.0 113.32 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.07 -37.73 28.16 Favored Glycine 0 N--CA 1.476 1.304 0 CA-C-N 118.258 1.029 . . . . 1.0 113.326 173.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -58.66 -35.14 72.07 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.647 1.223 . . . . 1.0 113.167 173.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -68.29 -33.48 74.42 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.244 0.618 . . . . 1.0 112.14 172.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -63.69 -37.13 86.19 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.759 1.163 . . . . 1.0 110.963 172.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.1 -48.14 79.85 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.98 0.912 . . . . 1.0 112.139 174.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.98 -35.15 70.78 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.816 0.672 . . . . 1.0 112.816 173.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.82 -50.12 74.36 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 123.525 1.631 . . . . 1.0 110.906 -176.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.419 HD12 ' CD1' ' A' ' 87' ' ' TYR . 6.3 mt -66.34 -40.52 89.88 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 120.762 -1.211 . . . . 1.0 111.262 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -70.73 -16.91 62.81 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.241 0.83 . . . . 1.0 113.241 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.81 -20.4 53.27 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.579 1.081 . . . . 1.0 110.798 175.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -97.79 -79.37 0.47 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.377 1.471 . . . . 1.0 110.28 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.0 t -175.27 -3.28 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.79 1.636 . . . . 1.0 112.573 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.83 151.95 29.98 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 122.962 1.363 . . . . 1.0 113.596 -169.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -88.44 168.2 12.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.049 1.74 . . . . 1.0 113.799 -168.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -119.4 148.04 43.67 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.779 2.031 . . . . 1.0 110.922 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.3 t -120.71 128.31 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.149 1.38 . . . . 1.0 108.798 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 50.06 -158.13 1.68 Allowed Glycine 0 N--CA 1.48 1.609 0 C-N-CA 125.087 1.327 . . . . 1.0 114.569 -172.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -110.91 142.49 42.92 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.088 1.355 . . . . 1.0 109.277 169.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.36 157.84 33.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.184 0.994 . . . . 1.0 113.049 -169.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.439 ' HB2' ' CD1' ' A' ' 140' ' ' TRP . 1.4 tm? -90.69 137.11 32.62 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.918 1.287 . . . . 1.0 110.27 173.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.9 mt -127.84 109.35 11.53 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.624 1.57 . . . . 1.0 109.98 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.4 mt -98.25 134.24 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.11 0.964 . . . . 1.0 113.014 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -100.18 91.86 4.95 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.919 2.488 . . . . 1.0 112.71 174.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.82 -23.28 66.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.209 1.004 . . . . 1.0 112.733 -174.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.9 p -54.1 -30.88 50.22 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 129.373 3.069 . . . . 1.0 114.158 169.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -121.28 -26.19 5.09 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.586 1.954 . . . . 1.0 111.508 -171.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -140.32 89.26 10.86 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 125.184 1.393 . . . . 1.0 111.474 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -75.66 11.39 1.64 Allowed 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.842 3.028 . . . . 1.0 114.005 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -113.77 65.3 1.23 Allowed Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 127.358 2.263 . . . . 1.0 110.072 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -55.72 -22.37 36.21 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.561 2.174 . . . . 1.0 116.176 -169.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.7 pm0 -64.49 -25.01 67.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 119.553 1.069 . . . . 1.0 111.817 175.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.5 p -72.82 -17.14 61.59 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 120.628 -1.295 . . . . 1.0 112.372 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -102.54 -55.79 2.38 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.258 1.823 . . . . 1.0 111.957 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 63.6 p -68.73 -33.31 73.71 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 113.817 1.043 . . . . 1.0 113.817 -176.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 36.5 m-20 -60.11 -59.23 14.53 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 120.688 1.585 . . . . 1.0 112.399 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -62.33 -22.32 73.93 Favored 'Trans proline' 0 C--N 1.352 0.713 0 CA-C-N 121.377 1.527 . . . . 1.0 112.943 175.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.439 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 87.2 t90 -68.71 -46.07 69.93 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 118.776 0.716 . . . . 1.0 111.2 172.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.448 HG11 ' HA ' ' A' ' 22' ' ' ALA . 92.2 t -63.84 -34.62 69.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 175.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.07 -30.83 70.12 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.299 1.44 . . . . 1.0 112.071 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -78.01 -61.87 1.86 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.113 1.765 . . . . 1.0 112.355 170.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -56.04 -36.43 68.0 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 126.046 1.738 . . . . 1.0 112.694 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.88 -32.32 26.11 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.393 0.997 . . . . 1.0 113.958 173.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.5 p -67.91 -13.8 62.45 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.073 1.138 . . . . 1.0 114.073 177.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.42 -17.71 50.99 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.002 1.721 . . . . 1.0 111.899 176.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.06 176.24 7.71 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.356 1.462 . . . . 1.0 110.911 -177.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 C--O 1.25 1.081 0 N-CA-C 114.803 1.408 . . . . 1.0 114.803 -170.077 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 113.049 0.759 . . . . 1.0 113.049 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -124.78 121.25 34.08 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.404 1.082 . . . . 1.0 111.178 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mp -118.91 116.25 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 126.579 1.952 . . . . 1.0 112.803 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.04 127.42 9.06 Favored Glycine 0 C--O 1.221 -0.668 0 N-CA-C 111.159 -0.776 . . . . 1.0 111.159 169.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.3 mt -106.36 120.17 56.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 118.682 1.241 . . . . 1.0 109.979 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -111.44 107.63 16.91 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 125.332 1.453 . . . . 1.0 107.598 -169.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.469 0.51 0 CA-C-O 121.32 0.581 . . . . 1.0 112.013 -171.94 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.1 tp . . . . . 0 N--CA 1.467 0.415 0 N-CA-C 112.864 0.69 . . . . 1.0 112.864 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -53.03 -33.07 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.857 0.863 . . . . 1.0 111.995 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.71 -47.15 86.57 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 120.002 1.274 . . . . 1.0 112.72 174.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -65.94 -33.54 76.06 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.835 0.854 . . . . 1.0 110.839 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -66.1 -48.22 71.61 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 123.361 0.664 . . . . 1.0 109.234 173.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.07 -41.83 97.21 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 112.857 0.688 . . . . 1.0 112.857 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.44 -51.14 65.91 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 169.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.08 -37.54 81.35 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.572 -0.705 . . . . 1.0 112.808 -174.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.4 mt -68.27 -46.78 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 119.371 0.987 . . . . 1.0 109.572 176.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.66 -36.3 83.28 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.565 0.697 . . . . 1.0 110.633 -177.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.3 m -61.04 -43.75 98.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.989 0.916 . . . . 1.0 112.908 170.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.45 -29.58 67.31 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.505 1.122 . . . . 1.0 113.548 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -67.35 -30.07 69.79 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.334 1.054 . . . . 1.0 111.891 170.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.02 15.77 1.85 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.455 1.026 . . . . 1.0 115.28 169.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -102.54 -179.08 3.87 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.851 1.26 . . . . 1.0 109.977 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -108.15 98.66 8.19 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 124.982 1.313 . . . . 1.0 108.054 169.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -110.08 148.14 32.28 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 122.785 0.434 . . . . 1.0 111.231 176.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.2 m -146.28 147.0 30.93 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.673 1.189 . . . . 1.0 111.173 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.1 t -96.73 138.24 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 114.245 1.202 . . . . 1.0 114.245 174.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -117.73 112.29 20.26 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.671 1.988 . . . . 1.0 110.576 169.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -93.92 138.51 31.97 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.086 1.754 . . . . 1.0 111.1 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 42.65 55.31 10.34 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 124.789 1.236 . . . . 1.0 110.999 -169.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -68.21 146.02 68.4 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.72 2.947 . . . . 1.0 117.632 -168.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -89.68 155.7 19.05 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.091 1.757 . . . . 1.0 112.523 168.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -69.09 -21.35 64.06 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 120.574 -1.329 . . . . 1.0 109.525 168.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 m -67.24 -21.57 65.73 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.168 -0.957 . . . . 1.0 112.357 170.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -82.88 -27.28 30.82 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.01 0.924 . . . . 1.0 112.5 169.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -82.06 -36.51 27.61 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.488 1.04 . . . . 1.0 113.686 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.9 mt -48.07 -40.44 34.4 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-O 117.708 -1.139 . . . . 1.0 113.668 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -52.45 -16.83 5.69 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 124.373 3.382 . . . . 1.0 117.532 172.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -110.22 8.09 23.5 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 116.195 1.924 . . . . 1.0 116.195 -172.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -51.3 -26.73 7.91 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 127.156 2.183 . . . . 1.0 114.336 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -121.63 15.98 11.13 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.897 1.679 . . . . 1.0 113.485 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -128.62 -154.23 0.62 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 128.163 2.585 . . . . 1.0 109.747 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -122.07 164.05 18.38 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 123.161 1.458 . . . . 1.0 112.371 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.93 164.55 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 124.846 1.258 . . . . 1.0 109.434 -172.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.6 tp -144.39 128.6 17.73 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 125.1 1.36 . . . . 1.0 108.53 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.2 t -102.13 124.81 56.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 124.518 1.127 . . . . 1.0 109.328 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.2 110.85 25.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 106.043 -1.836 . . . . 1.0 106.043 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.485 1.306 0 C-N-CA 123.398 0.679 . . . . 1.0 111.732 -168.907 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.4 tt . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 113.657 0.984 . . . . 1.0 113.657 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.7 t -47.32 -51.19 44.38 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 125.629 1.571 . . . . 1.0 112.204 168.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.48 -31.74 16.78 Favored 'Trans proline' 0 C--N 1.352 0.737 0 CA-C-N 120.57 1.239 . . . . 1.0 111.277 -173.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.7 tp -63.03 -49.78 73.25 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 124.719 1.208 . . . . 1.0 111.331 169.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -54.53 -54.41 41.54 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.761 1.224 . . . . 1.0 112.679 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -64.08 -38.76 92.24 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.689 0.796 . . . . 1.0 111.242 177.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.45 -36.67 91.86 Favored Glycine 0 CA--C 1.528 0.87 0 O-C-N 121.69 -0.631 . . . . 1.0 112.69 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.06 -49.5 79.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 120.008 -1.877 . . . . 1.0 108.291 172.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.9 ptmt -69.93 -31.6 69.45 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.464 -1.398 . . . . 1.0 113.529 -171.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -106.77 -37.43 6.4 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.692 1.597 . . . . 1.0 114.963 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.6 m -92.75 -23.07 19.02 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.295 1.038 . . . . 1.0 112.661 -177.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.22 -71.85 0.64 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 106.934 -1.506 . . . . 1.0 106.934 169.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.61 -9.47 2.58 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 126.73 2.11 . . . . 1.0 115.622 170.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -153.96 147.1 24.64 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 128.734 2.814 . . . . 1.0 107.788 169.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 39.7 mm-40 -136.76 125.17 14.97 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 123.261 0.625 . . . . 1.0 110.8 -174.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -83.05 -40.76 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.458 2.106 . . . . 1.0 114.097 -174.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -146.9 18.95 1.27 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.628 1.171 . . . . 1.0 113.846 -169.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.2 tp -80.95 140.0 35.5 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.606 -1.309 . . . . 1.0 112.782 -169.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 -135.26 154.6 51.51 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.624 2.369 . . . . 1.0 109.158 169.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.419 ' CD1' HD13 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -162.03 167.15 24.88 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.91 0.777 . . . . 1.0 112.195 -179.602 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.423 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -122.56 172.82 15.87 Favored Glycine 0 N--CA 1.473 1.139 0 C-N-CA 125.702 1.62 . . . . 1.0 114.096 173.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.4 t -146.7 133.79 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 114.421 1.267 . . . . 1.0 114.421 -169.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.3 mt -131.4 110.37 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 106.97 -1.493 . . . . 1.0 106.97 168.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.91 145.01 24.93 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.741 1.216 . . . . 1.0 110.711 170.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.09 150.57 43.07 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.317 0.647 . . . . 1.0 111.571 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.631 0 CA-C-O 122.077 0.821 . . . . 1.0 114.67 169.485 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 113.489 0.922 . . . . 1.0 113.489 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -55.55 -29.53 59.14 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.896 1.278 . . . . 1.0 114.407 -174.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.01 -43.3 95.11 Favored Glycine 0 N--CA 1.476 1.349 0 CA-C-N 121.115 1.78 . . . . 1.0 114.444 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.49 -37.04 36.73 Favored Glycine 0 N--CA 1.478 1.449 0 O-C-N 121.082 -1.246 . . . . 1.0 112.772 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -60.37 -38.31 83.46 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.322 1.049 . . . . 1.0 113.111 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -59.51 -42.87 93.19 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.259 1.024 . . . . 1.0 111.951 170.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.28 -38.18 90.16 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.638 0.654 . . . . 1.0 110.889 176.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -37.59 88.06 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.746 0.819 . . . . 1.0 112.698 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.71 93.52 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.819 -0.61 . . . . 1.0 112.213 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.7 -48.25 58.74 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.115 2.166 . . . . 1.0 111.885 -171.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.419 HD13 ' CD1' ' A' ' 87' ' ' TYR . 6.6 mt -66.48 -42.39 87.55 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.41 -0.814 . . . . 1.0 111.516 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -67.44 -21.43 65.55 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.887 1.069 . . . . 1.0 113.887 175.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -67.09 -33.88 76.44 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.279 1.032 . . . . 1.0 111.331 174.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -85.15 -73.99 0.42 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 114.129 -1.396 . . . . 1.0 110.709 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.4 m 174.97 -0.72 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.953 2.501 . . . . 1.0 112.001 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.61 152.14 34.04 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-O 122.222 1.01 . . . . 1.0 113.599 -169.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -86.03 161.48 18.93 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.404 1.482 . . . . 1.0 112.876 -169.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.68 127.01 37.99 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.143 1.777 . . . . 1.0 108.99 -173.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.7 t -106.78 129.85 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.635 0.774 . . . . 1.0 110.45 -169.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 51.64 -154.68 4.42 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.768 1.175 . . . . 1.0 113.544 -171.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -115.85 147.24 41.26 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.73 1.612 . . . . 1.0 109.142 169.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -73.78 157.35 36.59 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.05 -1.031 . . . . 1.0 112.231 -169.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.438 ' CD1' HG13 ' A' ' 125' ' ' ILE . 0.9 OUTLIER -90.39 138.06 31.85 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.857 0.863 . . . . 1.0 110.442 171.306 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.8 mt -122.65 108.03 12.63 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.089 1.356 . . . . 1.0 111.316 175.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.438 HG13 ' CD1' ' A' ' 123' ' ' LEU . 4.1 mt -95.84 133.74 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 125.227 1.411 . . . . 1.0 112.944 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -107.67 89.31 2.96 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.689 2.796 . . . . 1.0 113.097 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.72 -24.66 67.64 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.814 -1.179 . . . . 1.0 113.162 -173.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.2 m -62.79 -16.26 57.3 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.947 2.099 . . . . 1.0 113.776 172.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -131.38 -28.26 1.9 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.872 2.069 . . . . 1.0 112.658 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -139.01 88.54 13.29 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 126.251 1.821 . . . . 1.0 110.917 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -75.59 11.03 1.71 Allowed 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 123.67 2.913 . . . . 1.0 114.05 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -112.79 68.36 1.04 Allowed Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 127.578 2.351 . . . . 1.0 110.127 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -58.09 -20.03 43.95 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.942 2.428 . . . . 1.0 116.87 -169.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -66.55 -26.53 67.17 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.559 -0.713 . . . . 1.0 112.011 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 26.9 p -71.77 -21.59 61.71 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 120.971 -1.081 . . . . 1.0 111.762 -175.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -95.51 -55.53 3.0 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.124 1.77 . . . . 1.0 112.009 176.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.5 t -71.06 -32.0 68.57 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.809 1.04 . . . . 1.0 113.809 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -62.1 -53.19 61.47 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 120.9 1.682 . . . . 1.0 113.286 -177.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -63.49 -24.79 70.4 Favored 'Trans proline' 0 C--N 1.353 0.787 0 CA-C-N 121.157 1.449 . . . . 1.0 112.36 173.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.429 ' CD1' HD22 ' A' ' 123' ' ' LEU . 91.8 t90 -67.77 -47.98 67.67 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 118.858 0.753 . . . . 1.0 110.764 175.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.4 -32.61 59.0 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.71 -52.13 61.89 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.062 -1.024 . . . . 1.0 109.749 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -64.55 -50.82 65.8 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.882 0.873 . . . . 1.0 111.855 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.423 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 85.6 t90 -59.05 -35.66 73.69 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 125.269 1.428 . . . . 1.0 111.737 175.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.23 -34.39 40.31 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.932 1.254 . . . . 1.0 113.247 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.0 p -68.12 -13.04 61.91 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 114.884 1.439 . . . . 1.0 114.884 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.74 -13.32 54.24 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.525 1.53 . . . . 1.0 112.542 176.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -74.41 169.54 17.49 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.556 1.071 . . . . 1.0 112.005 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.0 t . . . . . 0 C--O 1.257 1.489 0 C-N-CA 125.916 1.686 . . . . 1.0 112.605 -169.458 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 113.495 0.924 . . . . 1.0 113.495 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -117.02 125.38 51.26 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.063 1.345 . . . . 1.0 110.461 173.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 mp -122.91 115.26 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.063 0 C-N-CA 126.262 1.825 . . . . 1.0 112.351 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.49 125.55 8.26 Favored Glycine 0 N--CA 1.462 0.41 0 N-CA-C 110.432 -1.067 . . . . 1.0 110.432 169.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 mt -104.86 121.05 56.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 117.875 0.838 . . . . 1.0 109.071 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -113.66 115.22 27.54 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 124.648 1.179 . . . . 1.0 108.548 -169.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.535 0.373 0 N-CA-C 112.537 0.569 . . . . 1.0 112.537 -172.869 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.8 tp . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 113.975 1.102 . . . . 1.0 113.975 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.9 t -49.48 -34.26 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 127.077 2.151 . . . . 1.0 112.427 -176.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.01 -47.63 85.55 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.852 1.205 . . . . 1.0 112.978 174.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -67.59 -31.84 72.16 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.744 0.818 . . . . 1.0 110.605 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.77 -49.86 64.57 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 123.785 0.834 . . . . 1.0 109.06 173.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.4 ' HA ' HG12 ' A' ' 141' ' ' VAL . . . -62.3 -42.74 99.62 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 123.633 0.773 . . . . 1.0 112.509 -176.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.15 -51.37 66.69 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 170.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.04 -36.57 80.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.521 -0.737 . . . . 1.0 112.868 -174.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.2 mt -68.62 -47.34 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 119.345 0.975 . . . . 1.0 109.511 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.97 -36.89 85.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.856 0.836 . . . . 1.0 110.657 -177.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.0 m -61.38 -42.02 98.04 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 121.201 -0.937 . . . . 1.0 113.022 170.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.34 -29.57 66.3 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.604 1.162 . . . . 1.0 113.392 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -66.69 -30.67 70.98 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.582 1.153 . . . . 1.0 111.388 170.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.57 11.05 1.75 Allowed Glycine 0 CA--C 1.53 0.988 0 N-CA-C 115.498 0.959 . . . . 1.0 115.498 169.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 -101.21 -177.09 3.34 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.829 1.252 . . . . 1.0 110.898 -174.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -109.71 97.15 6.75 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.973 1.309 . . . . 1.0 108.266 169.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.37 150.12 27.08 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.492 0.317 . . . . 1.0 111.262 176.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.6 m -145.16 147.79 32.86 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.784 1.234 . . . . 1.0 111.509 -175.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.3 t -98.09 138.83 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 114.899 1.444 . . . . 1.0 114.899 174.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -117.66 110.71 18.21 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.742 1.617 . . . . 1.0 110.748 169.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -90.06 144.2 26.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.787 1.635 . . . . 1.0 110.848 170.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 40.29 55.08 6.84 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 125.019 1.328 . . . . 1.0 112.51 -169.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.24 142.2 49.57 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.813 3.009 . . . . 1.0 117.179 -168.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.44 ' HB3' ' H ' ' A' ' 42' ' ' SER . 52.0 mm-40 -97.49 163.24 12.94 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 122.71 1.243 . . . . 1.0 112.783 168.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -67.28 -23.82 65.71 Favored 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 121.004 -1.06 . . . . 1.0 110.461 167.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.44 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 62.9 p -68.39 -18.65 64.51 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.941 -1.1 . . . . 1.0 112.337 172.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -82.49 -24.85 33.96 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.896 0.878 . . . . 1.0 112.178 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -87.52 -36.52 17.56 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.399 1.259 . . . . 1.0 114.399 -178.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.7 mt -46.7 -37.89 10.25 Favored Pre-proline 0 CA--C 1.553 1.069 0 N-CA-C 114.413 1.264 . . . . 1.0 114.413 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -61.11 -14.36 33.07 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 123.745 2.964 . . . . 1.0 116.695 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -107.87 8.4 28.59 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 115.745 1.757 . . . . 1.0 115.745 -173.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -54.85 -27.82 45.21 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.631 1.972 . . . . 1.0 113.874 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -107.67 3.02 24.25 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.562 1.545 . . . . 1.0 113.41 176.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -114.93 -163.34 0.87 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.915 2.486 . . . . 1.0 110.836 -174.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -106.81 162.84 13.45 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 123.387 1.565 . . . . 1.0 110.936 169.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.63 151.66 13.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.253 -1.34 . . . . 1.0 108.056 -173.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.1 tp -133.62 130.27 38.07 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 124.471 1.108 . . . . 1.0 108.667 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.4 t -105.11 126.79 60.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.263 -0.643 . . . . 1.0 109.263 174.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.4 t -122.97 111.38 29.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.963 -1.866 . . . . 1.0 105.963 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 114.496 1.295 . . . . 1.0 114.496 -167.916 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.5 tt . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 113.283 0.846 . . . . 1.0 113.283 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.1 t -44.91 -53.31 16.22 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.422 1.089 . . . . 1.0 112.323 168.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.17 -31.87 28.49 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.647 1.565 . . . . 1.0 111.702 -173.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.2 tp -63.1 -52.15 63.77 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.146 0.978 . . . . 1.0 111.257 169.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -56.02 -53.41 57.27 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.927 0.891 . . . . 1.0 112.385 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -63.88 -39.91 95.3 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.814 0.846 . . . . 1.0 111.544 177.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.76 -36.86 91.83 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 123.47 0.557 . . . . 1.0 112.589 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 82.5 mt -65.19 -47.74 86.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 120.024 1.912 . . . . 1.0 108.412 172.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -71.63 -31.27 66.68 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.224 -1.547 . . . . 1.0 113.289 -171.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -104.42 -38.71 6.71 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 115.519 1.674 . . . . 1.0 115.519 -175.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.1 m -95.09 -22.43 17.9 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.639 1.176 . . . . 1.0 113.326 -174.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.23 -71.71 0.62 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 106.93 -1.507 . . . . 1.0 106.93 170.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.53 -16.86 0.91 Allowed Glycine 0 CA--C 1.538 1.488 0 C-N-CA 127.562 2.506 . . . . 1.0 116.804 169.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -152.27 138.15 18.05 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.862 2.465 . . . . 1.0 108.227 174.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -133.72 124.12 17.65 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 119.086 0.857 . . . . 1.0 112.546 -172.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -82.65 -35.93 0.28 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.598 2.199 . . . . 1.0 114.726 -173.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -144.99 11.1 1.36 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.589 1.7 . . . . 1.0 115.589 -169.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 39.1 tp -75.06 142.05 43.78 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 120.27 -1.519 . . . . 1.0 113.004 -169.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -134.2 144.11 48.26 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 129.317 3.047 . . . . 1.0 107.493 169.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.454 ' CD1' HD11 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -154.38 164.25 38.92 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 120.046 1.294 . . . . 1.0 113.568 179.564 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -125.78 170.67 17.65 Favored Glycine 0 N--CA 1.468 0.8 0 C-N-CA 126.537 2.018 . . . . 1.0 112.248 172.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -160.25 146.6 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 O-C-N 120.836 -1.391 . . . . 1.0 114.442 -169.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.1 mt -138.4 98.69 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 127.92 2.488 . . . . 1.0 107.005 -172.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.09 147.88 23.99 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.408 1.483 . . . . 1.0 111.867 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.4 mp -140.48 152.31 45.52 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.297 0.639 . . . . 1.0 112.629 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.509 0 N-CA-C 115.097 0.799 . . . . 1.0 115.097 169.201 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.543 0.68 0 N-CA-C 113.317 0.858 . . . . 1.0 113.317 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -51.06 -28.49 10.51 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.548 1.539 . . . . 1.0 114.009 -177.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.71 -42.78 59.32 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-N 120.436 1.471 . . . . 1.0 113.895 175.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.52 -34.88 18.46 Favored Glycine 0 N--CA 1.478 1.491 0 CA-C-N 118.864 1.332 . . . . 1.0 113.806 174.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -59.48 -32.87 70.66 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 118.465 1.132 . . . . 1.0 112.974 174.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -61.67 -41.69 97.89 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.217 1.007 . . . . 1.0 111.997 170.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -65.28 -34.89 79.42 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.234 0.924 . . . . 1.0 111.671 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -60.61 -55.19 36.26 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.344 0.657 . . . . 1.0 110.95 172.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.64 -34.71 62.56 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.974 0.731 . . . . 1.0 112.974 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.66 -50.29 72.53 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 123.562 1.648 . . . . 1.0 111.692 -178.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.454 HD11 ' CD1' ' A' ' 87' ' ' TYR . 14.9 mt -68.1 -36.98 80.66 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 120.606 -1.309 . . . . 1.0 111.423 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -73.79 -11.96 60.55 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.7 1.0 . . . . 1.0 113.7 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.84 -17.28 41.47 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.758 1.163 . . . . 1.0 110.918 175.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -96.51 -84.03 0.37 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.42 1.488 . . . . 1.0 108.729 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.5 -8.75 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.898 1.679 . . . . 1.0 112.67 -169.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -81.06 162.5 23.73 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 122.156 0.979 . . . . 1.0 113.312 -168.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -106.33 163.55 12.74 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.376 1.071 . . . . 1.0 111.793 -169.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.12 138.93 53.29 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.824 1.65 . . . . 1.0 110.802 -178.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.472 HG13 ' H ' ' A' ' 120' ' ' GLY . 18.5 t -84.91 -162.51 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 125.577 1.551 . . . . 1.0 107.699 173.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.472 ' H ' HG13 ' A' ' 119' ' ' VAL . . . -48.44 152.73 2.32 Favored Glycine 0 N--CA 1.482 1.743 0 O-C-N 120.121 -1.612 . . . . 1.0 113.901 173.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -63.75 151.01 43.27 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 122.746 1.26 . . . . 1.0 112.768 -172.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.43 157.64 37.69 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.992 1.317 . . . . 1.0 113.091 -168.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.441 ' HB2' ' CD1' ' A' ' 140' ' ' TRP . 0.9 OUTLIER -87.21 140.34 29.65 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.749 1.22 . . . . 1.0 110.084 170.128 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.0 mt -127.51 110.65 12.95 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.129 1.372 . . . . 1.0 109.83 173.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.7 mt -99.31 130.66 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.361 1.064 . . . . 1.0 112.929 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -105.55 98.34 8.05 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.648 2.379 . . . . 1.0 113.495 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.28 -22.42 66.84 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.819 1.044 . . . . 1.0 113.819 -175.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.6 t -58.85 -27.06 64.78 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.8 1.24 . . . . 1.0 112.845 171.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -120.34 -30.35 4.61 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.17 1.788 . . . . 1.0 112.303 -169.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -143.42 96.31 5.78 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.111 0.965 . . . . 1.0 112.938 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.42 7.13 4.64 Favored 'Trans proline' 0 CA--C 1.551 1.325 0 C-N-CA 123.877 3.051 . . . . 1.0 114.719 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -110.54 73.15 0.78 Allowed Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 126.539 1.936 . . . . 1.0 109.819 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -59.05 -26.87 83.31 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.753 2.302 . . . . 1.0 115.93 -169.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.7 pm0 -62.66 -25.92 68.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 119.45 1.023 . . . . 1.0 111.213 176.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.6 p -72.15 -15.88 61.98 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 120.974 -1.079 . . . . 1.0 112.788 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -104.18 -55.31 2.38 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.213 1.805 . . . . 1.0 111.894 177.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.5 p -67.95 -33.01 73.85 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 114.02 1.119 . . . . 1.0 114.02 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.8 m-20 -60.94 -56.63 33.13 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 121.035 1.743 . . . . 1.0 112.99 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -62.93 -23.49 74.17 Favored 'Trans proline' 0 C--N 1.353 0.803 0 CA-C-N 121.279 1.492 . . . . 1.0 112.933 174.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.441 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 88.9 t90 -67.53 -46.13 73.69 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 118.561 0.619 . . . . 1.0 110.739 172.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 22' ' ' ALA . 96.6 t -66.19 -34.69 71.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -62.87 -49.87 73.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.212 -0.93 . . . . 1.0 109.588 174.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -63.15 -54.42 38.03 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.602 1.161 . . . . 1.0 111.752 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 87.7 t90 -59.16 -34.43 72.08 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 125.13 1.372 . . . . 1.0 112.05 175.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.4 -33.02 38.92 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.9 1.238 . . . . 1.0 113.272 173.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.6 p -69.27 -11.95 61.25 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.839 1.422 . . . . 1.0 114.839 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.06 -15.34 47.83 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.539 1.536 . . . . 1.0 111.875 177.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -75.81 168.38 20.13 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 119.243 0.929 . . . . 1.0 111.733 -177.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.6 p . . . . . 0 C--O 1.254 1.315 0 C-N-CA 126.633 1.973 . . . . 1.0 114.545 -175.897 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 114.012 1.116 . . . . 1.0 114.012 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -122.64 121.48 36.53 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.486 1.515 . . . . 1.0 110.865 178.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mp -119.15 113.67 42.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 126.396 1.878 . . . . 1.0 112.444 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.59 124.0 7.18 Favored Glycine 0 C--O 1.223 -0.594 0 N-CA-C 110.89 -0.884 . . . . 1.0 110.89 169.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.8 mt -105.83 122.93 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-N 118.78 1.29 . . . . 1.0 110.131 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -114.82 111.5 21.33 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 -169.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.466 0.343 0 CA-C-O 121.428 0.632 . . . . 1.0 111.759 -170.274 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.6 tp . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 114.841 1.423 . . . . 1.0 114.841 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.0 t -46.8 -33.77 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.437 1.495 . . . . 1.0 112.547 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.06 -49.17 76.68 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.622 -1.299 . . . . 1.0 113.247 172.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -67.85 -29.68 68.87 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.732 1.213 . . . . 1.0 111.122 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -69.32 -47.34 64.73 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 123.91 0.884 . . . . 1.0 109.127 173.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.442 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.05 -42.43 94.25 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 112.3 0.481 . . . . 1.0 112.3 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -52.74 -49.98 64.37 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.945 0.898 . . . . 1.0 110.273 169.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.17 -38.04 72.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.255 0.622 . . . . 1.0 112.556 -174.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.5 mt -66.43 -48.64 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-N 119.041 0.837 . . . . 1.0 109.089 175.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.84 -35.72 82.02 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.927 0.87 . . . . 1.0 110.427 -176.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.2 m -61.98 -41.46 98.06 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.633 1.173 . . . . 1.0 113.504 170.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.92 -30.59 69.08 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.559 1.144 . . . . 1.0 112.665 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -69.95 -30.5 67.88 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.466 0.707 . . . . 1.0 112.091 171.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.01 16.73 1.92 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.987 0.803 . . . . 1.0 114.827 169.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -99.0 174.92 6.11 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.311 1.044 . . . . 1.0 110.123 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -103.73 91.2 3.9 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.918 1.287 . . . . 1.0 108.414 171.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.14 145.99 29.39 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.392 0.277 . . . . 1.0 110.98 176.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.1 m -146.74 137.65 24.02 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.901 0.88 . . . . 1.0 112.023 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.9 t -84.53 136.03 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 114.855 1.428 . . . . 1.0 114.855 170.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -113.13 109.54 18.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.905 2.082 . . . . 1.0 109.915 169.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -90.24 139.4 30.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.327 1.851 . . . . 1.0 110.932 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t0 43.26 53.56 9.6 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 124.387 1.075 . . . . 1.0 111.033 -169.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -68.74 141.7 50.39 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.718 2.945 . . . . 1.0 116.289 -168.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.475 ' HB3' ' H ' ' A' ' 42' ' ' SER . 56.1 mm-40 -93.57 162.01 14.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 122.373 1.082 . . . . 1.0 111.774 168.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -65.21 -20.76 66.59 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.02 -1.05 . . . . 1.0 109.838 167.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.475 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 15.1 m -68.28 -22.12 64.75 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 120.861 -1.15 . . . . 1.0 112.297 172.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -80.59 -27.9 37.25 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.964 0.906 . . . . 1.0 112.062 169.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 16.0 t-105 -85.21 -37.39 20.17 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.915 1.08 . . . . 1.0 113.915 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.9 mt -42.94 -44.61 10.89 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 114.998 1.481 . . . . 1.0 114.998 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.92 -2.22 8.31 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.351 2.034 . . . . 1.0 115.575 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.41 ' CD2' ' HE2' ' A' ' 50' ' ' LYS . 96.6 m-85 -108.29 8.66 27.84 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 115.793 1.775 . . . . 1.0 115.793 176.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -51.81 -27.73 13.34 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.786 2.034 . . . . 1.0 114.242 174.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.09 12.56 14.55 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.591 1.156 . . . . 1.0 112.494 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.41 ' HE2' ' CD2' ' A' ' 47' ' ' TYR . 22.4 mtmm -127.51 -163.81 1.3 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.109 2.564 . . . . 1.0 111.346 -174.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -109.96 158.11 18.57 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 122.921 1.343 . . . . 1.0 112.955 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.44 161.99 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.121 1.368 . . . . 1.0 109.828 -173.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.0 tp -139.75 130.31 25.7 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.406 1.482 . . . . 1.0 108.227 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.3 t -104.71 123.8 58.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 124.403 1.081 . . . . 1.0 108.919 173.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.1 t -122.04 111.28 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.551 -2.018 . . . . 1.0 105.551 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 114.572 1.323 . . . . 1.0 114.572 -167.764 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.5 tt . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 114.134 1.161 . . . . 1.0 114.134 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.9 t -45.7 -53.61 19.23 Favored Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 124.484 1.114 . . . . 1.0 112.1 168.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -67.78 -31.17 32.68 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.665 1.577 . . . . 1.0 111.79 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.0 tp -63.15 -54.3 39.91 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 124.271 1.028 . . . . 1.0 111.32 169.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -55.23 -52.03 64.69 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.723 0.809 . . . . 1.0 112.464 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -65.11 -40.14 94.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.43 -0.805 . . . . 1.0 111.382 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.17 -33.59 78.8 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.488 -0.618 . . . . 1.0 112.837 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 93.4 mt -65.19 -47.75 86.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 120.115 1.958 . . . . 1.0 108.676 170.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -72.61 -31.54 65.24 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.347 -1.47 . . . . 1.0 113.232 -171.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -104.87 -39.85 6.15 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.719 1.608 . . . . 1.0 115.302 -174.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.0 m -92.89 -24.27 18.51 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.125 0.97 . . . . 1.0 113.13 -175.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.413 ' CD1' HE22 ' A' ' 82' ' ' GLN . 0.1 OUTLIER -90.36 -72.03 0.59 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.9 -1.148 . . . . 1.0 107.9 171.505 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.44 -13.11 2.25 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 126.612 2.053 . . . . 1.0 116.331 169.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -156.89 139.85 15.33 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.335 2.254 . . . . 1.0 108.653 173.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.413 HE22 ' CD1' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -134.77 126.13 17.76 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 118.756 0.707 . . . . 1.0 111.373 -171.244 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -82.18 -41.36 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.532 2.154 . . . . 1.0 113.832 -173.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -145.77 21.2 1.46 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.681 1.192 . . . . 1.0 113.878 -170.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 65.0 tp -81.83 135.14 35.46 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.757 -1.214 . . . . 1.0 112.27 -169.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.5 mtm-85 -134.6 154.16 51.62 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.003 2.121 . . . . 1.0 109.534 169.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.47 169.08 23.75 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.569 -0.707 . . . . 1.0 111.644 -176.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -128.41 171.35 19.52 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 124.167 0.889 . . . . 1.0 113.672 170.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.7 140.12 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 113.978 1.103 . . . . 1.0 113.978 -169.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.4 mt -132.12 99.13 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 125.824 1.65 . . . . 1.0 107.065 169.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.05 142.08 28.06 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.731 1.613 . . . . 1.0 112.195 173.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.4 mp -138.51 156.98 47.03 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.169 0.804 . . . . 1.0 113.169 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.791 0 CA-C-N 115.504 -0.771 . . . . 1.0 113.277 169.017 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.452 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 24.5 p . . . . . 0 CA--C 1.541 0.612 0 N-CA-C 113.707 1.002 . . . . 1.0 113.707 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -60.18 -21.63 61.93 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 125.317 1.447 . . . . 1.0 114.173 -169.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.14 -31.03 77.49 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 120.832 1.651 . . . . 1.0 113.74 174.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.84 -37.0 17.39 Favored Glycine 0 N--CA 1.479 1.528 0 O-C-N 121.019 -1.283 . . . . 1.0 113.03 169.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.452 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 82.5 mttt -61.77 -29.36 70.08 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 121.025 -1.279 . . . . 1.0 112.642 172.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -62.85 -36.67 84.02 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.944 1.298 . . . . 1.0 111.747 170.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -65.8 -36.5 83.68 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.396 0.998 . . . . 1.0 111.781 172.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -63.67 -50.16 70.36 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.49 -0.757 . . . . 1.0 111.408 174.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.15 -33.73 65.47 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.674 0.79 . . . . 1.0 112.755 174.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.96 -49.68 76.95 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 123.349 1.547 . . . . 1.0 111.019 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.3 mt -66.65 -38.26 86.51 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 120.841 -1.162 . . . . 1.0 111.788 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -69.22 -20.05 63.96 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.801 1.037 . . . . 1.0 113.801 175.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.02 -16.83 59.17 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.845 0.858 . . . . 1.0 110.942 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -98.59 -74.35 0.59 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.92 1.288 . . . . 1.0 109.344 177.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.2 p 177.15 -17.27 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.713 2.005 . . . . 1.0 113.986 -173.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.36 159.21 33.59 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.716 1.376 . . . . 1.0 114.716 -169.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -97.02 170.24 9.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.223 1.809 . . . . 1.0 112.122 -169.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.67 151.41 49.25 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.463 1.105 . . . . 1.0 112.23 175.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.32 133.4 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.028 1.731 . . . . 1.0 109.621 -169.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 50.47 -158.79 1.74 Allowed Glycine 0 N--CA 1.48 1.582 0 C-N-CA 125.181 1.372 . . . . 1.0 115.268 -176.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -105.01 139.49 39.61 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.423 1.489 . . . . 1.0 109.504 169.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -76.11 155.32 34.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.901 0.857 . . . . 1.0 111.927 -172.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 140' ' ' TRP . 1.4 tm? -89.54 138.51 31.4 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.504 1.122 . . . . 1.0 110.276 174.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 mt -128.95 108.02 10.08 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.979 1.711 . . . . 1.0 109.749 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 29.8 mt -99.3 134.55 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.437 1.095 . . . . 1.0 112.885 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -105.13 109.47 21.47 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 124.478 1.111 . . . . 1.0 112.629 169.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.67 -23.95 61.76 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.54 1.136 . . . . 1.0 113.431 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.0 t -66.99 -19.46 65.72 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.371 1.069 . . . . 1.0 112.81 174.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -116.1 -30.11 6.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.084 1.753 . . . . 1.0 111.785 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -140.52 87.07 11.9 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.54 1.536 . . . . 1.0 111.638 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.04 7.82 1.93 Allowed 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 123.648 2.899 . . . . 1.0 114.559 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -114.73 69.06 2.1 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 127.715 2.406 . . . . 1.0 110.136 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -56.94 -22.53 46.73 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.605 2.204 . . . . 1.0 116.805 -169.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -64.26 -25.63 68.14 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.292 0.951 . . . . 1.0 111.811 174.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.8 p -72.86 -18.63 61.42 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.004 -1.06 . . . . 1.0 111.815 -175.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -101.77 -54.44 2.73 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.039 1.735 . . . . 1.0 111.475 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 64.7 p -69.8 -34.61 73.94 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.775 1.028 . . . . 1.0 113.775 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -60.16 -57.15 28.78 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 120.706 1.594 . . . . 1.0 112.558 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -62.17 -24.39 76.26 Favored 'Trans proline' 0 C--N 1.352 0.743 0 CA-C-N 121.273 1.49 . . . . 1.0 112.902 174.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 83.9 t90 -67.29 -45.5 76.39 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 119.062 0.846 . . . . 1.0 110.937 173.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.442 HG11 ' HA ' ' A' ' 22' ' ' ALA . 97.8 t -63.81 -33.61 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.635 -0.876 . . . . 1.0 108.635 176.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -70.0 -27.18 64.49 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 120.603 -1.311 . . . . 1.0 113.04 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -82.99 -56.59 3.71 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.352 1.461 . . . . 1.0 111.725 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -56.47 -36.39 69.03 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 125.855 1.662 . . . . 1.0 112.973 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.37 -32.89 30.97 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.825 1.202 . . . . 1.0 114.048 173.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.9 p -68.6 -13.24 62.22 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 114.405 1.261 . . . . 1.0 114.405 177.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.61 -17.49 51.17 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.471 1.509 . . . . 1.0 111.891 176.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -83.83 171.11 13.42 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.033 0.833 . . . . 1.0 111.887 -175.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.5 t . . . . . 0 C--O 1.255 1.351 0 C-N-CA 126.178 1.791 . . . . 1.0 113.033 -174.909 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 ttp . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.78 0.324 . . . . 1.0 110.822 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.07 174.2 11.05 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.88 1.672 . . . . 1.0 113.521 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -123.46 123.74 41.33 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.991 1.316 . . . . 1.0 110.48 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 mp -117.11 115.6 49.38 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.065 0 C-N-CA 126.168 1.787 . . . . 1.0 112.845 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.48 119.48 5.61 Favored Glycine 0 C--O 1.224 -0.519 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 169.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.6 mt -103.25 120.97 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 118.04 0.92 . . . . 1.0 109.171 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -118.39 115.99 25.81 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.153 -1.054 . . . . 1.0 108.153 -171.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.7 p -96.09 136.02 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 122.833 0.453 . . . . 1.0 112.109 -170.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.03 89.81 0.18 Allowed Glycine 0 N--CA 1.469 0.876 0 C-N-CA 123.689 0.662 . . . . 1.0 113.787 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.7 m -138.97 145.45 39.76 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.642 1.177 . . . . 1.0 110.07 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.8 ttt -63.32 -36.39 83.54 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.675 0.79 . . . . 1.0 112.684 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -84.48 121.92 28.26 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.668 1.187 . . . . 1.0 110.711 173.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.2 -27.57 55.37 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 123.712 0.672 . . . . 1.0 114.298 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -86.43 159.53 19.31 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.505 1.122 . . . . 1.0 112.102 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.9 m 58.28 25.62 12.93 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 116.032 1.864 . . . . 1.0 116.032 172.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 pp -68.46 151.67 46.5 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.439 -0.788 . . . . 1.0 111.405 170.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.5 tp -147.76 -57.55 0.24 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.123 1.527 . . . . 1.0 115.123 -169.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.5 t -54.77 -32.5 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.667 0.787 . . . . 1.0 112.529 -169.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.92 -48.81 78.81 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.852 -1.155 . . . . 1.0 113.461 172.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -69.15 -30.38 68.6 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.545 0.738 . . . . 1.0 110.969 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.73 -47.91 70.83 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.537 0.735 . . . . 1.0 109.237 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.432 ' HA ' HG12 ' A' ' 141' ' ' VAL . . . -64.96 -43.35 92.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 112.559 0.577 . . . . 1.0 112.559 -175.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -53.54 -48.69 68.86 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.051 0.94 . . . . 1.0 110.455 170.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.17 -37.84 69.24 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.495 0.718 . . . . 1.0 112.697 -174.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.7 mt -65.55 -46.65 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 CA-C-N 119.288 0.949 . . . . 1.0 109.141 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -35.48 80.22 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 119.442 -0.903 . . . . 1.0 110.276 -176.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.6 m -62.34 -41.19 98.38 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.21 1.404 . . . . 1.0 113.57 170.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.94 -33.81 75.4 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.397 1.079 . . . . 1.0 111.9 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -71.59 -29.01 64.21 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.749 1.22 . . . . 1.0 112.806 172.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.44 25.92 2.54 Favored Glycine 0 N--CA 1.468 0.812 0 C-N-CA 124.378 0.989 . . . . 1.0 114.323 169.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -114.11 146.19 40.61 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.536 1.134 . . . . 1.0 109.574 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -84.1 83.27 8.02 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.859 1.263 . . . . 1.0 108.729 -173.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.91 146.65 26.41 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.301 0.641 . . . . 1.0 111.13 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.8 m -146.98 137.95 23.89 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.696 0.799 . . . . 1.0 112.772 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.3 t -84.35 136.76 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 115.109 1.522 . . . . 1.0 115.109 171.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -115.75 117.6 30.69 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.871 2.069 . . . . 1.0 110.595 169.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -93.12 147.93 22.44 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.287 1.835 . . . . 1.0 110.717 173.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 41.84 61.07 8.57 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 125.125 1.37 . . . . 1.0 112.022 -169.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -48.79 123.87 10.3 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.406 3.404 . . . . 1.0 119.883 -168.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -94.28 146.62 23.9 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.907 1.283 . . . . 1.0 111.285 168.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -71.09 -25.01 62.42 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 121.447 -0.783 . . . . 1.0 110.141 169.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.7 m -67.15 -19.02 65.53 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.493 -0.754 . . . . 1.0 112.609 170.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -91.7 -21.9 20.5 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.587 1.155 . . . . 1.0 113.443 169.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -79.54 -35.02 40.56 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 120.028 1.286 . . . . 1.0 113.36 172.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.1 mt -50.86 -39.54 55.29 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 117.622 -1.18 . . . . 1.0 113.884 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -52.55 -16.62 5.62 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 124.432 3.421 . . . . 1.0 117.495 171.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -107.85 8.61 28.74 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.982 1.845 . . . . 1.0 115.982 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -52.7 -31.12 35.83 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.224 1.81 . . . . 1.0 113.749 173.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -112.66 13.35 19.9 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.102 1.361 . . . . 1.0 112.389 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -126.97 -158.3 0.86 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.613 2.365 . . . . 1.0 111.214 -174.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -114.14 162.81 16.04 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 122.947 1.356 . . . . 1.0 111.833 172.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.71 156.99 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.329 1.452 . . . . 1.0 109.007 -171.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.0 tp -137.38 129.3 28.96 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.813 1.245 . . . . 1.0 109.117 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.6 t -106.03 122.17 59.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.216 -0.661 . . . . 1.0 109.216 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.1 t -120.11 111.31 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 106.871 -1.529 . . . . 1.0 106.871 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.0 t -148.47 119.28 7.56 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.217 1.191 . . . . 1.0 114.217 -168.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.9 t -99.86 -171.22 2.01 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.475 1.11 . . . . 1.0 110.852 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.264 29.7 p 58.29 42.27 21.96 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.367 1.467 . . . . 1.0 113.61 169.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.8 m -53.04 -32.67 48.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.85 1.66 . . . . 1.0 112.743 169.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.44 -132.08 46.41 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.658 0.647 . . . . 1.0 112.523 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -79.36 11.18 3.09 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.438 1.095 . . . . 1.0 113.668 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 111.35 42.28 1.08 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.263 1.411 . . . . 1.0 113.201 177.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -135.05 164.55 27.38 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.244 1.818 . . . . 1.0 112.333 -173.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 68.3 mt -102.88 145.73 31.1 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 123.934 0.893 . . . . 1.0 112.541 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.04 152.09 62.36 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.829 2.353 . . . . 1.0 112.224 171.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -60.79 -20.95 62.53 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.441 1.096 . . . . 1.0 113.886 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.1 p -66.78 -29.48 69.45 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.894 1.278 . . . . 1.0 114.113 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.1 tt -117.02 -14.25 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.809 1.244 . . . . 1.0 114.236 -177.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -43.33 -53.07 11.89 Favored Pre-proline 0 N--CA 1.478 0.948 0 C-N-CA 124.643 1.177 . . . . 1.0 112.604 168.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.83 -31.71 19.67 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 121.576 1.517 . . . . 1.0 111.774 -172.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.4 tp -63.47 -51.26 66.39 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.333 1.053 . . . . 1.0 111.419 169.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -56.31 -52.46 64.45 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.121 0.968 . . . . 1.0 112.364 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -63.2 -39.41 94.56 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.787 0.835 . . . . 1.0 111.443 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.72 -36.84 92.83 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.064 0.84 . . . . 1.0 112.728 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 86.4 mt -65.37 -51.18 67.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 119.949 1.875 . . . . 1.0 107.976 172.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.4 ptmm? -69.25 -31.14 69.49 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 120.39 -1.444 . . . . 1.0 113.564 -169.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -103.43 -38.0 7.37 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.777 1.631 . . . . 1.0 115.279 -176.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.6 m -95.57 -20.88 18.63 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.468 1.107 . . . . 1.0 113.229 -175.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.67 -71.94 0.61 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 106.872 -1.529 . . . . 1.0 106.872 169.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.98 -18.92 1.06 Allowed Glycine 0 CA--C 1.539 1.58 0 C-N-CA 127.644 2.545 . . . . 1.0 115.265 169.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -151.87 138.99 19.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 128.386 2.674 . . . . 1.0 107.896 169.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -137.75 121.78 11.85 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 118.664 -0.684 . . . . 1.0 109.637 -171.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.72 -35.77 0.28 Allowed 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.422 2.081 . . . . 1.0 115.39 -169.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -141.68 15.51 2.15 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.292 1.219 . . . . 1.0 114.292 -169.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 64.9 tp -80.79 139.93 35.77 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 120.563 -1.336 . . . . 1.0 113.027 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -137.12 154.74 50.21 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.66 2.384 . . . . 1.0 109.032 169.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -161.02 163.85 31.35 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.244 0.929 . . . . 1.0 112.217 -176.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.65 172.22 16.27 Favored Glycine 0 N--CA 1.467 0.703 0 C-N-CA 125.707 1.622 . . . . 1.0 112.109 169.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -160.52 145.56 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 O-C-N 121.161 -1.199 . . . . 1.0 114.086 -169.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.6 mt -134.76 100.26 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 127.794 2.438 . . . . 1.0 106.942 -175.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.27 146.17 24.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.267 1.427 . . . . 1.0 111.581 173.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.6 mp -140.09 156.45 46.57 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.453 0.701 . . . . 1.0 112.269 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.02 -149.06 15.77 Favored Glycine 0 C--O 1.224 -0.496 0 CA-C-N 116.208 -0.451 . . . . 1.0 112.499 169.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -116.03 117.62 30.63 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.014 0.907 . . . . 1.0 110.415 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.0 t -63.82 -6.39 5.75 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.905 1.076 . . . . 1.0 113.905 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.1 t -63.79 -26.85 68.81 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 120.721 -1.237 . . . . 1.0 111.984 169.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -75.73 138.76 41.47 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.285 -0.884 . . . . 1.0 111.253 169.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -43.09 -50.24 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 126.573 1.949 . . . . 1.0 114.593 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -100.43 20.5 14.77 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.451 2.3 . . . . 1.0 115.1 -175.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.1 t80 34.12 -81.65 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 129.201 3.0 . . . . 1.0 117.973 169.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.7 m -122.6 24.28 9.25 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.116 1.766 . . . . 1.0 113.191 -171.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -53.01 -25.51 12.47 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.082 1.353 . . . . 1.0 114.37 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.87 -43.47 60.88 Favored Glycine 0 CA--C 1.538 1.519 0 CA-C-N 121.522 1.965 . . . . 1.0 114.878 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -80.12 -33.5 32.51 Favored Glycine 0 N--CA 1.481 1.691 0 O-C-N 120.711 -1.464 . . . . 1.0 113.768 173.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -62.41 -33.41 74.72 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 121.366 -1.079 . . . . 1.0 112.672 174.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 40.7 mm-40 -60.63 -42.57 97.16 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.891 0.876 . . . . 1.0 111.163 169.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -64.05 -36.82 85.25 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.566 -0.709 . . . . 1.0 111.998 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -62.42 -49.62 74.74 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.405 -0.81 . . . . 1.0 112.498 173.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.34 -35.73 67.97 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.503 0.556 . . . . 1.0 112.503 174.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.04 -51.3 70.25 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 123.113 1.435 . . . . 1.0 110.926 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 mt -65.74 -38.84 90.21 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 121.033 -1.042 . . . . 1.0 111.64 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -70.51 -18.92 62.95 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.344 0.868 . . . . 1.0 113.344 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.83 -19.01 58.03 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.298 0.954 . . . . 1.0 110.869 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -99.86 -76.8 0.54 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.886 1.274 . . . . 1.0 110.953 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.9 m -178.17 -2.88 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.587 1.955 . . . . 1.0 112.818 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.95 162.47 26.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 122.31 1.052 . . . . 1.0 113.304 -169.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -102.53 174.58 5.84 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.817 1.647 . . . . 1.0 113.221 -168.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.6 153.3 42.4 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.159 2.184 . . . . 1.0 112.433 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.5 t -126.78 127.66 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 126.206 1.802 . . . . 1.0 108.46 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 49.21 -156.52 1.53 Allowed Glycine 0 N--CA 1.48 1.615 0 C-N-CA 125.032 1.301 . . . . 1.0 114.615 -169.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -118.22 144.82 45.46 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.856 1.662 . . . . 1.0 109.803 169.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -71.91 155.39 40.43 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.224 1.012 . . . . 1.0 113.063 -169.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.45 ' HB2' ' CD1' ' A' ' 140' ' ' TRP . 1.1 tm? -84.18 139.62 32.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.048 -0.978 . . . . 1.0 109.815 170.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.5 mt -127.38 110.15 12.5 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.363 1.465 . . . . 1.0 110.098 173.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 24.4 mt -98.56 129.86 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.092 0.957 . . . . 1.0 112.749 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -103.75 110.92 23.2 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 122.278 1.037 . . . . 1.0 112.55 171.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.21 -22.44 64.8 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.623 1.169 . . . . 1.0 113.379 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.0 t -65.13 -21.99 66.87 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.897 0.879 . . . . 1.0 112.795 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -119.25 -30.5 4.92 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.162 1.785 . . . . 1.0 111.98 -174.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -142.34 85.95 10.32 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.073 1.349 . . . . 1.0 111.975 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.79 7.84 2.22 Favored 'Trans proline' 0 CA--C 1.551 1.333 0 C-N-CA 123.625 2.883 . . . . 1.0 114.419 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -113.79 69.56 1.63 Allowed Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 127.432 2.293 . . . . 1.0 109.909 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -56.6 -24.45 54.06 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.667 2.245 . . . . 1.0 116.304 -169.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.8 pm0 -66.08 -24.43 66.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 119.385 0.993 . . . . 1.0 111.725 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 15.1 p -73.78 -15.53 61.19 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.661 -1.274 . . . . 1.0 112.27 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -105.02 -55.44 2.33 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.296 1.838 . . . . 1.0 111.482 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 65.7 p -69.29 -33.88 73.87 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 113.938 1.088 . . . . 1.0 113.938 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -60.57 -57.45 26.44 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 120.801 1.637 . . . . 1.0 112.485 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -62.96 -23.35 74.13 Favored 'Trans proline' 0 C--N 1.354 0.832 0 CA-C-N 121.386 1.531 . . . . 1.0 112.449 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.45 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 86.8 t90 -67.12 -46.82 72.98 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 119.258 0.936 . . . . 1.0 110.749 173.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.432 HG12 ' HA ' ' A' ' 22' ' ' ALA . 96.1 t -63.4 -33.83 63.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 108.922 -0.77 . . . . 1.0 108.922 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.76 -28.35 65.7 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.823 1.249 . . . . 1.0 113.132 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -81.83 -56.96 3.65 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.169 1.388 . . . . 1.0 112.073 169.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 85.1 t90 -57.14 -36.93 71.3 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 125.498 1.519 . . . . 1.0 112.727 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.83 -33.01 34.65 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.766 1.174 . . . . 1.0 113.765 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.8 p -65.79 -13.99 60.5 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.576 1.325 . . . . 1.0 114.576 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.27 -16.78 53.93 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.008 1.723 . . . . 1.0 112.005 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.17 -176.98 5.89 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.174 1.39 . . . . 1.0 110.754 -176.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 31.9 m . . . . . 0 C--O 1.253 1.277 0 C-N-CA 125.624 1.57 . . . . 1.0 115.01 -172.045 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 119.938 -0.077 . . . . 1.0 110.877 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.52 163.65 35.88 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.24 1.416 . . . . 1.0 112.678 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -120.67 124.42 45.18 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.664 1.586 . . . . 1.0 110.466 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 mp -123.14 113.47 37.95 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.071 0 C-N-CA 125.963 1.705 . . . . 1.0 112.664 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.8 123.64 7.18 Favored Glycine 0 C--O 1.224 -0.523 0 N-CA-C 110.551 -1.019 . . . . 1.0 110.551 169.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.4 mt -105.15 122.23 58.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 118.184 0.992 . . . . 1.0 109.459 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -114.16 108.75 17.39 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 124.869 1.268 . . . . 1.0 108.277 -169.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.6 p -92.46 134.66 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.037 -173.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -123.39 115.44 2.64 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.656 1.122 . . . . 1.0 111.366 176.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -148.59 145.91 28.01 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.641 0.776 . . . . 1.0 112.747 -169.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.11 165.79 6.73 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.463 0.705 . . . . 1.0 111.709 168.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -64.9 122.47 17.05 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.255 -0.903 . . . . 1.0 111.315 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.06 -148.81 19.39 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.529 1.061 . . . . 1.0 113.434 -173.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -71.07 167.98 18.1 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.653 1.181 . . . . 1.0 112.505 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.4 t -55.61 150.32 12.51 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.083 1.353 . . . . 1.0 113.029 174.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.56 -12.13 60.94 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.596 0.759 . . . . 1.0 112.266 171.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.4 tp 63.71 -52.4 0.24 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 128.019 2.528 . . . . 1.0 115.265 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.2 t -53.65 -35.29 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.913 1.685 . . . . 1.0 112.47 -175.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.21 -45.79 87.02 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.858 -1.151 . . . . 1.0 112.487 174.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.83 -31.08 68.77 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.586 1.154 . . . . 1.0 110.759 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -66.56 -48.23 70.3 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.239 0.616 . . . . 1.0 109.341 170.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.425 ' HA ' HG13 ' A' ' 141' ' ' VAL . . . -65.41 -42.9 92.05 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 112.823 0.675 . . . . 1.0 112.823 -173.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -54.01 -49.24 69.31 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 123.717 0.807 . . . . 1.0 110.409 169.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.99 -37.0 69.92 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.285 0.634 . . . . 1.0 112.491 -174.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.4 mt -66.41 -46.96 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 119.015 0.825 . . . . 1.0 109.191 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.52 -34.65 77.54 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 119.57 -0.852 . . . . 1.0 110.613 -176.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.6 m -62.58 -40.07 95.71 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.226 1.41 . . . . 1.0 113.484 170.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.87 -32.72 72.58 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.177 0.991 . . . . 1.0 112.066 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -70.6 -29.77 66.26 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.597 1.159 . . . . 1.0 113.059 170.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.91 23.05 3.12 Favored Glycine 0 N--CA 1.47 0.95 0 C-N-CA 124.516 1.055 . . . . 1.0 114.585 169.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -109.61 151.99 26.11 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.363 1.065 . . . . 1.0 109.652 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.3 tptt -85.39 85.55 7.43 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.756 1.223 . . . . 1.0 108.665 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.3 145.44 28.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.68 -0.691 . . . . 1.0 111.11 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.2 m -147.3 139.02 24.13 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.843 0.857 . . . . 1.0 112.341 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.1 t -86.78 136.08 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 115.022 1.49 . . . . 1.0 115.022 171.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -113.43 113.5 25.27 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.331 1.852 . . . . 1.0 110.017 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -93.56 138.24 32.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.131 1.772 . . . . 1.0 110.848 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 42.39 55.06 9.8 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 124.498 1.119 . . . . 1.0 111.309 -169.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -67.84 140.09 49.66 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.699 2.933 . . . . 1.0 117.089 -168.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.448 ' HB3' ' H ' ' A' ' 42' ' ' SER . 48.6 mm-40 -93.64 163.46 13.54 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 122.466 1.127 . . . . 1.0 111.986 168.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.76 -22.61 66.04 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 121.074 -1.016 . . . . 1.0 110.738 167.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.448 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 68.2 p -68.57 -18.44 64.34 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.959 1.254 . . . . 1.0 112.386 171.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -82.67 -25.22 33.24 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.174 0.99 . . . . 1.0 112.276 169.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.1 t-105 -89.38 -33.81 16.73 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.175 1.176 . . . . 1.0 114.175 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.6 mt -48.2 -38.67 22.38 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 117.549 -1.215 . . . . 1.0 114.046 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.2 -6.92 7.24 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 124.053 3.169 . . . . 1.0 116.863 175.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -114.76 6.17 15.48 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 116.126 1.899 . . . . 1.0 116.126 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -50.25 -29.44 9.56 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.562 1.945 . . . . 1.0 113.824 171.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -105.53 7.92 33.14 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 128.144 2.578 . . . . 1.0 113.156 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -132.78 -161.36 1.13 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.933 2.093 . . . . 1.0 112.728 -168.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -110.59 157.48 19.62 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 123.191 1.472 . . . . 1.0 111.042 171.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.81 155.63 14.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 124.941 1.297 . . . . 1.0 108.285 -172.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.6 tp -134.98 127.74 31.09 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 124.568 1.147 . . . . 1.0 108.642 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.8 t -102.8 124.21 56.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.338 -0.616 . . . . 1.0 109.338 175.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.7 t -124.64 108.72 20.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 106.493 -1.669 . . . . 1.0 106.493 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -146.63 127.48 14.43 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.923 1.083 . . . . 1.0 113.923 -167.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.1 p -109.01 -149.96 0.45 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.089 1.756 . . . . 1.0 109.975 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.4 m 73.79 -21.34 0.27 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 127.462 2.305 . . . . 1.0 115.068 168.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 93.6 m -54.93 113.63 1.41 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.01 1.324 . . . . 1.0 110.664 169.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.13 -100.93 2.68 Favored Glycine 0 N--CA 1.472 1.049 0 N-CA-C 109.739 -1.344 . . . . 1.0 109.739 173.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -69.64 0.02 6.13 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.647 1.179 . . . . 1.0 112.53 169.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.33 -161.21 28.71 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 126.947 2.213 . . . . 1.0 111.441 -175.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 64.23 165.41 0.14 Allowed 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 117.492 2.404 . . . . 1.0 117.492 172.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 64.5 mt -106.71 154.11 40.29 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.788 2.035 . . . . 1.0 112.187 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -67.9 144.86 66.28 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.804 2.336 . . . . 1.0 112.122 169.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -62.97 -21.69 66.29 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.935 1.087 . . . . 1.0 113.935 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.6 p -72.86 -20.84 61.04 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.3 1.222 . . . . 1.0 114.3 172.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.7 tt -112.41 -14.07 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 113.818 1.044 . . . . 1.0 113.818 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.1 t -45.77 -53.5 20.06 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.432 1.093 . . . . 1.0 112.52 168.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -67.98 -33.66 25.41 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.531 1.487 . . . . 1.0 111.537 -173.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.4 tp -61.2 -53.03 62.1 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 124.586 1.154 . . . . 1.0 111.287 170.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -54.3 -53.49 53.1 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.128 0.971 . . . . 1.0 112.25 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -64.02 -40.5 96.47 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.792 0.837 . . . . 1.0 111.531 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.11 -35.93 89.6 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.563 0.601 . . . . 1.0 112.642 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.8 mt -64.82 -47.79 87.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 120.173 1.986 . . . . 1.0 108.259 172.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -71.5 -32.58 68.39 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.566 -1.333 . . . . 1.0 113.201 -171.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -105.17 -36.97 7.07 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.161 1.541 . . . . 1.0 115.161 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.9 m -94.05 -24.98 17.39 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.23 1.012 . . . . 1.0 112.84 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.49 -71.59 0.61 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.415 -1.328 . . . . 1.0 107.415 169.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.98 -8.46 2.5 Favored Glycine 0 CA--C 1.543 1.786 0 C-N-CA 126.419 1.962 . . . . 1.0 115.13 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -153.88 146.45 24.12 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 129.851 3.26 . . . . 1.0 106.906 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -136.62 125.37 15.25 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 123.192 0.597 . . . . 1.0 111.099 -176.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.97 -41.85 0.14 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 121.983 1.789 . . . . 1.0 114.314 -171.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -147.84 22.54 1.12 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.829 1.252 . . . . 1.0 113.129 -171.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.0 tp -83.2 137.6 33.96 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.624 -1.298 . . . . 1.0 113.909 -169.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -135.23 153.94 51.75 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 127.821 2.448 . . . . 1.0 108.957 169.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.449 ' CD1' HD11 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -158.07 164.77 36.37 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.316 -0.865 . . . . 1.0 112.302 -177.352 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -124.88 172.26 17.02 Favored Glycine 0 N--CA 1.467 0.766 0 C-N-CA 125.703 1.62 . . . . 1.0 111.978 169.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -159.03 146.45 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 O-C-N 120.875 -1.367 . . . . 1.0 114.44 -169.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.7 mt -133.45 105.64 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 127.308 2.243 . . . . 1.0 107.738 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.91 144.32 26.03 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.416 1.486 . . . . 1.0 110.863 175.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.5 mp -137.93 155.35 49.0 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.652 0.612 . . . . 1.0 112.652 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.25 -155.33 26.64 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 116.15 -0.477 . . . . 1.0 113.639 169.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.63 113.99 27.66 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.462 1.105 . . . . 1.0 111.393 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.4 t -74.57 1.8 11.23 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.973 1.101 . . . . 1.0 113.973 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 46.0 p -66.08 -14.65 62.11 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.614 -1.303 . . . . 1.0 113.61 170.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -117.6 157.53 26.22 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.625 1.57 . . . . 1.0 112.119 169.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.0 m -67.35 167.96 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.011 0.924 . . . . 1.0 110.531 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 61.14 22.51 12.81 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.122 1.369 . . . . 1.0 114.323 -169.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -28.83 -55.23 0.12 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 129.2 3.0 . . . . 1.0 116.11 -170.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.406 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 17.4 p -124.56 17.96 8.83 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.557 1.543 . . . . 1.0 113.019 -169.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -62.06 -19.04 62.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.257 1.423 . . . . 1.0 114.257 -169.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.34 -52.62 52.12 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-N 120.432 1.469 . . . . 1.0 113.732 174.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.41 -34.98 68.59 Favored Glycine 0 N--CA 1.479 1.51 0 O-C-N 120.807 -1.408 . . . . 1.0 112.995 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.406 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 87.0 mttt -63.41 -35.33 80.05 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.536 1.134 . . . . 1.0 113.137 173.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -64.34 -39.72 94.45 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 119.062 -0.495 . . . . 1.0 111.735 169.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -61.34 -33.49 73.71 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 118.961 0.801 . . . . 1.0 111.843 174.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -66.32 -51.81 53.53 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.571 0.748 . . . . 1.0 111.359 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.76 -35.24 63.56 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.657 0.783 . . . . 1.0 112.863 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.05 -49.91 75.27 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-O 123.3 1.524 . . . . 1.0 110.867 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.449 HD11 ' CD1' ' A' ' 87' ' ' TYR . 12.4 mt -67.27 -37.53 83.6 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 120.907 -1.12 . . . . 1.0 112.117 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -69.12 -20.87 64.05 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.54 -16.43 58.67 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.249 0.931 . . . . 1.0 110.991 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -100.29 -78.51 0.51 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.165 1.386 . . . . 1.0 110.175 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -175.72 -13.58 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.751 -1.568 . . . . 1.0 113.347 -169.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -80.44 163.06 24.1 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.966 1.469 . . . . 1.0 114.966 -168.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -103.76 175.5 5.46 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.046 1.738 . . . . 1.0 112.183 -169.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.02 141.89 48.52 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.232 1.813 . . . . 1.0 110.349 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.447 HG13 ' H ' ' A' ' 120' ' ' GLY 0.257 12.9 t -93.54 -161.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 125.55 1.54 . . . . 1.0 106.85 174.004 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.447 ' H ' HG13 ' A' ' 119' ' ' VAL . . . -49.53 149.49 5.12 Favored Glycine 0 CA--C 1.547 2.066 0 O-C-N 119.775 -1.828 . . . . 1.0 114.589 177.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.11 149.65 40.69 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.973 1.309 . . . . 1.0 112.48 -172.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -70.57 157.05 38.6 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 122.546 1.165 . . . . 1.0 113.759 -169.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.427 ' CD1' HG13 ' A' ' 125' ' ' ILE . 0.9 OUTLIER -87.5 141.43 28.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.309 -1.314 . . . . 1.0 109.795 170.137 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.9 mt -124.33 103.5 8.25 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 125.508 1.523 . . . . 1.0 110.948 175.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.427 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.5 mt -89.61 128.07 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.41 1.484 . . . . 1.0 112.344 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -106.35 108.43 19.94 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.066 0.936 . . . . 1.0 112.139 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.02 -22.57 64.97 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.008 0.923 . . . . 1.0 113.29 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.9 t -65.18 -21.78 66.81 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.379 1.072 . . . . 1.0 112.935 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -119.36 -29.72 5.08 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.061 1.744 . . . . 1.0 112.096 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -143.33 84.89 9.9 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 125.448 1.499 . . . . 1.0 112.048 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.44 7.29 2.29 Favored 'Trans proline' 0 CA--C 1.551 1.333 0 C-N-CA 123.742 2.961 . . . . 1.0 114.45 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -111.74 71.31 0.95 Allowed Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 127.592 2.357 . . . . 1.0 109.966 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -58.69 -20.15 49.38 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.89 2.393 . . . . 1.0 116.747 -169.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -66.16 -27.0 67.68 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 119.596 1.089 . . . . 1.0 111.639 172.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 22.1 p -74.56 -21.67 59.39 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.544 1.065 . . . . 1.0 111.943 -172.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -93.19 -51.29 5.09 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.335 1.454 . . . . 1.0 111.996 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 77.3 p -73.26 -33.64 65.38 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 115.711 1.745 . . . . 1.0 115.711 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -56.22 -58.07 18.78 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 121.003 1.728 . . . . 1.0 111.836 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -62.21 -24.35 76.12 Favored 'Trans proline' 0 C--N 1.352 0.761 0 CA-C-N 121.514 1.577 . . . . 1.0 113.155 175.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.416 ' CD1' HD21 ' A' ' 123' ' ' LEU . 91.2 t90 -68.12 -47.73 67.34 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 118.972 0.805 . . . . 1.0 110.982 174.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 22' ' ' ALA . 86.6 t -64.66 -33.57 64.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 176.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -69.34 -28.97 66.69 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.761 1.225 . . . . 1.0 112.085 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -81.5 -60.44 2.26 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.137 1.775 . . . . 1.0 112.021 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 82.1 t90 -56.0 -36.0 67.42 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 126.2 1.8 . . . . 1.0 112.654 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.59 -32.31 23.89 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.771 1.177 . . . . 1.0 113.764 173.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.2 p -69.45 -12.77 61.93 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.333 1.234 . . . . 1.0 114.333 177.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.57 -16.89 50.22 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.209 1.804 . . . . 1.0 111.862 175.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.25 174.79 11.19 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.378 1.071 . . . . 1.0 111.168 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.251 1.156 0 N-CA-C 115.242 1.571 . . . . 1.0 115.242 -175.068 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 111.793 0.294 . . . . 1.0 111.793 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.7 166.58 32.96 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.427 1.491 . . . . 1.0 112.714 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -125.77 122.81 37.29 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.903 1.281 . . . . 1.0 110.254 175.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mp -120.99 116.89 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 126.2 1.8 . . . . 1.0 113.044 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.8 124.34 7.8 Favored Glycine 0 N--CA 1.467 0.758 0 CA-C-O 119.382 -0.677 . . . . 1.0 111.507 169.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 mt -107.37 121.39 60.19 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-N 118.8 1.3 . . . . 1.0 109.743 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -116.71 109.58 17.34 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 124.661 1.185 . . . . 1.0 108.615 -169.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 p -89.24 140.84 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.0 -0.545 . . . . 1.0 111.502 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -126.42 140.57 12.13 Favored Glycine 0 N--CA 1.469 0.898 0 N-CA-C 111.066 -0.814 . . . . 1.0 111.066 169.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.2 t -160.3 152.09 20.0 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.109 1.455 . . . . 1.0 112.649 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 20.2 ttt -87.61 -12.55 45.3 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.413 1.485 . . . . 1.0 111.81 169.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -79.15 163.61 24.92 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.945 1.298 . . . . 1.0 112.8 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.74 -7.3 69.31 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 116.088 1.195 . . . . 1.0 116.088 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -142.15 151.99 42.76 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.406 1.482 . . . . 1.0 111.39 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.4 m -69.94 146.0 51.48 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.247 1.019 . . . . 1.0 113.101 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.5 tp -76.83 130.01 37.04 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.518 0.933 . . . . 1.0 113.518 -174.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 37.0 tp -34.94 -49.31 0.44 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 128.138 2.575 . . . . 1.0 114.765 169.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.4 t -53.97 -37.7 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.807 0.843 . . . . 1.0 112.183 -172.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.27 -38.47 86.87 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.956 -1.09 . . . . 1.0 112.407 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -75.9 -32.41 59.64 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.138 0.575 . . . . 1.0 111.439 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -60.52 -45.49 93.62 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.219 -1.03 . . . . 1.0 108.219 170.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.421 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.46 -40.66 93.46 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 112.624 0.601 . . . . 1.0 112.624 -174.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -57.34 -48.3 79.36 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.193 0.451 . . . . 1.0 109.8 169.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.38 -35.12 75.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 112.89 0.7 . . . . 1.0 112.89 -173.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.9 mt -72.66 -46.44 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 O-C-N 121.321 -0.862 . . . . 1.0 109.346 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.81 -33.36 75.81 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 119.162 -1.015 . . . . 1.0 109.976 -178.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.1 m -62.14 -45.99 90.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.984 1.314 . . . . 1.0 113.133 169.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.69 -33.03 74.99 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.193 0.997 . . . . 1.0 112.69 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -69.91 -29.8 67.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.941 1.297 . . . . 1.0 112.378 172.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.24 21.51 2.28 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.729 1.157 . . . . 1.0 115.175 169.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -117.02 153.37 32.8 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.432 1.093 . . . . 1.0 110.655 -175.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -87.12 72.16 10.03 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 123.118 1.437 . . . . 1.0 110.278 -173.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.11 144.9 27.28 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 112.954 -1.93 . . . . 1.0 111.941 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.6 m -142.63 136.23 28.91 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 125.746 1.618 . . . . 1.0 108.739 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.71 143.9 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.697 1.199 . . . . 1.0 113.437 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.65 133.82 53.1 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.329 1.851 . . . . 1.0 111.316 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -107.14 141.17 38.84 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.673 1.989 . . . . 1.0 111.13 178.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 t0 41.3 55.47 8.36 Favored Pre-proline 0 CA--C 1.559 1.309 0 C-N-CA 124.519 1.128 . . . . 1.0 112.478 -172.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.78 148.16 45.92 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.531 2.821 . . . . 1.0 117.072 -168.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.418 ' HB3' ' H ' ' A' ' 42' ' ' SER . 56.3 mm-40 -99.25 164.75 12.0 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.951 1.3 . . . . 1.0 112.461 168.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -68.15 -22.35 64.86 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 121.03 -1.044 . . . . 1.0 110.727 167.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.418 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 67.4 p -68.19 -20.21 64.83 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.656 1.117 . . . . 1.0 112.219 171.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -81.68 -24.9 35.96 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.253 1.021 . . . . 1.0 112.359 169.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -88.85 -34.78 16.89 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.346 1.239 . . . . 1.0 114.346 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.4 mt -47.5 -38.46 16.24 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-O 117.358 -1.306 . . . . 1.0 114.314 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -57.1 -18.77 30.4 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.43 2.753 . . . . 1.0 116.416 175.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -105.79 7.49 32.41 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 116.13 1.9 . . . . 1.0 116.13 -172.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -51.43 -34.71 36.25 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.619 1.967 . . . . 1.0 113.525 174.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -110.35 8.53 23.38 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.791 1.636 . . . . 1.0 112.373 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -115.78 -163.93 0.92 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.639 2.376 . . . . 1.0 110.299 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -108.48 164.26 12.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 122.613 1.197 . . . . 1.0 112.147 170.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -148.35 162.12 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.121 1.369 . . . . 1.0 109.906 -170.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.3 tp -144.9 128.65 17.25 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.931 1.292 . . . . 1.0 108.852 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.69 128.3 58.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 C-N-CA 124.141 0.976 . . . . 1.0 109.728 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.2 t -127.04 108.87 19.43 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 p -111.27 114.46 27.68 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.033 -1.099 . . . . 1.0 108.033 -170.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 m -87.85 -27.03 22.48 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 119.566 3.173 . . . . 1.0 119.566 -166.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.4 p -122.7 -39.74 2.51 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.756 1.021 . . . . 1.0 113.756 -168.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.439 ' CG2' ' H ' ' A' ' 103' ' ' GLY . 20.3 m 46.62 43.41 12.54 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.914 1.45 . . . . 1.0 114.914 169.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.74 128.97 47.77 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 121.056 -1.027 . . . . 1.0 112.424 -175.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 54.43 15.04 0.9 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.98 1.312 . . . . 1.0 114.387 -171.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.94 6.85 88.59 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.888 1.708 . . . . 1.0 116.09 -172.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -106.92 169.02 8.8 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.288 1.544 . . . . 1.0 112.61 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 40.1 mt -92.52 137.57 24.38 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.724 1.21 . . . . 1.0 113.756 -172.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.73 162.35 27.06 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.88 3.054 . . . . 1.0 113.91 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -63.81 -20.75 66.03 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 115.407 1.632 . . . . 1.0 115.407 -169.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.9 m -75.75 -19.06 59.31 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.793 1.035 . . . . 1.0 113.793 175.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.5 tt -113.01 -15.3 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.695 1.198 . . . . 1.0 113.618 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.7 t -40.71 -52.78 6.24 Favored Pre-proline 0 N--CA 1.478 0.951 0 CA-C-O 117.477 -1.249 . . . . 1.0 112.665 168.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -67.15 -32.31 34.26 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 121.725 1.616 . . . . 1.0 112.181 -173.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.1 tp -65.73 -52.96 47.01 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 124.051 0.94 . . . . 1.0 111.302 169.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -56.24 -52.41 64.57 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.727 0.811 . . . . 1.0 112.666 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -64.04 -40.33 96.06 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.669 1.188 . . . . 1.0 111.445 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.68 -35.85 90.42 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 123.604 0.621 . . . . 1.0 112.808 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 90.5 mt -66.42 -46.54 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 120.199 2.0 . . . . 1.0 108.578 172.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.4 ptmm? -72.25 -30.63 65.04 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.039 -1.663 . . . . 1.0 113.267 -171.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -109.77 -37.48 5.64 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.402 1.63 . . . . 1.0 115.402 -173.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.7 m -90.55 -26.8 19.53 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.302 1.041 . . . . 1.0 112.695 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.12 -71.44 0.62 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.214 -1.402 . . . . 1.0 107.214 169.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.7 -6.21 2.85 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 126.317 1.913 . . . . 1.0 115.496 172.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -156.22 146.78 21.74 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.035 2.934 . . . . 1.0 107.315 173.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -137.94 126.06 14.17 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 123.73 0.812 . . . . 1.0 110.207 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -84.63 -37.99 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 121.924 1.75 . . . . 1.0 114.414 -172.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -147.64 18.66 1.16 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.757 1.223 . . . . 1.0 114.14 -169.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 38.2 tp -77.31 139.98 39.9 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.5 -1.375 . . . . 1.0 113.629 -169.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -132.85 146.76 52.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 128.815 2.846 . . . . 1.0 107.252 169.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.434 ' CD1' HD11 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -159.33 167.63 28.38 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 118.981 0.81 . . . . 1.0 113.069 -177.494 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.452 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -125.32 173.49 17.4 Favored Glycine 0 N--CA 1.474 1.208 0 C-N-CA 125.025 1.298 . . . . 1.0 114.228 173.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.6 t -144.61 131.43 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.185 0.994 . . . . 1.0 113.641 -169.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.4 mt -131.54 102.24 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.846 1.658 . . . . 1.0 107.203 169.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -91.94 145.32 24.63 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.859 0.838 . . . . 1.0 111.27 170.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.5 mp -139.86 152.96 46.88 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.07 1.348 . . . . 1.0 110.622 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.56 -173.18 43.22 Favored Glycine 0 C--O 1.227 -0.31 0 C-N-CA 120.851 -0.69 . . . . 1.0 113.676 169.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -86.8 113.79 22.92 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.942 -0.74 . . . . 1.0 110.352 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 36.0 p -62.47 -4.74 2.05 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.994 1.318 . . . . 1.0 114.335 176.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.6 t -67.59 -25.44 65.77 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.034 0.934 . . . . 1.0 112.438 169.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -75.02 153.97 38.23 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.155 -0.966 . . . . 1.0 112.708 169.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.13 161.06 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 168.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 60.06 24.71 13.94 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 113.944 1.09 . . . . 1.0 113.944 176.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.3 t80 11.39 -85.48 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 129.942 3.297 . . . . 1.0 117.081 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.7 m -114.38 22.2 13.93 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.95 1.7 . . . . 1.0 113.417 -172.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -60.18 -17.96 44.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.886 1.674 . . . . 1.0 115.005 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.439 ' H ' ' CG2' ' A' ' 59' ' ' THR . . . -60.2 -41.01 98.04 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-N 120.833 1.652 . . . . 1.0 114.37 175.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -75.91 -34.58 47.45 Favored Glycine 0 N--CA 1.477 1.429 0 O-C-N 120.626 -1.514 . . . . 1.0 112.935 172.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -62.97 -33.88 76.33 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 121.23 -1.159 . . . . 1.0 112.418 173.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -59.97 -41.72 92.58 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.601 1.16 . . . . 1.0 111.539 170.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -64.9 -37.74 88.64 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.729 0.695 . . . . 1.0 111.546 174.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -62.56 -49.43 75.29 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.181 -0.949 . . . . 1.0 110.994 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.19 -33.81 63.35 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.953 0.901 . . . . 1.0 113.111 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.2 -49.75 75.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 122.933 1.349 . . . . 1.0 110.613 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.434 HD11 ' CD1' ' A' ' 87' ' ' TYR . 10.3 mt -65.86 -37.49 86.3 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 120.945 -1.097 . . . . 1.0 112.083 178.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -68.95 -21.16 64.21 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.922 1.082 . . . . 1.0 113.922 174.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.89 -17.82 58.7 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.532 1.06 . . . . 1.0 111.188 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -97.66 -74.21 0.58 Allowed 'General case' 0 C--N 1.343 0.299 0 C-N-CA 125.129 1.372 . . . . 1.0 110.999 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.9 m 176.6 -2.69 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 127.384 2.274 . . . . 1.0 112.141 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.84 161.06 27.03 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 122.264 1.03 . . . . 1.0 113.507 -169.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -104.25 170.42 7.92 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.19 -1.368 . . . . 1.0 112.224 -169.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.75 145.35 50.94 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.924 1.29 . . . . 1.0 111.894 176.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 50.9 t -101.73 132.04 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 127.591 2.356 . . . . 1.0 108.639 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 46.97 -142.3 5.97 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.401 1.0 . . . . 1.0 113.889 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -100.65 -162.31 0.93 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.405 1.482 . . . . 1.0 110.29 169.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.72 157.12 22.62 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.215 1.806 . . . . 1.0 111.042 168.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.52 142.11 27.81 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 125.409 1.484 . . . . 1.0 109.484 169.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.5 mt -125.82 113.97 17.96 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.858 1.663 . . . . 1.0 110.379 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 40.5 mt -106.44 132.45 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 124.696 1.198 . . . . 1.0 113.101 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -107.57 96.9 6.72 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 128.145 2.578 . . . . 1.0 112.991 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.77 -22.8 66.85 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.913 1.079 . . . . 1.0 113.913 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.3 t -60.07 -25.25 65.23 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.434 1.094 . . . . 1.0 112.71 172.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -122.53 -29.06 4.14 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.373 1.869 . . . . 1.0 112.276 -170.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -138.5 89.36 13.77 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.794 1.238 . . . . 1.0 111.687 175.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -76.78 11.02 2.07 Favored 'Trans proline' 0 CA--C 1.549 1.246 0 C-N-CA 123.943 3.096 . . . . 1.0 114.255 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -114.54 66.68 1.72 Allowed Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 127.326 2.25 . . . . 1.0 110.112 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -57.73 -18.62 34.48 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.927 2.418 . . . . 1.0 117.738 -169.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -68.2 -25.6 65.3 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.446 1.476 . . . . 1.0 111.386 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 28.6 p -70.41 -23.46 62.75 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.756 1.162 . . . . 1.0 112.24 -173.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -93.66 -56.56 2.86 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.802 1.641 . . . . 1.0 112.081 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 79.0 p -68.58 -30.28 69.0 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 114.325 1.231 . . . . 1.0 114.325 -174.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -60.98 -59.28 14.34 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 120.773 1.624 . . . . 1.0 112.395 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -62.91 -24.43 74.19 Favored 'Trans proline' 0 C--N 1.352 0.743 0 CA-C-N 121.124 1.437 . . . . 1.0 113.002 173.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 73.8 t90 -70.39 -45.12 66.61 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 119.005 0.821 . . . . 1.0 111.704 175.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.421 HG11 ' HA ' ' A' ' 22' ' ' ALA . 69.1 t -66.5 -32.95 60.36 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 C-N-CA 123.167 0.587 . . . . 1.0 110.094 175.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -63.5 -48.11 78.93 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.162 -0.961 . . . . 1.0 109.822 173.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -64.16 -55.99 17.91 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.871 1.268 . . . . 1.0 111.651 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.452 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 89.0 t90 -57.17 -35.79 69.98 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 125.222 1.409 . . . . 1.0 111.785 172.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -49.75 -34.65 22.02 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.864 1.697 . . . . 1.0 113.938 171.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.6 p -67.86 -13.62 62.29 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.85 1.426 . . . . 1.0 114.85 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.18 -18.24 50.18 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.395 1.478 . . . . 1.0 111.886 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -86.32 167.87 14.39 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.193 0.997 . . . . 1.0 111.952 -175.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 11.2 m . . . . . 0 C--O 1.251 1.178 0 N-CA-C 115.725 1.75 . . . . 1.0 115.725 -169.861 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 109.776 -0.453 . . . . 1.0 109.776 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.63 142.97 50.98 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 115.321 1.6 . . . . 1.0 115.321 -169.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -125.49 122.35 36.36 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.645 1.578 . . . . 1.0 110.706 172.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 mp -121.89 113.41 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 C-N-CA 126.26 1.824 . . . . 1.0 112.416 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.12 123.75 7.27 Favored Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.169 -1.173 . . . . 1.0 110.169 169.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.9 mt -104.54 123.51 58.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 123.946 0.898 . . . . 1.0 109.355 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -115.6 111.03 20.06 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 124.766 1.227 . . . . 1.0 107.921 -170.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.3 p -96.45 128.11 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 112.412 0.523 . . . . 1.0 112.412 -175.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -119.28 120.41 4.62 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.781 1.181 . . . . 1.0 111.22 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.5 t -165.6 145.86 6.77 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 119.728 1.764 . . . . 1.0 113.73 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.1 tpt -98.3 -17.43 18.91 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.603 1.161 . . . . 1.0 110.243 168.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -80.43 -26.86 38.16 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.564 1.546 . . . . 1.0 112.376 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.14 -43.53 2.49 Favored Glycine 0 N--CA 1.474 1.196 0 C-N-CA 125.642 1.592 . . . . 1.0 114.42 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -60.02 -23.42 63.67 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.795 1.238 . . . . 1.0 113.021 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.42 -18.01 35.62 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.058 1.343 . . . . 1.0 113.888 177.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.9 tp -47.92 -39.47 19.15 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.017 1.327 . . . . 1.0 111.814 169.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.3 tp -47.48 -54.13 12.36 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.611 1.164 . . . . 1.0 112.494 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.1 t -58.35 -37.26 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 119.127 -0.464 . . . . 1.0 111.132 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.56 -45.87 88.52 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.768 1.167 . . . . 1.0 112.859 173.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -63.49 -33.4 75.49 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.454 0.645 . . . . 1.0 110.966 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -69.93 -46.93 64.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.762 0.825 . . . . 1.0 109.818 176.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.412 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -55.42 -45.43 76.73 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.959 1.304 . . . . 1.0 113.017 176.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.33 -49.26 78.52 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.855 0.462 . . . . 1.0 110.181 173.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.6 -37.47 73.88 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.449 -0.782 . . . . 1.0 112.867 -173.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.5 mt -69.42 -48.17 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 124.501 1.12 . . . . 1.0 109.447 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.17 -34.86 77.21 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 122.485 1.136 . . . . 1.0 109.185 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.3 m -62.28 -44.9 95.47 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.602 1.161 . . . . 1.0 112.704 172.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.78 -29.82 69.12 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.676 1.19 . . . . 1.0 113.439 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -65.23 -33.94 77.17 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.516 1.526 . . . . 1.0 110.981 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.52 13.3 1.13 Allowed Glycine 0 CA--C 1.535 1.293 0 N-CA-C 115.864 1.105 . . . . 1.0 115.864 169.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 -108.02 177.02 4.93 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.985 1.314 . . . . 1.0 111.725 -169.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -101.5 99.71 10.06 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.053 1.341 . . . . 1.0 108.564 169.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.26 148.85 36.78 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.58 0.752 . . . . 1.0 111.217 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.4 m -149.0 146.12 27.64 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.146 0.978 . . . . 1.0 111.459 -174.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.9 t -95.93 137.08 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 114.168 1.173 . . . . 1.0 114.168 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -115.34 122.4 45.76 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.135 1.774 . . . . 1.0 110.995 169.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -103.21 137.0 41.95 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.597 1.959 . . . . 1.0 111.272 -177.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.6 t0 41.48 53.15 6.95 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 124.339 1.056 . . . . 1.0 111.237 -169.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -68.28 142.43 55.13 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.861 3.041 . . . . 1.0 116.85 -168.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.461 ' HB3' ' H ' ' A' ' 42' ' ' SER . 49.9 mm-40 -92.41 163.43 13.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 122.666 1.222 . . . . 1.0 111.309 168.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.0 -20.84 66.32 Favored 'General case' 0 N--CA 1.442 -0.856 0 O-C-N 120.688 -1.257 . . . . 1.0 110.388 167.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.461 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 16.1 m -68.49 -20.54 64.6 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 120.793 -1.192 . . . . 1.0 112.126 172.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -82.58 -24.47 33.94 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.292 1.037 . . . . 1.0 112.446 170.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 12.3 t-105 -88.68 -35.05 16.99 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.453 1.279 . . . . 1.0 114.453 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.7 mt -47.73 -37.37 12.71 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-O 117.466 -1.254 . . . . 1.0 114.129 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -58.79 -11.02 10.77 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.697 2.932 . . . . 1.0 117.27 175.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -114.81 9.31 16.25 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 116.303 1.964 . . . . 1.0 116.303 -174.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -51.24 -27.15 8.37 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 127.259 2.224 . . . . 1.0 114.048 175.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -117.28 13.02 14.51 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.299 1.84 . . . . 1.0 113.323 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -126.85 -155.41 0.69 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.889 2.476 . . . . 1.0 110.978 -175.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -115.96 162.64 17.07 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 122.906 1.336 . . . . 1.0 112.073 175.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -152.24 157.36 5.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 124.798 1.239 . . . . 1.0 109.053 -171.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.4 tp -139.98 127.82 21.98 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.559 1.143 . . . . 1.0 109.388 176.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.1 t -103.41 120.43 53.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 124.271 1.028 . . . . 1.0 109.001 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.0 t -118.4 112.21 37.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 105.602 -1.999 . . . . 1.0 105.602 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.3 t -147.09 121.13 9.4 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.237 1.569 . . . . 1.0 115.237 -168.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.8 m -96.65 -174.5 3.04 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.872 2.069 . . . . 1.0 110.951 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.2 m 63.79 41.24 7.01 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.511 0.93 . . . . 1.0 113.511 169.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.6 m -57.9 -39.13 77.17 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.643 0.777 . . . . 1.0 111.356 169.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.85 -128.98 44.41 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 121.516 -0.74 . . . . 1.0 111.993 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -68.34 -10.61 56.12 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.24 1.2 . . . . 1.0 114.24 175.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.06 7.55 0.19 Allowed Glycine 0 CA--C 1.539 1.58 0 N-CA-C 117.771 1.868 . . . . 1.0 117.771 170.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -116.63 -141.5 0.37 Allowed 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 119.653 1.726 . . . . 1.0 112.418 -169.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 85.9 mt -135.22 154.48 78.84 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.855 1.662 . . . . 1.0 113.59 -172.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.11 152.91 46.13 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.395 2.73 . . . . 1.0 111.763 169.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -63.64 -17.17 62.64 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.457 1.28 . . . . 1.0 114.457 -176.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.2 p -73.16 -17.38 61.38 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.955 1.302 . . . . 1.0 114.371 173.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.5 tt -123.12 -13.47 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 114.692 1.368 . . . . 1.0 114.692 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -42.76 -52.62 10.84 Favored Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 124.532 1.133 . . . . 1.0 112.588 168.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -67.8 -32.04 30.55 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.87 1.713 . . . . 1.0 111.985 -173.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.7 tp -63.64 -53.19 55.38 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 124.283 1.033 . . . . 1.0 111.225 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -55.05 -52.99 61.46 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.726 0.81 . . . . 1.0 112.572 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -64.32 -40.52 96.08 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.813 0.845 . . . . 1.0 111.433 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.61 -35.29 89.69 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 119.662 -0.521 . . . . 1.0 112.557 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.1 mt -65.69 -47.46 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 120.145 1.972 . . . . 1.0 108.382 172.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -71.43 -32.22 68.11 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 120.309 -1.494 . . . . 1.0 113.508 -171.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -105.92 -36.82 6.87 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 115.028 1.492 . . . . 1.0 115.028 -173.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 m -94.73 -24.85 16.94 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.261 1.025 . . . . 1.0 112.663 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.23 -72.53 0.56 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.15 -1.426 . . . . 1.0 107.15 169.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.0 -9.35 2.06 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 126.316 1.912 . . . . 1.0 115.265 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -152.35 145.87 24.91 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.929 2.892 . . . . 1.0 107.499 171.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -136.82 128.5 16.84 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-O 118.438 -0.792 . . . . 1.0 110.435 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -83.68 -42.86 0.08 OUTLIER 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.148 1.899 . . . . 1.0 114.445 -171.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -147.32 20.7 1.21 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.045 1.338 . . . . 1.0 113.74 -170.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.0 tp -78.46 141.34 38.34 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.451 -1.405 . . . . 1.0 113.459 -169.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.87 149.73 49.12 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 128.766 2.826 . . . . 1.0 108.196 169.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.42 ' CD1' HD13 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -159.9 168.16 26.4 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.382 0.882 . . . . 1.0 113.382 -178.151 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.435 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -124.39 168.95 16.43 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 125.361 1.457 . . . . 1.0 114.026 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.0 t -143.75 133.39 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.536 1.134 . . . . 1.0 113.338 -169.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.7 mt -129.43 100.15 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 126.036 1.735 . . . . 1.0 107.346 169.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.48 145.62 25.18 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.686 1.194 . . . . 1.0 112.045 174.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.6 mp -138.04 150.83 47.29 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.804 0.841 . . . . 1.0 112.774 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.64 -152.39 21.69 Favored Glycine 0 C--O 1.223 -0.571 0 C-N-CA 121.081 -0.58 . . . . 1.0 113.744 169.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -112.96 114.16 26.53 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.92 0.888 . . . . 1.0 110.302 -176.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.6 t -64.7 -3.75 3.56 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.164 1.172 . . . . 1.0 114.164 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.7 t -63.91 -26.07 68.43 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.762 -1.211 . . . . 1.0 112.056 169.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -79.26 147.98 32.34 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.357 -0.839 . . . . 1.0 111.909 169.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -53.41 -55.0 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.614 1.566 . . . . 1.0 113.828 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -87.35 56.91 4.17 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.023 1.729 . . . . 1.0 112.23 -173.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -52.23 127.78 23.02 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.125 0.97 . . . . 1.0 113.335 -175.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 21.7 m 56.07 17.46 2.68 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.237 1.815 . . . . 1.0 115.54 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -63.97 -18.24 64.08 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.17 1.174 . . . . 1.0 114.17 -175.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.34 -49.28 69.62 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-N 119.872 1.214 . . . . 1.0 113.368 171.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -75.47 -34.25 50.66 Favored Glycine 0 N--CA 1.478 1.443 0 O-C-N 120.705 -1.468 . . . . 1.0 113.23 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -61.35 -34.47 75.34 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.263 -1.139 . . . . 1.0 112.731 173.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -63.3 -39.77 95.51 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.865 0.866 . . . . 1.0 112.316 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.1 -40.0 96.35 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.036 0.835 . . . . 1.0 110.697 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -41.07 98.03 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.427 -0.796 . . . . 1.0 112.583 176.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.63 -46.19 89.74 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 118.744 -0.646 . . . . 1.0 111.997 170.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.56 -49.31 46.86 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.259 2.224 . . . . 1.0 111.932 -172.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.42 HD13 ' CD1' ' A' ' 87' ' ' TYR . 8.1 mt -66.0 -43.03 88.93 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.214 -0.903 . . . . 1.0 111.439 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -66.96 -22.03 65.95 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -66.08 -35.87 81.67 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.422 1.089 . . . . 1.0 111.46 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -82.65 -75.87 0.29 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 113.785 -1.552 . . . . 1.0 110.432 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.7 t 179.0 -3.22 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.11 2.164 . . . . 1.0 111.574 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.24 150.44 38.59 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 122.775 1.274 . . . . 1.0 112.83 -169.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -90.61 172.48 8.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.271 -1.786 . . . . 1.0 113.036 -168.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.36 139.03 46.58 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.322 1.849 . . . . 1.0 109.914 -175.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.433 HG13 ' H ' ' A' ' 120' ' ' GLY 0.258 20.2 t -90.86 -163.3 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 107.786 -1.19 . . . . 1.0 107.786 178.035 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.433 ' H ' HG13 ' A' ' 119' ' ' VAL . . . -48.6 149.73 3.89 Favored Glycine 0 CA--C 1.544 1.867 0 O-C-N 120.067 -1.646 . . . . 1.0 113.936 177.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -59.73 146.49 41.27 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.21 1.404 . . . . 1.0 112.701 -171.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -67.62 158.78 31.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.767 1.627 . . . . 1.0 114.759 -168.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.443 ' HB2' ' CD1' ' A' ' 140' ' ' TRP . 1.0 OUTLIER -90.44 138.91 31.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.272 -1.331 . . . . 1.0 109.133 169.083 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.1 mt -126.61 110.05 12.78 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.359 1.464 . . . . 1.0 109.828 173.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 27.3 mt -97.59 129.07 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 124.06 0.944 . . . . 1.0 112.394 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -103.76 110.35 22.41 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.113 0.959 . . . . 1.0 111.709 173.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.39 -22.08 64.66 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.298 1.039 . . . . 1.0 113.241 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.6 t -64.55 -22.41 66.96 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.679 0.792 . . . . 1.0 112.895 173.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -119.93 -30.17 4.78 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.267 1.827 . . . . 1.0 112.0 -173.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.26 82.78 12.81 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.904 1.282 . . . . 1.0 112.515 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -75.42 6.56 3.5 Favored 'Trans proline' 0 CA--C 1.549 1.235 0 C-N-CA 123.791 2.994 . . . . 1.0 114.737 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -109.7 72.23 0.58 Allowed Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 127.2 2.2 . . . . 1.0 110.074 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -59.09 -26.92 83.51 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.481 2.12 . . . . 1.0 117.073 -169.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -65.91 -24.67 66.88 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.924 1.238 . . . . 1.0 110.983 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 31.9 p -71.42 -18.1 62.35 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.937 -1.102 . . . . 1.0 112.311 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -102.22 -55.17 2.53 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.296 1.838 . . . . 1.0 111.442 177.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.4 p -68.64 -35.04 76.75 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 114.18 1.178 . . . . 1.0 114.18 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -60.36 -55.4 45.59 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 120.992 1.724 . . . . 1.0 112.392 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -63.41 -26.88 70.8 Favored 'Trans proline' 0 C--N 1.351 0.68 0 CA-C-N 121.881 1.708 . . . . 1.0 112.665 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.443 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 88.8 t90 -63.57 -45.64 89.53 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 118.807 0.731 . . . . 1.0 111.192 172.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.412 HG11 ' HA ' ' A' ' 22' ' ' ALA . 53.1 t -66.75 -34.09 67.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.437 1.095 . . . . 1.0 109.537 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -70.63 -21.22 62.65 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.469 1.508 . . . . 1.0 113.189 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -87.64 -58.07 2.71 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.435 1.894 . . . . 1.0 109.878 168.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.435 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 89.8 t90 -58.58 -39.62 80.85 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.001 1.72 . . . . 1.0 113.861 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -53.5 -27.15 33.02 Favored Glycine 0 CA--C 1.537 1.439 0 O-C-N 121.11 -0.994 . . . . 1.0 113.936 173.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.4 p -68.94 -15.0 63.37 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.729 1.764 . . . . 1.0 114.045 175.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.77 -15.98 56.44 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.431 1.492 . . . . 1.0 111.669 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -76.59 169.34 18.45 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.97 0.908 . . . . 1.0 111.214 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.255 1.343 0 N-CA-C 114.866 1.432 . . . . 1.0 114.866 -173.368 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttm . . . . . 0 N--CA 1.499 1.976 0 CA-C-O 119.816 -0.135 . . . . 1.0 110.966 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.56 152.66 40.54 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.084 0.772 . . . . 1.0 113.084 175.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -121.73 121.81 38.12 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.56 1.144 . . . . 1.0 110.709 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 mp -117.31 114.34 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 C-N-CA 126.138 1.775 . . . . 1.0 112.597 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.54 121.86 6.4 Favored Glycine 0 C--O 1.224 -0.522 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 169.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 mt -105.51 125.25 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 118.666 1.233 . . . . 1.0 109.411 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -118.31 111.78 19.2 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.763 -0.829 . . . . 1.0 108.763 -169.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p -95.07 127.79 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 112.165 0.431 . . . . 1.0 112.165 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -120.12 94.15 0.56 Allowed Glycine 0 N--CA 1.463 0.449 0 C-N-CA 124.666 1.127 . . . . 1.0 112.298 177.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -158.21 160.35 37.07 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.35 0.66 . . . . 1.0 111.681 172.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 93.5 mtp -126.97 18.56 7.18 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.797 2.039 . . . . 1.0 110.206 169.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -137.8 166.33 24.27 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.457 1.903 . . . . 1.0 111.953 -169.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.36 -163.52 52.88 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.011 0.815 . . . . 1.0 114.48 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -111.57 143.1 42.98 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.783 1.233 . . . . 1.0 112.727 -173.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 86.7 p 47.84 15.27 0.06 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 118.801 2.889 . . . . 1.0 118.801 169.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.2 mt 53.99 25.21 5.24 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.693 1.197 . . . . 1.0 112.569 -171.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.5 tp -25.65 -70.64 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 129.852 3.261 . . . . 1.0 118.336 -168.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 81.2 t -56.46 -36.36 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 118.697 0.68 . . . . 1.0 112.071 -169.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.76 -38.61 86.95 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.682 -1.261 . . . . 1.0 112.732 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -66.65 -35.72 80.85 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.015 0.436 . . . . 1.0 110.869 174.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -66.29 -44.81 82.46 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 123.806 0.843 . . . . 1.0 109.1 176.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.44 ' HA ' HG13 ' A' ' 141' ' ' VAL . . . -63.88 -41.49 97.72 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 123.343 0.657 . . . . 1.0 112.671 -176.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -56.06 -48.85 75.26 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 170.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.19 -38.23 75.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.684 0.794 . . . . 1.0 112.828 -173.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.7 mt -66.61 -47.6 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-N 119.177 0.899 . . . . 1.0 108.945 175.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.17 -33.9 76.81 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 119.459 -0.897 . . . . 1.0 111.021 -176.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.9 m -63.2 -41.9 99.23 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.325 1.45 . . . . 1.0 113.207 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.52 -32.1 71.81 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.105 0.962 . . . . 1.0 112.433 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -69.56 -29.16 66.67 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.432 1.093 . . . . 1.0 113.051 170.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.17 29.33 2.58 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.526 1.06 . . . . 1.0 113.668 170.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -112.32 155.59 23.84 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.441 1.096 . . . . 1.0 109.267 175.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -86.95 78.46 9.0 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.688 1.195 . . . . 1.0 108.369 -177.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.5 142.84 26.97 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.374 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 96.4 m -143.32 127.48 17.56 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 124.484 1.113 . . . . 1.0 109.333 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 p -92.28 140.67 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 114.378 1.251 . . . . 1.0 114.378 170.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -114.44 127.64 55.93 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.808 2.043 . . . . 1.0 111.144 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -100.86 132.54 46.21 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.637 1.975 . . . . 1.0 110.481 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.6 t0 43.76 55.59 12.2 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 124.1 0.96 . . . . 1.0 111.653 -169.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -68.81 144.24 58.49 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.067 3.178 . . . . 1.0 117.061 -168.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.451 ' HB3' ' H ' ' A' ' 42' ' ' SER . 54.9 mm-40 -95.22 163.89 13.08 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 122.465 1.126 . . . . 1.0 111.979 168.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -66.55 -21.23 66.15 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 120.959 -1.088 . . . . 1.0 110.16 167.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.451 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 18.8 m -68.1 -21.51 64.95 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.864 -1.148 . . . . 1.0 112.242 172.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -82.02 -24.37 35.41 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.355 1.062 . . . . 1.0 112.449 170.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -88.55 -34.23 17.44 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.115 1.154 . . . . 1.0 114.115 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.1 mt -48.41 -38.41 22.3 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-O 117.538 -1.22 . . . . 1.0 114.209 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -57.81 -18.64 35.22 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.669 2.912 . . . . 1.0 116.435 174.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -105.03 7.4 33.98 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.774 1.768 . . . . 1.0 115.774 -171.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -53.37 -31.12 43.19 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.507 1.923 . . . . 1.0 113.857 176.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -112.42 8.48 19.48 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.081 1.352 . . . . 1.0 112.664 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -113.72 -162.86 0.83 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.815 2.446 . . . . 1.0 110.727 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -109.1 161.63 15.01 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.849 1.309 . . . . 1.0 111.443 169.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.89 157.35 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.537 1.135 . . . . 1.0 109.268 -171.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.1 tp -138.99 128.99 25.13 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.891 1.276 . . . . 1.0 108.553 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.4 t -103.36 128.59 56.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.933 -0.765 . . . . 1.0 108.933 175.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.45 112.15 30.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 105.925 -1.88 . . . . 1.0 105.925 176.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -149.23 135.34 19.05 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.181 1.548 . . . . 1.0 115.181 -167.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.5 m -116.07 158.81 22.59 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.726 1.61 . . . . 1.0 112.998 -169.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.7 m 64.1 66.63 0.63 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.304 1.441 . . . . 1.0 112.479 169.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.4 m -55.87 -28.33 56.06 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.787 2.035 . . . . 1.0 113.875 170.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.06 -128.96 38.76 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 121.379 -0.825 . . . . 1.0 113.666 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -83.09 16.57 2.31 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.133 1.373 . . . . 1.0 112.887 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.28 41.04 4.08 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.04 1.305 . . . . 1.0 112.165 -169.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -131.89 167.41 19.66 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.952 2.101 . . . . 1.0 112.43 -173.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.9 mt -116.69 150.85 46.4 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.47 1.108 . . . . 1.0 113.537 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -59.24 145.82 96.57 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.604 2.87 . . . . 1.0 113.202 171.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -61.94 -22.06 65.3 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.874 1.064 . . . . 1.0 113.874 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.6 p -72.39 -22.51 61.12 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.405 1.261 . . . . 1.0 114.405 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 tt -115.77 -15.46 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.109 1.363 . . . . 1.0 114.141 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -43.27 -53.25 11.43 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 124.383 1.073 . . . . 1.0 112.034 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -67.81 -31.1 32.6 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 121.677 1.585 . . . . 1.0 111.873 -173.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.8 tp -65.35 -53.18 47.32 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 124.475 1.11 . . . . 1.0 111.417 170.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -55.51 -53.23 58.9 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.778 0.831 . . . . 1.0 112.385 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -69.08 -35.17 76.2 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.63 -0.714 . . . . 1.0 111.813 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.68 -35.79 91.51 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 121.819 -0.551 . . . . 1.0 112.502 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 87.4 mt -65.12 -49.77 77.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.899 1.849 . . . . 1.0 108.296 171.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -69.72 -31.43 69.43 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.505 -1.372 . . . . 1.0 112.947 -169.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -105.28 -39.91 6.02 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 115.334 1.605 . . . . 1.0 115.334 -175.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.8 m -93.88 -23.04 18.26 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.239 1.016 . . . . 1.0 112.962 -174.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.1 -70.33 0.69 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 106.81 -1.552 . . . . 1.0 106.81 169.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.03 -11.44 1.35 Allowed Glycine 0 CA--C 1.538 1.481 0 C-N-CA 127.438 2.446 . . . . 1.0 116.514 169.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -155.77 141.08 17.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.825 2.45 . . . . 1.0 108.513 172.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -137.43 125.84 14.62 Favored Pre-proline 0 CA--C 1.546 0.815 0 O-C-N 121.281 -0.887 . . . . 1.0 111.097 -173.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.81 -40.52 0.09 OUTLIER 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.849 2.366 . . . . 1.0 114.87 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -140.31 13.85 2.39 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.866 1.432 . . . . 1.0 114.866 -169.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 40.9 tp -74.86 141.26 44.24 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.582 -1.323 . . . . 1.0 113.491 -169.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -132.83 147.39 52.3 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.195 2.598 . . . . 1.0 107.719 169.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.95 165.53 35.92 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.219 0.918 . . . . 1.0 113.349 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -127.0 173.33 18.41 Favored Glycine 0 N--CA 1.471 0.978 0 C-N-CA 125.35 1.452 . . . . 1.0 112.338 170.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -158.81 146.22 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 114.536 1.31 . . . . 1.0 114.536 -169.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.0 mt -133.5 109.41 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 127.478 2.311 . . . . 1.0 107.736 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -94.68 142.0 27.96 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.023 1.729 . . . . 1.0 111.466 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.6 mp -137.26 154.39 50.14 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.375 0.88 . . . . 1.0 113.375 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.91 -179.04 39.1 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 114.274 0.47 . . . . 1.0 114.274 168.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -93.95 114.07 26.2 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.655 -0.909 . . . . 1.0 109.479 171.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 92.8 p -59.22 -15.02 12.81 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.32 1.23 . . . . 1.0 114.32 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.4 t -64.83 -19.27 65.77 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.723 0.809 . . . . 1.0 112.968 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -89.76 7.67 35.69 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.142 1.377 . . . . 1.0 114.497 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.333 1.0 OUTLIER 56.22 176.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 129.771 3.228 . . . . 1.0 114.831 -177.305 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 60.86 8.59 1.9 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.939 1.696 . . . . 1.0 115.389 -170.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.4 t80 22.68 -78.97 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 130.524 3.53 . . . . 1.0 117.05 -169.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.449 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 20.8 p -122.82 7.26 9.35 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.768 1.627 . . . . 1.0 114.329 -169.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -61.01 -21.22 63.38 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.831 1.252 . . . . 1.0 114.299 -170.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.93 -37.85 95.6 Favored Glycine 0 CA--C 1.535 1.326 0 CA-C-N 119.881 1.219 . . . . 1.0 113.109 171.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.79 -38.22 24.23 Favored Glycine 0 N--CA 1.476 1.318 0 O-C-N 121.407 -1.055 . . . . 1.0 113.046 172.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.449 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 89.2 mttt -62.12 -29.31 70.24 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 120.978 -1.307 . . . . 1.0 113.388 173.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -64.03 -28.98 70.17 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.059 0.763 . . . . 1.0 113.059 171.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -66.36 -35.57 80.67 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.643 1.11 . . . . 1.0 111.304 171.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -63.53 -48.96 75.39 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.239 -0.913 . . . . 1.0 110.968 172.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.25 -34.61 66.55 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.804 0.668 . . . . 1.0 112.804 175.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.93 -49.94 75.7 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 123.321 1.534 . . . . 1.0 110.83 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.9 mt -66.08 -37.83 86.78 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 120.908 -1.12 . . . . 1.0 111.717 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -69.02 -21.16 64.14 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.992 1.108 . . . . 1.0 113.992 174.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.91 -18.13 58.49 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.277 0.944 . . . . 1.0 111.238 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -96.83 -76.7 0.51 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.287 1.435 . . . . 1.0 110.574 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.3 m 178.32 -2.57 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 127.318 2.247 . . . . 1.0 112.154 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.13 159.55 29.68 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.043 0.925 . . . . 1.0 112.877 -169.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -100.97 174.19 6.13 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.246 -1.343 . . . . 1.0 111.559 -169.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.4 ttm105 -127.36 156.38 42.09 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.865 1.266 . . . . 1.0 112.731 171.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.41 HG11 ' H ' ' A' ' 120' ' ' GLY . 17.3 t -95.43 -168.81 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 C-N-CA 127.333 2.253 . . . . 1.0 105.93 169.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.41 ' H ' HG11 ' A' ' 119' ' ' VAL . . . -49.05 154.96 1.87 Allowed Glycine 0 CA--C 1.542 1.762 0 O-C-N 120.402 -1.436 . . . . 1.0 115.586 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -59.17 149.59 27.81 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.085 1.354 . . . . 1.0 113.15 -171.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -73.78 157.8 35.75 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 122.462 1.125 . . . . 1.0 112.38 -169.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.432 ' CD1' HG13 ' A' ' 125' ' ' ILE . 1.2 tm? -86.7 140.51 29.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.824 -1.08 . . . . 1.0 109.39 171.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.6 mt -123.65 104.39 8.99 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.818 1.247 . . . . 1.0 110.886 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.432 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.9 mt -90.26 128.21 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 125.109 1.363 . . . . 1.0 111.652 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -108.16 109.52 20.94 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 124.3 1.0 . . . . 1.0 112.174 171.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.76 -20.74 65.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.788 0.835 . . . . 1.0 112.948 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.2 t -63.6 -21.4 66.34 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.724 1.21 . . . . 1.0 112.675 173.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -124.67 -29.62 3.41 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.149 1.78 . . . . 1.0 112.584 -173.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -140.59 87.11 11.77 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.479 1.512 . . . . 1.0 112.068 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.2 6.85 2.8 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 123.675 2.917 . . . . 1.0 114.631 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -112.81 71.86 1.33 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 127.449 2.299 . . . . 1.0 109.699 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -57.87 -23.32 58.59 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.434 2.089 . . . . 1.0 116.827 -168.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -65.62 -25.69 67.49 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 119.128 0.876 . . . . 1.0 111.733 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 p -73.5 -16.99 61.27 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 120.902 -1.124 . . . . 1.0 111.706 -175.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -102.27 -53.87 2.81 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.163 1.785 . . . . 1.0 111.212 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 59.3 p -72.14 -33.9 68.13 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 114.706 1.372 . . . . 1.0 114.706 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -60.18 -55.55 44.2 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 120.923 1.692 . . . . 1.0 112.64 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -62.33 -22.64 74.39 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 121.329 1.51 . . . . 1.0 112.628 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.417 ' CD1' HD22 ' A' ' 123' ' ' LEU . 90.1 t90 -70.26 -45.55 66.19 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 121.67 -0.644 . . . . 1.0 111.264 174.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.44 HG13 ' HA ' ' A' ' 22' ' ' ALA . 91.5 t -64.69 -34.22 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.835 -0.802 . . . . 1.0 108.835 176.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.75 -29.77 68.24 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.132 1.373 . . . . 1.0 112.195 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -79.9 -61.38 2.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.104 1.762 . . . . 1.0 112.239 171.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 85.3 t90 -56.76 -36.43 69.78 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 126.724 2.01 . . . . 1.0 112.49 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.46 -32.28 22.86 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.684 1.135 . . . . 1.0 113.438 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 p -70.22 -13.12 62.04 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.332 1.234 . . . . 1.0 114.332 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.0 -14.72 55.57 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.151 1.78 . . . . 1.0 111.773 175.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.57 -178.27 5.77 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.223 1.009 . . . . 1.0 110.45 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 9.7 m . . . . . 0 C--O 1.254 1.324 0 C-N-CA 126.607 1.963 . . . . 1.0 114.251 -179.444 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttp . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 119.951 -0.071 . . . . 1.0 110.859 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.86 168.82 19.32 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.309 1.444 . . . . 1.0 113.058 -176.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -113.73 124.73 52.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.369 -1.287 . . . . 1.0 111.877 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 mp -120.92 112.82 37.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 126.424 1.889 . . . . 1.0 113.044 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.64 122.59 6.84 Favored Glycine 0 N--CA 1.467 0.742 0 N-CA-C 110.918 -0.873 . . . . 1.0 110.918 169.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.5 mt -104.17 119.63 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 118.464 1.132 . . . . 1.0 109.804 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -112.17 108.91 18.33 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.635 -1.246 . . . . 1.0 107.635 -171.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 p -96.64 118.66 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.288 0.566 . . . . 1.0 112.434 -169.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -92.03 109.31 3.73 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 109.287 -1.525 . . . . 1.0 109.287 171.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 t -148.86 165.1 32.51 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.757 1.021 . . . . 1.0 113.757 -169.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 76.3 mtm -75.42 173.99 10.2 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.181 0.992 . . . . 1.0 109.349 168.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -52.27 144.11 13.41 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 113.962 1.097 . . . . 1.0 113.962 -175.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.94 -165.66 52.81 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.269 0.938 . . . . 1.0 113.91 -175.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -81.93 56.11 2.99 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.155 0.982 . . . . 1.0 111.776 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 55.3 m -82.59 -0.71 48.2 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.847 1.425 . . . . 1.0 114.847 -172.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.63 63.3 1.55 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 122.361 1.077 . . . . 1.0 112.998 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.8 tp -26.3 -45.16 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 129.449 3.099 . . . . 1.0 116.121 170.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.4 t -47.87 -32.36 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.114 1.366 . . . . 1.0 112.727 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.15 -49.19 76.72 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.632 -1.293 . . . . 1.0 113.113 172.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -67.71 -30.33 69.8 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.674 1.19 . . . . 1.0 110.648 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.29 -46.62 69.82 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 123.397 0.679 . . . . 1.0 109.297 173.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.452 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.36 -42.12 93.13 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 123.225 0.61 . . . . 1.0 112.329 -176.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -54.27 -49.13 70.28 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.121 0.968 . . . . 1.0 110.312 169.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.57 -38.7 70.9 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.633 0.773 . . . . 1.0 112.453 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.4 mt -68.04 -45.81 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 O-C-N 121.117 -0.989 . . . . 1.0 109.357 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -31.5 72.52 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.56 1.073 . . . . 1.0 110.708 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.6 m -63.14 -45.05 93.78 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.241 1.016 . . . . 1.0 112.919 169.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.65 -30.89 69.69 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.777 1.231 . . . . 1.0 113.163 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -67.33 -27.64 67.31 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.485 1.914 . . . . 1.0 111.809 172.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.32 26.21 2.73 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.535 1.064 . . . . 1.0 114.737 171.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -117.54 173.19 6.86 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.999 1.319 . . . . 1.0 110.304 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -102.04 94.14 5.62 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 125.459 1.503 . . . . 1.0 108.429 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.34 147.44 31.51 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.283 0.633 . . . . 1.0 111.459 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.3 m -146.81 140.38 25.75 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.153 0.981 . . . . 1.0 112.428 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.1 t -87.2 137.71 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 115.071 1.508 . . . . 1.0 115.071 172.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -116.86 109.86 17.62 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.132 2.173 . . . . 1.0 109.993 169.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -88.04 145.93 25.73 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.081 1.752 . . . . 1.0 110.84 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.1 t0 43.33 57.77 12.21 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 124.517 1.127 . . . . 1.0 110.264 -169.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -55.23 128.06 28.89 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.775 3.65 . . . . 1.0 118.486 -167.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -91.75 150.34 21.15 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.368 1.467 . . . . 1.0 113.131 169.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -70.6 -25.9 63.26 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.342 -0.849 . . . . 1.0 110.175 168.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.1 m -66.53 -20.97 66.16 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.494 -0.753 . . . . 1.0 112.272 171.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -87.14 -24.07 24.63 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.252 1.021 . . . . 1.0 113.249 169.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.2 t-105 -79.4 -36.08 39.67 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.608 1.095 . . . . 1.0 113.529 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.9 mt -48.82 -40.53 43.41 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 117.845 -1.074 . . . . 1.0 113.879 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -53.8 -15.72 7.37 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.613 3.542 . . . . 1.0 117.826 172.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -110.46 8.0 22.94 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 116.139 1.903 . . . . 1.0 116.139 -172.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -53.11 -29.28 29.89 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.612 1.965 . . . . 1.0 114.115 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -114.28 11.68 17.46 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.151 1.781 . . . . 1.0 113.267 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -125.57 -159.54 0.91 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.611 2.365 . . . . 1.0 110.818 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -113.24 158.9 19.91 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 123.211 1.481 . . . . 1.0 113.073 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.37 156.61 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 125.302 1.441 . . . . 1.0 109.796 -170.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.4 tp -139.36 127.59 22.62 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.733 1.213 . . . . 1.0 109.044 176.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.9 t -102.42 123.03 55.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 123.762 0.825 . . . . 1.0 109.151 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.4 t -122.46 111.96 32.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 105.057 -2.201 . . . . 1.0 105.057 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -146.59 129.29 16.15 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.852 1.056 . . . . 1.0 113.852 -167.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 t -116.26 179.37 4.01 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.748 1.219 . . . . 1.0 113.125 -169.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.335 5.0 t 56.68 41.02 28.92 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.398 1.879 . . . . 1.0 113.488 169.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.9 m -49.79 -43.03 48.13 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.38 1.472 . . . . 1.0 112.306 169.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 52.52 -122.26 18.24 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 123.964 0.792 . . . . 1.0 112.844 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -62.92 -15.14 54.31 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.283 1.216 . . . . 1.0 114.283 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.46 -11.55 2.73 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 116.05 1.18 . . . . 1.0 116.05 169.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -87.45 -174.87 5.02 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.799 1.64 . . . . 1.0 113.152 -174.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 74.2 mt -105.32 152.17 39.8 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 126.724 2.009 . . . . 1.0 112.764 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.03 152.02 62.34 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.623 2.215 . . . . 1.0 111.726 169.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -64.31 -16.8 62.86 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.728 1.381 . . . . 1.0 114.728 -172.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.8 p -73.14 -23.43 60.46 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.643 1.177 . . . . 1.0 113.981 173.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.8 tt -118.95 -14.8 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 114.394 1.257 . . . . 1.0 114.394 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.9 t -45.13 -51.95 22.2 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 124.267 1.027 . . . . 1.0 111.717 168.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.42 -29.5 20.61 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.329 1.353 . . . . 1.0 111.664 -173.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.4 tp -64.75 -50.61 66.17 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.255 1.022 . . . . 1.0 110.909 169.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -55.2 -53.72 52.38 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.0 0.92 . . . . 1.0 112.473 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -69.06 -34.47 75.23 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.704 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.27 -34.69 88.79 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 123.876 0.75 . . . . 1.0 112.747 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 90.8 mt -65.23 -51.88 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 120.119 -1.812 . . . . 1.0 108.438 170.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -67.78 -32.32 72.82 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.524 -1.36 . . . . 1.0 113.178 -170.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -104.07 -36.59 7.67 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.27 1.582 . . . . 1.0 115.27 -173.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.7 m -97.22 -19.63 18.46 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.196 0.999 . . . . 1.0 112.938 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.62 -70.92 0.69 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 107.534 -1.284 . . . . 1.0 107.534 169.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.63 -13.32 1.69 Allowed Glycine 0 CA--C 1.536 1.404 0 C-N-CA 127.257 2.36 . . . . 1.0 116.454 169.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -155.76 141.49 17.97 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 127.668 2.387 . . . . 1.0 108.603 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -135.33 124.35 16.09 Favored Pre-proline 0 CA--C 1.546 0.808 0 O-C-N 121.449 -0.782 . . . . 1.0 111.237 -171.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.4 -39.07 0.2 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.35 2.034 . . . . 1.0 114.415 -171.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -146.7 18.1 1.29 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.255 1.206 . . . . 1.0 114.255 -170.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.0 tp -77.83 141.78 38.95 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 120.424 -1.422 . . . . 1.0 113.373 -169.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -136.73 146.65 46.07 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 129.519 3.127 . . . . 1.0 108.36 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.425 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -159.4 168.53 26.08 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.053 0.842 . . . . 1.0 113.126 -177.144 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.434 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -127.64 170.52 19.19 Favored Glycine 0 N--CA 1.472 1.082 0 C-N-CA 124.678 1.133 . . . . 1.0 114.281 172.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 86.6 t -142.28 133.5 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.668 1.187 . . . . 1.0 113.34 -169.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.5 mt -128.12 98.57 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.151 1.78 . . . . 1.0 106.781 169.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.27 145.37 25.43 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.151 1.38 . . . . 1.0 111.09 173.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.8 mp -138.88 149.79 45.25 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.601 -0.687 . . . . 1.0 111.974 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 176.46 168.55 36.71 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 119.38 -1.39 . . . . 1.0 115.793 169.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -71.71 107.57 4.6 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.201 1.4 . . . . 1.0 110.905 172.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 78.1 p -71.13 -1.75 13.44 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.553 1.541 . . . . 1.0 113.99 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 57.1 p -62.06 -22.94 66.17 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.148 0.979 . . . . 1.0 112.442 169.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -92.94 148.75 21.75 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.212 1.405 . . . . 1.0 112.629 169.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -50.09 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 126.491 1.916 . . . . 1.0 114.708 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -85.86 17.3 3.5 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.686 1.736 . . . . 1.0 115.686 -170.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.8 t80 27.07 -83.92 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 129.089 2.955 . . . . 1.0 117.628 169.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.9 m -124.89 19.19 8.51 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.72 2.008 . . . . 1.0 113.03 -173.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -53.65 -23.98 12.89 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.57 1.948 . . . . 1.0 114.28 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -54.89 -50.12 59.64 Favored Glycine 0 CA--C 1.536 1.36 0 CA-C-N 120.039 1.29 . . . . 1.0 113.237 173.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -77.89 -34.21 39.13 Favored Glycine 0 N--CA 1.479 1.54 0 O-C-N 120.798 -1.413 . . . . 1.0 113.639 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -59.6 -34.74 73.14 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.431 -1.04 . . . . 1.0 112.904 173.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -62.98 -39.3 94.32 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.869 0.868 . . . . 1.0 112.232 172.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -62.87 -39.76 95.43 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.435 1.016 . . . . 1.0 110.689 173.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.29 -40.1 96.42 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.802 0.441 . . . . 1.0 111.664 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.08 83.06 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 118.496 -0.764 . . . . 1.0 111.786 169.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.21 -49.05 34.39 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.391 2.277 . . . . 1.0 111.864 -172.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.425 HD12 ' CD1' ' A' ' 87' ' ' TYR . 7.3 mt -65.91 -43.86 86.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.939 -1.028 . . . . 1.0 111.35 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -65.92 -24.74 66.89 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.883 1.068 . . . . 1.0 113.883 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -66.1 -32.82 74.5 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.522 1.129 . . . . 1.0 111.466 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -83.08 -73.3 0.41 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.369 -1.287 . . . . 1.0 109.1 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.5 p 176.02 -15.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 127.32 2.248 . . . . 1.0 113.8 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.08 148.88 50.35 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 122.888 1.328 . . . . 1.0 113.927 -169.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -90.16 171.76 9.29 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 113.131 -1.85 . . . . 1.0 112.899 -168.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.94 138.14 49.61 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.239 1.816 . . . . 1.0 110.195 -175.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.2 t -88.57 -168.26 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 124.818 1.247 . . . . 1.0 107.832 174.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -51.38 153.4 4.89 Favored Glycine 0 CA--C 1.544 1.86 0 O-C-N 119.779 -1.826 . . . . 1.0 115.604 -176.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.58 137.5 15.31 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.123 1.769 . . . . 1.0 114.596 -172.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -68.22 159.35 31.37 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.505 1.522 . . . . 1.0 113.088 -169.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.443 ' HB2' ' CD1' ' A' ' 140' ' ' TRP . 1.3 tm? -91.2 139.1 31.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.539 -1.21 . . . . 1.0 109.86 169.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.6 mt -127.87 111.49 13.66 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.624 1.569 . . . . 1.0 109.52 174.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 25.7 mt -100.58 133.44 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.612 1.165 . . . . 1.0 113.499 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.05 97.0 10.42 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.478 1.511 . . . . 1.0 111.346 174.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.08 -25.2 65.22 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.145 -1.597 . . . . 1.0 112.72 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.4 m -63.66 -17.74 63.24 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.722 2.009 . . . . 1.0 113.75 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -125.14 -29.32 3.31 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.233 1.813 . . . . 1.0 112.129 -173.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -143.12 89.5 7.76 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.475 1.51 . . . . 1.0 110.754 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -77.41 12.41 1.86 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.03 3.154 . . . . 1.0 114.026 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -111.34 65.53 0.57 Allowed Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 127.428 2.291 . . . . 1.0 109.915 174.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -57.36 -22.67 50.97 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.366 2.044 . . . . 1.0 115.956 -169.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.8 pm0 -63.94 -24.31 67.68 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.332 0.969 . . . . 1.0 111.603 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.4 p -72.4 -17.55 61.8 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 120.765 -1.209 . . . . 1.0 112.111 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -104.64 -54.7 2.47 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.06 1.744 . . . . 1.0 111.895 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.0 p -69.7 -33.91 73.19 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.704 1.002 . . . . 1.0 113.704 -177.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -59.51 -57.09 29.55 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 120.765 1.62 . . . . 1.0 112.435 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -62.09 -23.94 76.07 Favored 'Trans proline' 0 C--N 1.352 0.735 0 CA-C-N 121.304 1.502 . . . . 1.0 112.776 174.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.443 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 87.5 t90 -67.35 -46.69 72.66 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 119.094 0.861 . . . . 1.0 110.725 174.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.452 HG11 ' HA ' ' A' ' 22' ' ' ALA . 92.5 t -64.42 -32.29 57.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 122.337 1.065 . . . . 1.0 109.253 175.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -71.16 -22.73 62.01 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 120.066 -1.646 . . . . 1.0 113.359 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -88.53 -59.38 2.25 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.379 1.871 . . . . 1.0 111.247 168.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.434 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 89.5 t90 -56.93 -36.49 70.28 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.697 1.599 . . . . 1.0 113.388 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.62 -30.72 35.56 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 121.315 -0.865 . . . . 1.0 114.196 173.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.6 p -68.22 -12.55 61.17 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.213 1.19 . . . . 1.0 114.213 176.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.74 -16.19 51.9 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.98 1.712 . . . . 1.0 111.881 176.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.78 177.08 9.09 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.198 0.999 . . . . 1.0 110.829 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 8.9 m . . . . . 0 C--O 1.251 1.149 0 N-CA-C 115.882 1.808 . . . . 1.0 115.882 -172.014 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 tpt . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 109.972 -0.381 . . . . 1.0 109.972 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.41 156.98 41.79 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.687 0.995 . . . . 1.0 113.687 -171.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -124.2 125.37 44.31 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.479 1.511 . . . . 1.0 110.267 173.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 mp -121.51 114.99 45.18 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 C-N-CA 126.026 1.73 . . . . 1.0 112.832 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.4 123.37 7.13 Favored Glycine 0 C--O 1.225 -0.446 0 N-CA-C 110.313 -1.115 . . . . 1.0 110.313 169.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.8 mt -103.67 116.22 47.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 118.167 0.983 . . . . 1.0 109.312 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -112.3 112.05 23.36 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.198 -1.408 . . . . 1.0 107.198 -172.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.5 p -97.62 137.55 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 116.66 -0.246 . . . . 1.0 111.582 -172.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -116.35 122.83 5.65 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 123.79 0.71 . . . . 1.0 111.396 176.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -152.5 146.49 25.31 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.939 0.718 . . . . 1.0 112.939 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.3 ttt -75.63 -19.52 59.15 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.864 1.265 . . . . 1.0 112.742 172.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -148.67 148.73 30.4 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.865 1.061 . . . . 1.0 113.865 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.68 -179.52 53.04 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.613 1.101 . . . . 1.0 115.606 173.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -144.69 159.92 42.04 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.746 2.019 . . . . 1.0 109.873 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.6 m 49.63 55.88 8.71 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.304 1.442 . . . . 1.0 111.691 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 27.3 tp -77.61 127.68 32.89 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.994 1.109 . . . . 1.0 113.994 -169.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.6 tp -35.53 -68.33 0.13 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 117.326 2.343 . . . . 1.0 117.326 -169.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.6 t -58.18 -35.15 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 118.685 0.675 . . . . 1.0 111.861 -169.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.24 -48.1 83.0 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 120.845 -1.159 . . . . 1.0 112.679 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -67.09 -30.95 71.12 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.879 0.371 . . . . 1.0 111.312 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -66.31 -48.31 70.76 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 173.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.401 ' HA ' HG12 ' A' ' 141' ' ' VAL . . . -63.04 -44.0 97.1 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 112.673 0.62 . . . . 1.0 112.673 -176.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -53.56 -49.43 67.71 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.376 1.07 . . . . 1.0 110.701 170.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.06 -37.51 75.51 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.632 0.773 . . . . 1.0 112.656 -175.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.5 mt -69.49 -45.56 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 119.119 0.872 . . . . 1.0 109.568 175.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -33.84 76.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 119.651 -0.819 . . . . 1.0 110.269 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.4 m -61.71 -45.03 95.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.392 1.477 . . . . 1.0 112.669 169.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.69 -32.98 74.64 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.346 1.058 . . . . 1.0 113.011 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -68.44 -30.62 69.55 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.752 1.221 . . . . 1.0 112.102 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.87 20.93 2.01 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.847 1.213 . . . . 1.0 115.214 169.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -118.85 153.53 34.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.785 1.234 . . . . 1.0 111.167 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -88.31 75.38 8.53 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.244 1.417 . . . . 1.0 110.637 -172.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.01 144.85 25.55 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.387 -1.733 . . . . 1.0 112.449 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.1 m -147.52 141.48 25.9 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.986 1.315 . . . . 1.0 112.055 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -88.96 139.23 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 115.56 1.689 . . . . 1.0 115.56 172.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -116.95 109.85 17.55 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.181 2.192 . . . . 1.0 110.327 169.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -88.23 144.02 26.69 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.384 1.874 . . . . 1.0 110.462 171.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 43.06 59.48 11.26 Favored Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 124.488 1.115 . . . . 1.0 111.193 -169.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -60.85 130.94 34.93 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 124.483 3.455 . . . . 1.0 118.356 -168.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -93.15 150.26 20.64 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.683 1.593 . . . . 1.0 112.896 169.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -69.56 -25.81 64.18 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.2 -0.937 . . . . 1.0 110.031 168.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.9 m -66.68 -20.6 66.01 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.446 -0.784 . . . . 1.0 112.615 171.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -88.73 -22.29 23.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.669 1.188 . . . . 1.0 113.207 169.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -80.53 -35.58 34.34 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.799 1.181 . . . . 1.0 113.863 174.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.1 mt -49.43 -40.24 47.29 Favored Pre-proline 0 CA--C 1.551 1.006 0 CA-C-O 117.785 -1.103 . . . . 1.0 113.828 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -55.97 -14.06 10.39 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 124.509 3.473 . . . . 1.0 117.153 172.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -109.48 7.49 24.84 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.967 1.84 . . . . 1.0 115.967 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -53.13 -31.54 42.86 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.607 1.963 . . . . 1.0 113.819 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -112.12 11.62 20.41 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.966 1.307 . . . . 1.0 112.689 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -120.17 -157.59 0.71 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.977 2.511 . . . . 1.0 110.895 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -115.45 165.53 12.89 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.629 1.204 . . . . 1.0 111.445 171.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.14 159.54 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.616 1.166 . . . . 1.0 109.214 -170.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.5 tp -140.29 129.01 23.07 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 124.425 1.09 . . . . 1.0 108.954 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.6 t -107.11 123.95 62.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 124.299 1.039 . . . . 1.0 109.626 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.0 t -123.04 111.71 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 107.546 -1.279 . . . . 1.0 107.546 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.5 p -117.41 114.53 23.66 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.288 1.035 . . . . 1.0 108.958 -169.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.2 m -107.62 -8.8 16.03 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 119.066 2.987 . . . . 1.0 119.066 -167.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.4 p -135.33 17.48 3.4 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 115.806 1.78 . . . . 1.0 115.806 -169.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.4 m -53.62 -51.19 63.86 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.909 -1.119 . . . . 1.0 112.424 174.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 48.52 -112.19 1.11 Allowed Glycine 0 CA--C 1.537 1.453 0 C-N-CA 123.824 0.726 . . . . 1.0 113.403 177.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -62.69 -19.82 64.25 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.391 1.476 . . . . 1.0 114.647 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.76 161.05 10.36 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 120.419 1.463 . . . . 1.0 116.502 170.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.7 t0 58.38 -174.47 0.09 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.182 2.193 . . . . 1.0 115.752 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.2 mt -93.92 148.18 34.82 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 126.651 1.98 . . . . 1.0 113.624 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.3 156.48 54.87 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.409 2.739 . . . . 1.0 113.35 170.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -63.16 -20.63 65.57 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.41 1.263 . . . . 1.0 114.41 -174.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.8 p -72.59 -28.08 62.57 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.189 1.181 . . . . 1.0 114.189 174.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.4 tt -109.01 -18.68 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.551 1.141 . . . . 1.0 113.477 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -42.37 -52.23 10.32 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 124.638 1.175 . . . . 1.0 112.533 168.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -71.27 -29.84 16.59 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.383 1.389 . . . . 1.0 111.662 -173.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.9 tp -64.91 -49.66 69.57 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 124.227 1.011 . . . . 1.0 110.767 169.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -56.4 -52.57 64.13 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.312 1.045 . . . . 1.0 112.483 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -64.02 -40.75 97.02 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.864 0.866 . . . . 1.0 111.4 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.95 -33.66 84.62 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.943 0.783 . . . . 1.0 112.801 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 91.8 mt -66.54 -50.76 64.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 120.116 1.958 . . . . 1.0 108.47 170.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -69.6 -30.23 67.94 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.371 -1.456 . . . . 1.0 112.998 -170.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -106.94 -37.74 6.25 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.779 1.77 . . . . 1.0 115.779 -175.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.1 m -93.99 -22.41 18.57 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.958 0.903 . . . . 1.0 113.028 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.74 -71.1 0.67 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.204 -1.406 . . . . 1.0 107.204 169.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.02 -11.44 1.34 Allowed Glycine 0 CA--C 1.538 1.5 0 C-N-CA 127.213 2.339 . . . . 1.0 116.41 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -155.3 140.12 17.17 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.508 2.323 . . . . 1.0 108.38 172.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -135.81 123.58 15.03 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 121.267 -0.895 . . . . 1.0 111.365 -173.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -82.73 -39.3 0.14 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.845 2.363 . . . . 1.0 114.654 -173.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -141.28 13.57 2.2 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 115.14 1.533 . . . . 1.0 115.14 -169.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.8 tp -79.4 140.72 37.34 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.585 -1.322 . . . . 1.0 113.138 -169.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.83 151.3 48.98 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 127.959 2.504 . . . . 1.0 109.188 169.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.446 ' CD1' HD11 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -160.62 166.13 29.46 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.329 0.968 . . . . 1.0 113.603 -175.008 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.407 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -121.15 169.95 14.48 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 125.662 1.601 . . . . 1.0 113.876 175.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 66.0 t -145.78 132.38 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 114.364 1.246 . . . . 1.0 114.364 -169.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.5 mt -134.21 110.92 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.591 1.556 . . . . 1.0 108.774 169.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -105.07 146.94 28.44 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.6 -0.687 . . . . 1.0 111.546 171.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.24 153.39 44.8 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.441 1.497 . . . . 1.0 109.915 177.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 176.75 173.64 42.51 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-O 122.116 0.842 . . . . 1.0 114.137 169.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -85.43 102.22 13.27 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.001 -1.294 . . . . 1.0 111.086 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 9.0 t -59.63 -12.43 6.75 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.395 1.878 . . . . 1.0 113.896 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 48.5 m -60.6 -13.59 15.23 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.535 1.134 . . . . 1.0 113.697 169.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -117.76 162.76 17.55 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.715 1.606 . . . . 1.0 113.054 169.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.6 m -63.71 174.92 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.078 1.351 . . . . 1.0 110.993 169.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 59.97 20.22 9.28 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.719 1.608 . . . . 1.0 114.611 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -16.84 -69.82 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 129.928 3.291 . . . . 1.0 117.034 -169.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 7.2 m -126.24 29.58 5.79 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.135 1.374 . . . . 1.0 112.491 -173.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -61.28 -21.83 64.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.154 1.538 . . . . 1.0 115.154 -169.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.93 -51.2 57.3 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 121.679 2.036 . . . . 1.0 114.099 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.55 -35.55 92.07 Favored Glycine 0 N--CA 1.474 1.228 0 O-C-N 120.547 -1.561 . . . . 1.0 112.845 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -63.5 -38.55 91.55 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.255 1.022 . . . . 1.0 113.119 173.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -58.32 -46.5 86.04 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.748 0.819 . . . . 1.0 111.021 170.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -63.17 -37.93 89.15 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.738 -0.601 . . . . 1.0 111.792 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.78 -45.61 93.12 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.464 -0.773 . . . . 1.0 112.081 177.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.63 -36.65 74.41 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.066 0.765 . . . . 1.0 113.066 171.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.65 -49.03 79.35 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 123.351 1.548 . . . . 1.0 111.199 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.446 HD11 ' CD1' ' A' ' 87' ' ' TYR . 8.9 mt -66.1 -39.95 90.37 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 120.789 -1.194 . . . . 1.0 111.47 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -71.27 -19.1 62.39 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.136 0.791 . . . . 1.0 113.136 177.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.23 -21.93 58.27 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.407 1.003 . . . . 1.0 111.098 176.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -92.05 -78.4 0.41 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 125.356 1.462 . . . . 1.0 110.019 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.4 t -178.89 -3.75 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.085 2.154 . . . . 1.0 112.027 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.54 148.58 38.79 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 122.632 1.206 . . . . 1.0 112.639 -169.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -90.8 170.29 10.23 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.17 1.788 . . . . 1.0 114.048 -168.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.73 143.35 50.82 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.885 2.074 . . . . 1.0 111.018 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.9 t -118.22 130.15 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.25 1.42 . . . . 1.0 108.664 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 48.51 -154.44 1.77 Allowed Glycine 0 N--CA 1.48 1.575 0 C-N-CA 124.834 1.207 . . . . 1.0 114.317 -170.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -119.16 147.52 44.1 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.986 1.714 . . . . 1.0 109.961 169.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.26 157.66 37.28 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.239 -0.913 . . . . 1.0 113.301 -169.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.448 ' CD1' HG13 ' A' ' 125' ' ' ILE . 0.8 OUTLIER -93.99 134.79 36.03 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.221 1.009 . . . . 1.0 110.573 171.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.3 mt -120.69 107.61 13.0 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.468 1.507 . . . . 1.0 111.451 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.448 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.9 mt -93.56 130.78 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 126.344 1.858 . . . . 1.0 113.054 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -106.13 89.51 3.08 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.663 2.385 . . . . 1.0 113.245 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.32 -24.68 67.74 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.893 -1.13 . . . . 1.0 113.26 -175.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.7 m -60.68 -18.13 52.12 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.424 2.29 . . . . 1.0 113.865 172.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -127.9 -31.94 2.36 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.148 2.179 . . . . 1.0 112.501 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -138.06 91.91 12.81 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 126.046 1.739 . . . . 1.0 111.483 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -75.83 9.05 2.46 Favored 'Trans proline' 0 CA--C 1.549 1.235 0 C-N-CA 123.589 2.859 . . . . 1.0 114.517 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -112.05 70.45 0.98 Allowed Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 127.482 2.313 . . . . 1.0 110.057 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -57.81 -20.51 43.97 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.627 2.218 . . . . 1.0 116.417 -169.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -65.0 -26.67 68.39 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 118.91 0.777 . . . . 1.0 111.713 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.0 p -72.6 -16.7 61.73 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 120.866 -1.146 . . . . 1.0 111.743 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -101.1 -56.16 2.38 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.179 1.792 . . . . 1.0 111.711 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 60.3 p -69.59 -32.22 70.83 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.777 1.399 . . . . 1.0 114.777 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -62.1 -55.41 40.99 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 120.939 1.7 . . . . 1.0 113.176 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -62.84 -23.59 74.34 Favored 'Trans proline' 0 C--N 1.355 0.882 0 CA-C-N 121.28 1.493 . . . . 1.0 112.255 175.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.445 ' CD1' HD21 ' A' ' 123' ' ' LEU . 92.6 t90 -69.29 -47.5 64.37 Favored 'General case' 0 C--O 1.218 -0.594 0 C-N-CA 123.258 0.623 . . . . 1.0 111.053 174.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.401 HG12 ' HA ' ' A' ' 22' ' ' ALA . 95.7 t -66.45 -32.79 59.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 N-CA-C 109.554 -0.535 . . . . 1.0 109.554 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -64.51 -50.35 67.74 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.228 -0.92 . . . . 1.0 109.477 173.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -63.47 -54.73 31.88 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.703 1.201 . . . . 1.0 111.743 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.407 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 86.3 t90 -56.58 -37.7 70.95 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 125.843 1.657 . . . . 1.0 111.262 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.2 -33.68 23.46 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.434 1.492 . . . . 1.0 113.619 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.3 p -68.8 -14.03 62.77 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 114.802 1.408 . . . . 1.0 114.802 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.53 -19.63 45.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.35 1.46 . . . . 1.0 111.692 176.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -83.68 173.7 11.13 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.48 1.112 . . . . 1.0 110.583 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--O 1.252 1.213 0 C-N-CA 124.662 1.185 . . . . 1.0 113.923 -176.23 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 110.819 -0.067 . . . . 1.0 110.819 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.95 166.7 28.83 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.255 1.422 . . . . 1.0 112.597 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -122.48 125.08 45.06 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.035 1.334 . . . . 1.0 110.04 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 mp -121.58 114.07 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 126.778 2.031 . . . . 1.0 112.346 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.31 125.55 8.06 Favored Glycine 0 C--O 1.223 -0.539 0 N-CA-C 110.315 -1.114 . . . . 1.0 110.315 169.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 mt -106.16 121.37 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-N 118.547 1.174 . . . . 1.0 109.803 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -113.35 108.58 17.42 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.514 -1.291 . . . . 1.0 107.514 -169.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.45 127.28 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 O-C-N 123.375 0.422 . . . . 1.0 111.869 -174.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.81 46.89 3.2 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 115.855 1.102 . . . . 1.0 115.855 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.4 t -160.86 164.78 31.04 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.08 1.352 . . . . 1.0 111.378 169.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.8 ttt -102.74 -16.86 15.85 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.371 1.468 . . . . 1.0 112.491 169.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -145.67 164.51 31.55 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.879 1.271 . . . . 1.0 113.254 -170.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.98 -179.62 53.11 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 115.82 1.088 . . . . 1.0 115.82 169.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -59.92 -29.07 68.12 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.582 1.153 . . . . 1.0 113.823 -170.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.1 m -61.34 -16.83 50.05 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.941 1.089 . . . . 1.0 113.941 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 90.3 mt -62.36 -35.71 79.98 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.212 0.915 . . . . 1.0 112.68 169.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.3 tp -53.45 -53.99 43.38 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.851 1.26 . . . . 1.0 112.954 -170.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.1 t -56.35 -32.85 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.017 0.527 . . . . 1.0 111.5 -173.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.47 -47.62 85.34 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.793 -1.192 . . . . 1.0 113.105 172.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -66.98 -30.35 70.44 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.682 0.793 . . . . 1.0 111.117 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -68.86 -48.36 63.64 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 123.795 0.838 . . . . 1.0 109.394 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.432 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -63.8 -42.84 97.64 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 112.769 0.655 . . . . 1.0 112.769 -176.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -53.96 -49.44 68.73 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.093 0.957 . . . . 1.0 110.129 170.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.09 -37.84 72.4 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.484 0.713 . . . . 1.0 112.737 -174.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.5 mt -66.18 -46.83 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 119.355 0.98 . . . . 1.0 109.117 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.98 -35.14 79.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 119.543 -0.863 . . . . 1.0 110.468 -176.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 51.8 m -61.9 -41.92 98.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.24 1.416 . . . . 1.0 113.711 170.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.2 -33.06 74.58 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.049 0.94 . . . . 1.0 112.272 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -70.64 -30.04 66.56 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.629 1.172 . . . . 1.0 113.203 171.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.91 23.11 2.81 Favored Glycine 0 N--CA 1.468 0.799 0 C-N-CA 124.543 1.068 . . . . 1.0 114.433 169.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -111.52 148.96 32.08 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.543 1.137 . . . . 1.0 109.55 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.91 90.57 6.46 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.05 1.34 . . . . 1.0 108.008 -176.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.07 145.71 31.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.576 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 56.5 m -148.49 139.89 23.43 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.545 0.738 . . . . 1.0 112.076 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.45 138.72 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 115.48 1.659 . . . . 1.0 115.48 173.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -119.94 112.76 19.58 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.195 2.198 . . . . 1.0 110.292 169.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -95.01 138.23 33.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.725 2.01 . . . . 1.0 110.461 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.9 t70 42.95 54.39 10.02 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 123.753 0.821 . . . . 1.0 111.379 -169.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -71.18 147.74 54.48 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.777 2.985 . . . . 1.0 117.064 -168.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.427 ' HB3' ' H ' ' A' ' 42' ' ' SER . 55.4 mm-40 -98.02 164.81 12.19 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 124.934 1.294 . . . . 1.0 113.034 168.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -68.01 -22.5 64.98 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 121.169 -0.957 . . . . 1.0 110.523 167.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.427 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 67.0 p -68.33 -20.22 64.72 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.759 1.163 . . . . 1.0 112.481 171.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -81.13 -25.38 36.96 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.232 1.013 . . . . 1.0 112.248 169.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.7 t-105 -88.28 -35.39 17.29 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.504 1.298 . . . . 1.0 114.504 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.6 mt -47.72 -38.39 17.47 Favored Pre-proline 0 CA--C 1.554 1.116 0 CA-C-O 117.681 -1.152 . . . . 1.0 114.058 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -58.99 -14.47 23.13 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 123.674 2.916 . . . . 1.0 116.526 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -110.54 9.53 23.13 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.63 1.715 . . . . 1.0 115.63 -174.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -51.44 -30.4 19.46 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.86 2.064 . . . . 1.0 113.729 174.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -108.82 7.2 26.1 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.316 1.847 . . . . 1.0 113.489 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -122.39 -163.18 1.06 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.888 2.475 . . . . 1.0 110.706 -174.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -110.62 165.33 11.9 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 123.081 1.419 . . . . 1.0 111.963 171.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.86 159.97 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.485 1.514 . . . . 1.0 109.567 -172.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.2 tp -139.25 130.09 26.2 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.006 1.322 . . . . 1.0 108.308 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.3 t -106.63 123.05 61.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 C-N-CA 123.944 0.897 . . . . 1.0 108.959 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.9 t -122.1 111.89 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 106.222 -1.77 . . . . 1.0 106.222 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -153.03 142.34 21.58 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 113.731 1.012 . . . . 1.0 113.731 -167.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.4 t -121.48 -169.89 1.94 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.852 1.261 . . . . 1.0 113.153 -169.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.4 m 73.9 -62.06 0.48 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 128.885 2.874 . . . . 1.0 114.737 169.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 m 59.3 -38.76 0.07 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 117.656 2.465 . . . . 1.0 117.656 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 51.98 -128.77 34.32 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-N 120.771 1.623 . . . . 1.0 114.143 172.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -81.04 29.78 0.33 Allowed 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.718 1.207 . . . . 1.0 113.39 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.49 41.08 8.57 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.659 1.123 . . . . 1.0 112.741 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -136.29 -177.55 4.76 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.031 1.733 . . . . 1.0 111.485 -173.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.3 mt -122.42 151.65 59.88 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 126.111 1.764 . . . . 1.0 113.11 -175.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.1 153.87 66.94 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.091 2.527 . . . . 1.0 112.345 170.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -61.4 -21.67 64.3 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.499 1.12 . . . . 1.0 114.006 -173.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.4 p -71.32 -23.55 61.96 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.458 1.281 . . . . 1.0 114.458 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.4 tt -118.11 -14.88 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 114.138 1.162 . . . . 1.0 114.138 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -44.54 -53.53 14.59 Favored Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 124.912 1.285 . . . . 1.0 112.073 168.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -68.39 -30.55 29.68 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.833 1.689 . . . . 1.0 111.746 -173.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.7 tp -65.31 -52.87 51.16 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 123.908 0.883 . . . . 1.0 111.126 169.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -55.86 -53.2 59.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.78 0.832 . . . . 1.0 112.498 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -69.52 -34.81 74.81 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.837 -0.619 . . . . 1.0 111.696 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.95 -35.41 90.69 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.77 -0.581 . . . . 1.0 112.473 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.4 mt -65.47 -50.08 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.87 1.835 . . . . 1.0 108.707 171.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -69.37 -31.83 70.49 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 120.324 -1.485 . . . . 1.0 113.303 -170.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -105.69 -39.33 6.11 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.309 1.596 . . . . 1.0 115.309 -173.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.9 m -93.29 -22.94 18.69 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.054 0.941 . . . . 1.0 112.901 -176.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.75 -71.33 0.65 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.164 -1.421 . . . . 1.0 107.164 169.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.63 -13.6 1.62 Allowed Glycine 0 CA--C 1.539 1.536 0 C-N-CA 127.413 2.435 . . . . 1.0 116.587 169.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -154.18 141.05 19.18 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 127.342 2.257 . . . . 1.0 108.72 171.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -136.97 125.0 14.63 Favored Pre-proline 0 CA--C 1.544 0.729 0 O-C-N 121.287 -0.883 . . . . 1.0 111.668 -172.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -86.54 -36.63 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.037 2.492 . . . . 1.0 114.967 -174.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -142.53 15.89 2.0 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.534 1.309 . . . . 1.0 114.534 -169.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.3 tp -84.78 138.46 32.59 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.514 -1.366 . . . . 1.0 112.773 -169.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.9 mtm-85 -135.74 156.43 48.83 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 127.944 2.498 . . . . 1.0 109.558 169.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.402 ' CD1' HD13 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -162.44 169.0 21.15 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.186 -0.946 . . . . 1.0 111.587 -177.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -129.58 173.11 19.75 Favored Glycine 0 N--CA 1.475 1.291 0 C-N-CA 124.734 1.159 . . . . 1.0 114.189 170.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.01 141.39 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 114.3 1.222 . . . . 1.0 114.3 -169.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.5 mt -131.94 99.3 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 125.915 1.686 . . . . 1.0 107.11 169.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.3 143.34 26.9 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.575 1.55 . . . . 1.0 111.998 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.2 mp -137.88 161.46 36.56 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.813 0.845 . . . . 1.0 112.966 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 160.86 -170.67 36.79 Favored Glycine 0 N--CA 1.465 0.62 0 CA-C-N 116.231 -0.441 . . . . 1.0 114.055 168.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -102.85 110.62 22.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.893 0.877 . . . . 1.0 110.06 176.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.4 t -63.62 -7.63 7.82 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.676 1.191 . . . . 1.0 113.67 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.7 t -62.43 -26.19 68.37 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.712 -1.243 . . . . 1.0 111.078 169.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -92.36 148.15 22.35 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.345 1.458 . . . . 1.0 110.799 169.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.0 m -71.46 169.97 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.667 0.787 . . . . 1.0 111.806 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 65.2 5.07 2.86 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.914 2.086 . . . . 1.0 116.597 -170.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 12.1 t80 21.69 -80.92 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 129.585 3.154 . . . . 1.0 117.204 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.469 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 20.7 p -120.45 8.95 10.82 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.708 2.003 . . . . 1.0 114.376 -169.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -60.61 -16.99 44.03 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 115.112 1.523 . . . . 1.0 115.112 -169.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.17 -40.68 98.9 Favored Glycine 0 N--CA 1.474 1.231 0 CA-C-N 120.69 1.586 . . . . 1.0 113.314 173.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.61 -37.34 35.27 Favored Glycine 0 N--CA 1.477 1.392 0 O-C-N 120.974 -1.309 . . . . 1.0 112.806 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.469 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 84.2 mttt -61.29 -33.53 73.72 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 121.155 -1.203 . . . . 1.0 112.857 174.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -63.28 -36.04 82.34 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.523 0.729 . . . . 1.0 112.503 170.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -63.0 -37.19 86.18 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.285 0.948 . . . . 1.0 111.196 172.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -46.96 83.8 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.81 -0.556 . . . . 1.0 111.72 174.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.91 -44.51 78.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.702 -0.666 . . . . 1.0 111.82 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -49.45 57.76 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.862 2.065 . . . . 1.0 112.018 -175.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.402 HD13 ' CD1' ' A' ' 87' ' ' TYR . 7.9 mt -66.37 -41.78 88.96 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.313 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -68.85 -20.03 64.27 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.747 1.017 . . . . 1.0 113.747 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -66.98 -36.14 81.52 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.749 1.22 . . . . 1.0 111.112 172.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -84.26 -75.15 0.35 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 113.777 -1.556 . . . . 1.0 110.336 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.6 m 177.91 -0.55 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.605 2.362 . . . . 1.0 112.024 172.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.83 149.3 34.39 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 122.638 1.208 . . . . 1.0 113.373 -169.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -85.77 171.35 11.64 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.255 1.822 . . . . 1.0 111.884 -169.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 2.2 ttm105 -133.87 152.77 51.97 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.353 1.061 . . . . 1.0 112.135 175.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.0 t -119.1 124.17 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.521 1.528 . . . . 1.0 109.14 -172.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 51.85 -168.03 0.69 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.941 1.257 . . . . 1.0 115.352 -172.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -102.35 145.1 29.98 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.984 1.314 . . . . 1.0 108.563 169.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -78.14 159.81 28.39 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.118 1.155 . . . . 1.0 114.118 -169.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 140' ' ' TRP . 1.4 tm? -85.17 138.48 32.35 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.854 1.261 . . . . 1.0 110.079 170.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.6 mt -127.53 108.76 11.07 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.714 1.605 . . . . 1.0 109.676 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 25.5 mt -97.82 130.76 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 124.045 0.938 . . . . 1.0 112.304 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -105.35 110.24 22.53 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.963 0.905 . . . . 1.0 112.422 170.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.92 -24.57 66.11 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.146 1.378 . . . . 1.0 113.7 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.45 -17.62 64.77 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.896 1.073 . . . . 1.0 113.896 173.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -118.99 -28.72 5.46 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.88 1.672 . . . . 1.0 111.958 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -143.81 86.08 8.83 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 125.41 1.484 . . . . 1.0 111.947 -178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.92 6.06 3.12 Favored 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 123.537 2.825 . . . . 1.0 114.443 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -112.63 70.83 1.16 Allowed Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 127.221 2.208 . . . . 1.0 110.163 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -57.59 -22.16 50.32 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.455 2.104 . . . . 1.0 116.756 -169.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -64.6 -26.19 68.29 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.325 0.966 . . . . 1.0 111.864 174.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 p -73.62 -14.23 61.14 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.864 -1.148 . . . . 1.0 112.1 -175.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -106.99 -55.86 2.27 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 126.811 2.044 . . . . 1.0 111.464 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.9 p -69.49 -33.86 73.48 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.929 1.085 . . . . 1.0 113.929 -177.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -61.15 -57.65 24.49 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 120.623 1.556 . . . . 1.0 112.266 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -62.32 -23.84 75.48 Favored 'Trans proline' 0 C--N 1.353 0.772 0 CA-C-N 121.359 1.521 . . . . 1.0 112.502 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 88.4 t90 -68.15 -46.87 69.6 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 119.104 0.865 . . . . 1.0 111.226 174.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.432 HG11 ' HA ' ' A' ' 22' ' ' ALA . 98.3 t -62.31 -33.57 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 175.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -68.62 -29.85 68.44 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.99 1.316 . . . . 1.0 112.588 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -81.49 -57.96 3.24 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.369 1.467 . . . . 1.0 112.397 170.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 84.4 t90 -56.84 -36.87 70.49 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 125.352 1.461 . . . . 1.0 112.633 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.27 -32.55 21.89 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.531 1.062 . . . . 1.0 113.871 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.8 p -68.14 -14.05 62.69 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.373 1.249 . . . . 1.0 114.373 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.44 -17.68 53.75 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.997 1.719 . . . . 1.0 111.843 175.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.38 172.3 10.5 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.842 1.257 . . . . 1.0 111.269 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 13.5 m . . . . . 0 C--O 1.25 1.086 0 N-CA-C 116.085 1.883 . . . . 1.0 116.085 -169.586 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.9 mtt . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 110.046 -0.353 . . . . 1.0 110.046 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.29 174.14 11.9 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.414 1.486 . . . . 1.0 114.943 -174.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -118.86 124.33 46.88 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.221 1.808 . . . . 1.0 110.241 175.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mp -121.75 116.07 48.31 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 C-N-CA 126.937 2.095 . . . . 1.0 112.416 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.91 125.49 8.27 Favored Glycine 0 C--O 1.225 -0.45 0 N-CA-C 110.158 -1.177 . . . . 1.0 110.158 169.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 mt -104.84 117.63 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-N 118.133 0.966 . . . . 1.0 109.21 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -109.29 109.68 20.65 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.732 -1.581 . . . . 1.0 106.732 -171.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.6 p -103.27 127.35 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.543 0.572 . . . . 1.0 112.543 -169.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.85 55.38 4.75 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 114.968 0.747 . . . . 1.0 114.968 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.2 p -146.05 157.21 43.86 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.291 1.436 . . . . 1.0 112.391 174.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 10.0 tpt -147.04 147.56 30.78 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.157 1.783 . . . . 1.0 111.119 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 69.4 t80 53.84 -76.5 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 128.635 2.774 . . . . 1.0 116.707 170.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.37 -18.01 77.99 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 124.725 1.155 . . . . 1.0 114.539 -175.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -147.57 158.17 43.88 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.137 1.375 . . . . 1.0 111.356 175.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 79.5 p -121.25 -5.44 9.42 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.506 1.522 . . . . 1.0 114.989 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 43.52 65.58 0.96 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.763 2.025 . . . . 1.0 111.885 -174.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.7 tp -18.93 -50.73 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 129.369 3.068 . . . . 1.0 115.979 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.7 t -44.8 -35.48 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.506 1.522 . . . . 1.0 112.916 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.7 -48.81 79.84 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 120.384 1.447 . . . . 1.0 113.198 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -66.69 -32.72 74.2 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.093 0.957 . . . . 1.0 110.775 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -65.63 -47.47 75.52 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 123.675 0.79 . . . . 1.0 109.287 173.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.35 -42.62 96.14 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 123.385 0.674 . . . . 1.0 112.724 -175.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.68 -48.59 72.21 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.906 0.482 . . . . 1.0 109.777 169.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.53 -37.07 76.96 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.994 0.738 . . . . 1.0 112.994 -175.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.0 mt -70.02 -46.22 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-N 119.194 0.907 . . . . 1.0 109.258 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.78 -34.98 79.62 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 119.606 -0.838 . . . . 1.0 110.088 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.3 m -60.67 -46.14 91.47 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.122 1.369 . . . . 1.0 112.91 169.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.95 -32.64 74.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.341 1.056 . . . . 1.0 112.891 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -70.31 -29.12 65.77 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.932 1.293 . . . . 1.0 112.333 172.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.62 23.02 2.16 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.673 1.13 . . . . 1.0 115.119 169.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -121.34 148.51 44.25 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.563 1.145 . . . . 1.0 110.301 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -79.98 93.56 5.74 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 125.267 1.427 . . . . 1.0 108.69 -175.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.32 147.34 35.32 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.068 0.547 . . . . 1.0 111.373 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 93.0 m -150.08 146.73 27.1 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.518 1.127 . . . . 1.0 111.096 -173.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.5 t -97.98 138.84 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 114.049 1.129 . . . . 1.0 114.049 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -118.12 106.69 13.13 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.726 2.011 . . . . 1.0 110.692 169.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -85.26 146.51 27.02 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.917 1.687 . . . . 1.0 110.909 175.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t0 41.75 57.81 9.7 Favored Pre-proline 0 CA--C 1.557 1.236 0 C-N-CA 124.644 1.177 . . . . 1.0 111.174 -169.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -57.93 130.0 36.13 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 125.122 3.881 . . . . 1.0 118.706 -167.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -91.24 150.53 21.3 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.751 1.62 . . . . 1.0 112.288 168.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -70.15 -25.34 63.41 Favored 'General case' 0 N--CA 1.444 -0.757 0 O-C-N 121.13 -0.981 . . . . 1.0 110.282 168.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.2 m -66.26 -21.67 66.29 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.65 -0.656 . . . . 1.0 112.31 171.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -86.93 -23.79 25.02 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.159 0.983 . . . . 1.0 112.994 169.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 12.3 t-105 -80.16 -34.63 37.44 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.806 1.185 . . . . 1.0 113.778 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.8 mt -50.11 -39.62 48.31 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-O 117.744 -1.122 . . . . 1.0 113.589 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -52.65 -13.36 2.38 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 124.843 3.696 . . . . 1.0 117.892 170.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -112.87 8.02 18.54 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 116.332 1.975 . . . . 1.0 116.332 -176.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -50.86 -30.74 15.31 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.2 1.8 . . . . 1.0 113.642 174.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -107.11 8.13 30.01 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.821 2.049 . . . . 1.0 113.407 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -127.97 -159.66 0.96 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.274 2.229 . . . . 1.0 112.267 -169.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -112.41 159.33 18.83 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 122.805 1.288 . . . . 1.0 110.907 171.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -148.47 154.86 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 124.909 1.284 . . . . 1.0 108.735 -171.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.1 tp -133.99 128.05 33.61 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.06 0.944 . . . . 1.0 108.865 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.5 t -103.75 124.18 57.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 C-N-CA 124.326 1.05 . . . . 1.0 109.184 176.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.9 t -125.39 112.06 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 107.183 -1.414 . . . . 1.0 107.183 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.3 t -153.25 126.76 8.7 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.628 0.973 . . . . 1.0 113.628 -168.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.5 m -98.77 177.92 5.14 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.513 1.525 . . . . 1.0 111.48 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.8 m 64.63 60.28 0.89 Allowed 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 122.597 1.189 . . . . 1.0 113.775 168.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.4 m -59.89 -39.12 84.24 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.565 1.546 . . . . 1.0 113.321 171.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 50.99 -135.94 30.22 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 119.16 0.891 . . . . 1.0 113.897 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -81.52 53.01 1.99 Allowed 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.136 -1.214 . . . . 1.0 112.816 174.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.92 41.89 70.96 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 124.379 0.99 . . . . 1.0 113.338 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -130.58 -172.82 2.9 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.5 1.92 . . . . 1.0 111.471 -173.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 53.3 mt -136.69 156.84 75.95 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 126.006 1.722 . . . . 1.0 114.631 -173.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -55.39 140.38 82.32 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.964 3.109 . . . . 1.0 112.38 169.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.07 -21.67 65.14 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.211 -0.93 . . . . 1.0 113.406 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.6 p -77.31 -19.55 56.23 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.658 1.355 . . . . 1.0 114.658 172.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.2 tt -111.27 -18.02 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.579 1.151 . . . . 1.0 113.407 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.8 t -44.15 -52.6 15.69 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 125.302 1.441 . . . . 1.0 112.289 168.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.89 -29.43 18.5 Favored 'Trans proline' 0 C--N 1.35 0.641 0 CA-C-N 120.774 1.312 . . . . 1.0 111.272 -173.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.4 tp -65.08 -50.46 66.06 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 124.046 0.939 . . . . 1.0 110.793 169.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -55.53 -52.13 64.73 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.219 1.008 . . . . 1.0 112.213 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -64.35 -40.34 95.66 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.094 0.958 . . . . 1.0 111.733 176.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.73 -35.81 90.3 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.073 0.844 . . . . 1.0 112.628 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 91.5 mt -64.73 -51.3 69.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 120.071 1.935 . . . . 1.0 107.988 171.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.4 ptmm? -68.59 -31.72 71.1 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.394 -1.441 . . . . 1.0 113.289 -169.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -103.64 -37.25 7.6 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.513 1.671 . . . . 1.0 115.513 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.1 m -96.43 -19.52 19.11 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.416 1.087 . . . . 1.0 113.266 -174.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.15 -73.08 0.57 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.158 -1.423 . . . . 1.0 107.158 169.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.35 -21.43 1.45 Allowed Glycine 0 CA--C 1.536 1.347 0 C-N-CA 127.756 2.598 . . . . 1.0 114.727 169.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -151.19 141.32 22.19 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 128.392 2.677 . . . . 1.0 108.041 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -138.15 121.79 11.45 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.74 0.816 . . . . 1.0 110.165 -169.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -78.55 -38.02 0.59 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.121 1.881 . . . . 1.0 115.822 -169.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -143.98 21.17 1.78 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.129 1.159 . . . . 1.0 114.129 -169.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.8 tp -84.51 140.26 31.58 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.559 -1.338 . . . . 1.0 114.6 -169.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -137.12 155.31 49.76 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 128.64 2.776 . . . . 1.0 108.065 169.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.36 171.81 19.11 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.355 -0.841 . . . . 1.0 111.589 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -131.73 172.25 20.99 Favored Glycine 0 N--CA 1.471 0.974 0 C-N-CA 124.902 1.239 . . . . 1.0 113.415 170.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.57 143.38 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 114.009 1.114 . . . . 1.0 114.009 -169.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.1 mt -133.16 98.17 2.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 106.532 -1.655 . . . . 1.0 106.532 169.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.44 144.12 26.56 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.442 1.497 . . . . 1.0 111.349 171.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.1 mp -140.79 154.98 46.49 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.447 0.906 . . . . 1.0 113.447 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.65 -169.75 41.87 Favored Glycine 0 C--O 1.221 -0.659 0 N-CA-C 114.227 0.451 . . . . 1.0 114.227 168.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -100.99 110.95 23.04 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.057 0.943 . . . . 1.0 110.031 175.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.1 t -63.43 -7.92 7.84 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.737 1.215 . . . . 1.0 113.69 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.9 t -62.19 -26.66 68.47 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.92 -1.113 . . . . 1.0 110.841 168.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -91.14 146.63 23.67 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.358 1.463 . . . . 1.0 110.517 169.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.2 m -71.41 170.12 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 121.713 0.768 . . . . 1.0 112.227 -177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.92 6.61 3.48 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 127.036 2.134 . . . . 1.0 116.754 -171.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 12.8 t80 28.79 -85.49 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 129.151 2.98 . . . . 1.0 116.719 -175.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 6.9 m -123.35 20.74 9.64 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.72 1.608 . . . . 1.0 113.685 -174.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -54.13 -23.14 13.04 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.72 1.608 . . . . 1.0 114.611 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.31 -46.93 85.63 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 120.661 1.573 . . . . 1.0 113.588 175.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.75 -35.6 39.78 Favored Glycine 0 N--CA 1.478 1.435 0 O-C-N 120.766 -1.432 . . . . 1.0 113.141 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -60.59 -32.4 71.52 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 121.264 -1.139 . . . . 1.0 112.86 172.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -66.82 -34.99 79.02 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.033 0.933 . . . . 1.0 112.361 169.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -62.75 -35.45 79.83 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.603 1.092 . . . . 1.0 111.136 170.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -65.99 -49.04 69.23 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.804 -0.56 . . . . 1.0 111.062 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.5 -33.58 66.14 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.876 0.871 . . . . 1.0 113.272 174.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.91 -50.59 72.81 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 123.117 1.437 . . . . 1.0 110.867 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.6 mt -65.68 -40.03 91.93 Favored 'General case' 0 C--N 1.321 -0.67 0 O-C-N 121.074 -1.016 . . . . 1.0 111.478 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -67.17 -20.52 65.75 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.534 0.938 . . . . 1.0 113.534 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.03 -17.06 57.51 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.589 1.086 . . . . 1.0 111.112 177.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -100.42 -73.57 0.63 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.8 1.24 . . . . 1.0 109.75 -178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 77.4 p -179.37 -19.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.165 1.786 . . . . 1.0 114.147 -174.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.69 161.1 31.4 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 123.14 1.448 . . . . 1.0 114.139 -169.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -98.47 179.53 4.68 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.306 1.842 . . . . 1.0 110.934 -170.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.0 ttm105 -131.37 158.35 40.97 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.519 1.127 . . . . 1.0 112.828 169.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.9 t -96.96 -173.44 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 C-N-CA 126.493 1.917 . . . . 1.0 106.394 169.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.49 164.69 3.06 Favored Glycine 0 CA--C 1.545 1.919 0 N-CA-C 116.924 1.529 . . . . 1.0 116.924 -170.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -43.75 131.42 5.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.859 2.064 . . . . 1.0 113.953 -175.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -74.16 157.62 35.63 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.333 1.053 . . . . 1.0 111.869 -172.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.427 ' HB2' ' CD1' ' A' ' 140' ' ' TRP . 1.4 tm? -91.48 137.27 32.49 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.215 -0.902 . . . . 1.0 110.353 174.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.6 mt -127.26 110.69 13.11 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.844 1.657 . . . . 1.0 109.445 174.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 24.0 mt -99.15 131.5 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 124.085 0.954 . . . . 1.0 112.582 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -104.31 108.97 20.62 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.118 0.967 . . . . 1.0 112.606 170.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.43 -24.99 66.54 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.88 1.272 . . . . 1.0 113.775 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.64 -17.46 64.61 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.776 1.028 . . . . 1.0 113.776 173.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -116.46 -29.28 6.21 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.677 1.591 . . . . 1.0 111.633 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -145.16 87.73 7.04 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 125.323 1.449 . . . . 1.0 111.901 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.98 5.01 3.24 Favored 'Trans proline' 0 CA--C 1.549 1.247 0 C-N-CA 123.689 2.926 . . . . 1.0 114.731 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -113.72 71.02 1.75 Allowed Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 127.179 2.192 . . . . 1.0 109.634 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -54.93 -28.3 58.39 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.391 2.061 . . . . 1.0 115.845 -169.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -62.99 -24.38 67.89 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.611 0.642 . . . . 1.0 112.006 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.1 p -75.08 -16.57 60.56 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 120.612 -1.305 . . . . 1.0 111.82 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -101.56 -55.68 2.47 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.371 1.868 . . . . 1.0 111.438 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 90.7 p -65.23 -34.13 77.62 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 113.779 1.029 . . . . 1.0 113.779 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 -64.03 -55.2 34.13 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 120.501 1.501 . . . . 1.0 112.92 -175.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -62.1 -24.42 76.47 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 CA-C-N 121.328 1.51 . . . . 1.0 112.849 172.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.427 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 87.5 t90 -68.28 -45.44 73.07 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 118.592 0.633 . . . . 1.0 111.314 173.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 83.3 t -66.41 -33.64 64.82 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -63.69 -48.77 75.79 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.225 -0.922 . . . . 1.0 109.528 173.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -63.99 -54.98 25.85 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.489 1.116 . . . . 1.0 111.827 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -58.49 -35.61 72.49 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 125.611 1.564 . . . . 1.0 111.76 174.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.19 -34.53 25.06 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.583 1.563 . . . . 1.0 113.458 171.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.9 p -67.82 -12.99 61.76 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.826 1.417 . . . . 1.0 114.826 176.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.35 -16.29 49.74 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.869 1.667 . . . . 1.0 112.072 176.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.57 -179.56 7.47 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.289 1.036 . . . . 1.0 110.924 -177.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 C--O 1.25 1.129 0 C-N-CA 126.202 1.801 . . . . 1.0 114.52 -175.549 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 119.952 -0.07 . . . . 1.0 110.816 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.5 167.41 26.33 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.186 1.395 . . . . 1.0 112.905 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -120.84 123.83 43.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.08 1.352 . . . . 1.0 110.502 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 mp -120.43 112.79 37.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 C-N-CA 126.632 1.973 . . . . 1.0 112.497 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.61 124.27 7.3 Favored Glycine 0 C--O 1.223 -0.561 0 N-CA-C 110.328 -1.109 . . . . 1.0 110.328 169.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.5 mt -105.27 119.23 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-N 118.614 1.207 . . . . 1.0 109.691 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -110.01 107.45 17.33 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.181 -1.414 . . . . 1.0 107.181 -170.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.4 p -93.26 123.26 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 121.484 0.659 . . . . 1.0 111.105 -172.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.56 47.59 1.01 Allowed Glycine 0 CA--C 1.524 0.596 0 C-N-CA 126.001 1.762 . . . . 1.0 111.621 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.9 p -103.01 131.63 49.86 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.451 -1.029 . . . . 1.0 111.49 -173.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.7 ttt -79.58 -20.82 46.06 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.384 1.253 . . . . 1.0 114.384 -171.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -131.79 151.8 51.41 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.377 1.071 . . . . 1.0 113.076 -174.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -62.5 -27.29 69.35 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.794 1.187 . . . . 1.0 115.373 -171.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -68.23 -31.75 71.47 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.221 1.01 . . . . 1.0 112.214 173.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.0 m -88.16 -28.43 21.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.013 0.925 . . . . 1.0 113.05 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.47 66.29 0.32 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.043 1.737 . . . . 1.0 109.793 170.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.1 tp -161.23 -51.34 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 127.514 2.326 . . . . 1.0 109.935 -170.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.7 t -56.01 -34.43 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.176 0.59 . . . . 1.0 111.243 -173.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.44 -45.57 88.27 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.783 -1.198 . . . . 1.0 113.414 173.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -68.81 -30.36 68.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.303 0.573 . . . . 1.0 111.048 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -68.18 -47.11 68.85 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 123.761 0.824 . . . . 1.0 109.109 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.443 ' HA ' HG12 ' A' ' 141' ' ' VAL . . . -64.32 -43.32 95.04 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 123.56 0.744 . . . . 1.0 112.804 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -53.57 -48.67 68.97 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.092 0.957 . . . . 1.0 110.456 170.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.31 -37.97 71.76 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.593 0.757 . . . . 1.0 112.285 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.0 mt -68.79 -45.83 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 O-C-N 121.63 -0.669 . . . . 1.0 109.338 175.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.99 -31.45 72.36 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.495 1.043 . . . . 1.0 110.649 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.4 m -63.12 -45.04 93.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.586 1.154 . . . . 1.0 112.711 169.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.08 -31.36 70.93 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.799 1.239 . . . . 1.0 113.032 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -67.68 -29.03 68.2 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.211 1.804 . . . . 1.0 111.695 172.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.43 28.27 2.39 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.715 1.15 . . . . 1.0 114.905 171.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -120.52 164.39 16.51 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.016 1.326 . . . . 1.0 110.169 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -93.44 89.81 6.47 Favored 'General case' 0 CA--C 1.52 -0.183 0 O-C-N 120.659 -1.275 . . . . 1.0 108.559 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.16 145.87 29.57 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 122.766 0.426 . . . . 1.0 111.22 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.7 m -147.77 139.08 23.61 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.864 0.866 . . . . 1.0 112.041 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.4 t -86.93 137.72 20.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 114.916 1.45 . . . . 1.0 114.916 172.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -117.89 113.74 22.19 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.85 2.06 . . . . 1.0 110.32 171.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -94.7 137.75 33.4 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.686 1.994 . . . . 1.0 111.158 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.5 t70 41.79 55.37 9.07 Favored Pre-proline 0 CA--C 1.559 1.293 0 C-N-CA 124.61 1.164 . . . . 1.0 111.08 -169.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -68.59 145.63 64.71 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.016 3.144 . . . . 1.0 117.638 -167.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -88.79 154.5 20.22 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.892 1.677 . . . . 1.0 112.442 168.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -69.41 -21.72 63.74 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 120.899 -1.125 . . . . 1.0 109.762 168.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.1 m -66.13 -22.89 66.4 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.284 -0.885 . . . . 1.0 112.332 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -82.52 -24.94 33.87 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.136 0.974 . . . . 1.0 113.098 169.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.8 t-105 -83.9 -35.54 24.01 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.799 1.182 . . . . 1.0 113.994 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.3 mt -48.16 -39.17 25.32 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-O 117.58 -1.2 . . . . 1.0 113.897 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -55.31 -14.98 10.27 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.306 3.337 . . . . 1.0 117.224 172.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -109.03 8.24 26.12 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 116.027 1.862 . . . . 1.0 116.027 -174.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -52.98 -23.47 7.38 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.977 2.111 . . . . 1.0 114.218 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -124.91 17.74 8.57 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.546 1.538 . . . . 1.0 113.484 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -126.47 -158.24 0.85 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.936 2.494 . . . . 1.0 110.345 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -116.79 161.85 18.63 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 122.984 1.373 . . . . 1.0 112.313 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.08 160.59 4.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 125.14 1.376 . . . . 1.0 108.966 -172.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.4 tp -138.17 130.05 28.35 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.007 1.323 . . . . 1.0 108.369 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.8 t -105.23 124.21 59.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 124.088 0.955 . . . . 1.0 109.03 174.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.1 t -122.26 111.86 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 105.476 -2.046 . . . . 1.0 105.476 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.3 t -148.38 132.93 17.72 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.227 1.195 . . . . 1.0 114.227 -167.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.6 p -121.49 162.94 19.63 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.762 0.825 . . . . 1.0 113.014 -172.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.0 m 66.22 55.71 0.86 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 122.743 1.258 . . . . 1.0 112.758 169.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.0 m -55.16 128.83 35.68 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.84 1.256 . . . . 1.0 109.553 169.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.43 -128.49 4.94 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.974 0.797 . . . . 1.0 112.797 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 41.8 mm-40 -76.43 52.18 0.76 Allowed 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.025 -1.279 . . . . 1.0 111.834 172.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.3 11.95 83.86 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.892 1.235 . . . . 1.0 113.805 -169.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -111.95 175.11 5.56 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.123 1.769 . . . . 1.0 111.879 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 52.9 mt -114.84 160.25 34.27 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 127.91 2.484 . . . . 1.0 113.389 -169.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.73 154.25 63.99 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.925 2.417 . . . . 1.0 111.84 169.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -62.14 -23.19 66.41 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.215 1.191 . . . . 1.0 114.215 -169.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.9 p -68.69 -22.55 64.36 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.292 1.219 . . . . 1.0 114.292 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.0 tt -122.52 -12.81 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 114.477 1.288 . . . . 1.0 114.477 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.9 t -44.06 -52.73 15.0 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 124.424 1.09 . . . . 1.0 112.912 168.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.36 -31.48 17.77 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.686 1.591 . . . . 1.0 111.757 -172.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.2 tp -62.67 -52.16 64.4 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 124.602 1.161 . . . . 1.0 111.336 169.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -55.83 -51.44 67.49 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.718 0.807 . . . . 1.0 112.65 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -63.15 -39.32 94.31 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.424 0.69 . . . . 1.0 111.682 176.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.18 -34.65 81.37 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 123.801 0.715 . . . . 1.0 113.009 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 91.6 mt -65.66 -44.14 93.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 120.354 2.077 . . . . 1.0 108.866 171.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? -74.39 -32.01 62.55 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.304 -1.498 . . . . 1.0 113.415 -173.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -106.55 -38.57 6.12 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 115.138 1.532 . . . . 1.0 115.138 -174.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.7 m -91.06 -25.05 19.84 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.252 1.021 . . . . 1.0 112.712 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.04 -71.06 0.65 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 107.497 -1.297 . . . . 1.0 107.497 169.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.0 -8.22 2.66 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 126.369 1.938 . . . . 1.0 115.481 171.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -156.0 147.97 23.24 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 129.322 3.049 . . . . 1.0 107.023 171.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -134.84 127.92 18.57 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.113 0.565 . . . . 1.0 111.037 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -81.3 -44.65 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 121.847 1.698 . . . . 1.0 113.485 -172.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -148.49 28.11 0.89 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.674 1.189 . . . . 1.0 112.88 -172.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.4 tp -85.51 137.95 32.54 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.691 -1.256 . . . . 1.0 112.682 -169.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.2 mtm-85 -134.46 157.71 45.77 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.461 2.305 . . . . 1.0 109.153 169.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.429 ' CD1' HD13 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -163.24 169.41 19.24 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.136 0.88 . . . . 1.0 111.441 -177.591 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -129.92 173.47 19.8 Favored Glycine 0 N--CA 1.469 0.848 0 C-N-CA 124.096 0.855 . . . . 1.0 113.558 169.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.55 140.81 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 114.133 1.16 . . . . 1.0 114.133 -169.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.6 mt -131.57 97.23 2.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 106.841 -1.54 . . . . 1.0 106.841 168.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.12 148.97 28.24 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.806 1.242 . . . . 1.0 111.47 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.7 mp -141.61 151.61 43.28 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.853 0.686 . . . . 1.0 112.853 176.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 170.38 -160.1 32.72 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 121.691 -0.29 . . . . 1.0 112.691 169.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -109.85 122.23 47.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.004 0.902 . . . . 1.0 110.009 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 96.3 p -63.04 -8.29 7.17 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.43 1.27 . . . . 1.0 114.43 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.0 t -72.33 -21.41 61.32 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.876 0.87 . . . . 1.0 112.217 169.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -75.22 147.59 40.2 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.234 -0.916 . . . . 1.0 111.084 173.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -53.15 -50.55 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.866 1.266 . . . . 1.0 113.787 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -96.57 13.12 29.21 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.276 1.584 . . . . 1.0 115.276 -171.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 17.4 t80 28.5 -88.77 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 128.64 2.776 . . . . 1.0 116.22 -176.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 9.5 m -123.11 17.66 9.98 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.88 1.672 . . . . 1.0 113.469 -174.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -63.0 -12.37 25.37 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.861 1.265 . . . . 1.0 114.289 -174.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.36 -39.37 97.15 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-N 120.308 1.413 . . . . 1.0 113.599 171.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -77.25 -36.04 36.08 Favored Glycine 0 N--CA 1.477 1.432 0 O-C-N 120.616 -1.52 . . . . 1.0 112.737 172.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -62.85 -31.62 72.67 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.256 -1.144 . . . . 1.0 112.469 173.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -62.52 -41.21 98.71 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.211 1.004 . . . . 1.0 111.071 169.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -62.8 -38.67 91.61 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 118.804 0.729 . . . . 1.0 111.41 174.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -61.86 -48.63 79.65 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.387 -0.821 . . . . 1.0 112.316 173.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.95 -35.28 70.91 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.278 0.631 . . . . 1.0 112.699 174.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.68 -49.22 78.37 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 125.456 1.502 . . . . 1.0 111.079 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.429 HD13 ' CD1' ' A' ' 87' ' ' TYR . 11.0 mt -67.31 -40.21 85.99 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 120.9 -1.125 . . . . 1.0 111.762 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -70.15 -18.69 63.22 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.244 0.831 . . . . 1.0 113.244 176.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.75 -18.45 59.55 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.674 1.124 . . . . 1.0 111.198 175.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -97.23 -72.83 0.63 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.089 1.355 . . . . 1.0 109.608 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.6 p 176.54 -18.04 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.476 2.31 . . . . 1.0 113.348 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.44 151.54 46.68 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 123.149 1.452 . . . . 1.0 114.457 -169.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -90.93 168.07 11.96 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.73 2.012 . . . . 1.0 114.006 -168.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.97 154.43 27.61 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.172 2.189 . . . . 1.0 111.454 176.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.1 t -124.92 129.46 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.301 1.441 . . . . 1.0 108.764 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 49.79 -154.49 2.7 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 125.328 1.442 . . . . 1.0 115.279 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -111.52 143.35 42.51 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.31 1.844 . . . . 1.0 109.914 169.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -77.07 156.46 31.74 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.731 0.777 . . . . 1.0 112.257 -173.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.442 HD21 ' CD1' ' A' ' 140' ' ' TRP . 0.8 OUTLIER -92.26 137.15 32.61 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 123.87 0.868 . . . . 1.0 110.291 174.118 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.2 mt -123.16 102.54 8.01 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.825 1.25 . . . . 1.0 110.532 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.7 mt -79.41 133.21 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 C-N-CA 124.461 1.104 . . . . 1.0 111.22 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -109.48 106.98 16.94 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 122.374 1.083 . . . . 1.0 113.448 172.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.21 -23.47 64.82 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.093 0.957 . . . . 1.0 113.26 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.2 t -62.91 -22.97 67.13 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.371 1.068 . . . . 1.0 112.665 174.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -120.0 -29.6 4.89 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.361 1.864 . . . . 1.0 111.925 -174.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -144.8 84.68 8.79 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.756 1.622 . . . . 1.0 112.058 -172.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -73.65 8.25 2.0 Allowed 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 123.635 2.89 . . . . 1.0 114.495 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -111.54 71.17 0.88 Allowed Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 127.953 2.501 . . . . 1.0 109.551 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -57.67 -22.21 51.21 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.696 2.264 . . . . 1.0 116.554 -169.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -64.48 -26.16 68.31 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 118.963 0.802 . . . . 1.0 111.758 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.7 p -77.12 -19.05 57.45 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 120.434 -1.416 . . . . 1.0 112.046 -174.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -94.82 -51.99 4.45 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.028 1.331 . . . . 1.0 111.883 172.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.8 p -72.17 -35.58 69.06 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 115.078 1.51 . . . . 1.0 115.078 -176.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -59.85 -55.04 49.65 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 120.612 1.551 . . . . 1.0 112.54 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -63.35 -23.12 71.94 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 121.482 1.565 . . . . 1.0 112.515 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.442 ' CD1' HD21 ' A' ' 123' ' ' LEU . 89.6 t90 -69.19 -46.75 66.7 Favored 'General case' 0 C--O 1.218 -0.572 0 O-C-N 121.828 -0.545 . . . . 1.0 110.846 174.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 22' ' ' ALA . 91.7 t -64.77 -32.25 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.877 0.846 . . . . 1.0 108.85 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -71.82 -23.51 61.56 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.154 -1.591 . . . . 1.0 113.292 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -86.91 -61.21 1.78 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.867 2.067 . . . . 1.0 111.698 169.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 89.4 t90 -54.72 -37.68 66.18 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 126.715 2.006 . . . . 1.0 112.658 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.85 -29.57 34.44 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 121.519 -0.738 . . . . 1.0 114.383 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.2 p -69.05 -13.47 62.46 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.273 1.212 . . . . 1.0 114.273 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.43 -18.33 52.43 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.651 1.58 . . . . 1.0 111.833 176.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.41 171.79 12.31 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.672 1.189 . . . . 1.0 110.964 -176.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 C--O 1.253 1.253 0 N-CA-C 116.17 1.915 . . . . 1.0 116.17 -169.67 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.616 -0.513 . . . . 1.0 109.616 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.9 154.38 45.08 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.574 1.15 . . . . 1.0 113.116 -170.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -120.17 122.34 40.77 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.454 1.502 . . . . 1.0 110.231 174.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 mp -122.4 113.36 38.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 126.622 1.969 . . . . 1.0 111.972 -176.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.9 124.52 7.58 Favored Glycine 0 C--O 1.224 -0.52 0 N-CA-C 110.263 -1.135 . . . . 1.0 110.263 169.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 mt -105.44 123.96 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-N 118.069 0.934 . . . . 1.0 109.225 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -115.47 109.35 17.71 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 124.195 0.998 . . . . 1.0 108.368 -169.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -86.64 131.73 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.105 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.26 113.66 2.98 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.753 1.168 . . . . 1.0 110.861 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.3 t -149.18 164.23 35.33 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 118.083 0.942 . . . . 1.0 113.138 -170.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 13.9 ptt? -124.42 6.48 8.34 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.927 1.291 . . . . 1.0 113.095 169.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -100.68 167.27 10.43 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.1 1.36 . . . . 1.0 113.191 -171.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.19 -26.87 73.95 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 123.901 0.762 . . . . 1.0 114.061 175.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -87.27 142.08 28.16 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.421 1.089 . . . . 1.0 111.135 169.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.0 m -77.77 43.18 0.4 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.481 1.512 . . . . 1.0 113.741 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 47.29 75.01 0.14 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.067 2.147 . . . . 1.0 112.496 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.1 tp -11.46 -54.78 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 129.546 3.139 . . . . 1.0 116.683 169.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.4 t -53.34 -33.67 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.968 0.907 . . . . 1.0 112.914 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.46 -46.84 87.62 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 120.285 1.402 . . . . 1.0 112.48 173.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -68.64 -32.09 71.7 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.077 0.951 . . . . 1.0 111.046 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -65.21 -49.12 70.91 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.982 -0.748 . . . . 1.0 108.982 171.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.4 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.19 -42.41 93.6 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 112.983 0.734 . . . . 1.0 112.983 -172.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -53.95 -49.99 67.48 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.701 0.8 . . . . 1.0 110.09 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.83 -35.64 74.94 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 112.625 0.602 . . . . 1.0 112.625 -175.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.1 mt -70.47 -46.01 72.29 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 119.063 0.847 . . . . 1.0 109.658 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.72 -33.6 76.25 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 119.863 -0.735 . . . . 1.0 110.189 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 54.0 m -61.96 -44.6 96.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.058 1.343 . . . . 1.0 113.085 169.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.78 -32.03 73.05 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.196 0.998 . . . . 1.0 112.92 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -70.03 -29.43 66.47 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.846 1.259 . . . . 1.0 112.279 171.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.13 21.8 2.49 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.723 1.154 . . . . 1.0 115.056 169.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -114.24 158.39 21.44 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.816 1.246 . . . . 1.0 110.792 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -86.03 89.47 7.81 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 125.461 1.504 . . . . 1.0 108.587 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.23 145.35 31.68 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 122.446 0.298 . . . . 1.0 111.123 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 78.6 m -148.08 138.71 23.0 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.642 0.777 . . . . 1.0 112.018 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.7 t -85.57 134.58 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.726 1.21 . . . . 1.0 114.151 171.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -110.3 109.9 20.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.799 1.64 . . . . 1.0 110.385 169.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -87.47 137.52 32.27 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.113 1.765 . . . . 1.0 111.115 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.2 t0 40.89 56.85 8.34 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 124.868 1.267 . . . . 1.0 111.354 -169.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -68.9 140.95 47.37 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.898 3.065 . . . . 1.0 116.973 -168.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.465 ' HB3' ' H ' ' A' ' 42' ' ' SER . 52.6 mm-40 -93.83 163.47 13.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 122.357 1.075 . . . . 1.0 111.847 168.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -65.86 -22.04 66.51 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 120.886 -1.134 . . . . 1.0 109.796 167.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.465 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 17.9 m -68.3 -19.7 64.71 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.878 -1.139 . . . . 1.0 112.613 172.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -83.1 -24.69 32.53 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.385 1.074 . . . . 1.0 112.444 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 -88.68 -34.56 17.17 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.075 1.139 . . . . 1.0 114.075 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.9 mt -48.09 -38.57 20.96 Favored Pre-proline 0 CA--C 1.554 1.109 0 CA-C-O 117.608 -1.186 . . . . 1.0 114.103 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.71 -11.68 21.7 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.132 3.221 . . . . 1.0 116.352 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -109.36 6.9 24.8 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 116.095 1.887 . . . . 1.0 116.095 -174.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -52.88 -31.02 37.3 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.88 2.072 . . . . 1.0 113.723 172.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -109.81 11.5 24.33 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.176 1.391 . . . . 1.0 112.499 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -124.83 -159.03 0.86 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.904 2.482 . . . . 1.0 111.034 -174.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -116.13 162.85 16.82 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 122.874 1.321 . . . . 1.0 111.834 170.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.93 160.52 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.432 1.093 . . . . 1.0 109.182 -172.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.8 tp -139.29 128.0 23.29 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.68 1.192 . . . . 1.0 108.924 175.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.1 t -100.52 128.3 52.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 174.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.4 t -126.04 110.92 25.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 106.254 -1.758 . . . . 1.0 106.254 175.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.2 t -144.12 128.94 18.36 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.228 0.825 . . . . 1.0 113.228 -168.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.9 t -118.82 154.65 32.53 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.593 1.157 . . . . 1.0 113.106 -169.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.7 m 64.6 60.13 0.91 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 123.312 1.529 . . . . 1.0 112.077 169.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.9 m -56.03 -29.61 60.66 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 113.809 -1.541 . . . . 1.0 112.138 169.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.11 -136.96 49.5 Favored Glycine 0 C--N 1.343 0.944 0 C-N-CA 124.054 0.835 . . . . 1.0 111.913 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -61.77 -26.1 67.87 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.506 0.722 . . . . 1.0 112.916 177.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 148.0 52.91 0.02 OUTLIER Glycine 0 CA--C 1.537 1.412 0 CA-C-N 119.216 0.916 . . . . 1.0 114.721 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -143.1 -178.98 6.1 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.267 1.033 . . . . 1.0 111.821 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.9 mt -108.49 148.36 37.52 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 126.051 1.74 . . . . 1.0 113.659 176.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.55 147.22 95.94 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.283 2.655 . . . . 1.0 113.182 169.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -63.63 -23.11 67.24 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.965 1.098 . . . . 1.0 113.965 -175.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.9 p -67.51 -26.82 66.53 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.149 1.166 . . . . 1.0 114.149 173.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.2 tt -113.38 -14.65 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 125.259 1.424 . . . . 1.0 113.712 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.1 t -44.96 -53.27 16.48 Favored Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 124.444 1.098 . . . . 1.0 112.238 168.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -68.09 -32.38 27.89 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.747 1.631 . . . . 1.0 111.819 -173.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.2 tp -63.15 -53.24 56.51 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 124.429 1.092 . . . . 1.0 111.259 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -55.2 -53.75 52.09 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.747 0.819 . . . . 1.0 112.393 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -68.38 -35.1 77.21 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.769 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.36 -35.3 90.02 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 121.709 -0.62 . . . . 1.0 112.585 175.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 88.7 mt -65.98 -50.14 71.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 119.926 1.863 . . . . 1.0 108.414 171.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.6 ptmm? -69.35 -32.28 71.27 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.222 -1.549 . . . . 1.0 113.145 -170.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -104.61 -40.47 6.01 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.054 1.501 . . . . 1.0 115.054 -174.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.3 m -92.01 -24.13 19.31 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.006 0.922 . . . . 1.0 113.011 -175.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.1 -71.04 0.65 Allowed 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 106.804 -1.554 . . . . 1.0 106.804 169.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.43 -13.53 1.11 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 127.61 2.529 . . . . 1.0 117.011 168.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -155.24 140.39 17.5 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.557 2.343 . . . . 1.0 108.398 172.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -136.33 128.41 17.28 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 121.328 -0.858 . . . . 1.0 112.028 -172.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -89.3 -34.98 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.948 2.432 . . . . 1.0 115.123 -175.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -142.52 12.97 1.94 Allowed 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 115.138 1.533 . . . . 1.0 115.138 -169.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.9 tp -84.39 132.7 34.56 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.51 -1.369 . . . . 1.0 113.362 -169.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.7 mtm-85 -130.32 153.64 48.46 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.395 1.878 . . . . 1.0 109.716 169.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.414 ' CD1' HD11 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -160.82 165.27 30.53 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.548 1.067 . . . . 1.0 112.277 -176.46 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -124.0 173.37 16.68 Favored Glycine 0 N--CA 1.467 0.726 0 C-N-CA 125.401 1.476 . . . . 1.0 112.109 169.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -159.54 142.54 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 O-C-N 120.854 -1.38 . . . . 1.0 114.416 -169.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.9 mt -132.01 109.72 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 126.806 2.043 . . . . 1.0 108.24 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.11 145.47 24.49 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.192 1.397 . . . . 1.0 110.846 172.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.9 mp -137.09 152.41 49.99 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.466 0.706 . . . . 1.0 112.222 177.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.1 -153.32 23.41 Favored Glycine 0 C--O 1.222 -0.629 0 CA-C-N 116.354 -0.384 . . . . 1.0 112.421 169.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -114.45 119.19 36.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.979 0.889 . . . . 1.0 110.39 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 60.5 p -63.15 -6.04 3.83 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.529 1.307 . . . . 1.0 114.529 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.9 t -63.94 -25.55 68.19 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.598 0.759 . . . . 1.0 112.742 170.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -79.36 140.22 37.54 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.115 -0.991 . . . . 1.0 111.266 169.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -50.57 -50.53 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.273 1.429 . . . . 1.0 113.113 176.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -88.72 21.29 3.07 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.807 1.643 . . . . 1.0 114.525 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.8 t80 11.9 -75.17 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 130.158 3.383 . . . . 1.0 117.611 175.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.551 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 19.8 p -123.04 13.02 9.71 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.793 2.037 . . . . 1.0 114.017 -169.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -57.44 -21.41 36.75 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.477 1.288 . . . . 1.0 114.477 -173.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -54.21 -44.24 74.74 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 120.592 1.542 . . . . 1.0 113.467 174.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -79.54 -36.61 25.93 Favored Glycine 0 N--CA 1.479 1.547 0 O-C-N 120.993 -1.298 . . . . 1.0 113.476 174.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.551 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 78.7 mttt -60.04 -34.41 73.35 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.207 1.004 . . . . 1.0 112.789 174.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -64.79 -38.28 90.46 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.159 0.984 . . . . 1.0 111.914 172.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -64.25 -37.71 88.44 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.421 1.009 . . . . 1.0 111.036 173.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.53 -43.57 93.6 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.132 0.573 . . . . 1.0 112.229 176.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.41 82.77 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.857 -0.592 . . . . 1.0 111.754 170.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.46 -49.46 45.28 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.868 2.067 . . . . 1.0 111.939 -173.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.414 HD11 ' CD1' ' A' ' 87' ' ' TYR . 8.5 mt -65.59 -43.96 88.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.463 -0.79 . . . . 1.0 111.005 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -67.1 -21.68 65.85 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.941 1.089 . . . . 1.0 113.941 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -66.13 -36.47 83.24 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.415 1.086 . . . . 1.0 110.938 173.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -81.02 -77.61 0.2 Allowed 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 113.996 -1.456 . . . . 1.0 109.888 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.7 t -179.72 -2.34 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.195 2.198 . . . . 1.0 111.498 170.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.19 146.8 43.11 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 114.819 1.415 . . . . 1.0 114.819 -168.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.13 167.31 18.88 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.657 2.383 . . . . 1.0 114.896 -168.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.43 149.5 42.92 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.907 2.083 . . . . 1.0 111.693 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.8 t -123.93 128.66 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.775 1.63 . . . . 1.0 108.497 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 50.25 -155.03 2.82 Favored Glycine 0 CA--C 1.542 1.77 0 C-N-CA 124.908 1.242 . . . . 1.0 114.988 -171.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -114.59 144.38 43.49 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.317 1.847 . . . . 1.0 109.962 169.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.18 155.71 39.34 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 122.134 0.969 . . . . 1.0 111.424 -174.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.446 HD21 ' CD1' ' A' ' 140' ' ' TRP . 0.9 OUTLIER -93.73 140.04 30.11 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.309 1.043 . . . . 1.0 110.197 176.16 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.7 mt -124.83 102.13 7.41 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.082 1.353 . . . . 1.0 110.891 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.403 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.2 mt -86.11 128.75 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.576 1.55 . . . . 1.0 111.909 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -108.03 110.5 22.21 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 124.328 1.018 . . . . 1.0 112.261 174.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -70.13 -23.3 63.0 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.132 0.973 . . . . 1.0 112.79 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.5 t -62.77 -23.17 67.08 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.291 1.036 . . . . 1.0 112.73 173.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -119.27 -29.94 5.06 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.293 1.837 . . . . 1.0 112.2 -173.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -143.79 91.11 6.76 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 125.196 1.398 . . . . 1.0 112.603 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.76 7.17 3.28 Favored 'Trans proline' 0 CA--C 1.552 1.39 0 C-N-CA 123.414 2.743 . . . . 1.0 114.483 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -110.07 71.52 0.61 Allowed Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 127.307 2.243 . . . . 1.0 110.116 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -58.34 -18.8 39.92 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.803 2.335 . . . . 1.0 117.629 -168.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -69.47 -25.45 64.09 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.122 1.328 . . . . 1.0 111.644 172.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 28.0 p -72.78 -22.85 60.77 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.942 1.246 . . . . 1.0 111.969 -173.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -91.01 -54.2 4.06 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.654 1.582 . . . . 1.0 111.767 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.7 p -70.88 -32.78 69.87 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 115.022 1.489 . . . . 1.0 115.022 -176.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -58.42 -55.62 43.79 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 120.94 1.7 . . . . 1.0 112.705 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -64.32 -24.45 64.82 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 CA-C-N 121.277 1.492 . . . . 1.0 113.134 174.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.446 ' CD1' HD21 ' A' ' 123' ' ' LEU . 92.2 t90 -68.0 -48.2 66.4 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 118.795 0.725 . . . . 1.0 110.728 174.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' A' ' 22' ' ' ALA . 96.2 t -67.04 -33.09 61.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 C-N-CA 122.842 0.457 . . . . 1.0 110.044 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.59 -48.9 73.22 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.02 -1.05 . . . . 1.0 109.785 173.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -64.35 -54.77 27.68 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.539 1.136 . . . . 1.0 112.102 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 87.3 t90 -56.24 -37.17 69.37 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 125.886 1.674 . . . . 1.0 111.401 173.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -49.99 -34.1 22.67 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.505 1.526 . . . . 1.0 113.482 173.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.6 p -68.78 -13.37 62.35 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 115.097 1.518 . . . . 1.0 115.097 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.61 -20.03 44.13 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.619 1.568 . . . . 1.0 111.778 176.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -84.18 172.5 11.85 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.65 1.18 . . . . 1.0 110.879 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--O 1.252 1.222 0 C-N-CA 124.655 1.182 . . . . 1.0 113.941 -176.052 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 tpt . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 119.916 -0.087 . . . . 1.0 110.831 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.23 168.2 26.13 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.284 1.434 . . . . 1.0 112.822 -174.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -122.89 121.56 36.48 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.562 1.545 . . . . 1.0 110.845 177.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mp -121.77 117.79 53.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 127.418 2.287 . . . . 1.0 112.65 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.32 125.7 8.47 Favored Glycine 0 N--CA 1.465 0.615 0 N-CA-C 110.785 -0.926 . . . . 1.0 110.785 169.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.6 mt -104.61 120.77 55.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-N 118.565 1.183 . . . . 1.0 109.81 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -113.13 111.18 21.67 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 125.109 1.363 . . . . 1.0 107.638 -171.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 p -103.63 126.6 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 112.515 0.561 . . . . 1.0 112.515 -170.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.6 119.2 4.6 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.621 1.105 . . . . 1.0 111.364 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.5 m -152.04 137.05 17.28 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.223 1.009 . . . . 1.0 110.838 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 17.1 ptt? -135.88 31.23 3.03 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.015 1.117 . . . . 1.0 114.015 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -135.94 166.35 23.54 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.381 1.472 . . . . 1.0 111.323 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.05 65.81 0.9 Allowed Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.708 1.623 . . . . 1.0 113.967 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -131.05 153.95 48.75 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.639 1.976 . . . . 1.0 111.306 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 89.2 p -73.64 -12.61 60.79 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.917 1.451 . . . . 1.0 114.917 -177.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.372 1.4 pp 53.33 18.2 1.24 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 128.109 2.563 . . . . 1.0 116.093 -174.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.8 tp -36.1 -42.88 0.31 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 130.112 3.365 . . . . 1.0 115.936 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.7 t -52.0 -33.52 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 118.782 0.719 . . . . 1.0 112.602 -176.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.89 -49.91 76.0 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.001 -1.062 . . . . 1.0 113.048 173.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.73 -28.15 62.48 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.256 0.622 . . . . 1.0 110.771 -178.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -62.13 -49.42 75.94 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.122 -1.066 . . . . 1.0 108.122 169.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.406 ' HA ' HG13 ' A' ' 141' ' ' VAL . . . -65.02 -42.41 94.44 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 112.725 0.639 . . . . 1.0 112.725 -173.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.87 -49.67 70.58 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.196 0.598 . . . . 1.0 110.145 169.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.66 -35.76 77.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.381 0.512 . . . . 1.0 112.381 -175.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.7 mt -71.82 -45.42 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 O-C-N 121.023 -1.048 . . . . 1.0 109.71 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.62 -33.46 75.96 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 119.572 -0.851 . . . . 1.0 110.049 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.2 m -61.86 -45.09 95.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.206 1.402 . . . . 1.0 113.084 169.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.07 -32.26 73.63 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.343 1.057 . . . . 1.0 112.888 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -70.97 -28.37 64.41 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.901 1.281 . . . . 1.0 112.578 172.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.14 27.11 2.11 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.721 1.153 . . . . 1.0 114.622 170.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -121.95 148.9 44.2 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.67 1.188 . . . . 1.0 110.415 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -77.43 101.33 6.35 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 125.4 1.48 . . . . 1.0 108.092 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.48 148.06 42.98 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 122.745 0.418 . . . . 1.0 110.937 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.5 m -149.54 146.61 27.45 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.305 1.042 . . . . 1.0 111.749 -172.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.1 t -97.9 137.18 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 114.485 1.291 . . . . 1.0 114.485 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -119.93 109.24 15.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.659 1.984 . . . . 1.0 110.878 169.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -89.82 139.94 30.09 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.462 1.905 . . . . 1.0 111.235 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t0 40.93 55.73 7.92 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 124.869 1.267 . . . . 1.0 111.613 -169.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -71.03 144.01 46.22 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.949 3.099 . . . . 1.0 117.606 -168.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -86.51 155.87 20.33 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.637 1.575 . . . . 1.0 112.616 168.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -68.5 -23.46 64.55 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 120.595 -1.316 . . . . 1.0 109.887 168.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.6 m -66.25 -21.35 66.28 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.5 -0.75 . . . . 1.0 112.488 170.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -85.31 -24.52 27.64 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.488 1.115 . . . . 1.0 112.928 169.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.9 t-105 -82.13 -35.51 28.43 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.86 1.209 . . . . 1.0 113.743 175.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.5 mt -50.57 -39.8 54.88 Favored Pre-proline 0 CA--C 1.552 1.039 0 CA-C-O 117.678 -1.153 . . . . 1.0 113.781 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -55.07 -14.47 8.55 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 124.059 3.173 . . . . 1.0 117.023 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -110.46 9.98 23.28 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 115.391 1.626 . . . . 1.0 115.391 -175.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -53.26 -34.91 59.16 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.281 1.832 . . . . 1.0 113.463 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.33 -0.6 38.07 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.462 1.505 . . . . 1.0 113.379 177.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -111.03 -164.7 0.93 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.695 2.398 . . . . 1.0 111.108 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -109.4 165.66 11.47 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 122.871 1.32 . . . . 1.0 111.359 169.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.62 160.85 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.91 1.284 . . . . 1.0 109.677 -171.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.1 tp -142.37 124.76 15.63 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.949 0.9 . . . . 1.0 108.975 177.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.9 t -99.26 123.43 51.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 123.86 0.864 . . . . 1.0 109.244 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.2 t -121.64 115.81 47.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.984 -1.858 . . . . 1.0 105.984 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.7 t -145.99 117.46 8.0 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.283 0.845 . . . . 1.0 113.283 -168.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.1 p -107.66 146.44 32.03 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.262 1.825 . . . . 1.0 111.474 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.7 m 65.03 66.08 0.57 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 123.021 1.391 . . . . 1.0 111.254 174.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.6 m -50.33 -28.39 7.83 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.795 2.438 . . . . 1.0 114.746 174.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.46 -149.91 50.27 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 124.221 0.915 . . . . 1.0 112.109 -173.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -82.23 49.82 1.48 Allowed 'General case' 0 CA--C 1.554 1.098 0 O-C-N 120.789 -1.418 . . . . 1.0 111.247 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.15 27.47 73.7 Favored Glycine 0 CA--C 1.541 1.681 0 C-N-CA 124.507 1.051 . . . . 1.0 112.967 -170.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -93.8 -23.2 18.25 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.906 1.447 . . . . 1.0 114.906 -169.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 39.8 mt 64.14 149.14 0.11 Allowed Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 128.008 2.523 . . . . 1.0 115.484 -169.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.06 137.64 81.82 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.134 2.556 . . . . 1.0 112.861 169.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -60.52 -22.98 64.19 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.334 0.864 . . . . 1.0 113.334 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.9 p -74.32 -17.04 60.9 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.98 1.312 . . . . 1.0 114.494 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.2 tt -121.48 -12.95 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.685 1.194 . . . . 1.0 114.057 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.8 t -48.16 -51.7 47.23 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 125.047 1.339 . . . . 1.0 111.918 168.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.47 -31.59 21.5 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.32 1.347 . . . . 1.0 111.259 -173.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.2 tp -63.11 -51.52 66.23 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.747 1.219 . . . . 1.0 111.205 169.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -52.86 -55.12 25.51 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.706 1.203 . . . . 1.0 112.544 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -67.65 -35.55 79.08 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.753 -0.658 . . . . 1.0 111.8 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.62 -36.72 92.78 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.586 0.613 . . . . 1.0 112.566 176.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 92.3 mt -64.37 -50.94 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 120.114 1.957 . . . . 1.0 108.111 171.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.7 ptmm? -67.91 -31.76 71.75 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.561 -1.337 . . . . 1.0 113.281 -170.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -103.74 -37.37 7.5 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.63 1.572 . . . . 1.0 115.157 -175.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.8 m -97.06 -19.17 18.9 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.566 1.146 . . . . 1.0 113.235 -174.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.07 -72.27 0.62 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 107.086 -1.45 . . . . 1.0 107.086 169.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.65 -20.8 1.3 Allowed Glycine 0 CA--C 1.539 1.567 0 C-N-CA 127.715 2.579 . . . . 1.0 114.873 170.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -152.73 141.84 21.35 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 128.528 2.731 . . . . 1.0 107.985 169.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -137.6 119.57 10.98 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.016 0.926 . . . . 1.0 109.485 -170.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.03 -36.49 1.95 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.223 1.949 . . . . 1.0 115.737 -169.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -144.4 18.46 1.71 Allowed 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.993 1.109 . . . . 1.0 113.993 -169.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.6 tp -82.22 139.93 33.98 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 120.681 -1.262 . . . . 1.0 113.441 -169.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.7 mtm-85 -136.6 152.82 50.87 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.976 2.51 . . . . 1.0 109.56 169.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.407 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -161.22 168.14 24.71 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.467 1.03 . . . . 1.0 112.854 -175.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -124.8 171.36 16.86 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.176 1.37 . . . . 1.0 113.908 173.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 88.3 t -143.57 133.5 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.639 1.175 . . . . 1.0 113.585 -169.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.2 mt -130.63 103.53 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.144 1.778 . . . . 1.0 108.293 170.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.83 142.28 27.5 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.224 1.409 . . . . 1.0 111.656 173.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.9 mp -138.71 150.17 45.88 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.414 -0.804 . . . . 1.0 113.079 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.78 -163.83 36.57 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 116.676 -0.238 . . . . 1.0 113.042 169.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -97.12 118.08 32.75 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.049 1.34 . . . . 1.0 111.793 173.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.1 p -65.66 -5.52 8.69 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.493 1.294 . . . . 1.0 114.493 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 89.2 p -62.14 -21.24 64.87 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.655 1.182 . . . . 1.0 112.768 169.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -85.59 141.03 30.12 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.352 1.461 . . . . 1.0 111.928 170.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -44.98 -54.97 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 127.199 2.2 . . . . 1.0 115.123 -173.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.83 26.47 4.05 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 127.132 2.173 . . . . 1.0 113.955 -174.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.7 t80 15.32 -81.46 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 129.544 3.138 . . . . 1.0 117.407 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.44 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 22.3 p -116.63 15.79 15.48 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.234 1.814 . . . . 1.0 114.889 -168.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -54.46 -22.87 13.92 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 124.801 1.24 . . . . 1.0 114.271 -173.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.19 -49.05 70.21 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 121.121 1.782 . . . . 1.0 113.829 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -72.14 -35.1 60.98 Favored Glycine 0 N--CA 1.477 1.38 0 O-C-N 120.72 -1.459 . . . . 1.0 112.842 175.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.44 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 82.2 mttt -64.66 -35.87 82.42 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.693 1.197 . . . . 1.0 112.805 176.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -61.48 -43.44 98.87 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.628 1.171 . . . . 1.0 111.23 170.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -62.09 -39.08 91.25 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.41 0.55 . . . . 1.0 111.087 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -44.85 94.98 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.264 0.626 . . . . 1.0 111.781 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.03 74.16 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.037 0.754 . . . . 1.0 113.037 171.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.91 -49.53 77.45 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 123.44 1.591 . . . . 1.0 110.859 -175.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.407 HD12 ' CD1' ' A' ' 87' ' ' TYR . 4.0 mt -67.07 -40.57 87.05 Favored 'General case' 0 C--N 1.32 -0.692 0 O-C-N 120.885 -1.134 . . . . 1.0 110.936 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -69.29 -18.76 63.87 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.313 0.857 . . . . 1.0 113.313 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.81 -18.0 58.67 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.69 1.132 . . . . 1.0 110.765 175.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -100.03 -73.45 0.63 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.086 1.354 . . . . 1.0 109.606 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 62.2 p 179.76 -18.92 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.414 1.886 . . . . 1.0 114.075 -174.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.71 150.9 44.07 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 114.794 1.405 . . . . 1.0 114.794 -169.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -88.96 166.51 13.88 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 113.017 -1.901 . . . . 1.0 113.342 -168.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.21 136.72 52.43 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.269 1.828 . . . . 1.0 110.645 -175.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.3 t -113.59 128.9 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.889 1.276 . . . . 1.0 109.345 -173.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 50.98 -158.12 2.23 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 124.884 1.23 . . . . 1.0 114.324 -171.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -115.39 144.69 43.41 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.751 1.62 . . . . 1.0 109.445 169.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -71.19 158.16 36.9 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.918 1.081 . . . . 1.0 113.918 -169.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.443 ' HB2' ' CD1' ' A' ' 140' ' ' TRP . 1.4 tm? -89.49 138.39 31.49 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.049 1.34 . . . . 1.0 110.139 169.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 mt -127.78 107.81 10.2 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.708 1.603 . . . . 1.0 109.32 173.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 25.3 mt -96.51 128.15 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 121.086 -1.009 . . . . 1.0 111.541 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -104.98 109.2 21.1 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 124.628 1.205 . . . . 1.0 111.705 174.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.25 -22.06 64.79 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.269 1.028 . . . . 1.0 113.24 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.7 t -65.13 -20.23 66.36 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.867 1.267 . . . . 1.0 112.602 173.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -120.09 -29.9 4.79 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.071 1.748 . . . . 1.0 112.298 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -143.43 88.14 8.12 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.975 1.31 . . . . 1.0 112.266 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.25 4.98 4.39 Favored 'Trans proline' 0 CA--C 1.546 1.125 0 C-N-CA 123.521 2.814 . . . . 1.0 114.761 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -111.55 73.82 1.13 Allowed Pre-proline 0 N--CA 1.469 0.503 0 C-N-CA 126.794 2.038 . . . . 1.0 110.233 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -60.42 -25.88 81.46 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.999 2.466 . . . . 1.0 116.135 -169.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -65.63 -24.42 67.04 Favored 'General case' 0 C--O 1.222 -0.384 0 O-C-N 120.983 -1.073 . . . . 1.0 111.521 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 30.1 p -72.75 -18.38 61.51 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.183 -0.948 . . . . 1.0 112.498 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -100.84 -55.05 2.67 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.256 1.822 . . . . 1.0 111.297 177.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 63.4 p -67.38 -31.64 72.01 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 117.771 -1.109 . . . . 1.0 113.906 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -59.11 -59.89 12.34 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-N 121.192 1.814 . . . . 1.0 112.854 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -61.92 -26.4 78.92 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 CA-C-N 121.203 1.465 . . . . 1.0 112.813 174.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.443 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 91.1 t90 -65.6 -48.88 70.78 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.353 0.979 . . . . 1.0 110.66 174.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.406 HG13 ' HA ' ' A' ' 22' ' ' ALA . 80.0 t -66.05 -32.92 60.27 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 C-N-CA 123.08 0.552 . . . . 1.0 110.143 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.72 -51.18 68.16 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 121.076 -1.015 . . . . 1.0 109.958 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 60.0 m170 -65.19 -51.63 59.86 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.178 0.991 . . . . 1.0 111.431 -177.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 86.9 t90 -57.42 -37.3 72.53 Favored 'General case' 0 C--O 1.219 -0.514 0 C-N-CA 125.293 1.437 . . . . 1.0 111.542 171.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -49.42 -34.69 19.71 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.751 1.644 . . . . 1.0 113.507 172.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 p -68.62 -13.69 62.52 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 114.896 1.443 . . . . 1.0 114.896 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.48 -19.54 45.71 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.609 1.563 . . . . 1.0 111.87 175.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -84.04 169.23 15.15 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.219 1.007 . . . . 1.0 111.193 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 C--O 1.252 1.19 0 N-CA-C 115.652 1.723 . . . . 1.0 115.652 -169.645 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.2 ttm . . . . . 0 N--CA 1.498 1.957 0 CA-C-O 119.611 -0.233 . . . . 1.0 110.413 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.12 151.94 42.77 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.71 1.004 . . . . 1.0 113.71 -176.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -126.1 125.05 41.92 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.661 1.584 . . . . 1.0 110.305 174.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 mp -121.68 113.94 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 126.152 1.781 . . . . 1.0 113.262 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.32 122.21 6.64 Favored Glycine 0 C--O 1.223 -0.544 0 O-C-N 121.33 -0.856 . . . . 1.0 111.245 169.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.3 mt -104.4 122.18 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-N 118.407 1.103 . . . . 1.0 109.872 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -114.72 112.7 23.24 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.089 1.355 . . . . 1.0 107.455 -171.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.2 p -99.93 124.43 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 122.586 0.355 . . . . 1.0 111.473 -172.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -112.93 112.21 2.91 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.42 1.009 . . . . 1.0 112.395 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.5 t -162.42 151.46 15.29 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.412 1.085 . . . . 1.0 111.836 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -89.81 -5.22 57.12 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.431 1.092 . . . . 1.0 112.924 169.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -115.05 43.93 1.9 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.256 1.822 . . . . 1.0 111.824 -178.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.39 -22.8 46.13 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.621 1.105 . . . . 1.0 115.026 -174.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -54.61 -23.05 15.31 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 115.037 1.495 . . . . 1.0 115.037 169.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.5 m -132.03 25.79 4.59 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.569 1.148 . . . . 1.0 113.496 -175.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 pp -69.0 152.32 45.4 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 121.228 -0.92 . . . . 1.0 112.377 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.9 tp -154.0 -52.56 0.1 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.626 1.343 . . . . 1.0 114.626 -172.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.9 t -56.8 -31.14 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.22 -0.925 . . . . 1.0 112.269 -171.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.58 -48.2 80.03 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.193 -0.942 . . . . 1.0 113.203 171.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.67 -28.41 62.7 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.031 0.532 . . . . 1.0 110.72 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -63.15 -49.7 73.3 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.924 -0.769 . . . . 1.0 108.924 169.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.421 ' HA ' HG12 ' A' ' 141' ' ' VAL . . . -65.16 -43.36 92.02 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 112.521 0.563 . . . . 1.0 112.521 -173.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -53.34 -49.99 65.95 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.07 0.948 . . . . 1.0 110.291 169.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.71 -37.09 73.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.2 0.6 . . . . 1.0 112.345 -174.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.9 mt -67.43 -46.74 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 118.994 0.816 . . . . 1.0 109.084 176.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.51 -34.13 76.49 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 119.667 -0.813 . . . . 1.0 110.457 -176.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.5 m -62.83 -40.26 96.87 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.731 1.612 . . . . 1.0 113.325 170.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.56 -33.26 73.77 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.978 0.911 . . . . 1.0 112.029 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -69.3 -31.48 69.99 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.529 1.132 . . . . 1.0 112.45 170.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 126.68 18.61 2.16 Favored Glycine 0 N--CA 1.472 1.058 0 C-N-CA 124.409 1.004 . . . . 1.0 115.066 169.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -111.22 152.32 27.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.637 1.175 . . . . 1.0 111.007 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.9 73.65 9.9 Favored 'General case' 0 CA--C 1.51 -0.561 0 C-N-CA 124.629 1.172 . . . . 1.0 110.391 -172.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.99 142.39 27.83 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.29 -1.777 . . . . 1.0 112.061 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.6 m -147.94 138.97 23.33 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.549 1.14 . . . . 1.0 112.36 -177.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.5 t -84.64 135.29 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 114.781 1.401 . . . . 1.0 114.781 171.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -116.34 114.54 24.46 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.732 2.013 . . . . 1.0 110.536 169.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -95.32 139.01 32.24 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.465 1.906 . . . . 1.0 111.138 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.2 t0 41.18 54.92 7.93 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 124.865 1.266 . . . . 1.0 111.982 -169.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -71.92 143.06 40.13 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.902 3.068 . . . . 1.0 116.553 -168.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.446 ' HB3' ' H ' ' A' ' 42' ' ' SER . 50.7 mm-40 -94.27 164.93 12.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 122.431 1.11 . . . . 1.0 111.85 168.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -65.8 -22.16 66.54 Favored 'General case' 0 N--CA 1.44 -0.93 0 O-C-N 120.859 -1.151 . . . . 1.0 110.064 167.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.446 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 16.3 m -68.18 -20.08 64.84 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.07 -1.019 . . . . 1.0 112.376 172.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -83.73 -23.99 31.38 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.605 1.162 . . . . 1.0 112.47 169.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.9 t-105 -88.41 -33.96 17.7 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.064 1.135 . . . . 1.0 114.064 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.3 mt -49.89 -38.54 35.8 Favored Pre-proline 0 CA--C 1.555 1.163 0 CA-C-O 117.558 -1.21 . . . . 1.0 113.944 178.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -58.76 -8.81 6.3 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 124.031 3.154 . . . . 1.0 116.797 173.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -114.89 8.04 15.84 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 116.091 1.885 . . . . 1.0 116.091 -177.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -51.05 -32.35 21.59 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.935 1.694 . . . . 1.0 113.436 171.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -102.11 6.23 40.79 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.721 2.408 . . . . 1.0 113.588 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -128.79 -159.47 0.96 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 127.056 2.142 . . . . 1.0 112.222 -169.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -112.57 160.8 17.48 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 122.862 1.315 . . . . 1.0 111.404 170.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.92 159.4 9.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 125.076 1.35 . . . . 1.0 108.908 -171.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.7 tp -141.76 125.86 17.35 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 124.197 0.999 . . . . 1.0 109.211 177.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.5 t -102.37 120.41 52.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 C-N-CA 123.767 0.827 . . . . 1.0 109.182 176.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.4 t -119.77 113.53 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 105.944 -1.873 . . . . 1.0 105.944 177.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.1 t -148.07 126.43 12.31 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.561 0.949 . . . . 1.0 113.561 -168.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.5 p -117.26 158.26 24.64 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.304 1.441 . . . . 1.0 112.876 -169.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.1 m 62.73 53.18 2.59 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 122.996 1.379 . . . . 1.0 111.904 169.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 m -51.68 134.63 29.99 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.397 1.479 . . . . 1.0 110.426 169.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -84.09 -139.9 4.3 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.934 0.778 . . . . 1.0 112.611 175.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -76.2 54.72 0.9 Allowed 'General case' 0 CA--C 1.551 0.997 0 O-C-N 121.082 -1.246 . . . . 1.0 111.065 171.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.11 7.74 88.27 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 125.746 1.641 . . . . 1.0 114.584 -169.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -104.69 173.57 6.25 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.627 1.571 . . . . 1.0 112.481 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.6 mt -114.29 158.24 40.29 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 127.046 2.138 . . . . 1.0 114.814 -169.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.22 144.31 95.38 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.62 2.88 . . . . 1.0 112.489 169.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -62.96 -22.31 66.72 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.915 1.08 . . . . 1.0 113.915 -175.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.6 p -72.01 -24.63 61.59 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.065 1.135 . . . . 1.0 114.065 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.0 tt -111.72 -13.72 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.125 1.37 . . . . 1.0 113.682 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -44.61 -52.74 16.89 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 124.768 1.227 . . . . 1.0 112.622 168.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.73 -32.7 29.55 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 121.851 1.701 . . . . 1.0 111.954 -173.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 tp -62.92 -52.85 61.48 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.523 1.129 . . . . 1.0 111.375 169.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -55.13 -53.08 60.42 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.629 0.771 . . . . 1.0 112.651 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 -64.61 -40.58 95.75 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.717 0.807 . . . . 1.0 111.465 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.94 -35.78 91.2 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.41 -0.661 . . . . 1.0 112.333 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.4 mt -64.81 -50.09 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 120.229 2.015 . . . . 1.0 108.246 172.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -69.46 -31.83 70.38 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.326 -1.484 . . . . 1.0 113.188 -170.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -101.76 -37.61 8.23 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 115.133 1.531 . . . . 1.0 115.133 -175.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 m -97.79 -19.51 18.13 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.333 1.053 . . . . 1.0 113.446 -174.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.86 -72.53 0.6 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 107.391 -1.337 . . . . 1.0 107.391 169.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.81 -20.67 1.38 Allowed Glycine 0 CA--C 1.539 1.564 0 C-N-CA 127.541 2.496 . . . . 1.0 114.902 170.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -153.21 142.08 21.14 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 128.408 2.683 . . . . 1.0 108.07 169.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -137.35 119.96 11.38 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.929 0.891 . . . . 1.0 109.701 -169.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -77.55 -35.3 1.61 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.451 2.101 . . . . 1.0 115.965 -169.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -143.64 19.28 1.84 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.056 1.132 . . . . 1.0 114.056 -169.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.1 tp -85.84 140.06 30.75 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.686 -1.259 . . . . 1.0 114.176 -169.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.4 mtm-85 -137.33 153.57 50.22 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.989 2.516 . . . . 1.0 109.619 169.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.411 ' CD1' HD11 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -161.56 168.17 24.04 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.073 0.851 . . . . 1.0 112.543 -176.485 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -125.19 170.54 17.13 Favored Glycine 0 N--CA 1.472 1.093 0 C-N-CA 125.201 1.382 . . . . 1.0 114.134 174.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.3 t -142.44 132.7 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.658 1.183 . . . . 1.0 113.695 -169.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.1 mt -129.54 102.84 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.802 1.641 . . . . 1.0 108.035 170.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -91.86 142.3 27.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.526 1.531 . . . . 1.0 111.726 173.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.5 mp -138.13 152.7 48.97 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.235 -0.915 . . . . 1.0 112.793 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.42 -154.46 25.19 Favored Glycine 0 C--O 1.221 -0.697 0 C-N-CA 121.528 -0.368 . . . . 1.0 112.583 169.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -111.79 117.87 34.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.205 1.002 . . . . 1.0 109.786 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.1 t -63.8 -7.06 6.81 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.826 1.047 . . . . 1.0 113.826 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.7 t -65.04 -24.17 67.4 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.876 -1.14 . . . . 1.0 112.162 169.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -78.42 138.34 38.45 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.386 -0.821 . . . . 1.0 111.299 169.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -49.09 -49.65 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.726 1.61 . . . . 1.0 113.729 177.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -88.66 22.18 2.71 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.938 1.695 . . . . 1.0 114.542 -175.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.9 t80 1.76 -70.54 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 129.874 3.27 . . . . 1.0 117.73 -177.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.439 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 26.7 p -125.4 11.77 8.07 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.989 1.315 . . . . 1.0 114.519 -169.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -58.18 -21.63 48.17 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 117.573 -1.203 . . . . 1.0 114.08 -173.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.95 -43.0 87.77 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-N 121.371 1.896 . . . . 1.0 114.007 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -77.59 -36.88 32.25 Favored Glycine 0 N--CA 1.478 1.471 0 O-C-N 120.909 -1.348 . . . . 1.0 113.036 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.439 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 85.2 mttt -63.58 -33.49 75.71 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.34 1.056 . . . . 1.0 112.978 176.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -59.93 -44.15 94.5 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.263 1.425 . . . . 1.0 111.012 169.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -63.65 -39.12 93.55 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.662 -0.649 . . . . 1.0 110.948 175.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -42.99 99.63 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.774 -0.579 . . . . 1.0 111.709 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.83 -35.64 77.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 112.978 0.733 . . . . 1.0 112.978 171.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.91 -49.66 76.97 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 123.463 1.601 . . . . 1.0 110.902 -175.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.411 HD11 ' CD1' ' A' ' 87' ' ' TYR . 4.0 mt -67.52 -40.3 85.1 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 120.92 -1.112 . . . . 1.0 110.996 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -70.09 -17.87 63.24 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.364 0.876 . . . . 1.0 113.364 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.77 -17.08 59.26 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.488 1.04 . . . . 1.0 110.957 174.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -101.63 -73.28 0.66 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.147 1.379 . . . . 1.0 109.904 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 65.8 p 179.52 -19.32 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.106 1.763 . . . . 1.0 113.984 -174.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.1 151.59 42.95 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 123.06 1.41 . . . . 1.0 114.464 -169.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -87.75 165.37 15.4 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 113.071 -1.877 . . . . 1.0 113.298 -169.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.69 133.32 47.0 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.222 1.809 . . . . 1.0 110.21 -174.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 32.6 t -112.46 130.99 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.61 1.164 . . . . 1.0 109.857 -171.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 52.46 -157.72 3.77 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 125.314 1.435 . . . . 1.0 114.765 -173.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -111.9 139.82 47.07 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.839 1.656 . . . . 1.0 110.097 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -70.61 155.29 40.92 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 122.332 1.063 . . . . 1.0 112.222 -171.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.437 ' HB2' ' CD1' ' A' ' 140' ' ' TRP . 1.2 tm? -87.96 139.07 30.89 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.722 -1.127 . . . . 1.0 109.957 171.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 mt -127.65 106.57 9.24 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.404 1.482 . . . . 1.0 109.69 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 23.8 mt -95.84 127.79 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 O-C-N 121.169 -0.957 . . . . 1.0 112.042 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -104.68 109.59 21.57 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 122.4 1.095 . . . . 1.0 111.982 173.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.74 -22.71 66.04 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.558 1.143 . . . . 1.0 113.433 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.1 t -64.38 -22.48 66.97 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.035 0.934 . . . . 1.0 112.718 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -118.1 -29.91 5.46 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.0 1.72 . . . . 1.0 111.961 -175.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -142.54 87.72 9.11 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 125.086 1.354 . . . . 1.0 112.06 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.62 8.11 2.42 Favored 'Trans proline' 0 CA--C 1.552 1.404 0 C-N-CA 123.655 2.904 . . . . 1.0 114.271 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -114.73 69.97 2.24 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 127.2 2.2 . . . . 1.0 109.859 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -56.9 -23.13 49.45 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.723 2.282 . . . . 1.0 116.197 -169.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 pm0 -67.03 -24.13 65.97 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 121.028 -1.045 . . . . 1.0 112.251 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.9 p -74.77 -17.92 60.56 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.329 0.968 . . . . 1.0 112.301 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -100.33 -54.05 2.96 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.456 1.903 . . . . 1.0 111.509 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.5 p -68.19 -33.82 75.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 117.764 -1.112 . . . . 1.0 113.912 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -57.47 -61.69 6.73 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 120.877 1.671 . . . . 1.0 112.009 176.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -60.54 -23.58 75.81 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 CA-C-N 121.882 1.708 . . . . 1.0 113.744 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.437 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 87.9 t90 -68.87 -47.13 66.66 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 119.217 0.917 . . . . 1.0 110.984 173.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.421 HG12 ' HA ' ' A' ' 22' ' ' ALA . 93.2 t -65.27 -33.83 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 176.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.01 -31.0 70.38 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.0 1.32 . . . . 1.0 112.038 177.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -77.56 -62.34 1.69 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.994 1.718 . . . . 1.0 111.877 169.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -55.06 -36.89 66.05 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 126.191 1.796 . . . . 1.0 112.709 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.93 -31.93 25.72 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.98 1.276 . . . . 1.0 113.803 174.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.0 p -70.2 -13.77 62.33 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 114.352 1.241 . . . . 1.0 114.352 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.41 -17.02 53.04 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.85 1.66 . . . . 1.0 111.705 175.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -81.75 172.38 13.44 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.06 0.944 . . . . 1.0 111.6 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 C--O 1.255 1.371 0 C-N-CA 125.637 1.575 . . . . 1.0 112.619 -172.31 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 119.997 -0.049 . . . . 1.0 110.98 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.68 162.48 41.21 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.654 1.182 . . . . 1.0 113.348 -176.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -122.23 121.28 36.44 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.342 1.457 . . . . 1.0 110.346 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 mp -120.15 114.03 42.55 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 C-N-CA 126.057 1.743 . . . . 1.0 112.857 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.48 122.53 6.79 Favored Glycine 0 C--O 1.222 -0.624 0 N-CA-C 110.573 -1.011 . . . . 1.0 110.573 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.4 mt -103.18 120.93 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-N 118.113 0.956 . . . . 1.0 109.271 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -114.2 113.21 24.35 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.245 -1.391 . . . . 1.0 107.245 -171.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.9 p -106.64 126.49 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.66 0.615 . . . . 1.0 112.66 -171.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -117.25 116.45 3.52 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.822 1.201 . . . . 1.0 111.002 176.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.4 m -151.19 133.49 15.36 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 120.751 2.276 . . . . 1.0 110.762 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.75 -16.92 11.18 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.834 1.05 . . . . 1.0 113.834 174.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -143.97 146.6 33.04 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.602 1.161 . . . . 1.0 112.025 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.11 178.23 50.7 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.779 1.181 . . . . 1.0 114.768 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -87.34 13.32 10.03 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.917 1.287 . . . . 1.0 113.772 -174.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.1 m -59.51 -18.12 37.6 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 115.78 1.771 . . . . 1.0 115.78 -170.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.9 mt -49.51 -35.47 20.18 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.388 1.075 . . . . 1.0 112.263 169.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.4 tp -44.39 -50.83 9.05 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.048 1.739 . . . . 1.0 113.641 172.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.6 t -55.04 -33.93 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.639 0.776 . . . . 1.0 111.567 -173.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.27 -45.89 92.6 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.706 -1.246 . . . . 1.0 113.04 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -66.61 -29.98 70.15 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.774 0.83 . . . . 1.0 110.844 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -70.2 -47.14 62.8 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.79 0.836 . . . . 1.0 109.139 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.458 ' HA ' HG12 ' A' ' 141' ' ' VAL . . . -64.0 -41.35 97.52 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 113.297 0.851 . . . . 1.0 113.297 -176.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -56.26 -48.46 76.52 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.307 1.043 . . . . 1.0 110.572 170.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.27 -37.8 71.88 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.754 0.822 . . . . 1.0 112.055 -174.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.1 mt -69.29 -45.55 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 O-C-N 121.322 -0.862 . . . . 1.0 109.602 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.67 -31.52 72.57 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.878 1.217 . . . . 1.0 110.816 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.5 m -62.56 -45.82 91.17 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.843 1.257 . . . . 1.0 112.687 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.22 -31.02 70.23 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.675 1.19 . . . . 1.0 113.254 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -67.65 -29.46 68.77 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.121 1.768 . . . . 1.0 111.606 171.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.02 27.6 2.22 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.802 1.192 . . . . 1.0 114.882 171.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -123.42 159.2 29.5 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.083 1.353 . . . . 1.0 110.389 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -90.61 87.54 6.76 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 120.645 -1.284 . . . . 1.0 108.649 -177.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.83 146.62 27.99 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.113 0.565 . . . . 1.0 111.379 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.9 m -147.31 140.86 25.52 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.472 1.109 . . . . 1.0 112.188 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.0 t -89.76 139.22 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 115.613 1.709 . . . . 1.0 115.613 173.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -121.04 111.88 18.03 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.303 2.241 . . . . 1.0 110.136 169.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -95.13 139.15 31.88 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.011 1.724 . . . . 1.0 111.634 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.4 t70 42.63 52.94 8.18 Favored Pre-proline 0 CA--C 1.56 1.365 0 C-N-CA 124.943 1.297 . . . . 1.0 111.581 -169.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -70.96 147.63 55.6 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.075 3.183 . . . . 1.0 117.013 -168.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.451 ' HB3' ' H ' ' A' ' 42' ' ' SER . 52.4 mm-40 -93.81 163.81 13.37 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.452 1.101 . . . . 1.0 112.035 168.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -65.52 -22.26 66.7 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 120.729 -1.232 . . . . 1.0 110.269 167.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.451 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 16.8 m -68.29 -20.41 64.77 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.921 -1.112 . . . . 1.0 112.116 172.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -82.96 -25.51 32.25 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.499 1.12 . . . . 1.0 112.31 169.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.9 t-105 -86.42 -35.43 19.73 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.909 1.077 . . . . 1.0 113.909 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.1 mt -48.21 -38.43 21.04 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 114.464 1.283 . . . . 1.0 114.464 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -60.59 -11.75 18.4 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 123.691 2.928 . . . . 1.0 116.573 175.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -111.14 8.31 21.66 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 116.243 1.942 . . . . 1.0 116.243 -172.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -54.3 -35.04 62.19 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.073 1.749 . . . . 1.0 113.628 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -99.03 -2.39 37.35 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.025 1.73 . . . . 1.0 113.274 177.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -109.64 -164.98 0.97 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.819 2.447 . . . . 1.0 110.938 -176.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -109.77 163.22 13.71 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.937 1.351 . . . . 1.0 111.773 169.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.25 157.7 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.822 1.249 . . . . 1.0 109.519 -170.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.2 tp -139.33 124.37 18.83 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 124.235 1.014 . . . . 1.0 108.735 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.7 t -99.36 121.53 50.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.383 -0.826 . . . . 1.0 109.238 174.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.7 t -120.06 113.98 42.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 105.319 -2.104 . . . . 1.0 105.319 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -149.21 130.84 14.94 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.161 1.541 . . . . 1.0 115.161 -168.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 m -117.77 178.07 4.54 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 127.102 2.161 . . . . 1.0 111.735 -169.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.86 33.42 15.17 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.923 1.083 . . . . 1.0 113.923 168.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.2 m -53.35 -37.86 62.74 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.195 1.398 . . . . 1.0 112.255 169.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.57 -126.57 35.07 Favored Glycine 0 CA--C 1.533 1.205 0 O-C-N 121.445 -0.784 . . . . 1.0 112.426 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -63.45 -15.21 57.06 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.208 1.188 . . . . 1.0 114.208 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 148.25 -19.01 1.36 Allowed Glycine 0 CA--C 1.535 1.325 0 N-CA-C 116.894 1.517 . . . . 1.0 116.894 169.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -90.55 160.51 15.92 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.022 1.329 . . . . 1.0 113.857 -175.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.1 mt -80.73 144.5 56.22 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 123.708 0.803 . . . . 1.0 112.898 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.12 156.88 30.15 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.249 2.633 . . . . 1.0 113.404 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -60.23 -23.24 63.9 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.127 1.529 . . . . 1.0 115.127 -169.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.9 t -67.43 -31.72 72.11 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.203 0.816 . . . . 1.0 113.203 175.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.7 tt -111.82 -12.85 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.464 1.106 . . . . 1.0 113.894 -177.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.8 t -43.46 -52.38 13.52 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.835 1.254 . . . . 1.0 112.878 168.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.86 -33.11 34.62 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.714 1.609 . . . . 1.0 111.915 -173.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 tp -63.41 -53.83 46.21 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 124.235 1.014 . . . . 1.0 111.223 169.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -54.69 -52.81 61.22 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.796 0.839 . . . . 1.0 112.477 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -64.85 -40.77 95.69 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.424 1.09 . . . . 1.0 111.384 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.44 -34.91 86.1 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.371 0.51 . . . . 1.0 112.656 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.79 -49.31 80.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.866 1.833 . . . . 1.0 108.558 171.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.4 ptmm? -70.91 -32.12 68.96 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.2 -1.562 . . . . 1.0 112.85 -169.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -104.62 -38.49 6.72 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.082 1.512 . . . . 1.0 115.082 -174.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.2 m -95.0 -23.37 17.41 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.26 1.024 . . . . 1.0 113.171 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.32 -70.98 0.66 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 169.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.24 -11.95 1.95 Allowed Glycine 0 CA--C 1.538 1.507 0 C-N-CA 126.776 2.131 . . . . 1.0 116.255 169.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -157.6 141.84 16.16 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 127.81 2.444 . . . . 1.0 108.366 174.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -136.0 123.15 14.53 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.962 0.905 . . . . 1.0 111.148 -172.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.41 -37.82 0.36 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.205 1.937 . . . . 1.0 114.724 -171.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -146.94 19.07 1.27 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.069 1.137 . . . . 1.0 114.069 -169.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.8 tp -79.46 140.56 37.3 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.404 -1.435 . . . . 1.0 113.861 -169.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -133.49 150.2 51.71 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 128.636 2.774 . . . . 1.0 107.571 169.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.416 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -160.88 166.85 27.78 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.319 -0.863 . . . . 1.0 112.932 -178.166 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.436 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -124.65 171.85 16.83 Favored Glycine 0 N--CA 1.475 1.295 0 C-N-CA 125.003 1.287 . . . . 1.0 114.531 173.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.5 t -143.52 133.08 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 114.852 1.427 . . . . 1.0 114.852 -169.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.0 mt -130.79 104.85 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.683 1.593 . . . . 1.0 107.968 169.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -91.74 143.19 26.8 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.891 1.677 . . . . 1.0 111.797 175.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.9 mp -137.44 148.41 46.1 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.448 0.907 . . . . 1.0 113.448 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.55 -172.6 43.08 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 114.805 0.682 . . . . 1.0 114.805 169.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -86.47 120.13 27.47 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.107 -1.231 . . . . 1.0 110.604 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.1 t -68.18 -3.61 11.16 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.985 1.106 . . . . 1.0 113.985 -176.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.6 t -64.32 -26.9 68.69 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.941 -1.099 . . . . 1.0 113.022 171.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -80.93 143.05 32.92 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.208 -0.932 . . . . 1.0 112.829 176.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -50.94 -50.91 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.399 1.48 . . . . 1.0 113.569 175.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -88.92 20.22 3.69 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.993 1.717 . . . . 1.0 114.638 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.3 t80 9.07 -74.23 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 130.42 3.488 . . . . 1.0 117.663 175.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 20.1 p -117.2 9.76 13.6 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.816 2.046 . . . . 1.0 114.193 -169.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -55.95 -23.49 32.45 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.481 1.912 . . . . 1.0 114.607 -172.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.32 -48.44 83.66 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-N 120.357 1.435 . . . . 1.0 113.412 174.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.25 -36.51 50.41 Favored Glycine 0 N--CA 1.478 1.474 0 O-C-N 120.782 -1.422 . . . . 1.0 113.248 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -60.31 -35.8 76.45 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.928 0.891 . . . . 1.0 113.168 172.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -65.24 -33.94 77.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 118.603 -0.713 . . . . 1.0 112.826 172.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -63.95 -37.4 87.28 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.689 1.131 . . . . 1.0 111.032 172.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -63.14 -49.88 72.64 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.027 0.831 . . . . 1.0 110.473 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.64 -33.0 59.96 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.251 0.834 . . . . 1.0 113.251 173.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.27 -50.28 73.66 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 123.238 1.494 . . . . 1.0 110.727 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.416 HD12 ' CD1' ' A' ' 87' ' ' TYR . 8.0 mt -65.1 -39.27 92.9 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 120.966 -1.084 . . . . 1.0 111.19 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -67.31 -22.39 65.63 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.557 0.947 . . . . 1.0 113.557 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.54 -17.53 59.19 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.393 0.997 . . . . 1.0 111.464 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -96.51 -73.61 0.59 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.994 1.318 . . . . 1.0 109.206 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 56.2 p 177.18 -18.32 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.755 2.022 . . . . 1.0 113.534 -175.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.59 157.26 34.86 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.793 1.282 . . . . 1.0 113.933 -169.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -99.4 173.39 6.78 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 113.239 -1.8 . . . . 1.0 112.155 -169.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -128.63 160.49 32.26 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.758 1.223 . . . . 1.0 113.509 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.1 t -119.25 126.71 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 127.232 2.213 . . . . 1.0 108.811 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 52.35 -165.0 1.42 Allowed Glycine 0 CA--C 1.542 1.762 0 C-N-CA 124.748 1.166 . . . . 1.0 115.628 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -107.56 149.41 28.06 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.726 1.611 . . . . 1.0 110.118 169.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.78 159.15 32.35 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.717 1.207 . . . . 1.0 113.188 -169.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.438 ' CD1' HG13 ' A' ' 125' ' ' ILE . 1.2 tm? -91.32 139.57 30.61 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.098 0.959 . . . . 1.0 110.165 169.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.4 mt -122.83 105.76 10.3 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.205 1.402 . . . . 1.0 111.103 174.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.438 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.9 mt -91.95 131.19 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 125.331 1.452 . . . . 1.0 112.341 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -108.25 92.27 3.99 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.86 2.464 . . . . 1.0 112.617 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.4 -23.6 67.0 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.995 1.318 . . . . 1.0 112.794 -173.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.7 p -53.47 -30.39 40.64 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 129.329 3.052 . . . . 1.0 114.334 169.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -124.79 -26.53 3.77 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.849 2.06 . . . . 1.0 111.585 -171.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -143.22 88.59 8.07 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.44 1.496 . . . . 1.0 112.184 -177.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -76.53 11.19 1.95 Allowed 'Trans proline' 0 CA--C 1.549 1.251 0 C-N-CA 123.77 2.98 . . . . 1.0 114.211 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -111.62 68.77 0.77 Allowed Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 127.672 2.389 . . . . 1.0 110.042 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -57.38 -21.39 44.6 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.777 2.318 . . . . 1.0 116.809 -169.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -64.25 -27.25 68.92 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 118.934 0.788 . . . . 1.0 111.902 174.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.6 p -72.27 -18.78 61.78 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 120.939 -1.1 . . . . 1.0 111.813 -174.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -99.22 -53.66 3.18 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.807 1.643 . . . . 1.0 111.933 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 48.1 p -71.28 -33.77 70.06 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 114.599 1.333 . . . . 1.0 114.599 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -59.32 -56.63 34.06 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 120.723 1.601 . . . . 1.0 112.453 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -62.66 -22.64 74.15 Favored 'Trans proline' 0 C--N 1.355 0.871 0 CA-C-N 121.459 1.557 . . . . 1.0 112.735 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.426 ' CD1' HD22 ' A' ' 123' ' ' LEU . 91.4 t90 -69.19 -47.37 65.05 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 123.279 0.632 . . . . 1.0 111.093 174.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 22' ' ' ALA . 97.5 t -65.23 -32.0 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 122.03 0.919 . . . . 1.0 108.899 176.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.93 -22.33 61.48 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 120.045 -1.659 . . . . 1.0 113.401 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -87.07 -62.52 1.48 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.858 2.063 . . . . 1.0 111.265 169.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.436 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 87.6 t90 -54.88 -38.26 67.32 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 126.892 2.077 . . . . 1.0 112.99 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.96 -29.26 27.11 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 121.42 -0.8 . . . . 1.0 114.488 173.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.1 p -69.32 -13.29 62.3 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.809 1.304 . . . . 1.0 114.367 175.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.5 -18.59 51.64 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.34 1.456 . . . . 1.0 111.774 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -84.41 170.1 13.91 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.517 1.127 . . . . 1.0 111.521 -175.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.251 1.182 0 N-CA-C 116.697 2.11 . . . . 1.0 116.697 -169.465 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 118.019 -0.991 . . . . 1.0 112.398 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.62 140.27 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.254 2.221 . . . . 1.0 116.469 -172.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -121.46 124.49 44.6 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 126.643 1.977 . . . . 1.0 110.057 170.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 mp -126.62 113.06 31.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 126.8 2.04 . . . . 1.0 111.898 -174.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.19 124.51 7.81 Favored Glycine 0 C--O 1.224 -0.518 0 N-CA-C 110.01 -1.236 . . . . 1.0 110.01 169.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.8 mt -104.59 123.34 58.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 118.151 0.976 . . . . 1.0 109.545 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -115.95 110.63 19.23 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.598 1.159 . . . . 1.0 108.266 -169.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.82 135.92 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.619 -0.264 . . . . 1.0 111.441 -175.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -123.92 131.49 8.02 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.571 1.081 . . . . 1.0 110.897 169.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.7 t -155.36 147.75 23.9 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 119.415 1.608 . . . . 1.0 114.599 -174.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.8 ttt -123.16 69.39 1.0 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.656 1.582 . . . . 1.0 107.801 169.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 60.82 21.68 11.78 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.383 1.873 . . . . 1.0 114.963 -171.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.78 177.22 46.49 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.552 1.549 . . . . 1.0 113.015 169.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -106.91 31.73 5.1 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.388 1.255 . . . . 1.0 114.388 -172.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.3 p -66.33 -20.83 66.19 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.418 -1.426 . . . . 1.0 112.973 172.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.81 -40.94 94.57 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.347 0.976 . . . . 1.0 112.298 173.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.7 tp -62.17 -50.28 72.48 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 118.08 0.4 . . . . 1.0 110.663 172.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -56.66 -39.23 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 O-C-N 121.79 -0.569 . . . . 1.0 110.891 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.7 -49.65 74.25 Favored 'General case' 0 C--O 1.23 0.062 0 CA-C-N 119.606 1.093 . . . . 1.0 112.615 176.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -67.79 -26.93 66.33 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.105 0.479 . . . . 1.0 112.055 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -70.74 -48.72 53.01 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 123.952 0.901 . . . . 1.0 109.938 169.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.98 -44.38 97.46 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 112.651 0.611 . . . . 1.0 112.651 -176.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -51.52 -51.24 56.9 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.521 1.128 . . . . 1.0 110.221 169.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.86 -35.62 74.87 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.633 0.773 . . . . 1.0 112.764 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.7 mt -70.43 -45.41 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 O-C-N 121.175 -0.953 . . . . 1.0 109.342 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.86 -34.44 78.16 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 120.028 -0.669 . . . . 1.0 110.213 -178.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.4 m -61.75 -44.42 96.93 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.973 1.309 . . . . 1.0 113.155 169.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.17 -32.61 73.83 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.62 1.168 . . . . 1.0 112.944 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -66.49 -32.78 74.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.534 1.134 . . . . 1.0 111.75 170.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.27 12.98 1.56 Allowed Glycine 0 CA--C 1.532 1.135 0 N-CA-C 116.091 1.196 . . . . 1.0 116.091 169.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -105.85 168.32 9.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.865 1.266 . . . . 1.0 112.116 -170.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? -90.64 97.26 11.08 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.914 1.286 . . . . 1.0 107.847 170.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.91 144.87 42.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.64 0.257 . . . . 1.0 110.693 174.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.6 m -147.59 138.74 23.61 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.72 0.808 . . . . 1.0 111.91 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.1 t -86.92 136.64 22.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 114.502 1.297 . . . . 1.0 114.502 171.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -111.59 114.63 27.81 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.135 1.774 . . . . 1.0 110.464 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -94.04 139.23 31.21 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.332 1.853 . . . . 1.0 110.61 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.6 t0 43.12 54.82 10.7 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 124.274 1.029 . . . . 1.0 110.664 -169.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -64.15 140.22 70.44 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.855 3.036 . . . . 1.0 117.259 -167.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -89.36 154.25 20.22 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.742 1.617 . . . . 1.0 112.043 168.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -69.47 -21.62 63.69 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 120.674 -1.266 . . . . 1.0 109.648 168.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 26.0 m -66.79 -21.86 66.04 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.286 -0.884 . . . . 1.0 112.448 169.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -82.47 -28.58 31.14 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.789 0.836 . . . . 1.0 112.599 169.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.0 t-105 -80.17 -38.75 30.7 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.571 1.078 . . . . 1.0 113.515 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.3 mt -44.1 -47.31 23.12 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 114.411 1.263 . . . . 1.0 114.411 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.1 4.98 1.61 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.79 2.327 . . . . 1.0 115.811 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -113.06 5.63 17.24 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 116.053 1.871 . . . . 1.0 116.053 174.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -49.51 -30.74 8.83 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 126.836 2.054 . . . . 1.0 113.275 170.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -104.65 7.83 35.04 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.228 2.611 . . . . 1.0 113.288 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -133.5 -155.4 0.67 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.518 2.327 . . . . 1.0 112.096 -169.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -114.3 160.34 19.18 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-O 123.504 1.621 . . . . 1.0 111.801 169.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.48 150.75 14.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 125.289 1.436 . . . . 1.0 107.454 -174.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.0 tp -129.63 127.31 40.33 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 124.753 1.221 . . . . 1.0 108.666 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.7 t -99.82 127.65 52.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 t -127.01 104.12 12.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.518 -1.66 . . . . 1.0 106.518 175.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t -136.82 128.61 29.03 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.502 0.927 . . . . 1.0 113.502 -167.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 t -111.77 -179.49 3.71 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 115.737 1.754 . . . . 1.0 115.737 -168.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.8 m 75.36 -58.72 0.56 Allowed 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 129.523 3.129 . . . . 1.0 112.449 169.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.1 m 58.65 -35.84 0.05 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.301 2.241 . . . . 1.0 116.944 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.88 -134.88 47.24 Favored Glycine 0 CA--C 1.532 1.144 0 O-C-N 119.988 -1.695 . . . . 1.0 111.45 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -70.24 -1.84 11.51 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.201 1.186 . . . . 1.0 114.201 174.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.76 -11.65 2.65 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 116.409 1.324 . . . . 1.0 116.409 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -83.27 179.49 7.69 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 118.788 1.294 . . . . 1.0 113.359 -174.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 18.2 mt -96.07 148.36 34.4 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.872 1.669 . . . . 1.0 113.435 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -61.4 145.28 98.32 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.917 2.412 . . . . 1.0 113.457 170.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -62.01 -22.57 65.8 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.089 0.956 . . . . 1.0 113.552 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.8 p -68.66 -27.12 65.7 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.838 1.255 . . . . 1.0 113.88 174.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.9 tt -113.54 -15.3 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.211 1.404 . . . . 1.0 114.015 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.8 t -42.66 -51.26 12.12 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 124.788 1.235 . . . . 1.0 112.612 168.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.0 -31.7 18.96 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.385 1.39 . . . . 1.0 111.776 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.7 tp -64.15 -51.03 65.8 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 124.219 1.008 . . . . 1.0 110.961 169.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -54.91 -53.63 53.06 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.502 1.121 . . . . 1.0 112.478 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -67.21 -34.6 77.83 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.964 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.55 -37.1 93.97 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.701 0.667 . . . . 1.0 112.523 174.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 78.6 mt -65.44 -49.43 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.96 1.88 . . . . 1.0 108.264 171.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -69.35 -31.16 69.4 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.241 -1.537 . . . . 1.0 113.358 -171.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -105.66 -38.02 6.55 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.406 1.632 . . . . 1.0 115.406 -174.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.6 m -93.85 -23.02 18.29 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.153 0.981 . . . . 1.0 112.873 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.11 -71.13 0.66 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 106.277 -1.749 . . . . 1.0 106.277 169.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.5 -10.21 1.51 Allowed Glycine 0 CA--C 1.539 1.571 0 C-N-CA 127.386 2.422 . . . . 1.0 115.554 169.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -153.19 146.62 24.91 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 129.269 3.028 . . . . 1.0 107.214 170.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 39.7 mm-40 -136.01 125.57 16.07 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.339 0.656 . . . . 1.0 110.548 -174.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -82.8 -39.94 0.13 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.352 2.035 . . . . 1.0 114.241 -173.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -146.87 18.01 1.26 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.596 1.158 . . . . 1.0 113.785 -169.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 42.1 tp -76.88 140.48 40.6 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.598 -1.314 . . . . 1.0 113.412 -169.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -133.45 147.85 51.71 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 129.421 3.088 . . . . 1.0 107.714 170.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.409 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -157.27 166.04 34.24 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.835 1.198 . . . . 1.0 112.384 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -130.05 173.63 19.81 Favored Glycine 0 N--CA 1.467 0.74 0 C-N-CA 125.43 1.491 . . . . 1.0 112.142 170.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -160.07 143.14 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 114.829 1.418 . . . . 1.0 114.829 -169.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.39 113.74 37.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 126.721 2.008 . . . . 1.0 108.397 169.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.59 150.13 20.92 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 125.342 1.457 . . . . 1.0 110.462 169.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.97 152.05 44.65 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 121.801 -0.562 . . . . 1.0 111.419 173.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.57 174.12 39.61 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 115.515 0.966 . . . . 1.0 115.515 169.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -83.3 110.51 18.17 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.42 -1.047 . . . . 1.0 110.218 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.6 p -69.39 0.89 4.45 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.746 1.387 . . . . 1.0 114.746 -177.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.3 t -65.76 -29.25 69.73 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.326 0.966 . . . . 1.0 112.256 170.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -78.97 160.78 27.06 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.932 0.893 . . . . 1.0 112.655 171.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.45 168.04 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 116.155 -0.475 . . . . 1.0 109.973 168.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 60.42 46.58 9.68 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.113 0.965 . . . . 1.0 112.638 173.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -49.76 126.74 14.52 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.309 1.044 . . . . 1.0 112.574 -176.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 19.9 m 57.73 14.62 2.53 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.718 1.747 . . . . 1.0 115.718 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -59.0 -23.74 62.17 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.921 1.288 . . . . 1.0 114.196 -175.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.21 -46.2 94.17 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-N 120.335 1.425 . . . . 1.0 113.004 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.95 -36.29 47.39 Favored Glycine 0 N--CA 1.478 1.469 0 O-C-N 121.014 -1.286 . . . . 1.0 113.121 176.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -59.54 -34.97 73.32 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 117.922 0.861 . . . . 1.0 112.806 172.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 -67.04 -33.09 74.77 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.997 0.74 . . . . 1.0 112.997 173.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -62.16 -35.96 80.39 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.796 1.18 . . . . 1.0 111.314 171.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.22 -44.62 83.32 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.233 0.469 . . . . 1.0 111.342 175.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.72 -44.12 81.3 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 118.807 -0.616 . . . . 1.0 112.086 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.18 -48.97 61.79 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.746 2.018 . . . . 1.0 111.49 -177.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.409 HD12 ' CD1' ' A' ' 87' ' ' TYR . 8.0 mt -66.03 -40.07 90.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.331 -0.849 . . . . 1.0 111.928 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -67.4 -24.91 65.71 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.95 1.092 . . . . 1.0 113.95 175.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -64.62 -35.13 80.02 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.409 1.084 . . . . 1.0 111.491 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -83.96 -73.28 0.43 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 113.709 -1.587 . . . . 1.0 110.461 -175.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.5 m 174.14 -0.89 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.118 2.567 . . . . 1.0 111.821 173.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.19 159.58 32.34 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 122.414 1.102 . . . . 1.0 113.541 -169.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -100.69 171.46 7.68 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 113.898 -1.501 . . . . 1.0 111.362 -169.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 2.2 ttm105 -126.43 154.02 44.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.547 1.139 . . . . 1.0 112.779 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.4 t -92.86 -173.1 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 C-N-CA 127.009 2.124 . . . . 1.0 106.009 169.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -51.17 154.76 3.79 Favored Glycine 0 CA--C 1.543 1.838 0 O-C-N 120.345 -1.472 . . . . 1.0 115.929 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -48.9 143.33 5.54 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.327 1.851 . . . . 1.0 114.771 -172.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -75.62 156.57 34.77 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.669 1.187 . . . . 1.0 111.879 -169.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.413 HD23 ' CD1' ' A' ' 140' ' ' TRP . 0.9 OUTLIER -90.98 137.81 32.08 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.537 -0.756 . . . . 1.0 109.719 174.325 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.5 mt -122.41 109.13 14.0 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.641 1.176 . . . . 1.0 110.459 174.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.404 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.2 mt -91.45 130.44 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.062 1.345 . . . . 1.0 112.611 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.74 98.52 10.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.206 1.002 . . . . 1.0 110.039 175.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -70.4 -23.93 62.84 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.108 -1.62 . . . . 1.0 112.232 -175.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.65 -30.65 44.13 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 130.191 3.396 . . . . 1.0 114.12 169.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -124.67 -26.86 3.75 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.539 1.935 . . . . 1.0 111.957 -169.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -141.92 83.23 12.9 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 125.565 1.546 . . . . 1.0 111.276 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.76 12.45 1.41 Allowed 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 124.009 3.14 . . . . 1.0 113.904 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -109.64 65.5 0.36 Allowed Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 127.899 2.479 . . . . 1.0 109.553 174.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -58.65 -19.08 43.68 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.496 2.131 . . . . 1.0 116.952 -168.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -65.12 -28.44 69.44 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 121.343 -0.848 . . . . 1.0 111.919 173.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.6 p -70.75 -21.75 62.49 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.226 0.921 . . . . 1.0 112.181 -175.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -96.24 -54.69 3.2 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.899 1.679 . . . . 1.0 111.399 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 85.6 p -68.4 -33.07 73.58 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.656 1.354 . . . . 1.0 114.656 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.27 -50.03 51.5 Favored Pre-proline 0 CA--C 1.542 0.645 0 O-C-N 120.315 -1.49 . . . . 1.0 113.014 -173.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.69 -23.44 69.68 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 CA-C-N 121.289 1.496 . . . . 1.0 112.552 170.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.413 ' CD1' HD23 ' A' ' 123' ' ' LEU . 90.6 t90 -70.28 -46.32 64.57 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 123.342 0.657 . . . . 1.0 110.832 175.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 88.9 t -66.08 -34.63 71.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -63.55 -48.46 77.37 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.216 -0.928 . . . . 1.0 110.043 174.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -63.7 -55.68 21.52 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.73 1.212 . . . . 1.0 111.67 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.2 t90 -58.09 -35.05 70.86 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 125.693 1.597 . . . . 1.0 111.953 175.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.47 -32.87 31.69 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.462 1.505 . . . . 1.0 113.811 172.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.0 p -70.12 -12.65 61.75 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.832 1.419 . . . . 1.0 114.832 175.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.94 -17.33 43.99 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.67 1.588 . . . . 1.0 111.882 176.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -77.79 171.46 14.93 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 118.945 0.793 . . . . 1.0 110.871 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 56.4 m . . . . . 0 C--O 1.252 1.187 0 C-N-CA 125.44 1.496 . . . . 1.0 114.777 -173.416 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptp . . . . . 0 N--CA 1.498 1.936 0 N-CA-C 112.197 0.443 . . . . 1.0 112.197 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.79 157.5 21.07 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 114.694 1.368 . . . . 1.0 114.694 174.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -121.0 123.75 43.18 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.669 1.587 . . . . 1.0 109.775 173.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 mp -124.27 112.92 34.35 Favored 'Isoleucine or valine' 0 C--O 1.23 0.05 0 C-N-CA 125.856 1.662 . . . . 1.0 112.439 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.22 125.49 7.92 Favored Glycine 0 C--O 1.224 -0.492 0 N-CA-C 110.24 -1.144 . . . . 1.0 110.24 169.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.5 mt -105.79 124.14 60.71 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 118.523 1.162 . . . . 1.0 109.591 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -115.57 110.22 18.91 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 125.109 1.364 . . . . 1.0 107.813 -170.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.9 p -93.29 131.05 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 O-C-N 123.266 0.354 . . . . 1.0 111.468 -175.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -118.75 113.92 2.7 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.306 0.955 . . . . 1.0 111.605 173.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.3 p -148.43 148.05 29.86 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 118.508 1.154 . . . . 1.0 112.149 -172.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -71.45 171.44 11.28 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.133 0.573 . . . . 1.0 111.866 169.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -59.26 146.21 40.17 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.531 0.732 . . . . 1.0 112.404 175.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.08 -153.18 46.44 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 123.912 0.768 . . . . 1.0 113.356 -172.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 51.47 -138.7 1.04 Allowed 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 125.3 1.44 . . . . 1.0 112.249 -176.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.1 t -150.55 153.23 35.4 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.637 1.108 . . . . 1.0 112.919 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -79.26 -5.17 53.78 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.767 1.627 . . . . 1.0 114.491 170.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.7 tp -20.78 -63.32 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 129.078 2.951 . . . . 1.0 116.829 -169.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.8 t -57.44 -32.76 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 119.344 -0.36 . . . . 1.0 111.717 -170.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.47 -45.29 94.28 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.76 1.164 . . . . 1.0 112.521 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -68.42 -31.06 70.13 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.81 0.844 . . . . 1.0 111.017 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -67.7 -47.15 70.22 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 173.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.451 ' HA ' HG12 ' A' ' 141' ' ' VAL . . . -64.74 -42.45 95.17 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 113.122 0.786 . . . . 1.0 113.122 -176.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -54.72 -48.43 72.51 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.344 1.058 . . . . 1.0 110.404 170.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.89 -38.21 70.02 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.517 0.727 . . . . 1.0 112.067 -174.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.3 mt -68.26 -45.48 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 O-C-N 121.33 -0.856 . . . . 1.0 109.35 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.16 -31.02 71.61 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.653 1.115 . . . . 1.0 110.884 -178.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 34.6 m -63.07 -45.55 91.66 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.796 1.238 . . . . 1.0 112.539 169.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.39 -31.97 71.7 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.57 1.148 . . . . 1.0 113.236 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -65.74 -30.47 71.14 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.123 1.769 . . . . 1.0 111.648 171.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.0 31.61 1.7 Allowed Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.702 1.144 . . . . 1.0 114.833 172.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -124.7 161.66 25.86 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.302 1.441 . . . . 1.0 110.739 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -91.8 86.24 5.86 Favored 'General case' 0 N--CA 1.46 0.071 0 C-N-CA 125.034 1.334 . . . . 1.0 108.939 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.5 146.2 28.46 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.05 0.54 . . . . 1.0 111.404 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.2 m -147.5 140.66 25.16 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.344 1.058 . . . . 1.0 112.198 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -87.04 137.31 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 115.108 1.521 . . . . 1.0 115.108 171.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -111.86 120.86 43.39 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.262 1.825 . . . . 1.0 111.126 169.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -99.92 138.23 37.28 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.587 1.955 . . . . 1.0 110.942 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.7 t0 42.18 54.85 9.34 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 124.39 1.076 . . . . 1.0 111.378 -169.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -63.56 137.32 58.9 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.836 3.024 . . . . 1.0 116.707 -168.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -88.56 157.35 18.63 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.547 1.539 . . . . 1.0 111.706 168.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -68.52 -21.27 64.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 120.261 -1.525 . . . . 1.0 109.567 167.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.2 m -68.86 -19.83 64.25 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.455 -0.778 . . . . 1.0 112.319 169.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -81.98 -28.57 32.57 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.546 1.138 . . . . 1.0 112.129 169.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 12.6 t-105 -82.7 -36.9 25.47 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.671 0.989 . . . . 1.0 113.671 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.8 mt -48.6 -39.83 34.87 Favored Pre-proline 0 CA--C 1.552 1.054 0 CA-C-O 117.482 -1.246 . . . . 1.0 114.123 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -57.59 -12.36 11.1 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 124.428 3.418 . . . . 1.0 117.144 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -110.53 8.13 22.84 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 116.121 1.897 . . . . 1.0 116.121 -174.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -52.72 -30.94 35.11 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.941 2.096 . . . . 1.0 113.782 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -113.48 13.1 18.81 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.882 1.273 . . . . 1.0 112.602 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -122.65 -159.51 0.84 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.273 2.629 . . . . 1.0 110.854 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -115.12 165.09 13.29 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 123.018 1.389 . . . . 1.0 111.763 170.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.49 163.19 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.331 1.452 . . . . 1.0 108.945 -172.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.4 tp -141.45 127.08 19.0 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.509 1.123 . . . . 1.0 108.951 175.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.46 124.0 52.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 124.055 0.942 . . . . 1.0 109.533 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.0 t -122.58 112.37 34.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 174.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t -148.4 128.98 14.05 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.136 1.532 . . . . 1.0 115.136 -167.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.7 m -110.1 175.4 5.45 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.931 2.092 . . . . 1.0 111.846 -173.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 65.25 42.15 4.1 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.222 1.193 . . . . 1.0 114.222 168.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.6 m -55.95 124.1 16.54 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.097 -1.075 . . . . 1.0 108.097 168.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.05 -130.73 2.65 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.558 1.075 . . . . 1.0 112.188 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -75.81 51.86 0.65 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.793 1.237 . . . . 1.0 110.721 169.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.18 -10.69 71.45 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 126.538 2.018 . . . . 1.0 115.801 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.9 -179.52 3.72 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 118.845 1.322 . . . . 1.0 113.806 -173.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 49.6 mt -94.87 159.16 33.83 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 127.294 2.238 . . . . 1.0 114.074 -169.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.85 154.9 43.58 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.835 2.356 . . . . 1.0 112.141 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -62.79 -19.61 64.19 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.601 1.334 . . . . 1.0 114.601 -170.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.9 p -71.13 -29.42 65.22 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.628 1.171 . . . . 1.0 114.05 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.6 tt -112.42 -16.03 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.745 1.218 . . . . 1.0 113.471 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.5 t -40.77 -50.61 7.29 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 124.638 1.175 . . . . 1.0 112.816 168.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.38 -30.03 20.04 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.506 1.471 . . . . 1.0 111.913 -172.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.5 tp -66.45 -50.58 62.85 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 123.804 0.842 . . . . 1.0 110.534 169.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -54.69 -54.31 43.44 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.018 0.927 . . . . 1.0 112.306 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -68.05 -35.4 78.17 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.132 -0.486 . . . . 1.0 111.915 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.18 -36.72 93.58 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 123.941 0.781 . . . . 1.0 112.367 176.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 79.7 mt -62.43 -51.87 66.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.521 1.661 . . . . 1.0 108.136 170.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -68.43 -32.59 72.73 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 120.435 -1.415 . . . . 1.0 113.141 -169.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -99.58 -37.26 9.23 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.771 1.629 . . . . 1.0 114.808 -174.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 m -99.8 -19.17 16.83 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.613 1.165 . . . . 1.0 113.17 -174.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.3 -71.54 0.66 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 106.409 -1.7 . . . . 1.0 106.409 169.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.89 -13.88 1.65 Allowed Glycine 0 CA--C 1.537 1.426 0 C-N-CA 127.642 2.544 . . . . 1.0 116.719 168.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -154.67 137.89 15.7 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.872 2.069 . . . . 1.0 108.633 172.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -134.92 124.0 16.31 Favored Pre-proline 0 CA--C 1.546 0.816 0 O-C-N 121.354 -0.841 . . . . 1.0 111.499 -171.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.83 -39.62 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.015 2.477 . . . . 1.0 114.72 -174.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -140.63 14.84 2.34 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.5 1.296 . . . . 1.0 114.5 -169.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 70.0 tp -80.84 138.06 36.21 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.579 -1.326 . . . . 1.0 112.862 -169.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.1 mtm-85 -135.97 156.76 48.26 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.963 2.505 . . . . 1.0 109.085 169.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.78 166.82 21.63 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.306 -0.871 . . . . 1.0 112.181 -176.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.448 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -120.05 171.92 14.69 Favored Glycine 0 N--CA 1.472 1.058 0 C-N-CA 125.487 1.518 . . . . 1.0 114.438 173.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.0 t -146.35 133.07 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 115.63 1.715 . . . . 1.0 115.63 -169.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.5 mt -131.6 108.38 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 125.719 1.608 . . . . 1.0 107.481 168.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.84 148.3 23.26 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.236 1.414 . . . . 1.0 112.017 170.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.8 mp -139.78 149.04 43.07 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.869 0.692 . . . . 1.0 112.869 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.52 -167.96 40.91 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 116.115 -0.493 . . . . 1.0 113.443 169.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -95.18 116.7 29.09 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.675 1.19 . . . . 1.0 111.792 173.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.3 t -65.37 -5.43 7.46 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.846 1.054 . . . . 1.0 113.846 178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.9 p -64.03 -22.45 66.93 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.985 -1.072 . . . . 1.0 112.892 169.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -86.88 141.57 28.67 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.893 1.277 . . . . 1.0 111.985 170.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -46.55 -50.8 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 126.339 1.856 . . . . 1.0 114.504 -178.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -90.13 15.08 10.87 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.719 1.608 . . . . 1.0 115.027 -174.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.4 t80 25.59 -83.54 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 129.44 3.096 . . . . 1.0 117.063 175.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.6 m -120.89 16.23 11.75 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.138 1.775 . . . . 1.0 113.609 -172.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -61.48 -16.03 43.37 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.494 1.517 . . . . 1.0 114.545 -173.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.32 -42.02 97.17 Favored Glycine 0 CA--C 1.537 1.408 0 CA-C-N 120.271 1.396 . . . . 1.0 113.22 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.97 -36.53 46.51 Favored Glycine 0 N--CA 1.48 1.626 0 O-C-N 120.258 -1.731 . . . . 1.0 112.724 174.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -63.02 -33.36 75.26 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.871 0.868 . . . . 1.0 112.785 174.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -58.4 -42.73 87.77 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.807 0.843 . . . . 1.0 111.856 170.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -62.06 -37.89 86.69 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.763 0.71 . . . . 1.0 111.14 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.55 -46.16 84.03 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.657 0.662 . . . . 1.0 111.366 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.61 -43.48 68.7 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.442 -0.789 . . . . 1.0 112.0 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.24 -49.44 64.0 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.787 2.035 . . . . 1.0 111.733 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.3 mt -65.31 -40.35 93.63 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.471 -0.786 . . . . 1.0 111.232 178.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -67.65 -22.81 65.29 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.247 1.203 . . . . 1.0 114.247 175.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -64.42 -35.7 81.76 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.666 1.186 . . . . 1.0 110.7 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -86.01 -78.46 0.27 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 113.361 -1.745 . . . . 1.0 110.041 -175.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.2 t 179.26 0.01 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.474 1.91 . . . . 1.0 112.171 172.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.45 155.48 33.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 122.264 1.031 . . . . 1.0 113.443 -169.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -92.8 170.84 9.39 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.997 1.719 . . . . 1.0 112.018 -169.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -129.36 159.91 34.7 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.779 1.231 . . . . 1.0 112.342 172.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.0 t -122.62 126.09 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 125.981 1.712 . . . . 1.0 108.209 -176.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 52.4 -168.71 0.74 Allowed Glycine 0 CA--C 1.542 1.739 0 C-N-CA 125.642 1.591 . . . . 1.0 116.199 -176.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -92.37 146.76 23.44 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.163 1.385 . . . . 1.0 110.038 169.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.88 156.34 36.52 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.764 0.826 . . . . 1.0 111.456 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.417 HD22 ' CD1' ' A' ' 140' ' ' TRP . 1.0 OUTLIER -92.52 138.54 31.42 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.937 0.895 . . . . 1.0 110.258 170.509 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.3 mt -121.71 104.46 9.61 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.764 1.226 . . . . 1.0 111.265 173.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.68 131.49 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 C-N-CA 125.034 1.334 . . . . 1.0 112.049 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -107.54 106.29 16.59 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.175 0.988 . . . . 1.0 112.925 172.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -69.24 -22.86 63.83 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.565 0.95 . . . . 1.0 113.565 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.9 t -63.8 -22.52 66.95 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.389 1.076 . . . . 1.0 112.512 173.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -116.13 -30.2 6.06 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.279 1.831 . . . . 1.0 111.884 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -145.6 91.52 5.7 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 124.909 1.283 . . . . 1.0 112.601 -173.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.4 2.54 7.19 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 123.363 2.709 . . . . 1.0 114.383 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -109.82 72.35 0.61 Allowed Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 129.152 2.981 . . . . 1.0 110.444 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -60.5 -12.53 21.15 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.622 2.881 . . . . 1.0 116.723 -169.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -67.0 -28.19 68.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.803 0.729 . . . . 1.0 111.541 172.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 44.3 p -68.91 -26.21 64.98 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.117 -0.99 . . . . 1.0 111.935 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -93.78 -53.1 4.15 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.849 1.26 . . . . 1.0 111.818 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.7 t -72.42 -32.26 66.19 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.503 1.297 . . . . 1.0 114.503 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -61.17 -55.4 44.36 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 121.243 1.838 . . . . 1.0 112.731 -177.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -62.99 -22.65 73.92 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 121.567 1.595 . . . . 1.0 112.676 175.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.417 ' CD1' HD22 ' A' ' 123' ' ' LEU . 92.0 t90 -68.53 -48.62 63.87 Favored 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.345 0.658 . . . . 1.0 110.602 174.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.451 HG12 ' HA ' ' A' ' 22' ' ' ALA . 83.9 t -65.43 -32.06 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 122.002 0.906 . . . . 1.0 109.042 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.96 -23.22 61.4 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 119.991 -1.693 . . . . 1.0 113.336 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -86.79 -61.98 1.61 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.978 2.111 . . . . 1.0 111.403 169.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.448 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 83.9 t90 -54.98 -38.2 67.49 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 126.844 2.058 . . . . 1.0 112.823 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.2 -28.71 27.37 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 118.913 0.778 . . . . 1.0 114.513 173.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.5 p -69.93 -12.78 61.87 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.808 1.304 . . . . 1.0 114.043 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.03 -18.98 48.75 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.91 1.684 . . . . 1.0 111.615 176.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.88 171.99 11.08 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.991 1.316 . . . . 1.0 111.194 -177.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 C--O 1.255 1.35 0 C-N-CA 125.252 1.421 . . . . 1.0 114.743 -171.92 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.502 2.163 0 N-CA-C 113.799 1.037 . . . . 1.0 113.799 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.34 172.56 2.47 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 117.717 2.488 . . . . 1.0 117.717 -169.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -122.23 126.95 49.31 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.582 1.953 . . . . 1.0 109.726 173.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mp -123.91 114.25 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 C-N-CA 127.078 2.151 . . . . 1.0 112.213 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.71 124.44 7.63 Favored Glycine 0 C--O 1.224 -0.512 0 N-CA-C 110.315 -1.114 . . . . 1.0 110.315 169.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.0 mt -104.43 118.97 52.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 118.283 1.042 . . . . 1.0 109.618 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -111.51 108.79 18.43 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.941 -1.503 . . . . 1.0 106.941 -170.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.6 p -100.41 130.69 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 O-C-N 123.235 0.334 . . . . 1.0 111.375 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.87 150.85 49.73 Favored Glycine 0 CA--C 1.542 1.744 0 O-C-N 122.072 -0.393 . . . . 1.0 112.765 175.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.35 1.4 t 54.82 170.37 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 127.238 2.215 . . . . 1.0 116.562 -170.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -95.35 -34.98 11.94 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.634 1.574 . . . . 1.0 113.061 -171.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -142.29 146.39 35.02 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.654 1.182 . . . . 1.0 112.551 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.04 154.21 6.72 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.271 1.415 . . . . 1.0 112.634 175.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -63.72 -27.79 69.44 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.436 -1.038 . . . . 1.0 113.426 -173.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.6 p -69.18 -21.91 63.94 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.672 1.189 . . . . 1.0 113.876 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.37 -24.55 67.89 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.272 0.942 . . . . 1.0 112.253 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.5 tp -39.96 -47.79 2.28 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.019 1.727 . . . . 1.0 112.644 169.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.5 t -52.63 -33.14 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.17 0.988 . . . . 1.0 112.184 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.19 -48.69 80.37 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 120.0 1.273 . . . . 1.0 113.208 173.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -65.79 -33.11 75.09 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.577 0.751 . . . . 1.0 110.682 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -66.46 -47.79 72.0 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 123.934 0.893 . . . . 1.0 109.406 173.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.448 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -63.78 -43.07 97.45 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 112.584 0.587 . . . . 1.0 112.584 -176.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.11 -49.01 72.82 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.951 0.5 . . . . 1.0 110.029 170.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.42 -38.07 74.53 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.776 0.658 . . . . 1.0 112.776 -173.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.9 mt -65.88 -47.5 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 174.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.14 -34.32 77.33 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 119.651 -0.82 . . . . 1.0 110.573 -175.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.0 m -62.76 -41.63 99.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.691 1.597 . . . . 1.0 113.52 170.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.5 -32.81 73.88 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.825 0.85 . . . . 1.0 112.308 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -71.49 -29.32 64.68 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.638 1.175 . . . . 1.0 113.447 171.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.53 26.83 2.3 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.393 0.996 . . . . 1.0 114.086 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -116.35 146.56 42.36 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.381 1.072 . . . . 1.0 109.769 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -79.99 89.41 5.34 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 125.088 1.355 . . . . 1.0 108.448 -175.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.52 146.61 30.4 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 122.552 0.341 . . . . 1.0 110.737 -178.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.7 m -149.29 146.76 27.71 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.011 0.924 . . . . 1.0 111.399 -172.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.3 t -97.51 139.27 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 114.794 1.405 . . . . 1.0 114.794 176.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -122.61 113.66 19.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.974 2.11 . . . . 1.0 109.966 169.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -98.88 138.11 36.48 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.746 1.618 . . . . 1.0 111.188 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 43.24 55.45 11.31 Favored Pre-proline 0 CA--C 1.564 1.496 0 C-N-CA 124.518 1.127 . . . . 1.0 111.475 -169.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.52 152.09 59.61 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 125.167 3.911 . . . . 1.0 119.198 -167.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -93.84 155.47 17.17 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.216 2.206 . . . . 1.0 113.008 168.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -69.46 -23.22 63.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 120.827 -1.171 . . . . 1.0 109.983 168.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.6 m -65.93 -23.13 66.56 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.27 -0.894 . . . . 1.0 112.228 171.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -83.07 -24.68 32.61 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.242 1.017 . . . . 1.0 113.122 169.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 11.6 t-105 -82.27 -35.82 27.69 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.74 1.154 . . . . 1.0 113.786 177.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.4 mt -50.08 -38.62 38.33 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-O 117.567 -1.206 . . . . 1.0 114.098 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -52.92 -16.92 6.72 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 124.202 3.268 . . . . 1.0 117.319 171.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -109.24 9.88 25.84 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 115.486 1.662 . . . . 1.0 115.486 -175.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -52.6 -33.09 44.72 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 126.08 1.752 . . . . 1.0 113.708 177.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -105.01 1.69 28.88 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.555 1.542 . . . . 1.0 113.576 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -112.56 -164.05 0.89 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.62 2.368 . . . . 1.0 110.932 -175.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -109.04 164.98 11.94 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 122.982 1.373 . . . . 1.0 111.541 169.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.64 159.92 5.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 125.245 1.418 . . . . 1.0 109.164 -172.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.4 tp -138.73 129.95 27.01 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 124.792 1.237 . . . . 1.0 108.698 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.8 t -105.16 125.55 60.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 124.247 1.019 . . . . 1.0 108.964 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.59 114.45 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 107.484 -1.302 . . . . 1.0 107.484 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 t -150.06 116.83 5.87 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.797 1.036 . . . . 1.0 113.797 -169.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.6 t -103.53 13.24 33.85 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.786 2.034 . . . . 1.0 111.732 173.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.2 p -88.46 -6.7 57.48 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.542 1.682 . . . . 1.0 115.542 -168.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.5 m -42.65 -49.25 5.56 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.729 2.011 . . . . 1.0 114.093 178.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 52.0 -130.04 35.91 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-N 119.071 0.851 . . . . 1.0 111.915 -175.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -56.81 -32.45 65.72 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.943 0.897 . . . . 1.0 113.012 172.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 165.33 -24.49 0.16 Allowed Glycine 0 CA--C 1.535 1.343 0 N-CA-C 116.99 1.556 . . . . 1.0 116.99 169.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -99.11 153.26 19.03 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.89 1.676 . . . . 1.0 114.254 -173.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.74 146.83 61.13 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 113.402 0.89 . . . . 1.0 113.402 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -88.02 165.97 7.09 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.781 3.654 . . . . 1.0 113.643 177.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -55.8 -13.75 1.95 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.989 2.116 . . . . 1.0 115.684 -177.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.5 p -78.25 -39.89 38.82 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.092 1.145 . . . . 1.0 114.092 176.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.8 tt -110.47 -15.36 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.941 1.296 . . . . 1.0 112.78 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.4 t -46.24 -50.56 37.86 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 125.18 1.392 . . . . 1.0 112.298 167.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.6 -28.19 31.75 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.688 1.592 . . . . 1.0 111.609 -173.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 tp -70.46 -51.66 27.63 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 123.673 0.789 . . . . 1.0 110.722 169.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -55.4 -55.38 32.28 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.234 1.014 . . . . 1.0 112.493 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -68.05 -35.36 78.1 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.44 0.696 . . . . 1.0 111.832 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.13 -35.91 92.58 Favored Glycine 0 CA--C 1.529 0.91 0 O-C-N 121.662 -0.649 . . . . 1.0 112.359 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 88.8 mt -65.88 -51.57 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 119.871 1.835 . . . . 1.0 107.901 170.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? -68.28 -30.52 69.55 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 120.165 -1.585 . . . . 1.0 113.715 -169.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -107.61 -37.45 6.17 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.995 1.718 . . . . 1.0 115.217 -176.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.5 m -94.1 -21.0 19.39 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.985 0.914 . . . . 1.0 113.197 -176.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.38 -71.49 0.64 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 106.523 -1.658 . . . . 1.0 106.523 169.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.94 -19.33 1.0 Allowed Glycine 0 CA--C 1.535 1.314 0 C-N-CA 127.945 2.688 . . . . 1.0 115.38 169.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -152.19 139.31 19.23 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 128.185 2.594 . . . . 1.0 107.885 169.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -137.86 121.8 11.75 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 118.829 -0.605 . . . . 1.0 109.838 -170.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -81.61 -35.99 0.37 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.713 2.275 . . . . 1.0 115.496 -169.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -142.91 15.84 1.93 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.18 1.178 . . . . 1.0 114.18 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 67.2 tp -81.74 140.1 34.48 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.716 -1.24 . . . . 1.0 112.881 -169.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.5 mtm-85 -136.51 154.68 50.66 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.694 2.397 . . . . 1.0 109.311 169.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.419 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -160.18 170.29 21.48 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.286 0.948 . . . . 1.0 111.87 -177.714 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -129.25 171.45 20.01 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 124.744 1.164 . . . . 1.0 113.393 170.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.88 138.41 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.134 0.973 . . . . 1.0 113.521 -169.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.1 mt -130.81 96.52 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.631 1.572 . . . . 1.0 107.096 169.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.92 145.61 25.42 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.494 1.518 . . . . 1.0 111.066 172.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.4 mp -140.71 157.32 45.61 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 121.611 -0.681 . . . . 1.0 112.17 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.58 167.95 34.67 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 121.976 0.764 . . . . 1.0 114.715 169.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -74.3 119.48 18.56 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.005 -1.291 . . . . 1.0 109.763 170.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.5 t -64.33 -4.61 3.97 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.85 1.055 . . . . 1.0 113.85 -177.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.3 t -71.11 -22.37 62.09 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.931 -1.106 . . . . 1.0 112.781 170.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -72.86 158.57 35.28 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.551 0.945 . . . . 1.0 113.551 176.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.3 t -62.26 -37.53 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.187 1.395 . . . . 1.0 113.464 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -121.97 27.86 7.86 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.699 1.6 . . . . 1.0 114.424 -169.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 18.8 t80 32.93 -87.29 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 128.198 2.599 . . . . 1.0 117.019 172.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 15.5 m -121.35 17.28 11.42 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.66 1.984 . . . . 1.0 113.2 -174.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -54.12 -30.34 48.4 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.013 1.725 . . . . 1.0 114.722 -174.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.88 -41.55 94.23 Favored Glycine 0 N--CA 1.473 1.132 0 CA-C-N 121.477 1.944 . . . . 1.0 113.32 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.07 -37.73 28.16 Favored Glycine 0 N--CA 1.476 1.304 0 CA-C-N 118.258 1.029 . . . . 1.0 113.326 173.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -58.66 -35.14 72.07 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.647 1.223 . . . . 1.0 113.167 173.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -68.29 -33.48 74.42 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.244 0.618 . . . . 1.0 112.14 172.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -63.69 -37.13 86.19 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.759 1.163 . . . . 1.0 110.963 172.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.1 -48.14 79.85 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.98 0.912 . . . . 1.0 112.139 174.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.98 -35.15 70.78 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.816 0.672 . . . . 1.0 112.816 173.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.82 -50.12 74.36 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 123.525 1.631 . . . . 1.0 110.906 -176.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.419 HD12 ' CD1' ' A' ' 87' ' ' TYR . 6.3 mt -66.34 -40.52 89.88 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 120.762 -1.211 . . . . 1.0 111.262 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -70.73 -16.91 62.81 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.241 0.83 . . . . 1.0 113.241 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.81 -20.4 53.27 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.579 1.081 . . . . 1.0 110.798 175.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -97.79 -79.37 0.47 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.377 1.471 . . . . 1.0 110.28 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.0 t -175.27 -3.28 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.79 1.636 . . . . 1.0 112.573 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.83 151.95 29.98 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 122.962 1.363 . . . . 1.0 113.596 -169.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -88.44 168.2 12.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.049 1.74 . . . . 1.0 113.799 -168.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -119.4 148.04 43.67 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.779 2.031 . . . . 1.0 110.922 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.3 t -120.71 128.31 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.149 1.38 . . . . 1.0 108.798 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 50.06 -158.13 1.68 Allowed Glycine 0 N--CA 1.48 1.609 0 C-N-CA 125.087 1.327 . . . . 1.0 114.569 -172.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -110.91 142.49 42.92 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.088 1.355 . . . . 1.0 109.277 169.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.36 157.84 33.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.184 0.994 . . . . 1.0 113.049 -169.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.439 ' HB2' ' CD1' ' A' ' 140' ' ' TRP . 1.4 tm? -90.69 137.11 32.62 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.918 1.287 . . . . 1.0 110.27 173.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.9 mt -127.84 109.35 11.53 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.624 1.57 . . . . 1.0 109.98 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.4 mt -98.25 134.24 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.11 0.964 . . . . 1.0 113.014 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -100.18 91.86 4.95 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.919 2.488 . . . . 1.0 112.71 174.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.82 -23.28 66.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.209 1.004 . . . . 1.0 112.733 -174.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.9 p -54.1 -30.88 50.22 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 129.373 3.069 . . . . 1.0 114.158 169.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -121.28 -26.19 5.09 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.586 1.954 . . . . 1.0 111.508 -171.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -140.32 89.26 10.86 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 125.184 1.393 . . . . 1.0 111.474 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -75.66 11.39 1.64 Allowed 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.842 3.028 . . . . 1.0 114.005 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -113.77 65.3 1.23 Allowed Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 127.358 2.263 . . . . 1.0 110.072 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -55.72 -22.37 36.21 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.561 2.174 . . . . 1.0 116.176 -169.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.7 pm0 -64.49 -25.01 67.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 119.553 1.069 . . . . 1.0 111.817 175.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.5 p -72.82 -17.14 61.59 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 120.628 -1.295 . . . . 1.0 112.372 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -102.54 -55.79 2.38 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.258 1.823 . . . . 1.0 111.957 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 63.6 p -68.73 -33.31 73.71 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 113.817 1.043 . . . . 1.0 113.817 -176.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 36.5 m-20 -60.11 -59.23 14.53 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 120.688 1.585 . . . . 1.0 112.399 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -62.33 -22.32 73.93 Favored 'Trans proline' 0 C--N 1.352 0.713 0 CA-C-N 121.377 1.527 . . . . 1.0 112.943 175.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.439 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 87.2 t90 -68.71 -46.07 69.93 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 118.776 0.716 . . . . 1.0 111.2 172.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.448 HG11 ' HA ' ' A' ' 22' ' ' ALA . 92.2 t -63.84 -34.62 69.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 175.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.07 -30.83 70.12 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.299 1.44 . . . . 1.0 112.071 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -78.01 -61.87 1.86 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.113 1.765 . . . . 1.0 112.355 170.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -56.04 -36.43 68.0 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 126.046 1.738 . . . . 1.0 112.694 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.88 -32.32 26.11 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.393 0.997 . . . . 1.0 113.958 173.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.5 p -67.91 -13.8 62.45 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.073 1.138 . . . . 1.0 114.073 177.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.42 -17.71 50.99 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.002 1.721 . . . . 1.0 111.899 176.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.06 176.24 7.71 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.356 1.462 . . . . 1.0 110.911 -177.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 C--O 1.25 1.081 0 N-CA-C 114.803 1.408 . . . . 1.0 114.803 -170.077 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtt . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 111.316 0.117 . . . . 1.0 111.316 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.32 144.69 49.84 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.785 0.834 . . . . 1.0 113.049 175.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -124.78 121.25 34.08 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.404 1.082 . . . . 1.0 111.178 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mp -118.91 116.25 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 126.579 1.952 . . . . 1.0 112.803 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.04 127.42 9.06 Favored Glycine 0 C--O 1.221 -0.668 0 N-CA-C 111.159 -0.776 . . . . 1.0 111.159 169.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.3 mt -106.36 120.17 56.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 118.682 1.241 . . . . 1.0 109.979 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -111.44 107.63 16.91 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 125.332 1.453 . . . . 1.0 107.598 -169.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.7 p -95.7 123.38 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.32 0.581 . . . . 1.0 112.013 -171.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.22 73.33 0.21 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.589 1.566 . . . . 1.0 111.523 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 95.1 m -132.26 115.72 16.01 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.592 1.157 . . . . 1.0 110.323 -176.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 90.5 mtp -86.57 -28.97 22.99 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.276 0.843 . . . . 1.0 113.276 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -149.98 154.88 38.97 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.9 1.28 . . . . 1.0 112.23 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.85 172.32 43.69 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.82 1.2 . . . . 1.0 114.802 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -80.21 -2.8 46.45 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.97 1.1 . . . . 1.0 113.97 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.9 m -54.01 -27.39 31.57 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.515 1.526 . . . . 1.0 114.443 -174.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.7 pp -54.23 -24.96 20.58 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.194 1.398 . . . . 1.0 113.753 173.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.1 tp -39.4 -47.32 1.77 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.691 1.997 . . . . 1.0 112.864 170.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -53.03 -33.07 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.857 0.863 . . . . 1.0 111.995 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.71 -47.15 86.57 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 120.002 1.274 . . . . 1.0 112.72 174.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -65.94 -33.54 76.06 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.835 0.854 . . . . 1.0 110.839 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -66.1 -48.22 71.61 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 123.361 0.664 . . . . 1.0 109.234 173.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.07 -41.83 97.21 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 112.857 0.688 . . . . 1.0 112.857 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.44 -51.14 65.91 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 169.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.08 -37.54 81.35 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.572 -0.705 . . . . 1.0 112.808 -174.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.4 mt -68.27 -46.78 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 119.371 0.987 . . . . 1.0 109.572 176.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.66 -36.3 83.28 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.565 0.697 . . . . 1.0 110.633 -177.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.3 m -61.04 -43.75 98.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.989 0.916 . . . . 1.0 112.908 170.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.45 -29.58 67.31 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.505 1.122 . . . . 1.0 113.548 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -67.35 -30.07 69.79 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.334 1.054 . . . . 1.0 111.891 170.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.02 15.77 1.85 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.455 1.026 . . . . 1.0 115.28 169.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -102.54 -179.08 3.87 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.851 1.26 . . . . 1.0 109.977 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -108.15 98.66 8.19 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 124.982 1.313 . . . . 1.0 108.054 169.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -110.08 148.14 32.28 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 122.785 0.434 . . . . 1.0 111.231 176.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.2 m -146.28 147.0 30.93 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.673 1.189 . . . . 1.0 111.173 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.1 t -96.73 138.24 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 114.245 1.202 . . . . 1.0 114.245 174.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -117.73 112.29 20.26 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.671 1.988 . . . . 1.0 110.576 169.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -93.92 138.51 31.97 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.086 1.754 . . . . 1.0 111.1 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 42.65 55.31 10.34 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 124.789 1.236 . . . . 1.0 110.999 -169.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -68.21 146.02 68.4 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.72 2.947 . . . . 1.0 117.632 -168.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -89.68 155.7 19.05 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.091 1.757 . . . . 1.0 112.523 168.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -69.09 -21.35 64.06 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 120.574 -1.329 . . . . 1.0 109.525 168.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 m -67.24 -21.57 65.73 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.168 -0.957 . . . . 1.0 112.357 170.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -82.88 -27.28 30.82 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.01 0.924 . . . . 1.0 112.5 169.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -82.06 -36.51 27.61 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.488 1.04 . . . . 1.0 113.686 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.9 mt -48.07 -40.44 34.4 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-O 117.708 -1.139 . . . . 1.0 113.668 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -52.45 -16.83 5.69 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 124.373 3.382 . . . . 1.0 117.532 172.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -110.22 8.09 23.5 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 116.195 1.924 . . . . 1.0 116.195 -172.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -51.3 -26.73 7.91 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 127.156 2.183 . . . . 1.0 114.336 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -121.63 15.98 11.13 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.897 1.679 . . . . 1.0 113.485 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -128.62 -154.23 0.62 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 128.163 2.585 . . . . 1.0 109.747 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -122.07 164.05 18.38 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 123.161 1.458 . . . . 1.0 112.371 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.93 164.55 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 124.846 1.258 . . . . 1.0 109.434 -172.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.6 tp -144.39 128.6 17.73 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 125.1 1.36 . . . . 1.0 108.53 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.2 t -102.13 124.81 56.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 124.518 1.127 . . . . 1.0 109.328 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.2 110.85 25.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 106.043 -1.836 . . . . 1.0 106.043 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 t -135.15 122.04 21.11 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.398 0.679 . . . . 1.0 111.732 -168.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 m -115.66 4.58 14.11 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 116.49 2.033 . . . . 1.0 116.49 -168.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.33 29.7 7.63 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 113.291 0.848 . . . . 1.0 113.291 -169.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -58.09 -37.87 75.32 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.352 1.061 . . . . 1.0 112.205 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.01 -125.85 34.3 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.144 0.878 . . . . 1.0 113.206 176.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -76.73 -7.97 56.38 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.886 1.069 . . . . 1.0 113.886 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 130.61 43.55 0.19 Allowed Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.972 1.273 . . . . 1.0 115.143 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -133.79 155.04 50.51 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.292 1.437 . . . . 1.0 111.616 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.1 mt -75.87 147.25 80.59 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 121.069 -1.019 . . . . 1.0 112.591 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -59.37 131.3 40.07 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.565 2.177 . . . . 1.0 110.794 169.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.2 -23.72 64.23 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.249 -0.907 . . . . 1.0 112.994 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.0 p -73.15 -19.56 61.1 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.609 1.563 . . . . 1.0 114.434 173.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.4 tt -118.72 -11.73 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.836 1.255 . . . . 1.0 113.657 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.7 t -47.32 -51.19 44.38 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 125.629 1.571 . . . . 1.0 112.204 168.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.48 -31.74 16.78 Favored 'Trans proline' 0 C--N 1.352 0.737 0 CA-C-N 120.57 1.239 . . . . 1.0 111.277 -173.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.7 tp -63.03 -49.78 73.25 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 124.719 1.208 . . . . 1.0 111.331 169.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -54.53 -54.41 41.54 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.761 1.224 . . . . 1.0 112.679 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -64.08 -38.76 92.24 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.689 0.796 . . . . 1.0 111.242 177.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.45 -36.67 91.86 Favored Glycine 0 CA--C 1.528 0.87 0 O-C-N 121.69 -0.631 . . . . 1.0 112.69 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.06 -49.5 79.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 120.008 -1.877 . . . . 1.0 108.291 172.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.9 ptmt -69.93 -31.6 69.45 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.464 -1.398 . . . . 1.0 113.529 -171.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -106.77 -37.43 6.4 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.692 1.597 . . . . 1.0 114.963 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.6 m -92.75 -23.07 19.02 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.295 1.038 . . . . 1.0 112.661 -177.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.22 -71.85 0.64 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 106.934 -1.506 . . . . 1.0 106.934 169.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.61 -9.47 2.58 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 126.73 2.11 . . . . 1.0 115.622 170.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -153.96 147.1 24.64 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 128.734 2.814 . . . . 1.0 107.788 169.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 39.7 mm-40 -136.76 125.17 14.97 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 123.261 0.625 . . . . 1.0 110.8 -174.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -83.05 -40.76 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.458 2.106 . . . . 1.0 114.097 -174.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -146.9 18.95 1.27 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.628 1.171 . . . . 1.0 113.846 -169.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.2 tp -80.95 140.0 35.5 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.606 -1.309 . . . . 1.0 112.782 -169.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 -135.26 154.6 51.51 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.624 2.369 . . . . 1.0 109.158 169.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.419 ' CD1' HD13 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -162.03 167.15 24.88 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.91 0.777 . . . . 1.0 112.195 -179.602 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.423 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -122.56 172.82 15.87 Favored Glycine 0 N--CA 1.473 1.139 0 C-N-CA 125.702 1.62 . . . . 1.0 114.096 173.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.4 t -146.7 133.79 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 114.421 1.267 . . . . 1.0 114.421 -169.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.3 mt -131.4 110.37 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 106.97 -1.493 . . . . 1.0 106.97 168.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.91 145.01 24.93 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.741 1.216 . . . . 1.0 110.711 170.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.09 150.57 43.07 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.317 0.647 . . . . 1.0 111.571 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 170.85 -179.14 42.97 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-O 122.077 0.821 . . . . 1.0 114.67 169.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -81.05 106.63 13.2 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.157 1.383 . . . . 1.0 111.593 177.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 79.7 p -68.7 -4.89 17.41 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.554 1.542 . . . . 1.0 114.017 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.3 p -61.99 -19.55 62.93 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.291 1.036 . . . . 1.0 113.594 169.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -105.47 162.41 13.49 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.507 1.523 . . . . 1.0 112.879 169.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.9 m -63.56 175.96 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.993 1.317 . . . . 1.0 111.205 169.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 59.56 20.83 9.35 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.693 1.597 . . . . 1.0 114.834 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -10.88 -65.74 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 130.497 3.519 . . . . 1.0 117.554 -169.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.8 m -128.58 24.93 5.75 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.035 1.334 . . . . 1.0 113.489 -172.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -55.55 -29.53 59.14 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.896 1.278 . . . . 1.0 114.407 -174.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.01 -43.3 95.11 Favored Glycine 0 N--CA 1.476 1.349 0 CA-C-N 121.115 1.78 . . . . 1.0 114.444 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.49 -37.04 36.73 Favored Glycine 0 N--CA 1.478 1.449 0 O-C-N 121.082 -1.246 . . . . 1.0 112.772 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -60.37 -38.31 83.46 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.322 1.049 . . . . 1.0 113.111 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -59.51 -42.87 93.19 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.259 1.024 . . . . 1.0 111.951 170.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.28 -38.18 90.16 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.638 0.654 . . . . 1.0 110.889 176.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -37.59 88.06 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.746 0.819 . . . . 1.0 112.698 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.71 93.52 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.819 -0.61 . . . . 1.0 112.213 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.7 -48.25 58.74 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.115 2.166 . . . . 1.0 111.885 -171.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.419 HD13 ' CD1' ' A' ' 87' ' ' TYR . 6.6 mt -66.48 -42.39 87.55 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.41 -0.814 . . . . 1.0 111.516 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -67.44 -21.43 65.55 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.887 1.069 . . . . 1.0 113.887 175.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -67.09 -33.88 76.44 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.279 1.032 . . . . 1.0 111.331 174.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -85.15 -73.99 0.42 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 114.129 -1.396 . . . . 1.0 110.709 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.4 m 174.97 -0.72 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.953 2.501 . . . . 1.0 112.001 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.61 152.14 34.04 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-O 122.222 1.01 . . . . 1.0 113.599 -169.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -86.03 161.48 18.93 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.404 1.482 . . . . 1.0 112.876 -169.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.68 127.01 37.99 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.143 1.777 . . . . 1.0 108.99 -173.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.7 t -106.78 129.85 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.635 0.774 . . . . 1.0 110.45 -169.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 51.64 -154.68 4.42 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.768 1.175 . . . . 1.0 113.544 -171.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -115.85 147.24 41.26 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.73 1.612 . . . . 1.0 109.142 169.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -73.78 157.35 36.59 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.05 -1.031 . . . . 1.0 112.231 -169.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.438 ' CD1' HG13 ' A' ' 125' ' ' ILE . 0.9 OUTLIER -90.39 138.06 31.85 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.857 0.863 . . . . 1.0 110.442 171.306 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.8 mt -122.65 108.03 12.63 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.089 1.356 . . . . 1.0 111.316 175.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.438 HG13 ' CD1' ' A' ' 123' ' ' LEU . 4.1 mt -95.84 133.74 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 125.227 1.411 . . . . 1.0 112.944 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -107.67 89.31 2.96 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.689 2.796 . . . . 1.0 113.097 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.72 -24.66 67.64 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.814 -1.179 . . . . 1.0 113.162 -173.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.2 m -62.79 -16.26 57.3 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.947 2.099 . . . . 1.0 113.776 172.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -131.38 -28.26 1.9 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.872 2.069 . . . . 1.0 112.658 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -139.01 88.54 13.29 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 126.251 1.821 . . . . 1.0 110.917 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -75.59 11.03 1.71 Allowed 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 123.67 2.913 . . . . 1.0 114.05 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -112.79 68.36 1.04 Allowed Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 127.578 2.351 . . . . 1.0 110.127 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -58.09 -20.03 43.95 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.942 2.428 . . . . 1.0 116.87 -169.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -66.55 -26.53 67.17 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.559 -0.713 . . . . 1.0 112.011 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 26.9 p -71.77 -21.59 61.71 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 120.971 -1.081 . . . . 1.0 111.762 -175.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -95.51 -55.53 3.0 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.124 1.77 . . . . 1.0 112.009 176.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.5 t -71.06 -32.0 68.57 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.809 1.04 . . . . 1.0 113.809 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -62.1 -53.19 61.47 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 120.9 1.682 . . . . 1.0 113.286 -177.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -63.49 -24.79 70.4 Favored 'Trans proline' 0 C--N 1.353 0.787 0 CA-C-N 121.157 1.449 . . . . 1.0 112.36 173.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.429 ' CD1' HD22 ' A' ' 123' ' ' LEU . 91.8 t90 -67.77 -47.98 67.67 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 118.858 0.753 . . . . 1.0 110.764 175.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.4 -32.61 59.0 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.71 -52.13 61.89 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.062 -1.024 . . . . 1.0 109.749 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -64.55 -50.82 65.8 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.882 0.873 . . . . 1.0 111.855 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.423 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 85.6 t90 -59.05 -35.66 73.69 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 125.269 1.428 . . . . 1.0 111.737 175.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.23 -34.39 40.31 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.932 1.254 . . . . 1.0 113.247 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.0 p -68.12 -13.04 61.91 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 114.884 1.439 . . . . 1.0 114.884 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.74 -13.32 54.24 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.525 1.53 . . . . 1.0 112.542 176.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -74.41 169.54 17.49 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.556 1.071 . . . . 1.0 112.005 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.0 t . . . . . 0 C--O 1.257 1.489 0 C-N-CA 125.916 1.686 . . . . 1.0 112.605 -169.458 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 mmt . . . . . 0 N--CA 1.5 2.071 0 CA-C-O 120.369 0.128 . . . . 1.0 111.153 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.24 144.79 53.57 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.495 0.924 . . . . 1.0 113.495 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -117.02 125.38 51.26 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.063 1.345 . . . . 1.0 110.461 173.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 mp -122.91 115.26 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.063 0 C-N-CA 126.262 1.825 . . . . 1.0 112.351 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.49 125.55 8.26 Favored Glycine 0 N--CA 1.462 0.41 0 N-CA-C 110.432 -1.067 . . . . 1.0 110.432 169.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 mt -104.86 121.05 56.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 117.875 0.838 . . . . 1.0 109.071 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -113.66 115.22 27.54 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 124.648 1.179 . . . . 1.0 108.548 -169.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.2 p -93.85 137.6 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 112.537 0.569 . . . . 1.0 112.537 -172.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -117.39 102.76 1.03 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.367 1.46 . . . . 1.0 111.016 172.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.5 m -153.89 156.76 38.15 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.546 1.138 . . . . 1.0 110.465 -169.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.56 138.05 52.62 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.384 0.993 . . . . 1.0 110.321 169.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 55.65 14.21 1.2 Allowed 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 115.161 1.541 . . . . 1.0 115.161 -170.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.63 14.44 69.8 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.681 1.134 . . . . 1.0 115.822 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -62.88 149.05 45.41 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 118.77 1.285 . . . . 1.0 114.016 -174.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.2 p -53.76 -16.64 1.8 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 116.845 2.165 . . . . 1.0 116.845 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.0 tp 55.27 19.25 2.86 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.23 1.412 . . . . 1.0 113.336 -177.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.8 tp 60.84 -57.06 0.09 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.357 2.263 . . . . 1.0 113.975 -169.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.9 t -49.48 -34.26 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 127.077 2.151 . . . . 1.0 112.427 -176.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.01 -47.63 85.55 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.852 1.205 . . . . 1.0 112.978 174.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -67.59 -31.84 72.16 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.744 0.818 . . . . 1.0 110.605 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.77 -49.86 64.57 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 123.785 0.834 . . . . 1.0 109.06 173.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.4 ' HA ' HG12 ' A' ' 141' ' ' VAL . . . -62.3 -42.74 99.62 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 123.633 0.773 . . . . 1.0 112.509 -176.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.15 -51.37 66.69 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 170.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.04 -36.57 80.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.521 -0.737 . . . . 1.0 112.868 -174.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.2 mt -68.62 -47.34 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 119.345 0.975 . . . . 1.0 109.511 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.97 -36.89 85.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.856 0.836 . . . . 1.0 110.657 -177.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.0 m -61.38 -42.02 98.04 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 121.201 -0.937 . . . . 1.0 113.022 170.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.34 -29.57 66.3 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.604 1.162 . . . . 1.0 113.392 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -66.69 -30.67 70.98 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.582 1.153 . . . . 1.0 111.388 170.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.57 11.05 1.75 Allowed Glycine 0 CA--C 1.53 0.988 0 N-CA-C 115.498 0.959 . . . . 1.0 115.498 169.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 -101.21 -177.09 3.34 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.829 1.252 . . . . 1.0 110.898 -174.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -109.71 97.15 6.75 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.973 1.309 . . . . 1.0 108.266 169.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.37 150.12 27.08 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.492 0.317 . . . . 1.0 111.262 176.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.6 m -145.16 147.79 32.86 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.784 1.234 . . . . 1.0 111.509 -175.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.3 t -98.09 138.83 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 114.899 1.444 . . . . 1.0 114.899 174.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -117.66 110.71 18.21 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.742 1.617 . . . . 1.0 110.748 169.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -90.06 144.2 26.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.787 1.635 . . . . 1.0 110.848 170.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 40.29 55.08 6.84 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 125.019 1.328 . . . . 1.0 112.51 -169.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.24 142.2 49.57 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.813 3.009 . . . . 1.0 117.179 -168.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.44 ' HB3' ' H ' ' A' ' 42' ' ' SER . 52.0 mm-40 -97.49 163.24 12.94 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 122.71 1.243 . . . . 1.0 112.783 168.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -67.28 -23.82 65.71 Favored 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 121.004 -1.06 . . . . 1.0 110.461 167.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.44 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 62.9 p -68.39 -18.65 64.51 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.941 -1.1 . . . . 1.0 112.337 172.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -82.49 -24.85 33.96 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.896 0.878 . . . . 1.0 112.178 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -87.52 -36.52 17.56 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.399 1.259 . . . . 1.0 114.399 -178.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.7 mt -46.7 -37.89 10.25 Favored Pre-proline 0 CA--C 1.553 1.069 0 N-CA-C 114.413 1.264 . . . . 1.0 114.413 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -61.11 -14.36 33.07 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 123.745 2.964 . . . . 1.0 116.695 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -107.87 8.4 28.59 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 115.745 1.757 . . . . 1.0 115.745 -173.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -54.85 -27.82 45.21 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.631 1.972 . . . . 1.0 113.874 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -107.67 3.02 24.25 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.562 1.545 . . . . 1.0 113.41 176.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -114.93 -163.34 0.87 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.915 2.486 . . . . 1.0 110.836 -174.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -106.81 162.84 13.45 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 123.387 1.565 . . . . 1.0 110.936 169.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.63 151.66 13.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.253 -1.34 . . . . 1.0 108.056 -173.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.1 tp -133.62 130.27 38.07 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 124.471 1.108 . . . . 1.0 108.667 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.4 t -105.11 126.79 60.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.263 -0.643 . . . . 1.0 109.263 174.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.4 t -122.97 111.38 29.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.963 -1.866 . . . . 1.0 105.963 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -148.29 127.21 12.7 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.496 1.295 . . . . 1.0 114.496 -167.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 t -114.8 176.89 4.86 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.385 1.474 . . . . 1.0 111.581 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.7 m 62.91 47.17 4.53 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 122.453 1.12 . . . . 1.0 112.015 169.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -55.46 -35.22 65.25 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.959 1.303 . . . . 1.0 111.698 169.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 56.91 -134.4 52.1 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 123.661 0.648 . . . . 1.0 112.059 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -63.85 -22.06 66.74 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.362 0.875 . . . . 1.0 113.362 175.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.31 55.22 0.04 OUTLIER Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.598 1.094 . . . . 1.0 113.79 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -144.25 -177.36 5.43 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.957 1.303 . . . . 1.0 112.123 -177.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 17.0 mt -116.46 146.88 38.46 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 126.585 1.954 . . . . 1.0 113.3 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.32 148.08 93.86 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.408 2.738 . . . . 1.0 113.309 169.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -63.91 -20.89 66.19 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.066 1.135 . . . . 1.0 114.066 -175.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.8 p -70.61 -29.34 65.7 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.787 1.235 . . . . 1.0 114.058 173.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.5 tt -107.87 -16.19 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.763 1.625 . . . . 1.0 113.283 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.1 t -44.91 -53.31 16.22 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.422 1.089 . . . . 1.0 112.323 168.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.17 -31.87 28.49 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.647 1.565 . . . . 1.0 111.702 -173.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.2 tp -63.1 -52.15 63.77 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.146 0.978 . . . . 1.0 111.257 169.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -56.02 -53.41 57.27 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.927 0.891 . . . . 1.0 112.385 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -63.88 -39.91 95.3 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.814 0.846 . . . . 1.0 111.544 177.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.76 -36.86 91.83 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 123.47 0.557 . . . . 1.0 112.589 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 82.5 mt -65.19 -47.74 86.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 120.024 1.912 . . . . 1.0 108.412 172.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -71.63 -31.27 66.68 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.224 -1.547 . . . . 1.0 113.289 -171.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -104.42 -38.71 6.71 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 115.519 1.674 . . . . 1.0 115.519 -175.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.1 m -95.09 -22.43 17.9 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.639 1.176 . . . . 1.0 113.326 -174.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.23 -71.71 0.62 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 106.93 -1.507 . . . . 1.0 106.93 170.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.53 -16.86 0.91 Allowed Glycine 0 CA--C 1.538 1.488 0 C-N-CA 127.562 2.506 . . . . 1.0 116.804 169.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -152.27 138.15 18.05 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.862 2.465 . . . . 1.0 108.227 174.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -133.72 124.12 17.65 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 119.086 0.857 . . . . 1.0 112.546 -172.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -82.65 -35.93 0.28 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.598 2.199 . . . . 1.0 114.726 -173.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -144.99 11.1 1.36 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.589 1.7 . . . . 1.0 115.589 -169.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 39.1 tp -75.06 142.05 43.78 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 120.27 -1.519 . . . . 1.0 113.004 -169.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -134.2 144.11 48.26 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 129.317 3.047 . . . . 1.0 107.493 169.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.454 ' CD1' HD11 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -154.38 164.25 38.92 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 120.046 1.294 . . . . 1.0 113.568 179.564 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -125.78 170.67 17.65 Favored Glycine 0 N--CA 1.468 0.8 0 C-N-CA 126.537 2.018 . . . . 1.0 112.248 172.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -160.25 146.6 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 O-C-N 120.836 -1.391 . . . . 1.0 114.442 -169.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.1 mt -138.4 98.69 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 127.92 2.488 . . . . 1.0 107.005 -172.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.09 147.88 23.99 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.408 1.483 . . . . 1.0 111.867 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.4 mp -140.48 152.31 45.52 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.297 0.639 . . . . 1.0 112.629 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.11 -172.26 42.71 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 115.097 0.799 . . . . 1.0 115.097 169.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -87.78 113.91 23.89 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.632 -0.923 . . . . 1.0 110.404 176.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 40.4 p -63.11 -6.06 3.77 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.401 1.26 . . . . 1.0 114.401 177.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.4 t -64.74 -26.06 68.2 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.944 0.898 . . . . 1.0 112.455 169.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -78.22 141.21 38.76 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.043 -1.036 . . . . 1.0 111.94 170.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -48.81 -50.02 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.558 1.543 . . . . 1.0 113.706 177.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -90.13 16.15 8.98 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 115.276 1.584 . . . . 1.0 115.276 -174.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.5 t80 29.32 -82.94 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 129.15 2.98 . . . . 1.0 117.573 171.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.7 m -121.05 19.49 11.61 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.366 1.866 . . . . 1.0 113.317 -171.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -51.06 -28.49 10.51 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.548 1.539 . . . . 1.0 114.009 -177.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.71 -42.78 59.32 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-N 120.436 1.471 . . . . 1.0 113.895 175.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.52 -34.88 18.46 Favored Glycine 0 N--CA 1.478 1.491 0 CA-C-N 118.864 1.332 . . . . 1.0 113.806 174.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -59.48 -32.87 70.66 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 118.465 1.132 . . . . 1.0 112.974 174.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -61.67 -41.69 97.89 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.217 1.007 . . . . 1.0 111.997 170.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -65.28 -34.89 79.42 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.234 0.924 . . . . 1.0 111.671 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -60.61 -55.19 36.26 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.344 0.657 . . . . 1.0 110.95 172.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.64 -34.71 62.56 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.974 0.731 . . . . 1.0 112.974 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.66 -50.29 72.53 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 123.562 1.648 . . . . 1.0 111.692 -178.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.454 HD11 ' CD1' ' A' ' 87' ' ' TYR . 14.9 mt -68.1 -36.98 80.66 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 120.606 -1.309 . . . . 1.0 111.423 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -73.79 -11.96 60.55 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.7 1.0 . . . . 1.0 113.7 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.84 -17.28 41.47 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.758 1.163 . . . . 1.0 110.918 175.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -96.51 -84.03 0.37 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.42 1.488 . . . . 1.0 108.729 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.5 -8.75 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.898 1.679 . . . . 1.0 112.67 -169.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -81.06 162.5 23.73 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 122.156 0.979 . . . . 1.0 113.312 -168.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -106.33 163.55 12.74 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.376 1.071 . . . . 1.0 111.793 -169.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.12 138.93 53.29 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.824 1.65 . . . . 1.0 110.802 -178.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.472 HG13 ' H ' ' A' ' 120' ' ' GLY . 18.5 t -84.91 -162.51 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 125.577 1.551 . . . . 1.0 107.699 173.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.472 ' H ' HG13 ' A' ' 119' ' ' VAL . . . -48.44 152.73 2.32 Favored Glycine 0 N--CA 1.482 1.743 0 O-C-N 120.121 -1.612 . . . . 1.0 113.901 173.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -63.75 151.01 43.27 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 122.746 1.26 . . . . 1.0 112.768 -172.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.43 157.64 37.69 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.992 1.317 . . . . 1.0 113.091 -168.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.441 ' HB2' ' CD1' ' A' ' 140' ' ' TRP . 0.9 OUTLIER -87.21 140.34 29.65 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.749 1.22 . . . . 1.0 110.084 170.128 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.0 mt -127.51 110.65 12.95 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.129 1.372 . . . . 1.0 109.83 173.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.7 mt -99.31 130.66 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.361 1.064 . . . . 1.0 112.929 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -105.55 98.34 8.05 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.648 2.379 . . . . 1.0 113.495 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.28 -22.42 66.84 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.819 1.044 . . . . 1.0 113.819 -175.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.6 t -58.85 -27.06 64.78 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.8 1.24 . . . . 1.0 112.845 171.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -120.34 -30.35 4.61 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.17 1.788 . . . . 1.0 112.303 -169.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -143.42 96.31 5.78 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.111 0.965 . . . . 1.0 112.938 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.42 7.13 4.64 Favored 'Trans proline' 0 CA--C 1.551 1.325 0 C-N-CA 123.877 3.051 . . . . 1.0 114.719 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -110.54 73.15 0.78 Allowed Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 126.539 1.936 . . . . 1.0 109.819 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -59.05 -26.87 83.31 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.753 2.302 . . . . 1.0 115.93 -169.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.7 pm0 -62.66 -25.92 68.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 119.45 1.023 . . . . 1.0 111.213 176.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.6 p -72.15 -15.88 61.98 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 120.974 -1.079 . . . . 1.0 112.788 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -104.18 -55.31 2.38 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.213 1.805 . . . . 1.0 111.894 177.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.5 p -67.95 -33.01 73.85 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 114.02 1.119 . . . . 1.0 114.02 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.8 m-20 -60.94 -56.63 33.13 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 121.035 1.743 . . . . 1.0 112.99 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -62.93 -23.49 74.17 Favored 'Trans proline' 0 C--N 1.353 0.803 0 CA-C-N 121.279 1.492 . . . . 1.0 112.933 174.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.441 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 88.9 t90 -67.53 -46.13 73.69 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 118.561 0.619 . . . . 1.0 110.739 172.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 22' ' ' ALA . 96.6 t -66.19 -34.69 71.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -62.87 -49.87 73.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.212 -0.93 . . . . 1.0 109.588 174.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -63.15 -54.42 38.03 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.602 1.161 . . . . 1.0 111.752 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 87.7 t90 -59.16 -34.43 72.08 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 125.13 1.372 . . . . 1.0 112.05 175.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.4 -33.02 38.92 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.9 1.238 . . . . 1.0 113.272 173.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.6 p -69.27 -11.95 61.25 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.839 1.422 . . . . 1.0 114.839 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.06 -15.34 47.83 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.539 1.536 . . . . 1.0 111.875 177.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -75.81 168.38 20.13 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 119.243 0.929 . . . . 1.0 111.733 -177.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.6 p . . . . . 0 C--O 1.254 1.315 0 C-N-CA 126.633 1.973 . . . . 1.0 114.545 -175.897 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptm . . . . . 0 N--CA 1.5 2.066 0 N-CA-C 112.012 0.375 . . . . 1.0 112.012 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.87 159.32 42.32 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.012 1.116 . . . . 1.0 114.012 -177.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -122.64 121.48 36.53 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.486 1.515 . . . . 1.0 110.865 178.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mp -119.15 113.67 42.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 126.396 1.878 . . . . 1.0 112.444 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.59 124.0 7.18 Favored Glycine 0 C--O 1.223 -0.594 0 N-CA-C 110.89 -0.884 . . . . 1.0 110.89 169.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.8 mt -105.83 122.93 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-N 118.78 1.29 . . . . 1.0 110.131 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -114.82 111.5 21.33 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 -169.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 p -97.6 116.72 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.428 0.632 . . . . 1.0 111.759 -170.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.9 94.66 1.99 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.969 1.271 . . . . 1.0 109.96 170.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.5 p -75.86 165.04 25.58 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.101 1.76 . . . . 1.0 113.957 -169.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.67 170.87 15.28 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.076 1.35 . . . . 1.0 112.516 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -64.32 154.57 34.89 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.31 1.044 . . . . 1.0 112.99 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.8 -135.87 17.12 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 123.844 0.735 . . . . 1.0 111.978 -171.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -66.65 148.21 52.22 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 117.591 0.696 . . . . 1.0 111.72 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.4 t -74.22 167.75 20.97 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.959 0.904 . . . . 1.0 112.957 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.1 tp -82.7 65.2 7.72 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.76 1.624 . . . . 1.0 112.077 -175.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.6 tp -27.63 -44.15 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 129.55 3.14 . . . . 1.0 114.841 170.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.0 t -46.8 -33.77 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.437 1.495 . . . . 1.0 112.547 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.06 -49.17 76.68 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.622 -1.299 . . . . 1.0 113.247 172.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -67.85 -29.68 68.87 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.732 1.213 . . . . 1.0 111.122 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -69.32 -47.34 64.73 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 123.91 0.884 . . . . 1.0 109.127 173.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.442 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.05 -42.43 94.25 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 112.3 0.481 . . . . 1.0 112.3 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -52.74 -49.98 64.37 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.945 0.898 . . . . 1.0 110.273 169.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.17 -38.04 72.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.255 0.622 . . . . 1.0 112.556 -174.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.5 mt -66.43 -48.64 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-N 119.041 0.837 . . . . 1.0 109.089 175.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.84 -35.72 82.02 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.927 0.87 . . . . 1.0 110.427 -176.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.2 m -61.98 -41.46 98.06 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.633 1.173 . . . . 1.0 113.504 170.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.92 -30.59 69.08 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.559 1.144 . . . . 1.0 112.665 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -69.95 -30.5 67.88 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.466 0.707 . . . . 1.0 112.091 171.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.01 16.73 1.92 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.987 0.803 . . . . 1.0 114.827 169.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -99.0 174.92 6.11 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.311 1.044 . . . . 1.0 110.123 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -103.73 91.2 3.9 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.918 1.287 . . . . 1.0 108.414 171.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.14 145.99 29.39 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.392 0.277 . . . . 1.0 110.98 176.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.1 m -146.74 137.65 24.02 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.901 0.88 . . . . 1.0 112.023 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.9 t -84.53 136.03 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 114.855 1.428 . . . . 1.0 114.855 170.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -113.13 109.54 18.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.905 2.082 . . . . 1.0 109.915 169.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -90.24 139.4 30.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.327 1.851 . . . . 1.0 110.932 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t0 43.26 53.56 9.6 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 124.387 1.075 . . . . 1.0 111.033 -169.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -68.74 141.7 50.39 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.718 2.945 . . . . 1.0 116.289 -168.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.475 ' HB3' ' H ' ' A' ' 42' ' ' SER . 56.1 mm-40 -93.57 162.01 14.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 122.373 1.082 . . . . 1.0 111.774 168.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -65.21 -20.76 66.59 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.02 -1.05 . . . . 1.0 109.838 167.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.475 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 15.1 m -68.28 -22.12 64.75 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 120.861 -1.15 . . . . 1.0 112.297 172.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -80.59 -27.9 37.25 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.964 0.906 . . . . 1.0 112.062 169.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 16.0 t-105 -85.21 -37.39 20.17 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.915 1.08 . . . . 1.0 113.915 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.9 mt -42.94 -44.61 10.89 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 114.998 1.481 . . . . 1.0 114.998 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.92 -2.22 8.31 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.351 2.034 . . . . 1.0 115.575 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.41 ' CD2' ' HE2' ' A' ' 50' ' ' LYS . 96.6 m-85 -108.29 8.66 27.84 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 115.793 1.775 . . . . 1.0 115.793 176.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -51.81 -27.73 13.34 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.786 2.034 . . . . 1.0 114.242 174.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.09 12.56 14.55 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.591 1.156 . . . . 1.0 112.494 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.41 ' HE2' ' CD2' ' A' ' 47' ' ' TYR . 22.4 mtmm -127.51 -163.81 1.3 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.109 2.564 . . . . 1.0 111.346 -174.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -109.96 158.11 18.57 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 122.921 1.343 . . . . 1.0 112.955 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.44 161.99 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.121 1.368 . . . . 1.0 109.828 -173.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.0 tp -139.75 130.31 25.7 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.406 1.482 . . . . 1.0 108.227 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.3 t -104.71 123.8 58.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 124.403 1.081 . . . . 1.0 108.919 173.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.1 t -122.04 111.28 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.551 -2.018 . . . . 1.0 105.551 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.2 t -148.97 128.63 13.22 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.572 1.323 . . . . 1.0 114.572 -167.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.3 t -106.16 175.18 5.58 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.38 1.072 . . . . 1.0 112.198 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 m 64.57 59.59 0.95 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.109 1.363 . . . . 1.0 112.938 169.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 m -57.58 -32.49 67.2 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.479 1.911 . . . . 1.0 113.928 170.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 51.59 -126.98 29.79 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.099 0.856 . . . . 1.0 114.362 173.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -84.65 23.53 1.14 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.786 1.634 . . . . 1.0 112.729 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.66 32.14 16.41 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 124.648 1.118 . . . . 1.0 111.973 -169.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -118.58 171.45 8.17 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.103 2.161 . . . . 1.0 112.25 -175.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.2 mt -122.01 152.28 59.58 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.48 1.112 . . . . 1.0 113.471 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.6 147.09 88.85 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.406 2.737 . . . . 1.0 113.361 169.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -61.18 -24.42 66.3 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.665 0.987 . . . . 1.0 113.665 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 59.8 p -71.46 -21.2 61.98 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.256 1.206 . . . . 1.0 114.256 175.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.5 tt -119.17 -13.53 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.442 1.497 . . . . 1.0 114.134 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.9 t -45.7 -53.61 19.23 Favored Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 124.484 1.114 . . . . 1.0 112.1 168.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -67.78 -31.17 32.68 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.665 1.577 . . . . 1.0 111.79 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.0 tp -63.15 -54.3 39.91 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 124.271 1.028 . . . . 1.0 111.32 169.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -55.23 -52.03 64.69 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.723 0.809 . . . . 1.0 112.464 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -65.11 -40.14 94.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.43 -0.805 . . . . 1.0 111.382 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.17 -33.59 78.8 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.488 -0.618 . . . . 1.0 112.837 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 93.4 mt -65.19 -47.75 86.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 120.115 1.958 . . . . 1.0 108.676 170.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -72.61 -31.54 65.24 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.347 -1.47 . . . . 1.0 113.232 -171.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -104.87 -39.85 6.15 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.719 1.608 . . . . 1.0 115.302 -174.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.0 m -92.89 -24.27 18.51 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.125 0.97 . . . . 1.0 113.13 -175.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.413 ' CD1' HE22 ' A' ' 82' ' ' GLN . 0.1 OUTLIER -90.36 -72.03 0.59 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.9 -1.148 . . . . 1.0 107.9 171.505 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.44 -13.11 2.25 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 126.612 2.053 . . . . 1.0 116.331 169.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -156.89 139.85 15.33 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.335 2.254 . . . . 1.0 108.653 173.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.413 HE22 ' CD1' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -134.77 126.13 17.76 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 118.756 0.707 . . . . 1.0 111.373 -171.244 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -82.18 -41.36 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.532 2.154 . . . . 1.0 113.832 -173.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -145.77 21.2 1.46 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.681 1.192 . . . . 1.0 113.878 -170.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 65.0 tp -81.83 135.14 35.46 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.757 -1.214 . . . . 1.0 112.27 -169.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.5 mtm-85 -134.6 154.16 51.62 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.003 2.121 . . . . 1.0 109.534 169.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.47 169.08 23.75 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.569 -0.707 . . . . 1.0 111.644 -176.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -128.41 171.35 19.52 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 124.167 0.889 . . . . 1.0 113.672 170.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.7 140.12 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 113.978 1.103 . . . . 1.0 113.978 -169.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.4 mt -132.12 99.13 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 125.824 1.65 . . . . 1.0 107.065 169.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.05 142.08 28.06 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.731 1.613 . . . . 1.0 112.195 173.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.4 mp -138.51 156.98 47.03 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.169 0.804 . . . . 1.0 113.169 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.29 -176.04 42.25 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 115.504 -0.771 . . . . 1.0 113.277 169.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -95.57 118.81 32.97 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.078 -1.248 . . . . 1.0 111.714 172.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 65.8 p -60.56 -11.92 8.47 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.969 1.1 . . . . 1.0 113.969 175.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.8 m -58.86 -18.2 30.68 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.721 1.608 . . . . 1.0 112.829 169.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -112.1 151.0 29.94 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.3 1.84 . . . . 1.0 110.996 169.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.1 m -70.72 172.71 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.003 0.921 . . . . 1.0 112.105 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 65.68 0.13 1.4 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.057 2.143 . . . . 1.0 116.604 -170.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 15.7 t80 27.89 -80.44 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 129.505 3.122 . . . . 1.0 116.915 -172.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.452 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 24.5 p -121.77 5.8 9.96 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.209 2.204 . . . . 1.0 113.707 -170.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -60.18 -21.63 61.93 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 125.317 1.447 . . . . 1.0 114.173 -169.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.14 -31.03 77.49 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 120.832 1.651 . . . . 1.0 113.74 174.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.84 -37.0 17.39 Favored Glycine 0 N--CA 1.479 1.528 0 O-C-N 121.019 -1.283 . . . . 1.0 113.03 169.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.452 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 82.5 mttt -61.77 -29.36 70.08 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 121.025 -1.279 . . . . 1.0 112.642 172.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -62.85 -36.67 84.02 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.944 1.298 . . . . 1.0 111.747 170.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -65.8 -36.5 83.68 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.396 0.998 . . . . 1.0 111.781 172.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -63.67 -50.16 70.36 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.49 -0.757 . . . . 1.0 111.408 174.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.15 -33.73 65.47 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.674 0.79 . . . . 1.0 112.755 174.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.96 -49.68 76.95 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 123.349 1.547 . . . . 1.0 111.019 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.3 mt -66.65 -38.26 86.51 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 120.841 -1.162 . . . . 1.0 111.788 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -69.22 -20.05 63.96 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.801 1.037 . . . . 1.0 113.801 175.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.02 -16.83 59.17 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.845 0.858 . . . . 1.0 110.942 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -98.59 -74.35 0.59 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.92 1.288 . . . . 1.0 109.344 177.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.2 p 177.15 -17.27 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.713 2.005 . . . . 1.0 113.986 -173.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.36 159.21 33.59 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.716 1.376 . . . . 1.0 114.716 -169.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -97.02 170.24 9.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.223 1.809 . . . . 1.0 112.122 -169.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.67 151.41 49.25 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.463 1.105 . . . . 1.0 112.23 175.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.32 133.4 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.028 1.731 . . . . 1.0 109.621 -169.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 50.47 -158.79 1.74 Allowed Glycine 0 N--CA 1.48 1.582 0 C-N-CA 125.181 1.372 . . . . 1.0 115.268 -176.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -105.01 139.49 39.61 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.423 1.489 . . . . 1.0 109.504 169.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -76.11 155.32 34.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.901 0.857 . . . . 1.0 111.927 -172.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 140' ' ' TRP . 1.4 tm? -89.54 138.51 31.4 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.504 1.122 . . . . 1.0 110.276 174.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 mt -128.95 108.02 10.08 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.979 1.711 . . . . 1.0 109.749 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 29.8 mt -99.3 134.55 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.437 1.095 . . . . 1.0 112.885 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -105.13 109.47 21.47 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 124.478 1.111 . . . . 1.0 112.629 169.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.67 -23.95 61.76 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.54 1.136 . . . . 1.0 113.431 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.0 t -66.99 -19.46 65.72 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.371 1.069 . . . . 1.0 112.81 174.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -116.1 -30.11 6.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.084 1.753 . . . . 1.0 111.785 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -140.52 87.07 11.9 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.54 1.536 . . . . 1.0 111.638 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.04 7.82 1.93 Allowed 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 123.648 2.899 . . . . 1.0 114.559 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -114.73 69.06 2.1 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 127.715 2.406 . . . . 1.0 110.136 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -56.94 -22.53 46.73 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.605 2.204 . . . . 1.0 116.805 -169.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -64.26 -25.63 68.14 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.292 0.951 . . . . 1.0 111.811 174.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.8 p -72.86 -18.63 61.42 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.004 -1.06 . . . . 1.0 111.815 -175.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -101.77 -54.44 2.73 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.039 1.735 . . . . 1.0 111.475 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 64.7 p -69.8 -34.61 73.94 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.775 1.028 . . . . 1.0 113.775 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -60.16 -57.15 28.78 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 120.706 1.594 . . . . 1.0 112.558 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -62.17 -24.39 76.26 Favored 'Trans proline' 0 C--N 1.352 0.743 0 CA-C-N 121.273 1.49 . . . . 1.0 112.902 174.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 83.9 t90 -67.29 -45.5 76.39 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 119.062 0.846 . . . . 1.0 110.937 173.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.442 HG11 ' HA ' ' A' ' 22' ' ' ALA . 97.8 t -63.81 -33.61 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.635 -0.876 . . . . 1.0 108.635 176.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -70.0 -27.18 64.49 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 120.603 -1.311 . . . . 1.0 113.04 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -82.99 -56.59 3.71 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.352 1.461 . . . . 1.0 111.725 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -56.47 -36.39 69.03 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 125.855 1.662 . . . . 1.0 112.973 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.37 -32.89 30.97 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.825 1.202 . . . . 1.0 114.048 173.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.9 p -68.6 -13.24 62.22 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 114.405 1.261 . . . . 1.0 114.405 177.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.61 -17.49 51.17 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.471 1.509 . . . . 1.0 111.891 176.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -83.83 171.11 13.42 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.033 0.833 . . . . 1.0 111.887 -175.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.5 t . . . . . 0 C--O 1.255 1.351 0 C-N-CA 126.178 1.791 . . . . 1.0 113.033 -174.909 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 113.521 0.934 . . . . 1.0 113.521 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -123.46 123.74 41.33 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.991 1.316 . . . . 1.0 110.48 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.567 HD13 HD12 ' A' ' 26' ' ' LEU . 2.2 mp -117.11 115.6 49.38 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.065 0 C-N-CA 126.168 1.787 . . . . 1.0 112.845 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.48 119.48 5.61 Favored Glycine 0 C--O 1.224 -0.519 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 169.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.6 mt -103.25 120.97 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 118.04 0.92 . . . . 1.0 109.171 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -118.39 115.99 25.81 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.153 -1.054 . . . . 1.0 108.153 -171.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.473 0.685 0 C-N-CA 122.833 0.453 . . . . 1.0 112.109 -170.602 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.5 tp . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 115.123 1.527 . . . . 1.0 115.123 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.5 t -54.77 -32.5 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.667 0.787 . . . . 1.0 112.529 -169.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.92 -48.81 78.81 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.852 -1.155 . . . . 1.0 113.461 172.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -69.15 -30.38 68.6 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.545 0.738 . . . . 1.0 110.969 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.73 -47.91 70.83 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.537 0.735 . . . . 1.0 109.237 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.537 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -64.96 -43.35 92.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 112.559 0.577 . . . . 1.0 112.559 -175.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -53.54 -48.69 68.86 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.051 0.94 . . . . 1.0 110.455 170.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.17 -37.84 69.24 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.495 0.718 . . . . 1.0 112.697 -174.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.7 mt -65.55 -46.65 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 CA-C-N 119.288 0.949 . . . . 1.0 109.141 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.567 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -66.72 -35.48 80.22 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 119.442 -0.903 . . . . 1.0 110.276 -176.283 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.6 m -62.34 -41.19 98.38 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.21 1.404 . . . . 1.0 113.57 170.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.94 -33.81 75.4 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.397 1.079 . . . . 1.0 111.9 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -71.59 -29.01 64.21 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.749 1.22 . . . . 1.0 112.806 172.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.44 25.92 2.54 Favored Glycine 0 N--CA 1.468 0.812 0 C-N-CA 124.378 0.989 . . . . 1.0 114.323 169.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -114.11 146.19 40.61 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.536 1.134 . . . . 1.0 109.574 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -84.1 83.27 8.02 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.859 1.263 . . . . 1.0 108.729 -173.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.91 146.65 26.41 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.301 0.641 . . . . 1.0 111.13 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.8 m -146.98 137.95 23.89 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.696 0.799 . . . . 1.0 112.772 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.3 t -84.35 136.76 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 115.109 1.522 . . . . 1.0 115.109 171.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -115.75 117.6 30.69 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.871 2.069 . . . . 1.0 110.595 169.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -93.12 147.93 22.44 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.287 1.835 . . . . 1.0 110.717 173.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 41.84 61.07 8.57 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 125.125 1.37 . . . . 1.0 112.022 -169.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -48.79 123.87 10.3 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.406 3.404 . . . . 1.0 119.883 -168.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -94.28 146.62 23.9 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.907 1.283 . . . . 1.0 111.285 168.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.49 HD21 HD21 ' A' ' 79' ' ' LEU . 2.4 tm? -71.09 -25.01 62.42 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 121.447 -0.783 . . . . 1.0 110.141 169.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.7 m -67.15 -19.02 65.53 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.493 -0.754 . . . . 1.0 112.609 170.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -91.7 -21.9 20.5 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.587 1.155 . . . . 1.0 113.443 169.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.473 ' HB3' HD22 ' A' ' 41' ' ' LEU . 10.8 t-105 -79.54 -35.02 40.56 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 120.028 1.286 . . . . 1.0 113.36 172.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.1 mt -50.86 -39.54 55.29 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 117.622 -1.18 . . . . 1.0 113.884 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -52.55 -16.62 5.62 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 124.432 3.421 . . . . 1.0 117.495 171.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -107.85 8.61 28.74 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.982 1.845 . . . . 1.0 115.982 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -52.7 -31.12 35.83 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.224 1.81 . . . . 1.0 113.749 173.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -112.66 13.35 19.9 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.102 1.361 . . . . 1.0 112.389 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -126.97 -158.3 0.86 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.613 2.365 . . . . 1.0 111.214 -174.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -114.14 162.81 16.04 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 122.947 1.356 . . . . 1.0 111.833 172.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.524 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -147.71 156.99 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.329 1.452 . . . . 1.0 109.007 -171.619 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.0 tp -137.38 129.3 28.96 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.813 1.245 . . . . 1.0 109.117 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.6 t -106.03 122.17 59.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.216 -0.661 . . . . 1.0 109.216 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.1 t -120.11 111.31 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 106.871 -1.529 . . . . 1.0 106.871 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 114.217 1.191 . . . . 1.0 114.217 -168.341 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.1 tt . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 114.236 1.198 . . . . 1.0 114.236 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -43.33 -53.07 11.89 Favored Pre-proline 0 N--CA 1.478 0.948 0 C-N-CA 124.643 1.177 . . . . 1.0 112.604 168.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.83 -31.71 19.67 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 121.576 1.517 . . . . 1.0 111.774 -172.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.4 tp -63.47 -51.26 66.39 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.333 1.053 . . . . 1.0 111.419 169.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.664 ' CE1' HD23 ' A' ' 110' ' ' LEU . 91.3 t80 -56.31 -52.46 64.45 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.121 0.968 . . . . 1.0 112.364 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -63.2 -39.41 94.56 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.787 0.835 . . . . 1.0 111.443 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.72 -36.84 92.83 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.064 0.84 . . . . 1.0 112.728 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.572 HG22 HD12 ' A' ' 110' ' ' LEU . 86.4 mt -65.37 -51.18 67.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 119.949 1.875 . . . . 1.0 107.976 172.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.709 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.4 ptmm? -69.25 -31.14 69.49 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 120.39 -1.444 . . . . 1.0 113.564 -169.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -103.43 -38.0 7.37 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.777 1.631 . . . . 1.0 115.279 -176.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.6 m -95.57 -20.88 18.63 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.468 1.107 . . . . 1.0 113.229 -175.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.49 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -91.67 -71.94 0.61 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 106.872 -1.529 . . . . 1.0 106.872 169.555 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.98 -18.92 1.06 Allowed Glycine 0 CA--C 1.539 1.58 0 C-N-CA 127.644 2.545 . . . . 1.0 115.265 169.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -151.87 138.99 19.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 128.386 2.674 . . . . 1.0 107.896 169.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.427 HE21 HD12 ' A' ' 79' ' ' LEU . 11.1 mt-30 -137.75 121.78 11.85 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 118.664 -0.684 . . . . 1.0 109.637 -171.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.72 -35.77 0.28 Allowed 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.422 2.081 . . . . 1.0 115.39 -169.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -141.68 15.51 2.15 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.292 1.219 . . . . 1.0 114.292 -169.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.524 HD11 ' CG2' ' A' ' 52' ' ' VAL . 64.9 tp -80.79 139.93 35.77 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 120.563 -1.336 . . . . 1.0 113.027 -169.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -137.12 154.74 50.21 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.66 2.384 . . . . 1.0 109.032 169.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.624 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -161.02 163.85 31.35 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.244 0.929 . . . . 1.0 112.217 -176.153 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.409 ' HA3' ' CE2' ' A' ' 144' ' ' TRP . . . -123.65 172.22 16.27 Favored Glycine 0 N--CA 1.467 0.703 0 C-N-CA 125.707 1.622 . . . . 1.0 112.109 169.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.551 HG13 ' HB3' ' A' ' 122' ' ' MET . 0.2 OUTLIER -160.52 145.56 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 O-C-N 121.161 -1.199 . . . . 1.0 114.086 -169.362 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.97 HG23 HD12 ' A' ' 123' ' ' LEU . 8.6 mt -134.76 100.26 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 127.794 2.438 . . . . 1.0 106.942 -175.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.27 146.17 24.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.267 1.427 . . . . 1.0 111.581 173.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.6 mp -140.09 156.45 46.57 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.453 0.701 . . . . 1.0 112.269 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.496 0 CA-C-N 116.208 -0.451 . . . . 1.0 112.499 169.438 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.545 0.772 0 N-CA-C 113.191 0.812 . . . . 1.0 113.191 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -53.01 -25.51 12.47 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.082 1.353 . . . . 1.0 114.37 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.87 -43.47 60.88 Favored Glycine 0 CA--C 1.538 1.519 0 CA-C-N 121.522 1.965 . . . . 1.0 114.878 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -80.12 -33.5 32.51 Favored Glycine 0 N--CA 1.481 1.691 0 O-C-N 120.711 -1.464 . . . . 1.0 113.768 173.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -62.41 -33.41 74.72 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 121.366 -1.079 . . . . 1.0 112.672 174.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 40.7 mm-40 -60.63 -42.57 97.16 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.891 0.876 . . . . 1.0 111.163 169.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -64.05 -36.82 85.25 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.566 -0.709 . . . . 1.0 111.998 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -62.42 -49.62 74.74 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.405 -0.81 . . . . 1.0 112.498 173.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.34 -35.73 67.97 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.503 0.556 . . . . 1.0 112.503 174.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.709 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -58.04 -51.3 70.25 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 123.113 1.435 . . . . 1.0 110.926 -178.172 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.624 HD12 ' CD1' ' A' ' 87' ' ' TYR . 7.1 mt -65.74 -38.84 90.21 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 121.033 -1.042 . . . . 1.0 111.64 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -70.51 -18.92 62.95 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.344 0.868 . . . . 1.0 113.344 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.83 -19.01 58.03 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.298 0.954 . . . . 1.0 110.869 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -99.86 -76.8 0.54 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.886 1.274 . . . . 1.0 110.953 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.9 m -178.17 -2.88 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.587 1.955 . . . . 1.0 112.818 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -77.95 162.47 26.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 122.31 1.052 . . . . 1.0 113.304 -169.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -102.53 174.58 5.84 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.817 1.647 . . . . 1.0 113.221 -168.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.6 153.3 42.4 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.159 2.184 . . . . 1.0 112.433 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.5 t -126.78 127.66 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 126.206 1.802 . . . . 1.0 108.46 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 49.21 -156.52 1.53 Allowed Glycine 0 N--CA 1.48 1.615 0 C-N-CA 125.032 1.301 . . . . 1.0 114.615 -169.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -118.22 144.82 45.46 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.856 1.662 . . . . 1.0 109.803 169.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.551 ' HB3' HG13 ' A' ' 89' ' ' VAL . 1.1 pmm? -71.91 155.39 40.43 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.224 1.012 . . . . 1.0 113.063 -169.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.97 HD12 HG23 ' A' ' 90' ' ' ILE . 1.1 tm? -84.18 139.62 32.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.048 -0.978 . . . . 1.0 109.815 170.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.5 mt -127.38 110.15 12.5 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.363 1.465 . . . . 1.0 110.098 173.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.563 ' CD1' HD11 ' A' ' 123' ' ' LEU . 24.4 mt -98.56 129.86 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.092 0.957 . . . . 1.0 112.749 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -103.75 110.92 23.2 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 122.278 1.037 . . . . 1.0 112.55 171.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.21 -22.44 64.8 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.623 1.169 . . . . 1.0 113.379 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.0 t -65.13 -21.99 66.87 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.897 0.879 . . . . 1.0 112.795 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -119.25 -30.5 4.92 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.162 1.785 . . . . 1.0 111.98 -174.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -142.34 85.95 10.32 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.073 1.349 . . . . 1.0 111.975 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.79 7.84 2.22 Favored 'Trans proline' 0 CA--C 1.551 1.333 0 C-N-CA 123.625 2.883 . . . . 1.0 114.419 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -113.79 69.56 1.63 Allowed Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 127.432 2.293 . . . . 1.0 109.909 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -56.6 -24.45 54.06 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.667 2.245 . . . . 1.0 116.304 -169.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.8 pm0 -66.08 -24.43 66.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 119.385 0.993 . . . . 1.0 111.725 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 15.1 p -73.78 -15.53 61.19 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.661 -1.274 . . . . 1.0 112.27 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.434 ' HB2' HD11 ' A' ' 125' ' ' ILE . 5.0 mm-40 -105.02 -55.44 2.33 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.296 1.838 . . . . 1.0 111.482 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 65.7 p -69.29 -33.88 73.87 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 113.938 1.088 . . . . 1.0 113.938 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -60.57 -57.45 26.44 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 120.801 1.637 . . . . 1.0 112.485 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -62.96 -23.35 74.13 Favored 'Trans proline' 0 C--N 1.354 0.832 0 CA-C-N 121.386 1.531 . . . . 1.0 112.449 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.467 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 86.8 t90 -67.12 -46.82 72.98 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 119.258 0.936 . . . . 1.0 110.749 173.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.537 HG11 ' HA ' ' A' ' 22' ' ' ALA . 96.1 t -63.4 -33.83 63.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 108.922 -0.77 . . . . 1.0 108.922 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.76 -28.35 65.7 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.823 1.249 . . . . 1.0 113.132 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -81.83 -56.96 3.65 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.169 1.388 . . . . 1.0 112.073 169.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.41 ' CZ3' HD11 ' A' ' 26' ' ' LEU . 85.1 t90 -57.14 -36.93 71.3 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 125.498 1.519 . . . . 1.0 112.727 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.83 -33.01 34.65 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.766 1.174 . . . . 1.0 113.765 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.8 p -65.79 -13.99 60.5 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.576 1.325 . . . . 1.0 114.576 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.27 -16.78 53.93 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.008 1.723 . . . . 1.0 112.005 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.17 -176.98 5.89 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.174 1.39 . . . . 1.0 110.754 -176.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 31.9 m . . . . . 0 C--O 1.253 1.277 0 C-N-CA 125.624 1.57 . . . . 1.0 115.01 -172.045 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.403 0 N-CA-C 112.678 0.622 . . . . 1.0 112.678 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -120.67 124.42 45.18 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.664 1.586 . . . . 1.0 110.466 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.518 HD13 HD12 ' A' ' 26' ' ' LEU . 2.0 mp -123.14 113.47 37.95 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.071 0 C-N-CA 125.963 1.705 . . . . 1.0 112.664 -178.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.8 123.64 7.18 Favored Glycine 0 C--O 1.224 -0.523 0 N-CA-C 110.551 -1.019 . . . . 1.0 110.551 169.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.4 mt -105.15 122.23 58.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 118.184 0.992 . . . . 1.0 109.459 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -114.16 108.75 17.39 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 124.869 1.268 . . . . 1.0 108.277 -169.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.533 0.307 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.037 -173.284 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.4 tp . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 115.265 1.58 . . . . 1.0 115.265 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.2 t -53.65 -35.29 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.913 1.685 . . . . 1.0 112.47 -175.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.21 -45.79 87.02 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.858 -1.151 . . . . 1.0 112.487 174.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.83 -31.08 68.77 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.586 1.154 . . . . 1.0 110.759 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -66.56 -48.23 70.3 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.239 0.616 . . . . 1.0 109.341 170.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.536 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.41 -42.9 92.05 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 112.823 0.675 . . . . 1.0 112.823 -173.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -54.01 -49.24 69.31 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 123.717 0.807 . . . . 1.0 110.409 169.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.99 -37.0 69.92 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.285 0.634 . . . . 1.0 112.491 -174.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.4 mt -66.41 -46.96 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 119.015 0.825 . . . . 1.0 109.191 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.518 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -67.52 -34.65 77.54 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 119.57 -0.852 . . . . 1.0 110.613 -176.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.6 m -62.58 -40.07 95.71 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.226 1.41 . . . . 1.0 113.484 170.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.87 -32.72 72.58 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.177 0.991 . . . . 1.0 112.066 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -70.6 -29.77 66.26 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.597 1.159 . . . . 1.0 113.059 170.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.91 23.05 3.12 Favored Glycine 0 N--CA 1.47 0.95 0 C-N-CA 124.516 1.055 . . . . 1.0 114.585 169.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -109.61 151.99 26.11 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.363 1.065 . . . . 1.0 109.652 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.3 tptt -85.39 85.55 7.43 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.756 1.223 . . . . 1.0 108.665 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.3 145.44 28.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.68 -0.691 . . . . 1.0 111.11 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.2 m -147.3 139.02 24.13 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.843 0.857 . . . . 1.0 112.341 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.1 t -86.78 136.08 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 115.022 1.49 . . . . 1.0 115.022 171.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -113.43 113.5 25.27 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.331 1.852 . . . . 1.0 110.017 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -93.56 138.24 32.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.131 1.772 . . . . 1.0 110.848 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 42.39 55.06 9.8 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 124.498 1.119 . . . . 1.0 111.309 -169.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -67.84 140.09 49.66 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.699 2.933 . . . . 1.0 117.089 -168.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -93.64 163.46 13.54 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 122.466 1.127 . . . . 1.0 111.986 168.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.604 HD21 HD21 ' A' ' 79' ' ' LEU . 2.1 tm? -66.76 -22.61 66.04 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 121.074 -1.016 . . . . 1.0 110.738 167.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.2 p -68.57 -18.44 64.34 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.959 1.254 . . . . 1.0 112.386 171.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -82.67 -25.22 33.24 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.174 0.99 . . . . 1.0 112.276 169.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.467 ' HB3' HD22 ' A' ' 41' ' ' LEU . 11.1 t-105 -89.38 -33.81 16.73 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.175 1.176 . . . . 1.0 114.175 -177.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.6 mt -48.2 -38.67 22.38 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 117.549 -1.215 . . . . 1.0 114.046 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.2 -6.92 7.24 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 124.053 3.169 . . . . 1.0 116.863 175.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -114.76 6.17 15.48 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 116.126 1.899 . . . . 1.0 116.126 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -50.25 -29.44 9.56 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.562 1.945 . . . . 1.0 113.824 171.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -105.53 7.92 33.14 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 128.144 2.578 . . . . 1.0 113.156 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -132.78 -161.36 1.13 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.933 2.093 . . . . 1.0 112.728 -168.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -110.59 157.48 19.62 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 123.191 1.472 . . . . 1.0 111.042 171.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.605 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -144.81 155.63 14.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 124.941 1.297 . . . . 1.0 108.285 -172.295 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.6 tp -134.98 127.74 31.09 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 124.568 1.147 . . . . 1.0 108.642 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.8 t -102.8 124.21 56.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.338 -0.616 . . . . 1.0 109.338 175.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.7 t -124.64 108.72 20.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 106.493 -1.669 . . . . 1.0 106.493 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 113.923 1.083 . . . . 1.0 113.923 -167.99 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.7 tt . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 113.818 1.044 . . . . 1.0 113.818 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.1 t -45.77 -53.5 20.06 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.432 1.093 . . . . 1.0 112.52 168.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -67.98 -33.66 25.41 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.531 1.487 . . . . 1.0 111.537 -173.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.4 tp -61.2 -53.03 62.1 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 124.586 1.154 . . . . 1.0 111.287 170.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.692 ' CE1' HD23 ' A' ' 110' ' ' LEU . 91.9 t80 -54.3 -53.49 53.1 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.128 0.971 . . . . 1.0 112.25 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -64.02 -40.5 96.47 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.792 0.837 . . . . 1.0 111.531 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.11 -35.93 89.6 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.563 0.601 . . . . 1.0 112.642 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.612 HG22 HD12 ' A' ' 110' ' ' LEU . 89.8 mt -64.82 -47.79 87.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 120.173 1.986 . . . . 1.0 108.259 172.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.739 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.2 ptmm? -71.5 -32.58 68.39 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.566 -1.333 . . . . 1.0 113.201 -171.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -105.17 -36.97 7.07 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.161 1.541 . . . . 1.0 115.161 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.9 m -94.05 -24.98 17.39 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.23 1.012 . . . . 1.0 112.84 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.604 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -90.49 -71.59 0.61 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.415 -1.328 . . . . 1.0 107.415 169.468 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.98 -8.46 2.5 Favored Glycine 0 CA--C 1.543 1.786 0 C-N-CA 126.419 1.962 . . . . 1.0 115.13 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -153.88 146.45 24.12 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 129.851 3.26 . . . . 1.0 106.906 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -136.62 125.37 15.25 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 123.192 0.597 . . . . 1.0 111.099 -176.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.97 -41.85 0.14 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 121.983 1.789 . . . . 1.0 114.314 -171.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -147.84 22.54 1.12 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.829 1.252 . . . . 1.0 113.129 -171.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.605 HD11 ' CG2' ' A' ' 52' ' ' VAL . 53.0 tp -83.2 137.6 33.96 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.624 -1.298 . . . . 1.0 113.909 -169.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -135.23 153.94 51.75 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 127.821 2.448 . . . . 1.0 108.957 169.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.665 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -158.07 164.77 36.37 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.316 -0.865 . . . . 1.0 112.302 -177.352 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -124.88 172.26 17.02 Favored Glycine 0 N--CA 1.467 0.766 0 C-N-CA 125.703 1.62 . . . . 1.0 111.978 169.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.576 HG13 ' HB3' ' A' ' 122' ' ' MET . 0.2 OUTLIER -159.03 146.45 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 O-C-N 120.875 -1.367 . . . . 1.0 114.44 -169.492 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.7 mt -133.45 105.64 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 127.308 2.243 . . . . 1.0 107.738 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.91 144.32 26.03 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.416 1.486 . . . . 1.0 110.863 175.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.5 mp -137.93 155.35 49.0 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.652 0.612 . . . . 1.0 112.652 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.598 0 CA-C-N 116.15 -0.477 . . . . 1.0 113.639 169.361 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.406 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 17.4 p . . . . . 0 CA--C 1.541 0.61 0 N-CA-C 113.019 0.748 . . . . 1.0 113.019 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -62.06 -19.04 62.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.257 1.423 . . . . 1.0 114.257 -169.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.34 -52.62 52.12 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-N 120.432 1.469 . . . . 1.0 113.732 174.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.41 -34.98 68.59 Favored Glycine 0 N--CA 1.479 1.51 0 O-C-N 120.807 -1.408 . . . . 1.0 112.995 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.406 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 87.0 mttt -63.41 -35.33 80.05 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.536 1.134 . . . . 1.0 113.137 173.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -64.34 -39.72 94.45 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 119.062 -0.495 . . . . 1.0 111.735 169.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -61.34 -33.49 73.71 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 118.961 0.801 . . . . 1.0 111.843 174.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -66.32 -51.81 53.53 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.571 0.748 . . . . 1.0 111.359 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.76 -35.24 63.56 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.657 0.783 . . . . 1.0 112.863 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.739 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -58.05 -49.91 75.27 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-O 123.3 1.524 . . . . 1.0 110.867 -179.066 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.665 HD12 ' CD1' ' A' ' 87' ' ' TYR . 12.4 mt -67.27 -37.53 83.6 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 120.907 -1.12 . . . . 1.0 112.117 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -69.12 -20.87 64.05 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.54 -16.43 58.67 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.249 0.931 . . . . 1.0 110.991 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -100.29 -78.51 0.51 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.165 1.386 . . . . 1.0 110.175 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -175.72 -13.58 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.751 -1.568 . . . . 1.0 113.347 -169.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -80.44 163.06 24.1 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.966 1.469 . . . . 1.0 114.966 -168.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -103.76 175.5 5.46 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.046 1.738 . . . . 1.0 112.183 -169.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.02 141.89 48.52 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.232 1.813 . . . . 1.0 110.349 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 120' ' ' GLY 0.257 12.9 t -93.54 -161.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 125.55 1.54 . . . . 1.0 106.85 174.004 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.547 ' H ' HG12 ' A' ' 119' ' ' VAL . . . -49.53 149.49 5.12 Favored Glycine 0 CA--C 1.547 2.066 0 O-C-N 119.775 -1.828 . . . . 1.0 114.589 177.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.11 149.65 40.69 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.973 1.309 . . . . 1.0 112.48 -172.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.576 ' HB3' HG13 ' A' ' 89' ' ' VAL . 1.0 OUTLIER -70.57 157.05 38.6 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 122.546 1.165 . . . . 1.0 113.759 -169.145 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.643 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -87.5 141.43 28.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.309 -1.314 . . . . 1.0 109.795 170.137 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.643 ' N ' HD13 ' A' ' 123' ' ' LEU . 5.9 mt -124.33 103.5 8.25 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 125.508 1.523 . . . . 1.0 110.948 175.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.448 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.5 mt -89.61 128.07 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.41 1.484 . . . . 1.0 112.344 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -106.35 108.43 19.94 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.066 0.936 . . . . 1.0 112.139 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.02 -22.57 64.97 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.008 0.923 . . . . 1.0 113.29 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.9 t -65.18 -21.78 66.81 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.379 1.072 . . . . 1.0 112.935 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -119.36 -29.72 5.08 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.061 1.744 . . . . 1.0 112.096 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -143.33 84.89 9.9 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 125.448 1.499 . . . . 1.0 112.048 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.44 7.29 2.29 Favored 'Trans proline' 0 CA--C 1.551 1.333 0 C-N-CA 123.742 2.961 . . . . 1.0 114.45 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -111.74 71.31 0.95 Allowed Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 127.592 2.357 . . . . 1.0 109.966 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -58.69 -20.15 49.38 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.89 2.393 . . . . 1.0 116.747 -169.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -66.16 -27.0 67.68 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 119.596 1.089 . . . . 1.0 111.639 172.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 22.1 p -74.56 -21.67 59.39 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.544 1.065 . . . . 1.0 111.943 -172.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -93.19 -51.29 5.09 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.335 1.454 . . . . 1.0 111.996 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 77.3 p -73.26 -33.64 65.38 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 115.711 1.745 . . . . 1.0 115.711 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -56.22 -58.07 18.78 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 121.003 1.728 . . . . 1.0 111.836 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -62.21 -24.35 76.12 Favored 'Trans proline' 0 C--N 1.352 0.761 0 CA-C-N 121.514 1.577 . . . . 1.0 113.155 175.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.505 ' HB2' HD23 ' A' ' 123' ' ' LEU . 91.2 t90 -68.12 -47.73 67.34 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 118.972 0.805 . . . . 1.0 110.982 174.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.536 HG11 ' HA ' ' A' ' 22' ' ' ALA . 86.6 t -64.66 -33.57 64.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 176.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -69.34 -28.97 66.69 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.761 1.225 . . . . 1.0 112.085 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -81.5 -60.44 2.26 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.137 1.775 . . . . 1.0 112.021 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 82.1 t90 -56.0 -36.0 67.42 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 126.2 1.8 . . . . 1.0 112.654 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.59 -32.31 23.89 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.771 1.177 . . . . 1.0 113.764 173.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.2 p -69.45 -12.77 61.93 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.333 1.234 . . . . 1.0 114.333 177.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.57 -16.89 50.22 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.209 1.804 . . . . 1.0 111.862 175.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.25 174.79 11.19 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.378 1.071 . . . . 1.0 111.168 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.251 1.156 0 N-CA-C 115.242 1.571 . . . . 1.0 115.242 -175.068 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.569 0 N-CA-C 112.714 0.635 . . . . 1.0 112.714 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -125.77 122.81 37.29 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.903 1.281 . . . . 1.0 110.254 175.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.585 HD13 HD12 ' A' ' 26' ' ' LEU . 2.1 mp -120.99 116.89 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 126.2 1.8 . . . . 1.0 113.044 -177.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.8 124.34 7.8 Favored Glycine 0 N--CA 1.467 0.758 0 CA-C-O 119.382 -0.677 . . . . 1.0 111.507 169.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 mt -107.37 121.39 60.19 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-N 118.8 1.3 . . . . 1.0 109.743 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -116.71 109.58 17.34 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 124.661 1.185 . . . . 1.0 108.615 -169.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.466 0.33 0 CA-C-N 116.0 -0.545 . . . . 1.0 111.502 -178.062 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 37.0 tp . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 114.765 1.395 . . . . 1.0 114.765 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.4 t -53.97 -37.7 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.807 0.843 . . . . 1.0 112.183 -172.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.27 -38.47 86.87 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.956 -1.09 . . . . 1.0 112.407 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -75.9 -32.41 59.64 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.138 0.575 . . . . 1.0 111.439 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -60.52 -45.49 93.62 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.219 -1.03 . . . . 1.0 108.219 170.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.614 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.46 -40.66 93.46 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 112.624 0.601 . . . . 1.0 112.624 -174.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -57.34 -48.3 79.36 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.193 0.451 . . . . 1.0 109.8 169.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.38 -35.12 75.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 112.89 0.7 . . . . 1.0 112.89 -173.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.9 mt -72.66 -46.44 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 O-C-N 121.321 -0.862 . . . . 1.0 109.346 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.585 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -64.81 -33.36 75.81 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 119.162 -1.015 . . . . 1.0 109.976 -178.602 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.1 m -62.14 -45.99 90.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.984 1.314 . . . . 1.0 113.133 169.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.69 -33.03 74.99 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.193 0.997 . . . . 1.0 112.69 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -69.91 -29.8 67.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.941 1.297 . . . . 1.0 112.378 172.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.24 21.51 2.28 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.729 1.157 . . . . 1.0 115.175 169.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -117.02 153.37 32.8 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.432 1.093 . . . . 1.0 110.655 -175.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -87.12 72.16 10.03 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 123.118 1.437 . . . . 1.0 110.278 -173.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.11 144.9 27.28 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 112.954 -1.93 . . . . 1.0 111.941 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.6 m -142.63 136.23 28.91 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 125.746 1.618 . . . . 1.0 108.739 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.71 143.9 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.697 1.199 . . . . 1.0 113.437 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.65 133.82 53.1 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.329 1.851 . . . . 1.0 111.316 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -107.14 141.17 38.84 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.673 1.989 . . . . 1.0 111.13 178.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 t0 41.3 55.47 8.36 Favored Pre-proline 0 CA--C 1.559 1.309 0 C-N-CA 124.519 1.128 . . . . 1.0 112.478 -172.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.78 148.16 45.92 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.531 2.821 . . . . 1.0 117.072 -168.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -99.25 164.75 12.0 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.951 1.3 . . . . 1.0 112.461 168.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.568 HD21 HD21 ' A' ' 79' ' ' LEU . 2.2 tm? -68.15 -22.35 64.86 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 121.03 -1.044 . . . . 1.0 110.727 167.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 67.4 p -68.19 -20.21 64.83 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.656 1.117 . . . . 1.0 112.219 171.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -81.68 -24.9 35.96 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.253 1.021 . . . . 1.0 112.359 169.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.469 ' HB3' HD22 ' A' ' 41' ' ' LEU . 10.3 t-105 -88.85 -34.78 16.89 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.346 1.239 . . . . 1.0 114.346 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.4 mt -47.5 -38.46 16.24 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-O 117.358 -1.306 . . . . 1.0 114.314 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -57.1 -18.77 30.4 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.43 2.753 . . . . 1.0 116.416 175.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -105.79 7.49 32.41 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 116.13 1.9 . . . . 1.0 116.13 -172.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -51.43 -34.71 36.25 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.619 1.967 . . . . 1.0 113.525 174.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -110.35 8.53 23.38 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.791 1.636 . . . . 1.0 112.373 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -115.78 -163.93 0.92 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.639 2.376 . . . . 1.0 110.299 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -108.48 164.26 12.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 122.613 1.197 . . . . 1.0 112.147 170.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.604 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -148.35 162.12 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.121 1.369 . . . . 1.0 109.906 -170.879 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.64 HD11 HD12 ' A' ' 90' ' ' ILE . 13.3 tp -144.9 128.65 17.25 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.931 1.292 . . . . 1.0 108.852 177.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.69 128.3 58.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 C-N-CA 124.141 0.976 . . . . 1.0 109.728 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.2 t -127.04 108.87 19.43 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 108.033 -1.099 . . . . 1.0 108.033 -170.761 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.5 tt . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 113.618 0.97 . . . . 1.0 113.618 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.7 t -40.71 -52.78 6.24 Favored Pre-proline 0 N--CA 1.478 0.951 0 CA-C-O 117.477 -1.249 . . . . 1.0 112.665 168.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -67.15 -32.31 34.26 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 121.725 1.616 . . . . 1.0 112.181 -173.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.1 tp -65.73 -52.96 47.01 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 124.051 0.94 . . . . 1.0 111.302 169.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.653 ' CE1' HD23 ' A' ' 110' ' ' LEU . 92.6 t80 -56.24 -52.41 64.57 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.727 0.811 . . . . 1.0 112.666 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -64.04 -40.33 96.06 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.669 1.188 . . . . 1.0 111.445 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.68 -35.85 90.42 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 123.604 0.621 . . . . 1.0 112.808 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.618 HG22 HD12 ' A' ' 110' ' ' LEU . 90.5 mt -66.42 -46.54 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 120.199 2.0 . . . . 1.0 108.578 172.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.717 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.4 ptmm? -72.25 -30.63 65.04 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.039 -1.663 . . . . 1.0 113.267 -171.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -109.77 -37.48 5.64 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.402 1.63 . . . . 1.0 115.402 -173.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.7 m -90.55 -26.8 19.53 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.302 1.041 . . . . 1.0 112.695 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.568 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -90.12 -71.44 0.62 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.214 -1.402 . . . . 1.0 107.214 169.379 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.7 -6.21 2.85 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 126.317 1.913 . . . . 1.0 115.496 172.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -156.22 146.78 21.74 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.035 2.934 . . . . 1.0 107.315 173.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.407 ' HG3' ' HB2' ' A' ' 116' ' ' ALA . 43.4 mm-40 -137.94 126.06 14.17 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 123.73 0.812 . . . . 1.0 110.207 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -84.63 -37.99 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 121.924 1.75 . . . . 1.0 114.414 -172.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -147.64 18.66 1.16 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.757 1.223 . . . . 1.0 114.14 -169.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.604 HD11 ' CG2' ' A' ' 52' ' ' VAL . 38.2 tp -77.31 139.98 39.9 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.5 -1.375 . . . . 1.0 113.629 -169.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -132.85 146.76 52.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 128.815 2.846 . . . . 1.0 107.252 169.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.645 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -159.33 167.63 28.38 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 118.981 0.81 . . . . 1.0 113.069 -177.494 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.484 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -125.32 173.49 17.4 Favored Glycine 0 N--CA 1.474 1.208 0 C-N-CA 125.025 1.298 . . . . 1.0 114.228 173.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.6 t -144.61 131.43 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.185 0.994 . . . . 1.0 113.641 -169.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 1.054 HG23 HD12 ' A' ' 123' ' ' LEU . 3.4 mt -131.54 102.24 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.846 1.658 . . . . 1.0 107.203 169.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -91.94 145.32 24.63 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.859 0.838 . . . . 1.0 111.27 170.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.437 HD11 HG22 ' A' ' 90' ' ' ILE . 3.5 mp -139.86 152.96 46.88 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.07 1.348 . . . . 1.0 110.622 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.31 0 C-N-CA 120.851 -0.69 . . . . 1.0 113.676 169.378 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 113.417 0.895 . . . . 1.0 113.417 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -60.18 -17.96 44.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.886 1.674 . . . . 1.0 115.005 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.2 -41.01 98.04 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-N 120.833 1.652 . . . . 1.0 114.37 175.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -75.91 -34.58 47.45 Favored Glycine 0 N--CA 1.477 1.429 0 O-C-N 120.626 -1.514 . . . . 1.0 112.935 172.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -62.97 -33.88 76.33 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 121.23 -1.159 . . . . 1.0 112.418 173.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -59.97 -41.72 92.58 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.601 1.16 . . . . 1.0 111.539 170.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -64.9 -37.74 88.64 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.729 0.695 . . . . 1.0 111.546 174.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -62.56 -49.43 75.29 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.181 -0.949 . . . . 1.0 110.994 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.19 -33.81 63.35 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.953 0.901 . . . . 1.0 113.111 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.717 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -61.2 -49.75 75.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 122.933 1.349 . . . . 1.0 110.613 178.888 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.645 HD12 ' CD1' ' A' ' 87' ' ' TYR . 10.3 mt -65.86 -37.49 86.3 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 120.945 -1.097 . . . . 1.0 112.083 178.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -68.95 -21.16 64.21 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.922 1.082 . . . . 1.0 113.922 174.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.89 -17.82 58.7 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.532 1.06 . . . . 1.0 111.188 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -97.66 -74.21 0.58 Allowed 'General case' 0 C--N 1.343 0.299 0 C-N-CA 125.129 1.372 . . . . 1.0 110.999 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.9 m 176.6 -2.69 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 127.384 2.274 . . . . 1.0 112.141 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -78.84 161.06 27.03 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 122.264 1.03 . . . . 1.0 113.507 -169.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -104.25 170.42 7.92 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.19 -1.368 . . . . 1.0 112.224 -169.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.75 145.35 50.94 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.924 1.29 . . . . 1.0 111.894 176.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 50.9 t -101.73 132.04 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 127.591 2.356 . . . . 1.0 108.639 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 46.97 -142.3 5.97 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.401 1.0 . . . . 1.0 113.889 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -100.65 -162.31 0.93 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.405 1.482 . . . . 1.0 110.29 169.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.72 157.12 22.62 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.215 1.806 . . . . 1.0 111.042 168.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 1.054 HD12 HG23 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -94.52 142.11 27.81 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 125.409 1.484 . . . . 1.0 109.484 169.13 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.5 mt -125.82 113.97 17.96 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.858 1.663 . . . . 1.0 110.379 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.557 ' CD1' HD11 ' A' ' 123' ' ' LEU . 40.5 mt -106.44 132.45 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 124.696 1.198 . . . . 1.0 113.101 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -107.57 96.9 6.72 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 128.145 2.578 . . . . 1.0 112.991 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.77 -22.8 66.85 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.913 1.079 . . . . 1.0 113.913 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.3 t -60.07 -25.25 65.23 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.434 1.094 . . . . 1.0 112.71 172.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -122.53 -29.06 4.14 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.373 1.869 . . . . 1.0 112.276 -170.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -138.5 89.36 13.77 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.794 1.238 . . . . 1.0 111.687 175.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -76.78 11.02 2.07 Favored 'Trans proline' 0 CA--C 1.549 1.246 0 C-N-CA 123.943 3.096 . . . . 1.0 114.255 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -114.54 66.68 1.72 Allowed Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 127.326 2.25 . . . . 1.0 110.112 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -57.73 -18.62 34.48 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.927 2.418 . . . . 1.0 117.738 -169.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -68.2 -25.6 65.3 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.446 1.476 . . . . 1.0 111.386 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 28.6 p -70.41 -23.46 62.75 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.756 1.162 . . . . 1.0 112.24 -173.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.425 ' HB2' HD11 ' A' ' 125' ' ' ILE . 28.6 mm-40 -93.66 -56.56 2.86 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.802 1.641 . . . . 1.0 112.081 173.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 79.0 p -68.58 -30.28 69.0 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 114.325 1.231 . . . . 1.0 114.325 -174.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -60.98 -59.28 14.34 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 120.773 1.624 . . . . 1.0 112.395 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -62.91 -24.43 74.19 Favored 'Trans proline' 0 C--N 1.352 0.743 0 CA-C-N 121.124 1.437 . . . . 1.0 113.002 173.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 73.8 t90 -70.39 -45.12 66.61 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 119.005 0.821 . . . . 1.0 111.704 175.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.614 HG11 ' HA ' ' A' ' 22' ' ' ALA . 69.1 t -66.5 -32.95 60.36 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 C-N-CA 123.167 0.587 . . . . 1.0 110.094 175.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -63.5 -48.11 78.93 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.162 -0.961 . . . . 1.0 109.822 173.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -64.16 -55.99 17.91 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.871 1.268 . . . . 1.0 111.651 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.484 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 89.0 t90 -57.17 -35.79 69.98 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 125.222 1.409 . . . . 1.0 111.785 172.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -49.75 -34.65 22.02 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.864 1.697 . . . . 1.0 113.938 171.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.6 p -67.86 -13.62 62.29 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.85 1.426 . . . . 1.0 114.85 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.18 -18.24 50.18 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.395 1.478 . . . . 1.0 111.886 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -86.32 167.87 14.39 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.193 0.997 . . . . 1.0 111.952 -175.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 11.2 m . . . . . 0 C--O 1.251 1.178 0 N-CA-C 115.725 1.75 . . . . 1.0 115.725 -169.861 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.408 0 N-CA-C 115.321 1.6 . . . . 1.0 115.321 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -125.49 122.35 36.36 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.645 1.578 . . . . 1.0 110.706 172.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 mp -121.89 113.41 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 C-N-CA 126.26 1.824 . . . . 1.0 112.416 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.12 123.75 7.27 Favored Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.169 -1.173 . . . . 1.0 110.169 169.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.9 mt -104.54 123.51 58.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 123.946 0.898 . . . . 1.0 109.355 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -115.6 111.03 20.06 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 124.766 1.227 . . . . 1.0 107.921 -170.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 112.412 0.523 . . . . 1.0 112.412 -175.427 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.3 tp . . . . . 0 CA--C 1.53 0.185 0 N-CA-C 112.494 0.553 . . . . 1.0 112.494 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.1 t -58.35 -37.26 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 119.127 -0.464 . . . . 1.0 111.132 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.56 -45.87 88.52 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.768 1.167 . . . . 1.0 112.859 173.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -63.49 -33.4 75.49 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.454 0.645 . . . . 1.0 110.966 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -69.93 -46.93 64.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.762 0.825 . . . . 1.0 109.818 176.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.856 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -55.42 -45.43 76.73 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.959 1.304 . . . . 1.0 113.017 176.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.33 -49.26 78.52 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.855 0.462 . . . . 1.0 110.181 173.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.6 -37.47 73.88 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.449 -0.782 . . . . 1.0 112.867 -173.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.575 ' CG2' HG12 ' A' ' 141' ' ' VAL . 16.5 mt -69.42 -48.17 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 124.501 1.12 . . . . 1.0 109.447 175.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.478 HD23 ' CG1' ' A' ' 141' ' ' VAL . 0.5 OUTLIER -62.17 -34.86 77.21 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 122.485 1.136 . . . . 1.0 109.185 -178.163 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.3 m -62.28 -44.9 95.47 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.602 1.161 . . . . 1.0 112.704 172.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.78 -29.82 69.12 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.676 1.19 . . . . 1.0 113.439 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -65.23 -33.94 77.17 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.516 1.526 . . . . 1.0 110.981 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.52 13.3 1.13 Allowed Glycine 0 CA--C 1.535 1.293 0 N-CA-C 115.864 1.105 . . . . 1.0 115.864 169.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 -108.02 177.02 4.93 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.985 1.314 . . . . 1.0 111.725 -169.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -101.5 99.71 10.06 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.053 1.341 . . . . 1.0 108.564 169.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.26 148.85 36.78 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.58 0.752 . . . . 1.0 111.217 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.4 m -149.0 146.12 27.64 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.146 0.978 . . . . 1.0 111.459 -174.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.9 t -95.93 137.08 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 114.168 1.173 . . . . 1.0 114.168 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -115.34 122.4 45.76 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.135 1.774 . . . . 1.0 110.995 169.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -103.21 137.0 41.95 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.597 1.959 . . . . 1.0 111.272 -177.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.6 t0 41.48 53.15 6.95 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 124.339 1.056 . . . . 1.0 111.237 -169.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -68.28 142.43 55.13 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.861 3.041 . . . . 1.0 116.85 -168.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.451 ' HB3' ' H ' ' A' ' 42' ' ' SER . 49.9 mm-40 -92.41 163.43 13.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 122.666 1.222 . . . . 1.0 111.309 168.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.62 HD21 HD21 ' A' ' 79' ' ' LEU . 2.1 tm? -66.0 -20.84 66.32 Favored 'General case' 0 N--CA 1.442 -0.856 0 O-C-N 120.688 -1.257 . . . . 1.0 110.388 167.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.451 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 16.1 m -68.49 -20.54 64.6 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 120.793 -1.192 . . . . 1.0 112.126 172.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -82.58 -24.47 33.94 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.292 1.037 . . . . 1.0 112.446 170.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.515 ' HB3' HD22 ' A' ' 41' ' ' LEU . 12.3 t-105 -88.68 -35.05 16.99 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.453 1.279 . . . . 1.0 114.453 -178.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.7 mt -47.73 -37.37 12.71 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-O 117.466 -1.254 . . . . 1.0 114.129 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -58.79 -11.02 10.77 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.697 2.932 . . . . 1.0 117.27 175.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -114.81 9.31 16.25 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 116.303 1.964 . . . . 1.0 116.303 -174.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -51.24 -27.15 8.37 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 127.259 2.224 . . . . 1.0 114.048 175.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -117.28 13.02 14.51 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.299 1.84 . . . . 1.0 113.323 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -126.85 -155.41 0.69 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.889 2.476 . . . . 1.0 110.978 -175.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -115.96 162.64 17.07 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 122.906 1.336 . . . . 1.0 112.073 175.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.564 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -152.24 157.36 5.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 124.798 1.239 . . . . 1.0 109.053 -171.098 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.626 HD11 HD12 ' A' ' 90' ' ' ILE . 15.4 tp -139.98 127.82 21.98 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.559 1.143 . . . . 1.0 109.388 176.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.1 t -103.41 120.43 53.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 124.271 1.028 . . . . 1.0 109.001 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.0 t -118.4 112.21 37.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 105.602 -1.999 . . . . 1.0 105.602 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 115.237 1.569 . . . . 1.0 115.237 -168.161 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 114.692 1.368 . . . . 1.0 114.692 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -42.76 -52.62 10.84 Favored Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 124.532 1.133 . . . . 1.0 112.588 168.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -67.8 -32.04 30.55 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.87 1.713 . . . . 1.0 111.985 -173.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.7 tp -63.64 -53.19 55.38 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 124.283 1.033 . . . . 1.0 111.225 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.695 ' CE1' HD23 ' A' ' 110' ' ' LEU . 93.0 t80 -55.05 -52.99 61.46 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.726 0.81 . . . . 1.0 112.572 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -64.32 -40.52 96.08 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.813 0.845 . . . . 1.0 111.433 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.61 -35.29 89.69 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 119.662 -0.521 . . . . 1.0 112.557 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.602 HG22 HD12 ' A' ' 110' ' ' LEU . 89.1 mt -65.69 -47.46 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 120.145 1.972 . . . . 1.0 108.382 172.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.717 ' HB3' HD21 ' A' ' 110' ' ' LEU . 3.2 ptmm? -71.43 -32.22 68.11 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 120.309 -1.494 . . . . 1.0 113.508 -171.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -105.92 -36.82 6.87 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 115.028 1.492 . . . . 1.0 115.028 -173.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 m -94.73 -24.85 16.94 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.261 1.025 . . . . 1.0 112.663 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.62 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -90.23 -72.53 0.56 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.15 -1.426 . . . . 1.0 107.15 169.422 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.0 -9.35 2.06 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 126.316 1.912 . . . . 1.0 115.265 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -152.35 145.87 24.91 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.929 2.892 . . . . 1.0 107.499 171.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -136.82 128.5 16.84 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-O 118.438 -0.792 . . . . 1.0 110.435 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -83.68 -42.86 0.08 OUTLIER 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.148 1.899 . . . . 1.0 114.445 -171.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -147.32 20.7 1.21 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.045 1.338 . . . . 1.0 113.74 -170.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.564 HD11 ' CG2' ' A' ' 52' ' ' VAL . 51.0 tp -78.46 141.34 38.34 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.451 -1.405 . . . . 1.0 113.459 -169.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.87 149.73 49.12 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 128.766 2.826 . . . . 1.0 108.196 169.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.653 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -159.9 168.16 26.4 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.382 0.882 . . . . 1.0 113.382 -178.151 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.471 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -124.39 168.95 16.43 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 125.361 1.457 . . . . 1.0 114.026 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.0 t -143.75 133.39 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.536 1.134 . . . . 1.0 113.338 -169.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.972 HG23 HD12 ' A' ' 123' ' ' LEU . 3.7 mt -129.43 100.15 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 126.036 1.735 . . . . 1.0 107.346 169.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.48 145.62 25.18 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.686 1.194 . . . . 1.0 112.045 174.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.6 mp -138.04 150.83 47.29 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.804 0.841 . . . . 1.0 112.774 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.571 0 C-N-CA 121.081 -0.58 . . . . 1.0 113.744 169.248 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 21.7 m . . . . . 0 CA--C 1.547 0.831 0 N-CA-C 115.54 1.682 . . . . 1.0 115.54 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -63.97 -18.24 64.08 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.17 1.174 . . . . 1.0 114.17 -175.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.34 -49.28 69.62 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-N 119.872 1.214 . . . . 1.0 113.368 171.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -75.47 -34.25 50.66 Favored Glycine 0 N--CA 1.478 1.443 0 O-C-N 120.705 -1.468 . . . . 1.0 113.23 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -61.35 -34.47 75.34 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.263 -1.139 . . . . 1.0 112.731 173.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -63.3 -39.77 95.51 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.865 0.866 . . . . 1.0 112.316 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.1 -40.0 96.35 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.036 0.835 . . . . 1.0 110.697 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -41.07 98.03 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.427 -0.796 . . . . 1.0 112.583 176.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.63 -46.19 89.74 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 118.744 -0.646 . . . . 1.0 111.997 170.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.717 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -49.56 -49.31 46.86 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.259 2.224 . . . . 1.0 111.932 -172.517 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.653 HD12 ' CD1' ' A' ' 87' ' ' TYR . 8.1 mt -66.0 -43.03 88.93 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.214 -0.903 . . . . 1.0 111.439 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -66.96 -22.03 65.95 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -66.08 -35.87 81.67 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.422 1.089 . . . . 1.0 111.46 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -82.65 -75.87 0.29 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 113.785 -1.552 . . . . 1.0 110.432 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.43 ' H ' ' H ' ' A' ' 116' ' ' ALA . 2.7 t 179.0 -3.22 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.11 2.164 . . . . 1.0 111.574 173.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -75.24 150.44 38.59 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 122.775 1.274 . . . . 1.0 112.83 -169.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -90.61 172.48 8.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.271 -1.786 . . . . 1.0 113.036 -168.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.36 139.03 46.58 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.322 1.849 . . . . 1.0 109.914 -175.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.589 HG12 ' H ' ' A' ' 120' ' ' GLY 0.258 20.2 t -90.86 -163.3 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 107.786 -1.19 . . . . 1.0 107.786 178.035 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.589 ' H ' HG12 ' A' ' 119' ' ' VAL . . . -48.6 149.73 3.89 Favored Glycine 0 CA--C 1.544 1.867 0 O-C-N 120.067 -1.646 . . . . 1.0 113.936 177.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -59.73 146.49 41.27 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.21 1.404 . . . . 1.0 112.701 -171.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -67.62 158.78 31.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.767 1.627 . . . . 1.0 114.759 -168.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.972 HD12 HG23 ' A' ' 90' ' ' ILE . 1.0 OUTLIER -90.44 138.91 31.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.272 -1.331 . . . . 1.0 109.133 169.083 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.1 mt -126.61 110.05 12.78 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.359 1.464 . . . . 1.0 109.828 173.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.573 HG13 HD11 ' A' ' 123' ' ' LEU . 27.3 mt -97.59 129.07 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 124.06 0.944 . . . . 1.0 112.394 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -103.76 110.35 22.41 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.113 0.959 . . . . 1.0 111.709 173.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.39 -22.08 64.66 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.298 1.039 . . . . 1.0 113.241 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.6 t -64.55 -22.41 66.96 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.679 0.792 . . . . 1.0 112.895 173.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -119.93 -30.17 4.78 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.267 1.827 . . . . 1.0 112.0 -173.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.26 82.78 12.81 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.904 1.282 . . . . 1.0 112.515 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -75.42 6.56 3.5 Favored 'Trans proline' 0 CA--C 1.549 1.235 0 C-N-CA 123.791 2.994 . . . . 1.0 114.737 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -109.7 72.23 0.58 Allowed Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 127.2 2.2 . . . . 1.0 110.074 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -59.09 -26.92 83.51 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.481 2.12 . . . . 1.0 117.073 -169.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -65.91 -24.67 66.88 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.924 1.238 . . . . 1.0 110.983 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 31.9 p -71.42 -18.1 62.35 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.937 -1.102 . . . . 1.0 112.311 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.427 ' HB2' HD11 ' A' ' 125' ' ' ILE . 4.8 mm-40 -102.22 -55.17 2.53 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.296 1.838 . . . . 1.0 111.442 177.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.4 p -68.64 -35.04 76.75 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 114.18 1.178 . . . . 1.0 114.18 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -60.36 -55.4 45.59 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 120.992 1.724 . . . . 1.0 112.392 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -63.41 -26.88 70.8 Favored 'Trans proline' 0 C--N 1.351 0.68 0 CA-C-N 121.881 1.708 . . . . 1.0 112.665 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.477 ' CG ' ' HB2' ' A' ' 123' ' ' LEU . 88.8 t90 -63.57 -45.64 89.53 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 118.807 0.731 . . . . 1.0 111.192 172.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.856 HG11 ' HA ' ' A' ' 22' ' ' ALA . 53.1 t -66.75 -34.09 67.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.437 1.095 . . . . 1.0 109.537 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -70.63 -21.22 62.65 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.469 1.508 . . . . 1.0 113.189 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -87.64 -58.07 2.71 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.435 1.894 . . . . 1.0 109.878 168.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.471 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 89.8 t90 -58.58 -39.62 80.85 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.001 1.72 . . . . 1.0 113.861 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -53.5 -27.15 33.02 Favored Glycine 0 CA--C 1.537 1.439 0 O-C-N 121.11 -0.994 . . . . 1.0 113.936 173.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.4 p -68.94 -15.0 63.37 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.729 1.764 . . . . 1.0 114.045 175.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.77 -15.98 56.44 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.431 1.492 . . . . 1.0 111.669 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -76.59 169.34 18.45 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.97 0.908 . . . . 1.0 111.214 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.255 1.343 0 N-CA-C 114.866 1.432 . . . . 1.0 114.866 -173.368 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 113.084 0.772 . . . . 1.0 113.084 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -121.73 121.81 38.12 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.56 1.144 . . . . 1.0 110.709 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.512 HD13 HD12 ' A' ' 26' ' ' LEU . 2.2 mp -117.31 114.34 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 C-N-CA 126.138 1.775 . . . . 1.0 112.597 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.54 121.86 6.4 Favored Glycine 0 C--O 1.224 -0.522 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 169.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 mt -105.51 125.25 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 118.666 1.233 . . . . 1.0 109.411 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -118.31 111.78 19.2 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.763 -0.829 . . . . 1.0 108.763 -169.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 N--CA 1.467 0.414 0 N-CA-C 112.165 0.431 . . . . 1.0 112.165 -173.761 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.5 tp . . . . . 0 N--CA 1.465 0.315 0 N-CA-C 118.336 2.717 . . . . 1.0 118.336 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 81.2 t -56.46 -36.36 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 118.697 0.68 . . . . 1.0 112.071 -169.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.76 -38.61 86.95 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.682 -1.261 . . . . 1.0 112.732 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.415 ' HA ' HG11 ' A' ' 35' ' ' VAL . 20.4 mm-40 -66.65 -35.72 80.85 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.015 0.436 . . . . 1.0 110.869 174.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -66.29 -44.81 82.46 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 123.806 0.843 . . . . 1.0 109.1 176.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.535 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -63.88 -41.49 97.72 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 123.343 0.657 . . . . 1.0 112.671 -176.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -56.06 -48.85 75.26 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 170.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.19 -38.23 75.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.684 0.794 . . . . 1.0 112.828 -173.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.7 mt -66.61 -47.6 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-N 119.177 0.899 . . . . 1.0 108.945 175.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.512 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -66.17 -33.9 76.81 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 119.459 -0.897 . . . . 1.0 111.021 -176.652 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.9 m -63.2 -41.9 99.23 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.325 1.45 . . . . 1.0 113.207 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.52 -32.1 71.81 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.105 0.962 . . . . 1.0 112.433 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -69.56 -29.16 66.67 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.432 1.093 . . . . 1.0 113.051 170.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.17 29.33 2.58 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.526 1.06 . . . . 1.0 113.668 170.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -112.32 155.59 23.84 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.441 1.096 . . . . 1.0 109.267 175.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -86.95 78.46 9.0 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.688 1.195 . . . . 1.0 108.369 -177.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.5 142.84 26.97 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.374 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 96.4 m -143.32 127.48 17.56 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 124.484 1.113 . . . . 1.0 109.333 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.415 HG11 ' HA ' ' A' ' 20' ' ' GLU . 3.6 p -92.28 140.67 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 114.378 1.251 . . . . 1.0 114.378 170.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -114.44 127.64 55.93 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.808 2.043 . . . . 1.0 111.144 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -100.86 132.54 46.21 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.637 1.975 . . . . 1.0 110.481 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.6 t0 43.76 55.59 12.2 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 124.1 0.96 . . . . 1.0 111.653 -169.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -68.81 144.24 58.49 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.067 3.178 . . . . 1.0 117.061 -168.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.425 ' HB3' ' H ' ' A' ' 42' ' ' SER . 54.9 mm-40 -95.22 163.89 13.08 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 122.465 1.126 . . . . 1.0 111.979 168.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.55 HD21 HD21 ' A' ' 79' ' ' LEU . 2.2 tm? -66.55 -21.23 66.15 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 120.959 -1.088 . . . . 1.0 110.16 167.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.425 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 18.8 m -68.1 -21.51 64.95 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.864 -1.148 . . . . 1.0 112.242 172.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -82.02 -24.37 35.41 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.355 1.062 . . . . 1.0 112.449 170.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.451 ' HB3' HD22 ' A' ' 41' ' ' LEU . 11.5 t-105 -88.55 -34.23 17.44 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.115 1.154 . . . . 1.0 114.115 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.1 mt -48.41 -38.41 22.3 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-O 117.538 -1.22 . . . . 1.0 114.209 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -57.81 -18.64 35.22 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.669 2.912 . . . . 1.0 116.435 174.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -105.03 7.4 33.98 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.774 1.768 . . . . 1.0 115.774 -171.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -53.37 -31.12 43.19 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.507 1.923 . . . . 1.0 113.857 176.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -112.42 8.48 19.48 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.081 1.352 . . . . 1.0 112.664 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -113.72 -162.86 0.83 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.815 2.446 . . . . 1.0 110.727 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -109.1 161.63 15.01 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.849 1.309 . . . . 1.0 111.443 169.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.556 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -146.89 157.35 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.537 1.135 . . . . 1.0 109.268 -171.491 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.1 tp -138.99 128.99 25.13 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.891 1.276 . . . . 1.0 108.553 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.4 t -103.36 128.59 56.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.933 -0.765 . . . . 1.0 108.933 175.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.45 112.15 30.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 105.925 -1.88 . . . . 1.0 105.925 176.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 115.181 1.548 . . . . 1.0 115.181 -167.833 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 114.141 1.163 . . . . 1.0 114.141 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -43.27 -53.25 11.43 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 124.383 1.073 . . . . 1.0 112.034 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -67.81 -31.1 32.6 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 121.677 1.585 . . . . 1.0 111.873 -173.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.8 tp -65.35 -53.18 47.32 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 124.475 1.11 . . . . 1.0 111.417 170.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.626 ' CE1' HD23 ' A' ' 110' ' ' LEU . 93.3 t80 -55.51 -53.23 58.9 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.778 0.831 . . . . 1.0 112.385 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -69.08 -35.17 76.2 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.63 -0.714 . . . . 1.0 111.813 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.68 -35.79 91.51 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 121.819 -0.551 . . . . 1.0 112.502 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.602 HG22 HD12 ' A' ' 110' ' ' LEU . 87.4 mt -65.12 -49.77 77.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.899 1.849 . . . . 1.0 108.296 171.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.677 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.2 ptmm? -69.72 -31.43 69.43 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.505 -1.372 . . . . 1.0 112.947 -169.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -105.28 -39.91 6.02 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 115.334 1.605 . . . . 1.0 115.334 -175.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.8 m -93.88 -23.04 18.26 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.239 1.016 . . . . 1.0 112.962 -174.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.55 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -91.1 -70.33 0.69 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 106.81 -1.552 . . . . 1.0 106.81 169.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.03 -11.44 1.35 Allowed Glycine 0 CA--C 1.538 1.481 0 C-N-CA 127.438 2.446 . . . . 1.0 116.514 169.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -155.77 141.08 17.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.825 2.45 . . . . 1.0 108.513 172.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.476 HE22 HD12 ' A' ' 79' ' ' LEU . 2.2 mm-40 -137.43 125.84 14.62 Favored Pre-proline 0 CA--C 1.546 0.815 0 O-C-N 121.281 -0.887 . . . . 1.0 111.097 -173.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.81 -40.52 0.09 OUTLIER 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.849 2.366 . . . . 1.0 114.87 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -140.31 13.85 2.39 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.866 1.432 . . . . 1.0 114.866 -169.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.556 HD11 ' CG2' ' A' ' 52' ' ' VAL . 40.9 tp -74.86 141.26 44.24 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.582 -1.323 . . . . 1.0 113.491 -169.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -132.83 147.39 52.3 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.195 2.598 . . . . 1.0 107.719 169.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.635 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -156.95 165.53 35.92 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.219 0.918 . . . . 1.0 113.349 178.623 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.407 ' HA3' ' CE2' ' A' ' 144' ' ' TRP . . . -127.0 173.33 18.41 Favored Glycine 0 N--CA 1.471 0.978 0 C-N-CA 125.35 1.452 . . . . 1.0 112.338 170.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.492 HG13 ' HB3' ' A' ' 122' ' ' MET . 0.2 OUTLIER -158.81 146.22 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 114.536 1.31 . . . . 1.0 114.536 -169.492 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.0 mt -133.5 109.41 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 127.478 2.311 . . . . 1.0 107.736 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -94.68 142.0 27.96 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.023 1.729 . . . . 1.0 111.466 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.6 mp -137.26 154.39 50.14 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.375 0.88 . . . . 1.0 113.375 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.73 0 N-CA-C 114.274 0.47 . . . . 1.0 114.274 168.775 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.445 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 20.8 p . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 114.329 1.233 . . . . 1.0 114.329 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -61.01 -21.22 63.38 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.831 1.252 . . . . 1.0 114.299 -170.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.93 -37.85 95.6 Favored Glycine 0 CA--C 1.535 1.326 0 CA-C-N 119.881 1.219 . . . . 1.0 113.109 171.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.79 -38.22 24.23 Favored Glycine 0 N--CA 1.476 1.318 0 O-C-N 121.407 -1.055 . . . . 1.0 113.046 172.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.445 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 89.2 mttt -62.12 -29.31 70.24 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 120.978 -1.307 . . . . 1.0 113.388 173.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -64.03 -28.98 70.17 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.059 0.763 . . . . 1.0 113.059 171.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -66.36 -35.57 80.67 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.643 1.11 . . . . 1.0 111.304 171.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -63.53 -48.96 75.39 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.239 -0.913 . . . . 1.0 110.968 172.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.25 -34.61 66.55 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.804 0.668 . . . . 1.0 112.804 175.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.677 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -59.93 -49.94 75.7 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 123.321 1.534 . . . . 1.0 110.83 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.635 HD12 ' CD1' ' A' ' 87' ' ' TYR . 9.9 mt -66.08 -37.83 86.78 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 120.908 -1.12 . . . . 1.0 111.717 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -69.02 -21.16 64.14 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.992 1.108 . . . . 1.0 113.992 174.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.91 -18.13 58.49 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.277 0.944 . . . . 1.0 111.238 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -96.83 -76.7 0.51 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.287 1.435 . . . . 1.0 110.574 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.3 m 178.32 -2.57 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 127.318 2.247 . . . . 1.0 112.154 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.527 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -77.13 159.55 29.68 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.043 0.925 . . . . 1.0 112.877 -169.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -100.97 174.19 6.13 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.246 -1.343 . . . . 1.0 111.559 -169.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.4 ttm105 -127.36 156.38 42.09 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.865 1.266 . . . . 1.0 112.731 171.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 120' ' ' GLY . 17.3 t -95.43 -168.81 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 C-N-CA 127.333 2.253 . . . . 1.0 105.93 169.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.541 ' H ' HG12 ' A' ' 119' ' ' VAL . . . -49.05 154.96 1.87 Allowed Glycine 0 CA--C 1.542 1.762 0 O-C-N 120.402 -1.436 . . . . 1.0 115.586 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -59.17 149.59 27.81 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.085 1.354 . . . . 1.0 113.15 -171.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.492 ' HB3' HG13 ' A' ' 89' ' ' VAL . 1.1 pmm? -73.78 157.8 35.75 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 122.462 1.125 . . . . 1.0 112.38 -169.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.65 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.2 tm? -86.7 140.51 29.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.824 -1.08 . . . . 1.0 109.39 171.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.65 ' N ' HD13 ' A' ' 123' ' ' LEU . 5.6 mt -123.65 104.39 8.99 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.818 1.247 . . . . 1.0 110.886 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.442 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.9 mt -90.26 128.21 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 125.109 1.363 . . . . 1.0 111.652 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -108.16 109.52 20.94 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 124.3 1.0 . . . . 1.0 112.174 171.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.76 -20.74 65.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.788 0.835 . . . . 1.0 112.948 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.2 t -63.6 -21.4 66.34 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.724 1.21 . . . . 1.0 112.675 173.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -124.67 -29.62 3.41 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.149 1.78 . . . . 1.0 112.584 -173.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -140.59 87.11 11.77 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.479 1.512 . . . . 1.0 112.068 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.2 6.85 2.8 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 123.675 2.917 . . . . 1.0 114.631 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -112.81 71.86 1.33 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 127.449 2.299 . . . . 1.0 109.699 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -57.87 -23.32 58.59 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.434 2.089 . . . . 1.0 116.827 -168.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -65.62 -25.69 67.49 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 119.128 0.876 . . . . 1.0 111.733 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 p -73.5 -16.99 61.27 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 120.902 -1.124 . . . . 1.0 111.706 -175.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -102.27 -53.87 2.81 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.163 1.785 . . . . 1.0 111.212 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 59.3 p -72.14 -33.9 68.13 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 114.706 1.372 . . . . 1.0 114.706 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -60.18 -55.55 44.2 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 120.923 1.692 . . . . 1.0 112.64 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -62.33 -22.64 74.39 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 121.329 1.51 . . . . 1.0 112.628 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.477 ' HB2' HD23 ' A' ' 123' ' ' LEU . 90.1 t90 -70.26 -45.55 66.19 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 121.67 -0.644 . . . . 1.0 111.264 174.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.535 HG11 ' HA ' ' A' ' 22' ' ' ALA . 91.5 t -64.69 -34.22 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.835 -0.802 . . . . 1.0 108.835 176.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.75 -29.77 68.24 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.132 1.373 . . . . 1.0 112.195 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -79.9 -61.38 2.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.104 1.762 . . . . 1.0 112.239 171.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.407 ' CE2' ' HA3' ' A' ' 88' ' ' GLY . 85.3 t90 -56.76 -36.43 69.78 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 126.724 2.01 . . . . 1.0 112.49 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.46 -32.28 22.86 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.684 1.135 . . . . 1.0 113.438 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 p -70.22 -13.12 62.04 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.332 1.234 . . . . 1.0 114.332 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.0 -14.72 55.57 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.151 1.78 . . . . 1.0 111.773 175.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.57 -178.27 5.77 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.223 1.009 . . . . 1.0 110.45 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 9.7 m . . . . . 0 C--O 1.254 1.324 0 C-N-CA 126.607 1.963 . . . . 1.0 114.251 -179.444 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.406 0 CA-C-O 121.731 0.777 . . . . 1.0 113.058 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -113.73 124.73 52.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.369 -1.287 . . . . 1.0 111.877 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.521 HD13 HD12 ' A' ' 26' ' ' LEU . 1.7 mp -120.92 112.82 37.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 126.424 1.889 . . . . 1.0 113.044 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.64 122.59 6.84 Favored Glycine 0 N--CA 1.467 0.742 0 N-CA-C 110.918 -0.873 . . . . 1.0 110.918 169.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.5 mt -104.17 119.63 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 118.464 1.132 . . . . 1.0 109.804 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -112.17 108.91 18.33 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.635 -1.246 . . . . 1.0 107.635 -171.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.47 0.536 0 CA-C-O 121.288 0.566 . . . . 1.0 112.434 -169.925 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.8 tp . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 116.121 1.896 . . . . 1.0 116.121 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.4 t -47.87 -32.36 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.114 1.366 . . . . 1.0 112.727 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.15 -49.19 76.72 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.632 -1.293 . . . . 1.0 113.113 172.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -67.71 -30.33 69.8 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.674 1.19 . . . . 1.0 110.648 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.29 -46.62 69.82 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 123.397 0.679 . . . . 1.0 109.297 173.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.557 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.36 -42.12 93.13 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 123.225 0.61 . . . . 1.0 112.329 -176.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -54.27 -49.13 70.28 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.121 0.968 . . . . 1.0 110.312 169.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.57 -38.7 70.9 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.633 0.773 . . . . 1.0 112.453 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.4 mt -68.04 -45.81 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 O-C-N 121.117 -0.989 . . . . 1.0 109.357 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.521 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.76 -31.5 72.52 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.56 1.073 . . . . 1.0 110.708 -178.591 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.6 m -63.14 -45.05 93.78 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.241 1.016 . . . . 1.0 112.919 169.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.65 -30.89 69.69 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.777 1.231 . . . . 1.0 113.163 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -67.33 -27.64 67.31 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.485 1.914 . . . . 1.0 111.809 172.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.32 26.21 2.73 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.535 1.064 . . . . 1.0 114.737 171.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -117.54 173.19 6.86 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.999 1.319 . . . . 1.0 110.304 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -102.04 94.14 5.62 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 125.459 1.503 . . . . 1.0 108.429 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.34 147.44 31.51 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.283 0.633 . . . . 1.0 111.459 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.3 m -146.81 140.38 25.75 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.153 0.981 . . . . 1.0 112.428 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.1 t -87.2 137.71 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 115.071 1.508 . . . . 1.0 115.071 172.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -116.86 109.86 17.62 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.132 2.173 . . . . 1.0 109.993 169.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -88.04 145.93 25.73 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.081 1.752 . . . . 1.0 110.84 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.1 t0 43.33 57.77 12.21 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 124.517 1.127 . . . . 1.0 110.264 -169.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -55.23 128.06 28.89 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.775 3.65 . . . . 1.0 118.486 -167.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -91.75 150.34 21.15 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.368 1.467 . . . . 1.0 113.131 169.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.487 HD21 HD21 ' A' ' 79' ' ' LEU . 2.6 tm? -70.6 -25.9 63.26 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.342 -0.849 . . . . 1.0 110.175 168.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.1 m -66.53 -20.97 66.16 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.494 -0.753 . . . . 1.0 112.272 171.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -87.14 -24.07 24.63 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.252 1.021 . . . . 1.0 113.249 169.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.463 ' HB3' HD22 ' A' ' 41' ' ' LEU . 15.2 t-105 -79.4 -36.08 39.67 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.608 1.095 . . . . 1.0 113.529 175.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.9 mt -48.82 -40.53 43.41 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 117.845 -1.074 . . . . 1.0 113.879 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -53.8 -15.72 7.37 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.613 3.542 . . . . 1.0 117.826 172.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -110.46 8.0 22.94 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 116.139 1.903 . . . . 1.0 116.139 -172.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -53.11 -29.28 29.89 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.612 1.965 . . . . 1.0 114.115 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -114.28 11.68 17.46 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.151 1.781 . . . . 1.0 113.267 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -125.57 -159.54 0.91 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.611 2.365 . . . . 1.0 110.818 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -113.24 158.9 19.91 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 123.211 1.481 . . . . 1.0 113.073 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.584 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -147.37 156.61 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 125.302 1.441 . . . . 1.0 109.796 -170.42 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.676 HD11 HD12 ' A' ' 90' ' ' ILE . 19.4 tp -139.36 127.59 22.62 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.733 1.213 . . . . 1.0 109.044 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.9 t -102.42 123.03 55.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 123.762 0.825 . . . . 1.0 109.151 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.4 t -122.46 111.96 32.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 105.057 -2.201 . . . . 1.0 105.057 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 113.852 1.056 . . . . 1.0 113.852 -167.765 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.8 tt . . . . . 0 N--CA 1.47 0.541 0 N-CA-C 114.394 1.257 . . . . 1.0 114.394 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.9 t -45.13 -51.95 22.2 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 124.267 1.027 . . . . 1.0 111.717 168.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.42 -29.5 20.61 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.329 1.353 . . . . 1.0 111.664 -173.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.4 tp -64.75 -50.61 66.17 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.255 1.022 . . . . 1.0 110.909 169.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.648 ' CE1' HD23 ' A' ' 110' ' ' LEU . 88.2 t80 -55.2 -53.72 52.38 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.0 0.92 . . . . 1.0 112.473 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -69.06 -34.47 75.23 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.704 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.27 -34.69 88.79 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 123.876 0.75 . . . . 1.0 112.747 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.535 HG22 HD12 ' A' ' 110' ' ' LEU . 90.8 mt -65.23 -51.88 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 120.119 -1.812 . . . . 1.0 108.438 170.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.671 ' HB3' HD21 ' A' ' 110' ' ' LEU . 11.4 ptmt -67.78 -32.32 72.82 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.524 -1.36 . . . . 1.0 113.178 -170.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -104.07 -36.59 7.67 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.27 1.582 . . . . 1.0 115.27 -173.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.7 m -97.22 -19.63 18.46 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.196 0.999 . . . . 1.0 112.938 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.487 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -95.62 -70.92 0.69 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 107.534 -1.284 . . . . 1.0 107.534 169.726 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.63 -13.32 1.69 Allowed Glycine 0 CA--C 1.536 1.404 0 C-N-CA 127.257 2.36 . . . . 1.0 116.454 169.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -155.76 141.49 17.97 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 127.668 2.387 . . . . 1.0 108.603 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.465 HE22 HD12 ' A' ' 79' ' ' LEU . 10.4 mm-40 -135.33 124.35 16.09 Favored Pre-proline 0 CA--C 1.546 0.808 0 O-C-N 121.449 -0.782 . . . . 1.0 111.237 -171.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.4 -39.07 0.2 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.35 2.034 . . . . 1.0 114.415 -171.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -146.7 18.1 1.29 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.255 1.206 . . . . 1.0 114.255 -170.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.584 HD11 ' CG2' ' A' ' 52' ' ' VAL . 46.0 tp -77.83 141.78 38.95 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 120.424 -1.422 . . . . 1.0 113.373 -169.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -136.73 146.65 46.07 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 129.519 3.127 . . . . 1.0 108.36 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.674 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -159.4 168.53 26.08 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.053 0.842 . . . . 1.0 113.126 -177.144 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.461 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -127.64 170.52 19.19 Favored Glycine 0 N--CA 1.472 1.082 0 C-N-CA 124.678 1.133 . . . . 1.0 114.281 172.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 86.6 t -142.28 133.5 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.668 1.187 . . . . 1.0 113.34 -169.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.982 HG23 HD12 ' A' ' 123' ' ' LEU . 3.5 mt -128.12 98.57 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.151 1.78 . . . . 1.0 106.781 169.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.27 145.37 25.43 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.151 1.38 . . . . 1.0 111.09 173.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.8 mp -138.88 149.79 45.25 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.601 -0.687 . . . . 1.0 111.974 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.347 0 C-N-CA 119.38 -1.39 . . . . 1.0 115.793 169.295 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.9 m . . . . . 0 CA--C 1.544 0.722 0 N-CA-C 113.03 0.752 . . . . 1.0 113.03 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -53.65 -23.98 12.89 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.57 1.948 . . . . 1.0 114.28 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -54.89 -50.12 59.64 Favored Glycine 0 CA--C 1.536 1.36 0 CA-C-N 120.039 1.29 . . . . 1.0 113.237 173.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -77.89 -34.21 39.13 Favored Glycine 0 N--CA 1.479 1.54 0 O-C-N 120.798 -1.413 . . . . 1.0 113.639 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -59.6 -34.74 73.14 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.431 -1.04 . . . . 1.0 112.904 173.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -62.98 -39.3 94.32 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.869 0.868 . . . . 1.0 112.232 172.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -62.87 -39.76 95.43 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.435 1.016 . . . . 1.0 110.689 173.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.29 -40.1 96.42 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.802 0.441 . . . . 1.0 111.664 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.08 83.06 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 118.496 -0.764 . . . . 1.0 111.786 169.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.671 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -48.21 -49.05 34.39 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.391 2.277 . . . . 1.0 111.864 -172.07 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.674 HD12 ' CD1' ' A' ' 87' ' ' TYR . 7.3 mt -65.91 -43.86 86.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.939 -1.028 . . . . 1.0 111.35 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -65.92 -24.74 66.89 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.883 1.068 . . . . 1.0 113.883 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -66.1 -32.82 74.5 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.522 1.129 . . . . 1.0 111.466 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -83.08 -73.3 0.41 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.369 -1.287 . . . . 1.0 109.1 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.5 p 176.02 -15.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 127.32 2.248 . . . . 1.0 113.8 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.503 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -68.08 148.88 50.35 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 122.888 1.328 . . . . 1.0 113.927 -169.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -90.16 171.76 9.29 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 113.131 -1.85 . . . . 1.0 112.899 -168.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.94 138.14 49.61 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.239 1.816 . . . . 1.0 110.195 -175.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 120' ' ' GLY . 18.2 t -88.57 -168.26 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 124.818 1.247 . . . . 1.0 107.832 174.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.588 ' H ' HG12 ' A' ' 119' ' ' VAL . . . -51.38 153.4 4.89 Favored Glycine 0 CA--C 1.544 1.86 0 O-C-N 119.779 -1.826 . . . . 1.0 115.604 -176.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.58 137.5 15.31 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.123 1.769 . . . . 1.0 114.596 -172.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -68.22 159.35 31.37 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.505 1.522 . . . . 1.0 113.088 -169.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.982 HD12 HG23 ' A' ' 90' ' ' ILE . 1.3 tm? -91.2 139.1 31.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.539 -1.21 . . . . 1.0 109.86 169.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.407 ' N ' HD13 ' A' ' 123' ' ' LEU . 6.6 mt -127.87 111.49 13.66 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.624 1.569 . . . . 1.0 109.52 174.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.582 HG13 HD11 ' A' ' 123' ' ' LEU . 25.7 mt -100.58 133.44 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.612 1.165 . . . . 1.0 113.499 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.05 97.0 10.42 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.478 1.511 . . . . 1.0 111.346 174.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.08 -25.2 65.22 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.145 -1.597 . . . . 1.0 112.72 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.4 m -63.66 -17.74 63.24 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.722 2.009 . . . . 1.0 113.75 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -125.14 -29.32 3.31 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.233 1.813 . . . . 1.0 112.129 -173.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -143.12 89.5 7.76 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.475 1.51 . . . . 1.0 110.754 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -77.41 12.41 1.86 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.03 3.154 . . . . 1.0 114.026 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -111.34 65.53 0.57 Allowed Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 127.428 2.291 . . . . 1.0 109.915 174.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -57.36 -22.67 50.97 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.366 2.044 . . . . 1.0 115.956 -169.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.8 pm0 -63.94 -24.31 67.68 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.332 0.969 . . . . 1.0 111.603 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.4 p -72.4 -17.55 61.8 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 120.765 -1.209 . . . . 1.0 112.111 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.414 ' HB2' HD11 ' A' ' 125' ' ' ILE . 5.7 mm-40 -104.64 -54.7 2.47 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.06 1.744 . . . . 1.0 111.895 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.0 p -69.7 -33.91 73.19 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.704 1.002 . . . . 1.0 113.704 -177.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -59.51 -57.09 29.55 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 120.765 1.62 . . . . 1.0 112.435 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -62.09 -23.94 76.07 Favored 'Trans proline' 0 C--N 1.352 0.735 0 CA-C-N 121.304 1.502 . . . . 1.0 112.776 174.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.473 ' CG ' ' HB2' ' A' ' 123' ' ' LEU . 87.5 t90 -67.35 -46.69 72.66 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 119.094 0.861 . . . . 1.0 110.725 174.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.557 HG11 ' HA ' ' A' ' 22' ' ' ALA . 92.5 t -64.42 -32.29 57.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 122.337 1.065 . . . . 1.0 109.253 175.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -71.16 -22.73 62.01 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 120.066 -1.646 . . . . 1.0 113.359 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -88.53 -59.38 2.25 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.379 1.871 . . . . 1.0 111.247 168.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.461 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 89.5 t90 -56.93 -36.49 70.28 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.697 1.599 . . . . 1.0 113.388 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.62 -30.72 35.56 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 121.315 -0.865 . . . . 1.0 114.196 173.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.6 p -68.22 -12.55 61.17 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.213 1.19 . . . . 1.0 114.213 176.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.74 -16.19 51.9 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.98 1.712 . . . . 1.0 111.881 176.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.78 177.08 9.09 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.198 0.999 . . . . 1.0 110.829 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 8.9 m . . . . . 0 C--O 1.251 1.149 0 N-CA-C 115.882 1.808 . . . . 1.0 115.882 -172.014 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.475 0 N-CA-C 113.687 0.995 . . . . 1.0 113.687 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -124.2 125.37 44.31 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.479 1.511 . . . . 1.0 110.267 173.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.588 HD13 HD12 ' A' ' 26' ' ' LEU . 2.2 mp -121.51 114.99 45.18 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 C-N-CA 126.026 1.73 . . . . 1.0 112.832 -178.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.4 123.37 7.13 Favored Glycine 0 C--O 1.225 -0.446 0 N-CA-C 110.313 -1.115 . . . . 1.0 110.313 169.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.8 mt -103.67 116.22 47.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 118.167 0.983 . . . . 1.0 109.312 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -112.3 112.05 23.36 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.198 -1.408 . . . . 1.0 107.198 -172.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.469 0.498 0 CA-C-N 116.66 -0.246 . . . . 1.0 111.582 -172.58 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.6 tp . . . . . 0 N--CA 1.468 0.44 0 N-CA-C 117.326 2.343 . . . . 1.0 117.326 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.6 t -58.18 -35.15 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 118.685 0.675 . . . . 1.0 111.861 -169.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.24 -48.1 83.0 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 120.845 -1.159 . . . . 1.0 112.679 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -67.09 -30.95 71.12 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.879 0.371 . . . . 1.0 111.312 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -66.31 -48.31 70.76 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 173.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.651 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -63.04 -44.0 97.1 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 112.673 0.62 . . . . 1.0 112.673 -176.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -53.56 -49.43 67.71 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.376 1.07 . . . . 1.0 110.701 170.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.06 -37.51 75.51 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.632 0.773 . . . . 1.0 112.656 -175.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.5 mt -69.49 -45.56 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 119.119 0.872 . . . . 1.0 109.568 175.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.588 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.52 -33.84 76.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 119.651 -0.819 . . . . 1.0 110.269 -178.255 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.4 m -61.71 -45.03 95.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.392 1.477 . . . . 1.0 112.669 169.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.69 -32.98 74.64 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.346 1.058 . . . . 1.0 113.011 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -68.44 -30.62 69.55 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.752 1.221 . . . . 1.0 112.102 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.87 20.93 2.01 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.847 1.213 . . . . 1.0 115.214 169.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -118.85 153.53 34.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.785 1.234 . . . . 1.0 111.167 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -88.31 75.38 8.53 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.244 1.417 . . . . 1.0 110.637 -172.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.01 144.85 25.55 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.387 -1.733 . . . . 1.0 112.449 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.1 m -147.52 141.48 25.9 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.986 1.315 . . . . 1.0 112.055 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -88.96 139.23 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 115.56 1.689 . . . . 1.0 115.56 172.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -116.95 109.85 17.55 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.181 2.192 . . . . 1.0 110.327 169.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -88.23 144.02 26.69 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.384 1.874 . . . . 1.0 110.462 171.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 43.06 59.48 11.26 Favored Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 124.488 1.115 . . . . 1.0 111.193 -169.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -60.85 130.94 34.93 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 124.483 3.455 . . . . 1.0 118.356 -168.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -93.15 150.26 20.64 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.683 1.593 . . . . 1.0 112.896 169.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.508 HD21 HD21 ' A' ' 79' ' ' LEU . 2.5 tm? -69.56 -25.81 64.18 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.2 -0.937 . . . . 1.0 110.031 168.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.9 m -66.68 -20.6 66.01 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.446 -0.784 . . . . 1.0 112.615 171.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -88.73 -22.29 23.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.669 1.188 . . . . 1.0 113.207 169.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.466 ' HB3' HD22 ' A' ' 41' ' ' LEU . 15.5 t-105 -80.53 -35.58 34.34 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.799 1.181 . . . . 1.0 113.863 174.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.1 mt -49.43 -40.24 47.29 Favored Pre-proline 0 CA--C 1.551 1.006 0 CA-C-O 117.785 -1.103 . . . . 1.0 113.828 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -55.97 -14.06 10.39 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 124.509 3.473 . . . . 1.0 117.153 172.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -109.48 7.49 24.84 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.967 1.84 . . . . 1.0 115.967 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -53.13 -31.54 42.86 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.607 1.963 . . . . 1.0 113.819 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -112.12 11.62 20.41 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.966 1.307 . . . . 1.0 112.689 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -120.17 -157.59 0.71 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.977 2.511 . . . . 1.0 110.895 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -115.45 165.53 12.89 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.629 1.204 . . . . 1.0 111.445 171.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.649 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -150.14 159.54 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.616 1.166 . . . . 1.0 109.214 -170.344 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.536 HD11 HD12 ' A' ' 90' ' ' ILE . 14.5 tp -140.29 129.01 23.07 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 124.425 1.09 . . . . 1.0 108.954 174.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.6 t -107.11 123.95 62.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 124.299 1.039 . . . . 1.0 109.626 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.0 t -123.04 111.71 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 107.546 -1.279 . . . . 1.0 107.546 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.488 1.435 0 C-N-CA 124.288 1.035 . . . . 1.0 108.958 -169.694 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.4 tt . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 113.477 0.918 . . . . 1.0 113.477 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -42.37 -52.23 10.32 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 124.638 1.175 . . . . 1.0 112.533 168.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -71.27 -29.84 16.59 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.383 1.389 . . . . 1.0 111.662 -173.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.9 tp -64.91 -49.66 69.57 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 124.227 1.011 . . . . 1.0 110.767 169.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.722 ' CE1' HD23 ' A' ' 110' ' ' LEU . 93.6 t80 -56.4 -52.57 64.13 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.312 1.045 . . . . 1.0 112.483 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -64.02 -40.75 97.02 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.864 0.866 . . . . 1.0 111.4 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.95 -33.66 84.62 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.943 0.783 . . . . 1.0 112.801 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.561 HG22 HD12 ' A' ' 110' ' ' LEU . 91.8 mt -66.54 -50.76 64.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 120.116 1.958 . . . . 1.0 108.47 170.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.744 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.1 ptmm? -69.6 -30.23 67.94 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.371 -1.456 . . . . 1.0 112.998 -170.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -106.94 -37.74 6.25 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.779 1.77 . . . . 1.0 115.779 -175.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.1 m -93.99 -22.41 18.57 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.958 0.903 . . . . 1.0 113.028 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.508 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -92.74 -71.1 0.67 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.204 -1.406 . . . . 1.0 107.204 169.813 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.02 -11.44 1.34 Allowed Glycine 0 CA--C 1.538 1.5 0 C-N-CA 127.213 2.339 . . . . 1.0 116.41 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -155.3 140.12 17.17 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.508 2.323 . . . . 1.0 108.38 172.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.431 HE22 HD12 ' A' ' 79' ' ' LEU . 2.1 mm-40 -135.81 123.58 15.03 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 121.267 -0.895 . . . . 1.0 111.365 -173.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -82.73 -39.3 0.14 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.845 2.363 . . . . 1.0 114.654 -173.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -141.28 13.57 2.2 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 115.14 1.533 . . . . 1.0 115.14 -169.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.649 HD11 ' CG2' ' A' ' 52' ' ' VAL . 53.8 tp -79.4 140.72 37.34 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.585 -1.322 . . . . 1.0 113.138 -169.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.83 151.3 48.98 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 127.959 2.504 . . . . 1.0 109.188 169.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.675 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -160.62 166.13 29.46 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.329 0.968 . . . . 1.0 113.603 -175.008 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.435 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -121.15 169.95 14.48 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 125.662 1.601 . . . . 1.0 113.876 175.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 66.0 t -145.78 132.38 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 114.364 1.246 . . . . 1.0 114.364 -169.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.536 HD12 HD11 ' A' ' 53' ' ' LEU . 3.5 mt -134.21 110.92 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.591 1.556 . . . . 1.0 108.774 169.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -105.07 146.94 28.44 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.6 -0.687 . . . . 1.0 111.546 171.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.24 153.39 44.8 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.441 1.497 . . . . 1.0 109.915 177.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.604 0 CA-C-O 122.116 0.842 . . . . 1.0 114.137 169.294 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 7.2 m . . . . . 0 CA--C 1.542 0.654 0 CA-C-O 121.364 0.602 . . . . 1.0 112.491 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -61.28 -21.83 64.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.154 1.538 . . . . 1.0 115.154 -169.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.93 -51.2 57.3 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 121.679 2.036 . . . . 1.0 114.099 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.55 -35.55 92.07 Favored Glycine 0 N--CA 1.474 1.228 0 O-C-N 120.547 -1.561 . . . . 1.0 112.845 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -63.5 -38.55 91.55 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.255 1.022 . . . . 1.0 113.119 173.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -58.32 -46.5 86.04 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.748 0.819 . . . . 1.0 111.021 170.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -63.17 -37.93 89.15 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.738 -0.601 . . . . 1.0 111.792 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.78 -45.61 93.12 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.464 -0.773 . . . . 1.0 112.081 177.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.63 -36.65 74.41 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.066 0.765 . . . . 1.0 113.066 171.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.744 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -59.65 -49.03 79.35 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 123.351 1.548 . . . . 1.0 111.199 -175.645 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.675 HD12 ' CD1' ' A' ' 87' ' ' TYR . 8.9 mt -66.1 -39.95 90.37 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 120.789 -1.194 . . . . 1.0 111.47 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -71.27 -19.1 62.39 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.136 0.791 . . . . 1.0 113.136 177.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.23 -21.93 58.27 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.407 1.003 . . . . 1.0 111.098 176.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -92.05 -78.4 0.41 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 125.356 1.462 . . . . 1.0 110.019 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.429 ' H ' ' H ' ' A' ' 116' ' ' ALA . 2.4 t -178.89 -3.75 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.085 2.154 . . . . 1.0 112.027 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -75.54 148.58 38.79 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 122.632 1.206 . . . . 1.0 112.639 -169.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -90.8 170.29 10.23 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.17 1.788 . . . . 1.0 114.048 -168.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.73 143.35 50.82 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.885 2.074 . . . . 1.0 111.018 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.9 t -118.22 130.15 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.25 1.42 . . . . 1.0 108.664 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 48.51 -154.44 1.77 Allowed Glycine 0 N--CA 1.48 1.575 0 C-N-CA 124.834 1.207 . . . . 1.0 114.317 -170.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -119.16 147.52 44.1 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.986 1.714 . . . . 1.0 109.961 169.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.26 157.66 37.28 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.239 -0.913 . . . . 1.0 113.301 -169.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.634 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.8 OUTLIER -93.99 134.79 36.03 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.221 1.009 . . . . 1.0 110.573 171.559 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.634 ' N ' HD13 ' A' ' 123' ' ' LEU . 10.3 mt -120.69 107.61 13.0 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.468 1.507 . . . . 1.0 111.451 175.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.458 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.9 mt -93.56 130.78 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 126.344 1.858 . . . . 1.0 113.054 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -106.13 89.51 3.08 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.663 2.385 . . . . 1.0 113.245 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.32 -24.68 67.74 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.893 -1.13 . . . . 1.0 113.26 -175.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.7 m -60.68 -18.13 52.12 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.424 2.29 . . . . 1.0 113.865 172.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -127.9 -31.94 2.36 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.148 2.179 . . . . 1.0 112.501 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -138.06 91.91 12.81 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 126.046 1.739 . . . . 1.0 111.483 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -75.83 9.05 2.46 Favored 'Trans proline' 0 CA--C 1.549 1.235 0 C-N-CA 123.589 2.859 . . . . 1.0 114.517 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -112.05 70.45 0.98 Allowed Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 127.482 2.313 . . . . 1.0 110.057 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -57.81 -20.51 43.97 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.627 2.218 . . . . 1.0 116.417 -169.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -65.0 -26.67 68.39 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 118.91 0.777 . . . . 1.0 111.713 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.0 p -72.6 -16.7 61.73 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 120.866 -1.146 . . . . 1.0 111.743 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -101.1 -56.16 2.38 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.179 1.792 . . . . 1.0 111.711 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 60.3 p -69.59 -32.22 70.83 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.777 1.399 . . . . 1.0 114.777 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -62.1 -55.41 40.99 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 120.939 1.7 . . . . 1.0 113.176 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -62.84 -23.59 74.34 Favored 'Trans proline' 0 C--N 1.355 0.882 0 CA-C-N 121.28 1.493 . . . . 1.0 112.255 175.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.437 ' HB2' HD23 ' A' ' 123' ' ' LEU . 92.6 t90 -69.29 -47.5 64.37 Favored 'General case' 0 C--O 1.218 -0.594 0 C-N-CA 123.258 0.623 . . . . 1.0 111.053 174.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.651 HG11 ' HA ' ' A' ' 22' ' ' ALA . 95.7 t -66.45 -32.79 59.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 N-CA-C 109.554 -0.535 . . . . 1.0 109.554 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -64.51 -50.35 67.74 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.228 -0.92 . . . . 1.0 109.477 173.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -63.47 -54.73 31.88 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.703 1.201 . . . . 1.0 111.743 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.435 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 86.3 t90 -56.58 -37.7 70.95 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 125.843 1.657 . . . . 1.0 111.262 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.2 -33.68 23.46 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.434 1.492 . . . . 1.0 113.619 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.3 p -68.8 -14.03 62.77 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 114.802 1.408 . . . . 1.0 114.802 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.53 -19.63 45.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.35 1.46 . . . . 1.0 111.692 176.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -83.68 173.7 11.13 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.48 1.112 . . . . 1.0 110.583 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--O 1.252 1.213 0 C-N-CA 124.662 1.185 . . . . 1.0 113.923 -176.23 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.48 0 N-CA-C 112.597 0.592 . . . . 1.0 112.597 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -122.48 125.08 45.06 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.035 1.334 . . . . 1.0 110.04 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.557 HD13 HD12 ' A' ' 26' ' ' LEU . 2.2 mp -121.58 114.07 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 126.778 2.031 . . . . 1.0 112.346 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.31 125.55 8.06 Favored Glycine 0 C--O 1.223 -0.539 0 N-CA-C 110.315 -1.114 . . . . 1.0 110.315 169.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 mt -106.16 121.37 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-N 118.547 1.174 . . . . 1.0 109.803 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -113.35 108.58 17.42 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.514 -1.291 . . . . 1.0 107.514 -169.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.467 0.419 0 O-C-N 123.375 0.422 . . . . 1.0 111.869 -174.185 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.3 tp . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 112.954 0.724 . . . . 1.0 112.954 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.1 t -56.35 -32.85 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.017 0.527 . . . . 1.0 111.5 -173.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.47 -47.62 85.34 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.793 -1.192 . . . . 1.0 113.105 172.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -66.98 -30.35 70.44 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.682 0.793 . . . . 1.0 111.117 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -68.86 -48.36 63.64 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 123.795 0.838 . . . . 1.0 109.394 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.541 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -63.8 -42.84 97.64 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 112.769 0.655 . . . . 1.0 112.769 -176.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -53.96 -49.44 68.73 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.093 0.957 . . . . 1.0 110.129 170.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.09 -37.84 72.4 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.484 0.713 . . . . 1.0 112.737 -174.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.5 mt -66.18 -46.83 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 119.355 0.98 . . . . 1.0 109.117 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.557 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -66.98 -35.14 79.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 119.543 -0.863 . . . . 1.0 110.468 -176.442 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 51.8 m -61.9 -41.92 98.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.24 1.416 . . . . 1.0 113.711 170.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.2 -33.06 74.58 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.049 0.94 . . . . 1.0 112.272 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -70.64 -30.04 66.56 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.629 1.172 . . . . 1.0 113.203 171.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.91 23.11 2.81 Favored Glycine 0 N--CA 1.468 0.799 0 C-N-CA 124.543 1.068 . . . . 1.0 114.433 169.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -111.52 148.96 32.08 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.543 1.137 . . . . 1.0 109.55 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.91 90.57 6.46 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.05 1.34 . . . . 1.0 108.008 -176.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.07 145.71 31.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.576 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 56.5 m -148.49 139.89 23.43 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.545 0.738 . . . . 1.0 112.076 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.45 138.72 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 115.48 1.659 . . . . 1.0 115.48 173.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -119.94 112.76 19.58 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.195 2.198 . . . . 1.0 110.292 169.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -95.01 138.23 33.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.725 2.01 . . . . 1.0 110.461 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.9 t70 42.95 54.39 10.02 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 123.753 0.821 . . . . 1.0 111.379 -169.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -71.18 147.74 54.48 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.777 2.985 . . . . 1.0 117.064 -168.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -98.02 164.81 12.19 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 124.934 1.294 . . . . 1.0 113.034 168.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.566 HD21 HD21 ' A' ' 79' ' ' LEU . 2.2 tm? -68.01 -22.5 64.98 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 121.169 -0.957 . . . . 1.0 110.523 167.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 67.0 p -68.33 -20.22 64.72 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.759 1.163 . . . . 1.0 112.481 171.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -81.13 -25.38 36.96 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.232 1.013 . . . . 1.0 112.248 169.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.454 ' HB3' HD22 ' A' ' 41' ' ' LEU . 15.7 t-105 -88.28 -35.39 17.29 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.504 1.298 . . . . 1.0 114.504 -177.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.6 mt -47.72 -38.39 17.47 Favored Pre-proline 0 CA--C 1.554 1.116 0 CA-C-O 117.681 -1.152 . . . . 1.0 114.058 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -58.99 -14.47 23.13 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 123.674 2.916 . . . . 1.0 116.526 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -110.54 9.53 23.13 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.63 1.715 . . . . 1.0 115.63 -174.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -51.44 -30.4 19.46 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.86 2.064 . . . . 1.0 113.729 174.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -108.82 7.2 26.1 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.316 1.847 . . . . 1.0 113.489 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -122.39 -163.18 1.06 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.888 2.475 . . . . 1.0 110.706 -174.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -110.62 165.33 11.9 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 123.081 1.419 . . . . 1.0 111.963 171.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.428 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -150.86 159.97 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.485 1.514 . . . . 1.0 109.567 -172.391 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.42 HD11 HD12 ' A' ' 90' ' ' ILE . 14.2 tp -139.25 130.09 26.2 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.006 1.322 . . . . 1.0 108.308 177.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.3 t -106.63 123.05 61.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 C-N-CA 123.944 0.897 . . . . 1.0 108.959 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.9 t -122.1 111.89 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 106.222 -1.77 . . . . 1.0 106.222 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 113.731 1.012 . . . . 1.0 113.731 -167.875 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.4 tt . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 114.138 1.162 . . . . 1.0 114.138 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -44.54 -53.53 14.59 Favored Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 124.912 1.285 . . . . 1.0 112.073 168.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -68.39 -30.55 29.68 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.833 1.689 . . . . 1.0 111.746 -173.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.7 tp -65.31 -52.87 51.16 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 123.908 0.883 . . . . 1.0 111.126 169.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.632 ' CE1' HD23 ' A' ' 110' ' ' LEU . 93.0 t80 -55.86 -53.2 59.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.78 0.832 . . . . 1.0 112.498 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -69.52 -34.81 74.81 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.837 -0.619 . . . . 1.0 111.696 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.95 -35.41 90.69 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.77 -0.581 . . . . 1.0 112.473 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.597 HG22 HD12 ' A' ' 110' ' ' LEU . 95.4 mt -65.47 -50.08 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.87 1.835 . . . . 1.0 108.707 171.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.67 ' HB3' HD21 ' A' ' 110' ' ' LEU . 4.5 ptmm? -69.37 -31.83 70.49 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 120.324 -1.485 . . . . 1.0 113.303 -170.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -105.69 -39.33 6.11 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.309 1.596 . . . . 1.0 115.309 -173.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.9 m -93.29 -22.94 18.69 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.054 0.941 . . . . 1.0 112.901 -176.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.566 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -92.75 -71.33 0.65 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.164 -1.421 . . . . 1.0 107.164 169.864 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.63 -13.6 1.62 Allowed Glycine 0 CA--C 1.539 1.536 0 C-N-CA 127.413 2.435 . . . . 1.0 116.587 169.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -154.18 141.05 19.18 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 127.342 2.257 . . . . 1.0 108.72 171.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.444 HE22 HD12 ' A' ' 79' ' ' LEU . 1.4 mm-40 -136.97 125.0 14.63 Favored Pre-proline 0 CA--C 1.544 0.729 0 O-C-N 121.287 -0.883 . . . . 1.0 111.668 -172.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -86.54 -36.63 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.037 2.492 . . . . 1.0 114.967 -174.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -142.53 15.89 2.0 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.534 1.309 . . . . 1.0 114.534 -169.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.428 HD11 ' CG2' ' A' ' 52' ' ' VAL . 66.3 tp -84.78 138.46 32.59 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.514 -1.366 . . . . 1.0 112.773 -169.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.9 mtm-85 -135.74 156.43 48.83 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 127.944 2.498 . . . . 1.0 109.558 169.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.676 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -162.44 169.0 21.15 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.186 -0.946 . . . . 1.0 111.587 -177.854 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.404 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -129.58 173.11 19.75 Favored Glycine 0 N--CA 1.475 1.291 0 C-N-CA 124.734 1.159 . . . . 1.0 114.189 170.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.01 141.39 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 114.3 1.222 . . . . 1.0 114.3 -169.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.96 HG23 HD12 ' A' ' 123' ' ' LEU . 7.5 mt -131.94 99.3 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 125.915 1.686 . . . . 1.0 107.11 169.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.3 143.34 26.9 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.575 1.55 . . . . 1.0 111.998 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.2 mp -137.88 161.46 36.56 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.813 0.845 . . . . 1.0 112.966 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.62 0 CA-C-N 116.231 -0.441 . . . . 1.0 114.055 168.748 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.466 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 20.7 p . . . . . 0 CA--C 1.542 0.655 0 N-CA-C 114.376 1.25 . . . . 1.0 114.376 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -60.61 -16.99 44.03 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 115.112 1.523 . . . . 1.0 115.112 -169.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.17 -40.68 98.9 Favored Glycine 0 N--CA 1.474 1.231 0 CA-C-N 120.69 1.586 . . . . 1.0 113.314 173.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.61 -37.34 35.27 Favored Glycine 0 N--CA 1.477 1.392 0 O-C-N 120.974 -1.309 . . . . 1.0 112.806 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.466 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 84.2 mttt -61.29 -33.53 73.72 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 121.155 -1.203 . . . . 1.0 112.857 174.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -63.28 -36.04 82.34 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.523 0.729 . . . . 1.0 112.503 170.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -63.0 -37.19 86.18 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.285 0.948 . . . . 1.0 111.196 172.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -46.96 83.8 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.81 -0.556 . . . . 1.0 111.72 174.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.91 -44.51 78.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.702 -0.666 . . . . 1.0 111.82 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.67 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -50.73 -49.45 57.76 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.862 2.065 . . . . 1.0 112.018 -175.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.676 HD12 ' CD1' ' A' ' 87' ' ' TYR . 7.9 mt -66.37 -41.78 88.96 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.313 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -68.85 -20.03 64.27 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.747 1.017 . . . . 1.0 113.747 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -66.98 -36.14 81.52 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.749 1.22 . . . . 1.0 111.112 172.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -84.26 -75.15 0.35 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 113.777 -1.556 . . . . 1.0 110.336 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.412 ' H ' ' H ' ' A' ' 116' ' ' ALA . 3.6 m 177.91 -0.55 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.605 2.362 . . . . 1.0 112.024 172.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -77.83 149.3 34.39 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 122.638 1.208 . . . . 1.0 113.373 -169.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -85.77 171.35 11.64 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.255 1.822 . . . . 1.0 111.884 -169.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 2.2 ttm105 -133.87 152.77 51.97 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.353 1.061 . . . . 1.0 112.135 175.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.0 t -119.1 124.17 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.521 1.528 . . . . 1.0 109.14 -172.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 51.85 -168.03 0.69 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.941 1.257 . . . . 1.0 115.352 -172.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -102.35 145.1 29.98 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.984 1.314 . . . . 1.0 108.563 169.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -78.14 159.81 28.39 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.118 1.155 . . . . 1.0 114.118 -169.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.96 HD12 HG23 ' A' ' 90' ' ' ILE . 1.4 tm? -85.17 138.48 32.35 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.854 1.261 . . . . 1.0 110.079 170.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.6 mt -127.53 108.76 11.07 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.714 1.605 . . . . 1.0 109.676 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.581 HG13 HD11 ' A' ' 123' ' ' LEU . 25.5 mt -97.82 130.76 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 124.045 0.938 . . . . 1.0 112.304 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -105.35 110.24 22.53 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.963 0.905 . . . . 1.0 112.422 170.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.92 -24.57 66.11 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.146 1.378 . . . . 1.0 113.7 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.45 -17.62 64.77 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.896 1.073 . . . . 1.0 113.896 173.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -118.99 -28.72 5.46 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.88 1.672 . . . . 1.0 111.958 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -143.81 86.08 8.83 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 125.41 1.484 . . . . 1.0 111.947 -178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.92 6.06 3.12 Favored 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 123.537 2.825 . . . . 1.0 114.443 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -112.63 70.83 1.16 Allowed Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 127.221 2.208 . . . . 1.0 110.163 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -57.59 -22.16 50.32 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.455 2.104 . . . . 1.0 116.756 -169.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -64.6 -26.19 68.29 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.325 0.966 . . . . 1.0 111.864 174.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 p -73.62 -14.23 61.14 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.864 -1.148 . . . . 1.0 112.1 -175.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.436 ' HB2' HD11 ' A' ' 125' ' ' ILE . 4.8 mm-40 -106.99 -55.86 2.27 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 126.811 2.044 . . . . 1.0 111.464 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.9 p -69.49 -33.86 73.48 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.929 1.085 . . . . 1.0 113.929 -177.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -61.15 -57.65 24.49 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 120.623 1.556 . . . . 1.0 112.266 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -62.32 -23.84 75.48 Favored 'Trans proline' 0 C--N 1.353 0.772 0 CA-C-N 121.359 1.521 . . . . 1.0 112.502 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.464 ' CG ' ' HB2' ' A' ' 123' ' ' LEU . 88.4 t90 -68.15 -46.87 69.6 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 119.104 0.865 . . . . 1.0 111.226 174.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.541 HG11 ' HA ' ' A' ' 22' ' ' ALA . 98.3 t -62.31 -33.57 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 175.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -68.62 -29.85 68.44 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.99 1.316 . . . . 1.0 112.588 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -81.49 -57.96 3.24 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.369 1.467 . . . . 1.0 112.397 170.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.404 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 84.4 t90 -56.84 -36.87 70.49 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 125.352 1.461 . . . . 1.0 112.633 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.27 -32.55 21.89 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.531 1.062 . . . . 1.0 113.871 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.8 p -68.14 -14.05 62.69 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.373 1.249 . . . . 1.0 114.373 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.44 -17.68 53.75 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.997 1.719 . . . . 1.0 111.843 175.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.38 172.3 10.5 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.842 1.257 . . . . 1.0 111.269 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 13.5 m . . . . . 0 C--O 1.25 1.086 0 N-CA-C 116.085 1.883 . . . . 1.0 116.085 -169.586 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.349 0 N-CA-C 114.943 1.461 . . . . 1.0 114.943 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -118.86 124.33 46.88 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.221 1.808 . . . . 1.0 110.241 175.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.521 HD13 HD12 ' A' ' 26' ' ' LEU . 2.1 mp -121.75 116.07 48.31 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 C-N-CA 126.937 2.095 . . . . 1.0 112.416 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.91 125.49 8.27 Favored Glycine 0 C--O 1.225 -0.45 0 N-CA-C 110.158 -1.177 . . . . 1.0 110.158 169.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 mt -104.84 117.63 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-N 118.133 0.966 . . . . 1.0 109.21 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -109.29 109.68 20.65 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.732 -1.581 . . . . 1.0 106.732 -171.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.467 0.383 0 N-CA-C 112.543 0.572 . . . . 1.0 112.543 -169.432 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.7 tp . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 115.979 1.844 . . . . 1.0 115.979 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.423 HG11 HG21 ' A' ' 90' ' ' ILE . 78.7 t -44.8 -35.48 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.506 1.522 . . . . 1.0 112.916 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.7 -48.81 79.84 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 120.384 1.447 . . . . 1.0 113.198 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -66.69 -32.72 74.2 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.093 0.957 . . . . 1.0 110.775 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -65.63 -47.47 75.52 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 123.675 0.79 . . . . 1.0 109.287 173.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.622 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -64.35 -42.62 96.14 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 123.385 0.674 . . . . 1.0 112.724 -175.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.68 -48.59 72.21 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.906 0.482 . . . . 1.0 109.777 169.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.53 -37.07 76.96 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.994 0.738 . . . . 1.0 112.994 -175.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.0 mt -70.02 -46.22 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-N 119.194 0.907 . . . . 1.0 109.258 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.521 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -64.78 -34.98 79.62 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 119.606 -0.838 . . . . 1.0 110.088 -177.761 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.3 m -60.67 -46.14 91.47 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.122 1.369 . . . . 1.0 112.91 169.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.95 -32.64 74.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.341 1.056 . . . . 1.0 112.891 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -70.31 -29.12 65.77 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.932 1.293 . . . . 1.0 112.333 172.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.62 23.02 2.16 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.673 1.13 . . . . 1.0 115.119 169.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -121.34 148.51 44.25 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.563 1.145 . . . . 1.0 110.301 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -79.98 93.56 5.74 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 125.267 1.427 . . . . 1.0 108.69 -175.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.32 147.34 35.32 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.068 0.547 . . . . 1.0 111.373 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 93.0 m -150.08 146.73 27.1 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.518 1.127 . . . . 1.0 111.096 -173.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.5 t -97.98 138.84 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 114.049 1.129 . . . . 1.0 114.049 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -118.12 106.69 13.13 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.726 2.011 . . . . 1.0 110.692 169.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -85.26 146.51 27.02 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.917 1.687 . . . . 1.0 110.909 175.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t0 41.75 57.81 9.7 Favored Pre-proline 0 CA--C 1.557 1.236 0 C-N-CA 124.644 1.177 . . . . 1.0 111.174 -169.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -57.93 130.0 36.13 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 125.122 3.881 . . . . 1.0 118.706 -167.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -91.24 150.53 21.3 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.751 1.62 . . . . 1.0 112.288 168.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.53 HD21 HD21 ' A' ' 79' ' ' LEU . 2.4 tm? -70.15 -25.34 63.41 Favored 'General case' 0 N--CA 1.444 -0.757 0 O-C-N 121.13 -0.981 . . . . 1.0 110.282 168.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.2 m -66.26 -21.67 66.29 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.65 -0.656 . . . . 1.0 112.31 171.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -86.93 -23.79 25.02 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.159 0.983 . . . . 1.0 112.994 169.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.502 ' HB3' HD22 ' A' ' 41' ' ' LEU . 12.3 t-105 -80.16 -34.63 37.44 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.806 1.185 . . . . 1.0 113.778 175.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.8 mt -50.11 -39.62 48.31 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-O 117.744 -1.122 . . . . 1.0 113.589 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -52.65 -13.36 2.38 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 124.843 3.696 . . . . 1.0 117.892 170.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -112.87 8.02 18.54 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 116.332 1.975 . . . . 1.0 116.332 -176.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -50.86 -30.74 15.31 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.2 1.8 . . . . 1.0 113.642 174.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -107.11 8.13 30.01 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.821 2.049 . . . . 1.0 113.407 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -127.97 -159.66 0.96 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.274 2.229 . . . . 1.0 112.267 -169.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -112.41 159.33 18.83 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 122.805 1.288 . . . . 1.0 110.907 171.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.412 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -148.47 154.86 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 124.909 1.284 . . . . 1.0 108.735 -171.754 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.1 tp -133.99 128.05 33.61 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.06 0.944 . . . . 1.0 108.865 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.5 t -103.75 124.18 57.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 C-N-CA 124.326 1.05 . . . . 1.0 109.184 176.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.421 HG22 HD12 ' A' ' 90' ' ' ILE . 19.9 t -125.39 112.06 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 107.183 -1.414 . . . . 1.0 107.183 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 113.628 0.973 . . . . 1.0 113.628 -168.244 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.2 tt . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 113.407 0.892 . . . . 1.0 113.407 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.8 t -44.15 -52.6 15.69 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 125.302 1.441 . . . . 1.0 112.289 168.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.89 -29.43 18.5 Favored 'Trans proline' 0 C--N 1.35 0.641 0 CA-C-N 120.774 1.312 . . . . 1.0 111.272 -173.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.4 tp -65.08 -50.46 66.06 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 124.046 0.939 . . . . 1.0 110.793 169.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.62 ' CE1' HD23 ' A' ' 110' ' ' LEU . 89.8 t80 -55.53 -52.13 64.73 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.219 1.008 . . . . 1.0 112.213 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -64.35 -40.34 95.66 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.094 0.958 . . . . 1.0 111.733 176.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.73 -35.81 90.3 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.073 0.844 . . . . 1.0 112.628 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.586 HG22 HD12 ' A' ' 110' ' ' LEU . 91.5 mt -64.73 -51.3 69.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 120.071 1.935 . . . . 1.0 107.988 171.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.691 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.4 ptmm? -68.59 -31.72 71.1 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.394 -1.441 . . . . 1.0 113.289 -169.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -103.64 -37.25 7.6 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.513 1.671 . . . . 1.0 115.513 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.1 m -96.43 -19.52 19.11 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.416 1.087 . . . . 1.0 113.266 -174.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.53 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -93.15 -73.08 0.57 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.158 -1.423 . . . . 1.0 107.158 169.522 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.35 -21.43 1.45 Allowed Glycine 0 CA--C 1.536 1.347 0 C-N-CA 127.756 2.598 . . . . 1.0 114.727 169.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -151.19 141.32 22.19 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 128.392 2.677 . . . . 1.0 108.041 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.43 HE21 HD12 ' A' ' 79' ' ' LEU . 6.4 mt-30 -138.15 121.79 11.45 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.74 0.816 . . . . 1.0 110.165 -169.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -78.55 -38.02 0.59 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.121 1.881 . . . . 1.0 115.822 -169.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -143.98 21.17 1.78 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.129 1.159 . . . . 1.0 114.129 -169.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.412 HD11 ' CG2' ' A' ' 52' ' ' VAL . 60.8 tp -84.51 140.26 31.58 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.559 -1.338 . . . . 1.0 114.6 -169.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -137.12 155.31 49.76 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 128.64 2.776 . . . . 1.0 108.065 169.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.59 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -159.36 171.81 19.11 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.355 -0.841 . . . . 1.0 111.589 -179.163 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -131.73 172.25 20.99 Favored Glycine 0 N--CA 1.471 0.974 0 C-N-CA 124.902 1.239 . . . . 1.0 113.415 170.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.422 HG23 ' HB3' ' A' ' 122' ' ' MET . 0.0 OUTLIER -142.57 143.38 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 114.009 1.114 . . . . 1.0 114.009 -169.517 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 1.04 HG23 HD12 ' A' ' 123' ' ' LEU . 12.1 mt -133.16 98.17 2.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 106.532 -1.655 . . . . 1.0 106.532 169.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.44 144.12 26.56 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.442 1.497 . . . . 1.0 111.349 171.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.1 mp -140.79 154.98 46.49 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.447 0.906 . . . . 1.0 113.447 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.659 0 N-CA-C 114.227 0.451 . . . . 1.0 114.227 168.957 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 6.9 m . . . . . 0 CA--C 1.548 0.866 0 N-CA-C 113.685 0.994 . . . . 1.0 113.685 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -54.13 -23.14 13.04 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.72 1.608 . . . . 1.0 114.611 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.31 -46.93 85.63 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 120.661 1.573 . . . . 1.0 113.588 175.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.75 -35.6 39.78 Favored Glycine 0 N--CA 1.478 1.435 0 O-C-N 120.766 -1.432 . . . . 1.0 113.141 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -60.59 -32.4 71.52 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 121.264 -1.139 . . . . 1.0 112.86 172.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -66.82 -34.99 79.02 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.033 0.933 . . . . 1.0 112.361 169.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -62.75 -35.45 79.83 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.603 1.092 . . . . 1.0 111.136 170.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -65.99 -49.04 69.23 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.804 -0.56 . . . . 1.0 111.062 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.5 -33.58 66.14 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.876 0.871 . . . . 1.0 113.272 174.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.691 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -57.91 -50.59 72.81 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 123.117 1.437 . . . . 1.0 110.867 179.564 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.59 HD12 ' CD1' ' A' ' 87' ' ' TYR . 6.6 mt -65.68 -40.03 91.93 Favored 'General case' 0 C--N 1.321 -0.67 0 O-C-N 121.074 -1.016 . . . . 1.0 111.478 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -67.17 -20.52 65.75 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.534 0.938 . . . . 1.0 113.534 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.03 -17.06 57.51 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.589 1.086 . . . . 1.0 111.112 177.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -100.42 -73.57 0.63 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.8 1.24 . . . . 1.0 109.75 -178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 77.4 p -179.37 -19.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.165 1.786 . . . . 1.0 114.147 -174.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -70.69 161.1 31.4 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 123.14 1.448 . . . . 1.0 114.139 -169.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -98.47 179.53 4.68 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.306 1.842 . . . . 1.0 110.934 -170.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.0 ttm105 -131.37 158.35 40.97 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.519 1.127 . . . . 1.0 112.828 169.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.488 HG12 ' H ' ' A' ' 120' ' ' GLY . 13.9 t -96.96 -173.44 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 C-N-CA 126.493 1.917 . . . . 1.0 106.394 169.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.488 ' H ' HG12 ' A' ' 119' ' ' VAL . . . -54.49 164.69 3.06 Favored Glycine 0 CA--C 1.545 1.919 0 N-CA-C 116.924 1.529 . . . . 1.0 116.924 -170.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -43.75 131.42 5.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.859 2.064 . . . . 1.0 113.953 -175.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.422 ' HB3' HG23 ' A' ' 89' ' ' VAL . 1.0 OUTLIER -74.16 157.62 35.63 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.333 1.053 . . . . 1.0 111.869 -172.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 1.04 HD12 HG23 ' A' ' 90' ' ' ILE . 1.4 tm? -91.48 137.27 32.49 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.215 -0.902 . . . . 1.0 110.353 174.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.6 mt -127.26 110.69 13.11 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.844 1.657 . . . . 1.0 109.445 174.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.588 ' CD1' HD11 ' A' ' 123' ' ' LEU . 24.0 mt -99.15 131.5 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 124.085 0.954 . . . . 1.0 112.582 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -104.31 108.97 20.62 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.118 0.967 . . . . 1.0 112.606 170.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.43 -24.99 66.54 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.88 1.272 . . . . 1.0 113.775 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.64 -17.46 64.61 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.776 1.028 . . . . 1.0 113.776 173.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -116.46 -29.28 6.21 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.677 1.591 . . . . 1.0 111.633 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -145.16 87.73 7.04 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 125.323 1.449 . . . . 1.0 111.901 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.98 5.01 3.24 Favored 'Trans proline' 0 CA--C 1.549 1.247 0 C-N-CA 123.689 2.926 . . . . 1.0 114.731 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -113.72 71.02 1.75 Allowed Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 127.179 2.192 . . . . 1.0 109.634 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -54.93 -28.3 58.39 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.391 2.061 . . . . 1.0 115.845 -169.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -62.99 -24.38 67.89 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.611 0.642 . . . . 1.0 112.006 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.1 p -75.08 -16.57 60.56 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 120.612 -1.305 . . . . 1.0 111.82 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -101.56 -55.68 2.47 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.371 1.868 . . . . 1.0 111.438 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 90.7 p -65.23 -34.13 77.62 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 113.779 1.029 . . . . 1.0 113.779 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 -64.03 -55.2 34.13 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 120.501 1.501 . . . . 1.0 112.92 -175.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -62.1 -24.42 76.47 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 CA-C-N 121.328 1.51 . . . . 1.0 112.849 172.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.475 ' CG ' ' HB2' ' A' ' 123' ' ' LEU . 87.5 t90 -68.28 -45.44 73.07 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 118.592 0.633 . . . . 1.0 111.314 173.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.622 HG11 ' HA ' ' A' ' 22' ' ' ALA . 83.3 t -66.41 -33.64 64.82 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -63.69 -48.77 75.79 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.225 -0.922 . . . . 1.0 109.528 173.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -63.99 -54.98 25.85 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.489 1.116 . . . . 1.0 111.827 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -58.49 -35.61 72.49 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 125.611 1.564 . . . . 1.0 111.76 174.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.19 -34.53 25.06 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.583 1.563 . . . . 1.0 113.458 171.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.9 p -67.82 -12.99 61.76 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.826 1.417 . . . . 1.0 114.826 176.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.35 -16.29 49.74 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.869 1.667 . . . . 1.0 112.072 176.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.57 -179.56 7.47 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.289 1.036 . . . . 1.0 110.924 -177.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 C--O 1.25 1.129 0 C-N-CA 126.202 1.801 . . . . 1.0 114.52 -175.549 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.405 0 N-CA-C 112.905 0.706 . . . . 1.0 112.905 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -120.84 123.83 43.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.08 1.352 . . . . 1.0 110.502 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.551 HD13 HD12 ' A' ' 26' ' ' LEU . 2.2 mp -120.43 112.79 37.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 C-N-CA 126.632 1.973 . . . . 1.0 112.497 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.61 124.27 7.3 Favored Glycine 0 C--O 1.223 -0.561 0 N-CA-C 110.328 -1.109 . . . . 1.0 110.328 169.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.5 mt -105.27 119.23 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-N 118.614 1.207 . . . . 1.0 109.691 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -110.01 107.45 17.33 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.181 -1.414 . . . . 1.0 107.181 -170.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.4 p . . . . . 0 N--CA 1.466 0.354 0 CA-C-O 121.484 0.659 . . . . 1.0 111.105 -172.742 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.1 tp . . . . . 0 C--O 1.225 -0.231 0 N-CA-C 109.935 -0.394 . . . . 1.0 109.935 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.7 t -56.01 -34.43 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.176 0.59 . . . . 1.0 111.243 -173.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.44 -45.57 88.27 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.783 -1.198 . . . . 1.0 113.414 173.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -68.81 -30.36 68.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.303 0.573 . . . . 1.0 111.048 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -68.18 -47.11 68.85 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 123.761 0.824 . . . . 1.0 109.109 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.551 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -64.32 -43.32 95.04 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 123.56 0.744 . . . . 1.0 112.804 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -53.57 -48.67 68.97 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.092 0.957 . . . . 1.0 110.456 170.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.31 -37.97 71.76 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.593 0.757 . . . . 1.0 112.285 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.0 mt -68.79 -45.83 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 O-C-N 121.63 -0.669 . . . . 1.0 109.338 175.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.551 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.99 -31.45 72.36 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.495 1.043 . . . . 1.0 110.649 -178.666 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.4 m -63.12 -45.04 93.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.586 1.154 . . . . 1.0 112.711 169.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.08 -31.36 70.93 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.799 1.239 . . . . 1.0 113.032 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -67.68 -29.03 68.2 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.211 1.804 . . . . 1.0 111.695 172.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.43 28.27 2.39 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.715 1.15 . . . . 1.0 114.905 171.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -120.52 164.39 16.51 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.016 1.326 . . . . 1.0 110.169 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -93.44 89.81 6.47 Favored 'General case' 0 CA--C 1.52 -0.183 0 O-C-N 120.659 -1.275 . . . . 1.0 108.559 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.16 145.87 29.57 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 122.766 0.426 . . . . 1.0 111.22 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.7 m -147.77 139.08 23.61 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.864 0.866 . . . . 1.0 112.041 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.4 t -86.93 137.72 20.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 114.916 1.45 . . . . 1.0 114.916 172.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -117.89 113.74 22.19 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.85 2.06 . . . . 1.0 110.32 171.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -94.7 137.75 33.4 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.686 1.994 . . . . 1.0 111.158 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.5 t70 41.79 55.37 9.07 Favored Pre-proline 0 CA--C 1.559 1.293 0 C-N-CA 124.61 1.164 . . . . 1.0 111.08 -169.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -68.59 145.63 64.71 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.016 3.144 . . . . 1.0 117.638 -167.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -88.79 154.5 20.22 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.892 1.677 . . . . 1.0 112.442 168.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.539 HD21 HD21 ' A' ' 79' ' ' LEU . 2.3 tm? -69.41 -21.72 63.74 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 120.899 -1.125 . . . . 1.0 109.762 168.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.1 m -66.13 -22.89 66.4 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.284 -0.885 . . . . 1.0 112.332 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -82.52 -24.94 33.87 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.136 0.974 . . . . 1.0 113.098 169.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.49 ' HB3' HD22 ' A' ' 41' ' ' LEU . 11.8 t-105 -83.9 -35.54 24.01 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.799 1.182 . . . . 1.0 113.994 177.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.3 mt -48.16 -39.17 25.32 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-O 117.58 -1.2 . . . . 1.0 113.897 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -55.31 -14.98 10.27 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.306 3.337 . . . . 1.0 117.224 172.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -109.03 8.24 26.12 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 116.027 1.862 . . . . 1.0 116.027 -174.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -52.98 -23.47 7.38 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.977 2.111 . . . . 1.0 114.218 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -124.91 17.74 8.57 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.546 1.538 . . . . 1.0 113.484 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -126.47 -158.24 0.85 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.936 2.494 . . . . 1.0 110.345 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -116.79 161.85 18.63 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 122.984 1.373 . . . . 1.0 112.313 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.426 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -150.08 160.59 4.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 125.14 1.376 . . . . 1.0 108.966 -172.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.4 tp -138.17 130.05 28.35 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.007 1.323 . . . . 1.0 108.369 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.8 t -105.23 124.21 59.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 124.088 0.955 . . . . 1.0 109.03 174.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.1 t -122.26 111.86 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 105.476 -2.046 . . . . 1.0 105.476 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 114.227 1.195 . . . . 1.0 114.227 -167.536 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.0 tt . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 114.477 1.288 . . . . 1.0 114.477 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.9 t -44.06 -52.73 15.0 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 124.424 1.09 . . . . 1.0 112.912 168.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.36 -31.48 17.77 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.686 1.591 . . . . 1.0 111.757 -172.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.2 tp -62.67 -52.16 64.4 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 124.602 1.161 . . . . 1.0 111.336 169.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.655 ' CE1' HD23 ' A' ' 110' ' ' LEU . 86.2 t80 -55.83 -51.44 67.49 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.718 0.807 . . . . 1.0 112.65 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -63.15 -39.32 94.31 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.424 0.69 . . . . 1.0 111.682 176.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.18 -34.65 81.37 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 123.801 0.715 . . . . 1.0 113.009 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.615 HG22 HD12 ' A' ' 110' ' ' LEU . 91.6 mt -65.66 -44.14 93.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 120.354 2.077 . . . . 1.0 108.866 171.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.716 ' HB3' HD21 ' A' ' 110' ' ' LEU . 1.8 ptmm? -74.39 -32.01 62.55 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.304 -1.498 . . . . 1.0 113.415 -173.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -106.55 -38.57 6.12 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 115.138 1.532 . . . . 1.0 115.138 -174.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.7 m -91.06 -25.05 19.84 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.252 1.021 . . . . 1.0 112.712 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.539 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -91.04 -71.06 0.65 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 107.497 -1.297 . . . . 1.0 107.497 169.594 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.0 -8.22 2.66 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 126.369 1.938 . . . . 1.0 115.481 171.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -156.0 147.97 23.24 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 129.322 3.049 . . . . 1.0 107.023 171.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -134.84 127.92 18.57 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.113 0.565 . . . . 1.0 111.037 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -81.3 -44.65 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 121.847 1.698 . . . . 1.0 113.485 -172.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -148.49 28.11 0.89 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.674 1.189 . . . . 1.0 112.88 -172.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.426 HD11 ' CG2' ' A' ' 52' ' ' VAL . 52.4 tp -85.51 137.95 32.54 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.691 -1.256 . . . . 1.0 112.682 -169.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.2 mtm-85 -134.46 157.71 45.77 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.461 2.305 . . . . 1.0 109.153 169.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.66 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -163.24 169.41 19.24 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.136 0.88 . . . . 1.0 111.441 -177.591 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.41 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -129.92 173.47 19.8 Favored Glycine 0 N--CA 1.469 0.848 0 C-N-CA 124.096 0.855 . . . . 1.0 113.558 169.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.479 HG23 ' HB3' ' A' ' 122' ' ' MET . 0.0 OUTLIER -143.55 140.81 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 114.133 1.16 . . . . 1.0 114.133 -169.815 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.6 mt -131.57 97.23 2.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 106.841 -1.54 . . . . 1.0 106.841 168.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.12 148.97 28.24 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.806 1.242 . . . . 1.0 111.47 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.7 mp -141.61 151.61 43.28 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.853 0.686 . . . . 1.0 112.853 176.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.531 0 C-N-CA 121.691 -0.29 . . . . 1.0 112.691 169.287 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 9.5 m . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 113.469 0.914 . . . . 1.0 113.469 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -63.0 -12.37 25.37 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.861 1.265 . . . . 1.0 114.289 -174.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.36 -39.37 97.15 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-N 120.308 1.413 . . . . 1.0 113.599 171.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -77.25 -36.04 36.08 Favored Glycine 0 N--CA 1.477 1.432 0 O-C-N 120.616 -1.52 . . . . 1.0 112.737 172.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -62.85 -31.62 72.67 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.256 -1.144 . . . . 1.0 112.469 173.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -62.52 -41.21 98.71 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.211 1.004 . . . . 1.0 111.071 169.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -62.8 -38.67 91.61 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 118.804 0.729 . . . . 1.0 111.41 174.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -61.86 -48.63 79.65 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.387 -0.821 . . . . 1.0 112.316 173.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.95 -35.28 70.91 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.278 0.631 . . . . 1.0 112.699 174.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.716 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -58.68 -49.22 78.37 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 125.456 1.502 . . . . 1.0 111.079 -177.78 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.66 HD12 ' CD1' ' A' ' 87' ' ' TYR . 11.0 mt -67.31 -40.21 85.99 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 120.9 -1.125 . . . . 1.0 111.762 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -70.15 -18.69 63.22 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.244 0.831 . . . . 1.0 113.244 176.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.75 -18.45 59.55 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.674 1.124 . . . . 1.0 111.198 175.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -97.23 -72.83 0.63 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.089 1.355 . . . . 1.0 109.608 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.6 p 176.54 -18.04 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.476 2.31 . . . . 1.0 113.348 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -68.44 151.54 46.68 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 123.149 1.452 . . . . 1.0 114.457 -169.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -90.93 168.07 11.96 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.73 2.012 . . . . 1.0 114.006 -168.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.97 154.43 27.61 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.172 2.189 . . . . 1.0 111.454 176.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.1 t -124.92 129.46 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.301 1.441 . . . . 1.0 108.764 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 49.79 -154.49 2.7 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 125.328 1.442 . . . . 1.0 115.279 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -111.52 143.35 42.51 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.31 1.844 . . . . 1.0 109.914 169.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.479 ' HB3' HG23 ' A' ' 89' ' ' VAL . 1.3 pmm? -77.07 156.46 31.74 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.731 0.777 . . . . 1.0 112.257 -173.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.603 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.8 OUTLIER -92.26 137.15 32.61 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 123.87 0.868 . . . . 1.0 110.291 174.118 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.603 ' N ' HD13 ' A' ' 123' ' ' LEU . 6.2 mt -123.16 102.54 8.01 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.825 1.25 . . . . 1.0 110.532 172.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.7 mt -79.41 133.21 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 C-N-CA 124.461 1.104 . . . . 1.0 111.22 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -109.48 106.98 16.94 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 122.374 1.083 . . . . 1.0 113.448 172.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.21 -23.47 64.82 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.093 0.957 . . . . 1.0 113.26 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.2 t -62.91 -22.97 67.13 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.371 1.068 . . . . 1.0 112.665 174.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -120.0 -29.6 4.89 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.361 1.864 . . . . 1.0 111.925 -174.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -144.8 84.68 8.79 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.756 1.622 . . . . 1.0 112.058 -172.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -73.65 8.25 2.0 Allowed 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 123.635 2.89 . . . . 1.0 114.495 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -111.54 71.17 0.88 Allowed Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 127.953 2.501 . . . . 1.0 109.551 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -57.67 -22.21 51.21 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.696 2.264 . . . . 1.0 116.554 -169.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -64.48 -26.16 68.31 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 118.963 0.802 . . . . 1.0 111.758 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.7 p -77.12 -19.05 57.45 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 120.434 -1.416 . . . . 1.0 112.046 -174.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -94.82 -51.99 4.45 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.028 1.331 . . . . 1.0 111.883 172.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.8 p -72.17 -35.58 69.06 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 115.078 1.51 . . . . 1.0 115.078 -176.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -59.85 -55.04 49.65 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 120.612 1.551 . . . . 1.0 112.54 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -63.35 -23.12 71.94 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 121.482 1.565 . . . . 1.0 112.515 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.461 ' HB2' HD23 ' A' ' 123' ' ' LEU . 89.6 t90 -69.19 -46.75 66.7 Favored 'General case' 0 C--O 1.218 -0.572 0 O-C-N 121.828 -0.545 . . . . 1.0 110.846 174.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.551 HG11 ' HA ' ' A' ' 22' ' ' ALA . 91.7 t -64.77 -32.25 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.877 0.846 . . . . 1.0 108.85 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -71.82 -23.51 61.56 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.154 -1.591 . . . . 1.0 113.292 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -86.91 -61.21 1.78 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.867 2.067 . . . . 1.0 111.698 169.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.41 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 89.4 t90 -54.72 -37.68 66.18 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 126.715 2.006 . . . . 1.0 112.658 178.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.85 -29.57 34.44 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 121.519 -0.738 . . . . 1.0 114.383 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.2 p -69.05 -13.47 62.46 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.273 1.212 . . . . 1.0 114.273 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.43 -18.33 52.43 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.651 1.58 . . . . 1.0 111.833 176.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.41 171.79 12.31 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.672 1.189 . . . . 1.0 110.964 -176.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 C--O 1.253 1.253 0 N-CA-C 116.17 1.915 . . . . 1.0 116.17 -169.67 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.331 0 N-CA-C 113.116 0.784 . . . . 1.0 113.116 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -120.17 122.34 40.77 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.454 1.502 . . . . 1.0 110.231 174.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.562 HD13 HD12 ' A' ' 26' ' ' LEU . 2.0 mp -122.4 113.36 38.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 126.622 1.969 . . . . 1.0 111.972 -176.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.9 124.52 7.58 Favored Glycine 0 C--O 1.224 -0.52 0 N-CA-C 110.263 -1.135 . . . . 1.0 110.263 169.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 mt -105.44 123.96 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-N 118.069 0.934 . . . . 1.0 109.225 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -115.47 109.35 17.71 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 124.195 0.998 . . . . 1.0 108.368 -169.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.535 0.384 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.105 -177.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.1 tp . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 116.683 2.105 . . . . 1.0 116.683 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.4 t -53.34 -33.67 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.968 0.907 . . . . 1.0 112.914 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.46 -46.84 87.62 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 120.285 1.402 . . . . 1.0 112.48 173.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -68.64 -32.09 71.7 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.077 0.951 . . . . 1.0 111.046 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -65.21 -49.12 70.91 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.982 -0.748 . . . . 1.0 108.982 171.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.598 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.19 -42.41 93.6 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 112.983 0.734 . . . . 1.0 112.983 -172.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -53.95 -49.99 67.48 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.701 0.8 . . . . 1.0 110.09 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.83 -35.64 74.94 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 112.625 0.602 . . . . 1.0 112.625 -175.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.1 mt -70.47 -46.01 72.29 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 119.063 0.847 . . . . 1.0 109.658 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.562 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.72 -33.6 76.25 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 119.863 -0.735 . . . . 1.0 110.189 -178.375 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 54.0 m -61.96 -44.6 96.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.058 1.343 . . . . 1.0 113.085 169.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.78 -32.03 73.05 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.196 0.998 . . . . 1.0 112.92 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -70.03 -29.43 66.47 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.846 1.259 . . . . 1.0 112.279 171.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.13 21.8 2.49 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.723 1.154 . . . . 1.0 115.056 169.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -114.24 158.39 21.44 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.816 1.246 . . . . 1.0 110.792 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -86.03 89.47 7.81 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 125.461 1.504 . . . . 1.0 108.587 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.23 145.35 31.68 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 122.446 0.298 . . . . 1.0 111.123 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 78.6 m -148.08 138.71 23.0 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.642 0.777 . . . . 1.0 112.018 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.7 t -85.57 134.58 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.726 1.21 . . . . 1.0 114.151 171.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -110.3 109.9 20.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.799 1.64 . . . . 1.0 110.385 169.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -87.47 137.52 32.27 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.113 1.765 . . . . 1.0 111.115 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.2 t0 40.89 56.85 8.34 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 124.868 1.267 . . . . 1.0 111.354 -169.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -68.9 140.95 47.37 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.898 3.065 . . . . 1.0 116.973 -168.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.435 ' HB3' ' H ' ' A' ' 42' ' ' SER . 52.6 mm-40 -93.83 163.47 13.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 122.357 1.075 . . . . 1.0 111.847 168.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.545 HD21 HD21 ' A' ' 79' ' ' LEU . 2.2 tm? -65.86 -22.04 66.51 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 120.886 -1.134 . . . . 1.0 109.796 167.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.435 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 17.9 m -68.3 -19.7 64.71 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.878 -1.139 . . . . 1.0 112.613 172.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -83.1 -24.69 32.53 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.385 1.074 . . . . 1.0 112.444 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.443 ' HB3' HD22 ' A' ' 41' ' ' LEU . 13.0 t-105 -88.68 -34.56 17.17 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.075 1.139 . . . . 1.0 114.075 -178.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.9 mt -48.09 -38.57 20.96 Favored Pre-proline 0 CA--C 1.554 1.109 0 CA-C-O 117.608 -1.186 . . . . 1.0 114.103 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.71 -11.68 21.7 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.132 3.221 . . . . 1.0 116.352 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -109.36 6.9 24.8 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 116.095 1.887 . . . . 1.0 116.095 -174.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -52.88 -31.02 37.3 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.88 2.072 . . . . 1.0 113.723 172.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -109.81 11.5 24.33 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.176 1.391 . . . . 1.0 112.499 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -124.83 -159.03 0.86 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.904 2.482 . . . . 1.0 111.034 -174.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -116.13 162.85 16.82 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 122.874 1.321 . . . . 1.0 111.834 170.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.614 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -146.93 160.52 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.432 1.093 . . . . 1.0 109.182 -172.022 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.417 HD11 HD12 ' A' ' 90' ' ' ILE . 14.8 tp -139.29 128.0 23.29 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.68 1.192 . . . . 1.0 108.924 175.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.1 t -100.52 128.3 52.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 174.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.4 t -126.04 110.92 25.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 106.254 -1.758 . . . . 1.0 106.254 175.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 113.228 0.825 . . . . 1.0 113.228 -168.15 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.2 tt . . . . . 0 N--CA 1.471 0.575 0 N-CA-C 113.712 1.004 . . . . 1.0 113.712 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.1 t -44.96 -53.27 16.48 Favored Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 124.444 1.098 . . . . 1.0 112.238 168.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -68.09 -32.38 27.89 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.747 1.631 . . . . 1.0 111.819 -173.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.2 tp -63.15 -53.24 56.51 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 124.429 1.092 . . . . 1.0 111.259 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.664 ' CE1' HD23 ' A' ' 110' ' ' LEU . 92.8 t80 -55.2 -53.75 52.09 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.747 0.819 . . . . 1.0 112.393 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -68.38 -35.1 77.21 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.769 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.36 -35.3 90.02 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 121.709 -0.62 . . . . 1.0 112.585 175.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.6 HG22 HD12 ' A' ' 110' ' ' LEU . 88.7 mt -65.98 -50.14 71.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 119.926 1.863 . . . . 1.0 108.414 171.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.681 ' HB3' HD21 ' A' ' 110' ' ' LEU . 5.6 ptmm? -69.35 -32.28 71.27 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.222 -1.549 . . . . 1.0 113.145 -170.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -104.61 -40.47 6.01 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.054 1.501 . . . . 1.0 115.054 -174.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.3 m -92.01 -24.13 19.31 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.006 0.922 . . . . 1.0 113.011 -175.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.545 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -91.1 -71.04 0.65 Allowed 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 106.804 -1.554 . . . . 1.0 106.804 169.875 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.43 -13.53 1.11 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 127.61 2.529 . . . . 1.0 117.011 168.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -155.24 140.39 17.5 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.557 2.343 . . . . 1.0 108.398 172.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -136.33 128.41 17.28 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 121.328 -0.858 . . . . 1.0 112.028 -172.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -89.3 -34.98 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.948 2.432 . . . . 1.0 115.123 -175.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -142.52 12.97 1.94 Allowed 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 115.138 1.533 . . . . 1.0 115.138 -169.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.614 HD11 ' CG2' ' A' ' 52' ' ' VAL . 63.9 tp -84.39 132.7 34.56 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.51 -1.369 . . . . 1.0 113.362 -169.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.7 mtm-85 -130.32 153.64 48.46 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.395 1.878 . . . . 1.0 109.716 169.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.661 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -160.82 165.27 30.53 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.548 1.067 . . . . 1.0 112.277 -176.46 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.402 ' HA3' ' CE2' ' A' ' 144' ' ' TRP . . . -124.0 173.37 16.68 Favored Glycine 0 N--CA 1.467 0.726 0 C-N-CA 125.401 1.476 . . . . 1.0 112.109 169.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.546 HG13 ' HB3' ' A' ' 122' ' ' MET . 0.2 OUTLIER -159.54 142.54 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 O-C-N 120.854 -1.38 . . . . 1.0 114.416 -169.571 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.417 HD12 HD11 ' A' ' 53' ' ' LEU . 4.9 mt -132.01 109.72 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 126.806 2.043 . . . . 1.0 108.24 178.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.11 145.47 24.49 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.192 1.397 . . . . 1.0 110.846 172.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.9 mp -137.09 152.41 49.99 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.466 0.706 . . . . 1.0 112.222 177.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.629 0 CA-C-N 116.354 -0.384 . . . . 1.0 112.421 169.342 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.55 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 19.8 p . . . . . 0 CA--C 1.537 0.476 0 N-CA-C 114.017 1.118 . . . . 1.0 114.017 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -57.44 -21.41 36.75 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.477 1.288 . . . . 1.0 114.477 -173.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -54.21 -44.24 74.74 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 120.592 1.542 . . . . 1.0 113.467 174.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -79.54 -36.61 25.93 Favored Glycine 0 N--CA 1.479 1.547 0 O-C-N 120.993 -1.298 . . . . 1.0 113.476 174.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.55 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 78.7 mttt -60.04 -34.41 73.35 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.207 1.004 . . . . 1.0 112.789 174.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -64.79 -38.28 90.46 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.159 0.984 . . . . 1.0 111.914 172.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -64.25 -37.71 88.44 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.421 1.009 . . . . 1.0 111.036 173.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.53 -43.57 93.6 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.132 0.573 . . . . 1.0 112.229 176.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.41 82.77 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.857 -0.592 . . . . 1.0 111.754 170.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.681 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -49.46 -49.46 45.28 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.868 2.067 . . . . 1.0 111.939 -173.464 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.661 HD12 ' CD1' ' A' ' 87' ' ' TYR . 8.5 mt -65.59 -43.96 88.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.463 -0.79 . . . . 1.0 111.005 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -67.1 -21.68 65.85 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.941 1.089 . . . . 1.0 113.941 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -66.13 -36.47 83.24 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.415 1.086 . . . . 1.0 110.938 173.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -81.02 -77.61 0.2 Allowed 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 113.996 -1.456 . . . . 1.0 109.888 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.419 ' H ' ' H ' ' A' ' 116' ' ' ALA . 4.7 t -179.72 -2.34 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.195 2.198 . . . . 1.0 111.498 170.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.436 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -74.19 146.8 43.11 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 114.819 1.415 . . . . 1.0 114.819 -168.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.13 167.31 18.88 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.657 2.383 . . . . 1.0 114.896 -168.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.43 149.5 42.92 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.907 2.083 . . . . 1.0 111.693 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.8 t -123.93 128.66 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.775 1.63 . . . . 1.0 108.497 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 50.25 -155.03 2.82 Favored Glycine 0 CA--C 1.542 1.77 0 C-N-CA 124.908 1.242 . . . . 1.0 114.988 -171.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -114.59 144.38 43.49 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.317 1.847 . . . . 1.0 109.962 169.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.546 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -73.18 155.71 39.34 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 122.134 0.969 . . . . 1.0 111.424 -174.097 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.649 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -93.73 140.04 30.11 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.309 1.043 . . . . 1.0 110.197 176.16 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.649 ' N ' HD13 ' A' ' 123' ' ' LEU . 6.7 mt -124.83 102.13 7.41 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.082 1.353 . . . . 1.0 110.891 176.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.403 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.2 mt -86.11 128.75 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.576 1.55 . . . . 1.0 111.909 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -108.03 110.5 22.21 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 124.328 1.018 . . . . 1.0 112.261 174.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -70.13 -23.3 63.0 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.132 0.973 . . . . 1.0 112.79 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.5 t -62.77 -23.17 67.08 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.291 1.036 . . . . 1.0 112.73 173.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -119.27 -29.94 5.06 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.293 1.837 . . . . 1.0 112.2 -173.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -143.79 91.11 6.76 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 125.196 1.398 . . . . 1.0 112.603 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.76 7.17 3.28 Favored 'Trans proline' 0 CA--C 1.552 1.39 0 C-N-CA 123.414 2.743 . . . . 1.0 114.483 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -110.07 71.52 0.61 Allowed Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 127.307 2.243 . . . . 1.0 110.116 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -58.34 -18.8 39.92 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.803 2.335 . . . . 1.0 117.629 -168.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -69.47 -25.45 64.09 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.122 1.328 . . . . 1.0 111.644 172.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 28.0 p -72.78 -22.85 60.77 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.942 1.246 . . . . 1.0 111.969 -173.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -91.01 -54.2 4.06 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.654 1.582 . . . . 1.0 111.767 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.7 p -70.88 -32.78 69.87 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 115.022 1.489 . . . . 1.0 115.022 -176.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -58.42 -55.62 43.79 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 120.94 1.7 . . . . 1.0 112.705 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -64.32 -24.45 64.82 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 CA-C-N 121.277 1.492 . . . . 1.0 113.134 174.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.413 ' HB2' HD23 ' A' ' 123' ' ' LEU . 92.2 t90 -68.0 -48.2 66.4 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 118.795 0.725 . . . . 1.0 110.728 174.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.598 HG11 ' HA ' ' A' ' 22' ' ' ALA . 96.2 t -67.04 -33.09 61.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 C-N-CA 122.842 0.457 . . . . 1.0 110.044 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.59 -48.9 73.22 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.02 -1.05 . . . . 1.0 109.785 173.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -64.35 -54.77 27.68 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.539 1.136 . . . . 1.0 112.102 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.434 ' CZ3' HD11 ' A' ' 26' ' ' LEU . 87.3 t90 -56.24 -37.17 69.37 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 125.886 1.674 . . . . 1.0 111.401 173.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -49.99 -34.1 22.67 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.505 1.526 . . . . 1.0 113.482 173.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.6 p -68.78 -13.37 62.35 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 115.097 1.518 . . . . 1.0 115.097 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.61 -20.03 44.13 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.619 1.568 . . . . 1.0 111.778 176.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -84.18 172.5 11.85 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.65 1.18 . . . . 1.0 110.879 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--O 1.252 1.222 0 C-N-CA 124.655 1.182 . . . . 1.0 113.941 -176.052 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 112.822 0.675 . . . . 1.0 112.822 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -122.89 121.56 36.48 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.562 1.545 . . . . 1.0 110.845 177.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.555 HD13 HD12 ' A' ' 26' ' ' LEU . 2.1 mp -121.77 117.79 53.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 127.418 2.287 . . . . 1.0 112.65 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.32 125.7 8.47 Favored Glycine 0 N--CA 1.465 0.615 0 N-CA-C 110.785 -0.926 . . . . 1.0 110.785 169.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.6 mt -104.61 120.77 55.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-N 118.565 1.183 . . . . 1.0 109.81 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -113.13 111.18 21.67 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 125.109 1.363 . . . . 1.0 107.638 -171.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.468 0.456 0 N-CA-C 112.515 0.561 . . . . 1.0 112.515 -170.328 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.8 tp . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 115.936 1.828 . . . . 1.0 115.936 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.7 t -52.0 -33.52 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 118.782 0.719 . . . . 1.0 112.602 -176.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.89 -49.91 76.0 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.001 -1.062 . . . . 1.0 113.048 173.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.73 -28.15 62.48 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.256 0.622 . . . . 1.0 110.771 -178.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -62.13 -49.42 75.94 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.122 -1.066 . . . . 1.0 108.122 169.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.605 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.02 -42.41 94.44 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 112.725 0.639 . . . . 1.0 112.725 -173.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.87 -49.67 70.58 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.196 0.598 . . . . 1.0 110.145 169.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.66 -35.76 77.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.381 0.512 . . . . 1.0 112.381 -175.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.7 mt -71.82 -45.42 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 O-C-N 121.023 -1.048 . . . . 1.0 109.71 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.555 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.62 -33.46 75.96 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 119.572 -0.851 . . . . 1.0 110.049 -179.09 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.2 m -61.86 -45.09 95.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.206 1.402 . . . . 1.0 113.084 169.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.07 -32.26 73.63 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.343 1.057 . . . . 1.0 112.888 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -70.97 -28.37 64.41 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.901 1.281 . . . . 1.0 112.578 172.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.14 27.11 2.11 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.721 1.153 . . . . 1.0 114.622 170.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -121.95 148.9 44.2 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.67 1.188 . . . . 1.0 110.415 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -77.43 101.33 6.35 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 125.4 1.48 . . . . 1.0 108.092 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.48 148.06 42.98 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 122.745 0.418 . . . . 1.0 110.937 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.5 m -149.54 146.61 27.45 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.305 1.042 . . . . 1.0 111.749 -172.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.1 t -97.9 137.18 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 114.485 1.291 . . . . 1.0 114.485 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -119.93 109.24 15.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.659 1.984 . . . . 1.0 110.878 169.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -89.82 139.94 30.09 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.462 1.905 . . . . 1.0 111.235 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t0 40.93 55.73 7.92 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 124.869 1.267 . . . . 1.0 111.613 -169.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -71.03 144.01 46.22 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.949 3.099 . . . . 1.0 117.606 -168.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -86.51 155.87 20.33 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.637 1.575 . . . . 1.0 112.616 168.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.506 HD21 HD21 ' A' ' 79' ' ' LEU . 2.3 tm? -68.5 -23.46 64.55 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 120.595 -1.316 . . . . 1.0 109.887 168.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.6 m -66.25 -21.35 66.28 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.5 -0.75 . . . . 1.0 112.488 170.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -85.31 -24.52 27.64 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.488 1.115 . . . . 1.0 112.928 169.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.484 ' HB3' HD22 ' A' ' 41' ' ' LEU . 10.9 t-105 -82.13 -35.51 28.43 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.86 1.209 . . . . 1.0 113.743 175.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.5 mt -50.57 -39.8 54.88 Favored Pre-proline 0 CA--C 1.552 1.039 0 CA-C-O 117.678 -1.153 . . . . 1.0 113.781 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -55.07 -14.47 8.55 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 124.059 3.173 . . . . 1.0 117.023 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -110.46 9.98 23.28 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 115.391 1.626 . . . . 1.0 115.391 -175.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -53.26 -34.91 59.16 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.281 1.832 . . . . 1.0 113.463 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.33 -0.6 38.07 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.462 1.505 . . . . 1.0 113.379 177.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -111.03 -164.7 0.93 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.695 2.398 . . . . 1.0 111.108 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -109.4 165.66 11.47 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 122.871 1.32 . . . . 1.0 111.359 169.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.597 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -149.62 160.85 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.91 1.284 . . . . 1.0 109.677 -171.036 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.599 HD11 HD12 ' A' ' 90' ' ' ILE . 19.1 tp -142.37 124.76 15.63 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.949 0.9 . . . . 1.0 108.975 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.9 t -99.26 123.43 51.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 123.86 0.864 . . . . 1.0 109.244 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.2 t -121.64 115.81 47.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.984 -1.858 . . . . 1.0 105.984 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 113.283 0.845 . . . . 1.0 113.283 -168.632 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.2 tt . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 114.057 1.132 . . . . 1.0 114.057 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.8 t -48.16 -51.7 47.23 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 125.047 1.339 . . . . 1.0 111.918 168.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.47 -31.59 21.5 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.32 1.347 . . . . 1.0 111.259 -173.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.2 tp -63.11 -51.52 66.23 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.747 1.219 . . . . 1.0 111.205 169.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.646 ' CE1' HD23 ' A' ' 110' ' ' LEU . 92.6 t80 -52.86 -55.12 25.51 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.706 1.203 . . . . 1.0 112.544 178.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -67.65 -35.55 79.08 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.753 -0.658 . . . . 1.0 111.8 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.62 -36.72 92.78 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.586 0.613 . . . . 1.0 112.566 176.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.568 HG22 HD12 ' A' ' 110' ' ' LEU . 92.3 mt -64.37 -50.94 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 120.114 1.957 . . . . 1.0 108.111 171.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.692 ' HB3' HD21 ' A' ' 110' ' ' LEU . 1.7 ptmm? -67.91 -31.76 71.75 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.561 -1.337 . . . . 1.0 113.281 -170.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -103.74 -37.37 7.5 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.63 1.572 . . . . 1.0 115.157 -175.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.8 m -97.06 -19.17 18.9 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.566 1.146 . . . . 1.0 113.235 -174.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.506 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -94.07 -72.27 0.62 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 107.086 -1.45 . . . . 1.0 107.086 169.718 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.65 -20.8 1.3 Allowed Glycine 0 CA--C 1.539 1.567 0 C-N-CA 127.715 2.579 . . . . 1.0 114.873 170.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -152.73 141.84 21.35 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 128.528 2.731 . . . . 1.0 107.985 169.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.415 HE21 HD12 ' A' ' 79' ' ' LEU . 6.3 mt-30 -137.6 119.57 10.98 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.016 0.926 . . . . 1.0 109.485 -170.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.03 -36.49 1.95 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.223 1.949 . . . . 1.0 115.737 -169.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -144.4 18.46 1.71 Allowed 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.993 1.109 . . . . 1.0 113.993 -169.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.597 HD11 ' CG2' ' A' ' 52' ' ' VAL . 62.6 tp -82.22 139.93 33.98 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 120.681 -1.262 . . . . 1.0 113.441 -169.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.7 mtm-85 -136.6 152.82 50.87 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.976 2.51 . . . . 1.0 109.56 169.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.651 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -161.22 168.14 24.71 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.467 1.03 . . . . 1.0 112.854 -175.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.406 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -124.8 171.36 16.86 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.176 1.37 . . . . 1.0 113.908 173.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 88.3 t -143.57 133.5 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.639 1.175 . . . . 1.0 113.585 -169.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 1.009 HG23 HD12 ' A' ' 123' ' ' LEU . 4.2 mt -130.63 103.53 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.144 1.778 . . . . 1.0 108.293 170.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.83 142.28 27.5 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.224 1.409 . . . . 1.0 111.656 173.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.9 mp -138.71 150.17 45.88 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.414 -0.804 . . . . 1.0 113.079 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.686 0 CA-C-N 116.676 -0.238 . . . . 1.0 113.042 169.317 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.441 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 22.3 p . . . . . 0 CA--C 1.537 0.48 0 N-CA-C 114.889 1.44 . . . . 1.0 114.889 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -54.46 -22.87 13.92 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 124.801 1.24 . . . . 1.0 114.271 -173.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.19 -49.05 70.21 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 121.121 1.782 . . . . 1.0 113.829 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -72.14 -35.1 60.98 Favored Glycine 0 N--CA 1.477 1.38 0 O-C-N 120.72 -1.459 . . . . 1.0 112.842 175.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.441 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 82.2 mttt -64.66 -35.87 82.42 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.693 1.197 . . . . 1.0 112.805 176.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -61.48 -43.44 98.87 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.628 1.171 . . . . 1.0 111.23 170.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -62.09 -39.08 91.25 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.41 0.55 . . . . 1.0 111.087 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -44.85 94.98 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.264 0.626 . . . . 1.0 111.781 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.03 74.16 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.037 0.754 . . . . 1.0 113.037 171.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.692 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -58.91 -49.53 77.45 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 123.44 1.591 . . . . 1.0 110.859 -175.835 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.651 HD12 ' CD1' ' A' ' 87' ' ' TYR . 4.0 mt -67.07 -40.57 87.05 Favored 'General case' 0 C--N 1.32 -0.692 0 O-C-N 120.885 -1.134 . . . . 1.0 110.936 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -69.29 -18.76 63.87 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.313 0.857 . . . . 1.0 113.313 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.81 -18.0 58.67 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.69 1.132 . . . . 1.0 110.765 175.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -100.03 -73.45 0.63 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.086 1.354 . . . . 1.0 109.606 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 62.2 p 179.76 -18.92 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.414 1.886 . . . . 1.0 114.075 -174.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -71.71 150.9 44.07 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 114.794 1.405 . . . . 1.0 114.794 -169.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -88.96 166.51 13.88 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 113.017 -1.901 . . . . 1.0 113.342 -168.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.21 136.72 52.43 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.269 1.828 . . . . 1.0 110.645 -175.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.3 t -113.59 128.9 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.889 1.276 . . . . 1.0 109.345 -173.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 50.98 -158.12 2.23 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 124.884 1.23 . . . . 1.0 114.324 -171.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -115.39 144.69 43.41 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.751 1.62 . . . . 1.0 109.445 169.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -71.19 158.16 36.9 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.918 1.081 . . . . 1.0 113.918 -169.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 1.009 HD12 HG23 ' A' ' 90' ' ' ILE . 1.4 tm? -89.49 138.39 31.49 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.049 1.34 . . . . 1.0 110.139 169.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 mt -127.78 107.81 10.2 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.708 1.603 . . . . 1.0 109.32 173.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.593 HG13 HD11 ' A' ' 123' ' ' LEU . 25.3 mt -96.51 128.15 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 121.086 -1.009 . . . . 1.0 111.541 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -104.98 109.2 21.1 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 124.628 1.205 . . . . 1.0 111.705 174.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.25 -22.06 64.79 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.269 1.028 . . . . 1.0 113.24 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.7 t -65.13 -20.23 66.36 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.867 1.267 . . . . 1.0 112.602 173.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -120.09 -29.9 4.79 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.071 1.748 . . . . 1.0 112.298 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -143.43 88.14 8.12 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.975 1.31 . . . . 1.0 112.266 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.25 4.98 4.39 Favored 'Trans proline' 0 CA--C 1.546 1.125 0 C-N-CA 123.521 2.814 . . . . 1.0 114.761 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -111.55 73.82 1.13 Allowed Pre-proline 0 N--CA 1.469 0.503 0 C-N-CA 126.794 2.038 . . . . 1.0 110.233 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -60.42 -25.88 81.46 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.999 2.466 . . . . 1.0 116.135 -169.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -65.63 -24.42 67.04 Favored 'General case' 0 C--O 1.222 -0.384 0 O-C-N 120.983 -1.073 . . . . 1.0 111.521 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 30.1 p -72.75 -18.38 61.51 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.183 -0.948 . . . . 1.0 112.498 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.41 ' HB2' HD11 ' A' ' 125' ' ' ILE . 5.1 mm-40 -100.84 -55.05 2.67 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.256 1.822 . . . . 1.0 111.297 177.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 63.4 p -67.38 -31.64 72.01 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 117.771 -1.109 . . . . 1.0 113.906 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -59.11 -59.89 12.34 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-N 121.192 1.814 . . . . 1.0 112.854 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -61.92 -26.4 78.92 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 CA-C-N 121.203 1.465 . . . . 1.0 112.813 174.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.457 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 91.1 t90 -65.6 -48.88 70.78 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.353 0.979 . . . . 1.0 110.66 174.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.605 HG11 ' HA ' ' A' ' 22' ' ' ALA . 80.0 t -66.05 -32.92 60.27 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 C-N-CA 123.08 0.552 . . . . 1.0 110.143 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.72 -51.18 68.16 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 121.076 -1.015 . . . . 1.0 109.958 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 60.0 m170 -65.19 -51.63 59.86 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.178 0.991 . . . . 1.0 111.431 -177.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.418 ' CZ3' HD11 ' A' ' 26' ' ' LEU . 86.9 t90 -57.42 -37.3 72.53 Favored 'General case' 0 C--O 1.219 -0.514 0 C-N-CA 125.293 1.437 . . . . 1.0 111.542 171.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -49.42 -34.69 19.71 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.751 1.644 . . . . 1.0 113.507 172.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 p -68.62 -13.69 62.52 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 114.896 1.443 . . . . 1.0 114.896 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.48 -19.54 45.71 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.609 1.563 . . . . 1.0 111.87 175.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -84.04 169.23 15.15 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.219 1.007 . . . . 1.0 111.193 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 C--O 1.252 1.19 0 N-CA-C 115.652 1.723 . . . . 1.0 115.652 -169.645 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 113.71 1.004 . . . . 1.0 113.71 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -126.1 125.05 41.92 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.661 1.584 . . . . 1.0 110.305 174.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.551 HD13 HD12 ' A' ' 26' ' ' LEU . 2.0 mp -121.68 113.94 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 126.152 1.781 . . . . 1.0 113.262 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.32 122.21 6.64 Favored Glycine 0 C--O 1.223 -0.544 0 O-C-N 121.33 -0.856 . . . . 1.0 111.245 169.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.3 mt -104.4 122.18 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-N 118.407 1.103 . . . . 1.0 109.872 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -114.72 112.7 23.24 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.089 1.355 . . . . 1.0 107.455 -171.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.469 0.482 0 C-N-CA 122.586 0.355 . . . . 1.0 111.473 -172.201 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.9 tp . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 114.626 1.343 . . . . 1.0 114.626 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.9 t -56.8 -31.14 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.22 -0.925 . . . . 1.0 112.269 -171.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.58 -48.2 80.03 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.193 -0.942 . . . . 1.0 113.203 171.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.67 -28.41 62.7 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.031 0.532 . . . . 1.0 110.72 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -63.15 -49.7 73.3 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.924 -0.769 . . . . 1.0 108.924 169.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.532 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.16 -43.36 92.02 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 112.521 0.563 . . . . 1.0 112.521 -173.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -53.34 -49.99 65.95 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.07 0.948 . . . . 1.0 110.291 169.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.71 -37.09 73.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.2 0.6 . . . . 1.0 112.345 -174.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.9 mt -67.43 -46.74 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 118.994 0.816 . . . . 1.0 109.084 176.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.551 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -67.51 -34.13 76.49 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 119.667 -0.813 . . . . 1.0 110.457 -176.554 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.5 m -62.83 -40.26 96.87 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.731 1.612 . . . . 1.0 113.325 170.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.56 -33.26 73.77 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.978 0.911 . . . . 1.0 112.029 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -69.3 -31.48 69.99 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.529 1.132 . . . . 1.0 112.45 170.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 126.68 18.61 2.16 Favored Glycine 0 N--CA 1.472 1.058 0 C-N-CA 124.409 1.004 . . . . 1.0 115.066 169.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -111.22 152.32 27.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.637 1.175 . . . . 1.0 111.007 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.9 73.65 9.9 Favored 'General case' 0 CA--C 1.51 -0.561 0 C-N-CA 124.629 1.172 . . . . 1.0 110.391 -172.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.99 142.39 27.83 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.29 -1.777 . . . . 1.0 112.061 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.6 m -147.94 138.97 23.33 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.549 1.14 . . . . 1.0 112.36 -177.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.5 t -84.64 135.29 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 114.781 1.401 . . . . 1.0 114.781 171.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -116.34 114.54 24.46 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.732 2.013 . . . . 1.0 110.536 169.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -95.32 139.01 32.24 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.465 1.906 . . . . 1.0 111.138 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.2 t0 41.18 54.92 7.93 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 124.865 1.266 . . . . 1.0 111.982 -169.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -71.92 143.06 40.13 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.902 3.068 . . . . 1.0 116.553 -168.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.431 ' HB3' ' H ' ' A' ' 42' ' ' SER . 50.7 mm-40 -94.27 164.93 12.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 122.431 1.11 . . . . 1.0 111.85 168.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.556 HD21 HD21 ' A' ' 79' ' ' LEU . 2.2 tm? -65.8 -22.16 66.54 Favored 'General case' 0 N--CA 1.44 -0.93 0 O-C-N 120.859 -1.151 . . . . 1.0 110.064 167.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.431 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 16.3 m -68.18 -20.08 64.84 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.07 -1.019 . . . . 1.0 112.376 172.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -83.73 -23.99 31.38 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.605 1.162 . . . . 1.0 112.47 169.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.49 ' HB3' HD22 ' A' ' 41' ' ' LEU . 10.9 t-105 -88.41 -33.96 17.7 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.064 1.135 . . . . 1.0 114.064 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.3 mt -49.89 -38.54 35.8 Favored Pre-proline 0 CA--C 1.555 1.163 0 CA-C-O 117.558 -1.21 . . . . 1.0 113.944 178.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -58.76 -8.81 6.3 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 124.031 3.154 . . . . 1.0 116.797 173.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -114.89 8.04 15.84 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 116.091 1.885 . . . . 1.0 116.091 -177.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -51.05 -32.35 21.59 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.935 1.694 . . . . 1.0 113.436 171.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -102.11 6.23 40.79 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.721 2.408 . . . . 1.0 113.588 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -128.79 -159.47 0.96 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 127.056 2.142 . . . . 1.0 112.222 -169.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -112.57 160.8 17.48 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 122.862 1.315 . . . . 1.0 111.404 170.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.567 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -146.92 159.4 9.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 125.076 1.35 . . . . 1.0 108.908 -171.658 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.616 HD11 HD12 ' A' ' 90' ' ' ILE . 19.7 tp -141.76 125.86 17.35 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 124.197 0.999 . . . . 1.0 109.211 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.5 t -102.37 120.41 52.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 C-N-CA 123.767 0.827 . . . . 1.0 109.182 176.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.4 t -119.77 113.53 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 105.944 -1.873 . . . . 1.0 105.944 177.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 113.561 0.949 . . . . 1.0 113.561 -168.331 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.0 tt . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 113.682 0.993 . . . . 1.0 113.682 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -44.61 -52.74 16.89 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 124.768 1.227 . . . . 1.0 112.622 168.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.73 -32.7 29.55 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 121.851 1.701 . . . . 1.0 111.954 -173.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 tp -62.92 -52.85 61.48 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.523 1.129 . . . . 1.0 111.375 169.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.643 ' CE1' HD23 ' A' ' 110' ' ' LEU . 92.5 t80 -55.13 -53.08 60.42 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.629 0.771 . . . . 1.0 112.651 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 -64.61 -40.58 95.75 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.717 0.807 . . . . 1.0 111.465 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.94 -35.78 91.2 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.41 -0.661 . . . . 1.0 112.333 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.591 HG22 HD12 ' A' ' 110' ' ' LEU . 89.4 mt -64.81 -50.09 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 120.229 2.015 . . . . 1.0 108.246 172.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.707 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.1 ptmm? -69.46 -31.83 70.38 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.326 -1.484 . . . . 1.0 113.188 -170.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -101.76 -37.61 8.23 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 115.133 1.531 . . . . 1.0 115.133 -175.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 m -97.79 -19.51 18.13 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.333 1.053 . . . . 1.0 113.446 -174.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.556 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -92.86 -72.53 0.6 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 107.391 -1.337 . . . . 1.0 107.391 169.906 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.81 -20.67 1.38 Allowed Glycine 0 CA--C 1.539 1.564 0 C-N-CA 127.541 2.496 . . . . 1.0 114.902 170.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -153.21 142.08 21.14 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 128.408 2.683 . . . . 1.0 108.07 169.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.401 HE21 HD12 ' A' ' 79' ' ' LEU . 5.5 mt-30 -137.35 119.96 11.38 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.929 0.891 . . . . 1.0 109.701 -169.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -77.55 -35.3 1.61 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.451 2.101 . . . . 1.0 115.965 -169.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -143.64 19.28 1.84 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.056 1.132 . . . . 1.0 114.056 -169.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.567 HD11 ' CG2' ' A' ' 52' ' ' VAL . 58.1 tp -85.84 140.06 30.75 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.686 -1.259 . . . . 1.0 114.176 -169.044 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.4 mtm-85 -137.33 153.57 50.22 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.989 2.516 . . . . 1.0 109.619 169.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.657 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -161.56 168.17 24.04 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.073 0.851 . . . . 1.0 112.543 -176.485 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.402 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -125.19 170.54 17.13 Favored Glycine 0 N--CA 1.472 1.093 0 C-N-CA 125.201 1.382 . . . . 1.0 114.134 174.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.3 t -142.44 132.7 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.658 1.183 . . . . 1.0 113.695 -169.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.97 HG23 HD12 ' A' ' 123' ' ' LEU . 4.1 mt -129.54 102.84 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.802 1.641 . . . . 1.0 108.035 170.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -91.86 142.3 27.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.526 1.531 . . . . 1.0 111.726 173.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.5 mp -138.13 152.7 48.97 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.235 -0.915 . . . . 1.0 112.793 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.697 0 C-N-CA 121.528 -0.368 . . . . 1.0 112.583 169.207 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.435 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 26.7 p . . . . . 0 CA--C 1.537 0.46 0 N-CA-C 114.519 1.303 . . . . 1.0 114.519 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -58.18 -21.63 48.17 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 117.573 -1.203 . . . . 1.0 114.08 -173.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.95 -43.0 87.77 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-N 121.371 1.896 . . . . 1.0 114.007 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -77.59 -36.88 32.25 Favored Glycine 0 N--CA 1.478 1.471 0 O-C-N 120.909 -1.348 . . . . 1.0 113.036 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.435 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 85.2 mttt -63.58 -33.49 75.71 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.34 1.056 . . . . 1.0 112.978 176.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -59.93 -44.15 94.5 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.263 1.425 . . . . 1.0 111.012 169.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -63.65 -39.12 93.55 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.662 -0.649 . . . . 1.0 110.948 175.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -42.99 99.63 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.774 -0.579 . . . . 1.0 111.709 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.83 -35.64 77.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 112.978 0.733 . . . . 1.0 112.978 171.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.707 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -58.91 -49.66 76.97 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 123.463 1.601 . . . . 1.0 110.902 -175.141 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.657 HD12 ' CD1' ' A' ' 87' ' ' TYR . 4.0 mt -67.52 -40.3 85.1 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 120.92 -1.112 . . . . 1.0 110.996 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -70.09 -17.87 63.24 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.364 0.876 . . . . 1.0 113.364 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.77 -17.08 59.26 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.488 1.04 . . . . 1.0 110.957 174.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -101.63 -73.28 0.66 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.147 1.379 . . . . 1.0 109.904 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 65.8 p 179.52 -19.32 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.106 1.763 . . . . 1.0 113.984 -174.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -72.1 151.59 42.95 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 123.06 1.41 . . . . 1.0 114.464 -169.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -87.75 165.37 15.4 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 113.071 -1.877 . . . . 1.0 113.298 -169.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.69 133.32 47.0 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.222 1.809 . . . . 1.0 110.21 -174.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 32.6 t -112.46 130.99 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.61 1.164 . . . . 1.0 109.857 -171.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 52.46 -157.72 3.77 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 125.314 1.435 . . . . 1.0 114.765 -173.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -111.9 139.82 47.07 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.839 1.656 . . . . 1.0 110.097 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -70.61 155.29 40.92 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 122.332 1.063 . . . . 1.0 112.222 -171.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.97 HD12 HG23 ' A' ' 90' ' ' ILE . 1.2 tm? -87.96 139.07 30.89 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.722 -1.127 . . . . 1.0 109.957 171.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 mt -127.65 106.57 9.24 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.404 1.482 . . . . 1.0 109.69 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.608 HG13 HD11 ' A' ' 123' ' ' LEU . 23.8 mt -95.84 127.79 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 O-C-N 121.169 -0.957 . . . . 1.0 112.042 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -104.68 109.59 21.57 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 122.4 1.095 . . . . 1.0 111.982 173.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.74 -22.71 66.04 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.558 1.143 . . . . 1.0 113.433 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.1 t -64.38 -22.48 66.97 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.035 0.934 . . . . 1.0 112.718 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -118.1 -29.91 5.46 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.0 1.72 . . . . 1.0 111.961 -175.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -142.54 87.72 9.11 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 125.086 1.354 . . . . 1.0 112.06 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.62 8.11 2.42 Favored 'Trans proline' 0 CA--C 1.552 1.404 0 C-N-CA 123.655 2.904 . . . . 1.0 114.271 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -114.73 69.97 2.24 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 127.2 2.2 . . . . 1.0 109.859 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -56.9 -23.13 49.45 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.723 2.282 . . . . 1.0 116.197 -169.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 pm0 -67.03 -24.13 65.97 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 121.028 -1.045 . . . . 1.0 112.251 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.9 p -74.77 -17.92 60.56 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.329 0.968 . . . . 1.0 112.301 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.425 ' HB2' HD11 ' A' ' 125' ' ' ILE . 5.1 mm-40 -100.33 -54.05 2.96 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.456 1.903 . . . . 1.0 111.509 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.5 p -68.19 -33.82 75.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 117.764 -1.112 . . . . 1.0 113.912 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -57.47 -61.69 6.73 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 120.877 1.671 . . . . 1.0 112.009 176.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -60.54 -23.58 75.81 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 CA-C-N 121.882 1.708 . . . . 1.0 113.744 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.456 ' CG ' ' HB2' ' A' ' 123' ' ' LEU . 87.9 t90 -68.87 -47.13 66.66 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 119.217 0.917 . . . . 1.0 110.984 173.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.532 HG11 ' HA ' ' A' ' 22' ' ' ALA . 93.2 t -65.27 -33.83 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 176.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.01 -31.0 70.38 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.0 1.32 . . . . 1.0 112.038 177.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -77.56 -62.34 1.69 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.994 1.718 . . . . 1.0 111.877 169.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.402 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 84.8 t90 -55.06 -36.89 66.05 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 126.191 1.796 . . . . 1.0 112.709 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.93 -31.93 25.72 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.98 1.276 . . . . 1.0 113.803 174.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.0 p -70.2 -13.77 62.33 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 114.352 1.241 . . . . 1.0 114.352 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.41 -17.02 53.04 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.85 1.66 . . . . 1.0 111.705 175.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -81.75 172.38 13.44 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.06 0.944 . . . . 1.0 111.6 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 C--O 1.255 1.371 0 C-N-CA 125.637 1.575 . . . . 1.0 112.619 -172.31 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.553 0 N-CA-C 113.348 0.87 . . . . 1.0 113.348 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -122.23 121.28 36.44 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.342 1.457 . . . . 1.0 110.346 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.595 HD13 HD12 ' A' ' 26' ' ' LEU . 2.2 mp -120.15 114.03 42.55 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 C-N-CA 126.057 1.743 . . . . 1.0 112.857 -178.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.48 122.53 6.79 Favored Glycine 0 C--O 1.222 -0.624 0 N-CA-C 110.573 -1.011 . . . . 1.0 110.573 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.4 mt -103.18 120.93 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-N 118.113 0.956 . . . . 1.0 109.271 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -114.2 113.21 24.35 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.245 -1.391 . . . . 1.0 107.245 -171.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.467 0.398 0 N-CA-C 112.66 0.615 . . . . 1.0 112.66 -171.011 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.4 tp . . . . . 0 N--CA 1.468 0.453 0 N-CA-C 113.641 0.978 . . . . 1.0 113.641 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.6 t -55.04 -33.93 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.639 0.776 . . . . 1.0 111.567 -173.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.27 -45.89 92.6 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.706 -1.246 . . . . 1.0 113.04 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -66.61 -29.98 70.15 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.774 0.83 . . . . 1.0 110.844 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -70.2 -47.14 62.8 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.79 0.836 . . . . 1.0 109.139 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.552 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -64.0 -41.35 97.52 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 113.297 0.851 . . . . 1.0 113.297 -176.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -56.26 -48.46 76.52 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.307 1.043 . . . . 1.0 110.572 170.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.27 -37.8 71.88 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.754 0.822 . . . . 1.0 112.055 -174.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.1 mt -69.29 -45.55 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 O-C-N 121.322 -0.862 . . . . 1.0 109.602 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.595 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.67 -31.52 72.57 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.878 1.217 . . . . 1.0 110.816 -179.133 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.5 m -62.56 -45.82 91.17 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.843 1.257 . . . . 1.0 112.687 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.22 -31.02 70.23 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.675 1.19 . . . . 1.0 113.254 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -67.65 -29.46 68.77 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.121 1.768 . . . . 1.0 111.606 171.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.02 27.6 2.22 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.802 1.192 . . . . 1.0 114.882 171.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -123.42 159.2 29.5 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.083 1.353 . . . . 1.0 110.389 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -90.61 87.54 6.76 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 120.645 -1.284 . . . . 1.0 108.649 -177.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.83 146.62 27.99 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.113 0.565 . . . . 1.0 111.379 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.9 m -147.31 140.86 25.52 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.472 1.109 . . . . 1.0 112.188 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.0 t -89.76 139.22 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 115.613 1.709 . . . . 1.0 115.613 173.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -121.04 111.88 18.03 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.303 2.241 . . . . 1.0 110.136 169.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -95.13 139.15 31.88 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.011 1.724 . . . . 1.0 111.634 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.4 t70 42.63 52.94 8.18 Favored Pre-proline 0 CA--C 1.56 1.365 0 C-N-CA 124.943 1.297 . . . . 1.0 111.581 -169.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -70.96 147.63 55.6 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.075 3.183 . . . . 1.0 117.013 -168.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.425 ' HB3' ' H ' ' A' ' 42' ' ' SER . 52.4 mm-40 -93.81 163.81 13.37 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.452 1.101 . . . . 1.0 112.035 168.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.577 HD21 HD21 ' A' ' 79' ' ' LEU . 2.3 tm? -65.52 -22.26 66.7 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 120.729 -1.232 . . . . 1.0 110.269 167.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.425 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 16.8 m -68.29 -20.41 64.77 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.921 -1.112 . . . . 1.0 112.116 172.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -82.96 -25.51 32.25 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.499 1.12 . . . . 1.0 112.31 169.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.489 ' HB3' HD22 ' A' ' 41' ' ' LEU . 14.9 t-105 -86.42 -35.43 19.73 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.909 1.077 . . . . 1.0 113.909 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.1 mt -48.21 -38.43 21.04 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 114.464 1.283 . . . . 1.0 114.464 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -60.59 -11.75 18.4 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 123.691 2.928 . . . . 1.0 116.573 175.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -111.14 8.31 21.66 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 116.243 1.942 . . . . 1.0 116.243 -172.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -54.3 -35.04 62.19 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.073 1.749 . . . . 1.0 113.628 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -99.03 -2.39 37.35 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.025 1.73 . . . . 1.0 113.274 177.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -109.64 -164.98 0.97 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.819 2.447 . . . . 1.0 110.938 -176.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -109.77 163.22 13.71 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.937 1.351 . . . . 1.0 111.773 169.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.623 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -144.25 157.7 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.822 1.249 . . . . 1.0 109.519 -170.805 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.541 HD11 HD12 ' A' ' 90' ' ' ILE . 18.2 tp -139.33 124.37 18.83 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 124.235 1.014 . . . . 1.0 108.735 174.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.7 t -99.36 121.53 50.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.383 -0.826 . . . . 1.0 109.238 174.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.7 t -120.06 113.98 42.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 105.319 -2.104 . . . . 1.0 105.319 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 115.161 1.541 . . . . 1.0 115.161 -168.298 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.7 tt . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 113.894 1.072 . . . . 1.0 113.894 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.8 t -43.46 -52.38 13.52 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.835 1.254 . . . . 1.0 112.878 168.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.86 -33.11 34.62 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.714 1.609 . . . . 1.0 111.915 -173.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 tp -63.41 -53.83 46.21 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 124.235 1.014 . . . . 1.0 111.223 169.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.658 ' CE1' HD23 ' A' ' 110' ' ' LEU . 91.6 t80 -54.69 -52.81 61.22 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.796 0.839 . . . . 1.0 112.477 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -64.85 -40.77 95.69 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.424 1.09 . . . . 1.0 111.384 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.44 -34.91 86.1 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.371 0.51 . . . . 1.0 112.656 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.611 HG22 HD12 ' A' ' 110' ' ' LEU . 92.0 mt -64.79 -49.31 80.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.866 1.833 . . . . 1.0 108.558 171.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.715 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.4 ptmm? -70.91 -32.12 68.96 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.2 -1.562 . . . . 1.0 112.85 -169.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -104.62 -38.49 6.72 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.082 1.512 . . . . 1.0 115.082 -174.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.2 m -95.0 -23.37 17.41 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.26 1.024 . . . . 1.0 113.171 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.577 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -91.32 -70.98 0.66 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 169.84 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.24 -11.95 1.95 Allowed Glycine 0 CA--C 1.538 1.507 0 C-N-CA 126.776 2.131 . . . . 1.0 116.255 169.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -157.6 141.84 16.16 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 127.81 2.444 . . . . 1.0 108.366 174.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.442 HE22 HD12 ' A' ' 79' ' ' LEU . 10.1 mm-40 -136.0 123.15 14.53 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.962 0.905 . . . . 1.0 111.148 -172.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.41 -37.82 0.36 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.205 1.937 . . . . 1.0 114.724 -171.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -146.94 19.07 1.27 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.069 1.137 . . . . 1.0 114.069 -169.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.623 HD11 ' CG2' ' A' ' 52' ' ' VAL . 45.8 tp -79.46 140.56 37.3 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.404 -1.435 . . . . 1.0 113.861 -169.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -133.49 150.2 51.71 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 128.636 2.774 . . . . 1.0 107.571 169.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.663 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -160.88 166.85 27.78 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.319 -0.863 . . . . 1.0 112.932 -178.166 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.47 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -124.65 171.85 16.83 Favored Glycine 0 N--CA 1.475 1.295 0 C-N-CA 125.003 1.287 . . . . 1.0 114.531 173.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.5 t -143.52 133.08 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 114.852 1.427 . . . . 1.0 114.852 -169.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.541 HD12 HD11 ' A' ' 53' ' ' LEU . 4.0 mt -130.79 104.85 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.683 1.593 . . . . 1.0 107.968 169.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -91.74 143.19 26.8 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.891 1.677 . . . . 1.0 111.797 175.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.9 mp -137.44 148.41 46.1 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.448 0.907 . . . . 1.0 113.448 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.63 0 N-CA-C 114.805 0.682 . . . . 1.0 114.805 169.014 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 20.1 p . . . . . 0 CA--C 1.542 0.66 0 N-CA-C 114.193 1.183 . . . . 1.0 114.193 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -55.95 -23.49 32.45 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.481 1.912 . . . . 1.0 114.607 -172.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.32 -48.44 83.66 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-N 120.357 1.435 . . . . 1.0 113.412 174.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.25 -36.51 50.41 Favored Glycine 0 N--CA 1.478 1.474 0 O-C-N 120.782 -1.422 . . . . 1.0 113.248 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -60.31 -35.8 76.45 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.928 0.891 . . . . 1.0 113.168 172.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -65.24 -33.94 77.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 118.603 -0.713 . . . . 1.0 112.826 172.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -63.95 -37.4 87.28 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.689 1.131 . . . . 1.0 111.032 172.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.413 ' CG ' ' HE ' ' A' ' 118' ' ' ARG . 12.0 t70 -63.14 -49.88 72.64 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.027 0.831 . . . . 1.0 110.473 177.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.64 -33.0 59.96 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.251 0.834 . . . . 1.0 113.251 173.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.715 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -61.27 -50.28 73.66 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 123.238 1.494 . . . . 1.0 110.727 178.408 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.663 HD12 ' CD1' ' A' ' 87' ' ' TYR . 8.0 mt -65.1 -39.27 92.9 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 120.966 -1.084 . . . . 1.0 111.19 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -67.31 -22.39 65.63 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.557 0.947 . . . . 1.0 113.557 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.54 -17.53 59.19 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.393 0.997 . . . . 1.0 111.464 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -96.51 -73.61 0.59 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.994 1.318 . . . . 1.0 109.206 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 56.2 p 177.18 -18.32 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.755 2.022 . . . . 1.0 113.534 -175.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -67.59 157.26 34.86 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.793 1.282 . . . . 1.0 113.933 -169.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -99.4 173.39 6.78 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 113.239 -1.8 . . . . 1.0 112.155 -169.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.413 ' HE ' ' CG ' ' A' ' 108' ' ' ASP . 4.7 ttm180 -128.63 160.49 32.26 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.758 1.223 . . . . 1.0 113.509 174.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.1 t -119.25 126.71 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 127.232 2.213 . . . . 1.0 108.811 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 52.35 -165.0 1.42 Allowed Glycine 0 CA--C 1.542 1.762 0 C-N-CA 124.748 1.166 . . . . 1.0 115.628 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -107.56 149.41 28.06 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.726 1.611 . . . . 1.0 110.118 169.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.78 159.15 32.35 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.717 1.207 . . . . 1.0 113.188 -169.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.659 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.2 tm? -91.32 139.57 30.61 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.098 0.959 . . . . 1.0 110.165 169.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.659 ' N ' HD13 ' A' ' 123' ' ' LEU . 6.4 mt -122.83 105.76 10.3 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.205 1.402 . . . . 1.0 111.103 174.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.447 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.9 mt -91.95 131.19 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 125.331 1.452 . . . . 1.0 112.341 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -108.25 92.27 3.99 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.86 2.464 . . . . 1.0 112.617 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.4 -23.6 67.0 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.995 1.318 . . . . 1.0 112.794 -173.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.7 p -53.47 -30.39 40.64 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 129.329 3.052 . . . . 1.0 114.334 169.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -124.79 -26.53 3.77 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.849 2.06 . . . . 1.0 111.585 -171.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -143.22 88.59 8.07 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.44 1.496 . . . . 1.0 112.184 -177.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -76.53 11.19 1.95 Allowed 'Trans proline' 0 CA--C 1.549 1.251 0 C-N-CA 123.77 2.98 . . . . 1.0 114.211 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -111.62 68.77 0.77 Allowed Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 127.672 2.389 . . . . 1.0 110.042 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -57.38 -21.39 44.6 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.777 2.318 . . . . 1.0 116.809 -169.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -64.25 -27.25 68.92 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 118.934 0.788 . . . . 1.0 111.902 174.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.6 p -72.27 -18.78 61.78 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 120.939 -1.1 . . . . 1.0 111.813 -174.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -99.22 -53.66 3.18 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.807 1.643 . . . . 1.0 111.933 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 48.1 p -71.28 -33.77 70.06 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 114.599 1.333 . . . . 1.0 114.599 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -59.32 -56.63 34.06 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 120.723 1.601 . . . . 1.0 112.453 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -62.66 -22.64 74.15 Favored 'Trans proline' 0 C--N 1.355 0.871 0 CA-C-N 121.459 1.557 . . . . 1.0 112.735 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.479 ' HB2' HD23 ' A' ' 123' ' ' LEU . 91.4 t90 -69.19 -47.37 65.05 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 123.279 0.632 . . . . 1.0 111.093 174.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.552 HG11 ' HA ' ' A' ' 22' ' ' ALA . 97.5 t -65.23 -32.0 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 122.03 0.919 . . . . 1.0 108.899 176.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.93 -22.33 61.48 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 120.045 -1.659 . . . . 1.0 113.401 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -87.07 -62.52 1.48 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.858 2.063 . . . . 1.0 111.265 169.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.47 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 87.6 t90 -54.88 -38.26 67.32 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 126.892 2.077 . . . . 1.0 112.99 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.96 -29.26 27.11 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 121.42 -0.8 . . . . 1.0 114.488 173.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.1 p -69.32 -13.29 62.3 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.809 1.304 . . . . 1.0 114.367 175.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.5 -18.59 51.64 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.34 1.456 . . . . 1.0 111.774 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -84.41 170.1 13.91 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.517 1.127 . . . . 1.0 111.521 -175.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.251 1.182 0 N-CA-C 116.697 2.11 . . . . 1.0 116.697 -169.465 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 116.469 2.026 . . . . 1.0 116.469 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -121.46 124.49 44.6 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 126.643 1.977 . . . . 1.0 110.057 170.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.492 HD13 HD12 ' A' ' 26' ' ' LEU . 1.7 mp -126.62 113.06 31.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 126.8 2.04 . . . . 1.0 111.898 -174.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.19 124.51 7.81 Favored Glycine 0 C--O 1.224 -0.518 0 N-CA-C 110.01 -1.236 . . . . 1.0 110.01 169.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.8 mt -104.59 123.34 58.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 118.151 0.976 . . . . 1.0 109.545 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -115.95 110.63 19.23 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.598 1.159 . . . . 1.0 108.266 -169.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.469 0.478 0 CA-C-N 116.619 -0.264 . . . . 1.0 111.441 -175.363 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.7 tp . . . . . 0 C--O 1.223 -0.322 0 CA-C-O 120.892 0.377 . . . . 1.0 110.663 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -56.66 -39.23 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 O-C-N 121.79 -0.569 . . . . 1.0 110.891 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.7 -49.65 74.25 Favored 'General case' 0 C--O 1.23 0.062 0 CA-C-N 119.606 1.093 . . . . 1.0 112.615 176.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -67.79 -26.93 66.33 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.105 0.479 . . . . 1.0 112.055 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -70.74 -48.72 53.01 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 123.952 0.901 . . . . 1.0 109.938 169.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.627 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -60.98 -44.38 97.46 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 112.651 0.611 . . . . 1.0 112.651 -176.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -51.52 -51.24 56.9 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.521 1.128 . . . . 1.0 110.221 169.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.86 -35.62 74.87 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.633 0.773 . . . . 1.0 112.764 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.7 mt -70.43 -45.41 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 O-C-N 121.175 -0.953 . . . . 1.0 109.342 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.492 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.86 -34.44 78.16 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 120.028 -0.669 . . . . 1.0 110.213 -178.536 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.4 m -61.75 -44.42 96.93 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.973 1.309 . . . . 1.0 113.155 169.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.17 -32.61 73.83 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.62 1.168 . . . . 1.0 112.944 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -66.49 -32.78 74.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.534 1.134 . . . . 1.0 111.75 170.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.27 12.98 1.56 Allowed Glycine 0 CA--C 1.532 1.135 0 N-CA-C 116.091 1.196 . . . . 1.0 116.091 169.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -105.85 168.32 9.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.865 1.266 . . . . 1.0 112.116 -170.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? -90.64 97.26 11.08 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.914 1.286 . . . . 1.0 107.847 170.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.91 144.87 42.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.64 0.257 . . . . 1.0 110.693 174.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.6 m -147.59 138.74 23.61 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.72 0.808 . . . . 1.0 111.91 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.1 t -86.92 136.64 22.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 114.502 1.297 . . . . 1.0 114.502 171.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -111.59 114.63 27.81 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.135 1.774 . . . . 1.0 110.464 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -94.04 139.23 31.21 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.332 1.853 . . . . 1.0 110.61 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.6 t0 43.12 54.82 10.7 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 124.274 1.029 . . . . 1.0 110.664 -169.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -64.15 140.22 70.44 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.855 3.036 . . . . 1.0 117.259 -167.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -89.36 154.25 20.22 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.742 1.617 . . . . 1.0 112.043 168.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.475 HD21 ' CD2' ' A' ' 79' ' ' LEU . 2.3 tm? -69.47 -21.62 63.69 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 120.674 -1.266 . . . . 1.0 109.648 168.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 26.0 m -66.79 -21.86 66.04 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.286 -0.884 . . . . 1.0 112.448 169.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -82.47 -28.58 31.14 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.789 0.836 . . . . 1.0 112.599 169.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.469 ' HB3' HD22 ' A' ' 41' ' ' LEU . 11.0 t-105 -80.17 -38.75 30.7 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.571 1.078 . . . . 1.0 113.515 178.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.3 mt -44.1 -47.31 23.12 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 114.411 1.263 . . . . 1.0 114.411 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.1 4.98 1.61 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.79 2.327 . . . . 1.0 115.811 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -113.06 5.63 17.24 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 116.053 1.871 . . . . 1.0 116.053 174.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -49.51 -30.74 8.83 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 126.836 2.054 . . . . 1.0 113.275 170.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -104.65 7.83 35.04 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.228 2.611 . . . . 1.0 113.288 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -133.5 -155.4 0.67 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.518 2.327 . . . . 1.0 112.096 -169.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -114.3 160.34 19.18 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-O 123.504 1.621 . . . . 1.0 111.801 169.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.476 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -146.48 150.75 14.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 125.289 1.436 . . . . 1.0 107.454 -174.32 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.426 HD11 HD12 ' A' ' 90' ' ' ILE . 16.0 tp -129.63 127.31 40.33 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 124.753 1.221 . . . . 1.0 108.666 176.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.7 t -99.82 127.65 52.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 t -127.01 104.12 12.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.518 -1.66 . . . . 1.0 106.518 175.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 113.502 0.927 . . . . 1.0 113.502 -167.773 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.9 tt . . . . . 0 N--CA 1.469 0.522 0 N-CA-C 114.015 1.117 . . . . 1.0 114.015 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.8 t -42.66 -51.26 12.12 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 124.788 1.235 . . . . 1.0 112.612 168.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.0 -31.7 18.96 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.385 1.39 . . . . 1.0 111.776 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.7 tp -64.15 -51.03 65.8 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 124.219 1.008 . . . . 1.0 110.961 169.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.621 ' CE1' HD23 ' A' ' 110' ' ' LEU . 88.5 t80 -54.91 -53.63 53.06 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.502 1.121 . . . . 1.0 112.478 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -67.21 -34.6 77.83 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.964 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.55 -37.1 93.97 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.701 0.667 . . . . 1.0 112.523 174.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.565 HG22 HD12 ' A' ' 110' ' ' LEU . 78.6 mt -65.44 -49.43 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.96 1.88 . . . . 1.0 108.264 171.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.695 ' HB3' HD21 ' A' ' 110' ' ' LEU . 3.8 ptmm? -69.35 -31.16 69.4 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.241 -1.537 . . . . 1.0 113.358 -171.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -105.66 -38.02 6.55 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.406 1.632 . . . . 1.0 115.406 -174.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.6 m -93.85 -23.02 18.29 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.153 0.981 . . . . 1.0 112.873 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.475 ' CD2' HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -92.11 -71.13 0.66 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 106.277 -1.749 . . . . 1.0 106.277 169.055 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.5 -10.21 1.51 Allowed Glycine 0 CA--C 1.539 1.571 0 C-N-CA 127.386 2.422 . . . . 1.0 115.554 169.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -153.19 146.62 24.91 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 129.269 3.028 . . . . 1.0 107.214 170.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.434 ' HG3' ' HB2' ' A' ' 116' ' ' ALA . 39.7 mm-40 -136.01 125.57 16.07 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.339 0.656 . . . . 1.0 110.548 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -82.8 -39.94 0.13 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.352 2.035 . . . . 1.0 114.241 -173.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -146.87 18.01 1.26 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.596 1.158 . . . . 1.0 113.785 -169.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.476 HD11 ' CG2' ' A' ' 52' ' ' VAL . 42.1 tp -76.88 140.48 40.6 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.598 -1.314 . . . . 1.0 113.412 -169.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -133.45 147.85 51.71 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 129.421 3.088 . . . . 1.0 107.714 170.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.655 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -157.27 166.04 34.24 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.835 1.198 . . . . 1.0 112.384 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.405 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -130.05 173.63 19.81 Favored Glycine 0 N--CA 1.467 0.74 0 C-N-CA 125.43 1.491 . . . . 1.0 112.142 170.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.556 HG13 ' HB3' ' A' ' 122' ' ' MET . 0.2 OUTLIER -160.07 143.14 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 114.829 1.418 . . . . 1.0 114.829 -169.118 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.426 HD12 HD11 ' A' ' 53' ' ' LEU . 3.4 mt -124.39 113.74 37.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 126.721 2.008 . . . . 1.0 108.397 169.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.59 150.13 20.92 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 125.342 1.457 . . . . 1.0 110.462 169.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.97 152.05 44.65 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 121.801 -0.562 . . . . 1.0 111.419 173.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.754 0 N-CA-C 115.515 0.966 . . . . 1.0 115.515 169.588 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 115.718 1.747 . . . . 1.0 115.718 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -59.0 -23.74 62.17 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.921 1.288 . . . . 1.0 114.196 -175.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.21 -46.2 94.17 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-N 120.335 1.425 . . . . 1.0 113.004 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.95 -36.29 47.39 Favored Glycine 0 N--CA 1.478 1.469 0 O-C-N 121.014 -1.286 . . . . 1.0 113.121 176.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -59.54 -34.97 73.32 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 117.922 0.861 . . . . 1.0 112.806 172.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 -67.04 -33.09 74.77 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.997 0.74 . . . . 1.0 112.997 173.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -62.16 -35.96 80.39 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.796 1.18 . . . . 1.0 111.314 171.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.22 -44.62 83.32 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.233 0.469 . . . . 1.0 111.342 175.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.72 -44.12 81.3 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 118.807 -0.616 . . . . 1.0 112.086 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.695 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -51.18 -48.97 61.79 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.746 2.018 . . . . 1.0 111.49 -177.466 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.655 HD12 ' CD1' ' A' ' 87' ' ' TYR . 8.0 mt -66.03 -40.07 90.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.331 -0.849 . . . . 1.0 111.928 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -67.4 -24.91 65.71 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.95 1.092 . . . . 1.0 113.95 175.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -64.62 -35.13 80.02 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.409 1.084 . . . . 1.0 111.491 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -83.96 -73.28 0.43 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 113.709 -1.587 . . . . 1.0 110.461 -175.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.5 m 174.14 -0.89 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.118 2.567 . . . . 1.0 111.821 173.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.527 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -74.19 159.58 32.34 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 122.414 1.102 . . . . 1.0 113.541 -169.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -100.69 171.46 7.68 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 113.898 -1.501 . . . . 1.0 111.362 -169.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 2.2 ttm105 -126.43 154.02 44.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.547 1.139 . . . . 1.0 112.779 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.485 HG12 ' H ' ' A' ' 120' ' ' GLY . 16.4 t -92.86 -173.1 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 C-N-CA 127.009 2.124 . . . . 1.0 106.009 169.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.485 ' H ' HG12 ' A' ' 119' ' ' VAL . . . -51.17 154.76 3.79 Favored Glycine 0 CA--C 1.543 1.838 0 O-C-N 120.345 -1.472 . . . . 1.0 115.929 -175.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -48.9 143.33 5.54 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.327 1.851 . . . . 1.0 114.771 -172.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.556 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.9 OUTLIER -75.62 156.57 34.77 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.669 1.187 . . . . 1.0 111.879 -169.93 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.634 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -90.98 137.81 32.08 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.537 -0.756 . . . . 1.0 109.719 174.325 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.634 ' N ' HD13 ' A' ' 123' ' ' LEU . 7.5 mt -122.41 109.13 14.0 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.641 1.176 . . . . 1.0 110.459 174.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.408 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.2 mt -91.45 130.44 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.062 1.345 . . . . 1.0 112.611 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.74 98.52 10.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.206 1.002 . . . . 1.0 110.039 175.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -70.4 -23.93 62.84 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.108 -1.62 . . . . 1.0 112.232 -175.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.65 -30.65 44.13 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 130.191 3.396 . . . . 1.0 114.12 169.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -124.67 -26.86 3.75 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.539 1.935 . . . . 1.0 111.957 -169.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -141.92 83.23 12.9 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 125.565 1.546 . . . . 1.0 111.276 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.76 12.45 1.41 Allowed 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 124.009 3.14 . . . . 1.0 113.904 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -109.64 65.5 0.36 Allowed Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 127.899 2.479 . . . . 1.0 109.553 174.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -58.65 -19.08 43.68 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.496 2.131 . . . . 1.0 116.952 -168.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -65.12 -28.44 69.44 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 121.343 -0.848 . . . . 1.0 111.919 173.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.6 p -70.75 -21.75 62.49 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.226 0.921 . . . . 1.0 112.181 -175.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -96.24 -54.69 3.2 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.899 1.679 . . . . 1.0 111.399 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 85.6 p -68.4 -33.07 73.58 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.656 1.354 . . . . 1.0 114.656 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.27 -50.03 51.5 Favored Pre-proline 0 CA--C 1.542 0.645 0 O-C-N 120.315 -1.49 . . . . 1.0 113.014 -173.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.69 -23.44 69.68 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 CA-C-N 121.289 1.496 . . . . 1.0 112.552 170.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.455 ' HB2' HD23 ' A' ' 123' ' ' LEU . 90.6 t90 -70.28 -46.32 64.57 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 123.342 0.657 . . . . 1.0 110.832 175.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.627 HG11 ' HA ' ' A' ' 22' ' ' ALA . 88.9 t -66.08 -34.63 71.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -63.55 -48.46 77.37 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.216 -0.928 . . . . 1.0 110.043 174.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -63.7 -55.68 21.52 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.73 1.212 . . . . 1.0 111.67 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.406 ' HE1' ' HB ' ' A' ' 119' ' ' VAL . 88.2 t90 -58.09 -35.05 70.86 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 125.693 1.597 . . . . 1.0 111.953 175.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.47 -32.87 31.69 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.462 1.505 . . . . 1.0 113.811 172.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.0 p -70.12 -12.65 61.75 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.832 1.419 . . . . 1.0 114.832 175.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.94 -17.33 43.99 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.67 1.588 . . . . 1.0 111.882 176.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -77.79 171.46 14.93 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 118.945 0.793 . . . . 1.0 110.871 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 56.4 m . . . . . 0 C--O 1.252 1.187 0 C-N-CA 125.44 1.496 . . . . 1.0 114.777 -173.416 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.306 0 N-CA-C 114.694 1.368 . . . . 1.0 114.694 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -121.0 123.75 43.18 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.669 1.587 . . . . 1.0 109.775 173.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.608 HD13 HD12 ' A' ' 26' ' ' LEU . 1.9 mp -124.27 112.92 34.35 Favored 'Isoleucine or valine' 0 C--O 1.23 0.05 0 C-N-CA 125.856 1.662 . . . . 1.0 112.439 -176.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.22 125.49 7.92 Favored Glycine 0 C--O 1.224 -0.492 0 N-CA-C 110.24 -1.144 . . . . 1.0 110.24 169.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.5 mt -105.79 124.14 60.71 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 118.523 1.162 . . . . 1.0 109.591 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -115.57 110.22 18.91 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 125.109 1.364 . . . . 1.0 107.813 -170.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 N--CA 1.466 0.354 0 O-C-N 123.266 0.354 . . . . 1.0 111.468 -175.006 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.7 tp . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 116.829 2.159 . . . . 1.0 116.829 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.8 t -57.44 -32.76 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 119.344 -0.36 . . . . 1.0 111.717 -170.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.47 -45.29 94.28 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.76 1.164 . . . . 1.0 112.521 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -68.42 -31.06 70.13 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.81 0.844 . . . . 1.0 111.017 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -67.7 -47.15 70.22 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 173.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.547 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -64.74 -42.45 95.17 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 113.122 0.786 . . . . 1.0 113.122 -176.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -54.72 -48.43 72.51 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.344 1.058 . . . . 1.0 110.404 170.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.89 -38.21 70.02 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.517 0.727 . . . . 1.0 112.067 -174.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.3 mt -68.26 -45.48 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 O-C-N 121.33 -0.856 . . . . 1.0 109.35 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.608 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -66.16 -31.02 71.61 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.653 1.115 . . . . 1.0 110.884 -178.376 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 34.6 m -63.07 -45.55 91.66 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.796 1.238 . . . . 1.0 112.539 169.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.39 -31.97 71.7 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.57 1.148 . . . . 1.0 113.236 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -65.74 -30.47 71.14 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.123 1.769 . . . . 1.0 111.648 171.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.0 31.61 1.7 Allowed Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.702 1.144 . . . . 1.0 114.833 172.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -124.7 161.66 25.86 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.302 1.441 . . . . 1.0 110.739 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -91.8 86.24 5.86 Favored 'General case' 0 N--CA 1.46 0.071 0 C-N-CA 125.034 1.334 . . . . 1.0 108.939 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.5 146.2 28.46 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.05 0.54 . . . . 1.0 111.404 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.2 m -147.5 140.66 25.16 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.344 1.058 . . . . 1.0 112.198 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -87.04 137.31 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 115.108 1.521 . . . . 1.0 115.108 171.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -111.86 120.86 43.39 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.262 1.825 . . . . 1.0 111.126 169.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -99.92 138.23 37.28 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.587 1.955 . . . . 1.0 110.942 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.7 t0 42.18 54.85 9.34 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 124.39 1.076 . . . . 1.0 111.378 -169.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -63.56 137.32 58.9 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.836 3.024 . . . . 1.0 116.707 -168.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -88.56 157.35 18.63 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.547 1.539 . . . . 1.0 111.706 168.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.47 HD21 HD21 ' A' ' 79' ' ' LEU . 2.3 tm? -68.52 -21.27 64.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 120.261 -1.525 . . . . 1.0 109.567 167.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.2 m -68.86 -19.83 64.25 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.455 -0.778 . . . . 1.0 112.319 169.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -81.98 -28.57 32.57 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.546 1.138 . . . . 1.0 112.129 169.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.427 ' HB3' HD22 ' A' ' 41' ' ' LEU . 12.6 t-105 -82.7 -36.9 25.47 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.671 0.989 . . . . 1.0 113.671 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.8 mt -48.6 -39.83 34.87 Favored Pre-proline 0 CA--C 1.552 1.054 0 CA-C-O 117.482 -1.246 . . . . 1.0 114.123 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -57.59 -12.36 11.1 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 124.428 3.418 . . . . 1.0 117.144 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -110.53 8.13 22.84 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 116.121 1.897 . . . . 1.0 116.121 -174.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -52.72 -30.94 35.11 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.941 2.096 . . . . 1.0 113.782 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -113.48 13.1 18.81 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.882 1.273 . . . . 1.0 112.602 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -122.65 -159.51 0.84 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.273 2.629 . . . . 1.0 110.854 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -115.12 165.09 13.29 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 123.018 1.389 . . . . 1.0 111.763 170.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.417 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -149.49 163.19 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.331 1.452 . . . . 1.0 108.945 -172.17 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.402 HD11 HD12 ' A' ' 90' ' ' ILE . 17.4 tp -141.45 127.08 19.0 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.509 1.123 . . . . 1.0 108.951 175.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.46 124.0 52.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 124.055 0.942 . . . . 1.0 109.533 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.0 t -122.58 112.37 34.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 174.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 115.136 1.532 . . . . 1.0 115.136 -167.98 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.6 tt . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 113.471 0.915 . . . . 1.0 113.471 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.5 t -40.77 -50.61 7.29 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 124.638 1.175 . . . . 1.0 112.816 168.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.38 -30.03 20.04 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.506 1.471 . . . . 1.0 111.913 -172.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.5 tp -66.45 -50.58 62.85 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 123.804 0.842 . . . . 1.0 110.534 169.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.676 ' CE1' HD23 ' A' ' 110' ' ' LEU . 76.0 t80 -54.69 -54.31 43.44 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.018 0.927 . . . . 1.0 112.306 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -68.05 -35.4 78.17 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.132 -0.486 . . . . 1.0 111.915 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.18 -36.72 93.58 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 123.941 0.781 . . . . 1.0 112.367 176.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.542 HG22 HD12 ' A' ' 110' ' ' LEU . 79.7 mt -62.43 -51.87 66.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.521 1.661 . . . . 1.0 108.136 170.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.711 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.3 ptmm? -68.43 -32.59 72.73 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 120.435 -1.415 . . . . 1.0 113.141 -169.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -99.58 -37.26 9.23 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.771 1.629 . . . . 1.0 114.808 -174.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 m -99.8 -19.17 16.83 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.613 1.165 . . . . 1.0 113.17 -174.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.47 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -94.3 -71.54 0.66 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 106.409 -1.7 . . . . 1.0 106.409 169.57 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.89 -13.88 1.65 Allowed Glycine 0 CA--C 1.537 1.426 0 C-N-CA 127.642 2.544 . . . . 1.0 116.719 168.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -154.67 137.89 15.7 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.872 2.069 . . . . 1.0 108.633 172.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.419 HE22 HD12 ' A' ' 79' ' ' LEU . 1.6 mm-40 -134.92 124.0 16.31 Favored Pre-proline 0 CA--C 1.546 0.816 0 O-C-N 121.354 -0.841 . . . . 1.0 111.499 -171.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.83 -39.62 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.015 2.477 . . . . 1.0 114.72 -174.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -140.63 14.84 2.34 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.5 1.296 . . . . 1.0 114.5 -169.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.417 HD11 ' CG2' ' A' ' 52' ' ' VAL . 70.0 tp -80.84 138.06 36.21 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.579 -1.326 . . . . 1.0 112.862 -169.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.1 mtm-85 -135.97 156.76 48.26 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.963 2.505 . . . . 1.0 109.085 169.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.63 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -163.78 166.82 21.63 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.306 -0.871 . . . . 1.0 112.181 -176.501 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.487 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -120.05 171.92 14.69 Favored Glycine 0 N--CA 1.472 1.058 0 C-N-CA 125.487 1.518 . . . . 1.0 114.438 173.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.0 t -146.35 133.07 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 115.63 1.715 . . . . 1.0 115.63 -169.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.402 HD12 HD11 ' A' ' 53' ' ' LEU . 4.5 mt -131.6 108.38 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 125.719 1.608 . . . . 1.0 107.481 168.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.84 148.3 23.26 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.236 1.414 . . . . 1.0 112.017 170.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.8 mp -139.78 149.04 43.07 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.869 0.692 . . . . 1.0 112.869 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.566 0 CA-C-N 116.115 -0.493 . . . . 1.0 113.443 169.254 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 CA--C 1.545 0.774 0 N-CA-C 113.609 0.966 . . . . 1.0 113.609 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -61.48 -16.03 43.37 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.494 1.517 . . . . 1.0 114.545 -173.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.32 -42.02 97.17 Favored Glycine 0 CA--C 1.537 1.408 0 CA-C-N 120.271 1.396 . . . . 1.0 113.22 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.97 -36.53 46.51 Favored Glycine 0 N--CA 1.48 1.626 0 O-C-N 120.258 -1.731 . . . . 1.0 112.724 174.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -63.02 -33.36 75.26 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.871 0.868 . . . . 1.0 112.785 174.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -58.4 -42.73 87.77 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.807 0.843 . . . . 1.0 111.856 170.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -62.06 -37.89 86.69 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.763 0.71 . . . . 1.0 111.14 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.55 -46.16 84.03 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.657 0.662 . . . . 1.0 111.366 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.61 -43.48 68.7 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.442 -0.789 . . . . 1.0 112.0 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.711 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -52.24 -49.44 64.0 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.787 2.035 . . . . 1.0 111.733 -177.558 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.63 HD12 ' CD1' ' A' ' 87' ' ' TYR . 6.3 mt -65.31 -40.35 93.63 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.471 -0.786 . . . . 1.0 111.232 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -67.65 -22.81 65.29 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.247 1.203 . . . . 1.0 114.247 175.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -64.42 -35.7 81.76 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.666 1.186 . . . . 1.0 110.7 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -86.01 -78.46 0.27 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 113.361 -1.745 . . . . 1.0 110.041 -175.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.2 t 179.26 0.01 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.474 1.91 . . . . 1.0 112.171 172.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -76.45 155.48 33.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 122.264 1.031 . . . . 1.0 113.443 -169.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -92.8 170.84 9.39 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.997 1.719 . . . . 1.0 112.018 -169.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -129.36 159.91 34.7 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.779 1.231 . . . . 1.0 112.342 172.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.0 t -122.62 126.09 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 125.981 1.712 . . . . 1.0 108.209 -176.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 52.4 -168.71 0.74 Allowed Glycine 0 CA--C 1.542 1.739 0 C-N-CA 125.642 1.591 . . . . 1.0 116.199 -176.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -92.37 146.76 23.44 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.163 1.385 . . . . 1.0 110.038 169.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.88 156.34 36.52 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.764 0.826 . . . . 1.0 111.456 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.628 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -92.52 138.54 31.42 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.937 0.895 . . . . 1.0 110.258 170.509 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.628 ' N ' HD13 ' A' ' 123' ' ' LEU . 7.3 mt -121.71 104.46 9.61 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.764 1.226 . . . . 1.0 111.265 173.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.68 131.49 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 C-N-CA 125.034 1.334 . . . . 1.0 112.049 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -107.54 106.29 16.59 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.175 0.988 . . . . 1.0 112.925 172.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -69.24 -22.86 63.83 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.565 0.95 . . . . 1.0 113.565 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.9 t -63.8 -22.52 66.95 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.389 1.076 . . . . 1.0 112.512 173.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -116.13 -30.2 6.06 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.279 1.831 . . . . 1.0 111.884 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -145.6 91.52 5.7 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 124.909 1.283 . . . . 1.0 112.601 -173.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.4 2.54 7.19 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 123.363 2.709 . . . . 1.0 114.383 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -109.82 72.35 0.61 Allowed Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 129.152 2.981 . . . . 1.0 110.444 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -60.5 -12.53 21.15 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.622 2.881 . . . . 1.0 116.723 -169.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -67.0 -28.19 68.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.803 0.729 . . . . 1.0 111.541 172.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 44.3 p -68.91 -26.21 64.98 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.117 -0.99 . . . . 1.0 111.935 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -93.78 -53.1 4.15 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.849 1.26 . . . . 1.0 111.818 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.7 t -72.42 -32.26 66.19 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.503 1.297 . . . . 1.0 114.503 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -61.17 -55.4 44.36 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 121.243 1.838 . . . . 1.0 112.731 -177.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -62.99 -22.65 73.92 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 121.567 1.595 . . . . 1.0 112.676 175.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.484 ' HB2' HD23 ' A' ' 123' ' ' LEU . 92.0 t90 -68.53 -48.62 63.87 Favored 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.345 0.658 . . . . 1.0 110.602 174.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 22' ' ' ALA . 83.9 t -65.43 -32.06 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 122.002 0.906 . . . . 1.0 109.042 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.96 -23.22 61.4 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 119.991 -1.693 . . . . 1.0 113.336 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -86.79 -61.98 1.61 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.978 2.111 . . . . 1.0 111.403 169.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.487 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 83.9 t90 -54.98 -38.2 67.49 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 126.844 2.058 . . . . 1.0 112.823 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.2 -28.71 27.37 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 118.913 0.778 . . . . 1.0 114.513 173.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.5 p -69.93 -12.78 61.87 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.808 1.304 . . . . 1.0 114.043 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.03 -18.98 48.75 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.91 1.684 . . . . 1.0 111.615 176.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.88 171.99 11.08 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.991 1.316 . . . . 1.0 111.194 -177.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 C--O 1.255 1.35 0 C-N-CA 125.252 1.421 . . . . 1.0 114.743 -171.92 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 117.717 2.488 . . . . 1.0 117.717 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -122.23 126.95 49.31 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.582 1.953 . . . . 1.0 109.726 173.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.563 HD13 HD12 ' A' ' 26' ' ' LEU . 2.1 mp -123.91 114.25 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 C-N-CA 127.078 2.151 . . . . 1.0 112.213 179.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.71 124.44 7.63 Favored Glycine 0 C--O 1.224 -0.512 0 N-CA-C 110.315 -1.114 . . . . 1.0 110.315 169.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.0 mt -104.43 118.97 52.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 118.283 1.042 . . . . 1.0 109.618 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -111.51 108.79 18.43 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.941 -1.503 . . . . 1.0 106.941 -170.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 N--CA 1.465 0.276 0 O-C-N 123.235 0.334 . . . . 1.0 111.375 -176.221 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.5 tp . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 112.644 0.609 . . . . 1.0 112.644 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.5 t -52.63 -33.14 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.17 0.988 . . . . 1.0 112.184 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.19 -48.69 80.37 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 120.0 1.273 . . . . 1.0 113.208 173.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -65.79 -33.11 75.09 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.577 0.751 . . . . 1.0 110.682 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -66.46 -47.79 72.0 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 123.934 0.893 . . . . 1.0 109.406 173.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.544 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -63.78 -43.07 97.45 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 112.584 0.587 . . . . 1.0 112.584 -176.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.11 -49.01 72.82 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.951 0.5 . . . . 1.0 110.029 170.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.42 -38.07 74.53 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.776 0.658 . . . . 1.0 112.776 -173.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.9 mt -65.88 -47.5 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 174.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.563 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -67.14 -34.32 77.33 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 119.651 -0.82 . . . . 1.0 110.573 -175.884 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.0 m -62.76 -41.63 99.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.691 1.597 . . . . 1.0 113.52 170.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.5 -32.81 73.88 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.825 0.85 . . . . 1.0 112.308 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -71.49 -29.32 64.68 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.638 1.175 . . . . 1.0 113.447 171.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.53 26.83 2.3 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.393 0.996 . . . . 1.0 114.086 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -116.35 146.56 42.36 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.381 1.072 . . . . 1.0 109.769 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -79.99 89.41 5.34 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 125.088 1.355 . . . . 1.0 108.448 -175.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.52 146.61 30.4 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 122.552 0.341 . . . . 1.0 110.737 -178.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.7 m -149.29 146.76 27.71 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.011 0.924 . . . . 1.0 111.399 -172.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.3 t -97.51 139.27 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 114.794 1.405 . . . . 1.0 114.794 176.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -122.61 113.66 19.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.974 2.11 . . . . 1.0 109.966 169.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -98.88 138.11 36.48 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.746 1.618 . . . . 1.0 111.188 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 43.24 55.45 11.31 Favored Pre-proline 0 CA--C 1.564 1.496 0 C-N-CA 124.518 1.127 . . . . 1.0 111.475 -169.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.52 152.09 59.61 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 125.167 3.911 . . . . 1.0 119.198 -167.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -93.84 155.47 17.17 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.216 2.206 . . . . 1.0 113.008 168.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.502 HD22 ' HB3' ' A' ' 44' ' ' TRP . 2.4 tm? -69.46 -23.22 63.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 120.827 -1.171 . . . . 1.0 109.983 168.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.6 m -65.93 -23.13 66.56 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.27 -0.894 . . . . 1.0 112.228 171.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -83.07 -24.68 32.61 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.242 1.017 . . . . 1.0 113.122 169.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.502 ' HB3' HD22 ' A' ' 41' ' ' LEU . 11.6 t-105 -82.27 -35.82 27.69 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.74 1.154 . . . . 1.0 113.786 177.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.4 mt -50.08 -38.62 38.33 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-O 117.567 -1.206 . . . . 1.0 114.098 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -52.92 -16.92 6.72 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 124.202 3.268 . . . . 1.0 117.319 171.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -109.24 9.88 25.84 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 115.486 1.662 . . . . 1.0 115.486 -175.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -52.6 -33.09 44.72 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 126.08 1.752 . . . . 1.0 113.708 177.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -105.01 1.69 28.88 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.555 1.542 . . . . 1.0 113.576 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -112.56 -164.05 0.89 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.62 2.368 . . . . 1.0 110.932 -175.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -109.04 164.98 11.94 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 122.982 1.373 . . . . 1.0 111.541 169.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.486 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -149.64 159.92 5.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 125.245 1.418 . . . . 1.0 109.164 -172.982 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.421 HD11 HD12 ' A' ' 90' ' ' ILE . 14.4 tp -138.73 129.95 27.01 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 124.792 1.237 . . . . 1.0 108.698 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.8 t -105.16 125.55 60.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 124.247 1.019 . . . . 1.0 108.964 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.59 114.45 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 107.484 -1.302 . . . . 1.0 107.484 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 113.797 1.036 . . . . 1.0 113.797 -169.199 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.8 tt . . . . . 0 N--CA 1.471 0.618 0 N-CA-C 112.78 0.659 . . . . 1.0 112.78 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.4 t -46.24 -50.56 37.86 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 125.18 1.392 . . . . 1.0 112.298 167.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.6 -28.19 31.75 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.688 1.592 . . . . 1.0 111.609 -173.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 tp -70.46 -51.66 27.63 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 123.673 0.789 . . . . 1.0 110.722 169.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.612 ' CE1' HD23 ' A' ' 110' ' ' LEU . 89.8 t80 -55.4 -55.38 32.28 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.234 1.014 . . . . 1.0 112.493 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -68.05 -35.36 78.1 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.44 0.696 . . . . 1.0 111.832 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.13 -35.91 92.58 Favored Glycine 0 CA--C 1.529 0.91 0 O-C-N 121.662 -0.649 . . . . 1.0 112.359 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.607 HG22 HD12 ' A' ' 110' ' ' LEU . 88.8 mt -65.88 -51.57 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 119.871 1.835 . . . . 1.0 107.901 170.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.671 ' HB3' HD21 ' A' ' 110' ' ' LEU . 1.8 ptmm? -68.28 -30.52 69.55 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 120.165 -1.585 . . . . 1.0 113.715 -169.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -107.61 -37.45 6.17 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.995 1.718 . . . . 1.0 115.217 -176.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.5 m -94.1 -21.0 19.39 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.985 0.914 . . . . 1.0 113.197 -176.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.495 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -92.38 -71.49 0.64 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 106.523 -1.658 . . . . 1.0 106.523 169.15 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.94 -19.33 1.0 Allowed Glycine 0 CA--C 1.535 1.314 0 C-N-CA 127.945 2.688 . . . . 1.0 115.38 169.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -152.19 139.31 19.23 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 128.185 2.594 . . . . 1.0 107.885 169.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.451 HE21 HD12 ' A' ' 79' ' ' LEU . 12.8 mt-30 -137.86 121.8 11.75 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 118.829 -0.605 . . . . 1.0 109.838 -170.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -81.61 -35.99 0.37 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.713 2.275 . . . . 1.0 115.496 -169.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -142.91 15.84 1.93 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.18 1.178 . . . . 1.0 114.18 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.486 HD11 ' CG2' ' A' ' 52' ' ' VAL . 67.2 tp -81.74 140.1 34.48 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.716 -1.24 . . . . 1.0 112.881 -169.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.5 mtm-85 -136.51 154.68 50.66 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.694 2.397 . . . . 1.0 109.311 169.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.665 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -160.18 170.29 21.48 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.286 0.948 . . . . 1.0 111.87 -177.714 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -129.25 171.45 20.01 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 124.744 1.164 . . . . 1.0 113.393 170.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 122' ' ' MET . 0.0 OUTLIER -140.88 138.41 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.134 0.973 . . . . 1.0 113.521 -169.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.942 HG23 HD12 ' A' ' 123' ' ' LEU . 7.1 mt -130.81 96.52 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.631 1.572 . . . . 1.0 107.096 169.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.92 145.61 25.42 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.494 1.518 . . . . 1.0 111.066 172.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.4 mp -140.71 157.32 45.61 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 121.611 -0.681 . . . . 1.0 112.17 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.68 0 CA-C-O 121.976 0.764 . . . . 1.0 114.715 169.342 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 15.5 m . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 113.2 0.815 . . . . 1.0 113.2 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -54.12 -30.34 48.4 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.013 1.725 . . . . 1.0 114.722 -174.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.88 -41.55 94.23 Favored Glycine 0 N--CA 1.473 1.132 0 CA-C-N 121.477 1.944 . . . . 1.0 113.32 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.07 -37.73 28.16 Favored Glycine 0 N--CA 1.476 1.304 0 CA-C-N 118.258 1.029 . . . . 1.0 113.326 173.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -58.66 -35.14 72.07 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.647 1.223 . . . . 1.0 113.167 173.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -68.29 -33.48 74.42 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.244 0.618 . . . . 1.0 112.14 172.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -63.69 -37.13 86.19 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.759 1.163 . . . . 1.0 110.963 172.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.1 -48.14 79.85 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.98 0.912 . . . . 1.0 112.139 174.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.98 -35.15 70.78 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.816 0.672 . . . . 1.0 112.816 173.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.671 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -57.82 -50.12 74.36 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 123.525 1.631 . . . . 1.0 110.906 -176.079 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.665 HD12 ' CD1' ' A' ' 87' ' ' TYR . 6.3 mt -66.34 -40.52 89.88 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 120.762 -1.211 . . . . 1.0 111.262 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -70.73 -16.91 62.81 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.241 0.83 . . . . 1.0 113.241 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.81 -20.4 53.27 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.579 1.081 . . . . 1.0 110.798 175.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -97.79 -79.37 0.47 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.377 1.471 . . . . 1.0 110.28 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.0 t -175.27 -3.28 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.79 1.636 . . . . 1.0 112.573 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.466 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -79.83 151.95 29.98 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 122.962 1.363 . . . . 1.0 113.596 -169.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -88.44 168.2 12.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.049 1.74 . . . . 1.0 113.799 -168.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -119.4 148.04 43.67 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.779 2.031 . . . . 1.0 110.922 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.3 t -120.71 128.31 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.149 1.38 . . . . 1.0 108.798 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 50.06 -158.13 1.68 Allowed Glycine 0 N--CA 1.48 1.609 0 C-N-CA 125.087 1.327 . . . . 1.0 114.569 -172.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -110.91 142.49 42.92 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.088 1.355 . . . . 1.0 109.277 169.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.425 ' HB3' HG23 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -75.36 157.84 33.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.184 0.994 . . . . 1.0 113.049 -169.386 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.942 HD12 HG23 ' A' ' 90' ' ' ILE . 1.4 tm? -90.69 137.11 32.62 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.918 1.287 . . . . 1.0 110.27 173.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.9 mt -127.84 109.35 11.53 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.624 1.57 . . . . 1.0 109.98 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.568 HG13 HD11 ' A' ' 123' ' ' LEU . 28.4 mt -98.25 134.24 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.11 0.964 . . . . 1.0 113.014 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -100.18 91.86 4.95 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.919 2.488 . . . . 1.0 112.71 174.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.82 -23.28 66.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.209 1.004 . . . . 1.0 112.733 -174.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.9 p -54.1 -30.88 50.22 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 129.373 3.069 . . . . 1.0 114.158 169.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -121.28 -26.19 5.09 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.586 1.954 . . . . 1.0 111.508 -171.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -140.32 89.26 10.86 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 125.184 1.393 . . . . 1.0 111.474 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -75.66 11.39 1.64 Allowed 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.842 3.028 . . . . 1.0 114.005 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -113.77 65.3 1.23 Allowed Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 127.358 2.263 . . . . 1.0 110.072 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -55.72 -22.37 36.21 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.561 2.174 . . . . 1.0 116.176 -169.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.7 pm0 -64.49 -25.01 67.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 119.553 1.069 . . . . 1.0 111.817 175.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.5 p -72.82 -17.14 61.59 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 120.628 -1.295 . . . . 1.0 112.372 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.404 ' HB2' HD11 ' A' ' 125' ' ' ILE . 65.3 mm-40 -102.54 -55.79 2.38 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.258 1.823 . . . . 1.0 111.957 176.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 63.6 p -68.73 -33.31 73.71 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 113.817 1.043 . . . . 1.0 113.817 -176.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 36.5 m-20 -60.11 -59.23 14.53 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 120.688 1.585 . . . . 1.0 112.399 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -62.33 -22.32 73.93 Favored 'Trans proline' 0 C--N 1.352 0.713 0 CA-C-N 121.377 1.527 . . . . 1.0 112.943 175.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.459 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 87.2 t90 -68.71 -46.07 69.93 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 118.776 0.716 . . . . 1.0 111.2 172.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' A' ' 22' ' ' ALA . 92.2 t -63.84 -34.62 69.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 175.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.07 -30.83 70.12 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.299 1.44 . . . . 1.0 112.071 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -78.01 -61.87 1.86 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.113 1.765 . . . . 1.0 112.355 170.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -56.04 -36.43 68.0 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 126.046 1.738 . . . . 1.0 112.694 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.88 -32.32 26.11 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.393 0.997 . . . . 1.0 113.958 173.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.5 p -67.91 -13.8 62.45 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.073 1.138 . . . . 1.0 114.073 177.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.42 -17.71 50.99 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.002 1.721 . . . . 1.0 111.899 176.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.06 176.24 7.71 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.356 1.462 . . . . 1.0 110.911 -177.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 C--O 1.25 1.081 0 N-CA-C 114.803 1.408 . . . . 1.0 114.803 -170.077 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 113.049 0.759 . . . . 1.0 113.049 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -124.78 121.25 34.08 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.404 1.082 . . . . 1.0 111.178 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.506 HD13 HD12 ' A' ' 26' ' ' LEU . 2.1 mp -118.91 116.25 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 126.579 1.952 . . . . 1.0 112.803 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.04 127.42 9.06 Favored Glycine 0 C--O 1.221 -0.668 0 N-CA-C 111.159 -0.776 . . . . 1.0 111.159 169.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.3 mt -106.36 120.17 56.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 118.682 1.241 . . . . 1.0 109.979 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -111.44 107.63 16.91 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 125.332 1.453 . . . . 1.0 107.598 -169.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.469 0.51 0 CA-C-O 121.32 0.581 . . . . 1.0 112.013 -171.94 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.1 tp . . . . . 0 N--CA 1.467 0.415 0 N-CA-C 112.864 0.69 . . . . 1.0 112.864 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -53.03 -33.07 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.857 0.863 . . . . 1.0 111.995 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.71 -47.15 86.57 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 120.002 1.274 . . . . 1.0 112.72 174.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -65.94 -33.54 76.06 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.835 0.854 . . . . 1.0 110.839 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -66.1 -48.22 71.61 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 123.361 0.664 . . . . 1.0 109.234 173.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.626 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -64.07 -41.83 97.21 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 112.857 0.688 . . . . 1.0 112.857 -175.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.44 -51.14 65.91 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 169.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.08 -37.54 81.35 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.572 -0.705 . . . . 1.0 112.808 -174.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.4 mt -68.27 -46.78 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 119.371 0.987 . . . . 1.0 109.572 176.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.506 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.66 -36.3 83.28 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.565 0.697 . . . . 1.0 110.633 -177.245 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.3 m -61.04 -43.75 98.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.989 0.916 . . . . 1.0 112.908 170.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.45 -29.58 67.31 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.505 1.122 . . . . 1.0 113.548 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -67.35 -30.07 69.79 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.334 1.054 . . . . 1.0 111.891 170.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.02 15.77 1.85 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.455 1.026 . . . . 1.0 115.28 169.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -102.54 -179.08 3.87 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.851 1.26 . . . . 1.0 109.977 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -108.15 98.66 8.19 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 124.982 1.313 . . . . 1.0 108.054 169.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -110.08 148.14 32.28 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 122.785 0.434 . . . . 1.0 111.231 176.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.2 m -146.28 147.0 30.93 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.673 1.189 . . . . 1.0 111.173 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.1 t -96.73 138.24 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 114.245 1.202 . . . . 1.0 114.245 174.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -117.73 112.29 20.26 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.671 1.988 . . . . 1.0 110.576 169.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -93.92 138.51 31.97 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.086 1.754 . . . . 1.0 111.1 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 42.65 55.31 10.34 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 124.789 1.236 . . . . 1.0 110.999 -169.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -68.21 146.02 68.4 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.72 2.947 . . . . 1.0 117.632 -168.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -89.68 155.7 19.05 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.091 1.757 . . . . 1.0 112.523 168.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.528 HD21 HD21 ' A' ' 79' ' ' LEU . 2.2 tm? -69.09 -21.35 64.06 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 120.574 -1.329 . . . . 1.0 109.525 168.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 m -67.24 -21.57 65.73 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.168 -0.957 . . . . 1.0 112.357 170.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -82.88 -27.28 30.82 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.01 0.924 . . . . 1.0 112.5 169.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.474 ' HB3' HD22 ' A' ' 41' ' ' LEU . 12.4 t-105 -82.06 -36.51 27.61 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.488 1.04 . . . . 1.0 113.686 178.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.9 mt -48.07 -40.44 34.4 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-O 117.708 -1.139 . . . . 1.0 113.668 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -52.45 -16.83 5.69 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 124.373 3.382 . . . . 1.0 117.532 172.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -110.22 8.09 23.5 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 116.195 1.924 . . . . 1.0 116.195 -172.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -51.3 -26.73 7.91 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 127.156 2.183 . . . . 1.0 114.336 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -121.63 15.98 11.13 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.897 1.679 . . . . 1.0 113.485 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -128.62 -154.23 0.62 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 128.163 2.585 . . . . 1.0 109.747 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -122.07 164.05 18.38 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 123.161 1.458 . . . . 1.0 112.371 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.408 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -151.93 164.55 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 124.846 1.258 . . . . 1.0 109.434 -172.375 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.428 HD11 HD12 ' A' ' 90' ' ' ILE . 14.6 tp -144.39 128.6 17.73 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 125.1 1.36 . . . . 1.0 108.53 176.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.2 t -102.13 124.81 56.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 124.518 1.127 . . . . 1.0 109.328 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.2 110.85 25.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 106.043 -1.836 . . . . 1.0 106.043 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.485 1.306 0 C-N-CA 123.398 0.679 . . . . 1.0 111.732 -168.907 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.4 tt . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 113.657 0.984 . . . . 1.0 113.657 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.7 t -47.32 -51.19 44.38 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 125.629 1.571 . . . . 1.0 112.204 168.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.48 -31.74 16.78 Favored 'Trans proline' 0 C--N 1.352 0.737 0 CA-C-N 120.57 1.239 . . . . 1.0 111.277 -173.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.7 tp -63.03 -49.78 73.25 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 124.719 1.208 . . . . 1.0 111.331 169.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.64 ' CE1' HD23 ' A' ' 110' ' ' LEU . 92.0 t80 -54.53 -54.41 41.54 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.761 1.224 . . . . 1.0 112.679 178.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -64.08 -38.76 92.24 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.689 0.796 . . . . 1.0 111.242 177.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.45 -36.67 91.86 Favored Glycine 0 CA--C 1.528 0.87 0 O-C-N 121.69 -0.631 . . . . 1.0 112.69 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.553 HG22 HD12 ' A' ' 110' ' ' LEU . 92.9 mt -65.06 -49.5 79.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 120.008 -1.877 . . . . 1.0 108.291 172.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.671 ' HB3' HD21 ' A' ' 110' ' ' LEU . 10.9 ptmt -69.93 -31.6 69.45 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.464 -1.398 . . . . 1.0 113.529 -171.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -106.77 -37.43 6.4 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.692 1.597 . . . . 1.0 114.963 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.6 m -92.75 -23.07 19.02 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.295 1.038 . . . . 1.0 112.661 -177.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.528 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -94.22 -71.85 0.64 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 106.934 -1.506 . . . . 1.0 106.934 169.368 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.61 -9.47 2.58 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 126.73 2.11 . . . . 1.0 115.622 170.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -153.96 147.1 24.64 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 128.734 2.814 . . . . 1.0 107.788 169.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.4 ' HG3' ' HB2' ' A' ' 116' ' ' ALA . 39.7 mm-40 -136.76 125.17 14.97 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 123.261 0.625 . . . . 1.0 110.8 -174.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -83.05 -40.76 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.458 2.106 . . . . 1.0 114.097 -174.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -146.9 18.95 1.27 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.628 1.171 . . . . 1.0 113.846 -169.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.408 HD11 ' CG2' ' A' ' 52' ' ' VAL . 62.2 tp -80.95 140.0 35.5 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.606 -1.309 . . . . 1.0 112.782 -169.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 -135.26 154.6 51.51 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.624 2.369 . . . . 1.0 109.158 169.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.678 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -162.03 167.15 24.88 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.91 0.777 . . . . 1.0 112.195 -179.602 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.456 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -122.56 172.82 15.87 Favored Glycine 0 N--CA 1.473 1.139 0 C-N-CA 125.702 1.62 . . . . 1.0 114.096 173.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.4 t -146.7 133.79 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 114.421 1.267 . . . . 1.0 114.421 -169.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.428 HD12 HD11 ' A' ' 53' ' ' LEU . 4.3 mt -131.4 110.37 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 106.97 -1.493 . . . . 1.0 106.97 168.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.91 145.01 24.93 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.741 1.216 . . . . 1.0 110.711 170.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.09 150.57 43.07 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.317 0.647 . . . . 1.0 111.571 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.631 0 CA-C-O 122.077 0.821 . . . . 1.0 114.67 169.485 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 113.489 0.922 . . . . 1.0 113.489 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -55.55 -29.53 59.14 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.896 1.278 . . . . 1.0 114.407 -174.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.01 -43.3 95.11 Favored Glycine 0 N--CA 1.476 1.349 0 CA-C-N 121.115 1.78 . . . . 1.0 114.444 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.49 -37.04 36.73 Favored Glycine 0 N--CA 1.478 1.449 0 O-C-N 121.082 -1.246 . . . . 1.0 112.772 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -60.37 -38.31 83.46 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.322 1.049 . . . . 1.0 113.111 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -59.51 -42.87 93.19 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.259 1.024 . . . . 1.0 111.951 170.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.28 -38.18 90.16 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.638 0.654 . . . . 1.0 110.889 176.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -37.59 88.06 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.746 0.819 . . . . 1.0 112.698 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.71 93.52 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.819 -0.61 . . . . 1.0 112.213 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.671 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -50.7 -48.25 58.74 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.115 2.166 . . . . 1.0 111.885 -171.583 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.678 HD12 ' CD1' ' A' ' 87' ' ' TYR . 6.6 mt -66.48 -42.39 87.55 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.41 -0.814 . . . . 1.0 111.516 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -67.44 -21.43 65.55 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.887 1.069 . . . . 1.0 113.887 175.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -67.09 -33.88 76.44 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.279 1.032 . . . . 1.0 111.331 174.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -85.15 -73.99 0.42 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 114.129 -1.396 . . . . 1.0 110.709 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.418 ' H ' ' H ' ' A' ' 116' ' ' ALA . 3.4 m 174.97 -0.72 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.953 2.501 . . . . 1.0 112.001 174.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -77.61 152.14 34.04 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-O 122.222 1.01 . . . . 1.0 113.599 -169.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -86.03 161.48 18.93 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.404 1.482 . . . . 1.0 112.876 -169.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.68 127.01 37.99 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.143 1.777 . . . . 1.0 108.99 -173.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.7 t -106.78 129.85 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.635 0.774 . . . . 1.0 110.45 -169.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 51.64 -154.68 4.42 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.768 1.175 . . . . 1.0 113.544 -171.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -115.85 147.24 41.26 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.73 1.612 . . . . 1.0 109.142 169.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -73.78 157.35 36.59 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.05 -1.031 . . . . 1.0 112.231 -169.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.632 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -90.39 138.06 31.85 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.857 0.863 . . . . 1.0 110.442 171.306 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.632 ' N ' HD13 ' A' ' 123' ' ' LEU . 8.8 mt -122.65 108.03 12.63 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.089 1.356 . . . . 1.0 111.316 175.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.452 HG13 ' CD1' ' A' ' 123' ' ' LEU . 4.1 mt -95.84 133.74 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 125.227 1.411 . . . . 1.0 112.944 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -107.67 89.31 2.96 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.689 2.796 . . . . 1.0 113.097 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.72 -24.66 67.64 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.814 -1.179 . . . . 1.0 113.162 -173.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.2 m -62.79 -16.26 57.3 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.947 2.099 . . . . 1.0 113.776 172.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -131.38 -28.26 1.9 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.872 2.069 . . . . 1.0 112.658 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -139.01 88.54 13.29 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 126.251 1.821 . . . . 1.0 110.917 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -75.59 11.03 1.71 Allowed 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 123.67 2.913 . . . . 1.0 114.05 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -112.79 68.36 1.04 Allowed Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 127.578 2.351 . . . . 1.0 110.127 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -58.09 -20.03 43.95 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.942 2.428 . . . . 1.0 116.87 -169.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -66.55 -26.53 67.17 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.559 -0.713 . . . . 1.0 112.011 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 26.9 p -71.77 -21.59 61.71 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 120.971 -1.081 . . . . 1.0 111.762 -175.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -95.51 -55.53 3.0 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.124 1.77 . . . . 1.0 112.009 176.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.5 t -71.06 -32.0 68.57 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.809 1.04 . . . . 1.0 113.809 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -62.1 -53.19 61.47 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 120.9 1.682 . . . . 1.0 113.286 -177.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -63.49 -24.79 70.4 Favored 'Trans proline' 0 C--N 1.353 0.787 0 CA-C-N 121.157 1.449 . . . . 1.0 112.36 173.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.432 ' HB2' HD23 ' A' ' 123' ' ' LEU . 91.8 t90 -67.77 -47.98 67.67 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 118.858 0.753 . . . . 1.0 110.764 175.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.626 HG11 ' HA ' ' A' ' 22' ' ' ALA . 93.8 t -65.4 -32.61 59.0 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.71 -52.13 61.89 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.062 -1.024 . . . . 1.0 109.749 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -64.55 -50.82 65.8 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.882 0.873 . . . . 1.0 111.855 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.456 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 85.6 t90 -59.05 -35.66 73.69 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 125.269 1.428 . . . . 1.0 111.737 175.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.23 -34.39 40.31 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.932 1.254 . . . . 1.0 113.247 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.0 p -68.12 -13.04 61.91 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 114.884 1.439 . . . . 1.0 114.884 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.74 -13.32 54.24 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.525 1.53 . . . . 1.0 112.542 176.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -74.41 169.54 17.49 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.556 1.071 . . . . 1.0 112.005 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.0 t . . . . . 0 C--O 1.257 1.489 0 C-N-CA 125.916 1.686 . . . . 1.0 112.605 -169.458 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 113.495 0.924 . . . . 1.0 113.495 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -117.02 125.38 51.26 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.063 1.345 . . . . 1.0 110.461 173.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.486 HD13 HD12 ' A' ' 26' ' ' LEU . 2.0 mp -122.91 115.26 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.063 0 C-N-CA 126.262 1.825 . . . . 1.0 112.351 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.49 125.55 8.26 Favored Glycine 0 N--CA 1.462 0.41 0 N-CA-C 110.432 -1.067 . . . . 1.0 110.432 169.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 mt -104.86 121.05 56.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 117.875 0.838 . . . . 1.0 109.071 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -113.66 115.22 27.54 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 124.648 1.179 . . . . 1.0 108.548 -169.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.535 0.373 0 N-CA-C 112.537 0.569 . . . . 1.0 112.537 -172.869 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.8 tp . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 113.975 1.102 . . . . 1.0 113.975 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.9 t -49.48 -34.26 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 127.077 2.151 . . . . 1.0 112.427 -176.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.01 -47.63 85.55 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.852 1.205 . . . . 1.0 112.978 174.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -67.59 -31.84 72.16 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.744 0.818 . . . . 1.0 110.605 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.77 -49.86 64.57 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 123.785 0.834 . . . . 1.0 109.06 173.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.648 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -62.3 -42.74 99.62 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 123.633 0.773 . . . . 1.0 112.509 -176.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.15 -51.37 66.69 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 170.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.04 -36.57 80.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.521 -0.737 . . . . 1.0 112.868 -174.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.2 mt -68.62 -47.34 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 119.345 0.975 . . . . 1.0 109.511 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.486 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -64.97 -36.89 85.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.856 0.836 . . . . 1.0 110.657 -177.721 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.0 m -61.38 -42.02 98.04 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 121.201 -0.937 . . . . 1.0 113.022 170.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.34 -29.57 66.3 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.604 1.162 . . . . 1.0 113.392 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -66.69 -30.67 70.98 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.582 1.153 . . . . 1.0 111.388 170.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.57 11.05 1.75 Allowed Glycine 0 CA--C 1.53 0.988 0 N-CA-C 115.498 0.959 . . . . 1.0 115.498 169.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 -101.21 -177.09 3.34 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.829 1.252 . . . . 1.0 110.898 -174.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -109.71 97.15 6.75 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.973 1.309 . . . . 1.0 108.266 169.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.37 150.12 27.08 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.492 0.317 . . . . 1.0 111.262 176.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.6 m -145.16 147.79 32.86 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.784 1.234 . . . . 1.0 111.509 -175.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.3 t -98.09 138.83 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 114.899 1.444 . . . . 1.0 114.899 174.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -117.66 110.71 18.21 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.742 1.617 . . . . 1.0 110.748 169.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -90.06 144.2 26.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.787 1.635 . . . . 1.0 110.848 170.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 40.29 55.08 6.84 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 125.019 1.328 . . . . 1.0 112.51 -169.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.24 142.2 49.57 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.813 3.009 . . . . 1.0 117.179 -168.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -97.49 163.24 12.94 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 122.71 1.243 . . . . 1.0 112.783 168.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.607 HD21 HD21 ' A' ' 79' ' ' LEU . 2.3 tm? -67.28 -23.82 65.71 Favored 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 121.004 -1.06 . . . . 1.0 110.461 167.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 62.9 p -68.39 -18.65 64.51 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.941 -1.1 . . . . 1.0 112.337 172.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -82.49 -24.85 33.96 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.896 0.878 . . . . 1.0 112.178 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.485 ' HB3' HD22 ' A' ' 41' ' ' LEU . 14.6 t-105 -87.52 -36.52 17.56 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.399 1.259 . . . . 1.0 114.399 -178.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.7 mt -46.7 -37.89 10.25 Favored Pre-proline 0 CA--C 1.553 1.069 0 N-CA-C 114.413 1.264 . . . . 1.0 114.413 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -61.11 -14.36 33.07 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 123.745 2.964 . . . . 1.0 116.695 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -107.87 8.4 28.59 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 115.745 1.757 . . . . 1.0 115.745 -173.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -54.85 -27.82 45.21 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.631 1.972 . . . . 1.0 113.874 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -107.67 3.02 24.25 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.562 1.545 . . . . 1.0 113.41 176.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -114.93 -163.34 0.87 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.915 2.486 . . . . 1.0 110.836 -174.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -106.81 162.84 13.45 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 123.387 1.565 . . . . 1.0 110.936 169.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.596 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -148.63 151.66 13.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.253 -1.34 . . . . 1.0 108.056 -173.426 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.1 tp -133.62 130.27 38.07 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 124.471 1.108 . . . . 1.0 108.667 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.4 t -105.11 126.79 60.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.263 -0.643 . . . . 1.0 109.263 174.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.4 t -122.97 111.38 29.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.963 -1.866 . . . . 1.0 105.963 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 114.496 1.295 . . . . 1.0 114.496 -167.916 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.5 tt . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 113.283 0.846 . . . . 1.0 113.283 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.1 t -44.91 -53.31 16.22 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.422 1.089 . . . . 1.0 112.323 168.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.17 -31.87 28.49 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.647 1.565 . . . . 1.0 111.702 -173.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.2 tp -63.1 -52.15 63.77 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.146 0.978 . . . . 1.0 111.257 169.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.725 ' CE1' HD23 ' A' ' 110' ' ' LEU . 89.7 t80 -56.02 -53.41 57.27 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.927 0.891 . . . . 1.0 112.385 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -63.88 -39.91 95.3 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.814 0.846 . . . . 1.0 111.544 177.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.76 -36.86 91.83 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 123.47 0.557 . . . . 1.0 112.589 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.621 HG22 HD12 ' A' ' 110' ' ' LEU . 82.5 mt -65.19 -47.74 86.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 120.024 1.912 . . . . 1.0 108.412 172.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.754 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.2 ptmm? -71.63 -31.27 66.68 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.224 -1.547 . . . . 1.0 113.289 -171.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -104.42 -38.71 6.71 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 115.519 1.674 . . . . 1.0 115.519 -175.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.1 m -95.09 -22.43 17.9 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.639 1.176 . . . . 1.0 113.326 -174.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.607 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -91.23 -71.71 0.62 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 106.93 -1.507 . . . . 1.0 106.93 170.037 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.53 -16.86 0.91 Allowed Glycine 0 CA--C 1.538 1.488 0 C-N-CA 127.562 2.506 . . . . 1.0 116.804 169.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -152.27 138.15 18.05 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.862 2.465 . . . . 1.0 108.227 174.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -133.72 124.12 17.65 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 119.086 0.857 . . . . 1.0 112.546 -172.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -82.65 -35.93 0.28 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.598 2.199 . . . . 1.0 114.726 -173.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -144.99 11.1 1.36 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.589 1.7 . . . . 1.0 115.589 -169.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.596 HD11 ' CG2' ' A' ' 52' ' ' VAL . 39.1 tp -75.06 142.05 43.78 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 120.27 -1.519 . . . . 1.0 113.004 -169.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -134.2 144.11 48.26 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 129.317 3.047 . . . . 1.0 107.493 169.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.661 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -154.38 164.25 38.92 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 120.046 1.294 . . . . 1.0 113.568 179.564 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.424 ' HA3' ' CE2' ' A' ' 144' ' ' TRP . . . -125.78 170.67 17.65 Favored Glycine 0 N--CA 1.468 0.8 0 C-N-CA 126.537 2.018 . . . . 1.0 112.248 172.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.586 HG13 ' HB3' ' A' ' 122' ' ' MET . 0.2 OUTLIER -160.25 146.6 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 O-C-N 120.836 -1.391 . . . . 1.0 114.442 -169.021 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.976 HG23 HD12 ' A' ' 123' ' ' LEU . 11.1 mt -138.4 98.69 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 127.92 2.488 . . . . 1.0 107.005 -172.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.09 147.88 23.99 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.408 1.483 . . . . 1.0 111.867 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.4 mp -140.48 152.31 45.52 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.297 0.639 . . . . 1.0 112.629 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.509 0 N-CA-C 115.097 0.799 . . . . 1.0 115.097 169.201 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.543 0.68 0 N-CA-C 113.317 0.858 . . . . 1.0 113.317 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -51.06 -28.49 10.51 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.548 1.539 . . . . 1.0 114.009 -177.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.71 -42.78 59.32 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-N 120.436 1.471 . . . . 1.0 113.895 175.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.52 -34.88 18.46 Favored Glycine 0 N--CA 1.478 1.491 0 CA-C-N 118.864 1.332 . . . . 1.0 113.806 174.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -59.48 -32.87 70.66 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 118.465 1.132 . . . . 1.0 112.974 174.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -61.67 -41.69 97.89 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.217 1.007 . . . . 1.0 111.997 170.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -65.28 -34.89 79.42 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.234 0.924 . . . . 1.0 111.671 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -60.61 -55.19 36.26 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.344 0.657 . . . . 1.0 110.95 172.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.64 -34.71 62.56 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.974 0.731 . . . . 1.0 112.974 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.754 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -56.66 -50.29 72.53 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 123.562 1.648 . . . . 1.0 111.692 -178.29 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.661 HD12 ' CD1' ' A' ' 87' ' ' TYR . 14.9 mt -68.1 -36.98 80.66 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 120.606 -1.309 . . . . 1.0 111.423 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -73.79 -11.96 60.55 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.7 1.0 . . . . 1.0 113.7 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.84 -17.28 41.47 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.758 1.163 . . . . 1.0 110.918 175.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -96.51 -84.03 0.37 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.42 1.488 . . . . 1.0 108.729 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.5 -8.75 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.898 1.679 . . . . 1.0 112.67 -169.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -81.06 162.5 23.73 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 122.156 0.979 . . . . 1.0 113.312 -168.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -106.33 163.55 12.74 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.376 1.071 . . . . 1.0 111.793 -169.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.12 138.93 53.29 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.824 1.65 . . . . 1.0 110.802 -178.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.58 HG12 ' H ' ' A' ' 120' ' ' GLY . 18.5 t -84.91 -162.51 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 125.577 1.551 . . . . 1.0 107.699 173.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.58 ' H ' HG12 ' A' ' 119' ' ' VAL . . . -48.44 152.73 2.32 Favored Glycine 0 N--CA 1.482 1.743 0 O-C-N 120.121 -1.612 . . . . 1.0 113.901 173.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -63.75 151.01 43.27 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 122.746 1.26 . . . . 1.0 112.768 -172.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.586 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -71.43 157.64 37.69 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.992 1.317 . . . . 1.0 113.091 -168.979 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.976 HD12 HG23 ' A' ' 90' ' ' ILE . 0.9 OUTLIER -87.21 140.34 29.65 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.749 1.22 . . . . 1.0 110.084 170.128 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.0 mt -127.51 110.65 12.95 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.129 1.372 . . . . 1.0 109.83 173.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.569 ' CD1' HD11 ' A' ' 123' ' ' LEU . 28.7 mt -99.31 130.66 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.361 1.064 . . . . 1.0 112.929 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -105.55 98.34 8.05 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.648 2.379 . . . . 1.0 113.495 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.28 -22.42 66.84 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.819 1.044 . . . . 1.0 113.819 -175.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.6 t -58.85 -27.06 64.78 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.8 1.24 . . . . 1.0 112.845 171.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -120.34 -30.35 4.61 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.17 1.788 . . . . 1.0 112.303 -169.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -143.42 96.31 5.78 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.111 0.965 . . . . 1.0 112.938 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.42 7.13 4.64 Favored 'Trans proline' 0 CA--C 1.551 1.325 0 C-N-CA 123.877 3.051 . . . . 1.0 114.719 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -110.54 73.15 0.78 Allowed Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 126.539 1.936 . . . . 1.0 109.819 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -59.05 -26.87 83.31 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.753 2.302 . . . . 1.0 115.93 -169.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.7 pm0 -62.66 -25.92 68.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 119.45 1.023 . . . . 1.0 111.213 176.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.6 p -72.15 -15.88 61.98 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 120.974 -1.079 . . . . 1.0 112.788 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -104.18 -55.31 2.38 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.213 1.805 . . . . 1.0 111.894 177.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.5 p -67.95 -33.01 73.85 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 114.02 1.119 . . . . 1.0 114.02 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.8 m-20 -60.94 -56.63 33.13 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 121.035 1.743 . . . . 1.0 112.99 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -62.93 -23.49 74.17 Favored 'Trans proline' 0 C--N 1.353 0.803 0 CA-C-N 121.279 1.492 . . . . 1.0 112.933 174.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.466 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 88.9 t90 -67.53 -46.13 73.69 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 118.561 0.619 . . . . 1.0 110.739 172.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.648 HG11 ' HA ' ' A' ' 22' ' ' ALA . 96.6 t -66.19 -34.69 71.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -62.87 -49.87 73.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.212 -0.93 . . . . 1.0 109.588 174.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -63.15 -54.42 38.03 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.602 1.161 . . . . 1.0 111.752 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.424 ' CE2' ' HA3' ' A' ' 88' ' ' GLY . 87.7 t90 -59.16 -34.43 72.08 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 125.13 1.372 . . . . 1.0 112.05 175.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.4 -33.02 38.92 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.9 1.238 . . . . 1.0 113.272 173.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.6 p -69.27 -11.95 61.25 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.839 1.422 . . . . 1.0 114.839 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.06 -15.34 47.83 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.539 1.536 . . . . 1.0 111.875 177.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -75.81 168.38 20.13 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 119.243 0.929 . . . . 1.0 111.733 -177.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.6 p . . . . . 0 C--O 1.254 1.315 0 C-N-CA 126.633 1.973 . . . . 1.0 114.545 -175.897 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 114.012 1.116 . . . . 1.0 114.012 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -122.64 121.48 36.53 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.486 1.515 . . . . 1.0 110.865 178.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.554 HD13 HD12 ' A' ' 26' ' ' LEU . 2.1 mp -119.15 113.67 42.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 126.396 1.878 . . . . 1.0 112.444 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.59 124.0 7.18 Favored Glycine 0 C--O 1.223 -0.594 0 N-CA-C 110.89 -0.884 . . . . 1.0 110.89 169.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.8 mt -105.83 122.93 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-N 118.78 1.29 . . . . 1.0 110.131 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -114.82 111.5 21.33 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 -169.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.466 0.343 0 CA-C-O 121.428 0.632 . . . . 1.0 111.759 -170.274 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.6 tp . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 114.841 1.423 . . . . 1.0 114.841 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.0 t -46.8 -33.77 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.437 1.495 . . . . 1.0 112.547 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.06 -49.17 76.68 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.622 -1.299 . . . . 1.0 113.247 172.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -67.85 -29.68 68.87 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.732 1.213 . . . . 1.0 111.122 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -69.32 -47.34 64.73 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 123.91 0.884 . . . . 1.0 109.127 173.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.556 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.05 -42.43 94.25 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 112.3 0.481 . . . . 1.0 112.3 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -52.74 -49.98 64.37 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.945 0.898 . . . . 1.0 110.273 169.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.17 -38.04 72.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.255 0.622 . . . . 1.0 112.556 -174.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.5 mt -66.43 -48.64 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-N 119.041 0.837 . . . . 1.0 109.089 175.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.554 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -64.84 -35.72 82.02 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.927 0.87 . . . . 1.0 110.427 -176.088 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.2 m -61.98 -41.46 98.06 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.633 1.173 . . . . 1.0 113.504 170.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.92 -30.59 69.08 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.559 1.144 . . . . 1.0 112.665 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -69.95 -30.5 67.88 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.466 0.707 . . . . 1.0 112.091 171.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.01 16.73 1.92 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.987 0.803 . . . . 1.0 114.827 169.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -99.0 174.92 6.11 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.311 1.044 . . . . 1.0 110.123 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -103.73 91.2 3.9 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.918 1.287 . . . . 1.0 108.414 171.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.14 145.99 29.39 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.392 0.277 . . . . 1.0 110.98 176.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.1 m -146.74 137.65 24.02 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.901 0.88 . . . . 1.0 112.023 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.9 t -84.53 136.03 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 114.855 1.428 . . . . 1.0 114.855 170.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -113.13 109.54 18.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.905 2.082 . . . . 1.0 109.915 169.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -90.24 139.4 30.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.327 1.851 . . . . 1.0 110.932 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t0 43.26 53.56 9.6 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 124.387 1.075 . . . . 1.0 111.033 -169.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -68.74 141.7 50.39 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.718 2.945 . . . . 1.0 116.289 -168.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.462 ' HB3' ' H ' ' A' ' 42' ' ' SER . 56.1 mm-40 -93.57 162.01 14.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 122.373 1.082 . . . . 1.0 111.774 168.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.566 HD21 HD21 ' A' ' 79' ' ' LEU . 2.2 tm? -65.21 -20.76 66.59 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.02 -1.05 . . . . 1.0 109.838 167.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.462 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 15.1 m -68.28 -22.12 64.75 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 120.861 -1.15 . . . . 1.0 112.297 172.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -80.59 -27.9 37.25 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.964 0.906 . . . . 1.0 112.062 169.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.459 ' HB3' HD22 ' A' ' 41' ' ' LEU . 16.0 t-105 -85.21 -37.39 20.17 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.915 1.08 . . . . 1.0 113.915 -177.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.9 mt -42.94 -44.61 10.89 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 114.998 1.481 . . . . 1.0 114.998 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.92 -2.22 8.31 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.351 2.034 . . . . 1.0 115.575 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -108.29 8.66 27.84 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 115.793 1.775 . . . . 1.0 115.793 176.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -51.81 -27.73 13.34 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.786 2.034 . . . . 1.0 114.242 174.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.09 12.56 14.55 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.591 1.156 . . . . 1.0 112.494 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -127.51 -163.81 1.3 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.109 2.564 . . . . 1.0 111.346 -174.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -109.96 158.11 18.57 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 122.921 1.343 . . . . 1.0 112.955 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.401 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -147.44 161.99 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.121 1.368 . . . . 1.0 109.828 -173.802 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.0 tp -139.75 130.31 25.7 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.406 1.482 . . . . 1.0 108.227 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.3 t -104.71 123.8 58.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 124.403 1.081 . . . . 1.0 108.919 173.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.1 t -122.04 111.28 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.551 -2.018 . . . . 1.0 105.551 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 114.572 1.323 . . . . 1.0 114.572 -167.764 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.5 tt . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 114.134 1.161 . . . . 1.0 114.134 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.9 t -45.7 -53.61 19.23 Favored Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 124.484 1.114 . . . . 1.0 112.1 168.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -67.78 -31.17 32.68 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.665 1.577 . . . . 1.0 111.79 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.0 tp -63.15 -54.3 39.91 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 124.271 1.028 . . . . 1.0 111.32 169.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.616 ' CE1' HD23 ' A' ' 110' ' ' LEU . 93.6 t80 -55.23 -52.03 64.69 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.723 0.809 . . . . 1.0 112.464 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -65.11 -40.14 94.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.43 -0.805 . . . . 1.0 111.382 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.17 -33.59 78.8 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.488 -0.618 . . . . 1.0 112.837 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.636 HG22 HD12 ' A' ' 110' ' ' LEU . 93.4 mt -65.19 -47.75 86.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 120.115 1.958 . . . . 1.0 108.676 170.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.698 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.3 ptmm? -72.61 -31.54 65.24 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.347 -1.47 . . . . 1.0 113.232 -171.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -104.87 -39.85 6.15 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.719 1.608 . . . . 1.0 115.302 -174.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.0 m -92.89 -24.27 18.51 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.125 0.97 . . . . 1.0 113.13 -175.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.566 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -90.36 -72.03 0.59 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.9 -1.148 . . . . 1.0 107.9 171.505 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.44 -13.11 2.25 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 126.612 2.053 . . . . 1.0 116.331 169.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -156.89 139.85 15.33 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.335 2.254 . . . . 1.0 108.653 173.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.505 HE22 HD12 ' A' ' 79' ' ' LEU . 9.0 mm-40 -134.77 126.13 17.76 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 118.756 0.707 . . . . 1.0 111.373 -171.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -82.18 -41.36 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.532 2.154 . . . . 1.0 113.832 -173.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -145.77 21.2 1.46 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.681 1.192 . . . . 1.0 113.878 -170.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.401 HD11 ' CG2' ' A' ' 52' ' ' VAL . 65.0 tp -81.83 135.14 35.46 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.757 -1.214 . . . . 1.0 112.27 -169.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.5 mtm-85 -134.6 154.16 51.62 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.003 2.121 . . . . 1.0 109.534 169.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.63 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -160.47 169.08 23.75 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.569 -0.707 . . . . 1.0 111.644 -176.397 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.415 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -128.41 171.35 19.52 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 124.167 0.889 . . . . 1.0 113.672 170.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.422 HG23 ' HB3' ' A' ' 122' ' ' MET . 0.0 OUTLIER -140.7 140.12 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 113.978 1.103 . . . . 1.0 113.978 -169.87 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 1.061 HG23 HD12 ' A' ' 123' ' ' LEU . 12.4 mt -132.12 99.13 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 125.824 1.65 . . . . 1.0 107.065 169.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.05 142.08 28.06 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.731 1.613 . . . . 1.0 112.195 173.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.4 mp -138.51 156.98 47.03 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.169 0.804 . . . . 1.0 113.169 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.791 0 CA-C-N 115.504 -0.771 . . . . 1.0 113.277 169.017 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.447 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 24.5 p . . . . . 0 CA--C 1.541 0.612 0 N-CA-C 113.707 1.002 . . . . 1.0 113.707 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -60.18 -21.63 61.93 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 125.317 1.447 . . . . 1.0 114.173 -169.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.14 -31.03 77.49 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 120.832 1.651 . . . . 1.0 113.74 174.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.84 -37.0 17.39 Favored Glycine 0 N--CA 1.479 1.528 0 O-C-N 121.019 -1.283 . . . . 1.0 113.03 169.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.447 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 82.5 mttt -61.77 -29.36 70.08 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 121.025 -1.279 . . . . 1.0 112.642 172.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -62.85 -36.67 84.02 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.944 1.298 . . . . 1.0 111.747 170.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -65.8 -36.5 83.68 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.396 0.998 . . . . 1.0 111.781 172.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -63.67 -50.16 70.36 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.49 -0.757 . . . . 1.0 111.408 174.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.15 -33.73 65.47 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.674 0.79 . . . . 1.0 112.755 174.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.698 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -58.96 -49.68 76.95 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 123.349 1.547 . . . . 1.0 111.019 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.63 HD12 ' CD1' ' A' ' 87' ' ' TYR . 10.3 mt -66.65 -38.26 86.51 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 120.841 -1.162 . . . . 1.0 111.788 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -69.22 -20.05 63.96 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.801 1.037 . . . . 1.0 113.801 175.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.02 -16.83 59.17 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.845 0.858 . . . . 1.0 110.942 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -98.59 -74.35 0.59 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.92 1.288 . . . . 1.0 109.344 177.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.2 p 177.15 -17.27 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.713 2.005 . . . . 1.0 113.986 -173.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -69.36 159.21 33.59 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.716 1.376 . . . . 1.0 114.716 -169.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -97.02 170.24 9.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.223 1.809 . . . . 1.0 112.122 -169.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.67 151.41 49.25 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.463 1.105 . . . . 1.0 112.23 175.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.32 133.4 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.028 1.731 . . . . 1.0 109.621 -169.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 50.47 -158.79 1.74 Allowed Glycine 0 N--CA 1.48 1.582 0 C-N-CA 125.181 1.372 . . . . 1.0 115.268 -176.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -105.01 139.49 39.61 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.423 1.489 . . . . 1.0 109.504 169.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.422 ' HB3' HG23 ' A' ' 89' ' ' VAL . 1.2 pmm? -76.11 155.32 34.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.901 0.857 . . . . 1.0 111.927 -172.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 1.061 HD12 HG23 ' A' ' 90' ' ' ILE . 1.4 tm? -89.54 138.51 31.4 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.504 1.122 . . . . 1.0 110.276 174.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 mt -128.95 108.02 10.08 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.979 1.711 . . . . 1.0 109.749 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.569 ' CD1' HD11 ' A' ' 123' ' ' LEU . 29.8 mt -99.3 134.55 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.437 1.095 . . . . 1.0 112.885 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -105.13 109.47 21.47 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 124.478 1.111 . . . . 1.0 112.629 169.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.67 -23.95 61.76 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.54 1.136 . . . . 1.0 113.431 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.0 t -66.99 -19.46 65.72 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.371 1.069 . . . . 1.0 112.81 174.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -116.1 -30.11 6.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.084 1.753 . . . . 1.0 111.785 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -140.52 87.07 11.9 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.54 1.536 . . . . 1.0 111.638 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.04 7.82 1.93 Allowed 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 123.648 2.899 . . . . 1.0 114.559 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -114.73 69.06 2.1 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 127.715 2.406 . . . . 1.0 110.136 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -56.94 -22.53 46.73 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.605 2.204 . . . . 1.0 116.805 -169.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -64.26 -25.63 68.14 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.292 0.951 . . . . 1.0 111.811 174.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.8 p -72.86 -18.63 61.42 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.004 -1.06 . . . . 1.0 111.815 -175.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -101.77 -54.44 2.73 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.039 1.735 . . . . 1.0 111.475 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 64.7 p -69.8 -34.61 73.94 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.775 1.028 . . . . 1.0 113.775 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -60.16 -57.15 28.78 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 120.706 1.594 . . . . 1.0 112.558 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -62.17 -24.39 76.26 Favored 'Trans proline' 0 C--N 1.352 0.743 0 CA-C-N 121.273 1.49 . . . . 1.0 112.902 174.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.464 ' CG ' ' HB2' ' A' ' 123' ' ' LEU . 83.9 t90 -67.29 -45.5 76.39 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 119.062 0.846 . . . . 1.0 110.937 173.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.556 HG11 ' HA ' ' A' ' 22' ' ' ALA . 97.8 t -63.81 -33.61 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.635 -0.876 . . . . 1.0 108.635 176.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -70.0 -27.18 64.49 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 120.603 -1.311 . . . . 1.0 113.04 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -82.99 -56.59 3.71 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.352 1.461 . . . . 1.0 111.725 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.415 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 89.8 t90 -56.47 -36.39 69.03 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 125.855 1.662 . . . . 1.0 112.973 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.37 -32.89 30.97 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.825 1.202 . . . . 1.0 114.048 173.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.9 p -68.6 -13.24 62.22 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 114.405 1.261 . . . . 1.0 114.405 177.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.61 -17.49 51.17 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.471 1.509 . . . . 1.0 111.891 176.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -83.83 171.11 13.42 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.033 0.833 . . . . 1.0 111.887 -175.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.5 t . . . . . 0 C--O 1.255 1.351 0 C-N-CA 126.178 1.791 . . . . 1.0 113.033 -174.909 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 ttp . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.78 0.324 . . . . 1.0 110.822 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.07 174.2 11.05 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.88 1.672 . . . . 1.0 113.521 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -123.46 123.74 41.33 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.991 1.316 . . . . 1.0 110.48 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.567 HD13 HD12 ' A' ' 26' ' ' LEU . 2.2 mp -117.11 115.6 49.38 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.065 0 C-N-CA 126.168 1.787 . . . . 1.0 112.845 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.48 119.48 5.61 Favored Glycine 0 C--O 1.224 -0.519 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 169.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.6 mt -103.25 120.97 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 118.04 0.92 . . . . 1.0 109.171 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -118.39 115.99 25.81 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.153 -1.054 . . . . 1.0 108.153 -171.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.7 p -96.09 136.02 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 122.833 0.453 . . . . 1.0 112.109 -170.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.03 89.81 0.18 Allowed Glycine 0 N--CA 1.469 0.876 0 C-N-CA 123.689 0.662 . . . . 1.0 113.787 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.7 m -138.97 145.45 39.76 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.642 1.177 . . . . 1.0 110.07 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.8 ttt -63.32 -36.39 83.54 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.675 0.79 . . . . 1.0 112.684 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -84.48 121.92 28.26 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.668 1.187 . . . . 1.0 110.711 173.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.2 -27.57 55.37 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 123.712 0.672 . . . . 1.0 114.298 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -86.43 159.53 19.31 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.505 1.122 . . . . 1.0 112.102 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.9 m 58.28 25.62 12.93 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 116.032 1.864 . . . . 1.0 116.032 172.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 pp -68.46 151.67 46.5 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.439 -0.788 . . . . 1.0 111.405 170.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.5 tp -147.76 -57.55 0.24 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.123 1.527 . . . . 1.0 115.123 -169.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.5 t -54.77 -32.5 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.667 0.787 . . . . 1.0 112.529 -169.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.92 -48.81 78.81 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.852 -1.155 . . . . 1.0 113.461 172.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -69.15 -30.38 68.6 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.545 0.738 . . . . 1.0 110.969 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.73 -47.91 70.83 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.537 0.735 . . . . 1.0 109.237 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.537 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -64.96 -43.35 92.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 112.559 0.577 . . . . 1.0 112.559 -175.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -53.54 -48.69 68.86 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.051 0.94 . . . . 1.0 110.455 170.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.17 -37.84 69.24 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.495 0.718 . . . . 1.0 112.697 -174.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.7 mt -65.55 -46.65 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 CA-C-N 119.288 0.949 . . . . 1.0 109.141 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.567 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -66.72 -35.48 80.22 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 119.442 -0.903 . . . . 1.0 110.276 -176.283 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.6 m -62.34 -41.19 98.38 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.21 1.404 . . . . 1.0 113.57 170.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.94 -33.81 75.4 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.397 1.079 . . . . 1.0 111.9 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -71.59 -29.01 64.21 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.749 1.22 . . . . 1.0 112.806 172.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.44 25.92 2.54 Favored Glycine 0 N--CA 1.468 0.812 0 C-N-CA 124.378 0.989 . . . . 1.0 114.323 169.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -114.11 146.19 40.61 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.536 1.134 . . . . 1.0 109.574 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -84.1 83.27 8.02 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.859 1.263 . . . . 1.0 108.729 -173.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.91 146.65 26.41 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.301 0.641 . . . . 1.0 111.13 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.8 m -146.98 137.95 23.89 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.696 0.799 . . . . 1.0 112.772 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.3 t -84.35 136.76 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 115.109 1.522 . . . . 1.0 115.109 171.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -115.75 117.6 30.69 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.871 2.069 . . . . 1.0 110.595 169.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -93.12 147.93 22.44 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.287 1.835 . . . . 1.0 110.717 173.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 41.84 61.07 8.57 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 125.125 1.37 . . . . 1.0 112.022 -169.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -48.79 123.87 10.3 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.406 3.404 . . . . 1.0 119.883 -168.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -94.28 146.62 23.9 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.907 1.283 . . . . 1.0 111.285 168.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.49 HD21 HD21 ' A' ' 79' ' ' LEU . 2.4 tm? -71.09 -25.01 62.42 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 121.447 -0.783 . . . . 1.0 110.141 169.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.7 m -67.15 -19.02 65.53 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.493 -0.754 . . . . 1.0 112.609 170.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -91.7 -21.9 20.5 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.587 1.155 . . . . 1.0 113.443 169.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.473 ' HB3' HD22 ' A' ' 41' ' ' LEU . 10.8 t-105 -79.54 -35.02 40.56 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 120.028 1.286 . . . . 1.0 113.36 172.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.1 mt -50.86 -39.54 55.29 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 117.622 -1.18 . . . . 1.0 113.884 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -52.55 -16.62 5.62 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 124.432 3.421 . . . . 1.0 117.495 171.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -107.85 8.61 28.74 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.982 1.845 . . . . 1.0 115.982 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -52.7 -31.12 35.83 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.224 1.81 . . . . 1.0 113.749 173.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -112.66 13.35 19.9 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.102 1.361 . . . . 1.0 112.389 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -126.97 -158.3 0.86 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.613 2.365 . . . . 1.0 111.214 -174.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -114.14 162.81 16.04 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 122.947 1.356 . . . . 1.0 111.833 172.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.524 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -147.71 156.99 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.329 1.452 . . . . 1.0 109.007 -171.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.0 tp -137.38 129.3 28.96 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.813 1.245 . . . . 1.0 109.117 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.6 t -106.03 122.17 59.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.216 -0.661 . . . . 1.0 109.216 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.1 t -120.11 111.31 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 106.871 -1.529 . . . . 1.0 106.871 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.0 t -148.47 119.28 7.56 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.217 1.191 . . . . 1.0 114.217 -168.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.9 t -99.86 -171.22 2.01 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.475 1.11 . . . . 1.0 110.852 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.264 29.7 p 58.29 42.27 21.96 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.367 1.467 . . . . 1.0 113.61 169.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.8 m -53.04 -32.67 48.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.85 1.66 . . . . 1.0 112.743 169.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.44 -132.08 46.41 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.658 0.647 . . . . 1.0 112.523 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -79.36 11.18 3.09 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.438 1.095 . . . . 1.0 113.668 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 111.35 42.28 1.08 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.263 1.411 . . . . 1.0 113.201 177.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -135.05 164.55 27.38 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.244 1.818 . . . . 1.0 112.333 -173.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 68.3 mt -102.88 145.73 31.1 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 123.934 0.893 . . . . 1.0 112.541 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.04 152.09 62.36 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.829 2.353 . . . . 1.0 112.224 171.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -60.79 -20.95 62.53 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.441 1.096 . . . . 1.0 113.886 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.1 p -66.78 -29.48 69.45 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.894 1.278 . . . . 1.0 114.113 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.1 tt -117.02 -14.25 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.809 1.244 . . . . 1.0 114.236 -177.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -43.33 -53.07 11.89 Favored Pre-proline 0 N--CA 1.478 0.948 0 C-N-CA 124.643 1.177 . . . . 1.0 112.604 168.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.83 -31.71 19.67 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 121.576 1.517 . . . . 1.0 111.774 -172.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.4 tp -63.47 -51.26 66.39 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.333 1.053 . . . . 1.0 111.419 169.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.664 ' CE1' HD23 ' A' ' 110' ' ' LEU . 91.3 t80 -56.31 -52.46 64.45 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.121 0.968 . . . . 1.0 112.364 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -63.2 -39.41 94.56 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.787 0.835 . . . . 1.0 111.443 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.72 -36.84 92.83 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.064 0.84 . . . . 1.0 112.728 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.572 HG22 HD12 ' A' ' 110' ' ' LEU . 86.4 mt -65.37 -51.18 67.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 119.949 1.875 . . . . 1.0 107.976 172.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.709 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.4 ptmm? -69.25 -31.14 69.49 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 120.39 -1.444 . . . . 1.0 113.564 -169.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -103.43 -38.0 7.37 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.777 1.631 . . . . 1.0 115.279 -176.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.6 m -95.57 -20.88 18.63 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.468 1.107 . . . . 1.0 113.229 -175.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.49 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -91.67 -71.94 0.61 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 106.872 -1.529 . . . . 1.0 106.872 169.555 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.98 -18.92 1.06 Allowed Glycine 0 CA--C 1.539 1.58 0 C-N-CA 127.644 2.545 . . . . 1.0 115.265 169.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -151.87 138.99 19.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 128.386 2.674 . . . . 1.0 107.896 169.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.427 HE21 HD12 ' A' ' 79' ' ' LEU . 11.1 mt-30 -137.75 121.78 11.85 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 118.664 -0.684 . . . . 1.0 109.637 -171.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.72 -35.77 0.28 Allowed 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.422 2.081 . . . . 1.0 115.39 -169.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -141.68 15.51 2.15 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.292 1.219 . . . . 1.0 114.292 -169.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.524 HD11 ' CG2' ' A' ' 52' ' ' VAL . 64.9 tp -80.79 139.93 35.77 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 120.563 -1.336 . . . . 1.0 113.027 -169.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -137.12 154.74 50.21 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.66 2.384 . . . . 1.0 109.032 169.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.624 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -161.02 163.85 31.35 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.244 0.929 . . . . 1.0 112.217 -176.153 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.409 ' HA3' ' CE2' ' A' ' 144' ' ' TRP . . . -123.65 172.22 16.27 Favored Glycine 0 N--CA 1.467 0.703 0 C-N-CA 125.707 1.622 . . . . 1.0 112.109 169.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.551 HG13 ' HB3' ' A' ' 122' ' ' MET . 0.2 OUTLIER -160.52 145.56 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 O-C-N 121.161 -1.199 . . . . 1.0 114.086 -169.362 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.97 HG23 HD12 ' A' ' 123' ' ' LEU . 8.6 mt -134.76 100.26 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 127.794 2.438 . . . . 1.0 106.942 -175.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.27 146.17 24.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.267 1.427 . . . . 1.0 111.581 173.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.6 mp -140.09 156.45 46.57 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.453 0.701 . . . . 1.0 112.269 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.02 -149.06 15.77 Favored Glycine 0 C--O 1.224 -0.496 0 CA-C-N 116.208 -0.451 . . . . 1.0 112.499 169.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -116.03 117.62 30.63 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.014 0.907 . . . . 1.0 110.415 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.0 t -63.82 -6.39 5.75 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.905 1.076 . . . . 1.0 113.905 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.1 t -63.79 -26.85 68.81 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 120.721 -1.237 . . . . 1.0 111.984 169.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -75.73 138.76 41.47 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.285 -0.884 . . . . 1.0 111.253 169.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -43.09 -50.24 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 126.573 1.949 . . . . 1.0 114.593 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -100.43 20.5 14.77 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.451 2.3 . . . . 1.0 115.1 -175.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.1 t80 34.12 -81.65 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 129.201 3.0 . . . . 1.0 117.973 169.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.7 m -122.6 24.28 9.25 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.116 1.766 . . . . 1.0 113.191 -171.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -53.01 -25.51 12.47 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.082 1.353 . . . . 1.0 114.37 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.87 -43.47 60.88 Favored Glycine 0 CA--C 1.538 1.519 0 CA-C-N 121.522 1.965 . . . . 1.0 114.878 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -80.12 -33.5 32.51 Favored Glycine 0 N--CA 1.481 1.691 0 O-C-N 120.711 -1.464 . . . . 1.0 113.768 173.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -62.41 -33.41 74.72 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 121.366 -1.079 . . . . 1.0 112.672 174.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 40.7 mm-40 -60.63 -42.57 97.16 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.891 0.876 . . . . 1.0 111.163 169.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -64.05 -36.82 85.25 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.566 -0.709 . . . . 1.0 111.998 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -62.42 -49.62 74.74 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.405 -0.81 . . . . 1.0 112.498 173.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.34 -35.73 67.97 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.503 0.556 . . . . 1.0 112.503 174.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.709 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -58.04 -51.3 70.25 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 123.113 1.435 . . . . 1.0 110.926 -178.172 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.624 HD12 ' CD1' ' A' ' 87' ' ' TYR . 7.1 mt -65.74 -38.84 90.21 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 121.033 -1.042 . . . . 1.0 111.64 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -70.51 -18.92 62.95 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.344 0.868 . . . . 1.0 113.344 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.83 -19.01 58.03 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.298 0.954 . . . . 1.0 110.869 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -99.86 -76.8 0.54 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.886 1.274 . . . . 1.0 110.953 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.9 m -178.17 -2.88 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.587 1.955 . . . . 1.0 112.818 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -77.95 162.47 26.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 122.31 1.052 . . . . 1.0 113.304 -169.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -102.53 174.58 5.84 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.817 1.647 . . . . 1.0 113.221 -168.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.6 153.3 42.4 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.159 2.184 . . . . 1.0 112.433 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.5 t -126.78 127.66 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 126.206 1.802 . . . . 1.0 108.46 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 49.21 -156.52 1.53 Allowed Glycine 0 N--CA 1.48 1.615 0 C-N-CA 125.032 1.301 . . . . 1.0 114.615 -169.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -118.22 144.82 45.46 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.856 1.662 . . . . 1.0 109.803 169.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.551 ' HB3' HG13 ' A' ' 89' ' ' VAL . 1.1 pmm? -71.91 155.39 40.43 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.224 1.012 . . . . 1.0 113.063 -169.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.97 HD12 HG23 ' A' ' 90' ' ' ILE . 1.1 tm? -84.18 139.62 32.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.048 -0.978 . . . . 1.0 109.815 170.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.5 mt -127.38 110.15 12.5 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.363 1.465 . . . . 1.0 110.098 173.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.563 ' CD1' HD11 ' A' ' 123' ' ' LEU . 24.4 mt -98.56 129.86 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.092 0.957 . . . . 1.0 112.749 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -103.75 110.92 23.2 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 122.278 1.037 . . . . 1.0 112.55 171.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.21 -22.44 64.8 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.623 1.169 . . . . 1.0 113.379 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.0 t -65.13 -21.99 66.87 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.897 0.879 . . . . 1.0 112.795 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -119.25 -30.5 4.92 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.162 1.785 . . . . 1.0 111.98 -174.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -142.34 85.95 10.32 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.073 1.349 . . . . 1.0 111.975 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.79 7.84 2.22 Favored 'Trans proline' 0 CA--C 1.551 1.333 0 C-N-CA 123.625 2.883 . . . . 1.0 114.419 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -113.79 69.56 1.63 Allowed Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 127.432 2.293 . . . . 1.0 109.909 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -56.6 -24.45 54.06 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.667 2.245 . . . . 1.0 116.304 -169.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.8 pm0 -66.08 -24.43 66.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 119.385 0.993 . . . . 1.0 111.725 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 15.1 p -73.78 -15.53 61.19 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.661 -1.274 . . . . 1.0 112.27 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.434 ' HB2' HD11 ' A' ' 125' ' ' ILE . 5.0 mm-40 -105.02 -55.44 2.33 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.296 1.838 . . . . 1.0 111.482 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 65.7 p -69.29 -33.88 73.87 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 113.938 1.088 . . . . 1.0 113.938 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -60.57 -57.45 26.44 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 120.801 1.637 . . . . 1.0 112.485 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -62.96 -23.35 74.13 Favored 'Trans proline' 0 C--N 1.354 0.832 0 CA-C-N 121.386 1.531 . . . . 1.0 112.449 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.467 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 86.8 t90 -67.12 -46.82 72.98 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 119.258 0.936 . . . . 1.0 110.749 173.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.537 HG11 ' HA ' ' A' ' 22' ' ' ALA . 96.1 t -63.4 -33.83 63.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 108.922 -0.77 . . . . 1.0 108.922 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.76 -28.35 65.7 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.823 1.249 . . . . 1.0 113.132 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -81.83 -56.96 3.65 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.169 1.388 . . . . 1.0 112.073 169.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.41 ' CZ3' HD11 ' A' ' 26' ' ' LEU . 85.1 t90 -57.14 -36.93 71.3 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 125.498 1.519 . . . . 1.0 112.727 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.83 -33.01 34.65 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.766 1.174 . . . . 1.0 113.765 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.8 p -65.79 -13.99 60.5 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.576 1.325 . . . . 1.0 114.576 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.27 -16.78 53.93 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.008 1.723 . . . . 1.0 112.005 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.17 -176.98 5.89 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.174 1.39 . . . . 1.0 110.754 -176.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 31.9 m . . . . . 0 C--O 1.253 1.277 0 C-N-CA 125.624 1.57 . . . . 1.0 115.01 -172.045 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 119.938 -0.077 . . . . 1.0 110.877 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.52 163.65 35.88 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.24 1.416 . . . . 1.0 112.678 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -120.67 124.42 45.18 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.664 1.586 . . . . 1.0 110.466 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.518 HD13 HD12 ' A' ' 26' ' ' LEU . 2.0 mp -123.14 113.47 37.95 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.071 0 C-N-CA 125.963 1.705 . . . . 1.0 112.664 -178.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.8 123.64 7.18 Favored Glycine 0 C--O 1.224 -0.523 0 N-CA-C 110.551 -1.019 . . . . 1.0 110.551 169.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.4 mt -105.15 122.23 58.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 118.184 0.992 . . . . 1.0 109.459 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -114.16 108.75 17.39 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 124.869 1.268 . . . . 1.0 108.277 -169.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.6 p -92.46 134.66 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.037 -173.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -123.39 115.44 2.64 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.656 1.122 . . . . 1.0 111.366 176.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -148.59 145.91 28.01 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.641 0.776 . . . . 1.0 112.747 -169.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.11 165.79 6.73 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.463 0.705 . . . . 1.0 111.709 168.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -64.9 122.47 17.05 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.255 -0.903 . . . . 1.0 111.315 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.06 -148.81 19.39 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.529 1.061 . . . . 1.0 113.434 -173.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -71.07 167.98 18.1 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.653 1.181 . . . . 1.0 112.505 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.4 t -55.61 150.32 12.51 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.083 1.353 . . . . 1.0 113.029 174.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.56 -12.13 60.94 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.596 0.759 . . . . 1.0 112.266 171.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.4 tp 63.71 -52.4 0.24 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 128.019 2.528 . . . . 1.0 115.265 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.2 t -53.65 -35.29 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.913 1.685 . . . . 1.0 112.47 -175.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.21 -45.79 87.02 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.858 -1.151 . . . . 1.0 112.487 174.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.83 -31.08 68.77 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.586 1.154 . . . . 1.0 110.759 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -66.56 -48.23 70.3 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.239 0.616 . . . . 1.0 109.341 170.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.536 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.41 -42.9 92.05 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 112.823 0.675 . . . . 1.0 112.823 -173.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -54.01 -49.24 69.31 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 123.717 0.807 . . . . 1.0 110.409 169.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.99 -37.0 69.92 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.285 0.634 . . . . 1.0 112.491 -174.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.4 mt -66.41 -46.96 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 119.015 0.825 . . . . 1.0 109.191 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.518 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -67.52 -34.65 77.54 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 119.57 -0.852 . . . . 1.0 110.613 -176.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.6 m -62.58 -40.07 95.71 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.226 1.41 . . . . 1.0 113.484 170.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.87 -32.72 72.58 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.177 0.991 . . . . 1.0 112.066 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -70.6 -29.77 66.26 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.597 1.159 . . . . 1.0 113.059 170.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.91 23.05 3.12 Favored Glycine 0 N--CA 1.47 0.95 0 C-N-CA 124.516 1.055 . . . . 1.0 114.585 169.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -109.61 151.99 26.11 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.363 1.065 . . . . 1.0 109.652 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.3 tptt -85.39 85.55 7.43 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.756 1.223 . . . . 1.0 108.665 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.3 145.44 28.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.68 -0.691 . . . . 1.0 111.11 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.2 m -147.3 139.02 24.13 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.843 0.857 . . . . 1.0 112.341 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.1 t -86.78 136.08 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 115.022 1.49 . . . . 1.0 115.022 171.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -113.43 113.5 25.27 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.331 1.852 . . . . 1.0 110.017 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -93.56 138.24 32.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.131 1.772 . . . . 1.0 110.848 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 42.39 55.06 9.8 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 124.498 1.119 . . . . 1.0 111.309 -169.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -67.84 140.09 49.66 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.699 2.933 . . . . 1.0 117.089 -168.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -93.64 163.46 13.54 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 122.466 1.127 . . . . 1.0 111.986 168.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.604 HD21 HD21 ' A' ' 79' ' ' LEU . 2.1 tm? -66.76 -22.61 66.04 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 121.074 -1.016 . . . . 1.0 110.738 167.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.2 p -68.57 -18.44 64.34 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.959 1.254 . . . . 1.0 112.386 171.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -82.67 -25.22 33.24 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.174 0.99 . . . . 1.0 112.276 169.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.467 ' HB3' HD22 ' A' ' 41' ' ' LEU . 11.1 t-105 -89.38 -33.81 16.73 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.175 1.176 . . . . 1.0 114.175 -177.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.6 mt -48.2 -38.67 22.38 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 117.549 -1.215 . . . . 1.0 114.046 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.2 -6.92 7.24 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 124.053 3.169 . . . . 1.0 116.863 175.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -114.76 6.17 15.48 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 116.126 1.899 . . . . 1.0 116.126 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -50.25 -29.44 9.56 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.562 1.945 . . . . 1.0 113.824 171.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -105.53 7.92 33.14 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 128.144 2.578 . . . . 1.0 113.156 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -132.78 -161.36 1.13 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.933 2.093 . . . . 1.0 112.728 -168.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -110.59 157.48 19.62 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 123.191 1.472 . . . . 1.0 111.042 171.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.605 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -144.81 155.63 14.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 124.941 1.297 . . . . 1.0 108.285 -172.295 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.6 tp -134.98 127.74 31.09 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 124.568 1.147 . . . . 1.0 108.642 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.8 t -102.8 124.21 56.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.338 -0.616 . . . . 1.0 109.338 175.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.7 t -124.64 108.72 20.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 106.493 -1.669 . . . . 1.0 106.493 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -146.63 127.48 14.43 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.923 1.083 . . . . 1.0 113.923 -167.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.1 p -109.01 -149.96 0.45 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.089 1.756 . . . . 1.0 109.975 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.4 m 73.79 -21.34 0.27 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 127.462 2.305 . . . . 1.0 115.068 168.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 93.6 m -54.93 113.63 1.41 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.01 1.324 . . . . 1.0 110.664 169.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.13 -100.93 2.68 Favored Glycine 0 N--CA 1.472 1.049 0 N-CA-C 109.739 -1.344 . . . . 1.0 109.739 173.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -69.64 0.02 6.13 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.647 1.179 . . . . 1.0 112.53 169.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.33 -161.21 28.71 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 126.947 2.213 . . . . 1.0 111.441 -175.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 64.23 165.41 0.14 Allowed 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 117.492 2.404 . . . . 1.0 117.492 172.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 64.5 mt -106.71 154.11 40.29 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.788 2.035 . . . . 1.0 112.187 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -67.9 144.86 66.28 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.804 2.336 . . . . 1.0 112.122 169.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -62.97 -21.69 66.29 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.935 1.087 . . . . 1.0 113.935 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.6 p -72.86 -20.84 61.04 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.3 1.222 . . . . 1.0 114.3 172.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.7 tt -112.41 -14.07 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 113.818 1.044 . . . . 1.0 113.818 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.1 t -45.77 -53.5 20.06 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.432 1.093 . . . . 1.0 112.52 168.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -67.98 -33.66 25.41 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.531 1.487 . . . . 1.0 111.537 -173.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.4 tp -61.2 -53.03 62.1 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 124.586 1.154 . . . . 1.0 111.287 170.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.692 ' CE1' HD23 ' A' ' 110' ' ' LEU . 91.9 t80 -54.3 -53.49 53.1 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.128 0.971 . . . . 1.0 112.25 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -64.02 -40.5 96.47 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.792 0.837 . . . . 1.0 111.531 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.11 -35.93 89.6 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.563 0.601 . . . . 1.0 112.642 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.612 HG22 HD12 ' A' ' 110' ' ' LEU . 89.8 mt -64.82 -47.79 87.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 120.173 1.986 . . . . 1.0 108.259 172.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.739 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.2 ptmm? -71.5 -32.58 68.39 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.566 -1.333 . . . . 1.0 113.201 -171.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -105.17 -36.97 7.07 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.161 1.541 . . . . 1.0 115.161 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.9 m -94.05 -24.98 17.39 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.23 1.012 . . . . 1.0 112.84 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.604 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -90.49 -71.59 0.61 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.415 -1.328 . . . . 1.0 107.415 169.468 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.98 -8.46 2.5 Favored Glycine 0 CA--C 1.543 1.786 0 C-N-CA 126.419 1.962 . . . . 1.0 115.13 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -153.88 146.45 24.12 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 129.851 3.26 . . . . 1.0 106.906 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -136.62 125.37 15.25 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 123.192 0.597 . . . . 1.0 111.099 -176.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.97 -41.85 0.14 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 121.983 1.789 . . . . 1.0 114.314 -171.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -147.84 22.54 1.12 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.829 1.252 . . . . 1.0 113.129 -171.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.605 HD11 ' CG2' ' A' ' 52' ' ' VAL . 53.0 tp -83.2 137.6 33.96 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.624 -1.298 . . . . 1.0 113.909 -169.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -135.23 153.94 51.75 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 127.821 2.448 . . . . 1.0 108.957 169.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.665 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -158.07 164.77 36.37 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.316 -0.865 . . . . 1.0 112.302 -177.352 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -124.88 172.26 17.02 Favored Glycine 0 N--CA 1.467 0.766 0 C-N-CA 125.703 1.62 . . . . 1.0 111.978 169.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.576 HG13 ' HB3' ' A' ' 122' ' ' MET . 0.2 OUTLIER -159.03 146.45 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 O-C-N 120.875 -1.367 . . . . 1.0 114.44 -169.492 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.7 mt -133.45 105.64 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 127.308 2.243 . . . . 1.0 107.738 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.91 144.32 26.03 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.416 1.486 . . . . 1.0 110.863 175.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.5 mp -137.93 155.35 49.0 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.652 0.612 . . . . 1.0 112.652 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.25 -155.33 26.64 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 116.15 -0.477 . . . . 1.0 113.639 169.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.63 113.99 27.66 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.462 1.105 . . . . 1.0 111.393 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.4 t -74.57 1.8 11.23 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.973 1.101 . . . . 1.0 113.973 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 46.0 p -66.08 -14.65 62.11 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.614 -1.303 . . . . 1.0 113.61 170.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -117.6 157.53 26.22 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.625 1.57 . . . . 1.0 112.119 169.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.0 m -67.35 167.96 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.011 0.924 . . . . 1.0 110.531 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 61.14 22.51 12.81 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.122 1.369 . . . . 1.0 114.323 -169.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -28.83 -55.23 0.12 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 129.2 3.0 . . . . 1.0 116.11 -170.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.406 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 17.4 p -124.56 17.96 8.83 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.557 1.543 . . . . 1.0 113.019 -169.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -62.06 -19.04 62.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.257 1.423 . . . . 1.0 114.257 -169.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.34 -52.62 52.12 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-N 120.432 1.469 . . . . 1.0 113.732 174.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.41 -34.98 68.59 Favored Glycine 0 N--CA 1.479 1.51 0 O-C-N 120.807 -1.408 . . . . 1.0 112.995 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.406 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 87.0 mttt -63.41 -35.33 80.05 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.536 1.134 . . . . 1.0 113.137 173.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -64.34 -39.72 94.45 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 119.062 -0.495 . . . . 1.0 111.735 169.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -61.34 -33.49 73.71 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 118.961 0.801 . . . . 1.0 111.843 174.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -66.32 -51.81 53.53 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.571 0.748 . . . . 1.0 111.359 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.76 -35.24 63.56 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.657 0.783 . . . . 1.0 112.863 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.739 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -58.05 -49.91 75.27 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-O 123.3 1.524 . . . . 1.0 110.867 -179.066 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.665 HD12 ' CD1' ' A' ' 87' ' ' TYR . 12.4 mt -67.27 -37.53 83.6 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 120.907 -1.12 . . . . 1.0 112.117 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -69.12 -20.87 64.05 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.54 -16.43 58.67 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.249 0.931 . . . . 1.0 110.991 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -100.29 -78.51 0.51 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.165 1.386 . . . . 1.0 110.175 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -175.72 -13.58 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.751 -1.568 . . . . 1.0 113.347 -169.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -80.44 163.06 24.1 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.966 1.469 . . . . 1.0 114.966 -168.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -103.76 175.5 5.46 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.046 1.738 . . . . 1.0 112.183 -169.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.02 141.89 48.52 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.232 1.813 . . . . 1.0 110.349 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 120' ' ' GLY 0.257 12.9 t -93.54 -161.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 125.55 1.54 . . . . 1.0 106.85 174.004 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.547 ' H ' HG12 ' A' ' 119' ' ' VAL . . . -49.53 149.49 5.12 Favored Glycine 0 CA--C 1.547 2.066 0 O-C-N 119.775 -1.828 . . . . 1.0 114.589 177.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.11 149.65 40.69 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.973 1.309 . . . . 1.0 112.48 -172.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.576 ' HB3' HG13 ' A' ' 89' ' ' VAL . 1.0 OUTLIER -70.57 157.05 38.6 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 122.546 1.165 . . . . 1.0 113.759 -169.145 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.643 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -87.5 141.43 28.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.309 -1.314 . . . . 1.0 109.795 170.137 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.643 ' N ' HD13 ' A' ' 123' ' ' LEU . 5.9 mt -124.33 103.5 8.25 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 125.508 1.523 . . . . 1.0 110.948 175.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.448 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.5 mt -89.61 128.07 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.41 1.484 . . . . 1.0 112.344 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -106.35 108.43 19.94 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.066 0.936 . . . . 1.0 112.139 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.02 -22.57 64.97 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.008 0.923 . . . . 1.0 113.29 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.9 t -65.18 -21.78 66.81 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.379 1.072 . . . . 1.0 112.935 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -119.36 -29.72 5.08 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.061 1.744 . . . . 1.0 112.096 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -143.33 84.89 9.9 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 125.448 1.499 . . . . 1.0 112.048 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.44 7.29 2.29 Favored 'Trans proline' 0 CA--C 1.551 1.333 0 C-N-CA 123.742 2.961 . . . . 1.0 114.45 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -111.74 71.31 0.95 Allowed Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 127.592 2.357 . . . . 1.0 109.966 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -58.69 -20.15 49.38 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.89 2.393 . . . . 1.0 116.747 -169.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -66.16 -27.0 67.68 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 119.596 1.089 . . . . 1.0 111.639 172.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 22.1 p -74.56 -21.67 59.39 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.544 1.065 . . . . 1.0 111.943 -172.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -93.19 -51.29 5.09 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.335 1.454 . . . . 1.0 111.996 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 77.3 p -73.26 -33.64 65.38 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 115.711 1.745 . . . . 1.0 115.711 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -56.22 -58.07 18.78 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 121.003 1.728 . . . . 1.0 111.836 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -62.21 -24.35 76.12 Favored 'Trans proline' 0 C--N 1.352 0.761 0 CA-C-N 121.514 1.577 . . . . 1.0 113.155 175.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.505 ' HB2' HD23 ' A' ' 123' ' ' LEU . 91.2 t90 -68.12 -47.73 67.34 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 118.972 0.805 . . . . 1.0 110.982 174.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.536 HG11 ' HA ' ' A' ' 22' ' ' ALA . 86.6 t -64.66 -33.57 64.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 176.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -69.34 -28.97 66.69 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.761 1.225 . . . . 1.0 112.085 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -81.5 -60.44 2.26 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.137 1.775 . . . . 1.0 112.021 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 82.1 t90 -56.0 -36.0 67.42 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 126.2 1.8 . . . . 1.0 112.654 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.59 -32.31 23.89 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.771 1.177 . . . . 1.0 113.764 173.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.2 p -69.45 -12.77 61.93 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.333 1.234 . . . . 1.0 114.333 177.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.57 -16.89 50.22 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.209 1.804 . . . . 1.0 111.862 175.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.25 174.79 11.19 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.378 1.071 . . . . 1.0 111.168 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.251 1.156 0 N-CA-C 115.242 1.571 . . . . 1.0 115.242 -175.068 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 111.793 0.294 . . . . 1.0 111.793 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.7 166.58 32.96 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.427 1.491 . . . . 1.0 112.714 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -125.77 122.81 37.29 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.903 1.281 . . . . 1.0 110.254 175.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.585 HD13 HD12 ' A' ' 26' ' ' LEU . 2.1 mp -120.99 116.89 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 126.2 1.8 . . . . 1.0 113.044 -177.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.8 124.34 7.8 Favored Glycine 0 N--CA 1.467 0.758 0 CA-C-O 119.382 -0.677 . . . . 1.0 111.507 169.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 mt -107.37 121.39 60.19 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-N 118.8 1.3 . . . . 1.0 109.743 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -116.71 109.58 17.34 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 124.661 1.185 . . . . 1.0 108.615 -169.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 p -89.24 140.84 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.0 -0.545 . . . . 1.0 111.502 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -126.42 140.57 12.13 Favored Glycine 0 N--CA 1.469 0.898 0 N-CA-C 111.066 -0.814 . . . . 1.0 111.066 169.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.2 t -160.3 152.09 20.0 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.109 1.455 . . . . 1.0 112.649 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 20.2 ttt -87.61 -12.55 45.3 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.413 1.485 . . . . 1.0 111.81 169.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -79.15 163.61 24.92 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.945 1.298 . . . . 1.0 112.8 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.74 -7.3 69.31 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 116.088 1.195 . . . . 1.0 116.088 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -142.15 151.99 42.76 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.406 1.482 . . . . 1.0 111.39 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.4 m -69.94 146.0 51.48 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.247 1.019 . . . . 1.0 113.101 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.418 ' HG ' ' H ' ' A' ' 18' ' ' VAL . 50.5 tp -76.83 130.01 37.04 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.518 0.933 . . . . 1.0 113.518 -174.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 37.0 tp -34.94 -49.31 0.44 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 128.138 2.575 . . . . 1.0 114.765 169.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.418 ' H ' ' HG ' ' A' ' 16' ' ' LEU . 76.4 t -53.97 -37.7 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.807 0.843 . . . . 1.0 112.183 -172.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.27 -38.47 86.87 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.956 -1.09 . . . . 1.0 112.407 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -75.9 -32.41 59.64 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.138 0.575 . . . . 1.0 111.439 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -60.52 -45.49 93.62 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.219 -1.03 . . . . 1.0 108.219 170.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.614 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.46 -40.66 93.46 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 112.624 0.601 . . . . 1.0 112.624 -174.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -57.34 -48.3 79.36 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.193 0.451 . . . . 1.0 109.8 169.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.38 -35.12 75.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 112.89 0.7 . . . . 1.0 112.89 -173.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.9 mt -72.66 -46.44 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 O-C-N 121.321 -0.862 . . . . 1.0 109.346 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.585 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -64.81 -33.36 75.81 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 119.162 -1.015 . . . . 1.0 109.976 -178.602 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.1 m -62.14 -45.99 90.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.984 1.314 . . . . 1.0 113.133 169.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.69 -33.03 74.99 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.193 0.997 . . . . 1.0 112.69 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -69.91 -29.8 67.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.941 1.297 . . . . 1.0 112.378 172.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.24 21.51 2.28 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.729 1.157 . . . . 1.0 115.175 169.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -117.02 153.37 32.8 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.432 1.093 . . . . 1.0 110.655 -175.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -87.12 72.16 10.03 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 123.118 1.437 . . . . 1.0 110.278 -173.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.11 144.9 27.28 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 112.954 -1.93 . . . . 1.0 111.941 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.6 m -142.63 136.23 28.91 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 125.746 1.618 . . . . 1.0 108.739 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.71 143.9 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.697 1.199 . . . . 1.0 113.437 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.65 133.82 53.1 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.329 1.851 . . . . 1.0 111.316 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -107.14 141.17 38.84 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.673 1.989 . . . . 1.0 111.13 178.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 t0 41.3 55.47 8.36 Favored Pre-proline 0 CA--C 1.559 1.309 0 C-N-CA 124.519 1.128 . . . . 1.0 112.478 -172.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.78 148.16 45.92 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.531 2.821 . . . . 1.0 117.072 -168.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -99.25 164.75 12.0 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.951 1.3 . . . . 1.0 112.461 168.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.568 HD21 HD21 ' A' ' 79' ' ' LEU . 2.2 tm? -68.15 -22.35 64.86 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 121.03 -1.044 . . . . 1.0 110.727 167.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 67.4 p -68.19 -20.21 64.83 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.656 1.117 . . . . 1.0 112.219 171.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -81.68 -24.9 35.96 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.253 1.021 . . . . 1.0 112.359 169.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.469 ' HB3' HD22 ' A' ' 41' ' ' LEU . 10.3 t-105 -88.85 -34.78 16.89 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.346 1.239 . . . . 1.0 114.346 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.4 mt -47.5 -38.46 16.24 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-O 117.358 -1.306 . . . . 1.0 114.314 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -57.1 -18.77 30.4 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.43 2.753 . . . . 1.0 116.416 175.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -105.79 7.49 32.41 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 116.13 1.9 . . . . 1.0 116.13 -172.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -51.43 -34.71 36.25 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.619 1.967 . . . . 1.0 113.525 174.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -110.35 8.53 23.38 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.791 1.636 . . . . 1.0 112.373 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -115.78 -163.93 0.92 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.639 2.376 . . . . 1.0 110.299 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -108.48 164.26 12.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 122.613 1.197 . . . . 1.0 112.147 170.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.604 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -148.35 162.12 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.121 1.369 . . . . 1.0 109.906 -170.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.64 HD11 HD12 ' A' ' 90' ' ' ILE . 13.3 tp -144.9 128.65 17.25 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.931 1.292 . . . . 1.0 108.852 177.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.69 128.3 58.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 C-N-CA 124.141 0.976 . . . . 1.0 109.728 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.2 t -127.04 108.87 19.43 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 p -111.27 114.46 27.68 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.033 -1.099 . . . . 1.0 108.033 -170.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 m -87.85 -27.03 22.48 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 119.566 3.173 . . . . 1.0 119.566 -166.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.4 p -122.7 -39.74 2.51 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.756 1.021 . . . . 1.0 113.756 -168.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.488 ' CG2' ' H ' ' A' ' 103' ' ' GLY . 20.3 m 46.62 43.41 12.54 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.914 1.45 . . . . 1.0 114.914 169.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.74 128.97 47.77 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 121.056 -1.027 . . . . 1.0 112.424 -175.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 54.43 15.04 0.9 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.98 1.312 . . . . 1.0 114.387 -171.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.449 ' HA3' ' HB2' ' A' ' 99' ' ' ASN . . . 81.94 6.85 88.59 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.888 1.708 . . . . 1.0 116.09 -172.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -106.92 169.02 8.8 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.288 1.544 . . . . 1.0 112.61 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 40.1 mt -92.52 137.57 24.38 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.724 1.21 . . . . 1.0 113.756 -172.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.73 162.35 27.06 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.88 3.054 . . . . 1.0 113.91 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -63.81 -20.75 66.03 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 115.407 1.632 . . . . 1.0 115.407 -169.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.9 m -75.75 -19.06 59.31 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.793 1.035 . . . . 1.0 113.793 175.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.5 tt -113.01 -15.3 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.695 1.198 . . . . 1.0 113.618 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.7 t -40.71 -52.78 6.24 Favored Pre-proline 0 N--CA 1.478 0.951 0 CA-C-O 117.477 -1.249 . . . . 1.0 112.665 168.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -67.15 -32.31 34.26 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 121.725 1.616 . . . . 1.0 112.181 -173.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.1 tp -65.73 -52.96 47.01 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 124.051 0.94 . . . . 1.0 111.302 169.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.653 ' CE1' HD23 ' A' ' 110' ' ' LEU . 92.6 t80 -56.24 -52.41 64.57 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.727 0.811 . . . . 1.0 112.666 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -64.04 -40.33 96.06 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.669 1.188 . . . . 1.0 111.445 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.68 -35.85 90.42 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 123.604 0.621 . . . . 1.0 112.808 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.618 HG22 HD12 ' A' ' 110' ' ' LEU . 90.5 mt -66.42 -46.54 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 120.199 2.0 . . . . 1.0 108.578 172.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.717 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.4 ptmm? -72.25 -30.63 65.04 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.039 -1.663 . . . . 1.0 113.267 -171.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -109.77 -37.48 5.64 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.402 1.63 . . . . 1.0 115.402 -173.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.7 m -90.55 -26.8 19.53 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.302 1.041 . . . . 1.0 112.695 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.568 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -90.12 -71.44 0.62 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.214 -1.402 . . . . 1.0 107.214 169.379 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.7 -6.21 2.85 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 126.317 1.913 . . . . 1.0 115.496 172.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -156.22 146.78 21.74 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.035 2.934 . . . . 1.0 107.315 173.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.407 ' HG3' ' HB2' ' A' ' 116' ' ' ALA . 43.4 mm-40 -137.94 126.06 14.17 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 123.73 0.812 . . . . 1.0 110.207 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -84.63 -37.99 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 121.924 1.75 . . . . 1.0 114.414 -172.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -147.64 18.66 1.16 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.757 1.223 . . . . 1.0 114.14 -169.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.604 HD11 ' CG2' ' A' ' 52' ' ' VAL . 38.2 tp -77.31 139.98 39.9 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.5 -1.375 . . . . 1.0 113.629 -169.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -132.85 146.76 52.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 128.815 2.846 . . . . 1.0 107.252 169.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.645 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -159.33 167.63 28.38 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 118.981 0.81 . . . . 1.0 113.069 -177.494 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.484 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -125.32 173.49 17.4 Favored Glycine 0 N--CA 1.474 1.208 0 C-N-CA 125.025 1.298 . . . . 1.0 114.228 173.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.6 t -144.61 131.43 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.185 0.994 . . . . 1.0 113.641 -169.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.054 HG23 HD12 ' A' ' 123' ' ' LEU . 3.4 mt -131.54 102.24 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.846 1.658 . . . . 1.0 107.203 169.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -91.94 145.32 24.63 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.859 0.838 . . . . 1.0 111.27 170.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.437 HD11 HG22 ' A' ' 90' ' ' ILE . 3.5 mp -139.86 152.96 46.88 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.07 1.348 . . . . 1.0 110.622 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.56 -173.18 43.22 Favored Glycine 0 C--O 1.227 -0.31 0 C-N-CA 120.851 -0.69 . . . . 1.0 113.676 169.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -86.8 113.79 22.92 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.942 -0.74 . . . . 1.0 110.352 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 36.0 p -62.47 -4.74 2.05 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.994 1.318 . . . . 1.0 114.335 176.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.6 t -67.59 -25.44 65.77 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.034 0.934 . . . . 1.0 112.438 169.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -75.02 153.97 38.23 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.155 -0.966 . . . . 1.0 112.708 169.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.13 161.06 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 168.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.449 ' HB2' ' HA3' ' A' ' 62' ' ' GLY . 9.6 m-80 60.06 24.71 13.94 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 113.944 1.09 . . . . 1.0 113.944 176.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.3 t80 11.39 -85.48 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 129.942 3.297 . . . . 1.0 117.081 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.7 m -114.38 22.2 13.93 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.95 1.7 . . . . 1.0 113.417 -172.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -60.18 -17.96 44.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.886 1.674 . . . . 1.0 115.005 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.488 ' H ' ' CG2' ' A' ' 59' ' ' THR . . . -60.2 -41.01 98.04 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-N 120.833 1.652 . . . . 1.0 114.37 175.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -75.91 -34.58 47.45 Favored Glycine 0 N--CA 1.477 1.429 0 O-C-N 120.626 -1.514 . . . . 1.0 112.935 172.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -62.97 -33.88 76.33 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 121.23 -1.159 . . . . 1.0 112.418 173.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -59.97 -41.72 92.58 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.601 1.16 . . . . 1.0 111.539 170.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -64.9 -37.74 88.64 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.729 0.695 . . . . 1.0 111.546 174.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -62.56 -49.43 75.29 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.181 -0.949 . . . . 1.0 110.994 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.19 -33.81 63.35 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.953 0.901 . . . . 1.0 113.111 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.717 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -61.2 -49.75 75.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 122.933 1.349 . . . . 1.0 110.613 178.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.645 HD12 ' CD1' ' A' ' 87' ' ' TYR . 10.3 mt -65.86 -37.49 86.3 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 120.945 -1.097 . . . . 1.0 112.083 178.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -68.95 -21.16 64.21 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.922 1.082 . . . . 1.0 113.922 174.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.89 -17.82 58.7 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.532 1.06 . . . . 1.0 111.188 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -97.66 -74.21 0.58 Allowed 'General case' 0 C--N 1.343 0.299 0 C-N-CA 125.129 1.372 . . . . 1.0 110.999 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.9 m 176.6 -2.69 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 127.384 2.274 . . . . 1.0 112.141 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -78.84 161.06 27.03 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 122.264 1.03 . . . . 1.0 113.507 -169.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -104.25 170.42 7.92 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.19 -1.368 . . . . 1.0 112.224 -169.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.75 145.35 50.94 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.924 1.29 . . . . 1.0 111.894 176.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 50.9 t -101.73 132.04 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 127.591 2.356 . . . . 1.0 108.639 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 46.97 -142.3 5.97 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.401 1.0 . . . . 1.0 113.889 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -100.65 -162.31 0.93 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.405 1.482 . . . . 1.0 110.29 169.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.72 157.12 22.62 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.215 1.806 . . . . 1.0 111.042 168.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 1.054 HD12 HG23 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -94.52 142.11 27.81 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 125.409 1.484 . . . . 1.0 109.484 169.13 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.5 mt -125.82 113.97 17.96 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.858 1.663 . . . . 1.0 110.379 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.557 ' CD1' HD11 ' A' ' 123' ' ' LEU . 40.5 mt -106.44 132.45 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 124.696 1.198 . . . . 1.0 113.101 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -107.57 96.9 6.72 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 128.145 2.578 . . . . 1.0 112.991 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.77 -22.8 66.85 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.913 1.079 . . . . 1.0 113.913 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.3 t -60.07 -25.25 65.23 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.434 1.094 . . . . 1.0 112.71 172.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -122.53 -29.06 4.14 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.373 1.869 . . . . 1.0 112.276 -170.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -138.5 89.36 13.77 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.794 1.238 . . . . 1.0 111.687 175.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -76.78 11.02 2.07 Favored 'Trans proline' 0 CA--C 1.549 1.246 0 C-N-CA 123.943 3.096 . . . . 1.0 114.255 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -114.54 66.68 1.72 Allowed Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 127.326 2.25 . . . . 1.0 110.112 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -57.73 -18.62 34.48 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.927 2.418 . . . . 1.0 117.738 -169.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -68.2 -25.6 65.3 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.446 1.476 . . . . 1.0 111.386 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 28.6 p -70.41 -23.46 62.75 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.756 1.162 . . . . 1.0 112.24 -173.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.425 ' HB2' HD11 ' A' ' 125' ' ' ILE . 28.6 mm-40 -93.66 -56.56 2.86 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.802 1.641 . . . . 1.0 112.081 173.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 79.0 p -68.58 -30.28 69.0 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 114.325 1.231 . . . . 1.0 114.325 -174.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -60.98 -59.28 14.34 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 120.773 1.624 . . . . 1.0 112.395 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -62.91 -24.43 74.19 Favored 'Trans proline' 0 C--N 1.352 0.743 0 CA-C-N 121.124 1.437 . . . . 1.0 113.002 173.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 73.8 t90 -70.39 -45.12 66.61 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 119.005 0.821 . . . . 1.0 111.704 175.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.614 HG11 ' HA ' ' A' ' 22' ' ' ALA . 69.1 t -66.5 -32.95 60.36 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 C-N-CA 123.167 0.587 . . . . 1.0 110.094 175.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -63.5 -48.11 78.93 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.162 -0.961 . . . . 1.0 109.822 173.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -64.16 -55.99 17.91 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.871 1.268 . . . . 1.0 111.651 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.484 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 89.0 t90 -57.17 -35.79 69.98 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 125.222 1.409 . . . . 1.0 111.785 172.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -49.75 -34.65 22.02 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.864 1.697 . . . . 1.0 113.938 171.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.6 p -67.86 -13.62 62.29 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.85 1.426 . . . . 1.0 114.85 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.18 -18.24 50.18 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.395 1.478 . . . . 1.0 111.886 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -86.32 167.87 14.39 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.193 0.997 . . . . 1.0 111.952 -175.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 11.2 m . . . . . 0 C--O 1.251 1.178 0 N-CA-C 115.725 1.75 . . . . 1.0 115.725 -169.861 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 109.776 -0.453 . . . . 1.0 109.776 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.63 142.97 50.98 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 115.321 1.6 . . . . 1.0 115.321 -169.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -125.49 122.35 36.36 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.645 1.578 . . . . 1.0 110.706 172.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 mp -121.89 113.41 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 C-N-CA 126.26 1.824 . . . . 1.0 112.416 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.12 123.75 7.27 Favored Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.169 -1.173 . . . . 1.0 110.169 169.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.9 mt -104.54 123.51 58.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 123.946 0.898 . . . . 1.0 109.355 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -115.6 111.03 20.06 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 124.766 1.227 . . . . 1.0 107.921 -170.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.3 p -96.45 128.11 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 112.412 0.523 . . . . 1.0 112.412 -175.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -119.28 120.41 4.62 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.781 1.181 . . . . 1.0 111.22 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.5 t -165.6 145.86 6.77 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 119.728 1.764 . . . . 1.0 113.73 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.1 tpt -98.3 -17.43 18.91 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.603 1.161 . . . . 1.0 110.243 168.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -80.43 -26.86 38.16 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.564 1.546 . . . . 1.0 112.376 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.14 -43.53 2.49 Favored Glycine 0 N--CA 1.474 1.196 0 C-N-CA 125.642 1.592 . . . . 1.0 114.42 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -60.02 -23.42 63.67 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.795 1.238 . . . . 1.0 113.021 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.42 -18.01 35.62 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.058 1.343 . . . . 1.0 113.888 177.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.9 tp -47.92 -39.47 19.15 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.017 1.327 . . . . 1.0 111.814 169.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.3 tp -47.48 -54.13 12.36 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.611 1.164 . . . . 1.0 112.494 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.1 t -58.35 -37.26 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 119.127 -0.464 . . . . 1.0 111.132 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.56 -45.87 88.52 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.768 1.167 . . . . 1.0 112.859 173.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -63.49 -33.4 75.49 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.454 0.645 . . . . 1.0 110.966 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -69.93 -46.93 64.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.762 0.825 . . . . 1.0 109.818 176.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.856 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -55.42 -45.43 76.73 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.959 1.304 . . . . 1.0 113.017 176.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.33 -49.26 78.52 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.855 0.462 . . . . 1.0 110.181 173.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.6 -37.47 73.88 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.449 -0.782 . . . . 1.0 112.867 -173.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.575 ' CG2' HG12 ' A' ' 141' ' ' VAL . 16.5 mt -69.42 -48.17 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 124.501 1.12 . . . . 1.0 109.447 175.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.478 HD23 ' CG1' ' A' ' 141' ' ' VAL . 0.5 OUTLIER -62.17 -34.86 77.21 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 122.485 1.136 . . . . 1.0 109.185 -178.163 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.3 m -62.28 -44.9 95.47 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.602 1.161 . . . . 1.0 112.704 172.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.78 -29.82 69.12 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.676 1.19 . . . . 1.0 113.439 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -65.23 -33.94 77.17 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.516 1.526 . . . . 1.0 110.981 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.52 13.3 1.13 Allowed Glycine 0 CA--C 1.535 1.293 0 N-CA-C 115.864 1.105 . . . . 1.0 115.864 169.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 -108.02 177.02 4.93 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.985 1.314 . . . . 1.0 111.725 -169.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -101.5 99.71 10.06 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.053 1.341 . . . . 1.0 108.564 169.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.26 148.85 36.78 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.58 0.752 . . . . 1.0 111.217 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.4 m -149.0 146.12 27.64 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.146 0.978 . . . . 1.0 111.459 -174.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.9 t -95.93 137.08 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 114.168 1.173 . . . . 1.0 114.168 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -115.34 122.4 45.76 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.135 1.774 . . . . 1.0 110.995 169.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -103.21 137.0 41.95 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.597 1.959 . . . . 1.0 111.272 -177.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.6 t0 41.48 53.15 6.95 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 124.339 1.056 . . . . 1.0 111.237 -169.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -68.28 142.43 55.13 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.861 3.041 . . . . 1.0 116.85 -168.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.451 ' HB3' ' H ' ' A' ' 42' ' ' SER . 49.9 mm-40 -92.41 163.43 13.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 122.666 1.222 . . . . 1.0 111.309 168.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.62 HD21 HD21 ' A' ' 79' ' ' LEU . 2.1 tm? -66.0 -20.84 66.32 Favored 'General case' 0 N--CA 1.442 -0.856 0 O-C-N 120.688 -1.257 . . . . 1.0 110.388 167.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.451 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 16.1 m -68.49 -20.54 64.6 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 120.793 -1.192 . . . . 1.0 112.126 172.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -82.58 -24.47 33.94 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.292 1.037 . . . . 1.0 112.446 170.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.515 ' HB3' HD22 ' A' ' 41' ' ' LEU . 12.3 t-105 -88.68 -35.05 16.99 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.453 1.279 . . . . 1.0 114.453 -178.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.7 mt -47.73 -37.37 12.71 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-O 117.466 -1.254 . . . . 1.0 114.129 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -58.79 -11.02 10.77 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.697 2.932 . . . . 1.0 117.27 175.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -114.81 9.31 16.25 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 116.303 1.964 . . . . 1.0 116.303 -174.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -51.24 -27.15 8.37 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 127.259 2.224 . . . . 1.0 114.048 175.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -117.28 13.02 14.51 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.299 1.84 . . . . 1.0 113.323 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -126.85 -155.41 0.69 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.889 2.476 . . . . 1.0 110.978 -175.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -115.96 162.64 17.07 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 122.906 1.336 . . . . 1.0 112.073 175.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.564 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -152.24 157.36 5.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 124.798 1.239 . . . . 1.0 109.053 -171.098 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.626 HD11 HD12 ' A' ' 90' ' ' ILE . 15.4 tp -139.98 127.82 21.98 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.559 1.143 . . . . 1.0 109.388 176.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.1 t -103.41 120.43 53.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 124.271 1.028 . . . . 1.0 109.001 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.0 t -118.4 112.21 37.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 105.602 -1.999 . . . . 1.0 105.602 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.3 t -147.09 121.13 9.4 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.237 1.569 . . . . 1.0 115.237 -168.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.8 m -96.65 -174.5 3.04 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.872 2.069 . . . . 1.0 110.951 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.2 m 63.79 41.24 7.01 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.511 0.93 . . . . 1.0 113.511 169.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.6 m -57.9 -39.13 77.17 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.643 0.777 . . . . 1.0 111.356 169.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.85 -128.98 44.41 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 121.516 -0.74 . . . . 1.0 111.993 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -68.34 -10.61 56.12 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.24 1.2 . . . . 1.0 114.24 175.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.06 7.55 0.19 Allowed Glycine 0 CA--C 1.539 1.58 0 N-CA-C 117.771 1.868 . . . . 1.0 117.771 170.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -116.63 -141.5 0.37 Allowed 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 119.653 1.726 . . . . 1.0 112.418 -169.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 85.9 mt -135.22 154.48 78.84 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.855 1.662 . . . . 1.0 113.59 -172.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.11 152.91 46.13 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.395 2.73 . . . . 1.0 111.763 169.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -63.64 -17.17 62.64 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.457 1.28 . . . . 1.0 114.457 -176.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.2 p -73.16 -17.38 61.38 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.955 1.302 . . . . 1.0 114.371 173.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.5 tt -123.12 -13.47 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 114.692 1.368 . . . . 1.0 114.692 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -42.76 -52.62 10.84 Favored Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 124.532 1.133 . . . . 1.0 112.588 168.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -67.8 -32.04 30.55 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.87 1.713 . . . . 1.0 111.985 -173.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.7 tp -63.64 -53.19 55.38 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 124.283 1.033 . . . . 1.0 111.225 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.695 ' CE1' HD23 ' A' ' 110' ' ' LEU . 93.0 t80 -55.05 -52.99 61.46 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.726 0.81 . . . . 1.0 112.572 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -64.32 -40.52 96.08 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.813 0.845 . . . . 1.0 111.433 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.61 -35.29 89.69 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 119.662 -0.521 . . . . 1.0 112.557 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.602 HG22 HD12 ' A' ' 110' ' ' LEU . 89.1 mt -65.69 -47.46 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 120.145 1.972 . . . . 1.0 108.382 172.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.717 ' HB3' HD21 ' A' ' 110' ' ' LEU . 3.2 ptmm? -71.43 -32.22 68.11 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 120.309 -1.494 . . . . 1.0 113.508 -171.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -105.92 -36.82 6.87 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 115.028 1.492 . . . . 1.0 115.028 -173.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 m -94.73 -24.85 16.94 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.261 1.025 . . . . 1.0 112.663 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.62 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -90.23 -72.53 0.56 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.15 -1.426 . . . . 1.0 107.15 169.422 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.0 -9.35 2.06 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 126.316 1.912 . . . . 1.0 115.265 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -152.35 145.87 24.91 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.929 2.892 . . . . 1.0 107.499 171.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -136.82 128.5 16.84 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-O 118.438 -0.792 . . . . 1.0 110.435 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -83.68 -42.86 0.08 OUTLIER 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.148 1.899 . . . . 1.0 114.445 -171.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -147.32 20.7 1.21 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.045 1.338 . . . . 1.0 113.74 -170.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.564 HD11 ' CG2' ' A' ' 52' ' ' VAL . 51.0 tp -78.46 141.34 38.34 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.451 -1.405 . . . . 1.0 113.459 -169.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.87 149.73 49.12 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 128.766 2.826 . . . . 1.0 108.196 169.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.653 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -159.9 168.16 26.4 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.382 0.882 . . . . 1.0 113.382 -178.151 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.471 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -124.39 168.95 16.43 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 125.361 1.457 . . . . 1.0 114.026 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.0 t -143.75 133.39 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.536 1.134 . . . . 1.0 113.338 -169.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.972 HG23 HD12 ' A' ' 123' ' ' LEU . 3.7 mt -129.43 100.15 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 126.036 1.735 . . . . 1.0 107.346 169.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.48 145.62 25.18 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.686 1.194 . . . . 1.0 112.045 174.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.6 mp -138.04 150.83 47.29 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.804 0.841 . . . . 1.0 112.774 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.64 -152.39 21.69 Favored Glycine 0 C--O 1.223 -0.571 0 C-N-CA 121.081 -0.58 . . . . 1.0 113.744 169.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -112.96 114.16 26.53 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.92 0.888 . . . . 1.0 110.302 -176.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.6 t -64.7 -3.75 3.56 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.164 1.172 . . . . 1.0 114.164 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.7 t -63.91 -26.07 68.43 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.762 -1.211 . . . . 1.0 112.056 169.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -79.26 147.98 32.34 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.357 -0.839 . . . . 1.0 111.909 169.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -53.41 -55.0 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.614 1.566 . . . . 1.0 113.828 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -87.35 56.91 4.17 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.023 1.729 . . . . 1.0 112.23 -173.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -52.23 127.78 23.02 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.125 0.97 . . . . 1.0 113.335 -175.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 21.7 m 56.07 17.46 2.68 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.237 1.815 . . . . 1.0 115.54 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -63.97 -18.24 64.08 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.17 1.174 . . . . 1.0 114.17 -175.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.34 -49.28 69.62 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-N 119.872 1.214 . . . . 1.0 113.368 171.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -75.47 -34.25 50.66 Favored Glycine 0 N--CA 1.478 1.443 0 O-C-N 120.705 -1.468 . . . . 1.0 113.23 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -61.35 -34.47 75.34 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.263 -1.139 . . . . 1.0 112.731 173.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -63.3 -39.77 95.51 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.865 0.866 . . . . 1.0 112.316 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.1 -40.0 96.35 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.036 0.835 . . . . 1.0 110.697 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -41.07 98.03 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.427 -0.796 . . . . 1.0 112.583 176.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.63 -46.19 89.74 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 118.744 -0.646 . . . . 1.0 111.997 170.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.717 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -49.56 -49.31 46.86 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.259 2.224 . . . . 1.0 111.932 -172.517 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.653 HD12 ' CD1' ' A' ' 87' ' ' TYR . 8.1 mt -66.0 -43.03 88.93 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.214 -0.903 . . . . 1.0 111.439 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -66.96 -22.03 65.95 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -66.08 -35.87 81.67 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.422 1.089 . . . . 1.0 111.46 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -82.65 -75.87 0.29 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 113.785 -1.552 . . . . 1.0 110.432 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.43 ' H ' ' H ' ' A' ' 116' ' ' ALA . 2.7 t 179.0 -3.22 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.11 2.164 . . . . 1.0 111.574 173.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -75.24 150.44 38.59 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 122.775 1.274 . . . . 1.0 112.83 -169.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -90.61 172.48 8.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.271 -1.786 . . . . 1.0 113.036 -168.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.36 139.03 46.58 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.322 1.849 . . . . 1.0 109.914 -175.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.589 HG12 ' H ' ' A' ' 120' ' ' GLY 0.258 20.2 t -90.86 -163.3 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 107.786 -1.19 . . . . 1.0 107.786 178.035 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.589 ' H ' HG12 ' A' ' 119' ' ' VAL . . . -48.6 149.73 3.89 Favored Glycine 0 CA--C 1.544 1.867 0 O-C-N 120.067 -1.646 . . . . 1.0 113.936 177.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -59.73 146.49 41.27 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.21 1.404 . . . . 1.0 112.701 -171.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -67.62 158.78 31.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.767 1.627 . . . . 1.0 114.759 -168.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.972 HD12 HG23 ' A' ' 90' ' ' ILE . 1.0 OUTLIER -90.44 138.91 31.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.272 -1.331 . . . . 1.0 109.133 169.083 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.1 mt -126.61 110.05 12.78 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.359 1.464 . . . . 1.0 109.828 173.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.573 HG13 HD11 ' A' ' 123' ' ' LEU . 27.3 mt -97.59 129.07 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 124.06 0.944 . . . . 1.0 112.394 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -103.76 110.35 22.41 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.113 0.959 . . . . 1.0 111.709 173.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.39 -22.08 64.66 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.298 1.039 . . . . 1.0 113.241 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.6 t -64.55 -22.41 66.96 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.679 0.792 . . . . 1.0 112.895 173.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -119.93 -30.17 4.78 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.267 1.827 . . . . 1.0 112.0 -173.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.26 82.78 12.81 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.904 1.282 . . . . 1.0 112.515 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -75.42 6.56 3.5 Favored 'Trans proline' 0 CA--C 1.549 1.235 0 C-N-CA 123.791 2.994 . . . . 1.0 114.737 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -109.7 72.23 0.58 Allowed Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 127.2 2.2 . . . . 1.0 110.074 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -59.09 -26.92 83.51 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.481 2.12 . . . . 1.0 117.073 -169.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -65.91 -24.67 66.88 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.924 1.238 . . . . 1.0 110.983 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 31.9 p -71.42 -18.1 62.35 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.937 -1.102 . . . . 1.0 112.311 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.427 ' HB2' HD11 ' A' ' 125' ' ' ILE . 4.8 mm-40 -102.22 -55.17 2.53 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.296 1.838 . . . . 1.0 111.442 177.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.4 p -68.64 -35.04 76.75 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 114.18 1.178 . . . . 1.0 114.18 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -60.36 -55.4 45.59 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 120.992 1.724 . . . . 1.0 112.392 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -63.41 -26.88 70.8 Favored 'Trans proline' 0 C--N 1.351 0.68 0 CA-C-N 121.881 1.708 . . . . 1.0 112.665 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.477 ' CG ' ' HB2' ' A' ' 123' ' ' LEU . 88.8 t90 -63.57 -45.64 89.53 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 118.807 0.731 . . . . 1.0 111.192 172.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.856 HG11 ' HA ' ' A' ' 22' ' ' ALA . 53.1 t -66.75 -34.09 67.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.437 1.095 . . . . 1.0 109.537 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -70.63 -21.22 62.65 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.469 1.508 . . . . 1.0 113.189 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -87.64 -58.07 2.71 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.435 1.894 . . . . 1.0 109.878 168.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.471 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 89.8 t90 -58.58 -39.62 80.85 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.001 1.72 . . . . 1.0 113.861 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -53.5 -27.15 33.02 Favored Glycine 0 CA--C 1.537 1.439 0 O-C-N 121.11 -0.994 . . . . 1.0 113.936 173.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.4 p -68.94 -15.0 63.37 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.729 1.764 . . . . 1.0 114.045 175.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.77 -15.98 56.44 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.431 1.492 . . . . 1.0 111.669 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -76.59 169.34 18.45 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.97 0.908 . . . . 1.0 111.214 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.255 1.343 0 N-CA-C 114.866 1.432 . . . . 1.0 114.866 -173.368 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttm . . . . . 0 N--CA 1.499 1.976 0 CA-C-O 119.816 -0.135 . . . . 1.0 110.966 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.56 152.66 40.54 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.084 0.772 . . . . 1.0 113.084 175.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -121.73 121.81 38.12 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.56 1.144 . . . . 1.0 110.709 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.512 HD13 HD12 ' A' ' 26' ' ' LEU . 2.2 mp -117.31 114.34 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 C-N-CA 126.138 1.775 . . . . 1.0 112.597 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.54 121.86 6.4 Favored Glycine 0 C--O 1.224 -0.522 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 169.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 mt -105.51 125.25 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 118.666 1.233 . . . . 1.0 109.411 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -118.31 111.78 19.2 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.763 -0.829 . . . . 1.0 108.763 -169.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p -95.07 127.79 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 112.165 0.431 . . . . 1.0 112.165 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -120.12 94.15 0.56 Allowed Glycine 0 N--CA 1.463 0.449 0 C-N-CA 124.666 1.127 . . . . 1.0 112.298 177.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -158.21 160.35 37.07 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.35 0.66 . . . . 1.0 111.681 172.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 93.5 mtp -126.97 18.56 7.18 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.797 2.039 . . . . 1.0 110.206 169.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -137.8 166.33 24.27 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.457 1.903 . . . . 1.0 111.953 -169.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.36 -163.52 52.88 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.011 0.815 . . . . 1.0 114.48 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -111.57 143.1 42.98 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.783 1.233 . . . . 1.0 112.727 -173.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 86.7 p 47.84 15.27 0.06 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 118.801 2.889 . . . . 1.0 118.801 169.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.2 mt 53.99 25.21 5.24 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.693 1.197 . . . . 1.0 112.569 -171.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.5 tp -25.65 -70.64 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 129.852 3.261 . . . . 1.0 118.336 -168.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 81.2 t -56.46 -36.36 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 118.697 0.68 . . . . 1.0 112.071 -169.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.76 -38.61 86.95 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.682 -1.261 . . . . 1.0 112.732 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.415 ' HA ' HG11 ' A' ' 35' ' ' VAL . 20.4 mm-40 -66.65 -35.72 80.85 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.015 0.436 . . . . 1.0 110.869 174.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -66.29 -44.81 82.46 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 123.806 0.843 . . . . 1.0 109.1 176.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.535 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -63.88 -41.49 97.72 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 123.343 0.657 . . . . 1.0 112.671 -176.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -56.06 -48.85 75.26 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 170.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.19 -38.23 75.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.684 0.794 . . . . 1.0 112.828 -173.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.7 mt -66.61 -47.6 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-N 119.177 0.899 . . . . 1.0 108.945 175.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.512 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -66.17 -33.9 76.81 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 119.459 -0.897 . . . . 1.0 111.021 -176.652 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.9 m -63.2 -41.9 99.23 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.325 1.45 . . . . 1.0 113.207 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.52 -32.1 71.81 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.105 0.962 . . . . 1.0 112.433 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -69.56 -29.16 66.67 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.432 1.093 . . . . 1.0 113.051 170.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.17 29.33 2.58 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.526 1.06 . . . . 1.0 113.668 170.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -112.32 155.59 23.84 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.441 1.096 . . . . 1.0 109.267 175.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -86.95 78.46 9.0 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.688 1.195 . . . . 1.0 108.369 -177.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.5 142.84 26.97 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.374 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 96.4 m -143.32 127.48 17.56 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 124.484 1.113 . . . . 1.0 109.333 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.415 HG11 ' HA ' ' A' ' 20' ' ' GLU . 3.6 p -92.28 140.67 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 114.378 1.251 . . . . 1.0 114.378 170.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -114.44 127.64 55.93 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.808 2.043 . . . . 1.0 111.144 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -100.86 132.54 46.21 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.637 1.975 . . . . 1.0 110.481 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.6 t0 43.76 55.59 12.2 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 124.1 0.96 . . . . 1.0 111.653 -169.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -68.81 144.24 58.49 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.067 3.178 . . . . 1.0 117.061 -168.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.425 ' HB3' ' H ' ' A' ' 42' ' ' SER . 54.9 mm-40 -95.22 163.89 13.08 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 122.465 1.126 . . . . 1.0 111.979 168.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.55 HD21 HD21 ' A' ' 79' ' ' LEU . 2.2 tm? -66.55 -21.23 66.15 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 120.959 -1.088 . . . . 1.0 110.16 167.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.425 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 18.8 m -68.1 -21.51 64.95 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.864 -1.148 . . . . 1.0 112.242 172.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -82.02 -24.37 35.41 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.355 1.062 . . . . 1.0 112.449 170.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.451 ' HB3' HD22 ' A' ' 41' ' ' LEU . 11.5 t-105 -88.55 -34.23 17.44 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.115 1.154 . . . . 1.0 114.115 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.1 mt -48.41 -38.41 22.3 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-O 117.538 -1.22 . . . . 1.0 114.209 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -57.81 -18.64 35.22 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.669 2.912 . . . . 1.0 116.435 174.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -105.03 7.4 33.98 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.774 1.768 . . . . 1.0 115.774 -171.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -53.37 -31.12 43.19 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.507 1.923 . . . . 1.0 113.857 176.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -112.42 8.48 19.48 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.081 1.352 . . . . 1.0 112.664 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -113.72 -162.86 0.83 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.815 2.446 . . . . 1.0 110.727 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -109.1 161.63 15.01 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.849 1.309 . . . . 1.0 111.443 169.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.556 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -146.89 157.35 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.537 1.135 . . . . 1.0 109.268 -171.491 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.1 tp -138.99 128.99 25.13 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.891 1.276 . . . . 1.0 108.553 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.4 t -103.36 128.59 56.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.933 -0.765 . . . . 1.0 108.933 175.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.45 112.15 30.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 105.925 -1.88 . . . . 1.0 105.925 176.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -149.23 135.34 19.05 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.181 1.548 . . . . 1.0 115.181 -167.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.5 m -116.07 158.81 22.59 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.726 1.61 . . . . 1.0 112.998 -169.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.7 m 64.1 66.63 0.63 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.304 1.441 . . . . 1.0 112.479 169.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.4 m -55.87 -28.33 56.06 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.787 2.035 . . . . 1.0 113.875 170.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.06 -128.96 38.76 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 121.379 -0.825 . . . . 1.0 113.666 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -83.09 16.57 2.31 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.133 1.373 . . . . 1.0 112.887 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.28 41.04 4.08 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.04 1.305 . . . . 1.0 112.165 -169.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -131.89 167.41 19.66 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.952 2.101 . . . . 1.0 112.43 -173.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.9 mt -116.69 150.85 46.4 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.47 1.108 . . . . 1.0 113.537 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -59.24 145.82 96.57 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.604 2.87 . . . . 1.0 113.202 171.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -61.94 -22.06 65.3 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.874 1.064 . . . . 1.0 113.874 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.6 p -72.39 -22.51 61.12 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.405 1.261 . . . . 1.0 114.405 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 tt -115.77 -15.46 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.109 1.363 . . . . 1.0 114.141 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -43.27 -53.25 11.43 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 124.383 1.073 . . . . 1.0 112.034 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -67.81 -31.1 32.6 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 121.677 1.585 . . . . 1.0 111.873 -173.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.8 tp -65.35 -53.18 47.32 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 124.475 1.11 . . . . 1.0 111.417 170.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.626 ' CE1' HD23 ' A' ' 110' ' ' LEU . 93.3 t80 -55.51 -53.23 58.9 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.778 0.831 . . . . 1.0 112.385 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -69.08 -35.17 76.2 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.63 -0.714 . . . . 1.0 111.813 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.68 -35.79 91.51 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 121.819 -0.551 . . . . 1.0 112.502 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.602 HG22 HD12 ' A' ' 110' ' ' LEU . 87.4 mt -65.12 -49.77 77.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.899 1.849 . . . . 1.0 108.296 171.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.677 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.2 ptmm? -69.72 -31.43 69.43 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.505 -1.372 . . . . 1.0 112.947 -169.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -105.28 -39.91 6.02 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 115.334 1.605 . . . . 1.0 115.334 -175.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.8 m -93.88 -23.04 18.26 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.239 1.016 . . . . 1.0 112.962 -174.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.55 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -91.1 -70.33 0.69 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 106.81 -1.552 . . . . 1.0 106.81 169.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.03 -11.44 1.35 Allowed Glycine 0 CA--C 1.538 1.481 0 C-N-CA 127.438 2.446 . . . . 1.0 116.514 169.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -155.77 141.08 17.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.825 2.45 . . . . 1.0 108.513 172.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.476 HE22 HD12 ' A' ' 79' ' ' LEU . 2.2 mm-40 -137.43 125.84 14.62 Favored Pre-proline 0 CA--C 1.546 0.815 0 O-C-N 121.281 -0.887 . . . . 1.0 111.097 -173.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.81 -40.52 0.09 OUTLIER 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.849 2.366 . . . . 1.0 114.87 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -140.31 13.85 2.39 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.866 1.432 . . . . 1.0 114.866 -169.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.556 HD11 ' CG2' ' A' ' 52' ' ' VAL . 40.9 tp -74.86 141.26 44.24 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.582 -1.323 . . . . 1.0 113.491 -169.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -132.83 147.39 52.3 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.195 2.598 . . . . 1.0 107.719 169.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.635 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -156.95 165.53 35.92 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.219 0.918 . . . . 1.0 113.349 178.623 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.407 ' HA3' ' CE2' ' A' ' 144' ' ' TRP . . . -127.0 173.33 18.41 Favored Glycine 0 N--CA 1.471 0.978 0 C-N-CA 125.35 1.452 . . . . 1.0 112.338 170.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.492 HG13 ' HB3' ' A' ' 122' ' ' MET . 0.2 OUTLIER -158.81 146.22 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 114.536 1.31 . . . . 1.0 114.536 -169.492 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.0 mt -133.5 109.41 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 127.478 2.311 . . . . 1.0 107.736 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -94.68 142.0 27.96 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.023 1.729 . . . . 1.0 111.466 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.6 mp -137.26 154.39 50.14 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.375 0.88 . . . . 1.0 113.375 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.91 -179.04 39.1 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 114.274 0.47 . . . . 1.0 114.274 168.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -93.95 114.07 26.2 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.655 -0.909 . . . . 1.0 109.479 171.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 92.8 p -59.22 -15.02 12.81 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.32 1.23 . . . . 1.0 114.32 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.4 t -64.83 -19.27 65.77 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.723 0.809 . . . . 1.0 112.968 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -89.76 7.67 35.69 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.142 1.377 . . . . 1.0 114.497 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.333 1.0 OUTLIER 56.22 176.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 129.771 3.228 . . . . 1.0 114.831 -177.305 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 60.86 8.59 1.9 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.939 1.696 . . . . 1.0 115.389 -170.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.4 t80 22.68 -78.97 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 130.524 3.53 . . . . 1.0 117.05 -169.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.445 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 20.8 p -122.82 7.26 9.35 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.768 1.627 . . . . 1.0 114.329 -169.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -61.01 -21.22 63.38 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.831 1.252 . . . . 1.0 114.299 -170.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.93 -37.85 95.6 Favored Glycine 0 CA--C 1.535 1.326 0 CA-C-N 119.881 1.219 . . . . 1.0 113.109 171.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.79 -38.22 24.23 Favored Glycine 0 N--CA 1.476 1.318 0 O-C-N 121.407 -1.055 . . . . 1.0 113.046 172.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.445 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 89.2 mttt -62.12 -29.31 70.24 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 120.978 -1.307 . . . . 1.0 113.388 173.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -64.03 -28.98 70.17 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.059 0.763 . . . . 1.0 113.059 171.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -66.36 -35.57 80.67 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.643 1.11 . . . . 1.0 111.304 171.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -63.53 -48.96 75.39 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.239 -0.913 . . . . 1.0 110.968 172.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.25 -34.61 66.55 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.804 0.668 . . . . 1.0 112.804 175.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.677 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -59.93 -49.94 75.7 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 123.321 1.534 . . . . 1.0 110.83 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.635 HD12 ' CD1' ' A' ' 87' ' ' TYR . 9.9 mt -66.08 -37.83 86.78 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 120.908 -1.12 . . . . 1.0 111.717 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -69.02 -21.16 64.14 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.992 1.108 . . . . 1.0 113.992 174.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.91 -18.13 58.49 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.277 0.944 . . . . 1.0 111.238 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -96.83 -76.7 0.51 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.287 1.435 . . . . 1.0 110.574 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.3 m 178.32 -2.57 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 127.318 2.247 . . . . 1.0 112.154 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.527 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -77.13 159.55 29.68 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.043 0.925 . . . . 1.0 112.877 -169.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -100.97 174.19 6.13 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.246 -1.343 . . . . 1.0 111.559 -169.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.4 ttm105 -127.36 156.38 42.09 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.865 1.266 . . . . 1.0 112.731 171.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 120' ' ' GLY . 17.3 t -95.43 -168.81 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 C-N-CA 127.333 2.253 . . . . 1.0 105.93 169.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.541 ' H ' HG12 ' A' ' 119' ' ' VAL . . . -49.05 154.96 1.87 Allowed Glycine 0 CA--C 1.542 1.762 0 O-C-N 120.402 -1.436 . . . . 1.0 115.586 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -59.17 149.59 27.81 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.085 1.354 . . . . 1.0 113.15 -171.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.492 ' HB3' HG13 ' A' ' 89' ' ' VAL . 1.1 pmm? -73.78 157.8 35.75 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 122.462 1.125 . . . . 1.0 112.38 -169.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.65 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.2 tm? -86.7 140.51 29.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.824 -1.08 . . . . 1.0 109.39 171.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.65 ' N ' HD13 ' A' ' 123' ' ' LEU . 5.6 mt -123.65 104.39 8.99 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.818 1.247 . . . . 1.0 110.886 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.442 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.9 mt -90.26 128.21 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 125.109 1.363 . . . . 1.0 111.652 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -108.16 109.52 20.94 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 124.3 1.0 . . . . 1.0 112.174 171.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.76 -20.74 65.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.788 0.835 . . . . 1.0 112.948 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.2 t -63.6 -21.4 66.34 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.724 1.21 . . . . 1.0 112.675 173.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -124.67 -29.62 3.41 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.149 1.78 . . . . 1.0 112.584 -173.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -140.59 87.11 11.77 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.479 1.512 . . . . 1.0 112.068 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.2 6.85 2.8 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 123.675 2.917 . . . . 1.0 114.631 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -112.81 71.86 1.33 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 127.449 2.299 . . . . 1.0 109.699 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -57.87 -23.32 58.59 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.434 2.089 . . . . 1.0 116.827 -168.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -65.62 -25.69 67.49 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 119.128 0.876 . . . . 1.0 111.733 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 p -73.5 -16.99 61.27 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 120.902 -1.124 . . . . 1.0 111.706 -175.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -102.27 -53.87 2.81 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.163 1.785 . . . . 1.0 111.212 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 59.3 p -72.14 -33.9 68.13 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 114.706 1.372 . . . . 1.0 114.706 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -60.18 -55.55 44.2 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 120.923 1.692 . . . . 1.0 112.64 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -62.33 -22.64 74.39 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 121.329 1.51 . . . . 1.0 112.628 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.477 ' HB2' HD23 ' A' ' 123' ' ' LEU . 90.1 t90 -70.26 -45.55 66.19 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 121.67 -0.644 . . . . 1.0 111.264 174.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.535 HG11 ' HA ' ' A' ' 22' ' ' ALA . 91.5 t -64.69 -34.22 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.835 -0.802 . . . . 1.0 108.835 176.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.75 -29.77 68.24 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.132 1.373 . . . . 1.0 112.195 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -79.9 -61.38 2.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.104 1.762 . . . . 1.0 112.239 171.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.407 ' CE2' ' HA3' ' A' ' 88' ' ' GLY . 85.3 t90 -56.76 -36.43 69.78 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 126.724 2.01 . . . . 1.0 112.49 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.46 -32.28 22.86 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.684 1.135 . . . . 1.0 113.438 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 p -70.22 -13.12 62.04 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.332 1.234 . . . . 1.0 114.332 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.0 -14.72 55.57 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.151 1.78 . . . . 1.0 111.773 175.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.57 -178.27 5.77 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.223 1.009 . . . . 1.0 110.45 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 9.7 m . . . . . 0 C--O 1.254 1.324 0 C-N-CA 126.607 1.963 . . . . 1.0 114.251 -179.444 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttp . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 119.951 -0.071 . . . . 1.0 110.859 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.86 168.82 19.32 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.309 1.444 . . . . 1.0 113.058 -176.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -113.73 124.73 52.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.369 -1.287 . . . . 1.0 111.877 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.521 HD13 HD12 ' A' ' 26' ' ' LEU . 1.7 mp -120.92 112.82 37.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 126.424 1.889 . . . . 1.0 113.044 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.64 122.59 6.84 Favored Glycine 0 N--CA 1.467 0.742 0 N-CA-C 110.918 -0.873 . . . . 1.0 110.918 169.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.5 mt -104.17 119.63 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 118.464 1.132 . . . . 1.0 109.804 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -112.17 108.91 18.33 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.635 -1.246 . . . . 1.0 107.635 -171.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 p -96.64 118.66 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.288 0.566 . . . . 1.0 112.434 -169.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -92.03 109.31 3.73 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 109.287 -1.525 . . . . 1.0 109.287 171.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 t -148.86 165.1 32.51 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.757 1.021 . . . . 1.0 113.757 -169.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 76.3 mtm -75.42 173.99 10.2 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.181 0.992 . . . . 1.0 109.349 168.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -52.27 144.11 13.41 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 113.962 1.097 . . . . 1.0 113.962 -175.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.94 -165.66 52.81 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.269 0.938 . . . . 1.0 113.91 -175.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -81.93 56.11 2.99 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.155 0.982 . . . . 1.0 111.776 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 55.3 m -82.59 -0.71 48.2 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.847 1.425 . . . . 1.0 114.847 -172.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.63 63.3 1.55 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 122.361 1.077 . . . . 1.0 112.998 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.8 tp -26.3 -45.16 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 129.449 3.099 . . . . 1.0 116.121 170.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.4 t -47.87 -32.36 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.114 1.366 . . . . 1.0 112.727 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.15 -49.19 76.72 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.632 -1.293 . . . . 1.0 113.113 172.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -67.71 -30.33 69.8 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.674 1.19 . . . . 1.0 110.648 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.29 -46.62 69.82 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 123.397 0.679 . . . . 1.0 109.297 173.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.557 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.36 -42.12 93.13 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 123.225 0.61 . . . . 1.0 112.329 -176.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -54.27 -49.13 70.28 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.121 0.968 . . . . 1.0 110.312 169.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.57 -38.7 70.9 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.633 0.773 . . . . 1.0 112.453 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.4 mt -68.04 -45.81 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 O-C-N 121.117 -0.989 . . . . 1.0 109.357 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.521 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.76 -31.5 72.52 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.56 1.073 . . . . 1.0 110.708 -178.591 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.6 m -63.14 -45.05 93.78 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.241 1.016 . . . . 1.0 112.919 169.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.65 -30.89 69.69 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.777 1.231 . . . . 1.0 113.163 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -67.33 -27.64 67.31 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.485 1.914 . . . . 1.0 111.809 172.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.32 26.21 2.73 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.535 1.064 . . . . 1.0 114.737 171.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -117.54 173.19 6.86 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.999 1.319 . . . . 1.0 110.304 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -102.04 94.14 5.62 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 125.459 1.503 . . . . 1.0 108.429 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.34 147.44 31.51 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.283 0.633 . . . . 1.0 111.459 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.3 m -146.81 140.38 25.75 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.153 0.981 . . . . 1.0 112.428 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.1 t -87.2 137.71 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 115.071 1.508 . . . . 1.0 115.071 172.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -116.86 109.86 17.62 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.132 2.173 . . . . 1.0 109.993 169.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -88.04 145.93 25.73 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.081 1.752 . . . . 1.0 110.84 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.1 t0 43.33 57.77 12.21 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 124.517 1.127 . . . . 1.0 110.264 -169.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -55.23 128.06 28.89 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.775 3.65 . . . . 1.0 118.486 -167.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -91.75 150.34 21.15 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.368 1.467 . . . . 1.0 113.131 169.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.487 HD21 HD21 ' A' ' 79' ' ' LEU . 2.6 tm? -70.6 -25.9 63.26 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.342 -0.849 . . . . 1.0 110.175 168.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.1 m -66.53 -20.97 66.16 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.494 -0.753 . . . . 1.0 112.272 171.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -87.14 -24.07 24.63 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.252 1.021 . . . . 1.0 113.249 169.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.463 ' HB3' HD22 ' A' ' 41' ' ' LEU . 15.2 t-105 -79.4 -36.08 39.67 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.608 1.095 . . . . 1.0 113.529 175.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.9 mt -48.82 -40.53 43.41 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 117.845 -1.074 . . . . 1.0 113.879 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -53.8 -15.72 7.37 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.613 3.542 . . . . 1.0 117.826 172.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -110.46 8.0 22.94 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 116.139 1.903 . . . . 1.0 116.139 -172.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -53.11 -29.28 29.89 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.612 1.965 . . . . 1.0 114.115 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -114.28 11.68 17.46 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.151 1.781 . . . . 1.0 113.267 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -125.57 -159.54 0.91 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.611 2.365 . . . . 1.0 110.818 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -113.24 158.9 19.91 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 123.211 1.481 . . . . 1.0 113.073 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.584 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -147.37 156.61 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 125.302 1.441 . . . . 1.0 109.796 -170.42 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.676 HD11 HD12 ' A' ' 90' ' ' ILE . 19.4 tp -139.36 127.59 22.62 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.733 1.213 . . . . 1.0 109.044 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.9 t -102.42 123.03 55.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 123.762 0.825 . . . . 1.0 109.151 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.4 t -122.46 111.96 32.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 105.057 -2.201 . . . . 1.0 105.057 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -146.59 129.29 16.15 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.852 1.056 . . . . 1.0 113.852 -167.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 t -116.26 179.37 4.01 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.748 1.219 . . . . 1.0 113.125 -169.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.335 5.0 t 56.68 41.02 28.92 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.398 1.879 . . . . 1.0 113.488 169.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.9 m -49.79 -43.03 48.13 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.38 1.472 . . . . 1.0 112.306 169.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 52.52 -122.26 18.24 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 123.964 0.792 . . . . 1.0 112.844 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -62.92 -15.14 54.31 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.283 1.216 . . . . 1.0 114.283 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.46 -11.55 2.73 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 116.05 1.18 . . . . 1.0 116.05 169.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -87.45 -174.87 5.02 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.799 1.64 . . . . 1.0 113.152 -174.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 74.2 mt -105.32 152.17 39.8 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 126.724 2.009 . . . . 1.0 112.764 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.03 152.02 62.34 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.623 2.215 . . . . 1.0 111.726 169.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -64.31 -16.8 62.86 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.728 1.381 . . . . 1.0 114.728 -172.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.8 p -73.14 -23.43 60.46 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.643 1.177 . . . . 1.0 113.981 173.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.8 tt -118.95 -14.8 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 114.394 1.257 . . . . 1.0 114.394 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.9 t -45.13 -51.95 22.2 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 124.267 1.027 . . . . 1.0 111.717 168.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.42 -29.5 20.61 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.329 1.353 . . . . 1.0 111.664 -173.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.4 tp -64.75 -50.61 66.17 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.255 1.022 . . . . 1.0 110.909 169.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.648 ' CE1' HD23 ' A' ' 110' ' ' LEU . 88.2 t80 -55.2 -53.72 52.38 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.0 0.92 . . . . 1.0 112.473 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -69.06 -34.47 75.23 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.704 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.27 -34.69 88.79 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 123.876 0.75 . . . . 1.0 112.747 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.535 HG22 HD12 ' A' ' 110' ' ' LEU . 90.8 mt -65.23 -51.88 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 120.119 -1.812 . . . . 1.0 108.438 170.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.671 ' HB3' HD21 ' A' ' 110' ' ' LEU . 11.4 ptmt -67.78 -32.32 72.82 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.524 -1.36 . . . . 1.0 113.178 -170.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -104.07 -36.59 7.67 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.27 1.582 . . . . 1.0 115.27 -173.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.7 m -97.22 -19.63 18.46 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.196 0.999 . . . . 1.0 112.938 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.487 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -95.62 -70.92 0.69 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 107.534 -1.284 . . . . 1.0 107.534 169.726 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.63 -13.32 1.69 Allowed Glycine 0 CA--C 1.536 1.404 0 C-N-CA 127.257 2.36 . . . . 1.0 116.454 169.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -155.76 141.49 17.97 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 127.668 2.387 . . . . 1.0 108.603 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.465 HE22 HD12 ' A' ' 79' ' ' LEU . 10.4 mm-40 -135.33 124.35 16.09 Favored Pre-proline 0 CA--C 1.546 0.808 0 O-C-N 121.449 -0.782 . . . . 1.0 111.237 -171.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.4 -39.07 0.2 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.35 2.034 . . . . 1.0 114.415 -171.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -146.7 18.1 1.29 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.255 1.206 . . . . 1.0 114.255 -170.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.584 HD11 ' CG2' ' A' ' 52' ' ' VAL . 46.0 tp -77.83 141.78 38.95 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 120.424 -1.422 . . . . 1.0 113.373 -169.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -136.73 146.65 46.07 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 129.519 3.127 . . . . 1.0 108.36 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.674 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -159.4 168.53 26.08 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.053 0.842 . . . . 1.0 113.126 -177.144 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.461 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -127.64 170.52 19.19 Favored Glycine 0 N--CA 1.472 1.082 0 C-N-CA 124.678 1.133 . . . . 1.0 114.281 172.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 86.6 t -142.28 133.5 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.668 1.187 . . . . 1.0 113.34 -169.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.982 HG23 HD12 ' A' ' 123' ' ' LEU . 3.5 mt -128.12 98.57 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.151 1.78 . . . . 1.0 106.781 169.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.27 145.37 25.43 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.151 1.38 . . . . 1.0 111.09 173.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.8 mp -138.88 149.79 45.25 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.601 -0.687 . . . . 1.0 111.974 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 176.46 168.55 36.71 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 119.38 -1.39 . . . . 1.0 115.793 169.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -71.71 107.57 4.6 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.201 1.4 . . . . 1.0 110.905 172.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 78.1 p -71.13 -1.75 13.44 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.553 1.541 . . . . 1.0 113.99 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 57.1 p -62.06 -22.94 66.17 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.148 0.979 . . . . 1.0 112.442 169.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -92.94 148.75 21.75 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.212 1.405 . . . . 1.0 112.629 169.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -50.09 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 126.491 1.916 . . . . 1.0 114.708 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -85.86 17.3 3.5 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.686 1.736 . . . . 1.0 115.686 -170.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.8 t80 27.07 -83.92 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 129.089 2.955 . . . . 1.0 117.628 169.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.9 m -124.89 19.19 8.51 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.72 2.008 . . . . 1.0 113.03 -173.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -53.65 -23.98 12.89 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.57 1.948 . . . . 1.0 114.28 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -54.89 -50.12 59.64 Favored Glycine 0 CA--C 1.536 1.36 0 CA-C-N 120.039 1.29 . . . . 1.0 113.237 173.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -77.89 -34.21 39.13 Favored Glycine 0 N--CA 1.479 1.54 0 O-C-N 120.798 -1.413 . . . . 1.0 113.639 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -59.6 -34.74 73.14 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.431 -1.04 . . . . 1.0 112.904 173.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -62.98 -39.3 94.32 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.869 0.868 . . . . 1.0 112.232 172.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -62.87 -39.76 95.43 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.435 1.016 . . . . 1.0 110.689 173.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.29 -40.1 96.42 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.802 0.441 . . . . 1.0 111.664 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.08 83.06 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 118.496 -0.764 . . . . 1.0 111.786 169.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.671 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -48.21 -49.05 34.39 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.391 2.277 . . . . 1.0 111.864 -172.07 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.674 HD12 ' CD1' ' A' ' 87' ' ' TYR . 7.3 mt -65.91 -43.86 86.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.939 -1.028 . . . . 1.0 111.35 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -65.92 -24.74 66.89 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.883 1.068 . . . . 1.0 113.883 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -66.1 -32.82 74.5 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.522 1.129 . . . . 1.0 111.466 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -83.08 -73.3 0.41 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.369 -1.287 . . . . 1.0 109.1 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.5 p 176.02 -15.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 127.32 2.248 . . . . 1.0 113.8 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.503 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -68.08 148.88 50.35 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 122.888 1.328 . . . . 1.0 113.927 -169.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -90.16 171.76 9.29 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 113.131 -1.85 . . . . 1.0 112.899 -168.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.94 138.14 49.61 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.239 1.816 . . . . 1.0 110.195 -175.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 120' ' ' GLY . 18.2 t -88.57 -168.26 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 124.818 1.247 . . . . 1.0 107.832 174.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.588 ' H ' HG12 ' A' ' 119' ' ' VAL . . . -51.38 153.4 4.89 Favored Glycine 0 CA--C 1.544 1.86 0 O-C-N 119.779 -1.826 . . . . 1.0 115.604 -176.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.58 137.5 15.31 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.123 1.769 . . . . 1.0 114.596 -172.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -68.22 159.35 31.37 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.505 1.522 . . . . 1.0 113.088 -169.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.982 HD12 HG23 ' A' ' 90' ' ' ILE . 1.3 tm? -91.2 139.1 31.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.539 -1.21 . . . . 1.0 109.86 169.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.407 ' N ' HD13 ' A' ' 123' ' ' LEU . 6.6 mt -127.87 111.49 13.66 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.624 1.569 . . . . 1.0 109.52 174.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.582 HG13 HD11 ' A' ' 123' ' ' LEU . 25.7 mt -100.58 133.44 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.612 1.165 . . . . 1.0 113.499 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.05 97.0 10.42 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.478 1.511 . . . . 1.0 111.346 174.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.08 -25.2 65.22 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.145 -1.597 . . . . 1.0 112.72 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.4 m -63.66 -17.74 63.24 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.722 2.009 . . . . 1.0 113.75 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -125.14 -29.32 3.31 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.233 1.813 . . . . 1.0 112.129 -173.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -143.12 89.5 7.76 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.475 1.51 . . . . 1.0 110.754 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -77.41 12.41 1.86 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.03 3.154 . . . . 1.0 114.026 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -111.34 65.53 0.57 Allowed Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 127.428 2.291 . . . . 1.0 109.915 174.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -57.36 -22.67 50.97 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.366 2.044 . . . . 1.0 115.956 -169.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.8 pm0 -63.94 -24.31 67.68 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.332 0.969 . . . . 1.0 111.603 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.4 p -72.4 -17.55 61.8 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 120.765 -1.209 . . . . 1.0 112.111 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.414 ' HB2' HD11 ' A' ' 125' ' ' ILE . 5.7 mm-40 -104.64 -54.7 2.47 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.06 1.744 . . . . 1.0 111.895 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.0 p -69.7 -33.91 73.19 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.704 1.002 . . . . 1.0 113.704 -177.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -59.51 -57.09 29.55 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 120.765 1.62 . . . . 1.0 112.435 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -62.09 -23.94 76.07 Favored 'Trans proline' 0 C--N 1.352 0.735 0 CA-C-N 121.304 1.502 . . . . 1.0 112.776 174.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.473 ' CG ' ' HB2' ' A' ' 123' ' ' LEU . 87.5 t90 -67.35 -46.69 72.66 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 119.094 0.861 . . . . 1.0 110.725 174.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.557 HG11 ' HA ' ' A' ' 22' ' ' ALA . 92.5 t -64.42 -32.29 57.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 122.337 1.065 . . . . 1.0 109.253 175.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -71.16 -22.73 62.01 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 120.066 -1.646 . . . . 1.0 113.359 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -88.53 -59.38 2.25 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.379 1.871 . . . . 1.0 111.247 168.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.461 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 89.5 t90 -56.93 -36.49 70.28 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.697 1.599 . . . . 1.0 113.388 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.62 -30.72 35.56 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 121.315 -0.865 . . . . 1.0 114.196 173.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.6 p -68.22 -12.55 61.17 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.213 1.19 . . . . 1.0 114.213 176.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.74 -16.19 51.9 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.98 1.712 . . . . 1.0 111.881 176.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.78 177.08 9.09 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.198 0.999 . . . . 1.0 110.829 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 8.9 m . . . . . 0 C--O 1.251 1.149 0 N-CA-C 115.882 1.808 . . . . 1.0 115.882 -172.014 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 tpt . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 109.972 -0.381 . . . . 1.0 109.972 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.41 156.98 41.79 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.687 0.995 . . . . 1.0 113.687 -171.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -124.2 125.37 44.31 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.479 1.511 . . . . 1.0 110.267 173.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.588 HD13 HD12 ' A' ' 26' ' ' LEU . 2.2 mp -121.51 114.99 45.18 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 C-N-CA 126.026 1.73 . . . . 1.0 112.832 -178.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.4 123.37 7.13 Favored Glycine 0 C--O 1.225 -0.446 0 N-CA-C 110.313 -1.115 . . . . 1.0 110.313 169.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.8 mt -103.67 116.22 47.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 118.167 0.983 . . . . 1.0 109.312 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -112.3 112.05 23.36 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.198 -1.408 . . . . 1.0 107.198 -172.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.5 p -97.62 137.55 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 116.66 -0.246 . . . . 1.0 111.582 -172.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -116.35 122.83 5.65 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 123.79 0.71 . . . . 1.0 111.396 176.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -152.5 146.49 25.31 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.939 0.718 . . . . 1.0 112.939 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.3 ttt -75.63 -19.52 59.15 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.864 1.265 . . . . 1.0 112.742 172.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -148.67 148.73 30.4 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.865 1.061 . . . . 1.0 113.865 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.68 -179.52 53.04 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.613 1.101 . . . . 1.0 115.606 173.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -144.69 159.92 42.04 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.746 2.019 . . . . 1.0 109.873 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.6 m 49.63 55.88 8.71 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.304 1.442 . . . . 1.0 111.691 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 27.3 tp -77.61 127.68 32.89 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.994 1.109 . . . . 1.0 113.994 -169.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.6 tp -35.53 -68.33 0.13 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 117.326 2.343 . . . . 1.0 117.326 -169.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.6 t -58.18 -35.15 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 118.685 0.675 . . . . 1.0 111.861 -169.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.24 -48.1 83.0 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 120.845 -1.159 . . . . 1.0 112.679 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -67.09 -30.95 71.12 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.879 0.371 . . . . 1.0 111.312 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -66.31 -48.31 70.76 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 173.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.651 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -63.04 -44.0 97.1 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 112.673 0.62 . . . . 1.0 112.673 -176.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -53.56 -49.43 67.71 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.376 1.07 . . . . 1.0 110.701 170.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.06 -37.51 75.51 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.632 0.773 . . . . 1.0 112.656 -175.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.5 mt -69.49 -45.56 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 119.119 0.872 . . . . 1.0 109.568 175.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.588 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.52 -33.84 76.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 119.651 -0.819 . . . . 1.0 110.269 -178.255 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.4 m -61.71 -45.03 95.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.392 1.477 . . . . 1.0 112.669 169.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.69 -32.98 74.64 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.346 1.058 . . . . 1.0 113.011 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -68.44 -30.62 69.55 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.752 1.221 . . . . 1.0 112.102 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.87 20.93 2.01 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.847 1.213 . . . . 1.0 115.214 169.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -118.85 153.53 34.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.785 1.234 . . . . 1.0 111.167 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -88.31 75.38 8.53 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.244 1.417 . . . . 1.0 110.637 -172.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.01 144.85 25.55 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.387 -1.733 . . . . 1.0 112.449 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.1 m -147.52 141.48 25.9 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.986 1.315 . . . . 1.0 112.055 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -88.96 139.23 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 115.56 1.689 . . . . 1.0 115.56 172.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -116.95 109.85 17.55 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.181 2.192 . . . . 1.0 110.327 169.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -88.23 144.02 26.69 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.384 1.874 . . . . 1.0 110.462 171.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 43.06 59.48 11.26 Favored Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 124.488 1.115 . . . . 1.0 111.193 -169.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -60.85 130.94 34.93 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 124.483 3.455 . . . . 1.0 118.356 -168.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -93.15 150.26 20.64 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.683 1.593 . . . . 1.0 112.896 169.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.508 HD21 HD21 ' A' ' 79' ' ' LEU . 2.5 tm? -69.56 -25.81 64.18 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.2 -0.937 . . . . 1.0 110.031 168.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.9 m -66.68 -20.6 66.01 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.446 -0.784 . . . . 1.0 112.615 171.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -88.73 -22.29 23.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.669 1.188 . . . . 1.0 113.207 169.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.466 ' HB3' HD22 ' A' ' 41' ' ' LEU . 15.5 t-105 -80.53 -35.58 34.34 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.799 1.181 . . . . 1.0 113.863 174.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.1 mt -49.43 -40.24 47.29 Favored Pre-proline 0 CA--C 1.551 1.006 0 CA-C-O 117.785 -1.103 . . . . 1.0 113.828 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -55.97 -14.06 10.39 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 124.509 3.473 . . . . 1.0 117.153 172.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -109.48 7.49 24.84 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.967 1.84 . . . . 1.0 115.967 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -53.13 -31.54 42.86 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.607 1.963 . . . . 1.0 113.819 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -112.12 11.62 20.41 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.966 1.307 . . . . 1.0 112.689 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -120.17 -157.59 0.71 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.977 2.511 . . . . 1.0 110.895 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -115.45 165.53 12.89 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.629 1.204 . . . . 1.0 111.445 171.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.649 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -150.14 159.54 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.616 1.166 . . . . 1.0 109.214 -170.344 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.536 HD11 HD12 ' A' ' 90' ' ' ILE . 14.5 tp -140.29 129.01 23.07 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 124.425 1.09 . . . . 1.0 108.954 174.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.6 t -107.11 123.95 62.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 124.299 1.039 . . . . 1.0 109.626 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.0 t -123.04 111.71 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 107.546 -1.279 . . . . 1.0 107.546 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.5 p -117.41 114.53 23.66 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.288 1.035 . . . . 1.0 108.958 -169.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.2 m -107.62 -8.8 16.03 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 119.066 2.987 . . . . 1.0 119.066 -167.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.4 p -135.33 17.48 3.4 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 115.806 1.78 . . . . 1.0 115.806 -169.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.4 m -53.62 -51.19 63.86 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.909 -1.119 . . . . 1.0 112.424 174.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 48.52 -112.19 1.11 Allowed Glycine 0 CA--C 1.537 1.453 0 C-N-CA 123.824 0.726 . . . . 1.0 113.403 177.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -62.69 -19.82 64.25 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.391 1.476 . . . . 1.0 114.647 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.76 161.05 10.36 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 120.419 1.463 . . . . 1.0 116.502 170.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.7 t0 58.38 -174.47 0.09 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.182 2.193 . . . . 1.0 115.752 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.2 mt -93.92 148.18 34.82 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 126.651 1.98 . . . . 1.0 113.624 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.3 156.48 54.87 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.409 2.739 . . . . 1.0 113.35 170.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -63.16 -20.63 65.57 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.41 1.263 . . . . 1.0 114.41 -174.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.8 p -72.59 -28.08 62.57 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.189 1.181 . . . . 1.0 114.189 174.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.4 tt -109.01 -18.68 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.551 1.141 . . . . 1.0 113.477 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -42.37 -52.23 10.32 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 124.638 1.175 . . . . 1.0 112.533 168.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -71.27 -29.84 16.59 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.383 1.389 . . . . 1.0 111.662 -173.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.9 tp -64.91 -49.66 69.57 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 124.227 1.011 . . . . 1.0 110.767 169.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.722 ' CE1' HD23 ' A' ' 110' ' ' LEU . 93.6 t80 -56.4 -52.57 64.13 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.312 1.045 . . . . 1.0 112.483 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -64.02 -40.75 97.02 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.864 0.866 . . . . 1.0 111.4 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.95 -33.66 84.62 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.943 0.783 . . . . 1.0 112.801 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.561 HG22 HD12 ' A' ' 110' ' ' LEU . 91.8 mt -66.54 -50.76 64.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 120.116 1.958 . . . . 1.0 108.47 170.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.744 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.1 ptmm? -69.6 -30.23 67.94 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.371 -1.456 . . . . 1.0 112.998 -170.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -106.94 -37.74 6.25 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.779 1.77 . . . . 1.0 115.779 -175.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.1 m -93.99 -22.41 18.57 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.958 0.903 . . . . 1.0 113.028 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.508 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -92.74 -71.1 0.67 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.204 -1.406 . . . . 1.0 107.204 169.813 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.02 -11.44 1.34 Allowed Glycine 0 CA--C 1.538 1.5 0 C-N-CA 127.213 2.339 . . . . 1.0 116.41 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -155.3 140.12 17.17 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.508 2.323 . . . . 1.0 108.38 172.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.431 HE22 HD12 ' A' ' 79' ' ' LEU . 2.1 mm-40 -135.81 123.58 15.03 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 121.267 -0.895 . . . . 1.0 111.365 -173.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -82.73 -39.3 0.14 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.845 2.363 . . . . 1.0 114.654 -173.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -141.28 13.57 2.2 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 115.14 1.533 . . . . 1.0 115.14 -169.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.649 HD11 ' CG2' ' A' ' 52' ' ' VAL . 53.8 tp -79.4 140.72 37.34 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.585 -1.322 . . . . 1.0 113.138 -169.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.83 151.3 48.98 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 127.959 2.504 . . . . 1.0 109.188 169.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.675 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -160.62 166.13 29.46 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.329 0.968 . . . . 1.0 113.603 -175.008 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.435 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -121.15 169.95 14.48 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 125.662 1.601 . . . . 1.0 113.876 175.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 66.0 t -145.78 132.38 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 114.364 1.246 . . . . 1.0 114.364 -169.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.536 HD12 HD11 ' A' ' 53' ' ' LEU . 3.5 mt -134.21 110.92 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.591 1.556 . . . . 1.0 108.774 169.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -105.07 146.94 28.44 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.6 -0.687 . . . . 1.0 111.546 171.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.24 153.39 44.8 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.441 1.497 . . . . 1.0 109.915 177.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 176.75 173.64 42.51 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-O 122.116 0.842 . . . . 1.0 114.137 169.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -85.43 102.22 13.27 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.001 -1.294 . . . . 1.0 111.086 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 9.0 t -59.63 -12.43 6.75 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.395 1.878 . . . . 1.0 113.896 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 48.5 m -60.6 -13.59 15.23 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.535 1.134 . . . . 1.0 113.697 169.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -117.76 162.76 17.55 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.715 1.606 . . . . 1.0 113.054 169.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.6 m -63.71 174.92 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.078 1.351 . . . . 1.0 110.993 169.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 59.97 20.22 9.28 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.719 1.608 . . . . 1.0 114.611 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -16.84 -69.82 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 129.928 3.291 . . . . 1.0 117.034 -169.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 7.2 m -126.24 29.58 5.79 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.135 1.374 . . . . 1.0 112.491 -173.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -61.28 -21.83 64.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.154 1.538 . . . . 1.0 115.154 -169.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.93 -51.2 57.3 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 121.679 2.036 . . . . 1.0 114.099 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.55 -35.55 92.07 Favored Glycine 0 N--CA 1.474 1.228 0 O-C-N 120.547 -1.561 . . . . 1.0 112.845 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -63.5 -38.55 91.55 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.255 1.022 . . . . 1.0 113.119 173.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -58.32 -46.5 86.04 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.748 0.819 . . . . 1.0 111.021 170.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -63.17 -37.93 89.15 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.738 -0.601 . . . . 1.0 111.792 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.78 -45.61 93.12 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.464 -0.773 . . . . 1.0 112.081 177.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.63 -36.65 74.41 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.066 0.765 . . . . 1.0 113.066 171.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.744 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -59.65 -49.03 79.35 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 123.351 1.548 . . . . 1.0 111.199 -175.645 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.675 HD12 ' CD1' ' A' ' 87' ' ' TYR . 8.9 mt -66.1 -39.95 90.37 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 120.789 -1.194 . . . . 1.0 111.47 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -71.27 -19.1 62.39 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.136 0.791 . . . . 1.0 113.136 177.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.23 -21.93 58.27 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.407 1.003 . . . . 1.0 111.098 176.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -92.05 -78.4 0.41 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 125.356 1.462 . . . . 1.0 110.019 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.429 ' H ' ' H ' ' A' ' 116' ' ' ALA . 2.4 t -178.89 -3.75 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.085 2.154 . . . . 1.0 112.027 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -75.54 148.58 38.79 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 122.632 1.206 . . . . 1.0 112.639 -169.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -90.8 170.29 10.23 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.17 1.788 . . . . 1.0 114.048 -168.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.73 143.35 50.82 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.885 2.074 . . . . 1.0 111.018 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.9 t -118.22 130.15 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.25 1.42 . . . . 1.0 108.664 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 48.51 -154.44 1.77 Allowed Glycine 0 N--CA 1.48 1.575 0 C-N-CA 124.834 1.207 . . . . 1.0 114.317 -170.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -119.16 147.52 44.1 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.986 1.714 . . . . 1.0 109.961 169.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.26 157.66 37.28 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.239 -0.913 . . . . 1.0 113.301 -169.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.634 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.8 OUTLIER -93.99 134.79 36.03 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.221 1.009 . . . . 1.0 110.573 171.559 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.634 ' N ' HD13 ' A' ' 123' ' ' LEU . 10.3 mt -120.69 107.61 13.0 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.468 1.507 . . . . 1.0 111.451 175.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.458 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.9 mt -93.56 130.78 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 126.344 1.858 . . . . 1.0 113.054 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -106.13 89.51 3.08 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.663 2.385 . . . . 1.0 113.245 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.32 -24.68 67.74 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.893 -1.13 . . . . 1.0 113.26 -175.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.7 m -60.68 -18.13 52.12 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.424 2.29 . . . . 1.0 113.865 172.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -127.9 -31.94 2.36 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.148 2.179 . . . . 1.0 112.501 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -138.06 91.91 12.81 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 126.046 1.739 . . . . 1.0 111.483 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -75.83 9.05 2.46 Favored 'Trans proline' 0 CA--C 1.549 1.235 0 C-N-CA 123.589 2.859 . . . . 1.0 114.517 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -112.05 70.45 0.98 Allowed Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 127.482 2.313 . . . . 1.0 110.057 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -57.81 -20.51 43.97 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.627 2.218 . . . . 1.0 116.417 -169.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -65.0 -26.67 68.39 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 118.91 0.777 . . . . 1.0 111.713 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.0 p -72.6 -16.7 61.73 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 120.866 -1.146 . . . . 1.0 111.743 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -101.1 -56.16 2.38 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.179 1.792 . . . . 1.0 111.711 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 60.3 p -69.59 -32.22 70.83 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.777 1.399 . . . . 1.0 114.777 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -62.1 -55.41 40.99 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 120.939 1.7 . . . . 1.0 113.176 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -62.84 -23.59 74.34 Favored 'Trans proline' 0 C--N 1.355 0.882 0 CA-C-N 121.28 1.493 . . . . 1.0 112.255 175.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.437 ' HB2' HD23 ' A' ' 123' ' ' LEU . 92.6 t90 -69.29 -47.5 64.37 Favored 'General case' 0 C--O 1.218 -0.594 0 C-N-CA 123.258 0.623 . . . . 1.0 111.053 174.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.651 HG11 ' HA ' ' A' ' 22' ' ' ALA . 95.7 t -66.45 -32.79 59.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 N-CA-C 109.554 -0.535 . . . . 1.0 109.554 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -64.51 -50.35 67.74 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.228 -0.92 . . . . 1.0 109.477 173.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -63.47 -54.73 31.88 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.703 1.201 . . . . 1.0 111.743 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.435 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 86.3 t90 -56.58 -37.7 70.95 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 125.843 1.657 . . . . 1.0 111.262 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.2 -33.68 23.46 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.434 1.492 . . . . 1.0 113.619 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.3 p -68.8 -14.03 62.77 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 114.802 1.408 . . . . 1.0 114.802 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.53 -19.63 45.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.35 1.46 . . . . 1.0 111.692 176.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -83.68 173.7 11.13 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.48 1.112 . . . . 1.0 110.583 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--O 1.252 1.213 0 C-N-CA 124.662 1.185 . . . . 1.0 113.923 -176.23 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 110.819 -0.067 . . . . 1.0 110.819 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.95 166.7 28.83 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.255 1.422 . . . . 1.0 112.597 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -122.48 125.08 45.06 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.035 1.334 . . . . 1.0 110.04 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.557 HD13 HD12 ' A' ' 26' ' ' LEU . 2.2 mp -121.58 114.07 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 126.778 2.031 . . . . 1.0 112.346 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.31 125.55 8.06 Favored Glycine 0 C--O 1.223 -0.539 0 N-CA-C 110.315 -1.114 . . . . 1.0 110.315 169.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 mt -106.16 121.37 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-N 118.547 1.174 . . . . 1.0 109.803 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -113.35 108.58 17.42 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.514 -1.291 . . . . 1.0 107.514 -169.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.45 127.28 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 O-C-N 123.375 0.422 . . . . 1.0 111.869 -174.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.81 46.89 3.2 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 115.855 1.102 . . . . 1.0 115.855 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.4 t -160.86 164.78 31.04 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.08 1.352 . . . . 1.0 111.378 169.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.8 ttt -102.74 -16.86 15.85 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.371 1.468 . . . . 1.0 112.491 169.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -145.67 164.51 31.55 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.879 1.271 . . . . 1.0 113.254 -170.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.98 -179.62 53.11 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 115.82 1.088 . . . . 1.0 115.82 169.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -59.92 -29.07 68.12 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.582 1.153 . . . . 1.0 113.823 -170.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.1 m -61.34 -16.83 50.05 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.941 1.089 . . . . 1.0 113.941 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 90.3 mt -62.36 -35.71 79.98 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.212 0.915 . . . . 1.0 112.68 169.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.3 tp -53.45 -53.99 43.38 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.851 1.26 . . . . 1.0 112.954 -170.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.1 t -56.35 -32.85 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.017 0.527 . . . . 1.0 111.5 -173.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.47 -47.62 85.34 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.793 -1.192 . . . . 1.0 113.105 172.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -66.98 -30.35 70.44 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.682 0.793 . . . . 1.0 111.117 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -68.86 -48.36 63.64 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 123.795 0.838 . . . . 1.0 109.394 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.541 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -63.8 -42.84 97.64 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 112.769 0.655 . . . . 1.0 112.769 -176.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -53.96 -49.44 68.73 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.093 0.957 . . . . 1.0 110.129 170.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.09 -37.84 72.4 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.484 0.713 . . . . 1.0 112.737 -174.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.5 mt -66.18 -46.83 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 119.355 0.98 . . . . 1.0 109.117 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.557 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -66.98 -35.14 79.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 119.543 -0.863 . . . . 1.0 110.468 -176.442 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 51.8 m -61.9 -41.92 98.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.24 1.416 . . . . 1.0 113.711 170.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.2 -33.06 74.58 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.049 0.94 . . . . 1.0 112.272 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -70.64 -30.04 66.56 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.629 1.172 . . . . 1.0 113.203 171.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.91 23.11 2.81 Favored Glycine 0 N--CA 1.468 0.799 0 C-N-CA 124.543 1.068 . . . . 1.0 114.433 169.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -111.52 148.96 32.08 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.543 1.137 . . . . 1.0 109.55 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.91 90.57 6.46 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.05 1.34 . . . . 1.0 108.008 -176.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.07 145.71 31.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.576 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 56.5 m -148.49 139.89 23.43 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.545 0.738 . . . . 1.0 112.076 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.45 138.72 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 115.48 1.659 . . . . 1.0 115.48 173.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -119.94 112.76 19.58 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.195 2.198 . . . . 1.0 110.292 169.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -95.01 138.23 33.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.725 2.01 . . . . 1.0 110.461 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.9 t70 42.95 54.39 10.02 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 123.753 0.821 . . . . 1.0 111.379 -169.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -71.18 147.74 54.48 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.777 2.985 . . . . 1.0 117.064 -168.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -98.02 164.81 12.19 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 124.934 1.294 . . . . 1.0 113.034 168.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.566 HD21 HD21 ' A' ' 79' ' ' LEU . 2.2 tm? -68.01 -22.5 64.98 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 121.169 -0.957 . . . . 1.0 110.523 167.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 67.0 p -68.33 -20.22 64.72 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.759 1.163 . . . . 1.0 112.481 171.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -81.13 -25.38 36.96 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.232 1.013 . . . . 1.0 112.248 169.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.454 ' HB3' HD22 ' A' ' 41' ' ' LEU . 15.7 t-105 -88.28 -35.39 17.29 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.504 1.298 . . . . 1.0 114.504 -177.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.6 mt -47.72 -38.39 17.47 Favored Pre-proline 0 CA--C 1.554 1.116 0 CA-C-O 117.681 -1.152 . . . . 1.0 114.058 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -58.99 -14.47 23.13 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 123.674 2.916 . . . . 1.0 116.526 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -110.54 9.53 23.13 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.63 1.715 . . . . 1.0 115.63 -174.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -51.44 -30.4 19.46 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.86 2.064 . . . . 1.0 113.729 174.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -108.82 7.2 26.1 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.316 1.847 . . . . 1.0 113.489 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -122.39 -163.18 1.06 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.888 2.475 . . . . 1.0 110.706 -174.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -110.62 165.33 11.9 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 123.081 1.419 . . . . 1.0 111.963 171.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.428 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -150.86 159.97 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.485 1.514 . . . . 1.0 109.567 -172.391 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.42 HD11 HD12 ' A' ' 90' ' ' ILE . 14.2 tp -139.25 130.09 26.2 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.006 1.322 . . . . 1.0 108.308 177.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.3 t -106.63 123.05 61.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 C-N-CA 123.944 0.897 . . . . 1.0 108.959 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.9 t -122.1 111.89 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 106.222 -1.77 . . . . 1.0 106.222 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -153.03 142.34 21.58 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 113.731 1.012 . . . . 1.0 113.731 -167.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.4 t -121.48 -169.89 1.94 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.852 1.261 . . . . 1.0 113.153 -169.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.4 m 73.9 -62.06 0.48 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 128.885 2.874 . . . . 1.0 114.737 169.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 m 59.3 -38.76 0.07 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 117.656 2.465 . . . . 1.0 117.656 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 51.98 -128.77 34.32 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-N 120.771 1.623 . . . . 1.0 114.143 172.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -81.04 29.78 0.33 Allowed 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.718 1.207 . . . . 1.0 113.39 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.49 41.08 8.57 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.659 1.123 . . . . 1.0 112.741 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -136.29 -177.55 4.76 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.031 1.733 . . . . 1.0 111.485 -173.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.3 mt -122.42 151.65 59.88 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 126.111 1.764 . . . . 1.0 113.11 -175.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.1 153.87 66.94 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.091 2.527 . . . . 1.0 112.345 170.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -61.4 -21.67 64.3 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.499 1.12 . . . . 1.0 114.006 -173.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.4 p -71.32 -23.55 61.96 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.458 1.281 . . . . 1.0 114.458 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.4 tt -118.11 -14.88 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 114.138 1.162 . . . . 1.0 114.138 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -44.54 -53.53 14.59 Favored Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 124.912 1.285 . . . . 1.0 112.073 168.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -68.39 -30.55 29.68 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.833 1.689 . . . . 1.0 111.746 -173.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.7 tp -65.31 -52.87 51.16 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 123.908 0.883 . . . . 1.0 111.126 169.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.632 ' CE1' HD23 ' A' ' 110' ' ' LEU . 93.0 t80 -55.86 -53.2 59.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.78 0.832 . . . . 1.0 112.498 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -69.52 -34.81 74.81 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.837 -0.619 . . . . 1.0 111.696 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.95 -35.41 90.69 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.77 -0.581 . . . . 1.0 112.473 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.597 HG22 HD12 ' A' ' 110' ' ' LEU . 95.4 mt -65.47 -50.08 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.87 1.835 . . . . 1.0 108.707 171.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.67 ' HB3' HD21 ' A' ' 110' ' ' LEU . 4.5 ptmm? -69.37 -31.83 70.49 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 120.324 -1.485 . . . . 1.0 113.303 -170.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -105.69 -39.33 6.11 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.309 1.596 . . . . 1.0 115.309 -173.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.9 m -93.29 -22.94 18.69 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.054 0.941 . . . . 1.0 112.901 -176.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.566 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -92.75 -71.33 0.65 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.164 -1.421 . . . . 1.0 107.164 169.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.63 -13.6 1.62 Allowed Glycine 0 CA--C 1.539 1.536 0 C-N-CA 127.413 2.435 . . . . 1.0 116.587 169.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -154.18 141.05 19.18 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 127.342 2.257 . . . . 1.0 108.72 171.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.444 HE22 HD12 ' A' ' 79' ' ' LEU . 1.4 mm-40 -136.97 125.0 14.63 Favored Pre-proline 0 CA--C 1.544 0.729 0 O-C-N 121.287 -0.883 . . . . 1.0 111.668 -172.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -86.54 -36.63 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.037 2.492 . . . . 1.0 114.967 -174.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -142.53 15.89 2.0 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.534 1.309 . . . . 1.0 114.534 -169.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.428 HD11 ' CG2' ' A' ' 52' ' ' VAL . 66.3 tp -84.78 138.46 32.59 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.514 -1.366 . . . . 1.0 112.773 -169.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.9 mtm-85 -135.74 156.43 48.83 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 127.944 2.498 . . . . 1.0 109.558 169.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.676 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -162.44 169.0 21.15 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.186 -0.946 . . . . 1.0 111.587 -177.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.404 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -129.58 173.11 19.75 Favored Glycine 0 N--CA 1.475 1.291 0 C-N-CA 124.734 1.159 . . . . 1.0 114.189 170.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.01 141.39 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 114.3 1.222 . . . . 1.0 114.3 -169.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.96 HG23 HD12 ' A' ' 123' ' ' LEU . 7.5 mt -131.94 99.3 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 125.915 1.686 . . . . 1.0 107.11 169.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.3 143.34 26.9 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.575 1.55 . . . . 1.0 111.998 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.2 mp -137.88 161.46 36.56 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.813 0.845 . . . . 1.0 112.966 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 160.86 -170.67 36.79 Favored Glycine 0 N--CA 1.465 0.62 0 CA-C-N 116.231 -0.441 . . . . 1.0 114.055 168.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -102.85 110.62 22.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.893 0.877 . . . . 1.0 110.06 176.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.4 t -63.62 -7.63 7.82 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.676 1.191 . . . . 1.0 113.67 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.7 t -62.43 -26.19 68.37 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.712 -1.243 . . . . 1.0 111.078 169.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -92.36 148.15 22.35 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.345 1.458 . . . . 1.0 110.799 169.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.0 m -71.46 169.97 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.667 0.787 . . . . 1.0 111.806 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 65.2 5.07 2.86 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.914 2.086 . . . . 1.0 116.597 -170.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 12.1 t80 21.69 -80.92 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 129.585 3.154 . . . . 1.0 117.204 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.466 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 20.7 p -120.45 8.95 10.82 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.708 2.003 . . . . 1.0 114.376 -169.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -60.61 -16.99 44.03 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 115.112 1.523 . . . . 1.0 115.112 -169.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.17 -40.68 98.9 Favored Glycine 0 N--CA 1.474 1.231 0 CA-C-N 120.69 1.586 . . . . 1.0 113.314 173.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.61 -37.34 35.27 Favored Glycine 0 N--CA 1.477 1.392 0 O-C-N 120.974 -1.309 . . . . 1.0 112.806 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.466 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 84.2 mttt -61.29 -33.53 73.72 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 121.155 -1.203 . . . . 1.0 112.857 174.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -63.28 -36.04 82.34 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.523 0.729 . . . . 1.0 112.503 170.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -63.0 -37.19 86.18 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.285 0.948 . . . . 1.0 111.196 172.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -46.96 83.8 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.81 -0.556 . . . . 1.0 111.72 174.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.91 -44.51 78.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.702 -0.666 . . . . 1.0 111.82 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.67 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -50.73 -49.45 57.76 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.862 2.065 . . . . 1.0 112.018 -175.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.676 HD12 ' CD1' ' A' ' 87' ' ' TYR . 7.9 mt -66.37 -41.78 88.96 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.313 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -68.85 -20.03 64.27 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.747 1.017 . . . . 1.0 113.747 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -66.98 -36.14 81.52 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.749 1.22 . . . . 1.0 111.112 172.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -84.26 -75.15 0.35 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 113.777 -1.556 . . . . 1.0 110.336 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.412 ' H ' ' H ' ' A' ' 116' ' ' ALA . 3.6 m 177.91 -0.55 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.605 2.362 . . . . 1.0 112.024 172.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -77.83 149.3 34.39 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 122.638 1.208 . . . . 1.0 113.373 -169.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -85.77 171.35 11.64 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.255 1.822 . . . . 1.0 111.884 -169.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 2.2 ttm105 -133.87 152.77 51.97 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.353 1.061 . . . . 1.0 112.135 175.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.0 t -119.1 124.17 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.521 1.528 . . . . 1.0 109.14 -172.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 51.85 -168.03 0.69 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.941 1.257 . . . . 1.0 115.352 -172.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -102.35 145.1 29.98 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.984 1.314 . . . . 1.0 108.563 169.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -78.14 159.81 28.39 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.118 1.155 . . . . 1.0 114.118 -169.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.96 HD12 HG23 ' A' ' 90' ' ' ILE . 1.4 tm? -85.17 138.48 32.35 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.854 1.261 . . . . 1.0 110.079 170.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.6 mt -127.53 108.76 11.07 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.714 1.605 . . . . 1.0 109.676 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.581 HG13 HD11 ' A' ' 123' ' ' LEU . 25.5 mt -97.82 130.76 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 124.045 0.938 . . . . 1.0 112.304 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -105.35 110.24 22.53 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.963 0.905 . . . . 1.0 112.422 170.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.92 -24.57 66.11 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.146 1.378 . . . . 1.0 113.7 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.45 -17.62 64.77 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.896 1.073 . . . . 1.0 113.896 173.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -118.99 -28.72 5.46 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.88 1.672 . . . . 1.0 111.958 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -143.81 86.08 8.83 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 125.41 1.484 . . . . 1.0 111.947 -178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.92 6.06 3.12 Favored 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 123.537 2.825 . . . . 1.0 114.443 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -112.63 70.83 1.16 Allowed Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 127.221 2.208 . . . . 1.0 110.163 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -57.59 -22.16 50.32 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.455 2.104 . . . . 1.0 116.756 -169.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -64.6 -26.19 68.29 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.325 0.966 . . . . 1.0 111.864 174.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 p -73.62 -14.23 61.14 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.864 -1.148 . . . . 1.0 112.1 -175.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.436 ' HB2' HD11 ' A' ' 125' ' ' ILE . 4.8 mm-40 -106.99 -55.86 2.27 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 126.811 2.044 . . . . 1.0 111.464 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.9 p -69.49 -33.86 73.48 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.929 1.085 . . . . 1.0 113.929 -177.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -61.15 -57.65 24.49 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 120.623 1.556 . . . . 1.0 112.266 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -62.32 -23.84 75.48 Favored 'Trans proline' 0 C--N 1.353 0.772 0 CA-C-N 121.359 1.521 . . . . 1.0 112.502 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.464 ' CG ' ' HB2' ' A' ' 123' ' ' LEU . 88.4 t90 -68.15 -46.87 69.6 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 119.104 0.865 . . . . 1.0 111.226 174.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.541 HG11 ' HA ' ' A' ' 22' ' ' ALA . 98.3 t -62.31 -33.57 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 175.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -68.62 -29.85 68.44 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.99 1.316 . . . . 1.0 112.588 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -81.49 -57.96 3.24 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.369 1.467 . . . . 1.0 112.397 170.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.404 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 84.4 t90 -56.84 -36.87 70.49 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 125.352 1.461 . . . . 1.0 112.633 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.27 -32.55 21.89 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.531 1.062 . . . . 1.0 113.871 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.8 p -68.14 -14.05 62.69 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.373 1.249 . . . . 1.0 114.373 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.44 -17.68 53.75 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.997 1.719 . . . . 1.0 111.843 175.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.38 172.3 10.5 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.842 1.257 . . . . 1.0 111.269 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 13.5 m . . . . . 0 C--O 1.25 1.086 0 N-CA-C 116.085 1.883 . . . . 1.0 116.085 -169.586 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.9 mtt . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 110.046 -0.353 . . . . 1.0 110.046 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.29 174.14 11.9 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.414 1.486 . . . . 1.0 114.943 -174.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -118.86 124.33 46.88 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.221 1.808 . . . . 1.0 110.241 175.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.521 HD13 HD12 ' A' ' 26' ' ' LEU . 2.1 mp -121.75 116.07 48.31 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 C-N-CA 126.937 2.095 . . . . 1.0 112.416 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.91 125.49 8.27 Favored Glycine 0 C--O 1.225 -0.45 0 N-CA-C 110.158 -1.177 . . . . 1.0 110.158 169.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 mt -104.84 117.63 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-N 118.133 0.966 . . . . 1.0 109.21 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -109.29 109.68 20.65 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.732 -1.581 . . . . 1.0 106.732 -171.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.6 p -103.27 127.35 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.543 0.572 . . . . 1.0 112.543 -169.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.85 55.38 4.75 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 114.968 0.747 . . . . 1.0 114.968 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.2 p -146.05 157.21 43.86 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.291 1.436 . . . . 1.0 112.391 174.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 10.0 tpt -147.04 147.56 30.78 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.157 1.783 . . . . 1.0 111.119 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 69.4 t80 53.84 -76.5 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 128.635 2.774 . . . . 1.0 116.707 170.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.37 -18.01 77.99 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 124.725 1.155 . . . . 1.0 114.539 -175.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -147.57 158.17 43.88 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.137 1.375 . . . . 1.0 111.356 175.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 79.5 p -121.25 -5.44 9.42 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.506 1.522 . . . . 1.0 114.989 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 43.52 65.58 0.96 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.763 2.025 . . . . 1.0 111.885 -174.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.7 tp -18.93 -50.73 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 129.369 3.068 . . . . 1.0 115.979 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.423 HG11 HG21 ' A' ' 90' ' ' ILE . 78.7 t -44.8 -35.48 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.506 1.522 . . . . 1.0 112.916 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.7 -48.81 79.84 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 120.384 1.447 . . . . 1.0 113.198 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -66.69 -32.72 74.2 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.093 0.957 . . . . 1.0 110.775 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -65.63 -47.47 75.52 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 123.675 0.79 . . . . 1.0 109.287 173.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.622 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -64.35 -42.62 96.14 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 123.385 0.674 . . . . 1.0 112.724 -175.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.68 -48.59 72.21 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.906 0.482 . . . . 1.0 109.777 169.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.53 -37.07 76.96 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.994 0.738 . . . . 1.0 112.994 -175.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.0 mt -70.02 -46.22 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-N 119.194 0.907 . . . . 1.0 109.258 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.521 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -64.78 -34.98 79.62 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 119.606 -0.838 . . . . 1.0 110.088 -177.761 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.3 m -60.67 -46.14 91.47 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.122 1.369 . . . . 1.0 112.91 169.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.95 -32.64 74.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.341 1.056 . . . . 1.0 112.891 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -70.31 -29.12 65.77 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.932 1.293 . . . . 1.0 112.333 172.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.62 23.02 2.16 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.673 1.13 . . . . 1.0 115.119 169.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -121.34 148.51 44.25 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.563 1.145 . . . . 1.0 110.301 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -79.98 93.56 5.74 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 125.267 1.427 . . . . 1.0 108.69 -175.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.32 147.34 35.32 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.068 0.547 . . . . 1.0 111.373 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 93.0 m -150.08 146.73 27.1 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.518 1.127 . . . . 1.0 111.096 -173.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.5 t -97.98 138.84 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 114.049 1.129 . . . . 1.0 114.049 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -118.12 106.69 13.13 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.726 2.011 . . . . 1.0 110.692 169.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -85.26 146.51 27.02 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.917 1.687 . . . . 1.0 110.909 175.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t0 41.75 57.81 9.7 Favored Pre-proline 0 CA--C 1.557 1.236 0 C-N-CA 124.644 1.177 . . . . 1.0 111.174 -169.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -57.93 130.0 36.13 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 125.122 3.881 . . . . 1.0 118.706 -167.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -91.24 150.53 21.3 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.751 1.62 . . . . 1.0 112.288 168.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.53 HD21 HD21 ' A' ' 79' ' ' LEU . 2.4 tm? -70.15 -25.34 63.41 Favored 'General case' 0 N--CA 1.444 -0.757 0 O-C-N 121.13 -0.981 . . . . 1.0 110.282 168.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.2 m -66.26 -21.67 66.29 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.65 -0.656 . . . . 1.0 112.31 171.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -86.93 -23.79 25.02 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.159 0.983 . . . . 1.0 112.994 169.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.502 ' HB3' HD22 ' A' ' 41' ' ' LEU . 12.3 t-105 -80.16 -34.63 37.44 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.806 1.185 . . . . 1.0 113.778 175.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.8 mt -50.11 -39.62 48.31 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-O 117.744 -1.122 . . . . 1.0 113.589 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -52.65 -13.36 2.38 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 124.843 3.696 . . . . 1.0 117.892 170.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -112.87 8.02 18.54 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 116.332 1.975 . . . . 1.0 116.332 -176.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -50.86 -30.74 15.31 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.2 1.8 . . . . 1.0 113.642 174.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -107.11 8.13 30.01 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.821 2.049 . . . . 1.0 113.407 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -127.97 -159.66 0.96 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.274 2.229 . . . . 1.0 112.267 -169.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -112.41 159.33 18.83 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 122.805 1.288 . . . . 1.0 110.907 171.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.412 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -148.47 154.86 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 124.909 1.284 . . . . 1.0 108.735 -171.754 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.1 tp -133.99 128.05 33.61 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.06 0.944 . . . . 1.0 108.865 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.5 t -103.75 124.18 57.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 C-N-CA 124.326 1.05 . . . . 1.0 109.184 176.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.421 HG22 HD12 ' A' ' 90' ' ' ILE . 19.9 t -125.39 112.06 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 107.183 -1.414 . . . . 1.0 107.183 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.3 t -153.25 126.76 8.7 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.628 0.973 . . . . 1.0 113.628 -168.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.5 m -98.77 177.92 5.14 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.513 1.525 . . . . 1.0 111.48 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.8 m 64.63 60.28 0.89 Allowed 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 122.597 1.189 . . . . 1.0 113.775 168.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.4 m -59.89 -39.12 84.24 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.565 1.546 . . . . 1.0 113.321 171.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 50.99 -135.94 30.22 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 119.16 0.891 . . . . 1.0 113.897 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -81.52 53.01 1.99 Allowed 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.136 -1.214 . . . . 1.0 112.816 174.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.92 41.89 70.96 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 124.379 0.99 . . . . 1.0 113.338 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -130.58 -172.82 2.9 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.5 1.92 . . . . 1.0 111.471 -173.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 53.3 mt -136.69 156.84 75.95 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 126.006 1.722 . . . . 1.0 114.631 -173.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -55.39 140.38 82.32 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.964 3.109 . . . . 1.0 112.38 169.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.07 -21.67 65.14 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.211 -0.93 . . . . 1.0 113.406 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.6 p -77.31 -19.55 56.23 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.658 1.355 . . . . 1.0 114.658 172.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.2 tt -111.27 -18.02 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.579 1.151 . . . . 1.0 113.407 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.8 t -44.15 -52.6 15.69 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 125.302 1.441 . . . . 1.0 112.289 168.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.89 -29.43 18.5 Favored 'Trans proline' 0 C--N 1.35 0.641 0 CA-C-N 120.774 1.312 . . . . 1.0 111.272 -173.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.4 tp -65.08 -50.46 66.06 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 124.046 0.939 . . . . 1.0 110.793 169.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.62 ' CE1' HD23 ' A' ' 110' ' ' LEU . 89.8 t80 -55.53 -52.13 64.73 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.219 1.008 . . . . 1.0 112.213 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -64.35 -40.34 95.66 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.094 0.958 . . . . 1.0 111.733 176.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.73 -35.81 90.3 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.073 0.844 . . . . 1.0 112.628 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.586 HG22 HD12 ' A' ' 110' ' ' LEU . 91.5 mt -64.73 -51.3 69.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 120.071 1.935 . . . . 1.0 107.988 171.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.691 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.4 ptmm? -68.59 -31.72 71.1 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.394 -1.441 . . . . 1.0 113.289 -169.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -103.64 -37.25 7.6 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.513 1.671 . . . . 1.0 115.513 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.1 m -96.43 -19.52 19.11 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.416 1.087 . . . . 1.0 113.266 -174.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.53 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -93.15 -73.08 0.57 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.158 -1.423 . . . . 1.0 107.158 169.522 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.35 -21.43 1.45 Allowed Glycine 0 CA--C 1.536 1.347 0 C-N-CA 127.756 2.598 . . . . 1.0 114.727 169.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -151.19 141.32 22.19 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 128.392 2.677 . . . . 1.0 108.041 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.43 HE21 HD12 ' A' ' 79' ' ' LEU . 6.4 mt-30 -138.15 121.79 11.45 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.74 0.816 . . . . 1.0 110.165 -169.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -78.55 -38.02 0.59 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.121 1.881 . . . . 1.0 115.822 -169.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -143.98 21.17 1.78 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.129 1.159 . . . . 1.0 114.129 -169.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.412 HD11 ' CG2' ' A' ' 52' ' ' VAL . 60.8 tp -84.51 140.26 31.58 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.559 -1.338 . . . . 1.0 114.6 -169.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -137.12 155.31 49.76 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 128.64 2.776 . . . . 1.0 108.065 169.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.59 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -159.36 171.81 19.11 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.355 -0.841 . . . . 1.0 111.589 -179.163 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -131.73 172.25 20.99 Favored Glycine 0 N--CA 1.471 0.974 0 C-N-CA 124.902 1.239 . . . . 1.0 113.415 170.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.422 HG23 ' HB3' ' A' ' 122' ' ' MET . 0.0 OUTLIER -142.57 143.38 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 114.009 1.114 . . . . 1.0 114.009 -169.517 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.04 HG23 HD12 ' A' ' 123' ' ' LEU . 12.1 mt -133.16 98.17 2.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 106.532 -1.655 . . . . 1.0 106.532 169.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.44 144.12 26.56 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.442 1.497 . . . . 1.0 111.349 171.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.1 mp -140.79 154.98 46.49 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.447 0.906 . . . . 1.0 113.447 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.65 -169.75 41.87 Favored Glycine 0 C--O 1.221 -0.659 0 N-CA-C 114.227 0.451 . . . . 1.0 114.227 168.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -100.99 110.95 23.04 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.057 0.943 . . . . 1.0 110.031 175.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.1 t -63.43 -7.92 7.84 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.737 1.215 . . . . 1.0 113.69 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.9 t -62.19 -26.66 68.47 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.92 -1.113 . . . . 1.0 110.841 168.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -91.14 146.63 23.67 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.358 1.463 . . . . 1.0 110.517 169.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.2 m -71.41 170.12 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 121.713 0.768 . . . . 1.0 112.227 -177.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.92 6.61 3.48 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 127.036 2.134 . . . . 1.0 116.754 -171.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 12.8 t80 28.79 -85.49 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 129.151 2.98 . . . . 1.0 116.719 -175.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 6.9 m -123.35 20.74 9.64 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.72 1.608 . . . . 1.0 113.685 -174.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -54.13 -23.14 13.04 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.72 1.608 . . . . 1.0 114.611 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.31 -46.93 85.63 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 120.661 1.573 . . . . 1.0 113.588 175.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.75 -35.6 39.78 Favored Glycine 0 N--CA 1.478 1.435 0 O-C-N 120.766 -1.432 . . . . 1.0 113.141 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -60.59 -32.4 71.52 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 121.264 -1.139 . . . . 1.0 112.86 172.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -66.82 -34.99 79.02 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.033 0.933 . . . . 1.0 112.361 169.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -62.75 -35.45 79.83 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.603 1.092 . . . . 1.0 111.136 170.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -65.99 -49.04 69.23 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.804 -0.56 . . . . 1.0 111.062 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.5 -33.58 66.14 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.876 0.871 . . . . 1.0 113.272 174.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.691 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -57.91 -50.59 72.81 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 123.117 1.437 . . . . 1.0 110.867 179.564 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.59 HD12 ' CD1' ' A' ' 87' ' ' TYR . 6.6 mt -65.68 -40.03 91.93 Favored 'General case' 0 C--N 1.321 -0.67 0 O-C-N 121.074 -1.016 . . . . 1.0 111.478 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -67.17 -20.52 65.75 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.534 0.938 . . . . 1.0 113.534 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.03 -17.06 57.51 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.589 1.086 . . . . 1.0 111.112 177.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -100.42 -73.57 0.63 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.8 1.24 . . . . 1.0 109.75 -178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 77.4 p -179.37 -19.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.165 1.786 . . . . 1.0 114.147 -174.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -70.69 161.1 31.4 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 123.14 1.448 . . . . 1.0 114.139 -169.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -98.47 179.53 4.68 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.306 1.842 . . . . 1.0 110.934 -170.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.0 ttm105 -131.37 158.35 40.97 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.519 1.127 . . . . 1.0 112.828 169.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.488 HG12 ' H ' ' A' ' 120' ' ' GLY . 13.9 t -96.96 -173.44 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 C-N-CA 126.493 1.917 . . . . 1.0 106.394 169.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.488 ' H ' HG12 ' A' ' 119' ' ' VAL . . . -54.49 164.69 3.06 Favored Glycine 0 CA--C 1.545 1.919 0 N-CA-C 116.924 1.529 . . . . 1.0 116.924 -170.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -43.75 131.42 5.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.859 2.064 . . . . 1.0 113.953 -175.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.422 ' HB3' HG23 ' A' ' 89' ' ' VAL . 1.0 OUTLIER -74.16 157.62 35.63 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.333 1.053 . . . . 1.0 111.869 -172.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 1.04 HD12 HG23 ' A' ' 90' ' ' ILE . 1.4 tm? -91.48 137.27 32.49 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.215 -0.902 . . . . 1.0 110.353 174.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.6 mt -127.26 110.69 13.11 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.844 1.657 . . . . 1.0 109.445 174.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.588 ' CD1' HD11 ' A' ' 123' ' ' LEU . 24.0 mt -99.15 131.5 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 124.085 0.954 . . . . 1.0 112.582 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -104.31 108.97 20.62 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.118 0.967 . . . . 1.0 112.606 170.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.43 -24.99 66.54 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.88 1.272 . . . . 1.0 113.775 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.64 -17.46 64.61 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.776 1.028 . . . . 1.0 113.776 173.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -116.46 -29.28 6.21 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.677 1.591 . . . . 1.0 111.633 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -145.16 87.73 7.04 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 125.323 1.449 . . . . 1.0 111.901 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.98 5.01 3.24 Favored 'Trans proline' 0 CA--C 1.549 1.247 0 C-N-CA 123.689 2.926 . . . . 1.0 114.731 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -113.72 71.02 1.75 Allowed Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 127.179 2.192 . . . . 1.0 109.634 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -54.93 -28.3 58.39 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.391 2.061 . . . . 1.0 115.845 -169.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -62.99 -24.38 67.89 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.611 0.642 . . . . 1.0 112.006 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.1 p -75.08 -16.57 60.56 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 120.612 -1.305 . . . . 1.0 111.82 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -101.56 -55.68 2.47 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.371 1.868 . . . . 1.0 111.438 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 90.7 p -65.23 -34.13 77.62 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 113.779 1.029 . . . . 1.0 113.779 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 -64.03 -55.2 34.13 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 120.501 1.501 . . . . 1.0 112.92 -175.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -62.1 -24.42 76.47 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 CA-C-N 121.328 1.51 . . . . 1.0 112.849 172.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.475 ' CG ' ' HB2' ' A' ' 123' ' ' LEU . 87.5 t90 -68.28 -45.44 73.07 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 118.592 0.633 . . . . 1.0 111.314 173.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.622 HG11 ' HA ' ' A' ' 22' ' ' ALA . 83.3 t -66.41 -33.64 64.82 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -63.69 -48.77 75.79 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.225 -0.922 . . . . 1.0 109.528 173.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -63.99 -54.98 25.85 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.489 1.116 . . . . 1.0 111.827 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -58.49 -35.61 72.49 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 125.611 1.564 . . . . 1.0 111.76 174.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.19 -34.53 25.06 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.583 1.563 . . . . 1.0 113.458 171.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.9 p -67.82 -12.99 61.76 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.826 1.417 . . . . 1.0 114.826 176.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.35 -16.29 49.74 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.869 1.667 . . . . 1.0 112.072 176.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.57 -179.56 7.47 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.289 1.036 . . . . 1.0 110.924 -177.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 C--O 1.25 1.129 0 C-N-CA 126.202 1.801 . . . . 1.0 114.52 -175.549 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 119.952 -0.07 . . . . 1.0 110.816 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.5 167.41 26.33 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.186 1.395 . . . . 1.0 112.905 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -120.84 123.83 43.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.08 1.352 . . . . 1.0 110.502 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.551 HD13 HD12 ' A' ' 26' ' ' LEU . 2.2 mp -120.43 112.79 37.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 C-N-CA 126.632 1.973 . . . . 1.0 112.497 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.61 124.27 7.3 Favored Glycine 0 C--O 1.223 -0.561 0 N-CA-C 110.328 -1.109 . . . . 1.0 110.328 169.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.5 mt -105.27 119.23 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-N 118.614 1.207 . . . . 1.0 109.691 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -110.01 107.45 17.33 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.181 -1.414 . . . . 1.0 107.181 -170.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.4 p -93.26 123.26 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 121.484 0.659 . . . . 1.0 111.105 -172.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.56 47.59 1.01 Allowed Glycine 0 CA--C 1.524 0.596 0 C-N-CA 126.001 1.762 . . . . 1.0 111.621 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.9 p -103.01 131.63 49.86 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.451 -1.029 . . . . 1.0 111.49 -173.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.7 ttt -79.58 -20.82 46.06 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.384 1.253 . . . . 1.0 114.384 -171.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -131.79 151.8 51.41 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.377 1.071 . . . . 1.0 113.076 -174.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -62.5 -27.29 69.35 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.794 1.187 . . . . 1.0 115.373 -171.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -68.23 -31.75 71.47 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.221 1.01 . . . . 1.0 112.214 173.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.0 m -88.16 -28.43 21.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.013 0.925 . . . . 1.0 113.05 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.47 66.29 0.32 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.043 1.737 . . . . 1.0 109.793 170.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.1 tp -161.23 -51.34 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 127.514 2.326 . . . . 1.0 109.935 -170.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.7 t -56.01 -34.43 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.176 0.59 . . . . 1.0 111.243 -173.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.44 -45.57 88.27 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.783 -1.198 . . . . 1.0 113.414 173.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -68.81 -30.36 68.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.303 0.573 . . . . 1.0 111.048 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -68.18 -47.11 68.85 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 123.761 0.824 . . . . 1.0 109.109 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.551 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -64.32 -43.32 95.04 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 123.56 0.744 . . . . 1.0 112.804 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -53.57 -48.67 68.97 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.092 0.957 . . . . 1.0 110.456 170.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.31 -37.97 71.76 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.593 0.757 . . . . 1.0 112.285 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.0 mt -68.79 -45.83 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 O-C-N 121.63 -0.669 . . . . 1.0 109.338 175.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.551 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.99 -31.45 72.36 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.495 1.043 . . . . 1.0 110.649 -178.666 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.4 m -63.12 -45.04 93.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.586 1.154 . . . . 1.0 112.711 169.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.08 -31.36 70.93 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.799 1.239 . . . . 1.0 113.032 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -67.68 -29.03 68.2 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.211 1.804 . . . . 1.0 111.695 172.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.43 28.27 2.39 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.715 1.15 . . . . 1.0 114.905 171.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -120.52 164.39 16.51 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.016 1.326 . . . . 1.0 110.169 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -93.44 89.81 6.47 Favored 'General case' 0 CA--C 1.52 -0.183 0 O-C-N 120.659 -1.275 . . . . 1.0 108.559 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.16 145.87 29.57 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 122.766 0.426 . . . . 1.0 111.22 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.7 m -147.77 139.08 23.61 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.864 0.866 . . . . 1.0 112.041 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.4 t -86.93 137.72 20.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 114.916 1.45 . . . . 1.0 114.916 172.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -117.89 113.74 22.19 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.85 2.06 . . . . 1.0 110.32 171.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -94.7 137.75 33.4 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.686 1.994 . . . . 1.0 111.158 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.5 t70 41.79 55.37 9.07 Favored Pre-proline 0 CA--C 1.559 1.293 0 C-N-CA 124.61 1.164 . . . . 1.0 111.08 -169.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -68.59 145.63 64.71 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.016 3.144 . . . . 1.0 117.638 -167.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -88.79 154.5 20.22 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.892 1.677 . . . . 1.0 112.442 168.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.539 HD21 HD21 ' A' ' 79' ' ' LEU . 2.3 tm? -69.41 -21.72 63.74 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 120.899 -1.125 . . . . 1.0 109.762 168.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.1 m -66.13 -22.89 66.4 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.284 -0.885 . . . . 1.0 112.332 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -82.52 -24.94 33.87 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.136 0.974 . . . . 1.0 113.098 169.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.49 ' HB3' HD22 ' A' ' 41' ' ' LEU . 11.8 t-105 -83.9 -35.54 24.01 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.799 1.182 . . . . 1.0 113.994 177.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.3 mt -48.16 -39.17 25.32 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-O 117.58 -1.2 . . . . 1.0 113.897 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -55.31 -14.98 10.27 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.306 3.337 . . . . 1.0 117.224 172.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -109.03 8.24 26.12 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 116.027 1.862 . . . . 1.0 116.027 -174.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -52.98 -23.47 7.38 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.977 2.111 . . . . 1.0 114.218 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -124.91 17.74 8.57 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.546 1.538 . . . . 1.0 113.484 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -126.47 -158.24 0.85 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.936 2.494 . . . . 1.0 110.345 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -116.79 161.85 18.63 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 122.984 1.373 . . . . 1.0 112.313 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.426 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -150.08 160.59 4.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 125.14 1.376 . . . . 1.0 108.966 -172.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.4 tp -138.17 130.05 28.35 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.007 1.323 . . . . 1.0 108.369 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.8 t -105.23 124.21 59.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 124.088 0.955 . . . . 1.0 109.03 174.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.1 t -122.26 111.86 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 105.476 -2.046 . . . . 1.0 105.476 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.3 t -148.38 132.93 17.72 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.227 1.195 . . . . 1.0 114.227 -167.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.6 p -121.49 162.94 19.63 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.762 0.825 . . . . 1.0 113.014 -172.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.0 m 66.22 55.71 0.86 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 122.743 1.258 . . . . 1.0 112.758 169.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.0 m -55.16 128.83 35.68 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.84 1.256 . . . . 1.0 109.553 169.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.43 -128.49 4.94 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.974 0.797 . . . . 1.0 112.797 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 41.8 mm-40 -76.43 52.18 0.76 Allowed 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.025 -1.279 . . . . 1.0 111.834 172.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.3 11.95 83.86 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.892 1.235 . . . . 1.0 113.805 -169.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -111.95 175.11 5.56 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.123 1.769 . . . . 1.0 111.879 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 52.9 mt -114.84 160.25 34.27 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 127.91 2.484 . . . . 1.0 113.389 -169.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.73 154.25 63.99 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.925 2.417 . . . . 1.0 111.84 169.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -62.14 -23.19 66.41 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.215 1.191 . . . . 1.0 114.215 -169.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.9 p -68.69 -22.55 64.36 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.292 1.219 . . . . 1.0 114.292 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.0 tt -122.52 -12.81 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 114.477 1.288 . . . . 1.0 114.477 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.9 t -44.06 -52.73 15.0 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 124.424 1.09 . . . . 1.0 112.912 168.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.36 -31.48 17.77 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.686 1.591 . . . . 1.0 111.757 -172.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.2 tp -62.67 -52.16 64.4 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 124.602 1.161 . . . . 1.0 111.336 169.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.655 ' CE1' HD23 ' A' ' 110' ' ' LEU . 86.2 t80 -55.83 -51.44 67.49 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.718 0.807 . . . . 1.0 112.65 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -63.15 -39.32 94.31 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.424 0.69 . . . . 1.0 111.682 176.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.18 -34.65 81.37 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 123.801 0.715 . . . . 1.0 113.009 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.615 HG22 HD12 ' A' ' 110' ' ' LEU . 91.6 mt -65.66 -44.14 93.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 120.354 2.077 . . . . 1.0 108.866 171.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.716 ' HB3' HD21 ' A' ' 110' ' ' LEU . 1.8 ptmm? -74.39 -32.01 62.55 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.304 -1.498 . . . . 1.0 113.415 -173.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -106.55 -38.57 6.12 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 115.138 1.532 . . . . 1.0 115.138 -174.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.7 m -91.06 -25.05 19.84 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.252 1.021 . . . . 1.0 112.712 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.539 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -91.04 -71.06 0.65 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 107.497 -1.297 . . . . 1.0 107.497 169.594 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.0 -8.22 2.66 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 126.369 1.938 . . . . 1.0 115.481 171.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -156.0 147.97 23.24 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 129.322 3.049 . . . . 1.0 107.023 171.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -134.84 127.92 18.57 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.113 0.565 . . . . 1.0 111.037 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -81.3 -44.65 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 121.847 1.698 . . . . 1.0 113.485 -172.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -148.49 28.11 0.89 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.674 1.189 . . . . 1.0 112.88 -172.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.426 HD11 ' CG2' ' A' ' 52' ' ' VAL . 52.4 tp -85.51 137.95 32.54 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.691 -1.256 . . . . 1.0 112.682 -169.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.2 mtm-85 -134.46 157.71 45.77 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.461 2.305 . . . . 1.0 109.153 169.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.66 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -163.24 169.41 19.24 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.136 0.88 . . . . 1.0 111.441 -177.591 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.41 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -129.92 173.47 19.8 Favored Glycine 0 N--CA 1.469 0.848 0 C-N-CA 124.096 0.855 . . . . 1.0 113.558 169.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.479 HG23 ' HB3' ' A' ' 122' ' ' MET . 0.0 OUTLIER -143.55 140.81 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 114.133 1.16 . . . . 1.0 114.133 -169.815 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.6 mt -131.57 97.23 2.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 106.841 -1.54 . . . . 1.0 106.841 168.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.12 148.97 28.24 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.806 1.242 . . . . 1.0 111.47 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.7 mp -141.61 151.61 43.28 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.853 0.686 . . . . 1.0 112.853 176.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 170.38 -160.1 32.72 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 121.691 -0.29 . . . . 1.0 112.691 169.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -109.85 122.23 47.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.004 0.902 . . . . 1.0 110.009 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 96.3 p -63.04 -8.29 7.17 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.43 1.27 . . . . 1.0 114.43 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.0 t -72.33 -21.41 61.32 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.876 0.87 . . . . 1.0 112.217 169.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -75.22 147.59 40.2 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.234 -0.916 . . . . 1.0 111.084 173.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -53.15 -50.55 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.866 1.266 . . . . 1.0 113.787 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -96.57 13.12 29.21 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.276 1.584 . . . . 1.0 115.276 -171.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 17.4 t80 28.5 -88.77 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 128.64 2.776 . . . . 1.0 116.22 -176.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 9.5 m -123.11 17.66 9.98 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.88 1.672 . . . . 1.0 113.469 -174.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -63.0 -12.37 25.37 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.861 1.265 . . . . 1.0 114.289 -174.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.36 -39.37 97.15 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-N 120.308 1.413 . . . . 1.0 113.599 171.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -77.25 -36.04 36.08 Favored Glycine 0 N--CA 1.477 1.432 0 O-C-N 120.616 -1.52 . . . . 1.0 112.737 172.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -62.85 -31.62 72.67 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.256 -1.144 . . . . 1.0 112.469 173.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -62.52 -41.21 98.71 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.211 1.004 . . . . 1.0 111.071 169.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -62.8 -38.67 91.61 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 118.804 0.729 . . . . 1.0 111.41 174.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -61.86 -48.63 79.65 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.387 -0.821 . . . . 1.0 112.316 173.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.95 -35.28 70.91 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.278 0.631 . . . . 1.0 112.699 174.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.716 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -58.68 -49.22 78.37 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 125.456 1.502 . . . . 1.0 111.079 -177.78 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.66 HD12 ' CD1' ' A' ' 87' ' ' TYR . 11.0 mt -67.31 -40.21 85.99 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 120.9 -1.125 . . . . 1.0 111.762 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -70.15 -18.69 63.22 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.244 0.831 . . . . 1.0 113.244 176.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.75 -18.45 59.55 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.674 1.124 . . . . 1.0 111.198 175.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -97.23 -72.83 0.63 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.089 1.355 . . . . 1.0 109.608 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.6 p 176.54 -18.04 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.476 2.31 . . . . 1.0 113.348 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -68.44 151.54 46.68 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 123.149 1.452 . . . . 1.0 114.457 -169.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -90.93 168.07 11.96 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.73 2.012 . . . . 1.0 114.006 -168.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.97 154.43 27.61 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.172 2.189 . . . . 1.0 111.454 176.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.1 t -124.92 129.46 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.301 1.441 . . . . 1.0 108.764 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 49.79 -154.49 2.7 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 125.328 1.442 . . . . 1.0 115.279 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -111.52 143.35 42.51 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.31 1.844 . . . . 1.0 109.914 169.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.479 ' HB3' HG23 ' A' ' 89' ' ' VAL . 1.3 pmm? -77.07 156.46 31.74 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.731 0.777 . . . . 1.0 112.257 -173.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.603 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.8 OUTLIER -92.26 137.15 32.61 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 123.87 0.868 . . . . 1.0 110.291 174.118 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.603 ' N ' HD13 ' A' ' 123' ' ' LEU . 6.2 mt -123.16 102.54 8.01 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.825 1.25 . . . . 1.0 110.532 172.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.7 mt -79.41 133.21 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 C-N-CA 124.461 1.104 . . . . 1.0 111.22 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -109.48 106.98 16.94 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 122.374 1.083 . . . . 1.0 113.448 172.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.21 -23.47 64.82 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.093 0.957 . . . . 1.0 113.26 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.2 t -62.91 -22.97 67.13 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.371 1.068 . . . . 1.0 112.665 174.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -120.0 -29.6 4.89 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.361 1.864 . . . . 1.0 111.925 -174.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -144.8 84.68 8.79 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.756 1.622 . . . . 1.0 112.058 -172.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -73.65 8.25 2.0 Allowed 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 123.635 2.89 . . . . 1.0 114.495 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -111.54 71.17 0.88 Allowed Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 127.953 2.501 . . . . 1.0 109.551 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -57.67 -22.21 51.21 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.696 2.264 . . . . 1.0 116.554 -169.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -64.48 -26.16 68.31 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 118.963 0.802 . . . . 1.0 111.758 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.7 p -77.12 -19.05 57.45 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 120.434 -1.416 . . . . 1.0 112.046 -174.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -94.82 -51.99 4.45 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.028 1.331 . . . . 1.0 111.883 172.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.8 p -72.17 -35.58 69.06 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 115.078 1.51 . . . . 1.0 115.078 -176.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -59.85 -55.04 49.65 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 120.612 1.551 . . . . 1.0 112.54 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -63.35 -23.12 71.94 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 121.482 1.565 . . . . 1.0 112.515 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.461 ' HB2' HD23 ' A' ' 123' ' ' LEU . 89.6 t90 -69.19 -46.75 66.7 Favored 'General case' 0 C--O 1.218 -0.572 0 O-C-N 121.828 -0.545 . . . . 1.0 110.846 174.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.551 HG11 ' HA ' ' A' ' 22' ' ' ALA . 91.7 t -64.77 -32.25 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.877 0.846 . . . . 1.0 108.85 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -71.82 -23.51 61.56 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.154 -1.591 . . . . 1.0 113.292 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -86.91 -61.21 1.78 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.867 2.067 . . . . 1.0 111.698 169.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.41 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 89.4 t90 -54.72 -37.68 66.18 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 126.715 2.006 . . . . 1.0 112.658 178.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.85 -29.57 34.44 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 121.519 -0.738 . . . . 1.0 114.383 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.2 p -69.05 -13.47 62.46 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.273 1.212 . . . . 1.0 114.273 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.43 -18.33 52.43 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.651 1.58 . . . . 1.0 111.833 176.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.41 171.79 12.31 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.672 1.189 . . . . 1.0 110.964 -176.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 C--O 1.253 1.253 0 N-CA-C 116.17 1.915 . . . . 1.0 116.17 -169.67 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.616 -0.513 . . . . 1.0 109.616 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.9 154.38 45.08 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.574 1.15 . . . . 1.0 113.116 -170.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -120.17 122.34 40.77 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.454 1.502 . . . . 1.0 110.231 174.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.562 HD13 HD12 ' A' ' 26' ' ' LEU . 2.0 mp -122.4 113.36 38.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 126.622 1.969 . . . . 1.0 111.972 -176.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.9 124.52 7.58 Favored Glycine 0 C--O 1.224 -0.52 0 N-CA-C 110.263 -1.135 . . . . 1.0 110.263 169.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 mt -105.44 123.96 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-N 118.069 0.934 . . . . 1.0 109.225 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -115.47 109.35 17.71 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 124.195 0.998 . . . . 1.0 108.368 -169.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -86.64 131.73 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.105 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.26 113.66 2.98 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.753 1.168 . . . . 1.0 110.861 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.3 t -149.18 164.23 35.33 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 118.083 0.942 . . . . 1.0 113.138 -170.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 13.9 ptt? -124.42 6.48 8.34 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.927 1.291 . . . . 1.0 113.095 169.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -100.68 167.27 10.43 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.1 1.36 . . . . 1.0 113.191 -171.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.19 -26.87 73.95 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 123.901 0.762 . . . . 1.0 114.061 175.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -87.27 142.08 28.16 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.421 1.089 . . . . 1.0 111.135 169.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.0 m -77.77 43.18 0.4 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.481 1.512 . . . . 1.0 113.741 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 47.29 75.01 0.14 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.067 2.147 . . . . 1.0 112.496 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.1 tp -11.46 -54.78 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 129.546 3.139 . . . . 1.0 116.683 169.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.4 t -53.34 -33.67 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.968 0.907 . . . . 1.0 112.914 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.46 -46.84 87.62 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 120.285 1.402 . . . . 1.0 112.48 173.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -68.64 -32.09 71.7 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.077 0.951 . . . . 1.0 111.046 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -65.21 -49.12 70.91 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.982 -0.748 . . . . 1.0 108.982 171.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.598 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.19 -42.41 93.6 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 112.983 0.734 . . . . 1.0 112.983 -172.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -53.95 -49.99 67.48 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.701 0.8 . . . . 1.0 110.09 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.83 -35.64 74.94 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 112.625 0.602 . . . . 1.0 112.625 -175.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.1 mt -70.47 -46.01 72.29 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 119.063 0.847 . . . . 1.0 109.658 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.562 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.72 -33.6 76.25 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 119.863 -0.735 . . . . 1.0 110.189 -178.375 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 54.0 m -61.96 -44.6 96.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.058 1.343 . . . . 1.0 113.085 169.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.78 -32.03 73.05 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.196 0.998 . . . . 1.0 112.92 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -70.03 -29.43 66.47 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.846 1.259 . . . . 1.0 112.279 171.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.13 21.8 2.49 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.723 1.154 . . . . 1.0 115.056 169.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -114.24 158.39 21.44 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.816 1.246 . . . . 1.0 110.792 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -86.03 89.47 7.81 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 125.461 1.504 . . . . 1.0 108.587 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.23 145.35 31.68 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 122.446 0.298 . . . . 1.0 111.123 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 78.6 m -148.08 138.71 23.0 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.642 0.777 . . . . 1.0 112.018 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.7 t -85.57 134.58 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.726 1.21 . . . . 1.0 114.151 171.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -110.3 109.9 20.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.799 1.64 . . . . 1.0 110.385 169.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -87.47 137.52 32.27 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.113 1.765 . . . . 1.0 111.115 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.2 t0 40.89 56.85 8.34 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 124.868 1.267 . . . . 1.0 111.354 -169.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -68.9 140.95 47.37 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.898 3.065 . . . . 1.0 116.973 -168.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.435 ' HB3' ' H ' ' A' ' 42' ' ' SER . 52.6 mm-40 -93.83 163.47 13.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 122.357 1.075 . . . . 1.0 111.847 168.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.545 HD21 HD21 ' A' ' 79' ' ' LEU . 2.2 tm? -65.86 -22.04 66.51 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 120.886 -1.134 . . . . 1.0 109.796 167.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.435 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 17.9 m -68.3 -19.7 64.71 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.878 -1.139 . . . . 1.0 112.613 172.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -83.1 -24.69 32.53 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.385 1.074 . . . . 1.0 112.444 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.443 ' HB3' HD22 ' A' ' 41' ' ' LEU . 13.0 t-105 -88.68 -34.56 17.17 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.075 1.139 . . . . 1.0 114.075 -178.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.9 mt -48.09 -38.57 20.96 Favored Pre-proline 0 CA--C 1.554 1.109 0 CA-C-O 117.608 -1.186 . . . . 1.0 114.103 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.71 -11.68 21.7 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.132 3.221 . . . . 1.0 116.352 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -109.36 6.9 24.8 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 116.095 1.887 . . . . 1.0 116.095 -174.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -52.88 -31.02 37.3 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.88 2.072 . . . . 1.0 113.723 172.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -109.81 11.5 24.33 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.176 1.391 . . . . 1.0 112.499 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -124.83 -159.03 0.86 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.904 2.482 . . . . 1.0 111.034 -174.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -116.13 162.85 16.82 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 122.874 1.321 . . . . 1.0 111.834 170.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.614 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -146.93 160.52 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.432 1.093 . . . . 1.0 109.182 -172.022 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.417 HD11 HD12 ' A' ' 90' ' ' ILE . 14.8 tp -139.29 128.0 23.29 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.68 1.192 . . . . 1.0 108.924 175.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.1 t -100.52 128.3 52.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 174.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.4 t -126.04 110.92 25.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 106.254 -1.758 . . . . 1.0 106.254 175.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.2 t -144.12 128.94 18.36 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.228 0.825 . . . . 1.0 113.228 -168.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.9 t -118.82 154.65 32.53 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.593 1.157 . . . . 1.0 113.106 -169.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.7 m 64.6 60.13 0.91 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 123.312 1.529 . . . . 1.0 112.077 169.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.9 m -56.03 -29.61 60.66 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 113.809 -1.541 . . . . 1.0 112.138 169.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.11 -136.96 49.5 Favored Glycine 0 C--N 1.343 0.944 0 C-N-CA 124.054 0.835 . . . . 1.0 111.913 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -61.77 -26.1 67.87 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.506 0.722 . . . . 1.0 112.916 177.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 148.0 52.91 0.02 OUTLIER Glycine 0 CA--C 1.537 1.412 0 CA-C-N 119.216 0.916 . . . . 1.0 114.721 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -143.1 -178.98 6.1 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.267 1.033 . . . . 1.0 111.821 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.9 mt -108.49 148.36 37.52 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 126.051 1.74 . . . . 1.0 113.659 176.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.55 147.22 95.94 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.283 2.655 . . . . 1.0 113.182 169.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -63.63 -23.11 67.24 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.965 1.098 . . . . 1.0 113.965 -175.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.9 p -67.51 -26.82 66.53 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.149 1.166 . . . . 1.0 114.149 173.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.2 tt -113.38 -14.65 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 125.259 1.424 . . . . 1.0 113.712 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.1 t -44.96 -53.27 16.48 Favored Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 124.444 1.098 . . . . 1.0 112.238 168.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -68.09 -32.38 27.89 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.747 1.631 . . . . 1.0 111.819 -173.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.2 tp -63.15 -53.24 56.51 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 124.429 1.092 . . . . 1.0 111.259 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.664 ' CE1' HD23 ' A' ' 110' ' ' LEU . 92.8 t80 -55.2 -53.75 52.09 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.747 0.819 . . . . 1.0 112.393 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -68.38 -35.1 77.21 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.769 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.36 -35.3 90.02 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 121.709 -0.62 . . . . 1.0 112.585 175.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.6 HG22 HD12 ' A' ' 110' ' ' LEU . 88.7 mt -65.98 -50.14 71.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 119.926 1.863 . . . . 1.0 108.414 171.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.681 ' HB3' HD21 ' A' ' 110' ' ' LEU . 5.6 ptmm? -69.35 -32.28 71.27 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.222 -1.549 . . . . 1.0 113.145 -170.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -104.61 -40.47 6.01 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.054 1.501 . . . . 1.0 115.054 -174.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.3 m -92.01 -24.13 19.31 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.006 0.922 . . . . 1.0 113.011 -175.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.545 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -91.1 -71.04 0.65 Allowed 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 106.804 -1.554 . . . . 1.0 106.804 169.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.43 -13.53 1.11 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 127.61 2.529 . . . . 1.0 117.011 168.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -155.24 140.39 17.5 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.557 2.343 . . . . 1.0 108.398 172.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -136.33 128.41 17.28 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 121.328 -0.858 . . . . 1.0 112.028 -172.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -89.3 -34.98 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.948 2.432 . . . . 1.0 115.123 -175.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -142.52 12.97 1.94 Allowed 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 115.138 1.533 . . . . 1.0 115.138 -169.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.614 HD11 ' CG2' ' A' ' 52' ' ' VAL . 63.9 tp -84.39 132.7 34.56 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.51 -1.369 . . . . 1.0 113.362 -169.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.7 mtm-85 -130.32 153.64 48.46 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.395 1.878 . . . . 1.0 109.716 169.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.661 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -160.82 165.27 30.53 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.548 1.067 . . . . 1.0 112.277 -176.46 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.402 ' HA3' ' CE2' ' A' ' 144' ' ' TRP . . . -124.0 173.37 16.68 Favored Glycine 0 N--CA 1.467 0.726 0 C-N-CA 125.401 1.476 . . . . 1.0 112.109 169.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.546 HG13 ' HB3' ' A' ' 122' ' ' MET . 0.2 OUTLIER -159.54 142.54 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 O-C-N 120.854 -1.38 . . . . 1.0 114.416 -169.571 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.417 HD12 HD11 ' A' ' 53' ' ' LEU . 4.9 mt -132.01 109.72 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 126.806 2.043 . . . . 1.0 108.24 178.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.11 145.47 24.49 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.192 1.397 . . . . 1.0 110.846 172.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.9 mp -137.09 152.41 49.99 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.466 0.706 . . . . 1.0 112.222 177.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.1 -153.32 23.41 Favored Glycine 0 C--O 1.222 -0.629 0 CA-C-N 116.354 -0.384 . . . . 1.0 112.421 169.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -114.45 119.19 36.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.979 0.889 . . . . 1.0 110.39 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 60.5 p -63.15 -6.04 3.83 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.529 1.307 . . . . 1.0 114.529 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.9 t -63.94 -25.55 68.19 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.598 0.759 . . . . 1.0 112.742 170.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -79.36 140.22 37.54 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.115 -0.991 . . . . 1.0 111.266 169.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -50.57 -50.53 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.273 1.429 . . . . 1.0 113.113 176.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -88.72 21.29 3.07 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.807 1.643 . . . . 1.0 114.525 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.8 t80 11.9 -75.17 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 130.158 3.383 . . . . 1.0 117.611 175.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.55 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 19.8 p -123.04 13.02 9.71 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.793 2.037 . . . . 1.0 114.017 -169.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -57.44 -21.41 36.75 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.477 1.288 . . . . 1.0 114.477 -173.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -54.21 -44.24 74.74 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 120.592 1.542 . . . . 1.0 113.467 174.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -79.54 -36.61 25.93 Favored Glycine 0 N--CA 1.479 1.547 0 O-C-N 120.993 -1.298 . . . . 1.0 113.476 174.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.55 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 78.7 mttt -60.04 -34.41 73.35 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.207 1.004 . . . . 1.0 112.789 174.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -64.79 -38.28 90.46 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.159 0.984 . . . . 1.0 111.914 172.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -64.25 -37.71 88.44 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.421 1.009 . . . . 1.0 111.036 173.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.53 -43.57 93.6 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.132 0.573 . . . . 1.0 112.229 176.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.41 82.77 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.857 -0.592 . . . . 1.0 111.754 170.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.681 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -49.46 -49.46 45.28 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.868 2.067 . . . . 1.0 111.939 -173.464 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.661 HD12 ' CD1' ' A' ' 87' ' ' TYR . 8.5 mt -65.59 -43.96 88.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.463 -0.79 . . . . 1.0 111.005 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -67.1 -21.68 65.85 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.941 1.089 . . . . 1.0 113.941 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -66.13 -36.47 83.24 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.415 1.086 . . . . 1.0 110.938 173.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -81.02 -77.61 0.2 Allowed 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 113.996 -1.456 . . . . 1.0 109.888 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.419 ' H ' ' H ' ' A' ' 116' ' ' ALA . 4.7 t -179.72 -2.34 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.195 2.198 . . . . 1.0 111.498 170.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.436 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -74.19 146.8 43.11 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 114.819 1.415 . . . . 1.0 114.819 -168.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.13 167.31 18.88 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.657 2.383 . . . . 1.0 114.896 -168.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.43 149.5 42.92 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.907 2.083 . . . . 1.0 111.693 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.8 t -123.93 128.66 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.775 1.63 . . . . 1.0 108.497 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 50.25 -155.03 2.82 Favored Glycine 0 CA--C 1.542 1.77 0 C-N-CA 124.908 1.242 . . . . 1.0 114.988 -171.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -114.59 144.38 43.49 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.317 1.847 . . . . 1.0 109.962 169.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.546 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -73.18 155.71 39.34 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 122.134 0.969 . . . . 1.0 111.424 -174.097 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.649 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -93.73 140.04 30.11 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.309 1.043 . . . . 1.0 110.197 176.16 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.649 ' N ' HD13 ' A' ' 123' ' ' LEU . 6.7 mt -124.83 102.13 7.41 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.082 1.353 . . . . 1.0 110.891 176.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.403 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.2 mt -86.11 128.75 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.576 1.55 . . . . 1.0 111.909 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -108.03 110.5 22.21 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 124.328 1.018 . . . . 1.0 112.261 174.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -70.13 -23.3 63.0 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.132 0.973 . . . . 1.0 112.79 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.5 t -62.77 -23.17 67.08 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.291 1.036 . . . . 1.0 112.73 173.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -119.27 -29.94 5.06 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.293 1.837 . . . . 1.0 112.2 -173.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -143.79 91.11 6.76 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 125.196 1.398 . . . . 1.0 112.603 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.76 7.17 3.28 Favored 'Trans proline' 0 CA--C 1.552 1.39 0 C-N-CA 123.414 2.743 . . . . 1.0 114.483 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -110.07 71.52 0.61 Allowed Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 127.307 2.243 . . . . 1.0 110.116 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -58.34 -18.8 39.92 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.803 2.335 . . . . 1.0 117.629 -168.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -69.47 -25.45 64.09 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.122 1.328 . . . . 1.0 111.644 172.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 28.0 p -72.78 -22.85 60.77 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.942 1.246 . . . . 1.0 111.969 -173.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -91.01 -54.2 4.06 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.654 1.582 . . . . 1.0 111.767 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.7 p -70.88 -32.78 69.87 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 115.022 1.489 . . . . 1.0 115.022 -176.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -58.42 -55.62 43.79 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 120.94 1.7 . . . . 1.0 112.705 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -64.32 -24.45 64.82 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 CA-C-N 121.277 1.492 . . . . 1.0 113.134 174.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.413 ' HB2' HD23 ' A' ' 123' ' ' LEU . 92.2 t90 -68.0 -48.2 66.4 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 118.795 0.725 . . . . 1.0 110.728 174.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.598 HG11 ' HA ' ' A' ' 22' ' ' ALA . 96.2 t -67.04 -33.09 61.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 C-N-CA 122.842 0.457 . . . . 1.0 110.044 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.59 -48.9 73.22 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.02 -1.05 . . . . 1.0 109.785 173.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -64.35 -54.77 27.68 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.539 1.136 . . . . 1.0 112.102 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.434 ' CZ3' HD11 ' A' ' 26' ' ' LEU . 87.3 t90 -56.24 -37.17 69.37 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 125.886 1.674 . . . . 1.0 111.401 173.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -49.99 -34.1 22.67 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.505 1.526 . . . . 1.0 113.482 173.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.6 p -68.78 -13.37 62.35 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 115.097 1.518 . . . . 1.0 115.097 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.61 -20.03 44.13 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.619 1.568 . . . . 1.0 111.778 176.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -84.18 172.5 11.85 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.65 1.18 . . . . 1.0 110.879 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--O 1.252 1.222 0 C-N-CA 124.655 1.182 . . . . 1.0 113.941 -176.052 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 tpt . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 119.916 -0.087 . . . . 1.0 110.831 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.23 168.2 26.13 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.284 1.434 . . . . 1.0 112.822 -174.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -122.89 121.56 36.48 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.562 1.545 . . . . 1.0 110.845 177.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.555 HD13 HD12 ' A' ' 26' ' ' LEU . 2.1 mp -121.77 117.79 53.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 127.418 2.287 . . . . 1.0 112.65 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.32 125.7 8.47 Favored Glycine 0 N--CA 1.465 0.615 0 N-CA-C 110.785 -0.926 . . . . 1.0 110.785 169.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.6 mt -104.61 120.77 55.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-N 118.565 1.183 . . . . 1.0 109.81 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -113.13 111.18 21.67 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 125.109 1.363 . . . . 1.0 107.638 -171.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 p -103.63 126.6 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 112.515 0.561 . . . . 1.0 112.515 -170.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.6 119.2 4.6 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.621 1.105 . . . . 1.0 111.364 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.5 m -152.04 137.05 17.28 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.223 1.009 . . . . 1.0 110.838 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 17.1 ptt? -135.88 31.23 3.03 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.015 1.117 . . . . 1.0 114.015 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -135.94 166.35 23.54 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.381 1.472 . . . . 1.0 111.323 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.05 65.81 0.9 Allowed Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.708 1.623 . . . . 1.0 113.967 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -131.05 153.95 48.75 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.639 1.976 . . . . 1.0 111.306 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 89.2 p -73.64 -12.61 60.79 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.917 1.451 . . . . 1.0 114.917 -177.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.372 1.4 pp 53.33 18.2 1.24 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 128.109 2.563 . . . . 1.0 116.093 -174.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.8 tp -36.1 -42.88 0.31 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 130.112 3.365 . . . . 1.0 115.936 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.7 t -52.0 -33.52 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 118.782 0.719 . . . . 1.0 112.602 -176.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.89 -49.91 76.0 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.001 -1.062 . . . . 1.0 113.048 173.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.73 -28.15 62.48 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.256 0.622 . . . . 1.0 110.771 -178.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -62.13 -49.42 75.94 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.122 -1.066 . . . . 1.0 108.122 169.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.605 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.02 -42.41 94.44 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 112.725 0.639 . . . . 1.0 112.725 -173.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.87 -49.67 70.58 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.196 0.598 . . . . 1.0 110.145 169.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.66 -35.76 77.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.381 0.512 . . . . 1.0 112.381 -175.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.7 mt -71.82 -45.42 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 O-C-N 121.023 -1.048 . . . . 1.0 109.71 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.555 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.62 -33.46 75.96 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 119.572 -0.851 . . . . 1.0 110.049 -179.09 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.2 m -61.86 -45.09 95.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.206 1.402 . . . . 1.0 113.084 169.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.07 -32.26 73.63 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.343 1.057 . . . . 1.0 112.888 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -70.97 -28.37 64.41 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.901 1.281 . . . . 1.0 112.578 172.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.14 27.11 2.11 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.721 1.153 . . . . 1.0 114.622 170.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -121.95 148.9 44.2 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.67 1.188 . . . . 1.0 110.415 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -77.43 101.33 6.35 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 125.4 1.48 . . . . 1.0 108.092 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.48 148.06 42.98 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 122.745 0.418 . . . . 1.0 110.937 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.5 m -149.54 146.61 27.45 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.305 1.042 . . . . 1.0 111.749 -172.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.1 t -97.9 137.18 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 114.485 1.291 . . . . 1.0 114.485 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -119.93 109.24 15.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.659 1.984 . . . . 1.0 110.878 169.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -89.82 139.94 30.09 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.462 1.905 . . . . 1.0 111.235 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t0 40.93 55.73 7.92 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 124.869 1.267 . . . . 1.0 111.613 -169.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -71.03 144.01 46.22 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.949 3.099 . . . . 1.0 117.606 -168.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -86.51 155.87 20.33 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.637 1.575 . . . . 1.0 112.616 168.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.506 HD21 HD21 ' A' ' 79' ' ' LEU . 2.3 tm? -68.5 -23.46 64.55 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 120.595 -1.316 . . . . 1.0 109.887 168.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.6 m -66.25 -21.35 66.28 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.5 -0.75 . . . . 1.0 112.488 170.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -85.31 -24.52 27.64 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.488 1.115 . . . . 1.0 112.928 169.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.484 ' HB3' HD22 ' A' ' 41' ' ' LEU . 10.9 t-105 -82.13 -35.51 28.43 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.86 1.209 . . . . 1.0 113.743 175.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.5 mt -50.57 -39.8 54.88 Favored Pre-proline 0 CA--C 1.552 1.039 0 CA-C-O 117.678 -1.153 . . . . 1.0 113.781 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -55.07 -14.47 8.55 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 124.059 3.173 . . . . 1.0 117.023 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -110.46 9.98 23.28 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 115.391 1.626 . . . . 1.0 115.391 -175.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -53.26 -34.91 59.16 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.281 1.832 . . . . 1.0 113.463 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.33 -0.6 38.07 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.462 1.505 . . . . 1.0 113.379 177.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -111.03 -164.7 0.93 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.695 2.398 . . . . 1.0 111.108 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -109.4 165.66 11.47 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 122.871 1.32 . . . . 1.0 111.359 169.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.597 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -149.62 160.85 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.91 1.284 . . . . 1.0 109.677 -171.036 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.599 HD11 HD12 ' A' ' 90' ' ' ILE . 19.1 tp -142.37 124.76 15.63 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.949 0.9 . . . . 1.0 108.975 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.9 t -99.26 123.43 51.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 123.86 0.864 . . . . 1.0 109.244 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.2 t -121.64 115.81 47.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.984 -1.858 . . . . 1.0 105.984 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.7 t -145.99 117.46 8.0 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.283 0.845 . . . . 1.0 113.283 -168.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.1 p -107.66 146.44 32.03 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.262 1.825 . . . . 1.0 111.474 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.7 m 65.03 66.08 0.57 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 123.021 1.391 . . . . 1.0 111.254 174.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.6 m -50.33 -28.39 7.83 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.795 2.438 . . . . 1.0 114.746 174.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.46 -149.91 50.27 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 124.221 0.915 . . . . 1.0 112.109 -173.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -82.23 49.82 1.48 Allowed 'General case' 0 CA--C 1.554 1.098 0 O-C-N 120.789 -1.418 . . . . 1.0 111.247 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.15 27.47 73.7 Favored Glycine 0 CA--C 1.541 1.681 0 C-N-CA 124.507 1.051 . . . . 1.0 112.967 -170.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -93.8 -23.2 18.25 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.906 1.447 . . . . 1.0 114.906 -169.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 39.8 mt 64.14 149.14 0.11 Allowed Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 128.008 2.523 . . . . 1.0 115.484 -169.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.06 137.64 81.82 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.134 2.556 . . . . 1.0 112.861 169.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -60.52 -22.98 64.19 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.334 0.864 . . . . 1.0 113.334 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.9 p -74.32 -17.04 60.9 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.98 1.312 . . . . 1.0 114.494 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.2 tt -121.48 -12.95 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.685 1.194 . . . . 1.0 114.057 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.8 t -48.16 -51.7 47.23 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 125.047 1.339 . . . . 1.0 111.918 168.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.47 -31.59 21.5 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.32 1.347 . . . . 1.0 111.259 -173.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.2 tp -63.11 -51.52 66.23 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.747 1.219 . . . . 1.0 111.205 169.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.646 ' CE1' HD23 ' A' ' 110' ' ' LEU . 92.6 t80 -52.86 -55.12 25.51 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.706 1.203 . . . . 1.0 112.544 178.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -67.65 -35.55 79.08 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.753 -0.658 . . . . 1.0 111.8 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.62 -36.72 92.78 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.586 0.613 . . . . 1.0 112.566 176.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.568 HG22 HD12 ' A' ' 110' ' ' LEU . 92.3 mt -64.37 -50.94 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 120.114 1.957 . . . . 1.0 108.111 171.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.692 ' HB3' HD21 ' A' ' 110' ' ' LEU . 1.7 ptmm? -67.91 -31.76 71.75 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.561 -1.337 . . . . 1.0 113.281 -170.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -103.74 -37.37 7.5 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.63 1.572 . . . . 1.0 115.157 -175.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.8 m -97.06 -19.17 18.9 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.566 1.146 . . . . 1.0 113.235 -174.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.506 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -94.07 -72.27 0.62 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 107.086 -1.45 . . . . 1.0 107.086 169.718 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.65 -20.8 1.3 Allowed Glycine 0 CA--C 1.539 1.567 0 C-N-CA 127.715 2.579 . . . . 1.0 114.873 170.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -152.73 141.84 21.35 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 128.528 2.731 . . . . 1.0 107.985 169.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.415 HE21 HD12 ' A' ' 79' ' ' LEU . 6.3 mt-30 -137.6 119.57 10.98 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.016 0.926 . . . . 1.0 109.485 -170.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.03 -36.49 1.95 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.223 1.949 . . . . 1.0 115.737 -169.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -144.4 18.46 1.71 Allowed 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.993 1.109 . . . . 1.0 113.993 -169.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.597 HD11 ' CG2' ' A' ' 52' ' ' VAL . 62.6 tp -82.22 139.93 33.98 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 120.681 -1.262 . . . . 1.0 113.441 -169.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.7 mtm-85 -136.6 152.82 50.87 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.976 2.51 . . . . 1.0 109.56 169.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.651 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -161.22 168.14 24.71 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.467 1.03 . . . . 1.0 112.854 -175.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.406 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -124.8 171.36 16.86 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.176 1.37 . . . . 1.0 113.908 173.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 88.3 t -143.57 133.5 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.639 1.175 . . . . 1.0 113.585 -169.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.009 HG23 HD12 ' A' ' 123' ' ' LEU . 4.2 mt -130.63 103.53 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.144 1.778 . . . . 1.0 108.293 170.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.83 142.28 27.5 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.224 1.409 . . . . 1.0 111.656 173.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.9 mp -138.71 150.17 45.88 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.414 -0.804 . . . . 1.0 113.079 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.78 -163.83 36.57 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 116.676 -0.238 . . . . 1.0 113.042 169.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -97.12 118.08 32.75 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.049 1.34 . . . . 1.0 111.793 173.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.1 p -65.66 -5.52 8.69 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.493 1.294 . . . . 1.0 114.493 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 89.2 p -62.14 -21.24 64.87 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.655 1.182 . . . . 1.0 112.768 169.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -85.59 141.03 30.12 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.352 1.461 . . . . 1.0 111.928 170.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -44.98 -54.97 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 127.199 2.2 . . . . 1.0 115.123 -173.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.83 26.47 4.05 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 127.132 2.173 . . . . 1.0 113.955 -174.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.7 t80 15.32 -81.46 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 129.544 3.138 . . . . 1.0 117.407 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.441 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 22.3 p -116.63 15.79 15.48 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.234 1.814 . . . . 1.0 114.889 -168.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -54.46 -22.87 13.92 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 124.801 1.24 . . . . 1.0 114.271 -173.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.19 -49.05 70.21 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 121.121 1.782 . . . . 1.0 113.829 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -72.14 -35.1 60.98 Favored Glycine 0 N--CA 1.477 1.38 0 O-C-N 120.72 -1.459 . . . . 1.0 112.842 175.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.441 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 82.2 mttt -64.66 -35.87 82.42 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.693 1.197 . . . . 1.0 112.805 176.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -61.48 -43.44 98.87 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.628 1.171 . . . . 1.0 111.23 170.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -62.09 -39.08 91.25 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.41 0.55 . . . . 1.0 111.087 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -44.85 94.98 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.264 0.626 . . . . 1.0 111.781 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.03 74.16 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.037 0.754 . . . . 1.0 113.037 171.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.692 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -58.91 -49.53 77.45 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 123.44 1.591 . . . . 1.0 110.859 -175.835 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.651 HD12 ' CD1' ' A' ' 87' ' ' TYR . 4.0 mt -67.07 -40.57 87.05 Favored 'General case' 0 C--N 1.32 -0.692 0 O-C-N 120.885 -1.134 . . . . 1.0 110.936 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -69.29 -18.76 63.87 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.313 0.857 . . . . 1.0 113.313 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.81 -18.0 58.67 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.69 1.132 . . . . 1.0 110.765 175.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -100.03 -73.45 0.63 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.086 1.354 . . . . 1.0 109.606 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 62.2 p 179.76 -18.92 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.414 1.886 . . . . 1.0 114.075 -174.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -71.71 150.9 44.07 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 114.794 1.405 . . . . 1.0 114.794 -169.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -88.96 166.51 13.88 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 113.017 -1.901 . . . . 1.0 113.342 -168.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.21 136.72 52.43 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.269 1.828 . . . . 1.0 110.645 -175.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.3 t -113.59 128.9 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.889 1.276 . . . . 1.0 109.345 -173.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 50.98 -158.12 2.23 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 124.884 1.23 . . . . 1.0 114.324 -171.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -115.39 144.69 43.41 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.751 1.62 . . . . 1.0 109.445 169.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -71.19 158.16 36.9 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.918 1.081 . . . . 1.0 113.918 -169.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 1.009 HD12 HG23 ' A' ' 90' ' ' ILE . 1.4 tm? -89.49 138.39 31.49 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.049 1.34 . . . . 1.0 110.139 169.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 mt -127.78 107.81 10.2 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.708 1.603 . . . . 1.0 109.32 173.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.593 HG13 HD11 ' A' ' 123' ' ' LEU . 25.3 mt -96.51 128.15 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 121.086 -1.009 . . . . 1.0 111.541 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -104.98 109.2 21.1 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 124.628 1.205 . . . . 1.0 111.705 174.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.25 -22.06 64.79 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.269 1.028 . . . . 1.0 113.24 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.7 t -65.13 -20.23 66.36 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.867 1.267 . . . . 1.0 112.602 173.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -120.09 -29.9 4.79 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.071 1.748 . . . . 1.0 112.298 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -143.43 88.14 8.12 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.975 1.31 . . . . 1.0 112.266 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.25 4.98 4.39 Favored 'Trans proline' 0 CA--C 1.546 1.125 0 C-N-CA 123.521 2.814 . . . . 1.0 114.761 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -111.55 73.82 1.13 Allowed Pre-proline 0 N--CA 1.469 0.503 0 C-N-CA 126.794 2.038 . . . . 1.0 110.233 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -60.42 -25.88 81.46 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.999 2.466 . . . . 1.0 116.135 -169.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -65.63 -24.42 67.04 Favored 'General case' 0 C--O 1.222 -0.384 0 O-C-N 120.983 -1.073 . . . . 1.0 111.521 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 30.1 p -72.75 -18.38 61.51 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.183 -0.948 . . . . 1.0 112.498 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.41 ' HB2' HD11 ' A' ' 125' ' ' ILE . 5.1 mm-40 -100.84 -55.05 2.67 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.256 1.822 . . . . 1.0 111.297 177.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 63.4 p -67.38 -31.64 72.01 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 117.771 -1.109 . . . . 1.0 113.906 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -59.11 -59.89 12.34 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-N 121.192 1.814 . . . . 1.0 112.854 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -61.92 -26.4 78.92 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 CA-C-N 121.203 1.465 . . . . 1.0 112.813 174.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.457 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 91.1 t90 -65.6 -48.88 70.78 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.353 0.979 . . . . 1.0 110.66 174.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.605 HG11 ' HA ' ' A' ' 22' ' ' ALA . 80.0 t -66.05 -32.92 60.27 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 C-N-CA 123.08 0.552 . . . . 1.0 110.143 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.72 -51.18 68.16 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 121.076 -1.015 . . . . 1.0 109.958 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 60.0 m170 -65.19 -51.63 59.86 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.178 0.991 . . . . 1.0 111.431 -177.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.418 ' CZ3' HD11 ' A' ' 26' ' ' LEU . 86.9 t90 -57.42 -37.3 72.53 Favored 'General case' 0 C--O 1.219 -0.514 0 C-N-CA 125.293 1.437 . . . . 1.0 111.542 171.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -49.42 -34.69 19.71 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.751 1.644 . . . . 1.0 113.507 172.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 p -68.62 -13.69 62.52 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 114.896 1.443 . . . . 1.0 114.896 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.48 -19.54 45.71 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.609 1.563 . . . . 1.0 111.87 175.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -84.04 169.23 15.15 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.219 1.007 . . . . 1.0 111.193 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 C--O 1.252 1.19 0 N-CA-C 115.652 1.723 . . . . 1.0 115.652 -169.645 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.2 ttm . . . . . 0 N--CA 1.498 1.957 0 CA-C-O 119.611 -0.233 . . . . 1.0 110.413 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.12 151.94 42.77 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.71 1.004 . . . . 1.0 113.71 -176.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -126.1 125.05 41.92 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.661 1.584 . . . . 1.0 110.305 174.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.551 HD13 HD12 ' A' ' 26' ' ' LEU . 2.0 mp -121.68 113.94 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 126.152 1.781 . . . . 1.0 113.262 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.32 122.21 6.64 Favored Glycine 0 C--O 1.223 -0.544 0 O-C-N 121.33 -0.856 . . . . 1.0 111.245 169.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.3 mt -104.4 122.18 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-N 118.407 1.103 . . . . 1.0 109.872 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -114.72 112.7 23.24 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.089 1.355 . . . . 1.0 107.455 -171.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.2 p -99.93 124.43 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 122.586 0.355 . . . . 1.0 111.473 -172.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -112.93 112.21 2.91 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.42 1.009 . . . . 1.0 112.395 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.5 t -162.42 151.46 15.29 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.412 1.085 . . . . 1.0 111.836 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -89.81 -5.22 57.12 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.431 1.092 . . . . 1.0 112.924 169.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -115.05 43.93 1.9 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.256 1.822 . . . . 1.0 111.824 -178.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.39 -22.8 46.13 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.621 1.105 . . . . 1.0 115.026 -174.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -54.61 -23.05 15.31 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 115.037 1.495 . . . . 1.0 115.037 169.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.5 m -132.03 25.79 4.59 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.569 1.148 . . . . 1.0 113.496 -175.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 pp -69.0 152.32 45.4 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 121.228 -0.92 . . . . 1.0 112.377 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.9 tp -154.0 -52.56 0.1 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.626 1.343 . . . . 1.0 114.626 -172.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.9 t -56.8 -31.14 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.22 -0.925 . . . . 1.0 112.269 -171.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.58 -48.2 80.03 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.193 -0.942 . . . . 1.0 113.203 171.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.67 -28.41 62.7 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.031 0.532 . . . . 1.0 110.72 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -63.15 -49.7 73.3 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.924 -0.769 . . . . 1.0 108.924 169.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.532 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.16 -43.36 92.02 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 112.521 0.563 . . . . 1.0 112.521 -173.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -53.34 -49.99 65.95 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.07 0.948 . . . . 1.0 110.291 169.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.71 -37.09 73.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.2 0.6 . . . . 1.0 112.345 -174.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.9 mt -67.43 -46.74 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 118.994 0.816 . . . . 1.0 109.084 176.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.551 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -67.51 -34.13 76.49 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 119.667 -0.813 . . . . 1.0 110.457 -176.554 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.5 m -62.83 -40.26 96.87 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.731 1.612 . . . . 1.0 113.325 170.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.56 -33.26 73.77 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.978 0.911 . . . . 1.0 112.029 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -69.3 -31.48 69.99 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.529 1.132 . . . . 1.0 112.45 170.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 126.68 18.61 2.16 Favored Glycine 0 N--CA 1.472 1.058 0 C-N-CA 124.409 1.004 . . . . 1.0 115.066 169.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -111.22 152.32 27.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.637 1.175 . . . . 1.0 111.007 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.9 73.65 9.9 Favored 'General case' 0 CA--C 1.51 -0.561 0 C-N-CA 124.629 1.172 . . . . 1.0 110.391 -172.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.99 142.39 27.83 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.29 -1.777 . . . . 1.0 112.061 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.6 m -147.94 138.97 23.33 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.549 1.14 . . . . 1.0 112.36 -177.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.5 t -84.64 135.29 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 114.781 1.401 . . . . 1.0 114.781 171.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -116.34 114.54 24.46 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.732 2.013 . . . . 1.0 110.536 169.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -95.32 139.01 32.24 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.465 1.906 . . . . 1.0 111.138 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.2 t0 41.18 54.92 7.93 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 124.865 1.266 . . . . 1.0 111.982 -169.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -71.92 143.06 40.13 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.902 3.068 . . . . 1.0 116.553 -168.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.431 ' HB3' ' H ' ' A' ' 42' ' ' SER . 50.7 mm-40 -94.27 164.93 12.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 122.431 1.11 . . . . 1.0 111.85 168.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.556 HD21 HD21 ' A' ' 79' ' ' LEU . 2.2 tm? -65.8 -22.16 66.54 Favored 'General case' 0 N--CA 1.44 -0.93 0 O-C-N 120.859 -1.151 . . . . 1.0 110.064 167.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.431 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 16.3 m -68.18 -20.08 64.84 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.07 -1.019 . . . . 1.0 112.376 172.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -83.73 -23.99 31.38 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.605 1.162 . . . . 1.0 112.47 169.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.49 ' HB3' HD22 ' A' ' 41' ' ' LEU . 10.9 t-105 -88.41 -33.96 17.7 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.064 1.135 . . . . 1.0 114.064 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.3 mt -49.89 -38.54 35.8 Favored Pre-proline 0 CA--C 1.555 1.163 0 CA-C-O 117.558 -1.21 . . . . 1.0 113.944 178.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -58.76 -8.81 6.3 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 124.031 3.154 . . . . 1.0 116.797 173.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -114.89 8.04 15.84 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 116.091 1.885 . . . . 1.0 116.091 -177.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -51.05 -32.35 21.59 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.935 1.694 . . . . 1.0 113.436 171.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -102.11 6.23 40.79 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.721 2.408 . . . . 1.0 113.588 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -128.79 -159.47 0.96 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 127.056 2.142 . . . . 1.0 112.222 -169.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -112.57 160.8 17.48 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 122.862 1.315 . . . . 1.0 111.404 170.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.567 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -146.92 159.4 9.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 125.076 1.35 . . . . 1.0 108.908 -171.658 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.616 HD11 HD12 ' A' ' 90' ' ' ILE . 19.7 tp -141.76 125.86 17.35 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 124.197 0.999 . . . . 1.0 109.211 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.5 t -102.37 120.41 52.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 C-N-CA 123.767 0.827 . . . . 1.0 109.182 176.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.4 t -119.77 113.53 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 105.944 -1.873 . . . . 1.0 105.944 177.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.1 t -148.07 126.43 12.31 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.561 0.949 . . . . 1.0 113.561 -168.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.5 p -117.26 158.26 24.64 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.304 1.441 . . . . 1.0 112.876 -169.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.1 m 62.73 53.18 2.59 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 122.996 1.379 . . . . 1.0 111.904 169.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 m -51.68 134.63 29.99 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.397 1.479 . . . . 1.0 110.426 169.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -84.09 -139.9 4.3 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.934 0.778 . . . . 1.0 112.611 175.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -76.2 54.72 0.9 Allowed 'General case' 0 CA--C 1.551 0.997 0 O-C-N 121.082 -1.246 . . . . 1.0 111.065 171.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.11 7.74 88.27 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 125.746 1.641 . . . . 1.0 114.584 -169.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -104.69 173.57 6.25 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.627 1.571 . . . . 1.0 112.481 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.6 mt -114.29 158.24 40.29 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 127.046 2.138 . . . . 1.0 114.814 -169.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.22 144.31 95.38 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.62 2.88 . . . . 1.0 112.489 169.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -62.96 -22.31 66.72 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.915 1.08 . . . . 1.0 113.915 -175.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.6 p -72.01 -24.63 61.59 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.065 1.135 . . . . 1.0 114.065 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.0 tt -111.72 -13.72 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.125 1.37 . . . . 1.0 113.682 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -44.61 -52.74 16.89 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 124.768 1.227 . . . . 1.0 112.622 168.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.73 -32.7 29.55 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 121.851 1.701 . . . . 1.0 111.954 -173.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 tp -62.92 -52.85 61.48 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.523 1.129 . . . . 1.0 111.375 169.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.643 ' CE1' HD23 ' A' ' 110' ' ' LEU . 92.5 t80 -55.13 -53.08 60.42 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.629 0.771 . . . . 1.0 112.651 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 -64.61 -40.58 95.75 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.717 0.807 . . . . 1.0 111.465 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.94 -35.78 91.2 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.41 -0.661 . . . . 1.0 112.333 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.591 HG22 HD12 ' A' ' 110' ' ' LEU . 89.4 mt -64.81 -50.09 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 120.229 2.015 . . . . 1.0 108.246 172.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.707 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.1 ptmm? -69.46 -31.83 70.38 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.326 -1.484 . . . . 1.0 113.188 -170.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -101.76 -37.61 8.23 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 115.133 1.531 . . . . 1.0 115.133 -175.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 m -97.79 -19.51 18.13 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.333 1.053 . . . . 1.0 113.446 -174.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.556 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -92.86 -72.53 0.6 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 107.391 -1.337 . . . . 1.0 107.391 169.906 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.81 -20.67 1.38 Allowed Glycine 0 CA--C 1.539 1.564 0 C-N-CA 127.541 2.496 . . . . 1.0 114.902 170.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -153.21 142.08 21.14 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 128.408 2.683 . . . . 1.0 108.07 169.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.401 HE21 HD12 ' A' ' 79' ' ' LEU . 5.5 mt-30 -137.35 119.96 11.38 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.929 0.891 . . . . 1.0 109.701 -169.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -77.55 -35.3 1.61 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.451 2.101 . . . . 1.0 115.965 -169.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -143.64 19.28 1.84 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.056 1.132 . . . . 1.0 114.056 -169.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.567 HD11 ' CG2' ' A' ' 52' ' ' VAL . 58.1 tp -85.84 140.06 30.75 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.686 -1.259 . . . . 1.0 114.176 -169.044 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.4 mtm-85 -137.33 153.57 50.22 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.989 2.516 . . . . 1.0 109.619 169.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.657 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -161.56 168.17 24.04 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.073 0.851 . . . . 1.0 112.543 -176.485 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.402 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -125.19 170.54 17.13 Favored Glycine 0 N--CA 1.472 1.093 0 C-N-CA 125.201 1.382 . . . . 1.0 114.134 174.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.3 t -142.44 132.7 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.658 1.183 . . . . 1.0 113.695 -169.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.97 HG23 HD12 ' A' ' 123' ' ' LEU . 4.1 mt -129.54 102.84 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.802 1.641 . . . . 1.0 108.035 170.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -91.86 142.3 27.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.526 1.531 . . . . 1.0 111.726 173.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.5 mp -138.13 152.7 48.97 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.235 -0.915 . . . . 1.0 112.793 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.42 -154.46 25.19 Favored Glycine 0 C--O 1.221 -0.697 0 C-N-CA 121.528 -0.368 . . . . 1.0 112.583 169.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -111.79 117.87 34.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.205 1.002 . . . . 1.0 109.786 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.1 t -63.8 -7.06 6.81 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.826 1.047 . . . . 1.0 113.826 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.7 t -65.04 -24.17 67.4 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.876 -1.14 . . . . 1.0 112.162 169.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -78.42 138.34 38.45 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.386 -0.821 . . . . 1.0 111.299 169.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -49.09 -49.65 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.726 1.61 . . . . 1.0 113.729 177.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -88.66 22.18 2.71 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.938 1.695 . . . . 1.0 114.542 -175.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.9 t80 1.76 -70.54 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 129.874 3.27 . . . . 1.0 117.73 -177.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.435 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 26.7 p -125.4 11.77 8.07 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.989 1.315 . . . . 1.0 114.519 -169.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -58.18 -21.63 48.17 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 117.573 -1.203 . . . . 1.0 114.08 -173.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.95 -43.0 87.77 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-N 121.371 1.896 . . . . 1.0 114.007 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -77.59 -36.88 32.25 Favored Glycine 0 N--CA 1.478 1.471 0 O-C-N 120.909 -1.348 . . . . 1.0 113.036 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.435 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 85.2 mttt -63.58 -33.49 75.71 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.34 1.056 . . . . 1.0 112.978 176.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -59.93 -44.15 94.5 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.263 1.425 . . . . 1.0 111.012 169.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -63.65 -39.12 93.55 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.662 -0.649 . . . . 1.0 110.948 175.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -42.99 99.63 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.774 -0.579 . . . . 1.0 111.709 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.83 -35.64 77.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 112.978 0.733 . . . . 1.0 112.978 171.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.707 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -58.91 -49.66 76.97 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 123.463 1.601 . . . . 1.0 110.902 -175.141 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.657 HD12 ' CD1' ' A' ' 87' ' ' TYR . 4.0 mt -67.52 -40.3 85.1 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 120.92 -1.112 . . . . 1.0 110.996 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -70.09 -17.87 63.24 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.364 0.876 . . . . 1.0 113.364 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.77 -17.08 59.26 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.488 1.04 . . . . 1.0 110.957 174.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -101.63 -73.28 0.66 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.147 1.379 . . . . 1.0 109.904 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 65.8 p 179.52 -19.32 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.106 1.763 . . . . 1.0 113.984 -174.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -72.1 151.59 42.95 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 123.06 1.41 . . . . 1.0 114.464 -169.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -87.75 165.37 15.4 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 113.071 -1.877 . . . . 1.0 113.298 -169.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.69 133.32 47.0 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.222 1.809 . . . . 1.0 110.21 -174.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 32.6 t -112.46 130.99 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.61 1.164 . . . . 1.0 109.857 -171.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 52.46 -157.72 3.77 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 125.314 1.435 . . . . 1.0 114.765 -173.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -111.9 139.82 47.07 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.839 1.656 . . . . 1.0 110.097 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -70.61 155.29 40.92 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 122.332 1.063 . . . . 1.0 112.222 -171.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.97 HD12 HG23 ' A' ' 90' ' ' ILE . 1.2 tm? -87.96 139.07 30.89 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.722 -1.127 . . . . 1.0 109.957 171.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 mt -127.65 106.57 9.24 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.404 1.482 . . . . 1.0 109.69 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.608 HG13 HD11 ' A' ' 123' ' ' LEU . 23.8 mt -95.84 127.79 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 O-C-N 121.169 -0.957 . . . . 1.0 112.042 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -104.68 109.59 21.57 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 122.4 1.095 . . . . 1.0 111.982 173.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.74 -22.71 66.04 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.558 1.143 . . . . 1.0 113.433 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.1 t -64.38 -22.48 66.97 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.035 0.934 . . . . 1.0 112.718 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -118.1 -29.91 5.46 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.0 1.72 . . . . 1.0 111.961 -175.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -142.54 87.72 9.11 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 125.086 1.354 . . . . 1.0 112.06 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.62 8.11 2.42 Favored 'Trans proline' 0 CA--C 1.552 1.404 0 C-N-CA 123.655 2.904 . . . . 1.0 114.271 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -114.73 69.97 2.24 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 127.2 2.2 . . . . 1.0 109.859 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -56.9 -23.13 49.45 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.723 2.282 . . . . 1.0 116.197 -169.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 pm0 -67.03 -24.13 65.97 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 121.028 -1.045 . . . . 1.0 112.251 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.9 p -74.77 -17.92 60.56 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.329 0.968 . . . . 1.0 112.301 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.425 ' HB2' HD11 ' A' ' 125' ' ' ILE . 5.1 mm-40 -100.33 -54.05 2.96 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.456 1.903 . . . . 1.0 111.509 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.5 p -68.19 -33.82 75.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 117.764 -1.112 . . . . 1.0 113.912 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -57.47 -61.69 6.73 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 120.877 1.671 . . . . 1.0 112.009 176.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -60.54 -23.58 75.81 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 CA-C-N 121.882 1.708 . . . . 1.0 113.744 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.456 ' CG ' ' HB2' ' A' ' 123' ' ' LEU . 87.9 t90 -68.87 -47.13 66.66 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 119.217 0.917 . . . . 1.0 110.984 173.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.532 HG11 ' HA ' ' A' ' 22' ' ' ALA . 93.2 t -65.27 -33.83 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 176.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.01 -31.0 70.38 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.0 1.32 . . . . 1.0 112.038 177.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -77.56 -62.34 1.69 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.994 1.718 . . . . 1.0 111.877 169.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.402 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 84.8 t90 -55.06 -36.89 66.05 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 126.191 1.796 . . . . 1.0 112.709 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.93 -31.93 25.72 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.98 1.276 . . . . 1.0 113.803 174.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.0 p -70.2 -13.77 62.33 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 114.352 1.241 . . . . 1.0 114.352 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.41 -17.02 53.04 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.85 1.66 . . . . 1.0 111.705 175.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -81.75 172.38 13.44 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.06 0.944 . . . . 1.0 111.6 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 C--O 1.255 1.371 0 C-N-CA 125.637 1.575 . . . . 1.0 112.619 -172.31 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 119.997 -0.049 . . . . 1.0 110.98 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.68 162.48 41.21 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.654 1.182 . . . . 1.0 113.348 -176.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -122.23 121.28 36.44 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.342 1.457 . . . . 1.0 110.346 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.595 HD13 HD12 ' A' ' 26' ' ' LEU . 2.2 mp -120.15 114.03 42.55 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 C-N-CA 126.057 1.743 . . . . 1.0 112.857 -178.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.48 122.53 6.79 Favored Glycine 0 C--O 1.222 -0.624 0 N-CA-C 110.573 -1.011 . . . . 1.0 110.573 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.4 mt -103.18 120.93 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-N 118.113 0.956 . . . . 1.0 109.271 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -114.2 113.21 24.35 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.245 -1.391 . . . . 1.0 107.245 -171.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.9 p -106.64 126.49 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.66 0.615 . . . . 1.0 112.66 -171.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -117.25 116.45 3.52 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.822 1.201 . . . . 1.0 111.002 176.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.4 m -151.19 133.49 15.36 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 120.751 2.276 . . . . 1.0 110.762 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.75 -16.92 11.18 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.834 1.05 . . . . 1.0 113.834 174.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -143.97 146.6 33.04 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.602 1.161 . . . . 1.0 112.025 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.11 178.23 50.7 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.779 1.181 . . . . 1.0 114.768 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -87.34 13.32 10.03 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.917 1.287 . . . . 1.0 113.772 -174.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.1 m -59.51 -18.12 37.6 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 115.78 1.771 . . . . 1.0 115.78 -170.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.9 mt -49.51 -35.47 20.18 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.388 1.075 . . . . 1.0 112.263 169.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.4 tp -44.39 -50.83 9.05 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.048 1.739 . . . . 1.0 113.641 172.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.6 t -55.04 -33.93 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.639 0.776 . . . . 1.0 111.567 -173.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.27 -45.89 92.6 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.706 -1.246 . . . . 1.0 113.04 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -66.61 -29.98 70.15 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.774 0.83 . . . . 1.0 110.844 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -70.2 -47.14 62.8 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.79 0.836 . . . . 1.0 109.139 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.552 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -64.0 -41.35 97.52 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 113.297 0.851 . . . . 1.0 113.297 -176.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -56.26 -48.46 76.52 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.307 1.043 . . . . 1.0 110.572 170.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.27 -37.8 71.88 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.754 0.822 . . . . 1.0 112.055 -174.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.1 mt -69.29 -45.55 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 O-C-N 121.322 -0.862 . . . . 1.0 109.602 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.595 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.67 -31.52 72.57 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.878 1.217 . . . . 1.0 110.816 -179.133 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.5 m -62.56 -45.82 91.17 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.843 1.257 . . . . 1.0 112.687 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.22 -31.02 70.23 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.675 1.19 . . . . 1.0 113.254 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -67.65 -29.46 68.77 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.121 1.768 . . . . 1.0 111.606 171.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.02 27.6 2.22 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.802 1.192 . . . . 1.0 114.882 171.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -123.42 159.2 29.5 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.083 1.353 . . . . 1.0 110.389 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -90.61 87.54 6.76 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 120.645 -1.284 . . . . 1.0 108.649 -177.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.83 146.62 27.99 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.113 0.565 . . . . 1.0 111.379 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.9 m -147.31 140.86 25.52 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.472 1.109 . . . . 1.0 112.188 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.0 t -89.76 139.22 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 115.613 1.709 . . . . 1.0 115.613 173.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -121.04 111.88 18.03 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.303 2.241 . . . . 1.0 110.136 169.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -95.13 139.15 31.88 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.011 1.724 . . . . 1.0 111.634 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.4 t70 42.63 52.94 8.18 Favored Pre-proline 0 CA--C 1.56 1.365 0 C-N-CA 124.943 1.297 . . . . 1.0 111.581 -169.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -70.96 147.63 55.6 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.075 3.183 . . . . 1.0 117.013 -168.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.425 ' HB3' ' H ' ' A' ' 42' ' ' SER . 52.4 mm-40 -93.81 163.81 13.37 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.452 1.101 . . . . 1.0 112.035 168.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.577 HD21 HD21 ' A' ' 79' ' ' LEU . 2.3 tm? -65.52 -22.26 66.7 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 120.729 -1.232 . . . . 1.0 110.269 167.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.425 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 16.8 m -68.29 -20.41 64.77 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.921 -1.112 . . . . 1.0 112.116 172.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -82.96 -25.51 32.25 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.499 1.12 . . . . 1.0 112.31 169.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.489 ' HB3' HD22 ' A' ' 41' ' ' LEU . 14.9 t-105 -86.42 -35.43 19.73 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.909 1.077 . . . . 1.0 113.909 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.1 mt -48.21 -38.43 21.04 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 114.464 1.283 . . . . 1.0 114.464 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -60.59 -11.75 18.4 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 123.691 2.928 . . . . 1.0 116.573 175.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -111.14 8.31 21.66 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 116.243 1.942 . . . . 1.0 116.243 -172.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -54.3 -35.04 62.19 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.073 1.749 . . . . 1.0 113.628 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -99.03 -2.39 37.35 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.025 1.73 . . . . 1.0 113.274 177.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -109.64 -164.98 0.97 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.819 2.447 . . . . 1.0 110.938 -176.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -109.77 163.22 13.71 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.937 1.351 . . . . 1.0 111.773 169.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.623 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -144.25 157.7 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.822 1.249 . . . . 1.0 109.519 -170.805 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.541 HD11 HD12 ' A' ' 90' ' ' ILE . 18.2 tp -139.33 124.37 18.83 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 124.235 1.014 . . . . 1.0 108.735 174.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.7 t -99.36 121.53 50.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.383 -0.826 . . . . 1.0 109.238 174.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.7 t -120.06 113.98 42.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 105.319 -2.104 . . . . 1.0 105.319 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -149.21 130.84 14.94 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.161 1.541 . . . . 1.0 115.161 -168.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 m -117.77 178.07 4.54 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 127.102 2.161 . . . . 1.0 111.735 -169.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.86 33.42 15.17 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.923 1.083 . . . . 1.0 113.923 168.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.2 m -53.35 -37.86 62.74 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.195 1.398 . . . . 1.0 112.255 169.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.57 -126.57 35.07 Favored Glycine 0 CA--C 1.533 1.205 0 O-C-N 121.445 -0.784 . . . . 1.0 112.426 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -63.45 -15.21 57.06 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.208 1.188 . . . . 1.0 114.208 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 148.25 -19.01 1.36 Allowed Glycine 0 CA--C 1.535 1.325 0 N-CA-C 116.894 1.517 . . . . 1.0 116.894 169.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -90.55 160.51 15.92 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.022 1.329 . . . . 1.0 113.857 -175.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.1 mt -80.73 144.5 56.22 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 123.708 0.803 . . . . 1.0 112.898 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.12 156.88 30.15 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.249 2.633 . . . . 1.0 113.404 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -60.23 -23.24 63.9 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.127 1.529 . . . . 1.0 115.127 -169.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.9 t -67.43 -31.72 72.11 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.203 0.816 . . . . 1.0 113.203 175.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.7 tt -111.82 -12.85 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.464 1.106 . . . . 1.0 113.894 -177.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.8 t -43.46 -52.38 13.52 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.835 1.254 . . . . 1.0 112.878 168.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.86 -33.11 34.62 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.714 1.609 . . . . 1.0 111.915 -173.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 tp -63.41 -53.83 46.21 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 124.235 1.014 . . . . 1.0 111.223 169.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.658 ' CE1' HD23 ' A' ' 110' ' ' LEU . 91.6 t80 -54.69 -52.81 61.22 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.796 0.839 . . . . 1.0 112.477 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -64.85 -40.77 95.69 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.424 1.09 . . . . 1.0 111.384 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.44 -34.91 86.1 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.371 0.51 . . . . 1.0 112.656 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.611 HG22 HD12 ' A' ' 110' ' ' LEU . 92.0 mt -64.79 -49.31 80.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.866 1.833 . . . . 1.0 108.558 171.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.715 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.4 ptmm? -70.91 -32.12 68.96 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.2 -1.562 . . . . 1.0 112.85 -169.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -104.62 -38.49 6.72 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.082 1.512 . . . . 1.0 115.082 -174.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.2 m -95.0 -23.37 17.41 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.26 1.024 . . . . 1.0 113.171 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.577 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -91.32 -70.98 0.66 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 169.84 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.24 -11.95 1.95 Allowed Glycine 0 CA--C 1.538 1.507 0 C-N-CA 126.776 2.131 . . . . 1.0 116.255 169.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -157.6 141.84 16.16 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 127.81 2.444 . . . . 1.0 108.366 174.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.442 HE22 HD12 ' A' ' 79' ' ' LEU . 10.1 mm-40 -136.0 123.15 14.53 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.962 0.905 . . . . 1.0 111.148 -172.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.41 -37.82 0.36 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.205 1.937 . . . . 1.0 114.724 -171.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -146.94 19.07 1.27 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.069 1.137 . . . . 1.0 114.069 -169.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.623 HD11 ' CG2' ' A' ' 52' ' ' VAL . 45.8 tp -79.46 140.56 37.3 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.404 -1.435 . . . . 1.0 113.861 -169.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -133.49 150.2 51.71 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 128.636 2.774 . . . . 1.0 107.571 169.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.663 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -160.88 166.85 27.78 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.319 -0.863 . . . . 1.0 112.932 -178.166 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.47 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -124.65 171.85 16.83 Favored Glycine 0 N--CA 1.475 1.295 0 C-N-CA 125.003 1.287 . . . . 1.0 114.531 173.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.5 t -143.52 133.08 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 114.852 1.427 . . . . 1.0 114.852 -169.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.541 HD12 HD11 ' A' ' 53' ' ' LEU . 4.0 mt -130.79 104.85 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.683 1.593 . . . . 1.0 107.968 169.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -91.74 143.19 26.8 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.891 1.677 . . . . 1.0 111.797 175.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.9 mp -137.44 148.41 46.1 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.448 0.907 . . . . 1.0 113.448 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.55 -172.6 43.08 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 114.805 0.682 . . . . 1.0 114.805 169.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -86.47 120.13 27.47 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.107 -1.231 . . . . 1.0 110.604 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.1 t -68.18 -3.61 11.16 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.985 1.106 . . . . 1.0 113.985 -176.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.6 t -64.32 -26.9 68.69 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.941 -1.099 . . . . 1.0 113.022 171.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -80.93 143.05 32.92 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.208 -0.932 . . . . 1.0 112.829 176.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -50.94 -50.91 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.399 1.48 . . . . 1.0 113.569 175.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -88.92 20.22 3.69 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.993 1.717 . . . . 1.0 114.638 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.3 t80 9.07 -74.23 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 130.42 3.488 . . . . 1.0 117.663 175.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 20.1 p -117.2 9.76 13.6 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.816 2.046 . . . . 1.0 114.193 -169.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -55.95 -23.49 32.45 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.481 1.912 . . . . 1.0 114.607 -172.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.32 -48.44 83.66 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-N 120.357 1.435 . . . . 1.0 113.412 174.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.25 -36.51 50.41 Favored Glycine 0 N--CA 1.478 1.474 0 O-C-N 120.782 -1.422 . . . . 1.0 113.248 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -60.31 -35.8 76.45 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.928 0.891 . . . . 1.0 113.168 172.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -65.24 -33.94 77.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 118.603 -0.713 . . . . 1.0 112.826 172.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -63.95 -37.4 87.28 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.689 1.131 . . . . 1.0 111.032 172.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.413 ' CG ' ' HE ' ' A' ' 118' ' ' ARG . 12.0 t70 -63.14 -49.88 72.64 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.027 0.831 . . . . 1.0 110.473 177.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.64 -33.0 59.96 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.251 0.834 . . . . 1.0 113.251 173.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.715 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -61.27 -50.28 73.66 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 123.238 1.494 . . . . 1.0 110.727 178.408 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.663 HD12 ' CD1' ' A' ' 87' ' ' TYR . 8.0 mt -65.1 -39.27 92.9 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 120.966 -1.084 . . . . 1.0 111.19 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -67.31 -22.39 65.63 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.557 0.947 . . . . 1.0 113.557 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.54 -17.53 59.19 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.393 0.997 . . . . 1.0 111.464 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -96.51 -73.61 0.59 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.994 1.318 . . . . 1.0 109.206 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 56.2 p 177.18 -18.32 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.755 2.022 . . . . 1.0 113.534 -175.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -67.59 157.26 34.86 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.793 1.282 . . . . 1.0 113.933 -169.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -99.4 173.39 6.78 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 113.239 -1.8 . . . . 1.0 112.155 -169.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.413 ' HE ' ' CG ' ' A' ' 108' ' ' ASP . 4.7 ttm180 -128.63 160.49 32.26 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.758 1.223 . . . . 1.0 113.509 174.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.1 t -119.25 126.71 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 127.232 2.213 . . . . 1.0 108.811 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 52.35 -165.0 1.42 Allowed Glycine 0 CA--C 1.542 1.762 0 C-N-CA 124.748 1.166 . . . . 1.0 115.628 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -107.56 149.41 28.06 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.726 1.611 . . . . 1.0 110.118 169.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.78 159.15 32.35 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.717 1.207 . . . . 1.0 113.188 -169.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.659 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.2 tm? -91.32 139.57 30.61 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.098 0.959 . . . . 1.0 110.165 169.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.659 ' N ' HD13 ' A' ' 123' ' ' LEU . 6.4 mt -122.83 105.76 10.3 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.205 1.402 . . . . 1.0 111.103 174.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.447 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.9 mt -91.95 131.19 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 125.331 1.452 . . . . 1.0 112.341 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -108.25 92.27 3.99 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.86 2.464 . . . . 1.0 112.617 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.4 -23.6 67.0 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.995 1.318 . . . . 1.0 112.794 -173.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.7 p -53.47 -30.39 40.64 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 129.329 3.052 . . . . 1.0 114.334 169.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -124.79 -26.53 3.77 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.849 2.06 . . . . 1.0 111.585 -171.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -143.22 88.59 8.07 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.44 1.496 . . . . 1.0 112.184 -177.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -76.53 11.19 1.95 Allowed 'Trans proline' 0 CA--C 1.549 1.251 0 C-N-CA 123.77 2.98 . . . . 1.0 114.211 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -111.62 68.77 0.77 Allowed Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 127.672 2.389 . . . . 1.0 110.042 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -57.38 -21.39 44.6 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.777 2.318 . . . . 1.0 116.809 -169.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -64.25 -27.25 68.92 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 118.934 0.788 . . . . 1.0 111.902 174.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.6 p -72.27 -18.78 61.78 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 120.939 -1.1 . . . . 1.0 111.813 -174.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -99.22 -53.66 3.18 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.807 1.643 . . . . 1.0 111.933 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 48.1 p -71.28 -33.77 70.06 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 114.599 1.333 . . . . 1.0 114.599 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -59.32 -56.63 34.06 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 120.723 1.601 . . . . 1.0 112.453 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -62.66 -22.64 74.15 Favored 'Trans proline' 0 C--N 1.355 0.871 0 CA-C-N 121.459 1.557 . . . . 1.0 112.735 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.479 ' HB2' HD23 ' A' ' 123' ' ' LEU . 91.4 t90 -69.19 -47.37 65.05 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 123.279 0.632 . . . . 1.0 111.093 174.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.552 HG11 ' HA ' ' A' ' 22' ' ' ALA . 97.5 t -65.23 -32.0 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 122.03 0.919 . . . . 1.0 108.899 176.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.93 -22.33 61.48 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 120.045 -1.659 . . . . 1.0 113.401 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -87.07 -62.52 1.48 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.858 2.063 . . . . 1.0 111.265 169.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.47 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 87.6 t90 -54.88 -38.26 67.32 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 126.892 2.077 . . . . 1.0 112.99 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.96 -29.26 27.11 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 121.42 -0.8 . . . . 1.0 114.488 173.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.1 p -69.32 -13.29 62.3 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.809 1.304 . . . . 1.0 114.367 175.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.5 -18.59 51.64 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.34 1.456 . . . . 1.0 111.774 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -84.41 170.1 13.91 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.517 1.127 . . . . 1.0 111.521 -175.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.251 1.182 0 N-CA-C 116.697 2.11 . . . . 1.0 116.697 -169.465 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 118.019 -0.991 . . . . 1.0 112.398 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.62 140.27 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.254 2.221 . . . . 1.0 116.469 -172.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -121.46 124.49 44.6 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 126.643 1.977 . . . . 1.0 110.057 170.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.492 HD13 HD12 ' A' ' 26' ' ' LEU . 1.7 mp -126.62 113.06 31.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 126.8 2.04 . . . . 1.0 111.898 -174.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.19 124.51 7.81 Favored Glycine 0 C--O 1.224 -0.518 0 N-CA-C 110.01 -1.236 . . . . 1.0 110.01 169.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.8 mt -104.59 123.34 58.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 118.151 0.976 . . . . 1.0 109.545 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -115.95 110.63 19.23 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.598 1.159 . . . . 1.0 108.266 -169.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.82 135.92 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.619 -0.264 . . . . 1.0 111.441 -175.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -123.92 131.49 8.02 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.571 1.081 . . . . 1.0 110.897 169.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.7 t -155.36 147.75 23.9 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 119.415 1.608 . . . . 1.0 114.599 -174.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.8 ttt -123.16 69.39 1.0 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.656 1.582 . . . . 1.0 107.801 169.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 60.82 21.68 11.78 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.383 1.873 . . . . 1.0 114.963 -171.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.78 177.22 46.49 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.552 1.549 . . . . 1.0 113.015 169.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -106.91 31.73 5.1 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.388 1.255 . . . . 1.0 114.388 -172.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.3 p -66.33 -20.83 66.19 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.418 -1.426 . . . . 1.0 112.973 172.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.81 -40.94 94.57 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.347 0.976 . . . . 1.0 112.298 173.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.7 tp -62.17 -50.28 72.48 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 118.08 0.4 . . . . 1.0 110.663 172.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -56.66 -39.23 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 O-C-N 121.79 -0.569 . . . . 1.0 110.891 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.7 -49.65 74.25 Favored 'General case' 0 C--O 1.23 0.062 0 CA-C-N 119.606 1.093 . . . . 1.0 112.615 176.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -67.79 -26.93 66.33 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.105 0.479 . . . . 1.0 112.055 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -70.74 -48.72 53.01 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 123.952 0.901 . . . . 1.0 109.938 169.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.627 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -60.98 -44.38 97.46 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 112.651 0.611 . . . . 1.0 112.651 -176.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -51.52 -51.24 56.9 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.521 1.128 . . . . 1.0 110.221 169.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.86 -35.62 74.87 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.633 0.773 . . . . 1.0 112.764 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.7 mt -70.43 -45.41 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 O-C-N 121.175 -0.953 . . . . 1.0 109.342 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.492 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.86 -34.44 78.16 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 120.028 -0.669 . . . . 1.0 110.213 -178.536 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.4 m -61.75 -44.42 96.93 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.973 1.309 . . . . 1.0 113.155 169.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.17 -32.61 73.83 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.62 1.168 . . . . 1.0 112.944 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -66.49 -32.78 74.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.534 1.134 . . . . 1.0 111.75 170.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.27 12.98 1.56 Allowed Glycine 0 CA--C 1.532 1.135 0 N-CA-C 116.091 1.196 . . . . 1.0 116.091 169.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -105.85 168.32 9.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.865 1.266 . . . . 1.0 112.116 -170.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? -90.64 97.26 11.08 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.914 1.286 . . . . 1.0 107.847 170.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.91 144.87 42.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.64 0.257 . . . . 1.0 110.693 174.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.6 m -147.59 138.74 23.61 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.72 0.808 . . . . 1.0 111.91 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.1 t -86.92 136.64 22.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 114.502 1.297 . . . . 1.0 114.502 171.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -111.59 114.63 27.81 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.135 1.774 . . . . 1.0 110.464 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -94.04 139.23 31.21 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.332 1.853 . . . . 1.0 110.61 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.6 t0 43.12 54.82 10.7 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 124.274 1.029 . . . . 1.0 110.664 -169.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -64.15 140.22 70.44 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.855 3.036 . . . . 1.0 117.259 -167.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -89.36 154.25 20.22 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.742 1.617 . . . . 1.0 112.043 168.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.475 HD21 ' CD2' ' A' ' 79' ' ' LEU . 2.3 tm? -69.47 -21.62 63.69 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 120.674 -1.266 . . . . 1.0 109.648 168.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 26.0 m -66.79 -21.86 66.04 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.286 -0.884 . . . . 1.0 112.448 169.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -82.47 -28.58 31.14 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.789 0.836 . . . . 1.0 112.599 169.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.469 ' HB3' HD22 ' A' ' 41' ' ' LEU . 11.0 t-105 -80.17 -38.75 30.7 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.571 1.078 . . . . 1.0 113.515 178.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.3 mt -44.1 -47.31 23.12 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 114.411 1.263 . . . . 1.0 114.411 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.1 4.98 1.61 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.79 2.327 . . . . 1.0 115.811 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -113.06 5.63 17.24 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 116.053 1.871 . . . . 1.0 116.053 174.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -49.51 -30.74 8.83 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 126.836 2.054 . . . . 1.0 113.275 170.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -104.65 7.83 35.04 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.228 2.611 . . . . 1.0 113.288 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -133.5 -155.4 0.67 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.518 2.327 . . . . 1.0 112.096 -169.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -114.3 160.34 19.18 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-O 123.504 1.621 . . . . 1.0 111.801 169.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.476 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -146.48 150.75 14.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 125.289 1.436 . . . . 1.0 107.454 -174.32 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.426 HD11 HD12 ' A' ' 90' ' ' ILE . 16.0 tp -129.63 127.31 40.33 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 124.753 1.221 . . . . 1.0 108.666 176.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.7 t -99.82 127.65 52.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 t -127.01 104.12 12.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.518 -1.66 . . . . 1.0 106.518 175.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t -136.82 128.61 29.03 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.502 0.927 . . . . 1.0 113.502 -167.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 t -111.77 -179.49 3.71 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 115.737 1.754 . . . . 1.0 115.737 -168.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.8 m 75.36 -58.72 0.56 Allowed 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 129.523 3.129 . . . . 1.0 112.449 169.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.1 m 58.65 -35.84 0.05 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.301 2.241 . . . . 1.0 116.944 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.88 -134.88 47.24 Favored Glycine 0 CA--C 1.532 1.144 0 O-C-N 119.988 -1.695 . . . . 1.0 111.45 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -70.24 -1.84 11.51 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.201 1.186 . . . . 1.0 114.201 174.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.76 -11.65 2.65 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 116.409 1.324 . . . . 1.0 116.409 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -83.27 179.49 7.69 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 118.788 1.294 . . . . 1.0 113.359 -174.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 18.2 mt -96.07 148.36 34.4 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.872 1.669 . . . . 1.0 113.435 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -61.4 145.28 98.32 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.917 2.412 . . . . 1.0 113.457 170.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -62.01 -22.57 65.8 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.089 0.956 . . . . 1.0 113.552 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.8 p -68.66 -27.12 65.7 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.838 1.255 . . . . 1.0 113.88 174.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.9 tt -113.54 -15.3 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.211 1.404 . . . . 1.0 114.015 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.8 t -42.66 -51.26 12.12 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 124.788 1.235 . . . . 1.0 112.612 168.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.0 -31.7 18.96 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.385 1.39 . . . . 1.0 111.776 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.7 tp -64.15 -51.03 65.8 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 124.219 1.008 . . . . 1.0 110.961 169.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.621 ' CE1' HD23 ' A' ' 110' ' ' LEU . 88.5 t80 -54.91 -53.63 53.06 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.502 1.121 . . . . 1.0 112.478 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -67.21 -34.6 77.83 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.964 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.55 -37.1 93.97 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.701 0.667 . . . . 1.0 112.523 174.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.565 HG22 HD12 ' A' ' 110' ' ' LEU . 78.6 mt -65.44 -49.43 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.96 1.88 . . . . 1.0 108.264 171.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.695 ' HB3' HD21 ' A' ' 110' ' ' LEU . 3.8 ptmm? -69.35 -31.16 69.4 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.241 -1.537 . . . . 1.0 113.358 -171.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -105.66 -38.02 6.55 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.406 1.632 . . . . 1.0 115.406 -174.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.6 m -93.85 -23.02 18.29 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.153 0.981 . . . . 1.0 112.873 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.475 ' CD2' HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -92.11 -71.13 0.66 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 106.277 -1.749 . . . . 1.0 106.277 169.055 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.5 -10.21 1.51 Allowed Glycine 0 CA--C 1.539 1.571 0 C-N-CA 127.386 2.422 . . . . 1.0 115.554 169.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -153.19 146.62 24.91 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 129.269 3.028 . . . . 1.0 107.214 170.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.434 ' HG3' ' HB2' ' A' ' 116' ' ' ALA . 39.7 mm-40 -136.01 125.57 16.07 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.339 0.656 . . . . 1.0 110.548 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -82.8 -39.94 0.13 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.352 2.035 . . . . 1.0 114.241 -173.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -146.87 18.01 1.26 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.596 1.158 . . . . 1.0 113.785 -169.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.476 HD11 ' CG2' ' A' ' 52' ' ' VAL . 42.1 tp -76.88 140.48 40.6 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.598 -1.314 . . . . 1.0 113.412 -169.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -133.45 147.85 51.71 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 129.421 3.088 . . . . 1.0 107.714 170.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.655 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -157.27 166.04 34.24 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.835 1.198 . . . . 1.0 112.384 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.405 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -130.05 173.63 19.81 Favored Glycine 0 N--CA 1.467 0.74 0 C-N-CA 125.43 1.491 . . . . 1.0 112.142 170.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.556 HG13 ' HB3' ' A' ' 122' ' ' MET . 0.2 OUTLIER -160.07 143.14 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 114.829 1.418 . . . . 1.0 114.829 -169.118 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.426 HD12 HD11 ' A' ' 53' ' ' LEU . 3.4 mt -124.39 113.74 37.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 126.721 2.008 . . . . 1.0 108.397 169.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.59 150.13 20.92 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 125.342 1.457 . . . . 1.0 110.462 169.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.97 152.05 44.65 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 121.801 -0.562 . . . . 1.0 111.419 173.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.57 174.12 39.61 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 115.515 0.966 . . . . 1.0 115.515 169.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -83.3 110.51 18.17 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.42 -1.047 . . . . 1.0 110.218 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.6 p -69.39 0.89 4.45 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.746 1.387 . . . . 1.0 114.746 -177.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.3 t -65.76 -29.25 69.73 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.326 0.966 . . . . 1.0 112.256 170.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -78.97 160.78 27.06 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.932 0.893 . . . . 1.0 112.655 171.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.45 168.04 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 116.155 -0.475 . . . . 1.0 109.973 168.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 60.42 46.58 9.68 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.113 0.965 . . . . 1.0 112.638 173.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -49.76 126.74 14.52 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.309 1.044 . . . . 1.0 112.574 -176.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 19.9 m 57.73 14.62 2.53 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.718 1.747 . . . . 1.0 115.718 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -59.0 -23.74 62.17 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.921 1.288 . . . . 1.0 114.196 -175.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.21 -46.2 94.17 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-N 120.335 1.425 . . . . 1.0 113.004 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.95 -36.29 47.39 Favored Glycine 0 N--CA 1.478 1.469 0 O-C-N 121.014 -1.286 . . . . 1.0 113.121 176.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -59.54 -34.97 73.32 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 117.922 0.861 . . . . 1.0 112.806 172.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 -67.04 -33.09 74.77 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.997 0.74 . . . . 1.0 112.997 173.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -62.16 -35.96 80.39 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.796 1.18 . . . . 1.0 111.314 171.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.22 -44.62 83.32 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.233 0.469 . . . . 1.0 111.342 175.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.72 -44.12 81.3 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 118.807 -0.616 . . . . 1.0 112.086 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.695 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -51.18 -48.97 61.79 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.746 2.018 . . . . 1.0 111.49 -177.466 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.655 HD12 ' CD1' ' A' ' 87' ' ' TYR . 8.0 mt -66.03 -40.07 90.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.331 -0.849 . . . . 1.0 111.928 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -67.4 -24.91 65.71 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.95 1.092 . . . . 1.0 113.95 175.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -64.62 -35.13 80.02 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.409 1.084 . . . . 1.0 111.491 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -83.96 -73.28 0.43 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 113.709 -1.587 . . . . 1.0 110.461 -175.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.5 m 174.14 -0.89 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.118 2.567 . . . . 1.0 111.821 173.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.527 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -74.19 159.58 32.34 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 122.414 1.102 . . . . 1.0 113.541 -169.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -100.69 171.46 7.68 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 113.898 -1.501 . . . . 1.0 111.362 -169.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 2.2 ttm105 -126.43 154.02 44.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.547 1.139 . . . . 1.0 112.779 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.485 HG12 ' H ' ' A' ' 120' ' ' GLY . 16.4 t -92.86 -173.1 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 C-N-CA 127.009 2.124 . . . . 1.0 106.009 169.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.485 ' H ' HG12 ' A' ' 119' ' ' VAL . . . -51.17 154.76 3.79 Favored Glycine 0 CA--C 1.543 1.838 0 O-C-N 120.345 -1.472 . . . . 1.0 115.929 -175.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -48.9 143.33 5.54 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.327 1.851 . . . . 1.0 114.771 -172.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.556 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.9 OUTLIER -75.62 156.57 34.77 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.669 1.187 . . . . 1.0 111.879 -169.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.634 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -90.98 137.81 32.08 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.537 -0.756 . . . . 1.0 109.719 174.325 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.634 ' N ' HD13 ' A' ' 123' ' ' LEU . 7.5 mt -122.41 109.13 14.0 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.641 1.176 . . . . 1.0 110.459 174.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.408 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.2 mt -91.45 130.44 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.062 1.345 . . . . 1.0 112.611 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.74 98.52 10.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.206 1.002 . . . . 1.0 110.039 175.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -70.4 -23.93 62.84 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.108 -1.62 . . . . 1.0 112.232 -175.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.65 -30.65 44.13 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 130.191 3.396 . . . . 1.0 114.12 169.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -124.67 -26.86 3.75 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.539 1.935 . . . . 1.0 111.957 -169.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -141.92 83.23 12.9 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 125.565 1.546 . . . . 1.0 111.276 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.76 12.45 1.41 Allowed 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 124.009 3.14 . . . . 1.0 113.904 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -109.64 65.5 0.36 Allowed Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 127.899 2.479 . . . . 1.0 109.553 174.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -58.65 -19.08 43.68 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.496 2.131 . . . . 1.0 116.952 -168.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -65.12 -28.44 69.44 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 121.343 -0.848 . . . . 1.0 111.919 173.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.6 p -70.75 -21.75 62.49 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.226 0.921 . . . . 1.0 112.181 -175.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -96.24 -54.69 3.2 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.899 1.679 . . . . 1.0 111.399 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 85.6 p -68.4 -33.07 73.58 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.656 1.354 . . . . 1.0 114.656 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.27 -50.03 51.5 Favored Pre-proline 0 CA--C 1.542 0.645 0 O-C-N 120.315 -1.49 . . . . 1.0 113.014 -173.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.69 -23.44 69.68 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 CA-C-N 121.289 1.496 . . . . 1.0 112.552 170.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.455 ' HB2' HD23 ' A' ' 123' ' ' LEU . 90.6 t90 -70.28 -46.32 64.57 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 123.342 0.657 . . . . 1.0 110.832 175.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.627 HG11 ' HA ' ' A' ' 22' ' ' ALA . 88.9 t -66.08 -34.63 71.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -63.55 -48.46 77.37 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.216 -0.928 . . . . 1.0 110.043 174.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -63.7 -55.68 21.52 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.73 1.212 . . . . 1.0 111.67 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.406 ' HE1' ' HB ' ' A' ' 119' ' ' VAL . 88.2 t90 -58.09 -35.05 70.86 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 125.693 1.597 . . . . 1.0 111.953 175.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.47 -32.87 31.69 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.462 1.505 . . . . 1.0 113.811 172.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.0 p -70.12 -12.65 61.75 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.832 1.419 . . . . 1.0 114.832 175.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.94 -17.33 43.99 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.67 1.588 . . . . 1.0 111.882 176.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -77.79 171.46 14.93 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 118.945 0.793 . . . . 1.0 110.871 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 56.4 m . . . . . 0 C--O 1.252 1.187 0 C-N-CA 125.44 1.496 . . . . 1.0 114.777 -173.416 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptp . . . . . 0 N--CA 1.498 1.936 0 N-CA-C 112.197 0.443 . . . . 1.0 112.197 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.79 157.5 21.07 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 114.694 1.368 . . . . 1.0 114.694 174.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -121.0 123.75 43.18 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.669 1.587 . . . . 1.0 109.775 173.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.608 HD13 HD12 ' A' ' 26' ' ' LEU . 1.9 mp -124.27 112.92 34.35 Favored 'Isoleucine or valine' 0 C--O 1.23 0.05 0 C-N-CA 125.856 1.662 . . . . 1.0 112.439 -176.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.22 125.49 7.92 Favored Glycine 0 C--O 1.224 -0.492 0 N-CA-C 110.24 -1.144 . . . . 1.0 110.24 169.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.5 mt -105.79 124.14 60.71 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 118.523 1.162 . . . . 1.0 109.591 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -115.57 110.22 18.91 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 125.109 1.364 . . . . 1.0 107.813 -170.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.9 p -93.29 131.05 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 O-C-N 123.266 0.354 . . . . 1.0 111.468 -175.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -118.75 113.92 2.7 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.306 0.955 . . . . 1.0 111.605 173.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.3 p -148.43 148.05 29.86 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 118.508 1.154 . . . . 1.0 112.149 -172.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -71.45 171.44 11.28 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.133 0.573 . . . . 1.0 111.866 169.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -59.26 146.21 40.17 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.531 0.732 . . . . 1.0 112.404 175.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.08 -153.18 46.44 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 123.912 0.768 . . . . 1.0 113.356 -172.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 51.47 -138.7 1.04 Allowed 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 125.3 1.44 . . . . 1.0 112.249 -176.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.1 t -150.55 153.23 35.4 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.637 1.108 . . . . 1.0 112.919 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -79.26 -5.17 53.78 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.767 1.627 . . . . 1.0 114.491 170.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.7 tp -20.78 -63.32 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 129.078 2.951 . . . . 1.0 116.829 -169.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.8 t -57.44 -32.76 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 119.344 -0.36 . . . . 1.0 111.717 -170.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.47 -45.29 94.28 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.76 1.164 . . . . 1.0 112.521 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -68.42 -31.06 70.13 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.81 0.844 . . . . 1.0 111.017 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -67.7 -47.15 70.22 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 173.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.547 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -64.74 -42.45 95.17 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 113.122 0.786 . . . . 1.0 113.122 -176.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -54.72 -48.43 72.51 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.344 1.058 . . . . 1.0 110.404 170.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.89 -38.21 70.02 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.517 0.727 . . . . 1.0 112.067 -174.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.3 mt -68.26 -45.48 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 O-C-N 121.33 -0.856 . . . . 1.0 109.35 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.608 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -66.16 -31.02 71.61 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.653 1.115 . . . . 1.0 110.884 -178.376 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 34.6 m -63.07 -45.55 91.66 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.796 1.238 . . . . 1.0 112.539 169.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.39 -31.97 71.7 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.57 1.148 . . . . 1.0 113.236 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -65.74 -30.47 71.14 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.123 1.769 . . . . 1.0 111.648 171.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.0 31.61 1.7 Allowed Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.702 1.144 . . . . 1.0 114.833 172.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -124.7 161.66 25.86 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.302 1.441 . . . . 1.0 110.739 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -91.8 86.24 5.86 Favored 'General case' 0 N--CA 1.46 0.071 0 C-N-CA 125.034 1.334 . . . . 1.0 108.939 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.5 146.2 28.46 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.05 0.54 . . . . 1.0 111.404 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.2 m -147.5 140.66 25.16 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.344 1.058 . . . . 1.0 112.198 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -87.04 137.31 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 115.108 1.521 . . . . 1.0 115.108 171.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -111.86 120.86 43.39 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.262 1.825 . . . . 1.0 111.126 169.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -99.92 138.23 37.28 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.587 1.955 . . . . 1.0 110.942 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.7 t0 42.18 54.85 9.34 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 124.39 1.076 . . . . 1.0 111.378 -169.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -63.56 137.32 58.9 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.836 3.024 . . . . 1.0 116.707 -168.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -88.56 157.35 18.63 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.547 1.539 . . . . 1.0 111.706 168.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.47 HD21 HD21 ' A' ' 79' ' ' LEU . 2.3 tm? -68.52 -21.27 64.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 120.261 -1.525 . . . . 1.0 109.567 167.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.2 m -68.86 -19.83 64.25 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.455 -0.778 . . . . 1.0 112.319 169.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -81.98 -28.57 32.57 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.546 1.138 . . . . 1.0 112.129 169.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.427 ' HB3' HD22 ' A' ' 41' ' ' LEU . 12.6 t-105 -82.7 -36.9 25.47 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.671 0.989 . . . . 1.0 113.671 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.8 mt -48.6 -39.83 34.87 Favored Pre-proline 0 CA--C 1.552 1.054 0 CA-C-O 117.482 -1.246 . . . . 1.0 114.123 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -57.59 -12.36 11.1 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 124.428 3.418 . . . . 1.0 117.144 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -110.53 8.13 22.84 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 116.121 1.897 . . . . 1.0 116.121 -174.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -52.72 -30.94 35.11 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.941 2.096 . . . . 1.0 113.782 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -113.48 13.1 18.81 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.882 1.273 . . . . 1.0 112.602 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -122.65 -159.51 0.84 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.273 2.629 . . . . 1.0 110.854 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -115.12 165.09 13.29 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 123.018 1.389 . . . . 1.0 111.763 170.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.417 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -149.49 163.19 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.331 1.452 . . . . 1.0 108.945 -172.17 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.402 HD11 HD12 ' A' ' 90' ' ' ILE . 17.4 tp -141.45 127.08 19.0 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.509 1.123 . . . . 1.0 108.951 175.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.46 124.0 52.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 124.055 0.942 . . . . 1.0 109.533 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.0 t -122.58 112.37 34.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 174.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t -148.4 128.98 14.05 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.136 1.532 . . . . 1.0 115.136 -167.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.7 m -110.1 175.4 5.45 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.931 2.092 . . . . 1.0 111.846 -173.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 65.25 42.15 4.1 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.222 1.193 . . . . 1.0 114.222 168.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.6 m -55.95 124.1 16.54 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.097 -1.075 . . . . 1.0 108.097 168.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.05 -130.73 2.65 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.558 1.075 . . . . 1.0 112.188 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -75.81 51.86 0.65 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.793 1.237 . . . . 1.0 110.721 169.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.18 -10.69 71.45 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 126.538 2.018 . . . . 1.0 115.801 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.9 -179.52 3.72 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 118.845 1.322 . . . . 1.0 113.806 -173.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 49.6 mt -94.87 159.16 33.83 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 127.294 2.238 . . . . 1.0 114.074 -169.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.85 154.9 43.58 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.835 2.356 . . . . 1.0 112.141 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -62.79 -19.61 64.19 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.601 1.334 . . . . 1.0 114.601 -170.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.9 p -71.13 -29.42 65.22 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.628 1.171 . . . . 1.0 114.05 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.6 tt -112.42 -16.03 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.745 1.218 . . . . 1.0 113.471 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.5 t -40.77 -50.61 7.29 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 124.638 1.175 . . . . 1.0 112.816 168.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.38 -30.03 20.04 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.506 1.471 . . . . 1.0 111.913 -172.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.5 tp -66.45 -50.58 62.85 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 123.804 0.842 . . . . 1.0 110.534 169.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.676 ' CE1' HD23 ' A' ' 110' ' ' LEU . 76.0 t80 -54.69 -54.31 43.44 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.018 0.927 . . . . 1.0 112.306 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -68.05 -35.4 78.17 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.132 -0.486 . . . . 1.0 111.915 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.18 -36.72 93.58 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 123.941 0.781 . . . . 1.0 112.367 176.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.542 HG22 HD12 ' A' ' 110' ' ' LEU . 79.7 mt -62.43 -51.87 66.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.521 1.661 . . . . 1.0 108.136 170.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.711 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.3 ptmm? -68.43 -32.59 72.73 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 120.435 -1.415 . . . . 1.0 113.141 -169.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -99.58 -37.26 9.23 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.771 1.629 . . . . 1.0 114.808 -174.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 m -99.8 -19.17 16.83 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.613 1.165 . . . . 1.0 113.17 -174.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.47 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -94.3 -71.54 0.66 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 106.409 -1.7 . . . . 1.0 106.409 169.57 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.89 -13.88 1.65 Allowed Glycine 0 CA--C 1.537 1.426 0 C-N-CA 127.642 2.544 . . . . 1.0 116.719 168.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -154.67 137.89 15.7 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.872 2.069 . . . . 1.0 108.633 172.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.419 HE22 HD12 ' A' ' 79' ' ' LEU . 1.6 mm-40 -134.92 124.0 16.31 Favored Pre-proline 0 CA--C 1.546 0.816 0 O-C-N 121.354 -0.841 . . . . 1.0 111.499 -171.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.83 -39.62 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.015 2.477 . . . . 1.0 114.72 -174.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -140.63 14.84 2.34 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.5 1.296 . . . . 1.0 114.5 -169.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.417 HD11 ' CG2' ' A' ' 52' ' ' VAL . 70.0 tp -80.84 138.06 36.21 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.579 -1.326 . . . . 1.0 112.862 -169.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.1 mtm-85 -135.97 156.76 48.26 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.963 2.505 . . . . 1.0 109.085 169.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.63 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -163.78 166.82 21.63 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.306 -0.871 . . . . 1.0 112.181 -176.501 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.487 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -120.05 171.92 14.69 Favored Glycine 0 N--CA 1.472 1.058 0 C-N-CA 125.487 1.518 . . . . 1.0 114.438 173.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.0 t -146.35 133.07 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 115.63 1.715 . . . . 1.0 115.63 -169.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.402 HD12 HD11 ' A' ' 53' ' ' LEU . 4.5 mt -131.6 108.38 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 125.719 1.608 . . . . 1.0 107.481 168.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.84 148.3 23.26 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.236 1.414 . . . . 1.0 112.017 170.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.8 mp -139.78 149.04 43.07 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.869 0.692 . . . . 1.0 112.869 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.52 -167.96 40.91 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 116.115 -0.493 . . . . 1.0 113.443 169.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -95.18 116.7 29.09 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.675 1.19 . . . . 1.0 111.792 173.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.3 t -65.37 -5.43 7.46 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.846 1.054 . . . . 1.0 113.846 178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.9 p -64.03 -22.45 66.93 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.985 -1.072 . . . . 1.0 112.892 169.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -86.88 141.57 28.67 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.893 1.277 . . . . 1.0 111.985 170.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -46.55 -50.8 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 126.339 1.856 . . . . 1.0 114.504 -178.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -90.13 15.08 10.87 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.719 1.608 . . . . 1.0 115.027 -174.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.4 t80 25.59 -83.54 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 129.44 3.096 . . . . 1.0 117.063 175.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.6 m -120.89 16.23 11.75 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.138 1.775 . . . . 1.0 113.609 -172.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -61.48 -16.03 43.37 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.494 1.517 . . . . 1.0 114.545 -173.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.32 -42.02 97.17 Favored Glycine 0 CA--C 1.537 1.408 0 CA-C-N 120.271 1.396 . . . . 1.0 113.22 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.97 -36.53 46.51 Favored Glycine 0 N--CA 1.48 1.626 0 O-C-N 120.258 -1.731 . . . . 1.0 112.724 174.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -63.02 -33.36 75.26 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.871 0.868 . . . . 1.0 112.785 174.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -58.4 -42.73 87.77 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.807 0.843 . . . . 1.0 111.856 170.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -62.06 -37.89 86.69 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.763 0.71 . . . . 1.0 111.14 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.55 -46.16 84.03 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.657 0.662 . . . . 1.0 111.366 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.61 -43.48 68.7 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.442 -0.789 . . . . 1.0 112.0 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.711 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -52.24 -49.44 64.0 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.787 2.035 . . . . 1.0 111.733 -177.558 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.63 HD12 ' CD1' ' A' ' 87' ' ' TYR . 6.3 mt -65.31 -40.35 93.63 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.471 -0.786 . . . . 1.0 111.232 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -67.65 -22.81 65.29 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.247 1.203 . . . . 1.0 114.247 175.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -64.42 -35.7 81.76 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.666 1.186 . . . . 1.0 110.7 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -86.01 -78.46 0.27 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 113.361 -1.745 . . . . 1.0 110.041 -175.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.2 t 179.26 0.01 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.474 1.91 . . . . 1.0 112.171 172.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -76.45 155.48 33.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 122.264 1.031 . . . . 1.0 113.443 -169.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -92.8 170.84 9.39 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.997 1.719 . . . . 1.0 112.018 -169.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -129.36 159.91 34.7 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.779 1.231 . . . . 1.0 112.342 172.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.0 t -122.62 126.09 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 125.981 1.712 . . . . 1.0 108.209 -176.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 52.4 -168.71 0.74 Allowed Glycine 0 CA--C 1.542 1.739 0 C-N-CA 125.642 1.591 . . . . 1.0 116.199 -176.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -92.37 146.76 23.44 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.163 1.385 . . . . 1.0 110.038 169.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.88 156.34 36.52 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.764 0.826 . . . . 1.0 111.456 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.628 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -92.52 138.54 31.42 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.937 0.895 . . . . 1.0 110.258 170.509 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.628 ' N ' HD13 ' A' ' 123' ' ' LEU . 7.3 mt -121.71 104.46 9.61 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.764 1.226 . . . . 1.0 111.265 173.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.68 131.49 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 C-N-CA 125.034 1.334 . . . . 1.0 112.049 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -107.54 106.29 16.59 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.175 0.988 . . . . 1.0 112.925 172.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -69.24 -22.86 63.83 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.565 0.95 . . . . 1.0 113.565 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.9 t -63.8 -22.52 66.95 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.389 1.076 . . . . 1.0 112.512 173.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -116.13 -30.2 6.06 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.279 1.831 . . . . 1.0 111.884 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -145.6 91.52 5.7 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 124.909 1.283 . . . . 1.0 112.601 -173.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.4 2.54 7.19 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 123.363 2.709 . . . . 1.0 114.383 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -109.82 72.35 0.61 Allowed Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 129.152 2.981 . . . . 1.0 110.444 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -60.5 -12.53 21.15 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.622 2.881 . . . . 1.0 116.723 -169.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -67.0 -28.19 68.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.803 0.729 . . . . 1.0 111.541 172.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 44.3 p -68.91 -26.21 64.98 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.117 -0.99 . . . . 1.0 111.935 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -93.78 -53.1 4.15 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.849 1.26 . . . . 1.0 111.818 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.7 t -72.42 -32.26 66.19 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.503 1.297 . . . . 1.0 114.503 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -61.17 -55.4 44.36 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 121.243 1.838 . . . . 1.0 112.731 -177.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -62.99 -22.65 73.92 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 121.567 1.595 . . . . 1.0 112.676 175.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.484 ' HB2' HD23 ' A' ' 123' ' ' LEU . 92.0 t90 -68.53 -48.62 63.87 Favored 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.345 0.658 . . . . 1.0 110.602 174.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 22' ' ' ALA . 83.9 t -65.43 -32.06 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 122.002 0.906 . . . . 1.0 109.042 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.96 -23.22 61.4 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 119.991 -1.693 . . . . 1.0 113.336 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -86.79 -61.98 1.61 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.978 2.111 . . . . 1.0 111.403 169.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.487 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 83.9 t90 -54.98 -38.2 67.49 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 126.844 2.058 . . . . 1.0 112.823 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.2 -28.71 27.37 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 118.913 0.778 . . . . 1.0 114.513 173.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.5 p -69.93 -12.78 61.87 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.808 1.304 . . . . 1.0 114.043 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.03 -18.98 48.75 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.91 1.684 . . . . 1.0 111.615 176.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.88 171.99 11.08 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.991 1.316 . . . . 1.0 111.194 -177.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 C--O 1.255 1.35 0 C-N-CA 125.252 1.421 . . . . 1.0 114.743 -171.92 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.502 2.163 0 N-CA-C 113.799 1.037 . . . . 1.0 113.799 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.34 172.56 2.47 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 117.717 2.488 . . . . 1.0 117.717 -169.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -122.23 126.95 49.31 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.582 1.953 . . . . 1.0 109.726 173.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.563 HD13 HD12 ' A' ' 26' ' ' LEU . 2.1 mp -123.91 114.25 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 C-N-CA 127.078 2.151 . . . . 1.0 112.213 179.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.71 124.44 7.63 Favored Glycine 0 C--O 1.224 -0.512 0 N-CA-C 110.315 -1.114 . . . . 1.0 110.315 169.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.0 mt -104.43 118.97 52.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 118.283 1.042 . . . . 1.0 109.618 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -111.51 108.79 18.43 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.941 -1.503 . . . . 1.0 106.941 -170.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.6 p -100.41 130.69 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 O-C-N 123.235 0.334 . . . . 1.0 111.375 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.87 150.85 49.73 Favored Glycine 0 CA--C 1.542 1.744 0 O-C-N 122.072 -0.393 . . . . 1.0 112.765 175.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.35 1.4 t 54.82 170.37 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 127.238 2.215 . . . . 1.0 116.562 -170.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -95.35 -34.98 11.94 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.634 1.574 . . . . 1.0 113.061 -171.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -142.29 146.39 35.02 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.654 1.182 . . . . 1.0 112.551 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.04 154.21 6.72 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.271 1.415 . . . . 1.0 112.634 175.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -63.72 -27.79 69.44 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.436 -1.038 . . . . 1.0 113.426 -173.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.6 p -69.18 -21.91 63.94 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.672 1.189 . . . . 1.0 113.876 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.37 -24.55 67.89 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.272 0.942 . . . . 1.0 112.253 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.5 tp -39.96 -47.79 2.28 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.019 1.727 . . . . 1.0 112.644 169.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.5 t -52.63 -33.14 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.17 0.988 . . . . 1.0 112.184 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.19 -48.69 80.37 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 120.0 1.273 . . . . 1.0 113.208 173.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -65.79 -33.11 75.09 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.577 0.751 . . . . 1.0 110.682 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -66.46 -47.79 72.0 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 123.934 0.893 . . . . 1.0 109.406 173.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.544 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -63.78 -43.07 97.45 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 112.584 0.587 . . . . 1.0 112.584 -176.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.11 -49.01 72.82 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.951 0.5 . . . . 1.0 110.029 170.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.42 -38.07 74.53 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.776 0.658 . . . . 1.0 112.776 -173.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.9 mt -65.88 -47.5 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 174.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.563 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -67.14 -34.32 77.33 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 119.651 -0.82 . . . . 1.0 110.573 -175.884 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.0 m -62.76 -41.63 99.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.691 1.597 . . . . 1.0 113.52 170.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.5 -32.81 73.88 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.825 0.85 . . . . 1.0 112.308 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -71.49 -29.32 64.68 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.638 1.175 . . . . 1.0 113.447 171.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.53 26.83 2.3 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.393 0.996 . . . . 1.0 114.086 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -116.35 146.56 42.36 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.381 1.072 . . . . 1.0 109.769 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -79.99 89.41 5.34 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 125.088 1.355 . . . . 1.0 108.448 -175.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.52 146.61 30.4 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 122.552 0.341 . . . . 1.0 110.737 -178.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.7 m -149.29 146.76 27.71 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.011 0.924 . . . . 1.0 111.399 -172.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.3 t -97.51 139.27 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 114.794 1.405 . . . . 1.0 114.794 176.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -122.61 113.66 19.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.974 2.11 . . . . 1.0 109.966 169.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -98.88 138.11 36.48 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.746 1.618 . . . . 1.0 111.188 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 43.24 55.45 11.31 Favored Pre-proline 0 CA--C 1.564 1.496 0 C-N-CA 124.518 1.127 . . . . 1.0 111.475 -169.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.52 152.09 59.61 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 125.167 3.911 . . . . 1.0 119.198 -167.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -93.84 155.47 17.17 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.216 2.206 . . . . 1.0 113.008 168.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.502 HD22 ' HB3' ' A' ' 44' ' ' TRP . 2.4 tm? -69.46 -23.22 63.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 120.827 -1.171 . . . . 1.0 109.983 168.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.6 m -65.93 -23.13 66.56 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.27 -0.894 . . . . 1.0 112.228 171.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -83.07 -24.68 32.61 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.242 1.017 . . . . 1.0 113.122 169.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.502 ' HB3' HD22 ' A' ' 41' ' ' LEU . 11.6 t-105 -82.27 -35.82 27.69 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.74 1.154 . . . . 1.0 113.786 177.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.4 mt -50.08 -38.62 38.33 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-O 117.567 -1.206 . . . . 1.0 114.098 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -52.92 -16.92 6.72 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 124.202 3.268 . . . . 1.0 117.319 171.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -109.24 9.88 25.84 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 115.486 1.662 . . . . 1.0 115.486 -175.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -52.6 -33.09 44.72 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 126.08 1.752 . . . . 1.0 113.708 177.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -105.01 1.69 28.88 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.555 1.542 . . . . 1.0 113.576 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -112.56 -164.05 0.89 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.62 2.368 . . . . 1.0 110.932 -175.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -109.04 164.98 11.94 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 122.982 1.373 . . . . 1.0 111.541 169.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.486 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -149.64 159.92 5.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 125.245 1.418 . . . . 1.0 109.164 -172.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.421 HD11 HD12 ' A' ' 90' ' ' ILE . 14.4 tp -138.73 129.95 27.01 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 124.792 1.237 . . . . 1.0 108.698 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.8 t -105.16 125.55 60.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 124.247 1.019 . . . . 1.0 108.964 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.59 114.45 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 107.484 -1.302 . . . . 1.0 107.484 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 t -150.06 116.83 5.87 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.797 1.036 . . . . 1.0 113.797 -169.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.6 t -103.53 13.24 33.85 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.786 2.034 . . . . 1.0 111.732 173.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.2 p -88.46 -6.7 57.48 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.542 1.682 . . . . 1.0 115.542 -168.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.5 m -42.65 -49.25 5.56 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.729 2.011 . . . . 1.0 114.093 178.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 52.0 -130.04 35.91 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-N 119.071 0.851 . . . . 1.0 111.915 -175.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -56.81 -32.45 65.72 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.943 0.897 . . . . 1.0 113.012 172.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 165.33 -24.49 0.16 Allowed Glycine 0 CA--C 1.535 1.343 0 N-CA-C 116.99 1.556 . . . . 1.0 116.99 169.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -99.11 153.26 19.03 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.89 1.676 . . . . 1.0 114.254 -173.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.74 146.83 61.13 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 113.402 0.89 . . . . 1.0 113.402 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -88.02 165.97 7.09 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.781 3.654 . . . . 1.0 113.643 177.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -55.8 -13.75 1.95 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.989 2.116 . . . . 1.0 115.684 -177.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.5 p -78.25 -39.89 38.82 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.092 1.145 . . . . 1.0 114.092 176.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.8 tt -110.47 -15.36 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.941 1.296 . . . . 1.0 112.78 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.4 t -46.24 -50.56 37.86 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 125.18 1.392 . . . . 1.0 112.298 167.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.6 -28.19 31.75 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.688 1.592 . . . . 1.0 111.609 -173.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 tp -70.46 -51.66 27.63 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 123.673 0.789 . . . . 1.0 110.722 169.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.612 ' CE1' HD23 ' A' ' 110' ' ' LEU . 89.8 t80 -55.4 -55.38 32.28 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.234 1.014 . . . . 1.0 112.493 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -68.05 -35.36 78.1 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.44 0.696 . . . . 1.0 111.832 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.13 -35.91 92.58 Favored Glycine 0 CA--C 1.529 0.91 0 O-C-N 121.662 -0.649 . . . . 1.0 112.359 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.607 HG22 HD12 ' A' ' 110' ' ' LEU . 88.8 mt -65.88 -51.57 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 119.871 1.835 . . . . 1.0 107.901 170.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.671 ' HB3' HD21 ' A' ' 110' ' ' LEU . 1.8 ptmm? -68.28 -30.52 69.55 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 120.165 -1.585 . . . . 1.0 113.715 -169.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -107.61 -37.45 6.17 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.995 1.718 . . . . 1.0 115.217 -176.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.5 m -94.1 -21.0 19.39 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.985 0.914 . . . . 1.0 113.197 -176.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.495 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -92.38 -71.49 0.64 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 106.523 -1.658 . . . . 1.0 106.523 169.15 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.94 -19.33 1.0 Allowed Glycine 0 CA--C 1.535 1.314 0 C-N-CA 127.945 2.688 . . . . 1.0 115.38 169.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -152.19 139.31 19.23 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 128.185 2.594 . . . . 1.0 107.885 169.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.451 HE21 HD12 ' A' ' 79' ' ' LEU . 12.8 mt-30 -137.86 121.8 11.75 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 118.829 -0.605 . . . . 1.0 109.838 -170.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -81.61 -35.99 0.37 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.713 2.275 . . . . 1.0 115.496 -169.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -142.91 15.84 1.93 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.18 1.178 . . . . 1.0 114.18 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.486 HD11 ' CG2' ' A' ' 52' ' ' VAL . 67.2 tp -81.74 140.1 34.48 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.716 -1.24 . . . . 1.0 112.881 -169.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.5 mtm-85 -136.51 154.68 50.66 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.694 2.397 . . . . 1.0 109.311 169.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.665 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -160.18 170.29 21.48 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.286 0.948 . . . . 1.0 111.87 -177.714 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -129.25 171.45 20.01 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 124.744 1.164 . . . . 1.0 113.393 170.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 122' ' ' MET . 0.0 OUTLIER -140.88 138.41 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.134 0.973 . . . . 1.0 113.521 -169.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.942 HG23 HD12 ' A' ' 123' ' ' LEU . 7.1 mt -130.81 96.52 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.631 1.572 . . . . 1.0 107.096 169.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.92 145.61 25.42 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.494 1.518 . . . . 1.0 111.066 172.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.4 mp -140.71 157.32 45.61 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 121.611 -0.681 . . . . 1.0 112.17 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.58 167.95 34.67 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 121.976 0.764 . . . . 1.0 114.715 169.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -74.3 119.48 18.56 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.005 -1.291 . . . . 1.0 109.763 170.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.5 t -64.33 -4.61 3.97 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.85 1.055 . . . . 1.0 113.85 -177.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.3 t -71.11 -22.37 62.09 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.931 -1.106 . . . . 1.0 112.781 170.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -72.86 158.57 35.28 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.551 0.945 . . . . 1.0 113.551 176.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.3 t -62.26 -37.53 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.187 1.395 . . . . 1.0 113.464 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -121.97 27.86 7.86 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.699 1.6 . . . . 1.0 114.424 -169.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 18.8 t80 32.93 -87.29 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 128.198 2.599 . . . . 1.0 117.019 172.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 15.5 m -121.35 17.28 11.42 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.66 1.984 . . . . 1.0 113.2 -174.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -54.12 -30.34 48.4 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.013 1.725 . . . . 1.0 114.722 -174.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.88 -41.55 94.23 Favored Glycine 0 N--CA 1.473 1.132 0 CA-C-N 121.477 1.944 . . . . 1.0 113.32 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.07 -37.73 28.16 Favored Glycine 0 N--CA 1.476 1.304 0 CA-C-N 118.258 1.029 . . . . 1.0 113.326 173.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -58.66 -35.14 72.07 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.647 1.223 . . . . 1.0 113.167 173.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -68.29 -33.48 74.42 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.244 0.618 . . . . 1.0 112.14 172.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -63.69 -37.13 86.19 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.759 1.163 . . . . 1.0 110.963 172.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.1 -48.14 79.85 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.98 0.912 . . . . 1.0 112.139 174.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.98 -35.15 70.78 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.816 0.672 . . . . 1.0 112.816 173.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.671 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -57.82 -50.12 74.36 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 123.525 1.631 . . . . 1.0 110.906 -176.079 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.665 HD12 ' CD1' ' A' ' 87' ' ' TYR . 6.3 mt -66.34 -40.52 89.88 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 120.762 -1.211 . . . . 1.0 111.262 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -70.73 -16.91 62.81 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.241 0.83 . . . . 1.0 113.241 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.81 -20.4 53.27 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.579 1.081 . . . . 1.0 110.798 175.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -97.79 -79.37 0.47 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.377 1.471 . . . . 1.0 110.28 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.0 t -175.27 -3.28 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.79 1.636 . . . . 1.0 112.573 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.466 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -79.83 151.95 29.98 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 122.962 1.363 . . . . 1.0 113.596 -169.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -88.44 168.2 12.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.049 1.74 . . . . 1.0 113.799 -168.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -119.4 148.04 43.67 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.779 2.031 . . . . 1.0 110.922 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.3 t -120.71 128.31 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.149 1.38 . . . . 1.0 108.798 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 50.06 -158.13 1.68 Allowed Glycine 0 N--CA 1.48 1.609 0 C-N-CA 125.087 1.327 . . . . 1.0 114.569 -172.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -110.91 142.49 42.92 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.088 1.355 . . . . 1.0 109.277 169.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.425 ' HB3' HG23 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -75.36 157.84 33.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.184 0.994 . . . . 1.0 113.049 -169.386 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.942 HD12 HG23 ' A' ' 90' ' ' ILE . 1.4 tm? -90.69 137.11 32.62 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.918 1.287 . . . . 1.0 110.27 173.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.9 mt -127.84 109.35 11.53 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.624 1.57 . . . . 1.0 109.98 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.568 HG13 HD11 ' A' ' 123' ' ' LEU . 28.4 mt -98.25 134.24 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.11 0.964 . . . . 1.0 113.014 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -100.18 91.86 4.95 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.919 2.488 . . . . 1.0 112.71 174.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.82 -23.28 66.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.209 1.004 . . . . 1.0 112.733 -174.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.9 p -54.1 -30.88 50.22 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 129.373 3.069 . . . . 1.0 114.158 169.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -121.28 -26.19 5.09 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.586 1.954 . . . . 1.0 111.508 -171.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -140.32 89.26 10.86 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 125.184 1.393 . . . . 1.0 111.474 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -75.66 11.39 1.64 Allowed 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.842 3.028 . . . . 1.0 114.005 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -113.77 65.3 1.23 Allowed Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 127.358 2.263 . . . . 1.0 110.072 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -55.72 -22.37 36.21 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.561 2.174 . . . . 1.0 116.176 -169.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.7 pm0 -64.49 -25.01 67.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 119.553 1.069 . . . . 1.0 111.817 175.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.5 p -72.82 -17.14 61.59 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 120.628 -1.295 . . . . 1.0 112.372 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.404 ' HB2' HD11 ' A' ' 125' ' ' ILE . 65.3 mm-40 -102.54 -55.79 2.38 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.258 1.823 . . . . 1.0 111.957 176.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 63.6 p -68.73 -33.31 73.71 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 113.817 1.043 . . . . 1.0 113.817 -176.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 36.5 m-20 -60.11 -59.23 14.53 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 120.688 1.585 . . . . 1.0 112.399 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -62.33 -22.32 73.93 Favored 'Trans proline' 0 C--N 1.352 0.713 0 CA-C-N 121.377 1.527 . . . . 1.0 112.943 175.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.459 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 87.2 t90 -68.71 -46.07 69.93 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 118.776 0.716 . . . . 1.0 111.2 172.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' A' ' 22' ' ' ALA . 92.2 t -63.84 -34.62 69.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 175.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.07 -30.83 70.12 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.299 1.44 . . . . 1.0 112.071 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -78.01 -61.87 1.86 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.113 1.765 . . . . 1.0 112.355 170.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -56.04 -36.43 68.0 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 126.046 1.738 . . . . 1.0 112.694 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.88 -32.32 26.11 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.393 0.997 . . . . 1.0 113.958 173.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.5 p -67.91 -13.8 62.45 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.073 1.138 . . . . 1.0 114.073 177.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.42 -17.71 50.99 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.002 1.721 . . . . 1.0 111.899 176.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.06 176.24 7.71 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.356 1.462 . . . . 1.0 110.911 -177.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 C--O 1.25 1.081 0 N-CA-C 114.803 1.408 . . . . 1.0 114.803 -170.077 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtt . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 111.316 0.117 . . . . 1.0 111.316 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.32 144.69 49.84 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.785 0.834 . . . . 1.0 113.049 175.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -124.78 121.25 34.08 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.404 1.082 . . . . 1.0 111.178 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.506 HD13 HD12 ' A' ' 26' ' ' LEU . 2.1 mp -118.91 116.25 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 126.579 1.952 . . . . 1.0 112.803 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.04 127.42 9.06 Favored Glycine 0 C--O 1.221 -0.668 0 N-CA-C 111.159 -0.776 . . . . 1.0 111.159 169.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.3 mt -106.36 120.17 56.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 118.682 1.241 . . . . 1.0 109.979 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -111.44 107.63 16.91 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 125.332 1.453 . . . . 1.0 107.598 -169.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.7 p -95.7 123.38 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.32 0.581 . . . . 1.0 112.013 -171.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.22 73.33 0.21 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.589 1.566 . . . . 1.0 111.523 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 95.1 m -132.26 115.72 16.01 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.592 1.157 . . . . 1.0 110.323 -176.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 90.5 mtp -86.57 -28.97 22.99 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.276 0.843 . . . . 1.0 113.276 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -149.98 154.88 38.97 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.9 1.28 . . . . 1.0 112.23 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.85 172.32 43.69 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.82 1.2 . . . . 1.0 114.802 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -80.21 -2.8 46.45 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.97 1.1 . . . . 1.0 113.97 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.9 m -54.01 -27.39 31.57 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.515 1.526 . . . . 1.0 114.443 -174.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.7 pp -54.23 -24.96 20.58 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.194 1.398 . . . . 1.0 113.753 173.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.1 tp -39.4 -47.32 1.77 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.691 1.997 . . . . 1.0 112.864 170.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -53.03 -33.07 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.857 0.863 . . . . 1.0 111.995 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.71 -47.15 86.57 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 120.002 1.274 . . . . 1.0 112.72 174.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -65.94 -33.54 76.06 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.835 0.854 . . . . 1.0 110.839 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -66.1 -48.22 71.61 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 123.361 0.664 . . . . 1.0 109.234 173.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.626 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -64.07 -41.83 97.21 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 112.857 0.688 . . . . 1.0 112.857 -175.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.44 -51.14 65.91 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 169.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.08 -37.54 81.35 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.572 -0.705 . . . . 1.0 112.808 -174.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.4 mt -68.27 -46.78 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 119.371 0.987 . . . . 1.0 109.572 176.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.506 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.66 -36.3 83.28 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.565 0.697 . . . . 1.0 110.633 -177.245 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.3 m -61.04 -43.75 98.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.989 0.916 . . . . 1.0 112.908 170.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.45 -29.58 67.31 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.505 1.122 . . . . 1.0 113.548 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -67.35 -30.07 69.79 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.334 1.054 . . . . 1.0 111.891 170.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.02 15.77 1.85 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.455 1.026 . . . . 1.0 115.28 169.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -102.54 -179.08 3.87 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.851 1.26 . . . . 1.0 109.977 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -108.15 98.66 8.19 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 124.982 1.313 . . . . 1.0 108.054 169.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -110.08 148.14 32.28 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 122.785 0.434 . . . . 1.0 111.231 176.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.2 m -146.28 147.0 30.93 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.673 1.189 . . . . 1.0 111.173 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.1 t -96.73 138.24 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 114.245 1.202 . . . . 1.0 114.245 174.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -117.73 112.29 20.26 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.671 1.988 . . . . 1.0 110.576 169.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -93.92 138.51 31.97 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.086 1.754 . . . . 1.0 111.1 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 42.65 55.31 10.34 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 124.789 1.236 . . . . 1.0 110.999 -169.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -68.21 146.02 68.4 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.72 2.947 . . . . 1.0 117.632 -168.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -89.68 155.7 19.05 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.091 1.757 . . . . 1.0 112.523 168.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.528 HD21 HD21 ' A' ' 79' ' ' LEU . 2.2 tm? -69.09 -21.35 64.06 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 120.574 -1.329 . . . . 1.0 109.525 168.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 m -67.24 -21.57 65.73 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.168 -0.957 . . . . 1.0 112.357 170.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -82.88 -27.28 30.82 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.01 0.924 . . . . 1.0 112.5 169.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.474 ' HB3' HD22 ' A' ' 41' ' ' LEU . 12.4 t-105 -82.06 -36.51 27.61 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.488 1.04 . . . . 1.0 113.686 178.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.9 mt -48.07 -40.44 34.4 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-O 117.708 -1.139 . . . . 1.0 113.668 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -52.45 -16.83 5.69 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 124.373 3.382 . . . . 1.0 117.532 172.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -110.22 8.09 23.5 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 116.195 1.924 . . . . 1.0 116.195 -172.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -51.3 -26.73 7.91 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 127.156 2.183 . . . . 1.0 114.336 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -121.63 15.98 11.13 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.897 1.679 . . . . 1.0 113.485 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -128.62 -154.23 0.62 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 128.163 2.585 . . . . 1.0 109.747 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -122.07 164.05 18.38 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 123.161 1.458 . . . . 1.0 112.371 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.408 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -151.93 164.55 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 124.846 1.258 . . . . 1.0 109.434 -172.375 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.428 HD11 HD12 ' A' ' 90' ' ' ILE . 14.6 tp -144.39 128.6 17.73 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 125.1 1.36 . . . . 1.0 108.53 176.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.2 t -102.13 124.81 56.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 124.518 1.127 . . . . 1.0 109.328 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.2 110.85 25.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 106.043 -1.836 . . . . 1.0 106.043 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 t -135.15 122.04 21.11 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.398 0.679 . . . . 1.0 111.732 -168.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 m -115.66 4.58 14.11 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 116.49 2.033 . . . . 1.0 116.49 -168.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.33 29.7 7.63 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 113.291 0.848 . . . . 1.0 113.291 -169.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -58.09 -37.87 75.32 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.352 1.061 . . . . 1.0 112.205 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.01 -125.85 34.3 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.144 0.878 . . . . 1.0 113.206 176.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -76.73 -7.97 56.38 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.886 1.069 . . . . 1.0 113.886 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 130.61 43.55 0.19 Allowed Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.972 1.273 . . . . 1.0 115.143 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -133.79 155.04 50.51 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.292 1.437 . . . . 1.0 111.616 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.1 mt -75.87 147.25 80.59 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 121.069 -1.019 . . . . 1.0 112.591 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -59.37 131.3 40.07 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.565 2.177 . . . . 1.0 110.794 169.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.2 -23.72 64.23 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.249 -0.907 . . . . 1.0 112.994 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.0 p -73.15 -19.56 61.1 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.609 1.563 . . . . 1.0 114.434 173.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.4 tt -118.72 -11.73 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.836 1.255 . . . . 1.0 113.657 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.7 t -47.32 -51.19 44.38 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 125.629 1.571 . . . . 1.0 112.204 168.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.48 -31.74 16.78 Favored 'Trans proline' 0 C--N 1.352 0.737 0 CA-C-N 120.57 1.239 . . . . 1.0 111.277 -173.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.7 tp -63.03 -49.78 73.25 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 124.719 1.208 . . . . 1.0 111.331 169.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.64 ' CE1' HD23 ' A' ' 110' ' ' LEU . 92.0 t80 -54.53 -54.41 41.54 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.761 1.224 . . . . 1.0 112.679 178.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -64.08 -38.76 92.24 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.689 0.796 . . . . 1.0 111.242 177.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.45 -36.67 91.86 Favored Glycine 0 CA--C 1.528 0.87 0 O-C-N 121.69 -0.631 . . . . 1.0 112.69 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.553 HG22 HD12 ' A' ' 110' ' ' LEU . 92.9 mt -65.06 -49.5 79.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 120.008 -1.877 . . . . 1.0 108.291 172.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.671 ' HB3' HD21 ' A' ' 110' ' ' LEU . 10.9 ptmt -69.93 -31.6 69.45 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.464 -1.398 . . . . 1.0 113.529 -171.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -106.77 -37.43 6.4 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.692 1.597 . . . . 1.0 114.963 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.6 m -92.75 -23.07 19.02 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.295 1.038 . . . . 1.0 112.661 -177.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.528 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -94.22 -71.85 0.64 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 106.934 -1.506 . . . . 1.0 106.934 169.368 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.61 -9.47 2.58 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 126.73 2.11 . . . . 1.0 115.622 170.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -153.96 147.1 24.64 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 128.734 2.814 . . . . 1.0 107.788 169.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.4 ' HG3' ' HB2' ' A' ' 116' ' ' ALA . 39.7 mm-40 -136.76 125.17 14.97 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 123.261 0.625 . . . . 1.0 110.8 -174.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -83.05 -40.76 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.458 2.106 . . . . 1.0 114.097 -174.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -146.9 18.95 1.27 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.628 1.171 . . . . 1.0 113.846 -169.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.408 HD11 ' CG2' ' A' ' 52' ' ' VAL . 62.2 tp -80.95 140.0 35.5 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.606 -1.309 . . . . 1.0 112.782 -169.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 -135.26 154.6 51.51 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.624 2.369 . . . . 1.0 109.158 169.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.678 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -162.03 167.15 24.88 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.91 0.777 . . . . 1.0 112.195 -179.602 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.456 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -122.56 172.82 15.87 Favored Glycine 0 N--CA 1.473 1.139 0 C-N-CA 125.702 1.62 . . . . 1.0 114.096 173.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.4 t -146.7 133.79 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 114.421 1.267 . . . . 1.0 114.421 -169.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.428 HD12 HD11 ' A' ' 53' ' ' LEU . 4.3 mt -131.4 110.37 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 106.97 -1.493 . . . . 1.0 106.97 168.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.91 145.01 24.93 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.741 1.216 . . . . 1.0 110.711 170.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.09 150.57 43.07 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.317 0.647 . . . . 1.0 111.571 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 170.85 -179.14 42.97 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-O 122.077 0.821 . . . . 1.0 114.67 169.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -81.05 106.63 13.2 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.157 1.383 . . . . 1.0 111.593 177.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 79.7 p -68.7 -4.89 17.41 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.554 1.542 . . . . 1.0 114.017 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.3 p -61.99 -19.55 62.93 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.291 1.036 . . . . 1.0 113.594 169.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -105.47 162.41 13.49 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.507 1.523 . . . . 1.0 112.879 169.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.9 m -63.56 175.96 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.993 1.317 . . . . 1.0 111.205 169.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 59.56 20.83 9.35 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.693 1.597 . . . . 1.0 114.834 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -10.88 -65.74 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 130.497 3.519 . . . . 1.0 117.554 -169.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.8 m -128.58 24.93 5.75 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.035 1.334 . . . . 1.0 113.489 -172.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -55.55 -29.53 59.14 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.896 1.278 . . . . 1.0 114.407 -174.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.01 -43.3 95.11 Favored Glycine 0 N--CA 1.476 1.349 0 CA-C-N 121.115 1.78 . . . . 1.0 114.444 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.49 -37.04 36.73 Favored Glycine 0 N--CA 1.478 1.449 0 O-C-N 121.082 -1.246 . . . . 1.0 112.772 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -60.37 -38.31 83.46 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.322 1.049 . . . . 1.0 113.111 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -59.51 -42.87 93.19 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.259 1.024 . . . . 1.0 111.951 170.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.28 -38.18 90.16 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.638 0.654 . . . . 1.0 110.889 176.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -37.59 88.06 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.746 0.819 . . . . 1.0 112.698 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.71 93.52 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.819 -0.61 . . . . 1.0 112.213 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.671 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -50.7 -48.25 58.74 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.115 2.166 . . . . 1.0 111.885 -171.583 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.678 HD12 ' CD1' ' A' ' 87' ' ' TYR . 6.6 mt -66.48 -42.39 87.55 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.41 -0.814 . . . . 1.0 111.516 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -67.44 -21.43 65.55 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.887 1.069 . . . . 1.0 113.887 175.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -67.09 -33.88 76.44 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.279 1.032 . . . . 1.0 111.331 174.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -85.15 -73.99 0.42 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 114.129 -1.396 . . . . 1.0 110.709 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.418 ' H ' ' H ' ' A' ' 116' ' ' ALA . 3.4 m 174.97 -0.72 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.953 2.501 . . . . 1.0 112.001 174.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -77.61 152.14 34.04 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-O 122.222 1.01 . . . . 1.0 113.599 -169.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -86.03 161.48 18.93 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.404 1.482 . . . . 1.0 112.876 -169.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.68 127.01 37.99 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.143 1.777 . . . . 1.0 108.99 -173.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.7 t -106.78 129.85 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.635 0.774 . . . . 1.0 110.45 -169.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 51.64 -154.68 4.42 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.768 1.175 . . . . 1.0 113.544 -171.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -115.85 147.24 41.26 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.73 1.612 . . . . 1.0 109.142 169.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -73.78 157.35 36.59 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.05 -1.031 . . . . 1.0 112.231 -169.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.632 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -90.39 138.06 31.85 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.857 0.863 . . . . 1.0 110.442 171.306 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.632 ' N ' HD13 ' A' ' 123' ' ' LEU . 8.8 mt -122.65 108.03 12.63 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.089 1.356 . . . . 1.0 111.316 175.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.452 HG13 ' CD1' ' A' ' 123' ' ' LEU . 4.1 mt -95.84 133.74 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 125.227 1.411 . . . . 1.0 112.944 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -107.67 89.31 2.96 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.689 2.796 . . . . 1.0 113.097 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.72 -24.66 67.64 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.814 -1.179 . . . . 1.0 113.162 -173.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.2 m -62.79 -16.26 57.3 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.947 2.099 . . . . 1.0 113.776 172.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -131.38 -28.26 1.9 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.872 2.069 . . . . 1.0 112.658 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -139.01 88.54 13.29 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 126.251 1.821 . . . . 1.0 110.917 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -75.59 11.03 1.71 Allowed 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 123.67 2.913 . . . . 1.0 114.05 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -112.79 68.36 1.04 Allowed Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 127.578 2.351 . . . . 1.0 110.127 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -58.09 -20.03 43.95 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.942 2.428 . . . . 1.0 116.87 -169.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -66.55 -26.53 67.17 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.559 -0.713 . . . . 1.0 112.011 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 26.9 p -71.77 -21.59 61.71 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 120.971 -1.081 . . . . 1.0 111.762 -175.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -95.51 -55.53 3.0 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.124 1.77 . . . . 1.0 112.009 176.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.5 t -71.06 -32.0 68.57 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.809 1.04 . . . . 1.0 113.809 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -62.1 -53.19 61.47 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 120.9 1.682 . . . . 1.0 113.286 -177.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -63.49 -24.79 70.4 Favored 'Trans proline' 0 C--N 1.353 0.787 0 CA-C-N 121.157 1.449 . . . . 1.0 112.36 173.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.432 ' HB2' HD23 ' A' ' 123' ' ' LEU . 91.8 t90 -67.77 -47.98 67.67 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 118.858 0.753 . . . . 1.0 110.764 175.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.626 HG11 ' HA ' ' A' ' 22' ' ' ALA . 93.8 t -65.4 -32.61 59.0 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.71 -52.13 61.89 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.062 -1.024 . . . . 1.0 109.749 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -64.55 -50.82 65.8 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.882 0.873 . . . . 1.0 111.855 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.456 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 85.6 t90 -59.05 -35.66 73.69 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 125.269 1.428 . . . . 1.0 111.737 175.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.23 -34.39 40.31 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.932 1.254 . . . . 1.0 113.247 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.0 p -68.12 -13.04 61.91 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 114.884 1.439 . . . . 1.0 114.884 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.74 -13.32 54.24 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.525 1.53 . . . . 1.0 112.542 176.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -74.41 169.54 17.49 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.556 1.071 . . . . 1.0 112.005 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.0 t . . . . . 0 C--O 1.257 1.489 0 C-N-CA 125.916 1.686 . . . . 1.0 112.605 -169.458 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 mmt . . . . . 0 N--CA 1.5 2.071 0 CA-C-O 120.369 0.128 . . . . 1.0 111.153 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.24 144.79 53.57 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.495 0.924 . . . . 1.0 113.495 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -117.02 125.38 51.26 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.063 1.345 . . . . 1.0 110.461 173.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.486 HD13 HD12 ' A' ' 26' ' ' LEU . 2.0 mp -122.91 115.26 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.063 0 C-N-CA 126.262 1.825 . . . . 1.0 112.351 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.49 125.55 8.26 Favored Glycine 0 N--CA 1.462 0.41 0 N-CA-C 110.432 -1.067 . . . . 1.0 110.432 169.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 mt -104.86 121.05 56.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 117.875 0.838 . . . . 1.0 109.071 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -113.66 115.22 27.54 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 124.648 1.179 . . . . 1.0 108.548 -169.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.2 p -93.85 137.6 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 112.537 0.569 . . . . 1.0 112.537 -172.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -117.39 102.76 1.03 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.367 1.46 . . . . 1.0 111.016 172.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.5 m -153.89 156.76 38.15 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.546 1.138 . . . . 1.0 110.465 -169.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.56 138.05 52.62 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.384 0.993 . . . . 1.0 110.321 169.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 55.65 14.21 1.2 Allowed 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 115.161 1.541 . . . . 1.0 115.161 -170.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.63 14.44 69.8 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.681 1.134 . . . . 1.0 115.822 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -62.88 149.05 45.41 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 118.77 1.285 . . . . 1.0 114.016 -174.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.2 p -53.76 -16.64 1.8 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 116.845 2.165 . . . . 1.0 116.845 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.0 tp 55.27 19.25 2.86 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.23 1.412 . . . . 1.0 113.336 -177.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.8 tp 60.84 -57.06 0.09 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.357 2.263 . . . . 1.0 113.975 -169.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.9 t -49.48 -34.26 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 127.077 2.151 . . . . 1.0 112.427 -176.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.01 -47.63 85.55 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.852 1.205 . . . . 1.0 112.978 174.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -67.59 -31.84 72.16 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.744 0.818 . . . . 1.0 110.605 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.77 -49.86 64.57 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 123.785 0.834 . . . . 1.0 109.06 173.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.648 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -62.3 -42.74 99.62 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 123.633 0.773 . . . . 1.0 112.509 -176.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.15 -51.37 66.69 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 170.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.04 -36.57 80.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.521 -0.737 . . . . 1.0 112.868 -174.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.2 mt -68.62 -47.34 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 119.345 0.975 . . . . 1.0 109.511 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.486 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -64.97 -36.89 85.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.856 0.836 . . . . 1.0 110.657 -177.721 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.0 m -61.38 -42.02 98.04 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 121.201 -0.937 . . . . 1.0 113.022 170.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.34 -29.57 66.3 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.604 1.162 . . . . 1.0 113.392 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -66.69 -30.67 70.98 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.582 1.153 . . . . 1.0 111.388 170.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.57 11.05 1.75 Allowed Glycine 0 CA--C 1.53 0.988 0 N-CA-C 115.498 0.959 . . . . 1.0 115.498 169.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 -101.21 -177.09 3.34 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.829 1.252 . . . . 1.0 110.898 -174.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -109.71 97.15 6.75 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.973 1.309 . . . . 1.0 108.266 169.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.37 150.12 27.08 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.492 0.317 . . . . 1.0 111.262 176.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.6 m -145.16 147.79 32.86 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.784 1.234 . . . . 1.0 111.509 -175.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.3 t -98.09 138.83 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 114.899 1.444 . . . . 1.0 114.899 174.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -117.66 110.71 18.21 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.742 1.617 . . . . 1.0 110.748 169.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -90.06 144.2 26.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.787 1.635 . . . . 1.0 110.848 170.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 40.29 55.08 6.84 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 125.019 1.328 . . . . 1.0 112.51 -169.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.24 142.2 49.57 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.813 3.009 . . . . 1.0 117.179 -168.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -97.49 163.24 12.94 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 122.71 1.243 . . . . 1.0 112.783 168.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.607 HD21 HD21 ' A' ' 79' ' ' LEU . 2.3 tm? -67.28 -23.82 65.71 Favored 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 121.004 -1.06 . . . . 1.0 110.461 167.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 62.9 p -68.39 -18.65 64.51 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.941 -1.1 . . . . 1.0 112.337 172.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -82.49 -24.85 33.96 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.896 0.878 . . . . 1.0 112.178 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.485 ' HB3' HD22 ' A' ' 41' ' ' LEU . 14.6 t-105 -87.52 -36.52 17.56 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.399 1.259 . . . . 1.0 114.399 -178.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.7 mt -46.7 -37.89 10.25 Favored Pre-proline 0 CA--C 1.553 1.069 0 N-CA-C 114.413 1.264 . . . . 1.0 114.413 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -61.11 -14.36 33.07 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 123.745 2.964 . . . . 1.0 116.695 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -107.87 8.4 28.59 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 115.745 1.757 . . . . 1.0 115.745 -173.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -54.85 -27.82 45.21 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.631 1.972 . . . . 1.0 113.874 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -107.67 3.02 24.25 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.562 1.545 . . . . 1.0 113.41 176.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -114.93 -163.34 0.87 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.915 2.486 . . . . 1.0 110.836 -174.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -106.81 162.84 13.45 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 123.387 1.565 . . . . 1.0 110.936 169.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.596 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -148.63 151.66 13.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.253 -1.34 . . . . 1.0 108.056 -173.426 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.1 tp -133.62 130.27 38.07 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 124.471 1.108 . . . . 1.0 108.667 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.4 t -105.11 126.79 60.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.263 -0.643 . . . . 1.0 109.263 174.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.4 t -122.97 111.38 29.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.963 -1.866 . . . . 1.0 105.963 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -148.29 127.21 12.7 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.496 1.295 . . . . 1.0 114.496 -167.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 t -114.8 176.89 4.86 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.385 1.474 . . . . 1.0 111.581 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.7 m 62.91 47.17 4.53 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 122.453 1.12 . . . . 1.0 112.015 169.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -55.46 -35.22 65.25 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.959 1.303 . . . . 1.0 111.698 169.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 56.91 -134.4 52.1 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 123.661 0.648 . . . . 1.0 112.059 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -63.85 -22.06 66.74 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.362 0.875 . . . . 1.0 113.362 175.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.31 55.22 0.04 OUTLIER Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.598 1.094 . . . . 1.0 113.79 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -144.25 -177.36 5.43 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.957 1.303 . . . . 1.0 112.123 -177.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 17.0 mt -116.46 146.88 38.46 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 126.585 1.954 . . . . 1.0 113.3 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.32 148.08 93.86 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.408 2.738 . . . . 1.0 113.309 169.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -63.91 -20.89 66.19 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.066 1.135 . . . . 1.0 114.066 -175.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.8 p -70.61 -29.34 65.7 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.787 1.235 . . . . 1.0 114.058 173.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.5 tt -107.87 -16.19 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.763 1.625 . . . . 1.0 113.283 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.1 t -44.91 -53.31 16.22 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.422 1.089 . . . . 1.0 112.323 168.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.17 -31.87 28.49 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.647 1.565 . . . . 1.0 111.702 -173.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.2 tp -63.1 -52.15 63.77 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.146 0.978 . . . . 1.0 111.257 169.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.725 ' CE1' HD23 ' A' ' 110' ' ' LEU . 89.7 t80 -56.02 -53.41 57.27 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.927 0.891 . . . . 1.0 112.385 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -63.88 -39.91 95.3 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.814 0.846 . . . . 1.0 111.544 177.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.76 -36.86 91.83 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 123.47 0.557 . . . . 1.0 112.589 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.621 HG22 HD12 ' A' ' 110' ' ' LEU . 82.5 mt -65.19 -47.74 86.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 120.024 1.912 . . . . 1.0 108.412 172.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.754 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.2 ptmm? -71.63 -31.27 66.68 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.224 -1.547 . . . . 1.0 113.289 -171.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -104.42 -38.71 6.71 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 115.519 1.674 . . . . 1.0 115.519 -175.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.1 m -95.09 -22.43 17.9 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.639 1.176 . . . . 1.0 113.326 -174.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.607 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -91.23 -71.71 0.62 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 106.93 -1.507 . . . . 1.0 106.93 170.037 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.53 -16.86 0.91 Allowed Glycine 0 CA--C 1.538 1.488 0 C-N-CA 127.562 2.506 . . . . 1.0 116.804 169.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -152.27 138.15 18.05 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.862 2.465 . . . . 1.0 108.227 174.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -133.72 124.12 17.65 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 119.086 0.857 . . . . 1.0 112.546 -172.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -82.65 -35.93 0.28 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.598 2.199 . . . . 1.0 114.726 -173.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -144.99 11.1 1.36 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.589 1.7 . . . . 1.0 115.589 -169.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.596 HD11 ' CG2' ' A' ' 52' ' ' VAL . 39.1 tp -75.06 142.05 43.78 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 120.27 -1.519 . . . . 1.0 113.004 -169.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -134.2 144.11 48.26 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 129.317 3.047 . . . . 1.0 107.493 169.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.661 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -154.38 164.25 38.92 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 120.046 1.294 . . . . 1.0 113.568 179.564 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.424 ' HA3' ' CE2' ' A' ' 144' ' ' TRP . . . -125.78 170.67 17.65 Favored Glycine 0 N--CA 1.468 0.8 0 C-N-CA 126.537 2.018 . . . . 1.0 112.248 172.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.586 HG13 ' HB3' ' A' ' 122' ' ' MET . 0.2 OUTLIER -160.25 146.6 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 O-C-N 120.836 -1.391 . . . . 1.0 114.442 -169.021 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.976 HG23 HD12 ' A' ' 123' ' ' LEU . 11.1 mt -138.4 98.69 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 127.92 2.488 . . . . 1.0 107.005 -172.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.09 147.88 23.99 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.408 1.483 . . . . 1.0 111.867 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.4 mp -140.48 152.31 45.52 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.297 0.639 . . . . 1.0 112.629 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.11 -172.26 42.71 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 115.097 0.799 . . . . 1.0 115.097 169.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -87.78 113.91 23.89 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.632 -0.923 . . . . 1.0 110.404 176.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 40.4 p -63.11 -6.06 3.77 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.401 1.26 . . . . 1.0 114.401 177.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.4 t -64.74 -26.06 68.2 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.944 0.898 . . . . 1.0 112.455 169.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -78.22 141.21 38.76 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.043 -1.036 . . . . 1.0 111.94 170.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -48.81 -50.02 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.558 1.543 . . . . 1.0 113.706 177.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -90.13 16.15 8.98 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 115.276 1.584 . . . . 1.0 115.276 -174.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.5 t80 29.32 -82.94 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 129.15 2.98 . . . . 1.0 117.573 171.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.7 m -121.05 19.49 11.61 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.366 1.866 . . . . 1.0 113.317 -171.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -51.06 -28.49 10.51 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.548 1.539 . . . . 1.0 114.009 -177.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.71 -42.78 59.32 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-N 120.436 1.471 . . . . 1.0 113.895 175.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.52 -34.88 18.46 Favored Glycine 0 N--CA 1.478 1.491 0 CA-C-N 118.864 1.332 . . . . 1.0 113.806 174.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -59.48 -32.87 70.66 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 118.465 1.132 . . . . 1.0 112.974 174.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -61.67 -41.69 97.89 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.217 1.007 . . . . 1.0 111.997 170.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -65.28 -34.89 79.42 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.234 0.924 . . . . 1.0 111.671 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -60.61 -55.19 36.26 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.344 0.657 . . . . 1.0 110.95 172.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.64 -34.71 62.56 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.974 0.731 . . . . 1.0 112.974 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.754 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -56.66 -50.29 72.53 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 123.562 1.648 . . . . 1.0 111.692 -178.29 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.661 HD12 ' CD1' ' A' ' 87' ' ' TYR . 14.9 mt -68.1 -36.98 80.66 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 120.606 -1.309 . . . . 1.0 111.423 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -73.79 -11.96 60.55 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.7 1.0 . . . . 1.0 113.7 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.84 -17.28 41.47 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.758 1.163 . . . . 1.0 110.918 175.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -96.51 -84.03 0.37 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.42 1.488 . . . . 1.0 108.729 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.5 -8.75 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.898 1.679 . . . . 1.0 112.67 -169.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -81.06 162.5 23.73 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 122.156 0.979 . . . . 1.0 113.312 -168.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -106.33 163.55 12.74 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.376 1.071 . . . . 1.0 111.793 -169.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.12 138.93 53.29 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.824 1.65 . . . . 1.0 110.802 -178.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.58 HG12 ' H ' ' A' ' 120' ' ' GLY . 18.5 t -84.91 -162.51 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 125.577 1.551 . . . . 1.0 107.699 173.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.58 ' H ' HG12 ' A' ' 119' ' ' VAL . . . -48.44 152.73 2.32 Favored Glycine 0 N--CA 1.482 1.743 0 O-C-N 120.121 -1.612 . . . . 1.0 113.901 173.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -63.75 151.01 43.27 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 122.746 1.26 . . . . 1.0 112.768 -172.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.586 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -71.43 157.64 37.69 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.992 1.317 . . . . 1.0 113.091 -168.979 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.976 HD12 HG23 ' A' ' 90' ' ' ILE . 0.9 OUTLIER -87.21 140.34 29.65 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.749 1.22 . . . . 1.0 110.084 170.128 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.0 mt -127.51 110.65 12.95 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.129 1.372 . . . . 1.0 109.83 173.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.569 ' CD1' HD11 ' A' ' 123' ' ' LEU . 28.7 mt -99.31 130.66 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.361 1.064 . . . . 1.0 112.929 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -105.55 98.34 8.05 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.648 2.379 . . . . 1.0 113.495 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.28 -22.42 66.84 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.819 1.044 . . . . 1.0 113.819 -175.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.6 t -58.85 -27.06 64.78 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.8 1.24 . . . . 1.0 112.845 171.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -120.34 -30.35 4.61 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.17 1.788 . . . . 1.0 112.303 -169.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -143.42 96.31 5.78 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.111 0.965 . . . . 1.0 112.938 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.42 7.13 4.64 Favored 'Trans proline' 0 CA--C 1.551 1.325 0 C-N-CA 123.877 3.051 . . . . 1.0 114.719 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -110.54 73.15 0.78 Allowed Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 126.539 1.936 . . . . 1.0 109.819 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -59.05 -26.87 83.31 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.753 2.302 . . . . 1.0 115.93 -169.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.7 pm0 -62.66 -25.92 68.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 119.45 1.023 . . . . 1.0 111.213 176.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.6 p -72.15 -15.88 61.98 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 120.974 -1.079 . . . . 1.0 112.788 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -104.18 -55.31 2.38 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.213 1.805 . . . . 1.0 111.894 177.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.5 p -67.95 -33.01 73.85 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 114.02 1.119 . . . . 1.0 114.02 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.8 m-20 -60.94 -56.63 33.13 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 121.035 1.743 . . . . 1.0 112.99 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -62.93 -23.49 74.17 Favored 'Trans proline' 0 C--N 1.353 0.803 0 CA-C-N 121.279 1.492 . . . . 1.0 112.933 174.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.466 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 88.9 t90 -67.53 -46.13 73.69 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 118.561 0.619 . . . . 1.0 110.739 172.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.648 HG11 ' HA ' ' A' ' 22' ' ' ALA . 96.6 t -66.19 -34.69 71.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -62.87 -49.87 73.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.212 -0.93 . . . . 1.0 109.588 174.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -63.15 -54.42 38.03 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.602 1.161 . . . . 1.0 111.752 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.424 ' CE2' ' HA3' ' A' ' 88' ' ' GLY . 87.7 t90 -59.16 -34.43 72.08 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 125.13 1.372 . . . . 1.0 112.05 175.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.4 -33.02 38.92 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.9 1.238 . . . . 1.0 113.272 173.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.6 p -69.27 -11.95 61.25 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.839 1.422 . . . . 1.0 114.839 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.06 -15.34 47.83 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.539 1.536 . . . . 1.0 111.875 177.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -75.81 168.38 20.13 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 119.243 0.929 . . . . 1.0 111.733 -177.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.6 p . . . . . 0 C--O 1.254 1.315 0 C-N-CA 126.633 1.973 . . . . 1.0 114.545 -175.897 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptm . . . . . 0 N--CA 1.5 2.066 0 N-CA-C 112.012 0.375 . . . . 1.0 112.012 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.87 159.32 42.32 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.012 1.116 . . . . 1.0 114.012 -177.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -122.64 121.48 36.53 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.486 1.515 . . . . 1.0 110.865 178.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.554 HD13 HD12 ' A' ' 26' ' ' LEU . 2.1 mp -119.15 113.67 42.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 126.396 1.878 . . . . 1.0 112.444 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.59 124.0 7.18 Favored Glycine 0 C--O 1.223 -0.594 0 N-CA-C 110.89 -0.884 . . . . 1.0 110.89 169.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.8 mt -105.83 122.93 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-N 118.78 1.29 . . . . 1.0 110.131 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -114.82 111.5 21.33 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 -169.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 p -97.6 116.72 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.428 0.632 . . . . 1.0 111.759 -170.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.9 94.66 1.99 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.969 1.271 . . . . 1.0 109.96 170.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.5 p -75.86 165.04 25.58 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.101 1.76 . . . . 1.0 113.957 -169.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.67 170.87 15.28 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.076 1.35 . . . . 1.0 112.516 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -64.32 154.57 34.89 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.31 1.044 . . . . 1.0 112.99 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.8 -135.87 17.12 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 123.844 0.735 . . . . 1.0 111.978 -171.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -66.65 148.21 52.22 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 117.591 0.696 . . . . 1.0 111.72 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.4 t -74.22 167.75 20.97 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.959 0.904 . . . . 1.0 112.957 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.1 tp -82.7 65.2 7.72 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.76 1.624 . . . . 1.0 112.077 -175.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.6 tp -27.63 -44.15 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 129.55 3.14 . . . . 1.0 114.841 170.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.0 t -46.8 -33.77 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.437 1.495 . . . . 1.0 112.547 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.06 -49.17 76.68 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.622 -1.299 . . . . 1.0 113.247 172.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -67.85 -29.68 68.87 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.732 1.213 . . . . 1.0 111.122 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -69.32 -47.34 64.73 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 123.91 0.884 . . . . 1.0 109.127 173.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.556 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.05 -42.43 94.25 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 112.3 0.481 . . . . 1.0 112.3 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -52.74 -49.98 64.37 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.945 0.898 . . . . 1.0 110.273 169.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.17 -38.04 72.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.255 0.622 . . . . 1.0 112.556 -174.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.5 mt -66.43 -48.64 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-N 119.041 0.837 . . . . 1.0 109.089 175.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.554 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -64.84 -35.72 82.02 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.927 0.87 . . . . 1.0 110.427 -176.088 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.2 m -61.98 -41.46 98.06 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.633 1.173 . . . . 1.0 113.504 170.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.92 -30.59 69.08 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.559 1.144 . . . . 1.0 112.665 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -69.95 -30.5 67.88 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.466 0.707 . . . . 1.0 112.091 171.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.01 16.73 1.92 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.987 0.803 . . . . 1.0 114.827 169.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -99.0 174.92 6.11 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.311 1.044 . . . . 1.0 110.123 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -103.73 91.2 3.9 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.918 1.287 . . . . 1.0 108.414 171.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.14 145.99 29.39 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.392 0.277 . . . . 1.0 110.98 176.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.1 m -146.74 137.65 24.02 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.901 0.88 . . . . 1.0 112.023 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.9 t -84.53 136.03 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 114.855 1.428 . . . . 1.0 114.855 170.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -113.13 109.54 18.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.905 2.082 . . . . 1.0 109.915 169.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -90.24 139.4 30.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.327 1.851 . . . . 1.0 110.932 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t0 43.26 53.56 9.6 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 124.387 1.075 . . . . 1.0 111.033 -169.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -68.74 141.7 50.39 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.718 2.945 . . . . 1.0 116.289 -168.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.462 ' HB3' ' H ' ' A' ' 42' ' ' SER . 56.1 mm-40 -93.57 162.01 14.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 122.373 1.082 . . . . 1.0 111.774 168.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.566 HD21 HD21 ' A' ' 79' ' ' LEU . 2.2 tm? -65.21 -20.76 66.59 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.02 -1.05 . . . . 1.0 109.838 167.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.462 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 15.1 m -68.28 -22.12 64.75 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 120.861 -1.15 . . . . 1.0 112.297 172.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -80.59 -27.9 37.25 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.964 0.906 . . . . 1.0 112.062 169.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.459 ' HB3' HD22 ' A' ' 41' ' ' LEU . 16.0 t-105 -85.21 -37.39 20.17 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.915 1.08 . . . . 1.0 113.915 -177.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.9 mt -42.94 -44.61 10.89 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 114.998 1.481 . . . . 1.0 114.998 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.92 -2.22 8.31 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.351 2.034 . . . . 1.0 115.575 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -108.29 8.66 27.84 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 115.793 1.775 . . . . 1.0 115.793 176.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -51.81 -27.73 13.34 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.786 2.034 . . . . 1.0 114.242 174.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.09 12.56 14.55 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.591 1.156 . . . . 1.0 112.494 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -127.51 -163.81 1.3 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.109 2.564 . . . . 1.0 111.346 -174.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -109.96 158.11 18.57 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 122.921 1.343 . . . . 1.0 112.955 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.401 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -147.44 161.99 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.121 1.368 . . . . 1.0 109.828 -173.802 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.0 tp -139.75 130.31 25.7 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.406 1.482 . . . . 1.0 108.227 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.3 t -104.71 123.8 58.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 124.403 1.081 . . . . 1.0 108.919 173.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.1 t -122.04 111.28 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.551 -2.018 . . . . 1.0 105.551 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.2 t -148.97 128.63 13.22 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.572 1.323 . . . . 1.0 114.572 -167.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.3 t -106.16 175.18 5.58 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.38 1.072 . . . . 1.0 112.198 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 m 64.57 59.59 0.95 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.109 1.363 . . . . 1.0 112.938 169.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 m -57.58 -32.49 67.2 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.479 1.911 . . . . 1.0 113.928 170.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 51.59 -126.98 29.79 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.099 0.856 . . . . 1.0 114.362 173.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -84.65 23.53 1.14 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.786 1.634 . . . . 1.0 112.729 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.66 32.14 16.41 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 124.648 1.118 . . . . 1.0 111.973 -169.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -118.58 171.45 8.17 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.103 2.161 . . . . 1.0 112.25 -175.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.2 mt -122.01 152.28 59.58 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.48 1.112 . . . . 1.0 113.471 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.6 147.09 88.85 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.406 2.737 . . . . 1.0 113.361 169.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -61.18 -24.42 66.3 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.665 0.987 . . . . 1.0 113.665 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 59.8 p -71.46 -21.2 61.98 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.256 1.206 . . . . 1.0 114.256 175.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.5 tt -119.17 -13.53 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.442 1.497 . . . . 1.0 114.134 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.9 t -45.7 -53.61 19.23 Favored Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 124.484 1.114 . . . . 1.0 112.1 168.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -67.78 -31.17 32.68 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.665 1.577 . . . . 1.0 111.79 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.0 tp -63.15 -54.3 39.91 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 124.271 1.028 . . . . 1.0 111.32 169.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.616 ' CE1' HD23 ' A' ' 110' ' ' LEU . 93.6 t80 -55.23 -52.03 64.69 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.723 0.809 . . . . 1.0 112.464 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -65.11 -40.14 94.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.43 -0.805 . . . . 1.0 111.382 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.17 -33.59 78.8 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.488 -0.618 . . . . 1.0 112.837 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.636 HG22 HD12 ' A' ' 110' ' ' LEU . 93.4 mt -65.19 -47.75 86.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 120.115 1.958 . . . . 1.0 108.676 170.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.698 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.3 ptmm? -72.61 -31.54 65.24 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.347 -1.47 . . . . 1.0 113.232 -171.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -104.87 -39.85 6.15 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.719 1.608 . . . . 1.0 115.302 -174.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.0 m -92.89 -24.27 18.51 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.125 0.97 . . . . 1.0 113.13 -175.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.566 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -90.36 -72.03 0.59 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.9 -1.148 . . . . 1.0 107.9 171.505 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.44 -13.11 2.25 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 126.612 2.053 . . . . 1.0 116.331 169.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -156.89 139.85 15.33 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.335 2.254 . . . . 1.0 108.653 173.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.505 HE22 HD12 ' A' ' 79' ' ' LEU . 9.0 mm-40 -134.77 126.13 17.76 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 118.756 0.707 . . . . 1.0 111.373 -171.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -82.18 -41.36 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.532 2.154 . . . . 1.0 113.832 -173.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -145.77 21.2 1.46 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.681 1.192 . . . . 1.0 113.878 -170.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.401 HD11 ' CG2' ' A' ' 52' ' ' VAL . 65.0 tp -81.83 135.14 35.46 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.757 -1.214 . . . . 1.0 112.27 -169.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.5 mtm-85 -134.6 154.16 51.62 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.003 2.121 . . . . 1.0 109.534 169.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.63 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -160.47 169.08 23.75 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.569 -0.707 . . . . 1.0 111.644 -176.397 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.415 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -128.41 171.35 19.52 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 124.167 0.889 . . . . 1.0 113.672 170.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.422 HG23 ' HB3' ' A' ' 122' ' ' MET . 0.0 OUTLIER -140.7 140.12 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 113.978 1.103 . . . . 1.0 113.978 -169.87 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.061 HG23 HD12 ' A' ' 123' ' ' LEU . 12.4 mt -132.12 99.13 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 125.824 1.65 . . . . 1.0 107.065 169.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.05 142.08 28.06 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.731 1.613 . . . . 1.0 112.195 173.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.4 mp -138.51 156.98 47.03 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.169 0.804 . . . . 1.0 113.169 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.29 -176.04 42.25 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 115.504 -0.771 . . . . 1.0 113.277 169.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -95.57 118.81 32.97 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.078 -1.248 . . . . 1.0 111.714 172.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 65.8 p -60.56 -11.92 8.47 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.969 1.1 . . . . 1.0 113.969 175.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.8 m -58.86 -18.2 30.68 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.721 1.608 . . . . 1.0 112.829 169.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -112.1 151.0 29.94 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.3 1.84 . . . . 1.0 110.996 169.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.1 m -70.72 172.71 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.003 0.921 . . . . 1.0 112.105 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 65.68 0.13 1.4 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.057 2.143 . . . . 1.0 116.604 -170.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 15.7 t80 27.89 -80.44 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 129.505 3.122 . . . . 1.0 116.915 -172.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.447 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 24.5 p -121.77 5.8 9.96 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.209 2.204 . . . . 1.0 113.707 -170.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -60.18 -21.63 61.93 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 125.317 1.447 . . . . 1.0 114.173 -169.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.14 -31.03 77.49 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 120.832 1.651 . . . . 1.0 113.74 174.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.84 -37.0 17.39 Favored Glycine 0 N--CA 1.479 1.528 0 O-C-N 121.019 -1.283 . . . . 1.0 113.03 169.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.447 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 82.5 mttt -61.77 -29.36 70.08 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 121.025 -1.279 . . . . 1.0 112.642 172.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -62.85 -36.67 84.02 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.944 1.298 . . . . 1.0 111.747 170.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -65.8 -36.5 83.68 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.396 0.998 . . . . 1.0 111.781 172.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -63.67 -50.16 70.36 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.49 -0.757 . . . . 1.0 111.408 174.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.15 -33.73 65.47 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.674 0.79 . . . . 1.0 112.755 174.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.698 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -58.96 -49.68 76.95 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 123.349 1.547 . . . . 1.0 111.019 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.63 HD12 ' CD1' ' A' ' 87' ' ' TYR . 10.3 mt -66.65 -38.26 86.51 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 120.841 -1.162 . . . . 1.0 111.788 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -69.22 -20.05 63.96 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.801 1.037 . . . . 1.0 113.801 175.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.02 -16.83 59.17 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.845 0.858 . . . . 1.0 110.942 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -98.59 -74.35 0.59 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.92 1.288 . . . . 1.0 109.344 177.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.2 p 177.15 -17.27 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.713 2.005 . . . . 1.0 113.986 -173.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -69.36 159.21 33.59 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.716 1.376 . . . . 1.0 114.716 -169.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -97.02 170.24 9.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.223 1.809 . . . . 1.0 112.122 -169.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.67 151.41 49.25 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.463 1.105 . . . . 1.0 112.23 175.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.32 133.4 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.028 1.731 . . . . 1.0 109.621 -169.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 50.47 -158.79 1.74 Allowed Glycine 0 N--CA 1.48 1.582 0 C-N-CA 125.181 1.372 . . . . 1.0 115.268 -176.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -105.01 139.49 39.61 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.423 1.489 . . . . 1.0 109.504 169.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.422 ' HB3' HG23 ' A' ' 89' ' ' VAL . 1.2 pmm? -76.11 155.32 34.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.901 0.857 . . . . 1.0 111.927 -172.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 1.061 HD12 HG23 ' A' ' 90' ' ' ILE . 1.4 tm? -89.54 138.51 31.4 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.504 1.122 . . . . 1.0 110.276 174.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 mt -128.95 108.02 10.08 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.979 1.711 . . . . 1.0 109.749 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.569 ' CD1' HD11 ' A' ' 123' ' ' LEU . 29.8 mt -99.3 134.55 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.437 1.095 . . . . 1.0 112.885 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -105.13 109.47 21.47 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 124.478 1.111 . . . . 1.0 112.629 169.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.67 -23.95 61.76 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.54 1.136 . . . . 1.0 113.431 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.0 t -66.99 -19.46 65.72 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.371 1.069 . . . . 1.0 112.81 174.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -116.1 -30.11 6.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.084 1.753 . . . . 1.0 111.785 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -140.52 87.07 11.9 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.54 1.536 . . . . 1.0 111.638 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.04 7.82 1.93 Allowed 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 123.648 2.899 . . . . 1.0 114.559 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -114.73 69.06 2.1 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 127.715 2.406 . . . . 1.0 110.136 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -56.94 -22.53 46.73 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.605 2.204 . . . . 1.0 116.805 -169.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -64.26 -25.63 68.14 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.292 0.951 . . . . 1.0 111.811 174.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.8 p -72.86 -18.63 61.42 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.004 -1.06 . . . . 1.0 111.815 -175.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -101.77 -54.44 2.73 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.039 1.735 . . . . 1.0 111.475 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 64.7 p -69.8 -34.61 73.94 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.775 1.028 . . . . 1.0 113.775 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -60.16 -57.15 28.78 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 120.706 1.594 . . . . 1.0 112.558 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -62.17 -24.39 76.26 Favored 'Trans proline' 0 C--N 1.352 0.743 0 CA-C-N 121.273 1.49 . . . . 1.0 112.902 174.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.464 ' CG ' ' HB2' ' A' ' 123' ' ' LEU . 83.9 t90 -67.29 -45.5 76.39 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 119.062 0.846 . . . . 1.0 110.937 173.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.556 HG11 ' HA ' ' A' ' 22' ' ' ALA . 97.8 t -63.81 -33.61 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.635 -0.876 . . . . 1.0 108.635 176.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -70.0 -27.18 64.49 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 120.603 -1.311 . . . . 1.0 113.04 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -82.99 -56.59 3.71 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.352 1.461 . . . . 1.0 111.725 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.415 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 89.8 t90 -56.47 -36.39 69.03 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 125.855 1.662 . . . . 1.0 112.973 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.37 -32.89 30.97 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.825 1.202 . . . . 1.0 114.048 173.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.9 p -68.6 -13.24 62.22 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 114.405 1.261 . . . . 1.0 114.405 177.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.61 -17.49 51.17 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.471 1.509 . . . . 1.0 111.891 176.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -83.83 171.11 13.42 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.033 0.833 . . . . 1.0 111.887 -175.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.5 t . . . . . 0 C--O 1.255 1.351 0 C-N-CA 126.178 1.791 . . . . 1.0 113.033 -174.909 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 113.521 0.934 . . . . 1.0 113.521 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -123.46 123.74 41.33 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.991 1.316 . . . . 1.0 110.48 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.567 HD13 HD12 ' A' ' 26' ' ' LEU . 2.2 mp -117.11 115.6 49.38 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.065 0 C-N-CA 126.168 1.787 . . . . 1.0 112.845 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.48 119.48 5.61 Favored Glycine 0 C--O 1.224 -0.519 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 169.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.6 mt -103.25 120.97 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 118.04 0.92 . . . . 1.0 109.171 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -118.39 115.99 25.81 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.153 -1.054 . . . . 1.0 108.153 -171.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.473 0.685 0 C-N-CA 122.833 0.453 . . . . 1.0 112.109 -170.602 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.5 tp . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 115.123 1.527 . . . . 1.0 115.123 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.5 t -54.77 -32.5 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.667 0.787 . . . . 1.0 112.529 -169.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.92 -48.81 78.81 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.852 -1.155 . . . . 1.0 113.461 172.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -69.15 -30.38 68.6 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.545 0.738 . . . . 1.0 110.969 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.73 -47.91 70.83 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.537 0.735 . . . . 1.0 109.237 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.537 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -64.96 -43.35 92.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 112.559 0.577 . . . . 1.0 112.559 -175.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -53.54 -48.69 68.86 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.051 0.94 . . . . 1.0 110.455 170.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.17 -37.84 69.24 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.495 0.718 . . . . 1.0 112.697 -174.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.7 mt -65.55 -46.65 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 CA-C-N 119.288 0.949 . . . . 1.0 109.141 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.567 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -66.72 -35.48 80.22 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 119.442 -0.903 . . . . 1.0 110.276 -176.283 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.6 m -62.34 -41.19 98.38 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.21 1.404 . . . . 1.0 113.57 170.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.94 -33.81 75.4 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.397 1.079 . . . . 1.0 111.9 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -71.59 -29.01 64.21 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.749 1.22 . . . . 1.0 112.806 172.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.44 25.92 2.54 Favored Glycine 0 N--CA 1.468 0.812 0 C-N-CA 124.378 0.989 . . . . 1.0 114.323 169.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -114.11 146.19 40.61 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.536 1.134 . . . . 1.0 109.574 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -84.1 83.27 8.02 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.859 1.263 . . . . 1.0 108.729 -173.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.91 146.65 26.41 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.301 0.641 . . . . 1.0 111.13 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.8 m -146.98 137.95 23.89 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.696 0.799 . . . . 1.0 112.772 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.3 t -84.35 136.76 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 115.109 1.522 . . . . 1.0 115.109 171.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -115.75 117.6 30.69 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.871 2.069 . . . . 1.0 110.595 169.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -93.12 147.93 22.44 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.287 1.835 . . . . 1.0 110.717 173.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 41.84 61.07 8.57 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 125.125 1.37 . . . . 1.0 112.022 -169.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -48.79 123.87 10.3 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.406 3.404 . . . . 1.0 119.883 -168.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -94.28 146.62 23.9 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.907 1.283 . . . . 1.0 111.285 168.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.49 HD21 HD21 ' A' ' 79' ' ' LEU . 2.4 tm? -71.09 -25.01 62.42 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 121.447 -0.783 . . . . 1.0 110.141 169.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.7 m -67.15 -19.02 65.53 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.493 -0.754 . . . . 1.0 112.609 170.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -91.7 -21.9 20.5 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.587 1.155 . . . . 1.0 113.443 169.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.473 ' HB3' HD22 ' A' ' 41' ' ' LEU . 10.8 t-105 -79.54 -35.02 40.56 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 120.028 1.286 . . . . 1.0 113.36 172.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.1 mt -50.86 -39.54 55.29 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 117.622 -1.18 . . . . 1.0 113.884 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -52.55 -16.62 5.62 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 124.432 3.421 . . . . 1.0 117.495 171.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -107.85 8.61 28.74 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.982 1.845 . . . . 1.0 115.982 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -52.7 -31.12 35.83 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.224 1.81 . . . . 1.0 113.749 173.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -112.66 13.35 19.9 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.102 1.361 . . . . 1.0 112.389 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -126.97 -158.3 0.86 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.613 2.365 . . . . 1.0 111.214 -174.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -114.14 162.81 16.04 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 122.947 1.356 . . . . 1.0 111.833 172.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.524 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -147.71 156.99 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.329 1.452 . . . . 1.0 109.007 -171.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.0 tp -137.38 129.3 28.96 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.813 1.245 . . . . 1.0 109.117 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.6 t -106.03 122.17 59.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.216 -0.661 . . . . 1.0 109.216 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.1 t -120.11 111.31 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 106.871 -1.529 . . . . 1.0 106.871 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 114.217 1.191 . . . . 1.0 114.217 -168.341 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.1 tt . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 114.236 1.198 . . . . 1.0 114.236 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -43.33 -53.07 11.89 Favored Pre-proline 0 N--CA 1.478 0.948 0 C-N-CA 124.643 1.177 . . . . 1.0 112.604 168.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.83 -31.71 19.67 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 121.576 1.517 . . . . 1.0 111.774 -172.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.4 tp -63.47 -51.26 66.39 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.333 1.053 . . . . 1.0 111.419 169.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.664 ' CE1' HD23 ' A' ' 110' ' ' LEU . 91.3 t80 -56.31 -52.46 64.45 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.121 0.968 . . . . 1.0 112.364 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -63.2 -39.41 94.56 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.787 0.835 . . . . 1.0 111.443 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.72 -36.84 92.83 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.064 0.84 . . . . 1.0 112.728 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.572 HG22 HD12 ' A' ' 110' ' ' LEU . 86.4 mt -65.37 -51.18 67.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 119.949 1.875 . . . . 1.0 107.976 172.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.709 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.4 ptmm? -69.25 -31.14 69.49 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 120.39 -1.444 . . . . 1.0 113.564 -169.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -103.43 -38.0 7.37 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.777 1.631 . . . . 1.0 115.279 -176.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.6 m -95.57 -20.88 18.63 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.468 1.107 . . . . 1.0 113.229 -175.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.49 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -91.67 -71.94 0.61 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 106.872 -1.529 . . . . 1.0 106.872 169.555 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.98 -18.92 1.06 Allowed Glycine 0 CA--C 1.539 1.58 0 C-N-CA 127.644 2.545 . . . . 1.0 115.265 169.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -151.87 138.99 19.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 128.386 2.674 . . . . 1.0 107.896 169.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.427 HE21 HD12 ' A' ' 79' ' ' LEU . 11.1 mt-30 -137.75 121.78 11.85 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 118.664 -0.684 . . . . 1.0 109.637 -171.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.72 -35.77 0.28 Allowed 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.422 2.081 . . . . 1.0 115.39 -169.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -141.68 15.51 2.15 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.292 1.219 . . . . 1.0 114.292 -169.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.524 HD11 ' CG2' ' A' ' 52' ' ' VAL . 64.9 tp -80.79 139.93 35.77 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 120.563 -1.336 . . . . 1.0 113.027 -169.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -137.12 154.74 50.21 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.66 2.384 . . . . 1.0 109.032 169.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.624 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -161.02 163.85 31.35 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.244 0.929 . . . . 1.0 112.217 -176.153 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.409 ' HA3' ' CE2' ' A' ' 144' ' ' TRP . . . -123.65 172.22 16.27 Favored Glycine 0 N--CA 1.467 0.703 0 C-N-CA 125.707 1.622 . . . . 1.0 112.109 169.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.551 HG13 ' HB3' ' A' ' 122' ' ' MET . 0.2 OUTLIER -160.52 145.56 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 O-C-N 121.161 -1.199 . . . . 1.0 114.086 -169.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.97 HG23 HD12 ' A' ' 123' ' ' LEU . 8.6 mt -134.76 100.26 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 127.794 2.438 . . . . 1.0 106.942 -175.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.27 146.17 24.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.267 1.427 . . . . 1.0 111.581 173.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.6 mp -140.09 156.45 46.57 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.453 0.701 . . . . 1.0 112.269 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.496 0 CA-C-N 116.208 -0.451 . . . . 1.0 112.499 169.438 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.545 0.772 0 N-CA-C 113.191 0.812 . . . . 1.0 113.191 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -53.01 -25.51 12.47 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.082 1.353 . . . . 1.0 114.37 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.87 -43.47 60.88 Favored Glycine 0 CA--C 1.538 1.519 0 CA-C-N 121.522 1.965 . . . . 1.0 114.878 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -80.12 -33.5 32.51 Favored Glycine 0 N--CA 1.481 1.691 0 O-C-N 120.711 -1.464 . . . . 1.0 113.768 173.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -62.41 -33.41 74.72 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 121.366 -1.079 . . . . 1.0 112.672 174.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 40.7 mm-40 -60.63 -42.57 97.16 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.891 0.876 . . . . 1.0 111.163 169.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -64.05 -36.82 85.25 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.566 -0.709 . . . . 1.0 111.998 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -62.42 -49.62 74.74 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.405 -0.81 . . . . 1.0 112.498 173.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.34 -35.73 67.97 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.503 0.556 . . . . 1.0 112.503 174.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.709 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -58.04 -51.3 70.25 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 123.113 1.435 . . . . 1.0 110.926 -178.172 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.624 HD12 ' CD1' ' A' ' 87' ' ' TYR . 7.1 mt -65.74 -38.84 90.21 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 121.033 -1.042 . . . . 1.0 111.64 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -70.51 -18.92 62.95 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.344 0.868 . . . . 1.0 113.344 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.83 -19.01 58.03 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.298 0.954 . . . . 1.0 110.869 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -99.86 -76.8 0.54 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.886 1.274 . . . . 1.0 110.953 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.9 m -178.17 -2.88 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.587 1.955 . . . . 1.0 112.818 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -77.95 162.47 26.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 122.31 1.052 . . . . 1.0 113.304 -169.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -102.53 174.58 5.84 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.817 1.647 . . . . 1.0 113.221 -168.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.6 153.3 42.4 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.159 2.184 . . . . 1.0 112.433 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.5 t -126.78 127.66 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 126.206 1.802 . . . . 1.0 108.46 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 49.21 -156.52 1.53 Allowed Glycine 0 N--CA 1.48 1.615 0 C-N-CA 125.032 1.301 . . . . 1.0 114.615 -169.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -118.22 144.82 45.46 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.856 1.662 . . . . 1.0 109.803 169.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.551 ' HB3' HG13 ' A' ' 89' ' ' VAL . 1.1 pmm? -71.91 155.39 40.43 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.224 1.012 . . . . 1.0 113.063 -169.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.97 HD12 HG23 ' A' ' 90' ' ' ILE . 1.1 tm? -84.18 139.62 32.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.048 -0.978 . . . . 1.0 109.815 170.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.5 mt -127.38 110.15 12.5 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.363 1.465 . . . . 1.0 110.098 173.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.563 ' CD1' HD11 ' A' ' 123' ' ' LEU . 24.4 mt -98.56 129.86 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.092 0.957 . . . . 1.0 112.749 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -103.75 110.92 23.2 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 122.278 1.037 . . . . 1.0 112.55 171.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.21 -22.44 64.8 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.623 1.169 . . . . 1.0 113.379 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.0 t -65.13 -21.99 66.87 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.897 0.879 . . . . 1.0 112.795 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -119.25 -30.5 4.92 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.162 1.785 . . . . 1.0 111.98 -174.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -142.34 85.95 10.32 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.073 1.349 . . . . 1.0 111.975 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.79 7.84 2.22 Favored 'Trans proline' 0 CA--C 1.551 1.333 0 C-N-CA 123.625 2.883 . . . . 1.0 114.419 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -113.79 69.56 1.63 Allowed Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 127.432 2.293 . . . . 1.0 109.909 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -56.6 -24.45 54.06 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.667 2.245 . . . . 1.0 116.304 -169.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.8 pm0 -66.08 -24.43 66.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 119.385 0.993 . . . . 1.0 111.725 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 15.1 p -73.78 -15.53 61.19 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.661 -1.274 . . . . 1.0 112.27 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.434 ' HB2' HD11 ' A' ' 125' ' ' ILE . 5.0 mm-40 -105.02 -55.44 2.33 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.296 1.838 . . . . 1.0 111.482 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 65.7 p -69.29 -33.88 73.87 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 113.938 1.088 . . . . 1.0 113.938 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -60.57 -57.45 26.44 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 120.801 1.637 . . . . 1.0 112.485 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -62.96 -23.35 74.13 Favored 'Trans proline' 0 C--N 1.354 0.832 0 CA-C-N 121.386 1.531 . . . . 1.0 112.449 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.467 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 86.8 t90 -67.12 -46.82 72.98 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 119.258 0.936 . . . . 1.0 110.749 173.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.537 HG11 ' HA ' ' A' ' 22' ' ' ALA . 96.1 t -63.4 -33.83 63.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 108.922 -0.77 . . . . 1.0 108.922 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.76 -28.35 65.7 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.823 1.249 . . . . 1.0 113.132 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -81.83 -56.96 3.65 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.169 1.388 . . . . 1.0 112.073 169.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.41 ' CZ3' HD11 ' A' ' 26' ' ' LEU . 85.1 t90 -57.14 -36.93 71.3 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 125.498 1.519 . . . . 1.0 112.727 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.83 -33.01 34.65 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.766 1.174 . . . . 1.0 113.765 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.8 p -65.79 -13.99 60.5 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.576 1.325 . . . . 1.0 114.576 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.27 -16.78 53.93 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.008 1.723 . . . . 1.0 112.005 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.17 -176.98 5.89 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.174 1.39 . . . . 1.0 110.754 -176.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 31.9 m . . . . . 0 C--O 1.253 1.277 0 C-N-CA 125.624 1.57 . . . . 1.0 115.01 -172.045 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.403 0 N-CA-C 112.678 0.622 . . . . 1.0 112.678 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -120.67 124.42 45.18 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.664 1.586 . . . . 1.0 110.466 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.518 HD13 HD12 ' A' ' 26' ' ' LEU . 2.0 mp -123.14 113.47 37.95 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.071 0 C-N-CA 125.963 1.705 . . . . 1.0 112.664 -178.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.8 123.64 7.18 Favored Glycine 0 C--O 1.224 -0.523 0 N-CA-C 110.551 -1.019 . . . . 1.0 110.551 169.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.4 mt -105.15 122.23 58.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 118.184 0.992 . . . . 1.0 109.459 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -114.16 108.75 17.39 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 124.869 1.268 . . . . 1.0 108.277 -169.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.533 0.307 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.037 -173.284 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.4 tp . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 115.265 1.58 . . . . 1.0 115.265 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.2 t -53.65 -35.29 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.913 1.685 . . . . 1.0 112.47 -175.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.21 -45.79 87.02 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.858 -1.151 . . . . 1.0 112.487 174.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.83 -31.08 68.77 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.586 1.154 . . . . 1.0 110.759 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -66.56 -48.23 70.3 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.239 0.616 . . . . 1.0 109.341 170.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.536 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.41 -42.9 92.05 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 112.823 0.675 . . . . 1.0 112.823 -173.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -54.01 -49.24 69.31 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 123.717 0.807 . . . . 1.0 110.409 169.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.99 -37.0 69.92 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.285 0.634 . . . . 1.0 112.491 -174.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.4 mt -66.41 -46.96 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 119.015 0.825 . . . . 1.0 109.191 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.518 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -67.52 -34.65 77.54 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 119.57 -0.852 . . . . 1.0 110.613 -176.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.6 m -62.58 -40.07 95.71 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.226 1.41 . . . . 1.0 113.484 170.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.87 -32.72 72.58 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.177 0.991 . . . . 1.0 112.066 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -70.6 -29.77 66.26 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.597 1.159 . . . . 1.0 113.059 170.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.91 23.05 3.12 Favored Glycine 0 N--CA 1.47 0.95 0 C-N-CA 124.516 1.055 . . . . 1.0 114.585 169.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -109.61 151.99 26.11 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.363 1.065 . . . . 1.0 109.652 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.3 tptt -85.39 85.55 7.43 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.756 1.223 . . . . 1.0 108.665 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.3 145.44 28.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.68 -0.691 . . . . 1.0 111.11 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.2 m -147.3 139.02 24.13 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.843 0.857 . . . . 1.0 112.341 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.1 t -86.78 136.08 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 115.022 1.49 . . . . 1.0 115.022 171.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -113.43 113.5 25.27 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.331 1.852 . . . . 1.0 110.017 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -93.56 138.24 32.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.131 1.772 . . . . 1.0 110.848 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 42.39 55.06 9.8 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 124.498 1.119 . . . . 1.0 111.309 -169.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -67.84 140.09 49.66 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.699 2.933 . . . . 1.0 117.089 -168.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -93.64 163.46 13.54 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 122.466 1.127 . . . . 1.0 111.986 168.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.604 HD21 HD21 ' A' ' 79' ' ' LEU . 2.1 tm? -66.76 -22.61 66.04 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 121.074 -1.016 . . . . 1.0 110.738 167.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.2 p -68.57 -18.44 64.34 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.959 1.254 . . . . 1.0 112.386 171.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -82.67 -25.22 33.24 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.174 0.99 . . . . 1.0 112.276 169.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.467 ' HB3' HD22 ' A' ' 41' ' ' LEU . 11.1 t-105 -89.38 -33.81 16.73 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.175 1.176 . . . . 1.0 114.175 -177.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.6 mt -48.2 -38.67 22.38 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 117.549 -1.215 . . . . 1.0 114.046 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.2 -6.92 7.24 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 124.053 3.169 . . . . 1.0 116.863 175.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -114.76 6.17 15.48 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 116.126 1.899 . . . . 1.0 116.126 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -50.25 -29.44 9.56 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.562 1.945 . . . . 1.0 113.824 171.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -105.53 7.92 33.14 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 128.144 2.578 . . . . 1.0 113.156 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -132.78 -161.36 1.13 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.933 2.093 . . . . 1.0 112.728 -168.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -110.59 157.48 19.62 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 123.191 1.472 . . . . 1.0 111.042 171.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.605 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -144.81 155.63 14.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 124.941 1.297 . . . . 1.0 108.285 -172.295 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.6 tp -134.98 127.74 31.09 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 124.568 1.147 . . . . 1.0 108.642 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.8 t -102.8 124.21 56.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.338 -0.616 . . . . 1.0 109.338 175.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.7 t -124.64 108.72 20.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 106.493 -1.669 . . . . 1.0 106.493 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 113.923 1.083 . . . . 1.0 113.923 -167.99 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.7 tt . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 113.818 1.044 . . . . 1.0 113.818 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.1 t -45.77 -53.5 20.06 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.432 1.093 . . . . 1.0 112.52 168.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -67.98 -33.66 25.41 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.531 1.487 . . . . 1.0 111.537 -173.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.4 tp -61.2 -53.03 62.1 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 124.586 1.154 . . . . 1.0 111.287 170.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.692 ' CE1' HD23 ' A' ' 110' ' ' LEU . 91.9 t80 -54.3 -53.49 53.1 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.128 0.971 . . . . 1.0 112.25 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -64.02 -40.5 96.47 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.792 0.837 . . . . 1.0 111.531 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.11 -35.93 89.6 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.563 0.601 . . . . 1.0 112.642 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.612 HG22 HD12 ' A' ' 110' ' ' LEU . 89.8 mt -64.82 -47.79 87.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 120.173 1.986 . . . . 1.0 108.259 172.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.739 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.2 ptmm? -71.5 -32.58 68.39 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.566 -1.333 . . . . 1.0 113.201 -171.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -105.17 -36.97 7.07 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.161 1.541 . . . . 1.0 115.161 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.9 m -94.05 -24.98 17.39 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.23 1.012 . . . . 1.0 112.84 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.604 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -90.49 -71.59 0.61 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.415 -1.328 . . . . 1.0 107.415 169.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.98 -8.46 2.5 Favored Glycine 0 CA--C 1.543 1.786 0 C-N-CA 126.419 1.962 . . . . 1.0 115.13 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -153.88 146.45 24.12 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 129.851 3.26 . . . . 1.0 106.906 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -136.62 125.37 15.25 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 123.192 0.597 . . . . 1.0 111.099 -176.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.97 -41.85 0.14 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 121.983 1.789 . . . . 1.0 114.314 -171.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -147.84 22.54 1.12 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.829 1.252 . . . . 1.0 113.129 -171.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.605 HD11 ' CG2' ' A' ' 52' ' ' VAL . 53.0 tp -83.2 137.6 33.96 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.624 -1.298 . . . . 1.0 113.909 -169.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -135.23 153.94 51.75 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 127.821 2.448 . . . . 1.0 108.957 169.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.665 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -158.07 164.77 36.37 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.316 -0.865 . . . . 1.0 112.302 -177.352 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -124.88 172.26 17.02 Favored Glycine 0 N--CA 1.467 0.766 0 C-N-CA 125.703 1.62 . . . . 1.0 111.978 169.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.576 HG13 ' HB3' ' A' ' 122' ' ' MET . 0.2 OUTLIER -159.03 146.45 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 O-C-N 120.875 -1.367 . . . . 1.0 114.44 -169.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.7 mt -133.45 105.64 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 127.308 2.243 . . . . 1.0 107.738 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.91 144.32 26.03 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.416 1.486 . . . . 1.0 110.863 175.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.5 mp -137.93 155.35 49.0 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.652 0.612 . . . . 1.0 112.652 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.598 0 CA-C-N 116.15 -0.477 . . . . 1.0 113.639 169.361 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.406 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 17.4 p . . . . . 0 CA--C 1.541 0.61 0 N-CA-C 113.019 0.748 . . . . 1.0 113.019 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -62.06 -19.04 62.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.257 1.423 . . . . 1.0 114.257 -169.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.34 -52.62 52.12 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-N 120.432 1.469 . . . . 1.0 113.732 174.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.41 -34.98 68.59 Favored Glycine 0 N--CA 1.479 1.51 0 O-C-N 120.807 -1.408 . . . . 1.0 112.995 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.406 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 87.0 mttt -63.41 -35.33 80.05 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.536 1.134 . . . . 1.0 113.137 173.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -64.34 -39.72 94.45 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 119.062 -0.495 . . . . 1.0 111.735 169.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -61.34 -33.49 73.71 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 118.961 0.801 . . . . 1.0 111.843 174.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -66.32 -51.81 53.53 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.571 0.748 . . . . 1.0 111.359 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.76 -35.24 63.56 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.657 0.783 . . . . 1.0 112.863 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.739 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -58.05 -49.91 75.27 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-O 123.3 1.524 . . . . 1.0 110.867 -179.066 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.665 HD12 ' CD1' ' A' ' 87' ' ' TYR . 12.4 mt -67.27 -37.53 83.6 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 120.907 -1.12 . . . . 1.0 112.117 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -69.12 -20.87 64.05 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.54 -16.43 58.67 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.249 0.931 . . . . 1.0 110.991 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -100.29 -78.51 0.51 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.165 1.386 . . . . 1.0 110.175 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -175.72 -13.58 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.751 -1.568 . . . . 1.0 113.347 -169.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -80.44 163.06 24.1 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.966 1.469 . . . . 1.0 114.966 -168.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -103.76 175.5 5.46 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.046 1.738 . . . . 1.0 112.183 -169.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.02 141.89 48.52 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.232 1.813 . . . . 1.0 110.349 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 120' ' ' GLY 0.257 12.9 t -93.54 -161.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 125.55 1.54 . . . . 1.0 106.85 174.004 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.547 ' H ' HG12 ' A' ' 119' ' ' VAL . . . -49.53 149.49 5.12 Favored Glycine 0 CA--C 1.547 2.066 0 O-C-N 119.775 -1.828 . . . . 1.0 114.589 177.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.11 149.65 40.69 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.973 1.309 . . . . 1.0 112.48 -172.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.576 ' HB3' HG13 ' A' ' 89' ' ' VAL . 1.0 OUTLIER -70.57 157.05 38.6 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 122.546 1.165 . . . . 1.0 113.759 -169.145 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.643 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -87.5 141.43 28.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.309 -1.314 . . . . 1.0 109.795 170.137 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.643 ' N ' HD13 ' A' ' 123' ' ' LEU . 5.9 mt -124.33 103.5 8.25 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 125.508 1.523 . . . . 1.0 110.948 175.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.448 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.5 mt -89.61 128.07 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.41 1.484 . . . . 1.0 112.344 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -106.35 108.43 19.94 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.066 0.936 . . . . 1.0 112.139 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.02 -22.57 64.97 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.008 0.923 . . . . 1.0 113.29 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.9 t -65.18 -21.78 66.81 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.379 1.072 . . . . 1.0 112.935 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -119.36 -29.72 5.08 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.061 1.744 . . . . 1.0 112.096 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -143.33 84.89 9.9 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 125.448 1.499 . . . . 1.0 112.048 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.44 7.29 2.29 Favored 'Trans proline' 0 CA--C 1.551 1.333 0 C-N-CA 123.742 2.961 . . . . 1.0 114.45 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -111.74 71.31 0.95 Allowed Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 127.592 2.357 . . . . 1.0 109.966 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -58.69 -20.15 49.38 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.89 2.393 . . . . 1.0 116.747 -169.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -66.16 -27.0 67.68 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 119.596 1.089 . . . . 1.0 111.639 172.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 22.1 p -74.56 -21.67 59.39 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.544 1.065 . . . . 1.0 111.943 -172.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -93.19 -51.29 5.09 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.335 1.454 . . . . 1.0 111.996 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 77.3 p -73.26 -33.64 65.38 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 115.711 1.745 . . . . 1.0 115.711 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -56.22 -58.07 18.78 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 121.003 1.728 . . . . 1.0 111.836 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -62.21 -24.35 76.12 Favored 'Trans proline' 0 C--N 1.352 0.761 0 CA-C-N 121.514 1.577 . . . . 1.0 113.155 175.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.505 ' HB2' HD23 ' A' ' 123' ' ' LEU . 91.2 t90 -68.12 -47.73 67.34 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 118.972 0.805 . . . . 1.0 110.982 174.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.536 HG11 ' HA ' ' A' ' 22' ' ' ALA . 86.6 t -64.66 -33.57 64.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 176.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -69.34 -28.97 66.69 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.761 1.225 . . . . 1.0 112.085 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -81.5 -60.44 2.26 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.137 1.775 . . . . 1.0 112.021 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 82.1 t90 -56.0 -36.0 67.42 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 126.2 1.8 . . . . 1.0 112.654 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.59 -32.31 23.89 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.771 1.177 . . . . 1.0 113.764 173.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.2 p -69.45 -12.77 61.93 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.333 1.234 . . . . 1.0 114.333 177.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.57 -16.89 50.22 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.209 1.804 . . . . 1.0 111.862 175.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.25 174.79 11.19 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.378 1.071 . . . . 1.0 111.168 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.251 1.156 0 N-CA-C 115.242 1.571 . . . . 1.0 115.242 -175.068 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.569 0 N-CA-C 112.714 0.635 . . . . 1.0 112.714 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -125.77 122.81 37.29 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.903 1.281 . . . . 1.0 110.254 175.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.585 HD13 HD12 ' A' ' 26' ' ' LEU . 2.1 mp -120.99 116.89 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 126.2 1.8 . . . . 1.0 113.044 -177.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.8 124.34 7.8 Favored Glycine 0 N--CA 1.467 0.758 0 CA-C-O 119.382 -0.677 . . . . 1.0 111.507 169.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 mt -107.37 121.39 60.19 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-N 118.8 1.3 . . . . 1.0 109.743 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -116.71 109.58 17.34 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 124.661 1.185 . . . . 1.0 108.615 -169.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.466 0.33 0 CA-C-N 116.0 -0.545 . . . . 1.0 111.502 -178.062 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 37.0 tp . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 114.765 1.395 . . . . 1.0 114.765 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.4 t -53.97 -37.7 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.807 0.843 . . . . 1.0 112.183 -172.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.27 -38.47 86.87 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.956 -1.09 . . . . 1.0 112.407 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -75.9 -32.41 59.64 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.138 0.575 . . . . 1.0 111.439 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -60.52 -45.49 93.62 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.219 -1.03 . . . . 1.0 108.219 170.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.614 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.46 -40.66 93.46 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 112.624 0.601 . . . . 1.0 112.624 -174.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -57.34 -48.3 79.36 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.193 0.451 . . . . 1.0 109.8 169.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.38 -35.12 75.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 112.89 0.7 . . . . 1.0 112.89 -173.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.9 mt -72.66 -46.44 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 O-C-N 121.321 -0.862 . . . . 1.0 109.346 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.585 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -64.81 -33.36 75.81 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 119.162 -1.015 . . . . 1.0 109.976 -178.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.1 m -62.14 -45.99 90.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.984 1.314 . . . . 1.0 113.133 169.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.69 -33.03 74.99 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.193 0.997 . . . . 1.0 112.69 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -69.91 -29.8 67.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.941 1.297 . . . . 1.0 112.378 172.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.24 21.51 2.28 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.729 1.157 . . . . 1.0 115.175 169.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -117.02 153.37 32.8 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.432 1.093 . . . . 1.0 110.655 -175.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -87.12 72.16 10.03 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 123.118 1.437 . . . . 1.0 110.278 -173.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.11 144.9 27.28 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 112.954 -1.93 . . . . 1.0 111.941 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.6 m -142.63 136.23 28.91 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 125.746 1.618 . . . . 1.0 108.739 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.71 143.9 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.697 1.199 . . . . 1.0 113.437 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.65 133.82 53.1 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.329 1.851 . . . . 1.0 111.316 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -107.14 141.17 38.84 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.673 1.989 . . . . 1.0 111.13 178.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 t0 41.3 55.47 8.36 Favored Pre-proline 0 CA--C 1.559 1.309 0 C-N-CA 124.519 1.128 . . . . 1.0 112.478 -172.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.78 148.16 45.92 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.531 2.821 . . . . 1.0 117.072 -168.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -99.25 164.75 12.0 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.951 1.3 . . . . 1.0 112.461 168.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.568 HD21 HD21 ' A' ' 79' ' ' LEU . 2.2 tm? -68.15 -22.35 64.86 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 121.03 -1.044 . . . . 1.0 110.727 167.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 67.4 p -68.19 -20.21 64.83 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.656 1.117 . . . . 1.0 112.219 171.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -81.68 -24.9 35.96 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.253 1.021 . . . . 1.0 112.359 169.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.469 ' HB3' HD22 ' A' ' 41' ' ' LEU . 10.3 t-105 -88.85 -34.78 16.89 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.346 1.239 . . . . 1.0 114.346 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.4 mt -47.5 -38.46 16.24 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-O 117.358 -1.306 . . . . 1.0 114.314 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -57.1 -18.77 30.4 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.43 2.753 . . . . 1.0 116.416 175.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -105.79 7.49 32.41 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 116.13 1.9 . . . . 1.0 116.13 -172.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -51.43 -34.71 36.25 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.619 1.967 . . . . 1.0 113.525 174.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -110.35 8.53 23.38 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.791 1.636 . . . . 1.0 112.373 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -115.78 -163.93 0.92 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.639 2.376 . . . . 1.0 110.299 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -108.48 164.26 12.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 122.613 1.197 . . . . 1.0 112.147 170.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.604 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -148.35 162.12 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.121 1.369 . . . . 1.0 109.906 -170.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.64 HD11 HD12 ' A' ' 90' ' ' ILE . 13.3 tp -144.9 128.65 17.25 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.931 1.292 . . . . 1.0 108.852 177.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.69 128.3 58.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 C-N-CA 124.141 0.976 . . . . 1.0 109.728 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.2 t -127.04 108.87 19.43 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 108.033 -1.099 . . . . 1.0 108.033 -170.761 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.5 tt . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 113.618 0.97 . . . . 1.0 113.618 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.7 t -40.71 -52.78 6.24 Favored Pre-proline 0 N--CA 1.478 0.951 0 CA-C-O 117.477 -1.249 . . . . 1.0 112.665 168.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -67.15 -32.31 34.26 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 121.725 1.616 . . . . 1.0 112.181 -173.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.1 tp -65.73 -52.96 47.01 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 124.051 0.94 . . . . 1.0 111.302 169.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.653 ' CE1' HD23 ' A' ' 110' ' ' LEU . 92.6 t80 -56.24 -52.41 64.57 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.727 0.811 . . . . 1.0 112.666 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -64.04 -40.33 96.06 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.669 1.188 . . . . 1.0 111.445 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.68 -35.85 90.42 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 123.604 0.621 . . . . 1.0 112.808 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.618 HG22 HD12 ' A' ' 110' ' ' LEU . 90.5 mt -66.42 -46.54 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 120.199 2.0 . . . . 1.0 108.578 172.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.717 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.4 ptmm? -72.25 -30.63 65.04 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.039 -1.663 . . . . 1.0 113.267 -171.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -109.77 -37.48 5.64 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.402 1.63 . . . . 1.0 115.402 -173.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.7 m -90.55 -26.8 19.53 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.302 1.041 . . . . 1.0 112.695 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.568 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -90.12 -71.44 0.62 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.214 -1.402 . . . . 1.0 107.214 169.379 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.7 -6.21 2.85 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 126.317 1.913 . . . . 1.0 115.496 172.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -156.22 146.78 21.74 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.035 2.934 . . . . 1.0 107.315 173.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.407 ' HG3' ' HB2' ' A' ' 116' ' ' ALA . 43.4 mm-40 -137.94 126.06 14.17 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 123.73 0.812 . . . . 1.0 110.207 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -84.63 -37.99 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 121.924 1.75 . . . . 1.0 114.414 -172.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -147.64 18.66 1.16 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.757 1.223 . . . . 1.0 114.14 -169.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.604 HD11 ' CG2' ' A' ' 52' ' ' VAL . 38.2 tp -77.31 139.98 39.9 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.5 -1.375 . . . . 1.0 113.629 -169.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -132.85 146.76 52.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 128.815 2.846 . . . . 1.0 107.252 169.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.645 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -159.33 167.63 28.38 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 118.981 0.81 . . . . 1.0 113.069 -177.494 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.484 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -125.32 173.49 17.4 Favored Glycine 0 N--CA 1.474 1.208 0 C-N-CA 125.025 1.298 . . . . 1.0 114.228 173.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.6 t -144.61 131.43 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.185 0.994 . . . . 1.0 113.641 -169.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 1.054 HG23 HD12 ' A' ' 123' ' ' LEU . 3.4 mt -131.54 102.24 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.846 1.658 . . . . 1.0 107.203 169.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -91.94 145.32 24.63 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.859 0.838 . . . . 1.0 111.27 170.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.437 HD11 HG22 ' A' ' 90' ' ' ILE . 3.5 mp -139.86 152.96 46.88 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.07 1.348 . . . . 1.0 110.622 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.31 0 C-N-CA 120.851 -0.69 . . . . 1.0 113.676 169.378 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 113.417 0.895 . . . . 1.0 113.417 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -60.18 -17.96 44.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.886 1.674 . . . . 1.0 115.005 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.2 -41.01 98.04 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-N 120.833 1.652 . . . . 1.0 114.37 175.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -75.91 -34.58 47.45 Favored Glycine 0 N--CA 1.477 1.429 0 O-C-N 120.626 -1.514 . . . . 1.0 112.935 172.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -62.97 -33.88 76.33 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 121.23 -1.159 . . . . 1.0 112.418 173.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -59.97 -41.72 92.58 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.601 1.16 . . . . 1.0 111.539 170.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -64.9 -37.74 88.64 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.729 0.695 . . . . 1.0 111.546 174.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -62.56 -49.43 75.29 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.181 -0.949 . . . . 1.0 110.994 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.19 -33.81 63.35 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.953 0.901 . . . . 1.0 113.111 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.717 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -61.2 -49.75 75.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 122.933 1.349 . . . . 1.0 110.613 178.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.645 HD12 ' CD1' ' A' ' 87' ' ' TYR . 10.3 mt -65.86 -37.49 86.3 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 120.945 -1.097 . . . . 1.0 112.083 178.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -68.95 -21.16 64.21 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.922 1.082 . . . . 1.0 113.922 174.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.89 -17.82 58.7 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.532 1.06 . . . . 1.0 111.188 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -97.66 -74.21 0.58 Allowed 'General case' 0 C--N 1.343 0.299 0 C-N-CA 125.129 1.372 . . . . 1.0 110.999 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.9 m 176.6 -2.69 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 127.384 2.274 . . . . 1.0 112.141 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -78.84 161.06 27.03 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 122.264 1.03 . . . . 1.0 113.507 -169.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -104.25 170.42 7.92 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.19 -1.368 . . . . 1.0 112.224 -169.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.75 145.35 50.94 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.924 1.29 . . . . 1.0 111.894 176.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 50.9 t -101.73 132.04 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 127.591 2.356 . . . . 1.0 108.639 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 46.97 -142.3 5.97 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.401 1.0 . . . . 1.0 113.889 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -100.65 -162.31 0.93 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.405 1.482 . . . . 1.0 110.29 169.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.72 157.12 22.62 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.215 1.806 . . . . 1.0 111.042 168.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 1.054 HD12 HG23 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -94.52 142.11 27.81 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 125.409 1.484 . . . . 1.0 109.484 169.13 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.5 mt -125.82 113.97 17.96 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.858 1.663 . . . . 1.0 110.379 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.557 ' CD1' HD11 ' A' ' 123' ' ' LEU . 40.5 mt -106.44 132.45 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 124.696 1.198 . . . . 1.0 113.101 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -107.57 96.9 6.72 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 128.145 2.578 . . . . 1.0 112.991 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.77 -22.8 66.85 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.913 1.079 . . . . 1.0 113.913 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.3 t -60.07 -25.25 65.23 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.434 1.094 . . . . 1.0 112.71 172.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -122.53 -29.06 4.14 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.373 1.869 . . . . 1.0 112.276 -170.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -138.5 89.36 13.77 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.794 1.238 . . . . 1.0 111.687 175.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -76.78 11.02 2.07 Favored 'Trans proline' 0 CA--C 1.549 1.246 0 C-N-CA 123.943 3.096 . . . . 1.0 114.255 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -114.54 66.68 1.72 Allowed Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 127.326 2.25 . . . . 1.0 110.112 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -57.73 -18.62 34.48 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.927 2.418 . . . . 1.0 117.738 -169.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -68.2 -25.6 65.3 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.446 1.476 . . . . 1.0 111.386 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 28.6 p -70.41 -23.46 62.75 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.756 1.162 . . . . 1.0 112.24 -173.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.425 ' HB2' HD11 ' A' ' 125' ' ' ILE . 28.6 mm-40 -93.66 -56.56 2.86 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.802 1.641 . . . . 1.0 112.081 173.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 79.0 p -68.58 -30.28 69.0 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 114.325 1.231 . . . . 1.0 114.325 -174.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -60.98 -59.28 14.34 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 120.773 1.624 . . . . 1.0 112.395 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -62.91 -24.43 74.19 Favored 'Trans proline' 0 C--N 1.352 0.743 0 CA-C-N 121.124 1.437 . . . . 1.0 113.002 173.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 73.8 t90 -70.39 -45.12 66.61 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 119.005 0.821 . . . . 1.0 111.704 175.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.614 HG11 ' HA ' ' A' ' 22' ' ' ALA . 69.1 t -66.5 -32.95 60.36 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 C-N-CA 123.167 0.587 . . . . 1.0 110.094 175.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -63.5 -48.11 78.93 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.162 -0.961 . . . . 1.0 109.822 173.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -64.16 -55.99 17.91 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.871 1.268 . . . . 1.0 111.651 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.484 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 89.0 t90 -57.17 -35.79 69.98 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 125.222 1.409 . . . . 1.0 111.785 172.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -49.75 -34.65 22.02 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.864 1.697 . . . . 1.0 113.938 171.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.6 p -67.86 -13.62 62.29 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.85 1.426 . . . . 1.0 114.85 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.18 -18.24 50.18 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.395 1.478 . . . . 1.0 111.886 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -86.32 167.87 14.39 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.193 0.997 . . . . 1.0 111.952 -175.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 11.2 m . . . . . 0 C--O 1.251 1.178 0 N-CA-C 115.725 1.75 . . . . 1.0 115.725 -169.861 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.408 0 N-CA-C 115.321 1.6 . . . . 1.0 115.321 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -125.49 122.35 36.36 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.645 1.578 . . . . 1.0 110.706 172.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 mp -121.89 113.41 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 C-N-CA 126.26 1.824 . . . . 1.0 112.416 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.12 123.75 7.27 Favored Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.169 -1.173 . . . . 1.0 110.169 169.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.9 mt -104.54 123.51 58.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 123.946 0.898 . . . . 1.0 109.355 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -115.6 111.03 20.06 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 124.766 1.227 . . . . 1.0 107.921 -170.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 112.412 0.523 . . . . 1.0 112.412 -175.427 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.3 tp . . . . . 0 CA--C 1.53 0.185 0 N-CA-C 112.494 0.553 . . . . 1.0 112.494 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.1 t -58.35 -37.26 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 119.127 -0.464 . . . . 1.0 111.132 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.56 -45.87 88.52 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.768 1.167 . . . . 1.0 112.859 173.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -63.49 -33.4 75.49 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.454 0.645 . . . . 1.0 110.966 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -69.93 -46.93 64.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.762 0.825 . . . . 1.0 109.818 176.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.856 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -55.42 -45.43 76.73 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.959 1.304 . . . . 1.0 113.017 176.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.33 -49.26 78.52 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.855 0.462 . . . . 1.0 110.181 173.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.6 -37.47 73.88 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.449 -0.782 . . . . 1.0 112.867 -173.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.575 ' CG2' HG12 ' A' ' 141' ' ' VAL . 16.5 mt -69.42 -48.17 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 124.501 1.12 . . . . 1.0 109.447 175.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.478 HD23 ' CG1' ' A' ' 141' ' ' VAL . 0.5 OUTLIER -62.17 -34.86 77.21 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 122.485 1.136 . . . . 1.0 109.185 -178.163 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.3 m -62.28 -44.9 95.47 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.602 1.161 . . . . 1.0 112.704 172.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.78 -29.82 69.12 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.676 1.19 . . . . 1.0 113.439 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -65.23 -33.94 77.17 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.516 1.526 . . . . 1.0 110.981 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.52 13.3 1.13 Allowed Glycine 0 CA--C 1.535 1.293 0 N-CA-C 115.864 1.105 . . . . 1.0 115.864 169.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 -108.02 177.02 4.93 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.985 1.314 . . . . 1.0 111.725 -169.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -101.5 99.71 10.06 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.053 1.341 . . . . 1.0 108.564 169.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.26 148.85 36.78 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.58 0.752 . . . . 1.0 111.217 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.4 m -149.0 146.12 27.64 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.146 0.978 . . . . 1.0 111.459 -174.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.9 t -95.93 137.08 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 114.168 1.173 . . . . 1.0 114.168 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -115.34 122.4 45.76 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.135 1.774 . . . . 1.0 110.995 169.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -103.21 137.0 41.95 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.597 1.959 . . . . 1.0 111.272 -177.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.6 t0 41.48 53.15 6.95 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 124.339 1.056 . . . . 1.0 111.237 -169.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -68.28 142.43 55.13 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.861 3.041 . . . . 1.0 116.85 -168.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.451 ' HB3' ' H ' ' A' ' 42' ' ' SER . 49.9 mm-40 -92.41 163.43 13.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 122.666 1.222 . . . . 1.0 111.309 168.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.62 HD21 HD21 ' A' ' 79' ' ' LEU . 2.1 tm? -66.0 -20.84 66.32 Favored 'General case' 0 N--CA 1.442 -0.856 0 O-C-N 120.688 -1.257 . . . . 1.0 110.388 167.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.451 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 16.1 m -68.49 -20.54 64.6 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 120.793 -1.192 . . . . 1.0 112.126 172.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -82.58 -24.47 33.94 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.292 1.037 . . . . 1.0 112.446 170.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.515 ' HB3' HD22 ' A' ' 41' ' ' LEU . 12.3 t-105 -88.68 -35.05 16.99 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.453 1.279 . . . . 1.0 114.453 -178.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.7 mt -47.73 -37.37 12.71 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-O 117.466 -1.254 . . . . 1.0 114.129 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -58.79 -11.02 10.77 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.697 2.932 . . . . 1.0 117.27 175.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -114.81 9.31 16.25 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 116.303 1.964 . . . . 1.0 116.303 -174.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -51.24 -27.15 8.37 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 127.259 2.224 . . . . 1.0 114.048 175.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -117.28 13.02 14.51 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.299 1.84 . . . . 1.0 113.323 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -126.85 -155.41 0.69 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.889 2.476 . . . . 1.0 110.978 -175.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -115.96 162.64 17.07 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 122.906 1.336 . . . . 1.0 112.073 175.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.564 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -152.24 157.36 5.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 124.798 1.239 . . . . 1.0 109.053 -171.098 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.626 HD11 HD12 ' A' ' 90' ' ' ILE . 15.4 tp -139.98 127.82 21.98 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.559 1.143 . . . . 1.0 109.388 176.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.1 t -103.41 120.43 53.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 124.271 1.028 . . . . 1.0 109.001 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.0 t -118.4 112.21 37.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 105.602 -1.999 . . . . 1.0 105.602 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 115.237 1.569 . . . . 1.0 115.237 -168.161 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 114.692 1.368 . . . . 1.0 114.692 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -42.76 -52.62 10.84 Favored Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 124.532 1.133 . . . . 1.0 112.588 168.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -67.8 -32.04 30.55 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.87 1.713 . . . . 1.0 111.985 -173.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.7 tp -63.64 -53.19 55.38 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 124.283 1.033 . . . . 1.0 111.225 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.695 ' CE1' HD23 ' A' ' 110' ' ' LEU . 93.0 t80 -55.05 -52.99 61.46 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.726 0.81 . . . . 1.0 112.572 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -64.32 -40.52 96.08 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.813 0.845 . . . . 1.0 111.433 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.61 -35.29 89.69 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 119.662 -0.521 . . . . 1.0 112.557 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.602 HG22 HD12 ' A' ' 110' ' ' LEU . 89.1 mt -65.69 -47.46 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 120.145 1.972 . . . . 1.0 108.382 172.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.717 ' HB3' HD21 ' A' ' 110' ' ' LEU . 3.2 ptmm? -71.43 -32.22 68.11 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 120.309 -1.494 . . . . 1.0 113.508 -171.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -105.92 -36.82 6.87 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 115.028 1.492 . . . . 1.0 115.028 -173.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 m -94.73 -24.85 16.94 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.261 1.025 . . . . 1.0 112.663 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.62 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -90.23 -72.53 0.56 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.15 -1.426 . . . . 1.0 107.15 169.422 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.0 -9.35 2.06 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 126.316 1.912 . . . . 1.0 115.265 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -152.35 145.87 24.91 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.929 2.892 . . . . 1.0 107.499 171.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -136.82 128.5 16.84 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-O 118.438 -0.792 . . . . 1.0 110.435 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -83.68 -42.86 0.08 OUTLIER 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.148 1.899 . . . . 1.0 114.445 -171.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -147.32 20.7 1.21 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.045 1.338 . . . . 1.0 113.74 -170.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.564 HD11 ' CG2' ' A' ' 52' ' ' VAL . 51.0 tp -78.46 141.34 38.34 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.451 -1.405 . . . . 1.0 113.459 -169.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.87 149.73 49.12 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 128.766 2.826 . . . . 1.0 108.196 169.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.653 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -159.9 168.16 26.4 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.382 0.882 . . . . 1.0 113.382 -178.151 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.471 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -124.39 168.95 16.43 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 125.361 1.457 . . . . 1.0 114.026 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.0 t -143.75 133.39 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.536 1.134 . . . . 1.0 113.338 -169.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.972 HG23 HD12 ' A' ' 123' ' ' LEU . 3.7 mt -129.43 100.15 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 126.036 1.735 . . . . 1.0 107.346 169.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.48 145.62 25.18 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.686 1.194 . . . . 1.0 112.045 174.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.6 mp -138.04 150.83 47.29 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.804 0.841 . . . . 1.0 112.774 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.571 0 C-N-CA 121.081 -0.58 . . . . 1.0 113.744 169.248 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 21.7 m . . . . . 0 CA--C 1.547 0.831 0 N-CA-C 115.54 1.682 . . . . 1.0 115.54 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -63.97 -18.24 64.08 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.17 1.174 . . . . 1.0 114.17 -175.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.34 -49.28 69.62 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-N 119.872 1.214 . . . . 1.0 113.368 171.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -75.47 -34.25 50.66 Favored Glycine 0 N--CA 1.478 1.443 0 O-C-N 120.705 -1.468 . . . . 1.0 113.23 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -61.35 -34.47 75.34 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.263 -1.139 . . . . 1.0 112.731 173.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -63.3 -39.77 95.51 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.865 0.866 . . . . 1.0 112.316 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.1 -40.0 96.35 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.036 0.835 . . . . 1.0 110.697 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -41.07 98.03 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.427 -0.796 . . . . 1.0 112.583 176.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.63 -46.19 89.74 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 118.744 -0.646 . . . . 1.0 111.997 170.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.717 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -49.56 -49.31 46.86 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.259 2.224 . . . . 1.0 111.932 -172.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.653 HD12 ' CD1' ' A' ' 87' ' ' TYR . 8.1 mt -66.0 -43.03 88.93 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.214 -0.903 . . . . 1.0 111.439 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -66.96 -22.03 65.95 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -66.08 -35.87 81.67 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.422 1.089 . . . . 1.0 111.46 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -82.65 -75.87 0.29 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 113.785 -1.552 . . . . 1.0 110.432 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.43 ' H ' ' H ' ' A' ' 116' ' ' ALA . 2.7 t 179.0 -3.22 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.11 2.164 . . . . 1.0 111.574 173.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -75.24 150.44 38.59 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 122.775 1.274 . . . . 1.0 112.83 -169.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -90.61 172.48 8.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.271 -1.786 . . . . 1.0 113.036 -168.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.36 139.03 46.58 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.322 1.849 . . . . 1.0 109.914 -175.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.589 HG12 ' H ' ' A' ' 120' ' ' GLY 0.258 20.2 t -90.86 -163.3 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 107.786 -1.19 . . . . 1.0 107.786 178.035 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.589 ' H ' HG12 ' A' ' 119' ' ' VAL . . . -48.6 149.73 3.89 Favored Glycine 0 CA--C 1.544 1.867 0 O-C-N 120.067 -1.646 . . . . 1.0 113.936 177.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -59.73 146.49 41.27 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.21 1.404 . . . . 1.0 112.701 -171.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -67.62 158.78 31.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.767 1.627 . . . . 1.0 114.759 -168.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.972 HD12 HG23 ' A' ' 90' ' ' ILE . 1.0 OUTLIER -90.44 138.91 31.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.272 -1.331 . . . . 1.0 109.133 169.083 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.1 mt -126.61 110.05 12.78 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.359 1.464 . . . . 1.0 109.828 173.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.573 HG13 HD11 ' A' ' 123' ' ' LEU . 27.3 mt -97.59 129.07 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 124.06 0.944 . . . . 1.0 112.394 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -103.76 110.35 22.41 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.113 0.959 . . . . 1.0 111.709 173.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.39 -22.08 64.66 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.298 1.039 . . . . 1.0 113.241 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.6 t -64.55 -22.41 66.96 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.679 0.792 . . . . 1.0 112.895 173.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -119.93 -30.17 4.78 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.267 1.827 . . . . 1.0 112.0 -173.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.26 82.78 12.81 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.904 1.282 . . . . 1.0 112.515 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -75.42 6.56 3.5 Favored 'Trans proline' 0 CA--C 1.549 1.235 0 C-N-CA 123.791 2.994 . . . . 1.0 114.737 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -109.7 72.23 0.58 Allowed Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 127.2 2.2 . . . . 1.0 110.074 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -59.09 -26.92 83.51 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.481 2.12 . . . . 1.0 117.073 -169.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -65.91 -24.67 66.88 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.924 1.238 . . . . 1.0 110.983 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 31.9 p -71.42 -18.1 62.35 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.937 -1.102 . . . . 1.0 112.311 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.427 ' HB2' HD11 ' A' ' 125' ' ' ILE . 4.8 mm-40 -102.22 -55.17 2.53 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.296 1.838 . . . . 1.0 111.442 177.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.4 p -68.64 -35.04 76.75 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 114.18 1.178 . . . . 1.0 114.18 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -60.36 -55.4 45.59 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 120.992 1.724 . . . . 1.0 112.392 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -63.41 -26.88 70.8 Favored 'Trans proline' 0 C--N 1.351 0.68 0 CA-C-N 121.881 1.708 . . . . 1.0 112.665 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.477 ' CG ' ' HB2' ' A' ' 123' ' ' LEU . 88.8 t90 -63.57 -45.64 89.53 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 118.807 0.731 . . . . 1.0 111.192 172.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.856 HG11 ' HA ' ' A' ' 22' ' ' ALA . 53.1 t -66.75 -34.09 67.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.437 1.095 . . . . 1.0 109.537 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -70.63 -21.22 62.65 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.469 1.508 . . . . 1.0 113.189 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -87.64 -58.07 2.71 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.435 1.894 . . . . 1.0 109.878 168.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.471 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 89.8 t90 -58.58 -39.62 80.85 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.001 1.72 . . . . 1.0 113.861 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -53.5 -27.15 33.02 Favored Glycine 0 CA--C 1.537 1.439 0 O-C-N 121.11 -0.994 . . . . 1.0 113.936 173.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.4 p -68.94 -15.0 63.37 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.729 1.764 . . . . 1.0 114.045 175.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.77 -15.98 56.44 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.431 1.492 . . . . 1.0 111.669 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -76.59 169.34 18.45 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.97 0.908 . . . . 1.0 111.214 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.255 1.343 0 N-CA-C 114.866 1.432 . . . . 1.0 114.866 -173.368 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 113.084 0.772 . . . . 1.0 113.084 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -121.73 121.81 38.12 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.56 1.144 . . . . 1.0 110.709 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.512 HD13 HD12 ' A' ' 26' ' ' LEU . 2.2 mp -117.31 114.34 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 C-N-CA 126.138 1.775 . . . . 1.0 112.597 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.54 121.86 6.4 Favored Glycine 0 C--O 1.224 -0.522 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 169.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 mt -105.51 125.25 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 118.666 1.233 . . . . 1.0 109.411 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -118.31 111.78 19.2 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.763 -0.829 . . . . 1.0 108.763 -169.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 N--CA 1.467 0.414 0 N-CA-C 112.165 0.431 . . . . 1.0 112.165 -173.761 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.5 tp . . . . . 0 N--CA 1.465 0.315 0 N-CA-C 118.336 2.717 . . . . 1.0 118.336 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 81.2 t -56.46 -36.36 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 118.697 0.68 . . . . 1.0 112.071 -169.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.76 -38.61 86.95 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.682 -1.261 . . . . 1.0 112.732 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.415 ' HA ' HG11 ' A' ' 35' ' ' VAL . 20.4 mm-40 -66.65 -35.72 80.85 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.015 0.436 . . . . 1.0 110.869 174.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -66.29 -44.81 82.46 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 123.806 0.843 . . . . 1.0 109.1 176.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.535 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -63.88 -41.49 97.72 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 123.343 0.657 . . . . 1.0 112.671 -176.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -56.06 -48.85 75.26 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 170.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.19 -38.23 75.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.684 0.794 . . . . 1.0 112.828 -173.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.7 mt -66.61 -47.6 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-N 119.177 0.899 . . . . 1.0 108.945 175.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.512 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -66.17 -33.9 76.81 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 119.459 -0.897 . . . . 1.0 111.021 -176.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.9 m -63.2 -41.9 99.23 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.325 1.45 . . . . 1.0 113.207 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.52 -32.1 71.81 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.105 0.962 . . . . 1.0 112.433 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -69.56 -29.16 66.67 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.432 1.093 . . . . 1.0 113.051 170.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.17 29.33 2.58 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.526 1.06 . . . . 1.0 113.668 170.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -112.32 155.59 23.84 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.441 1.096 . . . . 1.0 109.267 175.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -86.95 78.46 9.0 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.688 1.195 . . . . 1.0 108.369 -177.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.5 142.84 26.97 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.374 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 96.4 m -143.32 127.48 17.56 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 124.484 1.113 . . . . 1.0 109.333 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.415 HG11 ' HA ' ' A' ' 20' ' ' GLU . 3.6 p -92.28 140.67 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 114.378 1.251 . . . . 1.0 114.378 170.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -114.44 127.64 55.93 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.808 2.043 . . . . 1.0 111.144 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -100.86 132.54 46.21 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.637 1.975 . . . . 1.0 110.481 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.6 t0 43.76 55.59 12.2 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 124.1 0.96 . . . . 1.0 111.653 -169.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -68.81 144.24 58.49 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.067 3.178 . . . . 1.0 117.061 -168.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.425 ' HB3' ' H ' ' A' ' 42' ' ' SER . 54.9 mm-40 -95.22 163.89 13.08 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 122.465 1.126 . . . . 1.0 111.979 168.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.55 HD21 HD21 ' A' ' 79' ' ' LEU . 2.2 tm? -66.55 -21.23 66.15 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 120.959 -1.088 . . . . 1.0 110.16 167.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.425 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 18.8 m -68.1 -21.51 64.95 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.864 -1.148 . . . . 1.0 112.242 172.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -82.02 -24.37 35.41 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.355 1.062 . . . . 1.0 112.449 170.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.451 ' HB3' HD22 ' A' ' 41' ' ' LEU . 11.5 t-105 -88.55 -34.23 17.44 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.115 1.154 . . . . 1.0 114.115 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.1 mt -48.41 -38.41 22.3 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-O 117.538 -1.22 . . . . 1.0 114.209 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -57.81 -18.64 35.22 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.669 2.912 . . . . 1.0 116.435 174.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -105.03 7.4 33.98 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.774 1.768 . . . . 1.0 115.774 -171.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -53.37 -31.12 43.19 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.507 1.923 . . . . 1.0 113.857 176.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -112.42 8.48 19.48 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.081 1.352 . . . . 1.0 112.664 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -113.72 -162.86 0.83 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.815 2.446 . . . . 1.0 110.727 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -109.1 161.63 15.01 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.849 1.309 . . . . 1.0 111.443 169.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.556 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -146.89 157.35 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.537 1.135 . . . . 1.0 109.268 -171.491 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.1 tp -138.99 128.99 25.13 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.891 1.276 . . . . 1.0 108.553 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.4 t -103.36 128.59 56.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.933 -0.765 . . . . 1.0 108.933 175.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.45 112.15 30.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 105.925 -1.88 . . . . 1.0 105.925 176.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 115.181 1.548 . . . . 1.0 115.181 -167.833 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 114.141 1.163 . . . . 1.0 114.141 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -43.27 -53.25 11.43 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 124.383 1.073 . . . . 1.0 112.034 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -67.81 -31.1 32.6 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 121.677 1.585 . . . . 1.0 111.873 -173.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.8 tp -65.35 -53.18 47.32 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 124.475 1.11 . . . . 1.0 111.417 170.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.626 ' CE1' HD23 ' A' ' 110' ' ' LEU . 93.3 t80 -55.51 -53.23 58.9 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.778 0.831 . . . . 1.0 112.385 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -69.08 -35.17 76.2 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.63 -0.714 . . . . 1.0 111.813 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.68 -35.79 91.51 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 121.819 -0.551 . . . . 1.0 112.502 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.602 HG22 HD12 ' A' ' 110' ' ' LEU . 87.4 mt -65.12 -49.77 77.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.899 1.849 . . . . 1.0 108.296 171.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.677 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.2 ptmm? -69.72 -31.43 69.43 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.505 -1.372 . . . . 1.0 112.947 -169.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -105.28 -39.91 6.02 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 115.334 1.605 . . . . 1.0 115.334 -175.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.8 m -93.88 -23.04 18.26 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.239 1.016 . . . . 1.0 112.962 -174.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.55 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -91.1 -70.33 0.69 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 106.81 -1.552 . . . . 1.0 106.81 169.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.03 -11.44 1.35 Allowed Glycine 0 CA--C 1.538 1.481 0 C-N-CA 127.438 2.446 . . . . 1.0 116.514 169.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -155.77 141.08 17.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.825 2.45 . . . . 1.0 108.513 172.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.476 HE22 HD12 ' A' ' 79' ' ' LEU . 2.2 mm-40 -137.43 125.84 14.62 Favored Pre-proline 0 CA--C 1.546 0.815 0 O-C-N 121.281 -0.887 . . . . 1.0 111.097 -173.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.81 -40.52 0.09 OUTLIER 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.849 2.366 . . . . 1.0 114.87 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -140.31 13.85 2.39 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.866 1.432 . . . . 1.0 114.866 -169.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.556 HD11 ' CG2' ' A' ' 52' ' ' VAL . 40.9 tp -74.86 141.26 44.24 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.582 -1.323 . . . . 1.0 113.491 -169.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -132.83 147.39 52.3 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.195 2.598 . . . . 1.0 107.719 169.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.635 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -156.95 165.53 35.92 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.219 0.918 . . . . 1.0 113.349 178.623 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.407 ' HA3' ' CE2' ' A' ' 144' ' ' TRP . . . -127.0 173.33 18.41 Favored Glycine 0 N--CA 1.471 0.978 0 C-N-CA 125.35 1.452 . . . . 1.0 112.338 170.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.492 HG13 ' HB3' ' A' ' 122' ' ' MET . 0.2 OUTLIER -158.81 146.22 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 114.536 1.31 . . . . 1.0 114.536 -169.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.0 mt -133.5 109.41 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 127.478 2.311 . . . . 1.0 107.736 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -94.68 142.0 27.96 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.023 1.729 . . . . 1.0 111.466 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.6 mp -137.26 154.39 50.14 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.375 0.88 . . . . 1.0 113.375 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.73 0 N-CA-C 114.274 0.47 . . . . 1.0 114.274 168.775 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.445 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 20.8 p . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 114.329 1.233 . . . . 1.0 114.329 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -61.01 -21.22 63.38 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.831 1.252 . . . . 1.0 114.299 -170.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.93 -37.85 95.6 Favored Glycine 0 CA--C 1.535 1.326 0 CA-C-N 119.881 1.219 . . . . 1.0 113.109 171.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.79 -38.22 24.23 Favored Glycine 0 N--CA 1.476 1.318 0 O-C-N 121.407 -1.055 . . . . 1.0 113.046 172.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.445 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 89.2 mttt -62.12 -29.31 70.24 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 120.978 -1.307 . . . . 1.0 113.388 173.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -64.03 -28.98 70.17 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.059 0.763 . . . . 1.0 113.059 171.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -66.36 -35.57 80.67 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.643 1.11 . . . . 1.0 111.304 171.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -63.53 -48.96 75.39 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.239 -0.913 . . . . 1.0 110.968 172.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.25 -34.61 66.55 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.804 0.668 . . . . 1.0 112.804 175.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.677 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -59.93 -49.94 75.7 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 123.321 1.534 . . . . 1.0 110.83 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.635 HD12 ' CD1' ' A' ' 87' ' ' TYR . 9.9 mt -66.08 -37.83 86.78 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 120.908 -1.12 . . . . 1.0 111.717 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -69.02 -21.16 64.14 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.992 1.108 . . . . 1.0 113.992 174.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.91 -18.13 58.49 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.277 0.944 . . . . 1.0 111.238 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -96.83 -76.7 0.51 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.287 1.435 . . . . 1.0 110.574 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.3 m 178.32 -2.57 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 127.318 2.247 . . . . 1.0 112.154 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.527 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -77.13 159.55 29.68 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.043 0.925 . . . . 1.0 112.877 -169.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -100.97 174.19 6.13 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.246 -1.343 . . . . 1.0 111.559 -169.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.4 ttm105 -127.36 156.38 42.09 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.865 1.266 . . . . 1.0 112.731 171.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 120' ' ' GLY . 17.3 t -95.43 -168.81 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 C-N-CA 127.333 2.253 . . . . 1.0 105.93 169.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.541 ' H ' HG12 ' A' ' 119' ' ' VAL . . . -49.05 154.96 1.87 Allowed Glycine 0 CA--C 1.542 1.762 0 O-C-N 120.402 -1.436 . . . . 1.0 115.586 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -59.17 149.59 27.81 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.085 1.354 . . . . 1.0 113.15 -171.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.492 ' HB3' HG13 ' A' ' 89' ' ' VAL . 1.1 pmm? -73.78 157.8 35.75 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 122.462 1.125 . . . . 1.0 112.38 -169.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.65 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.2 tm? -86.7 140.51 29.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.824 -1.08 . . . . 1.0 109.39 171.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.65 ' N ' HD13 ' A' ' 123' ' ' LEU . 5.6 mt -123.65 104.39 8.99 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.818 1.247 . . . . 1.0 110.886 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.442 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.9 mt -90.26 128.21 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 125.109 1.363 . . . . 1.0 111.652 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -108.16 109.52 20.94 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 124.3 1.0 . . . . 1.0 112.174 171.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.76 -20.74 65.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.788 0.835 . . . . 1.0 112.948 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.2 t -63.6 -21.4 66.34 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.724 1.21 . . . . 1.0 112.675 173.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -124.67 -29.62 3.41 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.149 1.78 . . . . 1.0 112.584 -173.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -140.59 87.11 11.77 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.479 1.512 . . . . 1.0 112.068 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.2 6.85 2.8 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 123.675 2.917 . . . . 1.0 114.631 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -112.81 71.86 1.33 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 127.449 2.299 . . . . 1.0 109.699 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -57.87 -23.32 58.59 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.434 2.089 . . . . 1.0 116.827 -168.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -65.62 -25.69 67.49 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 119.128 0.876 . . . . 1.0 111.733 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 p -73.5 -16.99 61.27 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 120.902 -1.124 . . . . 1.0 111.706 -175.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -102.27 -53.87 2.81 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.163 1.785 . . . . 1.0 111.212 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 59.3 p -72.14 -33.9 68.13 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 114.706 1.372 . . . . 1.0 114.706 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -60.18 -55.55 44.2 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 120.923 1.692 . . . . 1.0 112.64 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -62.33 -22.64 74.39 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 121.329 1.51 . . . . 1.0 112.628 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.477 ' HB2' HD23 ' A' ' 123' ' ' LEU . 90.1 t90 -70.26 -45.55 66.19 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 121.67 -0.644 . . . . 1.0 111.264 174.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.535 HG11 ' HA ' ' A' ' 22' ' ' ALA . 91.5 t -64.69 -34.22 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.835 -0.802 . . . . 1.0 108.835 176.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.75 -29.77 68.24 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.132 1.373 . . . . 1.0 112.195 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -79.9 -61.38 2.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.104 1.762 . . . . 1.0 112.239 171.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.407 ' CE2' ' HA3' ' A' ' 88' ' ' GLY . 85.3 t90 -56.76 -36.43 69.78 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 126.724 2.01 . . . . 1.0 112.49 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.46 -32.28 22.86 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.684 1.135 . . . . 1.0 113.438 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 p -70.22 -13.12 62.04 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.332 1.234 . . . . 1.0 114.332 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.0 -14.72 55.57 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.151 1.78 . . . . 1.0 111.773 175.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.57 -178.27 5.77 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.223 1.009 . . . . 1.0 110.45 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 9.7 m . . . . . 0 C--O 1.254 1.324 0 C-N-CA 126.607 1.963 . . . . 1.0 114.251 -179.444 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.406 0 CA-C-O 121.731 0.777 . . . . 1.0 113.058 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -113.73 124.73 52.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.369 -1.287 . . . . 1.0 111.877 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.521 HD13 HD12 ' A' ' 26' ' ' LEU . 1.7 mp -120.92 112.82 37.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 126.424 1.889 . . . . 1.0 113.044 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.64 122.59 6.84 Favored Glycine 0 N--CA 1.467 0.742 0 N-CA-C 110.918 -0.873 . . . . 1.0 110.918 169.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.5 mt -104.17 119.63 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 118.464 1.132 . . . . 1.0 109.804 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -112.17 108.91 18.33 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.635 -1.246 . . . . 1.0 107.635 -171.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.47 0.536 0 CA-C-O 121.288 0.566 . . . . 1.0 112.434 -169.925 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.8 tp . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 116.121 1.896 . . . . 1.0 116.121 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.4 t -47.87 -32.36 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.114 1.366 . . . . 1.0 112.727 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.15 -49.19 76.72 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.632 -1.293 . . . . 1.0 113.113 172.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -67.71 -30.33 69.8 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.674 1.19 . . . . 1.0 110.648 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.29 -46.62 69.82 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 123.397 0.679 . . . . 1.0 109.297 173.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.557 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.36 -42.12 93.13 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 123.225 0.61 . . . . 1.0 112.329 -176.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -54.27 -49.13 70.28 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.121 0.968 . . . . 1.0 110.312 169.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.57 -38.7 70.9 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.633 0.773 . . . . 1.0 112.453 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.4 mt -68.04 -45.81 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 O-C-N 121.117 -0.989 . . . . 1.0 109.357 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.521 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.76 -31.5 72.52 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.56 1.073 . . . . 1.0 110.708 -178.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.6 m -63.14 -45.05 93.78 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.241 1.016 . . . . 1.0 112.919 169.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.65 -30.89 69.69 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.777 1.231 . . . . 1.0 113.163 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -67.33 -27.64 67.31 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.485 1.914 . . . . 1.0 111.809 172.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.32 26.21 2.73 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.535 1.064 . . . . 1.0 114.737 171.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -117.54 173.19 6.86 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.999 1.319 . . . . 1.0 110.304 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -102.04 94.14 5.62 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 125.459 1.503 . . . . 1.0 108.429 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.34 147.44 31.51 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.283 0.633 . . . . 1.0 111.459 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.3 m -146.81 140.38 25.75 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.153 0.981 . . . . 1.0 112.428 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.1 t -87.2 137.71 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 115.071 1.508 . . . . 1.0 115.071 172.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -116.86 109.86 17.62 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.132 2.173 . . . . 1.0 109.993 169.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -88.04 145.93 25.73 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.081 1.752 . . . . 1.0 110.84 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.1 t0 43.33 57.77 12.21 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 124.517 1.127 . . . . 1.0 110.264 -169.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -55.23 128.06 28.89 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.775 3.65 . . . . 1.0 118.486 -167.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -91.75 150.34 21.15 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.368 1.467 . . . . 1.0 113.131 169.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.487 HD21 HD21 ' A' ' 79' ' ' LEU . 2.6 tm? -70.6 -25.9 63.26 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.342 -0.849 . . . . 1.0 110.175 168.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.1 m -66.53 -20.97 66.16 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.494 -0.753 . . . . 1.0 112.272 171.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -87.14 -24.07 24.63 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.252 1.021 . . . . 1.0 113.249 169.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.463 ' HB3' HD22 ' A' ' 41' ' ' LEU . 15.2 t-105 -79.4 -36.08 39.67 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.608 1.095 . . . . 1.0 113.529 175.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.9 mt -48.82 -40.53 43.41 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 117.845 -1.074 . . . . 1.0 113.879 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -53.8 -15.72 7.37 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.613 3.542 . . . . 1.0 117.826 172.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -110.46 8.0 22.94 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 116.139 1.903 . . . . 1.0 116.139 -172.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -53.11 -29.28 29.89 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.612 1.965 . . . . 1.0 114.115 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -114.28 11.68 17.46 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.151 1.781 . . . . 1.0 113.267 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -125.57 -159.54 0.91 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.611 2.365 . . . . 1.0 110.818 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -113.24 158.9 19.91 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 123.211 1.481 . . . . 1.0 113.073 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.584 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -147.37 156.61 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 125.302 1.441 . . . . 1.0 109.796 -170.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.676 HD11 HD12 ' A' ' 90' ' ' ILE . 19.4 tp -139.36 127.59 22.62 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.733 1.213 . . . . 1.0 109.044 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.9 t -102.42 123.03 55.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 123.762 0.825 . . . . 1.0 109.151 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.4 t -122.46 111.96 32.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 105.057 -2.201 . . . . 1.0 105.057 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 113.852 1.056 . . . . 1.0 113.852 -167.765 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.8 tt . . . . . 0 N--CA 1.47 0.541 0 N-CA-C 114.394 1.257 . . . . 1.0 114.394 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.9 t -45.13 -51.95 22.2 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 124.267 1.027 . . . . 1.0 111.717 168.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.42 -29.5 20.61 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.329 1.353 . . . . 1.0 111.664 -173.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.4 tp -64.75 -50.61 66.17 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.255 1.022 . . . . 1.0 110.909 169.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.648 ' CE1' HD23 ' A' ' 110' ' ' LEU . 88.2 t80 -55.2 -53.72 52.38 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.0 0.92 . . . . 1.0 112.473 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -69.06 -34.47 75.23 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.704 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.27 -34.69 88.79 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 123.876 0.75 . . . . 1.0 112.747 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.535 HG22 HD12 ' A' ' 110' ' ' LEU . 90.8 mt -65.23 -51.88 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 120.119 -1.812 . . . . 1.0 108.438 170.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.671 ' HB3' HD21 ' A' ' 110' ' ' LEU . 11.4 ptmt -67.78 -32.32 72.82 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.524 -1.36 . . . . 1.0 113.178 -170.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -104.07 -36.59 7.67 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.27 1.582 . . . . 1.0 115.27 -173.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.7 m -97.22 -19.63 18.46 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.196 0.999 . . . . 1.0 112.938 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.535 HD12 HE22 ' A' ' 82' ' ' GLN . 0.1 OUTLIER -95.62 -70.92 0.69 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 107.534 -1.284 . . . . 1.0 107.534 169.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.63 -13.32 1.69 Allowed Glycine 0 CA--C 1.536 1.404 0 C-N-CA 127.257 2.36 . . . . 1.0 116.454 169.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -155.76 141.49 17.97 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 127.668 2.387 . . . . 1.0 108.603 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.535 HE22 HD12 ' A' ' 79' ' ' LEU . 1.6 mm-40 -135.33 124.35 16.09 Favored Pre-proline 0 CA--C 1.546 0.808 0 O-C-N 121.449 -0.782 . . . . 1.0 111.237 -171.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.4 -39.07 0.2 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.35 2.034 . . . . 1.0 114.415 -171.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -146.7 18.1 1.29 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.255 1.206 . . . . 1.0 114.255 -170.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.584 HD11 ' CG2' ' A' ' 52' ' ' VAL . 46.0 tp -77.83 141.78 38.95 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 120.424 -1.422 . . . . 1.0 113.373 -169.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -136.73 146.65 46.07 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 129.519 3.127 . . . . 1.0 108.36 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.674 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -159.4 168.53 26.08 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.053 0.842 . . . . 1.0 113.126 -177.144 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.461 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -127.64 170.52 19.19 Favored Glycine 0 N--CA 1.472 1.082 0 C-N-CA 124.678 1.133 . . . . 1.0 114.281 172.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 86.6 t -142.28 133.5 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.668 1.187 . . . . 1.0 113.34 -169.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.982 HG23 HD12 ' A' ' 123' ' ' LEU . 3.5 mt -128.12 98.57 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.151 1.78 . . . . 1.0 106.781 169.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.27 145.37 25.43 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.151 1.38 . . . . 1.0 111.09 173.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.8 mp -138.88 149.79 45.25 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.601 -0.687 . . . . 1.0 111.974 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.347 0 C-N-CA 119.38 -1.39 . . . . 1.0 115.793 169.295 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.9 m . . . . . 0 CA--C 1.544 0.722 0 N-CA-C 113.03 0.752 . . . . 1.0 113.03 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -53.65 -23.98 12.89 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.57 1.948 . . . . 1.0 114.28 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -54.89 -50.12 59.64 Favored Glycine 0 CA--C 1.536 1.36 0 CA-C-N 120.039 1.29 . . . . 1.0 113.237 173.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -77.89 -34.21 39.13 Favored Glycine 0 N--CA 1.479 1.54 0 O-C-N 120.798 -1.413 . . . . 1.0 113.639 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -59.6 -34.74 73.14 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.431 -1.04 . . . . 1.0 112.904 173.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -62.98 -39.3 94.32 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.869 0.868 . . . . 1.0 112.232 172.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -62.87 -39.76 95.43 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.435 1.016 . . . . 1.0 110.689 173.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.29 -40.1 96.42 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.802 0.441 . . . . 1.0 111.664 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.08 83.06 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 118.496 -0.764 . . . . 1.0 111.786 169.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.671 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -48.21 -49.05 34.39 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.391 2.277 . . . . 1.0 111.864 -172.07 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.674 HD12 ' CD1' ' A' ' 87' ' ' TYR . 7.3 mt -65.91 -43.86 86.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.939 -1.028 . . . . 1.0 111.35 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -65.92 -24.74 66.89 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.883 1.068 . . . . 1.0 113.883 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -66.1 -32.82 74.5 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.522 1.129 . . . . 1.0 111.466 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -83.08 -73.3 0.41 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.369 -1.287 . . . . 1.0 109.1 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.5 p 176.02 -15.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 127.32 2.248 . . . . 1.0 113.8 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.503 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -68.08 148.88 50.35 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 122.888 1.328 . . . . 1.0 113.927 -169.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -90.16 171.76 9.29 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 113.131 -1.85 . . . . 1.0 112.899 -168.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.94 138.14 49.61 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.239 1.816 . . . . 1.0 110.195 -175.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 120' ' ' GLY . 18.2 t -88.57 -168.26 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 124.818 1.247 . . . . 1.0 107.832 174.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.588 ' H ' HG12 ' A' ' 119' ' ' VAL . . . -51.38 153.4 4.89 Favored Glycine 0 CA--C 1.544 1.86 0 O-C-N 119.779 -1.826 . . . . 1.0 115.604 -176.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.58 137.5 15.31 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.123 1.769 . . . . 1.0 114.596 -172.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -68.22 159.35 31.37 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.505 1.522 . . . . 1.0 113.088 -169.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.982 HD12 HG23 ' A' ' 90' ' ' ILE . 1.3 tm? -91.2 139.1 31.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.539 -1.21 . . . . 1.0 109.86 169.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.407 ' N ' HD13 ' A' ' 123' ' ' LEU . 6.6 mt -127.87 111.49 13.66 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.624 1.569 . . . . 1.0 109.52 174.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.582 HG13 HD11 ' A' ' 123' ' ' LEU . 25.7 mt -100.58 133.44 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.612 1.165 . . . . 1.0 113.499 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.05 97.0 10.42 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.478 1.511 . . . . 1.0 111.346 174.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.08 -25.2 65.22 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.145 -1.597 . . . . 1.0 112.72 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.4 m -63.66 -17.74 63.24 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.722 2.009 . . . . 1.0 113.75 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -125.14 -29.32 3.31 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.233 1.813 . . . . 1.0 112.129 -173.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -143.12 89.5 7.76 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.475 1.51 . . . . 1.0 110.754 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -77.41 12.41 1.86 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.03 3.154 . . . . 1.0 114.026 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -111.34 65.53 0.57 Allowed Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 127.428 2.291 . . . . 1.0 109.915 174.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -57.36 -22.67 50.97 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.366 2.044 . . . . 1.0 115.956 -169.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.8 pm0 -63.94 -24.31 67.68 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.332 0.969 . . . . 1.0 111.603 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.4 p -72.4 -17.55 61.8 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 120.765 -1.209 . . . . 1.0 112.111 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.414 ' HB2' HD11 ' A' ' 125' ' ' ILE . 5.7 mm-40 -104.64 -54.7 2.47 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.06 1.744 . . . . 1.0 111.895 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.0 p -69.7 -33.91 73.19 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.704 1.002 . . . . 1.0 113.704 -177.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -59.51 -57.09 29.55 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 120.765 1.62 . . . . 1.0 112.435 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -62.09 -23.94 76.07 Favored 'Trans proline' 0 C--N 1.352 0.735 0 CA-C-N 121.304 1.502 . . . . 1.0 112.776 174.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.473 ' CG ' ' HB2' ' A' ' 123' ' ' LEU . 87.5 t90 -67.35 -46.69 72.66 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 119.094 0.861 . . . . 1.0 110.725 174.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.557 HG11 ' HA ' ' A' ' 22' ' ' ALA . 92.5 t -64.42 -32.29 57.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 122.337 1.065 . . . . 1.0 109.253 175.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -71.16 -22.73 62.01 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 120.066 -1.646 . . . . 1.0 113.359 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -88.53 -59.38 2.25 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.379 1.871 . . . . 1.0 111.247 168.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.461 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 89.5 t90 -56.93 -36.49 70.28 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.697 1.599 . . . . 1.0 113.388 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.62 -30.72 35.56 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 121.315 -0.865 . . . . 1.0 114.196 173.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.6 p -68.22 -12.55 61.17 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.213 1.19 . . . . 1.0 114.213 176.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.74 -16.19 51.9 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.98 1.712 . . . . 1.0 111.881 176.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.78 177.08 9.09 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.198 0.999 . . . . 1.0 110.829 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 8.9 m . . . . . 0 C--O 1.251 1.149 0 N-CA-C 115.882 1.808 . . . . 1.0 115.882 -172.014 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.475 0 N-CA-C 113.687 0.995 . . . . 1.0 113.687 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -124.2 125.37 44.31 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.479 1.511 . . . . 1.0 110.267 173.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.588 HD13 HD12 ' A' ' 26' ' ' LEU . 2.2 mp -121.51 114.99 45.18 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 C-N-CA 126.026 1.73 . . . . 1.0 112.832 -178.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.4 123.37 7.13 Favored Glycine 0 C--O 1.225 -0.446 0 N-CA-C 110.313 -1.115 . . . . 1.0 110.313 169.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.8 mt -103.67 116.22 47.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 118.167 0.983 . . . . 1.0 109.312 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -112.3 112.05 23.36 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.198 -1.408 . . . . 1.0 107.198 -172.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.469 0.498 0 CA-C-N 116.66 -0.246 . . . . 1.0 111.582 -172.58 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.6 tp . . . . . 0 N--CA 1.468 0.44 0 N-CA-C 117.326 2.343 . . . . 1.0 117.326 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.6 t -58.18 -35.15 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 118.685 0.675 . . . . 1.0 111.861 -169.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.24 -48.1 83.0 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 120.845 -1.159 . . . . 1.0 112.679 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -67.09 -30.95 71.12 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.879 0.371 . . . . 1.0 111.312 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -66.31 -48.31 70.76 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 173.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.651 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -63.04 -44.0 97.1 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 112.673 0.62 . . . . 1.0 112.673 -176.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -53.56 -49.43 67.71 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.376 1.07 . . . . 1.0 110.701 170.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.06 -37.51 75.51 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.632 0.773 . . . . 1.0 112.656 -175.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.5 mt -69.49 -45.56 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 119.119 0.872 . . . . 1.0 109.568 175.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.588 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.52 -33.84 76.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 119.651 -0.819 . . . . 1.0 110.269 -178.255 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.4 m -61.71 -45.03 95.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.392 1.477 . . . . 1.0 112.669 169.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.69 -32.98 74.64 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.346 1.058 . . . . 1.0 113.011 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -68.44 -30.62 69.55 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.752 1.221 . . . . 1.0 112.102 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.87 20.93 2.01 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.847 1.213 . . . . 1.0 115.214 169.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -118.85 153.53 34.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.785 1.234 . . . . 1.0 111.167 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -88.31 75.38 8.53 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.244 1.417 . . . . 1.0 110.637 -172.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.01 144.85 25.55 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.387 -1.733 . . . . 1.0 112.449 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.1 m -147.52 141.48 25.9 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.986 1.315 . . . . 1.0 112.055 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -88.96 139.23 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 115.56 1.689 . . . . 1.0 115.56 172.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -116.95 109.85 17.55 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.181 2.192 . . . . 1.0 110.327 169.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -88.23 144.02 26.69 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.384 1.874 . . . . 1.0 110.462 171.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 43.06 59.48 11.26 Favored Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 124.488 1.115 . . . . 1.0 111.193 -169.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -60.85 130.94 34.93 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 124.483 3.455 . . . . 1.0 118.356 -168.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -93.15 150.26 20.64 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.683 1.593 . . . . 1.0 112.896 169.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.508 HD21 HD21 ' A' ' 79' ' ' LEU . 2.5 tm? -69.56 -25.81 64.18 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.2 -0.937 . . . . 1.0 110.031 168.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.9 m -66.68 -20.6 66.01 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.446 -0.784 . . . . 1.0 112.615 171.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -88.73 -22.29 23.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.669 1.188 . . . . 1.0 113.207 169.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.466 ' HB3' HD22 ' A' ' 41' ' ' LEU . 15.5 t-105 -80.53 -35.58 34.34 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.799 1.181 . . . . 1.0 113.863 174.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.1 mt -49.43 -40.24 47.29 Favored Pre-proline 0 CA--C 1.551 1.006 0 CA-C-O 117.785 -1.103 . . . . 1.0 113.828 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -55.97 -14.06 10.39 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 124.509 3.473 . . . . 1.0 117.153 172.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -109.48 7.49 24.84 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.967 1.84 . . . . 1.0 115.967 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -53.13 -31.54 42.86 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.607 1.963 . . . . 1.0 113.819 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -112.12 11.62 20.41 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.966 1.307 . . . . 1.0 112.689 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -120.17 -157.59 0.71 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.977 2.511 . . . . 1.0 110.895 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -115.45 165.53 12.89 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.629 1.204 . . . . 1.0 111.445 171.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.649 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -150.14 159.54 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.616 1.166 . . . . 1.0 109.214 -170.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.536 HD11 HD12 ' A' ' 90' ' ' ILE . 14.5 tp -140.29 129.01 23.07 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 124.425 1.09 . . . . 1.0 108.954 174.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.6 t -107.11 123.95 62.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 124.299 1.039 . . . . 1.0 109.626 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.0 t -123.04 111.71 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 107.546 -1.279 . . . . 1.0 107.546 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.488 1.435 0 C-N-CA 124.288 1.035 . . . . 1.0 108.958 -169.694 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.4 tt . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 113.477 0.918 . . . . 1.0 113.477 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -42.37 -52.23 10.32 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 124.638 1.175 . . . . 1.0 112.533 168.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -71.27 -29.84 16.59 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.383 1.389 . . . . 1.0 111.662 -173.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.9 tp -64.91 -49.66 69.57 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 124.227 1.011 . . . . 1.0 110.767 169.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.722 ' CE1' HD23 ' A' ' 110' ' ' LEU . 93.6 t80 -56.4 -52.57 64.13 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.312 1.045 . . . . 1.0 112.483 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -64.02 -40.75 97.02 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.864 0.866 . . . . 1.0 111.4 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.95 -33.66 84.62 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.943 0.783 . . . . 1.0 112.801 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.561 HG22 HD12 ' A' ' 110' ' ' LEU . 91.8 mt -66.54 -50.76 64.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 120.116 1.958 . . . . 1.0 108.47 170.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.744 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.1 ptmm? -69.6 -30.23 67.94 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.371 -1.456 . . . . 1.0 112.998 -170.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -106.94 -37.74 6.25 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.779 1.77 . . . . 1.0 115.779 -175.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.1 m -93.99 -22.41 18.57 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.958 0.903 . . . . 1.0 113.028 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.508 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -92.74 -71.1 0.67 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.204 -1.406 . . . . 1.0 107.204 169.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.02 -11.44 1.34 Allowed Glycine 0 CA--C 1.538 1.5 0 C-N-CA 127.213 2.339 . . . . 1.0 116.41 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -155.3 140.12 17.17 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.508 2.323 . . . . 1.0 108.38 172.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.431 HE22 HD12 ' A' ' 79' ' ' LEU . 2.1 mm-40 -135.81 123.58 15.03 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 121.267 -0.895 . . . . 1.0 111.365 -173.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -82.73 -39.3 0.14 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.845 2.363 . . . . 1.0 114.654 -173.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -141.28 13.57 2.2 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 115.14 1.533 . . . . 1.0 115.14 -169.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.649 HD11 ' CG2' ' A' ' 52' ' ' VAL . 53.8 tp -79.4 140.72 37.34 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.585 -1.322 . . . . 1.0 113.138 -169.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.83 151.3 48.98 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 127.959 2.504 . . . . 1.0 109.188 169.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.675 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -160.62 166.13 29.46 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.329 0.968 . . . . 1.0 113.603 -175.008 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.435 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -121.15 169.95 14.48 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 125.662 1.601 . . . . 1.0 113.876 175.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 66.0 t -145.78 132.38 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 114.364 1.246 . . . . 1.0 114.364 -169.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.536 HD12 HD11 ' A' ' 53' ' ' LEU . 3.5 mt -134.21 110.92 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.591 1.556 . . . . 1.0 108.774 169.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -105.07 146.94 28.44 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.6 -0.687 . . . . 1.0 111.546 171.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.24 153.39 44.8 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.441 1.497 . . . . 1.0 109.915 177.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.604 0 CA-C-O 122.116 0.842 . . . . 1.0 114.137 169.294 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 7.2 m . . . . . 0 CA--C 1.542 0.654 0 CA-C-O 121.364 0.602 . . . . 1.0 112.491 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -61.28 -21.83 64.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.154 1.538 . . . . 1.0 115.154 -169.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.93 -51.2 57.3 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 121.679 2.036 . . . . 1.0 114.099 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.55 -35.55 92.07 Favored Glycine 0 N--CA 1.474 1.228 0 O-C-N 120.547 -1.561 . . . . 1.0 112.845 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -63.5 -38.55 91.55 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.255 1.022 . . . . 1.0 113.119 173.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -58.32 -46.5 86.04 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.748 0.819 . . . . 1.0 111.021 170.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -63.17 -37.93 89.15 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.738 -0.601 . . . . 1.0 111.792 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.78 -45.61 93.12 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.464 -0.773 . . . . 1.0 112.081 177.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.63 -36.65 74.41 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.066 0.765 . . . . 1.0 113.066 171.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.744 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -59.65 -49.03 79.35 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 123.351 1.548 . . . . 1.0 111.199 -175.645 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.675 HD12 ' CD1' ' A' ' 87' ' ' TYR . 8.9 mt -66.1 -39.95 90.37 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 120.789 -1.194 . . . . 1.0 111.47 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -71.27 -19.1 62.39 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.136 0.791 . . . . 1.0 113.136 177.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.23 -21.93 58.27 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.407 1.003 . . . . 1.0 111.098 176.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -92.05 -78.4 0.41 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 125.356 1.462 . . . . 1.0 110.019 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.429 ' H ' ' H ' ' A' ' 116' ' ' ALA . 2.4 t -178.89 -3.75 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.085 2.154 . . . . 1.0 112.027 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -75.54 148.58 38.79 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 122.632 1.206 . . . . 1.0 112.639 -169.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -90.8 170.29 10.23 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.17 1.788 . . . . 1.0 114.048 -168.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.73 143.35 50.82 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.885 2.074 . . . . 1.0 111.018 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.9 t -118.22 130.15 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.25 1.42 . . . . 1.0 108.664 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 48.51 -154.44 1.77 Allowed Glycine 0 N--CA 1.48 1.575 0 C-N-CA 124.834 1.207 . . . . 1.0 114.317 -170.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -119.16 147.52 44.1 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.986 1.714 . . . . 1.0 109.961 169.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.26 157.66 37.28 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.239 -0.913 . . . . 1.0 113.301 -169.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.634 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.8 OUTLIER -93.99 134.79 36.03 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.221 1.009 . . . . 1.0 110.573 171.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.634 ' N ' HD13 ' A' ' 123' ' ' LEU . 10.3 mt -120.69 107.61 13.0 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.468 1.507 . . . . 1.0 111.451 175.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.458 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.9 mt -93.56 130.78 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 126.344 1.858 . . . . 1.0 113.054 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -106.13 89.51 3.08 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.663 2.385 . . . . 1.0 113.245 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.32 -24.68 67.74 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.893 -1.13 . . . . 1.0 113.26 -175.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.7 m -60.68 -18.13 52.12 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.424 2.29 . . . . 1.0 113.865 172.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -127.9 -31.94 2.36 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.148 2.179 . . . . 1.0 112.501 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -138.06 91.91 12.81 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 126.046 1.739 . . . . 1.0 111.483 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -75.83 9.05 2.46 Favored 'Trans proline' 0 CA--C 1.549 1.235 0 C-N-CA 123.589 2.859 . . . . 1.0 114.517 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -112.05 70.45 0.98 Allowed Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 127.482 2.313 . . . . 1.0 110.057 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -57.81 -20.51 43.97 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.627 2.218 . . . . 1.0 116.417 -169.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -65.0 -26.67 68.39 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 118.91 0.777 . . . . 1.0 111.713 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.0 p -72.6 -16.7 61.73 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 120.866 -1.146 . . . . 1.0 111.743 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -101.1 -56.16 2.38 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.179 1.792 . . . . 1.0 111.711 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 60.3 p -69.59 -32.22 70.83 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.777 1.399 . . . . 1.0 114.777 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -62.1 -55.41 40.99 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 120.939 1.7 . . . . 1.0 113.176 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -62.84 -23.59 74.34 Favored 'Trans proline' 0 C--N 1.355 0.882 0 CA-C-N 121.28 1.493 . . . . 1.0 112.255 175.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.437 ' HB2' HD23 ' A' ' 123' ' ' LEU . 92.6 t90 -69.29 -47.5 64.37 Favored 'General case' 0 C--O 1.218 -0.594 0 C-N-CA 123.258 0.623 . . . . 1.0 111.053 174.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.651 HG11 ' HA ' ' A' ' 22' ' ' ALA . 95.7 t -66.45 -32.79 59.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 N-CA-C 109.554 -0.535 . . . . 1.0 109.554 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -64.51 -50.35 67.74 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.228 -0.92 . . . . 1.0 109.477 173.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -63.47 -54.73 31.88 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.703 1.201 . . . . 1.0 111.743 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.435 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 86.3 t90 -56.58 -37.7 70.95 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 125.843 1.657 . . . . 1.0 111.262 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.2 -33.68 23.46 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.434 1.492 . . . . 1.0 113.619 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.3 p -68.8 -14.03 62.77 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 114.802 1.408 . . . . 1.0 114.802 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.53 -19.63 45.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.35 1.46 . . . . 1.0 111.692 176.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -83.68 173.7 11.13 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.48 1.112 . . . . 1.0 110.583 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--O 1.252 1.213 0 C-N-CA 124.662 1.185 . . . . 1.0 113.923 -176.23 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.48 0 N-CA-C 112.597 0.592 . . . . 1.0 112.597 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -122.48 125.08 45.06 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.035 1.334 . . . . 1.0 110.04 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.557 HD13 HD12 ' A' ' 26' ' ' LEU . 2.2 mp -121.58 114.07 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 126.778 2.031 . . . . 1.0 112.346 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.31 125.55 8.06 Favored Glycine 0 C--O 1.223 -0.539 0 N-CA-C 110.315 -1.114 . . . . 1.0 110.315 169.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 mt -106.16 121.37 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-N 118.547 1.174 . . . . 1.0 109.803 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -113.35 108.58 17.42 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.514 -1.291 . . . . 1.0 107.514 -169.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.467 0.419 0 O-C-N 123.375 0.422 . . . . 1.0 111.869 -174.185 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.3 tp . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 112.954 0.724 . . . . 1.0 112.954 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.1 t -56.35 -32.85 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.017 0.527 . . . . 1.0 111.5 -173.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.47 -47.62 85.34 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.793 -1.192 . . . . 1.0 113.105 172.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -66.98 -30.35 70.44 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.682 0.793 . . . . 1.0 111.117 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -68.86 -48.36 63.64 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 123.795 0.838 . . . . 1.0 109.394 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.541 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -63.8 -42.84 97.64 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 112.769 0.655 . . . . 1.0 112.769 -176.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -53.96 -49.44 68.73 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.093 0.957 . . . . 1.0 110.129 170.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.09 -37.84 72.4 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.484 0.713 . . . . 1.0 112.737 -174.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.5 mt -66.18 -46.83 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 119.355 0.98 . . . . 1.0 109.117 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.557 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -66.98 -35.14 79.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 119.543 -0.863 . . . . 1.0 110.468 -176.442 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 51.8 m -61.9 -41.92 98.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.24 1.416 . . . . 1.0 113.711 170.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.2 -33.06 74.58 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.049 0.94 . . . . 1.0 112.272 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -70.64 -30.04 66.56 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.629 1.172 . . . . 1.0 113.203 171.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.91 23.11 2.81 Favored Glycine 0 N--CA 1.468 0.799 0 C-N-CA 124.543 1.068 . . . . 1.0 114.433 169.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -111.52 148.96 32.08 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.543 1.137 . . . . 1.0 109.55 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.91 90.57 6.46 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.05 1.34 . . . . 1.0 108.008 -176.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.07 145.71 31.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.576 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 56.5 m -148.49 139.89 23.43 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.545 0.738 . . . . 1.0 112.076 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.45 138.72 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 115.48 1.659 . . . . 1.0 115.48 173.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -119.94 112.76 19.58 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.195 2.198 . . . . 1.0 110.292 169.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -95.01 138.23 33.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.725 2.01 . . . . 1.0 110.461 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.9 t70 42.95 54.39 10.02 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 123.753 0.821 . . . . 1.0 111.379 -169.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -71.18 147.74 54.48 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.777 2.985 . . . . 1.0 117.064 -168.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -98.02 164.81 12.19 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 124.934 1.294 . . . . 1.0 113.034 168.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.566 HD21 HD21 ' A' ' 79' ' ' LEU . 2.2 tm? -68.01 -22.5 64.98 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 121.169 -0.957 . . . . 1.0 110.523 167.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 67.0 p -68.33 -20.22 64.72 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.759 1.163 . . . . 1.0 112.481 171.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -81.13 -25.38 36.96 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.232 1.013 . . . . 1.0 112.248 169.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.454 ' HB3' HD22 ' A' ' 41' ' ' LEU . 15.7 t-105 -88.28 -35.39 17.29 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.504 1.298 . . . . 1.0 114.504 -177.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.6 mt -47.72 -38.39 17.47 Favored Pre-proline 0 CA--C 1.554 1.116 0 CA-C-O 117.681 -1.152 . . . . 1.0 114.058 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -58.99 -14.47 23.13 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 123.674 2.916 . . . . 1.0 116.526 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -110.54 9.53 23.13 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.63 1.715 . . . . 1.0 115.63 -174.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -51.44 -30.4 19.46 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.86 2.064 . . . . 1.0 113.729 174.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -108.82 7.2 26.1 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.316 1.847 . . . . 1.0 113.489 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -122.39 -163.18 1.06 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.888 2.475 . . . . 1.0 110.706 -174.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -110.62 165.33 11.9 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 123.081 1.419 . . . . 1.0 111.963 171.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.428 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -150.86 159.97 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.485 1.514 . . . . 1.0 109.567 -172.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.42 HD11 HD12 ' A' ' 90' ' ' ILE . 14.2 tp -139.25 130.09 26.2 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.006 1.322 . . . . 1.0 108.308 177.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.3 t -106.63 123.05 61.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 C-N-CA 123.944 0.897 . . . . 1.0 108.959 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.9 t -122.1 111.89 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 106.222 -1.77 . . . . 1.0 106.222 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 113.731 1.012 . . . . 1.0 113.731 -167.875 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.4 tt . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 114.138 1.162 . . . . 1.0 114.138 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -44.54 -53.53 14.59 Favored Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 124.912 1.285 . . . . 1.0 112.073 168.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -68.39 -30.55 29.68 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.833 1.689 . . . . 1.0 111.746 -173.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.7 tp -65.31 -52.87 51.16 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 123.908 0.883 . . . . 1.0 111.126 169.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.632 ' CE1' HD23 ' A' ' 110' ' ' LEU . 93.0 t80 -55.86 -53.2 59.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.78 0.832 . . . . 1.0 112.498 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -69.52 -34.81 74.81 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.837 -0.619 . . . . 1.0 111.696 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.95 -35.41 90.69 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.77 -0.581 . . . . 1.0 112.473 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.597 HG22 HD12 ' A' ' 110' ' ' LEU . 95.4 mt -65.47 -50.08 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.87 1.835 . . . . 1.0 108.707 171.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.67 ' HB3' HD21 ' A' ' 110' ' ' LEU . 4.5 ptmm? -69.37 -31.83 70.49 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 120.324 -1.485 . . . . 1.0 113.303 -170.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -105.69 -39.33 6.11 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.309 1.596 . . . . 1.0 115.309 -173.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.9 m -93.29 -22.94 18.69 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.054 0.941 . . . . 1.0 112.901 -176.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.566 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -92.75 -71.33 0.65 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.164 -1.421 . . . . 1.0 107.164 169.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.63 -13.6 1.62 Allowed Glycine 0 CA--C 1.539 1.536 0 C-N-CA 127.413 2.435 . . . . 1.0 116.587 169.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -154.18 141.05 19.18 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 127.342 2.257 . . . . 1.0 108.72 171.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.444 HE22 HD12 ' A' ' 79' ' ' LEU . 1.4 mm-40 -136.97 125.0 14.63 Favored Pre-proline 0 CA--C 1.544 0.729 0 O-C-N 121.287 -0.883 . . . . 1.0 111.668 -172.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -86.54 -36.63 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.037 2.492 . . . . 1.0 114.967 -174.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -142.53 15.89 2.0 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.534 1.309 . . . . 1.0 114.534 -169.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.428 HD11 ' CG2' ' A' ' 52' ' ' VAL . 66.3 tp -84.78 138.46 32.59 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.514 -1.366 . . . . 1.0 112.773 -169.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.9 mtm-85 -135.74 156.43 48.83 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 127.944 2.498 . . . . 1.0 109.558 169.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.676 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -162.44 169.0 21.15 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.186 -0.946 . . . . 1.0 111.587 -177.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.404 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -129.58 173.11 19.75 Favored Glycine 0 N--CA 1.475 1.291 0 C-N-CA 124.734 1.159 . . . . 1.0 114.189 170.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.01 141.39 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 114.3 1.222 . . . . 1.0 114.3 -169.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.96 HG23 HD12 ' A' ' 123' ' ' LEU . 7.5 mt -131.94 99.3 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 125.915 1.686 . . . . 1.0 107.11 169.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.3 143.34 26.9 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.575 1.55 . . . . 1.0 111.998 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.2 mp -137.88 161.46 36.56 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.813 0.845 . . . . 1.0 112.966 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.62 0 CA-C-N 116.231 -0.441 . . . . 1.0 114.055 168.748 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.466 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 20.7 p . . . . . 0 CA--C 1.542 0.655 0 N-CA-C 114.376 1.25 . . . . 1.0 114.376 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -60.61 -16.99 44.03 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 115.112 1.523 . . . . 1.0 115.112 -169.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.17 -40.68 98.9 Favored Glycine 0 N--CA 1.474 1.231 0 CA-C-N 120.69 1.586 . . . . 1.0 113.314 173.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.61 -37.34 35.27 Favored Glycine 0 N--CA 1.477 1.392 0 O-C-N 120.974 -1.309 . . . . 1.0 112.806 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.466 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 84.2 mttt -61.29 -33.53 73.72 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 121.155 -1.203 . . . . 1.0 112.857 174.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -63.28 -36.04 82.34 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.523 0.729 . . . . 1.0 112.503 170.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -63.0 -37.19 86.18 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.285 0.948 . . . . 1.0 111.196 172.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -46.96 83.8 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.81 -0.556 . . . . 1.0 111.72 174.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.91 -44.51 78.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.702 -0.666 . . . . 1.0 111.82 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.67 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -50.73 -49.45 57.76 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.862 2.065 . . . . 1.0 112.018 -175.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.676 HD12 ' CD1' ' A' ' 87' ' ' TYR . 7.9 mt -66.37 -41.78 88.96 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.313 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -68.85 -20.03 64.27 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.747 1.017 . . . . 1.0 113.747 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -66.98 -36.14 81.52 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.749 1.22 . . . . 1.0 111.112 172.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -84.26 -75.15 0.35 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 113.777 -1.556 . . . . 1.0 110.336 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.412 ' H ' ' H ' ' A' ' 116' ' ' ALA . 3.6 m 177.91 -0.55 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.605 2.362 . . . . 1.0 112.024 172.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -77.83 149.3 34.39 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 122.638 1.208 . . . . 1.0 113.373 -169.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -85.77 171.35 11.64 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.255 1.822 . . . . 1.0 111.884 -169.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 2.2 ttm105 -133.87 152.77 51.97 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.353 1.061 . . . . 1.0 112.135 175.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.0 t -119.1 124.17 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.521 1.528 . . . . 1.0 109.14 -172.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 51.85 -168.03 0.69 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.941 1.257 . . . . 1.0 115.352 -172.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -102.35 145.1 29.98 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.984 1.314 . . . . 1.0 108.563 169.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -78.14 159.81 28.39 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.118 1.155 . . . . 1.0 114.118 -169.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.96 HD12 HG23 ' A' ' 90' ' ' ILE . 1.4 tm? -85.17 138.48 32.35 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.854 1.261 . . . . 1.0 110.079 170.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.6 mt -127.53 108.76 11.07 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.714 1.605 . . . . 1.0 109.676 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.581 HG13 HD11 ' A' ' 123' ' ' LEU . 25.5 mt -97.82 130.76 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 124.045 0.938 . . . . 1.0 112.304 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -105.35 110.24 22.53 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.963 0.905 . . . . 1.0 112.422 170.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.92 -24.57 66.11 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.146 1.378 . . . . 1.0 113.7 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.45 -17.62 64.77 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.896 1.073 . . . . 1.0 113.896 173.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -118.99 -28.72 5.46 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.88 1.672 . . . . 1.0 111.958 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -143.81 86.08 8.83 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 125.41 1.484 . . . . 1.0 111.947 -178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.92 6.06 3.12 Favored 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 123.537 2.825 . . . . 1.0 114.443 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -112.63 70.83 1.16 Allowed Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 127.221 2.208 . . . . 1.0 110.163 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -57.59 -22.16 50.32 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.455 2.104 . . . . 1.0 116.756 -169.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -64.6 -26.19 68.29 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.325 0.966 . . . . 1.0 111.864 174.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 p -73.62 -14.23 61.14 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.864 -1.148 . . . . 1.0 112.1 -175.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.436 ' HB2' HD11 ' A' ' 125' ' ' ILE . 4.8 mm-40 -106.99 -55.86 2.27 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 126.811 2.044 . . . . 1.0 111.464 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.9 p -69.49 -33.86 73.48 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.929 1.085 . . . . 1.0 113.929 -177.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -61.15 -57.65 24.49 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 120.623 1.556 . . . . 1.0 112.266 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -62.32 -23.84 75.48 Favored 'Trans proline' 0 C--N 1.353 0.772 0 CA-C-N 121.359 1.521 . . . . 1.0 112.502 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.464 ' CG ' ' HB2' ' A' ' 123' ' ' LEU . 88.4 t90 -68.15 -46.87 69.6 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 119.104 0.865 . . . . 1.0 111.226 174.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.541 HG11 ' HA ' ' A' ' 22' ' ' ALA . 98.3 t -62.31 -33.57 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 175.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -68.62 -29.85 68.44 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.99 1.316 . . . . 1.0 112.588 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -81.49 -57.96 3.24 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.369 1.467 . . . . 1.0 112.397 170.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.404 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 84.4 t90 -56.84 -36.87 70.49 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 125.352 1.461 . . . . 1.0 112.633 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.27 -32.55 21.89 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.531 1.062 . . . . 1.0 113.871 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.8 p -68.14 -14.05 62.69 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.373 1.249 . . . . 1.0 114.373 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.44 -17.68 53.75 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.997 1.719 . . . . 1.0 111.843 175.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.38 172.3 10.5 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.842 1.257 . . . . 1.0 111.269 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 13.5 m . . . . . 0 C--O 1.25 1.086 0 N-CA-C 116.085 1.883 . . . . 1.0 116.085 -169.586 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.349 0 N-CA-C 114.943 1.461 . . . . 1.0 114.943 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -118.86 124.33 46.88 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.221 1.808 . . . . 1.0 110.241 175.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.521 HD13 HD12 ' A' ' 26' ' ' LEU . 2.1 mp -121.75 116.07 48.31 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 C-N-CA 126.937 2.095 . . . . 1.0 112.416 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.91 125.49 8.27 Favored Glycine 0 C--O 1.225 -0.45 0 N-CA-C 110.158 -1.177 . . . . 1.0 110.158 169.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 mt -104.84 117.63 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-N 118.133 0.966 . . . . 1.0 109.21 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -109.29 109.68 20.65 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.732 -1.581 . . . . 1.0 106.732 -171.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.467 0.383 0 N-CA-C 112.543 0.572 . . . . 1.0 112.543 -169.432 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.7 tp . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 115.979 1.844 . . . . 1.0 115.979 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.423 HG11 HG21 ' A' ' 90' ' ' ILE . 78.7 t -44.8 -35.48 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.506 1.522 . . . . 1.0 112.916 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.7 -48.81 79.84 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 120.384 1.447 . . . . 1.0 113.198 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -66.69 -32.72 74.2 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.093 0.957 . . . . 1.0 110.775 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -65.63 -47.47 75.52 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 123.675 0.79 . . . . 1.0 109.287 173.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.622 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -64.35 -42.62 96.14 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 123.385 0.674 . . . . 1.0 112.724 -175.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.68 -48.59 72.21 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.906 0.482 . . . . 1.0 109.777 169.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.53 -37.07 76.96 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.994 0.738 . . . . 1.0 112.994 -175.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.0 mt -70.02 -46.22 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-N 119.194 0.907 . . . . 1.0 109.258 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.521 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -64.78 -34.98 79.62 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 119.606 -0.838 . . . . 1.0 110.088 -177.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.3 m -60.67 -46.14 91.47 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.122 1.369 . . . . 1.0 112.91 169.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.95 -32.64 74.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.341 1.056 . . . . 1.0 112.891 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -70.31 -29.12 65.77 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.932 1.293 . . . . 1.0 112.333 172.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.62 23.02 2.16 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.673 1.13 . . . . 1.0 115.119 169.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -121.34 148.51 44.25 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.563 1.145 . . . . 1.0 110.301 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -79.98 93.56 5.74 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 125.267 1.427 . . . . 1.0 108.69 -175.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.32 147.34 35.32 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.068 0.547 . . . . 1.0 111.373 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 93.0 m -150.08 146.73 27.1 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.518 1.127 . . . . 1.0 111.096 -173.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.5 t -97.98 138.84 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 114.049 1.129 . . . . 1.0 114.049 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -118.12 106.69 13.13 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.726 2.011 . . . . 1.0 110.692 169.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -85.26 146.51 27.02 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.917 1.687 . . . . 1.0 110.909 175.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t0 41.75 57.81 9.7 Favored Pre-proline 0 CA--C 1.557 1.236 0 C-N-CA 124.644 1.177 . . . . 1.0 111.174 -169.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -57.93 130.0 36.13 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 125.122 3.881 . . . . 1.0 118.706 -167.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -91.24 150.53 21.3 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.751 1.62 . . . . 1.0 112.288 168.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.53 HD21 HD21 ' A' ' 79' ' ' LEU . 2.4 tm? -70.15 -25.34 63.41 Favored 'General case' 0 N--CA 1.444 -0.757 0 O-C-N 121.13 -0.981 . . . . 1.0 110.282 168.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.2 m -66.26 -21.67 66.29 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.65 -0.656 . . . . 1.0 112.31 171.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -86.93 -23.79 25.02 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.159 0.983 . . . . 1.0 112.994 169.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.502 ' HB3' HD22 ' A' ' 41' ' ' LEU . 12.3 t-105 -80.16 -34.63 37.44 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.806 1.185 . . . . 1.0 113.778 175.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.8 mt -50.11 -39.62 48.31 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-O 117.744 -1.122 . . . . 1.0 113.589 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -52.65 -13.36 2.38 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 124.843 3.696 . . . . 1.0 117.892 170.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -112.87 8.02 18.54 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 116.332 1.975 . . . . 1.0 116.332 -176.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -50.86 -30.74 15.31 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.2 1.8 . . . . 1.0 113.642 174.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -107.11 8.13 30.01 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.821 2.049 . . . . 1.0 113.407 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -127.97 -159.66 0.96 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.274 2.229 . . . . 1.0 112.267 -169.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -112.41 159.33 18.83 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 122.805 1.288 . . . . 1.0 110.907 171.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.412 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -148.47 154.86 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 124.909 1.284 . . . . 1.0 108.735 -171.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.1 tp -133.99 128.05 33.61 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.06 0.944 . . . . 1.0 108.865 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.5 t -103.75 124.18 57.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 C-N-CA 124.326 1.05 . . . . 1.0 109.184 176.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.421 HG22 HD12 ' A' ' 90' ' ' ILE . 19.9 t -125.39 112.06 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 107.183 -1.414 . . . . 1.0 107.183 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 113.628 0.973 . . . . 1.0 113.628 -168.244 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.2 tt . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 113.407 0.892 . . . . 1.0 113.407 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.8 t -44.15 -52.6 15.69 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 125.302 1.441 . . . . 1.0 112.289 168.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.89 -29.43 18.5 Favored 'Trans proline' 0 C--N 1.35 0.641 0 CA-C-N 120.774 1.312 . . . . 1.0 111.272 -173.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.4 tp -65.08 -50.46 66.06 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 124.046 0.939 . . . . 1.0 110.793 169.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.62 ' CE1' HD23 ' A' ' 110' ' ' LEU . 89.8 t80 -55.53 -52.13 64.73 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.219 1.008 . . . . 1.0 112.213 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -64.35 -40.34 95.66 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.094 0.958 . . . . 1.0 111.733 176.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.73 -35.81 90.3 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.073 0.844 . . . . 1.0 112.628 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.586 HG22 HD12 ' A' ' 110' ' ' LEU . 91.5 mt -64.73 -51.3 69.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 120.071 1.935 . . . . 1.0 107.988 171.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.691 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.4 ptmm? -68.59 -31.72 71.1 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.394 -1.441 . . . . 1.0 113.289 -169.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -103.64 -37.25 7.6 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.513 1.671 . . . . 1.0 115.513 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.1 m -96.43 -19.52 19.11 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.416 1.087 . . . . 1.0 113.266 -174.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.53 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -93.15 -73.08 0.57 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.158 -1.423 . . . . 1.0 107.158 169.522 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.35 -21.43 1.45 Allowed Glycine 0 CA--C 1.536 1.347 0 C-N-CA 127.756 2.598 . . . . 1.0 114.727 169.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -151.19 141.32 22.19 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 128.392 2.677 . . . . 1.0 108.041 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.43 HE21 HD12 ' A' ' 79' ' ' LEU . 6.4 mt-30 -138.15 121.79 11.45 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.74 0.816 . . . . 1.0 110.165 -169.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -78.55 -38.02 0.59 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.121 1.881 . . . . 1.0 115.822 -169.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -143.98 21.17 1.78 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.129 1.159 . . . . 1.0 114.129 -169.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.412 HD11 ' CG2' ' A' ' 52' ' ' VAL . 60.8 tp -84.51 140.26 31.58 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.559 -1.338 . . . . 1.0 114.6 -169.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -137.12 155.31 49.76 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 128.64 2.776 . . . . 1.0 108.065 169.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.59 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -159.36 171.81 19.11 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.355 -0.841 . . . . 1.0 111.589 -179.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -131.73 172.25 20.99 Favored Glycine 0 N--CA 1.471 0.974 0 C-N-CA 124.902 1.239 . . . . 1.0 113.415 170.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.422 HG23 ' HB3' ' A' ' 122' ' ' MET . 0.0 OUTLIER -142.57 143.38 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 114.009 1.114 . . . . 1.0 114.009 -169.517 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 1.04 HG23 HD12 ' A' ' 123' ' ' LEU . 12.1 mt -133.16 98.17 2.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 106.532 -1.655 . . . . 1.0 106.532 169.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.44 144.12 26.56 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.442 1.497 . . . . 1.0 111.349 171.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.1 mp -140.79 154.98 46.49 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.447 0.906 . . . . 1.0 113.447 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.659 0 N-CA-C 114.227 0.451 . . . . 1.0 114.227 168.957 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 6.9 m . . . . . 0 CA--C 1.548 0.866 0 N-CA-C 113.685 0.994 . . . . 1.0 113.685 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -54.13 -23.14 13.04 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.72 1.608 . . . . 1.0 114.611 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.31 -46.93 85.63 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 120.661 1.573 . . . . 1.0 113.588 175.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.75 -35.6 39.78 Favored Glycine 0 N--CA 1.478 1.435 0 O-C-N 120.766 -1.432 . . . . 1.0 113.141 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -60.59 -32.4 71.52 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 121.264 -1.139 . . . . 1.0 112.86 172.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -66.82 -34.99 79.02 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.033 0.933 . . . . 1.0 112.361 169.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -62.75 -35.45 79.83 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.603 1.092 . . . . 1.0 111.136 170.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -65.99 -49.04 69.23 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.804 -0.56 . . . . 1.0 111.062 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.5 -33.58 66.14 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.876 0.871 . . . . 1.0 113.272 174.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.691 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -57.91 -50.59 72.81 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 123.117 1.437 . . . . 1.0 110.867 179.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.59 HD12 ' CD1' ' A' ' 87' ' ' TYR . 6.6 mt -65.68 -40.03 91.93 Favored 'General case' 0 C--N 1.321 -0.67 0 O-C-N 121.074 -1.016 . . . . 1.0 111.478 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -67.17 -20.52 65.75 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.534 0.938 . . . . 1.0 113.534 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.03 -17.06 57.51 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.589 1.086 . . . . 1.0 111.112 177.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -100.42 -73.57 0.63 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.8 1.24 . . . . 1.0 109.75 -178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 77.4 p -179.37 -19.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.165 1.786 . . . . 1.0 114.147 -174.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -70.69 161.1 31.4 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 123.14 1.448 . . . . 1.0 114.139 -169.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -98.47 179.53 4.68 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.306 1.842 . . . . 1.0 110.934 -170.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.0 ttm105 -131.37 158.35 40.97 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.519 1.127 . . . . 1.0 112.828 169.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.488 HG12 ' H ' ' A' ' 120' ' ' GLY . 13.9 t -96.96 -173.44 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 C-N-CA 126.493 1.917 . . . . 1.0 106.394 169.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.488 ' H ' HG12 ' A' ' 119' ' ' VAL . . . -54.49 164.69 3.06 Favored Glycine 0 CA--C 1.545 1.919 0 N-CA-C 116.924 1.529 . . . . 1.0 116.924 -170.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -43.75 131.42 5.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.859 2.064 . . . . 1.0 113.953 -175.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.422 ' HB3' HG23 ' A' ' 89' ' ' VAL . 1.0 OUTLIER -74.16 157.62 35.63 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.333 1.053 . . . . 1.0 111.869 -172.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 1.04 HD12 HG23 ' A' ' 90' ' ' ILE . 1.4 tm? -91.48 137.27 32.49 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.215 -0.902 . . . . 1.0 110.353 174.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.6 mt -127.26 110.69 13.11 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.844 1.657 . . . . 1.0 109.445 174.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.588 ' CD1' HD11 ' A' ' 123' ' ' LEU . 24.0 mt -99.15 131.5 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 124.085 0.954 . . . . 1.0 112.582 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -104.31 108.97 20.62 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.118 0.967 . . . . 1.0 112.606 170.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.43 -24.99 66.54 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.88 1.272 . . . . 1.0 113.775 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.64 -17.46 64.61 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.776 1.028 . . . . 1.0 113.776 173.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -116.46 -29.28 6.21 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.677 1.591 . . . . 1.0 111.633 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -145.16 87.73 7.04 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 125.323 1.449 . . . . 1.0 111.901 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.98 5.01 3.24 Favored 'Trans proline' 0 CA--C 1.549 1.247 0 C-N-CA 123.689 2.926 . . . . 1.0 114.731 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -113.72 71.02 1.75 Allowed Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 127.179 2.192 . . . . 1.0 109.634 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -54.93 -28.3 58.39 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.391 2.061 . . . . 1.0 115.845 -169.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -62.99 -24.38 67.89 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.611 0.642 . . . . 1.0 112.006 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.1 p -75.08 -16.57 60.56 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 120.612 -1.305 . . . . 1.0 111.82 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -101.56 -55.68 2.47 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.371 1.868 . . . . 1.0 111.438 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 90.7 p -65.23 -34.13 77.62 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 113.779 1.029 . . . . 1.0 113.779 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 -64.03 -55.2 34.13 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 120.501 1.501 . . . . 1.0 112.92 -175.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -62.1 -24.42 76.47 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 CA-C-N 121.328 1.51 . . . . 1.0 112.849 172.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.475 ' CG ' ' HB2' ' A' ' 123' ' ' LEU . 87.5 t90 -68.28 -45.44 73.07 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 118.592 0.633 . . . . 1.0 111.314 173.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.622 HG11 ' HA ' ' A' ' 22' ' ' ALA . 83.3 t -66.41 -33.64 64.82 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -63.69 -48.77 75.79 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.225 -0.922 . . . . 1.0 109.528 173.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -63.99 -54.98 25.85 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.489 1.116 . . . . 1.0 111.827 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -58.49 -35.61 72.49 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 125.611 1.564 . . . . 1.0 111.76 174.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.19 -34.53 25.06 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.583 1.563 . . . . 1.0 113.458 171.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.9 p -67.82 -12.99 61.76 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.826 1.417 . . . . 1.0 114.826 176.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.35 -16.29 49.74 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.869 1.667 . . . . 1.0 112.072 176.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.57 -179.56 7.47 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.289 1.036 . . . . 1.0 110.924 -177.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 C--O 1.25 1.129 0 C-N-CA 126.202 1.801 . . . . 1.0 114.52 -175.549 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.405 0 N-CA-C 112.905 0.706 . . . . 1.0 112.905 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -120.84 123.83 43.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.08 1.352 . . . . 1.0 110.502 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.551 HD13 HD12 ' A' ' 26' ' ' LEU . 2.2 mp -120.43 112.79 37.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 C-N-CA 126.632 1.973 . . . . 1.0 112.497 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.61 124.27 7.3 Favored Glycine 0 C--O 1.223 -0.561 0 N-CA-C 110.328 -1.109 . . . . 1.0 110.328 169.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.5 mt -105.27 119.23 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-N 118.614 1.207 . . . . 1.0 109.691 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -110.01 107.45 17.33 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.181 -1.414 . . . . 1.0 107.181 -170.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.4 p . . . . . 0 N--CA 1.466 0.354 0 CA-C-O 121.484 0.659 . . . . 1.0 111.105 -172.742 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.1 tp . . . . . 0 C--O 1.225 -0.231 0 N-CA-C 109.935 -0.394 . . . . 1.0 109.935 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.7 t -56.01 -34.43 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.176 0.59 . . . . 1.0 111.243 -173.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.44 -45.57 88.27 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.783 -1.198 . . . . 1.0 113.414 173.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -68.81 -30.36 68.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.303 0.573 . . . . 1.0 111.048 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -68.18 -47.11 68.85 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 123.761 0.824 . . . . 1.0 109.109 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.551 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -64.32 -43.32 95.04 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 123.56 0.744 . . . . 1.0 112.804 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -53.57 -48.67 68.97 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.092 0.957 . . . . 1.0 110.456 170.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.31 -37.97 71.76 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.593 0.757 . . . . 1.0 112.285 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.0 mt -68.79 -45.83 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 O-C-N 121.63 -0.669 . . . . 1.0 109.338 175.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.551 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.99 -31.45 72.36 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.495 1.043 . . . . 1.0 110.649 -178.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.4 m -63.12 -45.04 93.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.586 1.154 . . . . 1.0 112.711 169.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.08 -31.36 70.93 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.799 1.239 . . . . 1.0 113.032 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -67.68 -29.03 68.2 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.211 1.804 . . . . 1.0 111.695 172.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.43 28.27 2.39 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.715 1.15 . . . . 1.0 114.905 171.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -120.52 164.39 16.51 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.016 1.326 . . . . 1.0 110.169 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -93.44 89.81 6.47 Favored 'General case' 0 CA--C 1.52 -0.183 0 O-C-N 120.659 -1.275 . . . . 1.0 108.559 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.16 145.87 29.57 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 122.766 0.426 . . . . 1.0 111.22 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.7 m -147.77 139.08 23.61 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.864 0.866 . . . . 1.0 112.041 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.4 t -86.93 137.72 20.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 114.916 1.45 . . . . 1.0 114.916 172.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -117.89 113.74 22.19 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.85 2.06 . . . . 1.0 110.32 171.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -94.7 137.75 33.4 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.686 1.994 . . . . 1.0 111.158 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.5 t70 41.79 55.37 9.07 Favored Pre-proline 0 CA--C 1.559 1.293 0 C-N-CA 124.61 1.164 . . . . 1.0 111.08 -169.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -68.59 145.63 64.71 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.016 3.144 . . . . 1.0 117.638 -167.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -88.79 154.5 20.22 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.892 1.677 . . . . 1.0 112.442 168.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.539 HD21 HD21 ' A' ' 79' ' ' LEU . 2.3 tm? -69.41 -21.72 63.74 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 120.899 -1.125 . . . . 1.0 109.762 168.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.1 m -66.13 -22.89 66.4 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.284 -0.885 . . . . 1.0 112.332 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -82.52 -24.94 33.87 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.136 0.974 . . . . 1.0 113.098 169.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.49 ' HB3' HD22 ' A' ' 41' ' ' LEU . 11.8 t-105 -83.9 -35.54 24.01 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.799 1.182 . . . . 1.0 113.994 177.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.3 mt -48.16 -39.17 25.32 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-O 117.58 -1.2 . . . . 1.0 113.897 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -55.31 -14.98 10.27 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.306 3.337 . . . . 1.0 117.224 172.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -109.03 8.24 26.12 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 116.027 1.862 . . . . 1.0 116.027 -174.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -52.98 -23.47 7.38 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.977 2.111 . . . . 1.0 114.218 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -124.91 17.74 8.57 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.546 1.538 . . . . 1.0 113.484 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -126.47 -158.24 0.85 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.936 2.494 . . . . 1.0 110.345 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -116.79 161.85 18.63 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 122.984 1.373 . . . . 1.0 112.313 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.426 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -150.08 160.59 4.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 125.14 1.376 . . . . 1.0 108.966 -172.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.4 tp -138.17 130.05 28.35 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.007 1.323 . . . . 1.0 108.369 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.8 t -105.23 124.21 59.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 124.088 0.955 . . . . 1.0 109.03 174.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.1 t -122.26 111.86 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 105.476 -2.046 . . . . 1.0 105.476 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 114.227 1.195 . . . . 1.0 114.227 -167.536 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.0 tt . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 114.477 1.288 . . . . 1.0 114.477 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.9 t -44.06 -52.73 15.0 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 124.424 1.09 . . . . 1.0 112.912 168.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.36 -31.48 17.77 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.686 1.591 . . . . 1.0 111.757 -172.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.2 tp -62.67 -52.16 64.4 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 124.602 1.161 . . . . 1.0 111.336 169.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.655 ' CE1' HD23 ' A' ' 110' ' ' LEU . 86.2 t80 -55.83 -51.44 67.49 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.718 0.807 . . . . 1.0 112.65 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -63.15 -39.32 94.31 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.424 0.69 . . . . 1.0 111.682 176.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.18 -34.65 81.37 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 123.801 0.715 . . . . 1.0 113.009 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.615 HG22 HD12 ' A' ' 110' ' ' LEU . 91.6 mt -65.66 -44.14 93.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 120.354 2.077 . . . . 1.0 108.866 171.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.716 ' HB3' HD21 ' A' ' 110' ' ' LEU . 1.8 ptmm? -74.39 -32.01 62.55 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.304 -1.498 . . . . 1.0 113.415 -173.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -106.55 -38.57 6.12 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 115.138 1.532 . . . . 1.0 115.138 -174.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.7 m -91.06 -25.05 19.84 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.252 1.021 . . . . 1.0 112.712 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.539 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -91.04 -71.06 0.65 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 107.497 -1.297 . . . . 1.0 107.497 169.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.0 -8.22 2.66 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 126.369 1.938 . . . . 1.0 115.481 171.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -156.0 147.97 23.24 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 129.322 3.049 . . . . 1.0 107.023 171.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -134.84 127.92 18.57 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.113 0.565 . . . . 1.0 111.037 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -81.3 -44.65 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 121.847 1.698 . . . . 1.0 113.485 -172.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -148.49 28.11 0.89 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.674 1.189 . . . . 1.0 112.88 -172.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.426 HD11 ' CG2' ' A' ' 52' ' ' VAL . 52.4 tp -85.51 137.95 32.54 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.691 -1.256 . . . . 1.0 112.682 -169.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.2 mtm-85 -134.46 157.71 45.77 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.461 2.305 . . . . 1.0 109.153 169.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.66 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -163.24 169.41 19.24 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.136 0.88 . . . . 1.0 111.441 -177.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.41 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -129.92 173.47 19.8 Favored Glycine 0 N--CA 1.469 0.848 0 C-N-CA 124.096 0.855 . . . . 1.0 113.558 169.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.479 HG23 ' HB3' ' A' ' 122' ' ' MET . 0.0 OUTLIER -143.55 140.81 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 114.133 1.16 . . . . 1.0 114.133 -169.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.6 mt -131.57 97.23 2.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 106.841 -1.54 . . . . 1.0 106.841 168.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.12 148.97 28.24 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.806 1.242 . . . . 1.0 111.47 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.7 mp -141.61 151.61 43.28 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.853 0.686 . . . . 1.0 112.853 176.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.531 0 C-N-CA 121.691 -0.29 . . . . 1.0 112.691 169.287 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 9.5 m . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 113.469 0.914 . . . . 1.0 113.469 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -63.0 -12.37 25.37 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.861 1.265 . . . . 1.0 114.289 -174.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.36 -39.37 97.15 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-N 120.308 1.413 . . . . 1.0 113.599 171.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -77.25 -36.04 36.08 Favored Glycine 0 N--CA 1.477 1.432 0 O-C-N 120.616 -1.52 . . . . 1.0 112.737 172.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -62.85 -31.62 72.67 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.256 -1.144 . . . . 1.0 112.469 173.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -62.52 -41.21 98.71 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.211 1.004 . . . . 1.0 111.071 169.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -62.8 -38.67 91.61 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 118.804 0.729 . . . . 1.0 111.41 174.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -61.86 -48.63 79.65 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.387 -0.821 . . . . 1.0 112.316 173.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.95 -35.28 70.91 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.278 0.631 . . . . 1.0 112.699 174.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.716 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -58.68 -49.22 78.37 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 125.456 1.502 . . . . 1.0 111.079 -177.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.66 HD12 ' CD1' ' A' ' 87' ' ' TYR . 11.0 mt -67.31 -40.21 85.99 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 120.9 -1.125 . . . . 1.0 111.762 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -70.15 -18.69 63.22 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.244 0.831 . . . . 1.0 113.244 176.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.75 -18.45 59.55 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.674 1.124 . . . . 1.0 111.198 175.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -97.23 -72.83 0.63 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.089 1.355 . . . . 1.0 109.608 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.6 p 176.54 -18.04 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.476 2.31 . . . . 1.0 113.348 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -68.44 151.54 46.68 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 123.149 1.452 . . . . 1.0 114.457 -169.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -90.93 168.07 11.96 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.73 2.012 . . . . 1.0 114.006 -168.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.97 154.43 27.61 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.172 2.189 . . . . 1.0 111.454 176.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.1 t -124.92 129.46 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.301 1.441 . . . . 1.0 108.764 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 49.79 -154.49 2.7 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 125.328 1.442 . . . . 1.0 115.279 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -111.52 143.35 42.51 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.31 1.844 . . . . 1.0 109.914 169.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.479 ' HB3' HG23 ' A' ' 89' ' ' VAL . 1.3 pmm? -77.07 156.46 31.74 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.731 0.777 . . . . 1.0 112.257 -173.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.603 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.8 OUTLIER -92.26 137.15 32.61 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 123.87 0.868 . . . . 1.0 110.291 174.118 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.603 ' N ' HD13 ' A' ' 123' ' ' LEU . 6.2 mt -123.16 102.54 8.01 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.825 1.25 . . . . 1.0 110.532 172.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.7 mt -79.41 133.21 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 C-N-CA 124.461 1.104 . . . . 1.0 111.22 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -109.48 106.98 16.94 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 122.374 1.083 . . . . 1.0 113.448 172.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.21 -23.47 64.82 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.093 0.957 . . . . 1.0 113.26 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.2 t -62.91 -22.97 67.13 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.371 1.068 . . . . 1.0 112.665 174.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -120.0 -29.6 4.89 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.361 1.864 . . . . 1.0 111.925 -174.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -144.8 84.68 8.79 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.756 1.622 . . . . 1.0 112.058 -172.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -73.65 8.25 2.0 Allowed 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 123.635 2.89 . . . . 1.0 114.495 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -111.54 71.17 0.88 Allowed Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 127.953 2.501 . . . . 1.0 109.551 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -57.67 -22.21 51.21 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.696 2.264 . . . . 1.0 116.554 -169.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -64.48 -26.16 68.31 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 118.963 0.802 . . . . 1.0 111.758 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.7 p -77.12 -19.05 57.45 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 120.434 -1.416 . . . . 1.0 112.046 -174.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -94.82 -51.99 4.45 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.028 1.331 . . . . 1.0 111.883 172.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.8 p -72.17 -35.58 69.06 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 115.078 1.51 . . . . 1.0 115.078 -176.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -59.85 -55.04 49.65 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 120.612 1.551 . . . . 1.0 112.54 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -63.35 -23.12 71.94 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 121.482 1.565 . . . . 1.0 112.515 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.461 ' HB2' HD23 ' A' ' 123' ' ' LEU . 89.6 t90 -69.19 -46.75 66.7 Favored 'General case' 0 C--O 1.218 -0.572 0 O-C-N 121.828 -0.545 . . . . 1.0 110.846 174.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.551 HG11 ' HA ' ' A' ' 22' ' ' ALA . 91.7 t -64.77 -32.25 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.877 0.846 . . . . 1.0 108.85 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -71.82 -23.51 61.56 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.154 -1.591 . . . . 1.0 113.292 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -86.91 -61.21 1.78 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.867 2.067 . . . . 1.0 111.698 169.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.41 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 89.4 t90 -54.72 -37.68 66.18 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 126.715 2.006 . . . . 1.0 112.658 178.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.85 -29.57 34.44 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 121.519 -0.738 . . . . 1.0 114.383 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.2 p -69.05 -13.47 62.46 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.273 1.212 . . . . 1.0 114.273 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.43 -18.33 52.43 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.651 1.58 . . . . 1.0 111.833 176.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.41 171.79 12.31 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.672 1.189 . . . . 1.0 110.964 -176.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 C--O 1.253 1.253 0 N-CA-C 116.17 1.915 . . . . 1.0 116.17 -169.67 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.331 0 N-CA-C 113.116 0.784 . . . . 1.0 113.116 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -120.17 122.34 40.77 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.454 1.502 . . . . 1.0 110.231 174.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.562 HD13 HD12 ' A' ' 26' ' ' LEU . 2.0 mp -122.4 113.36 38.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 126.622 1.969 . . . . 1.0 111.972 -176.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.9 124.52 7.58 Favored Glycine 0 C--O 1.224 -0.52 0 N-CA-C 110.263 -1.135 . . . . 1.0 110.263 169.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 mt -105.44 123.96 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-N 118.069 0.934 . . . . 1.0 109.225 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -115.47 109.35 17.71 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 124.195 0.998 . . . . 1.0 108.368 -169.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.535 0.384 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.105 -177.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.1 tp . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 116.683 2.105 . . . . 1.0 116.683 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.4 t -53.34 -33.67 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.968 0.907 . . . . 1.0 112.914 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.46 -46.84 87.62 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 120.285 1.402 . . . . 1.0 112.48 173.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -68.64 -32.09 71.7 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.077 0.951 . . . . 1.0 111.046 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -65.21 -49.12 70.91 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.982 -0.748 . . . . 1.0 108.982 171.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.598 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.19 -42.41 93.6 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 112.983 0.734 . . . . 1.0 112.983 -172.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -53.95 -49.99 67.48 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.701 0.8 . . . . 1.0 110.09 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.83 -35.64 74.94 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 112.625 0.602 . . . . 1.0 112.625 -175.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.1 mt -70.47 -46.01 72.29 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 119.063 0.847 . . . . 1.0 109.658 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.562 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.72 -33.6 76.25 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 119.863 -0.735 . . . . 1.0 110.189 -178.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 54.0 m -61.96 -44.6 96.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.058 1.343 . . . . 1.0 113.085 169.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.78 -32.03 73.05 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.196 0.998 . . . . 1.0 112.92 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -70.03 -29.43 66.47 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.846 1.259 . . . . 1.0 112.279 171.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.13 21.8 2.49 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.723 1.154 . . . . 1.0 115.056 169.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -114.24 158.39 21.44 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.816 1.246 . . . . 1.0 110.792 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -86.03 89.47 7.81 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 125.461 1.504 . . . . 1.0 108.587 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.23 145.35 31.68 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 122.446 0.298 . . . . 1.0 111.123 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 78.6 m -148.08 138.71 23.0 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.642 0.777 . . . . 1.0 112.018 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.7 t -85.57 134.58 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.726 1.21 . . . . 1.0 114.151 171.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -110.3 109.9 20.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.799 1.64 . . . . 1.0 110.385 169.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -87.47 137.52 32.27 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.113 1.765 . . . . 1.0 111.115 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.2 t0 40.89 56.85 8.34 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 124.868 1.267 . . . . 1.0 111.354 -169.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -68.9 140.95 47.37 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.898 3.065 . . . . 1.0 116.973 -168.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.435 ' HB3' ' H ' ' A' ' 42' ' ' SER . 52.6 mm-40 -93.83 163.47 13.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 122.357 1.075 . . . . 1.0 111.847 168.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.545 HD21 HD21 ' A' ' 79' ' ' LEU . 2.2 tm? -65.86 -22.04 66.51 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 120.886 -1.134 . . . . 1.0 109.796 167.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.435 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 17.9 m -68.3 -19.7 64.71 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.878 -1.139 . . . . 1.0 112.613 172.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -83.1 -24.69 32.53 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.385 1.074 . . . . 1.0 112.444 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.443 ' HB3' HD22 ' A' ' 41' ' ' LEU . 13.0 t-105 -88.68 -34.56 17.17 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.075 1.139 . . . . 1.0 114.075 -178.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.9 mt -48.09 -38.57 20.96 Favored Pre-proline 0 CA--C 1.554 1.109 0 CA-C-O 117.608 -1.186 . . . . 1.0 114.103 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.71 -11.68 21.7 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.132 3.221 . . . . 1.0 116.352 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -109.36 6.9 24.8 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 116.095 1.887 . . . . 1.0 116.095 -174.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -52.88 -31.02 37.3 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.88 2.072 . . . . 1.0 113.723 172.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -109.81 11.5 24.33 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.176 1.391 . . . . 1.0 112.499 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -124.83 -159.03 0.86 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.904 2.482 . . . . 1.0 111.034 -174.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -116.13 162.85 16.82 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 122.874 1.321 . . . . 1.0 111.834 170.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.614 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -146.93 160.52 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.432 1.093 . . . . 1.0 109.182 -172.022 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.417 HD11 HD12 ' A' ' 90' ' ' ILE . 14.8 tp -139.29 128.0 23.29 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.68 1.192 . . . . 1.0 108.924 175.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.1 t -100.52 128.3 52.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 174.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.4 t -126.04 110.92 25.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 106.254 -1.758 . . . . 1.0 106.254 175.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 113.228 0.825 . . . . 1.0 113.228 -168.15 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.2 tt . . . . . 0 N--CA 1.471 0.575 0 N-CA-C 113.712 1.004 . . . . 1.0 113.712 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.1 t -44.96 -53.27 16.48 Favored Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 124.444 1.098 . . . . 1.0 112.238 168.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -68.09 -32.38 27.89 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.747 1.631 . . . . 1.0 111.819 -173.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.2 tp -63.15 -53.24 56.51 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 124.429 1.092 . . . . 1.0 111.259 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.664 ' CE1' HD23 ' A' ' 110' ' ' LEU . 92.8 t80 -55.2 -53.75 52.09 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.747 0.819 . . . . 1.0 112.393 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -68.38 -35.1 77.21 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.769 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.36 -35.3 90.02 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 121.709 -0.62 . . . . 1.0 112.585 175.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.6 HG22 HD12 ' A' ' 110' ' ' LEU . 88.7 mt -65.98 -50.14 71.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 119.926 1.863 . . . . 1.0 108.414 171.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.681 ' HB3' HD21 ' A' ' 110' ' ' LEU . 5.6 ptmm? -69.35 -32.28 71.27 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.222 -1.549 . . . . 1.0 113.145 -170.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -104.61 -40.47 6.01 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.054 1.501 . . . . 1.0 115.054 -174.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.3 m -92.01 -24.13 19.31 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.006 0.922 . . . . 1.0 113.011 -175.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.545 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -91.1 -71.04 0.65 Allowed 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 106.804 -1.554 . . . . 1.0 106.804 169.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.43 -13.53 1.11 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 127.61 2.529 . . . . 1.0 117.011 168.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -155.24 140.39 17.5 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.557 2.343 . . . . 1.0 108.398 172.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -136.33 128.41 17.28 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 121.328 -0.858 . . . . 1.0 112.028 -172.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -89.3 -34.98 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.948 2.432 . . . . 1.0 115.123 -175.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -142.52 12.97 1.94 Allowed 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 115.138 1.533 . . . . 1.0 115.138 -169.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.614 HD11 ' CG2' ' A' ' 52' ' ' VAL . 63.9 tp -84.39 132.7 34.56 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.51 -1.369 . . . . 1.0 113.362 -169.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.7 mtm-85 -130.32 153.64 48.46 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.395 1.878 . . . . 1.0 109.716 169.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.661 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -160.82 165.27 30.53 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.548 1.067 . . . . 1.0 112.277 -176.46 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.402 ' HA3' ' CE2' ' A' ' 144' ' ' TRP . . . -124.0 173.37 16.68 Favored Glycine 0 N--CA 1.467 0.726 0 C-N-CA 125.401 1.476 . . . . 1.0 112.109 169.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.546 HG13 ' HB3' ' A' ' 122' ' ' MET . 0.2 OUTLIER -159.54 142.54 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 O-C-N 120.854 -1.38 . . . . 1.0 114.416 -169.571 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.417 HD12 HD11 ' A' ' 53' ' ' LEU . 4.9 mt -132.01 109.72 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 126.806 2.043 . . . . 1.0 108.24 178.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.11 145.47 24.49 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.192 1.397 . . . . 1.0 110.846 172.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.9 mp -137.09 152.41 49.99 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.466 0.706 . . . . 1.0 112.222 177.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.629 0 CA-C-N 116.354 -0.384 . . . . 1.0 112.421 169.342 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.55 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 19.8 p . . . . . 0 CA--C 1.537 0.476 0 N-CA-C 114.017 1.118 . . . . 1.0 114.017 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -57.44 -21.41 36.75 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.477 1.288 . . . . 1.0 114.477 -173.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -54.21 -44.24 74.74 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 120.592 1.542 . . . . 1.0 113.467 174.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -79.54 -36.61 25.93 Favored Glycine 0 N--CA 1.479 1.547 0 O-C-N 120.993 -1.298 . . . . 1.0 113.476 174.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.55 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 78.7 mttt -60.04 -34.41 73.35 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.207 1.004 . . . . 1.0 112.789 174.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -64.79 -38.28 90.46 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.159 0.984 . . . . 1.0 111.914 172.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -64.25 -37.71 88.44 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.421 1.009 . . . . 1.0 111.036 173.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.53 -43.57 93.6 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.132 0.573 . . . . 1.0 112.229 176.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.41 82.77 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.857 -0.592 . . . . 1.0 111.754 170.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.681 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -49.46 -49.46 45.28 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.868 2.067 . . . . 1.0 111.939 -173.464 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.661 HD12 ' CD1' ' A' ' 87' ' ' TYR . 8.5 mt -65.59 -43.96 88.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.463 -0.79 . . . . 1.0 111.005 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -67.1 -21.68 65.85 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.941 1.089 . . . . 1.0 113.941 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -66.13 -36.47 83.24 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.415 1.086 . . . . 1.0 110.938 173.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -81.02 -77.61 0.2 Allowed 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 113.996 -1.456 . . . . 1.0 109.888 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.419 ' H ' ' H ' ' A' ' 116' ' ' ALA . 4.7 t -179.72 -2.34 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.195 2.198 . . . . 1.0 111.498 170.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.436 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -74.19 146.8 43.11 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 114.819 1.415 . . . . 1.0 114.819 -168.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.13 167.31 18.88 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.657 2.383 . . . . 1.0 114.896 -168.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.43 149.5 42.92 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.907 2.083 . . . . 1.0 111.693 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.8 t -123.93 128.66 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.775 1.63 . . . . 1.0 108.497 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 50.25 -155.03 2.82 Favored Glycine 0 CA--C 1.542 1.77 0 C-N-CA 124.908 1.242 . . . . 1.0 114.988 -171.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -114.59 144.38 43.49 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.317 1.847 . . . . 1.0 109.962 169.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.546 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -73.18 155.71 39.34 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 122.134 0.969 . . . . 1.0 111.424 -174.097 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.649 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -93.73 140.04 30.11 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.309 1.043 . . . . 1.0 110.197 176.16 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.649 ' N ' HD13 ' A' ' 123' ' ' LEU . 6.7 mt -124.83 102.13 7.41 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.082 1.353 . . . . 1.0 110.891 176.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.403 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.2 mt -86.11 128.75 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.576 1.55 . . . . 1.0 111.909 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -108.03 110.5 22.21 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 124.328 1.018 . . . . 1.0 112.261 174.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -70.13 -23.3 63.0 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.132 0.973 . . . . 1.0 112.79 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.5 t -62.77 -23.17 67.08 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.291 1.036 . . . . 1.0 112.73 173.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -119.27 -29.94 5.06 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.293 1.837 . . . . 1.0 112.2 -173.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -143.79 91.11 6.76 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 125.196 1.398 . . . . 1.0 112.603 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.76 7.17 3.28 Favored 'Trans proline' 0 CA--C 1.552 1.39 0 C-N-CA 123.414 2.743 . . . . 1.0 114.483 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -110.07 71.52 0.61 Allowed Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 127.307 2.243 . . . . 1.0 110.116 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -58.34 -18.8 39.92 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.803 2.335 . . . . 1.0 117.629 -168.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -69.47 -25.45 64.09 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.122 1.328 . . . . 1.0 111.644 172.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 28.0 p -72.78 -22.85 60.77 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.942 1.246 . . . . 1.0 111.969 -173.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -91.01 -54.2 4.06 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.654 1.582 . . . . 1.0 111.767 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.7 p -70.88 -32.78 69.87 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 115.022 1.489 . . . . 1.0 115.022 -176.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -58.42 -55.62 43.79 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 120.94 1.7 . . . . 1.0 112.705 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -64.32 -24.45 64.82 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 CA-C-N 121.277 1.492 . . . . 1.0 113.134 174.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.413 ' HB2' HD23 ' A' ' 123' ' ' LEU . 92.2 t90 -68.0 -48.2 66.4 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 118.795 0.725 . . . . 1.0 110.728 174.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.598 HG11 ' HA ' ' A' ' 22' ' ' ALA . 96.2 t -67.04 -33.09 61.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 C-N-CA 122.842 0.457 . . . . 1.0 110.044 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.59 -48.9 73.22 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.02 -1.05 . . . . 1.0 109.785 173.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -64.35 -54.77 27.68 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.539 1.136 . . . . 1.0 112.102 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.434 ' CZ3' HD11 ' A' ' 26' ' ' LEU . 87.3 t90 -56.24 -37.17 69.37 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 125.886 1.674 . . . . 1.0 111.401 173.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -49.99 -34.1 22.67 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.505 1.526 . . . . 1.0 113.482 173.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.6 p -68.78 -13.37 62.35 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 115.097 1.518 . . . . 1.0 115.097 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.61 -20.03 44.13 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.619 1.568 . . . . 1.0 111.778 176.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -84.18 172.5 11.85 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.65 1.18 . . . . 1.0 110.879 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--O 1.252 1.222 0 C-N-CA 124.655 1.182 . . . . 1.0 113.941 -176.052 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 112.822 0.675 . . . . 1.0 112.822 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -122.89 121.56 36.48 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.562 1.545 . . . . 1.0 110.845 177.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.555 HD13 HD12 ' A' ' 26' ' ' LEU . 2.1 mp -121.77 117.79 53.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 127.418 2.287 . . . . 1.0 112.65 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.32 125.7 8.47 Favored Glycine 0 N--CA 1.465 0.615 0 N-CA-C 110.785 -0.926 . . . . 1.0 110.785 169.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.6 mt -104.61 120.77 55.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-N 118.565 1.183 . . . . 1.0 109.81 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -113.13 111.18 21.67 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 125.109 1.363 . . . . 1.0 107.638 -171.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.468 0.456 0 N-CA-C 112.515 0.561 . . . . 1.0 112.515 -170.328 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.8 tp . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 115.936 1.828 . . . . 1.0 115.936 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.7 t -52.0 -33.52 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 118.782 0.719 . . . . 1.0 112.602 -176.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.89 -49.91 76.0 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.001 -1.062 . . . . 1.0 113.048 173.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.73 -28.15 62.48 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.256 0.622 . . . . 1.0 110.771 -178.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -62.13 -49.42 75.94 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.122 -1.066 . . . . 1.0 108.122 169.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.605 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.02 -42.41 94.44 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 112.725 0.639 . . . . 1.0 112.725 -173.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.87 -49.67 70.58 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.196 0.598 . . . . 1.0 110.145 169.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.66 -35.76 77.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.381 0.512 . . . . 1.0 112.381 -175.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.7 mt -71.82 -45.42 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 O-C-N 121.023 -1.048 . . . . 1.0 109.71 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.555 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.62 -33.46 75.96 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 119.572 -0.851 . . . . 1.0 110.049 -179.09 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.2 m -61.86 -45.09 95.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.206 1.402 . . . . 1.0 113.084 169.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.07 -32.26 73.63 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.343 1.057 . . . . 1.0 112.888 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -70.97 -28.37 64.41 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.901 1.281 . . . . 1.0 112.578 172.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.14 27.11 2.11 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.721 1.153 . . . . 1.0 114.622 170.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -121.95 148.9 44.2 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.67 1.188 . . . . 1.0 110.415 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -77.43 101.33 6.35 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 125.4 1.48 . . . . 1.0 108.092 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.48 148.06 42.98 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 122.745 0.418 . . . . 1.0 110.937 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.5 m -149.54 146.61 27.45 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.305 1.042 . . . . 1.0 111.749 -172.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.1 t -97.9 137.18 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 114.485 1.291 . . . . 1.0 114.485 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -119.93 109.24 15.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.659 1.984 . . . . 1.0 110.878 169.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -89.82 139.94 30.09 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.462 1.905 . . . . 1.0 111.235 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t0 40.93 55.73 7.92 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 124.869 1.267 . . . . 1.0 111.613 -169.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -71.03 144.01 46.22 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.949 3.099 . . . . 1.0 117.606 -168.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -86.51 155.87 20.33 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.637 1.575 . . . . 1.0 112.616 168.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.506 HD21 HD21 ' A' ' 79' ' ' LEU . 2.3 tm? -68.5 -23.46 64.55 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 120.595 -1.316 . . . . 1.0 109.887 168.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.6 m -66.25 -21.35 66.28 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.5 -0.75 . . . . 1.0 112.488 170.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -85.31 -24.52 27.64 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.488 1.115 . . . . 1.0 112.928 169.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.484 ' HB3' HD22 ' A' ' 41' ' ' LEU . 10.9 t-105 -82.13 -35.51 28.43 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.86 1.209 . . . . 1.0 113.743 175.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.5 mt -50.57 -39.8 54.88 Favored Pre-proline 0 CA--C 1.552 1.039 0 CA-C-O 117.678 -1.153 . . . . 1.0 113.781 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -55.07 -14.47 8.55 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 124.059 3.173 . . . . 1.0 117.023 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -110.46 9.98 23.28 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 115.391 1.626 . . . . 1.0 115.391 -175.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -53.26 -34.91 59.16 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.281 1.832 . . . . 1.0 113.463 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.33 -0.6 38.07 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.462 1.505 . . . . 1.0 113.379 177.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -111.03 -164.7 0.93 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.695 2.398 . . . . 1.0 111.108 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -109.4 165.66 11.47 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 122.871 1.32 . . . . 1.0 111.359 169.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.597 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -149.62 160.85 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.91 1.284 . . . . 1.0 109.677 -171.036 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.599 HD11 HD12 ' A' ' 90' ' ' ILE . 19.1 tp -142.37 124.76 15.63 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.949 0.9 . . . . 1.0 108.975 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.9 t -99.26 123.43 51.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 123.86 0.864 . . . . 1.0 109.244 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.2 t -121.64 115.81 47.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.984 -1.858 . . . . 1.0 105.984 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 113.283 0.845 . . . . 1.0 113.283 -168.632 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.2 tt . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 114.057 1.132 . . . . 1.0 114.057 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.8 t -48.16 -51.7 47.23 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 125.047 1.339 . . . . 1.0 111.918 168.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.47 -31.59 21.5 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.32 1.347 . . . . 1.0 111.259 -173.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.2 tp -63.11 -51.52 66.23 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.747 1.219 . . . . 1.0 111.205 169.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.646 ' CE1' HD23 ' A' ' 110' ' ' LEU . 92.6 t80 -52.86 -55.12 25.51 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.706 1.203 . . . . 1.0 112.544 178.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -67.65 -35.55 79.08 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.753 -0.658 . . . . 1.0 111.8 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.62 -36.72 92.78 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.586 0.613 . . . . 1.0 112.566 176.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.568 HG22 HD12 ' A' ' 110' ' ' LEU . 92.3 mt -64.37 -50.94 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 120.114 1.957 . . . . 1.0 108.111 171.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.692 ' HB3' HD21 ' A' ' 110' ' ' LEU . 1.7 ptmm? -67.91 -31.76 71.75 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.561 -1.337 . . . . 1.0 113.281 -170.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -103.74 -37.37 7.5 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.63 1.572 . . . . 1.0 115.157 -175.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.8 m -97.06 -19.17 18.9 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.566 1.146 . . . . 1.0 113.235 -174.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.506 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -94.07 -72.27 0.62 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 107.086 -1.45 . . . . 1.0 107.086 169.718 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.65 -20.8 1.3 Allowed Glycine 0 CA--C 1.539 1.567 0 C-N-CA 127.715 2.579 . . . . 1.0 114.873 170.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -152.73 141.84 21.35 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 128.528 2.731 . . . . 1.0 107.985 169.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.415 HE21 HD12 ' A' ' 79' ' ' LEU . 6.3 mt-30 -137.6 119.57 10.98 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.016 0.926 . . . . 1.0 109.485 -170.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.03 -36.49 1.95 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.223 1.949 . . . . 1.0 115.737 -169.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -144.4 18.46 1.71 Allowed 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.993 1.109 . . . . 1.0 113.993 -169.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.597 HD11 ' CG2' ' A' ' 52' ' ' VAL . 62.6 tp -82.22 139.93 33.98 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 120.681 -1.262 . . . . 1.0 113.441 -169.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.7 mtm-85 -136.6 152.82 50.87 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.976 2.51 . . . . 1.0 109.56 169.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.651 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -161.22 168.14 24.71 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.467 1.03 . . . . 1.0 112.854 -175.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.406 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -124.8 171.36 16.86 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.176 1.37 . . . . 1.0 113.908 173.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 88.3 t -143.57 133.5 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.639 1.175 . . . . 1.0 113.585 -169.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 1.009 HG23 HD12 ' A' ' 123' ' ' LEU . 4.2 mt -130.63 103.53 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.144 1.778 . . . . 1.0 108.293 170.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.83 142.28 27.5 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.224 1.409 . . . . 1.0 111.656 173.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.9 mp -138.71 150.17 45.88 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.414 -0.804 . . . . 1.0 113.079 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.686 0 CA-C-N 116.676 -0.238 . . . . 1.0 113.042 169.317 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.441 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 22.3 p . . . . . 0 CA--C 1.537 0.48 0 N-CA-C 114.889 1.44 . . . . 1.0 114.889 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -54.46 -22.87 13.92 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 124.801 1.24 . . . . 1.0 114.271 -173.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.19 -49.05 70.21 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 121.121 1.782 . . . . 1.0 113.829 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -72.14 -35.1 60.98 Favored Glycine 0 N--CA 1.477 1.38 0 O-C-N 120.72 -1.459 . . . . 1.0 112.842 175.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.441 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 82.2 mttt -64.66 -35.87 82.42 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.693 1.197 . . . . 1.0 112.805 176.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -61.48 -43.44 98.87 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.628 1.171 . . . . 1.0 111.23 170.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -62.09 -39.08 91.25 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.41 0.55 . . . . 1.0 111.087 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -44.85 94.98 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.264 0.626 . . . . 1.0 111.781 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.03 74.16 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.037 0.754 . . . . 1.0 113.037 171.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.692 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -58.91 -49.53 77.45 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 123.44 1.591 . . . . 1.0 110.859 -175.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.651 HD12 ' CD1' ' A' ' 87' ' ' TYR . 4.0 mt -67.07 -40.57 87.05 Favored 'General case' 0 C--N 1.32 -0.692 0 O-C-N 120.885 -1.134 . . . . 1.0 110.936 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -69.29 -18.76 63.87 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.313 0.857 . . . . 1.0 113.313 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.81 -18.0 58.67 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.69 1.132 . . . . 1.0 110.765 175.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -100.03 -73.45 0.63 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.086 1.354 . . . . 1.0 109.606 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 62.2 p 179.76 -18.92 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.414 1.886 . . . . 1.0 114.075 -174.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -71.71 150.9 44.07 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 114.794 1.405 . . . . 1.0 114.794 -169.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -88.96 166.51 13.88 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 113.017 -1.901 . . . . 1.0 113.342 -168.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.21 136.72 52.43 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.269 1.828 . . . . 1.0 110.645 -175.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.3 t -113.59 128.9 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.889 1.276 . . . . 1.0 109.345 -173.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 50.98 -158.12 2.23 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 124.884 1.23 . . . . 1.0 114.324 -171.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -115.39 144.69 43.41 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.751 1.62 . . . . 1.0 109.445 169.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -71.19 158.16 36.9 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.918 1.081 . . . . 1.0 113.918 -169.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 1.009 HD12 HG23 ' A' ' 90' ' ' ILE . 1.4 tm? -89.49 138.39 31.49 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.049 1.34 . . . . 1.0 110.139 169.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 mt -127.78 107.81 10.2 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.708 1.603 . . . . 1.0 109.32 173.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.593 HG13 HD11 ' A' ' 123' ' ' LEU . 25.3 mt -96.51 128.15 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 121.086 -1.009 . . . . 1.0 111.541 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -104.98 109.2 21.1 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 124.628 1.205 . . . . 1.0 111.705 174.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.25 -22.06 64.79 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.269 1.028 . . . . 1.0 113.24 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.7 t -65.13 -20.23 66.36 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.867 1.267 . . . . 1.0 112.602 173.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -120.09 -29.9 4.79 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.071 1.748 . . . . 1.0 112.298 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -143.43 88.14 8.12 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.975 1.31 . . . . 1.0 112.266 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.25 4.98 4.39 Favored 'Trans proline' 0 CA--C 1.546 1.125 0 C-N-CA 123.521 2.814 . . . . 1.0 114.761 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -111.55 73.82 1.13 Allowed Pre-proline 0 N--CA 1.469 0.503 0 C-N-CA 126.794 2.038 . . . . 1.0 110.233 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -60.42 -25.88 81.46 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.999 2.466 . . . . 1.0 116.135 -169.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -65.63 -24.42 67.04 Favored 'General case' 0 C--O 1.222 -0.384 0 O-C-N 120.983 -1.073 . . . . 1.0 111.521 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 30.1 p -72.75 -18.38 61.51 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.183 -0.948 . . . . 1.0 112.498 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.41 ' HB2' HD11 ' A' ' 125' ' ' ILE . 5.1 mm-40 -100.84 -55.05 2.67 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.256 1.822 . . . . 1.0 111.297 177.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 63.4 p -67.38 -31.64 72.01 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 117.771 -1.109 . . . . 1.0 113.906 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -59.11 -59.89 12.34 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-N 121.192 1.814 . . . . 1.0 112.854 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -61.92 -26.4 78.92 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 CA-C-N 121.203 1.465 . . . . 1.0 112.813 174.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.457 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 91.1 t90 -65.6 -48.88 70.78 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.353 0.979 . . . . 1.0 110.66 174.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.605 HG11 ' HA ' ' A' ' 22' ' ' ALA . 80.0 t -66.05 -32.92 60.27 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 C-N-CA 123.08 0.552 . . . . 1.0 110.143 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.72 -51.18 68.16 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 121.076 -1.015 . . . . 1.0 109.958 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 60.0 m170 -65.19 -51.63 59.86 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.178 0.991 . . . . 1.0 111.431 -177.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.418 ' CZ3' HD11 ' A' ' 26' ' ' LEU . 86.9 t90 -57.42 -37.3 72.53 Favored 'General case' 0 C--O 1.219 -0.514 0 C-N-CA 125.293 1.437 . . . . 1.0 111.542 171.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -49.42 -34.69 19.71 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.751 1.644 . . . . 1.0 113.507 172.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 p -68.62 -13.69 62.52 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 114.896 1.443 . . . . 1.0 114.896 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.48 -19.54 45.71 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.609 1.563 . . . . 1.0 111.87 175.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -84.04 169.23 15.15 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.219 1.007 . . . . 1.0 111.193 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 C--O 1.252 1.19 0 N-CA-C 115.652 1.723 . . . . 1.0 115.652 -169.645 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 113.71 1.004 . . . . 1.0 113.71 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -126.1 125.05 41.92 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.661 1.584 . . . . 1.0 110.305 174.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.551 HD13 HD12 ' A' ' 26' ' ' LEU . 2.0 mp -121.68 113.94 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 126.152 1.781 . . . . 1.0 113.262 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.32 122.21 6.64 Favored Glycine 0 C--O 1.223 -0.544 0 O-C-N 121.33 -0.856 . . . . 1.0 111.245 169.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.3 mt -104.4 122.18 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-N 118.407 1.103 . . . . 1.0 109.872 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -114.72 112.7 23.24 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.089 1.355 . . . . 1.0 107.455 -171.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.469 0.482 0 C-N-CA 122.586 0.355 . . . . 1.0 111.473 -172.201 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.9 tp . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 114.626 1.343 . . . . 1.0 114.626 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.9 t -56.8 -31.14 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.22 -0.925 . . . . 1.0 112.269 -171.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.58 -48.2 80.03 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.193 -0.942 . . . . 1.0 113.203 171.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.67 -28.41 62.7 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.031 0.532 . . . . 1.0 110.72 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -63.15 -49.7 73.3 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.924 -0.769 . . . . 1.0 108.924 169.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.532 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.16 -43.36 92.02 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 112.521 0.563 . . . . 1.0 112.521 -173.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -53.34 -49.99 65.95 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.07 0.948 . . . . 1.0 110.291 169.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.71 -37.09 73.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.2 0.6 . . . . 1.0 112.345 -174.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.9 mt -67.43 -46.74 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 118.994 0.816 . . . . 1.0 109.084 176.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.551 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -67.51 -34.13 76.49 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 119.667 -0.813 . . . . 1.0 110.457 -176.554 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.5 m -62.83 -40.26 96.87 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.731 1.612 . . . . 1.0 113.325 170.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.56 -33.26 73.77 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.978 0.911 . . . . 1.0 112.029 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -69.3 -31.48 69.99 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.529 1.132 . . . . 1.0 112.45 170.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 126.68 18.61 2.16 Favored Glycine 0 N--CA 1.472 1.058 0 C-N-CA 124.409 1.004 . . . . 1.0 115.066 169.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -111.22 152.32 27.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.637 1.175 . . . . 1.0 111.007 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.9 73.65 9.9 Favored 'General case' 0 CA--C 1.51 -0.561 0 C-N-CA 124.629 1.172 . . . . 1.0 110.391 -172.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.99 142.39 27.83 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.29 -1.777 . . . . 1.0 112.061 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.6 m -147.94 138.97 23.33 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.549 1.14 . . . . 1.0 112.36 -177.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.5 t -84.64 135.29 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 114.781 1.401 . . . . 1.0 114.781 171.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -116.34 114.54 24.46 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.732 2.013 . . . . 1.0 110.536 169.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -95.32 139.01 32.24 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.465 1.906 . . . . 1.0 111.138 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.2 t0 41.18 54.92 7.93 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 124.865 1.266 . . . . 1.0 111.982 -169.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -71.92 143.06 40.13 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.902 3.068 . . . . 1.0 116.553 -168.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.431 ' HB3' ' H ' ' A' ' 42' ' ' SER . 50.7 mm-40 -94.27 164.93 12.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 122.431 1.11 . . . . 1.0 111.85 168.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.556 HD21 HD21 ' A' ' 79' ' ' LEU . 2.2 tm? -65.8 -22.16 66.54 Favored 'General case' 0 N--CA 1.44 -0.93 0 O-C-N 120.859 -1.151 . . . . 1.0 110.064 167.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.431 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 16.3 m -68.18 -20.08 64.84 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.07 -1.019 . . . . 1.0 112.376 172.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -83.73 -23.99 31.38 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.605 1.162 . . . . 1.0 112.47 169.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.49 ' HB3' HD22 ' A' ' 41' ' ' LEU . 10.9 t-105 -88.41 -33.96 17.7 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.064 1.135 . . . . 1.0 114.064 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.3 mt -49.89 -38.54 35.8 Favored Pre-proline 0 CA--C 1.555 1.163 0 CA-C-O 117.558 -1.21 . . . . 1.0 113.944 178.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -58.76 -8.81 6.3 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 124.031 3.154 . . . . 1.0 116.797 173.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -114.89 8.04 15.84 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 116.091 1.885 . . . . 1.0 116.091 -177.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -51.05 -32.35 21.59 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.935 1.694 . . . . 1.0 113.436 171.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -102.11 6.23 40.79 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.721 2.408 . . . . 1.0 113.588 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -128.79 -159.47 0.96 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 127.056 2.142 . . . . 1.0 112.222 -169.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -112.57 160.8 17.48 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 122.862 1.315 . . . . 1.0 111.404 170.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.567 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -146.92 159.4 9.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 125.076 1.35 . . . . 1.0 108.908 -171.658 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.616 HD11 HD12 ' A' ' 90' ' ' ILE . 19.7 tp -141.76 125.86 17.35 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 124.197 0.999 . . . . 1.0 109.211 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.5 t -102.37 120.41 52.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 C-N-CA 123.767 0.827 . . . . 1.0 109.182 176.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.4 t -119.77 113.53 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 105.944 -1.873 . . . . 1.0 105.944 177.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 113.561 0.949 . . . . 1.0 113.561 -168.331 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.0 tt . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 113.682 0.993 . . . . 1.0 113.682 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -44.61 -52.74 16.89 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 124.768 1.227 . . . . 1.0 112.622 168.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.73 -32.7 29.55 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 121.851 1.701 . . . . 1.0 111.954 -173.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 tp -62.92 -52.85 61.48 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.523 1.129 . . . . 1.0 111.375 169.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.643 ' CE1' HD23 ' A' ' 110' ' ' LEU . 92.5 t80 -55.13 -53.08 60.42 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.629 0.771 . . . . 1.0 112.651 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 -64.61 -40.58 95.75 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.717 0.807 . . . . 1.0 111.465 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.94 -35.78 91.2 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.41 -0.661 . . . . 1.0 112.333 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.591 HG22 HD12 ' A' ' 110' ' ' LEU . 89.4 mt -64.81 -50.09 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 120.229 2.015 . . . . 1.0 108.246 172.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.707 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.1 ptmm? -69.46 -31.83 70.38 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.326 -1.484 . . . . 1.0 113.188 -170.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -101.76 -37.61 8.23 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 115.133 1.531 . . . . 1.0 115.133 -175.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 m -97.79 -19.51 18.13 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.333 1.053 . . . . 1.0 113.446 -174.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.556 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -92.86 -72.53 0.6 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 107.391 -1.337 . . . . 1.0 107.391 169.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.81 -20.67 1.38 Allowed Glycine 0 CA--C 1.539 1.564 0 C-N-CA 127.541 2.496 . . . . 1.0 114.902 170.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -153.21 142.08 21.14 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 128.408 2.683 . . . . 1.0 108.07 169.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.401 HE21 HD12 ' A' ' 79' ' ' LEU . 5.5 mt-30 -137.35 119.96 11.38 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.929 0.891 . . . . 1.0 109.701 -169.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -77.55 -35.3 1.61 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.451 2.101 . . . . 1.0 115.965 -169.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -143.64 19.28 1.84 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.056 1.132 . . . . 1.0 114.056 -169.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.567 HD11 ' CG2' ' A' ' 52' ' ' VAL . 58.1 tp -85.84 140.06 30.75 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.686 -1.259 . . . . 1.0 114.176 -169.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.4 mtm-85 -137.33 153.57 50.22 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.989 2.516 . . . . 1.0 109.619 169.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.657 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -161.56 168.17 24.04 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.073 0.851 . . . . 1.0 112.543 -176.485 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.402 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -125.19 170.54 17.13 Favored Glycine 0 N--CA 1.472 1.093 0 C-N-CA 125.201 1.382 . . . . 1.0 114.134 174.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.3 t -142.44 132.7 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.658 1.183 . . . . 1.0 113.695 -169.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.97 HG23 HD12 ' A' ' 123' ' ' LEU . 4.1 mt -129.54 102.84 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.802 1.641 . . . . 1.0 108.035 170.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -91.86 142.3 27.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.526 1.531 . . . . 1.0 111.726 173.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.5 mp -138.13 152.7 48.97 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.235 -0.915 . . . . 1.0 112.793 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.697 0 C-N-CA 121.528 -0.368 . . . . 1.0 112.583 169.207 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.435 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 26.7 p . . . . . 0 CA--C 1.537 0.46 0 N-CA-C 114.519 1.303 . . . . 1.0 114.519 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -58.18 -21.63 48.17 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 117.573 -1.203 . . . . 1.0 114.08 -173.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.95 -43.0 87.77 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-N 121.371 1.896 . . . . 1.0 114.007 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -77.59 -36.88 32.25 Favored Glycine 0 N--CA 1.478 1.471 0 O-C-N 120.909 -1.348 . . . . 1.0 113.036 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.435 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 85.2 mttt -63.58 -33.49 75.71 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.34 1.056 . . . . 1.0 112.978 176.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -59.93 -44.15 94.5 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.263 1.425 . . . . 1.0 111.012 169.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -63.65 -39.12 93.55 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.662 -0.649 . . . . 1.0 110.948 175.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -42.99 99.63 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.774 -0.579 . . . . 1.0 111.709 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.83 -35.64 77.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 112.978 0.733 . . . . 1.0 112.978 171.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.707 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -58.91 -49.66 76.97 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 123.463 1.601 . . . . 1.0 110.902 -175.141 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.657 HD12 ' CD1' ' A' ' 87' ' ' TYR . 4.0 mt -67.52 -40.3 85.1 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 120.92 -1.112 . . . . 1.0 110.996 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -70.09 -17.87 63.24 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.364 0.876 . . . . 1.0 113.364 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.77 -17.08 59.26 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.488 1.04 . . . . 1.0 110.957 174.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -101.63 -73.28 0.66 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.147 1.379 . . . . 1.0 109.904 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 65.8 p 179.52 -19.32 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.106 1.763 . . . . 1.0 113.984 -174.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -72.1 151.59 42.95 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 123.06 1.41 . . . . 1.0 114.464 -169.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -87.75 165.37 15.4 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 113.071 -1.877 . . . . 1.0 113.298 -169.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.69 133.32 47.0 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.222 1.809 . . . . 1.0 110.21 -174.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 32.6 t -112.46 130.99 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.61 1.164 . . . . 1.0 109.857 -171.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 52.46 -157.72 3.77 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 125.314 1.435 . . . . 1.0 114.765 -173.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -111.9 139.82 47.07 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.839 1.656 . . . . 1.0 110.097 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -70.61 155.29 40.92 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 122.332 1.063 . . . . 1.0 112.222 -171.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.97 HD12 HG23 ' A' ' 90' ' ' ILE . 1.2 tm? -87.96 139.07 30.89 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.722 -1.127 . . . . 1.0 109.957 171.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 mt -127.65 106.57 9.24 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.404 1.482 . . . . 1.0 109.69 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.608 HG13 HD11 ' A' ' 123' ' ' LEU . 23.8 mt -95.84 127.79 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 O-C-N 121.169 -0.957 . . . . 1.0 112.042 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -104.68 109.59 21.57 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 122.4 1.095 . . . . 1.0 111.982 173.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.74 -22.71 66.04 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.558 1.143 . . . . 1.0 113.433 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.1 t -64.38 -22.48 66.97 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.035 0.934 . . . . 1.0 112.718 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -118.1 -29.91 5.46 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.0 1.72 . . . . 1.0 111.961 -175.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -142.54 87.72 9.11 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 125.086 1.354 . . . . 1.0 112.06 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.62 8.11 2.42 Favored 'Trans proline' 0 CA--C 1.552 1.404 0 C-N-CA 123.655 2.904 . . . . 1.0 114.271 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -114.73 69.97 2.24 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 127.2 2.2 . . . . 1.0 109.859 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -56.9 -23.13 49.45 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.723 2.282 . . . . 1.0 116.197 -169.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 pm0 -67.03 -24.13 65.97 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 121.028 -1.045 . . . . 1.0 112.251 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.9 p -74.77 -17.92 60.56 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.329 0.968 . . . . 1.0 112.301 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.425 ' HB2' HD11 ' A' ' 125' ' ' ILE . 5.1 mm-40 -100.33 -54.05 2.96 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.456 1.903 . . . . 1.0 111.509 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.5 p -68.19 -33.82 75.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 117.764 -1.112 . . . . 1.0 113.912 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -57.47 -61.69 6.73 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 120.877 1.671 . . . . 1.0 112.009 176.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -60.54 -23.58 75.81 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 CA-C-N 121.882 1.708 . . . . 1.0 113.744 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.456 ' CG ' ' HB2' ' A' ' 123' ' ' LEU . 87.9 t90 -68.87 -47.13 66.66 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 119.217 0.917 . . . . 1.0 110.984 173.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.532 HG11 ' HA ' ' A' ' 22' ' ' ALA . 93.2 t -65.27 -33.83 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 176.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.01 -31.0 70.38 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.0 1.32 . . . . 1.0 112.038 177.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -77.56 -62.34 1.69 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.994 1.718 . . . . 1.0 111.877 169.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.402 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 84.8 t90 -55.06 -36.89 66.05 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 126.191 1.796 . . . . 1.0 112.709 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.93 -31.93 25.72 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.98 1.276 . . . . 1.0 113.803 174.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.0 p -70.2 -13.77 62.33 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 114.352 1.241 . . . . 1.0 114.352 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.41 -17.02 53.04 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.85 1.66 . . . . 1.0 111.705 175.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -81.75 172.38 13.44 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.06 0.944 . . . . 1.0 111.6 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 C--O 1.255 1.371 0 C-N-CA 125.637 1.575 . . . . 1.0 112.619 -172.31 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.553 0 N-CA-C 113.348 0.87 . . . . 1.0 113.348 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -122.23 121.28 36.44 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.342 1.457 . . . . 1.0 110.346 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.595 HD13 HD12 ' A' ' 26' ' ' LEU . 2.2 mp -120.15 114.03 42.55 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 C-N-CA 126.057 1.743 . . . . 1.0 112.857 -178.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.48 122.53 6.79 Favored Glycine 0 C--O 1.222 -0.624 0 N-CA-C 110.573 -1.011 . . . . 1.0 110.573 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.4 mt -103.18 120.93 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-N 118.113 0.956 . . . . 1.0 109.271 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -114.2 113.21 24.35 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.245 -1.391 . . . . 1.0 107.245 -171.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.467 0.398 0 N-CA-C 112.66 0.615 . . . . 1.0 112.66 -171.011 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.4 tp . . . . . 0 N--CA 1.468 0.453 0 N-CA-C 113.641 0.978 . . . . 1.0 113.641 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.6 t -55.04 -33.93 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.639 0.776 . . . . 1.0 111.567 -173.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.27 -45.89 92.6 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.706 -1.246 . . . . 1.0 113.04 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -66.61 -29.98 70.15 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.774 0.83 . . . . 1.0 110.844 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -70.2 -47.14 62.8 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.79 0.836 . . . . 1.0 109.139 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.552 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -64.0 -41.35 97.52 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 113.297 0.851 . . . . 1.0 113.297 -176.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -56.26 -48.46 76.52 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.307 1.043 . . . . 1.0 110.572 170.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.27 -37.8 71.88 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.754 0.822 . . . . 1.0 112.055 -174.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.1 mt -69.29 -45.55 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 O-C-N 121.322 -0.862 . . . . 1.0 109.602 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.595 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.67 -31.52 72.57 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.878 1.217 . . . . 1.0 110.816 -179.133 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.5 m -62.56 -45.82 91.17 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.843 1.257 . . . . 1.0 112.687 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.22 -31.02 70.23 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.675 1.19 . . . . 1.0 113.254 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -67.65 -29.46 68.77 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.121 1.768 . . . . 1.0 111.606 171.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.02 27.6 2.22 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.802 1.192 . . . . 1.0 114.882 171.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -123.42 159.2 29.5 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.083 1.353 . . . . 1.0 110.389 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -90.61 87.54 6.76 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 120.645 -1.284 . . . . 1.0 108.649 -177.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.83 146.62 27.99 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.113 0.565 . . . . 1.0 111.379 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.9 m -147.31 140.86 25.52 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.472 1.109 . . . . 1.0 112.188 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.0 t -89.76 139.22 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 115.613 1.709 . . . . 1.0 115.613 173.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -121.04 111.88 18.03 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.303 2.241 . . . . 1.0 110.136 169.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -95.13 139.15 31.88 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.011 1.724 . . . . 1.0 111.634 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.4 t70 42.63 52.94 8.18 Favored Pre-proline 0 CA--C 1.56 1.365 0 C-N-CA 124.943 1.297 . . . . 1.0 111.581 -169.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -70.96 147.63 55.6 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.075 3.183 . . . . 1.0 117.013 -168.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.425 ' HB3' ' H ' ' A' ' 42' ' ' SER . 52.4 mm-40 -93.81 163.81 13.37 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.452 1.101 . . . . 1.0 112.035 168.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.577 HD21 HD21 ' A' ' 79' ' ' LEU . 2.3 tm? -65.52 -22.26 66.7 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 120.729 -1.232 . . . . 1.0 110.269 167.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.425 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 16.8 m -68.29 -20.41 64.77 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.921 -1.112 . . . . 1.0 112.116 172.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -82.96 -25.51 32.25 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.499 1.12 . . . . 1.0 112.31 169.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.489 ' HB3' HD22 ' A' ' 41' ' ' LEU . 14.9 t-105 -86.42 -35.43 19.73 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.909 1.077 . . . . 1.0 113.909 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.1 mt -48.21 -38.43 21.04 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 114.464 1.283 . . . . 1.0 114.464 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -60.59 -11.75 18.4 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 123.691 2.928 . . . . 1.0 116.573 175.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -111.14 8.31 21.66 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 116.243 1.942 . . . . 1.0 116.243 -172.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -54.3 -35.04 62.19 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.073 1.749 . . . . 1.0 113.628 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -99.03 -2.39 37.35 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.025 1.73 . . . . 1.0 113.274 177.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -109.64 -164.98 0.97 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.819 2.447 . . . . 1.0 110.938 -176.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -109.77 163.22 13.71 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.937 1.351 . . . . 1.0 111.773 169.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.623 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -144.25 157.7 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.822 1.249 . . . . 1.0 109.519 -170.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.541 HD11 HD12 ' A' ' 90' ' ' ILE . 18.2 tp -139.33 124.37 18.83 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 124.235 1.014 . . . . 1.0 108.735 174.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.7 t -99.36 121.53 50.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.383 -0.826 . . . . 1.0 109.238 174.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.7 t -120.06 113.98 42.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 105.319 -2.104 . . . . 1.0 105.319 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 115.161 1.541 . . . . 1.0 115.161 -168.298 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.7 tt . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 113.894 1.072 . . . . 1.0 113.894 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.8 t -43.46 -52.38 13.52 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.835 1.254 . . . . 1.0 112.878 168.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.86 -33.11 34.62 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.714 1.609 . . . . 1.0 111.915 -173.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 tp -63.41 -53.83 46.21 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 124.235 1.014 . . . . 1.0 111.223 169.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.658 ' CE1' HD23 ' A' ' 110' ' ' LEU . 91.6 t80 -54.69 -52.81 61.22 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.796 0.839 . . . . 1.0 112.477 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -64.85 -40.77 95.69 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.424 1.09 . . . . 1.0 111.384 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.44 -34.91 86.1 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.371 0.51 . . . . 1.0 112.656 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.611 HG22 HD12 ' A' ' 110' ' ' LEU . 92.0 mt -64.79 -49.31 80.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.866 1.833 . . . . 1.0 108.558 171.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.715 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.4 ptmm? -70.91 -32.12 68.96 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.2 -1.562 . . . . 1.0 112.85 -169.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -104.62 -38.49 6.72 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.082 1.512 . . . . 1.0 115.082 -174.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.2 m -95.0 -23.37 17.41 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.26 1.024 . . . . 1.0 113.171 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.577 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -91.32 -70.98 0.66 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 169.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.24 -11.95 1.95 Allowed Glycine 0 CA--C 1.538 1.507 0 C-N-CA 126.776 2.131 . . . . 1.0 116.255 169.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -157.6 141.84 16.16 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 127.81 2.444 . . . . 1.0 108.366 174.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.543 HE22 HD12 ' A' ' 79' ' ' LEU . 1.5 mm-40 -136.0 123.15 14.53 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.962 0.905 . . . . 1.0 111.148 -172.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.41 -37.82 0.36 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.205 1.937 . . . . 1.0 114.724 -171.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -146.94 19.07 1.27 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.069 1.137 . . . . 1.0 114.069 -169.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.623 HD11 ' CG2' ' A' ' 52' ' ' VAL . 45.8 tp -79.46 140.56 37.3 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.404 -1.435 . . . . 1.0 113.861 -169.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -133.49 150.2 51.71 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 128.636 2.774 . . . . 1.0 107.571 169.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.663 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -160.88 166.85 27.78 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.319 -0.863 . . . . 1.0 112.932 -178.166 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.47 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -124.65 171.85 16.83 Favored Glycine 0 N--CA 1.475 1.295 0 C-N-CA 125.003 1.287 . . . . 1.0 114.531 173.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.5 t -143.52 133.08 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 114.852 1.427 . . . . 1.0 114.852 -169.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.541 HD12 HD11 ' A' ' 53' ' ' LEU . 4.0 mt -130.79 104.85 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.683 1.593 . . . . 1.0 107.968 169.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -91.74 143.19 26.8 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.891 1.677 . . . . 1.0 111.797 175.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.9 mp -137.44 148.41 46.1 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.448 0.907 . . . . 1.0 113.448 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.63 0 N-CA-C 114.805 0.682 . . . . 1.0 114.805 169.014 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 20.1 p . . . . . 0 CA--C 1.542 0.66 0 N-CA-C 114.193 1.183 . . . . 1.0 114.193 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -55.95 -23.49 32.45 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.481 1.912 . . . . 1.0 114.607 -172.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.32 -48.44 83.66 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-N 120.357 1.435 . . . . 1.0 113.412 174.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.25 -36.51 50.41 Favored Glycine 0 N--CA 1.478 1.474 0 O-C-N 120.782 -1.422 . . . . 1.0 113.248 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -60.31 -35.8 76.45 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.928 0.891 . . . . 1.0 113.168 172.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -65.24 -33.94 77.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 118.603 -0.713 . . . . 1.0 112.826 172.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -63.95 -37.4 87.28 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.689 1.131 . . . . 1.0 111.032 172.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.413 ' CG ' ' HE ' ' A' ' 118' ' ' ARG . 12.0 t70 -63.14 -49.88 72.64 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.027 0.831 . . . . 1.0 110.473 177.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.64 -33.0 59.96 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.251 0.834 . . . . 1.0 113.251 173.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.715 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -61.27 -50.28 73.66 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 123.238 1.494 . . . . 1.0 110.727 178.408 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.663 HD12 ' CD1' ' A' ' 87' ' ' TYR . 8.0 mt -65.1 -39.27 92.9 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 120.966 -1.084 . . . . 1.0 111.19 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -67.31 -22.39 65.63 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.557 0.947 . . . . 1.0 113.557 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.54 -17.53 59.19 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.393 0.997 . . . . 1.0 111.464 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -96.51 -73.61 0.59 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.994 1.318 . . . . 1.0 109.206 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 56.2 p 177.18 -18.32 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.755 2.022 . . . . 1.0 113.534 -175.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -67.59 157.26 34.86 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.793 1.282 . . . . 1.0 113.933 -169.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -99.4 173.39 6.78 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 113.239 -1.8 . . . . 1.0 112.155 -169.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.413 ' HE ' ' CG ' ' A' ' 108' ' ' ASP . 4.7 ttm180 -128.63 160.49 32.26 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.758 1.223 . . . . 1.0 113.509 174.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.1 t -119.25 126.71 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 127.232 2.213 . . . . 1.0 108.811 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 52.35 -165.0 1.42 Allowed Glycine 0 CA--C 1.542 1.762 0 C-N-CA 124.748 1.166 . . . . 1.0 115.628 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -107.56 149.41 28.06 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.726 1.611 . . . . 1.0 110.118 169.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.78 159.15 32.35 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.717 1.207 . . . . 1.0 113.188 -169.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.659 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.2 tm? -91.32 139.57 30.61 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.098 0.959 . . . . 1.0 110.165 169.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.659 ' N ' HD13 ' A' ' 123' ' ' LEU . 6.4 mt -122.83 105.76 10.3 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.205 1.402 . . . . 1.0 111.103 174.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.447 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.9 mt -91.95 131.19 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 125.331 1.452 . . . . 1.0 112.341 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -108.25 92.27 3.99 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.86 2.464 . . . . 1.0 112.617 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.4 -23.6 67.0 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.995 1.318 . . . . 1.0 112.794 -173.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.7 p -53.47 -30.39 40.64 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 129.329 3.052 . . . . 1.0 114.334 169.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -124.79 -26.53 3.77 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.849 2.06 . . . . 1.0 111.585 -171.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -143.22 88.59 8.07 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.44 1.496 . . . . 1.0 112.184 -177.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -76.53 11.19 1.95 Allowed 'Trans proline' 0 CA--C 1.549 1.251 0 C-N-CA 123.77 2.98 . . . . 1.0 114.211 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -111.62 68.77 0.77 Allowed Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 127.672 2.389 . . . . 1.0 110.042 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -57.38 -21.39 44.6 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.777 2.318 . . . . 1.0 116.809 -169.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -64.25 -27.25 68.92 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 118.934 0.788 . . . . 1.0 111.902 174.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.6 p -72.27 -18.78 61.78 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 120.939 -1.1 . . . . 1.0 111.813 -174.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -99.22 -53.66 3.18 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.807 1.643 . . . . 1.0 111.933 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 48.1 p -71.28 -33.77 70.06 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 114.599 1.333 . . . . 1.0 114.599 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -59.32 -56.63 34.06 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 120.723 1.601 . . . . 1.0 112.453 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -62.66 -22.64 74.15 Favored 'Trans proline' 0 C--N 1.355 0.871 0 CA-C-N 121.459 1.557 . . . . 1.0 112.735 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.479 ' HB2' HD23 ' A' ' 123' ' ' LEU . 91.4 t90 -69.19 -47.37 65.05 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 123.279 0.632 . . . . 1.0 111.093 174.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.552 HG11 ' HA ' ' A' ' 22' ' ' ALA . 97.5 t -65.23 -32.0 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 122.03 0.919 . . . . 1.0 108.899 176.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.93 -22.33 61.48 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 120.045 -1.659 . . . . 1.0 113.401 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -87.07 -62.52 1.48 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.858 2.063 . . . . 1.0 111.265 169.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.47 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 87.6 t90 -54.88 -38.26 67.32 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 126.892 2.077 . . . . 1.0 112.99 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.96 -29.26 27.11 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 121.42 -0.8 . . . . 1.0 114.488 173.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.1 p -69.32 -13.29 62.3 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.809 1.304 . . . . 1.0 114.367 175.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.5 -18.59 51.64 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.34 1.456 . . . . 1.0 111.774 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -84.41 170.1 13.91 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.517 1.127 . . . . 1.0 111.521 -175.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.251 1.182 0 N-CA-C 116.697 2.11 . . . . 1.0 116.697 -169.465 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 116.469 2.026 . . . . 1.0 116.469 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -121.46 124.49 44.6 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 126.643 1.977 . . . . 1.0 110.057 170.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.492 HD13 HD12 ' A' ' 26' ' ' LEU . 1.7 mp -126.62 113.06 31.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 126.8 2.04 . . . . 1.0 111.898 -174.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.19 124.51 7.81 Favored Glycine 0 C--O 1.224 -0.518 0 N-CA-C 110.01 -1.236 . . . . 1.0 110.01 169.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.8 mt -104.59 123.34 58.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 118.151 0.976 . . . . 1.0 109.545 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -115.95 110.63 19.23 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.598 1.159 . . . . 1.0 108.266 -169.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.469 0.478 0 CA-C-N 116.619 -0.264 . . . . 1.0 111.441 -175.363 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.7 tp . . . . . 0 C--O 1.223 -0.322 0 CA-C-O 120.892 0.377 . . . . 1.0 110.663 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -56.66 -39.23 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 O-C-N 121.79 -0.569 . . . . 1.0 110.891 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.7 -49.65 74.25 Favored 'General case' 0 C--O 1.23 0.062 0 CA-C-N 119.606 1.093 . . . . 1.0 112.615 176.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -67.79 -26.93 66.33 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.105 0.479 . . . . 1.0 112.055 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -70.74 -48.72 53.01 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 123.952 0.901 . . . . 1.0 109.938 169.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.627 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -60.98 -44.38 97.46 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 112.651 0.611 . . . . 1.0 112.651 -176.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -51.52 -51.24 56.9 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.521 1.128 . . . . 1.0 110.221 169.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.86 -35.62 74.87 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.633 0.773 . . . . 1.0 112.764 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.7 mt -70.43 -45.41 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 O-C-N 121.175 -0.953 . . . . 1.0 109.342 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.492 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.86 -34.44 78.16 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 120.028 -0.669 . . . . 1.0 110.213 -178.536 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.4 m -61.75 -44.42 96.93 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.973 1.309 . . . . 1.0 113.155 169.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.17 -32.61 73.83 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.62 1.168 . . . . 1.0 112.944 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -66.49 -32.78 74.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.534 1.134 . . . . 1.0 111.75 170.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.27 12.98 1.56 Allowed Glycine 0 CA--C 1.532 1.135 0 N-CA-C 116.091 1.196 . . . . 1.0 116.091 169.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -105.85 168.32 9.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.865 1.266 . . . . 1.0 112.116 -170.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? -90.64 97.26 11.08 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.914 1.286 . . . . 1.0 107.847 170.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.91 144.87 42.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.64 0.257 . . . . 1.0 110.693 174.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.6 m -147.59 138.74 23.61 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.72 0.808 . . . . 1.0 111.91 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.1 t -86.92 136.64 22.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 114.502 1.297 . . . . 1.0 114.502 171.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -111.59 114.63 27.81 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.135 1.774 . . . . 1.0 110.464 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -94.04 139.23 31.21 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.332 1.853 . . . . 1.0 110.61 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.6 t0 43.12 54.82 10.7 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 124.274 1.029 . . . . 1.0 110.664 -169.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -64.15 140.22 70.44 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.855 3.036 . . . . 1.0 117.259 -167.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -89.36 154.25 20.22 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.742 1.617 . . . . 1.0 112.043 168.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.475 HD21 ' CD2' ' A' ' 79' ' ' LEU . 2.3 tm? -69.47 -21.62 63.69 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 120.674 -1.266 . . . . 1.0 109.648 168.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 26.0 m -66.79 -21.86 66.04 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.286 -0.884 . . . . 1.0 112.448 169.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -82.47 -28.58 31.14 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.789 0.836 . . . . 1.0 112.599 169.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.469 ' HB3' HD22 ' A' ' 41' ' ' LEU . 11.0 t-105 -80.17 -38.75 30.7 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.571 1.078 . . . . 1.0 113.515 178.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.3 mt -44.1 -47.31 23.12 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 114.411 1.263 . . . . 1.0 114.411 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.1 4.98 1.61 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.79 2.327 . . . . 1.0 115.811 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -113.06 5.63 17.24 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 116.053 1.871 . . . . 1.0 116.053 174.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -49.51 -30.74 8.83 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 126.836 2.054 . . . . 1.0 113.275 170.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -104.65 7.83 35.04 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.228 2.611 . . . . 1.0 113.288 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -133.5 -155.4 0.67 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.518 2.327 . . . . 1.0 112.096 -169.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -114.3 160.34 19.18 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-O 123.504 1.621 . . . . 1.0 111.801 169.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.476 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -146.48 150.75 14.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 125.289 1.436 . . . . 1.0 107.454 -174.32 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.426 HD11 HD12 ' A' ' 90' ' ' ILE . 16.0 tp -129.63 127.31 40.33 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 124.753 1.221 . . . . 1.0 108.666 176.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.7 t -99.82 127.65 52.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 t -127.01 104.12 12.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.518 -1.66 . . . . 1.0 106.518 175.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 113.502 0.927 . . . . 1.0 113.502 -167.773 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.9 tt . . . . . 0 N--CA 1.469 0.522 0 N-CA-C 114.015 1.117 . . . . 1.0 114.015 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.8 t -42.66 -51.26 12.12 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 124.788 1.235 . . . . 1.0 112.612 168.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.0 -31.7 18.96 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.385 1.39 . . . . 1.0 111.776 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.7 tp -64.15 -51.03 65.8 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 124.219 1.008 . . . . 1.0 110.961 169.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.621 ' CE1' HD23 ' A' ' 110' ' ' LEU . 88.5 t80 -54.91 -53.63 53.06 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.502 1.121 . . . . 1.0 112.478 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -67.21 -34.6 77.83 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.964 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.55 -37.1 93.97 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.701 0.667 . . . . 1.0 112.523 174.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.565 HG22 HD12 ' A' ' 110' ' ' LEU . 78.6 mt -65.44 -49.43 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.96 1.88 . . . . 1.0 108.264 171.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.695 ' HB3' HD21 ' A' ' 110' ' ' LEU . 3.8 ptmm? -69.35 -31.16 69.4 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.241 -1.537 . . . . 1.0 113.358 -171.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -105.66 -38.02 6.55 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.406 1.632 . . . . 1.0 115.406 -174.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.6 m -93.85 -23.02 18.29 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.153 0.981 . . . . 1.0 112.873 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.475 ' CD2' HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -92.11 -71.13 0.66 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 106.277 -1.749 . . . . 1.0 106.277 169.055 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.5 -10.21 1.51 Allowed Glycine 0 CA--C 1.539 1.571 0 C-N-CA 127.386 2.422 . . . . 1.0 115.554 169.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -153.19 146.62 24.91 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 129.269 3.028 . . . . 1.0 107.214 170.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.434 ' HG3' ' HB2' ' A' ' 116' ' ' ALA . 39.7 mm-40 -136.01 125.57 16.07 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.339 0.656 . . . . 1.0 110.548 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -82.8 -39.94 0.13 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.352 2.035 . . . . 1.0 114.241 -173.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -146.87 18.01 1.26 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.596 1.158 . . . . 1.0 113.785 -169.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.476 HD11 ' CG2' ' A' ' 52' ' ' VAL . 42.1 tp -76.88 140.48 40.6 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.598 -1.314 . . . . 1.0 113.412 -169.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -133.45 147.85 51.71 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 129.421 3.088 . . . . 1.0 107.714 170.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.655 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -157.27 166.04 34.24 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.835 1.198 . . . . 1.0 112.384 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.405 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -130.05 173.63 19.81 Favored Glycine 0 N--CA 1.467 0.74 0 C-N-CA 125.43 1.491 . . . . 1.0 112.142 170.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.556 HG13 ' HB3' ' A' ' 122' ' ' MET . 0.2 OUTLIER -160.07 143.14 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 114.829 1.418 . . . . 1.0 114.829 -169.118 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.426 HD12 HD11 ' A' ' 53' ' ' LEU . 3.4 mt -124.39 113.74 37.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 126.721 2.008 . . . . 1.0 108.397 169.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.59 150.13 20.92 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 125.342 1.457 . . . . 1.0 110.462 169.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.97 152.05 44.65 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 121.801 -0.562 . . . . 1.0 111.419 173.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.754 0 N-CA-C 115.515 0.966 . . . . 1.0 115.515 169.588 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 115.718 1.747 . . . . 1.0 115.718 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -59.0 -23.74 62.17 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.921 1.288 . . . . 1.0 114.196 -175.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.21 -46.2 94.17 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-N 120.335 1.425 . . . . 1.0 113.004 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.95 -36.29 47.39 Favored Glycine 0 N--CA 1.478 1.469 0 O-C-N 121.014 -1.286 . . . . 1.0 113.121 176.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -59.54 -34.97 73.32 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 117.922 0.861 . . . . 1.0 112.806 172.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 -67.04 -33.09 74.77 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.997 0.74 . . . . 1.0 112.997 173.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -62.16 -35.96 80.39 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.796 1.18 . . . . 1.0 111.314 171.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.22 -44.62 83.32 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.233 0.469 . . . . 1.0 111.342 175.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.72 -44.12 81.3 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 118.807 -0.616 . . . . 1.0 112.086 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.695 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -51.18 -48.97 61.79 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.746 2.018 . . . . 1.0 111.49 -177.466 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.655 HD12 ' CD1' ' A' ' 87' ' ' TYR . 8.0 mt -66.03 -40.07 90.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.331 -0.849 . . . . 1.0 111.928 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -67.4 -24.91 65.71 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.95 1.092 . . . . 1.0 113.95 175.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -64.62 -35.13 80.02 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.409 1.084 . . . . 1.0 111.491 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -83.96 -73.28 0.43 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 113.709 -1.587 . . . . 1.0 110.461 -175.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.5 m 174.14 -0.89 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.118 2.567 . . . . 1.0 111.821 173.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.527 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -74.19 159.58 32.34 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 122.414 1.102 . . . . 1.0 113.541 -169.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -100.69 171.46 7.68 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 113.898 -1.501 . . . . 1.0 111.362 -169.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 2.2 ttm105 -126.43 154.02 44.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.547 1.139 . . . . 1.0 112.779 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.485 HG12 ' H ' ' A' ' 120' ' ' GLY . 16.4 t -92.86 -173.1 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 C-N-CA 127.009 2.124 . . . . 1.0 106.009 169.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.485 ' H ' HG12 ' A' ' 119' ' ' VAL . . . -51.17 154.76 3.79 Favored Glycine 0 CA--C 1.543 1.838 0 O-C-N 120.345 -1.472 . . . . 1.0 115.929 -175.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -48.9 143.33 5.54 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.327 1.851 . . . . 1.0 114.771 -172.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.556 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.9 OUTLIER -75.62 156.57 34.77 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.669 1.187 . . . . 1.0 111.879 -169.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.634 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -90.98 137.81 32.08 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.537 -0.756 . . . . 1.0 109.719 174.325 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.634 ' N ' HD13 ' A' ' 123' ' ' LEU . 7.5 mt -122.41 109.13 14.0 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.641 1.176 . . . . 1.0 110.459 174.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.408 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.2 mt -91.45 130.44 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.062 1.345 . . . . 1.0 112.611 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.74 98.52 10.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.206 1.002 . . . . 1.0 110.039 175.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -70.4 -23.93 62.84 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.108 -1.62 . . . . 1.0 112.232 -175.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.65 -30.65 44.13 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 130.191 3.396 . . . . 1.0 114.12 169.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -124.67 -26.86 3.75 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.539 1.935 . . . . 1.0 111.957 -169.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -141.92 83.23 12.9 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 125.565 1.546 . . . . 1.0 111.276 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.76 12.45 1.41 Allowed 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 124.009 3.14 . . . . 1.0 113.904 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -109.64 65.5 0.36 Allowed Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 127.899 2.479 . . . . 1.0 109.553 174.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -58.65 -19.08 43.68 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.496 2.131 . . . . 1.0 116.952 -168.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -65.12 -28.44 69.44 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 121.343 -0.848 . . . . 1.0 111.919 173.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.6 p -70.75 -21.75 62.49 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.226 0.921 . . . . 1.0 112.181 -175.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -96.24 -54.69 3.2 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.899 1.679 . . . . 1.0 111.399 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 85.6 p -68.4 -33.07 73.58 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.656 1.354 . . . . 1.0 114.656 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.27 -50.03 51.5 Favored Pre-proline 0 CA--C 1.542 0.645 0 O-C-N 120.315 -1.49 . . . . 1.0 113.014 -173.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.69 -23.44 69.68 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 CA-C-N 121.289 1.496 . . . . 1.0 112.552 170.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.455 ' HB2' HD23 ' A' ' 123' ' ' LEU . 90.6 t90 -70.28 -46.32 64.57 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 123.342 0.657 . . . . 1.0 110.832 175.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.627 HG11 ' HA ' ' A' ' 22' ' ' ALA . 88.9 t -66.08 -34.63 71.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -63.55 -48.46 77.37 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.216 -0.928 . . . . 1.0 110.043 174.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -63.7 -55.68 21.52 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.73 1.212 . . . . 1.0 111.67 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.406 ' HE1' ' HB ' ' A' ' 119' ' ' VAL . 88.2 t90 -58.09 -35.05 70.86 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 125.693 1.597 . . . . 1.0 111.953 175.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.47 -32.87 31.69 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.462 1.505 . . . . 1.0 113.811 172.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.0 p -70.12 -12.65 61.75 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.832 1.419 . . . . 1.0 114.832 175.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.94 -17.33 43.99 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.67 1.588 . . . . 1.0 111.882 176.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -77.79 171.46 14.93 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 118.945 0.793 . . . . 1.0 110.871 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 56.4 m . . . . . 0 C--O 1.252 1.187 0 C-N-CA 125.44 1.496 . . . . 1.0 114.777 -173.416 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.306 0 N-CA-C 114.694 1.368 . . . . 1.0 114.694 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -121.0 123.75 43.18 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.669 1.587 . . . . 1.0 109.775 173.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.608 HD13 HD12 ' A' ' 26' ' ' LEU . 1.9 mp -124.27 112.92 34.35 Favored 'Isoleucine or valine' 0 C--O 1.23 0.05 0 C-N-CA 125.856 1.662 . . . . 1.0 112.439 -176.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.22 125.49 7.92 Favored Glycine 0 C--O 1.224 -0.492 0 N-CA-C 110.24 -1.144 . . . . 1.0 110.24 169.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.5 mt -105.79 124.14 60.71 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 118.523 1.162 . . . . 1.0 109.591 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -115.57 110.22 18.91 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 125.109 1.364 . . . . 1.0 107.813 -170.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 N--CA 1.466 0.354 0 O-C-N 123.266 0.354 . . . . 1.0 111.468 -175.006 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.7 tp . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 116.829 2.159 . . . . 1.0 116.829 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.8 t -57.44 -32.76 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 119.344 -0.36 . . . . 1.0 111.717 -170.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.47 -45.29 94.28 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.76 1.164 . . . . 1.0 112.521 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -68.42 -31.06 70.13 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.81 0.844 . . . . 1.0 111.017 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -67.7 -47.15 70.22 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 173.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.547 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -64.74 -42.45 95.17 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 113.122 0.786 . . . . 1.0 113.122 -176.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -54.72 -48.43 72.51 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.344 1.058 . . . . 1.0 110.404 170.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.89 -38.21 70.02 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.517 0.727 . . . . 1.0 112.067 -174.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.3 mt -68.26 -45.48 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 O-C-N 121.33 -0.856 . . . . 1.0 109.35 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.608 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -66.16 -31.02 71.61 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.653 1.115 . . . . 1.0 110.884 -178.376 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 34.6 m -63.07 -45.55 91.66 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.796 1.238 . . . . 1.0 112.539 169.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.39 -31.97 71.7 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.57 1.148 . . . . 1.0 113.236 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -65.74 -30.47 71.14 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.123 1.769 . . . . 1.0 111.648 171.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.0 31.61 1.7 Allowed Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.702 1.144 . . . . 1.0 114.833 172.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -124.7 161.66 25.86 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.302 1.441 . . . . 1.0 110.739 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -91.8 86.24 5.86 Favored 'General case' 0 N--CA 1.46 0.071 0 C-N-CA 125.034 1.334 . . . . 1.0 108.939 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.5 146.2 28.46 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.05 0.54 . . . . 1.0 111.404 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.2 m -147.5 140.66 25.16 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.344 1.058 . . . . 1.0 112.198 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -87.04 137.31 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 115.108 1.521 . . . . 1.0 115.108 171.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -111.86 120.86 43.39 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.262 1.825 . . . . 1.0 111.126 169.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -99.92 138.23 37.28 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.587 1.955 . . . . 1.0 110.942 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.7 t0 42.18 54.85 9.34 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 124.39 1.076 . . . . 1.0 111.378 -169.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -63.56 137.32 58.9 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.836 3.024 . . . . 1.0 116.707 -168.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -88.56 157.35 18.63 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.547 1.539 . . . . 1.0 111.706 168.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.47 HD21 HD21 ' A' ' 79' ' ' LEU . 2.3 tm? -68.52 -21.27 64.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 120.261 -1.525 . . . . 1.0 109.567 167.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.2 m -68.86 -19.83 64.25 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.455 -0.778 . . . . 1.0 112.319 169.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -81.98 -28.57 32.57 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.546 1.138 . . . . 1.0 112.129 169.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.427 ' HB3' HD22 ' A' ' 41' ' ' LEU . 12.6 t-105 -82.7 -36.9 25.47 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.671 0.989 . . . . 1.0 113.671 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.8 mt -48.6 -39.83 34.87 Favored Pre-proline 0 CA--C 1.552 1.054 0 CA-C-O 117.482 -1.246 . . . . 1.0 114.123 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -57.59 -12.36 11.1 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 124.428 3.418 . . . . 1.0 117.144 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -110.53 8.13 22.84 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 116.121 1.897 . . . . 1.0 116.121 -174.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -52.72 -30.94 35.11 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.941 2.096 . . . . 1.0 113.782 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -113.48 13.1 18.81 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.882 1.273 . . . . 1.0 112.602 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -122.65 -159.51 0.84 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.273 2.629 . . . . 1.0 110.854 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -115.12 165.09 13.29 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 123.018 1.389 . . . . 1.0 111.763 170.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.417 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -149.49 163.19 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.331 1.452 . . . . 1.0 108.945 -172.17 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.402 HD11 HD12 ' A' ' 90' ' ' ILE . 17.4 tp -141.45 127.08 19.0 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.509 1.123 . . . . 1.0 108.951 175.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.46 124.0 52.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 124.055 0.942 . . . . 1.0 109.533 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.0 t -122.58 112.37 34.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 174.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 115.136 1.532 . . . . 1.0 115.136 -167.98 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.6 tt . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 113.471 0.915 . . . . 1.0 113.471 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.5 t -40.77 -50.61 7.29 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 124.638 1.175 . . . . 1.0 112.816 168.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.38 -30.03 20.04 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.506 1.471 . . . . 1.0 111.913 -172.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.5 tp -66.45 -50.58 62.85 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 123.804 0.842 . . . . 1.0 110.534 169.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.676 ' CE1' HD23 ' A' ' 110' ' ' LEU . 76.0 t80 -54.69 -54.31 43.44 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.018 0.927 . . . . 1.0 112.306 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -68.05 -35.4 78.17 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.132 -0.486 . . . . 1.0 111.915 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.18 -36.72 93.58 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 123.941 0.781 . . . . 1.0 112.367 176.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.542 HG22 HD12 ' A' ' 110' ' ' LEU . 79.7 mt -62.43 -51.87 66.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.521 1.661 . . . . 1.0 108.136 170.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.711 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.3 ptmm? -68.43 -32.59 72.73 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 120.435 -1.415 . . . . 1.0 113.141 -169.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -99.58 -37.26 9.23 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.771 1.629 . . . . 1.0 114.808 -174.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 m -99.8 -19.17 16.83 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.613 1.165 . . . . 1.0 113.17 -174.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.47 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -94.3 -71.54 0.66 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 106.409 -1.7 . . . . 1.0 106.409 169.57 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.89 -13.88 1.65 Allowed Glycine 0 CA--C 1.537 1.426 0 C-N-CA 127.642 2.544 . . . . 1.0 116.719 168.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -154.67 137.89 15.7 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.872 2.069 . . . . 1.0 108.633 172.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.419 HE22 HD12 ' A' ' 79' ' ' LEU . 1.6 mm-40 -134.92 124.0 16.31 Favored Pre-proline 0 CA--C 1.546 0.816 0 O-C-N 121.354 -0.841 . . . . 1.0 111.499 -171.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.83 -39.62 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.015 2.477 . . . . 1.0 114.72 -174.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -140.63 14.84 2.34 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.5 1.296 . . . . 1.0 114.5 -169.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.417 HD11 ' CG2' ' A' ' 52' ' ' VAL . 70.0 tp -80.84 138.06 36.21 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.579 -1.326 . . . . 1.0 112.862 -169.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.1 mtm-85 -135.97 156.76 48.26 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.963 2.505 . . . . 1.0 109.085 169.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.63 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -163.78 166.82 21.63 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.306 -0.871 . . . . 1.0 112.181 -176.501 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.487 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -120.05 171.92 14.69 Favored Glycine 0 N--CA 1.472 1.058 0 C-N-CA 125.487 1.518 . . . . 1.0 114.438 173.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.0 t -146.35 133.07 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 115.63 1.715 . . . . 1.0 115.63 -169.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.402 HD12 HD11 ' A' ' 53' ' ' LEU . 4.5 mt -131.6 108.38 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 125.719 1.608 . . . . 1.0 107.481 168.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.84 148.3 23.26 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.236 1.414 . . . . 1.0 112.017 170.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.8 mp -139.78 149.04 43.07 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.869 0.692 . . . . 1.0 112.869 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.566 0 CA-C-N 116.115 -0.493 . . . . 1.0 113.443 169.254 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 CA--C 1.545 0.774 0 N-CA-C 113.609 0.966 . . . . 1.0 113.609 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -61.48 -16.03 43.37 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.494 1.517 . . . . 1.0 114.545 -173.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.32 -42.02 97.17 Favored Glycine 0 CA--C 1.537 1.408 0 CA-C-N 120.271 1.396 . . . . 1.0 113.22 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.97 -36.53 46.51 Favored Glycine 0 N--CA 1.48 1.626 0 O-C-N 120.258 -1.731 . . . . 1.0 112.724 174.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -63.02 -33.36 75.26 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.871 0.868 . . . . 1.0 112.785 174.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -58.4 -42.73 87.77 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.807 0.843 . . . . 1.0 111.856 170.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -62.06 -37.89 86.69 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.763 0.71 . . . . 1.0 111.14 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.55 -46.16 84.03 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.657 0.662 . . . . 1.0 111.366 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.61 -43.48 68.7 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.442 -0.789 . . . . 1.0 112.0 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.711 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -52.24 -49.44 64.0 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.787 2.035 . . . . 1.0 111.733 -177.558 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.63 HD12 ' CD1' ' A' ' 87' ' ' TYR . 6.3 mt -65.31 -40.35 93.63 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.471 -0.786 . . . . 1.0 111.232 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -67.65 -22.81 65.29 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.247 1.203 . . . . 1.0 114.247 175.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -64.42 -35.7 81.76 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.666 1.186 . . . . 1.0 110.7 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -86.01 -78.46 0.27 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 113.361 -1.745 . . . . 1.0 110.041 -175.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.2 t 179.26 0.01 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.474 1.91 . . . . 1.0 112.171 172.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -76.45 155.48 33.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 122.264 1.031 . . . . 1.0 113.443 -169.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -92.8 170.84 9.39 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.997 1.719 . . . . 1.0 112.018 -169.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -129.36 159.91 34.7 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.779 1.231 . . . . 1.0 112.342 172.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.0 t -122.62 126.09 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 125.981 1.712 . . . . 1.0 108.209 -176.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 52.4 -168.71 0.74 Allowed Glycine 0 CA--C 1.542 1.739 0 C-N-CA 125.642 1.591 . . . . 1.0 116.199 -176.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -92.37 146.76 23.44 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.163 1.385 . . . . 1.0 110.038 169.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.88 156.34 36.52 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.764 0.826 . . . . 1.0 111.456 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.628 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -92.52 138.54 31.42 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.937 0.895 . . . . 1.0 110.258 170.509 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.628 ' N ' HD13 ' A' ' 123' ' ' LEU . 7.3 mt -121.71 104.46 9.61 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.764 1.226 . . . . 1.0 111.265 173.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.68 131.49 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 C-N-CA 125.034 1.334 . . . . 1.0 112.049 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -107.54 106.29 16.59 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.175 0.988 . . . . 1.0 112.925 172.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -69.24 -22.86 63.83 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.565 0.95 . . . . 1.0 113.565 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.9 t -63.8 -22.52 66.95 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.389 1.076 . . . . 1.0 112.512 173.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -116.13 -30.2 6.06 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.279 1.831 . . . . 1.0 111.884 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -145.6 91.52 5.7 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 124.909 1.283 . . . . 1.0 112.601 -173.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.4 2.54 7.19 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 123.363 2.709 . . . . 1.0 114.383 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -109.82 72.35 0.61 Allowed Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 129.152 2.981 . . . . 1.0 110.444 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -60.5 -12.53 21.15 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.622 2.881 . . . . 1.0 116.723 -169.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -67.0 -28.19 68.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.803 0.729 . . . . 1.0 111.541 172.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 44.3 p -68.91 -26.21 64.98 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.117 -0.99 . . . . 1.0 111.935 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -93.78 -53.1 4.15 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.849 1.26 . . . . 1.0 111.818 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.7 t -72.42 -32.26 66.19 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.503 1.297 . . . . 1.0 114.503 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -61.17 -55.4 44.36 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 121.243 1.838 . . . . 1.0 112.731 -177.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -62.99 -22.65 73.92 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 121.567 1.595 . . . . 1.0 112.676 175.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.484 ' HB2' HD23 ' A' ' 123' ' ' LEU . 92.0 t90 -68.53 -48.62 63.87 Favored 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.345 0.658 . . . . 1.0 110.602 174.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 22' ' ' ALA . 83.9 t -65.43 -32.06 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 122.002 0.906 . . . . 1.0 109.042 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.96 -23.22 61.4 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 119.991 -1.693 . . . . 1.0 113.336 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -86.79 -61.98 1.61 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.978 2.111 . . . . 1.0 111.403 169.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.487 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 83.9 t90 -54.98 -38.2 67.49 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 126.844 2.058 . . . . 1.0 112.823 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.2 -28.71 27.37 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 118.913 0.778 . . . . 1.0 114.513 173.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.5 p -69.93 -12.78 61.87 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.808 1.304 . . . . 1.0 114.043 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.03 -18.98 48.75 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.91 1.684 . . . . 1.0 111.615 176.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.88 171.99 11.08 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.991 1.316 . . . . 1.0 111.194 -177.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 C--O 1.255 1.35 0 C-N-CA 125.252 1.421 . . . . 1.0 114.743 -171.92 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 117.717 2.488 . . . . 1.0 117.717 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -122.23 126.95 49.31 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.582 1.953 . . . . 1.0 109.726 173.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.563 HD13 HD12 ' A' ' 26' ' ' LEU . 2.1 mp -123.91 114.25 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 C-N-CA 127.078 2.151 . . . . 1.0 112.213 179.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.71 124.44 7.63 Favored Glycine 0 C--O 1.224 -0.512 0 N-CA-C 110.315 -1.114 . . . . 1.0 110.315 169.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.0 mt -104.43 118.97 52.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 118.283 1.042 . . . . 1.0 109.618 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -111.51 108.79 18.43 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.941 -1.503 . . . . 1.0 106.941 -170.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 N--CA 1.465 0.276 0 O-C-N 123.235 0.334 . . . . 1.0 111.375 -176.221 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.5 tp . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 112.644 0.609 . . . . 1.0 112.644 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.5 t -52.63 -33.14 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.17 0.988 . . . . 1.0 112.184 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.19 -48.69 80.37 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 120.0 1.273 . . . . 1.0 113.208 173.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -65.79 -33.11 75.09 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.577 0.751 . . . . 1.0 110.682 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -66.46 -47.79 72.0 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 123.934 0.893 . . . . 1.0 109.406 173.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.544 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -63.78 -43.07 97.45 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 112.584 0.587 . . . . 1.0 112.584 -176.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.11 -49.01 72.82 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.951 0.5 . . . . 1.0 110.029 170.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.42 -38.07 74.53 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.776 0.658 . . . . 1.0 112.776 -173.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.9 mt -65.88 -47.5 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 174.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.563 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -67.14 -34.32 77.33 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 119.651 -0.82 . . . . 1.0 110.573 -175.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.0 m -62.76 -41.63 99.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.691 1.597 . . . . 1.0 113.52 170.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.5 -32.81 73.88 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.825 0.85 . . . . 1.0 112.308 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -71.49 -29.32 64.68 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.638 1.175 . . . . 1.0 113.447 171.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.53 26.83 2.3 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.393 0.996 . . . . 1.0 114.086 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -116.35 146.56 42.36 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.381 1.072 . . . . 1.0 109.769 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -79.99 89.41 5.34 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 125.088 1.355 . . . . 1.0 108.448 -175.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.52 146.61 30.4 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 122.552 0.341 . . . . 1.0 110.737 -178.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.7 m -149.29 146.76 27.71 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.011 0.924 . . . . 1.0 111.399 -172.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.3 t -97.51 139.27 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 114.794 1.405 . . . . 1.0 114.794 176.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -122.61 113.66 19.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.974 2.11 . . . . 1.0 109.966 169.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -98.88 138.11 36.48 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.746 1.618 . . . . 1.0 111.188 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 43.24 55.45 11.31 Favored Pre-proline 0 CA--C 1.564 1.496 0 C-N-CA 124.518 1.127 . . . . 1.0 111.475 -169.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.52 152.09 59.61 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 125.167 3.911 . . . . 1.0 119.198 -167.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -93.84 155.47 17.17 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.216 2.206 . . . . 1.0 113.008 168.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.502 HD22 ' HB3' ' A' ' 44' ' ' TRP . 2.4 tm? -69.46 -23.22 63.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 120.827 -1.171 . . . . 1.0 109.983 168.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.6 m -65.93 -23.13 66.56 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.27 -0.894 . . . . 1.0 112.228 171.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -83.07 -24.68 32.61 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.242 1.017 . . . . 1.0 113.122 169.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.502 ' HB3' HD22 ' A' ' 41' ' ' LEU . 11.6 t-105 -82.27 -35.82 27.69 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.74 1.154 . . . . 1.0 113.786 177.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.4 mt -50.08 -38.62 38.33 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-O 117.567 -1.206 . . . . 1.0 114.098 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -52.92 -16.92 6.72 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 124.202 3.268 . . . . 1.0 117.319 171.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -109.24 9.88 25.84 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 115.486 1.662 . . . . 1.0 115.486 -175.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -52.6 -33.09 44.72 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 126.08 1.752 . . . . 1.0 113.708 177.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -105.01 1.69 28.88 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.555 1.542 . . . . 1.0 113.576 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -112.56 -164.05 0.89 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.62 2.368 . . . . 1.0 110.932 -175.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -109.04 164.98 11.94 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 122.982 1.373 . . . . 1.0 111.541 169.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.486 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -149.64 159.92 5.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 125.245 1.418 . . . . 1.0 109.164 -172.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.421 HD11 HD12 ' A' ' 90' ' ' ILE . 14.4 tp -138.73 129.95 27.01 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 124.792 1.237 . . . . 1.0 108.698 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.8 t -105.16 125.55 60.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 124.247 1.019 . . . . 1.0 108.964 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.59 114.45 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 107.484 -1.302 . . . . 1.0 107.484 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 113.797 1.036 . . . . 1.0 113.797 -169.199 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.8 tt . . . . . 0 N--CA 1.471 0.618 0 N-CA-C 112.78 0.659 . . . . 1.0 112.78 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.4 t -46.24 -50.56 37.86 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 125.18 1.392 . . . . 1.0 112.298 167.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.6 -28.19 31.75 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.688 1.592 . . . . 1.0 111.609 -173.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 tp -70.46 -51.66 27.63 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 123.673 0.789 . . . . 1.0 110.722 169.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.612 ' CE1' HD23 ' A' ' 110' ' ' LEU . 89.8 t80 -55.4 -55.38 32.28 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.234 1.014 . . . . 1.0 112.493 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -68.05 -35.36 78.1 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.44 0.696 . . . . 1.0 111.832 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.13 -35.91 92.58 Favored Glycine 0 CA--C 1.529 0.91 0 O-C-N 121.662 -0.649 . . . . 1.0 112.359 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.607 HG22 HD12 ' A' ' 110' ' ' LEU . 88.8 mt -65.88 -51.57 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 119.871 1.835 . . . . 1.0 107.901 170.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.671 ' HB3' HD21 ' A' ' 110' ' ' LEU . 1.8 ptmm? -68.28 -30.52 69.55 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 120.165 -1.585 . . . . 1.0 113.715 -169.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -107.61 -37.45 6.17 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.995 1.718 . . . . 1.0 115.217 -176.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.5 m -94.1 -21.0 19.39 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.985 0.914 . . . . 1.0 113.197 -176.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.495 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -92.38 -71.49 0.64 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 106.523 -1.658 . . . . 1.0 106.523 169.15 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.94 -19.33 1.0 Allowed Glycine 0 CA--C 1.535 1.314 0 C-N-CA 127.945 2.688 . . . . 1.0 115.38 169.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -152.19 139.31 19.23 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 128.185 2.594 . . . . 1.0 107.885 169.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.451 HE21 HD12 ' A' ' 79' ' ' LEU . 12.8 mt-30 -137.86 121.8 11.75 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 118.829 -0.605 . . . . 1.0 109.838 -170.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -81.61 -35.99 0.37 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.713 2.275 . . . . 1.0 115.496 -169.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -142.91 15.84 1.93 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.18 1.178 . . . . 1.0 114.18 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.486 HD11 ' CG2' ' A' ' 52' ' ' VAL . 67.2 tp -81.74 140.1 34.48 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.716 -1.24 . . . . 1.0 112.881 -169.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.5 mtm-85 -136.51 154.68 50.66 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.694 2.397 . . . . 1.0 109.311 169.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.665 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -160.18 170.29 21.48 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.286 0.948 . . . . 1.0 111.87 -177.714 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -129.25 171.45 20.01 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 124.744 1.164 . . . . 1.0 113.393 170.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 122' ' ' MET . 0.0 OUTLIER -140.88 138.41 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.134 0.973 . . . . 1.0 113.521 -169.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.942 HG23 HD12 ' A' ' 123' ' ' LEU . 7.1 mt -130.81 96.52 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.631 1.572 . . . . 1.0 107.096 169.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.92 145.61 25.42 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.494 1.518 . . . . 1.0 111.066 172.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.4 mp -140.71 157.32 45.61 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 121.611 -0.681 . . . . 1.0 112.17 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.68 0 CA-C-O 121.976 0.764 . . . . 1.0 114.715 169.342 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 15.5 m . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 113.2 0.815 . . . . 1.0 113.2 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -54.12 -30.34 48.4 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.013 1.725 . . . . 1.0 114.722 -174.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.88 -41.55 94.23 Favored Glycine 0 N--CA 1.473 1.132 0 CA-C-N 121.477 1.944 . . . . 1.0 113.32 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.07 -37.73 28.16 Favored Glycine 0 N--CA 1.476 1.304 0 CA-C-N 118.258 1.029 . . . . 1.0 113.326 173.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -58.66 -35.14 72.07 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.647 1.223 . . . . 1.0 113.167 173.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -68.29 -33.48 74.42 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.244 0.618 . . . . 1.0 112.14 172.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -63.69 -37.13 86.19 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.759 1.163 . . . . 1.0 110.963 172.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.1 -48.14 79.85 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.98 0.912 . . . . 1.0 112.139 174.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.98 -35.15 70.78 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.816 0.672 . . . . 1.0 112.816 173.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.671 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -57.82 -50.12 74.36 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 123.525 1.631 . . . . 1.0 110.906 -176.079 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.665 HD12 ' CD1' ' A' ' 87' ' ' TYR . 6.3 mt -66.34 -40.52 89.88 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 120.762 -1.211 . . . . 1.0 111.262 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -70.73 -16.91 62.81 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.241 0.83 . . . . 1.0 113.241 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.81 -20.4 53.27 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.579 1.081 . . . . 1.0 110.798 175.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -97.79 -79.37 0.47 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.377 1.471 . . . . 1.0 110.28 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.0 t -175.27 -3.28 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.79 1.636 . . . . 1.0 112.573 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.466 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -79.83 151.95 29.98 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 122.962 1.363 . . . . 1.0 113.596 -169.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -88.44 168.2 12.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.049 1.74 . . . . 1.0 113.799 -168.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -119.4 148.04 43.67 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.779 2.031 . . . . 1.0 110.922 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.3 t -120.71 128.31 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.149 1.38 . . . . 1.0 108.798 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 50.06 -158.13 1.68 Allowed Glycine 0 N--CA 1.48 1.609 0 C-N-CA 125.087 1.327 . . . . 1.0 114.569 -172.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -110.91 142.49 42.92 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.088 1.355 . . . . 1.0 109.277 169.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.425 ' HB3' HG23 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -75.36 157.84 33.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.184 0.994 . . . . 1.0 113.049 -169.386 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.942 HD12 HG23 ' A' ' 90' ' ' ILE . 1.4 tm? -90.69 137.11 32.62 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.918 1.287 . . . . 1.0 110.27 173.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.9 mt -127.84 109.35 11.53 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.624 1.57 . . . . 1.0 109.98 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.568 HG13 HD11 ' A' ' 123' ' ' LEU . 28.4 mt -98.25 134.24 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.11 0.964 . . . . 1.0 113.014 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -100.18 91.86 4.95 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.919 2.488 . . . . 1.0 112.71 174.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.82 -23.28 66.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.209 1.004 . . . . 1.0 112.733 -174.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.9 p -54.1 -30.88 50.22 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 129.373 3.069 . . . . 1.0 114.158 169.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -121.28 -26.19 5.09 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.586 1.954 . . . . 1.0 111.508 -171.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -140.32 89.26 10.86 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 125.184 1.393 . . . . 1.0 111.474 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -75.66 11.39 1.64 Allowed 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.842 3.028 . . . . 1.0 114.005 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -113.77 65.3 1.23 Allowed Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 127.358 2.263 . . . . 1.0 110.072 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -55.72 -22.37 36.21 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.561 2.174 . . . . 1.0 116.176 -169.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.7 pm0 -64.49 -25.01 67.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 119.553 1.069 . . . . 1.0 111.817 175.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.5 p -72.82 -17.14 61.59 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 120.628 -1.295 . . . . 1.0 112.372 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.404 ' HB2' HD11 ' A' ' 125' ' ' ILE . 65.3 mm-40 -102.54 -55.79 2.38 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.258 1.823 . . . . 1.0 111.957 176.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 63.6 p -68.73 -33.31 73.71 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 113.817 1.043 . . . . 1.0 113.817 -176.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 36.5 m-20 -60.11 -59.23 14.53 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 120.688 1.585 . . . . 1.0 112.399 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -62.33 -22.32 73.93 Favored 'Trans proline' 0 C--N 1.352 0.713 0 CA-C-N 121.377 1.527 . . . . 1.0 112.943 175.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.459 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 87.2 t90 -68.71 -46.07 69.93 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 118.776 0.716 . . . . 1.0 111.2 172.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' A' ' 22' ' ' ALA . 92.2 t -63.84 -34.62 69.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 175.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.07 -30.83 70.12 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.299 1.44 . . . . 1.0 112.071 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -78.01 -61.87 1.86 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.113 1.765 . . . . 1.0 112.355 170.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -56.04 -36.43 68.0 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 126.046 1.738 . . . . 1.0 112.694 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.88 -32.32 26.11 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.393 0.997 . . . . 1.0 113.958 173.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.5 p -67.91 -13.8 62.45 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.073 1.138 . . . . 1.0 114.073 177.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.42 -17.71 50.99 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.002 1.721 . . . . 1.0 111.899 176.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.06 176.24 7.71 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.356 1.462 . . . . 1.0 110.911 -177.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 C--O 1.25 1.081 0 N-CA-C 114.803 1.408 . . . . 1.0 114.803 -170.077 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 113.049 0.759 . . . . 1.0 113.049 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -124.78 121.25 34.08 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.404 1.082 . . . . 1.0 111.178 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.506 HD13 HD12 ' A' ' 26' ' ' LEU . 2.1 mp -118.91 116.25 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 126.579 1.952 . . . . 1.0 112.803 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.04 127.42 9.06 Favored Glycine 0 C--O 1.221 -0.668 0 N-CA-C 111.159 -0.776 . . . . 1.0 111.159 169.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.3 mt -106.36 120.17 56.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 118.682 1.241 . . . . 1.0 109.979 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -111.44 107.63 16.91 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 125.332 1.453 . . . . 1.0 107.598 -169.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.469 0.51 0 CA-C-O 121.32 0.581 . . . . 1.0 112.013 -171.94 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.1 tp . . . . . 0 N--CA 1.467 0.415 0 N-CA-C 112.864 0.69 . . . . 1.0 112.864 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -53.03 -33.07 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.857 0.863 . . . . 1.0 111.995 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.71 -47.15 86.57 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 120.002 1.274 . . . . 1.0 112.72 174.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -65.94 -33.54 76.06 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.835 0.854 . . . . 1.0 110.839 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -66.1 -48.22 71.61 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 123.361 0.664 . . . . 1.0 109.234 173.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.626 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -64.07 -41.83 97.21 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 112.857 0.688 . . . . 1.0 112.857 -175.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.44 -51.14 65.91 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 169.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.08 -37.54 81.35 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.572 -0.705 . . . . 1.0 112.808 -174.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.4 mt -68.27 -46.78 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 119.371 0.987 . . . . 1.0 109.572 176.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.506 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.66 -36.3 83.28 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.565 0.697 . . . . 1.0 110.633 -177.245 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.3 m -61.04 -43.75 98.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.989 0.916 . . . . 1.0 112.908 170.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.45 -29.58 67.31 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.505 1.122 . . . . 1.0 113.548 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -67.35 -30.07 69.79 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.334 1.054 . . . . 1.0 111.891 170.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.02 15.77 1.85 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.455 1.026 . . . . 1.0 115.28 169.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -102.54 -179.08 3.87 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.851 1.26 . . . . 1.0 109.977 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -108.15 98.66 8.19 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 124.982 1.313 . . . . 1.0 108.054 169.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -110.08 148.14 32.28 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 122.785 0.434 . . . . 1.0 111.231 176.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.2 m -146.28 147.0 30.93 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.673 1.189 . . . . 1.0 111.173 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.1 t -96.73 138.24 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 114.245 1.202 . . . . 1.0 114.245 174.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -117.73 112.29 20.26 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.671 1.988 . . . . 1.0 110.576 169.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -93.92 138.51 31.97 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.086 1.754 . . . . 1.0 111.1 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 42.65 55.31 10.34 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 124.789 1.236 . . . . 1.0 110.999 -169.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -68.21 146.02 68.4 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.72 2.947 . . . . 1.0 117.632 -168.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -89.68 155.7 19.05 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.091 1.757 . . . . 1.0 112.523 168.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.528 HD21 HD21 ' A' ' 79' ' ' LEU . 2.2 tm? -69.09 -21.35 64.06 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 120.574 -1.329 . . . . 1.0 109.525 168.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 m -67.24 -21.57 65.73 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.168 -0.957 . . . . 1.0 112.357 170.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -82.88 -27.28 30.82 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.01 0.924 . . . . 1.0 112.5 169.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.474 ' HB3' HD22 ' A' ' 41' ' ' LEU . 12.4 t-105 -82.06 -36.51 27.61 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.488 1.04 . . . . 1.0 113.686 178.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.9 mt -48.07 -40.44 34.4 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-O 117.708 -1.139 . . . . 1.0 113.668 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -52.45 -16.83 5.69 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 124.373 3.382 . . . . 1.0 117.532 172.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -110.22 8.09 23.5 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 116.195 1.924 . . . . 1.0 116.195 -172.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -51.3 -26.73 7.91 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 127.156 2.183 . . . . 1.0 114.336 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -121.63 15.98 11.13 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.897 1.679 . . . . 1.0 113.485 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -128.62 -154.23 0.62 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 128.163 2.585 . . . . 1.0 109.747 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -122.07 164.05 18.38 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 123.161 1.458 . . . . 1.0 112.371 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.408 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -151.93 164.55 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 124.846 1.258 . . . . 1.0 109.434 -172.375 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.428 HD11 HD12 ' A' ' 90' ' ' ILE . 14.6 tp -144.39 128.6 17.73 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 125.1 1.36 . . . . 1.0 108.53 176.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.2 t -102.13 124.81 56.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 124.518 1.127 . . . . 1.0 109.328 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.2 110.85 25.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 106.043 -1.836 . . . . 1.0 106.043 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.485 1.306 0 C-N-CA 123.398 0.679 . . . . 1.0 111.732 -168.907 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.4 tt . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 113.657 0.984 . . . . 1.0 113.657 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.7 t -47.32 -51.19 44.38 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 125.629 1.571 . . . . 1.0 112.204 168.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.48 -31.74 16.78 Favored 'Trans proline' 0 C--N 1.352 0.737 0 CA-C-N 120.57 1.239 . . . . 1.0 111.277 -173.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.7 tp -63.03 -49.78 73.25 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 124.719 1.208 . . . . 1.0 111.331 169.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.64 ' CE1' HD23 ' A' ' 110' ' ' LEU . 92.0 t80 -54.53 -54.41 41.54 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.761 1.224 . . . . 1.0 112.679 178.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -64.08 -38.76 92.24 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.689 0.796 . . . . 1.0 111.242 177.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.45 -36.67 91.86 Favored Glycine 0 CA--C 1.528 0.87 0 O-C-N 121.69 -0.631 . . . . 1.0 112.69 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.553 HG22 HD12 ' A' ' 110' ' ' LEU . 92.9 mt -65.06 -49.5 79.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 120.008 -1.877 . . . . 1.0 108.291 172.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.671 ' HB3' HD21 ' A' ' 110' ' ' LEU . 10.9 ptmt -69.93 -31.6 69.45 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.464 -1.398 . . . . 1.0 113.529 -171.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -106.77 -37.43 6.4 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.692 1.597 . . . . 1.0 114.963 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.6 m -92.75 -23.07 19.02 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.295 1.038 . . . . 1.0 112.661 -177.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.528 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -94.22 -71.85 0.64 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 106.934 -1.506 . . . . 1.0 106.934 169.368 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.61 -9.47 2.58 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 126.73 2.11 . . . . 1.0 115.622 170.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -153.96 147.1 24.64 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 128.734 2.814 . . . . 1.0 107.788 169.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.4 ' HG3' ' HB2' ' A' ' 116' ' ' ALA . 39.7 mm-40 -136.76 125.17 14.97 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 123.261 0.625 . . . . 1.0 110.8 -174.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -83.05 -40.76 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.458 2.106 . . . . 1.0 114.097 -174.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -146.9 18.95 1.27 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.628 1.171 . . . . 1.0 113.846 -169.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.408 HD11 ' CG2' ' A' ' 52' ' ' VAL . 62.2 tp -80.95 140.0 35.5 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.606 -1.309 . . . . 1.0 112.782 -169.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 -135.26 154.6 51.51 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.624 2.369 . . . . 1.0 109.158 169.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.678 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -162.03 167.15 24.88 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.91 0.777 . . . . 1.0 112.195 -179.602 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.456 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -122.56 172.82 15.87 Favored Glycine 0 N--CA 1.473 1.139 0 C-N-CA 125.702 1.62 . . . . 1.0 114.096 173.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.4 t -146.7 133.79 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 114.421 1.267 . . . . 1.0 114.421 -169.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.428 HD12 HD11 ' A' ' 53' ' ' LEU . 4.3 mt -131.4 110.37 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 106.97 -1.493 . . . . 1.0 106.97 168.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.91 145.01 24.93 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.741 1.216 . . . . 1.0 110.711 170.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.09 150.57 43.07 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.317 0.647 . . . . 1.0 111.571 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.631 0 CA-C-O 122.077 0.821 . . . . 1.0 114.67 169.485 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 113.489 0.922 . . . . 1.0 113.489 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -55.55 -29.53 59.14 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.896 1.278 . . . . 1.0 114.407 -174.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.01 -43.3 95.11 Favored Glycine 0 N--CA 1.476 1.349 0 CA-C-N 121.115 1.78 . . . . 1.0 114.444 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.49 -37.04 36.73 Favored Glycine 0 N--CA 1.478 1.449 0 O-C-N 121.082 -1.246 . . . . 1.0 112.772 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -60.37 -38.31 83.46 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.322 1.049 . . . . 1.0 113.111 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -59.51 -42.87 93.19 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.259 1.024 . . . . 1.0 111.951 170.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.28 -38.18 90.16 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.638 0.654 . . . . 1.0 110.889 176.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -37.59 88.06 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.746 0.819 . . . . 1.0 112.698 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.71 93.52 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.819 -0.61 . . . . 1.0 112.213 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.671 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -50.7 -48.25 58.74 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.115 2.166 . . . . 1.0 111.885 -171.583 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.678 HD12 ' CD1' ' A' ' 87' ' ' TYR . 6.6 mt -66.48 -42.39 87.55 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.41 -0.814 . . . . 1.0 111.516 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -67.44 -21.43 65.55 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.887 1.069 . . . . 1.0 113.887 175.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -67.09 -33.88 76.44 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.279 1.032 . . . . 1.0 111.331 174.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -85.15 -73.99 0.42 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 114.129 -1.396 . . . . 1.0 110.709 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.418 ' H ' ' H ' ' A' ' 116' ' ' ALA . 3.4 m 174.97 -0.72 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.953 2.501 . . . . 1.0 112.001 174.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -77.61 152.14 34.04 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-O 122.222 1.01 . . . . 1.0 113.599 -169.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -86.03 161.48 18.93 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.404 1.482 . . . . 1.0 112.876 -169.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.68 127.01 37.99 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.143 1.777 . . . . 1.0 108.99 -173.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.7 t -106.78 129.85 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.635 0.774 . . . . 1.0 110.45 -169.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 51.64 -154.68 4.42 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.768 1.175 . . . . 1.0 113.544 -171.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -115.85 147.24 41.26 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.73 1.612 . . . . 1.0 109.142 169.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -73.78 157.35 36.59 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.05 -1.031 . . . . 1.0 112.231 -169.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.632 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -90.39 138.06 31.85 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.857 0.863 . . . . 1.0 110.442 171.306 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.632 ' N ' HD13 ' A' ' 123' ' ' LEU . 8.8 mt -122.65 108.03 12.63 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.089 1.356 . . . . 1.0 111.316 175.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.452 HG13 ' CD1' ' A' ' 123' ' ' LEU . 4.1 mt -95.84 133.74 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 125.227 1.411 . . . . 1.0 112.944 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -107.67 89.31 2.96 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.689 2.796 . . . . 1.0 113.097 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.72 -24.66 67.64 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.814 -1.179 . . . . 1.0 113.162 -173.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.2 m -62.79 -16.26 57.3 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.947 2.099 . . . . 1.0 113.776 172.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -131.38 -28.26 1.9 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.872 2.069 . . . . 1.0 112.658 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -139.01 88.54 13.29 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 126.251 1.821 . . . . 1.0 110.917 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -75.59 11.03 1.71 Allowed 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 123.67 2.913 . . . . 1.0 114.05 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -112.79 68.36 1.04 Allowed Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 127.578 2.351 . . . . 1.0 110.127 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -58.09 -20.03 43.95 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.942 2.428 . . . . 1.0 116.87 -169.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -66.55 -26.53 67.17 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.559 -0.713 . . . . 1.0 112.011 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 26.9 p -71.77 -21.59 61.71 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 120.971 -1.081 . . . . 1.0 111.762 -175.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -95.51 -55.53 3.0 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.124 1.77 . . . . 1.0 112.009 176.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.5 t -71.06 -32.0 68.57 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.809 1.04 . . . . 1.0 113.809 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -62.1 -53.19 61.47 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 120.9 1.682 . . . . 1.0 113.286 -177.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -63.49 -24.79 70.4 Favored 'Trans proline' 0 C--N 1.353 0.787 0 CA-C-N 121.157 1.449 . . . . 1.0 112.36 173.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.432 ' HB2' HD23 ' A' ' 123' ' ' LEU . 91.8 t90 -67.77 -47.98 67.67 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 118.858 0.753 . . . . 1.0 110.764 175.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.626 HG11 ' HA ' ' A' ' 22' ' ' ALA . 93.8 t -65.4 -32.61 59.0 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.71 -52.13 61.89 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.062 -1.024 . . . . 1.0 109.749 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -64.55 -50.82 65.8 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.882 0.873 . . . . 1.0 111.855 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.456 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 85.6 t90 -59.05 -35.66 73.69 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 125.269 1.428 . . . . 1.0 111.737 175.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.23 -34.39 40.31 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.932 1.254 . . . . 1.0 113.247 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.0 p -68.12 -13.04 61.91 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 114.884 1.439 . . . . 1.0 114.884 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.74 -13.32 54.24 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.525 1.53 . . . . 1.0 112.542 176.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -74.41 169.54 17.49 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.556 1.071 . . . . 1.0 112.005 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.0 t . . . . . 0 C--O 1.257 1.489 0 C-N-CA 125.916 1.686 . . . . 1.0 112.605 -169.458 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 113.495 0.924 . . . . 1.0 113.495 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -117.02 125.38 51.26 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.063 1.345 . . . . 1.0 110.461 173.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.486 HD13 HD12 ' A' ' 26' ' ' LEU . 2.0 mp -122.91 115.26 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.063 0 C-N-CA 126.262 1.825 . . . . 1.0 112.351 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.49 125.55 8.26 Favored Glycine 0 N--CA 1.462 0.41 0 N-CA-C 110.432 -1.067 . . . . 1.0 110.432 169.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 mt -104.86 121.05 56.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 117.875 0.838 . . . . 1.0 109.071 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -113.66 115.22 27.54 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 124.648 1.179 . . . . 1.0 108.548 -169.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.535 0.373 0 N-CA-C 112.537 0.569 . . . . 1.0 112.537 -172.869 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.8 tp . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 113.975 1.102 . . . . 1.0 113.975 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.9 t -49.48 -34.26 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 127.077 2.151 . . . . 1.0 112.427 -176.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.01 -47.63 85.55 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.852 1.205 . . . . 1.0 112.978 174.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -67.59 -31.84 72.16 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.744 0.818 . . . . 1.0 110.605 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.77 -49.86 64.57 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 123.785 0.834 . . . . 1.0 109.06 173.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.648 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -62.3 -42.74 99.62 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 123.633 0.773 . . . . 1.0 112.509 -176.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.15 -51.37 66.69 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 170.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.04 -36.57 80.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.521 -0.737 . . . . 1.0 112.868 -174.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.2 mt -68.62 -47.34 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 119.345 0.975 . . . . 1.0 109.511 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.486 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -64.97 -36.89 85.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.856 0.836 . . . . 1.0 110.657 -177.721 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.0 m -61.38 -42.02 98.04 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 121.201 -0.937 . . . . 1.0 113.022 170.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.34 -29.57 66.3 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.604 1.162 . . . . 1.0 113.392 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -66.69 -30.67 70.98 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.582 1.153 . . . . 1.0 111.388 170.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.57 11.05 1.75 Allowed Glycine 0 CA--C 1.53 0.988 0 N-CA-C 115.498 0.959 . . . . 1.0 115.498 169.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 -101.21 -177.09 3.34 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.829 1.252 . . . . 1.0 110.898 -174.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -109.71 97.15 6.75 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.973 1.309 . . . . 1.0 108.266 169.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.37 150.12 27.08 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.492 0.317 . . . . 1.0 111.262 176.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.6 m -145.16 147.79 32.86 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.784 1.234 . . . . 1.0 111.509 -175.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.3 t -98.09 138.83 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 114.899 1.444 . . . . 1.0 114.899 174.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -117.66 110.71 18.21 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.742 1.617 . . . . 1.0 110.748 169.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -90.06 144.2 26.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.787 1.635 . . . . 1.0 110.848 170.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 40.29 55.08 6.84 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 125.019 1.328 . . . . 1.0 112.51 -169.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.24 142.2 49.57 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.813 3.009 . . . . 1.0 117.179 -168.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -97.49 163.24 12.94 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 122.71 1.243 . . . . 1.0 112.783 168.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.607 HD21 HD21 ' A' ' 79' ' ' LEU . 2.3 tm? -67.28 -23.82 65.71 Favored 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 121.004 -1.06 . . . . 1.0 110.461 167.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 62.9 p -68.39 -18.65 64.51 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.941 -1.1 . . . . 1.0 112.337 172.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -82.49 -24.85 33.96 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.896 0.878 . . . . 1.0 112.178 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.485 ' HB3' HD22 ' A' ' 41' ' ' LEU . 14.6 t-105 -87.52 -36.52 17.56 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.399 1.259 . . . . 1.0 114.399 -178.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.7 mt -46.7 -37.89 10.25 Favored Pre-proline 0 CA--C 1.553 1.069 0 N-CA-C 114.413 1.264 . . . . 1.0 114.413 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -61.11 -14.36 33.07 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 123.745 2.964 . . . . 1.0 116.695 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -107.87 8.4 28.59 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 115.745 1.757 . . . . 1.0 115.745 -173.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -54.85 -27.82 45.21 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.631 1.972 . . . . 1.0 113.874 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -107.67 3.02 24.25 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.562 1.545 . . . . 1.0 113.41 176.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -114.93 -163.34 0.87 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.915 2.486 . . . . 1.0 110.836 -174.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -106.81 162.84 13.45 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 123.387 1.565 . . . . 1.0 110.936 169.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.596 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -148.63 151.66 13.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.253 -1.34 . . . . 1.0 108.056 -173.426 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.1 tp -133.62 130.27 38.07 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 124.471 1.108 . . . . 1.0 108.667 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.4 t -105.11 126.79 60.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.263 -0.643 . . . . 1.0 109.263 174.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.4 t -122.97 111.38 29.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.963 -1.866 . . . . 1.0 105.963 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 114.496 1.295 . . . . 1.0 114.496 -167.916 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.5 tt . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 113.283 0.846 . . . . 1.0 113.283 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.1 t -44.91 -53.31 16.22 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.422 1.089 . . . . 1.0 112.323 168.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.17 -31.87 28.49 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.647 1.565 . . . . 1.0 111.702 -173.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.2 tp -63.1 -52.15 63.77 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.146 0.978 . . . . 1.0 111.257 169.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.725 ' CE1' HD23 ' A' ' 110' ' ' LEU . 89.7 t80 -56.02 -53.41 57.27 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.927 0.891 . . . . 1.0 112.385 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -63.88 -39.91 95.3 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.814 0.846 . . . . 1.0 111.544 177.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.76 -36.86 91.83 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 123.47 0.557 . . . . 1.0 112.589 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.621 HG22 HD12 ' A' ' 110' ' ' LEU . 82.5 mt -65.19 -47.74 86.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 120.024 1.912 . . . . 1.0 108.412 172.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.754 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.2 ptmm? -71.63 -31.27 66.68 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.224 -1.547 . . . . 1.0 113.289 -171.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -104.42 -38.71 6.71 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 115.519 1.674 . . . . 1.0 115.519 -175.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.1 m -95.09 -22.43 17.9 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.639 1.176 . . . . 1.0 113.326 -174.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.607 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -91.23 -71.71 0.62 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 106.93 -1.507 . . . . 1.0 106.93 170.037 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.53 -16.86 0.91 Allowed Glycine 0 CA--C 1.538 1.488 0 C-N-CA 127.562 2.506 . . . . 1.0 116.804 169.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -152.27 138.15 18.05 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.862 2.465 . . . . 1.0 108.227 174.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -133.72 124.12 17.65 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 119.086 0.857 . . . . 1.0 112.546 -172.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -82.65 -35.93 0.28 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.598 2.199 . . . . 1.0 114.726 -173.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -144.99 11.1 1.36 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.589 1.7 . . . . 1.0 115.589 -169.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.596 HD11 ' CG2' ' A' ' 52' ' ' VAL . 39.1 tp -75.06 142.05 43.78 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 120.27 -1.519 . . . . 1.0 113.004 -169.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -134.2 144.11 48.26 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 129.317 3.047 . . . . 1.0 107.493 169.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.661 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -154.38 164.25 38.92 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 120.046 1.294 . . . . 1.0 113.568 179.564 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.424 ' HA3' ' CE2' ' A' ' 144' ' ' TRP . . . -125.78 170.67 17.65 Favored Glycine 0 N--CA 1.468 0.8 0 C-N-CA 126.537 2.018 . . . . 1.0 112.248 172.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.586 HG13 ' HB3' ' A' ' 122' ' ' MET . 0.2 OUTLIER -160.25 146.6 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 O-C-N 120.836 -1.391 . . . . 1.0 114.442 -169.021 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.976 HG23 HD12 ' A' ' 123' ' ' LEU . 11.1 mt -138.4 98.69 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 127.92 2.488 . . . . 1.0 107.005 -172.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.09 147.88 23.99 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.408 1.483 . . . . 1.0 111.867 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.4 mp -140.48 152.31 45.52 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.297 0.639 . . . . 1.0 112.629 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.509 0 N-CA-C 115.097 0.799 . . . . 1.0 115.097 169.201 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.543 0.68 0 N-CA-C 113.317 0.858 . . . . 1.0 113.317 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -51.06 -28.49 10.51 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.548 1.539 . . . . 1.0 114.009 -177.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.71 -42.78 59.32 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-N 120.436 1.471 . . . . 1.0 113.895 175.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.52 -34.88 18.46 Favored Glycine 0 N--CA 1.478 1.491 0 CA-C-N 118.864 1.332 . . . . 1.0 113.806 174.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -59.48 -32.87 70.66 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 118.465 1.132 . . . . 1.0 112.974 174.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -61.67 -41.69 97.89 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.217 1.007 . . . . 1.0 111.997 170.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -65.28 -34.89 79.42 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.234 0.924 . . . . 1.0 111.671 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -60.61 -55.19 36.26 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.344 0.657 . . . . 1.0 110.95 172.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.64 -34.71 62.56 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.974 0.731 . . . . 1.0 112.974 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.754 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -56.66 -50.29 72.53 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 123.562 1.648 . . . . 1.0 111.692 -178.29 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.661 HD12 ' CD1' ' A' ' 87' ' ' TYR . 14.9 mt -68.1 -36.98 80.66 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 120.606 -1.309 . . . . 1.0 111.423 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -73.79 -11.96 60.55 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.7 1.0 . . . . 1.0 113.7 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.84 -17.28 41.47 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.758 1.163 . . . . 1.0 110.918 175.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -96.51 -84.03 0.37 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.42 1.488 . . . . 1.0 108.729 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.5 -8.75 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.898 1.679 . . . . 1.0 112.67 -169.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -81.06 162.5 23.73 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 122.156 0.979 . . . . 1.0 113.312 -168.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -106.33 163.55 12.74 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.376 1.071 . . . . 1.0 111.793 -169.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.12 138.93 53.29 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.824 1.65 . . . . 1.0 110.802 -178.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.58 HG12 ' H ' ' A' ' 120' ' ' GLY . 18.5 t -84.91 -162.51 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 125.577 1.551 . . . . 1.0 107.699 173.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.58 ' H ' HG12 ' A' ' 119' ' ' VAL . . . -48.44 152.73 2.32 Favored Glycine 0 N--CA 1.482 1.743 0 O-C-N 120.121 -1.612 . . . . 1.0 113.901 173.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -63.75 151.01 43.27 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 122.746 1.26 . . . . 1.0 112.768 -172.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.586 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -71.43 157.64 37.69 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.992 1.317 . . . . 1.0 113.091 -168.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.976 HD12 HG23 ' A' ' 90' ' ' ILE . 0.9 OUTLIER -87.21 140.34 29.65 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.749 1.22 . . . . 1.0 110.084 170.128 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.0 mt -127.51 110.65 12.95 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.129 1.372 . . . . 1.0 109.83 173.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.569 ' CD1' HD11 ' A' ' 123' ' ' LEU . 28.7 mt -99.31 130.66 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.361 1.064 . . . . 1.0 112.929 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -105.55 98.34 8.05 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.648 2.379 . . . . 1.0 113.495 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.28 -22.42 66.84 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.819 1.044 . . . . 1.0 113.819 -175.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.6 t -58.85 -27.06 64.78 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.8 1.24 . . . . 1.0 112.845 171.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -120.34 -30.35 4.61 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.17 1.788 . . . . 1.0 112.303 -169.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -143.42 96.31 5.78 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.111 0.965 . . . . 1.0 112.938 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.42 7.13 4.64 Favored 'Trans proline' 0 CA--C 1.551 1.325 0 C-N-CA 123.877 3.051 . . . . 1.0 114.719 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -110.54 73.15 0.78 Allowed Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 126.539 1.936 . . . . 1.0 109.819 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -59.05 -26.87 83.31 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.753 2.302 . . . . 1.0 115.93 -169.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.7 pm0 -62.66 -25.92 68.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 119.45 1.023 . . . . 1.0 111.213 176.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.6 p -72.15 -15.88 61.98 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 120.974 -1.079 . . . . 1.0 112.788 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -104.18 -55.31 2.38 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.213 1.805 . . . . 1.0 111.894 177.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.5 p -67.95 -33.01 73.85 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 114.02 1.119 . . . . 1.0 114.02 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.8 m-20 -60.94 -56.63 33.13 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 121.035 1.743 . . . . 1.0 112.99 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -62.93 -23.49 74.17 Favored 'Trans proline' 0 C--N 1.353 0.803 0 CA-C-N 121.279 1.492 . . . . 1.0 112.933 174.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.466 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 88.9 t90 -67.53 -46.13 73.69 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 118.561 0.619 . . . . 1.0 110.739 172.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.648 HG11 ' HA ' ' A' ' 22' ' ' ALA . 96.6 t -66.19 -34.69 71.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -62.87 -49.87 73.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.212 -0.93 . . . . 1.0 109.588 174.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -63.15 -54.42 38.03 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.602 1.161 . . . . 1.0 111.752 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.424 ' CE2' ' HA3' ' A' ' 88' ' ' GLY . 87.7 t90 -59.16 -34.43 72.08 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 125.13 1.372 . . . . 1.0 112.05 175.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.4 -33.02 38.92 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.9 1.238 . . . . 1.0 113.272 173.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.6 p -69.27 -11.95 61.25 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.839 1.422 . . . . 1.0 114.839 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.06 -15.34 47.83 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.539 1.536 . . . . 1.0 111.875 177.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -75.81 168.38 20.13 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 119.243 0.929 . . . . 1.0 111.733 -177.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.6 p . . . . . 0 C--O 1.254 1.315 0 C-N-CA 126.633 1.973 . . . . 1.0 114.545 -175.897 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 114.012 1.116 . . . . 1.0 114.012 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -122.64 121.48 36.53 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.486 1.515 . . . . 1.0 110.865 178.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.554 HD13 HD12 ' A' ' 26' ' ' LEU . 2.1 mp -119.15 113.67 42.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 126.396 1.878 . . . . 1.0 112.444 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.59 124.0 7.18 Favored Glycine 0 C--O 1.223 -0.594 0 N-CA-C 110.89 -0.884 . . . . 1.0 110.89 169.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.8 mt -105.83 122.93 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-N 118.78 1.29 . . . . 1.0 110.131 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -114.82 111.5 21.33 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 -169.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.466 0.343 0 CA-C-O 121.428 0.632 . . . . 1.0 111.759 -170.274 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.6 tp . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 114.841 1.423 . . . . 1.0 114.841 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.0 t -46.8 -33.77 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.437 1.495 . . . . 1.0 112.547 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.06 -49.17 76.68 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.622 -1.299 . . . . 1.0 113.247 172.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -67.85 -29.68 68.87 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.732 1.213 . . . . 1.0 111.122 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -69.32 -47.34 64.73 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 123.91 0.884 . . . . 1.0 109.127 173.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.556 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.05 -42.43 94.25 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 112.3 0.481 . . . . 1.0 112.3 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -52.74 -49.98 64.37 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.945 0.898 . . . . 1.0 110.273 169.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.17 -38.04 72.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.255 0.622 . . . . 1.0 112.556 -174.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.5 mt -66.43 -48.64 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-N 119.041 0.837 . . . . 1.0 109.089 175.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.554 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -64.84 -35.72 82.02 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.927 0.87 . . . . 1.0 110.427 -176.088 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.2 m -61.98 -41.46 98.06 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.633 1.173 . . . . 1.0 113.504 170.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.92 -30.59 69.08 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.559 1.144 . . . . 1.0 112.665 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -69.95 -30.5 67.88 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.466 0.707 . . . . 1.0 112.091 171.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.01 16.73 1.92 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.987 0.803 . . . . 1.0 114.827 169.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -99.0 174.92 6.11 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.311 1.044 . . . . 1.0 110.123 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -103.73 91.2 3.9 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.918 1.287 . . . . 1.0 108.414 171.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.14 145.99 29.39 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.392 0.277 . . . . 1.0 110.98 176.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.1 m -146.74 137.65 24.02 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.901 0.88 . . . . 1.0 112.023 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.9 t -84.53 136.03 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 114.855 1.428 . . . . 1.0 114.855 170.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -113.13 109.54 18.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.905 2.082 . . . . 1.0 109.915 169.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -90.24 139.4 30.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.327 1.851 . . . . 1.0 110.932 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t0 43.26 53.56 9.6 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 124.387 1.075 . . . . 1.0 111.033 -169.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -68.74 141.7 50.39 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.718 2.945 . . . . 1.0 116.289 -168.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.462 ' HB3' ' H ' ' A' ' 42' ' ' SER . 56.1 mm-40 -93.57 162.01 14.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 122.373 1.082 . . . . 1.0 111.774 168.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.566 HD21 HD21 ' A' ' 79' ' ' LEU . 2.2 tm? -65.21 -20.76 66.59 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.02 -1.05 . . . . 1.0 109.838 167.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.462 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 15.1 m -68.28 -22.12 64.75 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 120.861 -1.15 . . . . 1.0 112.297 172.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -80.59 -27.9 37.25 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.964 0.906 . . . . 1.0 112.062 169.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.459 ' HB3' HD22 ' A' ' 41' ' ' LEU . 16.0 t-105 -85.21 -37.39 20.17 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.915 1.08 . . . . 1.0 113.915 -177.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.9 mt -42.94 -44.61 10.89 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 114.998 1.481 . . . . 1.0 114.998 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.92 -2.22 8.31 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.351 2.034 . . . . 1.0 115.575 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -108.29 8.66 27.84 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 115.793 1.775 . . . . 1.0 115.793 176.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -51.81 -27.73 13.34 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.786 2.034 . . . . 1.0 114.242 174.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.09 12.56 14.55 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.591 1.156 . . . . 1.0 112.494 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -127.51 -163.81 1.3 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.109 2.564 . . . . 1.0 111.346 -174.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -109.96 158.11 18.57 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 122.921 1.343 . . . . 1.0 112.955 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.401 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -147.44 161.99 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.121 1.368 . . . . 1.0 109.828 -173.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.0 tp -139.75 130.31 25.7 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.406 1.482 . . . . 1.0 108.227 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.3 t -104.71 123.8 58.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 124.403 1.081 . . . . 1.0 108.919 173.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.1 t -122.04 111.28 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.551 -2.018 . . . . 1.0 105.551 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 114.572 1.323 . . . . 1.0 114.572 -167.764 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.5 tt . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 114.134 1.161 . . . . 1.0 114.134 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.9 t -45.7 -53.61 19.23 Favored Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 124.484 1.114 . . . . 1.0 112.1 168.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -67.78 -31.17 32.68 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.665 1.577 . . . . 1.0 111.79 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.0 tp -63.15 -54.3 39.91 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 124.271 1.028 . . . . 1.0 111.32 169.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.616 ' CE1' HD23 ' A' ' 110' ' ' LEU . 93.6 t80 -55.23 -52.03 64.69 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.723 0.809 . . . . 1.0 112.464 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -65.11 -40.14 94.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.43 -0.805 . . . . 1.0 111.382 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.17 -33.59 78.8 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.488 -0.618 . . . . 1.0 112.837 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.636 HG22 HD12 ' A' ' 110' ' ' LEU . 93.4 mt -65.19 -47.75 86.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 120.115 1.958 . . . . 1.0 108.676 170.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.698 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.3 ptmm? -72.61 -31.54 65.24 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.347 -1.47 . . . . 1.0 113.232 -171.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -104.87 -39.85 6.15 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.719 1.608 . . . . 1.0 115.302 -174.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.0 m -92.89 -24.27 18.51 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.125 0.97 . . . . 1.0 113.13 -175.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.566 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -90.36 -72.03 0.59 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.9 -1.148 . . . . 1.0 107.9 171.505 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.44 -13.11 2.25 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 126.612 2.053 . . . . 1.0 116.331 169.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -156.89 139.85 15.33 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.335 2.254 . . . . 1.0 108.653 173.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.558 HE22 HD12 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -134.77 126.13 17.76 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 118.756 0.707 . . . . 1.0 111.373 -171.244 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -82.18 -41.36 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.532 2.154 . . . . 1.0 113.832 -173.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -145.77 21.2 1.46 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.681 1.192 . . . . 1.0 113.878 -170.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.401 HD11 ' CG2' ' A' ' 52' ' ' VAL . 65.0 tp -81.83 135.14 35.46 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.757 -1.214 . . . . 1.0 112.27 -169.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.5 mtm-85 -134.6 154.16 51.62 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.003 2.121 . . . . 1.0 109.534 169.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.63 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -160.47 169.08 23.75 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.569 -0.707 . . . . 1.0 111.644 -176.397 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.415 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -128.41 171.35 19.52 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 124.167 0.889 . . . . 1.0 113.672 170.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.422 HG23 ' HB3' ' A' ' 122' ' ' MET . 0.0 OUTLIER -140.7 140.12 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 113.978 1.103 . . . . 1.0 113.978 -169.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 1.061 HG23 HD12 ' A' ' 123' ' ' LEU . 12.4 mt -132.12 99.13 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 125.824 1.65 . . . . 1.0 107.065 169.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.05 142.08 28.06 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.731 1.613 . . . . 1.0 112.195 173.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.4 mp -138.51 156.98 47.03 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.169 0.804 . . . . 1.0 113.169 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.791 0 CA-C-N 115.504 -0.771 . . . . 1.0 113.277 169.017 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.447 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 24.5 p . . . . . 0 CA--C 1.541 0.612 0 N-CA-C 113.707 1.002 . . . . 1.0 113.707 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -60.18 -21.63 61.93 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 125.317 1.447 . . . . 1.0 114.173 -169.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.14 -31.03 77.49 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 120.832 1.651 . . . . 1.0 113.74 174.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.84 -37.0 17.39 Favored Glycine 0 N--CA 1.479 1.528 0 O-C-N 121.019 -1.283 . . . . 1.0 113.03 169.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.447 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 82.5 mttt -61.77 -29.36 70.08 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 121.025 -1.279 . . . . 1.0 112.642 172.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -62.85 -36.67 84.02 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.944 1.298 . . . . 1.0 111.747 170.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -65.8 -36.5 83.68 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.396 0.998 . . . . 1.0 111.781 172.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -63.67 -50.16 70.36 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.49 -0.757 . . . . 1.0 111.408 174.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.15 -33.73 65.47 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.674 0.79 . . . . 1.0 112.755 174.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.698 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -58.96 -49.68 76.95 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 123.349 1.547 . . . . 1.0 111.019 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.63 HD12 ' CD1' ' A' ' 87' ' ' TYR . 10.3 mt -66.65 -38.26 86.51 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 120.841 -1.162 . . . . 1.0 111.788 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -69.22 -20.05 63.96 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.801 1.037 . . . . 1.0 113.801 175.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.02 -16.83 59.17 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.845 0.858 . . . . 1.0 110.942 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -98.59 -74.35 0.59 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.92 1.288 . . . . 1.0 109.344 177.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.2 p 177.15 -17.27 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.713 2.005 . . . . 1.0 113.986 -173.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -69.36 159.21 33.59 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.716 1.376 . . . . 1.0 114.716 -169.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -97.02 170.24 9.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.223 1.809 . . . . 1.0 112.122 -169.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.67 151.41 49.25 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.463 1.105 . . . . 1.0 112.23 175.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.32 133.4 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.028 1.731 . . . . 1.0 109.621 -169.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 50.47 -158.79 1.74 Allowed Glycine 0 N--CA 1.48 1.582 0 C-N-CA 125.181 1.372 . . . . 1.0 115.268 -176.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -105.01 139.49 39.61 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.423 1.489 . . . . 1.0 109.504 169.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.422 ' HB3' HG23 ' A' ' 89' ' ' VAL . 1.2 pmm? -76.11 155.32 34.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.901 0.857 . . . . 1.0 111.927 -172.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 1.061 HD12 HG23 ' A' ' 90' ' ' ILE . 1.4 tm? -89.54 138.51 31.4 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.504 1.122 . . . . 1.0 110.276 174.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 mt -128.95 108.02 10.08 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.979 1.711 . . . . 1.0 109.749 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.569 ' CD1' HD11 ' A' ' 123' ' ' LEU . 29.8 mt -99.3 134.55 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.437 1.095 . . . . 1.0 112.885 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -105.13 109.47 21.47 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 124.478 1.111 . . . . 1.0 112.629 169.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.67 -23.95 61.76 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.54 1.136 . . . . 1.0 113.431 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.0 t -66.99 -19.46 65.72 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.371 1.069 . . . . 1.0 112.81 174.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -116.1 -30.11 6.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.084 1.753 . . . . 1.0 111.785 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -140.52 87.07 11.9 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.54 1.536 . . . . 1.0 111.638 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.04 7.82 1.93 Allowed 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 123.648 2.899 . . . . 1.0 114.559 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -114.73 69.06 2.1 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 127.715 2.406 . . . . 1.0 110.136 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -56.94 -22.53 46.73 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.605 2.204 . . . . 1.0 116.805 -169.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -64.26 -25.63 68.14 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.292 0.951 . . . . 1.0 111.811 174.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.8 p -72.86 -18.63 61.42 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.004 -1.06 . . . . 1.0 111.815 -175.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -101.77 -54.44 2.73 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.039 1.735 . . . . 1.0 111.475 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 64.7 p -69.8 -34.61 73.94 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.775 1.028 . . . . 1.0 113.775 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -60.16 -57.15 28.78 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 120.706 1.594 . . . . 1.0 112.558 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -62.17 -24.39 76.26 Favored 'Trans proline' 0 C--N 1.352 0.743 0 CA-C-N 121.273 1.49 . . . . 1.0 112.902 174.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.464 ' CG ' ' HB2' ' A' ' 123' ' ' LEU . 83.9 t90 -67.29 -45.5 76.39 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 119.062 0.846 . . . . 1.0 110.937 173.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.556 HG11 ' HA ' ' A' ' 22' ' ' ALA . 97.8 t -63.81 -33.61 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.635 -0.876 . . . . 1.0 108.635 176.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -70.0 -27.18 64.49 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 120.603 -1.311 . . . . 1.0 113.04 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -82.99 -56.59 3.71 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.352 1.461 . . . . 1.0 111.725 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.415 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 89.8 t90 -56.47 -36.39 69.03 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 125.855 1.662 . . . . 1.0 112.973 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.37 -32.89 30.97 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.825 1.202 . . . . 1.0 114.048 173.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.9 p -68.6 -13.24 62.22 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 114.405 1.261 . . . . 1.0 114.405 177.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.61 -17.49 51.17 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.471 1.509 . . . . 1.0 111.891 176.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -83.83 171.11 13.42 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.033 0.833 . . . . 1.0 111.887 -175.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.5 t . . . . . 0 C--O 1.255 1.351 0 C-N-CA 126.178 1.791 . . . . 1.0 113.033 -174.909 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 ttp . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.78 0.324 . . . . 1.0 110.822 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.07 174.2 11.05 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.88 1.672 . . . . 1.0 113.521 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -123.46 123.74 41.33 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.991 1.316 . . . . 1.0 110.48 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.567 HD13 HD12 ' A' ' 26' ' ' LEU . 2.2 mp -117.11 115.6 49.38 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.065 0 C-N-CA 126.168 1.787 . . . . 1.0 112.845 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.48 119.48 5.61 Favored Glycine 0 C--O 1.224 -0.519 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 169.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.6 mt -103.25 120.97 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 118.04 0.92 . . . . 1.0 109.171 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -118.39 115.99 25.81 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.153 -1.054 . . . . 1.0 108.153 -171.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.7 p -96.09 136.02 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 122.833 0.453 . . . . 1.0 112.109 -170.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.03 89.81 0.18 Allowed Glycine 0 N--CA 1.469 0.876 0 C-N-CA 123.689 0.662 . . . . 1.0 113.787 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.7 m -138.97 145.45 39.76 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.642 1.177 . . . . 1.0 110.07 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.8 ttt -63.32 -36.39 83.54 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.675 0.79 . . . . 1.0 112.684 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -84.48 121.92 28.26 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.668 1.187 . . . . 1.0 110.711 173.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.2 -27.57 55.37 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 123.712 0.672 . . . . 1.0 114.298 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -86.43 159.53 19.31 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.505 1.122 . . . . 1.0 112.102 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.9 m 58.28 25.62 12.93 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 116.032 1.864 . . . . 1.0 116.032 172.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 pp -68.46 151.67 46.5 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.439 -0.788 . . . . 1.0 111.405 170.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.5 tp -147.76 -57.55 0.24 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.123 1.527 . . . . 1.0 115.123 -169.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.5 t -54.77 -32.5 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.667 0.787 . . . . 1.0 112.529 -169.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.92 -48.81 78.81 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.852 -1.155 . . . . 1.0 113.461 172.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -69.15 -30.38 68.6 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.545 0.738 . . . . 1.0 110.969 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.73 -47.91 70.83 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.537 0.735 . . . . 1.0 109.237 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.537 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -64.96 -43.35 92.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 112.559 0.577 . . . . 1.0 112.559 -175.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -53.54 -48.69 68.86 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.051 0.94 . . . . 1.0 110.455 170.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.17 -37.84 69.24 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.495 0.718 . . . . 1.0 112.697 -174.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.7 mt -65.55 -46.65 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 CA-C-N 119.288 0.949 . . . . 1.0 109.141 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.567 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -66.72 -35.48 80.22 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 119.442 -0.903 . . . . 1.0 110.276 -176.283 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.6 m -62.34 -41.19 98.38 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.21 1.404 . . . . 1.0 113.57 170.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.94 -33.81 75.4 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.397 1.079 . . . . 1.0 111.9 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -71.59 -29.01 64.21 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.749 1.22 . . . . 1.0 112.806 172.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.44 25.92 2.54 Favored Glycine 0 N--CA 1.468 0.812 0 C-N-CA 124.378 0.989 . . . . 1.0 114.323 169.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -114.11 146.19 40.61 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.536 1.134 . . . . 1.0 109.574 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -84.1 83.27 8.02 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.859 1.263 . . . . 1.0 108.729 -173.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.91 146.65 26.41 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.301 0.641 . . . . 1.0 111.13 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.8 m -146.98 137.95 23.89 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.696 0.799 . . . . 1.0 112.772 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.3 t -84.35 136.76 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 115.109 1.522 . . . . 1.0 115.109 171.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -115.75 117.6 30.69 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.871 2.069 . . . . 1.0 110.595 169.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -93.12 147.93 22.44 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.287 1.835 . . . . 1.0 110.717 173.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 41.84 61.07 8.57 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 125.125 1.37 . . . . 1.0 112.022 -169.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -48.79 123.87 10.3 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.406 3.404 . . . . 1.0 119.883 -168.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -94.28 146.62 23.9 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.907 1.283 . . . . 1.0 111.285 168.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.49 HD21 HD21 ' A' ' 79' ' ' LEU . 2.4 tm? -71.09 -25.01 62.42 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 121.447 -0.783 . . . . 1.0 110.141 169.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.7 m -67.15 -19.02 65.53 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.493 -0.754 . . . . 1.0 112.609 170.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -91.7 -21.9 20.5 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.587 1.155 . . . . 1.0 113.443 169.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.473 ' HB3' HD22 ' A' ' 41' ' ' LEU . 10.8 t-105 -79.54 -35.02 40.56 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 120.028 1.286 . . . . 1.0 113.36 172.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.1 mt -50.86 -39.54 55.29 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 117.622 -1.18 . . . . 1.0 113.884 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -52.55 -16.62 5.62 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 124.432 3.421 . . . . 1.0 117.495 171.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -107.85 8.61 28.74 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.982 1.845 . . . . 1.0 115.982 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -52.7 -31.12 35.83 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.224 1.81 . . . . 1.0 113.749 173.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -112.66 13.35 19.9 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.102 1.361 . . . . 1.0 112.389 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -126.97 -158.3 0.86 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.613 2.365 . . . . 1.0 111.214 -174.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -114.14 162.81 16.04 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 122.947 1.356 . . . . 1.0 111.833 172.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.524 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -147.71 156.99 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.329 1.452 . . . . 1.0 109.007 -171.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.0 tp -137.38 129.3 28.96 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.813 1.245 . . . . 1.0 109.117 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.6 t -106.03 122.17 59.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.216 -0.661 . . . . 1.0 109.216 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.1 t -120.11 111.31 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 106.871 -1.529 . . . . 1.0 106.871 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.0 t -148.47 119.28 7.56 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.217 1.191 . . . . 1.0 114.217 -168.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.9 t -99.86 -171.22 2.01 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.475 1.11 . . . . 1.0 110.852 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.264 29.7 p 58.29 42.27 21.96 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.367 1.467 . . . . 1.0 113.61 169.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.8 m -53.04 -32.67 48.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.85 1.66 . . . . 1.0 112.743 169.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.44 -132.08 46.41 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.658 0.647 . . . . 1.0 112.523 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -79.36 11.18 3.09 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.438 1.095 . . . . 1.0 113.668 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 111.35 42.28 1.08 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.263 1.411 . . . . 1.0 113.201 177.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -135.05 164.55 27.38 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.244 1.818 . . . . 1.0 112.333 -173.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 68.3 mt -102.88 145.73 31.1 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 123.934 0.893 . . . . 1.0 112.541 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.04 152.09 62.36 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.829 2.353 . . . . 1.0 112.224 171.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -60.79 -20.95 62.53 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.441 1.096 . . . . 1.0 113.886 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.1 p -66.78 -29.48 69.45 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.894 1.278 . . . . 1.0 114.113 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.1 tt -117.02 -14.25 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.809 1.244 . . . . 1.0 114.236 -177.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -43.33 -53.07 11.89 Favored Pre-proline 0 N--CA 1.478 0.948 0 C-N-CA 124.643 1.177 . . . . 1.0 112.604 168.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.83 -31.71 19.67 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 121.576 1.517 . . . . 1.0 111.774 -172.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.4 tp -63.47 -51.26 66.39 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.333 1.053 . . . . 1.0 111.419 169.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.664 ' CE1' HD23 ' A' ' 110' ' ' LEU . 91.3 t80 -56.31 -52.46 64.45 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.121 0.968 . . . . 1.0 112.364 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -63.2 -39.41 94.56 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.787 0.835 . . . . 1.0 111.443 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.72 -36.84 92.83 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.064 0.84 . . . . 1.0 112.728 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.572 HG22 HD12 ' A' ' 110' ' ' LEU . 86.4 mt -65.37 -51.18 67.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 119.949 1.875 . . . . 1.0 107.976 172.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.709 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.4 ptmm? -69.25 -31.14 69.49 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 120.39 -1.444 . . . . 1.0 113.564 -169.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -103.43 -38.0 7.37 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.777 1.631 . . . . 1.0 115.279 -176.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.6 m -95.57 -20.88 18.63 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.468 1.107 . . . . 1.0 113.229 -175.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.49 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -91.67 -71.94 0.61 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 106.872 -1.529 . . . . 1.0 106.872 169.555 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.98 -18.92 1.06 Allowed Glycine 0 CA--C 1.539 1.58 0 C-N-CA 127.644 2.545 . . . . 1.0 115.265 169.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -151.87 138.99 19.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 128.386 2.674 . . . . 1.0 107.896 169.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.427 HE21 HD12 ' A' ' 79' ' ' LEU . 11.1 mt-30 -137.75 121.78 11.85 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 118.664 -0.684 . . . . 1.0 109.637 -171.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.72 -35.77 0.28 Allowed 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.422 2.081 . . . . 1.0 115.39 -169.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -141.68 15.51 2.15 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.292 1.219 . . . . 1.0 114.292 -169.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.524 HD11 ' CG2' ' A' ' 52' ' ' VAL . 64.9 tp -80.79 139.93 35.77 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 120.563 -1.336 . . . . 1.0 113.027 -169.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -137.12 154.74 50.21 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.66 2.384 . . . . 1.0 109.032 169.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.624 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -161.02 163.85 31.35 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.244 0.929 . . . . 1.0 112.217 -176.153 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.409 ' HA3' ' CE2' ' A' ' 144' ' ' TRP . . . -123.65 172.22 16.27 Favored Glycine 0 N--CA 1.467 0.703 0 C-N-CA 125.707 1.622 . . . . 1.0 112.109 169.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.551 HG13 ' HB3' ' A' ' 122' ' ' MET . 0.2 OUTLIER -160.52 145.56 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 O-C-N 121.161 -1.199 . . . . 1.0 114.086 -169.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.97 HG23 HD12 ' A' ' 123' ' ' LEU . 8.6 mt -134.76 100.26 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 127.794 2.438 . . . . 1.0 106.942 -175.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.27 146.17 24.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.267 1.427 . . . . 1.0 111.581 173.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.6 mp -140.09 156.45 46.57 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.453 0.701 . . . . 1.0 112.269 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.02 -149.06 15.77 Favored Glycine 0 C--O 1.224 -0.496 0 CA-C-N 116.208 -0.451 . . . . 1.0 112.499 169.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -116.03 117.62 30.63 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.014 0.907 . . . . 1.0 110.415 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.0 t -63.82 -6.39 5.75 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.905 1.076 . . . . 1.0 113.905 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.1 t -63.79 -26.85 68.81 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 120.721 -1.237 . . . . 1.0 111.984 169.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -75.73 138.76 41.47 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.285 -0.884 . . . . 1.0 111.253 169.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -43.09 -50.24 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 126.573 1.949 . . . . 1.0 114.593 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -100.43 20.5 14.77 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.451 2.3 . . . . 1.0 115.1 -175.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.1 t80 34.12 -81.65 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 129.201 3.0 . . . . 1.0 117.973 169.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.7 m -122.6 24.28 9.25 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.116 1.766 . . . . 1.0 113.191 -171.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -53.01 -25.51 12.47 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.082 1.353 . . . . 1.0 114.37 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.87 -43.47 60.88 Favored Glycine 0 CA--C 1.538 1.519 0 CA-C-N 121.522 1.965 . . . . 1.0 114.878 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -80.12 -33.5 32.51 Favored Glycine 0 N--CA 1.481 1.691 0 O-C-N 120.711 -1.464 . . . . 1.0 113.768 173.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -62.41 -33.41 74.72 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 121.366 -1.079 . . . . 1.0 112.672 174.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 40.7 mm-40 -60.63 -42.57 97.16 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.891 0.876 . . . . 1.0 111.163 169.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -64.05 -36.82 85.25 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.566 -0.709 . . . . 1.0 111.998 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -62.42 -49.62 74.74 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.405 -0.81 . . . . 1.0 112.498 173.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.34 -35.73 67.97 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.503 0.556 . . . . 1.0 112.503 174.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.709 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -58.04 -51.3 70.25 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 123.113 1.435 . . . . 1.0 110.926 -178.172 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.624 HD12 ' CD1' ' A' ' 87' ' ' TYR . 7.1 mt -65.74 -38.84 90.21 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 121.033 -1.042 . . . . 1.0 111.64 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -70.51 -18.92 62.95 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.344 0.868 . . . . 1.0 113.344 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.83 -19.01 58.03 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.298 0.954 . . . . 1.0 110.869 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -99.86 -76.8 0.54 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.886 1.274 . . . . 1.0 110.953 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.9 m -178.17 -2.88 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.587 1.955 . . . . 1.0 112.818 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -77.95 162.47 26.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 122.31 1.052 . . . . 1.0 113.304 -169.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -102.53 174.58 5.84 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.817 1.647 . . . . 1.0 113.221 -168.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.6 153.3 42.4 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.159 2.184 . . . . 1.0 112.433 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.5 t -126.78 127.66 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 126.206 1.802 . . . . 1.0 108.46 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 49.21 -156.52 1.53 Allowed Glycine 0 N--CA 1.48 1.615 0 C-N-CA 125.032 1.301 . . . . 1.0 114.615 -169.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -118.22 144.82 45.46 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.856 1.662 . . . . 1.0 109.803 169.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.551 ' HB3' HG13 ' A' ' 89' ' ' VAL . 1.1 pmm? -71.91 155.39 40.43 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.224 1.012 . . . . 1.0 113.063 -169.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.97 HD12 HG23 ' A' ' 90' ' ' ILE . 1.1 tm? -84.18 139.62 32.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.048 -0.978 . . . . 1.0 109.815 170.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.5 mt -127.38 110.15 12.5 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.363 1.465 . . . . 1.0 110.098 173.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.563 ' CD1' HD11 ' A' ' 123' ' ' LEU . 24.4 mt -98.56 129.86 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.092 0.957 . . . . 1.0 112.749 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -103.75 110.92 23.2 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 122.278 1.037 . . . . 1.0 112.55 171.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.21 -22.44 64.8 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.623 1.169 . . . . 1.0 113.379 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.0 t -65.13 -21.99 66.87 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.897 0.879 . . . . 1.0 112.795 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -119.25 -30.5 4.92 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.162 1.785 . . . . 1.0 111.98 -174.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -142.34 85.95 10.32 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.073 1.349 . . . . 1.0 111.975 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.79 7.84 2.22 Favored 'Trans proline' 0 CA--C 1.551 1.333 0 C-N-CA 123.625 2.883 . . . . 1.0 114.419 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -113.79 69.56 1.63 Allowed Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 127.432 2.293 . . . . 1.0 109.909 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -56.6 -24.45 54.06 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.667 2.245 . . . . 1.0 116.304 -169.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.8 pm0 -66.08 -24.43 66.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 119.385 0.993 . . . . 1.0 111.725 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 15.1 p -73.78 -15.53 61.19 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.661 -1.274 . . . . 1.0 112.27 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.434 ' HB2' HD11 ' A' ' 125' ' ' ILE . 5.0 mm-40 -105.02 -55.44 2.33 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.296 1.838 . . . . 1.0 111.482 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 65.7 p -69.29 -33.88 73.87 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 113.938 1.088 . . . . 1.0 113.938 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -60.57 -57.45 26.44 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 120.801 1.637 . . . . 1.0 112.485 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -62.96 -23.35 74.13 Favored 'Trans proline' 0 C--N 1.354 0.832 0 CA-C-N 121.386 1.531 . . . . 1.0 112.449 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.467 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 86.8 t90 -67.12 -46.82 72.98 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 119.258 0.936 . . . . 1.0 110.749 173.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.537 HG11 ' HA ' ' A' ' 22' ' ' ALA . 96.1 t -63.4 -33.83 63.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 108.922 -0.77 . . . . 1.0 108.922 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.76 -28.35 65.7 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.823 1.249 . . . . 1.0 113.132 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -81.83 -56.96 3.65 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.169 1.388 . . . . 1.0 112.073 169.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.41 ' CZ3' HD11 ' A' ' 26' ' ' LEU . 85.1 t90 -57.14 -36.93 71.3 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 125.498 1.519 . . . . 1.0 112.727 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.83 -33.01 34.65 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.766 1.174 . . . . 1.0 113.765 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.8 p -65.79 -13.99 60.5 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.576 1.325 . . . . 1.0 114.576 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.27 -16.78 53.93 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.008 1.723 . . . . 1.0 112.005 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.17 -176.98 5.89 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.174 1.39 . . . . 1.0 110.754 -176.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 31.9 m . . . . . 0 C--O 1.253 1.277 0 C-N-CA 125.624 1.57 . . . . 1.0 115.01 -172.045 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 119.938 -0.077 . . . . 1.0 110.877 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.52 163.65 35.88 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.24 1.416 . . . . 1.0 112.678 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -120.67 124.42 45.18 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.664 1.586 . . . . 1.0 110.466 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.518 HD13 HD12 ' A' ' 26' ' ' LEU . 2.0 mp -123.14 113.47 37.95 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.071 0 C-N-CA 125.963 1.705 . . . . 1.0 112.664 -178.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.8 123.64 7.18 Favored Glycine 0 C--O 1.224 -0.523 0 N-CA-C 110.551 -1.019 . . . . 1.0 110.551 169.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.4 mt -105.15 122.23 58.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 118.184 0.992 . . . . 1.0 109.459 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -114.16 108.75 17.39 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 124.869 1.268 . . . . 1.0 108.277 -169.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.6 p -92.46 134.66 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.037 -173.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -123.39 115.44 2.64 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.656 1.122 . . . . 1.0 111.366 176.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -148.59 145.91 28.01 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.641 0.776 . . . . 1.0 112.747 -169.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.11 165.79 6.73 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.463 0.705 . . . . 1.0 111.709 168.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -64.9 122.47 17.05 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.255 -0.903 . . . . 1.0 111.315 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.06 -148.81 19.39 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.529 1.061 . . . . 1.0 113.434 -173.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -71.07 167.98 18.1 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.653 1.181 . . . . 1.0 112.505 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.4 t -55.61 150.32 12.51 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.083 1.353 . . . . 1.0 113.029 174.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.56 -12.13 60.94 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.596 0.759 . . . . 1.0 112.266 171.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.4 tp 63.71 -52.4 0.24 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 128.019 2.528 . . . . 1.0 115.265 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.2 t -53.65 -35.29 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.913 1.685 . . . . 1.0 112.47 -175.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.21 -45.79 87.02 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.858 -1.151 . . . . 1.0 112.487 174.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.83 -31.08 68.77 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.586 1.154 . . . . 1.0 110.759 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -66.56 -48.23 70.3 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.239 0.616 . . . . 1.0 109.341 170.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.536 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.41 -42.9 92.05 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 112.823 0.675 . . . . 1.0 112.823 -173.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -54.01 -49.24 69.31 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 123.717 0.807 . . . . 1.0 110.409 169.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.99 -37.0 69.92 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.285 0.634 . . . . 1.0 112.491 -174.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.4 mt -66.41 -46.96 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 119.015 0.825 . . . . 1.0 109.191 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.518 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -67.52 -34.65 77.54 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 119.57 -0.852 . . . . 1.0 110.613 -176.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.6 m -62.58 -40.07 95.71 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.226 1.41 . . . . 1.0 113.484 170.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.87 -32.72 72.58 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.177 0.991 . . . . 1.0 112.066 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -70.6 -29.77 66.26 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.597 1.159 . . . . 1.0 113.059 170.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.91 23.05 3.12 Favored Glycine 0 N--CA 1.47 0.95 0 C-N-CA 124.516 1.055 . . . . 1.0 114.585 169.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -109.61 151.99 26.11 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.363 1.065 . . . . 1.0 109.652 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.3 tptt -85.39 85.55 7.43 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.756 1.223 . . . . 1.0 108.665 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.3 145.44 28.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.68 -0.691 . . . . 1.0 111.11 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.2 m -147.3 139.02 24.13 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.843 0.857 . . . . 1.0 112.341 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.1 t -86.78 136.08 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 115.022 1.49 . . . . 1.0 115.022 171.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -113.43 113.5 25.27 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.331 1.852 . . . . 1.0 110.017 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -93.56 138.24 32.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.131 1.772 . . . . 1.0 110.848 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 42.39 55.06 9.8 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 124.498 1.119 . . . . 1.0 111.309 -169.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -67.84 140.09 49.66 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 123.699 2.933 . . . . 1.0 117.089 -168.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -93.64 163.46 13.54 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 122.466 1.127 . . . . 1.0 111.986 168.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.604 HD21 HD21 ' A' ' 79' ' ' LEU . 2.1 tm? -66.76 -22.61 66.04 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 121.074 -1.016 . . . . 1.0 110.738 167.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.2 p -68.57 -18.44 64.34 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.959 1.254 . . . . 1.0 112.386 171.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -82.67 -25.22 33.24 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.174 0.99 . . . . 1.0 112.276 169.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.467 ' HB3' HD22 ' A' ' 41' ' ' LEU . 11.1 t-105 -89.38 -33.81 16.73 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.175 1.176 . . . . 1.0 114.175 -177.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.6 mt -48.2 -38.67 22.38 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 117.549 -1.215 . . . . 1.0 114.046 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.2 -6.92 7.24 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 124.053 3.169 . . . . 1.0 116.863 175.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -114.76 6.17 15.48 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 116.126 1.899 . . . . 1.0 116.126 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -50.25 -29.44 9.56 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.562 1.945 . . . . 1.0 113.824 171.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -105.53 7.92 33.14 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 128.144 2.578 . . . . 1.0 113.156 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -132.78 -161.36 1.13 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.933 2.093 . . . . 1.0 112.728 -168.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -110.59 157.48 19.62 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 123.191 1.472 . . . . 1.0 111.042 171.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.605 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -144.81 155.63 14.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 124.941 1.297 . . . . 1.0 108.285 -172.295 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.6 tp -134.98 127.74 31.09 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 124.568 1.147 . . . . 1.0 108.642 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.8 t -102.8 124.21 56.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.338 -0.616 . . . . 1.0 109.338 175.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.7 t -124.64 108.72 20.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 106.493 -1.669 . . . . 1.0 106.493 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -146.63 127.48 14.43 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.923 1.083 . . . . 1.0 113.923 -167.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.1 p -109.01 -149.96 0.45 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.089 1.756 . . . . 1.0 109.975 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.4 m 73.79 -21.34 0.27 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 127.462 2.305 . . . . 1.0 115.068 168.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 93.6 m -54.93 113.63 1.41 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.01 1.324 . . . . 1.0 110.664 169.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.13 -100.93 2.68 Favored Glycine 0 N--CA 1.472 1.049 0 N-CA-C 109.739 -1.344 . . . . 1.0 109.739 173.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -69.64 0.02 6.13 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.647 1.179 . . . . 1.0 112.53 169.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.33 -161.21 28.71 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 126.947 2.213 . . . . 1.0 111.441 -175.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 64.23 165.41 0.14 Allowed 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 117.492 2.404 . . . . 1.0 117.492 172.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 64.5 mt -106.71 154.11 40.29 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.788 2.035 . . . . 1.0 112.187 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -67.9 144.86 66.28 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.804 2.336 . . . . 1.0 112.122 169.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -62.97 -21.69 66.29 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.935 1.087 . . . . 1.0 113.935 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.6 p -72.86 -20.84 61.04 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.3 1.222 . . . . 1.0 114.3 172.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.7 tt -112.41 -14.07 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 113.818 1.044 . . . . 1.0 113.818 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.1 t -45.77 -53.5 20.06 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.432 1.093 . . . . 1.0 112.52 168.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -67.98 -33.66 25.41 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.531 1.487 . . . . 1.0 111.537 -173.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.4 tp -61.2 -53.03 62.1 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 124.586 1.154 . . . . 1.0 111.287 170.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.692 ' CE1' HD23 ' A' ' 110' ' ' LEU . 91.9 t80 -54.3 -53.49 53.1 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.128 0.971 . . . . 1.0 112.25 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -64.02 -40.5 96.47 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.792 0.837 . . . . 1.0 111.531 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.11 -35.93 89.6 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.563 0.601 . . . . 1.0 112.642 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.612 HG22 HD12 ' A' ' 110' ' ' LEU . 89.8 mt -64.82 -47.79 87.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 120.173 1.986 . . . . 1.0 108.259 172.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.739 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.2 ptmm? -71.5 -32.58 68.39 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.566 -1.333 . . . . 1.0 113.201 -171.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -105.17 -36.97 7.07 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.161 1.541 . . . . 1.0 115.161 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.9 m -94.05 -24.98 17.39 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.23 1.012 . . . . 1.0 112.84 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.604 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -90.49 -71.59 0.61 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.415 -1.328 . . . . 1.0 107.415 169.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.98 -8.46 2.5 Favored Glycine 0 CA--C 1.543 1.786 0 C-N-CA 126.419 1.962 . . . . 1.0 115.13 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -153.88 146.45 24.12 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 129.851 3.26 . . . . 1.0 106.906 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -136.62 125.37 15.25 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 123.192 0.597 . . . . 1.0 111.099 -176.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.97 -41.85 0.14 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 121.983 1.789 . . . . 1.0 114.314 -171.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -147.84 22.54 1.12 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.829 1.252 . . . . 1.0 113.129 -171.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.605 HD11 ' CG2' ' A' ' 52' ' ' VAL . 53.0 tp -83.2 137.6 33.96 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.624 -1.298 . . . . 1.0 113.909 -169.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -135.23 153.94 51.75 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 127.821 2.448 . . . . 1.0 108.957 169.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.665 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -158.07 164.77 36.37 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.316 -0.865 . . . . 1.0 112.302 -177.352 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -124.88 172.26 17.02 Favored Glycine 0 N--CA 1.467 0.766 0 C-N-CA 125.703 1.62 . . . . 1.0 111.978 169.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.576 HG13 ' HB3' ' A' ' 122' ' ' MET . 0.2 OUTLIER -159.03 146.45 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 O-C-N 120.875 -1.367 . . . . 1.0 114.44 -169.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.7 mt -133.45 105.64 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 127.308 2.243 . . . . 1.0 107.738 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.91 144.32 26.03 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.416 1.486 . . . . 1.0 110.863 175.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.5 mp -137.93 155.35 49.0 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.652 0.612 . . . . 1.0 112.652 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.25 -155.33 26.64 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 116.15 -0.477 . . . . 1.0 113.639 169.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.63 113.99 27.66 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.462 1.105 . . . . 1.0 111.393 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.4 t -74.57 1.8 11.23 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.973 1.101 . . . . 1.0 113.973 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 46.0 p -66.08 -14.65 62.11 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.614 -1.303 . . . . 1.0 113.61 170.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -117.6 157.53 26.22 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.625 1.57 . . . . 1.0 112.119 169.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.0 m -67.35 167.96 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.011 0.924 . . . . 1.0 110.531 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 61.14 22.51 12.81 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.122 1.369 . . . . 1.0 114.323 -169.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -28.83 -55.23 0.12 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 129.2 3.0 . . . . 1.0 116.11 -170.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.406 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 17.4 p -124.56 17.96 8.83 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.557 1.543 . . . . 1.0 113.019 -169.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -62.06 -19.04 62.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.257 1.423 . . . . 1.0 114.257 -169.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.34 -52.62 52.12 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-N 120.432 1.469 . . . . 1.0 113.732 174.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.41 -34.98 68.59 Favored Glycine 0 N--CA 1.479 1.51 0 O-C-N 120.807 -1.408 . . . . 1.0 112.995 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.406 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 87.0 mttt -63.41 -35.33 80.05 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.536 1.134 . . . . 1.0 113.137 173.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -64.34 -39.72 94.45 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 119.062 -0.495 . . . . 1.0 111.735 169.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -61.34 -33.49 73.71 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 118.961 0.801 . . . . 1.0 111.843 174.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -66.32 -51.81 53.53 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.571 0.748 . . . . 1.0 111.359 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.76 -35.24 63.56 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.657 0.783 . . . . 1.0 112.863 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.739 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -58.05 -49.91 75.27 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-O 123.3 1.524 . . . . 1.0 110.867 -179.066 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.665 HD12 ' CD1' ' A' ' 87' ' ' TYR . 12.4 mt -67.27 -37.53 83.6 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 120.907 -1.12 . . . . 1.0 112.117 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -69.12 -20.87 64.05 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.54 -16.43 58.67 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.249 0.931 . . . . 1.0 110.991 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -100.29 -78.51 0.51 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.165 1.386 . . . . 1.0 110.175 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -175.72 -13.58 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.751 -1.568 . . . . 1.0 113.347 -169.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -80.44 163.06 24.1 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.966 1.469 . . . . 1.0 114.966 -168.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -103.76 175.5 5.46 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.046 1.738 . . . . 1.0 112.183 -169.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.02 141.89 48.52 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.232 1.813 . . . . 1.0 110.349 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 120' ' ' GLY 0.257 12.9 t -93.54 -161.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 125.55 1.54 . . . . 1.0 106.85 174.004 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.547 ' H ' HG12 ' A' ' 119' ' ' VAL . . . -49.53 149.49 5.12 Favored Glycine 0 CA--C 1.547 2.066 0 O-C-N 119.775 -1.828 . . . . 1.0 114.589 177.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.11 149.65 40.69 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.973 1.309 . . . . 1.0 112.48 -172.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.576 ' HB3' HG13 ' A' ' 89' ' ' VAL . 1.0 OUTLIER -70.57 157.05 38.6 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 122.546 1.165 . . . . 1.0 113.759 -169.145 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.643 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -87.5 141.43 28.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.309 -1.314 . . . . 1.0 109.795 170.137 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.643 ' N ' HD13 ' A' ' 123' ' ' LEU . 5.9 mt -124.33 103.5 8.25 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 125.508 1.523 . . . . 1.0 110.948 175.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.448 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.5 mt -89.61 128.07 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.41 1.484 . . . . 1.0 112.344 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -106.35 108.43 19.94 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.066 0.936 . . . . 1.0 112.139 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.02 -22.57 64.97 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.008 0.923 . . . . 1.0 113.29 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.9 t -65.18 -21.78 66.81 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.379 1.072 . . . . 1.0 112.935 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -119.36 -29.72 5.08 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.061 1.744 . . . . 1.0 112.096 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -143.33 84.89 9.9 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 125.448 1.499 . . . . 1.0 112.048 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.44 7.29 2.29 Favored 'Trans proline' 0 CA--C 1.551 1.333 0 C-N-CA 123.742 2.961 . . . . 1.0 114.45 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -111.74 71.31 0.95 Allowed Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 127.592 2.357 . . . . 1.0 109.966 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -58.69 -20.15 49.38 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.89 2.393 . . . . 1.0 116.747 -169.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -66.16 -27.0 67.68 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 119.596 1.089 . . . . 1.0 111.639 172.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 22.1 p -74.56 -21.67 59.39 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.544 1.065 . . . . 1.0 111.943 -172.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -93.19 -51.29 5.09 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.335 1.454 . . . . 1.0 111.996 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 77.3 p -73.26 -33.64 65.38 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 115.711 1.745 . . . . 1.0 115.711 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -56.22 -58.07 18.78 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 121.003 1.728 . . . . 1.0 111.836 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -62.21 -24.35 76.12 Favored 'Trans proline' 0 C--N 1.352 0.761 0 CA-C-N 121.514 1.577 . . . . 1.0 113.155 175.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.505 ' HB2' HD23 ' A' ' 123' ' ' LEU . 91.2 t90 -68.12 -47.73 67.34 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 118.972 0.805 . . . . 1.0 110.982 174.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.536 HG11 ' HA ' ' A' ' 22' ' ' ALA . 86.6 t -64.66 -33.57 64.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 176.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -69.34 -28.97 66.69 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.761 1.225 . . . . 1.0 112.085 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -81.5 -60.44 2.26 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.137 1.775 . . . . 1.0 112.021 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 82.1 t90 -56.0 -36.0 67.42 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 126.2 1.8 . . . . 1.0 112.654 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.59 -32.31 23.89 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.771 1.177 . . . . 1.0 113.764 173.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.2 p -69.45 -12.77 61.93 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.333 1.234 . . . . 1.0 114.333 177.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.57 -16.89 50.22 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.209 1.804 . . . . 1.0 111.862 175.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.25 174.79 11.19 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.378 1.071 . . . . 1.0 111.168 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.251 1.156 0 N-CA-C 115.242 1.571 . . . . 1.0 115.242 -175.068 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 111.793 0.294 . . . . 1.0 111.793 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.7 166.58 32.96 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.427 1.491 . . . . 1.0 112.714 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -125.77 122.81 37.29 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.903 1.281 . . . . 1.0 110.254 175.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.585 HD13 HD12 ' A' ' 26' ' ' LEU . 2.1 mp -120.99 116.89 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 126.2 1.8 . . . . 1.0 113.044 -177.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.8 124.34 7.8 Favored Glycine 0 N--CA 1.467 0.758 0 CA-C-O 119.382 -0.677 . . . . 1.0 111.507 169.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 mt -107.37 121.39 60.19 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-N 118.8 1.3 . . . . 1.0 109.743 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -116.71 109.58 17.34 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 124.661 1.185 . . . . 1.0 108.615 -169.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 p -89.24 140.84 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.0 -0.545 . . . . 1.0 111.502 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -126.42 140.57 12.13 Favored Glycine 0 N--CA 1.469 0.898 0 N-CA-C 111.066 -0.814 . . . . 1.0 111.066 169.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.2 t -160.3 152.09 20.0 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.109 1.455 . . . . 1.0 112.649 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 20.2 ttt -87.61 -12.55 45.3 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.413 1.485 . . . . 1.0 111.81 169.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -79.15 163.61 24.92 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.945 1.298 . . . . 1.0 112.8 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.74 -7.3 69.31 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 116.088 1.195 . . . . 1.0 116.088 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -142.15 151.99 42.76 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.406 1.482 . . . . 1.0 111.39 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.4 m -69.94 146.0 51.48 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.247 1.019 . . . . 1.0 113.101 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.418 ' HG ' ' H ' ' A' ' 18' ' ' VAL . 50.5 tp -76.83 130.01 37.04 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.518 0.933 . . . . 1.0 113.518 -174.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 37.0 tp -34.94 -49.31 0.44 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 128.138 2.575 . . . . 1.0 114.765 169.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.418 ' H ' ' HG ' ' A' ' 16' ' ' LEU . 76.4 t -53.97 -37.7 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.807 0.843 . . . . 1.0 112.183 -172.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.27 -38.47 86.87 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.956 -1.09 . . . . 1.0 112.407 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -75.9 -32.41 59.64 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.138 0.575 . . . . 1.0 111.439 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -60.52 -45.49 93.62 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.219 -1.03 . . . . 1.0 108.219 170.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.614 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.46 -40.66 93.46 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 112.624 0.601 . . . . 1.0 112.624 -174.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -57.34 -48.3 79.36 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.193 0.451 . . . . 1.0 109.8 169.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.38 -35.12 75.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 112.89 0.7 . . . . 1.0 112.89 -173.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.9 mt -72.66 -46.44 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 O-C-N 121.321 -0.862 . . . . 1.0 109.346 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.585 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -64.81 -33.36 75.81 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 119.162 -1.015 . . . . 1.0 109.976 -178.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.1 m -62.14 -45.99 90.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.984 1.314 . . . . 1.0 113.133 169.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.69 -33.03 74.99 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.193 0.997 . . . . 1.0 112.69 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -69.91 -29.8 67.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.941 1.297 . . . . 1.0 112.378 172.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.24 21.51 2.28 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.729 1.157 . . . . 1.0 115.175 169.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -117.02 153.37 32.8 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.432 1.093 . . . . 1.0 110.655 -175.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -87.12 72.16 10.03 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 123.118 1.437 . . . . 1.0 110.278 -173.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.11 144.9 27.28 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 112.954 -1.93 . . . . 1.0 111.941 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.6 m -142.63 136.23 28.91 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 125.746 1.618 . . . . 1.0 108.739 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.71 143.9 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.697 1.199 . . . . 1.0 113.437 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.65 133.82 53.1 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.329 1.851 . . . . 1.0 111.316 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -107.14 141.17 38.84 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.673 1.989 . . . . 1.0 111.13 178.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 t0 41.3 55.47 8.36 Favored Pre-proline 0 CA--C 1.559 1.309 0 C-N-CA 124.519 1.128 . . . . 1.0 112.478 -172.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.78 148.16 45.92 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.531 2.821 . . . . 1.0 117.072 -168.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -99.25 164.75 12.0 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.951 1.3 . . . . 1.0 112.461 168.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.568 HD21 HD21 ' A' ' 79' ' ' LEU . 2.2 tm? -68.15 -22.35 64.86 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 121.03 -1.044 . . . . 1.0 110.727 167.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 67.4 p -68.19 -20.21 64.83 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.656 1.117 . . . . 1.0 112.219 171.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -81.68 -24.9 35.96 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.253 1.021 . . . . 1.0 112.359 169.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.469 ' HB3' HD22 ' A' ' 41' ' ' LEU . 10.3 t-105 -88.85 -34.78 16.89 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.346 1.239 . . . . 1.0 114.346 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.4 mt -47.5 -38.46 16.24 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-O 117.358 -1.306 . . . . 1.0 114.314 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -57.1 -18.77 30.4 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.43 2.753 . . . . 1.0 116.416 175.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -105.79 7.49 32.41 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 116.13 1.9 . . . . 1.0 116.13 -172.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -51.43 -34.71 36.25 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.619 1.967 . . . . 1.0 113.525 174.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -110.35 8.53 23.38 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.791 1.636 . . . . 1.0 112.373 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -115.78 -163.93 0.92 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.639 2.376 . . . . 1.0 110.299 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -108.48 164.26 12.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 122.613 1.197 . . . . 1.0 112.147 170.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.604 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -148.35 162.12 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.121 1.369 . . . . 1.0 109.906 -170.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.64 HD11 HD12 ' A' ' 90' ' ' ILE . 13.3 tp -144.9 128.65 17.25 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.931 1.292 . . . . 1.0 108.852 177.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.69 128.3 58.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 C-N-CA 124.141 0.976 . . . . 1.0 109.728 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.2 t -127.04 108.87 19.43 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 p -111.27 114.46 27.68 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.033 -1.099 . . . . 1.0 108.033 -170.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 m -87.85 -27.03 22.48 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 119.566 3.173 . . . . 1.0 119.566 -166.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.4 p -122.7 -39.74 2.51 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.756 1.021 . . . . 1.0 113.756 -168.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.488 ' CG2' ' H ' ' A' ' 103' ' ' GLY . 20.3 m 46.62 43.41 12.54 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.914 1.45 . . . . 1.0 114.914 169.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.74 128.97 47.77 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 121.056 -1.027 . . . . 1.0 112.424 -175.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 54.43 15.04 0.9 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.98 1.312 . . . . 1.0 114.387 -171.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.449 ' HA3' ' HB2' ' A' ' 99' ' ' ASN . . . 81.94 6.85 88.59 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.888 1.708 . . . . 1.0 116.09 -172.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -106.92 169.02 8.8 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.288 1.544 . . . . 1.0 112.61 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 40.1 mt -92.52 137.57 24.38 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.724 1.21 . . . . 1.0 113.756 -172.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.73 162.35 27.06 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.88 3.054 . . . . 1.0 113.91 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -63.81 -20.75 66.03 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 115.407 1.632 . . . . 1.0 115.407 -169.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.9 m -75.75 -19.06 59.31 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.793 1.035 . . . . 1.0 113.793 175.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.5 tt -113.01 -15.3 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.695 1.198 . . . . 1.0 113.618 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.7 t -40.71 -52.78 6.24 Favored Pre-proline 0 N--CA 1.478 0.951 0 CA-C-O 117.477 -1.249 . . . . 1.0 112.665 168.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -67.15 -32.31 34.26 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 121.725 1.616 . . . . 1.0 112.181 -173.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.1 tp -65.73 -52.96 47.01 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 124.051 0.94 . . . . 1.0 111.302 169.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.653 ' CE1' HD23 ' A' ' 110' ' ' LEU . 92.6 t80 -56.24 -52.41 64.57 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.727 0.811 . . . . 1.0 112.666 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -64.04 -40.33 96.06 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.669 1.188 . . . . 1.0 111.445 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.68 -35.85 90.42 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 123.604 0.621 . . . . 1.0 112.808 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.618 HG22 HD12 ' A' ' 110' ' ' LEU . 90.5 mt -66.42 -46.54 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 120.199 2.0 . . . . 1.0 108.578 172.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.717 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.4 ptmm? -72.25 -30.63 65.04 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.039 -1.663 . . . . 1.0 113.267 -171.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -109.77 -37.48 5.64 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.402 1.63 . . . . 1.0 115.402 -173.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.7 m -90.55 -26.8 19.53 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.302 1.041 . . . . 1.0 112.695 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.568 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -90.12 -71.44 0.62 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.214 -1.402 . . . . 1.0 107.214 169.379 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.7 -6.21 2.85 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 126.317 1.913 . . . . 1.0 115.496 172.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -156.22 146.78 21.74 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.035 2.934 . . . . 1.0 107.315 173.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.407 ' HG3' ' HB2' ' A' ' 116' ' ' ALA . 43.4 mm-40 -137.94 126.06 14.17 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 123.73 0.812 . . . . 1.0 110.207 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -84.63 -37.99 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 121.924 1.75 . . . . 1.0 114.414 -172.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -147.64 18.66 1.16 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.757 1.223 . . . . 1.0 114.14 -169.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.604 HD11 ' CG2' ' A' ' 52' ' ' VAL . 38.2 tp -77.31 139.98 39.9 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.5 -1.375 . . . . 1.0 113.629 -169.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -132.85 146.76 52.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 128.815 2.846 . . . . 1.0 107.252 169.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.645 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -159.33 167.63 28.38 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 118.981 0.81 . . . . 1.0 113.069 -177.494 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.484 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -125.32 173.49 17.4 Favored Glycine 0 N--CA 1.474 1.208 0 C-N-CA 125.025 1.298 . . . . 1.0 114.228 173.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.6 t -144.61 131.43 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.185 0.994 . . . . 1.0 113.641 -169.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.054 HG23 HD12 ' A' ' 123' ' ' LEU . 3.4 mt -131.54 102.24 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.846 1.658 . . . . 1.0 107.203 169.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -91.94 145.32 24.63 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.859 0.838 . . . . 1.0 111.27 170.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.437 HD11 HG22 ' A' ' 90' ' ' ILE . 3.5 mp -139.86 152.96 46.88 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.07 1.348 . . . . 1.0 110.622 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.56 -173.18 43.22 Favored Glycine 0 C--O 1.227 -0.31 0 C-N-CA 120.851 -0.69 . . . . 1.0 113.676 169.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -86.8 113.79 22.92 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.942 -0.74 . . . . 1.0 110.352 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 36.0 p -62.47 -4.74 2.05 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.994 1.318 . . . . 1.0 114.335 176.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.6 t -67.59 -25.44 65.77 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.034 0.934 . . . . 1.0 112.438 169.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -75.02 153.97 38.23 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.155 -0.966 . . . . 1.0 112.708 169.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.13 161.06 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 168.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.449 ' HB2' ' HA3' ' A' ' 62' ' ' GLY . 9.6 m-80 60.06 24.71 13.94 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 113.944 1.09 . . . . 1.0 113.944 176.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.3 t80 11.39 -85.48 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 129.942 3.297 . . . . 1.0 117.081 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.7 m -114.38 22.2 13.93 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.95 1.7 . . . . 1.0 113.417 -172.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -60.18 -17.96 44.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.886 1.674 . . . . 1.0 115.005 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.488 ' H ' ' CG2' ' A' ' 59' ' ' THR . . . -60.2 -41.01 98.04 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-N 120.833 1.652 . . . . 1.0 114.37 175.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -75.91 -34.58 47.45 Favored Glycine 0 N--CA 1.477 1.429 0 O-C-N 120.626 -1.514 . . . . 1.0 112.935 172.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -62.97 -33.88 76.33 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 121.23 -1.159 . . . . 1.0 112.418 173.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -59.97 -41.72 92.58 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.601 1.16 . . . . 1.0 111.539 170.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -64.9 -37.74 88.64 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.729 0.695 . . . . 1.0 111.546 174.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -62.56 -49.43 75.29 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.181 -0.949 . . . . 1.0 110.994 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.19 -33.81 63.35 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.953 0.901 . . . . 1.0 113.111 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.717 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -61.2 -49.75 75.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 122.933 1.349 . . . . 1.0 110.613 178.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.645 HD12 ' CD1' ' A' ' 87' ' ' TYR . 10.3 mt -65.86 -37.49 86.3 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 120.945 -1.097 . . . . 1.0 112.083 178.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -68.95 -21.16 64.21 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.922 1.082 . . . . 1.0 113.922 174.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.89 -17.82 58.7 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.532 1.06 . . . . 1.0 111.188 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -97.66 -74.21 0.58 Allowed 'General case' 0 C--N 1.343 0.299 0 C-N-CA 125.129 1.372 . . . . 1.0 110.999 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.9 m 176.6 -2.69 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 127.384 2.274 . . . . 1.0 112.141 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -78.84 161.06 27.03 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 122.264 1.03 . . . . 1.0 113.507 -169.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -104.25 170.42 7.92 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.19 -1.368 . . . . 1.0 112.224 -169.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.75 145.35 50.94 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.924 1.29 . . . . 1.0 111.894 176.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 50.9 t -101.73 132.04 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 127.591 2.356 . . . . 1.0 108.639 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 46.97 -142.3 5.97 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.401 1.0 . . . . 1.0 113.889 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -100.65 -162.31 0.93 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.405 1.482 . . . . 1.0 110.29 169.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.72 157.12 22.62 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.215 1.806 . . . . 1.0 111.042 168.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 1.054 HD12 HG23 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -94.52 142.11 27.81 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 125.409 1.484 . . . . 1.0 109.484 169.13 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.5 mt -125.82 113.97 17.96 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.858 1.663 . . . . 1.0 110.379 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.557 ' CD1' HD11 ' A' ' 123' ' ' LEU . 40.5 mt -106.44 132.45 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 124.696 1.198 . . . . 1.0 113.101 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -107.57 96.9 6.72 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 128.145 2.578 . . . . 1.0 112.991 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.77 -22.8 66.85 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.913 1.079 . . . . 1.0 113.913 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.3 t -60.07 -25.25 65.23 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.434 1.094 . . . . 1.0 112.71 172.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -122.53 -29.06 4.14 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.373 1.869 . . . . 1.0 112.276 -170.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -138.5 89.36 13.77 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.794 1.238 . . . . 1.0 111.687 175.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -76.78 11.02 2.07 Favored 'Trans proline' 0 CA--C 1.549 1.246 0 C-N-CA 123.943 3.096 . . . . 1.0 114.255 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -114.54 66.68 1.72 Allowed Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 127.326 2.25 . . . . 1.0 110.112 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -57.73 -18.62 34.48 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.927 2.418 . . . . 1.0 117.738 -169.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -68.2 -25.6 65.3 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.446 1.476 . . . . 1.0 111.386 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 28.6 p -70.41 -23.46 62.75 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.756 1.162 . . . . 1.0 112.24 -173.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.425 ' HB2' HD11 ' A' ' 125' ' ' ILE . 28.6 mm-40 -93.66 -56.56 2.86 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.802 1.641 . . . . 1.0 112.081 173.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 79.0 p -68.58 -30.28 69.0 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 114.325 1.231 . . . . 1.0 114.325 -174.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -60.98 -59.28 14.34 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 120.773 1.624 . . . . 1.0 112.395 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -62.91 -24.43 74.19 Favored 'Trans proline' 0 C--N 1.352 0.743 0 CA-C-N 121.124 1.437 . . . . 1.0 113.002 173.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 73.8 t90 -70.39 -45.12 66.61 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 119.005 0.821 . . . . 1.0 111.704 175.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.614 HG11 ' HA ' ' A' ' 22' ' ' ALA . 69.1 t -66.5 -32.95 60.36 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 C-N-CA 123.167 0.587 . . . . 1.0 110.094 175.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -63.5 -48.11 78.93 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.162 -0.961 . . . . 1.0 109.822 173.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -64.16 -55.99 17.91 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.871 1.268 . . . . 1.0 111.651 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.484 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 89.0 t90 -57.17 -35.79 69.98 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 125.222 1.409 . . . . 1.0 111.785 172.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -49.75 -34.65 22.02 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.864 1.697 . . . . 1.0 113.938 171.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.6 p -67.86 -13.62 62.29 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.85 1.426 . . . . 1.0 114.85 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.18 -18.24 50.18 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.395 1.478 . . . . 1.0 111.886 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -86.32 167.87 14.39 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.193 0.997 . . . . 1.0 111.952 -175.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 11.2 m . . . . . 0 C--O 1.251 1.178 0 N-CA-C 115.725 1.75 . . . . 1.0 115.725 -169.861 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 109.776 -0.453 . . . . 1.0 109.776 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.63 142.97 50.98 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 115.321 1.6 . . . . 1.0 115.321 -169.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -125.49 122.35 36.36 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.645 1.578 . . . . 1.0 110.706 172.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 mp -121.89 113.41 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 C-N-CA 126.26 1.824 . . . . 1.0 112.416 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.12 123.75 7.27 Favored Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.169 -1.173 . . . . 1.0 110.169 169.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.9 mt -104.54 123.51 58.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 123.946 0.898 . . . . 1.0 109.355 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -115.6 111.03 20.06 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 124.766 1.227 . . . . 1.0 107.921 -170.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.3 p -96.45 128.11 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 112.412 0.523 . . . . 1.0 112.412 -175.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -119.28 120.41 4.62 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.781 1.181 . . . . 1.0 111.22 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.5 t -165.6 145.86 6.77 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 119.728 1.764 . . . . 1.0 113.73 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.1 tpt -98.3 -17.43 18.91 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.603 1.161 . . . . 1.0 110.243 168.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -80.43 -26.86 38.16 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.564 1.546 . . . . 1.0 112.376 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.14 -43.53 2.49 Favored Glycine 0 N--CA 1.474 1.196 0 C-N-CA 125.642 1.592 . . . . 1.0 114.42 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -60.02 -23.42 63.67 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.795 1.238 . . . . 1.0 113.021 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.42 -18.01 35.62 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.058 1.343 . . . . 1.0 113.888 177.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.9 tp -47.92 -39.47 19.15 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.017 1.327 . . . . 1.0 111.814 169.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.3 tp -47.48 -54.13 12.36 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.611 1.164 . . . . 1.0 112.494 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.1 t -58.35 -37.26 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 119.127 -0.464 . . . . 1.0 111.132 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.56 -45.87 88.52 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.768 1.167 . . . . 1.0 112.859 173.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -63.49 -33.4 75.49 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.454 0.645 . . . . 1.0 110.966 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -69.93 -46.93 64.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.762 0.825 . . . . 1.0 109.818 176.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.856 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -55.42 -45.43 76.73 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.959 1.304 . . . . 1.0 113.017 176.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.33 -49.26 78.52 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.855 0.462 . . . . 1.0 110.181 173.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.6 -37.47 73.88 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.449 -0.782 . . . . 1.0 112.867 -173.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.575 ' CG2' HG12 ' A' ' 141' ' ' VAL . 16.5 mt -69.42 -48.17 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 124.501 1.12 . . . . 1.0 109.447 175.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.478 HD23 ' CG1' ' A' ' 141' ' ' VAL . 0.5 OUTLIER -62.17 -34.86 77.21 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 122.485 1.136 . . . . 1.0 109.185 -178.163 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.3 m -62.28 -44.9 95.47 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.602 1.161 . . . . 1.0 112.704 172.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.78 -29.82 69.12 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.676 1.19 . . . . 1.0 113.439 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -65.23 -33.94 77.17 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.516 1.526 . . . . 1.0 110.981 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.52 13.3 1.13 Allowed Glycine 0 CA--C 1.535 1.293 0 N-CA-C 115.864 1.105 . . . . 1.0 115.864 169.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 -108.02 177.02 4.93 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.985 1.314 . . . . 1.0 111.725 -169.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -101.5 99.71 10.06 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.053 1.341 . . . . 1.0 108.564 169.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.26 148.85 36.78 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.58 0.752 . . . . 1.0 111.217 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.4 m -149.0 146.12 27.64 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.146 0.978 . . . . 1.0 111.459 -174.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.9 t -95.93 137.08 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 114.168 1.173 . . . . 1.0 114.168 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -115.34 122.4 45.76 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.135 1.774 . . . . 1.0 110.995 169.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -103.21 137.0 41.95 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.597 1.959 . . . . 1.0 111.272 -177.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.6 t0 41.48 53.15 6.95 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 124.339 1.056 . . . . 1.0 111.237 -169.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -68.28 142.43 55.13 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.861 3.041 . . . . 1.0 116.85 -168.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.451 ' HB3' ' H ' ' A' ' 42' ' ' SER . 49.9 mm-40 -92.41 163.43 13.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 122.666 1.222 . . . . 1.0 111.309 168.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.62 HD21 HD21 ' A' ' 79' ' ' LEU . 2.1 tm? -66.0 -20.84 66.32 Favored 'General case' 0 N--CA 1.442 -0.856 0 O-C-N 120.688 -1.257 . . . . 1.0 110.388 167.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.451 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 16.1 m -68.49 -20.54 64.6 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 120.793 -1.192 . . . . 1.0 112.126 172.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -82.58 -24.47 33.94 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.292 1.037 . . . . 1.0 112.446 170.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.515 ' HB3' HD22 ' A' ' 41' ' ' LEU . 12.3 t-105 -88.68 -35.05 16.99 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.453 1.279 . . . . 1.0 114.453 -178.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.7 mt -47.73 -37.37 12.71 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-O 117.466 -1.254 . . . . 1.0 114.129 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -58.79 -11.02 10.77 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.697 2.932 . . . . 1.0 117.27 175.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -114.81 9.31 16.25 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 116.303 1.964 . . . . 1.0 116.303 -174.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -51.24 -27.15 8.37 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 127.259 2.224 . . . . 1.0 114.048 175.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -117.28 13.02 14.51 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.299 1.84 . . . . 1.0 113.323 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -126.85 -155.41 0.69 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.889 2.476 . . . . 1.0 110.978 -175.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -115.96 162.64 17.07 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 122.906 1.336 . . . . 1.0 112.073 175.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.564 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -152.24 157.36 5.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 124.798 1.239 . . . . 1.0 109.053 -171.098 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.626 HD11 HD12 ' A' ' 90' ' ' ILE . 15.4 tp -139.98 127.82 21.98 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.559 1.143 . . . . 1.0 109.388 176.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.1 t -103.41 120.43 53.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 124.271 1.028 . . . . 1.0 109.001 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.0 t -118.4 112.21 37.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 105.602 -1.999 . . . . 1.0 105.602 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.3 t -147.09 121.13 9.4 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.237 1.569 . . . . 1.0 115.237 -168.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.8 m -96.65 -174.5 3.04 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.872 2.069 . . . . 1.0 110.951 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.2 m 63.79 41.24 7.01 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.511 0.93 . . . . 1.0 113.511 169.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.6 m -57.9 -39.13 77.17 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.643 0.777 . . . . 1.0 111.356 169.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.85 -128.98 44.41 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 121.516 -0.74 . . . . 1.0 111.993 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -68.34 -10.61 56.12 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.24 1.2 . . . . 1.0 114.24 175.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.06 7.55 0.19 Allowed Glycine 0 CA--C 1.539 1.58 0 N-CA-C 117.771 1.868 . . . . 1.0 117.771 170.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -116.63 -141.5 0.37 Allowed 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 119.653 1.726 . . . . 1.0 112.418 -169.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 85.9 mt -135.22 154.48 78.84 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.855 1.662 . . . . 1.0 113.59 -172.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.11 152.91 46.13 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.395 2.73 . . . . 1.0 111.763 169.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -63.64 -17.17 62.64 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.457 1.28 . . . . 1.0 114.457 -176.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.2 p -73.16 -17.38 61.38 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.955 1.302 . . . . 1.0 114.371 173.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.5 tt -123.12 -13.47 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 114.692 1.368 . . . . 1.0 114.692 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -42.76 -52.62 10.84 Favored Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 124.532 1.133 . . . . 1.0 112.588 168.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -67.8 -32.04 30.55 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.87 1.713 . . . . 1.0 111.985 -173.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.7 tp -63.64 -53.19 55.38 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 124.283 1.033 . . . . 1.0 111.225 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.695 ' CE1' HD23 ' A' ' 110' ' ' LEU . 93.0 t80 -55.05 -52.99 61.46 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.726 0.81 . . . . 1.0 112.572 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -64.32 -40.52 96.08 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.813 0.845 . . . . 1.0 111.433 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.61 -35.29 89.69 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 119.662 -0.521 . . . . 1.0 112.557 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.602 HG22 HD12 ' A' ' 110' ' ' LEU . 89.1 mt -65.69 -47.46 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 120.145 1.972 . . . . 1.0 108.382 172.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.717 ' HB3' HD21 ' A' ' 110' ' ' LEU . 3.2 ptmm? -71.43 -32.22 68.11 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 120.309 -1.494 . . . . 1.0 113.508 -171.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -105.92 -36.82 6.87 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 115.028 1.492 . . . . 1.0 115.028 -173.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 m -94.73 -24.85 16.94 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.261 1.025 . . . . 1.0 112.663 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.62 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -90.23 -72.53 0.56 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.15 -1.426 . . . . 1.0 107.15 169.422 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.0 -9.35 2.06 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 126.316 1.912 . . . . 1.0 115.265 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -152.35 145.87 24.91 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.929 2.892 . . . . 1.0 107.499 171.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -136.82 128.5 16.84 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-O 118.438 -0.792 . . . . 1.0 110.435 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -83.68 -42.86 0.08 OUTLIER 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.148 1.899 . . . . 1.0 114.445 -171.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -147.32 20.7 1.21 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.045 1.338 . . . . 1.0 113.74 -170.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.564 HD11 ' CG2' ' A' ' 52' ' ' VAL . 51.0 tp -78.46 141.34 38.34 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.451 -1.405 . . . . 1.0 113.459 -169.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.87 149.73 49.12 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 128.766 2.826 . . . . 1.0 108.196 169.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.653 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -159.9 168.16 26.4 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.382 0.882 . . . . 1.0 113.382 -178.151 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.471 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -124.39 168.95 16.43 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 125.361 1.457 . . . . 1.0 114.026 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.0 t -143.75 133.39 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.536 1.134 . . . . 1.0 113.338 -169.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.972 HG23 HD12 ' A' ' 123' ' ' LEU . 3.7 mt -129.43 100.15 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 126.036 1.735 . . . . 1.0 107.346 169.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.48 145.62 25.18 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.686 1.194 . . . . 1.0 112.045 174.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.6 mp -138.04 150.83 47.29 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.804 0.841 . . . . 1.0 112.774 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.64 -152.39 21.69 Favored Glycine 0 C--O 1.223 -0.571 0 C-N-CA 121.081 -0.58 . . . . 1.0 113.744 169.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -112.96 114.16 26.53 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.92 0.888 . . . . 1.0 110.302 -176.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.6 t -64.7 -3.75 3.56 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.164 1.172 . . . . 1.0 114.164 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.7 t -63.91 -26.07 68.43 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.762 -1.211 . . . . 1.0 112.056 169.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -79.26 147.98 32.34 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.357 -0.839 . . . . 1.0 111.909 169.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -53.41 -55.0 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.614 1.566 . . . . 1.0 113.828 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -87.35 56.91 4.17 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.023 1.729 . . . . 1.0 112.23 -173.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -52.23 127.78 23.02 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.125 0.97 . . . . 1.0 113.335 -175.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 21.7 m 56.07 17.46 2.68 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.237 1.815 . . . . 1.0 115.54 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -63.97 -18.24 64.08 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.17 1.174 . . . . 1.0 114.17 -175.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.34 -49.28 69.62 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-N 119.872 1.214 . . . . 1.0 113.368 171.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -75.47 -34.25 50.66 Favored Glycine 0 N--CA 1.478 1.443 0 O-C-N 120.705 -1.468 . . . . 1.0 113.23 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -61.35 -34.47 75.34 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.263 -1.139 . . . . 1.0 112.731 173.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -63.3 -39.77 95.51 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.865 0.866 . . . . 1.0 112.316 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.1 -40.0 96.35 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.036 0.835 . . . . 1.0 110.697 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -41.07 98.03 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.427 -0.796 . . . . 1.0 112.583 176.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.63 -46.19 89.74 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 118.744 -0.646 . . . . 1.0 111.997 170.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.717 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -49.56 -49.31 46.86 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.259 2.224 . . . . 1.0 111.932 -172.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.653 HD12 ' CD1' ' A' ' 87' ' ' TYR . 8.1 mt -66.0 -43.03 88.93 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.214 -0.903 . . . . 1.0 111.439 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -66.96 -22.03 65.95 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -66.08 -35.87 81.67 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.422 1.089 . . . . 1.0 111.46 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -82.65 -75.87 0.29 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 113.785 -1.552 . . . . 1.0 110.432 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.43 ' H ' ' H ' ' A' ' 116' ' ' ALA . 2.7 t 179.0 -3.22 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.11 2.164 . . . . 1.0 111.574 173.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -75.24 150.44 38.59 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 122.775 1.274 . . . . 1.0 112.83 -169.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -90.61 172.48 8.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.271 -1.786 . . . . 1.0 113.036 -168.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.36 139.03 46.58 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.322 1.849 . . . . 1.0 109.914 -175.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.589 HG12 ' H ' ' A' ' 120' ' ' GLY 0.258 20.2 t -90.86 -163.3 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 107.786 -1.19 . . . . 1.0 107.786 178.035 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.589 ' H ' HG12 ' A' ' 119' ' ' VAL . . . -48.6 149.73 3.89 Favored Glycine 0 CA--C 1.544 1.867 0 O-C-N 120.067 -1.646 . . . . 1.0 113.936 177.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -59.73 146.49 41.27 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.21 1.404 . . . . 1.0 112.701 -171.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -67.62 158.78 31.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.767 1.627 . . . . 1.0 114.759 -168.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.972 HD12 HG23 ' A' ' 90' ' ' ILE . 1.0 OUTLIER -90.44 138.91 31.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.272 -1.331 . . . . 1.0 109.133 169.083 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.1 mt -126.61 110.05 12.78 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.359 1.464 . . . . 1.0 109.828 173.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.573 HG13 HD11 ' A' ' 123' ' ' LEU . 27.3 mt -97.59 129.07 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 124.06 0.944 . . . . 1.0 112.394 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -103.76 110.35 22.41 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.113 0.959 . . . . 1.0 111.709 173.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.39 -22.08 64.66 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.298 1.039 . . . . 1.0 113.241 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.6 t -64.55 -22.41 66.96 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.679 0.792 . . . . 1.0 112.895 173.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -119.93 -30.17 4.78 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.267 1.827 . . . . 1.0 112.0 -173.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.26 82.78 12.81 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.904 1.282 . . . . 1.0 112.515 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -75.42 6.56 3.5 Favored 'Trans proline' 0 CA--C 1.549 1.235 0 C-N-CA 123.791 2.994 . . . . 1.0 114.737 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -109.7 72.23 0.58 Allowed Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 127.2 2.2 . . . . 1.0 110.074 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -59.09 -26.92 83.51 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.481 2.12 . . . . 1.0 117.073 -169.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -65.91 -24.67 66.88 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.924 1.238 . . . . 1.0 110.983 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 31.9 p -71.42 -18.1 62.35 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.937 -1.102 . . . . 1.0 112.311 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.427 ' HB2' HD11 ' A' ' 125' ' ' ILE . 4.8 mm-40 -102.22 -55.17 2.53 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.296 1.838 . . . . 1.0 111.442 177.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.4 p -68.64 -35.04 76.75 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 114.18 1.178 . . . . 1.0 114.18 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -60.36 -55.4 45.59 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 120.992 1.724 . . . . 1.0 112.392 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -63.41 -26.88 70.8 Favored 'Trans proline' 0 C--N 1.351 0.68 0 CA-C-N 121.881 1.708 . . . . 1.0 112.665 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.477 ' CG ' ' HB2' ' A' ' 123' ' ' LEU . 88.8 t90 -63.57 -45.64 89.53 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 118.807 0.731 . . . . 1.0 111.192 172.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.856 HG11 ' HA ' ' A' ' 22' ' ' ALA . 53.1 t -66.75 -34.09 67.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.437 1.095 . . . . 1.0 109.537 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -70.63 -21.22 62.65 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.469 1.508 . . . . 1.0 113.189 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -87.64 -58.07 2.71 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.435 1.894 . . . . 1.0 109.878 168.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.471 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 89.8 t90 -58.58 -39.62 80.85 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.001 1.72 . . . . 1.0 113.861 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -53.5 -27.15 33.02 Favored Glycine 0 CA--C 1.537 1.439 0 O-C-N 121.11 -0.994 . . . . 1.0 113.936 173.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.4 p -68.94 -15.0 63.37 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.729 1.764 . . . . 1.0 114.045 175.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.77 -15.98 56.44 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.431 1.492 . . . . 1.0 111.669 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -76.59 169.34 18.45 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.97 0.908 . . . . 1.0 111.214 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.255 1.343 0 N-CA-C 114.866 1.432 . . . . 1.0 114.866 -173.368 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttm . . . . . 0 N--CA 1.499 1.976 0 CA-C-O 119.816 -0.135 . . . . 1.0 110.966 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.56 152.66 40.54 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.084 0.772 . . . . 1.0 113.084 175.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -121.73 121.81 38.12 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.56 1.144 . . . . 1.0 110.709 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.512 HD13 HD12 ' A' ' 26' ' ' LEU . 2.2 mp -117.31 114.34 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 C-N-CA 126.138 1.775 . . . . 1.0 112.597 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.54 121.86 6.4 Favored Glycine 0 C--O 1.224 -0.522 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 169.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 mt -105.51 125.25 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 118.666 1.233 . . . . 1.0 109.411 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -118.31 111.78 19.2 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.763 -0.829 . . . . 1.0 108.763 -169.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p -95.07 127.79 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 112.165 0.431 . . . . 1.0 112.165 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -120.12 94.15 0.56 Allowed Glycine 0 N--CA 1.463 0.449 0 C-N-CA 124.666 1.127 . . . . 1.0 112.298 177.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -158.21 160.35 37.07 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.35 0.66 . . . . 1.0 111.681 172.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 93.5 mtp -126.97 18.56 7.18 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.797 2.039 . . . . 1.0 110.206 169.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -137.8 166.33 24.27 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.457 1.903 . . . . 1.0 111.953 -169.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.36 -163.52 52.88 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.011 0.815 . . . . 1.0 114.48 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -111.57 143.1 42.98 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.783 1.233 . . . . 1.0 112.727 -173.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 86.7 p 47.84 15.27 0.06 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 118.801 2.889 . . . . 1.0 118.801 169.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.2 mt 53.99 25.21 5.24 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.693 1.197 . . . . 1.0 112.569 -171.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.5 tp -25.65 -70.64 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 129.852 3.261 . . . . 1.0 118.336 -168.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 81.2 t -56.46 -36.36 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 118.697 0.68 . . . . 1.0 112.071 -169.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.76 -38.61 86.95 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.682 -1.261 . . . . 1.0 112.732 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.415 ' HA ' HG11 ' A' ' 35' ' ' VAL . 20.4 mm-40 -66.65 -35.72 80.85 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.015 0.436 . . . . 1.0 110.869 174.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -66.29 -44.81 82.46 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 123.806 0.843 . . . . 1.0 109.1 176.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.535 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -63.88 -41.49 97.72 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 123.343 0.657 . . . . 1.0 112.671 -176.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -56.06 -48.85 75.26 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 170.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.19 -38.23 75.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.684 0.794 . . . . 1.0 112.828 -173.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.7 mt -66.61 -47.6 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-N 119.177 0.899 . . . . 1.0 108.945 175.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.512 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -66.17 -33.9 76.81 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 119.459 -0.897 . . . . 1.0 111.021 -176.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.9 m -63.2 -41.9 99.23 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.325 1.45 . . . . 1.0 113.207 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.52 -32.1 71.81 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.105 0.962 . . . . 1.0 112.433 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -69.56 -29.16 66.67 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.432 1.093 . . . . 1.0 113.051 170.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.17 29.33 2.58 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.526 1.06 . . . . 1.0 113.668 170.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -112.32 155.59 23.84 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.441 1.096 . . . . 1.0 109.267 175.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -86.95 78.46 9.0 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.688 1.195 . . . . 1.0 108.369 -177.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.5 142.84 26.97 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.374 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 96.4 m -143.32 127.48 17.56 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 124.484 1.113 . . . . 1.0 109.333 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.415 HG11 ' HA ' ' A' ' 20' ' ' GLU . 3.6 p -92.28 140.67 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 114.378 1.251 . . . . 1.0 114.378 170.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -114.44 127.64 55.93 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.808 2.043 . . . . 1.0 111.144 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -100.86 132.54 46.21 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.637 1.975 . . . . 1.0 110.481 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.6 t0 43.76 55.59 12.2 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 124.1 0.96 . . . . 1.0 111.653 -169.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -68.81 144.24 58.49 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.067 3.178 . . . . 1.0 117.061 -168.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.425 ' HB3' ' H ' ' A' ' 42' ' ' SER . 54.9 mm-40 -95.22 163.89 13.08 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 122.465 1.126 . . . . 1.0 111.979 168.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.55 HD21 HD21 ' A' ' 79' ' ' LEU . 2.2 tm? -66.55 -21.23 66.15 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 120.959 -1.088 . . . . 1.0 110.16 167.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.425 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 18.8 m -68.1 -21.51 64.95 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.864 -1.148 . . . . 1.0 112.242 172.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -82.02 -24.37 35.41 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.355 1.062 . . . . 1.0 112.449 170.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.451 ' HB3' HD22 ' A' ' 41' ' ' LEU . 11.5 t-105 -88.55 -34.23 17.44 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.115 1.154 . . . . 1.0 114.115 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.1 mt -48.41 -38.41 22.3 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-O 117.538 -1.22 . . . . 1.0 114.209 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -57.81 -18.64 35.22 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.669 2.912 . . . . 1.0 116.435 174.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -105.03 7.4 33.98 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.774 1.768 . . . . 1.0 115.774 -171.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -53.37 -31.12 43.19 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.507 1.923 . . . . 1.0 113.857 176.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -112.42 8.48 19.48 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.081 1.352 . . . . 1.0 112.664 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -113.72 -162.86 0.83 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.815 2.446 . . . . 1.0 110.727 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -109.1 161.63 15.01 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.849 1.309 . . . . 1.0 111.443 169.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.556 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -146.89 157.35 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.537 1.135 . . . . 1.0 109.268 -171.491 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.1 tp -138.99 128.99 25.13 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.891 1.276 . . . . 1.0 108.553 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.4 t -103.36 128.59 56.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.933 -0.765 . . . . 1.0 108.933 175.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.45 112.15 30.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 105.925 -1.88 . . . . 1.0 105.925 176.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -149.23 135.34 19.05 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.181 1.548 . . . . 1.0 115.181 -167.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.5 m -116.07 158.81 22.59 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.726 1.61 . . . . 1.0 112.998 -169.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.7 m 64.1 66.63 0.63 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.304 1.441 . . . . 1.0 112.479 169.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.4 m -55.87 -28.33 56.06 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.787 2.035 . . . . 1.0 113.875 170.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.06 -128.96 38.76 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 121.379 -0.825 . . . . 1.0 113.666 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -83.09 16.57 2.31 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.133 1.373 . . . . 1.0 112.887 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.28 41.04 4.08 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.04 1.305 . . . . 1.0 112.165 -169.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -131.89 167.41 19.66 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.952 2.101 . . . . 1.0 112.43 -173.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.9 mt -116.69 150.85 46.4 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.47 1.108 . . . . 1.0 113.537 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -59.24 145.82 96.57 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.604 2.87 . . . . 1.0 113.202 171.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -61.94 -22.06 65.3 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.874 1.064 . . . . 1.0 113.874 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.6 p -72.39 -22.51 61.12 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.405 1.261 . . . . 1.0 114.405 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 tt -115.77 -15.46 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.109 1.363 . . . . 1.0 114.141 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -43.27 -53.25 11.43 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 124.383 1.073 . . . . 1.0 112.034 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -67.81 -31.1 32.6 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 121.677 1.585 . . . . 1.0 111.873 -173.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.8 tp -65.35 -53.18 47.32 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 124.475 1.11 . . . . 1.0 111.417 170.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.626 ' CE1' HD23 ' A' ' 110' ' ' LEU . 93.3 t80 -55.51 -53.23 58.9 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.778 0.831 . . . . 1.0 112.385 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -69.08 -35.17 76.2 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.63 -0.714 . . . . 1.0 111.813 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.68 -35.79 91.51 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 121.819 -0.551 . . . . 1.0 112.502 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.602 HG22 HD12 ' A' ' 110' ' ' LEU . 87.4 mt -65.12 -49.77 77.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.899 1.849 . . . . 1.0 108.296 171.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.677 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.2 ptmm? -69.72 -31.43 69.43 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.505 -1.372 . . . . 1.0 112.947 -169.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -105.28 -39.91 6.02 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 115.334 1.605 . . . . 1.0 115.334 -175.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.8 m -93.88 -23.04 18.26 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.239 1.016 . . . . 1.0 112.962 -174.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.55 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -91.1 -70.33 0.69 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 106.81 -1.552 . . . . 1.0 106.81 169.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.03 -11.44 1.35 Allowed Glycine 0 CA--C 1.538 1.481 0 C-N-CA 127.438 2.446 . . . . 1.0 116.514 169.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -155.77 141.08 17.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.825 2.45 . . . . 1.0 108.513 172.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.476 HE22 HD12 ' A' ' 79' ' ' LEU . 2.2 mm-40 -137.43 125.84 14.62 Favored Pre-proline 0 CA--C 1.546 0.815 0 O-C-N 121.281 -0.887 . . . . 1.0 111.097 -173.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.81 -40.52 0.09 OUTLIER 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.849 2.366 . . . . 1.0 114.87 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -140.31 13.85 2.39 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.866 1.432 . . . . 1.0 114.866 -169.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.556 HD11 ' CG2' ' A' ' 52' ' ' VAL . 40.9 tp -74.86 141.26 44.24 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.582 -1.323 . . . . 1.0 113.491 -169.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -132.83 147.39 52.3 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.195 2.598 . . . . 1.0 107.719 169.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.635 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -156.95 165.53 35.92 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.219 0.918 . . . . 1.0 113.349 178.623 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.407 ' HA3' ' CE2' ' A' ' 144' ' ' TRP . . . -127.0 173.33 18.41 Favored Glycine 0 N--CA 1.471 0.978 0 C-N-CA 125.35 1.452 . . . . 1.0 112.338 170.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.492 HG13 ' HB3' ' A' ' 122' ' ' MET . 0.2 OUTLIER -158.81 146.22 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 114.536 1.31 . . . . 1.0 114.536 -169.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.0 mt -133.5 109.41 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 127.478 2.311 . . . . 1.0 107.736 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -94.68 142.0 27.96 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.023 1.729 . . . . 1.0 111.466 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.6 mp -137.26 154.39 50.14 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.375 0.88 . . . . 1.0 113.375 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.91 -179.04 39.1 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 114.274 0.47 . . . . 1.0 114.274 168.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -93.95 114.07 26.2 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.655 -0.909 . . . . 1.0 109.479 171.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 92.8 p -59.22 -15.02 12.81 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.32 1.23 . . . . 1.0 114.32 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.4 t -64.83 -19.27 65.77 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.723 0.809 . . . . 1.0 112.968 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -89.76 7.67 35.69 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.142 1.377 . . . . 1.0 114.497 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.333 1.0 OUTLIER 56.22 176.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 129.771 3.228 . . . . 1.0 114.831 -177.305 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 60.86 8.59 1.9 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.939 1.696 . . . . 1.0 115.389 -170.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.4 t80 22.68 -78.97 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 130.524 3.53 . . . . 1.0 117.05 -169.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.445 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 20.8 p -122.82 7.26 9.35 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.768 1.627 . . . . 1.0 114.329 -169.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -61.01 -21.22 63.38 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.831 1.252 . . . . 1.0 114.299 -170.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.93 -37.85 95.6 Favored Glycine 0 CA--C 1.535 1.326 0 CA-C-N 119.881 1.219 . . . . 1.0 113.109 171.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.79 -38.22 24.23 Favored Glycine 0 N--CA 1.476 1.318 0 O-C-N 121.407 -1.055 . . . . 1.0 113.046 172.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.445 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 89.2 mttt -62.12 -29.31 70.24 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 120.978 -1.307 . . . . 1.0 113.388 173.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -64.03 -28.98 70.17 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.059 0.763 . . . . 1.0 113.059 171.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -66.36 -35.57 80.67 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.643 1.11 . . . . 1.0 111.304 171.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -63.53 -48.96 75.39 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.239 -0.913 . . . . 1.0 110.968 172.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.25 -34.61 66.55 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.804 0.668 . . . . 1.0 112.804 175.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.677 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -59.93 -49.94 75.7 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 123.321 1.534 . . . . 1.0 110.83 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.635 HD12 ' CD1' ' A' ' 87' ' ' TYR . 9.9 mt -66.08 -37.83 86.78 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 120.908 -1.12 . . . . 1.0 111.717 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -69.02 -21.16 64.14 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.992 1.108 . . . . 1.0 113.992 174.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.91 -18.13 58.49 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.277 0.944 . . . . 1.0 111.238 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -96.83 -76.7 0.51 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.287 1.435 . . . . 1.0 110.574 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.3 m 178.32 -2.57 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 127.318 2.247 . . . . 1.0 112.154 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.527 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -77.13 159.55 29.68 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.043 0.925 . . . . 1.0 112.877 -169.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -100.97 174.19 6.13 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.246 -1.343 . . . . 1.0 111.559 -169.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.4 ttm105 -127.36 156.38 42.09 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.865 1.266 . . . . 1.0 112.731 171.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 120' ' ' GLY . 17.3 t -95.43 -168.81 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 C-N-CA 127.333 2.253 . . . . 1.0 105.93 169.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.541 ' H ' HG12 ' A' ' 119' ' ' VAL . . . -49.05 154.96 1.87 Allowed Glycine 0 CA--C 1.542 1.762 0 O-C-N 120.402 -1.436 . . . . 1.0 115.586 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -59.17 149.59 27.81 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.085 1.354 . . . . 1.0 113.15 -171.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.492 ' HB3' HG13 ' A' ' 89' ' ' VAL . 1.1 pmm? -73.78 157.8 35.75 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 122.462 1.125 . . . . 1.0 112.38 -169.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.65 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.2 tm? -86.7 140.51 29.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.824 -1.08 . . . . 1.0 109.39 171.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.65 ' N ' HD13 ' A' ' 123' ' ' LEU . 5.6 mt -123.65 104.39 8.99 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.818 1.247 . . . . 1.0 110.886 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.442 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.9 mt -90.26 128.21 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 125.109 1.363 . . . . 1.0 111.652 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -108.16 109.52 20.94 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 124.3 1.0 . . . . 1.0 112.174 171.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.76 -20.74 65.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.788 0.835 . . . . 1.0 112.948 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.2 t -63.6 -21.4 66.34 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.724 1.21 . . . . 1.0 112.675 173.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -124.67 -29.62 3.41 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.149 1.78 . . . . 1.0 112.584 -173.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -140.59 87.11 11.77 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.479 1.512 . . . . 1.0 112.068 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.2 6.85 2.8 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 123.675 2.917 . . . . 1.0 114.631 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -112.81 71.86 1.33 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 127.449 2.299 . . . . 1.0 109.699 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -57.87 -23.32 58.59 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.434 2.089 . . . . 1.0 116.827 -168.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -65.62 -25.69 67.49 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 119.128 0.876 . . . . 1.0 111.733 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 p -73.5 -16.99 61.27 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 120.902 -1.124 . . . . 1.0 111.706 -175.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -102.27 -53.87 2.81 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.163 1.785 . . . . 1.0 111.212 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 59.3 p -72.14 -33.9 68.13 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 114.706 1.372 . . . . 1.0 114.706 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -60.18 -55.55 44.2 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 120.923 1.692 . . . . 1.0 112.64 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -62.33 -22.64 74.39 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 121.329 1.51 . . . . 1.0 112.628 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.477 ' HB2' HD23 ' A' ' 123' ' ' LEU . 90.1 t90 -70.26 -45.55 66.19 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 121.67 -0.644 . . . . 1.0 111.264 174.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.535 HG11 ' HA ' ' A' ' 22' ' ' ALA . 91.5 t -64.69 -34.22 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.835 -0.802 . . . . 1.0 108.835 176.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.75 -29.77 68.24 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.132 1.373 . . . . 1.0 112.195 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -79.9 -61.38 2.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.104 1.762 . . . . 1.0 112.239 171.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.407 ' CE2' ' HA3' ' A' ' 88' ' ' GLY . 85.3 t90 -56.76 -36.43 69.78 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 126.724 2.01 . . . . 1.0 112.49 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.46 -32.28 22.86 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.684 1.135 . . . . 1.0 113.438 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 p -70.22 -13.12 62.04 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.332 1.234 . . . . 1.0 114.332 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.0 -14.72 55.57 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.151 1.78 . . . . 1.0 111.773 175.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.57 -178.27 5.77 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.223 1.009 . . . . 1.0 110.45 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 9.7 m . . . . . 0 C--O 1.254 1.324 0 C-N-CA 126.607 1.963 . . . . 1.0 114.251 -179.444 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttp . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 119.951 -0.071 . . . . 1.0 110.859 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.86 168.82 19.32 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.309 1.444 . . . . 1.0 113.058 -176.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -113.73 124.73 52.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.369 -1.287 . . . . 1.0 111.877 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.521 HD13 HD12 ' A' ' 26' ' ' LEU . 1.7 mp -120.92 112.82 37.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 126.424 1.889 . . . . 1.0 113.044 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.64 122.59 6.84 Favored Glycine 0 N--CA 1.467 0.742 0 N-CA-C 110.918 -0.873 . . . . 1.0 110.918 169.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.5 mt -104.17 119.63 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 118.464 1.132 . . . . 1.0 109.804 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -112.17 108.91 18.33 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.635 -1.246 . . . . 1.0 107.635 -171.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 p -96.64 118.66 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.288 0.566 . . . . 1.0 112.434 -169.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -92.03 109.31 3.73 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 109.287 -1.525 . . . . 1.0 109.287 171.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 t -148.86 165.1 32.51 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.757 1.021 . . . . 1.0 113.757 -169.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 76.3 mtm -75.42 173.99 10.2 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.181 0.992 . . . . 1.0 109.349 168.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -52.27 144.11 13.41 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 113.962 1.097 . . . . 1.0 113.962 -175.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.94 -165.66 52.81 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.269 0.938 . . . . 1.0 113.91 -175.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -81.93 56.11 2.99 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.155 0.982 . . . . 1.0 111.776 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 55.3 m -82.59 -0.71 48.2 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.847 1.425 . . . . 1.0 114.847 -172.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.63 63.3 1.55 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 122.361 1.077 . . . . 1.0 112.998 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.8 tp -26.3 -45.16 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 129.449 3.099 . . . . 1.0 116.121 170.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.4 t -47.87 -32.36 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.114 1.366 . . . . 1.0 112.727 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.15 -49.19 76.72 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.632 -1.293 . . . . 1.0 113.113 172.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -67.71 -30.33 69.8 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.674 1.19 . . . . 1.0 110.648 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.29 -46.62 69.82 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 123.397 0.679 . . . . 1.0 109.297 173.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.557 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.36 -42.12 93.13 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 123.225 0.61 . . . . 1.0 112.329 -176.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -54.27 -49.13 70.28 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.121 0.968 . . . . 1.0 110.312 169.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.57 -38.7 70.9 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.633 0.773 . . . . 1.0 112.453 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.4 mt -68.04 -45.81 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 O-C-N 121.117 -0.989 . . . . 1.0 109.357 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.521 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.76 -31.5 72.52 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.56 1.073 . . . . 1.0 110.708 -178.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.6 m -63.14 -45.05 93.78 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.241 1.016 . . . . 1.0 112.919 169.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.65 -30.89 69.69 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.777 1.231 . . . . 1.0 113.163 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -67.33 -27.64 67.31 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.485 1.914 . . . . 1.0 111.809 172.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.32 26.21 2.73 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.535 1.064 . . . . 1.0 114.737 171.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -117.54 173.19 6.86 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.999 1.319 . . . . 1.0 110.304 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -102.04 94.14 5.62 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 125.459 1.503 . . . . 1.0 108.429 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.34 147.44 31.51 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.283 0.633 . . . . 1.0 111.459 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.3 m -146.81 140.38 25.75 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.153 0.981 . . . . 1.0 112.428 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.1 t -87.2 137.71 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 115.071 1.508 . . . . 1.0 115.071 172.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -116.86 109.86 17.62 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.132 2.173 . . . . 1.0 109.993 169.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -88.04 145.93 25.73 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.081 1.752 . . . . 1.0 110.84 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.1 t0 43.33 57.77 12.21 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 124.517 1.127 . . . . 1.0 110.264 -169.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -55.23 128.06 28.89 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.775 3.65 . . . . 1.0 118.486 -167.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -91.75 150.34 21.15 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.368 1.467 . . . . 1.0 113.131 169.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.487 HD21 HD21 ' A' ' 79' ' ' LEU . 2.6 tm? -70.6 -25.9 63.26 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.342 -0.849 . . . . 1.0 110.175 168.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.1 m -66.53 -20.97 66.16 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.494 -0.753 . . . . 1.0 112.272 171.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -87.14 -24.07 24.63 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.252 1.021 . . . . 1.0 113.249 169.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.463 ' HB3' HD22 ' A' ' 41' ' ' LEU . 15.2 t-105 -79.4 -36.08 39.67 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.608 1.095 . . . . 1.0 113.529 175.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.9 mt -48.82 -40.53 43.41 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 117.845 -1.074 . . . . 1.0 113.879 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -53.8 -15.72 7.37 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.613 3.542 . . . . 1.0 117.826 172.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -110.46 8.0 22.94 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 116.139 1.903 . . . . 1.0 116.139 -172.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -53.11 -29.28 29.89 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.612 1.965 . . . . 1.0 114.115 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -114.28 11.68 17.46 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.151 1.781 . . . . 1.0 113.267 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -125.57 -159.54 0.91 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.611 2.365 . . . . 1.0 110.818 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -113.24 158.9 19.91 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 123.211 1.481 . . . . 1.0 113.073 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.584 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -147.37 156.61 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 125.302 1.441 . . . . 1.0 109.796 -170.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.676 HD11 HD12 ' A' ' 90' ' ' ILE . 19.4 tp -139.36 127.59 22.62 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.733 1.213 . . . . 1.0 109.044 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.9 t -102.42 123.03 55.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 123.762 0.825 . . . . 1.0 109.151 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.4 t -122.46 111.96 32.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 105.057 -2.201 . . . . 1.0 105.057 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -146.59 129.29 16.15 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.852 1.056 . . . . 1.0 113.852 -167.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 t -116.26 179.37 4.01 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.748 1.219 . . . . 1.0 113.125 -169.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.335 5.0 t 56.68 41.02 28.92 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.398 1.879 . . . . 1.0 113.488 169.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.9 m -49.79 -43.03 48.13 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.38 1.472 . . . . 1.0 112.306 169.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 52.52 -122.26 18.24 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 123.964 0.792 . . . . 1.0 112.844 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -62.92 -15.14 54.31 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.283 1.216 . . . . 1.0 114.283 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.46 -11.55 2.73 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 116.05 1.18 . . . . 1.0 116.05 169.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -87.45 -174.87 5.02 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.799 1.64 . . . . 1.0 113.152 -174.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 74.2 mt -105.32 152.17 39.8 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 126.724 2.009 . . . . 1.0 112.764 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.03 152.02 62.34 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.623 2.215 . . . . 1.0 111.726 169.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -64.31 -16.8 62.86 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.728 1.381 . . . . 1.0 114.728 -172.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.8 p -73.14 -23.43 60.46 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.643 1.177 . . . . 1.0 113.981 173.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.8 tt -118.95 -14.8 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 114.394 1.257 . . . . 1.0 114.394 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.9 t -45.13 -51.95 22.2 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 124.267 1.027 . . . . 1.0 111.717 168.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.42 -29.5 20.61 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.329 1.353 . . . . 1.0 111.664 -173.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.4 tp -64.75 -50.61 66.17 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.255 1.022 . . . . 1.0 110.909 169.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.648 ' CE1' HD23 ' A' ' 110' ' ' LEU . 88.2 t80 -55.2 -53.72 52.38 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.0 0.92 . . . . 1.0 112.473 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -69.06 -34.47 75.23 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.704 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.27 -34.69 88.79 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 123.876 0.75 . . . . 1.0 112.747 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.535 HG22 HD12 ' A' ' 110' ' ' LEU . 90.8 mt -65.23 -51.88 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 120.119 -1.812 . . . . 1.0 108.438 170.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.671 ' HB3' HD21 ' A' ' 110' ' ' LEU . 11.4 ptmt -67.78 -32.32 72.82 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.524 -1.36 . . . . 1.0 113.178 -170.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -104.07 -36.59 7.67 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.27 1.582 . . . . 1.0 115.27 -173.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.7 m -97.22 -19.63 18.46 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.196 0.999 . . . . 1.0 112.938 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.535 HD12 HE22 ' A' ' 82' ' ' GLN . 0.1 OUTLIER -95.62 -70.92 0.69 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 107.534 -1.284 . . . . 1.0 107.534 169.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.63 -13.32 1.69 Allowed Glycine 0 CA--C 1.536 1.404 0 C-N-CA 127.257 2.36 . . . . 1.0 116.454 169.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -155.76 141.49 17.97 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 127.668 2.387 . . . . 1.0 108.603 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.535 HE22 HD12 ' A' ' 79' ' ' LEU . 1.6 mm-40 -135.33 124.35 16.09 Favored Pre-proline 0 CA--C 1.546 0.808 0 O-C-N 121.449 -0.782 . . . . 1.0 111.237 -171.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.4 -39.07 0.2 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.35 2.034 . . . . 1.0 114.415 -171.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -146.7 18.1 1.29 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.255 1.206 . . . . 1.0 114.255 -170.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.584 HD11 ' CG2' ' A' ' 52' ' ' VAL . 46.0 tp -77.83 141.78 38.95 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 120.424 -1.422 . . . . 1.0 113.373 -169.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -136.73 146.65 46.07 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 129.519 3.127 . . . . 1.0 108.36 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.674 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -159.4 168.53 26.08 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.053 0.842 . . . . 1.0 113.126 -177.144 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.461 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -127.64 170.52 19.19 Favored Glycine 0 N--CA 1.472 1.082 0 C-N-CA 124.678 1.133 . . . . 1.0 114.281 172.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 86.6 t -142.28 133.5 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.668 1.187 . . . . 1.0 113.34 -169.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.982 HG23 HD12 ' A' ' 123' ' ' LEU . 3.5 mt -128.12 98.57 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.151 1.78 . . . . 1.0 106.781 169.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.27 145.37 25.43 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.151 1.38 . . . . 1.0 111.09 173.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.8 mp -138.88 149.79 45.25 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.601 -0.687 . . . . 1.0 111.974 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 176.46 168.55 36.71 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 119.38 -1.39 . . . . 1.0 115.793 169.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -71.71 107.57 4.6 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.201 1.4 . . . . 1.0 110.905 172.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 78.1 p -71.13 -1.75 13.44 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.553 1.541 . . . . 1.0 113.99 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 57.1 p -62.06 -22.94 66.17 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.148 0.979 . . . . 1.0 112.442 169.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -92.94 148.75 21.75 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.212 1.405 . . . . 1.0 112.629 169.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -50.09 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 126.491 1.916 . . . . 1.0 114.708 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -85.86 17.3 3.5 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.686 1.736 . . . . 1.0 115.686 -170.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.8 t80 27.07 -83.92 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 129.089 2.955 . . . . 1.0 117.628 169.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.9 m -124.89 19.19 8.51 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.72 2.008 . . . . 1.0 113.03 -173.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -53.65 -23.98 12.89 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.57 1.948 . . . . 1.0 114.28 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -54.89 -50.12 59.64 Favored Glycine 0 CA--C 1.536 1.36 0 CA-C-N 120.039 1.29 . . . . 1.0 113.237 173.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -77.89 -34.21 39.13 Favored Glycine 0 N--CA 1.479 1.54 0 O-C-N 120.798 -1.413 . . . . 1.0 113.639 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -59.6 -34.74 73.14 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.431 -1.04 . . . . 1.0 112.904 173.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -62.98 -39.3 94.32 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.869 0.868 . . . . 1.0 112.232 172.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -62.87 -39.76 95.43 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.435 1.016 . . . . 1.0 110.689 173.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.29 -40.1 96.42 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.802 0.441 . . . . 1.0 111.664 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.08 83.06 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 118.496 -0.764 . . . . 1.0 111.786 169.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.671 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -48.21 -49.05 34.39 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.391 2.277 . . . . 1.0 111.864 -172.07 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.674 HD12 ' CD1' ' A' ' 87' ' ' TYR . 7.3 mt -65.91 -43.86 86.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.939 -1.028 . . . . 1.0 111.35 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -65.92 -24.74 66.89 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.883 1.068 . . . . 1.0 113.883 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -66.1 -32.82 74.5 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.522 1.129 . . . . 1.0 111.466 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -83.08 -73.3 0.41 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.369 -1.287 . . . . 1.0 109.1 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.5 p 176.02 -15.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 127.32 2.248 . . . . 1.0 113.8 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.503 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -68.08 148.88 50.35 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 122.888 1.328 . . . . 1.0 113.927 -169.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -90.16 171.76 9.29 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 113.131 -1.85 . . . . 1.0 112.899 -168.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.94 138.14 49.61 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.239 1.816 . . . . 1.0 110.195 -175.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 120' ' ' GLY . 18.2 t -88.57 -168.26 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 124.818 1.247 . . . . 1.0 107.832 174.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.588 ' H ' HG12 ' A' ' 119' ' ' VAL . . . -51.38 153.4 4.89 Favored Glycine 0 CA--C 1.544 1.86 0 O-C-N 119.779 -1.826 . . . . 1.0 115.604 -176.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.58 137.5 15.31 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.123 1.769 . . . . 1.0 114.596 -172.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -68.22 159.35 31.37 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.505 1.522 . . . . 1.0 113.088 -169.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.982 HD12 HG23 ' A' ' 90' ' ' ILE . 1.3 tm? -91.2 139.1 31.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.539 -1.21 . . . . 1.0 109.86 169.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.407 ' N ' HD13 ' A' ' 123' ' ' LEU . 6.6 mt -127.87 111.49 13.66 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.624 1.569 . . . . 1.0 109.52 174.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.582 HG13 HD11 ' A' ' 123' ' ' LEU . 25.7 mt -100.58 133.44 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.612 1.165 . . . . 1.0 113.499 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.05 97.0 10.42 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.478 1.511 . . . . 1.0 111.346 174.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.08 -25.2 65.22 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.145 -1.597 . . . . 1.0 112.72 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.4 m -63.66 -17.74 63.24 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.722 2.009 . . . . 1.0 113.75 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -125.14 -29.32 3.31 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.233 1.813 . . . . 1.0 112.129 -173.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -143.12 89.5 7.76 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.475 1.51 . . . . 1.0 110.754 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -77.41 12.41 1.86 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.03 3.154 . . . . 1.0 114.026 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -111.34 65.53 0.57 Allowed Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 127.428 2.291 . . . . 1.0 109.915 174.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -57.36 -22.67 50.97 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.366 2.044 . . . . 1.0 115.956 -169.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.8 pm0 -63.94 -24.31 67.68 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.332 0.969 . . . . 1.0 111.603 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.4 p -72.4 -17.55 61.8 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 120.765 -1.209 . . . . 1.0 112.111 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.414 ' HB2' HD11 ' A' ' 125' ' ' ILE . 5.7 mm-40 -104.64 -54.7 2.47 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.06 1.744 . . . . 1.0 111.895 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.0 p -69.7 -33.91 73.19 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.704 1.002 . . . . 1.0 113.704 -177.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -59.51 -57.09 29.55 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 120.765 1.62 . . . . 1.0 112.435 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -62.09 -23.94 76.07 Favored 'Trans proline' 0 C--N 1.352 0.735 0 CA-C-N 121.304 1.502 . . . . 1.0 112.776 174.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.473 ' CG ' ' HB2' ' A' ' 123' ' ' LEU . 87.5 t90 -67.35 -46.69 72.66 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 119.094 0.861 . . . . 1.0 110.725 174.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.557 HG11 ' HA ' ' A' ' 22' ' ' ALA . 92.5 t -64.42 -32.29 57.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 122.337 1.065 . . . . 1.0 109.253 175.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -71.16 -22.73 62.01 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 120.066 -1.646 . . . . 1.0 113.359 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -88.53 -59.38 2.25 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.379 1.871 . . . . 1.0 111.247 168.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.461 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 89.5 t90 -56.93 -36.49 70.28 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.697 1.599 . . . . 1.0 113.388 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.62 -30.72 35.56 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 121.315 -0.865 . . . . 1.0 114.196 173.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.6 p -68.22 -12.55 61.17 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.213 1.19 . . . . 1.0 114.213 176.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.74 -16.19 51.9 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.98 1.712 . . . . 1.0 111.881 176.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.78 177.08 9.09 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.198 0.999 . . . . 1.0 110.829 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 8.9 m . . . . . 0 C--O 1.251 1.149 0 N-CA-C 115.882 1.808 . . . . 1.0 115.882 -172.014 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 tpt . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 109.972 -0.381 . . . . 1.0 109.972 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.41 156.98 41.79 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.687 0.995 . . . . 1.0 113.687 -171.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -124.2 125.37 44.31 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.479 1.511 . . . . 1.0 110.267 173.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.588 HD13 HD12 ' A' ' 26' ' ' LEU . 2.2 mp -121.51 114.99 45.18 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 C-N-CA 126.026 1.73 . . . . 1.0 112.832 -178.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.4 123.37 7.13 Favored Glycine 0 C--O 1.225 -0.446 0 N-CA-C 110.313 -1.115 . . . . 1.0 110.313 169.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.8 mt -103.67 116.22 47.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 118.167 0.983 . . . . 1.0 109.312 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -112.3 112.05 23.36 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.198 -1.408 . . . . 1.0 107.198 -172.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.5 p -97.62 137.55 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 116.66 -0.246 . . . . 1.0 111.582 -172.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -116.35 122.83 5.65 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 123.79 0.71 . . . . 1.0 111.396 176.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -152.5 146.49 25.31 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.939 0.718 . . . . 1.0 112.939 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.3 ttt -75.63 -19.52 59.15 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.864 1.265 . . . . 1.0 112.742 172.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -148.67 148.73 30.4 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.865 1.061 . . . . 1.0 113.865 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.68 -179.52 53.04 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.613 1.101 . . . . 1.0 115.606 173.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -144.69 159.92 42.04 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.746 2.019 . . . . 1.0 109.873 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.6 m 49.63 55.88 8.71 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.304 1.442 . . . . 1.0 111.691 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 27.3 tp -77.61 127.68 32.89 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.994 1.109 . . . . 1.0 113.994 -169.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.6 tp -35.53 -68.33 0.13 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 117.326 2.343 . . . . 1.0 117.326 -169.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.6 t -58.18 -35.15 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 118.685 0.675 . . . . 1.0 111.861 -169.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.24 -48.1 83.0 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 120.845 -1.159 . . . . 1.0 112.679 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -67.09 -30.95 71.12 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.879 0.371 . . . . 1.0 111.312 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -66.31 -48.31 70.76 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 173.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.651 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -63.04 -44.0 97.1 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 112.673 0.62 . . . . 1.0 112.673 -176.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -53.56 -49.43 67.71 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.376 1.07 . . . . 1.0 110.701 170.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.06 -37.51 75.51 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.632 0.773 . . . . 1.0 112.656 -175.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.5 mt -69.49 -45.56 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 119.119 0.872 . . . . 1.0 109.568 175.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.588 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.52 -33.84 76.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 119.651 -0.819 . . . . 1.0 110.269 -178.255 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.4 m -61.71 -45.03 95.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.392 1.477 . . . . 1.0 112.669 169.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.69 -32.98 74.64 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.346 1.058 . . . . 1.0 113.011 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -68.44 -30.62 69.55 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.752 1.221 . . . . 1.0 112.102 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.87 20.93 2.01 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.847 1.213 . . . . 1.0 115.214 169.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -118.85 153.53 34.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.785 1.234 . . . . 1.0 111.167 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -88.31 75.38 8.53 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.244 1.417 . . . . 1.0 110.637 -172.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.01 144.85 25.55 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.387 -1.733 . . . . 1.0 112.449 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.1 m -147.52 141.48 25.9 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.986 1.315 . . . . 1.0 112.055 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -88.96 139.23 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 115.56 1.689 . . . . 1.0 115.56 172.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -116.95 109.85 17.55 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.181 2.192 . . . . 1.0 110.327 169.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -88.23 144.02 26.69 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.384 1.874 . . . . 1.0 110.462 171.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 43.06 59.48 11.26 Favored Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 124.488 1.115 . . . . 1.0 111.193 -169.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -60.85 130.94 34.93 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 124.483 3.455 . . . . 1.0 118.356 -168.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -93.15 150.26 20.64 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.683 1.593 . . . . 1.0 112.896 169.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.508 HD21 HD21 ' A' ' 79' ' ' LEU . 2.5 tm? -69.56 -25.81 64.18 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.2 -0.937 . . . . 1.0 110.031 168.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.9 m -66.68 -20.6 66.01 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.446 -0.784 . . . . 1.0 112.615 171.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -88.73 -22.29 23.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.669 1.188 . . . . 1.0 113.207 169.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.466 ' HB3' HD22 ' A' ' 41' ' ' LEU . 15.5 t-105 -80.53 -35.58 34.34 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.799 1.181 . . . . 1.0 113.863 174.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.1 mt -49.43 -40.24 47.29 Favored Pre-proline 0 CA--C 1.551 1.006 0 CA-C-O 117.785 -1.103 . . . . 1.0 113.828 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -55.97 -14.06 10.39 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 124.509 3.473 . . . . 1.0 117.153 172.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -109.48 7.49 24.84 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.967 1.84 . . . . 1.0 115.967 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -53.13 -31.54 42.86 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.607 1.963 . . . . 1.0 113.819 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -112.12 11.62 20.41 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.966 1.307 . . . . 1.0 112.689 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -120.17 -157.59 0.71 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.977 2.511 . . . . 1.0 110.895 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -115.45 165.53 12.89 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.629 1.204 . . . . 1.0 111.445 171.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.649 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -150.14 159.54 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.616 1.166 . . . . 1.0 109.214 -170.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.536 HD11 HD12 ' A' ' 90' ' ' ILE . 14.5 tp -140.29 129.01 23.07 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 124.425 1.09 . . . . 1.0 108.954 174.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.6 t -107.11 123.95 62.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 124.299 1.039 . . . . 1.0 109.626 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.0 t -123.04 111.71 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 107.546 -1.279 . . . . 1.0 107.546 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.5 p -117.41 114.53 23.66 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.288 1.035 . . . . 1.0 108.958 -169.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.2 m -107.62 -8.8 16.03 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 119.066 2.987 . . . . 1.0 119.066 -167.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.4 p -135.33 17.48 3.4 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 115.806 1.78 . . . . 1.0 115.806 -169.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.4 m -53.62 -51.19 63.86 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.909 -1.119 . . . . 1.0 112.424 174.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 48.52 -112.19 1.11 Allowed Glycine 0 CA--C 1.537 1.453 0 C-N-CA 123.824 0.726 . . . . 1.0 113.403 177.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -62.69 -19.82 64.25 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.391 1.476 . . . . 1.0 114.647 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.76 161.05 10.36 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 120.419 1.463 . . . . 1.0 116.502 170.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.7 t0 58.38 -174.47 0.09 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.182 2.193 . . . . 1.0 115.752 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.2 mt -93.92 148.18 34.82 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 126.651 1.98 . . . . 1.0 113.624 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.3 156.48 54.87 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.409 2.739 . . . . 1.0 113.35 170.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -63.16 -20.63 65.57 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.41 1.263 . . . . 1.0 114.41 -174.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.8 p -72.59 -28.08 62.57 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.189 1.181 . . . . 1.0 114.189 174.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.4 tt -109.01 -18.68 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.551 1.141 . . . . 1.0 113.477 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -42.37 -52.23 10.32 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 124.638 1.175 . . . . 1.0 112.533 168.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -71.27 -29.84 16.59 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.383 1.389 . . . . 1.0 111.662 -173.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.9 tp -64.91 -49.66 69.57 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 124.227 1.011 . . . . 1.0 110.767 169.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.722 ' CE1' HD23 ' A' ' 110' ' ' LEU . 93.6 t80 -56.4 -52.57 64.13 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.312 1.045 . . . . 1.0 112.483 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -64.02 -40.75 97.02 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.864 0.866 . . . . 1.0 111.4 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.95 -33.66 84.62 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.943 0.783 . . . . 1.0 112.801 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.561 HG22 HD12 ' A' ' 110' ' ' LEU . 91.8 mt -66.54 -50.76 64.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 120.116 1.958 . . . . 1.0 108.47 170.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.744 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.1 ptmm? -69.6 -30.23 67.94 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.371 -1.456 . . . . 1.0 112.998 -170.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -106.94 -37.74 6.25 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.779 1.77 . . . . 1.0 115.779 -175.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.1 m -93.99 -22.41 18.57 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.958 0.903 . . . . 1.0 113.028 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.508 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -92.74 -71.1 0.67 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.204 -1.406 . . . . 1.0 107.204 169.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.02 -11.44 1.34 Allowed Glycine 0 CA--C 1.538 1.5 0 C-N-CA 127.213 2.339 . . . . 1.0 116.41 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -155.3 140.12 17.17 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.508 2.323 . . . . 1.0 108.38 172.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.431 HE22 HD12 ' A' ' 79' ' ' LEU . 2.1 mm-40 -135.81 123.58 15.03 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 121.267 -0.895 . . . . 1.0 111.365 -173.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -82.73 -39.3 0.14 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.845 2.363 . . . . 1.0 114.654 -173.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -141.28 13.57 2.2 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 115.14 1.533 . . . . 1.0 115.14 -169.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.649 HD11 ' CG2' ' A' ' 52' ' ' VAL . 53.8 tp -79.4 140.72 37.34 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.585 -1.322 . . . . 1.0 113.138 -169.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.83 151.3 48.98 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 127.959 2.504 . . . . 1.0 109.188 169.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.675 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -160.62 166.13 29.46 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.329 0.968 . . . . 1.0 113.603 -175.008 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.435 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -121.15 169.95 14.48 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 125.662 1.601 . . . . 1.0 113.876 175.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 66.0 t -145.78 132.38 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 114.364 1.246 . . . . 1.0 114.364 -169.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.536 HD12 HD11 ' A' ' 53' ' ' LEU . 3.5 mt -134.21 110.92 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.591 1.556 . . . . 1.0 108.774 169.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -105.07 146.94 28.44 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.6 -0.687 . . . . 1.0 111.546 171.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.24 153.39 44.8 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.441 1.497 . . . . 1.0 109.915 177.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 176.75 173.64 42.51 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-O 122.116 0.842 . . . . 1.0 114.137 169.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -85.43 102.22 13.27 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.001 -1.294 . . . . 1.0 111.086 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 9.0 t -59.63 -12.43 6.75 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.395 1.878 . . . . 1.0 113.896 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 48.5 m -60.6 -13.59 15.23 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.535 1.134 . . . . 1.0 113.697 169.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -117.76 162.76 17.55 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.715 1.606 . . . . 1.0 113.054 169.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.6 m -63.71 174.92 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.078 1.351 . . . . 1.0 110.993 169.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 59.97 20.22 9.28 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.719 1.608 . . . . 1.0 114.611 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -16.84 -69.82 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 129.928 3.291 . . . . 1.0 117.034 -169.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 7.2 m -126.24 29.58 5.79 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.135 1.374 . . . . 1.0 112.491 -173.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -61.28 -21.83 64.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.154 1.538 . . . . 1.0 115.154 -169.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.93 -51.2 57.3 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 121.679 2.036 . . . . 1.0 114.099 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.55 -35.55 92.07 Favored Glycine 0 N--CA 1.474 1.228 0 O-C-N 120.547 -1.561 . . . . 1.0 112.845 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -63.5 -38.55 91.55 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.255 1.022 . . . . 1.0 113.119 173.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -58.32 -46.5 86.04 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.748 0.819 . . . . 1.0 111.021 170.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -63.17 -37.93 89.15 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.738 -0.601 . . . . 1.0 111.792 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.78 -45.61 93.12 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.464 -0.773 . . . . 1.0 112.081 177.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.63 -36.65 74.41 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.066 0.765 . . . . 1.0 113.066 171.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.744 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -59.65 -49.03 79.35 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 123.351 1.548 . . . . 1.0 111.199 -175.645 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.675 HD12 ' CD1' ' A' ' 87' ' ' TYR . 8.9 mt -66.1 -39.95 90.37 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 120.789 -1.194 . . . . 1.0 111.47 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -71.27 -19.1 62.39 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.136 0.791 . . . . 1.0 113.136 177.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.23 -21.93 58.27 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.407 1.003 . . . . 1.0 111.098 176.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -92.05 -78.4 0.41 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 125.356 1.462 . . . . 1.0 110.019 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.429 ' H ' ' H ' ' A' ' 116' ' ' ALA . 2.4 t -178.89 -3.75 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.085 2.154 . . . . 1.0 112.027 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -75.54 148.58 38.79 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 122.632 1.206 . . . . 1.0 112.639 -169.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -90.8 170.29 10.23 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.17 1.788 . . . . 1.0 114.048 -168.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.73 143.35 50.82 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.885 2.074 . . . . 1.0 111.018 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.9 t -118.22 130.15 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.25 1.42 . . . . 1.0 108.664 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 48.51 -154.44 1.77 Allowed Glycine 0 N--CA 1.48 1.575 0 C-N-CA 124.834 1.207 . . . . 1.0 114.317 -170.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -119.16 147.52 44.1 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.986 1.714 . . . . 1.0 109.961 169.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.26 157.66 37.28 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.239 -0.913 . . . . 1.0 113.301 -169.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.634 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.8 OUTLIER -93.99 134.79 36.03 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.221 1.009 . . . . 1.0 110.573 171.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.634 ' N ' HD13 ' A' ' 123' ' ' LEU . 10.3 mt -120.69 107.61 13.0 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.468 1.507 . . . . 1.0 111.451 175.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.458 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.9 mt -93.56 130.78 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 126.344 1.858 . . . . 1.0 113.054 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -106.13 89.51 3.08 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.663 2.385 . . . . 1.0 113.245 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.32 -24.68 67.74 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.893 -1.13 . . . . 1.0 113.26 -175.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.7 m -60.68 -18.13 52.12 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.424 2.29 . . . . 1.0 113.865 172.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -127.9 -31.94 2.36 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.148 2.179 . . . . 1.0 112.501 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -138.06 91.91 12.81 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 126.046 1.739 . . . . 1.0 111.483 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -75.83 9.05 2.46 Favored 'Trans proline' 0 CA--C 1.549 1.235 0 C-N-CA 123.589 2.859 . . . . 1.0 114.517 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -112.05 70.45 0.98 Allowed Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 127.482 2.313 . . . . 1.0 110.057 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -57.81 -20.51 43.97 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.627 2.218 . . . . 1.0 116.417 -169.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -65.0 -26.67 68.39 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 118.91 0.777 . . . . 1.0 111.713 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.0 p -72.6 -16.7 61.73 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 120.866 -1.146 . . . . 1.0 111.743 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -101.1 -56.16 2.38 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.179 1.792 . . . . 1.0 111.711 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 60.3 p -69.59 -32.22 70.83 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.777 1.399 . . . . 1.0 114.777 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -62.1 -55.41 40.99 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 120.939 1.7 . . . . 1.0 113.176 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -62.84 -23.59 74.34 Favored 'Trans proline' 0 C--N 1.355 0.882 0 CA-C-N 121.28 1.493 . . . . 1.0 112.255 175.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.437 ' HB2' HD23 ' A' ' 123' ' ' LEU . 92.6 t90 -69.29 -47.5 64.37 Favored 'General case' 0 C--O 1.218 -0.594 0 C-N-CA 123.258 0.623 . . . . 1.0 111.053 174.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.651 HG11 ' HA ' ' A' ' 22' ' ' ALA . 95.7 t -66.45 -32.79 59.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 N-CA-C 109.554 -0.535 . . . . 1.0 109.554 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -64.51 -50.35 67.74 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.228 -0.92 . . . . 1.0 109.477 173.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -63.47 -54.73 31.88 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.703 1.201 . . . . 1.0 111.743 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.435 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 86.3 t90 -56.58 -37.7 70.95 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 125.843 1.657 . . . . 1.0 111.262 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.2 -33.68 23.46 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.434 1.492 . . . . 1.0 113.619 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.3 p -68.8 -14.03 62.77 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 114.802 1.408 . . . . 1.0 114.802 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.53 -19.63 45.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.35 1.46 . . . . 1.0 111.692 176.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -83.68 173.7 11.13 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.48 1.112 . . . . 1.0 110.583 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--O 1.252 1.213 0 C-N-CA 124.662 1.185 . . . . 1.0 113.923 -176.23 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 110.819 -0.067 . . . . 1.0 110.819 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.95 166.7 28.83 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.255 1.422 . . . . 1.0 112.597 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -122.48 125.08 45.06 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.035 1.334 . . . . 1.0 110.04 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.557 HD13 HD12 ' A' ' 26' ' ' LEU . 2.2 mp -121.58 114.07 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 126.778 2.031 . . . . 1.0 112.346 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.31 125.55 8.06 Favored Glycine 0 C--O 1.223 -0.539 0 N-CA-C 110.315 -1.114 . . . . 1.0 110.315 169.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 mt -106.16 121.37 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-N 118.547 1.174 . . . . 1.0 109.803 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -113.35 108.58 17.42 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.514 -1.291 . . . . 1.0 107.514 -169.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.45 127.28 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 O-C-N 123.375 0.422 . . . . 1.0 111.869 -174.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.81 46.89 3.2 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 115.855 1.102 . . . . 1.0 115.855 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.4 t -160.86 164.78 31.04 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.08 1.352 . . . . 1.0 111.378 169.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.8 ttt -102.74 -16.86 15.85 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.371 1.468 . . . . 1.0 112.491 169.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -145.67 164.51 31.55 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.879 1.271 . . . . 1.0 113.254 -170.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.98 -179.62 53.11 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 115.82 1.088 . . . . 1.0 115.82 169.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -59.92 -29.07 68.12 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.582 1.153 . . . . 1.0 113.823 -170.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.1 m -61.34 -16.83 50.05 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.941 1.089 . . . . 1.0 113.941 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 90.3 mt -62.36 -35.71 79.98 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.212 0.915 . . . . 1.0 112.68 169.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.3 tp -53.45 -53.99 43.38 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.851 1.26 . . . . 1.0 112.954 -170.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.1 t -56.35 -32.85 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.017 0.527 . . . . 1.0 111.5 -173.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.47 -47.62 85.34 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.793 -1.192 . . . . 1.0 113.105 172.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -66.98 -30.35 70.44 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.682 0.793 . . . . 1.0 111.117 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -68.86 -48.36 63.64 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 123.795 0.838 . . . . 1.0 109.394 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.541 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -63.8 -42.84 97.64 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 112.769 0.655 . . . . 1.0 112.769 -176.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -53.96 -49.44 68.73 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.093 0.957 . . . . 1.0 110.129 170.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.09 -37.84 72.4 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.484 0.713 . . . . 1.0 112.737 -174.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.5 mt -66.18 -46.83 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 119.355 0.98 . . . . 1.0 109.117 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.557 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -66.98 -35.14 79.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 119.543 -0.863 . . . . 1.0 110.468 -176.442 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 51.8 m -61.9 -41.92 98.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.24 1.416 . . . . 1.0 113.711 170.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.2 -33.06 74.58 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.049 0.94 . . . . 1.0 112.272 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -70.64 -30.04 66.56 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.629 1.172 . . . . 1.0 113.203 171.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.91 23.11 2.81 Favored Glycine 0 N--CA 1.468 0.799 0 C-N-CA 124.543 1.068 . . . . 1.0 114.433 169.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -111.52 148.96 32.08 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.543 1.137 . . . . 1.0 109.55 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.91 90.57 6.46 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.05 1.34 . . . . 1.0 108.008 -176.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.07 145.71 31.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.576 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 56.5 m -148.49 139.89 23.43 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.545 0.738 . . . . 1.0 112.076 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.45 138.72 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 115.48 1.659 . . . . 1.0 115.48 173.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -119.94 112.76 19.58 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.195 2.198 . . . . 1.0 110.292 169.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -95.01 138.23 33.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.725 2.01 . . . . 1.0 110.461 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.9 t70 42.95 54.39 10.02 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 123.753 0.821 . . . . 1.0 111.379 -169.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -71.18 147.74 54.48 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.777 2.985 . . . . 1.0 117.064 -168.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -98.02 164.81 12.19 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 124.934 1.294 . . . . 1.0 113.034 168.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.566 HD21 HD21 ' A' ' 79' ' ' LEU . 2.2 tm? -68.01 -22.5 64.98 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 121.169 -0.957 . . . . 1.0 110.523 167.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 67.0 p -68.33 -20.22 64.72 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.759 1.163 . . . . 1.0 112.481 171.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -81.13 -25.38 36.96 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.232 1.013 . . . . 1.0 112.248 169.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.454 ' HB3' HD22 ' A' ' 41' ' ' LEU . 15.7 t-105 -88.28 -35.39 17.29 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.504 1.298 . . . . 1.0 114.504 -177.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.6 mt -47.72 -38.39 17.47 Favored Pre-proline 0 CA--C 1.554 1.116 0 CA-C-O 117.681 -1.152 . . . . 1.0 114.058 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -58.99 -14.47 23.13 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 123.674 2.916 . . . . 1.0 116.526 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -110.54 9.53 23.13 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.63 1.715 . . . . 1.0 115.63 -174.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -51.44 -30.4 19.46 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.86 2.064 . . . . 1.0 113.729 174.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -108.82 7.2 26.1 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.316 1.847 . . . . 1.0 113.489 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -122.39 -163.18 1.06 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.888 2.475 . . . . 1.0 110.706 -174.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -110.62 165.33 11.9 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 123.081 1.419 . . . . 1.0 111.963 171.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.428 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -150.86 159.97 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.485 1.514 . . . . 1.0 109.567 -172.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.42 HD11 HD12 ' A' ' 90' ' ' ILE . 14.2 tp -139.25 130.09 26.2 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.006 1.322 . . . . 1.0 108.308 177.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.3 t -106.63 123.05 61.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 C-N-CA 123.944 0.897 . . . . 1.0 108.959 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.9 t -122.1 111.89 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 106.222 -1.77 . . . . 1.0 106.222 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -153.03 142.34 21.58 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 113.731 1.012 . . . . 1.0 113.731 -167.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.4 t -121.48 -169.89 1.94 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.852 1.261 . . . . 1.0 113.153 -169.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.4 m 73.9 -62.06 0.48 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 128.885 2.874 . . . . 1.0 114.737 169.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 m 59.3 -38.76 0.07 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 117.656 2.465 . . . . 1.0 117.656 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 51.98 -128.77 34.32 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-N 120.771 1.623 . . . . 1.0 114.143 172.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -81.04 29.78 0.33 Allowed 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.718 1.207 . . . . 1.0 113.39 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.49 41.08 8.57 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.659 1.123 . . . . 1.0 112.741 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -136.29 -177.55 4.76 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.031 1.733 . . . . 1.0 111.485 -173.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.3 mt -122.42 151.65 59.88 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 126.111 1.764 . . . . 1.0 113.11 -175.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.1 153.87 66.94 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.091 2.527 . . . . 1.0 112.345 170.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -61.4 -21.67 64.3 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.499 1.12 . . . . 1.0 114.006 -173.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.4 p -71.32 -23.55 61.96 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.458 1.281 . . . . 1.0 114.458 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.4 tt -118.11 -14.88 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 114.138 1.162 . . . . 1.0 114.138 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -44.54 -53.53 14.59 Favored Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 124.912 1.285 . . . . 1.0 112.073 168.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -68.39 -30.55 29.68 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.833 1.689 . . . . 1.0 111.746 -173.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.7 tp -65.31 -52.87 51.16 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 123.908 0.883 . . . . 1.0 111.126 169.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.632 ' CE1' HD23 ' A' ' 110' ' ' LEU . 93.0 t80 -55.86 -53.2 59.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.78 0.832 . . . . 1.0 112.498 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -69.52 -34.81 74.81 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.837 -0.619 . . . . 1.0 111.696 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.95 -35.41 90.69 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.77 -0.581 . . . . 1.0 112.473 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.597 HG22 HD12 ' A' ' 110' ' ' LEU . 95.4 mt -65.47 -50.08 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.87 1.835 . . . . 1.0 108.707 171.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.67 ' HB3' HD21 ' A' ' 110' ' ' LEU . 4.5 ptmm? -69.37 -31.83 70.49 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 120.324 -1.485 . . . . 1.0 113.303 -170.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -105.69 -39.33 6.11 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.309 1.596 . . . . 1.0 115.309 -173.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.9 m -93.29 -22.94 18.69 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.054 0.941 . . . . 1.0 112.901 -176.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.566 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -92.75 -71.33 0.65 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.164 -1.421 . . . . 1.0 107.164 169.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.63 -13.6 1.62 Allowed Glycine 0 CA--C 1.539 1.536 0 C-N-CA 127.413 2.435 . . . . 1.0 116.587 169.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -154.18 141.05 19.18 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 127.342 2.257 . . . . 1.0 108.72 171.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.444 HE22 HD12 ' A' ' 79' ' ' LEU . 1.4 mm-40 -136.97 125.0 14.63 Favored Pre-proline 0 CA--C 1.544 0.729 0 O-C-N 121.287 -0.883 . . . . 1.0 111.668 -172.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -86.54 -36.63 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.037 2.492 . . . . 1.0 114.967 -174.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -142.53 15.89 2.0 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.534 1.309 . . . . 1.0 114.534 -169.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.428 HD11 ' CG2' ' A' ' 52' ' ' VAL . 66.3 tp -84.78 138.46 32.59 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.514 -1.366 . . . . 1.0 112.773 -169.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.9 mtm-85 -135.74 156.43 48.83 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 127.944 2.498 . . . . 1.0 109.558 169.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.676 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -162.44 169.0 21.15 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.186 -0.946 . . . . 1.0 111.587 -177.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.404 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -129.58 173.11 19.75 Favored Glycine 0 N--CA 1.475 1.291 0 C-N-CA 124.734 1.159 . . . . 1.0 114.189 170.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.01 141.39 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 114.3 1.222 . . . . 1.0 114.3 -169.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.96 HG23 HD12 ' A' ' 123' ' ' LEU . 7.5 mt -131.94 99.3 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 125.915 1.686 . . . . 1.0 107.11 169.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.3 143.34 26.9 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.575 1.55 . . . . 1.0 111.998 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.2 mp -137.88 161.46 36.56 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.813 0.845 . . . . 1.0 112.966 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 160.86 -170.67 36.79 Favored Glycine 0 N--CA 1.465 0.62 0 CA-C-N 116.231 -0.441 . . . . 1.0 114.055 168.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -102.85 110.62 22.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.893 0.877 . . . . 1.0 110.06 176.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.4 t -63.62 -7.63 7.82 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.676 1.191 . . . . 1.0 113.67 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.7 t -62.43 -26.19 68.37 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.712 -1.243 . . . . 1.0 111.078 169.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -92.36 148.15 22.35 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.345 1.458 . . . . 1.0 110.799 169.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.0 m -71.46 169.97 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.667 0.787 . . . . 1.0 111.806 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 65.2 5.07 2.86 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.914 2.086 . . . . 1.0 116.597 -170.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 12.1 t80 21.69 -80.92 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 129.585 3.154 . . . . 1.0 117.204 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.466 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 20.7 p -120.45 8.95 10.82 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.708 2.003 . . . . 1.0 114.376 -169.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -60.61 -16.99 44.03 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 115.112 1.523 . . . . 1.0 115.112 -169.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.17 -40.68 98.9 Favored Glycine 0 N--CA 1.474 1.231 0 CA-C-N 120.69 1.586 . . . . 1.0 113.314 173.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.61 -37.34 35.27 Favored Glycine 0 N--CA 1.477 1.392 0 O-C-N 120.974 -1.309 . . . . 1.0 112.806 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.466 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 84.2 mttt -61.29 -33.53 73.72 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 121.155 -1.203 . . . . 1.0 112.857 174.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -63.28 -36.04 82.34 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.523 0.729 . . . . 1.0 112.503 170.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -63.0 -37.19 86.18 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.285 0.948 . . . . 1.0 111.196 172.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -46.96 83.8 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.81 -0.556 . . . . 1.0 111.72 174.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.91 -44.51 78.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.702 -0.666 . . . . 1.0 111.82 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.67 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -50.73 -49.45 57.76 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.862 2.065 . . . . 1.0 112.018 -175.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.676 HD12 ' CD1' ' A' ' 87' ' ' TYR . 7.9 mt -66.37 -41.78 88.96 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.313 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -68.85 -20.03 64.27 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.747 1.017 . . . . 1.0 113.747 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -66.98 -36.14 81.52 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.749 1.22 . . . . 1.0 111.112 172.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -84.26 -75.15 0.35 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 113.777 -1.556 . . . . 1.0 110.336 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.412 ' H ' ' H ' ' A' ' 116' ' ' ALA . 3.6 m 177.91 -0.55 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.605 2.362 . . . . 1.0 112.024 172.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -77.83 149.3 34.39 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 122.638 1.208 . . . . 1.0 113.373 -169.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -85.77 171.35 11.64 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.255 1.822 . . . . 1.0 111.884 -169.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 2.2 ttm105 -133.87 152.77 51.97 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.353 1.061 . . . . 1.0 112.135 175.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.0 t -119.1 124.17 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.521 1.528 . . . . 1.0 109.14 -172.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 51.85 -168.03 0.69 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.941 1.257 . . . . 1.0 115.352 -172.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -102.35 145.1 29.98 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.984 1.314 . . . . 1.0 108.563 169.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -78.14 159.81 28.39 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.118 1.155 . . . . 1.0 114.118 -169.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.96 HD12 HG23 ' A' ' 90' ' ' ILE . 1.4 tm? -85.17 138.48 32.35 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.854 1.261 . . . . 1.0 110.079 170.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.6 mt -127.53 108.76 11.07 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.714 1.605 . . . . 1.0 109.676 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.581 HG13 HD11 ' A' ' 123' ' ' LEU . 25.5 mt -97.82 130.76 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 124.045 0.938 . . . . 1.0 112.304 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -105.35 110.24 22.53 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.963 0.905 . . . . 1.0 112.422 170.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.92 -24.57 66.11 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.146 1.378 . . . . 1.0 113.7 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.45 -17.62 64.77 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.896 1.073 . . . . 1.0 113.896 173.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -118.99 -28.72 5.46 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.88 1.672 . . . . 1.0 111.958 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -143.81 86.08 8.83 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 125.41 1.484 . . . . 1.0 111.947 -178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.92 6.06 3.12 Favored 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 123.537 2.825 . . . . 1.0 114.443 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -112.63 70.83 1.16 Allowed Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 127.221 2.208 . . . . 1.0 110.163 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -57.59 -22.16 50.32 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.455 2.104 . . . . 1.0 116.756 -169.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -64.6 -26.19 68.29 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.325 0.966 . . . . 1.0 111.864 174.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 p -73.62 -14.23 61.14 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.864 -1.148 . . . . 1.0 112.1 -175.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.436 ' HB2' HD11 ' A' ' 125' ' ' ILE . 4.8 mm-40 -106.99 -55.86 2.27 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 126.811 2.044 . . . . 1.0 111.464 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.9 p -69.49 -33.86 73.48 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.929 1.085 . . . . 1.0 113.929 -177.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -61.15 -57.65 24.49 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 120.623 1.556 . . . . 1.0 112.266 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -62.32 -23.84 75.48 Favored 'Trans proline' 0 C--N 1.353 0.772 0 CA-C-N 121.359 1.521 . . . . 1.0 112.502 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.464 ' CG ' ' HB2' ' A' ' 123' ' ' LEU . 88.4 t90 -68.15 -46.87 69.6 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 119.104 0.865 . . . . 1.0 111.226 174.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.541 HG11 ' HA ' ' A' ' 22' ' ' ALA . 98.3 t -62.31 -33.57 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 175.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -68.62 -29.85 68.44 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.99 1.316 . . . . 1.0 112.588 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -81.49 -57.96 3.24 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.369 1.467 . . . . 1.0 112.397 170.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.404 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 84.4 t90 -56.84 -36.87 70.49 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 125.352 1.461 . . . . 1.0 112.633 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.27 -32.55 21.89 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.531 1.062 . . . . 1.0 113.871 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.8 p -68.14 -14.05 62.69 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.373 1.249 . . . . 1.0 114.373 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.44 -17.68 53.75 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.997 1.719 . . . . 1.0 111.843 175.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.38 172.3 10.5 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.842 1.257 . . . . 1.0 111.269 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 13.5 m . . . . . 0 C--O 1.25 1.086 0 N-CA-C 116.085 1.883 . . . . 1.0 116.085 -169.586 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.9 mtt . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 110.046 -0.353 . . . . 1.0 110.046 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.29 174.14 11.9 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.414 1.486 . . . . 1.0 114.943 -174.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -118.86 124.33 46.88 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.221 1.808 . . . . 1.0 110.241 175.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.521 HD13 HD12 ' A' ' 26' ' ' LEU . 2.1 mp -121.75 116.07 48.31 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 C-N-CA 126.937 2.095 . . . . 1.0 112.416 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.91 125.49 8.27 Favored Glycine 0 C--O 1.225 -0.45 0 N-CA-C 110.158 -1.177 . . . . 1.0 110.158 169.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 mt -104.84 117.63 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-N 118.133 0.966 . . . . 1.0 109.21 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -109.29 109.68 20.65 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.732 -1.581 . . . . 1.0 106.732 -171.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.6 p -103.27 127.35 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.543 0.572 . . . . 1.0 112.543 -169.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.85 55.38 4.75 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 114.968 0.747 . . . . 1.0 114.968 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.2 p -146.05 157.21 43.86 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.291 1.436 . . . . 1.0 112.391 174.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 10.0 tpt -147.04 147.56 30.78 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.157 1.783 . . . . 1.0 111.119 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 69.4 t80 53.84 -76.5 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 128.635 2.774 . . . . 1.0 116.707 170.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.37 -18.01 77.99 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 124.725 1.155 . . . . 1.0 114.539 -175.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -147.57 158.17 43.88 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.137 1.375 . . . . 1.0 111.356 175.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 79.5 p -121.25 -5.44 9.42 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.506 1.522 . . . . 1.0 114.989 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 43.52 65.58 0.96 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.763 2.025 . . . . 1.0 111.885 -174.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.7 tp -18.93 -50.73 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 129.369 3.068 . . . . 1.0 115.979 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.423 HG11 HG21 ' A' ' 90' ' ' ILE . 78.7 t -44.8 -35.48 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.506 1.522 . . . . 1.0 112.916 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.7 -48.81 79.84 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 120.384 1.447 . . . . 1.0 113.198 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -66.69 -32.72 74.2 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.093 0.957 . . . . 1.0 110.775 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -65.63 -47.47 75.52 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 123.675 0.79 . . . . 1.0 109.287 173.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.622 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -64.35 -42.62 96.14 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 123.385 0.674 . . . . 1.0 112.724 -175.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.68 -48.59 72.21 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.906 0.482 . . . . 1.0 109.777 169.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.53 -37.07 76.96 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.994 0.738 . . . . 1.0 112.994 -175.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.0 mt -70.02 -46.22 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-N 119.194 0.907 . . . . 1.0 109.258 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.521 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -64.78 -34.98 79.62 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 119.606 -0.838 . . . . 1.0 110.088 -177.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.3 m -60.67 -46.14 91.47 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.122 1.369 . . . . 1.0 112.91 169.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.95 -32.64 74.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.341 1.056 . . . . 1.0 112.891 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -70.31 -29.12 65.77 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.932 1.293 . . . . 1.0 112.333 172.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.62 23.02 2.16 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.673 1.13 . . . . 1.0 115.119 169.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -121.34 148.51 44.25 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.563 1.145 . . . . 1.0 110.301 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -79.98 93.56 5.74 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 125.267 1.427 . . . . 1.0 108.69 -175.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.32 147.34 35.32 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.068 0.547 . . . . 1.0 111.373 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 93.0 m -150.08 146.73 27.1 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.518 1.127 . . . . 1.0 111.096 -173.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.5 t -97.98 138.84 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 114.049 1.129 . . . . 1.0 114.049 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -118.12 106.69 13.13 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.726 2.011 . . . . 1.0 110.692 169.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -85.26 146.51 27.02 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.917 1.687 . . . . 1.0 110.909 175.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t0 41.75 57.81 9.7 Favored Pre-proline 0 CA--C 1.557 1.236 0 C-N-CA 124.644 1.177 . . . . 1.0 111.174 -169.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -57.93 130.0 36.13 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 125.122 3.881 . . . . 1.0 118.706 -167.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -91.24 150.53 21.3 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.751 1.62 . . . . 1.0 112.288 168.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.53 HD21 HD21 ' A' ' 79' ' ' LEU . 2.4 tm? -70.15 -25.34 63.41 Favored 'General case' 0 N--CA 1.444 -0.757 0 O-C-N 121.13 -0.981 . . . . 1.0 110.282 168.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.2 m -66.26 -21.67 66.29 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.65 -0.656 . . . . 1.0 112.31 171.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -86.93 -23.79 25.02 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.159 0.983 . . . . 1.0 112.994 169.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.502 ' HB3' HD22 ' A' ' 41' ' ' LEU . 12.3 t-105 -80.16 -34.63 37.44 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.806 1.185 . . . . 1.0 113.778 175.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.8 mt -50.11 -39.62 48.31 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-O 117.744 -1.122 . . . . 1.0 113.589 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -52.65 -13.36 2.38 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 124.843 3.696 . . . . 1.0 117.892 170.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -112.87 8.02 18.54 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 116.332 1.975 . . . . 1.0 116.332 -176.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -50.86 -30.74 15.31 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.2 1.8 . . . . 1.0 113.642 174.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -107.11 8.13 30.01 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.821 2.049 . . . . 1.0 113.407 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -127.97 -159.66 0.96 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.274 2.229 . . . . 1.0 112.267 -169.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -112.41 159.33 18.83 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 122.805 1.288 . . . . 1.0 110.907 171.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.412 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -148.47 154.86 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 124.909 1.284 . . . . 1.0 108.735 -171.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.1 tp -133.99 128.05 33.61 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.06 0.944 . . . . 1.0 108.865 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.5 t -103.75 124.18 57.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 C-N-CA 124.326 1.05 . . . . 1.0 109.184 176.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.421 HG22 HD12 ' A' ' 90' ' ' ILE . 19.9 t -125.39 112.06 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 107.183 -1.414 . . . . 1.0 107.183 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.3 t -153.25 126.76 8.7 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.628 0.973 . . . . 1.0 113.628 -168.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.5 m -98.77 177.92 5.14 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.513 1.525 . . . . 1.0 111.48 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.8 m 64.63 60.28 0.89 Allowed 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 122.597 1.189 . . . . 1.0 113.775 168.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.4 m -59.89 -39.12 84.24 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.565 1.546 . . . . 1.0 113.321 171.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 50.99 -135.94 30.22 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 119.16 0.891 . . . . 1.0 113.897 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -81.52 53.01 1.99 Allowed 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.136 -1.214 . . . . 1.0 112.816 174.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.92 41.89 70.96 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 124.379 0.99 . . . . 1.0 113.338 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -130.58 -172.82 2.9 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.5 1.92 . . . . 1.0 111.471 -173.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 53.3 mt -136.69 156.84 75.95 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 126.006 1.722 . . . . 1.0 114.631 -173.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -55.39 140.38 82.32 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.964 3.109 . . . . 1.0 112.38 169.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.07 -21.67 65.14 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.211 -0.93 . . . . 1.0 113.406 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.6 p -77.31 -19.55 56.23 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.658 1.355 . . . . 1.0 114.658 172.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.2 tt -111.27 -18.02 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.579 1.151 . . . . 1.0 113.407 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.8 t -44.15 -52.6 15.69 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 125.302 1.441 . . . . 1.0 112.289 168.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.89 -29.43 18.5 Favored 'Trans proline' 0 C--N 1.35 0.641 0 CA-C-N 120.774 1.312 . . . . 1.0 111.272 -173.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.4 tp -65.08 -50.46 66.06 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 124.046 0.939 . . . . 1.0 110.793 169.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.62 ' CE1' HD23 ' A' ' 110' ' ' LEU . 89.8 t80 -55.53 -52.13 64.73 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.219 1.008 . . . . 1.0 112.213 178.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -64.35 -40.34 95.66 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.094 0.958 . . . . 1.0 111.733 176.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.73 -35.81 90.3 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.073 0.844 . . . . 1.0 112.628 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.586 HG22 HD12 ' A' ' 110' ' ' LEU . 91.5 mt -64.73 -51.3 69.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 120.071 1.935 . . . . 1.0 107.988 171.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.691 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.4 ptmm? -68.59 -31.72 71.1 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.394 -1.441 . . . . 1.0 113.289 -169.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -103.64 -37.25 7.6 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.513 1.671 . . . . 1.0 115.513 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.1 m -96.43 -19.52 19.11 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.416 1.087 . . . . 1.0 113.266 -174.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.53 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -93.15 -73.08 0.57 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.158 -1.423 . . . . 1.0 107.158 169.522 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.35 -21.43 1.45 Allowed Glycine 0 CA--C 1.536 1.347 0 C-N-CA 127.756 2.598 . . . . 1.0 114.727 169.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -151.19 141.32 22.19 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 128.392 2.677 . . . . 1.0 108.041 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.43 HE21 HD12 ' A' ' 79' ' ' LEU . 6.4 mt-30 -138.15 121.79 11.45 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.74 0.816 . . . . 1.0 110.165 -169.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -78.55 -38.02 0.59 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.121 1.881 . . . . 1.0 115.822 -169.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -143.98 21.17 1.78 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.129 1.159 . . . . 1.0 114.129 -169.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.412 HD11 ' CG2' ' A' ' 52' ' ' VAL . 60.8 tp -84.51 140.26 31.58 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.559 -1.338 . . . . 1.0 114.6 -169.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -137.12 155.31 49.76 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 128.64 2.776 . . . . 1.0 108.065 169.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.59 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -159.36 171.81 19.11 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.355 -0.841 . . . . 1.0 111.589 -179.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -131.73 172.25 20.99 Favored Glycine 0 N--CA 1.471 0.974 0 C-N-CA 124.902 1.239 . . . . 1.0 113.415 170.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.422 HG23 ' HB3' ' A' ' 122' ' ' MET . 0.0 OUTLIER -142.57 143.38 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 114.009 1.114 . . . . 1.0 114.009 -169.517 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.04 HG23 HD12 ' A' ' 123' ' ' LEU . 12.1 mt -133.16 98.17 2.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 106.532 -1.655 . . . . 1.0 106.532 169.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.44 144.12 26.56 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.442 1.497 . . . . 1.0 111.349 171.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.1 mp -140.79 154.98 46.49 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.447 0.906 . . . . 1.0 113.447 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.65 -169.75 41.87 Favored Glycine 0 C--O 1.221 -0.659 0 N-CA-C 114.227 0.451 . . . . 1.0 114.227 168.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -100.99 110.95 23.04 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.057 0.943 . . . . 1.0 110.031 175.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.1 t -63.43 -7.92 7.84 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.737 1.215 . . . . 1.0 113.69 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.9 t -62.19 -26.66 68.47 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.92 -1.113 . . . . 1.0 110.841 168.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -91.14 146.63 23.67 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.358 1.463 . . . . 1.0 110.517 169.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.2 m -71.41 170.12 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 121.713 0.768 . . . . 1.0 112.227 -177.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.92 6.61 3.48 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 127.036 2.134 . . . . 1.0 116.754 -171.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 12.8 t80 28.79 -85.49 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 129.151 2.98 . . . . 1.0 116.719 -175.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 6.9 m -123.35 20.74 9.64 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.72 1.608 . . . . 1.0 113.685 -174.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -54.13 -23.14 13.04 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.72 1.608 . . . . 1.0 114.611 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.31 -46.93 85.63 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 120.661 1.573 . . . . 1.0 113.588 175.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.75 -35.6 39.78 Favored Glycine 0 N--CA 1.478 1.435 0 O-C-N 120.766 -1.432 . . . . 1.0 113.141 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -60.59 -32.4 71.52 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 121.264 -1.139 . . . . 1.0 112.86 172.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -66.82 -34.99 79.02 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.033 0.933 . . . . 1.0 112.361 169.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -62.75 -35.45 79.83 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.603 1.092 . . . . 1.0 111.136 170.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -65.99 -49.04 69.23 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.804 -0.56 . . . . 1.0 111.062 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.5 -33.58 66.14 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.876 0.871 . . . . 1.0 113.272 174.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.691 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -57.91 -50.59 72.81 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 123.117 1.437 . . . . 1.0 110.867 179.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.59 HD12 ' CD1' ' A' ' 87' ' ' TYR . 6.6 mt -65.68 -40.03 91.93 Favored 'General case' 0 C--N 1.321 -0.67 0 O-C-N 121.074 -1.016 . . . . 1.0 111.478 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -67.17 -20.52 65.75 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.534 0.938 . . . . 1.0 113.534 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.03 -17.06 57.51 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.589 1.086 . . . . 1.0 111.112 177.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -100.42 -73.57 0.63 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.8 1.24 . . . . 1.0 109.75 -178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 77.4 p -179.37 -19.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.165 1.786 . . . . 1.0 114.147 -174.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -70.69 161.1 31.4 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 123.14 1.448 . . . . 1.0 114.139 -169.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -98.47 179.53 4.68 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.306 1.842 . . . . 1.0 110.934 -170.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.0 ttm105 -131.37 158.35 40.97 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.519 1.127 . . . . 1.0 112.828 169.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.488 HG12 ' H ' ' A' ' 120' ' ' GLY . 13.9 t -96.96 -173.44 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 C-N-CA 126.493 1.917 . . . . 1.0 106.394 169.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.488 ' H ' HG12 ' A' ' 119' ' ' VAL . . . -54.49 164.69 3.06 Favored Glycine 0 CA--C 1.545 1.919 0 N-CA-C 116.924 1.529 . . . . 1.0 116.924 -170.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -43.75 131.42 5.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.859 2.064 . . . . 1.0 113.953 -175.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.422 ' HB3' HG23 ' A' ' 89' ' ' VAL . 1.0 OUTLIER -74.16 157.62 35.63 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.333 1.053 . . . . 1.0 111.869 -172.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 1.04 HD12 HG23 ' A' ' 90' ' ' ILE . 1.4 tm? -91.48 137.27 32.49 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.215 -0.902 . . . . 1.0 110.353 174.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.6 mt -127.26 110.69 13.11 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.844 1.657 . . . . 1.0 109.445 174.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.588 ' CD1' HD11 ' A' ' 123' ' ' LEU . 24.0 mt -99.15 131.5 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 124.085 0.954 . . . . 1.0 112.582 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -104.31 108.97 20.62 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.118 0.967 . . . . 1.0 112.606 170.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.43 -24.99 66.54 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.88 1.272 . . . . 1.0 113.775 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.64 -17.46 64.61 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.776 1.028 . . . . 1.0 113.776 173.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -116.46 -29.28 6.21 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.677 1.591 . . . . 1.0 111.633 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -145.16 87.73 7.04 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 125.323 1.449 . . . . 1.0 111.901 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.98 5.01 3.24 Favored 'Trans proline' 0 CA--C 1.549 1.247 0 C-N-CA 123.689 2.926 . . . . 1.0 114.731 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -113.72 71.02 1.75 Allowed Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 127.179 2.192 . . . . 1.0 109.634 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -54.93 -28.3 58.39 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.391 2.061 . . . . 1.0 115.845 -169.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -62.99 -24.38 67.89 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.611 0.642 . . . . 1.0 112.006 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.1 p -75.08 -16.57 60.56 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 120.612 -1.305 . . . . 1.0 111.82 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -101.56 -55.68 2.47 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.371 1.868 . . . . 1.0 111.438 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 90.7 p -65.23 -34.13 77.62 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 113.779 1.029 . . . . 1.0 113.779 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 -64.03 -55.2 34.13 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 120.501 1.501 . . . . 1.0 112.92 -175.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -62.1 -24.42 76.47 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 CA-C-N 121.328 1.51 . . . . 1.0 112.849 172.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.475 ' CG ' ' HB2' ' A' ' 123' ' ' LEU . 87.5 t90 -68.28 -45.44 73.07 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 118.592 0.633 . . . . 1.0 111.314 173.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.622 HG11 ' HA ' ' A' ' 22' ' ' ALA . 83.3 t -66.41 -33.64 64.82 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -63.69 -48.77 75.79 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.225 -0.922 . . . . 1.0 109.528 173.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -63.99 -54.98 25.85 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.489 1.116 . . . . 1.0 111.827 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -58.49 -35.61 72.49 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 125.611 1.564 . . . . 1.0 111.76 174.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.19 -34.53 25.06 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.583 1.563 . . . . 1.0 113.458 171.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.9 p -67.82 -12.99 61.76 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.826 1.417 . . . . 1.0 114.826 176.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.35 -16.29 49.74 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.869 1.667 . . . . 1.0 112.072 176.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.57 -179.56 7.47 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.289 1.036 . . . . 1.0 110.924 -177.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 C--O 1.25 1.129 0 C-N-CA 126.202 1.801 . . . . 1.0 114.52 -175.549 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 119.952 -0.07 . . . . 1.0 110.816 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.5 167.41 26.33 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.186 1.395 . . . . 1.0 112.905 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -120.84 123.83 43.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.08 1.352 . . . . 1.0 110.502 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.551 HD13 HD12 ' A' ' 26' ' ' LEU . 2.2 mp -120.43 112.79 37.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 C-N-CA 126.632 1.973 . . . . 1.0 112.497 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.61 124.27 7.3 Favored Glycine 0 C--O 1.223 -0.561 0 N-CA-C 110.328 -1.109 . . . . 1.0 110.328 169.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.5 mt -105.27 119.23 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-N 118.614 1.207 . . . . 1.0 109.691 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -110.01 107.45 17.33 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.181 -1.414 . . . . 1.0 107.181 -170.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.4 p -93.26 123.26 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 121.484 0.659 . . . . 1.0 111.105 -172.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.56 47.59 1.01 Allowed Glycine 0 CA--C 1.524 0.596 0 C-N-CA 126.001 1.762 . . . . 1.0 111.621 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.9 p -103.01 131.63 49.86 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.451 -1.029 . . . . 1.0 111.49 -173.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.7 ttt -79.58 -20.82 46.06 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.384 1.253 . . . . 1.0 114.384 -171.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -131.79 151.8 51.41 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.377 1.071 . . . . 1.0 113.076 -174.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -62.5 -27.29 69.35 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.794 1.187 . . . . 1.0 115.373 -171.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -68.23 -31.75 71.47 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.221 1.01 . . . . 1.0 112.214 173.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.0 m -88.16 -28.43 21.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.013 0.925 . . . . 1.0 113.05 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.47 66.29 0.32 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.043 1.737 . . . . 1.0 109.793 170.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.1 tp -161.23 -51.34 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 127.514 2.326 . . . . 1.0 109.935 -170.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.7 t -56.01 -34.43 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.176 0.59 . . . . 1.0 111.243 -173.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.44 -45.57 88.27 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.783 -1.198 . . . . 1.0 113.414 173.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -68.81 -30.36 68.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.303 0.573 . . . . 1.0 111.048 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -68.18 -47.11 68.85 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 123.761 0.824 . . . . 1.0 109.109 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.551 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -64.32 -43.32 95.04 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 123.56 0.744 . . . . 1.0 112.804 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -53.57 -48.67 68.97 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.092 0.957 . . . . 1.0 110.456 170.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.31 -37.97 71.76 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.593 0.757 . . . . 1.0 112.285 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.0 mt -68.79 -45.83 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 O-C-N 121.63 -0.669 . . . . 1.0 109.338 175.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.551 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.99 -31.45 72.36 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.495 1.043 . . . . 1.0 110.649 -178.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.4 m -63.12 -45.04 93.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.586 1.154 . . . . 1.0 112.711 169.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.08 -31.36 70.93 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.799 1.239 . . . . 1.0 113.032 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -67.68 -29.03 68.2 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.211 1.804 . . . . 1.0 111.695 172.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.43 28.27 2.39 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.715 1.15 . . . . 1.0 114.905 171.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -120.52 164.39 16.51 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.016 1.326 . . . . 1.0 110.169 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -93.44 89.81 6.47 Favored 'General case' 0 CA--C 1.52 -0.183 0 O-C-N 120.659 -1.275 . . . . 1.0 108.559 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.16 145.87 29.57 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 122.766 0.426 . . . . 1.0 111.22 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.7 m -147.77 139.08 23.61 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.864 0.866 . . . . 1.0 112.041 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.4 t -86.93 137.72 20.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 114.916 1.45 . . . . 1.0 114.916 172.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -117.89 113.74 22.19 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.85 2.06 . . . . 1.0 110.32 171.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -94.7 137.75 33.4 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.686 1.994 . . . . 1.0 111.158 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.5 t70 41.79 55.37 9.07 Favored Pre-proline 0 CA--C 1.559 1.293 0 C-N-CA 124.61 1.164 . . . . 1.0 111.08 -169.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -68.59 145.63 64.71 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.016 3.144 . . . . 1.0 117.638 -167.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -88.79 154.5 20.22 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.892 1.677 . . . . 1.0 112.442 168.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.539 HD21 HD21 ' A' ' 79' ' ' LEU . 2.3 tm? -69.41 -21.72 63.74 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 120.899 -1.125 . . . . 1.0 109.762 168.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.1 m -66.13 -22.89 66.4 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.284 -0.885 . . . . 1.0 112.332 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -82.52 -24.94 33.87 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.136 0.974 . . . . 1.0 113.098 169.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.49 ' HB3' HD22 ' A' ' 41' ' ' LEU . 11.8 t-105 -83.9 -35.54 24.01 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.799 1.182 . . . . 1.0 113.994 177.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.3 mt -48.16 -39.17 25.32 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-O 117.58 -1.2 . . . . 1.0 113.897 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -55.31 -14.98 10.27 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.306 3.337 . . . . 1.0 117.224 172.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -109.03 8.24 26.12 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 116.027 1.862 . . . . 1.0 116.027 -174.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -52.98 -23.47 7.38 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.977 2.111 . . . . 1.0 114.218 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -124.91 17.74 8.57 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.546 1.538 . . . . 1.0 113.484 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -126.47 -158.24 0.85 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.936 2.494 . . . . 1.0 110.345 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -116.79 161.85 18.63 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 122.984 1.373 . . . . 1.0 112.313 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.426 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -150.08 160.59 4.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 125.14 1.376 . . . . 1.0 108.966 -172.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.4 tp -138.17 130.05 28.35 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.007 1.323 . . . . 1.0 108.369 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.8 t -105.23 124.21 59.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 124.088 0.955 . . . . 1.0 109.03 174.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.1 t -122.26 111.86 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 105.476 -2.046 . . . . 1.0 105.476 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.3 t -148.38 132.93 17.72 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.227 1.195 . . . . 1.0 114.227 -167.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.6 p -121.49 162.94 19.63 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.762 0.825 . . . . 1.0 113.014 -172.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.0 m 66.22 55.71 0.86 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 122.743 1.258 . . . . 1.0 112.758 169.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.0 m -55.16 128.83 35.68 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.84 1.256 . . . . 1.0 109.553 169.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.43 -128.49 4.94 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.974 0.797 . . . . 1.0 112.797 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 41.8 mm-40 -76.43 52.18 0.76 Allowed 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.025 -1.279 . . . . 1.0 111.834 172.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.3 11.95 83.86 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.892 1.235 . . . . 1.0 113.805 -169.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -111.95 175.11 5.56 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.123 1.769 . . . . 1.0 111.879 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 52.9 mt -114.84 160.25 34.27 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 127.91 2.484 . . . . 1.0 113.389 -169.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.73 154.25 63.99 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.925 2.417 . . . . 1.0 111.84 169.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -62.14 -23.19 66.41 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.215 1.191 . . . . 1.0 114.215 -169.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.9 p -68.69 -22.55 64.36 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.292 1.219 . . . . 1.0 114.292 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.0 tt -122.52 -12.81 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 114.477 1.288 . . . . 1.0 114.477 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.9 t -44.06 -52.73 15.0 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 124.424 1.09 . . . . 1.0 112.912 168.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.36 -31.48 17.77 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.686 1.591 . . . . 1.0 111.757 -172.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.2 tp -62.67 -52.16 64.4 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 124.602 1.161 . . . . 1.0 111.336 169.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.655 ' CE1' HD23 ' A' ' 110' ' ' LEU . 86.2 t80 -55.83 -51.44 67.49 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.718 0.807 . . . . 1.0 112.65 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -63.15 -39.32 94.31 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.424 0.69 . . . . 1.0 111.682 176.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.18 -34.65 81.37 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 123.801 0.715 . . . . 1.0 113.009 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.615 HG22 HD12 ' A' ' 110' ' ' LEU . 91.6 mt -65.66 -44.14 93.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 120.354 2.077 . . . . 1.0 108.866 171.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.716 ' HB3' HD21 ' A' ' 110' ' ' LEU . 1.8 ptmm? -74.39 -32.01 62.55 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.304 -1.498 . . . . 1.0 113.415 -173.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -106.55 -38.57 6.12 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 115.138 1.532 . . . . 1.0 115.138 -174.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.7 m -91.06 -25.05 19.84 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.252 1.021 . . . . 1.0 112.712 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.539 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -91.04 -71.06 0.65 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 107.497 -1.297 . . . . 1.0 107.497 169.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.0 -8.22 2.66 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 126.369 1.938 . . . . 1.0 115.481 171.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -156.0 147.97 23.24 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 129.322 3.049 . . . . 1.0 107.023 171.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -134.84 127.92 18.57 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.113 0.565 . . . . 1.0 111.037 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -81.3 -44.65 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 121.847 1.698 . . . . 1.0 113.485 -172.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -148.49 28.11 0.89 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.674 1.189 . . . . 1.0 112.88 -172.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.426 HD11 ' CG2' ' A' ' 52' ' ' VAL . 52.4 tp -85.51 137.95 32.54 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.691 -1.256 . . . . 1.0 112.682 -169.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.2 mtm-85 -134.46 157.71 45.77 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.461 2.305 . . . . 1.0 109.153 169.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.66 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -163.24 169.41 19.24 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.136 0.88 . . . . 1.0 111.441 -177.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.41 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -129.92 173.47 19.8 Favored Glycine 0 N--CA 1.469 0.848 0 C-N-CA 124.096 0.855 . . . . 1.0 113.558 169.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.479 HG23 ' HB3' ' A' ' 122' ' ' MET . 0.0 OUTLIER -143.55 140.81 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 114.133 1.16 . . . . 1.0 114.133 -169.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.6 mt -131.57 97.23 2.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 106.841 -1.54 . . . . 1.0 106.841 168.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.12 148.97 28.24 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.806 1.242 . . . . 1.0 111.47 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.7 mp -141.61 151.61 43.28 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.853 0.686 . . . . 1.0 112.853 176.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 170.38 -160.1 32.72 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 121.691 -0.29 . . . . 1.0 112.691 169.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -109.85 122.23 47.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.004 0.902 . . . . 1.0 110.009 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 96.3 p -63.04 -8.29 7.17 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.43 1.27 . . . . 1.0 114.43 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.0 t -72.33 -21.41 61.32 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.876 0.87 . . . . 1.0 112.217 169.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -75.22 147.59 40.2 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.234 -0.916 . . . . 1.0 111.084 173.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -53.15 -50.55 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.866 1.266 . . . . 1.0 113.787 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -96.57 13.12 29.21 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.276 1.584 . . . . 1.0 115.276 -171.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 17.4 t80 28.5 -88.77 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 128.64 2.776 . . . . 1.0 116.22 -176.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 9.5 m -123.11 17.66 9.98 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.88 1.672 . . . . 1.0 113.469 -174.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -63.0 -12.37 25.37 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.861 1.265 . . . . 1.0 114.289 -174.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.36 -39.37 97.15 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-N 120.308 1.413 . . . . 1.0 113.599 171.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -77.25 -36.04 36.08 Favored Glycine 0 N--CA 1.477 1.432 0 O-C-N 120.616 -1.52 . . . . 1.0 112.737 172.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -62.85 -31.62 72.67 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.256 -1.144 . . . . 1.0 112.469 173.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -62.52 -41.21 98.71 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.211 1.004 . . . . 1.0 111.071 169.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -62.8 -38.67 91.61 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 118.804 0.729 . . . . 1.0 111.41 174.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -61.86 -48.63 79.65 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.387 -0.821 . . . . 1.0 112.316 173.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.95 -35.28 70.91 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.278 0.631 . . . . 1.0 112.699 174.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.716 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -58.68 -49.22 78.37 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 125.456 1.502 . . . . 1.0 111.079 -177.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.66 HD12 ' CD1' ' A' ' 87' ' ' TYR . 11.0 mt -67.31 -40.21 85.99 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 120.9 -1.125 . . . . 1.0 111.762 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -70.15 -18.69 63.22 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.244 0.831 . . . . 1.0 113.244 176.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.75 -18.45 59.55 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.674 1.124 . . . . 1.0 111.198 175.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -97.23 -72.83 0.63 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.089 1.355 . . . . 1.0 109.608 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.6 p 176.54 -18.04 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.476 2.31 . . . . 1.0 113.348 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -68.44 151.54 46.68 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 123.149 1.452 . . . . 1.0 114.457 -169.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -90.93 168.07 11.96 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.73 2.012 . . . . 1.0 114.006 -168.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.97 154.43 27.61 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.172 2.189 . . . . 1.0 111.454 176.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.1 t -124.92 129.46 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.301 1.441 . . . . 1.0 108.764 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 49.79 -154.49 2.7 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 125.328 1.442 . . . . 1.0 115.279 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -111.52 143.35 42.51 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.31 1.844 . . . . 1.0 109.914 169.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.479 ' HB3' HG23 ' A' ' 89' ' ' VAL . 1.3 pmm? -77.07 156.46 31.74 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.731 0.777 . . . . 1.0 112.257 -173.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.603 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.8 OUTLIER -92.26 137.15 32.61 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 123.87 0.868 . . . . 1.0 110.291 174.118 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.603 ' N ' HD13 ' A' ' 123' ' ' LEU . 6.2 mt -123.16 102.54 8.01 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.825 1.25 . . . . 1.0 110.532 172.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.7 mt -79.41 133.21 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 C-N-CA 124.461 1.104 . . . . 1.0 111.22 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -109.48 106.98 16.94 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 122.374 1.083 . . . . 1.0 113.448 172.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.21 -23.47 64.82 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.093 0.957 . . . . 1.0 113.26 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.2 t -62.91 -22.97 67.13 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.371 1.068 . . . . 1.0 112.665 174.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -120.0 -29.6 4.89 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.361 1.864 . . . . 1.0 111.925 -174.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -144.8 84.68 8.79 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.756 1.622 . . . . 1.0 112.058 -172.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -73.65 8.25 2.0 Allowed 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 123.635 2.89 . . . . 1.0 114.495 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -111.54 71.17 0.88 Allowed Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 127.953 2.501 . . . . 1.0 109.551 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -57.67 -22.21 51.21 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.696 2.264 . . . . 1.0 116.554 -169.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -64.48 -26.16 68.31 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 118.963 0.802 . . . . 1.0 111.758 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.7 p -77.12 -19.05 57.45 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 120.434 -1.416 . . . . 1.0 112.046 -174.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -94.82 -51.99 4.45 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.028 1.331 . . . . 1.0 111.883 172.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.8 p -72.17 -35.58 69.06 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 115.078 1.51 . . . . 1.0 115.078 -176.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -59.85 -55.04 49.65 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 120.612 1.551 . . . . 1.0 112.54 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -63.35 -23.12 71.94 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 121.482 1.565 . . . . 1.0 112.515 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.461 ' HB2' HD23 ' A' ' 123' ' ' LEU . 89.6 t90 -69.19 -46.75 66.7 Favored 'General case' 0 C--O 1.218 -0.572 0 O-C-N 121.828 -0.545 . . . . 1.0 110.846 174.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.551 HG11 ' HA ' ' A' ' 22' ' ' ALA . 91.7 t -64.77 -32.25 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.877 0.846 . . . . 1.0 108.85 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -71.82 -23.51 61.56 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.154 -1.591 . . . . 1.0 113.292 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -86.91 -61.21 1.78 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.867 2.067 . . . . 1.0 111.698 169.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.41 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 89.4 t90 -54.72 -37.68 66.18 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 126.715 2.006 . . . . 1.0 112.658 178.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.85 -29.57 34.44 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 121.519 -0.738 . . . . 1.0 114.383 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.2 p -69.05 -13.47 62.46 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.273 1.212 . . . . 1.0 114.273 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.43 -18.33 52.43 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.651 1.58 . . . . 1.0 111.833 176.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.41 171.79 12.31 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.672 1.189 . . . . 1.0 110.964 -176.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 C--O 1.253 1.253 0 N-CA-C 116.17 1.915 . . . . 1.0 116.17 -169.67 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.616 -0.513 . . . . 1.0 109.616 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.9 154.38 45.08 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.574 1.15 . . . . 1.0 113.116 -170.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -120.17 122.34 40.77 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.454 1.502 . . . . 1.0 110.231 174.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.562 HD13 HD12 ' A' ' 26' ' ' LEU . 2.0 mp -122.4 113.36 38.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 126.622 1.969 . . . . 1.0 111.972 -176.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.9 124.52 7.58 Favored Glycine 0 C--O 1.224 -0.52 0 N-CA-C 110.263 -1.135 . . . . 1.0 110.263 169.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 mt -105.44 123.96 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-N 118.069 0.934 . . . . 1.0 109.225 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -115.47 109.35 17.71 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 124.195 0.998 . . . . 1.0 108.368 -169.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -86.64 131.73 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.105 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.26 113.66 2.98 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.753 1.168 . . . . 1.0 110.861 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.3 t -149.18 164.23 35.33 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 118.083 0.942 . . . . 1.0 113.138 -170.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 13.9 ptt? -124.42 6.48 8.34 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.927 1.291 . . . . 1.0 113.095 169.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -100.68 167.27 10.43 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.1 1.36 . . . . 1.0 113.191 -171.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.19 -26.87 73.95 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 123.901 0.762 . . . . 1.0 114.061 175.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -87.27 142.08 28.16 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.421 1.089 . . . . 1.0 111.135 169.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.0 m -77.77 43.18 0.4 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.481 1.512 . . . . 1.0 113.741 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 47.29 75.01 0.14 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.067 2.147 . . . . 1.0 112.496 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.1 tp -11.46 -54.78 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 129.546 3.139 . . . . 1.0 116.683 169.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.4 t -53.34 -33.67 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.968 0.907 . . . . 1.0 112.914 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.46 -46.84 87.62 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 120.285 1.402 . . . . 1.0 112.48 173.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -68.64 -32.09 71.7 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.077 0.951 . . . . 1.0 111.046 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -65.21 -49.12 70.91 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.982 -0.748 . . . . 1.0 108.982 171.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.598 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.19 -42.41 93.6 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 112.983 0.734 . . . . 1.0 112.983 -172.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -53.95 -49.99 67.48 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.701 0.8 . . . . 1.0 110.09 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.83 -35.64 74.94 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 112.625 0.602 . . . . 1.0 112.625 -175.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.1 mt -70.47 -46.01 72.29 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 119.063 0.847 . . . . 1.0 109.658 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.562 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.72 -33.6 76.25 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 119.863 -0.735 . . . . 1.0 110.189 -178.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 54.0 m -61.96 -44.6 96.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.058 1.343 . . . . 1.0 113.085 169.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.78 -32.03 73.05 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.196 0.998 . . . . 1.0 112.92 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -70.03 -29.43 66.47 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.846 1.259 . . . . 1.0 112.279 171.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.13 21.8 2.49 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.723 1.154 . . . . 1.0 115.056 169.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -114.24 158.39 21.44 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.816 1.246 . . . . 1.0 110.792 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -86.03 89.47 7.81 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 125.461 1.504 . . . . 1.0 108.587 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.23 145.35 31.68 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 122.446 0.298 . . . . 1.0 111.123 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 78.6 m -148.08 138.71 23.0 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.642 0.777 . . . . 1.0 112.018 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.7 t -85.57 134.58 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.726 1.21 . . . . 1.0 114.151 171.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -110.3 109.9 20.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.799 1.64 . . . . 1.0 110.385 169.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -87.47 137.52 32.27 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.113 1.765 . . . . 1.0 111.115 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.2 t0 40.89 56.85 8.34 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 124.868 1.267 . . . . 1.0 111.354 -169.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -68.9 140.95 47.37 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.898 3.065 . . . . 1.0 116.973 -168.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.435 ' HB3' ' H ' ' A' ' 42' ' ' SER . 52.6 mm-40 -93.83 163.47 13.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 122.357 1.075 . . . . 1.0 111.847 168.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.545 HD21 HD21 ' A' ' 79' ' ' LEU . 2.2 tm? -65.86 -22.04 66.51 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 120.886 -1.134 . . . . 1.0 109.796 167.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.435 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 17.9 m -68.3 -19.7 64.71 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.878 -1.139 . . . . 1.0 112.613 172.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -83.1 -24.69 32.53 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.385 1.074 . . . . 1.0 112.444 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.443 ' HB3' HD22 ' A' ' 41' ' ' LEU . 13.0 t-105 -88.68 -34.56 17.17 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.075 1.139 . . . . 1.0 114.075 -178.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.9 mt -48.09 -38.57 20.96 Favored Pre-proline 0 CA--C 1.554 1.109 0 CA-C-O 117.608 -1.186 . . . . 1.0 114.103 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.71 -11.68 21.7 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.132 3.221 . . . . 1.0 116.352 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -109.36 6.9 24.8 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 116.095 1.887 . . . . 1.0 116.095 -174.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -52.88 -31.02 37.3 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.88 2.072 . . . . 1.0 113.723 172.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -109.81 11.5 24.33 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.176 1.391 . . . . 1.0 112.499 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -124.83 -159.03 0.86 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.904 2.482 . . . . 1.0 111.034 -174.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -116.13 162.85 16.82 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 122.874 1.321 . . . . 1.0 111.834 170.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.614 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -146.93 160.52 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.432 1.093 . . . . 1.0 109.182 -172.022 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.417 HD11 HD12 ' A' ' 90' ' ' ILE . 14.8 tp -139.29 128.0 23.29 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.68 1.192 . . . . 1.0 108.924 175.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.1 t -100.52 128.3 52.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.154 -0.684 . . . . 1.0 109.154 174.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.4 t -126.04 110.92 25.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 106.254 -1.758 . . . . 1.0 106.254 175.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.2 t -144.12 128.94 18.36 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.228 0.825 . . . . 1.0 113.228 -168.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.9 t -118.82 154.65 32.53 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.593 1.157 . . . . 1.0 113.106 -169.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.7 m 64.6 60.13 0.91 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 123.312 1.529 . . . . 1.0 112.077 169.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.9 m -56.03 -29.61 60.66 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 113.809 -1.541 . . . . 1.0 112.138 169.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.11 -136.96 49.5 Favored Glycine 0 C--N 1.343 0.944 0 C-N-CA 124.054 0.835 . . . . 1.0 111.913 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -61.77 -26.1 67.87 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.506 0.722 . . . . 1.0 112.916 177.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 148.0 52.91 0.02 OUTLIER Glycine 0 CA--C 1.537 1.412 0 CA-C-N 119.216 0.916 . . . . 1.0 114.721 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -143.1 -178.98 6.1 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.267 1.033 . . . . 1.0 111.821 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.9 mt -108.49 148.36 37.52 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 126.051 1.74 . . . . 1.0 113.659 176.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.55 147.22 95.94 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.283 2.655 . . . . 1.0 113.182 169.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -63.63 -23.11 67.24 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.965 1.098 . . . . 1.0 113.965 -175.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.9 p -67.51 -26.82 66.53 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.149 1.166 . . . . 1.0 114.149 173.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.2 tt -113.38 -14.65 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 125.259 1.424 . . . . 1.0 113.712 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.1 t -44.96 -53.27 16.48 Favored Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 124.444 1.098 . . . . 1.0 112.238 168.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -68.09 -32.38 27.89 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 121.747 1.631 . . . . 1.0 111.819 -173.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.2 tp -63.15 -53.24 56.51 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 124.429 1.092 . . . . 1.0 111.259 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.664 ' CE1' HD23 ' A' ' 110' ' ' LEU . 92.8 t80 -55.2 -53.75 52.09 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.747 0.819 . . . . 1.0 112.393 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -68.38 -35.1 77.21 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.769 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.36 -35.3 90.02 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 121.709 -0.62 . . . . 1.0 112.585 175.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.6 HG22 HD12 ' A' ' 110' ' ' LEU . 88.7 mt -65.98 -50.14 71.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 119.926 1.863 . . . . 1.0 108.414 171.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.681 ' HB3' HD21 ' A' ' 110' ' ' LEU . 5.6 ptmm? -69.35 -32.28 71.27 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.222 -1.549 . . . . 1.0 113.145 -170.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -104.61 -40.47 6.01 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.054 1.501 . . . . 1.0 115.054 -174.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.3 m -92.01 -24.13 19.31 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.006 0.922 . . . . 1.0 113.011 -175.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.545 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -91.1 -71.04 0.65 Allowed 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 106.804 -1.554 . . . . 1.0 106.804 169.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.43 -13.53 1.11 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 127.61 2.529 . . . . 1.0 117.011 168.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -155.24 140.39 17.5 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.557 2.343 . . . . 1.0 108.398 172.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -136.33 128.41 17.28 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 121.328 -0.858 . . . . 1.0 112.028 -172.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -89.3 -34.98 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.948 2.432 . . . . 1.0 115.123 -175.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -142.52 12.97 1.94 Allowed 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 115.138 1.533 . . . . 1.0 115.138 -169.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.614 HD11 ' CG2' ' A' ' 52' ' ' VAL . 63.9 tp -84.39 132.7 34.56 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.51 -1.369 . . . . 1.0 113.362 -169.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.7 mtm-85 -130.32 153.64 48.46 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.395 1.878 . . . . 1.0 109.716 169.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.661 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -160.82 165.27 30.53 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.548 1.067 . . . . 1.0 112.277 -176.46 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.402 ' HA3' ' CE2' ' A' ' 144' ' ' TRP . . . -124.0 173.37 16.68 Favored Glycine 0 N--CA 1.467 0.726 0 C-N-CA 125.401 1.476 . . . . 1.0 112.109 169.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.546 HG13 ' HB3' ' A' ' 122' ' ' MET . 0.2 OUTLIER -159.54 142.54 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 O-C-N 120.854 -1.38 . . . . 1.0 114.416 -169.571 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.417 HD12 HD11 ' A' ' 53' ' ' LEU . 4.9 mt -132.01 109.72 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 126.806 2.043 . . . . 1.0 108.24 178.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.11 145.47 24.49 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.192 1.397 . . . . 1.0 110.846 172.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.9 mp -137.09 152.41 49.99 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.466 0.706 . . . . 1.0 112.222 177.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.1 -153.32 23.41 Favored Glycine 0 C--O 1.222 -0.629 0 CA-C-N 116.354 -0.384 . . . . 1.0 112.421 169.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -114.45 119.19 36.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.979 0.889 . . . . 1.0 110.39 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 60.5 p -63.15 -6.04 3.83 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.529 1.307 . . . . 1.0 114.529 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.9 t -63.94 -25.55 68.19 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.598 0.759 . . . . 1.0 112.742 170.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -79.36 140.22 37.54 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.115 -0.991 . . . . 1.0 111.266 169.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -50.57 -50.53 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.273 1.429 . . . . 1.0 113.113 176.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -88.72 21.29 3.07 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.807 1.643 . . . . 1.0 114.525 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.8 t80 11.9 -75.17 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 130.158 3.383 . . . . 1.0 117.611 175.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.55 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 19.8 p -123.04 13.02 9.71 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.793 2.037 . . . . 1.0 114.017 -169.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -57.44 -21.41 36.75 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.477 1.288 . . . . 1.0 114.477 -173.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -54.21 -44.24 74.74 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 120.592 1.542 . . . . 1.0 113.467 174.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -79.54 -36.61 25.93 Favored Glycine 0 N--CA 1.479 1.547 0 O-C-N 120.993 -1.298 . . . . 1.0 113.476 174.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.55 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 78.7 mttt -60.04 -34.41 73.35 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.207 1.004 . . . . 1.0 112.789 174.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -64.79 -38.28 90.46 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.159 0.984 . . . . 1.0 111.914 172.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -64.25 -37.71 88.44 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.421 1.009 . . . . 1.0 111.036 173.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.53 -43.57 93.6 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.132 0.573 . . . . 1.0 112.229 176.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.41 82.77 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.857 -0.592 . . . . 1.0 111.754 170.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.681 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -49.46 -49.46 45.28 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.868 2.067 . . . . 1.0 111.939 -173.464 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.661 HD12 ' CD1' ' A' ' 87' ' ' TYR . 8.5 mt -65.59 -43.96 88.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.463 -0.79 . . . . 1.0 111.005 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -67.1 -21.68 65.85 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.941 1.089 . . . . 1.0 113.941 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -66.13 -36.47 83.24 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.415 1.086 . . . . 1.0 110.938 173.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -81.02 -77.61 0.2 Allowed 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 113.996 -1.456 . . . . 1.0 109.888 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.419 ' H ' ' H ' ' A' ' 116' ' ' ALA . 4.7 t -179.72 -2.34 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.195 2.198 . . . . 1.0 111.498 170.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.436 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -74.19 146.8 43.11 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 114.819 1.415 . . . . 1.0 114.819 -168.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.13 167.31 18.88 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.657 2.383 . . . . 1.0 114.896 -168.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.43 149.5 42.92 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.907 2.083 . . . . 1.0 111.693 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.8 t -123.93 128.66 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.775 1.63 . . . . 1.0 108.497 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 50.25 -155.03 2.82 Favored Glycine 0 CA--C 1.542 1.77 0 C-N-CA 124.908 1.242 . . . . 1.0 114.988 -171.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -114.59 144.38 43.49 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.317 1.847 . . . . 1.0 109.962 169.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.546 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -73.18 155.71 39.34 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 122.134 0.969 . . . . 1.0 111.424 -174.097 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.649 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -93.73 140.04 30.11 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.309 1.043 . . . . 1.0 110.197 176.16 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.649 ' N ' HD13 ' A' ' 123' ' ' LEU . 6.7 mt -124.83 102.13 7.41 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.082 1.353 . . . . 1.0 110.891 176.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.403 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.2 mt -86.11 128.75 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.576 1.55 . . . . 1.0 111.909 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -108.03 110.5 22.21 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 124.328 1.018 . . . . 1.0 112.261 174.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -70.13 -23.3 63.0 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.132 0.973 . . . . 1.0 112.79 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.5 t -62.77 -23.17 67.08 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.291 1.036 . . . . 1.0 112.73 173.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -119.27 -29.94 5.06 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.293 1.837 . . . . 1.0 112.2 -173.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -143.79 91.11 6.76 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 125.196 1.398 . . . . 1.0 112.603 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.76 7.17 3.28 Favored 'Trans proline' 0 CA--C 1.552 1.39 0 C-N-CA 123.414 2.743 . . . . 1.0 114.483 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -110.07 71.52 0.61 Allowed Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 127.307 2.243 . . . . 1.0 110.116 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -58.34 -18.8 39.92 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.803 2.335 . . . . 1.0 117.629 -168.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -69.47 -25.45 64.09 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.122 1.328 . . . . 1.0 111.644 172.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 28.0 p -72.78 -22.85 60.77 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.942 1.246 . . . . 1.0 111.969 -173.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -91.01 -54.2 4.06 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.654 1.582 . . . . 1.0 111.767 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.7 p -70.88 -32.78 69.87 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 115.022 1.489 . . . . 1.0 115.022 -176.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -58.42 -55.62 43.79 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 120.94 1.7 . . . . 1.0 112.705 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -64.32 -24.45 64.82 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 CA-C-N 121.277 1.492 . . . . 1.0 113.134 174.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.413 ' HB2' HD23 ' A' ' 123' ' ' LEU . 92.2 t90 -68.0 -48.2 66.4 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 118.795 0.725 . . . . 1.0 110.728 174.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.598 HG11 ' HA ' ' A' ' 22' ' ' ALA . 96.2 t -67.04 -33.09 61.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 C-N-CA 122.842 0.457 . . . . 1.0 110.044 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.59 -48.9 73.22 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.02 -1.05 . . . . 1.0 109.785 173.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -64.35 -54.77 27.68 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.539 1.136 . . . . 1.0 112.102 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.434 ' CZ3' HD11 ' A' ' 26' ' ' LEU . 87.3 t90 -56.24 -37.17 69.37 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 125.886 1.674 . . . . 1.0 111.401 173.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -49.99 -34.1 22.67 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.505 1.526 . . . . 1.0 113.482 173.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.6 p -68.78 -13.37 62.35 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 115.097 1.518 . . . . 1.0 115.097 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.61 -20.03 44.13 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.619 1.568 . . . . 1.0 111.778 176.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -84.18 172.5 11.85 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.65 1.18 . . . . 1.0 110.879 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--O 1.252 1.222 0 C-N-CA 124.655 1.182 . . . . 1.0 113.941 -176.052 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 tpt . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 119.916 -0.087 . . . . 1.0 110.831 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.23 168.2 26.13 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.284 1.434 . . . . 1.0 112.822 -174.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -122.89 121.56 36.48 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.562 1.545 . . . . 1.0 110.845 177.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.555 HD13 HD12 ' A' ' 26' ' ' LEU . 2.1 mp -121.77 117.79 53.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 127.418 2.287 . . . . 1.0 112.65 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.32 125.7 8.47 Favored Glycine 0 N--CA 1.465 0.615 0 N-CA-C 110.785 -0.926 . . . . 1.0 110.785 169.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.6 mt -104.61 120.77 55.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-N 118.565 1.183 . . . . 1.0 109.81 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -113.13 111.18 21.67 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 125.109 1.363 . . . . 1.0 107.638 -171.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 p -103.63 126.6 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 112.515 0.561 . . . . 1.0 112.515 -170.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.6 119.2 4.6 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.621 1.105 . . . . 1.0 111.364 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.5 m -152.04 137.05 17.28 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.223 1.009 . . . . 1.0 110.838 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 17.1 ptt? -135.88 31.23 3.03 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.015 1.117 . . . . 1.0 114.015 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -135.94 166.35 23.54 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.381 1.472 . . . . 1.0 111.323 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.05 65.81 0.9 Allowed Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.708 1.623 . . . . 1.0 113.967 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -131.05 153.95 48.75 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.639 1.976 . . . . 1.0 111.306 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 89.2 p -73.64 -12.61 60.79 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.917 1.451 . . . . 1.0 114.917 -177.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.372 1.4 pp 53.33 18.2 1.24 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 128.109 2.563 . . . . 1.0 116.093 -174.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.8 tp -36.1 -42.88 0.31 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 130.112 3.365 . . . . 1.0 115.936 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.7 t -52.0 -33.52 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 118.782 0.719 . . . . 1.0 112.602 -176.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.89 -49.91 76.0 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.001 -1.062 . . . . 1.0 113.048 173.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.73 -28.15 62.48 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.256 0.622 . . . . 1.0 110.771 -178.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -62.13 -49.42 75.94 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.122 -1.066 . . . . 1.0 108.122 169.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.605 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.02 -42.41 94.44 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 112.725 0.639 . . . . 1.0 112.725 -173.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.87 -49.67 70.58 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.196 0.598 . . . . 1.0 110.145 169.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.66 -35.76 77.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.381 0.512 . . . . 1.0 112.381 -175.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.7 mt -71.82 -45.42 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 O-C-N 121.023 -1.048 . . . . 1.0 109.71 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.555 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.62 -33.46 75.96 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 119.572 -0.851 . . . . 1.0 110.049 -179.09 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.2 m -61.86 -45.09 95.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.206 1.402 . . . . 1.0 113.084 169.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.07 -32.26 73.63 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.343 1.057 . . . . 1.0 112.888 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -70.97 -28.37 64.41 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.901 1.281 . . . . 1.0 112.578 172.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.14 27.11 2.11 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.721 1.153 . . . . 1.0 114.622 170.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -121.95 148.9 44.2 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.67 1.188 . . . . 1.0 110.415 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -77.43 101.33 6.35 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 125.4 1.48 . . . . 1.0 108.092 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.48 148.06 42.98 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 122.745 0.418 . . . . 1.0 110.937 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.5 m -149.54 146.61 27.45 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.305 1.042 . . . . 1.0 111.749 -172.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.1 t -97.9 137.18 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 114.485 1.291 . . . . 1.0 114.485 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -119.93 109.24 15.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.659 1.984 . . . . 1.0 110.878 169.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -89.82 139.94 30.09 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.462 1.905 . . . . 1.0 111.235 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t0 40.93 55.73 7.92 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 124.869 1.267 . . . . 1.0 111.613 -169.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -71.03 144.01 46.22 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.949 3.099 . . . . 1.0 117.606 -168.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -86.51 155.87 20.33 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.637 1.575 . . . . 1.0 112.616 168.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.506 HD21 HD21 ' A' ' 79' ' ' LEU . 2.3 tm? -68.5 -23.46 64.55 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 120.595 -1.316 . . . . 1.0 109.887 168.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.6 m -66.25 -21.35 66.28 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.5 -0.75 . . . . 1.0 112.488 170.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -85.31 -24.52 27.64 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.488 1.115 . . . . 1.0 112.928 169.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.484 ' HB3' HD22 ' A' ' 41' ' ' LEU . 10.9 t-105 -82.13 -35.51 28.43 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.86 1.209 . . . . 1.0 113.743 175.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.5 mt -50.57 -39.8 54.88 Favored Pre-proline 0 CA--C 1.552 1.039 0 CA-C-O 117.678 -1.153 . . . . 1.0 113.781 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -55.07 -14.47 8.55 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 124.059 3.173 . . . . 1.0 117.023 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -110.46 9.98 23.28 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 115.391 1.626 . . . . 1.0 115.391 -175.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -53.26 -34.91 59.16 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.281 1.832 . . . . 1.0 113.463 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.33 -0.6 38.07 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.462 1.505 . . . . 1.0 113.379 177.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -111.03 -164.7 0.93 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.695 2.398 . . . . 1.0 111.108 -175.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -109.4 165.66 11.47 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 122.871 1.32 . . . . 1.0 111.359 169.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.597 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -149.62 160.85 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.91 1.284 . . . . 1.0 109.677 -171.036 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.599 HD11 HD12 ' A' ' 90' ' ' ILE . 19.1 tp -142.37 124.76 15.63 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.949 0.9 . . . . 1.0 108.975 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.9 t -99.26 123.43 51.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 123.86 0.864 . . . . 1.0 109.244 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.2 t -121.64 115.81 47.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.984 -1.858 . . . . 1.0 105.984 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.7 t -145.99 117.46 8.0 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.283 0.845 . . . . 1.0 113.283 -168.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.1 p -107.66 146.44 32.03 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.262 1.825 . . . . 1.0 111.474 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.7 m 65.03 66.08 0.57 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 123.021 1.391 . . . . 1.0 111.254 174.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.6 m -50.33 -28.39 7.83 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.795 2.438 . . . . 1.0 114.746 174.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.46 -149.91 50.27 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 124.221 0.915 . . . . 1.0 112.109 -173.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -82.23 49.82 1.48 Allowed 'General case' 0 CA--C 1.554 1.098 0 O-C-N 120.789 -1.418 . . . . 1.0 111.247 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.15 27.47 73.7 Favored Glycine 0 CA--C 1.541 1.681 0 C-N-CA 124.507 1.051 . . . . 1.0 112.967 -170.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -93.8 -23.2 18.25 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.906 1.447 . . . . 1.0 114.906 -169.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 39.8 mt 64.14 149.14 0.11 Allowed Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 128.008 2.523 . . . . 1.0 115.484 -169.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.06 137.64 81.82 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.134 2.556 . . . . 1.0 112.861 169.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -60.52 -22.98 64.19 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.334 0.864 . . . . 1.0 113.334 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.9 p -74.32 -17.04 60.9 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.98 1.312 . . . . 1.0 114.494 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.2 tt -121.48 -12.95 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.685 1.194 . . . . 1.0 114.057 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.8 t -48.16 -51.7 47.23 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 125.047 1.339 . . . . 1.0 111.918 168.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.47 -31.59 21.5 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.32 1.347 . . . . 1.0 111.259 -173.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.2 tp -63.11 -51.52 66.23 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.747 1.219 . . . . 1.0 111.205 169.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.646 ' CE1' HD23 ' A' ' 110' ' ' LEU . 92.6 t80 -52.86 -55.12 25.51 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.706 1.203 . . . . 1.0 112.544 178.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -67.65 -35.55 79.08 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.753 -0.658 . . . . 1.0 111.8 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.62 -36.72 92.78 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.586 0.613 . . . . 1.0 112.566 176.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.568 HG22 HD12 ' A' ' 110' ' ' LEU . 92.3 mt -64.37 -50.94 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 120.114 1.957 . . . . 1.0 108.111 171.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.692 ' HB3' HD21 ' A' ' 110' ' ' LEU . 1.7 ptmm? -67.91 -31.76 71.75 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.561 -1.337 . . . . 1.0 113.281 -170.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -103.74 -37.37 7.5 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.63 1.572 . . . . 1.0 115.157 -175.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.8 m -97.06 -19.17 18.9 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.566 1.146 . . . . 1.0 113.235 -174.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.506 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -94.07 -72.27 0.62 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 107.086 -1.45 . . . . 1.0 107.086 169.718 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.65 -20.8 1.3 Allowed Glycine 0 CA--C 1.539 1.567 0 C-N-CA 127.715 2.579 . . . . 1.0 114.873 170.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -152.73 141.84 21.35 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 128.528 2.731 . . . . 1.0 107.985 169.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.415 HE21 HD12 ' A' ' 79' ' ' LEU . 6.3 mt-30 -137.6 119.57 10.98 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.016 0.926 . . . . 1.0 109.485 -170.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.03 -36.49 1.95 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.223 1.949 . . . . 1.0 115.737 -169.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -144.4 18.46 1.71 Allowed 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.993 1.109 . . . . 1.0 113.993 -169.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.597 HD11 ' CG2' ' A' ' 52' ' ' VAL . 62.6 tp -82.22 139.93 33.98 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 120.681 -1.262 . . . . 1.0 113.441 -169.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.7 mtm-85 -136.6 152.82 50.87 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.976 2.51 . . . . 1.0 109.56 169.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.651 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -161.22 168.14 24.71 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.467 1.03 . . . . 1.0 112.854 -175.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.406 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -124.8 171.36 16.86 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.176 1.37 . . . . 1.0 113.908 173.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 88.3 t -143.57 133.5 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.639 1.175 . . . . 1.0 113.585 -169.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.009 HG23 HD12 ' A' ' 123' ' ' LEU . 4.2 mt -130.63 103.53 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.144 1.778 . . . . 1.0 108.293 170.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.83 142.28 27.5 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.224 1.409 . . . . 1.0 111.656 173.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.9 mp -138.71 150.17 45.88 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.414 -0.804 . . . . 1.0 113.079 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.78 -163.83 36.57 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 116.676 -0.238 . . . . 1.0 113.042 169.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -97.12 118.08 32.75 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.049 1.34 . . . . 1.0 111.793 173.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.1 p -65.66 -5.52 8.69 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.493 1.294 . . . . 1.0 114.493 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 89.2 p -62.14 -21.24 64.87 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.655 1.182 . . . . 1.0 112.768 169.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -85.59 141.03 30.12 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.352 1.461 . . . . 1.0 111.928 170.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -44.98 -54.97 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 127.199 2.2 . . . . 1.0 115.123 -173.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.83 26.47 4.05 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 127.132 2.173 . . . . 1.0 113.955 -174.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.7 t80 15.32 -81.46 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 129.544 3.138 . . . . 1.0 117.407 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.441 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 22.3 p -116.63 15.79 15.48 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.234 1.814 . . . . 1.0 114.889 -168.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -54.46 -22.87 13.92 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 124.801 1.24 . . . . 1.0 114.271 -173.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.19 -49.05 70.21 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 121.121 1.782 . . . . 1.0 113.829 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -72.14 -35.1 60.98 Favored Glycine 0 N--CA 1.477 1.38 0 O-C-N 120.72 -1.459 . . . . 1.0 112.842 175.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.441 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 82.2 mttt -64.66 -35.87 82.42 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.693 1.197 . . . . 1.0 112.805 176.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -61.48 -43.44 98.87 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.628 1.171 . . . . 1.0 111.23 170.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -62.09 -39.08 91.25 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.41 0.55 . . . . 1.0 111.087 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -44.85 94.98 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.264 0.626 . . . . 1.0 111.781 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.03 74.16 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.037 0.754 . . . . 1.0 113.037 171.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.692 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -58.91 -49.53 77.45 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 123.44 1.591 . . . . 1.0 110.859 -175.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.651 HD12 ' CD1' ' A' ' 87' ' ' TYR . 4.0 mt -67.07 -40.57 87.05 Favored 'General case' 0 C--N 1.32 -0.692 0 O-C-N 120.885 -1.134 . . . . 1.0 110.936 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -69.29 -18.76 63.87 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.313 0.857 . . . . 1.0 113.313 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.81 -18.0 58.67 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.69 1.132 . . . . 1.0 110.765 175.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -100.03 -73.45 0.63 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.086 1.354 . . . . 1.0 109.606 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 62.2 p 179.76 -18.92 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.414 1.886 . . . . 1.0 114.075 -174.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -71.71 150.9 44.07 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 114.794 1.405 . . . . 1.0 114.794 -169.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -88.96 166.51 13.88 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 113.017 -1.901 . . . . 1.0 113.342 -168.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.21 136.72 52.43 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.269 1.828 . . . . 1.0 110.645 -175.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.3 t -113.59 128.9 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.889 1.276 . . . . 1.0 109.345 -173.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 50.98 -158.12 2.23 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 124.884 1.23 . . . . 1.0 114.324 -171.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -115.39 144.69 43.41 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.751 1.62 . . . . 1.0 109.445 169.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -71.19 158.16 36.9 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.918 1.081 . . . . 1.0 113.918 -169.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 1.009 HD12 HG23 ' A' ' 90' ' ' ILE . 1.4 tm? -89.49 138.39 31.49 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.049 1.34 . . . . 1.0 110.139 169.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 mt -127.78 107.81 10.2 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.708 1.603 . . . . 1.0 109.32 173.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.593 HG13 HD11 ' A' ' 123' ' ' LEU . 25.3 mt -96.51 128.15 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 121.086 -1.009 . . . . 1.0 111.541 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -104.98 109.2 21.1 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 124.628 1.205 . . . . 1.0 111.705 174.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.25 -22.06 64.79 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.269 1.028 . . . . 1.0 113.24 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.7 t -65.13 -20.23 66.36 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.867 1.267 . . . . 1.0 112.602 173.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -120.09 -29.9 4.79 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.071 1.748 . . . . 1.0 112.298 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -143.43 88.14 8.12 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.975 1.31 . . . . 1.0 112.266 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.25 4.98 4.39 Favored 'Trans proline' 0 CA--C 1.546 1.125 0 C-N-CA 123.521 2.814 . . . . 1.0 114.761 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -111.55 73.82 1.13 Allowed Pre-proline 0 N--CA 1.469 0.503 0 C-N-CA 126.794 2.038 . . . . 1.0 110.233 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -60.42 -25.88 81.46 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.999 2.466 . . . . 1.0 116.135 -169.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -65.63 -24.42 67.04 Favored 'General case' 0 C--O 1.222 -0.384 0 O-C-N 120.983 -1.073 . . . . 1.0 111.521 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 30.1 p -72.75 -18.38 61.51 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.183 -0.948 . . . . 1.0 112.498 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.41 ' HB2' HD11 ' A' ' 125' ' ' ILE . 5.1 mm-40 -100.84 -55.05 2.67 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.256 1.822 . . . . 1.0 111.297 177.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 63.4 p -67.38 -31.64 72.01 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 117.771 -1.109 . . . . 1.0 113.906 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -59.11 -59.89 12.34 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-N 121.192 1.814 . . . . 1.0 112.854 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -61.92 -26.4 78.92 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 CA-C-N 121.203 1.465 . . . . 1.0 112.813 174.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.457 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 91.1 t90 -65.6 -48.88 70.78 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.353 0.979 . . . . 1.0 110.66 174.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.605 HG11 ' HA ' ' A' ' 22' ' ' ALA . 80.0 t -66.05 -32.92 60.27 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 C-N-CA 123.08 0.552 . . . . 1.0 110.143 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.72 -51.18 68.16 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 121.076 -1.015 . . . . 1.0 109.958 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 60.0 m170 -65.19 -51.63 59.86 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.178 0.991 . . . . 1.0 111.431 -177.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.418 ' CZ3' HD11 ' A' ' 26' ' ' LEU . 86.9 t90 -57.42 -37.3 72.53 Favored 'General case' 0 C--O 1.219 -0.514 0 C-N-CA 125.293 1.437 . . . . 1.0 111.542 171.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -49.42 -34.69 19.71 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.751 1.644 . . . . 1.0 113.507 172.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 p -68.62 -13.69 62.52 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 114.896 1.443 . . . . 1.0 114.896 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.48 -19.54 45.71 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.609 1.563 . . . . 1.0 111.87 175.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -84.04 169.23 15.15 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.219 1.007 . . . . 1.0 111.193 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 C--O 1.252 1.19 0 N-CA-C 115.652 1.723 . . . . 1.0 115.652 -169.645 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.2 ttm . . . . . 0 N--CA 1.498 1.957 0 CA-C-O 119.611 -0.233 . . . . 1.0 110.413 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.12 151.94 42.77 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.71 1.004 . . . . 1.0 113.71 -176.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -126.1 125.05 41.92 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.661 1.584 . . . . 1.0 110.305 174.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.551 HD13 HD12 ' A' ' 26' ' ' LEU . 2.0 mp -121.68 113.94 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 126.152 1.781 . . . . 1.0 113.262 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.32 122.21 6.64 Favored Glycine 0 C--O 1.223 -0.544 0 O-C-N 121.33 -0.856 . . . . 1.0 111.245 169.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.3 mt -104.4 122.18 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-N 118.407 1.103 . . . . 1.0 109.872 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -114.72 112.7 23.24 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.089 1.355 . . . . 1.0 107.455 -171.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.2 p -99.93 124.43 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 122.586 0.355 . . . . 1.0 111.473 -172.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -112.93 112.21 2.91 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.42 1.009 . . . . 1.0 112.395 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.5 t -162.42 151.46 15.29 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.412 1.085 . . . . 1.0 111.836 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -89.81 -5.22 57.12 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.431 1.092 . . . . 1.0 112.924 169.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -115.05 43.93 1.9 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.256 1.822 . . . . 1.0 111.824 -178.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.39 -22.8 46.13 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.621 1.105 . . . . 1.0 115.026 -174.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -54.61 -23.05 15.31 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 115.037 1.495 . . . . 1.0 115.037 169.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.5 m -132.03 25.79 4.59 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.569 1.148 . . . . 1.0 113.496 -175.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 pp -69.0 152.32 45.4 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 121.228 -0.92 . . . . 1.0 112.377 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.9 tp -154.0 -52.56 0.1 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.626 1.343 . . . . 1.0 114.626 -172.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.9 t -56.8 -31.14 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.22 -0.925 . . . . 1.0 112.269 -171.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.58 -48.2 80.03 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.193 -0.942 . . . . 1.0 113.203 171.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.67 -28.41 62.7 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.031 0.532 . . . . 1.0 110.72 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -63.15 -49.7 73.3 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.924 -0.769 . . . . 1.0 108.924 169.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.532 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.16 -43.36 92.02 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 112.521 0.563 . . . . 1.0 112.521 -173.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -53.34 -49.99 65.95 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.07 0.948 . . . . 1.0 110.291 169.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.71 -37.09 73.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.2 0.6 . . . . 1.0 112.345 -174.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.9 mt -67.43 -46.74 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 118.994 0.816 . . . . 1.0 109.084 176.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.551 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -67.51 -34.13 76.49 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 119.667 -0.813 . . . . 1.0 110.457 -176.554 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.5 m -62.83 -40.26 96.87 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.731 1.612 . . . . 1.0 113.325 170.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.56 -33.26 73.77 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.978 0.911 . . . . 1.0 112.029 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -69.3 -31.48 69.99 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.529 1.132 . . . . 1.0 112.45 170.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 126.68 18.61 2.16 Favored Glycine 0 N--CA 1.472 1.058 0 C-N-CA 124.409 1.004 . . . . 1.0 115.066 169.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -111.22 152.32 27.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.637 1.175 . . . . 1.0 111.007 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.9 73.65 9.9 Favored 'General case' 0 CA--C 1.51 -0.561 0 C-N-CA 124.629 1.172 . . . . 1.0 110.391 -172.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.99 142.39 27.83 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.29 -1.777 . . . . 1.0 112.061 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.6 m -147.94 138.97 23.33 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.549 1.14 . . . . 1.0 112.36 -177.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.5 t -84.64 135.29 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 114.781 1.401 . . . . 1.0 114.781 171.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -116.34 114.54 24.46 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.732 2.013 . . . . 1.0 110.536 169.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -95.32 139.01 32.24 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.465 1.906 . . . . 1.0 111.138 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.2 t0 41.18 54.92 7.93 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 124.865 1.266 . . . . 1.0 111.982 -169.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -71.92 143.06 40.13 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.902 3.068 . . . . 1.0 116.553 -168.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.431 ' HB3' ' H ' ' A' ' 42' ' ' SER . 50.7 mm-40 -94.27 164.93 12.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 122.431 1.11 . . . . 1.0 111.85 168.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.556 HD21 HD21 ' A' ' 79' ' ' LEU . 2.2 tm? -65.8 -22.16 66.54 Favored 'General case' 0 N--CA 1.44 -0.93 0 O-C-N 120.859 -1.151 . . . . 1.0 110.064 167.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.431 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 16.3 m -68.18 -20.08 64.84 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.07 -1.019 . . . . 1.0 112.376 172.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -83.73 -23.99 31.38 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.605 1.162 . . . . 1.0 112.47 169.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.49 ' HB3' HD22 ' A' ' 41' ' ' LEU . 10.9 t-105 -88.41 -33.96 17.7 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.064 1.135 . . . . 1.0 114.064 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.3 mt -49.89 -38.54 35.8 Favored Pre-proline 0 CA--C 1.555 1.163 0 CA-C-O 117.558 -1.21 . . . . 1.0 113.944 178.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -58.76 -8.81 6.3 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 124.031 3.154 . . . . 1.0 116.797 173.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -114.89 8.04 15.84 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 116.091 1.885 . . . . 1.0 116.091 -177.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -51.05 -32.35 21.59 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.935 1.694 . . . . 1.0 113.436 171.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -102.11 6.23 40.79 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.721 2.408 . . . . 1.0 113.588 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -128.79 -159.47 0.96 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 127.056 2.142 . . . . 1.0 112.222 -169.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -112.57 160.8 17.48 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 122.862 1.315 . . . . 1.0 111.404 170.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.567 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -146.92 159.4 9.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 125.076 1.35 . . . . 1.0 108.908 -171.658 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.616 HD11 HD12 ' A' ' 90' ' ' ILE . 19.7 tp -141.76 125.86 17.35 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 124.197 0.999 . . . . 1.0 109.211 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.5 t -102.37 120.41 52.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 C-N-CA 123.767 0.827 . . . . 1.0 109.182 176.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.4 t -119.77 113.53 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 105.944 -1.873 . . . . 1.0 105.944 177.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.1 t -148.07 126.43 12.31 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.561 0.949 . . . . 1.0 113.561 -168.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.5 p -117.26 158.26 24.64 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.304 1.441 . . . . 1.0 112.876 -169.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.1 m 62.73 53.18 2.59 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 122.996 1.379 . . . . 1.0 111.904 169.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 m -51.68 134.63 29.99 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.397 1.479 . . . . 1.0 110.426 169.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -84.09 -139.9 4.3 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.934 0.778 . . . . 1.0 112.611 175.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -76.2 54.72 0.9 Allowed 'General case' 0 CA--C 1.551 0.997 0 O-C-N 121.082 -1.246 . . . . 1.0 111.065 171.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.11 7.74 88.27 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 125.746 1.641 . . . . 1.0 114.584 -169.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -104.69 173.57 6.25 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.627 1.571 . . . . 1.0 112.481 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.6 mt -114.29 158.24 40.29 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 127.046 2.138 . . . . 1.0 114.814 -169.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.22 144.31 95.38 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.62 2.88 . . . . 1.0 112.489 169.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -62.96 -22.31 66.72 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.915 1.08 . . . . 1.0 113.915 -175.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.6 p -72.01 -24.63 61.59 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.065 1.135 . . . . 1.0 114.065 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.0 tt -111.72 -13.72 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.125 1.37 . . . . 1.0 113.682 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.0 t -44.61 -52.74 16.89 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 124.768 1.227 . . . . 1.0 112.622 168.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.73 -32.7 29.55 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 121.851 1.701 . . . . 1.0 111.954 -173.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 tp -62.92 -52.85 61.48 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.523 1.129 . . . . 1.0 111.375 169.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.643 ' CE1' HD23 ' A' ' 110' ' ' LEU . 92.5 t80 -55.13 -53.08 60.42 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.629 0.771 . . . . 1.0 112.651 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 -64.61 -40.58 95.75 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.717 0.807 . . . . 1.0 111.465 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.94 -35.78 91.2 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.41 -0.661 . . . . 1.0 112.333 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.591 HG22 HD12 ' A' ' 110' ' ' LEU . 89.4 mt -64.81 -50.09 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 120.229 2.015 . . . . 1.0 108.246 172.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.707 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.1 ptmm? -69.46 -31.83 70.38 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.326 -1.484 . . . . 1.0 113.188 -170.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -101.76 -37.61 8.23 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 115.133 1.531 . . . . 1.0 115.133 -175.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 m -97.79 -19.51 18.13 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.333 1.053 . . . . 1.0 113.446 -174.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.556 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -92.86 -72.53 0.6 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 107.391 -1.337 . . . . 1.0 107.391 169.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.81 -20.67 1.38 Allowed Glycine 0 CA--C 1.539 1.564 0 C-N-CA 127.541 2.496 . . . . 1.0 114.902 170.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -153.21 142.08 21.14 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 128.408 2.683 . . . . 1.0 108.07 169.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.401 HE21 HD12 ' A' ' 79' ' ' LEU . 5.5 mt-30 -137.35 119.96 11.38 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.929 0.891 . . . . 1.0 109.701 -169.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -77.55 -35.3 1.61 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.451 2.101 . . . . 1.0 115.965 -169.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -143.64 19.28 1.84 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.056 1.132 . . . . 1.0 114.056 -169.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.567 HD11 ' CG2' ' A' ' 52' ' ' VAL . 58.1 tp -85.84 140.06 30.75 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.686 -1.259 . . . . 1.0 114.176 -169.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.4 mtm-85 -137.33 153.57 50.22 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.989 2.516 . . . . 1.0 109.619 169.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.657 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -161.56 168.17 24.04 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.073 0.851 . . . . 1.0 112.543 -176.485 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.402 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -125.19 170.54 17.13 Favored Glycine 0 N--CA 1.472 1.093 0 C-N-CA 125.201 1.382 . . . . 1.0 114.134 174.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.3 t -142.44 132.7 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.658 1.183 . . . . 1.0 113.695 -169.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.97 HG23 HD12 ' A' ' 123' ' ' LEU . 4.1 mt -129.54 102.84 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.802 1.641 . . . . 1.0 108.035 170.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -91.86 142.3 27.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.526 1.531 . . . . 1.0 111.726 173.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.5 mp -138.13 152.7 48.97 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.235 -0.915 . . . . 1.0 112.793 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.42 -154.46 25.19 Favored Glycine 0 C--O 1.221 -0.697 0 C-N-CA 121.528 -0.368 . . . . 1.0 112.583 169.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -111.79 117.87 34.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.205 1.002 . . . . 1.0 109.786 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.1 t -63.8 -7.06 6.81 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.826 1.047 . . . . 1.0 113.826 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.7 t -65.04 -24.17 67.4 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.876 -1.14 . . . . 1.0 112.162 169.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -78.42 138.34 38.45 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.386 -0.821 . . . . 1.0 111.299 169.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -49.09 -49.65 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.726 1.61 . . . . 1.0 113.729 177.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -88.66 22.18 2.71 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.938 1.695 . . . . 1.0 114.542 -175.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.9 t80 1.76 -70.54 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 129.874 3.27 . . . . 1.0 117.73 -177.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.435 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 26.7 p -125.4 11.77 8.07 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.989 1.315 . . . . 1.0 114.519 -169.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -58.18 -21.63 48.17 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 117.573 -1.203 . . . . 1.0 114.08 -173.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -55.95 -43.0 87.77 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-N 121.371 1.896 . . . . 1.0 114.007 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -77.59 -36.88 32.25 Favored Glycine 0 N--CA 1.478 1.471 0 O-C-N 120.909 -1.348 . . . . 1.0 113.036 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.435 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 85.2 mttt -63.58 -33.49 75.71 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.34 1.056 . . . . 1.0 112.978 176.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -59.93 -44.15 94.5 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.263 1.425 . . . . 1.0 111.012 169.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -63.65 -39.12 93.55 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.662 -0.649 . . . . 1.0 110.948 175.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -42.99 99.63 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.774 -0.579 . . . . 1.0 111.709 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.83 -35.64 77.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 112.978 0.733 . . . . 1.0 112.978 171.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.707 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -58.91 -49.66 76.97 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 123.463 1.601 . . . . 1.0 110.902 -175.141 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.657 HD12 ' CD1' ' A' ' 87' ' ' TYR . 4.0 mt -67.52 -40.3 85.1 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 120.92 -1.112 . . . . 1.0 110.996 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -70.09 -17.87 63.24 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.364 0.876 . . . . 1.0 113.364 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.77 -17.08 59.26 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.488 1.04 . . . . 1.0 110.957 174.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -101.63 -73.28 0.66 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.147 1.379 . . . . 1.0 109.904 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 65.8 p 179.52 -19.32 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.106 1.763 . . . . 1.0 113.984 -174.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -72.1 151.59 42.95 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 123.06 1.41 . . . . 1.0 114.464 -169.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -87.75 165.37 15.4 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 113.071 -1.877 . . . . 1.0 113.298 -169.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.69 133.32 47.0 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.222 1.809 . . . . 1.0 110.21 -174.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 32.6 t -112.46 130.99 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.61 1.164 . . . . 1.0 109.857 -171.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 52.46 -157.72 3.77 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 125.314 1.435 . . . . 1.0 114.765 -173.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -111.9 139.82 47.07 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.839 1.656 . . . . 1.0 110.097 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -70.61 155.29 40.92 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 122.332 1.063 . . . . 1.0 112.222 -171.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.97 HD12 HG23 ' A' ' 90' ' ' ILE . 1.2 tm? -87.96 139.07 30.89 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.722 -1.127 . . . . 1.0 109.957 171.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 mt -127.65 106.57 9.24 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.404 1.482 . . . . 1.0 109.69 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.608 HG13 HD11 ' A' ' 123' ' ' LEU . 23.8 mt -95.84 127.79 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 O-C-N 121.169 -0.957 . . . . 1.0 112.042 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -104.68 109.59 21.57 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 122.4 1.095 . . . . 1.0 111.982 173.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.74 -22.71 66.04 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.558 1.143 . . . . 1.0 113.433 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.1 t -64.38 -22.48 66.97 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.035 0.934 . . . . 1.0 112.718 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -118.1 -29.91 5.46 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.0 1.72 . . . . 1.0 111.961 -175.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -142.54 87.72 9.11 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 125.086 1.354 . . . . 1.0 112.06 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.62 8.11 2.42 Favored 'Trans proline' 0 CA--C 1.552 1.404 0 C-N-CA 123.655 2.904 . . . . 1.0 114.271 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -114.73 69.97 2.24 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 127.2 2.2 . . . . 1.0 109.859 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -56.9 -23.13 49.45 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.723 2.282 . . . . 1.0 116.197 -169.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 pm0 -67.03 -24.13 65.97 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 121.028 -1.045 . . . . 1.0 112.251 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.9 p -74.77 -17.92 60.56 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.329 0.968 . . . . 1.0 112.301 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.425 ' HB2' HD11 ' A' ' 125' ' ' ILE . 5.1 mm-40 -100.33 -54.05 2.96 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.456 1.903 . . . . 1.0 111.509 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.5 p -68.19 -33.82 75.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 117.764 -1.112 . . . . 1.0 113.912 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -57.47 -61.69 6.73 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 120.877 1.671 . . . . 1.0 112.009 176.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -60.54 -23.58 75.81 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 CA-C-N 121.882 1.708 . . . . 1.0 113.744 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.456 ' CG ' ' HB2' ' A' ' 123' ' ' LEU . 87.9 t90 -68.87 -47.13 66.66 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 119.217 0.917 . . . . 1.0 110.984 173.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.532 HG11 ' HA ' ' A' ' 22' ' ' ALA . 93.2 t -65.27 -33.83 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 176.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.01 -31.0 70.38 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.0 1.32 . . . . 1.0 112.038 177.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -77.56 -62.34 1.69 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.994 1.718 . . . . 1.0 111.877 169.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.402 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 84.8 t90 -55.06 -36.89 66.05 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 126.191 1.796 . . . . 1.0 112.709 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.93 -31.93 25.72 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.98 1.276 . . . . 1.0 113.803 174.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.0 p -70.2 -13.77 62.33 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 114.352 1.241 . . . . 1.0 114.352 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.41 -17.02 53.04 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.85 1.66 . . . . 1.0 111.705 175.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -81.75 172.38 13.44 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.06 0.944 . . . . 1.0 111.6 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 C--O 1.255 1.371 0 C-N-CA 125.637 1.575 . . . . 1.0 112.619 -172.31 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 119.997 -0.049 . . . . 1.0 110.98 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.68 162.48 41.21 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.654 1.182 . . . . 1.0 113.348 -176.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -122.23 121.28 36.44 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.342 1.457 . . . . 1.0 110.346 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.595 HD13 HD12 ' A' ' 26' ' ' LEU . 2.2 mp -120.15 114.03 42.55 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 C-N-CA 126.057 1.743 . . . . 1.0 112.857 -178.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.48 122.53 6.79 Favored Glycine 0 C--O 1.222 -0.624 0 N-CA-C 110.573 -1.011 . . . . 1.0 110.573 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.4 mt -103.18 120.93 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-N 118.113 0.956 . . . . 1.0 109.271 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -114.2 113.21 24.35 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.245 -1.391 . . . . 1.0 107.245 -171.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.9 p -106.64 126.49 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.66 0.615 . . . . 1.0 112.66 -171.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -117.25 116.45 3.52 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.822 1.201 . . . . 1.0 111.002 176.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.4 m -151.19 133.49 15.36 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 120.751 2.276 . . . . 1.0 110.762 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.75 -16.92 11.18 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.834 1.05 . . . . 1.0 113.834 174.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -143.97 146.6 33.04 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.602 1.161 . . . . 1.0 112.025 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.11 178.23 50.7 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.779 1.181 . . . . 1.0 114.768 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -87.34 13.32 10.03 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.917 1.287 . . . . 1.0 113.772 -174.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.1 m -59.51 -18.12 37.6 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 115.78 1.771 . . . . 1.0 115.78 -170.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.9 mt -49.51 -35.47 20.18 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.388 1.075 . . . . 1.0 112.263 169.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.4 tp -44.39 -50.83 9.05 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.048 1.739 . . . . 1.0 113.641 172.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.6 t -55.04 -33.93 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.639 0.776 . . . . 1.0 111.567 -173.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.27 -45.89 92.6 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.706 -1.246 . . . . 1.0 113.04 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -66.61 -29.98 70.15 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.774 0.83 . . . . 1.0 110.844 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -70.2 -47.14 62.8 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.79 0.836 . . . . 1.0 109.139 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.552 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -64.0 -41.35 97.52 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 113.297 0.851 . . . . 1.0 113.297 -176.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -56.26 -48.46 76.52 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.307 1.043 . . . . 1.0 110.572 170.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.27 -37.8 71.88 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.754 0.822 . . . . 1.0 112.055 -174.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.1 mt -69.29 -45.55 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 O-C-N 121.322 -0.862 . . . . 1.0 109.602 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.595 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.67 -31.52 72.57 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.878 1.217 . . . . 1.0 110.816 -179.133 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.5 m -62.56 -45.82 91.17 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.843 1.257 . . . . 1.0 112.687 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.22 -31.02 70.23 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.675 1.19 . . . . 1.0 113.254 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -67.65 -29.46 68.77 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.121 1.768 . . . . 1.0 111.606 171.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.02 27.6 2.22 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.802 1.192 . . . . 1.0 114.882 171.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -123.42 159.2 29.5 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.083 1.353 . . . . 1.0 110.389 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -90.61 87.54 6.76 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 120.645 -1.284 . . . . 1.0 108.649 -177.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.83 146.62 27.99 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.113 0.565 . . . . 1.0 111.379 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.9 m -147.31 140.86 25.52 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.472 1.109 . . . . 1.0 112.188 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.0 t -89.76 139.22 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 115.613 1.709 . . . . 1.0 115.613 173.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -121.04 111.88 18.03 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.303 2.241 . . . . 1.0 110.136 169.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -95.13 139.15 31.88 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.011 1.724 . . . . 1.0 111.634 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.4 t70 42.63 52.94 8.18 Favored Pre-proline 0 CA--C 1.56 1.365 0 C-N-CA 124.943 1.297 . . . . 1.0 111.581 -169.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -70.96 147.63 55.6 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.075 3.183 . . . . 1.0 117.013 -168.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.425 ' HB3' ' H ' ' A' ' 42' ' ' SER . 52.4 mm-40 -93.81 163.81 13.37 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.452 1.101 . . . . 1.0 112.035 168.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.577 HD21 HD21 ' A' ' 79' ' ' LEU . 2.3 tm? -65.52 -22.26 66.7 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 120.729 -1.232 . . . . 1.0 110.269 167.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.425 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 16.8 m -68.29 -20.41 64.77 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.921 -1.112 . . . . 1.0 112.116 172.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -82.96 -25.51 32.25 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.499 1.12 . . . . 1.0 112.31 169.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.489 ' HB3' HD22 ' A' ' 41' ' ' LEU . 14.9 t-105 -86.42 -35.43 19.73 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.909 1.077 . . . . 1.0 113.909 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.1 mt -48.21 -38.43 21.04 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 114.464 1.283 . . . . 1.0 114.464 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -60.59 -11.75 18.4 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 123.691 2.928 . . . . 1.0 116.573 175.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -111.14 8.31 21.66 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 116.243 1.942 . . . . 1.0 116.243 -172.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -54.3 -35.04 62.19 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.073 1.749 . . . . 1.0 113.628 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -99.03 -2.39 37.35 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.025 1.73 . . . . 1.0 113.274 177.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -109.64 -164.98 0.97 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.819 2.447 . . . . 1.0 110.938 -176.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -109.77 163.22 13.71 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.937 1.351 . . . . 1.0 111.773 169.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.623 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -144.25 157.7 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.822 1.249 . . . . 1.0 109.519 -170.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.541 HD11 HD12 ' A' ' 90' ' ' ILE . 18.2 tp -139.33 124.37 18.83 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 124.235 1.014 . . . . 1.0 108.735 174.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.7 t -99.36 121.53 50.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.383 -0.826 . . . . 1.0 109.238 174.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.7 t -120.06 113.98 42.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 105.319 -2.104 . . . . 1.0 105.319 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -149.21 130.84 14.94 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.161 1.541 . . . . 1.0 115.161 -168.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 m -117.77 178.07 4.54 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 127.102 2.161 . . . . 1.0 111.735 -169.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.86 33.42 15.17 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.923 1.083 . . . . 1.0 113.923 168.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.2 m -53.35 -37.86 62.74 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.195 1.398 . . . . 1.0 112.255 169.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.57 -126.57 35.07 Favored Glycine 0 CA--C 1.533 1.205 0 O-C-N 121.445 -0.784 . . . . 1.0 112.426 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -63.45 -15.21 57.06 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.208 1.188 . . . . 1.0 114.208 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 148.25 -19.01 1.36 Allowed Glycine 0 CA--C 1.535 1.325 0 N-CA-C 116.894 1.517 . . . . 1.0 116.894 169.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -90.55 160.51 15.92 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.022 1.329 . . . . 1.0 113.857 -175.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.1 mt -80.73 144.5 56.22 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 123.708 0.803 . . . . 1.0 112.898 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.12 156.88 30.15 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.249 2.633 . . . . 1.0 113.404 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -60.23 -23.24 63.9 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.127 1.529 . . . . 1.0 115.127 -169.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.9 t -67.43 -31.72 72.11 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.203 0.816 . . . . 1.0 113.203 175.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.7 tt -111.82 -12.85 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.464 1.106 . . . . 1.0 113.894 -177.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.8 t -43.46 -52.38 13.52 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.835 1.254 . . . . 1.0 112.878 168.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.86 -33.11 34.62 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.714 1.609 . . . . 1.0 111.915 -173.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 tp -63.41 -53.83 46.21 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 124.235 1.014 . . . . 1.0 111.223 169.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.658 ' CE1' HD23 ' A' ' 110' ' ' LEU . 91.6 t80 -54.69 -52.81 61.22 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.796 0.839 . . . . 1.0 112.477 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -64.85 -40.77 95.69 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.424 1.09 . . . . 1.0 111.384 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.44 -34.91 86.1 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.371 0.51 . . . . 1.0 112.656 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.611 HG22 HD12 ' A' ' 110' ' ' LEU . 92.0 mt -64.79 -49.31 80.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.866 1.833 . . . . 1.0 108.558 171.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.715 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.4 ptmm? -70.91 -32.12 68.96 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.2 -1.562 . . . . 1.0 112.85 -169.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -104.62 -38.49 6.72 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.082 1.512 . . . . 1.0 115.082 -174.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.2 m -95.0 -23.37 17.41 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.26 1.024 . . . . 1.0 113.171 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.577 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -91.32 -70.98 0.66 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 169.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.24 -11.95 1.95 Allowed Glycine 0 CA--C 1.538 1.507 0 C-N-CA 126.776 2.131 . . . . 1.0 116.255 169.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -157.6 141.84 16.16 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 127.81 2.444 . . . . 1.0 108.366 174.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.543 HE22 HD12 ' A' ' 79' ' ' LEU . 1.5 mm-40 -136.0 123.15 14.53 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.962 0.905 . . . . 1.0 111.148 -172.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.41 -37.82 0.36 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.205 1.937 . . . . 1.0 114.724 -171.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -146.94 19.07 1.27 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.069 1.137 . . . . 1.0 114.069 -169.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.623 HD11 ' CG2' ' A' ' 52' ' ' VAL . 45.8 tp -79.46 140.56 37.3 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.404 -1.435 . . . . 1.0 113.861 -169.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -133.49 150.2 51.71 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 128.636 2.774 . . . . 1.0 107.571 169.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.663 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -160.88 166.85 27.78 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.319 -0.863 . . . . 1.0 112.932 -178.166 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.47 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -124.65 171.85 16.83 Favored Glycine 0 N--CA 1.475 1.295 0 C-N-CA 125.003 1.287 . . . . 1.0 114.531 173.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 75.5 t -143.52 133.08 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 114.852 1.427 . . . . 1.0 114.852 -169.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.541 HD12 HD11 ' A' ' 53' ' ' LEU . 4.0 mt -130.79 104.85 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.683 1.593 . . . . 1.0 107.968 169.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -91.74 143.19 26.8 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.891 1.677 . . . . 1.0 111.797 175.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.9 mp -137.44 148.41 46.1 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.448 0.907 . . . . 1.0 113.448 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.55 -172.6 43.08 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 114.805 0.682 . . . . 1.0 114.805 169.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -86.47 120.13 27.47 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.107 -1.231 . . . . 1.0 110.604 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.1 t -68.18 -3.61 11.16 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.985 1.106 . . . . 1.0 113.985 -176.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.6 t -64.32 -26.9 68.69 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.941 -1.099 . . . . 1.0 113.022 171.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -80.93 143.05 32.92 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.208 -0.932 . . . . 1.0 112.829 176.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -50.94 -50.91 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.399 1.48 . . . . 1.0 113.569 175.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -88.92 20.22 3.69 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.993 1.717 . . . . 1.0 114.638 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.3 t80 9.07 -74.23 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 130.42 3.488 . . . . 1.0 117.663 175.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 20.1 p -117.2 9.76 13.6 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.816 2.046 . . . . 1.0 114.193 -169.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -55.95 -23.49 32.45 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.481 1.912 . . . . 1.0 114.607 -172.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.32 -48.44 83.66 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-N 120.357 1.435 . . . . 1.0 113.412 174.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.25 -36.51 50.41 Favored Glycine 0 N--CA 1.478 1.474 0 O-C-N 120.782 -1.422 . . . . 1.0 113.248 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -60.31 -35.8 76.45 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.928 0.891 . . . . 1.0 113.168 172.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -65.24 -33.94 77.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 118.603 -0.713 . . . . 1.0 112.826 172.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -63.95 -37.4 87.28 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.689 1.131 . . . . 1.0 111.032 172.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.413 ' CG ' ' HE ' ' A' ' 118' ' ' ARG . 12.0 t70 -63.14 -49.88 72.64 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.027 0.831 . . . . 1.0 110.473 177.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.64 -33.0 59.96 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.251 0.834 . . . . 1.0 113.251 173.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.715 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -61.27 -50.28 73.66 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 123.238 1.494 . . . . 1.0 110.727 178.408 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.663 HD12 ' CD1' ' A' ' 87' ' ' TYR . 8.0 mt -65.1 -39.27 92.9 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 120.966 -1.084 . . . . 1.0 111.19 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -67.31 -22.39 65.63 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.557 0.947 . . . . 1.0 113.557 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.54 -17.53 59.19 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.393 0.997 . . . . 1.0 111.464 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -96.51 -73.61 0.59 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.994 1.318 . . . . 1.0 109.206 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 56.2 p 177.18 -18.32 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.755 2.022 . . . . 1.0 113.534 -175.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -67.59 157.26 34.86 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.793 1.282 . . . . 1.0 113.933 -169.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -99.4 173.39 6.78 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 113.239 -1.8 . . . . 1.0 112.155 -169.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.413 ' HE ' ' CG ' ' A' ' 108' ' ' ASP . 4.7 ttm180 -128.63 160.49 32.26 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.758 1.223 . . . . 1.0 113.509 174.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.1 t -119.25 126.71 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 127.232 2.213 . . . . 1.0 108.811 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 52.35 -165.0 1.42 Allowed Glycine 0 CA--C 1.542 1.762 0 C-N-CA 124.748 1.166 . . . . 1.0 115.628 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -107.56 149.41 28.06 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.726 1.611 . . . . 1.0 110.118 169.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.78 159.15 32.35 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.717 1.207 . . . . 1.0 113.188 -169.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.659 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.2 tm? -91.32 139.57 30.61 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.098 0.959 . . . . 1.0 110.165 169.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.659 ' N ' HD13 ' A' ' 123' ' ' LEU . 6.4 mt -122.83 105.76 10.3 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.205 1.402 . . . . 1.0 111.103 174.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.447 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.9 mt -91.95 131.19 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 125.331 1.452 . . . . 1.0 112.341 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -108.25 92.27 3.99 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.86 2.464 . . . . 1.0 112.617 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.4 -23.6 67.0 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.995 1.318 . . . . 1.0 112.794 -173.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.7 p -53.47 -30.39 40.64 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 129.329 3.052 . . . . 1.0 114.334 169.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -124.79 -26.53 3.77 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.849 2.06 . . . . 1.0 111.585 -171.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -143.22 88.59 8.07 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.44 1.496 . . . . 1.0 112.184 -177.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -76.53 11.19 1.95 Allowed 'Trans proline' 0 CA--C 1.549 1.251 0 C-N-CA 123.77 2.98 . . . . 1.0 114.211 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -111.62 68.77 0.77 Allowed Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 127.672 2.389 . . . . 1.0 110.042 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -57.38 -21.39 44.6 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.777 2.318 . . . . 1.0 116.809 -169.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -64.25 -27.25 68.92 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 118.934 0.788 . . . . 1.0 111.902 174.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.6 p -72.27 -18.78 61.78 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 120.939 -1.1 . . . . 1.0 111.813 -174.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -99.22 -53.66 3.18 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.807 1.643 . . . . 1.0 111.933 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 48.1 p -71.28 -33.77 70.06 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 114.599 1.333 . . . . 1.0 114.599 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -59.32 -56.63 34.06 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 120.723 1.601 . . . . 1.0 112.453 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -62.66 -22.64 74.15 Favored 'Trans proline' 0 C--N 1.355 0.871 0 CA-C-N 121.459 1.557 . . . . 1.0 112.735 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.479 ' HB2' HD23 ' A' ' 123' ' ' LEU . 91.4 t90 -69.19 -47.37 65.05 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 123.279 0.632 . . . . 1.0 111.093 174.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.552 HG11 ' HA ' ' A' ' 22' ' ' ALA . 97.5 t -65.23 -32.0 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 122.03 0.919 . . . . 1.0 108.899 176.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.93 -22.33 61.48 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 120.045 -1.659 . . . . 1.0 113.401 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -87.07 -62.52 1.48 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.858 2.063 . . . . 1.0 111.265 169.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.47 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 87.6 t90 -54.88 -38.26 67.32 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 126.892 2.077 . . . . 1.0 112.99 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.96 -29.26 27.11 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 121.42 -0.8 . . . . 1.0 114.488 173.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.1 p -69.32 -13.29 62.3 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.809 1.304 . . . . 1.0 114.367 175.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.5 -18.59 51.64 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.34 1.456 . . . . 1.0 111.774 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -84.41 170.1 13.91 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.517 1.127 . . . . 1.0 111.521 -175.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.251 1.182 0 N-CA-C 116.697 2.11 . . . . 1.0 116.697 -169.465 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 118.019 -0.991 . . . . 1.0 112.398 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.62 140.27 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.254 2.221 . . . . 1.0 116.469 -172.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -121.46 124.49 44.6 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 126.643 1.977 . . . . 1.0 110.057 170.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.492 HD13 HD12 ' A' ' 26' ' ' LEU . 1.7 mp -126.62 113.06 31.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 126.8 2.04 . . . . 1.0 111.898 -174.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.19 124.51 7.81 Favored Glycine 0 C--O 1.224 -0.518 0 N-CA-C 110.01 -1.236 . . . . 1.0 110.01 169.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.8 mt -104.59 123.34 58.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 118.151 0.976 . . . . 1.0 109.545 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -115.95 110.63 19.23 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.598 1.159 . . . . 1.0 108.266 -169.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.82 135.92 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.619 -0.264 . . . . 1.0 111.441 -175.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -123.92 131.49 8.02 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.571 1.081 . . . . 1.0 110.897 169.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.7 t -155.36 147.75 23.9 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 119.415 1.608 . . . . 1.0 114.599 -174.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.8 ttt -123.16 69.39 1.0 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.656 1.582 . . . . 1.0 107.801 169.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 60.82 21.68 11.78 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.383 1.873 . . . . 1.0 114.963 -171.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.78 177.22 46.49 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.552 1.549 . . . . 1.0 113.015 169.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -106.91 31.73 5.1 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.388 1.255 . . . . 1.0 114.388 -172.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.3 p -66.33 -20.83 66.19 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.418 -1.426 . . . . 1.0 112.973 172.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.81 -40.94 94.57 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.347 0.976 . . . . 1.0 112.298 173.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.7 tp -62.17 -50.28 72.48 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 118.08 0.4 . . . . 1.0 110.663 172.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -56.66 -39.23 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 O-C-N 121.79 -0.569 . . . . 1.0 110.891 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.7 -49.65 74.25 Favored 'General case' 0 C--O 1.23 0.062 0 CA-C-N 119.606 1.093 . . . . 1.0 112.615 176.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -67.79 -26.93 66.33 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.105 0.479 . . . . 1.0 112.055 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -70.74 -48.72 53.01 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 123.952 0.901 . . . . 1.0 109.938 169.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.627 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -60.98 -44.38 97.46 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 112.651 0.611 . . . . 1.0 112.651 -176.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -51.52 -51.24 56.9 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.521 1.128 . . . . 1.0 110.221 169.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.86 -35.62 74.87 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.633 0.773 . . . . 1.0 112.764 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.7 mt -70.43 -45.41 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 O-C-N 121.175 -0.953 . . . . 1.0 109.342 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.492 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.86 -34.44 78.16 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 120.028 -0.669 . . . . 1.0 110.213 -178.536 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.4 m -61.75 -44.42 96.93 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.973 1.309 . . . . 1.0 113.155 169.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.17 -32.61 73.83 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.62 1.168 . . . . 1.0 112.944 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -66.49 -32.78 74.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.534 1.134 . . . . 1.0 111.75 170.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.27 12.98 1.56 Allowed Glycine 0 CA--C 1.532 1.135 0 N-CA-C 116.091 1.196 . . . . 1.0 116.091 169.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -105.85 168.32 9.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.865 1.266 . . . . 1.0 112.116 -170.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? -90.64 97.26 11.08 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.914 1.286 . . . . 1.0 107.847 170.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.91 144.87 42.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.64 0.257 . . . . 1.0 110.693 174.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.6 m -147.59 138.74 23.61 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.72 0.808 . . . . 1.0 111.91 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.1 t -86.92 136.64 22.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 114.502 1.297 . . . . 1.0 114.502 171.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -111.59 114.63 27.81 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.135 1.774 . . . . 1.0 110.464 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -94.04 139.23 31.21 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.332 1.853 . . . . 1.0 110.61 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.6 t0 43.12 54.82 10.7 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 124.274 1.029 . . . . 1.0 110.664 -169.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -64.15 140.22 70.44 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.855 3.036 . . . . 1.0 117.259 -167.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -89.36 154.25 20.22 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.742 1.617 . . . . 1.0 112.043 168.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.475 HD21 ' CD2' ' A' ' 79' ' ' LEU . 2.3 tm? -69.47 -21.62 63.69 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 120.674 -1.266 . . . . 1.0 109.648 168.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 26.0 m -66.79 -21.86 66.04 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.286 -0.884 . . . . 1.0 112.448 169.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -82.47 -28.58 31.14 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.789 0.836 . . . . 1.0 112.599 169.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.469 ' HB3' HD22 ' A' ' 41' ' ' LEU . 11.0 t-105 -80.17 -38.75 30.7 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.571 1.078 . . . . 1.0 113.515 178.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.3 mt -44.1 -47.31 23.12 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 114.411 1.263 . . . . 1.0 114.411 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.1 4.98 1.61 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.79 2.327 . . . . 1.0 115.811 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -113.06 5.63 17.24 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 116.053 1.871 . . . . 1.0 116.053 174.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -49.51 -30.74 8.83 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 126.836 2.054 . . . . 1.0 113.275 170.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -104.65 7.83 35.04 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.228 2.611 . . . . 1.0 113.288 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -133.5 -155.4 0.67 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.518 2.327 . . . . 1.0 112.096 -169.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -114.3 160.34 19.18 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-O 123.504 1.621 . . . . 1.0 111.801 169.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.476 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -146.48 150.75 14.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 125.289 1.436 . . . . 1.0 107.454 -174.32 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.426 HD11 HD12 ' A' ' 90' ' ' ILE . 16.0 tp -129.63 127.31 40.33 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 124.753 1.221 . . . . 1.0 108.666 176.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.7 t -99.82 127.65 52.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 t -127.01 104.12 12.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.518 -1.66 . . . . 1.0 106.518 175.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t -136.82 128.61 29.03 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.502 0.927 . . . . 1.0 113.502 -167.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 t -111.77 -179.49 3.71 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 115.737 1.754 . . . . 1.0 115.737 -168.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.8 m 75.36 -58.72 0.56 Allowed 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 129.523 3.129 . . . . 1.0 112.449 169.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.1 m 58.65 -35.84 0.05 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.301 2.241 . . . . 1.0 116.944 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.88 -134.88 47.24 Favored Glycine 0 CA--C 1.532 1.144 0 O-C-N 119.988 -1.695 . . . . 1.0 111.45 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -70.24 -1.84 11.51 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.201 1.186 . . . . 1.0 114.201 174.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.76 -11.65 2.65 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 116.409 1.324 . . . . 1.0 116.409 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -83.27 179.49 7.69 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 118.788 1.294 . . . . 1.0 113.359 -174.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 18.2 mt -96.07 148.36 34.4 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.872 1.669 . . . . 1.0 113.435 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -61.4 145.28 98.32 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.917 2.412 . . . . 1.0 113.457 170.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -62.01 -22.57 65.8 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.089 0.956 . . . . 1.0 113.552 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.8 p -68.66 -27.12 65.7 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.838 1.255 . . . . 1.0 113.88 174.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.9 tt -113.54 -15.3 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.211 1.404 . . . . 1.0 114.015 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.8 t -42.66 -51.26 12.12 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 124.788 1.235 . . . . 1.0 112.612 168.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.0 -31.7 18.96 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.385 1.39 . . . . 1.0 111.776 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.7 tp -64.15 -51.03 65.8 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 124.219 1.008 . . . . 1.0 110.961 169.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.621 ' CE1' HD23 ' A' ' 110' ' ' LEU . 88.5 t80 -54.91 -53.63 53.06 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.502 1.121 . . . . 1.0 112.478 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -67.21 -34.6 77.83 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.964 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.55 -37.1 93.97 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.701 0.667 . . . . 1.0 112.523 174.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.565 HG22 HD12 ' A' ' 110' ' ' LEU . 78.6 mt -65.44 -49.43 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.96 1.88 . . . . 1.0 108.264 171.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.695 ' HB3' HD21 ' A' ' 110' ' ' LEU . 3.8 ptmm? -69.35 -31.16 69.4 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.241 -1.537 . . . . 1.0 113.358 -171.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -105.66 -38.02 6.55 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.406 1.632 . . . . 1.0 115.406 -174.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.6 m -93.85 -23.02 18.29 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.153 0.981 . . . . 1.0 112.873 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.475 ' CD2' HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -92.11 -71.13 0.66 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 106.277 -1.749 . . . . 1.0 106.277 169.055 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.5 -10.21 1.51 Allowed Glycine 0 CA--C 1.539 1.571 0 C-N-CA 127.386 2.422 . . . . 1.0 115.554 169.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -153.19 146.62 24.91 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 129.269 3.028 . . . . 1.0 107.214 170.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.434 ' HG3' ' HB2' ' A' ' 116' ' ' ALA . 39.7 mm-40 -136.01 125.57 16.07 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.339 0.656 . . . . 1.0 110.548 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -82.8 -39.94 0.13 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.352 2.035 . . . . 1.0 114.241 -173.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -146.87 18.01 1.26 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.596 1.158 . . . . 1.0 113.785 -169.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.476 HD11 ' CG2' ' A' ' 52' ' ' VAL . 42.1 tp -76.88 140.48 40.6 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.598 -1.314 . . . . 1.0 113.412 -169.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -133.45 147.85 51.71 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 129.421 3.088 . . . . 1.0 107.714 170.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.655 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -157.27 166.04 34.24 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.835 1.198 . . . . 1.0 112.384 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.405 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -130.05 173.63 19.81 Favored Glycine 0 N--CA 1.467 0.74 0 C-N-CA 125.43 1.491 . . . . 1.0 112.142 170.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.556 HG13 ' HB3' ' A' ' 122' ' ' MET . 0.2 OUTLIER -160.07 143.14 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 114.829 1.418 . . . . 1.0 114.829 -169.118 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.426 HD12 HD11 ' A' ' 53' ' ' LEU . 3.4 mt -124.39 113.74 37.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 126.721 2.008 . . . . 1.0 108.397 169.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.59 150.13 20.92 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 125.342 1.457 . . . . 1.0 110.462 169.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.97 152.05 44.65 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 121.801 -0.562 . . . . 1.0 111.419 173.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.57 174.12 39.61 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 115.515 0.966 . . . . 1.0 115.515 169.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -83.3 110.51 18.17 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.42 -1.047 . . . . 1.0 110.218 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.6 p -69.39 0.89 4.45 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.746 1.387 . . . . 1.0 114.746 -177.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.3 t -65.76 -29.25 69.73 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.326 0.966 . . . . 1.0 112.256 170.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -78.97 160.78 27.06 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.932 0.893 . . . . 1.0 112.655 171.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.45 168.04 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 116.155 -0.475 . . . . 1.0 109.973 168.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 60.42 46.58 9.68 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.113 0.965 . . . . 1.0 112.638 173.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -49.76 126.74 14.52 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.309 1.044 . . . . 1.0 112.574 -176.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 19.9 m 57.73 14.62 2.53 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.718 1.747 . . . . 1.0 115.718 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -59.0 -23.74 62.17 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.921 1.288 . . . . 1.0 114.196 -175.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.21 -46.2 94.17 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-N 120.335 1.425 . . . . 1.0 113.004 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.95 -36.29 47.39 Favored Glycine 0 N--CA 1.478 1.469 0 O-C-N 121.014 -1.286 . . . . 1.0 113.121 176.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -59.54 -34.97 73.32 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 117.922 0.861 . . . . 1.0 112.806 172.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 -67.04 -33.09 74.77 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.997 0.74 . . . . 1.0 112.997 173.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -62.16 -35.96 80.39 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.796 1.18 . . . . 1.0 111.314 171.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.22 -44.62 83.32 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.233 0.469 . . . . 1.0 111.342 175.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.72 -44.12 81.3 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 118.807 -0.616 . . . . 1.0 112.086 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.695 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -51.18 -48.97 61.79 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.746 2.018 . . . . 1.0 111.49 -177.466 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.655 HD12 ' CD1' ' A' ' 87' ' ' TYR . 8.0 mt -66.03 -40.07 90.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.331 -0.849 . . . . 1.0 111.928 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -67.4 -24.91 65.71 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.95 1.092 . . . . 1.0 113.95 175.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -64.62 -35.13 80.02 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.409 1.084 . . . . 1.0 111.491 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -83.96 -73.28 0.43 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 113.709 -1.587 . . . . 1.0 110.461 -175.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.5 m 174.14 -0.89 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.118 2.567 . . . . 1.0 111.821 173.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.527 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -74.19 159.58 32.34 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 122.414 1.102 . . . . 1.0 113.541 -169.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -100.69 171.46 7.68 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 113.898 -1.501 . . . . 1.0 111.362 -169.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 2.2 ttm105 -126.43 154.02 44.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.547 1.139 . . . . 1.0 112.779 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.485 HG12 ' H ' ' A' ' 120' ' ' GLY . 16.4 t -92.86 -173.1 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 C-N-CA 127.009 2.124 . . . . 1.0 106.009 169.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.485 ' H ' HG12 ' A' ' 119' ' ' VAL . . . -51.17 154.76 3.79 Favored Glycine 0 CA--C 1.543 1.838 0 O-C-N 120.345 -1.472 . . . . 1.0 115.929 -175.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -48.9 143.33 5.54 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.327 1.851 . . . . 1.0 114.771 -172.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.556 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.9 OUTLIER -75.62 156.57 34.77 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.669 1.187 . . . . 1.0 111.879 -169.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.634 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -90.98 137.81 32.08 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.537 -0.756 . . . . 1.0 109.719 174.325 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.634 ' N ' HD13 ' A' ' 123' ' ' LEU . 7.5 mt -122.41 109.13 14.0 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.641 1.176 . . . . 1.0 110.459 174.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.408 HG13 ' CD1' ' A' ' 123' ' ' LEU . 3.2 mt -91.45 130.44 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.062 1.345 . . . . 1.0 112.611 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.74 98.52 10.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.206 1.002 . . . . 1.0 110.039 175.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -70.4 -23.93 62.84 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.108 -1.62 . . . . 1.0 112.232 -175.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.65 -30.65 44.13 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 130.191 3.396 . . . . 1.0 114.12 169.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -124.67 -26.86 3.75 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.539 1.935 . . . . 1.0 111.957 -169.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -141.92 83.23 12.9 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 125.565 1.546 . . . . 1.0 111.276 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.76 12.45 1.41 Allowed 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 124.009 3.14 . . . . 1.0 113.904 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -109.64 65.5 0.36 Allowed Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 127.899 2.479 . . . . 1.0 109.553 174.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -58.65 -19.08 43.68 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.496 2.131 . . . . 1.0 116.952 -168.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -65.12 -28.44 69.44 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 121.343 -0.848 . . . . 1.0 111.919 173.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.6 p -70.75 -21.75 62.49 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.226 0.921 . . . . 1.0 112.181 -175.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -96.24 -54.69 3.2 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.899 1.679 . . . . 1.0 111.399 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 85.6 p -68.4 -33.07 73.58 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.656 1.354 . . . . 1.0 114.656 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.27 -50.03 51.5 Favored Pre-proline 0 CA--C 1.542 0.645 0 O-C-N 120.315 -1.49 . . . . 1.0 113.014 -173.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.69 -23.44 69.68 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 CA-C-N 121.289 1.496 . . . . 1.0 112.552 170.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.455 ' HB2' HD23 ' A' ' 123' ' ' LEU . 90.6 t90 -70.28 -46.32 64.57 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 123.342 0.657 . . . . 1.0 110.832 175.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.627 HG11 ' HA ' ' A' ' 22' ' ' ALA . 88.9 t -66.08 -34.63 71.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -63.55 -48.46 77.37 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.216 -0.928 . . . . 1.0 110.043 174.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -63.7 -55.68 21.52 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.73 1.212 . . . . 1.0 111.67 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.406 ' HE1' ' HB ' ' A' ' 119' ' ' VAL . 88.2 t90 -58.09 -35.05 70.86 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 125.693 1.597 . . . . 1.0 111.953 175.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.47 -32.87 31.69 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.462 1.505 . . . . 1.0 113.811 172.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.0 p -70.12 -12.65 61.75 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.832 1.419 . . . . 1.0 114.832 175.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.94 -17.33 43.99 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.67 1.588 . . . . 1.0 111.882 176.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -77.79 171.46 14.93 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 118.945 0.793 . . . . 1.0 110.871 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 56.4 m . . . . . 0 C--O 1.252 1.187 0 C-N-CA 125.44 1.496 . . . . 1.0 114.777 -173.416 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptp . . . . . 0 N--CA 1.498 1.936 0 N-CA-C 112.197 0.443 . . . . 1.0 112.197 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.79 157.5 21.07 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 114.694 1.368 . . . . 1.0 114.694 174.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -121.0 123.75 43.18 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.669 1.587 . . . . 1.0 109.775 173.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.608 HD13 HD12 ' A' ' 26' ' ' LEU . 1.9 mp -124.27 112.92 34.35 Favored 'Isoleucine or valine' 0 C--O 1.23 0.05 0 C-N-CA 125.856 1.662 . . . . 1.0 112.439 -176.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.22 125.49 7.92 Favored Glycine 0 C--O 1.224 -0.492 0 N-CA-C 110.24 -1.144 . . . . 1.0 110.24 169.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.5 mt -105.79 124.14 60.71 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 118.523 1.162 . . . . 1.0 109.591 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -115.57 110.22 18.91 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 125.109 1.364 . . . . 1.0 107.813 -170.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.9 p -93.29 131.05 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 O-C-N 123.266 0.354 . . . . 1.0 111.468 -175.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -118.75 113.92 2.7 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.306 0.955 . . . . 1.0 111.605 173.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.3 p -148.43 148.05 29.86 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 118.508 1.154 . . . . 1.0 112.149 -172.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -71.45 171.44 11.28 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.133 0.573 . . . . 1.0 111.866 169.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -59.26 146.21 40.17 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.531 0.732 . . . . 1.0 112.404 175.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.08 -153.18 46.44 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 123.912 0.768 . . . . 1.0 113.356 -172.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 51.47 -138.7 1.04 Allowed 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 125.3 1.44 . . . . 1.0 112.249 -176.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.1 t -150.55 153.23 35.4 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.637 1.108 . . . . 1.0 112.919 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -79.26 -5.17 53.78 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.767 1.627 . . . . 1.0 114.491 170.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.7 tp -20.78 -63.32 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 129.078 2.951 . . . . 1.0 116.829 -169.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.8 t -57.44 -32.76 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 119.344 -0.36 . . . . 1.0 111.717 -170.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.47 -45.29 94.28 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.76 1.164 . . . . 1.0 112.521 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -68.42 -31.06 70.13 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.81 0.844 . . . . 1.0 111.017 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -67.7 -47.15 70.22 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.113 -0.699 . . . . 1.0 109.113 173.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.547 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -64.74 -42.45 95.17 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 113.122 0.786 . . . . 1.0 113.122 -176.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -54.72 -48.43 72.51 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.344 1.058 . . . . 1.0 110.404 170.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.89 -38.21 70.02 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.517 0.727 . . . . 1.0 112.067 -174.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.3 mt -68.26 -45.48 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 O-C-N 121.33 -0.856 . . . . 1.0 109.35 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.608 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -66.16 -31.02 71.61 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.653 1.115 . . . . 1.0 110.884 -178.376 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 34.6 m -63.07 -45.55 91.66 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.796 1.238 . . . . 1.0 112.539 169.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.39 -31.97 71.7 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.57 1.148 . . . . 1.0 113.236 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -65.74 -30.47 71.14 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.123 1.769 . . . . 1.0 111.648 171.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.0 31.61 1.7 Allowed Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.702 1.144 . . . . 1.0 114.833 172.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -124.7 161.66 25.86 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.302 1.441 . . . . 1.0 110.739 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -91.8 86.24 5.86 Favored 'General case' 0 N--CA 1.46 0.071 0 C-N-CA 125.034 1.334 . . . . 1.0 108.939 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.5 146.2 28.46 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.05 0.54 . . . . 1.0 111.404 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.2 m -147.5 140.66 25.16 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.344 1.058 . . . . 1.0 112.198 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -87.04 137.31 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 115.108 1.521 . . . . 1.0 115.108 171.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -111.86 120.86 43.39 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.262 1.825 . . . . 1.0 111.126 169.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -99.92 138.23 37.28 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.587 1.955 . . . . 1.0 110.942 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.7 t0 42.18 54.85 9.34 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 124.39 1.076 . . . . 1.0 111.378 -169.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -63.56 137.32 58.9 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.836 3.024 . . . . 1.0 116.707 -168.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -88.56 157.35 18.63 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.547 1.539 . . . . 1.0 111.706 168.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.47 HD21 HD21 ' A' ' 79' ' ' LEU . 2.3 tm? -68.52 -21.27 64.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 120.261 -1.525 . . . . 1.0 109.567 167.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.2 m -68.86 -19.83 64.25 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.455 -0.778 . . . . 1.0 112.319 169.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -81.98 -28.57 32.57 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.546 1.138 . . . . 1.0 112.129 169.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.427 ' HB3' HD22 ' A' ' 41' ' ' LEU . 12.6 t-105 -82.7 -36.9 25.47 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.671 0.989 . . . . 1.0 113.671 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.8 mt -48.6 -39.83 34.87 Favored Pre-proline 0 CA--C 1.552 1.054 0 CA-C-O 117.482 -1.246 . . . . 1.0 114.123 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -57.59 -12.36 11.1 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 124.428 3.418 . . . . 1.0 117.144 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -110.53 8.13 22.84 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 116.121 1.897 . . . . 1.0 116.121 -174.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -52.72 -30.94 35.11 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.941 2.096 . . . . 1.0 113.782 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -113.48 13.1 18.81 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.882 1.273 . . . . 1.0 112.602 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -122.65 -159.51 0.84 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.273 2.629 . . . . 1.0 110.854 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -115.12 165.09 13.29 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 123.018 1.389 . . . . 1.0 111.763 170.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.417 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -149.49 163.19 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.331 1.452 . . . . 1.0 108.945 -172.17 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.402 HD11 HD12 ' A' ' 90' ' ' ILE . 17.4 tp -141.45 127.08 19.0 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.509 1.123 . . . . 1.0 108.951 175.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.46 124.0 52.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 124.055 0.942 . . . . 1.0 109.533 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.0 t -122.58 112.37 34.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 174.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t -148.4 128.98 14.05 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.136 1.532 . . . . 1.0 115.136 -167.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.7 m -110.1 175.4 5.45 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.931 2.092 . . . . 1.0 111.846 -173.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 65.25 42.15 4.1 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.222 1.193 . . . . 1.0 114.222 168.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.6 m -55.95 124.1 16.54 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.097 -1.075 . . . . 1.0 108.097 168.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.05 -130.73 2.65 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.558 1.075 . . . . 1.0 112.188 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -75.81 51.86 0.65 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.793 1.237 . . . . 1.0 110.721 169.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.18 -10.69 71.45 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 126.538 2.018 . . . . 1.0 115.801 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.9 -179.52 3.72 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 118.845 1.322 . . . . 1.0 113.806 -173.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 49.6 mt -94.87 159.16 33.83 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 127.294 2.238 . . . . 1.0 114.074 -169.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.85 154.9 43.58 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.835 2.356 . . . . 1.0 112.141 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -62.79 -19.61 64.19 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.601 1.334 . . . . 1.0 114.601 -170.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.9 p -71.13 -29.42 65.22 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.628 1.171 . . . . 1.0 114.05 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.6 tt -112.42 -16.03 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.745 1.218 . . . . 1.0 113.471 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.5 t -40.77 -50.61 7.29 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 124.638 1.175 . . . . 1.0 112.816 168.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.38 -30.03 20.04 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.506 1.471 . . . . 1.0 111.913 -172.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.5 tp -66.45 -50.58 62.85 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 123.804 0.842 . . . . 1.0 110.534 169.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.676 ' CE1' HD23 ' A' ' 110' ' ' LEU . 76.0 t80 -54.69 -54.31 43.44 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.018 0.927 . . . . 1.0 112.306 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -68.05 -35.4 78.17 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.132 -0.486 . . . . 1.0 111.915 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.18 -36.72 93.58 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 123.941 0.781 . . . . 1.0 112.367 176.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.542 HG22 HD12 ' A' ' 110' ' ' LEU . 79.7 mt -62.43 -51.87 66.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.521 1.661 . . . . 1.0 108.136 170.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.711 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.3 ptmm? -68.43 -32.59 72.73 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 120.435 -1.415 . . . . 1.0 113.141 -169.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -99.58 -37.26 9.23 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.771 1.629 . . . . 1.0 114.808 -174.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 m -99.8 -19.17 16.83 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.613 1.165 . . . . 1.0 113.17 -174.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.47 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -94.3 -71.54 0.66 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 106.409 -1.7 . . . . 1.0 106.409 169.57 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.89 -13.88 1.65 Allowed Glycine 0 CA--C 1.537 1.426 0 C-N-CA 127.642 2.544 . . . . 1.0 116.719 168.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -154.67 137.89 15.7 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.872 2.069 . . . . 1.0 108.633 172.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.419 HE22 HD12 ' A' ' 79' ' ' LEU . 1.6 mm-40 -134.92 124.0 16.31 Favored Pre-proline 0 CA--C 1.546 0.816 0 O-C-N 121.354 -0.841 . . . . 1.0 111.499 -171.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.83 -39.62 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.015 2.477 . . . . 1.0 114.72 -174.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -140.63 14.84 2.34 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.5 1.296 . . . . 1.0 114.5 -169.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.417 HD11 ' CG2' ' A' ' 52' ' ' VAL . 70.0 tp -80.84 138.06 36.21 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.579 -1.326 . . . . 1.0 112.862 -169.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.1 mtm-85 -135.97 156.76 48.26 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.963 2.505 . . . . 1.0 109.085 169.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.63 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -163.78 166.82 21.63 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.306 -0.871 . . . . 1.0 112.181 -176.501 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.487 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -120.05 171.92 14.69 Favored Glycine 0 N--CA 1.472 1.058 0 C-N-CA 125.487 1.518 . . . . 1.0 114.438 173.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.0 t -146.35 133.07 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 115.63 1.715 . . . . 1.0 115.63 -169.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.402 HD12 HD11 ' A' ' 53' ' ' LEU . 4.5 mt -131.6 108.38 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 125.719 1.608 . . . . 1.0 107.481 168.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.84 148.3 23.26 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.236 1.414 . . . . 1.0 112.017 170.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.8 mp -139.78 149.04 43.07 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.869 0.692 . . . . 1.0 112.869 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.52 -167.96 40.91 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 116.115 -0.493 . . . . 1.0 113.443 169.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -95.18 116.7 29.09 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.675 1.19 . . . . 1.0 111.792 173.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.3 t -65.37 -5.43 7.46 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.846 1.054 . . . . 1.0 113.846 178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.9 p -64.03 -22.45 66.93 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.985 -1.072 . . . . 1.0 112.892 169.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -86.88 141.57 28.67 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.893 1.277 . . . . 1.0 111.985 170.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -46.55 -50.8 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 126.339 1.856 . . . . 1.0 114.504 -178.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -90.13 15.08 10.87 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.719 1.608 . . . . 1.0 115.027 -174.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.4 t80 25.59 -83.54 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 129.44 3.096 . . . . 1.0 117.063 175.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.6 m -120.89 16.23 11.75 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.138 1.775 . . . . 1.0 113.609 -172.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -61.48 -16.03 43.37 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.494 1.517 . . . . 1.0 114.545 -173.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.32 -42.02 97.17 Favored Glycine 0 CA--C 1.537 1.408 0 CA-C-N 120.271 1.396 . . . . 1.0 113.22 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.97 -36.53 46.51 Favored Glycine 0 N--CA 1.48 1.626 0 O-C-N 120.258 -1.731 . . . . 1.0 112.724 174.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -63.02 -33.36 75.26 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.871 0.868 . . . . 1.0 112.785 174.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -58.4 -42.73 87.77 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.807 0.843 . . . . 1.0 111.856 170.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -62.06 -37.89 86.69 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.763 0.71 . . . . 1.0 111.14 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.55 -46.16 84.03 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.657 0.662 . . . . 1.0 111.366 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.61 -43.48 68.7 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.442 -0.789 . . . . 1.0 112.0 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.711 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -52.24 -49.44 64.0 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.787 2.035 . . . . 1.0 111.733 -177.558 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.63 HD12 ' CD1' ' A' ' 87' ' ' TYR . 6.3 mt -65.31 -40.35 93.63 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.471 -0.786 . . . . 1.0 111.232 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -67.65 -22.81 65.29 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.247 1.203 . . . . 1.0 114.247 175.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -64.42 -35.7 81.76 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.666 1.186 . . . . 1.0 110.7 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -86.01 -78.46 0.27 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 113.361 -1.745 . . . . 1.0 110.041 -175.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.2 t 179.26 0.01 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.474 1.91 . . . . 1.0 112.171 172.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -76.45 155.48 33.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 122.264 1.031 . . . . 1.0 113.443 -169.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -92.8 170.84 9.39 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.997 1.719 . . . . 1.0 112.018 -169.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -129.36 159.91 34.7 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.779 1.231 . . . . 1.0 112.342 172.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.0 t -122.62 126.09 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 125.981 1.712 . . . . 1.0 108.209 -176.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 52.4 -168.71 0.74 Allowed Glycine 0 CA--C 1.542 1.739 0 C-N-CA 125.642 1.591 . . . . 1.0 116.199 -176.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -92.37 146.76 23.44 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.163 1.385 . . . . 1.0 110.038 169.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.88 156.34 36.52 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.764 0.826 . . . . 1.0 111.456 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.628 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -92.52 138.54 31.42 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.937 0.895 . . . . 1.0 110.258 170.509 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.628 ' N ' HD13 ' A' ' 123' ' ' LEU . 7.3 mt -121.71 104.46 9.61 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.764 1.226 . . . . 1.0 111.265 173.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.68 131.49 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 C-N-CA 125.034 1.334 . . . . 1.0 112.049 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -107.54 106.29 16.59 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.175 0.988 . . . . 1.0 112.925 172.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -69.24 -22.86 63.83 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.565 0.95 . . . . 1.0 113.565 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.9 t -63.8 -22.52 66.95 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.389 1.076 . . . . 1.0 112.512 173.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -116.13 -30.2 6.06 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.279 1.831 . . . . 1.0 111.884 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -145.6 91.52 5.7 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 124.909 1.283 . . . . 1.0 112.601 -173.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.4 2.54 7.19 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 123.363 2.709 . . . . 1.0 114.383 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -109.82 72.35 0.61 Allowed Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 129.152 2.981 . . . . 1.0 110.444 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -60.5 -12.53 21.15 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.622 2.881 . . . . 1.0 116.723 -169.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -67.0 -28.19 68.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.803 0.729 . . . . 1.0 111.541 172.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 44.3 p -68.91 -26.21 64.98 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.117 -0.99 . . . . 1.0 111.935 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -93.78 -53.1 4.15 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.849 1.26 . . . . 1.0 111.818 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.7 t -72.42 -32.26 66.19 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.503 1.297 . . . . 1.0 114.503 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -61.17 -55.4 44.36 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 121.243 1.838 . . . . 1.0 112.731 -177.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -62.99 -22.65 73.92 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 121.567 1.595 . . . . 1.0 112.676 175.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.484 ' HB2' HD23 ' A' ' 123' ' ' LEU . 92.0 t90 -68.53 -48.62 63.87 Favored 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.345 0.658 . . . . 1.0 110.602 174.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 22' ' ' ALA . 83.9 t -65.43 -32.06 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 122.002 0.906 . . . . 1.0 109.042 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.96 -23.22 61.4 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 119.991 -1.693 . . . . 1.0 113.336 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -86.79 -61.98 1.61 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.978 2.111 . . . . 1.0 111.403 169.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.487 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 83.9 t90 -54.98 -38.2 67.49 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 126.844 2.058 . . . . 1.0 112.823 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.2 -28.71 27.37 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 118.913 0.778 . . . . 1.0 114.513 173.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.5 p -69.93 -12.78 61.87 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.808 1.304 . . . . 1.0 114.043 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.03 -18.98 48.75 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.91 1.684 . . . . 1.0 111.615 176.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.88 171.99 11.08 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.991 1.316 . . . . 1.0 111.194 -177.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 C--O 1.255 1.35 0 C-N-CA 125.252 1.421 . . . . 1.0 114.743 -171.92 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.502 2.163 0 N-CA-C 113.799 1.037 . . . . 1.0 113.799 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.34 172.56 2.47 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 117.717 2.488 . . . . 1.0 117.717 -169.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -122.23 126.95 49.31 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.582 1.953 . . . . 1.0 109.726 173.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.563 HD13 HD12 ' A' ' 26' ' ' LEU . 2.1 mp -123.91 114.25 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 C-N-CA 127.078 2.151 . . . . 1.0 112.213 179.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.71 124.44 7.63 Favored Glycine 0 C--O 1.224 -0.512 0 N-CA-C 110.315 -1.114 . . . . 1.0 110.315 169.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.0 mt -104.43 118.97 52.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 118.283 1.042 . . . . 1.0 109.618 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -111.51 108.79 18.43 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.941 -1.503 . . . . 1.0 106.941 -170.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.6 p -100.41 130.69 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 O-C-N 123.235 0.334 . . . . 1.0 111.375 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.87 150.85 49.73 Favored Glycine 0 CA--C 1.542 1.744 0 O-C-N 122.072 -0.393 . . . . 1.0 112.765 175.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.35 1.4 t 54.82 170.37 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 127.238 2.215 . . . . 1.0 116.562 -170.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -95.35 -34.98 11.94 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.634 1.574 . . . . 1.0 113.061 -171.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -142.29 146.39 35.02 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.654 1.182 . . . . 1.0 112.551 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.04 154.21 6.72 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.271 1.415 . . . . 1.0 112.634 175.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -63.72 -27.79 69.44 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.436 -1.038 . . . . 1.0 113.426 -173.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.6 p -69.18 -21.91 63.94 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.672 1.189 . . . . 1.0 113.876 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.37 -24.55 67.89 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.272 0.942 . . . . 1.0 112.253 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.5 tp -39.96 -47.79 2.28 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.019 1.727 . . . . 1.0 112.644 169.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.5 t -52.63 -33.14 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.17 0.988 . . . . 1.0 112.184 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.19 -48.69 80.37 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 120.0 1.273 . . . . 1.0 113.208 173.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -65.79 -33.11 75.09 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.577 0.751 . . . . 1.0 110.682 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -66.46 -47.79 72.0 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 123.934 0.893 . . . . 1.0 109.406 173.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.544 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -63.78 -43.07 97.45 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 112.584 0.587 . . . . 1.0 112.584 -176.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.11 -49.01 72.82 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.951 0.5 . . . . 1.0 110.029 170.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.42 -38.07 74.53 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.776 0.658 . . . . 1.0 112.776 -173.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.9 mt -65.88 -47.5 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 174.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.563 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -67.14 -34.32 77.33 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 119.651 -0.82 . . . . 1.0 110.573 -175.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.0 m -62.76 -41.63 99.31 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.691 1.597 . . . . 1.0 113.52 170.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.5 -32.81 73.88 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.825 0.85 . . . . 1.0 112.308 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -71.49 -29.32 64.68 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.638 1.175 . . . . 1.0 113.447 171.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.53 26.83 2.3 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.393 0.996 . . . . 1.0 114.086 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -116.35 146.56 42.36 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.381 1.072 . . . . 1.0 109.769 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -79.99 89.41 5.34 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 125.088 1.355 . . . . 1.0 108.448 -175.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.52 146.61 30.4 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 122.552 0.341 . . . . 1.0 110.737 -178.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.7 m -149.29 146.76 27.71 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.011 0.924 . . . . 1.0 111.399 -172.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.3 t -97.51 139.27 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 114.794 1.405 . . . . 1.0 114.794 176.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -122.61 113.66 19.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.974 2.11 . . . . 1.0 109.966 169.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -98.88 138.11 36.48 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.746 1.618 . . . . 1.0 111.188 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 43.24 55.45 11.31 Favored Pre-proline 0 CA--C 1.564 1.496 0 C-N-CA 124.518 1.127 . . . . 1.0 111.475 -169.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.52 152.09 59.61 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 125.167 3.911 . . . . 1.0 119.198 -167.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -93.84 155.47 17.17 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.216 2.206 . . . . 1.0 113.008 168.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.502 HD22 ' HB3' ' A' ' 44' ' ' TRP . 2.4 tm? -69.46 -23.22 63.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 120.827 -1.171 . . . . 1.0 109.983 168.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 31.6 m -65.93 -23.13 66.56 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.27 -0.894 . . . . 1.0 112.228 171.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -83.07 -24.68 32.61 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.242 1.017 . . . . 1.0 113.122 169.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.502 ' HB3' HD22 ' A' ' 41' ' ' LEU . 11.6 t-105 -82.27 -35.82 27.69 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.74 1.154 . . . . 1.0 113.786 177.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.4 mt -50.08 -38.62 38.33 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-O 117.567 -1.206 . . . . 1.0 114.098 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -52.92 -16.92 6.72 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 124.202 3.268 . . . . 1.0 117.319 171.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -109.24 9.88 25.84 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 115.486 1.662 . . . . 1.0 115.486 -175.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -52.6 -33.09 44.72 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 126.08 1.752 . . . . 1.0 113.708 177.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -105.01 1.69 28.88 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.555 1.542 . . . . 1.0 113.576 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -112.56 -164.05 0.89 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.62 2.368 . . . . 1.0 110.932 -175.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -109.04 164.98 11.94 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 122.982 1.373 . . . . 1.0 111.541 169.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.486 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -149.64 159.92 5.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 125.245 1.418 . . . . 1.0 109.164 -172.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.421 HD11 HD12 ' A' ' 90' ' ' ILE . 14.4 tp -138.73 129.95 27.01 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 124.792 1.237 . . . . 1.0 108.698 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.8 t -105.16 125.55 60.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 124.247 1.019 . . . . 1.0 108.964 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.59 114.45 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 107.484 -1.302 . . . . 1.0 107.484 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 t -150.06 116.83 5.87 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.797 1.036 . . . . 1.0 113.797 -169.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.6 t -103.53 13.24 33.85 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.786 2.034 . . . . 1.0 111.732 173.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.2 p -88.46 -6.7 57.48 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.542 1.682 . . . . 1.0 115.542 -168.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.5 m -42.65 -49.25 5.56 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.729 2.011 . . . . 1.0 114.093 178.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 52.0 -130.04 35.91 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-N 119.071 0.851 . . . . 1.0 111.915 -175.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -56.81 -32.45 65.72 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.943 0.897 . . . . 1.0 113.012 172.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 165.33 -24.49 0.16 Allowed Glycine 0 CA--C 1.535 1.343 0 N-CA-C 116.99 1.556 . . . . 1.0 116.99 169.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -99.11 153.26 19.03 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.89 1.676 . . . . 1.0 114.254 -173.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.74 146.83 61.13 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 113.402 0.89 . . . . 1.0 113.402 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -88.02 165.97 7.09 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.781 3.654 . . . . 1.0 113.643 177.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -55.8 -13.75 1.95 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.989 2.116 . . . . 1.0 115.684 -177.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.5 p -78.25 -39.89 38.82 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.092 1.145 . . . . 1.0 114.092 176.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.8 tt -110.47 -15.36 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.941 1.296 . . . . 1.0 112.78 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.4 t -46.24 -50.56 37.86 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 125.18 1.392 . . . . 1.0 112.298 167.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.6 -28.19 31.75 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.688 1.592 . . . . 1.0 111.609 -173.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 tp -70.46 -51.66 27.63 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 123.673 0.789 . . . . 1.0 110.722 169.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.612 ' CE1' HD23 ' A' ' 110' ' ' LEU . 89.8 t80 -55.4 -55.38 32.28 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.234 1.014 . . . . 1.0 112.493 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -68.05 -35.36 78.1 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.44 0.696 . . . . 1.0 111.832 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.13 -35.91 92.58 Favored Glycine 0 CA--C 1.529 0.91 0 O-C-N 121.662 -0.649 . . . . 1.0 112.359 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.607 HG22 HD12 ' A' ' 110' ' ' LEU . 88.8 mt -65.88 -51.57 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 119.871 1.835 . . . . 1.0 107.901 170.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.671 ' HB3' HD21 ' A' ' 110' ' ' LEU . 1.8 ptmm? -68.28 -30.52 69.55 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 120.165 -1.585 . . . . 1.0 113.715 -169.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -107.61 -37.45 6.17 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.995 1.718 . . . . 1.0 115.217 -176.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.5 m -94.1 -21.0 19.39 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.985 0.914 . . . . 1.0 113.197 -176.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.495 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -92.38 -71.49 0.64 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 106.523 -1.658 . . . . 1.0 106.523 169.15 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.94 -19.33 1.0 Allowed Glycine 0 CA--C 1.535 1.314 0 C-N-CA 127.945 2.688 . . . . 1.0 115.38 169.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -152.19 139.31 19.23 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 128.185 2.594 . . . . 1.0 107.885 169.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.451 HE21 HD12 ' A' ' 79' ' ' LEU . 12.8 mt-30 -137.86 121.8 11.75 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 118.829 -0.605 . . . . 1.0 109.838 -170.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -81.61 -35.99 0.37 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.713 2.275 . . . . 1.0 115.496 -169.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -142.91 15.84 1.93 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.18 1.178 . . . . 1.0 114.18 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.486 HD11 ' CG2' ' A' ' 52' ' ' VAL . 67.2 tp -81.74 140.1 34.48 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.716 -1.24 . . . . 1.0 112.881 -169.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.5 mtm-85 -136.51 154.68 50.66 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.694 2.397 . . . . 1.0 109.311 169.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.665 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -160.18 170.29 21.48 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.286 0.948 . . . . 1.0 111.87 -177.714 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -129.25 171.45 20.01 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 124.744 1.164 . . . . 1.0 113.393 170.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 122' ' ' MET . 0.0 OUTLIER -140.88 138.41 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.134 0.973 . . . . 1.0 113.521 -169.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.942 HG23 HD12 ' A' ' 123' ' ' LEU . 7.1 mt -130.81 96.52 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.631 1.572 . . . . 1.0 107.096 169.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.92 145.61 25.42 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.494 1.518 . . . . 1.0 111.066 172.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.4 mp -140.71 157.32 45.61 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 121.611 -0.681 . . . . 1.0 112.17 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.58 167.95 34.67 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 121.976 0.764 . . . . 1.0 114.715 169.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -74.3 119.48 18.56 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.005 -1.291 . . . . 1.0 109.763 170.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.5 t -64.33 -4.61 3.97 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.85 1.055 . . . . 1.0 113.85 -177.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.3 t -71.11 -22.37 62.09 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.931 -1.106 . . . . 1.0 112.781 170.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -72.86 158.57 35.28 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.551 0.945 . . . . 1.0 113.551 176.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.3 t -62.26 -37.53 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.187 1.395 . . . . 1.0 113.464 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -121.97 27.86 7.86 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.699 1.6 . . . . 1.0 114.424 -169.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 18.8 t80 32.93 -87.29 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 128.198 2.599 . . . . 1.0 117.019 172.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 15.5 m -121.35 17.28 11.42 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.66 1.984 . . . . 1.0 113.2 -174.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -54.12 -30.34 48.4 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.013 1.725 . . . . 1.0 114.722 -174.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.88 -41.55 94.23 Favored Glycine 0 N--CA 1.473 1.132 0 CA-C-N 121.477 1.944 . . . . 1.0 113.32 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.07 -37.73 28.16 Favored Glycine 0 N--CA 1.476 1.304 0 CA-C-N 118.258 1.029 . . . . 1.0 113.326 173.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -58.66 -35.14 72.07 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.647 1.223 . . . . 1.0 113.167 173.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -68.29 -33.48 74.42 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.244 0.618 . . . . 1.0 112.14 172.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -63.69 -37.13 86.19 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.759 1.163 . . . . 1.0 110.963 172.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.1 -48.14 79.85 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.98 0.912 . . . . 1.0 112.139 174.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.98 -35.15 70.78 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.816 0.672 . . . . 1.0 112.816 173.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.671 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -57.82 -50.12 74.36 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 123.525 1.631 . . . . 1.0 110.906 -176.079 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.665 HD12 ' CD1' ' A' ' 87' ' ' TYR . 6.3 mt -66.34 -40.52 89.88 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 120.762 -1.211 . . . . 1.0 111.262 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -70.73 -16.91 62.81 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.241 0.83 . . . . 1.0 113.241 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.81 -20.4 53.27 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.579 1.081 . . . . 1.0 110.798 175.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -97.79 -79.37 0.47 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.377 1.471 . . . . 1.0 110.28 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.0 t -175.27 -3.28 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.79 1.636 . . . . 1.0 112.573 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.466 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -79.83 151.95 29.98 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 122.962 1.363 . . . . 1.0 113.596 -169.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -88.44 168.2 12.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.049 1.74 . . . . 1.0 113.799 -168.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -119.4 148.04 43.67 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.779 2.031 . . . . 1.0 110.922 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.3 t -120.71 128.31 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.149 1.38 . . . . 1.0 108.798 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 50.06 -158.13 1.68 Allowed Glycine 0 N--CA 1.48 1.609 0 C-N-CA 125.087 1.327 . . . . 1.0 114.569 -172.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -110.91 142.49 42.92 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.088 1.355 . . . . 1.0 109.277 169.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.425 ' HB3' HG23 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -75.36 157.84 33.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.184 0.994 . . . . 1.0 113.049 -169.386 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.942 HD12 HG23 ' A' ' 90' ' ' ILE . 1.4 tm? -90.69 137.11 32.62 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.918 1.287 . . . . 1.0 110.27 173.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.9 mt -127.84 109.35 11.53 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.624 1.57 . . . . 1.0 109.98 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.568 HG13 HD11 ' A' ' 123' ' ' LEU . 28.4 mt -98.25 134.24 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.11 0.964 . . . . 1.0 113.014 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -100.18 91.86 4.95 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.919 2.488 . . . . 1.0 112.71 174.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.82 -23.28 66.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.209 1.004 . . . . 1.0 112.733 -174.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.9 p -54.1 -30.88 50.22 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 129.373 3.069 . . . . 1.0 114.158 169.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -121.28 -26.19 5.09 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.586 1.954 . . . . 1.0 111.508 -171.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -140.32 89.26 10.86 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 125.184 1.393 . . . . 1.0 111.474 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -75.66 11.39 1.64 Allowed 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.842 3.028 . . . . 1.0 114.005 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -113.77 65.3 1.23 Allowed Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 127.358 2.263 . . . . 1.0 110.072 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -55.72 -22.37 36.21 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.561 2.174 . . . . 1.0 116.176 -169.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.7 pm0 -64.49 -25.01 67.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 119.553 1.069 . . . . 1.0 111.817 175.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.5 p -72.82 -17.14 61.59 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 120.628 -1.295 . . . . 1.0 112.372 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.404 ' HB2' HD11 ' A' ' 125' ' ' ILE . 65.3 mm-40 -102.54 -55.79 2.38 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.258 1.823 . . . . 1.0 111.957 176.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 63.6 p -68.73 -33.31 73.71 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 113.817 1.043 . . . . 1.0 113.817 -176.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 36.5 m-20 -60.11 -59.23 14.53 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 120.688 1.585 . . . . 1.0 112.399 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -62.33 -22.32 73.93 Favored 'Trans proline' 0 C--N 1.352 0.713 0 CA-C-N 121.377 1.527 . . . . 1.0 112.943 175.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.459 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 87.2 t90 -68.71 -46.07 69.93 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 118.776 0.716 . . . . 1.0 111.2 172.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' A' ' 22' ' ' ALA . 92.2 t -63.84 -34.62 69.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 175.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.07 -30.83 70.12 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.299 1.44 . . . . 1.0 112.071 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -78.01 -61.87 1.86 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.113 1.765 . . . . 1.0 112.355 170.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -56.04 -36.43 68.0 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 126.046 1.738 . . . . 1.0 112.694 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.88 -32.32 26.11 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.393 0.997 . . . . 1.0 113.958 173.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.5 p -67.91 -13.8 62.45 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.073 1.138 . . . . 1.0 114.073 177.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.42 -17.71 50.99 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.002 1.721 . . . . 1.0 111.899 176.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.06 176.24 7.71 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.356 1.462 . . . . 1.0 110.911 -177.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 C--O 1.25 1.081 0 N-CA-C 114.803 1.408 . . . . 1.0 114.803 -170.077 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtt . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 111.316 0.117 . . . . 1.0 111.316 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.32 144.69 49.84 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.785 0.834 . . . . 1.0 113.049 175.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -124.78 121.25 34.08 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.404 1.082 . . . . 1.0 111.178 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.506 HD13 HD12 ' A' ' 26' ' ' LEU . 2.1 mp -118.91 116.25 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 126.579 1.952 . . . . 1.0 112.803 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.04 127.42 9.06 Favored Glycine 0 C--O 1.221 -0.668 0 N-CA-C 111.159 -0.776 . . . . 1.0 111.159 169.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.3 mt -106.36 120.17 56.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 118.682 1.241 . . . . 1.0 109.979 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -111.44 107.63 16.91 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 125.332 1.453 . . . . 1.0 107.598 -169.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.7 p -95.7 123.38 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.32 0.581 . . . . 1.0 112.013 -171.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.22 73.33 0.21 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.589 1.566 . . . . 1.0 111.523 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 95.1 m -132.26 115.72 16.01 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.592 1.157 . . . . 1.0 110.323 -176.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 90.5 mtp -86.57 -28.97 22.99 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.276 0.843 . . . . 1.0 113.276 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -149.98 154.88 38.97 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.9 1.28 . . . . 1.0 112.23 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.85 172.32 43.69 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.82 1.2 . . . . 1.0 114.802 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -80.21 -2.8 46.45 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.97 1.1 . . . . 1.0 113.97 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.9 m -54.01 -27.39 31.57 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.515 1.526 . . . . 1.0 114.443 -174.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.7 pp -54.23 -24.96 20.58 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.194 1.398 . . . . 1.0 113.753 173.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.1 tp -39.4 -47.32 1.77 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.691 1.997 . . . . 1.0 112.864 170.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -53.03 -33.07 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.857 0.863 . . . . 1.0 111.995 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.71 -47.15 86.57 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 120.002 1.274 . . . . 1.0 112.72 174.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -65.94 -33.54 76.06 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.835 0.854 . . . . 1.0 110.839 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -66.1 -48.22 71.61 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 123.361 0.664 . . . . 1.0 109.234 173.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.626 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -64.07 -41.83 97.21 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 112.857 0.688 . . . . 1.0 112.857 -175.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.44 -51.14 65.91 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 169.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.08 -37.54 81.35 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.572 -0.705 . . . . 1.0 112.808 -174.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.4 mt -68.27 -46.78 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 119.371 0.987 . . . . 1.0 109.572 176.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.506 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -65.66 -36.3 83.28 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.565 0.697 . . . . 1.0 110.633 -177.245 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.3 m -61.04 -43.75 98.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.989 0.916 . . . . 1.0 112.908 170.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.45 -29.58 67.31 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.505 1.122 . . . . 1.0 113.548 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -67.35 -30.07 69.79 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.334 1.054 . . . . 1.0 111.891 170.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.02 15.77 1.85 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.455 1.026 . . . . 1.0 115.28 169.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -102.54 -179.08 3.87 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.851 1.26 . . . . 1.0 109.977 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -108.15 98.66 8.19 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 124.982 1.313 . . . . 1.0 108.054 169.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -110.08 148.14 32.28 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 122.785 0.434 . . . . 1.0 111.231 176.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.2 m -146.28 147.0 30.93 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.673 1.189 . . . . 1.0 111.173 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.1 t -96.73 138.24 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 114.245 1.202 . . . . 1.0 114.245 174.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -117.73 112.29 20.26 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.671 1.988 . . . . 1.0 110.576 169.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -93.92 138.51 31.97 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.086 1.754 . . . . 1.0 111.1 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 42.65 55.31 10.34 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 124.789 1.236 . . . . 1.0 110.999 -169.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -68.21 146.02 68.4 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.72 2.947 . . . . 1.0 117.632 -168.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -89.68 155.7 19.05 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.091 1.757 . . . . 1.0 112.523 168.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.528 HD21 HD21 ' A' ' 79' ' ' LEU . 2.2 tm? -69.09 -21.35 64.06 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 120.574 -1.329 . . . . 1.0 109.525 168.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 m -67.24 -21.57 65.73 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.168 -0.957 . . . . 1.0 112.357 170.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -82.88 -27.28 30.82 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.01 0.924 . . . . 1.0 112.5 169.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.474 ' HB3' HD22 ' A' ' 41' ' ' LEU . 12.4 t-105 -82.06 -36.51 27.61 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.488 1.04 . . . . 1.0 113.686 178.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.9 mt -48.07 -40.44 34.4 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-O 117.708 -1.139 . . . . 1.0 113.668 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -52.45 -16.83 5.69 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 124.373 3.382 . . . . 1.0 117.532 172.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -110.22 8.09 23.5 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 116.195 1.924 . . . . 1.0 116.195 -172.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -51.3 -26.73 7.91 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 127.156 2.183 . . . . 1.0 114.336 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -121.63 15.98 11.13 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.897 1.679 . . . . 1.0 113.485 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -128.62 -154.23 0.62 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 128.163 2.585 . . . . 1.0 109.747 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -122.07 164.05 18.38 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 123.161 1.458 . . . . 1.0 112.371 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.408 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -151.93 164.55 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 124.846 1.258 . . . . 1.0 109.434 -172.375 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.428 HD11 HD12 ' A' ' 90' ' ' ILE . 14.6 tp -144.39 128.6 17.73 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 125.1 1.36 . . . . 1.0 108.53 176.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.2 t -102.13 124.81 56.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 124.518 1.127 . . . . 1.0 109.328 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.2 110.85 25.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 106.043 -1.836 . . . . 1.0 106.043 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 t -135.15 122.04 21.11 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.398 0.679 . . . . 1.0 111.732 -168.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 m -115.66 4.58 14.11 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 116.49 2.033 . . . . 1.0 116.49 -168.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.33 29.7 7.63 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 113.291 0.848 . . . . 1.0 113.291 -169.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -58.09 -37.87 75.32 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.352 1.061 . . . . 1.0 112.205 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.01 -125.85 34.3 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.144 0.878 . . . . 1.0 113.206 176.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -76.73 -7.97 56.38 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.886 1.069 . . . . 1.0 113.886 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 130.61 43.55 0.19 Allowed Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.972 1.273 . . . . 1.0 115.143 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -133.79 155.04 50.51 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.292 1.437 . . . . 1.0 111.616 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.1 mt -75.87 147.25 80.59 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 121.069 -1.019 . . . . 1.0 112.591 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -59.37 131.3 40.07 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.565 2.177 . . . . 1.0 110.794 169.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.2 -23.72 64.23 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.249 -0.907 . . . . 1.0 112.994 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.0 p -73.15 -19.56 61.1 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.609 1.563 . . . . 1.0 114.434 173.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.4 tt -118.72 -11.73 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.836 1.255 . . . . 1.0 113.657 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.7 t -47.32 -51.19 44.38 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 125.629 1.571 . . . . 1.0 112.204 168.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.48 -31.74 16.78 Favored 'Trans proline' 0 C--N 1.352 0.737 0 CA-C-N 120.57 1.239 . . . . 1.0 111.277 -173.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.7 tp -63.03 -49.78 73.25 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 124.719 1.208 . . . . 1.0 111.331 169.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.64 ' CE1' HD23 ' A' ' 110' ' ' LEU . 92.0 t80 -54.53 -54.41 41.54 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.761 1.224 . . . . 1.0 112.679 178.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -64.08 -38.76 92.24 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.689 0.796 . . . . 1.0 111.242 177.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.45 -36.67 91.86 Favored Glycine 0 CA--C 1.528 0.87 0 O-C-N 121.69 -0.631 . . . . 1.0 112.69 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.553 HG22 HD12 ' A' ' 110' ' ' LEU . 92.9 mt -65.06 -49.5 79.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 120.008 -1.877 . . . . 1.0 108.291 172.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.671 ' HB3' HD21 ' A' ' 110' ' ' LEU . 10.9 ptmt -69.93 -31.6 69.45 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.464 -1.398 . . . . 1.0 113.529 -171.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -106.77 -37.43 6.4 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.692 1.597 . . . . 1.0 114.963 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.6 m -92.75 -23.07 19.02 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.295 1.038 . . . . 1.0 112.661 -177.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.528 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -94.22 -71.85 0.64 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 106.934 -1.506 . . . . 1.0 106.934 169.368 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.61 -9.47 2.58 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 126.73 2.11 . . . . 1.0 115.622 170.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -153.96 147.1 24.64 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 128.734 2.814 . . . . 1.0 107.788 169.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.4 ' HG3' ' HB2' ' A' ' 116' ' ' ALA . 39.7 mm-40 -136.76 125.17 14.97 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 123.261 0.625 . . . . 1.0 110.8 -174.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -83.05 -40.76 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.458 2.106 . . . . 1.0 114.097 -174.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -146.9 18.95 1.27 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.628 1.171 . . . . 1.0 113.846 -169.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.408 HD11 ' CG2' ' A' ' 52' ' ' VAL . 62.2 tp -80.95 140.0 35.5 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.606 -1.309 . . . . 1.0 112.782 -169.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 -135.26 154.6 51.51 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.624 2.369 . . . . 1.0 109.158 169.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.678 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -162.03 167.15 24.88 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.91 0.777 . . . . 1.0 112.195 -179.602 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.456 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -122.56 172.82 15.87 Favored Glycine 0 N--CA 1.473 1.139 0 C-N-CA 125.702 1.62 . . . . 1.0 114.096 173.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.4 t -146.7 133.79 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 114.421 1.267 . . . . 1.0 114.421 -169.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.428 HD12 HD11 ' A' ' 53' ' ' LEU . 4.3 mt -131.4 110.37 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 106.97 -1.493 . . . . 1.0 106.97 168.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.91 145.01 24.93 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.741 1.216 . . . . 1.0 110.711 170.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.09 150.57 43.07 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.317 0.647 . . . . 1.0 111.571 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 170.85 -179.14 42.97 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-O 122.077 0.821 . . . . 1.0 114.67 169.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -81.05 106.63 13.2 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.157 1.383 . . . . 1.0 111.593 177.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 79.7 p -68.7 -4.89 17.41 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.554 1.542 . . . . 1.0 114.017 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.3 p -61.99 -19.55 62.93 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.291 1.036 . . . . 1.0 113.594 169.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -105.47 162.41 13.49 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.507 1.523 . . . . 1.0 112.879 169.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.9 m -63.56 175.96 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.993 1.317 . . . . 1.0 111.205 169.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 59.56 20.83 9.35 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.693 1.597 . . . . 1.0 114.834 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -10.88 -65.74 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 130.497 3.519 . . . . 1.0 117.554 -169.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.8 m -128.58 24.93 5.75 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.035 1.334 . . . . 1.0 113.489 -172.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -55.55 -29.53 59.14 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.896 1.278 . . . . 1.0 114.407 -174.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.01 -43.3 95.11 Favored Glycine 0 N--CA 1.476 1.349 0 CA-C-N 121.115 1.78 . . . . 1.0 114.444 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.49 -37.04 36.73 Favored Glycine 0 N--CA 1.478 1.449 0 O-C-N 121.082 -1.246 . . . . 1.0 112.772 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -60.37 -38.31 83.46 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.322 1.049 . . . . 1.0 113.111 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -59.51 -42.87 93.19 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.259 1.024 . . . . 1.0 111.951 170.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.28 -38.18 90.16 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.638 0.654 . . . . 1.0 110.889 176.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -37.59 88.06 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.746 0.819 . . . . 1.0 112.698 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.71 93.52 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.819 -0.61 . . . . 1.0 112.213 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.671 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -50.7 -48.25 58.74 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.115 2.166 . . . . 1.0 111.885 -171.583 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.678 HD12 ' CD1' ' A' ' 87' ' ' TYR . 6.6 mt -66.48 -42.39 87.55 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.41 -0.814 . . . . 1.0 111.516 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -67.44 -21.43 65.55 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.887 1.069 . . . . 1.0 113.887 175.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -67.09 -33.88 76.44 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.279 1.032 . . . . 1.0 111.331 174.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -85.15 -73.99 0.42 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 114.129 -1.396 . . . . 1.0 110.709 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.418 ' H ' ' H ' ' A' ' 116' ' ' ALA . 3.4 m 174.97 -0.72 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.953 2.501 . . . . 1.0 112.001 174.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -77.61 152.14 34.04 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-O 122.222 1.01 . . . . 1.0 113.599 -169.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -86.03 161.48 18.93 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.404 1.482 . . . . 1.0 112.876 -169.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.68 127.01 37.99 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.143 1.777 . . . . 1.0 108.99 -173.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.7 t -106.78 129.85 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.635 0.774 . . . . 1.0 110.45 -169.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 51.64 -154.68 4.42 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.768 1.175 . . . . 1.0 113.544 -171.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -115.85 147.24 41.26 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.73 1.612 . . . . 1.0 109.142 169.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -73.78 157.35 36.59 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.05 -1.031 . . . . 1.0 112.231 -169.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.632 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -90.39 138.06 31.85 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.857 0.863 . . . . 1.0 110.442 171.306 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.632 ' N ' HD13 ' A' ' 123' ' ' LEU . 8.8 mt -122.65 108.03 12.63 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.089 1.356 . . . . 1.0 111.316 175.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.452 HG13 ' CD1' ' A' ' 123' ' ' LEU . 4.1 mt -95.84 133.74 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 125.227 1.411 . . . . 1.0 112.944 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -107.67 89.31 2.96 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.689 2.796 . . . . 1.0 113.097 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.72 -24.66 67.64 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.814 -1.179 . . . . 1.0 113.162 -173.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.2 m -62.79 -16.26 57.3 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.947 2.099 . . . . 1.0 113.776 172.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -131.38 -28.26 1.9 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.872 2.069 . . . . 1.0 112.658 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -139.01 88.54 13.29 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 126.251 1.821 . . . . 1.0 110.917 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -75.59 11.03 1.71 Allowed 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 123.67 2.913 . . . . 1.0 114.05 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -112.79 68.36 1.04 Allowed Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 127.578 2.351 . . . . 1.0 110.127 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -58.09 -20.03 43.95 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.942 2.428 . . . . 1.0 116.87 -169.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -66.55 -26.53 67.17 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.559 -0.713 . . . . 1.0 112.011 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 26.9 p -71.77 -21.59 61.71 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 120.971 -1.081 . . . . 1.0 111.762 -175.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -95.51 -55.53 3.0 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.124 1.77 . . . . 1.0 112.009 176.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.5 t -71.06 -32.0 68.57 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.809 1.04 . . . . 1.0 113.809 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -62.1 -53.19 61.47 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 120.9 1.682 . . . . 1.0 113.286 -177.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -63.49 -24.79 70.4 Favored 'Trans proline' 0 C--N 1.353 0.787 0 CA-C-N 121.157 1.449 . . . . 1.0 112.36 173.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.432 ' HB2' HD23 ' A' ' 123' ' ' LEU . 91.8 t90 -67.77 -47.98 67.67 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 118.858 0.753 . . . . 1.0 110.764 175.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.626 HG11 ' HA ' ' A' ' 22' ' ' ALA . 93.8 t -65.4 -32.61 59.0 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.71 -52.13 61.89 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.062 -1.024 . . . . 1.0 109.749 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -64.55 -50.82 65.8 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.882 0.873 . . . . 1.0 111.855 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.456 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 85.6 t90 -59.05 -35.66 73.69 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 125.269 1.428 . . . . 1.0 111.737 175.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.23 -34.39 40.31 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.932 1.254 . . . . 1.0 113.247 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.0 p -68.12 -13.04 61.91 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 114.884 1.439 . . . . 1.0 114.884 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.74 -13.32 54.24 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.525 1.53 . . . . 1.0 112.542 176.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -74.41 169.54 17.49 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.556 1.071 . . . . 1.0 112.005 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.0 t . . . . . 0 C--O 1.257 1.489 0 C-N-CA 125.916 1.686 . . . . 1.0 112.605 -169.458 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 mmt . . . . . 0 N--CA 1.5 2.071 0 CA-C-O 120.369 0.128 . . . . 1.0 111.153 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.24 144.79 53.57 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.495 0.924 . . . . 1.0 113.495 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -117.02 125.38 51.26 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.063 1.345 . . . . 1.0 110.461 173.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.486 HD13 HD12 ' A' ' 26' ' ' LEU . 2.0 mp -122.91 115.26 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.063 0 C-N-CA 126.262 1.825 . . . . 1.0 112.351 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.49 125.55 8.26 Favored Glycine 0 N--CA 1.462 0.41 0 N-CA-C 110.432 -1.067 . . . . 1.0 110.432 169.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 mt -104.86 121.05 56.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 117.875 0.838 . . . . 1.0 109.071 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -113.66 115.22 27.54 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 124.648 1.179 . . . . 1.0 108.548 -169.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.2 p -93.85 137.6 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 112.537 0.569 . . . . 1.0 112.537 -172.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -117.39 102.76 1.03 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.367 1.46 . . . . 1.0 111.016 172.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.5 m -153.89 156.76 38.15 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.546 1.138 . . . . 1.0 110.465 -169.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.56 138.05 52.62 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.384 0.993 . . . . 1.0 110.321 169.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 55.65 14.21 1.2 Allowed 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 115.161 1.541 . . . . 1.0 115.161 -170.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.63 14.44 69.8 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.681 1.134 . . . . 1.0 115.822 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -62.88 149.05 45.41 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 118.77 1.285 . . . . 1.0 114.016 -174.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.2 p -53.76 -16.64 1.8 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 116.845 2.165 . . . . 1.0 116.845 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.0 tp 55.27 19.25 2.86 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.23 1.412 . . . . 1.0 113.336 -177.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.8 tp 60.84 -57.06 0.09 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.357 2.263 . . . . 1.0 113.975 -169.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.9 t -49.48 -34.26 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 127.077 2.151 . . . . 1.0 112.427 -176.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.01 -47.63 85.55 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.852 1.205 . . . . 1.0 112.978 174.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -67.59 -31.84 72.16 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.744 0.818 . . . . 1.0 110.605 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.77 -49.86 64.57 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 123.785 0.834 . . . . 1.0 109.06 173.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.648 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -62.3 -42.74 99.62 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 123.633 0.773 . . . . 1.0 112.509 -176.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.15 -51.37 66.69 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 170.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.04 -36.57 80.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.521 -0.737 . . . . 1.0 112.868 -174.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.2 mt -68.62 -47.34 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 119.345 0.975 . . . . 1.0 109.511 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.486 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -64.97 -36.89 85.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.856 0.836 . . . . 1.0 110.657 -177.721 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.0 m -61.38 -42.02 98.04 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 121.201 -0.937 . . . . 1.0 113.022 170.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.34 -29.57 66.3 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.604 1.162 . . . . 1.0 113.392 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -66.69 -30.67 70.98 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.582 1.153 . . . . 1.0 111.388 170.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.57 11.05 1.75 Allowed Glycine 0 CA--C 1.53 0.988 0 N-CA-C 115.498 0.959 . . . . 1.0 115.498 169.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 -101.21 -177.09 3.34 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.829 1.252 . . . . 1.0 110.898 -174.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -109.71 97.15 6.75 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.973 1.309 . . . . 1.0 108.266 169.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.37 150.12 27.08 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.492 0.317 . . . . 1.0 111.262 176.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.6 m -145.16 147.79 32.86 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.784 1.234 . . . . 1.0 111.509 -175.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.3 t -98.09 138.83 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 114.899 1.444 . . . . 1.0 114.899 174.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -117.66 110.71 18.21 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.742 1.617 . . . . 1.0 110.748 169.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -90.06 144.2 26.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.787 1.635 . . . . 1.0 110.848 170.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 40.29 55.08 6.84 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 125.019 1.328 . . . . 1.0 112.51 -169.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.24 142.2 49.57 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.813 3.009 . . . . 1.0 117.179 -168.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -97.49 163.24 12.94 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 122.71 1.243 . . . . 1.0 112.783 168.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.607 HD21 HD21 ' A' ' 79' ' ' LEU . 2.3 tm? -67.28 -23.82 65.71 Favored 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 121.004 -1.06 . . . . 1.0 110.461 167.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 62.9 p -68.39 -18.65 64.51 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.941 -1.1 . . . . 1.0 112.337 172.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -82.49 -24.85 33.96 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.896 0.878 . . . . 1.0 112.178 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.485 ' HB3' HD22 ' A' ' 41' ' ' LEU . 14.6 t-105 -87.52 -36.52 17.56 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.399 1.259 . . . . 1.0 114.399 -178.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.7 mt -46.7 -37.89 10.25 Favored Pre-proline 0 CA--C 1.553 1.069 0 N-CA-C 114.413 1.264 . . . . 1.0 114.413 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -61.11 -14.36 33.07 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 123.745 2.964 . . . . 1.0 116.695 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -107.87 8.4 28.59 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 115.745 1.757 . . . . 1.0 115.745 -173.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -54.85 -27.82 45.21 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.631 1.972 . . . . 1.0 113.874 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -107.67 3.02 24.25 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.562 1.545 . . . . 1.0 113.41 176.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -114.93 -163.34 0.87 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.915 2.486 . . . . 1.0 110.836 -174.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -106.81 162.84 13.45 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 123.387 1.565 . . . . 1.0 110.936 169.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.596 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -148.63 151.66 13.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.253 -1.34 . . . . 1.0 108.056 -173.426 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.1 tp -133.62 130.27 38.07 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 124.471 1.108 . . . . 1.0 108.667 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.4 t -105.11 126.79 60.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.263 -0.643 . . . . 1.0 109.263 174.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.4 t -122.97 111.38 29.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.963 -1.866 . . . . 1.0 105.963 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -148.29 127.21 12.7 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.496 1.295 . . . . 1.0 114.496 -167.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 t -114.8 176.89 4.86 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.385 1.474 . . . . 1.0 111.581 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.7 m 62.91 47.17 4.53 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 122.453 1.12 . . . . 1.0 112.015 169.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -55.46 -35.22 65.25 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.959 1.303 . . . . 1.0 111.698 169.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 56.91 -134.4 52.1 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 123.661 0.648 . . . . 1.0 112.059 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -63.85 -22.06 66.74 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.362 0.875 . . . . 1.0 113.362 175.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.31 55.22 0.04 OUTLIER Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.598 1.094 . . . . 1.0 113.79 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -144.25 -177.36 5.43 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.957 1.303 . . . . 1.0 112.123 -177.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 17.0 mt -116.46 146.88 38.46 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 126.585 1.954 . . . . 1.0 113.3 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.32 148.08 93.86 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.408 2.738 . . . . 1.0 113.309 169.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -63.91 -20.89 66.19 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.066 1.135 . . . . 1.0 114.066 -175.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.8 p -70.61 -29.34 65.7 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.787 1.235 . . . . 1.0 114.058 173.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.5 tt -107.87 -16.19 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.763 1.625 . . . . 1.0 113.283 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.1 t -44.91 -53.31 16.22 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.422 1.089 . . . . 1.0 112.323 168.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.17 -31.87 28.49 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.647 1.565 . . . . 1.0 111.702 -173.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.2 tp -63.1 -52.15 63.77 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.146 0.978 . . . . 1.0 111.257 169.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.725 ' CE1' HD23 ' A' ' 110' ' ' LEU . 89.7 t80 -56.02 -53.41 57.27 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.927 0.891 . . . . 1.0 112.385 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -63.88 -39.91 95.3 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.814 0.846 . . . . 1.0 111.544 177.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.76 -36.86 91.83 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 123.47 0.557 . . . . 1.0 112.589 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.621 HG22 HD12 ' A' ' 110' ' ' LEU . 82.5 mt -65.19 -47.74 86.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 120.024 1.912 . . . . 1.0 108.412 172.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.754 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.2 ptmm? -71.63 -31.27 66.68 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.224 -1.547 . . . . 1.0 113.289 -171.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -104.42 -38.71 6.71 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 115.519 1.674 . . . . 1.0 115.519 -175.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.1 m -95.09 -22.43 17.9 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.639 1.176 . . . . 1.0 113.326 -174.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.607 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -91.23 -71.71 0.62 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 106.93 -1.507 . . . . 1.0 106.93 170.037 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.53 -16.86 0.91 Allowed Glycine 0 CA--C 1.538 1.488 0 C-N-CA 127.562 2.506 . . . . 1.0 116.804 169.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -152.27 138.15 18.05 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.862 2.465 . . . . 1.0 108.227 174.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -133.72 124.12 17.65 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 119.086 0.857 . . . . 1.0 112.546 -172.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -82.65 -35.93 0.28 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.598 2.199 . . . . 1.0 114.726 -173.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -144.99 11.1 1.36 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.589 1.7 . . . . 1.0 115.589 -169.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.596 HD11 ' CG2' ' A' ' 52' ' ' VAL . 39.1 tp -75.06 142.05 43.78 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 120.27 -1.519 . . . . 1.0 113.004 -169.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -134.2 144.11 48.26 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 129.317 3.047 . . . . 1.0 107.493 169.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.661 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -154.38 164.25 38.92 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 120.046 1.294 . . . . 1.0 113.568 179.564 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.424 ' HA3' ' CE2' ' A' ' 144' ' ' TRP . . . -125.78 170.67 17.65 Favored Glycine 0 N--CA 1.468 0.8 0 C-N-CA 126.537 2.018 . . . . 1.0 112.248 172.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.586 HG13 ' HB3' ' A' ' 122' ' ' MET . 0.2 OUTLIER -160.25 146.6 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 O-C-N 120.836 -1.391 . . . . 1.0 114.442 -169.021 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.976 HG23 HD12 ' A' ' 123' ' ' LEU . 11.1 mt -138.4 98.69 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 127.92 2.488 . . . . 1.0 107.005 -172.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.09 147.88 23.99 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.408 1.483 . . . . 1.0 111.867 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.4 mp -140.48 152.31 45.52 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.297 0.639 . . . . 1.0 112.629 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.11 -172.26 42.71 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 115.097 0.799 . . . . 1.0 115.097 169.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -87.78 113.91 23.89 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.632 -0.923 . . . . 1.0 110.404 176.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 40.4 p -63.11 -6.06 3.77 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.401 1.26 . . . . 1.0 114.401 177.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.4 t -64.74 -26.06 68.2 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.944 0.898 . . . . 1.0 112.455 169.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -78.22 141.21 38.76 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.043 -1.036 . . . . 1.0 111.94 170.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -48.81 -50.02 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.558 1.543 . . . . 1.0 113.706 177.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -90.13 16.15 8.98 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 115.276 1.584 . . . . 1.0 115.276 -174.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.5 t80 29.32 -82.94 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 129.15 2.98 . . . . 1.0 117.573 171.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.7 m -121.05 19.49 11.61 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.366 1.866 . . . . 1.0 113.317 -171.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -51.06 -28.49 10.51 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.548 1.539 . . . . 1.0 114.009 -177.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -52.71 -42.78 59.32 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-N 120.436 1.471 . . . . 1.0 113.895 175.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.52 -34.88 18.46 Favored Glycine 0 N--CA 1.478 1.491 0 CA-C-N 118.864 1.332 . . . . 1.0 113.806 174.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -59.48 -32.87 70.66 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 118.465 1.132 . . . . 1.0 112.974 174.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -61.67 -41.69 97.89 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.217 1.007 . . . . 1.0 111.997 170.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -65.28 -34.89 79.42 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.234 0.924 . . . . 1.0 111.671 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -60.61 -55.19 36.26 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.344 0.657 . . . . 1.0 110.95 172.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.64 -34.71 62.56 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.974 0.731 . . . . 1.0 112.974 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.754 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -56.66 -50.29 72.53 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 123.562 1.648 . . . . 1.0 111.692 -178.29 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.661 HD12 ' CD1' ' A' ' 87' ' ' TYR . 14.9 mt -68.1 -36.98 80.66 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 120.606 -1.309 . . . . 1.0 111.423 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -73.79 -11.96 60.55 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.7 1.0 . . . . 1.0 113.7 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.84 -17.28 41.47 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.758 1.163 . . . . 1.0 110.918 175.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -96.51 -84.03 0.37 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.42 1.488 . . . . 1.0 108.729 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.5 -8.75 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.898 1.679 . . . . 1.0 112.67 -169.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -81.06 162.5 23.73 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 122.156 0.979 . . . . 1.0 113.312 -168.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -106.33 163.55 12.74 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.376 1.071 . . . . 1.0 111.793 -169.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.12 138.93 53.29 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.824 1.65 . . . . 1.0 110.802 -178.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.58 HG12 ' H ' ' A' ' 120' ' ' GLY . 18.5 t -84.91 -162.51 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 125.577 1.551 . . . . 1.0 107.699 173.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.58 ' H ' HG12 ' A' ' 119' ' ' VAL . . . -48.44 152.73 2.32 Favored Glycine 0 N--CA 1.482 1.743 0 O-C-N 120.121 -1.612 . . . . 1.0 113.901 173.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -63.75 151.01 43.27 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 122.746 1.26 . . . . 1.0 112.768 -172.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.586 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -71.43 157.64 37.69 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.992 1.317 . . . . 1.0 113.091 -168.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.976 HD12 HG23 ' A' ' 90' ' ' ILE . 0.9 OUTLIER -87.21 140.34 29.65 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.749 1.22 . . . . 1.0 110.084 170.128 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.0 mt -127.51 110.65 12.95 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.129 1.372 . . . . 1.0 109.83 173.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.569 ' CD1' HD11 ' A' ' 123' ' ' LEU . 28.7 mt -99.31 130.66 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.361 1.064 . . . . 1.0 112.929 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -105.55 98.34 8.05 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.648 2.379 . . . . 1.0 113.495 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.28 -22.42 66.84 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.819 1.044 . . . . 1.0 113.819 -175.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.6 t -58.85 -27.06 64.78 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.8 1.24 . . . . 1.0 112.845 171.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -120.34 -30.35 4.61 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.17 1.788 . . . . 1.0 112.303 -169.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -143.42 96.31 5.78 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.111 0.965 . . . . 1.0 112.938 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.42 7.13 4.64 Favored 'Trans proline' 0 CA--C 1.551 1.325 0 C-N-CA 123.877 3.051 . . . . 1.0 114.719 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -110.54 73.15 0.78 Allowed Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 126.539 1.936 . . . . 1.0 109.819 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -59.05 -26.87 83.31 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.753 2.302 . . . . 1.0 115.93 -169.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.7 pm0 -62.66 -25.92 68.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 119.45 1.023 . . . . 1.0 111.213 176.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.6 p -72.15 -15.88 61.98 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 120.974 -1.079 . . . . 1.0 112.788 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -104.18 -55.31 2.38 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.213 1.805 . . . . 1.0 111.894 177.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.5 p -67.95 -33.01 73.85 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 114.02 1.119 . . . . 1.0 114.02 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.8 m-20 -60.94 -56.63 33.13 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 121.035 1.743 . . . . 1.0 112.99 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -62.93 -23.49 74.17 Favored 'Trans proline' 0 C--N 1.353 0.803 0 CA-C-N 121.279 1.492 . . . . 1.0 112.933 174.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.466 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 88.9 t90 -67.53 -46.13 73.69 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 118.561 0.619 . . . . 1.0 110.739 172.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.648 HG11 ' HA ' ' A' ' 22' ' ' ALA . 96.6 t -66.19 -34.69 71.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -62.87 -49.87 73.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.212 -0.93 . . . . 1.0 109.588 174.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -63.15 -54.42 38.03 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.602 1.161 . . . . 1.0 111.752 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.424 ' CE2' ' HA3' ' A' ' 88' ' ' GLY . 87.7 t90 -59.16 -34.43 72.08 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 125.13 1.372 . . . . 1.0 112.05 175.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.4 -33.02 38.92 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.9 1.238 . . . . 1.0 113.272 173.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.6 p -69.27 -11.95 61.25 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.839 1.422 . . . . 1.0 114.839 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.06 -15.34 47.83 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.539 1.536 . . . . 1.0 111.875 177.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -75.81 168.38 20.13 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 119.243 0.929 . . . . 1.0 111.733 -177.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.6 p . . . . . 0 C--O 1.254 1.315 0 C-N-CA 126.633 1.973 . . . . 1.0 114.545 -175.897 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptm . . . . . 0 N--CA 1.5 2.066 0 N-CA-C 112.012 0.375 . . . . 1.0 112.012 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.87 159.32 42.32 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.012 1.116 . . . . 1.0 114.012 -177.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -122.64 121.48 36.53 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.486 1.515 . . . . 1.0 110.865 178.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.554 HD13 HD12 ' A' ' 26' ' ' LEU . 2.1 mp -119.15 113.67 42.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 126.396 1.878 . . . . 1.0 112.444 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.59 124.0 7.18 Favored Glycine 0 C--O 1.223 -0.594 0 N-CA-C 110.89 -0.884 . . . . 1.0 110.89 169.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.8 mt -105.83 122.93 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-N 118.78 1.29 . . . . 1.0 110.131 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -114.82 111.5 21.33 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 -169.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 p -97.6 116.72 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.428 0.632 . . . . 1.0 111.759 -170.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.9 94.66 1.99 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.969 1.271 . . . . 1.0 109.96 170.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.5 p -75.86 165.04 25.58 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.101 1.76 . . . . 1.0 113.957 -169.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.67 170.87 15.28 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.076 1.35 . . . . 1.0 112.516 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -64.32 154.57 34.89 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.31 1.044 . . . . 1.0 112.99 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.8 -135.87 17.12 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 123.844 0.735 . . . . 1.0 111.978 -171.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -66.65 148.21 52.22 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 117.591 0.696 . . . . 1.0 111.72 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.4 t -74.22 167.75 20.97 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.959 0.904 . . . . 1.0 112.957 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.1 tp -82.7 65.2 7.72 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.76 1.624 . . . . 1.0 112.077 -175.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.6 tp -27.63 -44.15 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 129.55 3.14 . . . . 1.0 114.841 170.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.0 t -46.8 -33.77 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.437 1.495 . . . . 1.0 112.547 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.06 -49.17 76.68 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.622 -1.299 . . . . 1.0 113.247 172.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -67.85 -29.68 68.87 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.732 1.213 . . . . 1.0 111.122 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -69.32 -47.34 64.73 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 123.91 0.884 . . . . 1.0 109.127 173.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.556 ' HA ' HG11 ' A' ' 141' ' ' VAL . . . -65.05 -42.43 94.25 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 112.3 0.481 . . . . 1.0 112.3 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -52.74 -49.98 64.37 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.945 0.898 . . . . 1.0 110.273 169.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.17 -38.04 72.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.255 0.622 . . . . 1.0 112.556 -174.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.5 mt -66.43 -48.64 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-N 119.041 0.837 . . . . 1.0 109.089 175.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.554 HD12 HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -64.84 -35.72 82.02 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.927 0.87 . . . . 1.0 110.427 -176.088 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.2 m -61.98 -41.46 98.06 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.633 1.173 . . . . 1.0 113.504 170.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.92 -30.59 69.08 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.559 1.144 . . . . 1.0 112.665 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -69.95 -30.5 67.88 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.466 0.707 . . . . 1.0 112.091 171.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.01 16.73 1.92 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.987 0.803 . . . . 1.0 114.827 169.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -99.0 174.92 6.11 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.311 1.044 . . . . 1.0 110.123 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -103.73 91.2 3.9 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.918 1.287 . . . . 1.0 108.414 171.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.14 145.99 29.39 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.392 0.277 . . . . 1.0 110.98 176.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.1 m -146.74 137.65 24.02 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.901 0.88 . . . . 1.0 112.023 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.9 t -84.53 136.03 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 114.855 1.428 . . . . 1.0 114.855 170.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -113.13 109.54 18.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.905 2.082 . . . . 1.0 109.915 169.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -90.24 139.4 30.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.327 1.851 . . . . 1.0 110.932 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t0 43.26 53.56 9.6 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 124.387 1.075 . . . . 1.0 111.033 -169.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -68.74 141.7 50.39 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.718 2.945 . . . . 1.0 116.289 -168.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.462 ' HB3' ' H ' ' A' ' 42' ' ' SER . 56.1 mm-40 -93.57 162.01 14.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 122.373 1.082 . . . . 1.0 111.774 168.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.566 HD21 HD21 ' A' ' 79' ' ' LEU . 2.2 tm? -65.21 -20.76 66.59 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.02 -1.05 . . . . 1.0 109.838 167.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.462 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 15.1 m -68.28 -22.12 64.75 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 120.861 -1.15 . . . . 1.0 112.297 172.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -80.59 -27.9 37.25 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.964 0.906 . . . . 1.0 112.062 169.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.459 ' HB3' HD22 ' A' ' 41' ' ' LEU . 16.0 t-105 -85.21 -37.39 20.17 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.915 1.08 . . . . 1.0 113.915 -177.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.9 mt -42.94 -44.61 10.89 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 114.998 1.481 . . . . 1.0 114.998 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.92 -2.22 8.31 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.351 2.034 . . . . 1.0 115.575 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -108.29 8.66 27.84 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 115.793 1.775 . . . . 1.0 115.793 176.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -51.81 -27.73 13.34 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.786 2.034 . . . . 1.0 114.242 174.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.09 12.56 14.55 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.591 1.156 . . . . 1.0 112.494 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -127.51 -163.81 1.3 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.109 2.564 . . . . 1.0 111.346 -174.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -109.96 158.11 18.57 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 122.921 1.343 . . . . 1.0 112.955 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.401 ' CG2' HD11 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -147.44 161.99 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.121 1.368 . . . . 1.0 109.828 -173.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.0 tp -139.75 130.31 25.7 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.406 1.482 . . . . 1.0 108.227 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.3 t -104.71 123.8 58.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 124.403 1.081 . . . . 1.0 108.919 173.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.1 t -122.04 111.28 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.551 -2.018 . . . . 1.0 105.551 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.2 t -148.97 128.63 13.22 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.572 1.323 . . . . 1.0 114.572 -167.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.3 t -106.16 175.18 5.58 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.38 1.072 . . . . 1.0 112.198 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 m 64.57 59.59 0.95 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.109 1.363 . . . . 1.0 112.938 169.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 m -57.58 -32.49 67.2 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.479 1.911 . . . . 1.0 113.928 170.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 51.59 -126.98 29.79 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 124.099 0.856 . . . . 1.0 114.362 173.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -84.65 23.53 1.14 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.786 1.634 . . . . 1.0 112.729 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.66 32.14 16.41 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 124.648 1.118 . . . . 1.0 111.973 -169.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -118.58 171.45 8.17 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.103 2.161 . . . . 1.0 112.25 -175.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.2 mt -122.01 152.28 59.58 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.48 1.112 . . . . 1.0 113.471 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.6 147.09 88.85 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.406 2.737 . . . . 1.0 113.361 169.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -61.18 -24.42 66.3 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.665 0.987 . . . . 1.0 113.665 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 59.8 p -71.46 -21.2 61.98 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.256 1.206 . . . . 1.0 114.256 175.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.5 tt -119.17 -13.53 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.442 1.497 . . . . 1.0 114.134 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.9 t -45.7 -53.61 19.23 Favored Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 124.484 1.114 . . . . 1.0 112.1 168.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -67.78 -31.17 32.68 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.665 1.577 . . . . 1.0 111.79 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.0 tp -63.15 -54.3 39.91 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 124.271 1.028 . . . . 1.0 111.32 169.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.616 ' CE1' HD23 ' A' ' 110' ' ' LEU . 93.6 t80 -55.23 -52.03 64.69 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.723 0.809 . . . . 1.0 112.464 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -65.11 -40.14 94.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.43 -0.805 . . . . 1.0 111.382 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.17 -33.59 78.8 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.488 -0.618 . . . . 1.0 112.837 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.636 HG22 HD12 ' A' ' 110' ' ' LEU . 93.4 mt -65.19 -47.75 86.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 120.115 1.958 . . . . 1.0 108.676 170.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.698 ' HB3' HD21 ' A' ' 110' ' ' LEU . 2.3 ptmm? -72.61 -31.54 65.24 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.347 -1.47 . . . . 1.0 113.232 -171.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -104.87 -39.85 6.15 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.719 1.608 . . . . 1.0 115.302 -174.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.0 m -92.89 -24.27 18.51 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.125 0.97 . . . . 1.0 113.13 -175.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.566 HD21 HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -90.36 -72.03 0.59 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.9 -1.148 . . . . 1.0 107.9 171.505 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.44 -13.11 2.25 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 126.612 2.053 . . . . 1.0 116.331 169.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -156.89 139.85 15.33 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.335 2.254 . . . . 1.0 108.653 173.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.558 HE22 HD12 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -134.77 126.13 17.76 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 118.756 0.707 . . . . 1.0 111.373 -171.244 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -82.18 -41.36 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.532 2.154 . . . . 1.0 113.832 -173.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -145.77 21.2 1.46 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.681 1.192 . . . . 1.0 113.878 -170.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.401 HD11 ' CG2' ' A' ' 52' ' ' VAL . 65.0 tp -81.83 135.14 35.46 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.757 -1.214 . . . . 1.0 112.27 -169.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.5 mtm-85 -134.6 154.16 51.62 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.003 2.121 . . . . 1.0 109.534 169.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.63 ' CD1' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -160.47 169.08 23.75 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.569 -0.707 . . . . 1.0 111.644 -176.397 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.415 ' HA3' ' CZ2' ' A' ' 144' ' ' TRP . . . -128.41 171.35 19.52 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 124.167 0.889 . . . . 1.0 113.672 170.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.422 HG23 ' HB3' ' A' ' 122' ' ' MET . 0.0 OUTLIER -140.7 140.12 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 113.978 1.103 . . . . 1.0 113.978 -169.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.061 HG23 HD12 ' A' ' 123' ' ' LEU . 12.4 mt -132.12 99.13 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 125.824 1.65 . . . . 1.0 107.065 169.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.05 142.08 28.06 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.731 1.613 . . . . 1.0 112.195 173.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.4 mp -138.51 156.98 47.03 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.169 0.804 . . . . 1.0 113.169 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.29 -176.04 42.25 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 115.504 -0.771 . . . . 1.0 113.277 169.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -95.57 118.81 32.97 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.078 -1.248 . . . . 1.0 111.714 172.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 65.8 p -60.56 -11.92 8.47 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.969 1.1 . . . . 1.0 113.969 175.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.8 m -58.86 -18.2 30.68 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.721 1.608 . . . . 1.0 112.829 169.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -112.1 151.0 29.94 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.3 1.84 . . . . 1.0 110.996 169.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.1 m -70.72 172.71 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.003 0.921 . . . . 1.0 112.105 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 65.68 0.13 1.4 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.057 2.143 . . . . 1.0 116.604 -170.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 15.7 t80 27.89 -80.44 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 129.505 3.122 . . . . 1.0 116.915 -172.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.447 ' SG ' ' HE3' ' A' ' 105' ' ' LYS . 24.5 p -121.77 5.8 9.96 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.209 2.204 . . . . 1.0 113.707 -170.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -60.18 -21.63 61.93 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 125.317 1.447 . . . . 1.0 114.173 -169.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.14 -31.03 77.49 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 120.832 1.651 . . . . 1.0 113.74 174.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.84 -37.0 17.39 Favored Glycine 0 N--CA 1.479 1.528 0 O-C-N 121.019 -1.283 . . . . 1.0 113.03 169.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.447 ' HE3' ' SG ' ' A' ' 101' ' ' CYS . 82.5 mttt -61.77 -29.36 70.08 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 121.025 -1.279 . . . . 1.0 112.642 172.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -62.85 -36.67 84.02 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.944 1.298 . . . . 1.0 111.747 170.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -65.8 -36.5 83.68 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.396 0.998 . . . . 1.0 111.781 172.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -63.67 -50.16 70.36 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.49 -0.757 . . . . 1.0 111.408 174.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.15 -33.73 65.47 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.674 0.79 . . . . 1.0 112.755 174.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.698 HD21 ' HB3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -58.96 -49.68 76.95 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 123.349 1.547 . . . . 1.0 111.019 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.63 HD12 ' CD1' ' A' ' 87' ' ' TYR . 10.3 mt -66.65 -38.26 86.51 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 120.841 -1.162 . . . . 1.0 111.788 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -69.22 -20.05 63.96 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.801 1.037 . . . . 1.0 113.801 175.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.02 -16.83 59.17 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.845 0.858 . . . . 1.0 110.942 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -98.59 -74.35 0.59 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.92 1.288 . . . . 1.0 109.344 177.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.2 p 177.15 -17.27 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.713 2.005 . . . . 1.0 113.986 -173.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 111' ' ' LEU . . . -69.36 159.21 33.59 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.716 1.376 . . . . 1.0 114.716 -169.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -97.02 170.24 9.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.223 1.809 . . . . 1.0 112.122 -169.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.67 151.41 49.25 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.463 1.105 . . . . 1.0 112.23 175.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.32 133.4 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.028 1.731 . . . . 1.0 109.621 -169.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 50.47 -158.79 1.74 Allowed Glycine 0 N--CA 1.48 1.582 0 C-N-CA 125.181 1.372 . . . . 1.0 115.268 -176.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -105.01 139.49 39.61 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.423 1.489 . . . . 1.0 109.504 169.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.422 ' HB3' HG23 ' A' ' 89' ' ' VAL . 1.2 pmm? -76.11 155.32 34.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.901 0.857 . . . . 1.0 111.927 -172.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 1.061 HD12 HG23 ' A' ' 90' ' ' ILE . 1.4 tm? -89.54 138.51 31.4 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.504 1.122 . . . . 1.0 110.276 174.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 mt -128.95 108.02 10.08 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.979 1.711 . . . . 1.0 109.749 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.569 ' CD1' HD11 ' A' ' 123' ' ' LEU . 29.8 mt -99.3 134.55 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.437 1.095 . . . . 1.0 112.885 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -105.13 109.47 21.47 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 124.478 1.111 . . . . 1.0 112.629 169.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.67 -23.95 61.76 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.54 1.136 . . . . 1.0 113.431 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.0 t -66.99 -19.46 65.72 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.371 1.069 . . . . 1.0 112.81 174.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -116.1 -30.11 6.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.084 1.753 . . . . 1.0 111.785 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -140.52 87.07 11.9 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.54 1.536 . . . . 1.0 111.638 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.04 7.82 1.93 Allowed 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 123.648 2.899 . . . . 1.0 114.559 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -114.73 69.06 2.1 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 127.715 2.406 . . . . 1.0 110.136 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -56.94 -22.53 46.73 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.605 2.204 . . . . 1.0 116.805 -169.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -64.26 -25.63 68.14 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.292 0.951 . . . . 1.0 111.811 174.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 21.8 p -72.86 -18.63 61.42 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.004 -1.06 . . . . 1.0 111.815 -175.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -101.77 -54.44 2.73 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.039 1.735 . . . . 1.0 111.475 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 64.7 p -69.8 -34.61 73.94 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.775 1.028 . . . . 1.0 113.775 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -60.16 -57.15 28.78 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 120.706 1.594 . . . . 1.0 112.558 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -62.17 -24.39 76.26 Favored 'Trans proline' 0 C--N 1.352 0.743 0 CA-C-N 121.273 1.49 . . . . 1.0 112.902 174.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.464 ' CG ' ' HB2' ' A' ' 123' ' ' LEU . 83.9 t90 -67.29 -45.5 76.39 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 119.062 0.846 . . . . 1.0 110.937 173.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.556 HG11 ' HA ' ' A' ' 22' ' ' ALA . 97.8 t -63.81 -33.61 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.635 -0.876 . . . . 1.0 108.635 176.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -70.0 -27.18 64.49 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 120.603 -1.311 . . . . 1.0 113.04 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -82.99 -56.59 3.71 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.352 1.461 . . . . 1.0 111.725 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.415 ' CZ2' ' HA3' ' A' ' 88' ' ' GLY . 89.8 t90 -56.47 -36.39 69.03 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 125.855 1.662 . . . . 1.0 112.973 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.37 -32.89 30.97 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.825 1.202 . . . . 1.0 114.048 173.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.9 p -68.6 -13.24 62.22 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 114.405 1.261 . . . . 1.0 114.405 177.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.61 -17.49 51.17 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.471 1.509 . . . . 1.0 111.891 176.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -83.83 171.11 13.42 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.033 0.833 . . . . 1.0 111.887 -175.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.5 t . . . . . 0 C--O 1.255 1.351 0 C-N-CA 126.178 1.791 . . . . 1.0 113.033 -174.909 . . . . . . . . 0 0 . 1 stop_ save_